Psyllid ID: psy15481

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------71
Protein Sequence
MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFSHIFPSSHQKNPSSYSVSVENDATLAKQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLVDHISRSYNSIFSLMEDKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTLSKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIKIGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQTKVIDEDVKFHENLMNLSKIKFTNHLNSNVNKLNNCLRIKSQDLKYIRTSIKDLSLIKNEFNQFLENNSHLVDDIKLLSEQSSSDT
Secondary Structure (PSIPRED)
ccccccccccEEEEcccccccccEEEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHccccccccEEEEEEEcccccEEEEEEEccccccHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEEEcccccccccccccccccccccccHHHHccHHHccccccccccccccHHcHHHHHHHHHHcccccccccccccHHHHHHHHHcccccccccccccccccEEccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccEEcccccEEEEEEccccccHHHHHHHHHHHHccccccHHHHccccccccccccccccccccccEEccccHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
cccccccccHEEEcccEEcccccEEEEEEEEcccccEEEEEEEcHHHccccHHHHHHHHHHHHHcccccEEEEEEEEEccccccEEEEEEEccccHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccEccccccccEEEEEccccccEEEEEEcccHHccccccEEEEEcccHHHccHHHHHHHHHHcccccccccHHEHHHHHHHHHHHHccccccccccccccHHHHHHHHHcccccccccccccccccEEEcccccccccccccccHHHHHHHHHHHcccHHHcccHHHHHcccHHHHcccccccccHHHHHEEEEEcccHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHccccccccccEEEEEEcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccEEHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHccHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHccccccHcHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHcccccccc
Coil and Loop (DISEMBL)
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
Flexible Loop (DISEMBL)
MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFnqlshmrphDVQMREFEVLKKVKHENIVKLLaieeeqegrgKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLrdnrlvhrdlkpgniMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHvatgnlpfrpyggrrNKETMYYITtkkasgvisgtqTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFSHIFPSSHQKNPSSYSVSVENDATLAKQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLVDHISRSYNSIFSLMEDKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKtlskewtnatrpiicpgkvkvpARAKTLTERLRDSWQHLLRDRAtrtlsyndeqfhvlerikigetgKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQTKVIDEDVKFHENLMNLSKIKFTNHLNSNVNKLNNCLRIKSQDLKYIRTSIKDLSLIKNEFNQFLEnnshlvddikllseqsssdt
Low Complexity Region (SEG)
MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFSHIFPSSHQKNPSSYSVSVENDATLAKQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLVDHISRSYNSIFSLMEDKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTLSKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIKIGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQTKVIDEDVKFHENLMNLSKIKFTnhlnsnvnklnnclRIKSQDLKYIRTSIKDLSLIKNEFNQFLENNSHLVDDIKLLSEQSSSDT
Disordered region (IsUnstruct)
*****GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFSHIF********************LAKQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLVDHISRSYNSIFSLM*******************NQLNSLSLNVEQLYQRCVLDKTLSKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIKIGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQTKVIDEDVKFHENLMNLSKIKFTNHLNSNVNKLNNCLRIKSQDLKYIRTSIKDLSLIKNEFNQFLENNSHLVDDIK**********
Disordered Region (DISOPRED)
*******TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTF***************FEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIR***************************ILLYKNTHFS*************YSVSVENDATLAKQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQ**********************************************SLSLNVEQLY****************************PARAKTLTERLRDSWQH************NDEQFHVLERIKIGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQTK************************************************************QFLENNSHLVDDI***********
Disordered Region (DISEMBL)
MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFSHIF***************ENDATLAKQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLVDHISRSYNSIFSLMEDKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTLSKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIKIGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQTKVIDEDVKFHENLMNLSKIKFTNHLNSNVNKLNNCLRIKSQDLKYIRTSIKDLSLIKNEFNQFLENNSHLVDDIKLLSEQSSSDT
Disordered Region (DISPRO)
**FLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFSHIFPSSHQKNPSSYSVSVENDATLAKQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLVDHISRSYNSIFSLMEDKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTLSKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIKIGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQTKVIDEDVKFHENLMNLSKIKFTNHLNSNVNKLNNCLRIKSQDLKYIRTSIKDLSLIKNEFNQFLENNSHLVDDIKLL********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFSHIFPSSHQKNPSSYSVSVENDATLAKQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLVDHISRSYNSIFSLxxxxxxxxxxxxxxxxxxxxxQLNSLSLNVEQLYQRCVLDKTLSKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIKIGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQTKVIDEDVKFHENLMNLSKIKFTNHLNSNVNKLNNCLRIKSQDLKYIRTSIKDLSLIKNEFNQFLENNSHLVDDIKLLSEQSSSDT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	708	2.2.26 [Sep-21-2011]
Q9WUN2	729	Serine/threonine-protein	yes	N/A	0.844	0.820	0.382	1e-125
Q9UHD2	729	Serine/threonine-protein	yes	N/A	0.775	0.753	0.406	1e-125
Q14164	716	Inhibitor of nuclear fact	no	N/A	0.512	0.506	0.550	1e-122
Q6DFJ6	725	Serine/threonine-protein	N/A	N/A	0.833	0.813	0.375	1e-122
Q9R0T8	717	Inhibitor of nuclear fact	no	N/A	0.501	0.495	0.553	1e-122
Q4G3H4	758	Inhibitor of nuclear fact	no	N/A	0.460	0.430	0.302	1e-34
Q5ZJB4	759	Inhibitor of nuclear fact	no	N/A	0.467	0.436	0.282	1e-34
Q6GM53	743	Inhibitor of nuclear fact	N/A	N/A	0.495	0.472	0.276	1e-31
Q28DZ1	743	Inhibitor of nuclear fact	no	N/A	0.495	0.472	0.276	2e-31
O15111	745	Inhibitor of nuclear fact	no	N/A	0.475	0.452	0.274	4e-31

>sp|Q9WUN2|TBK1_MOUSE Serine/threonine-protein kinase TBK1 OS=Mus musculus GN=Tbk1 PE=1 SV=1

 Score =  450 bits (1158), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 249/651 (38%), Positives = 371/651 (56%), Gaps = 53/651 (8%)

Query: 4   LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
           ++ ++N++W  + +LG+GAT  VF+G +K  G+  AVK FN +S +RP DVQMREFEVLK
Sbjct: 1   MQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLYAVKVFNNISFLRPVDVQMREFEVLK 60

Query: 64  KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
           K+ H+NIVKL AIEEE   R KV++ME C  GSL+ +L++P N YGL E EFL+VL  + 
Sbjct: 61  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 120

Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
            GM HLR+N +VHRD+KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+SLYGTEEYL
Sbjct: 121 GGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 180

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY-GGRRNKETMYYITTK 242
           HPDMYERAVLRK   K +GATVDLWS+GVT YH ATG+LPFRP+ G RRNKE MY I T 
Sbjct: 181 HPDMYERAVLRKDHQKKYGATVDLWSVGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 240

Query: 243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
           K SG ISG Q +ENG IDW  D+P +C LS GL+ L+TP+LA +LE D +K W F++FF+
Sbjct: 241 KPSGAISGVQKAENGPIDWSGDMPLSCSLSQGLQALLTPVLANILEADQEKCWGFDQFFA 300

Query: 303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKN---- 358
           E +  L+R ++H+F +  +   +IY+H  +      +L+ +QT +  + Q L+Y+     
Sbjct: 301 ETSDVLHRMVIHVFSLQHMTAHKIYIHSYNTAAVFHELVYKQTKIVSSNQELIYEGRRLV 360

Query: 359 ---THFSHIFPSSHQKNPSSYS-----------------------VSVENDATLAKQACS 392
                 +  FP + ++NP   +                         ++ DA++AK    
Sbjct: 361 LELGRLAQHFPKTTEENPIFVTSREQLNTVGLRYEKISLPKIHPRYDLDGDASMAKAV-- 418

Query: 393 TGHVCK--RRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLVDHI 450
           TG VC   R    L     L    V   + ++    +E    +H   +V   +   + +I
Sbjct: 419 TGVVCYACRTASTLLLYQELMRKGVRWLVELVKDDYNET---VHKKTEVVITLDFCIRNI 475

Query: 451 SRSYNSIFSLMEDKSNNA-----NDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTLSK 505
            ++      LM+     A     +D   ++  L ++Q  ++  +++ +  R      L+ 
Sbjct: 476 EKTVKVYEKLMKVNLEAAELGEISDIHTKLLRLSSSQ-GTIESSLQDISSRLSPGGLLAD 534

Query: 506 EWTN--ATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIK 563
            W +   T P     + +   + + L   + + +    +D+A R L+YN+EQ H  ++ K
Sbjct: 535 TWAHQEGTHP-----RDRNVEKLQVLLNCITEIYYQFKKDKAERRLAYNEEQIHKFDKQK 589

Query: 564 IGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTF 614
           +     +      ++         D   +W  M + ++L+   LS   Q F
Sbjct: 590 LYYHATKAMSHFSEECVRKYEAFKDKSEEW--MRKMLHLRKQLLSLTNQCF 638

Serine/threonine kinase that plays an essential role in regulating inflammatory responses to foreign agents. Following activation of toll-like receptors by viral or bacterial components, associates with TRAF3 and TANK and phosphorylates interferon regulatory factors (IRFs) IRF3 and IRF7 as well as DDX3X. This activity allows subsequent homodimerization and nuclear translocation of the IRFs leading to transcriptional activation of pro-inflammatory and antiviral genes including IFN-alpha and IFN-beta. In order to establish such an antiviral state, TBK1 form several different complexes whose composition depends on the type of cell and cellular stimuli. Thus, several scaffolding molecules including FADD, TRADD, MAVS or SINTBAD can be recruited to the TBK1-containing-complexes. Under particular conditions, functions as a NF-kappa-B effector by phosphorylating IKKA/CHUK or RELA to translocate NF-Kappa-B to the nucleus. Restricts bacterial proliferation by phosphorylating the autophagy receptor OPTN/Optineurin on 'Ser-177', thus enhancing LC3 binding affinity and antibacterial autophagy. Attenuates retroviral budding by phosphorylating the endosomal sorting complex required for transport-I (ESCRT-I) subunit VPS37C. Phosphorylates and activates AKT1.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9UHD2|TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens GN=TBK1 PE=1 SV=1

 Score =  449 bits (1156), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 245/602 (40%), Positives = 358/602 (59%), Gaps = 53/602 (8%)

Query: 4   LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
           ++ ++N++W  + +LG+GAT  VF+G +K  G+  A+K FN +S +RP DVQMREFEVLK
Sbjct: 1   MQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 60

Query: 64  KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
           K+ H+NIVKL AIEEE   R KV++ME C  GSL+ +L++P N YGL E EFL+VL  + 
Sbjct: 61  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 120

Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
            GM HLR+N +VHRD+KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+SLYGTEEYL
Sbjct: 121 GGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 180

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY-GGRRNKETMYYITTK 242
           HPDMYERAVLRK   K +GATVDLWSIGVT YH ATG+LPFRP+ G RRNKE MY I T 
Sbjct: 181 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 240

Query: 243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
           K SG ISG Q +ENG IDW  D+P +C LS GL+ L+TP+LA +LE D +K W F++FF+
Sbjct: 241 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 300

Query: 303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKN---- 358
           E +  L+R ++H+F + ++   +IY+H  +      +L+ +QT +  + Q L+Y+     
Sbjct: 301 ETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLV 360

Query: 359 ---THFSHIFPSSHQKNPSSYSVSVE------------------------NDATLAKQAC 391
                 +  FP + ++NP  + VS E                         DA++AK   
Sbjct: 361 LEPGRLAQHFPKTTEENP-IFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAI- 418

Query: 392 STGHVCK--RRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLVDH 449
            TG VC   R    L     L    +   I ++    +E    +H   +V   +   + +
Sbjct: 419 -TGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNET---VHKKTEVVITLDFCIRN 474

Query: 450 ISRSYNSIFSLMEDKSNNA-----NDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTLS 504
           I ++      LM+     A     +D   ++  L ++Q  ++  +++ +  R     +L+
Sbjct: 475 IEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQ-GTIETSLQDIDSRLSPGGSLA 533

Query: 505 KEWTN--ATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERI 562
             W +   T P     K +   + + L   + + +    +D+A R L+YN+EQ H  ++ 
Sbjct: 534 DAWAHQEGTHP-----KDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQ 588

Query: 563 KI 564
           K+
Sbjct: 589 KL 590

Serine/threonine kinase that plays an essential role in regulating inflammatory responses to foreign agents. Following activation of toll-like receptors by viral or bacterial components, associates with TRAF3 and TANK and phosphorylates interferon regulatory factors (IRFs) IRF3 and IRF7 as well as DDX3X. This activity allows subsequent homodimerization and nuclear translocation of the IRFs leading to transcriptional activation of pro-inflammatory and antiviral genes including IFN-alpha and IFN-beta. In order to establish such an antiviral state, TBK1 form several different complexes whose composition depends on the type of cell and cellular stimuli. Thus, several scaffolding molecules including FADD, TRADD, MAVS or SINTBAD can be recruited to the TBK1-containing-complexes. Under particular conditions, functions as a NF-kappa-B effector by phosphorylating NF-kappa-B inhibitor alpha/NFKBIA, IKBKB or RELA to translocate NF-Kappa-B to the nucleus. Restricts bacterial proliferation by phosphorylating the autophagy receptor OPTN/Optineurin on 'Ser-177', thus enhancing LC3 binding affinity and antibacterial autophagy. Attenuates retroviral budding by phosphorylating the endosomal sorting complex required for transport-I (ESCRT-I) subunit VPS37C. Phosphorylates and activates AKT1. Phosphorylates Borna disease virus (BDV) P protein.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q14164|IKKE_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit epsilon OS=Homo sapiens GN=IKBKE PE=1 SV=1

 Score =  439 bits (1130), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 201/365 (55%), Positives = 270/365 (73%), Gaps = 2/365 (0%)

Query: 4   LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
           ++ + NY+W T  +LG+GAT +V++  NK +GE VAVK FN  S++RP +VQ+REFEVL+
Sbjct: 1   MQSTANYLWHTDDLLGQGATASVYKARNKKSGELVAVKVFNTTSYLRPREVQVREFEVLR 60

Query: 64  KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
           K+ H+NIVKL A+EE    R KV+VME C+ GSL ++L+ PEN +GL E+EFL+VL  + 
Sbjct: 61  KLNHQNIVKLFAVEETGGSRQKVLVMEYCSSGSLLSVLESPENAFGLPEDEFLVVLRCVV 120

Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
           AGM HLR+N +VHRD+KPGNIM+ + ++G +IYKLTDFGAAREL++D++F+S+YGTEEYL
Sbjct: 121 AGMNHLRENGIVHRDIKPGNIMRLVGEEGQSIYKLTDFGAARELDDDEKFVSVYGTEEYL 180

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYITTK 242
           HPDMYERAVLRKP  K FG TVDLWSIGVTLYH ATG+LPF P+GG RRNKE MY ITT+
Sbjct: 181 HPDMYERAVLRKPQQKAFGVTVDLWSIGVTLYHAATGSLPFIPFGGPRRNKEIMYRITTE 240

Query: 243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
           K +G I+G Q  ENG ++W   LP  CQLSLGL+  + PILA +LEV+  K W F++FF+
Sbjct: 241 KPAGAIAGAQRRENGPLEWSYTLPITCQLSLGLQSQLVPILANILEVEQAKCWGFDQFFA 300

Query: 303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFS 362
           E +  L R +VH+F +++     IY+H  +     Q+ + +QT V P  Q  L++  H  
Sbjct: 301 ETSDILQRVVVHVFSLSQAVLHHIYIHAHNTIAIFQEAVHKQTSVAPRHQEYLFEG-HLC 359

Query: 363 HIFPS 367
            + PS
Sbjct: 360 VLEPS 364

Phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. May play a special role in the immune response. Protects cells against DNA damage-induced cell death.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 0

>sp|Q6DFJ6|TBK1_XENLA Serine/threonine-protein kinase TBK1 OS=Xenopus laevis GN=tbk1 PE=2 SV=1

 Score =  438 bits (1127), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 246/655 (37%), Positives = 360/655 (54%), Gaps = 65/655 (9%)

Query: 4   LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
           ++ + NY+W  + +LG+GAT  V++G NK  G+  AVK FN LS  RP DVQMREFEVLK
Sbjct: 1   MQSTANYLWMLSDILGQGATANVYRGRNKKTGDLYAVKVFNSLSFQRPADVQMREFEVLK 60

Query: 64  KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
           K+ H+NIVKL AIEEE   R KV+VME C   SL+++L++P N+YGL E EFL+V   + 
Sbjct: 61  KLNHKNIVKLFAIEEEMSSRHKVLVMEFCPCASLYSVLEEPTNSYGLPESEFLIVSRDVV 120

Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
           AGM HLR+N ++HRD+KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+SLYGTEEYL
Sbjct: 121 AGMNHLRENGIIHRDIKPGNIMREIGEDGKSVYKLTDFGAARELEDDEQFVSLYGTEEYL 180

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY-GGRRNKETMYYITTK 242
           HPDMYERAVLRK   K + ATVDLWSIGVT YH ATG+LPFRP+ G RRNKE MY I   
Sbjct: 181 HPDMYERAVLRKEHQKKYSATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIAG 240

Query: 243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
           K SG ISG Q +ENG I+W  +LP  C LS+GL+ L TP+LA +LE D +K W FE+FF+
Sbjct: 241 KPSGAISGVQRAENGPIEWSGELPATCNLSMGLQTLFTPVLANILEADQEKCWGFEQFFA 300

Query: 303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKN---- 358
                 NR +VH+F + ++   +IY++  D      DL+ +QT +    Q LL++     
Sbjct: 301 VTNDIFNRIVVHVFSLQQMTPHKIYINTYDKVPDFHDLVYKQTKIPGQNQELLFEGRRLV 360

Query: 359 ---THFSHIFPSSHQKNPSSYSVSVENDATLAKQACSTGHVCKRRIEKLSKSSCLTHYSV 415
                 +  FP +  +NP            L ++  S   V   R +++     ++HY +
Sbjct: 361 LEQGRLAQHFPITTDENPI---------FVLTREMVS---VIGLRFDEIVIPKPISHYDL 408

Query: 416 GVFITVLNQQLSEISAKIHHLKQVTGAVQSLVDHISRSYNSIFSLMEDKSN--------- 466
            V   +       ++    +  ++  ++  ++D + +    +  LM+++ N         
Sbjct: 409 DVDANMAKA----VTGVACYYCRIAASLLLVLDLMRKGIRWLSELMKEEYNENVHRNTEV 464

Query: 467 -------NANDFKD--------------EIDSLRTNQLN------SLSLNVEQLYQRCVL 499
                  N    KD              E+ ++    LN       L  +++++  +   
Sbjct: 465 SLKLNFCNRTTEKDLKIYEQLMQTSVESEVYAIHAKLLNLSSTQEGLKSSLQEVKNKLTP 524

Query: 500 DKTLSKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVL 559
             TL   W N          V+   + + L   + + +    +D+A R LSYN+EQ H  
Sbjct: 525 GGTLMDSWINTEGIHAADRNVE---KLQVLLSLITEIYCQFKKDKAQRRLSYNEEQIHKF 581

Query: 560 ERIKIGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTF 614
           ++ K+     +   L  D+             +W  M + I+++    S   + F
Sbjct: 582 DKQKLCLHAAKAYSLFKDECVGKYEVFRSKTLEW--MRKMIHVRKQLFSIKSKCF 634

Serine/threonine protein probably involved in innate immune response.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9R0T8|IKKE_MOUSE Inhibitor of nuclear factor kappa-B kinase subunit epsilon OS=Mus musculus GN=Ikbke PE=2 SV=2

 Score =  438 bits (1126), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 197/356 (55%), Positives = 269/356 (75%), Gaps = 1/356 (0%)

Query: 4   LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
           ++ +TNY+W T  +LG+GAT +V++  NK +GE VAVK FN  S+ RP +VQ+REFEVL+
Sbjct: 1   MQSTTNYLWHTDDLLGQGATASVYKARNKKSGEVVAVKVFNSASYRRPPEVQVREFEVLR 60

Query: 64  KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
           ++ H+NIVKL A+EE    R KV++ME C+ GSL ++L+DPENT+GL EEEFL+VL  + 
Sbjct: 61  RLNHQNIVKLFAVEETGGSRQKVLIMEYCSSGSLLSVLEDPENTFGLSEEEFLVVLRCVV 120

Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
           AGM HLR+N +VHRD+KPGNIM+ + ++G +IYKL+DFGAAR+L++D++F+S+YGTEEYL
Sbjct: 121 AGMNHLRENGIVHRDIKPGNIMRLVGEEGQSIYKLSDFGAARKLDDDEKFVSVYGTEEYL 180

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYITTK 242
           HPDMYERAVLRKP  K FG TVDLWSIGVTLYH ATG+LPF P+GG RRNKE MY ITT+
Sbjct: 181 HPDMYERAVLRKPQQKAFGVTVDLWSIGVTLYHAATGSLPFIPFGGPRRNKEIMYRITTE 240

Query: 243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
           K +G ISGTQ  ENG ++W   LP  C+LS+GL+  + PILA +LEV+  K W F++FF+
Sbjct: 241 KPAGAISGTQKQENGPLEWSYSLPITCRLSMGLQNQLVPILANILEVEEDKCWGFDQFFA 300

Query: 303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKN 358
           E +  L R ++H+F + +     +Y+H  +      + + EQT+VTP  Q  L++ 
Sbjct: 301 ETSDILQRTVIHVFSLPQAVLHHVYIHAHNTIAIFLEAVYEQTNVTPKHQEYLFEG 356

Phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. May play a special role in the immune response. Protects cells against DNA damage-induced cell death.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 0

>sp|Q4G3H4|IKKA_DANRE Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Danio rerio GN=chuk PE=1 SV=1

 Score =  148 bits (374), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 109/360 (30%), Positives = 178/360 (49%), Gaps = 34/360 (9%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG G  G V+   N+   E +AVK      + +  D   R  +++KK+KH N+V
Sbjct: 15  WVMKERLGTGGFGHVYLYQNQETSEKIAVKLCRLELNSKNKDRWSRGIQIMKKLKHLNVV 74

Query: 72  KLLAIEEEQEGRG----KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
               + EE          ++ ME C+ G L  +L  PEN  GL+E E L +L  + +G++
Sbjct: 75  TAKDVPEEMMHIALNDLPLLAMEYCSKGDLRKLLSKPENCCGLKESEVLSLLNDVGSGIQ 134

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           +L +N+++HRDLKP NI+     +G  ++K+ D G A++L++     S  GT +YL P++
Sbjct: 135 YLHENKIIHRDLKPENIV-LQEINGKLVHKIIDLGYAKDLDQGSLCTSFVGTLQYLAPEL 193

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV 247
           +E        GK++  TVD WS G  ++    G   FRP+    N + + + +  +  G 
Sbjct: 194 FE--------GKSYTVTVDFWSFGTMIFECCCG---FRPF--LHNLQPVQWTSKVRNKGP 240

Query: 248 ISGTQTSE-NGEIDWCTDL--PNNCQLSL-----GLKKLVT---PILAGL-LEVDSKKIW 295
                  + NGE+ + T L  PNN   +L     GL +L+    P+  GL L  DSK+  
Sbjct: 241 KDIMAVEDMNGEVRFSTHLPYPNNLSRTLLEPLEGLLQLMLKWDPVQRGLGLNTDSKQ-- 298

Query: 296 SFERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILL 355
              + F  + + L+ K+VH+ ++   Q     L PD+    LQ  I+ +T +    Q LL
Sbjct: 299 --PQCFVLLDQILSMKVVHILNMTTTQVHSFLLSPDEGLHSLQQRIENETKIELLNQDLL 356

Phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Phosphorylates 'Ser-10' of histone H3 at NF-kappa-B-regulated promoters during inflammatory responses triggered by cytokines.

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 0

>sp|Q5ZJB4|IKKA_CHICK Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Gallus gallus GN=CHUK PE=2 SV=1

 Score =  148 bits (374), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 100/354 (28%), Positives = 175/354 (49%), Gaps = 23/354 (6%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG G  G V    +++ G  VA+K+      ++  D    E +++KK+ H N+V
Sbjct: 29  WEMRDRLGTGGFGNVCLYQHQDTGARVAIKSCRLELSVKNKDRWCHEIDIMKKLNHPNVV 88

Query: 72  KLLAIEEEQE---GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           +   + EE         ++ ME C+GG L  +L+ PEN  GL+E + L +L  + +G+++
Sbjct: 89  RACEVPEEMNFLVNDVPLLAMEYCSGGDLRKLLNKPENCCGLKESQILSLLSDIGSGIQY 148

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           L +NR++HRDLKP NI+    + G  I+K+ D G A++L++     S  GT +YL P+++
Sbjct: 149 LHENRIIHRDLKPENIV-LQDEGGKIIHKIIDLGYAKDLDQGSLCTSFVGTLQYLAPELF 207

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI 248
           E         K++  TVD WS G  ++    G   FRP+       T +    KK    I
Sbjct: 208 EN--------KSYSVTVDYWSFGTMVFECIAG---FRPFLHNLQPFTWHEKIKKKDPKHI 256

Query: 249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-------FERFF 301
             ++   NGE+ + T LP    +   + + +   L  +L  D ++            + F
Sbjct: 257 FASEEM-NGEVRFSTHLPQPHSICSLIVEPMESWLQLMLNWDPEQRGGGLDPETNSPKCF 315

Query: 302 SEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILL 355
             +   LN K+VH+ ++   + +   LHP+++   LQ+ I+ +T ++   Q LL
Sbjct: 316 LLMDHILNLKIVHILNMTSAKIVSFLLHPEESLHFLQNRIESETGISTGNQELL 369

Phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Also phosphorylates NCOA3. Phosphorylates 'Ser-10' of histone H3 at NF-kappa-B-regulated promoters during inflammatory responses triggered by cytokines.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 0

>sp|Q6GM53|IKKA_XENLA Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Xenopus laevis GN=chuk PE=2 SV=1

 Score =  139 bits (349), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 103/373 (27%), Positives = 176/373 (47%), Gaps = 22/373 (5%)

Query: 6   GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV 65
           G+    W     LG G  G V    N+  GE  A+K+      ++  +   +E +++K++
Sbjct: 9   GAVCGPWDMKDRLGTGGFGNVCLYQNRETGELKAIKSCRLELSVKNKERWCQEIQIMKRL 68

Query: 66  KHENIVKLLAIEEEQE---GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
            H N+VK   +  E +        + ME C GG L  +L+ PEN  GL+E + L ++  +
Sbjct: 69  NHPNVVKACDVPPEMDFLVNDVPHLAMEYCAGGDLRKLLNKPENCCGLKESQVLNLISDI 128

Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
            +G+++L +NR++HRDLKP NI+   C +G T++K+ D G A++L++     S  GT +Y
Sbjct: 129 GSGIQYLHENRIIHRDLKPENIVLQEC-NGKTVHKIIDLGYAKDLDQGSLCTSFVGTLQY 187

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK 242
           L P+++E         K +  TVD WS G   +    G   FRP+       T +    K
Sbjct: 188 LAPELFE--------NKPYSVTVDYWSFGTMAFECIAG---FRPFLHNMQPFTWHEKIKK 236

Query: 243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKI-----WSF 297
           K    I   +   +GEI + T LP    L   +   +   L  LL  D  +         
Sbjct: 237 KDHKHIYAYEEM-SGEIRFSTSLPEPNNLCSIIVDKIETWLQLLLNWDPVQRGGGIDCGR 295

Query: 298 ERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDV-TPNKQILLY 356
            R F  + +  + K+VH+ ++   +    +L P+++   LQ  I+ +T + T N+++LL 
Sbjct: 296 PRCFMLMDQIFSLKIVHILNMTSAKIHSFHLQPEESLHTLQSRIERETGISTCNQELLLE 355

Query: 357 KNTHFSHIFPSSH 369
                    P+S 
Sbjct: 356 MGVSLDPRKPASQ 368

Phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Phosphorylates 'Ser-10' of histone H3 at NF-kappa-B-regulated promoters during inflammatory responses triggered by cytokines.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 0

>sp|Q28DZ1|IKKA_XENTR Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Xenopus tropicalis GN=chuk PE=2 SV=1

 Score =  138 bits (347), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 103/373 (27%), Positives = 177/373 (47%), Gaps = 22/373 (5%)

Query: 6   GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV 65
           G+    W     LG G  G V    N+  GE  A+K+      M+  +   +E +++K++
Sbjct: 9   GAVCGPWDMKDRLGTGGFGNVCLYQNRETGELKAIKSCRLELSMKNKERWCQEIQIMKRL 68

Query: 66  KHENIVKLLAIEEEQE---GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
            H N+VK   +  E +        + ME C GG L  +L+ PEN  GL+E + L ++  +
Sbjct: 69  NHPNVVKACEVPPEMDFLVNDVPHLAMEYCAGGDLRKLLNKPENCCGLKESQVLNLMSDI 128

Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
            +G+++L + R++HRDLKP NI+   C +G T++K+ D G A++L++     S  GT +Y
Sbjct: 129 GSGIQYLHEKRIIHRDLKPENIVLQEC-NGKTVHKIIDLGYAKDLDQGSLCTSFVGTLQY 187

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK 242
           L P+++E         K +  TVD WS G  ++    G   FRP+       T +    K
Sbjct: 188 LAPELFE--------NKPYSVTVDYWSFGTMVFECIAG---FRPFLHNMQPFTWHEKIKK 236

Query: 243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKI-----WSF 297
           K    I   +   +GEI + + LP    L   +   +   L  LL  D  +         
Sbjct: 237 KDHKHIYAYEEM-SGEIRFSSYLPQPNNLCSIIVDKIETWLQLLLNWDPIQRGGGMDCGR 295

Query: 298 ERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDV-TPNKQILLY 356
            + F  + + LN K+VH+ ++   +    +L P+++   LQ  I+ +T + T N+++LL 
Sbjct: 296 PQCFVLMDQILNLKIVHILNMTSAKIHSFHLQPEESLHTLQSRIETETGISTCNQELLLE 355

Query: 357 KNTHFSHIFPSSH 369
                    P+S 
Sbjct: 356 MGVSLDPRKPASQ 368

Phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Phosphorylates 'Ser-10' of histone H3 at NF-kappa-B-regulated promoters during inflammatory responses triggered by cytokines.

Xenopus tropicalis (taxid: 8364)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 0

>sp|O15111|IKKA_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Homo sapiens GN=CHUK PE=1 SV=2

 Score =  137 bits (344), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 100/364 (27%), Positives = 170/364 (46%), Gaps = 27/364 (7%)

Query: 4   LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
           LR      W     LG G  G V    ++     +A+K+       +  +    E +++K
Sbjct: 7   LRPGAGGPWEMRERLGTGGFGNVCLYQHRELDLKIAIKSCRLELSTKNRERWCHEIQIMK 66

Query: 64  KVKHENIVKLLAIEEEQE---GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           K+ H N+VK   + EE         ++ ME C+GG L  +L+ PEN  GL+E + L +L 
Sbjct: 67  KLNHANVVKACDVPEELNILIHDVPLLAMEYCSGGDLRKLLNKPENCCGLKESQILSLLS 126

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDD--GSTIYKLTDFGAARELEEDQQFMSLYG 178
            + +G+++L +N+++HRDLKP NI   +  D  G  I+K+ D G A+++++     S  G
Sbjct: 127 DIGSGIRYLHENKIIHRDLKPENI---VLQDVGGKIIHKIIDLGYAKDVDQGSLCTSFVG 183

Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY 238
           T +YL P+++E         K + ATVD WS G  ++    G   +RP+       T + 
Sbjct: 184 TLQYLAPELFE--------NKPYTATVDYWSFGTMVFECIAG---YRPFLHHLQPFTWHE 232

Query: 239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKK----- 293
              KK    I   +   +GE+ + + LP    L   + + +   L  +L  D ++     
Sbjct: 233 KIKKKDPKCIFACEEM-SGEVRFSSHLPQPNSLCSLVVEPMENWLQLMLNWDPQQRGGPV 291

Query: 294 --IWSFERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNK 351
                  R F  +   LN K+VH+ ++   + I   L PD++   LQ  I+ +T +    
Sbjct: 292 DLTLKQPRCFVLMDHILNLKIVHILNMTSAKIISFLLPPDESLHSLQSRIERETGINTGS 351

Query: 352 QILL 355
           Q LL
Sbjct: 352 QELL 355

Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. Acts as part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues. These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome. In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. Negatively regulates the pathway by phosphorylating the scaffold protein TAXBP1 and thus promoting the assembly of the A20/TNFAIP3 ubiquitin-editing complex (composed of A20/TNFAIP3, TAX1BP1, and the E3 ligases ITCH and RNF11). Therefore, CHUK plays a key role in the negative feedback of NF-kappa-B canonical signaling to limit inflammatory gene activation. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. In turn, these complexes regulate genes encoding molecules involved in B-cell survival and lymphoid organogenesis. Participates also in the negative feedback of the non-canonical NF-kappa-B signaling pathway by phosphorylating and destabilizing MAP3K14/NIK. Within the nucleus, phosphorylates CREBBP and consequently increases both its transcriptional and histone acetyltransferase activities. Modulates chromatin accessibility at NF-kappa-B-responsive promoters by phosphorylating histones H3 at 'Ser-10' that are subsequently acetylated at 'Lys-14' by CREBBP. Additionally, phosphorylates the CREBBP-interacting protein NCOA3.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 0

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	708
193595380	735	PREDICTED: serine/threonine-protein kina	0.971	0.936	0.621	0.0
242015732	753	serine/threonine-protein kinase TBK1, pu	0.980	0.921	0.609	0.0
307198846	744	Serine/threonine-protein kinase TBK1 [Ha	0.901	0.857	0.623	0.0
307181439	746	Serine/threonine-protein kinase TBK1 [Ca	0.901	0.855	0.633	0.0
332019368	744	Serine/threonine-protein kinase TBK1 [Ac	0.901	0.857	0.623	0.0
328785852	745	PREDICTED: serine/threonine-protein kina	0.977	0.928	0.589	0.0
380017999	745	PREDICTED: serine/threonine-protein kina	0.977	0.928	0.588	0.0
383853389	745	PREDICTED: inhibitor of nuclear factor k	0.977	0.928	0.577	0.0
350402875	745	PREDICTED: serine/threonine-protein kina	0.902	0.857	0.618	0.0
340716821	745	PREDICTED: inhibitor of nuclear factor k	0.902	0.857	0.615	0.0

>gi|193595380|ref|XP_001946184.1| PREDICTED: serine/threonine-protein kinase TBK1-like [Acyrthosiphon pisum]

 Score =  924 bits (2387), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 461/742 (62%), Positives = 553/742 (74%), Gaps = 54/742 (7%)

Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
           MSFLRGSTNYVWCTTSVLGKGATGAV+QGVNK+NGEPVAVKTFNQLSHMRP DVQMREFE
Sbjct: 1   MSFLRGSTNYVWCTTSVLGKGATGAVYQGVNKHNGEPVAVKTFNQLSHMRPFDVQMREFE 60

Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           VL+KVKHENIVKLLAIEEE E RGKVIVMELCTGGSLF ILDDPENTYGLQE+EFLLVLE
Sbjct: 61  VLEKVKHENIVKLLAIEEEHESRGKVIVMELCTGGSLFTILDDPENTYGLQEDEFLLVLE 120

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
           HLTAGMKHLRDN LVHRDLKPGNIMKF+ DDG  IYKLTDFGAAREL EDQ+FMSLYGTE
Sbjct: 121 HLTAGMKHLRDNNLVHRDLKPGNIMKFLSDDGLPIYKLTDFGAARELREDQEFMSLYGTE 180

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           EYLHP MYERAVLRKPV KTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM+YIT
Sbjct: 181 EYLHPHMYERAVLRKPVAKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMHYIT 240

Query: 241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF 300
           T+KASGV+SG QTSE G I W  DLP NCQLS G KKL+TPILAGLLE++S++IWSFE+F
Sbjct: 241 TEKASGVLSGVQTSEKGSITWSRDLPKNCQLSDGCKKLITPILAGLLELESQRIWSFEKF 300

Query: 301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTH 360
           F+EVTKTL+RKL+H+FH NR+Q IR+YLHPD+ Y++LQ LIQ+QT+++P  QILLYK+T+
Sbjct: 301 FAEVTKTLDRKLLHIFHTNRVQNIRVYLHPDETYERLQCLIQDQTEISPANQILLYKSTY 360

Query: 361 F----------SHIFPSSHQKNPSSYS----------------------------VSVEN 382
                          P+   K    +S                             SV++
Sbjct: 361 LLTEVGLDLPGRSYKPTEMHKPILLFSKENNNVTLVADGDVPNFPKFPDMSLPKLTSVDS 420

Query: 383 DATLAKQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGA 442
           DA LAK ACS GHVCK+R+EKLS++S L +  V VF  ++ ++L  + +K  HL+ V   
Sbjct: 421 DAGLAKTACSVGHVCKKRVEKLSQNSQLINKCVQVFTKIVTEKLKSVLSKSDHLQSVFKC 480

Query: 443 VQSLVDHISRSYNSIFSLMEDKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKT 502
            + LV+   R + S+ +++  K N + + KDE++ L     NSLSL ++QL+QR V ++T
Sbjct: 481 TKYLVEISVRGHKSVNNMIGIK-NISTELKDELEKLSDELNNSLSLAIQQLHQRYVKERT 539

Query: 503 LSKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERI 562
           L++EW +ATR   CP K + PAR KTL ERLRDSWQHLLRDRATR+L+YNDEQFHVLE I
Sbjct: 540 LTREWQSATRSFKCPNKNRAPARIKTLVERLRDSWQHLLRDRATRSLTYNDEQFHVLEII 599

Query: 563 KIGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQ 622
           KI ET +R + LLD D  P V+QL+DC+ADWYKMAQT+YLQ+  L KD  TF H L  F 
Sbjct: 600 KITETSRRARTLLDTDVQPVVMQLADCMADWYKMAQTVYLQAQILDKDFDTFEHRLLGFI 659

Query: 623 TKVIDEDVKFHENLMNLSKIKFTNHLNSNVNKLNNCLRIKSQDLKYIRTSIKDLSLI--- 679
            +  D D  FH+ L+N++K+KFT+      +   +  RI +QD++ +R S++ L  I   
Sbjct: 660 ERANDTDASFHDGLVNVAKVKFTS------SGAKHAGRISAQDIQALRASLRGLRDIDDL 713

Query: 680 ------KNEFNQFLENNSHLVD 695
                 KNE  + +   S L D
Sbjct: 714 VSDIKGKNEMLKHITEPSKLCD 735

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242015732|ref|XP_002428501.1| serine/threonine-protein kinase TBK1, putative [Pediculus humanus corporis] gi|212513135|gb|EEB15763.1| serine/threonine-protein kinase TBK1, putative [Pediculus humanus corporis]

 Score =  914 bits (2361), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 455/746 (60%), Positives = 554/746 (74%), Gaps = 52/746 (6%)

Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
           MSFLRGS NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ+SHMRPHDVQ+REFE
Sbjct: 1   MSFLRGSANYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQISHMRPHDVQVREFE 60

Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLV+E
Sbjct: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVVE 120

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
           HL+AGMKHLRDN LVHRDLKPGNIMKFI DDG+TIYKLTDFGAARELEEDQQFMSLYGTE
Sbjct: 121 HLSAGMKHLRDNNLVHRDLKPGNIMKFISDDGTTIYKLTDFGAARELEEDQQFMSLYGTE 180

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           EYLHPDMYERAVL+KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT
Sbjct: 181 EYLHPDMYERAVLKKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240

Query: 241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF 300
            KKASGVISG Q++E+G I+W  +LPNNCQLS G+KKLVTP+L GLLEVD ++IW+FERF
Sbjct: 241 AKKASGVISGIQSTESGPIEWSKELPNNCQLSAGIKKLVTPLLGGLLEVDPQRIWNFERF 300

Query: 301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYK--- 357
           F+EVT  L+RKL+H+FH+N LQ IR+YLHP++ YD+LQ+L+ EQTD+TP  QILL K   
Sbjct: 301 FNEVTNILSRKLIHIFHVNNLQMIRVYLHPEETYDELQNLLTEQTDITPQNQILLLKEKP 360

Query: 358 -----------------------------NTHFSHIFPSSHQKNPS-SYSVSVENDATLA 387
                                        N + + I  +   K PS   ++SVE+DA+L 
Sbjct: 361 LLSIVEETTLGKGYPKFDEMEPIMLFSKENNNVNVILENDGPKFPSFQNTISVESDASLG 420

Query: 388 KQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLV 447
           K ACS GHVCKR+IEK+SK+S   H  V  F T ++  L  + AK   LK++T  V+  V
Sbjct: 421 KVACSVGHVCKRKIEKISKASKFCHNCVQSFTTAISNDLDRVVAKSEKLKEMTKYVERTV 480

Query: 448 ------DHISRSYNSIFSLMEDKSNN---ANDFKDEIDSLRTNQLNSLSLNVEQLYQRCV 498
                 D  +++     S+    SN+    N+  +E   L    L+ L   ++QL+QR  
Sbjct: 481 FSTVQADKATKALTDFMSIKYSDSNDNFKGNELSNEFSVLSRELLSELGPAIQQLHQRYG 540

Query: 499 LDKTLSKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHV 558
           ++KTL +EW    + + CP + + PARA+TL ERLRDSWQHLLRDRA+R+L+YNDEQFHV
Sbjct: 541 VEKTLKQEWVKLVKTLNCPMETRAPARARTLVERLRDSWQHLLRDRASRSLTYNDEQFHV 600

Query: 559 LERIKIGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSL 618
           LERIK+GETGKR+K LL+ +  P + QL+D LADWYK+AQT+YLQ+  L KD+  +   L
Sbjct: 601 LERIKVGETGKRLKNLLELECQPEITQLADALADWYKVAQTVYLQARILDKDVDAYEKCL 660

Query: 619 AEFQTKVIDEDVKFHENLMNLSKIKFT-NHLNSNVNKLNNCLRIKSQDLKYIRT---SIK 674
            +F TK       +H+N  +L K++ T   L + +  L    +    + +Y ++   S+ 
Sbjct: 661 EDFATK----HSYYHKN--SLFKLQETIEKLKNEILDLKGKKKPAKNETEYFQSFMNSLS 714

Query: 675 DLSLIKNEFNQFLENNSHLVDDIKLL 700
           D+  I+NE + +L++NS LV + + L
Sbjct: 715 DMIAIQNEISLYLKDNSSLVYEFQQL 740

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307198846|gb|EFN79622.1| Serine/threonine-protein kinase TBK1 [Harpegnathos saltator]

 Score =  863 bits (2229), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/675 (62%), Positives = 511/675 (75%), Gaps = 37/675 (5%)

Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
           MSFLRGS NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE
Sbjct: 1   MSFLRGSANYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60

Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           VLKKVKHENIVKLLAIEEEQ+GRGKVIVMELCTGGSLFNILDDPENTYGL E EFLLVLE
Sbjct: 61  VLKKVKHENIVKLLAIEEEQDGRGKVIVMELCTGGSLFNILDDPENTYGLVESEFLLVLE 120

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
           HL+AGMKHLRDN LVHRDLKPGNIMKFI DDGSTIYKLTDFGAAREL+EDQQF+SLYGTE
Sbjct: 121 HLSAGMKHLRDNNLVHRDLKPGNIMKFIADDGSTIYKLTDFGAARELQEDQQFVSLYGTE 180

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           EYLHPDMYERAVLRKPV KTFGATVDLWSIGVTLYHVATGNLPFRP+GGRRNKETM+YIT
Sbjct: 181 EYLHPDMYERAVLRKPVSKTFGATVDLWSIGVTLYHVATGNLPFRPFGGRRNKETMFYIT 240

Query: 241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF 300
           TKK SG+ISG QTSENG I+W  +LP NCQLS+GLKK+VTP+LAGLLEVD ++IWSFERF
Sbjct: 241 TKKMSGMISGLQTSENGPIEWSRELPQNCQLSIGLKKIVTPLLAGLLEVDPQRIWSFERF 300

Query: 301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTH 360
           FSEVT TL RK +H+F++++   I+++LHP++    LQ  IQ+QT++ P+ QILL     
Sbjct: 301 FSEVTDTLCRKPIHIFNVHKASLIKVFLHPEEKLVALQIHIQDQTEIVPHAQILLLGEVP 360

Query: 361 FSHI---------FPSSHQKNP------------------------SSYSVSVENDATLA 387
            +++         +P+++   P                         +  VSVENDA+ A
Sbjct: 361 LTNLVEESTPGKGYPNTNNDKPLMLFSRENNNVLLPAESELPKFPVFANLVSVENDASQA 420

Query: 388 KQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLV 447
           K ACS GHVCKRRI+KL+  S L+  ++  F  +L+ +L+ +  K  H ++ T AV+  +
Sbjct: 421 KVACSVGHVCKRRIDKLALCSKLSRDAIEAFSGLLSIELTRVLGKYQHSREFTKAVEDTM 480

Query: 448 DHISRSYN---SIFSLMEDKSN-NANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTL 503
             I RS N    +F     +S      ++ E+D+      + L+  + QL+QR V + +L
Sbjct: 481 LAIERSENFAKQVFCKFGSQSTVEMKSWRKELDAKSKELTSELTPAIVQLHQRYVKEGSL 540

Query: 504 SKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIK 563
             EW N+TR + CP   K   RA TL +RLRD WQHLLRDRATR+L+YNDEQFHVLERIK
Sbjct: 541 RGEWDNSTRDLWCPWATKASQRAATLVDRLRDGWQHLLRDRATRSLTYNDEQFHVLERIK 600

Query: 564 IGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQT 623
           + ETG+R+K LL+ +  P + Q S+C+ADWYKMAQT+YLQ+  L KD+ ++ H+L  F  
Sbjct: 601 VTETGRRLKALLETECIPAITQRSECVADWYKMAQTVYLQTQILDKDIDSYEHALESFSY 660

Query: 624 KVIDEDVKFHENLMN 638
           ++  E  + +E+L++
Sbjct: 661 RLSQESKERNESLLH 675

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307181439|gb|EFN69034.1| Serine/threonine-protein kinase TBK1 [Camponotus floridanus]

 Score =  861 bits (2225), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 429/677 (63%), Positives = 512/677 (75%), Gaps = 39/677 (5%)

Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
           MSFLRGS NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ+REFE
Sbjct: 1   MSFLRGSANYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQVREFE 60

Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           VLKKVKHENIVKLLAIEEEQ+GRGKVIVMELCTGGSLFNILDDPENTYGL E EFLLVLE
Sbjct: 61  VLKKVKHENIVKLLAIEEEQDGRGKVIVMELCTGGSLFNILDDPENTYGLAESEFLLVLE 120

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
           HL+AGMKHLRDN LVHRDLKPGNIMKFI DDGSTIYKLTDFGAAREL+EDQQF+SLYGTE
Sbjct: 121 HLSAGMKHLRDNNLVHRDLKPGNIMKFIADDGSTIYKLTDFGAARELQEDQQFVSLYGTE 180

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP+GGRRNKETM+YIT
Sbjct: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPFGGRRNKETMFYIT 240

Query: 241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF 300
           TKKASGVISG QTSENG I+W  +LP  CQLS GLK++VTP+LAGLLEVD ++IWSF+RF
Sbjct: 241 TKKASGVISGLQTSENGPIEWSRELPQTCQLSAGLKRIVTPLLAGLLEVDQQRIWSFDRF 300

Query: 301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILL----- 355
           FSEVT TL RK VH+F+++R   I+++LHP++    LQ  IQ+QT++ P+ QILL     
Sbjct: 301 FSEVTDTLCRKPVHIFNVHRASLIKVFLHPEEKLVALQIHIQDQTEIIPHAQILLLGEVP 360

Query: 356 -------------YKNTH-------FSH-----IFPSSHQ--KNPSSYS-VSVENDATLA 387
                        Y NT        FS      + P+  +  K P   + VSVENDA+ A
Sbjct: 361 LTNFIEESTPGKGYPNTSNDKPLMLFSRENNNVVLPTETELPKFPVFANLVSVENDASQA 420

Query: 388 KQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLV 447
           K ACS GHVCKRRI+KL+  S L+  ++  F  +L+ +L+ +  K HH K+ T A++  +
Sbjct: 421 KVACSVGHVCKRRIDKLALCSKLSRDAIEAFGGLLSTELTRVLGKCHHSKEFTKAMEDTI 480

Query: 448 DHISRS---YNSIFSLMEDKSNNANDFKD---EIDSLRTNQLNSLSLNVEQLYQRCVLDK 501
             I R+      +F      S  A + K+   E+D+      + L+  + QL+QR V + 
Sbjct: 481 LAIERNETFARHVFRKFGSGSQTAIELKNWRKELDAKNKELTSELTPAIVQLHQRYVKEG 540

Query: 502 TLSKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLER 561
            L  EW N+TR + CP   K   RA TL +RLRD WQHLLRDRATR+L+YNDEQFHVLER
Sbjct: 541 NLRGEWDNSTRGLCCPWATKASQRAATLVDRLRDGWQHLLRDRATRSLTYNDEQFHVLER 600

Query: 562 IKIGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEF 621
           IK+ ETG+R+K LL+ +  P + Q S+C+ADWYKMAQT++LQ+  L KD+  + H+L  F
Sbjct: 601 IKVTETGRRLKALLETECVPAMTQRSECVADWYKMAQTVFLQTQILDKDIDGYEHALESF 660

Query: 622 QTKVIDEDVKFHENLMN 638
             ++  E  + +ENL++
Sbjct: 661 SYRLSQESKERNENLLH 677

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332019368|gb|EGI59869.1| Serine/threonine-protein kinase TBK1 [Acromyrmex echinatior]

 Score =  855 bits (2209), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/675 (62%), Positives = 507/675 (75%), Gaps = 37/675 (5%)

Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
           MSFLRGS NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ+REFE
Sbjct: 1   MSFLRGSANYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQVREFE 60

Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           VLKKVKHENIVKLLAIEEEQ+GRGKVIVMELCTGGSLFNILDDPENTYGL E EFLLVLE
Sbjct: 61  VLKKVKHENIVKLLAIEEEQDGRGKVIVMELCTGGSLFNILDDPENTYGLAESEFLLVLE 120

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
           HL+AGMKHLRDN LVHRDLKPGNIMKFI DDGSTIYKLTDFGAAREL+EDQQF+SLYGTE
Sbjct: 121 HLSAGMKHLRDNNLVHRDLKPGNIMKFIADDGSTIYKLTDFGAARELQEDQQFVSLYGTE 180

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP+GGRRNKETM+YIT
Sbjct: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPFGGRRNKETMFYIT 240

Query: 241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF 300
           TKKASGVISG QTSENG I+W  +LP  CQLS GLKK+VTP+LAGLLEVD ++IWSFERF
Sbjct: 241 TKKASGVISGLQTSENGPIEWSRELPQACQLSTGLKKIVTPLLAGLLEVDPQRIWSFERF 300

Query: 301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTH 360
           FSEVT TL RK +H+F+I++   I+++LHP++    LQ  IQ+QT++ P+ QILL     
Sbjct: 301 FSEVTDTLCRKPIHIFNIHKASLIKVFLHPEEKLVALQIHIQDQTEIMPHAQILLLGEIP 360

Query: 361 FSHI---------FPSSHQKNP------------------------SSYSVSVENDATLA 387
            +++         +P++    P                         +  VSVENDA+ A
Sbjct: 361 LTNLIEESTPGKGYPNTSNDKPLMLFSRENNNVVLPTETELPKFPVFANLVSVENDASQA 420

Query: 388 KQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLV 447
           K ACS GHVCKRRI+KL+  S L+  ++  F  +L+ +L+ +  K  H K+ T AV+  V
Sbjct: 421 KIACSVGHVCKRRIDKLALCSKLSRDAIDAFSGLLSTELTRVLEKCQHSKEFTKAVEDTV 480

Query: 448 DHISRS---YNSIFSLMEDKSN-NANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTL 503
             + RS      +F     ++     +++ E+D      ++ L+  + QL+QR V +  L
Sbjct: 481 LAVERSETFARHVFRKFGGQTAVEVKNWRKELDVKSKELMSELTPAIVQLHQRYVKEGNL 540

Query: 504 SKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIK 563
             EW N+TR + CP   K   RA TL +RLRD WQHLLRDRATR+L+YNDEQFHVLERIK
Sbjct: 541 HGEWDNSTRGLWCPWITKASQRAATLVDRLRDGWQHLLRDRATRSLTYNDEQFHVLERIK 600

Query: 564 IGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQT 623
           + ETG+R+K LL+ +  P + Q S+C+ADWYKMAQT++LQ+  L KD+ ++   L  F  
Sbjct: 601 VTETGRRLKALLETECIPAMTQRSECVADWYKMAQTVFLQTQILDKDIDSYERVLESFSY 660

Query: 624 KVIDEDVKFHENLMN 638
           ++  E  + +ENL++
Sbjct: 661 RLSQESKERNENLLH 675

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328785852|ref|XP_396937.4| PREDICTED: serine/threonine-protein kinase TBK1 [Apis mellifera]

 Score =  853 bits (2204), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/738 (58%), Positives = 529/738 (71%), Gaps = 46/738 (6%)

Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
           MSFLRGSTN+VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE
Sbjct: 1   MSFLRGSTNFVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60

Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           VLKKV HENIV+LLAIEEEQ+GRG VIVMELCTGGSLFNILDDPENTYGL E EFLLVLE
Sbjct: 61  VLKKVNHENIVQLLAIEEEQDGRGTVIVMELCTGGSLFNILDDPENTYGLAESEFLLVLE 120

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
           HLTAGMKHLRDN LVHRDLKPGNIMKFI DDGSTIYKLTDFGAAREL+EDQQF+SLYGTE
Sbjct: 121 HLTAGMKHLRDNNLVHRDLKPGNIMKFIADDGSTIYKLTDFGAARELQEDQQFVSLYGTE 180

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           EYLHPD+YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP+GGRRNKETM+YI 
Sbjct: 181 EYLHPDIYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPFGGRRNKETMFYII 240

Query: 241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF 300
           TKKASGVISG QTSENG I+W  +LP NCQLS GLKK+VTP+LAGLLEVD +KIWSFERF
Sbjct: 241 TKKASGVISGVQTSENGPIEWSRELPQNCQLSTGLKKIVTPLLAGLLEVDPQKIWSFERF 300

Query: 301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTH 360
           FSEVT TL RK +H+F+I++   I+I+LHP++    LQ  IQ+QTD+ P+ QILL+ +T 
Sbjct: 301 FSEVTDTLCRKRIHIFNIHKGSLIKIFLHPEEKLTALQVHIQDQTDIAPHAQILLFGDTF 360

Query: 361 FSHI---------FPSSHQKNP------------------------SSYSVSVENDATLA 387
            ++I         +P++ +  P                         +  VSVENDA+ A
Sbjct: 361 LTNIIEESTSGKGYPNTSENKPLMLFSRENNNVDLPVDTELPKFPVFANLVSVENDASQA 420

Query: 388 KQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLV 447
           K ACS G+VCKRRI+KL   S L+  ++  F  +++ +L+ +  K  H K+ T AV+   
Sbjct: 421 KVACSVGYVCKRRIDKLVLCSKLSQDAIEAFSGLVSTELTRLLEKCQHSKEFTKAVEDTT 480

Query: 448 DHISRSYNSIFS----LMEDKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTL 503
             I RS N  +     L    +    ++K E+D      L  L+  V QL+QR V + +L
Sbjct: 481 IAIERSENLAWQVSRKLGRQNTLEIKNWKKELDMKSKELLTELAPAVVQLHQRYVKEGSL 540

Query: 504 SKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIK 563
             EW N  R + CP   K   +A TL +RLRD WQHLLRDRATR L+YNDEQFHVLERIK
Sbjct: 541 RGEWDNIIRGLWCPWFNKASQKAATLVDRLRDGWQHLLRDRATRGLTYNDEQFHVLERIK 600

Query: 564 IGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQT 623
           +  TG+RIK LL+    P ++  S+C+ADWYKMAQT++LQ+  L KD+  + H L  F  
Sbjct: 601 VTSTGQRIKNLLETFCIPSMISRSECVADWYKMAQTVFLQTQILDKDVDNYEHILEAFSY 660

Query: 624 KVIDEDVKFHENLMNLSKIKFTNHLNSNVNKLNNCLRIKSQDLKYIRTSIKDLSLIKNEF 683
           ++  E  + +EN ++L   +F   L + + K N+  +  ++         K++ +++ + 
Sbjct: 661 RLSHESKERYENFVHLID-RFPEKLKT-IEKTNSPAQESTKKW-------KNICVMQEQI 711

Query: 684 NQFLENNSHLVDDIKLLS 701
              L  N  L+D +  LS
Sbjct: 712 AMILYKNGLLIDQLDRLS 729

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380017999|ref|XP_003692928.1| PREDICTED: serine/threonine-protein kinase TBK1-like [Apis florea]

 Score =  850 bits (2196), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 434/738 (58%), Positives = 529/738 (71%), Gaps = 46/738 (6%)

Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
           MSFLRGSTN+VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE
Sbjct: 1   MSFLRGSTNFVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60

Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           VLKKV HENIV+LLAIEEEQ+GRG VIVMELCTGGSLFNILDDPENTYGL E EFLLVLE
Sbjct: 61  VLKKVNHENIVQLLAIEEEQDGRGTVIVMELCTGGSLFNILDDPENTYGLAESEFLLVLE 120

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
           HLTAGMKHLRDN LVHRDLKPGNIMKFI DDGSTIYKLTDFGAAREL+EDQQF+SLYGTE
Sbjct: 121 HLTAGMKHLRDNNLVHRDLKPGNIMKFIADDGSTIYKLTDFGAARELQEDQQFVSLYGTE 180

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           EYLHPD+YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP+GGRRNKETM+YI 
Sbjct: 181 EYLHPDIYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPFGGRRNKETMFYII 240

Query: 241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF 300
           TKKASGVISG QTSENG I+W  +LP NCQLS GLKK+VTP+LAGLLEVD +KIWSFERF
Sbjct: 241 TKKASGVISGVQTSENGPIEWNRELPQNCQLSTGLKKIVTPLLAGLLEVDPQKIWSFERF 300

Query: 301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTH 360
           FSEVT TL RK +H+F+I++   I+++LHP++    LQ  IQ+QTD+ P+ QILL+ +T 
Sbjct: 301 FSEVTDTLCRKRIHIFNIHKGSLIKVFLHPEEKLTALQVHIQDQTDIAPHAQILLFGDTF 360

Query: 361 FSHI---------FPSSHQKNP------------------------SSYSVSVENDATLA 387
            ++I         +P++ +  P                         +  VSVENDA+ A
Sbjct: 361 LTNIIEESTPGKGYPNTSENKPLMLFSKENNNVDLPVDTELPKFPVFANLVSVENDASQA 420

Query: 388 KQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLV 447
           K ACS G+VCKRRI+KL   S L+  ++  F  +++ +L+ +  K  H K+ T AV+   
Sbjct: 421 KVACSVGYVCKRRIDKLVLCSKLSQDAIEAFSGLVSTELTRLLEKCQHSKEFTKAVEDTT 480

Query: 448 DHISRSYNSIFS----LMEDKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTL 503
             I RS N  +     L    +    ++K E+D      L  L+  V QL+QR V + +L
Sbjct: 481 IAIERSENLAWQVSRKLGRQNTLEIKNWKKELDIKSKELLTELAPAVVQLHQRYVKEGSL 540

Query: 504 SKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIK 563
             EW N  R + CP   K   +A TL +RLRD WQHLLRDRATR L+YNDEQFHVLERIK
Sbjct: 541 RGEWDNIIRGLWCPWFNKASQKAATLVDRLRDGWQHLLRDRATRGLTYNDEQFHVLERIK 600

Query: 564 IGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQT 623
           +  TG+RIK LL+    P ++  S+C+ADWYKMAQT++LQ+  L KD+  + H L  F  
Sbjct: 601 VTSTGQRIKNLLETFCIPSMISRSECVADWYKMAQTVFLQTQILDKDVDNYEHILETFSY 660

Query: 624 KVIDEDVKFHENLMNLSKIKFTNHLNSNVNKLNNCLRIKSQDLKYIRTSIKDLSLIKNEF 683
           ++  E  + +EN ++L   +F   L + + K N+  +  ++         K++ +++ + 
Sbjct: 661 RLSHESKERYENFVHLID-RFPEKLKT-IEKTNSPAQESTKKW-------KNICVMQEQI 711

Query: 684 NQFLENNSHLVDDIKLLS 701
              L  N  L+D +  LS
Sbjct: 712 AMILYKNGLLIDQLDRLS 729

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383853389|ref|XP_003702205.1| PREDICTED: inhibitor of nuclear factor kappa-B kinase subunit epsilon-like [Megachile rotundata]

 Score =  842 bits (2174), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 426/738 (57%), Positives = 528/738 (71%), Gaps = 46/738 (6%)

Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
           MSFLRGS N+VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP DVQMREFE
Sbjct: 1   MSFLRGSANFVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPPDVQMREFE 60

Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           VLKKV HENIV+LLAIEEEQ+GRG VIVMELCTGGSLFNILDDPENTYGL E EFLLVLE
Sbjct: 61  VLKKVNHENIVQLLAIEEEQDGRGMVIVMELCTGGSLFNILDDPENTYGLAESEFLLVLE 120

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
           HLTAGMKHLRDN LVHRDLKPGNIMKFI DDGSTIYKLTDFGAAREL+EDQQF+SLYGTE
Sbjct: 121 HLTAGMKHLRDNNLVHRDLKPGNIMKFIADDGSTIYKLTDFGAARELQEDQQFVSLYGTE 180

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           EYLHPD+YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM+YIT
Sbjct: 181 EYLHPDIYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMFYIT 240

Query: 241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF 300
           TKK+SGVISG QTSENG I+W  +LP NCQLS+GLKK+VTP+LAGLLEVD +KIWSF+RF
Sbjct: 241 TKKSSGVISGIQTSENGPIEWSRELPQNCQLSVGLKKIVTPLLAGLLEVDPQKIWSFDRF 300

Query: 301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTH 360
           F+EVT TL+RK +H+F+I++   I+++LHP++    LQ  +Q+QTD+ P+ QILL+ +  
Sbjct: 301 FTEVTDTLSRKRIHIFNIHKGSLIKVFLHPEEKLTALQVHVQDQTDIAPHAQILLFGDVF 360

Query: 361 FSHI---------FPSSHQKNP------------------------SSYSVSVENDATLA 387
            ++I         +P++ +K P                         +  VSVENDA+ A
Sbjct: 361 LTNIIEESTPGKGYPNTCEKKPLMLFSKENNNVNLPMDTELPKFPVFANLVSVENDASQA 420

Query: 388 KQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLV 447
           K ACS G+VCKRRIE+L   S L+  ++  F   + ++L+ +  K    K+ T A++   
Sbjct: 421 KTACSVGYVCKRRIERLVLCSKLSQDAIEAFSGYVLKELTRLLEKCQRSKEFTKAIEDTA 480

Query: 448 DHISRSYNSIFS----LMEDKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTL 503
             + RS N        L    S    ++K E+D      L  L+  + QL+QR V + +L
Sbjct: 481 IVVERSENLARQISRKLGGQNSLEVKNWKKELDLKSKELLTELAPAIMQLHQRYVKEGSL 540

Query: 504 SKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIK 563
             EW N  R + CP   K   +A TL +RLRD WQHLLRDRATR L+YNDEQFHVLERIK
Sbjct: 541 RSEWDNIIRGLWCPWVNKASQKATTLVDRLRDGWQHLLRDRATRNLTYNDEQFHVLERIK 600

Query: 564 IGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQT 623
           + ETG+R+K LL+    P ++  S+C+ADWYKMAQT++LQ+  L KD+  + H L  +  
Sbjct: 601 VTETGQRLKNLLETFCVPSMVSRSECVADWYKMAQTVFLQTQILDKDVDNYEHILETYSY 660

Query: 624 KVIDEDVKFHENLMNLSKIKFTNHLNSNVNKLNNCLRIKSQDLKYIRTSIKDLSLIKNEF 683
           ++  +  + +EN ++L   +    L + V K N+  +  ++         K++ +++   
Sbjct: 661 RLSQDSKERYENFLDLID-RLPGKLKT-VEKTNSPAQENTKKW-------KNMCVMQERI 711

Query: 684 NQFLENNSHLVDDIKLLS 701
           +  L  N  L+D+I  LS
Sbjct: 712 SMILYKNGLLIDEIDRLS 729

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350402875|ref|XP_003486634.1| PREDICTED: serine/threonine-protein kinase TBK1-like [Bombus impatiens]

 Score =  840 bits (2170), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 418/676 (61%), Positives = 503/676 (74%), Gaps = 37/676 (5%)

Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
           MSFLRGSTN+VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE
Sbjct: 1   MSFLRGSTNFVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60

Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           VLKKV HENIV+LLAIEEEQ+GRG VIVMELCTGGSLFNILDDPENTYGL E EFLLVLE
Sbjct: 61  VLKKVNHENIVQLLAIEEEQDGRGTVIVMELCTGGSLFNILDDPENTYGLAESEFLLVLE 120

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
           HLTAGMKHLRDN LVHRDLKPGNIMKFI DDGSTIYKLTDFGAAREL+EDQQF+SLYGTE
Sbjct: 121 HLTAGMKHLRDNNLVHRDLKPGNIMKFIADDGSTIYKLTDFGAARELQEDQQFVSLYGTE 180

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           EYLHPD+YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP+GGRRNKETM+YI 
Sbjct: 181 EYLHPDIYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPFGGRRNKETMFYII 240

Query: 241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF 300
           TKKASGVISG QTSE+G I+W  +LP NCQLS+GLKK+VTP+LAGLLEVD +K+WSFERF
Sbjct: 241 TKKASGVISGVQTSESGPIEWSRELPQNCQLSIGLKKIVTPLLAGLLEVDPQKMWSFERF 300

Query: 301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTH 360
           FSEVT TL RK +H+F++++   I+++LH ++    LQ  IQ+QTD+ P+ QI+L+ +T 
Sbjct: 301 FSEVTDTLCRKRIHIFNMHKGSLIKVFLHLEEKLTALQVHIQDQTDIAPHAQIILFGDTF 360

Query: 361 FSHI---------FPSSHQKNP------------------------SSYSVSVENDATLA 387
            ++I         +P++ +  P                         +  VSVENDA+ A
Sbjct: 361 LTNIVEECTPGKGYPNTSESKPLMLFSKENNNVDLPVDSELPKFPVFANLVSVENDASQA 420

Query: 388 KQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLV 447
           K ACS G+VCKRRI+KL   S L+  ++  F  +++ +L+ +  K  H K  T A++  V
Sbjct: 421 KVACSVGYVCKRRIDKLVLCSKLSQDAIEAFSGLVSTELTRLLEKCQHSKDFTKAIEDTV 480

Query: 448 DHISRSYN---SIF-SLMEDKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTL 503
             I RS N    IF  L    +    ++K E+D      L  L+  V QL+QR + + +L
Sbjct: 481 IAIERSENLAWQIFRKLGSQNTLEMKNWKKELDLKSKELLTELAPAVVQLHQRYMKEGSL 540

Query: 504 SKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIK 563
             EW N  R + CP   K   +A TL +RLRD WQHLLRDRATR L+YNDEQFHVLERIK
Sbjct: 541 RGEWDNIIRGLWCPWANKASQKASTLVDRLRDGWQHLLRDRATRGLTYNDEQFHVLERIK 600

Query: 564 IGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQT 623
           +  TG+RIK LL+    P ++  S+C+ADWYKMAQT++LQ   L KD+  + H L  +  
Sbjct: 601 VTSTGQRIKNLLETFCVPSMISRSECVADWYKMAQTVFLQIQILDKDVDNYEHILETYSY 660

Query: 624 KVIDEDVKFHENLMNL 639
           ++  E  + +EN ++L
Sbjct: 661 RLSHESKERYENFLHL 676

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340716821|ref|XP_003396891.1| PREDICTED: inhibitor of nuclear factor kappa-B kinase subunit epsilon-like [Bombus terrestris]

 Score =  840 bits (2169), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 416/676 (61%), Positives = 502/676 (74%), Gaps = 37/676 (5%)

Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
           MSFLRGSTN+VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE
Sbjct: 1   MSFLRGSTNFVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60

Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           VLKKV HENIV+LLAIEEEQ+GRG VIVMELCTGGSLFNILDDPENTYGL E EFLLVLE
Sbjct: 61  VLKKVNHENIVQLLAIEEEQDGRGTVIVMELCTGGSLFNILDDPENTYGLAESEFLLVLE 120

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
           HLTAGMKHLRDN LVHRDLKPGNIMKFI DDGSTIYKLTDFGAAREL+EDQQF+SLYGTE
Sbjct: 121 HLTAGMKHLRDNNLVHRDLKPGNIMKFIADDGSTIYKLTDFGAARELQEDQQFVSLYGTE 180

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           EYLHPD+YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP+GGRRNKETM+YI 
Sbjct: 181 EYLHPDIYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPFGGRRNKETMFYII 240

Query: 241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF 300
           TKKASGVISG QTSE+G I+W  +LP NCQLS+GLKK+VTP+LAGLLEVD +K+WSFERF
Sbjct: 241 TKKASGVISGVQTSESGPIEWSRELPQNCQLSIGLKKIVTPLLAGLLEVDPQKMWSFERF 300

Query: 301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTH 360
           FSEVT TL RK +H+F++++   I+++LH ++    LQ  IQ+QTD+ P+ QI+L+ +T 
Sbjct: 301 FSEVTDTLCRKRIHIFNMHKGSLIKVFLHLEEKLTALQVHIQDQTDIAPHAQIILFGDTF 360

Query: 361 FSHI---------FPSSHQKNP------------------------SSYSVSVENDATLA 387
            ++I         +P++ +  P                         +  VSVENDA+ A
Sbjct: 361 LTNIVEECTPGKGYPNTSESKPLMLFSKENNNVDLPVDSELPKFPVFANLVSVENDASQA 420

Query: 388 KQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLV 447
           K ACS G+VCKRRI+KL   S L+  ++  F  +++ +L+ +  K  H K  T A++  V
Sbjct: 421 KVACSVGYVCKRRIDKLVLCSKLSQDAIEAFSGLVSTELTRLLEKCQHSKDFTKAIEDTV 480

Query: 448 DHISRSYNSIFS----LMEDKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTL 503
             I RS N  +     L    +    ++K E+D      L  L+  V QL+QR + + +L
Sbjct: 481 VAIERSENLAWQISRKLGSQNTLEMKNWKKELDLKSKELLTELAPAVVQLHQRYMKEGSL 540

Query: 504 SKEWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIK 563
             EW N  R + CP   K   +A TL +RLRD WQHLLRDRATR L+YNDEQFHVLERIK
Sbjct: 541 RGEWDNIIRGLWCPWANKASQKASTLVDRLRDGWQHLLRDRATRGLTYNDEQFHVLERIK 600

Query: 564 IGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQT 623
           +  TG+RIK LL+    P ++  S+C+ADWYKMAQT++LQ   L KD+  + H L  +  
Sbjct: 601 VTSTGQRIKNLLETFCVPSMISRSECVADWYKMAQTVFLQIQILDKDVDNYEHILETYSY 660

Query: 624 KVIDEDVKFHENLMNL 639
           ++  E  + +EN ++L
Sbjct: 661 RLSHESKERYENFLHL 676

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	708
FB|FBgn0086657	720	ik2 "IkappaB kinase-like 2" [D	0.653	0.643	0.602	1.5e-145
RGD|1588588	729	Tbk1 "TANK-binding kinase 1" [	0.522	0.507	0.537	2e-119
UNIPROTKB|E1BKP4	729	TBK1 "Uncharacterized protein"	0.539	0.524	0.529	1.1e-118
UNIPROTKB|E2R4G3	729	TBK1 "Uncharacterized protein"	0.539	0.524	0.529	1.8e-118
MGI|MGI:1929658	729	Tbk1 "TANK-binding kinase 1" [	0.522	0.507	0.537	5.9e-118
ZFIN|ZDB-GENE-060512-359	727	tbk1 "TANK-binding kinase 1" [	0.522	0.508	0.542	5.9e-118
UNIPROTKB|Q9UHD2	729	TBK1 "Serine/threonine-protein	0.522	0.507	0.537	3.3e-117
UNIPROTKB|E2RAF7	718	IKBKE "Uncharacterized protein	0.546	0.538	0.524	9.3e-117
UNIPROTKB|E1C581	731	TBK1 "Uncharacterized protein"	0.522	0.506	0.528	6e-116
MGI|MGI:1929612	717	Ikbke "inhibitor of kappaB kin	0.512	0.506	0.547	5.4e-115

FB|FBgn0086657 ik2 "IkappaB kinase-like 2" [Drosophila melanogaster (taxid:7227)]

 Score = 1422 (505.6 bits), Expect = 1.5e-145, P = 1.5e-145
 Identities = 288/478 (60%), Positives = 345/478 (72%)

Query:     1 MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
             MSFLRGS +YVWCTTSVLGKGATG+VFQGVNK  GE VAVKTFN  SHMRP DVQMREFE
Sbjct:     1 MSFLRGSVSYVWCTTSVLGKGATGSVFQGVNKITGESVAVKTFNPYSHMRPADVQMREFE 60

Query:    61 VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
              LKKV HENIVKLLAIEE+QEGRGKVIVMELCTGGSLFNILDDPEN+YGL E EFLLVLE
Sbjct:    61 ALKKVNHENIVKLLAIEEDQEGRGKVIVMELCTGGSLFNILDDPENSYGLPEHEFLLVLE 120

Query:   121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
             HL AGMKHLRDN+LVHRDLKPGNIMKFI +DG TIYKLTDFGAARELE++Q F SLYGTE
Sbjct:   121 HLCAGMKHLRDNKLVHRDLKPGNIMKFISEDGQTIYKLTDFGAARELEDNQPFASLYGTE 180

Query:   181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
             EYLHPD+YERAVLRK + ++F A VDLWSIGVTLYHVATGNLPFRP+GGR+N+ETM+ IT
Sbjct:   181 EYLHPDLYERAVLRKSIQRSFTANVDLWSIGVTLYHVATGNLPFRPFGGRKNRETMHQIT 240

Query:   241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF 300
             TKKASGVISGTQ SENG I+W T LP +  LS GLK LVTP+LAGLLE + +K WSF+RF
Sbjct:   241 TKKASGVISGTQLSENGPIEWSTTLPPHAHLSQGLKTLVTPLLAGLLEENREKTWSFDRF 300

Query:   301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTH 360
             F EVT  L ++++H+F  NR   + ++L PD+  D  ++ I  QT+V   KQILL+ N H
Sbjct:   301 FHEVTLILRKRVIHVFFTNRTSSVEVFLEPDEQIDNFRERIFLQTEVPLEKQILLFNNEH 360

Query:   361 F---------SHIFPSSHQKNPSS-YS-----VSVENDATLAKQACSTGHVCKRRIEKLS 405
                       +  FP++  + P   YS     V +     L K      +V       L+
Sbjct:   361 LEKKVTPRTIAKAFPATTTEQPIFLYSNDDNNVQLPQQLDLPKFPVFPPNVSVENDASLA 420

Query:   406 KSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLVDHISRSYNSIFSLMED 463
             KS+C   +     + +       I   + H  ++     +L+   + S++++ S + D
Sbjct:   421 KSACSVGHECKRRVDIFTSMDILIKKGVEHFIEMLVTTITLLLKKTESFDNLLSTVID 478

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0008384 "IkappaB kinase activity" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0008385 "IkappaB kinase complex" evidence=NAS

GO:0004672 "protein kinase activity" evidence=NAS

GO:0006952 "defense response" evidence=NAS

GO:0007165 "signal transduction" evidence=NAS

GO:0005524 "ATP binding" evidence=IEA

GO:0035160 "maintenance of epithelial integrity, open tracheal system" evidence=IMP

GO:0000902 "cell morphogenesis" evidence=IMP

GO:0007015 "actin filament organization" evidence=IMP

GO:0043280 "positive regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0008219 "cell death" evidence=IMP

GO:0051493 "regulation of cytoskeleton organization" evidence=IPI

GO:0016322 "neuron remodeling" evidence=IMP

GO:0045035 "sensory organ precursor cell division" evidence=IGI

GO:0001578 "microtubule bundle formation" evidence=IMP

GO:0008407 "chaeta morphogenesis" evidence=IMP

RGD|1588588 Tbk1 "TANK-binding kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 1102 (393.0 bits), Expect = 2.0e-119, Sum P(2) = 2.0e-119
 Identities = 203/378 (53%), Positives = 274/378 (72%)

Query:     4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
             ++ ++N++W  + +LG+GAT  VF+G +K  G+  AVK FN +S +RP DVQMREFEVLK
Sbjct:     1 MQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLYAVKVFNNISFLRPVDVQMREFEVLK 60

Query:    64 KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
             K+ H+NIVKL AIEEE   R KV++ME C  GSL+ +L++P N YGL E EFL+VL  + 
Sbjct:    61 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 120

Query:   124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
              GM HLR+N +VHRD+KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+SLYGTEEYL
Sbjct:   121 GGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 180

Query:   184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYITTK 242
             HPDMYERAVLRK   K +GATVDLWS+GVT YH ATG+LPFRP+ G RRNKE MY I T 
Sbjct:   181 HPDMYERAVLRKDHQKKYGATVDLWSVGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 240

Query:   243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
             K SG ISG Q +ENG IDW  D+P +C LS GL+ L+TP+LA +LE D +K W F++FF+
Sbjct:   241 KPSGAISGVQKAENGPIDWSGDMPLSCSLSQGLQALLTPVLANILEADQEKCWGFDQFFA 300

Query:   303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHF- 361
             E +  L+R ++H+F +  +  ++IY+H  +      +L+ +QT +  + Q L+Y+     
Sbjct:   301 ETSDVLHRMVIHVFSLQHMTALKIYIHSYNTAAVFHELVYKQTKIISSNQELIYEGRRLV 360

Query:   362 ------SHIFPSSHQKNP 373
                   +  FP + ++NP
Sbjct:   361 LELGRLAQHFPKTTEENP 378

GO:0002218 "activation of innate immune response" evidence=IEA;ISO

GO:0003676 "nucleic acid binding" evidence=IEA;ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA;ISO

GO:0010629 "negative regulation of gene expression" evidence=IEA;ISO

GO:0032727 "positive regulation of interferon-alpha production" evidence=IEA;ISO

GO:0032728 "positive regulation of interferon-beta production" evidence=IEA;ISO

GO:0043123 "positive regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA;ISO

GO:0045359 "positive regulation of interferon-beta biosynthetic process" evidence=IEA;ISO

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA;ISO

GO:0050830 "defense response to Gram-positive bacterium" evidence=IEA;ISO

GO:0051219 "phosphoprotein binding" evidence=IEA;ISO

UNIPROTKB|E1BKP4 TBK1 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 1100 (392.3 bits), Expect = 1.1e-118, Sum P(2) = 1.1e-118
 Identities = 207/391 (52%), Positives = 281/391 (71%)

Query:     4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
             ++ ++N++W  + +LG+GAT  VF+G +K  G+  A+K FN +S +RP DVQMREFEVLK
Sbjct:     1 MQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 60

Query:    64 KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
             K+ H+NIVKL AIEEE   R KV++ME C  GSL+ +L++P N YGL E EFL+VL  + 
Sbjct:    61 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 120

Query:   124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
              GM HLR+N +VHRD+KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+SLYGTEEYL
Sbjct:   121 GGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 180

Query:   184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYITTK 242
             HPDMYERAVLRK   K +GATVDLWSIGVT YH ATG+LPFRP+ G RRNKE MY I T 
Sbjct:   181 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 240

Query:   243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
             K SG ISG Q +ENG IDW  D+P +C LS GL+ L+TP+LA +LE D +K W F++FF+
Sbjct:   241 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 300

Query:   303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHF- 361
             E +  L+R +VH+F + ++   ++Y+H  +      +L+ +QT +  + Q L+Y+     
Sbjct:   301 ETSDILHRMIVHVFSLQQMTAHKVYIHGYNTATVFHELVYKQTKIISSNQELIYEGRRLV 360

Query:   362 ------SHIFPSSHQKNPSSYSVSVENDATL 386
                   +  FP + ++NP  + VS E  +T+
Sbjct:   361 LEPGRLAQHFPKTSEENPI-FVVSREPLSTI 390

GO:0051219 "phosphoprotein binding" evidence=IEA

GO:0050830 "defense response to Gram-positive bacterium" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0045359 "positive regulation of interferon-beta biosynthetic process" evidence=IEA

GO:0043123 "positive regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA

GO:0032728 "positive regulation of interferon-beta production" evidence=IEA

GO:0032727 "positive regulation of interferon-alpha production" evidence=IEA

GO:0010629 "negative regulation of gene expression" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0003676 "nucleic acid binding" evidence=IEA

GO:0002218 "activation of innate immune response" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

UNIPROTKB|E2R4G3 TBK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1101 (392.6 bits), Expect = 1.8e-118, Sum P(2) = 1.8e-118
 Identities = 207/391 (52%), Positives = 281/391 (71%)

Query:     4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
             ++ ++N++W  + +LG+GAT  VF+G +K  G+  A+K FN +S +RP DVQMREFEVLK
Sbjct:     1 MQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 60

Query:    64 KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
             K+ H+NIVKL AIEEE   R KV++ME C  GSL+ +L++P N YGL E EFL+VL  + 
Sbjct:    61 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 120

Query:   124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
              GM HLR+N +VHRD+KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+SLYGTEEYL
Sbjct:   121 GGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 180

Query:   184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYITTK 242
             HPDMYERAVLRK   K +GATVDLWSIGVT YH ATG+LPFRP+ G RRNKE MY I T 
Sbjct:   181 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 240

Query:   243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
             K SG ISG Q +ENG IDW  D+P +C LS GL+ L+TP+LA +LE D +K W F++FF+
Sbjct:   241 KPSGAISGVQKAENGPIDWSRDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 300

Query:   303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHF- 361
             E +  L+R ++H+F + ++   +IY+H  +      +L+ +QT +  + Q L+Y+     
Sbjct:   301 ETSDILHRMIIHVFSLQQMTAHKIYIHGYNTATVFHELVYKQTKIISSNQELIYEGRRLI 360

Query:   362 ------SHIFPSSHQKNPSSYSVSVENDATL 386
                   +  FP + ++NP  + VS E  +T+
Sbjct:   361 IEPGRLAQHFPKTTEENPI-FVVSQEPLSTI 390

GO:0051219 "phosphoprotein binding" evidence=IEA

GO:0050830 "defense response to Gram-positive bacterium" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0045359 "positive regulation of interferon-beta biosynthetic process" evidence=IEA

GO:0043123 "positive regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA

GO:0032728 "positive regulation of interferon-beta production" evidence=IEA

GO:0032727 "positive regulation of interferon-alpha production" evidence=IEA

GO:0010629 "negative regulation of gene expression" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0003676 "nucleic acid binding" evidence=IEA

GO:0002218 "activation of innate immune response" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

MGI|MGI:1929658 Tbk1 "TANK-binding kinase 1" [Mus musculus (taxid:10090)]

 Score = 1098 (391.6 bits), Expect = 5.9e-118, Sum P(2) = 5.9e-118
 Identities = 203/378 (53%), Positives = 273/378 (72%)

Query:     4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
             ++ ++N++W  + +LG+GAT  VF+G +K  G+  AVK FN +S +RP DVQMREFEVLK
Sbjct:     1 MQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLYAVKVFNNISFLRPVDVQMREFEVLK 60

Query:    64 KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
             K+ H+NIVKL AIEEE   R KV++ME C  GSL+ +L++P N YGL E EFL+VL  + 
Sbjct:    61 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 120

Query:   124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
              GM HLR+N +VHRD+KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+SLYGTEEYL
Sbjct:   121 GGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 180

Query:   184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYITTK 242
             HPDMYERAVLRK   K +GATVDLWS+GVT YH ATG+LPFRP+ G RRNKE MY I T 
Sbjct:   181 HPDMYERAVLRKDHQKKYGATVDLWSVGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 240

Query:   243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
             K SG ISG Q +ENG IDW  D+P +C LS GL+ L+TP+LA +LE D +K W F++FF+
Sbjct:   241 KPSGAISGVQKAENGPIDWSGDMPLSCSLSQGLQALLTPVLANILEADQEKCWGFDQFFA 300

Query:   303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHF- 361
             E +  L+R ++H+F +  +   +IY+H  +      +L+ +QT +  + Q L+Y+     
Sbjct:   301 ETSDVLHRMVIHVFSLQHMTAHKIYIHSYNTAAVFHELVYKQTKIVSSNQELIYEGRRLV 360

Query:   362 ------SHIFPSSHQKNP 373
                   +  FP + ++NP
Sbjct:   361 LELGRLAQHFPKTTEENP 378

GO:0000166 "nucleotide binding" evidence=IEA

GO:0002218 "activation of innate immune response" evidence=IMP

GO:0003676 "nucleic acid binding" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0010629 "negative regulation of gene expression" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0032727 "positive regulation of interferon-alpha production" evidence=ISO

GO:0032728 "positive regulation of interferon-beta production" evidence=ISO

GO:0045087 "innate immune response" evidence=IEA

GO:0045359 "positive regulation of interferon-beta biosynthetic process" evidence=IMP

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0050830 "defense response to Gram-positive bacterium" evidence=IMP

GO:0051219 "phosphoprotein binding" evidence=ISO

GO:0051607 "defense response to virus" evidence=IEA

ZFIN|ZDB-GENE-060512-359 tbk1 "TANK-binding kinase 1" [Danio rerio (taxid:7955)]

 Score = 1095 (390.5 bits), Expect = 5.9e-118, Sum P(2) = 5.9e-118
 Identities = 205/378 (54%), Positives = 277/378 (73%)

Query:     4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
             ++ + NY+W  + +LG+GAT  V++G +K  G+  AVK FN LS +RP DVQMREFEVLK
Sbjct:     1 MQSTANYLWMMSDLLGQGATANVYRGRHKKTGDLYAVKVFNNLSFLRPLDVQMREFEVLK 60

Query:    64 KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
             K+ H+NIVKL A+EEE   R KV+VME C  GSL+ +L++P N YGL E+EFL+VL+ + 
Sbjct:    61 KLNHKNIVKLFAVEEESNTRHKVLVMEYCPCGSLYTVLEEPTNAYGLPEDEFLIVLQDVV 120

Query:   124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
             AGM HLR+  +VHRD+KPGNIM+ I DDG ++YKLTDFGAARELE+D+QF+SLYGTEEYL
Sbjct:   121 AGMNHLREYGIVHRDIKPGNIMRVIGDDGFSVYKLTDFGAARELEDDEQFVSLYGTEEYL 180

Query:   184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYITTK 242
             HPDMYERAVLRK   K +GATVDLWSIGVT YH ATG+LPFRP+ G RRNKE MY I T+
Sbjct:   181 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITE 240

Query:   243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
             K  G ISG Q  ENG+I+W +++P +C LS GL+ L+TP+LA +LE D +K W F++FF+
Sbjct:   241 KPPGAISGHQKFENGKIEWSSEMPISCSLSKGLQSLLTPVLANILEADQEKCWGFDQFFA 300

Query:   303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHF- 361
             E +  L+R +V++F + +     +Y+H  +  +  Q+L+  +T++TP+ Q LLY+     
Sbjct:   301 ETSDILHRIVVYVFSLQQATLHHVYIHTYNTANLFQELLFRRTNITPSHQELLYEGRRLV 360

Query:   362 ------SHIFPSSHQKNP 373
                   +  FP + + NP
Sbjct:   361 LDPNRQAQTFPKTSRDNP 378

GO:0005524 "ATP binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0005515 "protein binding" evidence=IPI

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

UNIPROTKB|Q9UHD2 TBK1 "Serine/threonine-protein kinase TBK1" [Homo sapiens (taxid:9606)]

 Score = 1096 (390.9 bits), Expect = 3.3e-117, Sum P(2) = 3.3e-117
 Identities = 203/378 (53%), Positives = 274/378 (72%)

Query:     4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
             ++ ++N++W  + +LG+GAT  VF+G +K  G+  A+K FN +S +RP DVQMREFEVLK
Sbjct:     1 MQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 60

Query:    64 KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
             K+ H+NIVKL AIEEE   R KV++ME C  GSL+ +L++P N YGL E EFL+VL  + 
Sbjct:    61 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 120

Query:   124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
              GM HLR+N +VHRD+KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+SLYGTEEYL
Sbjct:   121 GGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 180

Query:   184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYITTK 242
             HPDMYERAVLRK   K +GATVDLWSIGVT YH ATG+LPFRP+ G RRNKE MY I T 
Sbjct:   181 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 240

Query:   243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
             K SG ISG Q +ENG IDW  D+P +C LS GL+ L+TP+LA +LE D +K W F++FF+
Sbjct:   241 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 300

Query:   303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHF- 361
             E +  L+R ++H+F + ++   +IY+H  +      +L+ +QT +  + Q L+Y+     
Sbjct:   301 ETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLV 360

Query:   362 ------SHIFPSSHQKNP 373
                   +  FP + ++NP
Sbjct:   361 LEPGRLAQHFPKTTEENP 378

GO:0005524 "ATP binding" evidence=IEA

GO:0019048 "virus-host interaction" evidence=IEA

GO:0051607 "defense response to virus" evidence=IEA

GO:0003676 "nucleic acid binding" evidence=IEA

GO:0010629 "negative regulation of gene expression" evidence=IEA

GO:0045359 "positive regulation of interferon-beta biosynthetic process" evidence=IEA

GO:0050830 "defense response to Gram-positive bacterium" evidence=IEA

GO:0043123 "positive regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0051219 "phosphoprotein binding" evidence=IPI

GO:0007249 "I-kappaB kinase/NF-kappaB cascade" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0032606 "type I interferon production" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0009615 "response to virus" evidence=TAS

GO:0006954 "inflammatory response" evidence=TAS

GO:0005737 "cytoplasm" evidence=IDA

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0004672 "protein kinase activity" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0010008 "endosome membrane" evidence=TAS

GO:0032480 "negative regulation of type I interferon production" evidence=TAS

GO:0032481 "positive regulation of type I interferon production" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0032728 "positive regulation of interferon-beta production" evidence=IDA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IDA

GO:0032727 "positive regulation of interferon-alpha production" evidence=IDA

GO:0033138 "positive regulation of peptidyl-serine phosphorylation" evidence=NAS

UNIPROTKB|E2RAF7 IKBKE "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1077 (384.2 bits), Expect = 9.3e-117, Sum P(3) = 9.3e-117
 Identities = 205/391 (52%), Positives = 280/391 (71%)

Query:     4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
             ++ + NY+W T  +LG+GAT +V++  NK +GE VAVK FN  S++RP +VQ+REFEVL+
Sbjct:     1 MQSTINYLWHTDDLLGQGATASVYKARNKKSGELVAVKVFNTASYLRPREVQVREFEVLR 60

Query:    64 KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
             K+ H+NIVKL A+EE    R KV+VME C+ GSL ++L+ PEN +GL E+EFL+VL  + 
Sbjct:    61 KLNHQNIVKLFAVEETGGSRQKVLVMEYCSSGSLLSVLESPENAFGLPEDEFLVVLRCVV 120

Query:   124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
             AGM HLR+N +VHRD+KPGNIM+ + ++G +IYKLTDFGAAREL++D++F+S+YGTEEYL
Sbjct:   121 AGMNHLRENGIVHRDIKPGNIMRLMGEEGQSIYKLTDFGAARELDDDEKFVSVYGTEEYL 180

Query:   184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYITTK 242
             HPDMYERAVLRKP  KTFG TVDLWSIGVTLYH ATG+LPF P+GG RRNKE MY ITT+
Sbjct:   181 HPDMYERAVLRKPQQKTFGVTVDLWSIGVTLYHAATGSLPFVPFGGPRRNKEMMYRITTE 240

Query:   243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
             K +G I+GTQ  ENG ++W   LP  C+LS GL+  + PILA +LEV+  K W F++FF+
Sbjct:   241 KPAGAIAGTQRRENGPLEWSYGLPITCRLSPGLQSQLVPILANILEVEQAKCWGFDQFFA 300

Query:   303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFS 362
             E +  L R +VH+F +++     IY+H  +      + + EQT V P  Q   ++  H  
Sbjct:   301 ETSDILQRVVVHVFSLSQAVLHHIYIHAHNTIAIFLEAVYEQTSVAPQHQEYFFEG-HLC 359

Query:   363 HIFPSSHQKNPSSYSVSVENDATLAKQACST 393
              + PS   ++ +  + S  +  TL  +A  T
Sbjct:   360 VLEPSLSAQHITHTTAS--SPLTLFSKASET 388

GO:0043123 "positive regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA

GO:0016605 "PML body" evidence=IEA

GO:0008630 "intrinsic apoptotic signaling pathway in response to DNA damage" evidence=IEA

GO:0008384 "IkappaB kinase activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004704 "NF-kappaB-inducing kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E1C581 TBK1 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 1066 (380.3 bits), Expect = 6.0e-116, Sum P(2) = 6.0e-116
 Identities = 201/380 (52%), Positives = 272/380 (71%)

Query:     4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
             ++ ++NY+W  + +LG+GAT  VF+G +K  G+  AVK FN +S +RP DVQMREFEVL 
Sbjct:     1 MQSTSNYLWLLSDILGQGATANVFRGRHKKTGDLYAVKVFNSISFLRPVDVQMREFEVLT 60

Query:    64 KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
             K+ H+NIVKL AIEEE   R KV+VME C  GSL+ +L++P N +GL E EFL+VL  + 
Sbjct:    61 KLNHKNIVKLFAIEEETTTRHKVLVMEFCPCGSLYTVLEEPSNAFGLPESEFLIVLRDVV 120

Query:   124 --AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE 181
               AGM HLR+N +VHRD+KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+SLYGTEE
Sbjct:   121 KVAGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query:   182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYIT 240
             YLHPDMYERAVLRK   K +GATVDLWSIGVT YH ATG+LPFRP+ G RRNKE MY I 
Sbjct:   181 YLHPDMYERAVLRKEHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query:   241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF 300
             T K SG ISG Q + NG I+W  ++P +C LS GL+ L+TP+LA +LE D +K W F++F
Sbjct:   241 TGKPSGAISGIQKAANGPIEWSWEMPISCSLSKGLQVLLTPVLANILEADQEKCWGFDQF 300

Query:   301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTH 360
             F+E +  L+R ++H+F + ++   ++Y+H  +      +L+ +QT +    Q L+Y+   
Sbjct:   301 FAETSDILHRIIIHIFSLQQMTLHKVYIHSYNTAAIFHELVYKQTKIPSQNQELIYEGRR 360

Query:   361 F-------SHIFPSSHQKNP 373
                     +  FP + ++NP
Sbjct:   361 LILEPGRLAQHFPRTTEENP 380

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0003676 "nucleic acid binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0032727 "positive regulation of interferon-alpha production" evidence=IEA

GO:0032728 "positive regulation of interferon-beta production" evidence=IEA

GO:0043123 "positive regulation of I-kappaB kinase/NF-kappaB cascade" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0010629 "negative regulation of gene expression" evidence=ISS

GO:0051219 "phosphoprotein binding" evidence=ISS

GO:0005575 "cellular_component" evidence=ND

GO:0002218 "activation of innate immune response" evidence=ISS

GO:0045359 "positive regulation of interferon-beta biosynthetic process" evidence=ISS

GO:0050830 "defense response to Gram-positive bacterium" evidence=ISS

MGI|MGI:1929612 Ikbke "inhibitor of kappaB kinase epsilon" [Mus musculus (taxid:10090)]

 Score = 1090 (388.8 bits), Expect = 5.4e-115, Sum P(2) = 5.4e-115
 Identities = 200/365 (54%), Positives = 273/365 (74%)

Query:     4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK 63
             ++ +TNY+W T  +LG+GAT +V++  NK +GE VAVK FN  S+ RP +VQ+REFEVL+
Sbjct:     1 MQSTTNYLWHTDDLLGQGATASVYKARNKKSGEVVAVKVFNSASYRRPPEVQVREFEVLR 60

Query:    64 KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
             ++ H+NIVKL A+EE    R KV++ME C+ GSL ++L+DPENT+GL EEEFL+VL  + 
Sbjct:    61 RLNHQNIVKLFAVEETGGSRQKVLIMEYCSSGSLLSVLEDPENTFGLSEEEFLVVLRCVV 120

Query:   124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
             AGM HLR+N +VHRD+KPGNIM+ + ++G +IYKL+DFGAAR+L++D++F+S+YGTEEYL
Sbjct:   121 AGMNHLRENGIVHRDIKPGNIMRLVGEEGQSIYKLSDFGAARKLDDDEKFVSVYGTEEYL 180

Query:   184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYITTK 242
             HPDMYERAVLRKP  K FG TVDLWSIGVTLYH ATG+LPF P+GG RRNKE MY ITT+
Sbjct:   181 HPDMYERAVLRKPQQKAFGVTVDLWSIGVTLYHAATGSLPFIPFGGPRRNKEIMYRITTE 240

Query:   243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
             K +G ISGTQ  ENG ++W   LP  C+LS+GL+  + PILA +LEV+  K W F++FF+
Sbjct:   241 KPAGAISGTQKQENGPLEWSYSLPITCRLSMGLQNQLVPILANILEVEEDKCWGFDQFFA 300

Query:   303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFS 362
             E +  L R ++H+F + +     +Y+H  +      + + EQT+VTP  Q  L++  H  
Sbjct:   301 ETSDILQRTVIHVFSLPQAVLHHVYIHAHNTIAIFLEAVYEQTNVTPKHQEYLFEG-HPC 359

Query:   363 HIFPS 367
              + PS
Sbjct:   360 VLEPS 364

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004704 "NF-kappaB-inducing kinase activity" evidence=ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0006974 "response to DNA damage stimulus" evidence=IEA

GO:0007252 "I-kappaB phosphorylation" evidence=IDA

GO:0008384 "IkappaB kinase activity" evidence=IDA

GO:0008630 "intrinsic apoptotic signaling pathway in response to DNA damage" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016605 "PML body" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0023014 "signal transduction by phosphorylation" evidence=ISO

GO:0038061 "NIK/NF-kappaB cascade" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9UHD2	TBK1_HUMAN	2, ., 7, ., 1, 1, ., 1	0.4069	0.7754	0.7530	yes	N/A
Q9WUN2	TBK1_MOUSE	2, ., 7, ., 1, 1, ., 1	0.3824	0.8446	0.8203	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	708
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-44
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-44
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-38
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-30
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-28
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-26
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-25
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-25
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-23
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-22
cd12219	89	cd12219, UBL_TBK1_like, Ubiquitin-Like Domain Of H	1e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-22
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-21
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-20
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-18
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-18
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-18
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-17
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-17
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-16
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-09
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-05
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	9e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.001
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.002
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.002
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.003
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.003
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  161 bits (409), Expect = 6e-45
 Identities = 80/229 (34%), Positives = 123/229 (53%), Gaps = 24/229 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVKHENIVKLLA 75
            LG+G+ G V+   +K  G+ VA+K       ++    + +RE ++LKK+KH NIV+L  
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIK-KKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
           + E+     K+ +VME C GG LF++L        L E+E    L  + + +++L    +
Sbjct: 65  VFED---EDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLKP NI+  + +DG    KL DFG AR+L+  ++  +  GT EY+ P+     VL 
Sbjct: 119 VHRDLKPENIL--LDEDGHV--KLADFGLARQLDPGEKLTTFVGTPEYMAPE-----VLL 169

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
              GK +G  VD+WS+GV LY + TG  PF    G      ++    K 
Sbjct: 170 ---GKGYGKAVDIWSLGVILYELLTGKPPFP---GDDQLLELFKKIGKP 212

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  158 bits (401), Expect = 2e-44
 Identities = 69/199 (34%), Positives = 105/199 (52%), Gaps = 15/199 (7%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+   +K  G+ VA+K   +       +  +RE E+LKK+ H NIVKL  + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
           E++      +VME C GGSL ++L   EN   L E+E L +L  +  G+++L  N ++HR
Sbjct: 61  EDENHL--YLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRKP 196
           DLKP NI+    D  +   KL DFG ++ L  D     ++ GT  Y+ P++         
Sbjct: 117 DLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG------ 167

Query: 197 VGKTFGATVDLWSIGVTLY 215
               +    D+WS+GV LY
Sbjct: 168 -KGYYSEKSDIWSLGVILY 185

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  158 bits (401), Expect = 8e-44
 Identities = 72/234 (30%), Positives = 117/234 (50%), Gaps = 18/234 (7%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS-HMRPHDVQMREFEVLKKVKHENI 70
           +     LG G+ G V++  +K  G+ VAVK   + S   +      RE  +L+++ H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           V+L+   E+++     +VME C GG LF+ L        L E+E   +   +  G+++L 
Sbjct: 61  VRLIDAFEDKDHL--YLVMEYCEGGDLFDYLS--RGG-PLSEDEAKKIALQILRGLEYLH 115

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYE 189
            N ++HRDLKP NI+  + ++G    K+ DFG A++L +    + +  GT  Y+ P+   
Sbjct: 116 SNGIIHRDLKPENIL--LDENGVV--KIADFGLAKKLLKSSSSLTTFVGTPWYMAPE--- 168

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
             VL    G  +G  VD+WS+GV LY + TG  PF         + +  I    
Sbjct: 169 --VLLG--GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPP 218

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  142 bits (361), Expect = 2e-38
 Identities = 69/248 (27%), Positives = 123/248 (49%), Gaps = 24/248 (9%)

Query: 11  VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI 70
           ++     +GKG  G V++  +K  G+ VA+K     S  +   +   E ++LKK KH NI
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII-NEIQILKKCKHPNI 59

Query: 71  VKLL-AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           VK   +  ++     ++ IVME C+GGSL ++L        L E +   V + L  G+++
Sbjct: 60  VKYYGSYLKK----DELWIVMEFCSGGSLKDLLK--STNQTLTESQIAYVCKELLKGLEY 113

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           L  N ++HRD+K  NI+  +  DG    KL DFG + +L + +   ++ GT  ++ P++ 
Sbjct: 114 LHSNGIIHRDIKAANIL--LTSDGEV--KLIDFGLSAQLSDTKARNTMVGTPYWMAPEV- 168

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI 248
              +  KP    +    D+WS+G+T   +A G  P+      +    ++ I T    G+ 
Sbjct: 169 ---INGKP----YDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFKIATNGPPGLR 218

Query: 249 SGTQTSEN 256
           +  + S+ 
Sbjct: 219 NPEKWSDE 226

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  141 bits (358), Expect = 7e-38
 Identities = 69/218 (31%), Positives = 117/218 (53%), Gaps = 23/218 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LG+G+ G+V+  ++K+ GE +AVK+  +LS     +++   RE  +L  ++H NIV+  
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNR 133
             E ++E     I +E  +GGSL ++L      +G L E         +  G+ +L  N 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKLPEPVIRKYTRQILEGLAYLHSNG 121

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ---QFMSLYGTEEYLHPDMYER 190
           +VHRD+K  NI+  +  DG  + KL DFG A+ L + +      S+ GT  ++ P+    
Sbjct: 122 IVHRDIKGANIL--VDSDG--VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE---- 173

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
            V+R   G+ +G   D+WS+G T+  +ATG  P+   G
Sbjct: 174 -VIR---GEEYGRAADIWSLGCTVIEMATGKPPWSELG 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  136 bits (346), Expect = 3e-36
 Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 23/214 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +GKG+ G V+    K++G+   +K  + LS+M   + +  + E ++LKK+ H NI+K  
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEID-LSNMSEKEREDALNEVKILKKLNHPNIIKY- 64

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDD--PENTYGLQEEEFLLVLEHLTAGMKHLRD 131
              E  E +GK+ IVME   GG L   +     E      EE+ L     L   +K+L  
Sbjct: 65  --YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP-FPEEQILDWFVQLCLALKYLHS 121

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYER 190
            +++HRD+KP NI  F+  +G  + KL DFG ++ L        ++ GT  YL P++ + 
Sbjct: 122 RKILHRDIKPQNI--FLTSNG--LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQ- 176

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   K +    D+WS+G  LY + T   PF
Sbjct: 177 -------NKPYNYKSDIWSLGCVLYELCTLKHPF 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  121 bits (307), Expect = 5e-31
 Identities = 66/242 (27%), Positives = 104/242 (42%), Gaps = 40/242 (16%)

Query: 16  SVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVKHENI 70
             LG+GA G V++G            VAVKT  +         + +RE  +++K+ H N+
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE-DASEQQIEEFLREARIMRKLDHPNV 63

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           VKLL +  E+E     IVME   GG L + L        L   + L     +  GM++L 
Sbjct: 64  VKLLGVCTEEEPL--YIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
               +HRDL   N +     +   + K++DFG +R+L +D               D Y +
Sbjct: 120 SKNFIHRDLAARNCL---VGENLVV-KISDFGLSRDLYDD---------------DYYRK 160

Query: 191 AVLRKPV---------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
              + P+            F +  D+WS GV L+ + T  L  +PY G  N+E + Y+  
Sbjct: 161 RGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT--LGEQPYPGMSNEEVLEYLKN 218

Query: 242 KK 243
             
Sbjct: 219 GY 220

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  119 bits (300), Expect = 5e-30
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 45/241 (18%)

Query: 16  SVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVKHENI 70
             LG+GA G V++G            VAVKT  +         + +RE  +++K+ H NI
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           VKLL +  E+E    +IVME   GG L + L        L   + L     +  GM++L 
Sbjct: 64  VKLLGVCTEEEPL--MIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLE 120

Query: 131 DNRLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
               +HRDL   N +     +        K++DFG +R+L +D               D 
Sbjct: 121 SKNFIHRDLAARNCLVGENLVV-------KISDFGLSRDLYDD---------------DY 158

Query: 188 YERAVLRKPV---------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY 238
           Y+    + P+            F +  D+WS GV L+ + T  L   PY G  N E + Y
Sbjct: 159 YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT--LGEEPYPGMSNAEVLEY 216

Query: 239 I 239
           +
Sbjct: 217 L 217

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 7e-30
 Identities = 76/238 (31%), Positives = 108/238 (45%), Gaps = 41/238 (17%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ---MREFEVLKKVKHENIVKLL 74
           LGKG+ G V     K+ G+  A+K   +   +         + E  +L ++ H  IVKL 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKK-KKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEE-------EFLLVLEHLTAGM 126
              + +E   K+ +V+E   GG LF+ L          EE       E +L LE+L    
Sbjct: 60  YAFQTEE---KLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLALEYL---- 109

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHP 185
            H     +++RDLKP NI+  +  DG    KLTDFG A+EL  +    + + GT EYL P
Sbjct: 110 -HSLG--IIYRDLKPENIL--LDADGHI--KLTDFGLAKELSSEGSRTNTFCGTPEYLAP 162

Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
           ++          GK +G  VD WS+GV LY + TG  PF        KE    I    
Sbjct: 163 EVLL--------GKGYGKAVDWWSLGVLLYEMLTGKPPFY---AEDRKEIYEKILKDP 209

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  116 bits (292), Expect = 5e-29
 Identities = 72/214 (33%), Positives = 110/214 (51%), Gaps = 22/214 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +G G  G V+  VN + GE +AVK    Q +  +       E +VL+ +KH N+VK   +
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 77  EEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           E  +E   KV I ME C+GG+L  +L   E+   L E    +    L  G+ +L  + +V
Sbjct: 68  EVHRE---KVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-----QQFMSLYGTEEYLHPDMYER 190
           HRD+KP NI  F+  D + + KL DFG A +L+ +     ++  SL GT  Y+ P++   
Sbjct: 122 HRDIKPANI--FL--DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               K  G   G   D+WS+G  +  +ATG  P+
Sbjct: 178 G---KGKGH--GRAADIWSLGCVVLEMATGKRPW 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 1e-28
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 25/213 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           ++G+GA G V++G+N   G+ VA+K  + L  ++   ++  M+E ++LK +KH NIVK  
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQIS-LEKIKEEALKSIMQEIDLLKNLKHPNIVKY- 64

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            I   +      I++E    GSL  I+   +      E    + +  +  G+ +L +  +
Sbjct: 65  -IGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMSLYGTEEYLHPDMYERAVL 193
           +HRD+K  NI+     DG    KL DFG A +L +  +   S+ GT  ++ P++ E +  
Sbjct: 121 IHRDIKAANIL--TTKDGVV--KLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS-- 174

Query: 194 RKPVGKTFGATV--DLWSIGVTLYHVATGNLPF 224
                   GA+   D+WS+G T+  + TGN P+
Sbjct: 175 --------GASTASDIWSLGCTVIELLTGNPPY 199

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  112 bits (284), Expect = 6e-28
 Identities = 65/237 (27%), Positives = 104/237 (43%), Gaps = 39/237 (16%)

Query: 17  VLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
            LG+GA G V++G      +     VAVKT  + +     +  + E  ++KK+ H NIV+
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL +  + E     IV E   GG L + L        L  ++ L +   +  GM++L   
Sbjct: 66  LLGVCTQGEPLY--IVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIAKGMEYLESK 121

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
             VHRDL   N +     +   + K++DFG +R++ ED               D Y +  
Sbjct: 122 NFVHRDLAARNCL---VTENLVV-KISDFGLSRDIYED---------------DYYRKRG 162

Query: 193 LRK-PV---------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
             K P+            F +  D+WS GV L+ + T  L  +PY G  N+E +  +
Sbjct: 163 GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFT--LGEQPYPGMSNEEVLELL 217

Length = 258

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  111 bits (281), Expect = 3e-27
 Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 29/202 (14%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR------PHDVQMREFEVLKKVKHENIV 71
           +G+GA G VF+  ++  GE VA+K       +R      P+   +RE + L+  +H  +V
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALK----KVALRRLEGGIPNQA-LREIKALQACQHPYVV 62

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           KLL +     G G V+VME      L  +L D E    L E +    +  L  G+ ++  
Sbjct: 63  KLLDVF--PHGSGFVLVMEYM-PSDLSEVLRDEERP--LPEAQVKSYMRMLLKGVAYMHA 117

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL--EEDQQFMSLYGTEEYLHPDMYE 189
           N ++HRDLKP N+   I  DG    K+ DFG AR    EE + +     T  Y  P++  
Sbjct: 118 NGIMHRDLKPANL--LISADGVL--KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173

Query: 190 RAVLRKPVGKTFGATVDLWSIG 211
            A       + +   VDLW++G
Sbjct: 174 GA-------RKYDPGVDLWAVG 188

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (284), Expect = 3e-27
 Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 25/235 (10%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ---MREFEVLKKVKHE-NIV 71
             LG+G+ G V+   ++   + VA+K   +             +RE ++L  + H  NIV
Sbjct: 6   RKLGEGSFGEVYLARDR---KLVALKVLAK-KLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           KL    +++      +VME   GGSL ++L        L E E L +L  + + +++L  
Sbjct: 62  KLYDFFQDEGS--LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ-------FMSLYGTEEYLH 184
             ++HRD+KP NI+    D    + KL DFG A+ L +            +  GT  Y+ 
Sbjct: 120 KGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           P+     VL         ++ D+WS+G+TLY + TG  PF              I
Sbjct: 177 PE-----VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  109 bits (276), Expect = 8e-27
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 31/234 (13%)

Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVK 72
              VLG+G++G V++  +K  G+  A+K  + +        Q+ RE + L+  +   +VK
Sbjct: 5   RVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVVK 63

Query: 73  LL-AIEEEQEGRGKV-IVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGM 126
              A  +E    G++ IV+E   GGSL ++L      PE        + L  L++L    
Sbjct: 64  CYGAFYKE----GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYL---- 115

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQQFMSLYGTEEYLHP 185
            H     ++HRD+KP N++  I   G    K+ DFG ++ LE    Q  +  GT  Y+ P
Sbjct: 116 -H-TKRHIIHRDIKPSNLL--INSKGEV--KIADFGISKVLENTLDQCNTFVGTVTYMSP 169

Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
              ER  ++   G+++    D+WS+G+TL   A G  PF P G     E M  I
Sbjct: 170 ---ER--IQ---GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI 215

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  109 bits (274), Expect = 9e-27
 Identities = 68/218 (31%), Positives = 112/218 (51%), Gaps = 22/218 (10%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTF---NQLSHMRPHDVQM-REFEVLKKVKH 67
           W    +LG G+ G+V++G+N ++G+  AVK     +     +    Q+ +E  +L K++H
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGM 126
            NIV+ L  E E++     I +EL  GGSL  +L      YG   E    L    +  G+
Sbjct: 62  PNIVQYLGTEREEDNL--YIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGL 115

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
           ++L D   VHRD+K  NI+     D + + KL DFG A+++ E     S  G+  ++ P+
Sbjct: 116 EYLHDRNTVHRDIKGANILV----DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                V+ +  G  +G   D+WS+G T+  +ATG  P+
Sbjct: 172 -----VIAQQGG--YGLAADIWSLGCTVLEMATGKPPW 202

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  110 bits (276), Expect = 9e-27
 Identities = 77/232 (33%), Positives = 106/232 (45%), Gaps = 18/232 (7%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL- 74
           S LG+GA G+V +   KN G   A+KT     +       +RE E+ K  K   IVK   
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRDNR 133
           A  +E       I ME C GGSL +I    +   G   E+ L  + E +  G+ +L   +
Sbjct: 67  AFLDESSSSIG-IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+  +   G    KL DFG + EL       +  GT  Y+ P   ER   
Sbjct: 126 IIHRDIKPSNIL--LTRKGQV--KLCDFGVSGELVNSLA-GTFTGTSFYMAP---ERI-- 175

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK--ETMYYITTKK 243
               GK +  T D+WS+G+TL  VA    PF P G       E + YI    
Sbjct: 176 ---QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  108 bits (272), Expect = 2e-26
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 20/217 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH-DVQMREFEVLKKVKHENIVKLLA 75
           V+G GAT  V+  +   N E VA+K  + L   +   D   +E + + +  H N+VK   
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHPNVVK--Y 64

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                 G    +VM   +GGSL +I+       GL E     VL+ +  G+++L  N  +
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-----LYGTEEYLHPDMYER 190
           HRD+K GNI+  + +DGS   K+ DFG +  L +             GT  ++ P+    
Sbjct: 125 HRDIKAGNIL--LGEDGSV--KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE---- 176

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
            V+ +  G  F A  D+WS G+T   +ATG  P+  Y
Sbjct: 177 -VMEQVHGYDFKA--DIWSFGITAIELATGAAPYSKY 210

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  104 bits (262), Expect = 4e-25
 Identities = 76/226 (33%), Positives = 114/226 (50%), Gaps = 32/226 (14%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK-----TFNQLSHMRPHDVQMREFEVLKKVK 66
           W    VLGKGA G V+ G+  N G+ +AVK     T N L+  + ++    E ++LK +K
Sbjct: 2   WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAG 125
           H NIV+ L    +       I ME   GGS+ +IL    N +G L E  F    + +  G
Sbjct: 61  HVNIVQYLGTCLDDNTIS--IFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDG 114

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-------EEDQQFMSLYG 178
           + +L +N +VHRD+K  N+M  +  +G  I KL DFG AR L              S++G
Sbjct: 115 VAYLHNNCVVHRDIKGNNVM--LMPNG--IIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           T  ++ P+     V+ +     +G   D+WSIG T++ +ATG  P 
Sbjct: 171 TPYWMAPE-----VINE---SGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 5e-25
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 21/230 (9%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVKHENI 70
           +     +G+G  G V++  +K  GE VA+K               +RE ++LK++ H NI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           +KLL +   +      +V E      L+ ++ D     GL E      L  L  G+    
Sbjct: 61  IKLLDVFRHK--GDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYE 189
            + ++HRDLKP N++    +    + KL DFG AR      +  + Y  T  Y  P++  
Sbjct: 116 SHGILHRDLKPENLL---INTEGVL-KLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                    K +   VD+WS+G     + +   P  P  G+   + ++ I
Sbjct: 172 GD-------KGYSTPVDIWSVGCIFAELLSRR-PLFP--GKSEIDQLFKI 211

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  104 bits (261), Expect = 8e-25
 Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 24/222 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
            +GKG+ G V +   K++G+ +  K  +   +M   + Q    E  +L+++KH NIV+  
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEID-YGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDD--PENTYGLQEEEFLLVLEHLTAGMK--HLR 130
               ++  +   IVME C GG L  ++     E  Y ++EE    +L  L   +   H R
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLALYECHNR 124

Query: 131 ---DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPD 186
               N ++HRDLKP NI  F+  D +   KL DFG A+ L  D  F   Y GT  Y+ P+
Sbjct: 125 SDPGNTVLHRDLKPANI--FL--DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
                 L      ++    D+WS+G  +Y +   + PF    
Sbjct: 181 -----QLN---HMSYDEKSDIWSLGCLIYELCALSPPFTARN 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  104 bits (262), Expect = 9e-25
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 29/215 (13%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
            LG G+ G V    +K +G+  A+K  +  ++  ++  +  + E  +L+ ++H  +V L 
Sbjct: 8   TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKHLR 130
                Q+     +VME   GG LF+ L      PE        + +L LE+L     H  
Sbjct: 68  G--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL-----HSL 120

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
           D  +V+RDLKP N++  +  DG    K+TDFG A+ ++      +L GT EYL P++   
Sbjct: 121 D--IVYRDLKPENLL--LDSDGYI--KITDFGFAKRVKGRT--YTLCGTPEYLAPEI--- 169

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
            +L K  GK     VD W++G+ +Y +  G  PF 
Sbjct: 170 -ILSKGYGK----AVDWWALGILIYEMLAGYPPFF 199

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  101 bits (253), Expect = 1e-23
 Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 45/235 (19%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVK-HENIVKL 73
           ++G+G+   V     K   +  A+K  +  QL   +       E EVL ++  H  I+KL
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRD 131
               +++E    +  V+E    G L   +      YG L E+        +   +++L  
Sbjct: 68  YYTFQDEE---NLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-------------------- 171
             ++HRDLKP NI+  +  D     K+TDFG A+ L+ +                     
Sbjct: 121 KGIIHRDLKPENIL--LDKDMHI--KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 172 -QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
            +F S  GT EY+ P++    +  KP GK+     DLW++G  +Y + TG  PFR
Sbjct: 177 RRFASFVGTAEYVSPEL----LNEKPAGKS----SDLWALGCIIYQMLTGKPPFR 223

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 20/224 (8%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++G+ KN    VA+K       ++  D Q +E + LK+++H++++ L A+ 
Sbjct: 14  LGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQ-KEVQALKRLRHKHLISLFAVC 71

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    I+ EL   GSL   L  PE    L     + +   +  GM +L +   +HR
Sbjct: 72  --SVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQNSIHR 128

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPV 197
           DL   NI+     +     K+ DFG AR ++ED     +Y + +   P  Y+        
Sbjct: 129 DLAARNIL---VGEDLVC-KVADFGLARLIKED-----VYLSSDKKIP--YKWTAPEAAS 177

Query: 198 GKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYIT 240
             TF    D+WS G+ LY + T G +   PY G  N E    IT
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQV---PYPGMNNHEVYDQIT 218

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 99.4 bits (248), Expect = 5e-23
 Identities = 69/242 (28%), Positives = 109/242 (45%), Gaps = 37/242 (15%)

Query: 17  VLGKGATGAVFQGV-----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
            LG GA G V++G+            VAVKT  +    +     + E  ++ K  H+NIV
Sbjct: 13  ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMK 127
           +L+ +  E+  R   I++EL  GG L + L +    PE    L  ++ L     +  G K
Sbjct: 73  RLIGVSFERLPR--FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           +L +N  +HRD+   N +   C     + K+ DFG AR+         +Y    Y     
Sbjct: 131 YLEENHFIHRDIAARNCL-LTCKGPGRVAKIADFGMARD---------IYRASYYRKGG- 179

Query: 188 YERAVLRKPVGKT---------FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY 238
             RA+L  P+            F +  D+WS GV L+ + +  L + PY GR N+E M +
Sbjct: 180 --RAML--PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS--LGYMPYPGRTNQEVMEF 233

Query: 239 IT 240
           +T
Sbjct: 234 VT 235

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 98.4 bits (246), Expect = 6e-23
 Identities = 64/245 (26%), Positives = 104/245 (42%), Gaps = 46/245 (18%)

Query: 17  VLGKGATGAVFQGV---NKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVK 72
            LG+GA G V++G           VAVKT  +            +E  V+KK+ H N+V+
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 73  LLAIEEEQEGRGKV-IVMELCTGGSL------FNILDDPENTYGLQEEEFLLVLEHLTAG 125
           LL +  E+E    + +V+E   GG L         +        L  ++ L     +  G
Sbjct: 61  LLGVCTEEE---PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M++L   + VHRDL   N +  + +D   + K++DFG +R++ +D               
Sbjct: 118 MEYLASKKFVHRDLAARNCL--VGEDL--VVKISDFGLSRDVYDD--------------- 158

Query: 186 DMYERAVLRK-PV---------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKET 235
           D Y +    K P+            F +  D+WS GV L+ + T      PY G  N+E 
Sbjct: 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT--PYPGLSNEEV 216

Query: 236 MYYIT 240
           + Y+ 
Sbjct: 217 LEYLR 221

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 9e-23
 Identities = 67/229 (29%), Positives = 104/229 (45%), Gaps = 38/229 (16%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVKT    + M P    ++E +++KK++H+ +V+L A+ 
Sbjct: 14  LGAGQFGEVWMGT-WNGTTKVAVKTLKPGT-MSPEAF-LQEAQIMKKLRHDKLVQLYAVC 70

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+E     IV E  + GSL + L   E    L+  + + +   +  GM +L     +HR
Sbjct: 71  SEEEP--IYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLESRNYIHR 127

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPV 197
           DL   NI+       + + K+ DFG AR +E+D          EY       R   + P+
Sbjct: 128 DLAARNILV----GENLVCKIADFGLARLIEDD----------EYT-----AREGAKFPI 168

Query: 198 GKT---------FGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
             T         F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV---PYPGMTNREVL 214

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 26/213 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLA 75
            LG+G+ G+V++ ++K  G+ VA+K       +     ++ +E  +LK+     IVK   
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPYIVKYYG 65

Query: 76  --IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              +         IVME C  GS+ +I+     T  L EEE   +L     G+++L  N+
Sbjct: 66  SYFKNTD----LWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLHSNK 119

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYERAV 192
            +HRD+K GNI+  + ++G    KL DFG + +L +      ++ GT  ++ P+     V
Sbjct: 120 KIHRDIKAGNIL--LNEEG--QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE-----V 170

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           +++     +    D+WS+G+T   +A G  P+ 
Sbjct: 171 IQEI---GYNNKADIWSLGITAIEMAEGKPPYS 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|240618 cd12219, UBL_TBK1_like, Ubiquitin-Like Domain Of Human Tbk1 and similar proteins

 Score = 91.9 bits (229), Expect = 1e-22
 Identities = 28/63 (44%), Positives = 44/63 (69%)

Query: 299 RFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKN 358
           RFF+EVT  L+RK+VH+F +N+    ++Y+HP++     Q+L+ EQT+V P+ Q LLY+ 
Sbjct: 1   RFFAEVTDILSRKVVHIFSVNQATSHKVYIHPEETLVNFQELVFEQTEVPPSNQELLYEG 60

Query: 359 THF 361
            H 
Sbjct: 61  EHL 63

This family contains ubiquitin-like domain (UBL) found in TANK-binding kinase 1 (TBK1) and similar proteins. TBK1 regulates factors such as IRF3 and IRF7, promoting antiviral activity in the interferon signaling pathways. In addition to the central UBL, these proteins have an N-terminal kinase domain and a C-terminal elongated helical domain. The ubiquitin-like domain acts as a protein-protein interaction domain, and has been implicated in regulating kinase activity, which modulates interactions in the IFN pathway. Length = 89

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 30/232 (12%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR----EFEVLKKVKHENIV 71
             +G+GA+G V++  ++  G+ VA+K       MR           E  ++K  KH NIV
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKK------MRLRKQNKELIINEILIMKDCKHPNIV 78

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
                +    G    +VME   GGSL +I+   +N   + E +   V   +  G+++L  
Sbjct: 79  DY--YDSYLVGDELWVVMEYMDGGSLTDIIT--QNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMSLYGTEEYLHPDMYER 190
             ++HRD+K  NI+  +  DGS   KL DFG A +L +E  +  S+ GT  ++ P++   
Sbjct: 135 QNVIHRDIKSDNIL--LSKDGSV--KLADFGFAAQLTKEKSKRNSVVGTPYWMAPEV--- 187

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK 242
            + RK     +G  VD+WS+G+    +A G  P  PY        ++ ITTK
Sbjct: 188 -IKRKD----YGPKVDIWSLGIMCIEMAEGE-P--PYLREPPLRALFLITTK 231

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)

Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIV 71
              V+G+GA G V +  NK  GE VA+K F + S          +RE +VL++++HENIV
Sbjct: 5   VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKE-SEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 72  KLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
            L    E    +G++ +V E     +L  +L+   +  GL  +     +  L   + +  
Sbjct: 64  NLK---EAFRRKGRLYLVFEYV-ERTLLELLE--ASPGGLPPDAVRSYIWQLLQAIAYCH 117

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE--DQQFMSLYGTEEYLHPDMY 188
            + ++HRD+KP NI+       S + KL DFG AR L             T  Y  P+  
Sbjct: 118 SHNIIHRDIKPENILV----SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE-- 171

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGN 221
              +L       +G  VD+W+IG  +  +  G 
Sbjct: 172 ---LLVGDT--NYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 96.4 bits (240), Expect = 1e-21
 Identities = 77/234 (32%), Positives = 118/234 (50%), Gaps = 29/234 (12%)

Query: 17  VLGKGATGAVF---QGVNKNNGEPVAVKTFNQLS-HMRPHDVQMREFEVLKKVKHENIVK 72
           VLG+G+ G VF   +    + G+  A+K   + +  +R       E ++L +V H  IVK
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 73  L-LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           L  A + E    GK+ ++++   GG LF  L          EE+    L  L   + HL 
Sbjct: 63  LHYAFQTE----GKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLH 115

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYE 189
              +++RDLKP NI+    D+   I KLTDFG ++E ++ +++  S  GT EY+ P++  
Sbjct: 116 SLGIIYRDLKPENIL---LDEEGHI-KLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
           R       G T  A  D WS GV ++ + TG+LPF+   G+  KETM  I   K
Sbjct: 172 RR------GHTQSA--DWWSFGVLMFEMLTGSLPFQ---GKDRKETMTMILKAK 214

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 94.2 bits (234), Expect = 2e-21
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 24/218 (11%)

Query: 15  TSVLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVK 72
             V+G+GA G V     K + + V +K     Q++       Q  E +VLK + H NI++
Sbjct: 5   IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ-NECQVLKLLSHPNIIE 63

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
               E   E +  +IVME   GG+L   +    N+  L E+  L     +   + H+   
Sbjct: 64  Y--YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTK 120

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLK  NI+    D    + K+ DFG ++ L    +  ++ GT  Y+ P++ E   
Sbjct: 121 LILHRDLKTQNIL---LDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE--- 174

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT-------GNLP 223
                GK +    D+W++G  LY +A+        NLP
Sbjct: 175 -----GKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 25/222 (11%)

Query: 9   NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE 68
           N +W     LG GA G V++  +K  G   A K     S     D  M E ++L + KH 
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDF-MVEIDILSECKHP 62

Query: 69  NIVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
           NIV L    E      K+ I++E C GG+L +I+ + E   GL E +   V   +   + 
Sbjct: 63  NIVGLY---EAYFYENKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALN 117

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPD 186
            L  ++++HRDLK GNI+  +  DG    KL DFG +A+     Q+  +  GT  ++ P+
Sbjct: 118 FLHSHKVIHRDLKAGNIL--LTLDGDV--KLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173

Query: 187 MYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATGNLP 223
           +           +TF         D+WS+G+TL  +A    P
Sbjct: 174 VV--------ACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 93.4 bits (232), Expect = 3e-21
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 21/206 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +G+G+ G      +K +G+   +K  N +S M P + +   +E  VL  +KH NIV+   
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEIN-ISKMSPKEREESRKEVAVLSNMKHPNIVQY-- 64

Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +E  E  G + IVM+ C GG L+  ++         E++ L     +   +KH+ D ++
Sbjct: 65  -QESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-FPEDQILDWFVQICLALKHVHDRKI 122

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYERAVL 193
           +HRD+K  NI  F+  DG    KL DFG AR L    +   +  GT  YL P++ E    
Sbjct: 123 LHRDIKSQNI--FLTKDG--TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE---- 174

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVAT 219
                + +    D+W++G  LY + T
Sbjct: 175 ----NRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 92.7 bits (230), Expect = 6e-21
 Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 18/211 (8%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV--LKKVKHENIVKLL 74
            +G+G+ G ++    K++ E   +K  + L+ M   + +  + EV  L K+KH NIV   
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEID-LTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
           A  +E  GR   IVME C GG L   ++         E++ L     ++ G+KH+ D ++
Sbjct: 66  ASFQE-NGR-LFIVMEYCDGGDLMKRINRQRGVL-FSEDQILSWFVQISLGLKHIHDRKI 122

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF-MSLYGTEEYLHPDMYERAVL 193
           +HRD+K  NI  F+  +G  + KL DFG AR+L +  +   +  GT  YL P++ +    
Sbjct: 123 LHRDIKSQNI--FLSKNG-MVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ---- 175

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                + +    D+WS+G  LY + T   PF
Sbjct: 176 ----NRPYNNKTDIWSLGCVLYELCTLKHPF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 93.0 bits (231), Expect = 7e-21
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 17/215 (7%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           VLGKG  G V+   + +    +A+K   ++       VQ    E  +   +KH NIV+ L
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIK---EIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
               + E     I ME   GGSL  +L          E+  +   + +  G+K+L DN++
Sbjct: 72  G--SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           VHRD+K  N++    +  S + K++DFG ++ L         + GT +Y+ P++ ++   
Sbjct: 130 VHRDIKGDNVL---VNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP- 185

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
                + +GA  D+WS+G T+  +ATG  PF   G
Sbjct: 186 -----RGYGAPADIWSLGCTIVEMATGKPPFIELG 215

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 92.3 bits (230), Expect = 9e-21
 Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 56/288 (19%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           + KGA G VF    K+ G+  A+K   +   +R + V   + E ++L + +   +VKL  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNRL 134
               Q  +   +VME   GG L ++L+      G L E+   + +  +   +++L  N +
Sbjct: 60  -YSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSNGI 114

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMS--------LYGTEEYLHP 185
           +HRDLKP NI+  I  +G    KLTDFG ++  L   Q  ++        + GT +Y+ P
Sbjct: 115 IHRDLKPDNIL--IDSNG--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS 245
           ++    +L +   K    TVD WS+G  LY    G  PF       + ET   I      
Sbjct: 171 EV----ILGQGHSK----TVDWWSLGCILYEFLVGIPPF-------HGETPEEI------ 209

Query: 246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKK 293
                 Q   NG+I+W    P + ++S     L++     LL  D +K
Sbjct: 210 -----FQNILNGKIEW----PEDVEVSDEAIDLIS----KLLVPDPEK 244

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 27/225 (12%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFN---QLSHMRPHDVQMR-EFEVLKKVKH 67
           W    +LG+GA G V+   + + G  +AVK           +     +  E ++LK ++H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGM 126
           E IV+      + E     I ME   GGS+     D    YG L E         +  G+
Sbjct: 64  ERIVQYYGCLRDDETL--SIFMEYMPGGSV----KDQLKAYGALTETVTRKYTRQILEGV 117

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE---DQQFM-SLYGTEEY 182
           ++L  N +VHRD+K  NI++    D +   KL DFGA++ L+        M S+ GT  +
Sbjct: 118 EYLHSNMIVHRDIKGANILR----DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
           + P++          G+ +G   D+WS+G T+  + T   P+  +
Sbjct: 174 MSPEVIS--------GEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 24/236 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           V+GKGA G V     ++  +  A+K  N+   +    V+  + E  +L+++ H  +V L 
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 75  AIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
                Q+     +V++L  GG L +++           EE+    +  +   +++L    
Sbjct: 67  --YSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+     D      +TDF  A ++  D    S  GT  Y+ P++  R   
Sbjct: 121 IIHRDIKPDNILL----DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR--- 173

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS 249
                + +   VD WS+GVT Y    G    RPY G            ++ + V+ 
Sbjct: 174 -----QGYSVAVDWWSLGVTAYECLRGK---RPYRGHSRTIRDQIRAKQETADVLY 221

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 71/226 (31%), Positives = 113/226 (50%), Gaps = 32/226 (14%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +GKG  G V++GV K N E VAVKT    S + P   +  ++E E+LK+  H NIVKL+ 
Sbjct: 3   IGKGNFGDVYKGVLKGNTE-VAVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           +  +++     IVMEL  GGSL   L   +N   L  ++ L +     AGM++L     +
Sbjct: 60  VCVQKQP--IYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKNCI 115

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDM--YE 189
           HRDL   N +  + ++   + K++DFG +RE EE   +    G ++    +  P+   Y 
Sbjct: 116 HRDLAARNCL--VGENN--VLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYG 170

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKET 235
           R          + +  D+WS G+ L+   +      PY G  N++T
Sbjct: 171 R----------YTSESDVWSYGILLWETFSLGDT--PYPGMSNQQT 204

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 22/210 (10%)

Query: 18  LGKGATGAVFQG----VNKNNGEPVAVKTFNQLSHMRPHDVQM---REFEVLKKVKHENI 70
           LG+G  G V       +  N GE VAVK    L+H      +    RE E+L+ + HENI
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVK---SLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           VK   + E+  GR   ++ME    GSL + L    +   +  +  LL    +  GM +L 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM-YE 189
             R +HRDL   NI+     +   + K++DFG A+ L ED+ +   Y  E    P   Y 
Sbjct: 127 SQRYIHRDLAARNILV----ESEDLVKISDFGLAKVLPEDKDYY--YVKEPGESPIFWYA 180

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
              LR      F +  D+WS GVTLY + T
Sbjct: 181 PECLRT---SKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 90.3 bits (224), Expect = 6e-20
 Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 21/223 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVKL-L 74
           LGKG  G V     +  G+  A K  N+  L   + ++  M E  +L KV    IV L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 75  AIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           A + + +     +VM +  GG L ++I +  E   G  E         + +G++HL   R
Sbjct: 61  AFQTKTD---LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAV 192
           +++RDLKP N++  + +DG+   +++D G A EL++ Q     Y GT  ++ P++ +   
Sbjct: 118 IIYRDLKPENVL--LDNDGNV--RISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ--- 170

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-RNKE 234
                G+ +  +VD +++GVTLY +     PFR  G +  NKE
Sbjct: 171 -----GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 6e-20
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 31/217 (14%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD----VQMREFEVLKKVKHENIV 71
             +G G  G V++  +   GE VA+K       + P D    +Q +E  +LK+ +H NIV
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIK----LEPGDDFEIIQ-QEISMLKECRHPNIV 63

Query: 72  KLLAIEEEQEGRGKV-IVMELCTGGSL---FNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
                      R K+ IVME C GGSL   + +   P     L E +   V      G+ 
Sbjct: 64  AYFGSY---LRRDKLWIVMEYCGGGSLQDIYQVTRGP-----LSELQIAYVCRETLKGLA 115

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPD 186
           +L +   +HRD+K  NI+  + +DG    KL DFG + +L     +  S  GT  ++ P 
Sbjct: 116 YLHETGKIHRDIKGANIL--LTEDGDV--KLADFGVSAQLTATIAKRKSFIGTPYWMAP- 170

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
             E A + +  G  +    D+W++G+T   +A    P
Sbjct: 171 --EVAAVERKGG--YDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.1 bits (222), Expect = 2e-19
 Identities = 69/223 (30%), Positives = 98/223 (43%), Gaps = 44/223 (19%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--------MREFEVLKKVKHEN 69
           LG+G  G V++  +K  GE VA+K           D +        +RE  +LK++KH N
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKI-------RLDNEEEGIPSTALREISLLKELKHPN 59

Query: 70  IVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           IVKLL +        K+ +V E C    L   LD       L       ++  L  G+ +
Sbjct: 60  IVKLLDVIH---TERKLYLVFEYCDM-DLKKYLDK--RPGPLSPNLIKSIMYQLLRGLAY 113

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE-----YL 183
              +R++HRDLKP NI   I  DG  + KL DFG AR        +  Y T E     Y 
Sbjct: 114 CHSHRILHRDLKPQNI--LINRDG--VLKLADFGLARAFGIP---LRTY-THEVVTLWYR 165

Query: 184 HPDMYERAVLRKPVG-KTFGATVDLWSIGVTLYHVATGNLPFR 225
            P+     +L   +G K +   VD+WS+G     + TG   F 
Sbjct: 166 APE-----IL---LGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 48/227 (21%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKT---------FNQLSHMRPHDVQMREFEVLKKVK 66
             LG G +G V + +++  G+ +AVKT           Q+         +RE ++L K  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI---------LRELDILHKCN 57

Query: 67  HENIVKLL-AIEEEQEGRGKVIVMELCTGGSLFNILDD-----PENTYGLQEEEFLLVLE 120
              IV    A     +     I ME   GGSL  IL +     PE   G   +  + VL+
Sbjct: 58  SPYIVGFYGAFYNNGD---ISICMEYMDGGSLDKILKEVQGRIPERILG---KIAVAVLK 111

Query: 121 HLTAGMKHLRDNR-LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
               G+ +L +   ++HRD+KP NI+    +    I KL DFG + +L       +  GT
Sbjct: 112 ----GLTYLHEKHKIIHRDVKPSNIL---VNSRGQI-KLCDFGVSGQLVNSLA-KTFVGT 162

Query: 180 EEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             Y+ P   ER       G  +    D+WS+G++L  +ATG  P+ P
Sbjct: 163 SSYMAP---ERIQ-----GNDYSVKSDIWSLGLSLIELATGRFPYPP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.6 bits (217), Expect = 3e-19
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 19/210 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLA 75
           +GKG+ G VF+ V K +    A+K  + LS M  R  +  + E  VL K+    I++   
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQID-LSKMNRREREEAIDEARVLAKLDSSYIIRYY- 65

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
            E   +     IVME    G L  +L   +    L E++       +  G+ HL   +++
Sbjct: 66  -ESFLDKGKLNIVMEYAENGDLHKLLK-MQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYERAVLR 194
           HRD+K  N+  F+ D    + K+ D G A+ L ++  F  ++ GT  YL P++ E     
Sbjct: 124 HRDIKSLNL--FL-DAYDNV-KIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED---- 175

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               K +    D+W++GV LY   TG  PF
Sbjct: 176 ----KPYNEKSDVWALGVVLYECCTGKHPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 22/215 (10%)

Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVK 72
               LG G  G+V+   NK  GE VA+K   +  +     + +RE + L+K+  H NIVK
Sbjct: 3   VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 73  LL-AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           L     E  E      V E    G+L+ ++ D +      E     ++  +  G+ H+  
Sbjct: 63  LKEVFRENDE---LYFVFEYME-GNLYQLMKDRKGKP-FSESVIRSIIYQILQGLAHIHK 117

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
           +   HRDLKP N++      G  + K+ DFG ARE+     +     T  Y  P++    
Sbjct: 118 HGFFHRDLKPENLLV----SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI---- 169

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           +LR     ++ + VD+W++G  +  + T     RP
Sbjct: 170 LLRST---SYSSPVDIWALGCIMAELYT----LRP 197

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 87.9 bits (218), Expect = 3e-19
 Identities = 68/246 (27%), Positives = 114/246 (46%), Gaps = 34/246 (13%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKT--FNQLSHMRPHDVQMR--------EFEV 61
           W    ++GKG  G V+  +N   GE +AVK          R HD + +        E E 
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGR-HDSRQKDMVKALRSEIET 61

Query: 62  LKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL-LVLE 120
           LK + H NIV+ L  E  +E     I +E   GGS+ + L     TYG  EE+ +    E
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLS--IFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTE 115

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE---DQQFMSLY 177
            +  G+ +L    ++HRDLK  N++     D   I K++DFG +++ ++   + Q MS+ 
Sbjct: 116 QVLEGLAYLHSKGILHRDLKADNLLV----DADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 178 GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           G+  ++ P++           + + A VD+WS+G  +  +  G    RP+        M+
Sbjct: 172 GSVFWMAPEVIHSY------SQGYSAKVDIWSLGCVVLEMFAGR---RPWSDEEAIAAMF 222

Query: 238 YITTKK 243
            +  K+
Sbjct: 223 KLGNKR 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 45/280 (16%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+GA+G V+  ++   G+ VA+K  N L      ++ + E  V+++ KH NIV  L  +
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINEILVMRENKHPNIVNYL--D 83

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GGSL +++ +      + E +   V       ++ L  N+++HR
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQVIHR 139

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYERAVLRKP 196
           D+K  NI+  +  DGS   KLTDFG   ++  +Q   S + GT  ++ P++  R      
Sbjct: 140 DIKSDNIL--LGMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------ 189

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSEN 256
             K +G  VD+WS+G+    +  G     PY        +Y I T              N
Sbjct: 190 --KAYGPKVDIWSLGIMAIEMVEGE---PPYLNENPLRALYLIAT--------------N 230

Query: 257 GEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS 296
           G      +L N  +LS   +      L   LE+D +K  S
Sbjct: 231 GT----PELQNPEKLSAIFRDF----LNRCLEMDVEKRGS 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 74/250 (29%), Positives = 114/250 (45%), Gaps = 57/250 (22%)

Query: 18  LGKGATGAVFQGVNKN--NGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++G+ K    GE    VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQ---EEEFLLVLEHLTAG 125
           LL +     G+  ++VMEL   G L + L     + EN  GL     ++F+ +   +  G
Sbjct: 74  LLGVV--STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L   + VHRDL   N M  + +D +   K+ DFG  R                    
Sbjct: 132 MAYLAAKKFVHRDLAARNCM--VAEDLTV--KIGDFGMTR-------------------- 167

Query: 186 DMYERAVLRK------PV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
           D+YE    RK      PV          G  F    D+WS GV L+ +AT  L  +PY G
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMAT--LAEQPYQG 224

Query: 230 RRNKETMYYI 239
             N+E + ++
Sbjct: 225 LSNEEVLKFV 234

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 87.8 bits (217), Expect = 5e-19
 Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 15/212 (7%)

Query: 9   NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE 68
           N VW     LG GA G V++  NK  G   A K     S     D  M E E+L    H 
Sbjct: 11  NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY-MVEIEILATCNHP 69

Query: 69  NIVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            IVKLL         GK+ I++E C GG++  I+   E   GL E +  ++   +   ++
Sbjct: 70  YIVKLLGAFYWD---GKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVICRQMLEALQ 124

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPD 186
           +L   +++HRDLK GN++  +  DG    KL DFG +A+ ++  Q+  S  GT  ++ P+
Sbjct: 125 YLHSMKIIHRDLKAGNVL--LTLDGDI--KLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVA 218
           +     ++      +    D+WS+G+TL  +A
Sbjct: 181 VVMCETMKD---TPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 68/241 (28%), Positives = 116/241 (48%), Gaps = 38/241 (15%)

Query: 15  TSVLGKGATGAVFQGVNKNNGEPVAVKTFN------QLSHMRPHDVQMREFEVLKKVKH- 67
             ++G+GA GAV++G +   G  VA+K  N       +S     D+Q RE  +L +++  
Sbjct: 6   LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-----DIQ-REVALLSQLRQS 59

Query: 68  --ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL-LVLEHLTA 124
              NI K        +G    I+ME   GGS+  ++       G   E+++ +++  +  
Sbjct: 60  QPPNITKYYG--SYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLV 112

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYL 183
            +K++    ++HRD+K  NI+  + + G+   KL DFG A  L ++    S   GT  ++
Sbjct: 113 ALKYIHKVGVIHRDIKAANIL--VTNTGNV--KLCDFGVAALLNQNSSKRSTFVGTPYWM 168

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
            P+     V+ +  GK +    D+WS+G+T+Y +ATGN P  PY        M  I   K
Sbjct: 169 APE-----VITE--GKYYDTKADIWSLGITIYEMATGN-P--PYSDVDAFRAMMLIPKSK 218

Query: 244 A 244
            
Sbjct: 219 P 219

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 68/230 (29%), Positives = 107/230 (46%), Gaps = 40/230 (17%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++G+  NN  PVAVKT    + M P D  + E +++KK++H  +++L A+ 
Sbjct: 14  LGAGQFGEVWEGL-WNNTTPVAVKTLKPGT-MDPKDF-LAEAQIMKKLRHPKLIQLYAVC 70

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +E     IV EL   GSL   L        L+  + + +   + +GM +L     +HR
Sbjct: 71  TLEEP--IYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQNYIHR 127

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE-RAVLRKP 196
           DL   N++  + +  + I K+ DFG AR ++E                D+YE R   + P
Sbjct: 128 DLAARNVL--VGE--NNICKVADFGLARVIKE----------------DIYEAREGAKFP 167

Query: 197 VGKT---------FGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +  T         F    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 168 IKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM---PYPGMTNAEVL 214

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 21/221 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVKL-L 74
           LGKG  G V     K  G+  A K  ++  L   +   + + E ++L+KV    IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 75  AIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           A E + +     +VM L  GG L ++I +      G  E   +     +  G++HL   R
Sbjct: 61  AFETKDD---LCLVMTLMNGGDLKYHIYN--VGEPGFPEARAIFYAAQIICGLEHLHQRR 115

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +V+RDLKP N++  + D G+   +++D G A EL+  ++     GT  Y+ P++ +    
Sbjct: 116 IVYRDLKPENVL--LDDHGNV--RISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ---- 167

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
               G+ +  +VD +++G TLY +  G  PFR    +  KE
Sbjct: 168 ----GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 65/223 (29%), Positives = 112/223 (50%), Gaps = 23/223 (10%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVK-H 67
           W     +GKG  G VF+ +NK NG   AVK  + +     HD+      E+ +LK +  H
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-----HDIDEEIEAEYNILKALSDH 74

Query: 68  ENIVKLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL--VLEHL 122
            N+VK   +   ++ + G    +V+ELC GGS+ +++       G + EE ++  +L   
Sbjct: 75  PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEA 133

Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-QFMSLYGTEE 181
             G++HL  N+ +HRD+K  NI+  +  +G    KL DFG + +L   + +  +  GT  
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNIL--LTTEGGV--KLVDFGVSAQLTSTRLRRNTSVGTPF 189

Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++ P   E     + +  T+ A  D+WS+G+T   +  G+ P 
Sbjct: 190 WMAP---EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            +GKG+ G V++ ++K   + VA+K  +        +   +E + L + +   I K    
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG- 66

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
               +G    I+ME C GGS  ++L        L E     +L  +  G+++L +   +H
Sbjct: 67  -SFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEEGKIH 121

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVLRK 195
           RD+K  NI+  + ++G    KL DFG + +L       + + GT  ++ P++ +++    
Sbjct: 122 RDIKAANIL--LSEEGDV--KLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG--- 174

Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLP 223
                +    D+WS+G+T   +A G  P
Sbjct: 175 -----YDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 59/224 (26%), Positives = 107/224 (47%), Gaps = 28/224 (12%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK--TFNQLSHMRPHDVQ---MREFEVLKKVK 66
           W     LG GA  + +Q  +   G  +AVK  T+ + +     +V     +E  ++ ++ 
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAG 125
           H +I+++L    E       + +E   GGS+ ++L      YG  +E  ++   E L  G
Sbjct: 62  HPHIIRMLGATCEDSHFN--LFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRG 115

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED----QQFM-SLYGTE 180
           + +L +N+++HRD+K  N++    D      ++ DFGAA  L        +F   L GT 
Sbjct: 116 LSYLHENQIIHRDVKGANLL---IDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            ++ P+     VLR   G+ +G + D+WS+G  +  +AT   P+
Sbjct: 173 AFMAPE-----VLR---GEQYGRSCDVWSVGCVIIEMATAKPPW 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 18/211 (8%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           V+G+G+ G      + N+ +  A+K           +   +E  +L K+KH NIV   A 
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV---AF 63

Query: 77  EEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           +E  E  G + IVME C GG L   +          E+  L     +  G++H+ + R++
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHEKRVL 122

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVLR 194
           HRD+K  NI  F+  +G    KL DFG+AR L     +   Y GT  Y+ P+++E     
Sbjct: 123 HRDIKSKNI--FLTQNGKV--KLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM--- 175

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                 +    D+WS+G  LY + T   PF+
Sbjct: 176 -----PYNNKSDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 85.7 bits (213), Expect = 5e-18
 Identities = 75/309 (24%), Positives = 127/309 (41%), Gaps = 64/309 (20%)

Query: 15  TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ----MREFEVLKKVKHENI 70
              +G GA G V   V+K  G  VA+K   ++S++    +     +RE ++L+ ++HENI
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 71  VKLLAI--EEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
           + LL I      E    V IV EL     L  ++  P+    L ++     L  +  G+K
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTEL-METDLHKVIKSPQP---LTDDHIQYFLYQILRGLK 117

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED---QQFMSLYGTEEYLH 184
           +L    ++HRDLKP NI+    +    + K+ DFG AR ++ D   + F++ Y    +  
Sbjct: 118 YLHSANVIHRDLKPSNIL---VNSNCDL-KICDFGLARGVDPDEDEKGFLTEYVVTRW-- 171

Query: 185 PDMYERAVLRKP----VGKTFGATVDLWSIGVTLYHVATGNLPFRPY--G---------- 228
              Y     R P        +   +D+WS+G     + T     +P   G          
Sbjct: 172 ---Y-----RAPELLLSSSRYTKAIDIWSVGCIFAELLTR----KPLFPGRDYIDQLNLI 219

Query: 229 ----GRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILA 284
               G  ++E + +IT++KA   +         +       P     ++ L       L 
Sbjct: 220 VEVLGTPSEEDLKFITSEKARNYLKSLPKKP--KKPLSKLFPGASPEAIDL-------LE 270

Query: 285 GLLEVDSKK 293
            +L  D KK
Sbjct: 271 KMLVFDPKK 279

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 84.6 bits (209), Expect = 6e-18
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 16/207 (7%)

Query: 17  VLGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG+G  G V    +   N   GE VAVKT  +    +      +E  +LK + HENIVK
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
                 EQ G+G  ++ME    GSL + L  P++   L   + LL  + +  GM +L   
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLA--QLLLFAQQICEGMAYLHSQ 126

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
             +HRDL   N++     D   + K+ DFG A+ + E  ++   Y   E     ++  AV
Sbjct: 127 HYIHRDLAARNVLL----DNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVFWYAV 179

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT 219
                 K   A+ D+WS GVTLY + T
Sbjct: 180 ECLKENKFSYAS-DVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 25/234 (10%)

Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++G+ K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLE---HLTAG 125
           LL +    +G+  +++MEL T G L + L     + EN           +++    +  G
Sbjct: 74  LLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L  N+ VHRDL   N M  + +D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 132 MAYLNANKFVHRDLAARNCM--VAEDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 185

Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V   F    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 186 RWMSPESLKDGV---FTTYSDVWSFGVVLWEIAT--LAEQPYQGMSNEQVLRFV 234

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 85.2 bits (211), Expect = 7e-18
 Identities = 75/222 (33%), Positives = 104/222 (46%), Gaps = 36/222 (16%)

Query: 16  SVLGKGATGAVFQGVNK----NNGEPVAVKTFNQLSHMRPH-DVQMREFE--VLKKVKHE 68
            VLGKG  G VFQ V K    + G+  A+K   + + +R   D    + E  +L+ VKH 
Sbjct: 2   KVLGKGGYGKVFQ-VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDP----ENTYGLQEEEFLLVLEHL-T 123
            IV L  I   Q G    +++E  +GG LF  L+      E+T      E  L LEHL  
Sbjct: 61  FIVDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEY 182
            G        +++RDLKP NI+     D     KLTDFG  +E + E     +  GT EY
Sbjct: 119 QG--------IIYRDLKPENILL----DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEY 166

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + P++  R+          G  VD WS+G  +Y + TG  PF
Sbjct: 167 MAPEILMRS--------GHGKAVDWWSLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 84.4 bits (208), Expect = 8e-18
 Identities = 61/208 (29%), Positives = 106/208 (50%), Gaps = 20/208 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+GA+G VF  ++   G+ VA+K  N L      ++ + E  V+K++K+ NIV  L  +
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKELIINEILVMKELKNPNIVNFL--D 83

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GGSL +++ +      + E +   V       ++ L  N+++HR
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQVIHR 139

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYERAVLRKP 196
           D+K  N++  +  DGS   KLTDFG   ++  +Q   S + GT  ++ P++  R      
Sbjct: 140 DIKSDNVL--LGMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------ 189

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K +G  VD+WS+G+    +  G  P+
Sbjct: 190 --KAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 83.4 bits (207), Expect = 8e-18
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 37/218 (16%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-------MREFEVLKKVKHENI 70
           LG G  G V     K+     A+K        + H V+         E E+L++  H  I
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVK-----KRHIVETGQQEHIFSEKEILEECNHPFI 55

Query: 71  VKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLL--VLEHLTAGMK 127
           VKL    ++++    + ++ME C GG L+ IL D    +      F +  V+       +
Sbjct: 56  VKLYRTFKDKK---YIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVL----AFE 107

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIY-KLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
           +L +  +++RDLKP N++  +  +G   Y KL DFG A++L+  Q+  +  GT EY+ P+
Sbjct: 108 YLHNRGIIYRDLKPENLL--LDSNG---YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPE 162

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +           K +  +VD WS+G+ LY + TG  PF
Sbjct: 163 IIL--------NKGYDFSVDYWSLGILLYELLTGRPPF 192

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 66/234 (28%), Positives = 112/234 (47%), Gaps = 25/234 (10%)

Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++G  ++   GE    VAVKT N+ + +R     + E  V+K     ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQE---EEFLLVLEHLTAG 125
           LL +    +G+  ++VMEL   G L + L     + EN  G      +E + +   +  G
Sbjct: 74  LLGVV--SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L   + VHRDL   N M  +  D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 132 MAYLNAKKFVHRDLAARNCM--VAHDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 185

Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V   F  + D+WS GV L+ + +  L  +PY G  N++ + ++
Sbjct: 186 RWMAPESLKDGV---FTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQVLKFV 234

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 25/225 (11%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKT--FNQLSHMRPHDVQMREFEV--LKKVKH 67
           W    +LG+GA G V+   + + G  +AVK   F+  S     +V   E E+  LK + H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGM 126
           E IV+      +   R   I ME   GGS+     D   +YG L E         +  G+
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSI----KDQLKSYGALTENVTRKYTRQILEGV 119

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE----EDQQFMSLYGTEEY 182
            +L  N +VHRD+K  NI++    D     KL DFGA++ L+          S+ GT  +
Sbjct: 120 SYLHSNMIVHRDIKGANILR----DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
           + P++          G+ +G   D+WS+G T+  + T   P+  +
Sbjct: 176 MSPEVIS--------GEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 15/209 (7%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG GA G V++  NK  G   A K  +  S     D  M E ++L    H NIV
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDY-MVEIDILASCDHPNIV 65

Query: 72  KLL-AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           KLL A   E       I++E C GG++  ++ + E    L E +  +V +     + +L 
Sbjct: 66  KLLDAFYYENN---LWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLH 120

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYE 189
           +N+++HRDLK GNI+  +  DG    KL DFG +A+     Q+  S  GT  ++ P   E
Sbjct: 121 ENKIIHRDLKAGNILFTL--DGDI--KLADFGVSAKNTRTIQRRDSFIGTPYWMAP---E 173

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVA 218
             +      + +    D+WS+G+TL  +A
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 27/214 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG+ G+V++    ++ +  A+K  +   +S     D  + E  +L  V H NI+    
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED-AVNEIRILASVNHPNIISYK- 65

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEE-----FLLVLEHLTAGMKHLR 130
            E   +G    IVME    G L   +   +    L  E+     F+ +L     G++ L 
Sbjct: 66  -EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR----GLQALH 120

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
           + +++HRDLK  NI   +  +   + K+ D G ++ L+++     + GT  Y+ P++++ 
Sbjct: 121 EQKILHRDLKSANI--LLVAND--LVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWK- 174

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                  G+ +    D+WS+G  LY +AT   PF
Sbjct: 175 -------GRPYSYKSDIWSLGCLLYEMATFAPPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 24/221 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +GKG    V++ +   +G  VA+K       M     Q  ++E ++LK++ H N++K LA
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 76  --IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVL-EHLTAGMKHLRDN 132
             IE  +      IV+EL   G L  ++   +    L  E  +      L + ++H+   
Sbjct: 70  SFIENNE----LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMSLYGTEEYLHPDMYERA 191
           R++HRD+KP N+  FI   G  + KL D G  R    +     SL GT  Y+ P+     
Sbjct: 126 RIMHRDIKPANV--FITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
                 G  F +  D+WS+G  LY +A    PF  YG + N
Sbjct: 182 ------GYNFKS--DIWSLGCLLYEMAALQSPF--YGDKMN 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 20/208 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+GA+G V+  ++   G+ VA+K  N L      ++ + E  V+++ K+ NIV  L  +
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKKELIINEILVMRENKNPNIVNYL--D 83

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GGSL +++ +      + E +   V       +  L  N+++HR
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQVIHR 139

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYERAVLRKP 196
           D+K  NI+  +  DGS   KLTDFG   ++  +Q   S + GT  ++ P++  R      
Sbjct: 140 DIKSDNIL--LGMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------ 189

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K +G  VD+WS+G+    +  G  P+
Sbjct: 190 --KAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 69/232 (29%), Positives = 111/232 (47%), Gaps = 33/232 (14%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD-----VQMREFEVLKKVKHENIV 71
           ++G+G+ G V +  +K  G+ VA+K F +       D     + MRE  +LK+++HEN+V
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLE----SEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN-TYGLQEEEFLLVLEHLTAGMKHLR 130
            L  IE  +  +   +V E         +LDD E    GL E      L  +  G++   
Sbjct: 64  NL--IEVFRRKKRLYLVFEFVD----HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYE 189
            + ++HRD+KP NI+       S + KL DFG AR L    +  + Y  T  Y  P++  
Sbjct: 118 SHNIIHRDIKPENILV----SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL- 172

Query: 190 RAVLRKPVGKT-FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
                  VG T +G  VD+W++G  +  + TG  P  P  G  + + +Y+I 
Sbjct: 173 -------VGDTKYGRAVDIWAVGCLVTEMLTGE-PLFP--GDSDIDQLYHII 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 69/227 (30%), Positives = 107/227 (47%), Gaps = 25/227 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLA 75
           +G+G+ G VF+  N+  G+ VA+K F + S   P    + +RE  +LK++KH N+V L  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVE-SEDDPVIKKIALREIRMLKQLKHPNLVNL-- 65

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           IE  +  R   +V E C   ++ N L+  +N  G+ E     ++      +     +  +
Sbjct: 66  IEVFRRKRKLHLVFEYCD-HTVLNELE--KNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVLR 194
           HRD+KP NI   I   G    KL DFG AR L      +     T  Y  P++       
Sbjct: 123 HRDVKPENI--LITKQG--QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL------ 172

Query: 195 KPVGKT-FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
             VG T +G  VD+W+IG     + TG  P  P  G+ + + +Y I 
Sbjct: 173 --VGDTQYGPPVDVWAIGCVFAELLTG-QPLWP--GKSDVDQLYLIR 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 82.2 bits (204), Expect = 4e-17
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 39/208 (18%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQ-MREFEVLKKVKHENIVKLLA 75
           +G+G  G V++  NK  GE VA+K    + + +    +  +RE ++L+K++H NIV+L  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 76  IEEEQEGRGKV-IVMELC----TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           I    +G+G + +V E      TG     +LD PE  +   + +  +  + L  G+++L 
Sbjct: 66  IVTS-KGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYM--KQLLEGLQYLH 117

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
            N ++HRD+K  NI+  I +DG  + KL DFG AR   +                D   R
Sbjct: 118 SNGILHRDIKGSNIL--INNDG--VLKLADFGLARPYTKRNS------------ADYTNR 161

Query: 191 AV---LRKP---VGKT-FGATVDLWSIG 211
            +    R P   +G T +G  VD+WS+G
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVG 189

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 81.7 bits (201), Expect = 4e-17
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 25/225 (11%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKT--FNQLSHMRPHDVQMREFEV--LKKVKH 67
           W    +LG+GA G V+   + + G  +A K   F+  S     +V   E E+  LK ++H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGM 126
           E IV+      ++  +   I ME   GGS+     D    YG L E         +  GM
Sbjct: 64  ERIVQYYGCLRDRAEKTLTIFMEYMPGGSV----KDQLKAYGALTESVTRKYTRQILEGM 119

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE----EDQQFMSLYGTEEY 182
            +L  N +VHRD+K  NI++    D +   KL DFGA++ L+          S+ GT  +
Sbjct: 120 SYLHSNMIVHRDIKGANILR----DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
           + P++          G+ +G   D+WS+G T+  + T   P+  Y
Sbjct: 176 MSPEVIS--------GEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 39/232 (16%)

Query: 18  LGKGATGAVFQGV--NKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           LG G  G+V +GV   K+  E  VAVKT  Q          +RE  V+ ++ H  IV+L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            +    +G   ++VMEL   G L   +    E    +   +   +   +  GM +L    
Sbjct: 63  GV---CKGEPLMLVMELAPLGPLLKYLKKRRE----IPVSDLKELAHQVAMGMAYLESKH 115

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            VHRDL   N++  + +      K++DFG +R L          G++ Y        A  
Sbjct: 116 FVHRDLAARNVL--LVNRHQA--KISDFGMSRALG--------AGSDYY----RATTAG- 158

Query: 194 RKPVG---------KTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
           R P+            F +  D+WS GVTL+   +     +PYG  +  E +
Sbjct: 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS--YGAKPYGEMKGAEVI 208

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.0 bits (202), Expect = 5e-17
 Identities = 61/220 (27%), Positives = 111/220 (50%), Gaps = 17/220 (7%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR-EFEVLKKV-KHEN 69
           W     +GKG  G V++  NK +G   AVK  + +S +   D ++  E+ +L+ +  H N
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV---DEEIEAEYNILQSLPNHPN 80

Query: 70  IVKLLAI--EEEQEGRGKV-IVMELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAG 125
           +VK   +  + ++   G++ +V+ELC GGS+  ++         L E     +L     G
Sbjct: 81  VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-QFMSLYGTEEYLH 184
           ++HL +NR++HRD+K  NI+  +  +G    KL DFG + +L   + +  +  GT  ++ 
Sbjct: 141 LQHLHNNRIIHRDVKGNNIL--LTTEGGV--KLVDFGVSAQLTSTRLRRNTSVGTPFWMA 196

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P   E     +    ++ A  D+WS+G+T   +  G+ P 
Sbjct: 197 P---EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 82.1 bits (202), Expect = 5e-17
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 20/208 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+GA+G V+  ++   G+ VA++  N L      ++ + E  V+++ K+ NIV  L  +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYL--D 84

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GGSL +++ +      + E +   V       ++ L  N+++HR
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHR 140

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYERAVLRKP 196
           D+K  NI+  +  DGS   KLTDFG   ++  +Q   S + GT  ++ P++  R      
Sbjct: 141 DIKSDNIL--LGMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------ 190

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K +G  VD+WS+G+    +  G  P+
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 9e-17
 Identities = 76/267 (28%), Positives = 110/267 (41%), Gaps = 68/267 (25%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVKHENIVKL 73
           +LGKG  G VF    K  G+  A+K  ++   M   +   R   E E+L  + H  +  L
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDK-KEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGLQEE-------EFLLVLEHLTAG 125
            A  + +      +VM+ C GG LF +L   P     L EE       E LL LE+L   
Sbjct: 67  YASFQTETYLC--LVMDYCPGGELFRLLQRQPGKC--LSEEVARFYAAEVLLALEYL--- 119

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF----------------------GA 163
             HL    +V+RDLKP NI+  + + G  +  L+DF                       +
Sbjct: 120 --HL--LGIVYRDLKPENIL--LHESGHIM--LSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 164 ARELEEDQQF--------MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLY 215
           +      + F         S  GTEEY+ P+     V+    G   G+ VD W++G+ LY
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-----VIS---GDGHGSAVDWWTLGILLY 223

Query: 216 HVATGNLPFRPYGGRRNKETMYYITTK 242
            +  G  PF+   G    ET   I  K
Sbjct: 224 EMLYGTTPFK---GSNRDETFSNILKK 247

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 68/220 (30%), Positives = 105/220 (47%), Gaps = 21/220 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVKT      M P    + E +++KK++H+ +V+L A+ 
Sbjct: 14  LGNGQFGEVWMGT-WNGNTKVAVKTLKP-GTMSPESF-LEEAQIMKKLRHDKLVQLYAVV 70

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E       IV E  + GSL + L D E    L+    + +   + AGM ++     +HR
Sbjct: 71  SE---EPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERMNYIHR 126

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPV 197
           DL+  NI+     DG  + K+ DFG AR L ED ++ +  G +  +     E A+  +  
Sbjct: 127 DLRSANIL---VGDG-LVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR-- 179

Query: 198 GKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
              F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 180 ---FTIKSDVWSFGILLTELVTKGRV---PYPGMNNREVL 213

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 19/222 (8%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V     KN G+  A K  ++  L       + + E E+L+KV    IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 76  IEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
             E +      +VM L  GG L ++I +      GL+ E  +     +T G+ HL    +
Sbjct: 61  AFESKTHL--CLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHSMDI 116

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           V+RD+KP N++  + D G+   +L+D G A EL++ +      GT  Y+ P++ +     
Sbjct: 117 VYRDMKPENVL--LDDQGNC--RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYS 172

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
            P        VD +++G ++Y +  G  PF+ +  +  KE +
Sbjct: 173 YP--------VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 73/256 (28%), Positives = 106/256 (41%), Gaps = 61/256 (23%)

Query: 17  VLGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
            LG+GA G VF G       +N+ E VAVKT  + +         RE E+L   +HENIV
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSL----------FNILDDPENTYG-LQEEEFLLVLE 120
           K   +    EG   ++V E    G L             L  P++  G L   + L +  
Sbjct: 72  KFYGV--CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGT 179
            + +GM +L     VHRDL   N     C  G   + K+ DFG +R+         +Y T
Sbjct: 130 QIASGMVYLASQHFVHRDLATRN-----CLVGYDLVVKIGDFGMSRD---------VYTT 175

Query: 180 EEY------------LHPD--MYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
           + Y            + P+  MY +          F    D+WS GV L+ + T G    
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRK----------FTTESDVWSFGVVLWEIFTYGK--- 222

Query: 225 RPYGGRRNKETMYYIT 240
           +P+ G  N+E +  IT
Sbjct: 223 QPWYGLSNEEVIECIT 238

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 14  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 71  SEEP---IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 126

Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 127 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 178

Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 179 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 213

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 64/230 (27%), Positives = 115/230 (50%), Gaps = 36/230 (15%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTF--------NQLSHMRPHDVQMREFEVLK 63
           W   +++G G+ G+V+ G+N ++GE +AVK          ++       D   RE  +LK
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 64  KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL--LVLEH 121
           +++HENIV+ L    + +     I +E   GGS+  +L    N YG  EE  +   V + 
Sbjct: 62  ELQHENIVQYLGSSLDADHLN--IFLEYVPGGSVAALL----NNYGAFEETLVRNFVRQI 115

Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM------- 174
           L  G+ +L +  ++HRD+K  NI+    D+   I K++DFG +++LE +           
Sbjct: 116 LK-GLNYLHNRGIIHRDIKGANIL---VDNKGGI-KISDFGISKKLEANSLSTKTNGARP 170

Query: 175 SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           SL G+  ++ P++ ++         ++    D+WS+G  +  + TG  PF
Sbjct: 171 SLQGSVFWMAPEVVKQT--------SYTRKADIWSLGCLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 25/225 (11%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKT--FNQLSHMRPHDVQMREFEV--LKKVKH 67
           W    +LG+GA G V+   + + G  +AVK   F+  S     +V   E E+  LK ++H
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGM 126
           + IV+      + E +   I +E   GGS+     D    YG L E         +  G+
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSI----KDQLKAYGALTENVTRRYTRQILQGV 119

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE----EDQQFMSLYGTEEY 182
            +L  N +VHRD+K  NI++    D +   KL DFGA++ ++          S+ GT  +
Sbjct: 120 SYLHSNMIVHRDIKGANILR----DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
           + P++          G+ +G   D+WS+  T+  + T   P+  Y
Sbjct: 176 MSPEVIS--------GEGYGRKADVWSVACTVVEMLTEKPPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)

Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIV 71
               +G G  G V    ++ +    A+K       +R    Q    E  VLK+V H  I+
Sbjct: 5   RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFII 64

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           +L   E +Q  R   ++ME   GG LF+ L    N+        L     +   +++L  
Sbjct: 65  RLFWTEHDQ--RFLYMLMEYVPGGELFSYL---RNSGRFSNSTGLFYASEIVCALEYLHS 119

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
             +V+RDLKP NI+  +  +G    KLTDFG A++L +  +  +L GT EYL P++ +  
Sbjct: 120 KEIVYRDLKPENIL--LDKEGHI--KLTDFGFAKKLRD--RTWTLCGTPEYLAPEVIQS- 172

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                  K     VD W++G+ +Y +  G  PF 
Sbjct: 173 -------KGHNKAVDWWALGILIYEMLVGYPPFF 199

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 20/212 (9%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENI 70
           +C   V+GKG+ G V    ++ +G+   +K  N + +  R      +E ++L ++KH NI
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 71  VKLLAIEEEQEGRGKV--IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           V   A  E  EG   +  IVM  C GG L++ L + +    L E + +     +   +++
Sbjct: 62  V---AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQY 117

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDM 187
           L +  ++HRDLK  N+  F+    + I K+ D G AR LE      S L GT  Y+ P++
Sbjct: 118 LHEKHILHRDLKTQNV--FLTR--TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
           +          K +    D+W++G  +Y +AT
Sbjct: 174 FS--------NKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 79.2 bits (195), Expect = 4e-16
 Identities = 62/216 (28%), Positives = 92/216 (42%), Gaps = 34/216 (15%)

Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LG+G  G V    +     N GE VAVK+    S         +E E+L+ + HENIVK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             I  E  G G  ++ME    GSL   L  P N   +  ++ L     +  GM +L   +
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL----------YGTEEYL 183
            VHRDL   N++     +     K+ DFG  + +E D+++ ++          Y  E  +
Sbjct: 130 YVHRDLAARNVLV----ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
               Y  +              D+WS GVTLY + T
Sbjct: 186 QSKFYIAS--------------DVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 31/230 (13%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G  G VF G  + +  PVAVK+  +          ++E  +LK+  H NIV+L+ + 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYG--LQEEEFLLVLEHLTAGMKHLRDNRLV 135
            +++     IVMEL  GG     L     T G  L+ +E + ++E+  AGM++L     +
Sbjct: 63  TQKQP--IYIVMELVQGGDFLTFL----RTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDM--YE 189
           HRDL   N +         + K++DFG +RE EED  + S  G ++    +  P+   Y 
Sbjct: 117 HRDLAARNCLV----TEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           R          + +  D+WS G+ L+     +L   PY    N++T   I
Sbjct: 172 R----------YSSESDVWSFGILLWE--AFSLGAVPYANLSNQQTREAI 209

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 21/213 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTF-NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           V+G+GA G V +  +K   E VA+K F +   +    +  +RE ++L+ +K ENIV+L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL-- 65

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
            +E    RGK+ ++      ++  +L++  N  G+  E+    +  L   +     N +V
Sbjct: 66  -KEAFRRRGKLYLVFEYVEKNMLELLEEMPN--GVPPEKVRSYIYQLIKAIHWCHKNDIV 122

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE--DQQFMSLYGTEEYLHPDMYERAVL 193
           HRD+KP N++    D    + KL DFG AR L E  +  +     T  Y  P++      
Sbjct: 123 HRDIKPENLLISHND----VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL----- 173

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
              +G  +G  VD+WS+G  L  ++ G  P  P
Sbjct: 174 ---LGAPYGKAVDMWSVGCILGELSDGQ-PLFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 78.7 bits (194), Expect = 6e-16
 Identities = 67/251 (26%), Positives = 110/251 (43%), Gaps = 47/251 (18%)

Query: 18  LGKGATGAVFQG--VNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+GA G V++G     N       VA+KT  + +  +      +E E++  ++H NIV 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL------DDPENTYG-------LQEEEFLLVL 119
           LL +  +++     ++ E    G L   L       D     G       L   +FL + 
Sbjct: 73  LLGVCTKEQP--TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             + AGM++L  +  VHRDL   N +     +G T+ K++DFG +R+         +Y  
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCL---VGEGLTV-KISDFGLSRD---------IYSA 177

Query: 180 EEYLHPD--------MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR 231
           + Y            M   A+L    GK F    D+WS GV L+ + +  L  +PY G  
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAIL---YGK-FTTESDIWSFGVVLWEIFSYGL--QPYYGFS 231

Query: 232 NKETMYYITTK 242
           N+E +  I ++
Sbjct: 232 NQEVIEMIRSR 242

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 21/207 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           VLGKGA G         +   V  K  N  +LS     D  + E  +L  ++H NI+   
Sbjct: 7   VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA-LNEIVILSLLQHPNIIAYY 65

Query: 75  -AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
               ++      +I ME   GG+L++ +   +     +EE  L  L  + + + ++    
Sbjct: 66  NHFMDDNT---LLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIHKAG 121

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYERAV 192
           ++HRD+K  NI  F+   G  + KL DFG ++ L  +     ++ GT  Y+ P++ +   
Sbjct: 122 ILHRDIKTLNI--FLTKAG--LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQ--- 174

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT 219
                G  +    D+W++G  LY + T
Sbjct: 175 -----GVKYNFKSDIWALGCVLYELLT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 31/222 (13%)

Query: 18  LGKGATGAVFQGVNKNNGEP-VAVKTFNQLSHMRPHDVQMR---------EFEVLKK-VK 66
           LG GA G V++   KNNG+  +A+K  N  +     D + R         E  ++K+ ++
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSL---FNILDDPENTYGLQEEEFLLVLEHLT 123
           H NIV+        E     IVM+L  G  L   FN L + +  +   EE    +   + 
Sbjct: 68  HPNIVRYYKTF--LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF--TEERIWNIFVQMV 123

Query: 124 AGMKHL-RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             +++L ++ R+VHRDL P NIM    DD  TI   TDFG A++ + + +  S+ GT  Y
Sbjct: 124 LALRYLHKEKRIVHRDLTPNNIM-LGEDDKVTI---TDFGLAKQKQPESKLTSVVGTILY 179

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             P++ +         + +G   D+W+ G  LY + T   PF
Sbjct: 180 SCPEIVK--------NEPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 37/209 (17%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-----REFEVLKKVK---HEN 69
           +G+GA G V++  + N G  VA+K       +   +  +     RE  +LK+++   H N
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY-------GLQEEEFLLVLEHL 122
           IV+LL +        + + + L     +F  +D    TY       GL  E    ++  L
Sbjct: 63  IVRLLDVCHGPRTDRE-LKLTL-----VFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116

Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             G+  L  +R+VHRDLKP NI+  +  DG    K+ DFG AR    +    S+  T  Y
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNIL--VTSDG--QVKIADFGLARIYSFEMALTSVVVTLWY 172

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIG 211
             P+     VL   +  ++   VD+WS+G
Sbjct: 173 RAPE-----VL---LQSSYATPVDMWSVG 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 8e-16
 Identities = 67/227 (29%), Positives = 104/227 (45%), Gaps = 30/227 (13%)

Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++GV    GE    PVA+K   + +  + +   + E  V+  V H ++V+
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL I    + +    +M L   G L + + + ++  G Q    L     +  GM +L + 
Sbjct: 74  LLGICLSSQVQLITQLMPL---GCLLDYVRNHKDNIGSQY--LLNWCVQIAKGMSYLEEK 128

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---E 189
           RLVHRDL   N++           K+TDFG A+ L+ D+     Y  E    P  +   E
Sbjct: 129 RLVHRDLAARNVLV----KTPQHVKITDFGLAKLLDVDE---KEYHAEGGKVPIKWMALE 181

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF--RPYGGRRNKE 234
             + R    K+     D+WS GVT++ + T    F  +PY G    E
Sbjct: 182 SILHRIYTHKS-----DVWSYGVTVWELMT----FGAKPYEGIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 77.6 bits (191), Expect = 9e-16
 Identities = 71/238 (29%), Positives = 108/238 (45%), Gaps = 26/238 (10%)

Query: 18  LGKGATGAVFQGVNKN-----NGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           LG GA G V++G   +     +G   VAVKT  + +  +     ++E  ++    H NIV
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDP--ENTY--GLQEEEFLLVLEHLTAGMK 127
           KLL +    E   + I+MEL  GG L + L D   E      L  +E L +   +  G  
Sbjct: 63  KLLGVCLLNE--PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 128 HLRDNRLVHRDLKPGNIMKFICD-DGSTIYKLTDFGAARELEEDQQFMSLYGTE-EYLHP 185
           +L     +HRDL   N +      D   + K+ DFG AR++ +       Y  E E L P
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS----DYYRKEGEGLLP 176

Query: 186 D--MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
              M   ++L    GK F    D+WS GV ++ + T  L  +PY    N+E + ++T 
Sbjct: 177 VRWMAPESLLD---GK-FTTQSDVWSFGVLMWEILT--LGQQPYPALNNQEVLQHVTA 228

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 45/212 (21%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDVQM---REFEVLKKVKHENIVKL 73
           LG+G    V++  +K  G  VA+K             +     RE ++L+++KH NI+ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           L +   +      +V E      L  ++ D        + +  +++     G+++L  N 
Sbjct: 68  LDVFGHK--SNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLM--TLRGLEYLHSNW 122

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-------------LYGTE 180
           ++HRDLKP N+   I  DG  + KL DFG AR      + M+             L+G  
Sbjct: 123 ILHRDLKPNNL--LIASDG--VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGAR 178

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGV 212
            Y                   G  VD+WS+G 
Sbjct: 179 HY-------------------GVGVDMWSVGC 191

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 20/217 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKL-- 73
           V+G+G  G V++  +K  G+ VA+K  + +      +++  E+ +L+K   H NI     
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKE-EYNILRKYSNHPNIATFYG 70

Query: 74  LAIEEEQEGRGKVI--VMELCTGGS---LFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
             I++   G    +  VMELC GGS   L   L        L+EE    +L     G+ +
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKR--LKEEWIAYILRETLRGLAY 128

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDM 187
           L +N+++HRD+K  NI+  +  +     KL DFG + +L+      + + GT  ++ P++
Sbjct: 129 LHENKVIHRDIKGQNIL--LTKNAEV--KLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              A   +P   ++ A  D+WS+G+T   +A G  P 
Sbjct: 185 I--ACDEQP-DASYDARSDVWSLGITAIELADGKPPL 218

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 29/229 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V  G  +   + VA+K   + + M   D  + E +V+ K+ H N+V+L  + 
Sbjct: 12  LGSGQFGVVHLGKWRGKID-VAIKMIREGA-MSEDDF-IEEAKVMMKLSHPNLVQLYGVC 68

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            +Q  R   IV E    G L N L   E    L  E  L +   +   M++L  N  +HR
Sbjct: 69  TKQ--RPIFIVTEYMANGCLLNYLR--ERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124

Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVL 193
           DL   N     C  G   + K++DFG AR + +D Q+ S  GT+   ++  P++++ +  
Sbjct: 125 DLAARN-----CLVGEDNVVKVSDFGLARYVLDD-QYTSSQGTKFPVKWAPPEVFDYS-- 176

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITT 241
                  F +  D+WS GV ++ V + G +   PY    N E +  ++ 
Sbjct: 177 ------RFSSKSDVWSFGVLMWEVFSEGKM---PYERFSNSEVVESVSA 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 20/208 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+TG V     K++G  VAVK  +     R  ++   E  +++  +H+N+V++   +
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHQNVVEMY--K 85

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    ++ME   GG+L +I+        L EE+   V E +   + +L    ++HR
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQGVIHR 141

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  +I+  +  DG    KL+DFG   ++ +D  +  SL GT  ++ P++  R      
Sbjct: 142 DIKSDSIL--LTLDGRV--KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP---- 193

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  VD+WS+G+ +  +  G  P+
Sbjct: 194 ----YGTEVDIWSLGIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 22/210 (10%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           + +GKG  G V  G  +  G+ VAVK              + E  V+  ++H N+V+LL 
Sbjct: 12  ATIGKGEFGDVMLGDYR--GQKVAVKCLKD--DSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           +    +G    IV E    GSL + L        +   + L     +  GM++L +   V
Sbjct: 68  VV--LQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKNFV 124

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRDL   N++  + +D   + K++DFG A+E  + Q    L    ++  P+      LR+
Sbjct: 125 HRDLAARNVL--VSEDL--VAKVSDFGLAKEASQGQDSGKL--PVKWTAPE-----ALRE 173

Query: 196 PVGKTFGATVDLWSIGVTLYHV-ATGNLPF 224
              K F    D+WS G+ L+ + + G +P+
Sbjct: 174 ---KKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 20/224 (8%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL-AI 76
           LG+G    V++G N+  GE VA+K  +  +        +RE  ++K++KHENIV+L   I
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             E +    ++V E      L   +D       L           L  G+    +NR++H
Sbjct: 68  HTENK---LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I   G    KL DFG AR        F +   T  Y  PD     VL  
Sbjct: 124 RDLKPQNLL--INKRGE--LKLADFGLARAFGIPVNTFSNEVVTLWYRAPD-----VLLG 174

Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
              +T+  ++D+WS+G  +  + TG   F    G  N++ +  I
Sbjct: 175 --SRTYSTSIDIWSVGCIMAEMITGRPLFP---GTNNEDQLLKI 213

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 37/235 (15%)

Query: 18  LGKGATGAVFQGVNKN-NGE--PVAVKTFNQLSHMRPHDVQM---REFEVLKKVKHENIV 71
           LG G+ G V +G      G+  PVAVK    L   +  D+     +E  ++  + HEN++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKC---LKSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVL-----EHLTAGM 126
           +L  +         ++V EL   GSL + L             FL+         +  GM
Sbjct: 60  RLYGVVLTHP---LMMVTELAPLGSLLDRLRKD------ALGHFLISTLCDYAVQIANGM 110

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
           ++L   R +HRDL   NI+    D      K+ DFG  R L +++     Y  EE+L   
Sbjct: 111 RYLESKRFIHRDLAARNILLASDD----KVKIGDFGLMRALPQNEDH---YVMEEHLKVP 163

Query: 187 MYERAV--LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
               A   LR    +TF    D+W  GVTL+ + T      P+ G    + +  I
Sbjct: 164 FAWCAPESLRT---RTFSHASDVWMFGVTLWEMFT--YGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 22/222 (9%)

Query: 17  VLGKGATGAVF---QGVNKNNGEPVAVKTFNQLSHMRPHDVQ---MREFEVLKKVKHENI 70
           VLG GA G VF   +    + G+  A+K   + + ++          E +VL+ V+    
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           +  L    + + +   ++++   GG LF  L   E+     E E  + +  +   + HL 
Sbjct: 67  LVTLHYAFQTDTKLH-LILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALDHLH 122

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL--EEDQQFMSLYGTEEYLHPDMY 188
              +++RD+K  NI+     D      LTDFG ++E   EE+++  S  GT EY+ P++ 
Sbjct: 123 QLGIIYRDIKLENILL----DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV- 177

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR 230
              +     G      VD WS+GV  + + TG  PF   G +
Sbjct: 178 ---IRGGSGG--HDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 32/214 (14%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHENIV 71
            ++G+G  GAV QG  +  G+ VAVK           DV  + F     V+ K+ H+N+V
Sbjct: 12  EIIGEGEFGAVLQG--EYTGQKVAVKNIKC-------DVTAQAFLEETAVMTKLHHKNLV 62

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           +LL +       G  IVMEL + G+L N L        +   + L     +  GM++L  
Sbjct: 63  RLLGVILHN---GLYIVMELMSKGNLVNFLRT-RGRALVSVIQLLQFSLDVAEGMEYLES 118

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            +LVHRDL   NI+  + +DG  + K++DFG AR        +   G +    P  +   
Sbjct: 119 KKLVHRDLAARNIL--VSEDG--VAKVSDFGLAR--------VGSMGVDNSKLPVKWTAP 166

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHV-ATGNLPF 224
              K   K F +  D+WS GV L+ V + G  P+
Sbjct: 167 EALK--HKKFSSKSDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 47/215 (21%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-----RPHDVQMREFEVLKKVKHENIV 71
            +G GA G V   ++  +G+ VA+K       +     R      RE ++L+  KH+NI+
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----RELKILRHFKHDNII 67

Query: 72  KLLAI--EEEQEGRGKVIVMELCTGGSLFNIL--DDPENTYGLQEEEFLLVLEHLTAGMK 127
            +  I      + +   +VM+L     L +I+  D P     L EE     L  L  G+K
Sbjct: 68  AIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQP-----LTEEHIRYFLYQLLRGLK 121

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL----EEDQQFMSLY-GTEEY 182
           ++    ++HRDLKP N++  + +D     ++ DFG AR L     E + FM+ Y  T  Y
Sbjct: 122 YIHSANVIHRDLKPSNLL--VNEDCE--LRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177

Query: 183 LHPDM------YERAVLRKPVGKTFGATVDLWSIG 211
             P++      Y  A             +D+WS+G
Sbjct: 178 RAPELLLSLPEYTTA-------------IDMWSVG 199

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 68/213 (31%), Positives = 99/213 (46%), Gaps = 25/213 (11%)

Query: 16  SVLGKGATGAV----FQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHEN 69
             LGKG  G+V    +  +  N GE VAVK     +  H+R  D + RE E+LK ++H+N
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR--DFE-REIEILKSLQHDN 66

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           IVK   +      R   +VME    GSL + L   ++   L   + LL    +  GM++L
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ--KHRERLDHRKLLLYASQICKGMEYL 124

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
              R VHRDL   NI+     +     K+ DFG  + L +D+++   Y   E     ++ 
Sbjct: 125 GSKRYVHRDLATRNILV----ESENRVKIGDFGLTKVLPQDKEY---YKVREPGESPIFW 177

Query: 190 RAVLRKPVGKT---FGATVDLWSIGVTLYHVAT 219
            A    P   T   F    D+WS GV LY + T
Sbjct: 178 YA----PESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.0 bits (187), Expect = 9e-15
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 29/214 (13%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQM-REFEVLKKVKHENIVKLL 74
           +G GA G V++ +++  G   A+K    N    +R    Q+ RE E+L+ V H N+VK  
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR---RQICREIEILRDVNHPNVVKCH 138

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            + +   G  +V+ +E   GGSL       E T+   E+    V   + +G+ +L    +
Sbjct: 139 DMFD-HNGEIQVL-LEFMDGGSL-------EGTHIADEQFLADVARQILSGIAYLHRRHI 189

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM----SLYGTEEYLHPDMYER 190
           VHRD+KP N    + +    + K+ DFG +R L    Q M    S  GT  Y+ P   ER
Sbjct: 190 VHRDIKPSN---LLINSAKNV-KIADFGVSRIL---AQTMDPCNSSVGTIAYMSP---ER 239

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                  G   G   D+WS+GV++     G  PF
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 74.6 bits (183), Expect = 9e-15
 Identities = 67/231 (29%), Positives = 104/231 (45%), Gaps = 27/231 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G VF+G+ K  G     VA+KT       +     + E  ++ +  H NI++L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLV--LEHLTAGMKHLRD 131
             +  +   +  +I+ E    G+L   L D +  +      + LV  L  + AGMK+L D
Sbjct: 72  EGVVTKF--KPAMIITEYMENGALDKYLRDHDGEF----SSYQLVGMLRGIAAGMKYLSD 125

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY--- 188
              VHRDL   NI+     + +   K++DFG +R LE+D +    Y T     P  +   
Sbjct: 126 MNYVHRDLAARNILV----NSNLECKVSDFGLSRVLEDDPE--GTYTTSGGKIPIRWTAP 179

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           E    RK     F +  D+WS G+ ++ V +     RPY    N E M  I
Sbjct: 180 EAIAYRK-----FTSASDVWSFGIVMWEVMS--FGERPYWDMSNHEVMKAI 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.1 bits (184), Expect = 9e-15
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 20/208 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+TG V     K+ G+ VAVK  +     R  ++   E  +++   HEN+V +    
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR-RELLFNEVVIMRDYHHENVVDMYN-- 86

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GG+L +I+        + EE+   V   +   + +L +  ++HR
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQGVIHR 142

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  +I+  +  DG    KL+DFG  A+  +E  +  SL GT  ++ P++  R      
Sbjct: 143 DIKSDSIL--LTSDGRI--KLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL----- 193

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  VD+WS+G+ +  +  G  P+
Sbjct: 194 ---PYGTEVDIWSLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 31/212 (14%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVK-----TFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G  G V++      G  VA+K            +      +RE ++LKK+KH N+V 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPI----TALREIKILKKLKHPNVVP 71

Query: 73  LL--AIE---EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
           L+  A+E   + +  RG V ++       L  +L++P     L E +    +  L  G+ 
Sbjct: 72  LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYMLQLLEGIN 129

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           +L +N ++HRD+K  NI+  I + G  I K+ DFG AR  +         G         
Sbjct: 130 YLHENHILHRDIKAANIL--IDNQG--ILKIADFGLARPYDGPPP-NPKGGGGGGTRK-- 182

Query: 188 YERAVL----RKP---VG-KTFGATVDLWSIG 211
           Y   V+    R P   +G + +   VD+W IG
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIG 214

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 76.6 bits (188), Expect = 1e-14
 Identities = 73/279 (26%), Positives = 120/279 (43%), Gaps = 41/279 (14%)

Query: 10  YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHEN 69
           +++  T+++G+  T A F     ++ +   V  F  L+  R       E   L    H  
Sbjct: 67  HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFG 126

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLF-NILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           IVK    ++ +     +++ME  +GG L   I    +     QE E  L+   +   +  
Sbjct: 127 IVK--HFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDE 184

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF---MSLYGTEEYLHP 185
           +   +++HRDLK  NI  F+   G  I KL DFG +++  +        S  GT  YL P
Sbjct: 185 VHSRKMMHRDLKSANI--FLMPTG--IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP 240

Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS 245
           +++ER        K +    D+WS+GV LY + T +   RP+ G   +E M         
Sbjct: 241 ELWER--------KRYSKKADMWSLGVILYELLTLH---RPFKGPSQREIM--------- 280

Query: 246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILA 284
                 Q    G+ D     P  C +S G+K L+ P+L+
Sbjct: 281 ------QQVLYGKYD-----PFPCPVSSGMKALLDPLLS 308

Length = 478

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 34/210 (16%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKT--FNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G  G VF+  +K   + VA+K           P    +RE ++L+ +KHEN+V L+ 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIE 78

Query: 76  I---EEEQEGRGK---VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           I   +     R K    +V E C    L  +L +    + L   E   V++ L  G+ ++
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTL--SEIKKVMKMLLNGLYYI 135

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
             N+++HRD+K  NI+  I  DG  I KL DFG AR           +   +   P+ Y 
Sbjct: 136 HRNKILHRDMKAANIL--ITKDG--ILKLADFGLARA----------FSLSKNSKPNRYT 181

Query: 190 RAVL----RKP---VG-KTFGATVDLWSIG 211
             V+    R P   +G + +G  +D+W  G
Sbjct: 182 NRVVTLWYRPPELLLGERDYGPPIDMWGAG 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K  GE  A+K   +   ++   VQ   +E  +L ++ H  IV ++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKHLRD 131
               Q+      ++E   GG LF  L      P +       E +L  E+L     H +D
Sbjct: 86  --SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL-----HSKD 138

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
             +++RDLKP N++     D     K+TDFG A+++ +  +  +L GT EYL P++ +  
Sbjct: 139 --IIYRDLKPENLLL----DNKGHVKVTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQ-- 188

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                  K  G  VD W++GV LY    G  PF
Sbjct: 189 ------SKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 61/230 (26%), Positives = 108/230 (46%), Gaps = 44/230 (19%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN---QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G G+ GAV+   +    E VA+K  +   + S+ +  D+ ++E   L++++H N ++  
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVRFLQQLRHPNTIEYK 81

Query: 75  A--IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              + E        +VME C G S  +IL+   +   LQE E   +      G+ +L  +
Sbjct: 82  GCYLREHTAW----LVMEYCLG-SASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSH 134

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
             +HRD+K GNI+  + + G    KL DFG+A  +     F+   GT  ++ P++    +
Sbjct: 135 ERIHRDIKAGNIL--LTEPG--TVKLADFGSASLVSPANSFV---GTPYWMAPEV----I 183

Query: 193 LRKPVGKTFGATVDLWSIGVT-------------------LYHVATGNLP 223
           L    G+ +   VD+WS+G+T                   LYH+A  + P
Sbjct: 184 LAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 232

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 27/223 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +++KK++H+ +V L A+ 
Sbjct: 14  LGQGCFGEVWMG-TWNGTTKVAIKTLKP-GTMMP-EAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E    GSL + L + +  Y L+  + + +   +  GM ++     +HR
Sbjct: 71  SEEP---IYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMNYIHR 126

Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 127 DLRAANILVGDNLVC-------KIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 178

Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 179 R-----FTIKSDVWSFGILLTELVTKGRV---PYPGMVNREVL 213

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 49/231 (21%)

Query: 17  VLGKGATGAVFQGV---NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+GKG  G V+ G    +       AVK+ N+++ +   +  ++E  ++K   H N++ L
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENT--------YGLQEEEFLLVLEHLTAG 125
           L I    EG   V++  +   G L N +    +         +GLQ          +  G
Sbjct: 62  LGICLPSEGSPLVVLPYMKH-GDLRNFIRSETHNPTVKDLIGFGLQ----------VAKG 110

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M++L   + VHRDL   N M     D S   K+ DFG AR++ +          +EY   
Sbjct: 111 MEYLASKKFVHRDLAARNCML----DESFTVKVADFGLARDIYD----------KEYYSV 156

Query: 186 DMYERAVLRKPVG---------KTFGATVDLWSIGVTLYHVATGNLPFRPY 227
             +  A  + PV          + F    D+WS GV L+ + T   P  PY
Sbjct: 157 HNHTGA--KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 26/222 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           VLGKG  G V     +  G+  A K   +  +   +   + + E ++L+KV  + +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 75  AIEEEQEGRGKVIVMELCTGGSL-FNI--LDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
              E ++     +V+ +  GG L F+I  + +P    G +EE  L     +  G++ L  
Sbjct: 67  YAYETKDAL--CLVLTIMNGGDLKFHIYNMGNP----GFEEERALFYAAEILCGLEDLHR 120

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
              V+RDLKP NI+  + D G    +++D G A ++ E +      GT  Y+ P++    
Sbjct: 121 ENTVYRDLKPENIL--LDDYGHI--RISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN-- 174

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK 233
                  + +  + D W +G  +Y +  G  PFR   GR+ K
Sbjct: 175 ------NQRYTLSPDYWGLGCLIYEMIEGQSPFR---GRKEK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 26/225 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K  N+ +  + +   M E  ++  + H ++V+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE---HLTAGMKHL 129
           LL +      +   +V +L   G L + + + ++  G Q     L+L     +  GM +L
Sbjct: 74  LLGVCLSPTIQ---LVTQLMPHGCLLDYVHEHKDNIGSQ-----LLLNWCVQIAKGMMYL 125

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
            + RLVHRDL   N++           K+TDFG AR LE D++  +  G +  +     E
Sbjct: 126 EERRLVHRDLAARNVLV----KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
               RK     F    D+WS GVT++ + T     +PY G   +E
Sbjct: 182 CIHYRK-----FTHQSDVWSYGVTIWELMT--FGGKPYDGIPTRE 219

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 37/228 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVKHENIVKL 73
           +LGKG  G VF+G  K+   PVAVKT  +     P +++++   E  +LK+  H NIVKL
Sbjct: 2   LLGKGNFGEVFKGTLKDK-TPVAVKTCKE---DLPQELKIKFLSEARILKQYDHPNIVKL 57

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           + +  +++     IVMEL  GG   + L   ++   L+ ++ +       AGM +L    
Sbjct: 58  IGVCTQRQ--PIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLESKN 113

Query: 134 LVHRDLKPGNIMKFICDDG-STIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDM- 187
            +HRDL   N     C  G + + K++DFG +R  +ED    S  G ++    +  P+  
Sbjct: 114 CIHRDLAARN-----CLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEAL 166

Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
            Y R          + +  D+WS G+ L+   T +L   PY G  N++
Sbjct: 167 NYGR----------YSSESDVWSYGILLWE--TFSLGVCPYPGMTNQQ 202

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 20/208 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+TG V     K++G+ VAVK  +     R  ++   E  +++  +HEN+V++    
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMY--N 84

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GG+L +I+        + EE+   V   +   +  L    ++HR
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQGVIHR 140

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  +I+  +  DG    KL+DFG  A+  +E  +  SL GT  ++ P++  R      
Sbjct: 141 DIKSDSIL--LTHDGRV--KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL----- 191

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  VD+WS+G+ +  +  G  P+
Sbjct: 192 ---PYGPEVDIWSLGIMVIEMVDGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 23/223 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           VLGKG  G V     +  G+  A K   +    +     M   E ++L+KV    +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 75  AIEEEQEGRGKVIVMELCTGGSL-FNI--LDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
              E ++     +V+ L  GG L F+I  + +P    G  EE  +     +T G++ L  
Sbjct: 67  YAYETKDAL--CLVLTLMNGGDLKFHIYNMGNP----GFDEERAVFYAAEITCGLEDLHR 120

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            R+V+RDLKP NI+    DD   I +++D G A E+ E +      GT  Y+ P++ +  
Sbjct: 121 ERIVYRDLKPENIL---LDDYGHI-RISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK-- 174

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
                  + +  + D W +G  +Y +  G  PFR    +  +E
Sbjct: 175 ------NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE 211

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 70/227 (30%), Positives = 103/227 (45%), Gaps = 36/227 (15%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--------NQLSHMRPHDVQMREFEVLKKVKHEN 69
           +G+G  G VF    K+ GE VA+K          N++ H+      + E ++L   K E 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHV------LTERDILTTTKSEW 62

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           +VKLL     Q+     + ME   GG    +L+   N   L E+     +  +   +  L
Sbjct: 63  LVKLLY--AFQDDEYLYLAMEYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDAL 117

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
            +   +HRDLKP N   F+ D    I KLTDFG ++ +       S+ G+ +Y+ P+   
Sbjct: 118 HELGYIHRDLKPEN---FLIDASGHI-KLTDFGLSKGIVTYAN--SVVGSPDYMAPE--- 168

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
             VLR   GK +  TVD WS+G  LY    G   F P+ G    ET 
Sbjct: 169 --VLR---GKGYDFTVDYWSLGCMLYEFLCG---FPPFSGSTPNETW 207

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G V++  N N GE  A+K   +L       V  +E  ++K  KH NIV      
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVI-KLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG-- 73

Query: 78  EEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
                R K+ I ME C GGSL +I      T  L E +   V      G+ +L     +H
Sbjct: 74  -SYLRRDKLWICMEFCGGGSLQDIY---HVTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RD+K  NI+  + D+G    KL DFG + ++     +  S  GT  ++ P++   AV RK
Sbjct: 130 RDIKGANIL--LTDNGHV--KLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERK 183

Query: 196 PVGKTFGATVDLWSIGVTLYHVA 218
                +    D+W++G+T   +A
Sbjct: 184 ---GGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 72.5 bits (178), Expect = 6e-14
 Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 30/213 (14%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL---- 73
           +G+G+TG V    +K+ G  VAVK  +     R  ++   E  +++  +H NIV++    
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR-RELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDN 132
           L  +E        +VME   GG+L +I+     T+  + EE+   V   +   +  L   
Sbjct: 86  LVGDELW------VVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHAQ 134

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERA 191
            ++HRD+K  +I+  +  DG    KL+DFG   ++ ++  +  SL GT  ++ P++    
Sbjct: 135 GVIHRDIKSDSIL--LTSDGRV--KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEV---- 186

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + R P    +G  VD+WS+G+ +  +  G  P+
Sbjct: 187 ISRLP----YGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 33/226 (14%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G    +   VA+K+  Q S M P +  + E  ++K+++H  +V+L A+ 
Sbjct: 14  LGAGQFGEVWMGYYNGH-TKVAIKSLKQGS-MSP-EAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  PE    L   + + +   +  GM  +     +HR
Sbjct: 71  TQEP---IYIITEYMENGSLVDFLKTPEGI-KLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERA 191
           DL+  NI+      C       K+ DFG AR L ED ++ +  G +   ++  P+     
Sbjct: 127 DLRAANILVSETLCC-------KIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG 178

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                   TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 179 --------TFTIKSDVWSFGILLTEIVTYGRI---PYPGMTNPEVI 213

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 24/221 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +G+G    V++     +G PVA+K       M        ++E ++LK++ H N++K  A
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 76  --IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRDN 132
             IE+ +      IV+EL   G L  ++   +    L  E+ +      L + ++H+   
Sbjct: 70  SFIEDNELN----IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYERA 191
           R++HRD+KP N+  FI   G  + KL D G  R          SL GT  Y+ P+     
Sbjct: 126 RVMHRDIKPANV--FITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
                 G  F +  D+WS+G  LY +A    PF  YG + N
Sbjct: 182 ------GYNFKS--DIWSLGCLLYEMAALQSPF--YGDKMN 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 34/227 (14%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHENIVKL 73
           LG G  G V+ G   NN   VAVKT      ++P  + ++ F     ++K ++H+ +V+L
Sbjct: 14  LGAGQFGEVWMGY-YNNSTKVAVKT------LKPGTMSVQAFLEEANLMKTLQHDKLVRL 66

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A+  ++E     I+ E    GSL + L   E    +   + +     +  GM ++    
Sbjct: 67  YAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERKN 123

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYER 190
            +HRDL+  N++       S + K+ DFG AR + ED ++ +  G +   ++  P+    
Sbjct: 124 YIHRDLRAANVLV----SESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINF 178

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                    +F    D+WS G+ LY + T G +   PY G  N + M
Sbjct: 179 G--------SFTIKSDVWSFGILLYEIVTYGKI---PYPGMSNSDVM 214

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 71/232 (30%), Positives = 108/232 (46%), Gaps = 39/232 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVL-KKVKHENIVKL 73
           V+GKG+ G V    +K +G+  AVK   + + ++  + +  M E  VL K VKH  +V L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLL------VLEHLTAGM 126
               +  +   K+  V++   GG LF         + LQ E              + + +
Sbjct: 62  HYSFQTAD---KLYFVLDYVNGGELF---------FHLQRERSFPEPRARFYAAEIASAL 109

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHP 185
            +L    +++RDLKP NI+  +   G  +  LTDFG  +E  E  +  S + GT EYL P
Sbjct: 110 GYLHSLNIIYRDLKPENIL--LDSQGHVV--LTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165

Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           +     VLRK   + +  TVD W +G  LY +  G  PF  Y   R+   MY
Sbjct: 166 E-----VLRK---QPYDRTVDWWCLGAVLYEMLYGLPPF--YS--RDTAEMY 205

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 21/209 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +GKG+ G V++G++    E VA+K  + + +     D+Q +E  VL +     I +    
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYITRYYG- 69

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
               +G    I+ME   GGS  ++L        L+E     +L  +  G+ +L   R +H
Sbjct: 70  -SYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSERKIH 124

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRK 195
           RD+K  N++  + + G    KL DFG A +L + Q +  +  GT  ++ P++ +++    
Sbjct: 125 RDIKAANVL--LSEQGDV--KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS---- 176

Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                +    D+WS+G+T   +A G  P 
Sbjct: 177 ----AYDFKADIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 23/223 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           VLGKG  G V     +  G+  A K   +  +   +   + + E  +L+KV    +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 75  AIEEEQEGRGKVIVMELCTGGSL-FNI--LDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
              E ++     +V+ +  GG L F+I  + +P    G  E+  +     L  G++ L+ 
Sbjct: 67  YAYETKDAL--CLVLTIMNGGDLKFHIYNMGNP----GFDEQRAIFYAAELCCGLEDLQR 120

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            R+V+RDLKP NI+    DD   I +++D G A ++ E +      GT  Y+ P++    
Sbjct: 121 ERIVYRDLKPENIL---LDDRGHI-RISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN-- 174

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
                  + +  + D W +G  +Y +  G  PFR    R  +E
Sbjct: 175 ------NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE 211

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 19/212 (8%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           VLGKG  G V     +  G+  A K   +  +   +   + + E ++L+KV    +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 75  AIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              E ++     +V+ L  GG L F+I    E   G +E   +     +  G++ L   R
Sbjct: 67  YAYETKDAL--CLVLTLMNGGDLKFHIYHMGEA--GFEEGRAVFYAAEICCGLEDLHQER 122

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +V+RDLKP NI+    DD   I +++D G A  + E Q      GT  Y+ P++ +    
Sbjct: 123 IVYRDLKPENIL---LDDHGHI-RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK---- 174

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                + +  + D W++G  LY +  G  PF+
Sbjct: 175 ----NERYTFSPDWWALGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 38/230 (16%)

Query: 17  VLGKGATGAVFQGVNKN-NGE--PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
            +G+G  G V+QGV  +   E   VAVKT    +     +  ++E  ++++  H +IVKL
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           + +  E       IVMEL   G L + L    N Y L     +L    L+  + +L   R
Sbjct: 73  IGVITENP---VWIVMELAPLGELRSYLQ--VNKYSLDLASLILYSYQLSTALAYLESKR 127

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            VHRD+   N++  +        KL DFG +R LE+          E Y     Y+ +  
Sbjct: 128 FVHRDIAARNVL--VSS--PDCVKLGDFGLSRYLED----------ESY-----YKASKG 168

Query: 194 RKPVG---------KTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           + P+          + F +  D+W  GV ++ +    L  +P+ G +N +
Sbjct: 169 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL--MLGVKPFQGVKNND 216

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 21/208 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +GKG+ G VF+G++    + VA+K  + + +     D+Q +E  VL +     + K    
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYVTKYYG- 69

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
               +G    I+ME   GGS  ++L          E +   +L+ +  G+ +L   + +H
Sbjct: 70  -SYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHSEKKIH 124

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRK 195
           RD+K  N++  + + G    KL DFG A +L + Q +  +  GT  ++ P++ +++    
Sbjct: 125 RDIKAANVL--LSEQGDV--KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS---- 176

Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLP 223
                + +  D+WS+G+T   +A G  P
Sbjct: 177 ----AYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 33/220 (15%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 71

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +      +     L +   +++ M++L     +HR
Sbjct: 72  TREPPF--YIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKNFIHR 128

Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEED-------QQFMSLYGTEEYLHPDMYE 189
           DL   N     C  G   + K+ DFG +R +  D        +F   +   E L      
Sbjct: 129 DLAARN-----CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL------ 177

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
                      F    D+W+ GV L+ +AT  +   PY G
Sbjct: 178 -------AYNKFSIKSDVWAFGVLLWEIATYGMS--PYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 30/200 (15%)

Query: 21  GATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD-----VQMREFEVLKKVKHENIVKLLA 75
           G  G V++  +K  GE VA+K   +L  M           +RE  +L K++H NIV    
Sbjct: 16  GTYGVVYRARDKKTGEIVALK---KLK-MEKEKEGFPITSLREINILLKLQHPNIVT--- 68

Query: 76  IEEEQEGRG--KV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           ++E   G    K+ +VME      L ++++  +  +   E + L++   L +G+ HL DN
Sbjct: 69  VKEVVVGSNLDKIYMVME-YVEHDLKSLMETMKQPFLQSEVKCLML--QLLSGVAHLHDN 125

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERA 191
            ++HRDLK  N++     +   I K+ DFG ARE     + +  L  T  Y  P++   A
Sbjct: 126 WILHRDLKTSNLLL----NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181

Query: 192 VLRKPVGKTFGATVDLWSIG 211
                  K +   +D+WS+G
Sbjct: 182 -------KEYSTAIDMWSVG 194

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 66/251 (26%), Positives = 119/251 (47%), Gaps = 29/251 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN---QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G G+ GAV+   N +  E VAVK  +   + ++ +  D+ ++E + L+++KH N ++  
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDI-IKEVKFLQQLKHPNTIEYK 87

Query: 75  AIEEEQEGRGKVIVMELCTGGS--LFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
               ++      +VME C G +  L  +   P     LQE E   +      G+ +L  +
Sbjct: 88  GCYLKEHT--AWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHGALQGLAYLHSH 140

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRD+K GNI+  + + G    KL DFG+A +      F+   GT  ++ P++    +
Sbjct: 141 NMIHRDIKAGNIL--LTEPGQV--KLADFGSASKSSPANSFV---GTPYWMAPEV----I 189

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
           L    G+ +   VD+WS+G+T   +A    P            +Y+I    +  + S   
Sbjct: 190 LAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPTLQSNEW 245

Query: 253 T-SENGEIDWC 262
           T S  G +D+C
Sbjct: 246 TDSFRGFVDYC 256

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 71.2 bits (175), Expect = 3e-13
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 30/204 (14%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF-----NQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           +G+GA G V    N    E VA+K       N++   R     +RE ++L+ + HEN++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKR----TLREIKLLRHLDHENVIA 68

Query: 73  LLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           +  I      +      IV EL     L  I+   +    L ++     L  L  G+K++
Sbjct: 69  IKDIMPPPHREAFNDVYIVYEL-MDTDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYI 124

Query: 130 RDNRLVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDM 187
               ++HRDLKP N++    CD      K+ DFG AR   E   FM+ Y  T  Y  P++
Sbjct: 125 HSANVLHRDLKPSNLLLNANCD-----LKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179

Query: 188 YERAVLRKPVGKTFGATVDLWSIG 211
                        +   +D+WS+G
Sbjct: 180 LLNC-------SEYTTAIDVWSVG 196

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 44/236 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V +G  K  G+    VA+KT    S  +     + E  ++ +  H NI++L
Sbjct: 11  VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +    + R  +I+ E    GSL   L   EN       + + +L  + +GMK+L +  
Sbjct: 71  EGVV--TKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 134 LVHRDLKPGNI---MKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
            VHRDL   NI      +C       K++DFG +R LE+ +                Y  
Sbjct: 127 YVHRDLAARNILVNSNLVC-------KVSDFGLSRRLEDSE--------------ATYTT 165

Query: 191 AVLRKPVGKT---------FGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
              + P+  T         F +  D+WS G+ ++ V + G    RPY    N++ +
Sbjct: 166 KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE---RPYWDMSNQDVI 218

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 24/221 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +G+G    V++     + +PVA+K       M     Q  ++E ++LK++ H N++K L 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 76  --IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRDN 132
             IE+ +      IV+EL   G L  ++   +    L  E  +      L + ++H+   
Sbjct: 70  SFIEDNELN----IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMSLYGTEEYLHPDMYERA 191
           R++HRD+KP N+  FI   G  + KL D G  R    +     SL GT  Y+ P+     
Sbjct: 126 RVMHRDIKPANV--FITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
                 G  F +  D+WS+G  LY +A    PF  YG + N
Sbjct: 182 ------GYNFKS--DIWSLGCLLYEMAALQSPF--YGDKMN 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 70.8 bits (173), Expect = 4e-13
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 25/214 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +   G  VAVK  ++    + H  +  RE  +LK V H+NI+ LL +
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL        I  +      L  E    +L  +  G+KHL   
Sbjct: 89  FTPQKSLEEFQDVYLVMELMDANLCQVIHME------LDHERMSYLLYQMLCGIKHLHSA 142

Query: 133 RLVHRDLKPGNI-MKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            ++HRDLKP NI +K  C       K+ DFG AR    +        T  Y  P++    
Sbjct: 143 GIIHRDLKPSNIVVKSDC-----TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI--- 194

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                +G  +   VD+WS+G  +  +  G++ F+
Sbjct: 195 -----LGMGYKENVDIWSVGCIMGELVKGSVIFQ 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 70.5 bits (172), Expect = 5e-13
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV--QMREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K +G+  A+K   +   +   +V   + E  VLK  +H  +  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              + ++      VME   GG LF  L   E  +   E+        + + + +L   ++
Sbjct: 62  YSFQTKDRL--CFVMEYVNGGELFFHLSR-ERVF--SEDRTRFYGAEIVSALDYLHSGKI 116

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           V+RDLK  N+M  +  DG    K+TDFG  +E   D   M  + GT EYL P++ E    
Sbjct: 117 VYRDLKLENLM--LDKDGHI--KITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE---- 168

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                  +G  VD W +GV +Y +  G LPF
Sbjct: 169 ----DNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.0 bits (171), Expect = 6e-13
 Identities = 66/218 (30%), Positives = 98/218 (44%), Gaps = 33/218 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVL-KKVKHENIVKL 73
           V+GKG+ G V     K++G   AVK   + + ++  +    M E  VL K +KH  +V L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL------VLEHLTAGMK 127
                 Q       V++   GG LF         + LQ E   L          + + + 
Sbjct: 62  HY--SFQTAEKLYFVLDYVNGGELF---------FHLQRERCFLEPRARFYAAEVASAIG 110

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPD 186
           +L    +++RDLKP NI+     D      LTDFG  +E +E ++   +  GT EYL P+
Sbjct: 111 YLHSLNIIYRDLKPENILL----DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE 166

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                VLRK   + +  TVD W +G  LY +  G  PF
Sbjct: 167 -----VLRK---EPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 69.8 bits (171), Expect = 9e-13
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 48/231 (20%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL- 74
           LG G+ G VF  V+ +  + VAVK   ++    P  V+  +RE ++++++ H+NIVK+  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69

Query: 75  -----------AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
                       +    E     IV E      L N+L+       L EE   L +  L 
Sbjct: 70  VLGPSGSDLTEDVGSLTELNSVYIVQE-YMETDLANVLEQGP----LSEEHARLFMYQLL 124

Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED---QQFMSLYGTE 180
            G+K++    ++HRDLKP N+  FI  +   + K+ DFG AR ++     + ++S     
Sbjct: 125 RGLKYIHSANVLHRDLKPANV--FINTE-DLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 181 EY-------LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++       L P+ Y +A             +D+W+ G     + TG   F
Sbjct: 182 KWYRSPRLLLSPNNYTKA-------------IDMWAAGCIFAEMLTGKPLF 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 69.6 bits (170), Expect = 1e-12
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 24/227 (10%)

Query: 17  VLGKGATGAVF---QGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVKHENI 70
           VLG GA G VF   +    + G+  A+K   + + ++          E  VL+ V+    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           +  L    + E +  +I ++  +GG +F  L   +N     E+E       +   ++HL 
Sbjct: 67  LVTLHYAFQTEAKLHLI-LDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLH 122

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL--EEDQQFMSLYGTEEYLHPDMY 188
              +V+RD+K  NI+  +  +G  +  LTDFG ++E   EE ++  S  GT EY+ P+  
Sbjct: 123 KLGIVYRDIKLENIL--LDSEGHVV--LTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-- 176

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKET 235
              ++R   G   G  VD WS+G+ ++ + TG  PF    G RN ++
Sbjct: 177 ---IIRGKGGH--GKAVDWWSLGILIFELLTGASPF-TLEGERNTQS 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 36/230 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+   +GE    PVA+K   + +  + +   + E  V+  V    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL I      +   +V +L   G L + + + ++  G Q+   L     +  GM +L + 
Sbjct: 74  LLGICLTSTVQ---LVTQLMPYGCLLDYVRENKDRIGSQD--LLNWCVQIAKGMSYLEEV 128

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD------ 186
           RLVHRDL   N++           K+TDFG AR L+ D+         EY H D      
Sbjct: 129 RLVHRDLAARNVLV----KSPNHVKITDFGLARLLDIDET--------EY-HADGGKVPI 175

Query: 187 --MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
             M   ++L     + F    D+WS GVT++ + T     +PY G   +E
Sbjct: 176 KWMALESILH----RRFTHQSDVWSYGVTVWELMT--FGAKPYDGIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.6 bits (167), Expect = 1e-12
 Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 21/208 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +GKG+ G VF+G++    + VA+K  + + +     D+Q +E  VL +     + K    
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYVTKYYG- 69

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
               +     I+ME   GGS  ++L+       L E +   +L  +  G+ +L   + +H
Sbjct: 70  -SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSEKKIH 124

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVLRK 195
           RD+K  N++  + + G    KL DFG A +L + Q   + + GT  ++ P++ +++    
Sbjct: 125 RDIKAANVL--LSEHGEV--KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS---- 176

Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLP 223
                + +  D+WS+G+T   +A G  P
Sbjct: 177 ----AYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 21/212 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQ---LSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+GKG+ G V     K +G+  AVK   +   L+      +      +LK VKH  +V L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
                 Q       V++   GG LF  L   E ++      F      + + + +L    
Sbjct: 62  HY--SFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAA--EIASALGYLHSIN 116

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAV 192
           +V+RDLKP NI+     D      LTDFG  +E + +     +  GT EYL P+     V
Sbjct: 117 IVYRDLKPENILL----DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPE-----V 167

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +RK   + +  TVD W +G  LY +  G  PF
Sbjct: 168 IRK---QPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 45/268 (16%)

Query: 20  KGATGAVFQGVNKNNGEPVAVKTF--------NQLSHMRPHDVQMREFEVLKKVKHENIV 71
           KGA G+V+    ++ G+  A+K          NQ+++++     M     + + +   + 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM-----MIQGESPYVA 60

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           KL      Q      +VME   GG   +++   +   GL E+     +  +  G++ L  
Sbjct: 61  KLYY--SFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEVVLGVEDLHQ 115

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
             ++HRD+KP N++     D +   KLTDFG +R   E+++F+   GT +YL P+     
Sbjct: 116 RGIIHRDIKPENLLI----DQTGHLKLTDFGLSRNGLENKKFV---GTPDYLAPETIL-- 166

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT 251
                 G       D WS+G  ++    G  PF       + ET   +     S  I+  
Sbjct: 167 ------GVGDDKMSDWWSLGCVIFEFLFGYPPF-------HAETPDAVFDNILSRRINWP 213

Query: 252 QTSENGEIDWCTDLPN-----NCQLSLG 274
           +  +        DL N     +    LG
Sbjct: 214 EEVKEFCSPEAVDLINRLLCMDPAKRLG 241

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 21/226 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEP--VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LG G  G V +GV K   +   VA+K     +     D  MRE E++ ++ +  IV+++ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           + E +     ++VME+ +GG L   L   ++   +     + ++  ++ GMK+L     V
Sbjct: 63  VCEAE---ALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEGKNFV 117

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY-LHPDMYERAVLR 194
           HRDL   N++           K++DFG ++ L  D  +       ++ L     E    R
Sbjct: 118 HRDLAARNVLLV----NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 195 KPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRRNKETMYYI 239
           K     F +  D+WS G+T++   + G    +PY   +  E M +I
Sbjct: 174 K-----FSSRSDVWSYGITMWEAFSYGQ---KPYKKMKGPEVMSFI 211

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 43/250 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL I      +   ++ +L   G L + + + ++  G Q    L     +  GM +L + 
Sbjct: 74  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYLEER 128

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           RLVHRDL   N++           K+TDFG A+ L  D++        EY H +  +  +
Sbjct: 129 RLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGADEK--------EY-HAEGGKVPI 175

Query: 193 ----LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI 248
               L   + + +    D+WS GVT++ + T     +PY G         I   + S ++
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS--KPYDG---------IPASEISSIL 224

Query: 249 SGTQTSENGE 258
                 E GE
Sbjct: 225 ------EKGE 228

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKT----FNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           +G GA G+V    +    + VAVK     F  L H R      RE  +LK +KHEN++ L
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR---TYRELRLLKHMKHENVIGL 79

Query: 74  LAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           L +       E   +V ++    G  L NI+        L +E    ++  L  G+K++ 
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGADLNNIV----KCQKLSDEHVQFLIYQLLRGLKYIH 135

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              ++HRDLKP N+   + +D     ++ DFG AR  + D +      T  Y  P++   
Sbjct: 136 SAGIIHRDLKPSNVA--VNEDCE--LRILDFGLAR--QADDEMTGYVATRWYRAPEIMLN 189

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +        +  TVD+WS+G  +  +  G   F
Sbjct: 190 WM-------HYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 20/216 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH-ENIVKLLA 75
           ++G G  G V++G +   G+  A+K  + ++     +++ +E  +LKK  H  NI     
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIK-QEINMLKKYSHHRNIATYYG 70

Query: 76  --IEEEQEGRGKVI--VMELCTGGSLFNILDDPENTYG--LQEEEFLLVLEHLTAGMKHL 129
             I++   G    +  VME C  GS+ +++   +NT G  L+EE    +   +  G+ HL
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMY 188
             ++++HRD+K  N++  + ++     KL DFG + +L+    +  +  GT  ++ P++ 
Sbjct: 128 HQHKVIHRDIKGQNVL--LTENAEV--KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             A    P   T+    DLWS+G+T   +A G  P 
Sbjct: 184 --ACDENP-DATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 67/218 (30%), Positives = 95/218 (43%), Gaps = 34/218 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV--QMREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G+  A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL-------DDPENTYGLQEEEFLLVLEHLTAGMK 127
              +  +      VME   GG LF  L       +D    YG    E +  L +L     
Sbjct: 62  YSFQTHDRL--CFVMEYANGGELFFHLSRERVFSEDRARFYG---AEIVSALGYL----- 111

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPD 186
           H  D  +V+RDLK  N+M  +  DG    K+TDFG  +E   D   M  + GT EYL P+
Sbjct: 112 HSCD--VVYRDLKLENLM--LDKDGHI--KITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + E           +G  VD W +GV +Y +  G LPF
Sbjct: 166 VLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 68/219 (31%), Positives = 99/219 (45%), Gaps = 36/219 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV--QMREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H     L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF---LT 58

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNIL-------DDPENTYGLQEEEFLLVLEHLTAGM 126
           A++   +   ++  VME   GG LF  L       ++    YG    E +  LE+L    
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG---AEIVSALEYL---- 111

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHP 185
            H RD  +V+RD+K  N+M  +  DG    K+TDFG  +E   D   M  + GT EYL P
Sbjct: 112 -HSRD--VVYRDIKLENLM--LDKDGHI--KITDFGLCKEGISDGATMKTFCGTPEYLAP 164

Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++ E           +G  VD W +GV +Y +  G LPF
Sbjct: 165 EVLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 34/222 (15%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVK---------TFNQLSHMRPHDVQMREFEVLKKVKHE 68
           LGKG  G+V++ +++  G  +A+K          FNQ+         + E ++L K    
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQI---------IMELDILHKAVSP 59

Query: 69  NIVKLL-AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM 126
            IV    A   E    G V + ME    GSL  +      T G+ E+    +   +  G+
Sbjct: 60  YIVDFYGAFFIE----GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115

Query: 127 KHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           K L++   ++HRD+KP N++    +    + KL DFG +  L       ++ G + Y+ P
Sbjct: 116 KFLKEEHNIIHRDVKPTNVL---VNGNGQV-KLCDFGVSGNLVASLAKTNI-GCQSYMAP 170

Query: 186 DMYERAVLRKPVGK-TFGATVDLWSIGVTLYHVATGNLPFRP 226
              ER     P    T+    D+WS+G+++  +A G  P+ P
Sbjct: 171 ---ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 27/227 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V  G  +   + VA+K  N+ + M   D  + E +V+ K+ H  +V+L  + 
Sbjct: 12  LGSGQFGVVHLGKWRAQIK-VAIKAINEGA-MSEEDF-IEEAKVMMKLSHPKLVQLYGVC 68

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            +Q  +   IV E    G L N L   +    L ++  L + + +  GM++L  N  +HR
Sbjct: 69  TQQ--KPLYIVTEFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL   N +  +   G  + K++DFG  R + +D ++ S  G +   ++  P+++      
Sbjct: 125 DLAARNCL--VSSTG--VVKVSDFGMTRYVLDD-EYTSSSGAKFPVKWSPPEVFNF---- 175

Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYIT 240
                 + +  D+WS GV ++ V T G +PF       N E +  I+
Sbjct: 176 ----SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMIS 215

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 23/213 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVKL 73
           VLGKG+ G V     K   E  AVK   +   ++  DV+  M E  VL    KH  + +L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 74  LAIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
            +  + ++      VME   GG L F+I           E         +  G++ L + 
Sbjct: 62  HSCFQTKDRL--FFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHER 115

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERA 191
            +++RDLK  N++     D     K+ DFG  +E +       +  GT +Y+ P+     
Sbjct: 116 GIIYRDLKLDNVLL----DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPE----- 166

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +L     + +G  VD W++GV LY +  G  PF
Sbjct: 167 ILS---YQPYGPAVDWWALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 37/222 (16%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM------REFEVLKKVKHEN 69
           S +G GA G V    +   G  VA+K        RP    +      RE  +LK + HEN
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKL-----SRPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 70  IVKLLAI----EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           ++ LL +       ++ +   +V  L  G  L NI+        L ++    ++  +  G
Sbjct: 76  VIGLLDVFTPASSLEDFQDVYLVTHL-MGADLNNIV----KCQKLSDDHIQFLVYQILRG 130

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLH 184
           +K++    ++HRDLKP NI   + +D     K+ DFG AR  +++   M+ Y  T  Y  
Sbjct: 131 LKYIHSAGIIHRDLKPSNIA--VNEDCE--LKILDFGLARHTDDE---MTGYVATRWYRA 183

Query: 185 PD-MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           P+ M             +  TVD+WS+G  +  + TG   F 
Sbjct: 184 PEIMLNWM--------HYNQTVDIWSVGCIMAELLTGKTLFP 217

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 67.0 bits (163), Expect = 6e-12
 Identities = 71/231 (30%), Positives = 102/231 (44%), Gaps = 37/231 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVL-KKVKHENIVKL 73
           V+GKG+ G V    +K   +  AVK   + + ++  + +  M E  VL K VKH  +V L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL------VLEHLTAGMK 127
                 Q       V++   GG LF         Y LQ E   L          + + + 
Sbjct: 62  HF--SFQTADKLYFVLDYINGGELF---------YHLQRERCFLEPRARFYAAEIASALG 110

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPD 186
           +L    +V+RDLKP NI+  +   G  +  LTDFG  +E +E +    +  GT EYL P+
Sbjct: 111 YLHSLNIVYRDLKPENIL--LDSQGHIV--LTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
                VL K   + +  TVD W +G  LY +  G  PF      RN   MY
Sbjct: 167 -----VLHK---QPYDRTVDWWCLGAVLYEMLYGLPPFY----SRNTAEMY 205

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 64/243 (26%), Positives = 112/243 (46%), Gaps = 29/243 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN---QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G G+ GAV+   +  N E VA+K  +   + S+ +  D+ ++E   L+K++H N ++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-IKEVRFLQKLRHPNTIQYR 81

Query: 75  AIEEEQEGRGKVIVMELCTGGS--LFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
                +      +VME C G +  L  +   P     LQE E   V      G+ +L  +
Sbjct: 82  GCYLREHT--AWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLHSH 134

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRD+K GNI+  + + G  + KL DFG+A  +     F+   GT  ++ P++    +
Sbjct: 135 NMIHRDVKAGNIL--LSEPG--LVKLGDFGSASIMAPANXFV---GTPYWMAPEV----I 183

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
           L    G+ +   VD+WS+G+T   +A    P        N  +  Y   +  S  +    
Sbjct: 184 LAMDEGQ-YDGKVDVWSLGITCIELAERKPPLF----NMNAMSALYHIAQNESPALQSGH 238

Query: 253 TSE 255
            SE
Sbjct: 239 WSE 241

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 30/217 (13%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD-------VQMREFEVLKKVKHENI 70
           +G+G  G VF+  N+   E VA+K       +R  D         +RE  +LK++KH+NI
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALK------RVRLDDDDEGVPSSALREICLLKELKHKNI 61

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           V+L  +      +   +V E C    L    D       +  E     +  L  G+    
Sbjct: 62  VRLYDVLHSD--KKLTLVFEYCDQ-DLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCH 116

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYE 189
            + ++HRDLKP N++  I  +G    KL DFG AR      + + +   T  Y  PD+  
Sbjct: 117 SHNVLHRDLKPQNLL--INKNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 172

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
            A       K +  ++D+WS G     +A    P  P
Sbjct: 173 GA-------KLYSTSIDMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 66.3 bits (161), Expect = 1e-11
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 25/227 (11%)

Query: 3   FLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFN---QLSHMRPHDVQMREF 59
           F +     ++     +G G+ GAV+   +    E VA+K  +   + S+ +  D+ ++E 
Sbjct: 18  FFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEV 76

Query: 60  EVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGS--LFNILDDPENTYGLQEEEFLL 117
           + L+++KH N ++       +      +VME C G +  L  +   P     LQE E   
Sbjct: 77  KFLQRIKHPNSIEYKGCYLREHT--AWLVMEYCLGSASDLLEVHKKP-----LQEVEIAA 129

Query: 118 VLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY 177
           +      G+ +L  + ++HRD+K GNI+  + + G    KL DFG+A        F+   
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNIL--LTEPGQV--KLADFGSASIASPANSFV--- 182

Query: 178 GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           GT  ++ P++    +L    G+ +   VD+WS+G+T   +A    P 
Sbjct: 183 GTPYWMAPEV----ILAMDEGQ-YDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 57/216 (26%), Positives = 108/216 (50%), Gaps = 20/216 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIVKLLA 75
           V+G G  G V++G +   G+  A+K  + ++     ++++ E  +LKK  H  NI     
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKL-EINMLKKYSHHRNIATYYG 80

Query: 76  --IEEEQEGRGKVI--VMELCTGGSLFNILDDPENTYG--LQEEEFLLVLEHLTAGMKHL 129
             I++   G    +  VME C  GS+ +++   +NT G  L+E+    +   +  G+ HL
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLV---KNTKGNALKEDWIAYICREILRGLAHL 137

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMY 188
             ++++HRD+K  N++  + ++     KL DFG + +L+    +  +  GT  ++ P++ 
Sbjct: 138 HAHKVIHRDIKGQNVL--LTENAEV--KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             A    P   T+    D+WS+G+T   +A G  P 
Sbjct: 194 --ACDENP-DATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +GKG  G V+Q   K+     A+K  ++          + + EV   +   NI+    ++
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK-------KEIVAKKEVAHTIGERNILVRTLLD 53

Query: 78  EE----------QEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
           E           Q      +V +  +GG LF  L   E  +     +F +    L   ++
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIA--ELVLALE 110

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR-ELEEDQQFMSLYGTEEYLHPD 186
           HL    +V+RDLKP NI+     D +    L DFG ++  L +++   +  GT EYL P+
Sbjct: 111 HLHKYDIVYRDLKPENILL----DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                VL    G  +   VD WS+GV ++ +  G  PF
Sbjct: 167 -----VLLDEKG--YTKHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 34/218 (15%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM------REFEVLKKVKHENIV 71
           +G GA G+V   ++K  GE VA+K  +     RP   ++      RE  +LK ++HEN++
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLS-----RPFQSEIFAKRAYRELTLLKHMQHENVI 77

Query: 72  KLLAIEEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            LL +        E +   +VM       L  I+  P     L E++   ++  +  G+K
Sbjct: 78  GLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMGHP-----LSEDKVQYLVYQMLCGLK 131

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           ++    ++HRDLKPGN+   + +D     K+ DFG AR    D +      T  Y  P++
Sbjct: 132 YIHSAGIIHRDLKPGNLA--VNEDCE--LKILDFGLAR--HADAEMTGYVVTRWYRAPEV 185

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
               +        +  TVD+WS+G  +  + TG   F+
Sbjct: 186 ILNWM-------HYNQTVDIWSVGCIMAEMLTGKTLFK 216

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 34/219 (15%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQL-SHMRPHDVQMREFEVLKKVKHENIVKLL 74
            V+GKG+ G V   ++ + GE VA+K  N +  H+      +RE ++L+ ++H +IV++ 
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 75  AI---EEEQEGRGKVIVMELCTGGSLFNIL---DDPENTYGLQEEEFLLVLEHLTAGMKH 128
            I      +E +   +V EL     L  ++   DD      L  E     L  L   +K+
Sbjct: 66  HIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDD------LTPEHHQFFLYQLLRALKY 118

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED---QQFMSLY-GTEEYLH 184
           +    + HRDLKP NI+     +     K+ DFG AR    D     F + Y  T  Y  
Sbjct: 119 IHTANVFHRDLKPKNILA----NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 185 PDMYERAVLRKPVGKTFG---ATVDLWSIGVTLYHVATG 220
           P++          G  F      +D+WSIG     V TG
Sbjct: 175 PEL---------CGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 33/234 (14%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHEN 69
           V+G G  G V  G  K  G+   PVA+KT  +  +    + Q R+F     ++ +  H N
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYT---EKQRRDFLSEASIMGQFDHPN 66

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           I+ L  +    + +  +IV E    GSL   L   +  + + +   + +L  + +GMK+L
Sbjct: 67  IIHLEGVV--TKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMKYL 122

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY- 188
            D   VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  + 
Sbjct: 123 SDMGYVHRDLAARNILV----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWT 176

Query: 189 --ERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYI 239
             E    RK     F +  D+WS G+ ++ V + G    RPY    N++ +  I
Sbjct: 177 APEAIAYRK-----FTSASDVWSYGIVMWEVMSYGE---RPYWEMSNQDVIKAI 222

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.1 bits (162), Expect = 1e-11
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 48/214 (22%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDVQ--MREFEVLKKVK-HENIVKL 73
           LGKGA G V++ +++   E VA+K  F+   +    D Q   RE   L+++  H NIVKL
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGDHPNIVKL 72

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLF-----------NILDDPENTYGLQEEEFLLVLEHL 122
           L + + +  +   +V E       +           NIL+D    Y         ++  L
Sbjct: 73  LNVIKAENDKDIYLVFE-------YMETDLHAVIRANILEDVHKRY---------IMYQL 116

Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR---ELEEDQQFMSLYGT 179
              +K++    ++HRDLKP NI+    +    + KL DFG AR   ELEE+ +   L   
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNIL---LNSDCRV-KLADFGLARSLSELEENPENPVL--- 169

Query: 180 EEYLHPDMYERA--VLRKPVGKTFGATVDLWSIG 211
            +Y+    Y RA  +L      T G  VD+WS+G
Sbjct: 170 TDYVATRWY-RAPEILLGSTRYTKG--VDMWSVG 200

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 64/212 (30%), Positives = 92/212 (43%), Gaps = 21/212 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           VLGKG+ G V     K  GE  AVK   +   +   DV+  M E  VL  +  EN     
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLA-LAWENPFLTH 60

Query: 75  AIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
                Q       VME   GG L F+I D  +  + L    F      +  G++ L    
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAA--EIVCGLQFLHSKG 116

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAV 192
           +++RDLK  N+M     D     K+ DFG  +E +  D +  +  GT +Y+ P++ +   
Sbjct: 117 IIYRDLKLDNVML----DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ--- 169

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                G  +  +VD WS GV LY +  G  PF
Sbjct: 170 -----GLKYTFSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 29/217 (13%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKT--FNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G  G V++  +  +GE VA+K    +      P    +RE  +L  ++H NIV+L  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPIS-SLREITLLLNLRHPNIVELKE 73

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           +   +      +VME C    L ++LD+    +   E +   ++  L  G+++L +N ++
Sbjct: 74  VVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPF--SESQVKCLMLQLLRGLQYLHENFII 130

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS------LYGTEEYLHPDMYE 189
           HRDLK  N++  + D G    K+ DFG AR      + M+       Y   E L      
Sbjct: 131 HRDLKVSNLL--LTDKG--CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC--- 183

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
                     T+   +D+W++G  L  +     P  P
Sbjct: 184 ---------TTYTTAIDMWAVGCILAELLAHK-PLLP 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 68/226 (30%), Positives = 103/226 (45%), Gaps = 26/226 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD-VQMREFEVLKKVKHENIVKLLAI 76
           LG+G    VF+G +K     VA+K   +L H        +RE  +LK +KH NIV L  I
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +  R   +V E      L   LD+  N   +   +  +    L  G+ +    +++H
Sbjct: 72  IHTE--RCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF--QLLRGLSYCHKRKILH 126

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I + G    KL DFG AR      + + +   T  Y  PD+        
Sbjct: 127 RDLKPQNLL--INEKGE--LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL------- 175

Query: 196 PVGKT-FGATVDLWSIGVTLYHVATGNLPFRP-YGGRRNKETMYYI 239
            +G T +   +D+W +G  LY +ATG    RP + G   KE ++ I
Sbjct: 176 -LGSTEYSTPIDMWGVGCILYEMATG----RPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 30/213 (14%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHENIVK 72
            +GKG  G V  G     G  VAVK          +D   + F     V+ +++H N+V+
Sbjct: 13  TIGKGEFGDVMLG--DYRGNKVAVKCIK-------NDATAQAFLAEASVMTQLRHSNLVQ 63

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL +  E++G G  IV E    GSL + L     +  L  +  L     +   M++L  N
Sbjct: 64  LLGVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEAN 121

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
             VHRDL   N++  + +D   + K++DFG  +E    Q    L    ++  P+      
Sbjct: 122 NFVHRDLAARNVL--VSED--NVAKVSDFGLTKEASSTQDTGKL--PVKWTAPE-----A 170

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
           LR+   K F    D+WS G+ L+ + + G +P+
Sbjct: 171 LRE---KKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 33/218 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVKL 73
           +LGKG+ G VF    K   +  A+K   +   +   DV+  M E  VL    +H  +  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 74  LAIEEEQEGRGKVIVMELCTGGSL-FNI-----LDDPENTYGLQEEEFLLVLEHLTAGMK 127
               + +E      VME   GG L F+I      D P  T+   E         +  G++
Sbjct: 62  YCTFQTKENL--FFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE---------IICGLQ 110

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPD 186
            L    +V+RDLK  NI+  +  DG    K+ DFG  +E +  D +  +  GT +Y+ P+
Sbjct: 111 FLHSKGIVYRDLKLDNIL--LDTDGHI--KIADFGMCKENMLGDAKTCTFCGTPDYIAPE 166

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +         +G+ +  +VD WS GV LY +  G  PF
Sbjct: 167 IL--------LGQKYNTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 27/219 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV---QMREFEVLKKVKHEN-IVKL 73
           +G+G  G V++  +KN G+ VA+K       M    +    +RE  +L+ +     IV+L
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 74  LAIEEEQEGRGKV---IVME-LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           L +E  +E  GK    +V E L +    F   +       L  +     +  L  G+ H 
Sbjct: 67  LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP--DM 187
             + ++HRDLKP N++    D    + K+ D G  R              + Y H    +
Sbjct: 127 HKHGVMHRDLKPQNLL---VDKQKGLLKIADLGLGRAFS--------IPVKSYTHEIVTL 175

Query: 188 YERA--VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + RA  VL       +   VD+WS+G     ++     F
Sbjct: 176 WYRAPEVLLG--STHYSTPVDIWSVGCIFAEMSRKQPLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G V++  N + GE  AVK   +L       +  +E  ++K+ KH NIV      
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKII-KLEPGDDFSLIQQEIFMVKECKHCNIVAYFG-- 73

Query: 78  EEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
                R K+ I ME C GGSL +I      T  L E +   V      G+ +L     +H
Sbjct: 74  -SYLSREKLWICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RD+K  NI+  + D+G    KL DFG A ++     +  S  GT  ++ P   E A + K
Sbjct: 130 RDIKGANIL--LTDNGDV--KLADFGVAAKITATIAKRKSFIGTPYWMAP---EVAAVEK 182

Query: 196 PVGKTFGATVDLWSIGVTLYHVA 218
             G  +    D+W++G+T   +A
Sbjct: 183 NGG--YNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 48/208 (23%), Positives = 91/208 (43%), Gaps = 26/208 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAI 76
           +G+G    V +  ++  G+  A+K   +          +RE + L+++  H NI++L+ +
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             +++     +V EL    +L+ ++        L E+     +  L   + H+  N + H
Sbjct: 67  LFDRKTGRLALVFEL-MDMNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFH 123

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP-----DMYERA 191
           RD+KP NI+  I DD   I KL DFG+ R +     +     T  Y  P     D Y   
Sbjct: 124 RDIKPENIL--IKDD---ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGY--- 175

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT 219
                    +G  +D+W++G   + + +
Sbjct: 176 ---------YGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 33/218 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV--QMREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL-------DDPENTYGLQEEEFLLVLEHLTAGMK 127
              +  +      VME   GG LF  L       +D    YG    E +  L++L +   
Sbjct: 62  YSFQTHDRL--CFVMEYANGGELFFHLSRERVFSEDRARFYG---AEIVSALDYLHS--- 113

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPD 186
              +  +V+RDLK  N+M  +  DG    K+TDFG  +E  +D   M  + GT EYL P+
Sbjct: 114 ---EKNVVYRDLKLENLM--LDKDGHI--KITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + E           +G  VD W +GV +Y +  G LPF
Sbjct: 167 VLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 45/212 (21%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM------REFEVLKKVKHEN 69
             +G GA G V    +   G+ VA+K   +LS  RP           RE  ++K V H+N
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIK---KLS--RPFQNVTHAKRAYRELVLMKLVNHKN 76

Query: 70  IVKLL-------AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           I+ LL       ++EE Q+     +VMEL    +L  ++        L  E    +L  +
Sbjct: 77  IIGLLNVFTPQKSLEEFQD---VYLVMELMDA-NLCQVIQ-----MDLDHERMSYLLYQM 127

Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             G+KHL    ++HRDLKP NI+  +  D +   K+ DFG AR        M+ Y    Y
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCT--LKILDFGLARTAGTS-FMMTPYVVTRY 182

Query: 183 LHPDMYERAVLRKP---VGKTFGATVDLWSIG 211
                      R P   +G  +   VD+WS+G
Sbjct: 183 ----------YRAPEVILGMGYKENVDIWSVG 204

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 67/286 (23%), Positives = 110/286 (38%), Gaps = 67/286 (23%)

Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           +G+GA G VFQ         EP   VAVK   + +         RE  ++ +  H NIVK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD-------------------PENTYGLQEE 113
           LL +     G+   ++ E    G L   L                       N   L   
Sbjct: 73  LLGVC--AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 114 EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF 173
           E L + + + AGM +L + + VHRDL   N +       + + K+ DFG +R +     +
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV----GENMVVKIADFGLSRNIYS-ADY 185

Query: 174 MSLYGTE----EYLHPD--MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
                 +     ++ P+   Y R          +    D+W+ GV L+ + +  +  +PY
Sbjct: 186 YKASENDAIPIRWMPPESIFYNR----------YTTESDVWAYGVVLWEIFSYGM--QPY 233

Query: 228 GGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSL 273
            G  ++E +YY+                +G +  C   P+NC L L
Sbjct: 234 YGMAHEEVIYYV---------------RDGNVLSC---PDNCPLEL 261

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 18/215 (8%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKL 73
           S++G+G  G V     K  G+  A+K   +   +    V     E ++L       I +L
Sbjct: 7   SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL--LVLEHLTAGMKHLRD 131
                 Q+     +VME   GG L ++L    N Y  Q +E +    L  L   +  +  
Sbjct: 67  QY--AFQDKDNLYLVMEYQPGGDLLSLL----NRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY--GTEEYLHPDMYE 189
              VHRD+KP N++     D +   KL DFG+A  L  ++   S    GT +Y+ P++  
Sbjct: 121 MGYVHRDIKPENVLI----DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              +      T+G   D WS+GV  Y +  G  PF
Sbjct: 177 --TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 18  LGKGATGAVFQGVNKN-NGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           LG G+ G V     KN +  PVA+K F +   ++   V     E ++L  + H   V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKHLR 130
              +++      +V+E   GG  F  L      P +       + +L+ E+L       +
Sbjct: 98  GSFKDESYL--YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL-------Q 148

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              +V+RDLKP N++     D     K+TDFG A+ +  D +  +L GT EY+ P++   
Sbjct: 149 SLNIVYRDLKPENLLL----DKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPEILLN 202

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                 VG   G   D W++G+ +Y +  G  PF
Sbjct: 203 ------VGH--GKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 43/233 (18%)

Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIV 71
           T  ++  GA GAV+   +K   +  A+K  N+ + +  + +Q    E ++L   ++  +V
Sbjct: 5   TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVV 64

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMK 127
            +    E +  R   +VME   GG    +L +    P +   +   E +L LE+L     
Sbjct: 65  SMFCSFETK--RHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYL----- 117

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR-------------ELEED-QQF 173
              +  +VHRDLKP N++  I   G    KLTDFG ++              +E+D ++F
Sbjct: 118 --HNYGIVHRDLKPDNLL--ITSMGHI--KLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171

Query: 174 M--SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +   + GT EY+ P++    +LR+  GK     VD W++G+ LY    G +PF
Sbjct: 172 LDKQVCGTPEYIAPEV----ILRQGYGKP----VDWWAMGIILYEFLVGCVPF 216

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 23/213 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVK-HENIVKL 73
           VLGKG+ G V     K +G   AVK   +   ++  DV+  M E  +L   + H  + +L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 74  LAIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
               +  +      VME   GG L F+I    + +    E         +T+ +  L D 
Sbjct: 62  YCCFQTPDRL--FFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEITSALMFLHDK 115

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERA 191
            +++RDLK  N++  +  +G    KL DFG  +E   + +  S + GT +Y+ P++ +  
Sbjct: 116 GIIYRDLKLDNVL--LDHEGHC--KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +        +G +VD W++GV LY +  G+ PF
Sbjct: 172 L--------YGPSVDWWAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 29/217 (13%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKT----FNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 23  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR---TYRELRLLKHMKHENVI 79

Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 80  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 135

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDM 187
           +    ++HRDLKP N+   + +D     K+ DFG AR  +++   M+ Y  T  Y  P++
Sbjct: 136 IHSADIIHRDLKPSNLA--VNEDCE--LKILDFGLARHTDDE---MTGYVATRWYRAPEI 188

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +        +  TVD+WS+G  +  + TG   F
Sbjct: 189 MLNWM-------HYNQTVDIWSVGCIMAELLTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S +G+GA G V    +K  G  VA+K  +   H       +RE ++L++ KHENI+ +L 
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILD 70

Query: 76  I---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           I      +      IV EL     L+ ++     T  L  +     L  +  G+K++   
Sbjct: 71  IIRPPSFESFNDVYIVQELME-TDLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSA 125

Query: 133 RLVHRDLKPGNIM-KFICDDGSTIYKLTDFGAAR---ELEEDQQFMSLY-GTEEYLHPDM 187
            ++HRDLKP N++    CD      K+ DFG AR      +   F++ Y  T  Y  P++
Sbjct: 126 NVLHRDLKPSNLLLNTNCD-----LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTL 214
              +       K +   +D+WS+G  L
Sbjct: 181 MLNS-------KGYTKAIDIWSVGCIL 200

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 71/242 (29%), Positives = 110/242 (45%), Gaps = 32/242 (13%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD-VQMREFEVLKKVKHENIVKLLAI 76
           LG+G    V++G +K     VA+K   +L H        +RE  +LK +KH NIV L  I
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +  +   +V E      L   LDD  N+  +   +  L L  L  G+ +    +++H
Sbjct: 73  IHTE--KSLTLVFEYLDK-DLKQYLDDCGNSINMHNVK--LFLFQLLRGLNYCHRRKVLH 127

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I + G    KL DFG AR      + + +   T  Y  PD+        
Sbjct: 128 RDLKPQNLL--INERGE--LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL------- 176

Query: 196 PVGKT-FGATVDLWSIGVTLYHVATGNLPFRP-YGGRRNKETMYYITTKKASGVISGTQT 253
            +G T +   +D+W +G   Y ++TG    RP + G   +E +++I        I GT T
Sbjct: 177 -LGSTDYSTQIDMWGVGCIFYEMSTG----RPLFPGSTVEEQLHFIFR------ILGTPT 225

Query: 254 SE 255
            E
Sbjct: 226 EE 227

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 33/216 (15%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQ-----------MREFEVLKK 64
           LG+G  G V +  +   G+ VA+K     ++S+    D Q           +RE +++ +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 65  VKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           +KHENI+ L+ +  E +     +VM++     L  ++D       L E +   +L  +  
Sbjct: 77  IKHENIMGLVDVYVEGDFIN--LVMDI-MASDLKKVVD---RKIRLTESQVKCILLQILN 130

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
           G+  L     +HRDL P NI  FI   G  I K+ DFG AR       +      +E + 
Sbjct: 131 GLNVLHKWYFMHRDLSPANI--FINSKG--ICKIADFGLARRYGYP-PYSDTLSKDETMQ 185

Query: 185 P--DMYERAV---LRKP---VGKT-FGATVDLWSIG 211
              +M  + V    R P   +G   +   VD+WS+G
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221

Length = 335

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 31/216 (14%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKSLEEFQDVYIVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145

Query: 133 RLVHRDLKPGNI-MKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            ++HRDLKP NI +K  C       K+ DFG AR            GT   + P +  R 
Sbjct: 146 GIIHRDLKPSNIVVKSDC-----TLKILDFGLARTA----------GTSFMMTPYVVTR- 189

Query: 192 VLRKP---VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             R P   +G  +   VD+WS+G  +  +  G + F
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 26/218 (11%)

Query: 17  VLGKGATGAVF---QGVNKNNGEPVAVKTFNQ---LSHMRPHDVQMREFEVLKKVKHENI 70
           VLG GA G VF   +    ++G+  A+K   +   +   +  +    E +VL+ ++    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           +  L    + + +  +I ++   GG LF  L   E     +E+E  +    +   ++HL 
Sbjct: 67  LVTLHYAFQTDTKLHLI-LDYINGGELFTHLSQRER---FKEQEVQIYSGEIVLALEHLH 122

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED--QQFMSLYGTEEYLHPDMY 188
              +++RD+K  NI+  +  +G  +  LTDFG ++E  ED  ++  S  GT EY+ PD+ 
Sbjct: 123 KLGIIYRDIKLENIL--LDSNGHVV--LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 189 ERAVLRKPVGKTFG--ATVDLWSIGVTLYHVATGNLPF 224
                    G   G    VD WS+GV +Y + TG  PF
Sbjct: 179 R--------GGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 15/212 (7%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           V+G+GA G V     KN  +  A+K  N+   ++  +      E +VL    ++ I  L 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
                Q+     +VM+   GG L  +L   E+   L E+     L  +   +  +     
Sbjct: 68  Y--AFQDENNLYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYLAEMVIAIDSVHQLHY 123

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS--LYGTEEYLHPDMYERAV 192
           VHRD+KP NI+     D +   +L DFG+  +L ED    S    GT +Y+ P++ +   
Sbjct: 124 VHRDIKPDNILM----DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ--A 177

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +    GK +G   D WS+GV +Y +  G  PF
Sbjct: 178 MEDGKGK-YGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 29/217 (13%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL- 74
           S LG G  G VF+  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 11  SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKHLR 130
           A   + E     I ME   GGSL  +L      PE   G        V   +  G+ +LR
Sbjct: 71  AFYSDGE---ISICMEHMDGGSLDQVLKKAGRIPEQILGK-------VSIAVIKGLTYLR 120

Query: 131 D-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
           + ++++HRD+KP NI+  +   G    KL DFG + +L  D    S  GT  Y+ P+  +
Sbjct: 121 EKHKIMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ 175

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
                   G  +    D+WS+G++L  +A G  P  P
Sbjct: 176 --------GTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 21/226 (9%)

Query: 18  LGKGATGAVFQGV--NKNNGEPVAVKTF-NQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           LG G  G V +G+   K + + VAVK   N  +     D  +RE  V++++ +  IV+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            I    E    ++VMEL   G L   L   ++   + E+    ++  ++ GMK+L +   
Sbjct: 63  GI---CEAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEETNF 116

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP-DMYERAVL 193
           VHRDL   N++           K++DFG ++ L  D+ +       ++  P   Y    +
Sbjct: 117 VHRDLAARNVLLVT----QHYAKISDFGLSKALGADENYYKAKTHGKW--PVKWYAPECM 170

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  F +  D+WS GV ++   +     +PY G +  E    I
Sbjct: 171 NY---YKFSSKSDVWSFGVLMWEAFSYGQ--KPYKGMKGNEVTQMI 211

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 5e-11
 Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 30/234 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV--------LKKVK-H 67
           VLG GATG V      ++GEP AVK  + +  M   D    + EV           VK H
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFSIVKCH 97

Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGM 126
           E+  K      E       +V++    G L   I    +     +E E  L+   +   +
Sbjct: 98  EDFAKKDPRNPENVLM-IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE---EDQQFMSLYGTEEYL 183
            H+    ++HRD+K  NI+  +C +G  + KL DFG ++       D    +  GT  Y+
Sbjct: 157 HHVHSKHMIHRDIKSANIL--LCSNG--LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
            P+++     RKP  K      D++S+GV LY + T     RP+ G   +E M+
Sbjct: 213 APEIWR----RKPYSK----KADMFSLGVLLYELLTLK---RPFDGENMEEVMH 255

Length = 496

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 63.0 bits (153), Expect = 6e-11
 Identities = 63/230 (27%), Positives = 110/230 (47%), Gaps = 33/230 (14%)

Query: 18  LGKGATGAVFQGVNKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           LG G  G V  G  K  G+  VA+K   + S     D  + E +V+ K+ HE +V+L  +
Sbjct: 12  LGTGQFGVVKYG--KWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             +Q  R   IV E  + G L N L   E+    Q  + L + + +  GM +L   + +H
Sbjct: 68  CTKQ--RPIYIVTEYMSNGCLLNYLR--EHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPD--MYERA 191
           RDL   N +  + D G    K++DFG +R + +D ++ S  G++    +  P+  +Y + 
Sbjct: 124 RDLAARNCL--VDDQG--CVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSK- 177

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYIT 240
                    F +  D+W+ GV ++ V + G +P+  +    N ET+  ++
Sbjct: 178 ---------FSSKSDVWAFGVLMWEVYSLGKMPYERF---NNSETVEKVS 215

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 64.2 bits (156), Expect = 7e-11
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 33/218 (15%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM------REFEVLKKVKHENIV 71
           +G GA G V   +++  G  VA+K        RP   ++      RE  +LK +KHEN++
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLY-----RPFQSELFAKRAYRELRLLKHMKHENVI 77

Query: 72  KLLAIEEEQEGRGKV----IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            LL +        +     +VM    G  L  ++   +    L E+    ++  +  G+K
Sbjct: 78  GLLDVFTPDLSLDRFHDFYLVMPF-MGTDLGKLMKHEK----LSEDRIQFLVYQMLKGLK 132

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           ++    ++HRDLKPGN+   + +D     K+ DFG AR  + D +      T  Y  P++
Sbjct: 133 YIHAAGIIHRDLKPGNLA--VNEDCE--LKILDFGLAR--QTDSEMTGYVVTRWYRAPEV 186

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
               +        +  TVD+WS+G  +  + TG   F+
Sbjct: 187 ILNWM-------HYTQTVDIWSVGCIMAEMLTGKPLFK 217

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 8e-11
 Identities = 65/247 (26%), Positives = 98/247 (39%), Gaps = 55/247 (22%)

Query: 13  CTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENI 70
               V+G+GA G V+   +K+ G+  A+K   +   ++ + +     E ++L       I
Sbjct: 4   EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWI 63

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEE---FLLVLEHLTAGMK 127
           VKL    +++E     +VME   GG L N+L        +  EE   F +    L   + 
Sbjct: 64  VKLYYSFQDEEHL--YLVMEYMPGGDLMNLL----IRKDVFPEETARFYIA--ELVLALD 115

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA------------RELEEDQQFM- 174
            +     +HRD+KP NI+  I  DG    KL DFG                   +  F  
Sbjct: 116 SVHKLGFIHRDIKPDNIL--IDADGHI--KLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 175 -----------------SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHV 217
                            S  GT +Y+ P+     VLR   G  +G   D WS+GV LY +
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPE-----VLR---GTPYGLECDWWSLGVILYEM 223

Query: 218 ATGNLPF 224
             G  PF
Sbjct: 224 LYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 63.9 bits (155), Expect = 8e-11
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 26/216 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           V+G+GA G V    +K+  +  A+K  ++   ++  D      E +++       +V+L 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL---DDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
                Q+ R   +VME   GG L N++   D PE        E +L L+ +         
Sbjct: 110 Y--AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAI-------HS 160

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM--SLYGTEEYLHPDMYE 189
              +HRD+KP N++     D S   KL DFG   ++ ++      +  GT +Y+ P+   
Sbjct: 161 MGFIHRDVKPDNMLL----DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE--- 213

Query: 190 RAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
             VL+   G  + G   D WS+GV LY +  G+ PF
Sbjct: 214 --VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 64.0 bits (156), Expect = 9e-11
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 28/217 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKL- 73
           V+G+GA G V    +K++ +  A+K  ++   ++  D      E +++     E IV+L 
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNIL---DDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
            A    Q+ +   +VME   GG L N++   D PE        E +L L+ +        
Sbjct: 110 YAF---QDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAI-------H 159

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS--LYGTEEYLHPDMY 188
               +HRD+KP N++     D S   KL DFG   +++ +         GT +Y+ P+  
Sbjct: 160 SMGFIHRDVKPDNMLL----DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE-- 213

Query: 189 ERAVLRKPVGK-TFGATVDLWSIGVTLYHVATGNLPF 224
              VL+   G   +G   D WS+GV LY +  G+ PF
Sbjct: 214 ---VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +GKG+ G V Q   ++     A+KT  +   +   +V   + E  VL +V    IV L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-- 58

Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +   +   K+ +V+    GG LF+ L   E  + L    F      L   +++L    +
Sbjct: 59  -KFSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTA--ELLCALENLHKFNV 114

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAAR-ELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++RDLKP NI+     D      L DFG  +  +++D +  +  GT EYL P++      
Sbjct: 115 IYRDLKPENILL----DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELL----- 165

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              +G  +   VD W++GV LY + TG  PF
Sbjct: 166 ---LGHGYTKAVDWWTLGVLLYEMLTGLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 60/247 (24%), Positives = 101/247 (40%), Gaps = 53/247 (21%)

Query: 16  SVLGKGATGAVFQGVNKN-NGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI 70
             LG+G  G V +       G      VAVK   + +        + EF +LK+V H ++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 71  VKL-----------LAIEEEQEG--RG------KVIVMELCTGGSLFNILDDPENTYGLQ 111
           +KL           L +E  + G  R       KV    L + G+  +   D  +   L 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 112 EEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ 171
             + +     ++ GM++L + +LVHRDL   N++     +G    K++DFG +R++ E+ 
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL---VAEGR-KMKISDFGLSRDVYEED 181

Query: 172 QFMSLYGTEEYLHPDMYERAVLRKPV---------GKTFGATVDLWSIGVTLYHVATGNL 222
            ++              +R+  R PV            +    D+WS GV L+ + T  L
Sbjct: 182 SYV--------------KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--L 225

Query: 223 PFRPYGG 229
              PY G
Sbjct: 226 GGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 33/218 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLK-KVKHENIVKL 73
           VLGKG+ G V     K   E  A+K   +   ++  DV   M E  +L    KH  +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 74  LAIEEEQEGRGKVIVMELCTGGSL-FNI-----LDDPENTYGLQEEEFLLVLEHLTAGMK 127
               + ++      VME   GG L F I      D+P + +   E         +T  + 
Sbjct: 62  HCCFQTKDRL--FFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAE---------VTLALM 110

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPD 186
            L  + +++RDLK  NI+     D     KL DFG  +E +       +  GT +Y+ P+
Sbjct: 111 FLHRHGVIYRDLKLDNILL----DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + +           +G +VD W++GV +Y +  G  PF
Sbjct: 167 ILQE--------LEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 29/233 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHEN 69
           V+G G  G V +G  K  G+    VA+KT       +    Q R+F     ++ +  H N
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK----QRRDFLSEASIMGQFDHPN 66

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           I+ L  +  +   R  +I+ E    G+L + L   +  + + +   + +L  + AGMK+L
Sbjct: 67  IIHLEGVVTKS--RPVMIITEFMENGALDSFLRQNDGQFTVIQ--LVGMLRGIAAGMKYL 122

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPD 186
            +   VHRDL   NI+     + + + K++DFG +R LE+D     + S  G +  +   
Sbjct: 123 SEMNYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
             E    RK     F +  D+WS G+ ++ V +     RPY    N++ +  I
Sbjct: 179 APEAIAYRK-----FTSASDVWSYGIVMWEVMS--YGERPYWDMSNQDVINAI 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 17/213 (7%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL- 73
           V+G+GA G V     K+     A+K  N+   ++  +      E  VL     + I  L 
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A ++E       +VM+   GG L  +L   E+   L E+     +  +   +  +    
Sbjct: 68  YAFQDENY---LYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYIAEMVLAIHSIHQLH 122

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS--LYGTEEYLHPDMYERA 191
            VHRD+KP N++     D +   +L DFG+  ++ +D    S    GT +Y+ P++ +  
Sbjct: 123 YVHRDIKPDNVLL----DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ-- 176

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +   +GK +G   D WS+GV +Y +  G  PF
Sbjct: 177 AMEDGMGK-YGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 64.0 bits (155), Expect = 2e-10
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 28/229 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR-EFEVLKKVKHENIVKLLAI 76
           +G G  G VF   +K   E    K  +          Q+  E  V++++KH+NIV+ +  
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL----VLEHLTAGMKHLRD- 131
              +  +   I+ME C  G L   +      +G  EE  ++     L H  A   +L+D 
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140

Query: 132 ---NRLVHRDLKPGNIM---------KFICD----DGSTIYKLTDFGAARELEEDQQFMS 175
               R++HRDLKP NI          K        +G  I K+ DFG ++ +  +    S
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHS 200

Query: 176 LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             GT  Y  P++           K++    D+W++G  +Y + +G  PF
Sbjct: 201 CVGTPYYWSPELLLHET------KSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 27/213 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD----VQMREFEVLKKVKHENIVKL 73
           LG+G+   V++G+++ NG+ VA+K       M+  +      +RE  +LK +KH NIV L
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIVLL 68

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             I   +E      V E         ++  P    GL      L +  L  G+ ++    
Sbjct: 69  HDIIHTKETL--TFVFEYMHTDLAQYMIQHPG---GLHPYNVRLFMFQLLRGLAYIHGQH 123

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAV 192
           ++HRDLKP N++  I   G    KL DFG AR      Q + S   T  Y  PD+     
Sbjct: 124 ILHRDLKPQNLL--ISYLGE--LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL---- 175

Query: 193 LRKPVGKT-FGATVDLWSIGVTLYHVATGNLPF 224
               +G T + + +D+W  G     +  G   F
Sbjct: 176 ----LGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 25/212 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G+   V++G +K NG+ VA+K              +RE  +LK +KH NIV L  I 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 78  EEQEGRGKV---IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
             +E    V   +  +LC        +D  ++  GL  E   L L  L  G+ ++    +
Sbjct: 73  HTKETLTLVFEYVHTDLC------QYMD--KHPGGLHPENVKLFLFQLLRGLSYIHQRYI 124

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVL 193
           +HRDLKP N++  I D G    KL DFG AR        + +   T  Y  PD+      
Sbjct: 125 LHRDLKPQNLL--ISDTGE--LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL----- 175

Query: 194 RKPVGKT-FGATVDLWSIGVTLYHVATGNLPF 224
              +G T +   +D+W +G     +  G   F
Sbjct: 176 ---LGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 68/223 (30%), Positives = 100/223 (44%), Gaps = 37/223 (16%)

Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQ--MREFEVLKKVKHEN 69
               LG G  G V + +++ +G  +A K    L H+  +P      +RE +VL +     
Sbjct: 5   KLGELGAGNGGVVTKVLHRPSGLIMARK----LIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 70  IVKLL-AIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTA 124
           IV    A   + E     I ME   GGSL  +L      PEN  G   +  + VL     
Sbjct: 61  IVGFYGAFYSDGE---ISICMEHMDGGSLDQVLKKAGRIPENILG---KISIAVLR---- 110

Query: 125 GMKHLRDNR-LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
           G+ +LR+   ++HRD+KP NI+  +   G    KL DFG + +L  D    S  GT  Y+
Sbjct: 111 GLTYLREKHKIMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DSMANSFVGTRSYM 165

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
            P   ER       G  +    D+WS+G++L  +A G  P  P
Sbjct: 166 SP---ERLQ-----GTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 37/209 (17%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVK---HENIVKL 73
           +G GA G V++  + ++G  VA+K+    ++     +  +RE  +LK+++   H NIV+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 74  LAI----EEEQEGRGKVIVMELCTGGSLFNILDDPENTY-------GLQEEEFLLVLEHL 122
           + +      ++E +  ++          F  +D    TY       GL  E    ++   
Sbjct: 68  MDVCATSRTDRETKVTLV----------FEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF 117

Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             G+  L  N +VHRDLKP NI+      G  + KL DFG AR          +  T  Y
Sbjct: 118 LRGLDFLHANCIVHRDLKPENIL---VTSGGQV-KLADFGLARIYSCQMALTPVVVTLWY 173

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIG 211
             P++  ++        T+   VD+WS+G
Sbjct: 174 RAPEVLLQS--------TYATPVDMWSVG 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 64/254 (25%), Positives = 116/254 (45%), Gaps = 51/254 (20%)

Query: 18  LGKGATGAVFQG----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LG+ A G +++G       ++ + VA+KT   +++ +      +E  ++ ++ H NIV L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 74  L-AIEEEQEGRGKVIVMELCTGGSL--FNILDDPENTYGLQEEE------------FLLV 118
           L  + +EQ      ++ E    G L  F I+  P +  G   +E            FL +
Sbjct: 73  LGVVTQEQP---VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 119 LEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY-KLTDFGAARELEEDQQFMSLY 177
              + AGM++L  +  VH+DL   NI+      G  ++ K++D G +RE         +Y
Sbjct: 130 AIQIAAGMEYLSSHFFVHKDLAARNILI-----GEQLHVKISDLGLSRE---------IY 175

Query: 178 GTEEY-LHPD-------MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
             + Y + P        M   A++    GK F +  D+WS GV L+ + +  L  +PY G
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIM---YGK-FSSDSDIWSFGVVLWEIFSFGL--QPYYG 229

Query: 230 RRNKETMYYITTKK 243
             N+E +  +  ++
Sbjct: 230 FSNQEVIEMVRKRQ 243

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 62.0 bits (150), Expect = 4e-10
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 26/216 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           V+G+GA G V    +K++ +  A+K  ++   ++  D      E +++       +V+L 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL---DDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
                Q+ +   +VME   GG L N++   D PE        E +L L+ +         
Sbjct: 110 C--AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAI-------HS 160

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM--SLYGTEEYLHPDMYE 189
             L+HRD+KP N++     D     KL DFG   +++E       +  GT +Y+ P+   
Sbjct: 161 MGLIHRDVKPDNMLL----DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPE--- 213

Query: 190 RAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
             VL+   G  + G   D WS+GV L+ +  G+ PF
Sbjct: 214 --VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 25/223 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 85  FTPQKSLEEFQDVYLVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 138

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI+           K+ DFG AR             T  Y  P++     
Sbjct: 139 GIIHRDLKPSNIVV----KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 190

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 191 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 21/213 (9%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL- 74
           S LG G  G V +  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 11  SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NR 133
           A   + E     I ME   GGSL  +L + +    + EE    V   +  G+ +LR+ ++
Sbjct: 71  AFYSDGE---ISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQ 124

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+  +   G    KL DFG + +L  D    S  GT  Y+ P+  +    
Sbjct: 125 IMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ---- 175

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
               G  +    D+WS+G++L  +A G  P  P
Sbjct: 176 ----GTHYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 38/223 (17%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKH-ENIVK 72
           +G+GA G V + ++K +G  +AVK    T ++    R     + + +V+ +      IVK
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKR----LLMDLDVVMRSSDCPYIVK 67

Query: 73  LL-AIEEEQEGRGKVIVMELCTGGSL-------FNILDD--PENTYGLQEEEFLLVLEHL 122
              A+  E +     I MEL    SL       + +L    PE   G      +  L +L
Sbjct: 68  FYGALFREGDC---WICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123

Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
                   + +++HRD+KP NI+    D    I KL DFG + +L +        G   Y
Sbjct: 124 K------EELKIIHRDVKPSNIL---LDRNGNI-KLCDFGISGQLVDSIAKTRDAGCRPY 173

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           + P   ER  +       +    D+WS+G+TLY VATG  P+ 
Sbjct: 174 MAP---ER--IDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.6 bits (147), Expect = 9e-10
 Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 21/213 (9%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL 73
            VLGKG+ G V     K   E  A+K   +   ++  DV+  M E  VL        +  
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQ 65

Query: 74  LAIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L    +   R    VME   GG L ++I    +     +E   +     +  G+  L   
Sbjct: 66  LHSCFQTMDR-LYFVMEYVNGGDLMYHI----QQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERA 191
            +++RDLK  N+M     D     K+ DFG  +E +   +   +  GT +Y+ P++    
Sbjct: 121 GIIYRDLKLDNVML----DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEI---- 172

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +  +P GK+    VD W+ GV LY +  G  PF
Sbjct: 173 IAYQPYGKS----VDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 50/248 (20%)

Query: 17  VLGKGATGAVFQG-VNKNNGEP--VAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIV 71
           +LG+G  G+V +G +++++G    VAVKT     H    +++  + E   +K   H N++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNVM 64

Query: 72  KLLAIEEEQEGRGK----VIVMELCTGGSLFNIL------DDPENTYGLQEEEFLLVLEH 121
           KL+ +  E     K    ++++     G L + L        PE    L  +  L  +  
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK---LPLQTLLKFMVD 121

Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE 181
           +  GM++L +   +HRDL   N M     +  T+  + DFG ++++              
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCM---LREDMTVC-VADFGLSKKIYSG----------- 166

Query: 182 YLHPDMYERAVLRK-PV---------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR 231
               D Y +  + K PV          + + +  D+W+ GVT++ +AT      PY G  
Sbjct: 167 ----DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT--PYPGVE 220

Query: 232 NKETMYYI 239
           N E   Y+
Sbjct: 221 NHEIYDYL 228

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 44/232 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQM---REFEVLKKVKHE 68
            LG+G  G VF    K   E      V VK    L   +  ++Q    RE ++ +K+ H+
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKA---LQKTKDENLQSEFRRELDMFRKLSHK 68

Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNIL------DDPENTYGLQEEEFLLVLEHL 122
           N+V+LL +  E E     +++E    G L   L      D+      L  ++ + +   +
Sbjct: 69  NVVRLLGLCREAEPH--YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GM HL + R VHRDL   N +           K++    +++         +Y +E Y
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVS----SQREVKVSLLSLSKD---------VYNSEYY 173

Query: 183 LHPD-------MYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRP 226
              +       +   AV        F    D+WS GV ++ V T G LPF  
Sbjct: 174 KLRNALIPLRWLAPEAVQE----DDFSTKSDVWSFGVLMWEVFTQGELPFYG 221

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 67/241 (27%), Positives = 101/241 (41%), Gaps = 52/241 (21%)

Query: 18  LGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIV 71
           LG+GA G V +       N N    VAVK     +  +     + E E++K + KH+NI+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDD--PENTY----GLQEEEFLLVLEHLTA- 124
            LL +   QEG   V+V E    G+L + L    P   Y      +  E  L  + L + 
Sbjct: 80  NLLGVCT-QEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 125 ------GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG 178
                 GM+ L   + +HRDL   N++  + +D   + K+ DFG AR++           
Sbjct: 138 AYQVARGMEFLASKKCIHRDLAARNVL--VTED--HVMKIADFGLARDIH---------- 183

Query: 179 TEEYLHPDMYERAVL-RKPV---------GKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
                H D Y +    R PV          + +    D+WS GV L+ + T  L   PY 
Sbjct: 184 -----HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--LGGSPYP 236

Query: 229 G 229
           G
Sbjct: 237 G 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 32/212 (15%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G  G V++G NK  G+ VA+K     S     P    +RE  +LK+++H NIV L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP-STAIREISLLKELQHPNIVCLQD 66

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDD-PENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
           +   QE R   ++ E  +   L   LD  P+  Y +  E     L  +  G+      R+
Sbjct: 67  V-LMQESR-LYLIFEFLS-MDLKKYLDSLPKGQY-MDAELVKSYLYQILQGILFCHSRRV 122

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG--TEEYLHP--DMYER 190
           +HRDLKP N++    D+   I KL DFG AR           +G     Y H    ++ R
Sbjct: 123 LHRDLKPQNLL---IDNKGVI-KLADFGLARA----------FGIPVRVYTHEVVTLWYR 168

Query: 191 A--VLRKPVGKT-FGATVDLWSIGVTLYHVAT 219
           A  VL   +G   +   VD+WSIG     +AT
Sbjct: 169 APEVL---LGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 36/222 (16%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV-----QMREFEVLKKVKHENI 70
           +VLG+G  G V     K  GE  A+K   +   +   +V     + R FE     +H  +
Sbjct: 5   AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 71  VKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA----- 124
           V L A  + ++    V  VME   GG L            +  + F        A     
Sbjct: 65  VNLFACFQTED---HVCFVMEYAAGGDLM---------MHIHTDVFSEPRAVFYAACVVL 112

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYL 183
           G+++L +N++V+RDLK  N++     D     K+ DFG  +E +    +  +  GT E+L
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLL----DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFL 168

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
            P+     VL      ++   VD W +GV +Y +  G  PF 
Sbjct: 169 APE-----VL---TETSYTRAVDWWGLGVLIYEMLVGESPFP 202

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 37/208 (17%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF-----NQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           +G GA G V+   +  +G+ VA+K       N +S  R      RE ++L   KH+N++ 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKR----VFRELKMLCFFKHDNVLS 63

Query: 73  LLAI---------EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
            L I         EE       + V+       L  I+  P+    L  +   + L  + 
Sbjct: 64  ALDILQPPHIDPFEE-------IYVVTELMQSDLHKIIVSPQP---LSSDHVKVFLYQIL 113

Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
            G+K+L    ++HRD+KPGN++     + + + K+ DFG AR  E D+   S + T+E +
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLV----NSNCVLKICDFGLARVEEPDE---SKHMTQEVV 166

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIG 211
               Y RA       + + + VD+WS+G
Sbjct: 167 --TQYYRAPEILMGSRHYTSAVDIWSVG 192

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 19/214 (8%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL- 73
           V+G+GA G V     KN G+  A+K  N+   ++  +      E +VL       I  L 
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A ++E       +VM+   GG L  +L   E+   L E+     L  +   +  +    
Sbjct: 68  YAFQDENN---LYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYLAEMVLAIDSVHQLG 122

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY--GTEEYLHPDMYERA 191
            VHRD+KP N++     D +   +L DFG+   L  D    S    GT +Y+ P++  +A
Sbjct: 123 YVHRDIKPDNVLL----DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL-QA 177

Query: 192 VLRKPVGK-TFGATVDLWSIGVTLYHVATGNLPF 224
           +     GK  +G   D WS+GV +Y +  G  PF
Sbjct: 178 M---EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 23/208 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLL 74
            LG+G+   V++G +K  G+ VA+K   +L H    P    +RE  +LK +KH NIV L 
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPF-TAIREASLLKDLKHANIVTLH 69

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            I   +  +   +V E      L   +DD     GL      L L  L  G+ +    R+
Sbjct: 70  DIIHTK--KTLTLVFEYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRRV 124

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVL 193
           +HRDLKP N++  I + G    KL DFG AR      + + +   T  Y  PD     VL
Sbjct: 125 LHRDLKPQNLL--ISERGE--LKLADFGLARAKSVPSKTYSNEVVTLWYRPPD-----VL 175

Query: 194 RKPVGKT-FGATVDLWSIGVTLYHVATG 220
              +G T +  ++D+W +G   Y +ATG
Sbjct: 176 ---LGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 33/204 (16%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G  G V++  NK  GE VA+K     +     P    +RE  +LK++ H NIVKLL 
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP-STAIREISLLKELNHPNIVKLLD 66

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           +   +      +V E      L   +D    + G+        L  L  G+     +R++
Sbjct: 67  VIHTE--NKLYLVFEFLHQ-DLKKFMDASPLS-GIPLPLIKSYLFQLLQGLAFCHSHRVL 122

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT--EEYLHPDMYERAVL 193
           HRDLKP N++  I  +G+   KL DFG AR           +G     Y H    E   L
Sbjct: 123 HRDLKPQNLL--INTEGAI--KLADFGLARA----------FGVPVRTYTH----EVVTL 164

Query: 194 --RKP---VGKTFGAT-VDLWSIG 211
             R P   +G  + +T VD+WS+G
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLG 188

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 29/229 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G V+ G      + VA+KT  +   M   D  + E +V+ K+ H  +V+L  + 
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIRE-GAMSEEDF-IEEAQVMMKLSHPKLVQLYGVC 68

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      +V E    G L + L          +E  L +   +  GM +L  + ++HR
Sbjct: 69  TERSP--ICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLESSNVIHR 124

Query: 138 DLKPGNIMKFICDDG-STIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVL 193
           DL   N     C  G + + K++DFG  R + +D Q+ S  GT+   ++  P+++  +  
Sbjct: 125 DLAARN-----CLVGENQVVKVSDFGMTRFVLDD-QYTSSTGTKFPVKWSSPEVFSFS-- 176

Query: 194 RKPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRRNKETMYYITT 241
                  + +  D+WS GV ++ V + G     PY  R N E +  I  
Sbjct: 177 ------KYSSKSDVWSFGVLMWEVFSEGKT---PYENRSNSEVVETINA 216

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 21/216 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHD-VQMR-EFEVLKKVKHENIVKL 73
           LGKG+ G V+   +K       +K   ++    + P++ VQ   E ++L K+ H  IVK 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 74  LAIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
            A   E++     I+ E C G  L   + +       L E +       L  G+ ++   
Sbjct: 68  HASFLERDAF--CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF-MSLYGTEEYLHPDMYERA 191
           R++HRDLK  NI  F+ ++   + K+ DFG +R L        +  GT  Y+ P+  +  
Sbjct: 126 RILHRDLKAKNI--FLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH- 179

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
                  + + +  D+WS+G  LY +      F   
Sbjct: 180 -------QGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 23/213 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLK-KVKHENIVKL 73
           VLGKG+ G V     K   E  A+K   +   +   DV+  M E  VL    +H  +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 74  LAIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
               + +E      VME   GG L F+I    +++    E         +  G++ L   
Sbjct: 62  FCTFQTKEHL--FFVMEYLNGGDLMFHI----QSSGRFDEARARFYAAEIICGLQFLHKK 115

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERA 191
            +++RDLK  N++  +  DG    K+ DFG  +E +  + +  +  GT +Y+ P++ +  
Sbjct: 116 GIIYRDLKLDNVL--LDKDGHI--KIADFGMCKENMNGEGKASTFCGTPDYIAPEILK-- 169

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                 G+ +  +VD WS GV LY +  G  PF
Sbjct: 170 ------GQKYNESVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 31/244 (12%)

Query: 18  LGKGATGAVFQG--VNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+   G V++G       GE    VA+KT    +     +    E  +  +++H NIV 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSL--FNILDDPENTYG-----------LQEEEFLLVL 119
           LL +  +++     ++   C+   L  F ++  P +  G           L+  +F+ ++
Sbjct: 73  LLGVVTKEQPLS--MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             + AGM+ L  + +VH+DL   N++ F   D   + K++D G  RE+     +  L G 
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVF---DKLNV-KISDLGLFREVYA-ADYYKLMGN 185

Query: 180 EEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  M   A++    GK F    D+WS GV L+ V +  L  +PY G  N++ +  I
Sbjct: 186 SLLPIRWMSPEAIM---YGK-FSIDSDIWSYGVVLWEVFSYGL--QPYCGYSNQDVIEMI 239

Query: 240 TTKK 243
             ++
Sbjct: 240 RNRQ 243

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 21/217 (9%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHEN 69
           +    VLGKG+ G V     K   E  A+K   +   ++  DV+  M E  VL       
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +  L    +   R    VME   GG L ++I    +     +E + +     ++ G+  
Sbjct: 62  FLTQLHSCFQTVDR-LYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFF 116

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDM 187
           L    +++RDLK  N+M     D     K+ DFG  +E + +     +  GT +Y+ P++
Sbjct: 117 LHRRGIIYRDLKLDNVML----DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +  +P GK+    VD W+ GV LY +  G  PF
Sbjct: 173 ----IAYQPYGKS----VDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 26/222 (11%)

Query: 17  VLGKGATGAVFQ----GVNKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENI 70
            LG GA G V +    G++K++    VAVK     +H    +  M E +++  +  HENI
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           V LL       G   +++ E C  G L N L     ++ L  E+ L     +  GM  L 
Sbjct: 102 VNLLG--ACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFLA 158

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDM 187
               +HRDL   N++  +      I K+ DFG AR++  D  ++         +++ P+ 
Sbjct: 159 SKNCIHRDLAARNVL--LTH--GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               V        +    D+WS G+ L+ + +  L   PY G
Sbjct: 215 IFNCV--------YTFESDVWSYGILLWEIFS--LGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 38/210 (18%)

Query: 18  LGKGATGAVFQGVN-KNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVK---HENIVK 72
           +G+GA G VF+  + KN G  VA+K    Q          +RE  VL+ ++   H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 73  LLAI----EEEQEGRGKVIVMELCTGGSLFNILDDPENTY-------GLQEEEFLLVLEH 121
           L  +      ++E +  ++          F  +D    TY       G+  E    ++  
Sbjct: 69  LFDVCTVSRTDRETKLTLV----------FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118

Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE 181
           L  G+  L  +R+VHRDLKP NI+  +   G    KL DFG AR         S+  T  
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNIL--VTSSGQI--KLADFGLARIYSFQMALTSVVVTLW 174

Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIG 211
           Y  P++  ++        ++   VDLWS+G
Sbjct: 175 YRAPEVLLQS--------SYATPVDLWSVG 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 42/218 (19%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-------MREFEVLKKVKHEN 69
           +LG G  G V++  +      +AVK         P D+        M E E+L K     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVI-------PLDITVELQKQIMSELEILYKCDSPY 60

Query: 70  IVKLLA---IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM 126
           I+       +E         I  E   GGSL      PE+  G        +   +  G+
Sbjct: 61  IIGFYGAFFVENRIS-----ICTEFMDGGSLDVYRKIPEHVLGR-------IAVAVVKGL 108

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
            +L   +++HRD+KP N++  +   G    KL DFG + +L  +    +  GT  Y+ P+
Sbjct: 109 TYLWSLKILHRDVKPSNML--VNTRGQV--KLCDFGVSTQLV-NSIAKTYVGTNAYMAPE 163

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   +  G+ +G   D+WS+G++   +A G  P+
Sbjct: 164 --------RISGEQYGIHSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 35/227 (15%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHENIVKL 73
           LG G  G V+     N    VAVKT      M+P  + +  F     V+K ++H+ +VKL
Sbjct: 14  LGAGQFGEVWMA-TYNKHTKVAVKT------MKPGSMSVEAFLAEANVMKTLQHDKLVKL 66

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A+  ++      I+ E    GSL + L   E +      + +     +  GM  +    
Sbjct: 67  HAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRN 122

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYER 190
            +HRDL+  NI+       S + K+ DFG AR + ED ++ +  G +   ++  P+    
Sbjct: 123 YIHRDLRAANILV----SASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINF 177

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                    +F    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 178 G--------SFTIKSDVWSFGILLMEIVTYGRI---PYPGMSNPEVI 213

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 61/211 (28%), Positives = 89/211 (42%), Gaps = 47/211 (22%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKT--FNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G  G V++  +K  GE VA+K           P    +RE  +LK++ H NIV+LL 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP-STAIREISLLKELNHPNIVRLLD 65

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILD-------DPENTYGLQEEEFLLVLEHLTAGMKH 128
           +    E +  ++          F  LD       D     GL        L  L  G+ +
Sbjct: 66  VVH-SENKLYLV----------FEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT--EEYLHPD 186
              +R++HRDLKP N++  I  +G+   KL DFG AR           +G     Y H  
Sbjct: 115 CHSHRVLHRDLKPQNLL--IDREGAL--KLADFGLARA----------FGVPVRTYTH-- 158

Query: 187 MYERAVL--RKPV----GKTFGATVDLWSIG 211
             E   L  R P      + +   VD+WSIG
Sbjct: 159 --EVVTLWYRAPEILLGSRQYSTPVDIWSIG 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 69/286 (24%), Positives = 102/286 (35%), Gaps = 94/286 (32%)

Query: 17  VLGKGATGAVFQ----GVNKNNG-EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NI 70
            LG+GA G V Q    G+ K+     VAVK   + +    +   M E ++L  + H  N+
Sbjct: 14  PLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNV 73

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY---------------------- 108
           V LL    +  G   VIV E C  G+L N L      +                      
Sbjct: 74  VNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132

Query: 109 -------------GLQEEEFL----------------LVLEHLTA-------GMKHLRDN 132
                        G  E++ L                L LE L +       GM+ L   
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR 192

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           + +HRDL   NI+       + + K+ DFG AR++ +D              PD   +  
Sbjct: 193 KCIHRDLAARNILL----SENNVVKICDFGLARDIYKD--------------PDYVRKGD 234

Query: 193 LRKPV---------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
            R P+          K +    D+WS GV L+ + +  L   PY G
Sbjct: 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS--LGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 19/211 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           VLGKG+ G V     K   E  A+K   +   ++  DV+  M E  VL        +  L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
               +   R    VME   GG L   +   +     +E   +     +  G+  L    +
Sbjct: 67  HSCFQTMDR-LYFVMEYVNGGDLMYQI---QQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           ++RDLK  N+M     D     K+ DFG  +E   D      + GT +Y+ P++    + 
Sbjct: 123 IYRDLKLDNVML----DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI----IA 174

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +P GK+    VD W+ GV LY +  G  PF
Sbjct: 175 YQPYGKS----VDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 38/204 (18%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM------REFEVLKKVKHENIV 71
           +G GA G V    ++  G+ VA+K       M+P    +      RE ++LK ++HENI+
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKI-----MKPFSTPVLAKRTYRELKLLKHLRHENII 72

Query: 72  KL--LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL-LVLEHLTAGMKH 128
            L  + I   ++      V EL  G  L  +L     T    E++F+   L  +  G+K+
Sbjct: 73  SLSDIFISPLED---IYFVTEL-LGTDLHRLL-----TSRPLEKQFIQYFLYQILRGLKY 123

Query: 129 LRDNRLVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           +    +VHRDLKP NI+    CD      K+ DFG AR   +D Q      T  Y  P++
Sbjct: 124 VHSAGVVHRDLKPSNILINENCD-----LKICDFGLAR--IQDPQMTGYVSTRYYRAPEI 176

Query: 188 YERAVLRKPVGKTFGATVDLWSIG 211
                 +K     +   VD+WS G
Sbjct: 177 M--LTWQK-----YDVEVDIWSAG 193

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 55.5 bits (133), Expect = 3e-08
 Identities = 68/233 (29%), Positives = 98/233 (42%), Gaps = 48/233 (20%)

Query: 18  LGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+GA G VF     N     +   VAVKT    S     D   RE E+L  ++HE+IVK
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-REAELLTNLQHEHIVK 71

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL--DDPENTY--------GLQEEEFLLVLEHL 122
              +    EG   ++V E    G L   L    P+            L + + L + + +
Sbjct: 72  FYGVC--VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY-KLTDFGAARELEEDQQFMSLYGTEE 181
            AGM +L     VHRDL   N     C  G  +  K+ DFG +R+         +Y T+ 
Sbjct: 130 AAGMVYLASQHFVHRDLATRN-----CLVGENLLVKIGDFGMSRD---------VYSTDY 175

Query: 182 Y------LHPDMY---ERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
           Y      + P  +   E  + RK     F    D+WS+GV L+ + T G  P+
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRK-----FTTESDVWSLGVVLWEIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 67/235 (28%), Positives = 98/235 (41%), Gaps = 50/235 (21%)

Query: 18  LGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+GA G VF     N     +   VAVK   + S     D Q RE E+L  ++H++IV+
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ-REAELLTVLQHQHIVR 71

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSL----------FNILDDPENTY--GLQEEEFLLVLE 120
              +    EGR  ++V E    G L            IL   E+     L   + L +  
Sbjct: 72  FYGVC--TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS-TIYKLTDFGAARELEEDQQFMSLYGT 179
            + +GM +L     VHRDL   N     C  G   + K+ DFG +R+         +Y T
Sbjct: 130 QIASGMVYLASLHFVHRDLATRN-----CLVGQGLVVKIGDFGMSRD---------IYST 175

Query: 180 EEY------LHPDMY---ERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
           + Y      + P  +   E  + RK     F    D+WS GV L+ + T G  P+
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRK-----FTTESDIWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 39/143 (27%), Positives = 64/143 (44%), Gaps = 23/143 (16%)

Query: 86  VIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGN 143
            + ME    GSL  I        G +  E    +   +  G+ +L + +R++HRD+KP N
Sbjct: 79  CMCMEFMDCGSLDRIY----KKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSN 134

Query: 144 IMKFICDDGSTIYKLTDFGAARELEED--QQFMSLYGTEEYLHPDMYERAVLRKPVGKTF 201
           I+     +     KL DFG + EL       F+   GT  Y+ P+  +        G  +
Sbjct: 135 ILV----NSRGQIKLCDFGVSGELINSIADTFV---GTSTYMSPERIQ--------GGKY 179

Query: 202 GATVDLWSIGVTLYHVATGNLPF 224
               D+WS+G+++  +A G  PF
Sbjct: 180 TVKSDVWSLGISIIELALGKFPF 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 22/212 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD-VQMREFEVLKKVKHENIVKLLAI 76
           LG+G    VF+G +K     VA+K   +L H        +RE  +LK +KH NIV L  I
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
                 +   +V E      L   +DD  N   +   +  + L  +  G+ +    +++H
Sbjct: 73  VHTD--KSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVK--IFLYQILRGLAYCHRRKVLH 127

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I + G    KL DFG AR      + + +   T  Y  PD+        
Sbjct: 128 RDLKPQNLL--INERGE--LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL------- 176

Query: 196 PVGKT-FGATVDLWSIGVTLYHVATGNLPFRP 226
            +G + +   +D+W +G   + +A+G  P  P
Sbjct: 177 -LGSSEYSTQIDMWGVGCIFFEMASGR-PLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 5e-08
 Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 9/154 (5%)

Query: 19  GKGATGAVFQGVNKNN--GEPVAVKTFNQLSHMRPHDVQM---REFEVLKKVKHENIVKL 73
           G+G  G V++   KN   G+  A+K F      +   +     RE  +L+++KHEN+V L
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSL 67

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL--VLEHLTAGMKHLRD 131
           + +  E   +   ++ +      L+ I+        +     ++  +L  +  G+ +L  
Sbjct: 68  VEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR 165
           N ++HRDLKP NI+         + K+ D G AR
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 43/219 (19%)

Query: 88  VMELCTGGSLFNILDDPENTYGL-QEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMK 146
           +++L  GG L   L    + +G+  E+E       +  G++H+ +  +V+RDLKP NI+ 
Sbjct: 75  ILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL 130

Query: 147 FICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVD 206
               D     +++D G A +  + +   S+ GT  Y+ P++ ++       G  + ++ D
Sbjct: 131 ----DEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK-------GTAYDSSAD 178

Query: 207 LWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLP 266
            +S+G  L+ +  G+ PFR +                        +T +  EID  T L 
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQH------------------------KTKDKHEIDRMT-LT 213

Query: 267 NNCQLSLGLKKLVTPILAGLLEVD-SKKIWSFERFFSEV 304
            N +L       +  +L GLL+ D SK++    R   EV
Sbjct: 214 VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEV 252

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 53.9 bits (130), Expect = 8e-08
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 8/92 (8%)

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+    D    + KL DFG +  L + +      G   Y+ P   ER   
Sbjct: 136 VIHRDVKPSNIL---LDASGNV-KLCDFGISGRLVDSKAKTRSAGCAAYMAP---ERIDP 188

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
             P  K +    D+WS+G++L  +ATG  P++
Sbjct: 189 PDPNPK-YDIRADVWSLGISLVELATGQFPYK 219

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 48/199 (24%), Positives = 89/199 (44%), Gaps = 26/199 (13%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           L  G+ G VF        +PV +K        +     + E  +L+ V H +++++    
Sbjct: 74  LTPGSEGRVFVATKPGQPDPVVLKI-----GQKG--TTLIEAMLLQNVNHPSVIRMK--- 123

Query: 78  EEQEGRGKVIVMELCTGGS-LFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
            +    G +  M L    S L+  L   + +  L  ++ L++ + +  G+++L   R++H
Sbjct: 124 -DTLVSGAITCMVLPHYSSDLYTYLT--KRSRPLPIDQALIIEKQILEGLRYLHAQRIIH 180

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           RD+K  NI  FI +D   +  + D GAA+       F+ L GT E   P++  R      
Sbjct: 181 RDVKTENI--FI-NDVDQVC-IGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARD----- 231

Query: 197 VGKTFGATVDLWSIGVTLY 215
               + +  D+WS G+ L+
Sbjct: 232 ---KYNSKADIWSAGIVLF 247

Length = 357

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 43/231 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKL 73
           V+G+G  G V + + K +G  +  A+K   + +    H     E EVL K+  H NI+ L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNIL-------DDPE------NTYGLQEEEFLLVL 119
           L      E RG + I +E    G+L + L        DP           L  ++ L   
Sbjct: 69  LG---ACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             +  GM++L + + +HRDL   N++  + ++     K+ DFG +R            G 
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVL--VGEN--LASKIADFGLSR------------GE 169

Query: 180 EEYLHPDMYERAVLRKPVGKTFGATV-----DLWSIGVTLYH-VATGNLPF 224
           E Y+   M  R  +R    ++   +V     D+WS GV L+  V+ G  P+
Sbjct: 170 EVYVKKTM-GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 65/243 (26%), Positives = 106/243 (43%), Gaps = 54/243 (22%)

Query: 18  LGKGATGAVFQ----GVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+G  G V +    G++K+  +    VAVK     +  +     + E E++K + KH+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNIL-----DDPENTYGLQE-EEFLLVLEHLT 123
           I+ LL +   QEG   VIV E    G+L   L       P+ T+ + +  E  L  + L 
Sbjct: 80  IINLLGVCT-QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 124 A-------GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL 176
           +       GM++L   R +HRDL   N++  + +D   + K+ DFG AR +         
Sbjct: 138 SCAYQVARGMEYLESRRCIHRDLAARNVL--VTED--NVMKIADFGLARGVH-------- 185

Query: 177 YGTEEYLHPDMYERAVL-RKPV---------GKTFGATVDLWSIGVTLYHVATGNLPFRP 226
                    D Y++    R PV          + +    D+WS G+ ++ + T  L   P
Sbjct: 186 -------DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT--LGGSP 236

Query: 227 YGG 229
           Y G
Sbjct: 237 YPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 33/214 (15%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH--DVQMREFEVLKKVKHENIVKL 73
             +G+G  G V++  +K+ GE VA+K   +L + +       +RE ++L+++ H NIV L
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNHRNIVNL 71

Query: 74  L--------AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
                    A++ +++     +V E      L  +L+     +   E+     ++ L  G
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEY-MDHDLMGLLESGLVHF--SEDHIKSFMKQLLEG 128

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR--ELEEDQQFMSLYGTEEYL 183
           + +      +HRD+K  NI+  + + G    KL DFG AR    EE + + +   T  Y 
Sbjct: 129 LNYCHKKNFLHRDIKCSNIL--LNNKGQI--KLADFGLARLYNSEESRPYTNKVITLWYR 184

Query: 184 HPDMY---ERAVLRKPVGKTFGATVDLWSIGVTL 214
            P++    ER          +G  +D+WS G  L
Sbjct: 185 PPELLLGEER----------YGPAIDVWSCGCIL 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 54/239 (22%), Positives = 101/239 (42%), Gaps = 32/239 (13%)

Query: 17  VLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIV 71
           +LGKG  G+V +   K    + + VAVK   +       D++  +RE   +K+  H N++
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 72  KLLAIEEEQEGRGKV----IVMELCTGGSLFNIL---DDPENTYGLQEEEFLLVLEHLTA 124
           KL+ +      +G++    +++     G L   L      E  + L  +  +  +  + +
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
           GM++L     +HRDL   N M    ++  T+  + DFG +++         +Y  + Y  
Sbjct: 125 GMEYLSSKNFIHRDLAARNCM---LNENMTV-CVADFGLSKK---------IYSGDYYRQ 171

Query: 185 PDMYERAV----LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
               +  V    L       +    D+W+ GVT++ + T      PY G  N E   Y+
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--RGQTPYAGVENSEIYNYL 228

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 16/148 (10%)

Query: 88  VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKF 147
           V+E   GG L   +   +    L EE        ++  + +L +  +++RDLK  N++  
Sbjct: 74  VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL- 129

Query: 148 ICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVD 206
              D     KLTD+G  +E L       +  GT  Y+ P+     +LR   G+ +G +VD
Sbjct: 130 ---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE-----ILR---GEDYGFSVD 178

Query: 207 LWSIGVTLYHVATGNLPFRPYGGRRNKE 234
            W++GV ++ +  G  PF   G   N +
Sbjct: 179 WWALGVLMFEMMAGRSPFDIVGSSDNPD 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 52/193 (26%), Positives = 72/193 (37%), Gaps = 17/193 (8%)

Query: 35  GEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELC 92
           G  VA+K     +    H      RE  +  ++ H NIV LL   E   G     V E  
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYV 61

Query: 93  TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG 152
            G +L  +L        L   E   ++  +   +    +  +VHRDLKP NIM       
Sbjct: 62  PGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118

Query: 153 STIYKLTDFGAARELE--EDQQFMSLYGTEEYLHPDMY---ERAVLRKPVGKTFGATVDL 207
               K+ DFG    L    D    +L  T E L    Y   E+  LR   G+      DL
Sbjct: 119 PHA-KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQ--LR---GEPVTPNSDL 172

Query: 208 WSIGVTLYHVATG 220
           ++ G+      TG
Sbjct: 173 YAWGLIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 75/317 (23%), Positives = 120/317 (37%), Gaps = 71/317 (22%)

Query: 12  WCTTSVLGKGATGAVFQGVNK--NNGEPVAVKTF-----NQLSHMRPHDVQMREFEVLKK 64
           +     LG+GA G V    N   +  E VA+K        ++   R     +RE ++L+ 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR----ALRELKLLRH 57

Query: 65  VK-HENIVKLLAIEEEQEG--RGKVIVMELCTGGSLFNIL--DDPENTYGLQEEEFLLVL 119
            + H+NI  L  ++    G      +  EL     L  I+    P     L +  F   +
Sbjct: 58  FRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQP-----LTDAHFQSFI 111

Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL----EEDQQFMS 175
             +  G+K++    ++HRDLKPGN++    +    + K+ DFG AR       E+  FM+
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLL---VNADCEL-KICDFGLARGFSENPGENAGFMT 167

Query: 176 LY-GTEEYLHPDM------YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR--- 225
            Y  T  Y  P++      Y +A             +D+WS+G  L  +      F+   
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKA-------------IDVWSVGCILAELLGRKPVFKGKD 214

Query: 226 ---------PYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLK 276
                       G  ++ET+  I + KA   I           +     PN   L+L L 
Sbjct: 215 YVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESI--FPNANPLALDL- 271

Query: 277 KLVTPILAGLLEVDSKK 293
                 L  LL  D  K
Sbjct: 272 ------LEKLLAFDPTK 282

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 65/236 (27%), Positives = 95/236 (40%), Gaps = 51/236 (21%)

Query: 18  LGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+GA G VF           +   VAVK     +     D Q RE E+L  ++HE+IVK
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-REAELLTNLQHEHIVK 71

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL------------DDPENTYG-LQEEEFLLVL 119
              +    +G   ++V E    G L   L              P    G L   + L + 
Sbjct: 72  FYGVC--GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY-KLTDFGAARELEEDQQFMSLYG 178
             + +GM +L     VHRDL   N     C  G+ +  K+ DFG +R+         +Y 
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRN-----CLVGANLLVKIGDFGMSRD---------VYS 175

Query: 179 TEEY------LHPDMY---ERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
           T+ Y      + P  +   E  + RK     F    D+WS GV L+ + T G  P+
Sbjct: 176 TDYYRVGGHTMLPIRWMPPESIMYRK-----FTTESDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 51.5 bits (123), Expect = 5e-07
 Identities = 39/139 (28%), Positives = 71/139 (51%), Gaps = 17/139 (12%)

Query: 88  VMELCTGGSLFNILDDPENTYGL-QEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMK 146
           +++L  GG L   L    + +G+  E E       +  G++H+ +  +V+RDLKP NI+ 
Sbjct: 75  ILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 130

Query: 147 FICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVD 206
               D     +++D G A +  + +   S+ GT  Y+ P+     VL+K  G  + ++ D
Sbjct: 131 ----DEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPE-----VLQK--GVAYDSSAD 178

Query: 207 LWSIGVTLYHVATGNLPFR 225
            +S+G  L+ +  G+ PFR
Sbjct: 179 WFSLGCMLFKLLRGHSPFR 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 57/239 (23%), Positives = 104/239 (43%), Gaps = 35/239 (14%)

Query: 18  LGKGATGAVFQG-VNKNNG-EPVAVKTFNQLSHMRPH-DVQMREFEVLKKVKHENIVKLL 74
           LG+G  G+V +G +N+++    VAVKT       R   +  + E   +K+  H N+++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 75  AI---EEEQEGR-GKVIVMELCTGGSLFNIL------DDPENTYGLQEEEFLLVLEHLTA 124
            +     E EG    V+++     G L + L      D P+    L  +  +  +  + +
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY---LPTQMLVKFMTDIAS 123

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
           GM++L     +HRDL   N M     + +    + DFG +++         +Y  + Y  
Sbjct: 124 GMEYLSSKSFIHRDLAARNCML----NENMNVCVADFGLSKK---------IYNGDYYRQ 170

Query: 185 PDMYERAV----LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
             + +  V    +     + +    D+WS GVT++ +AT      PY G  N E   Y+
Sbjct: 171 GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT--PYPGVENSEIYDYL 227

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 50/235 (21%), Positives = 99/235 (42%), Gaps = 28/235 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVA---VKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G G  G V  G   + G   A   VK     +      + ++E +  +++ H N+++ L
Sbjct: 3   IGNGWFGKVLLG-EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL-DDPENTYGLQEEEFLLVLEH-LTAGMKHLRDN 132
              +  E    ++V+E C  G L N L  +      + +++ L  +   + +G+  L   
Sbjct: 62  G--QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-------LEEDQQFMSLYGTEEYLHP 185
             +H DL   N    +  D S   K+ D+G A E       + +D   + L     +L P
Sbjct: 120 DFIHSDLALRNC--QLTADLSV--KIGDYGLALEQYPEDYYITKDCHAVPL----RWLAP 171

Query: 186 D-MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           + +  R     P  +T  + +  WS+GVT++ + T     +PY    +++ +  +
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNI--WSLGVTMWELFT--AADQPYPDLSDEQVLKQV 222

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 32/204 (15%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKT--FNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G  G V++  ++   E +A+K     Q     P    +RE  +LK+++H NIV+L  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVP-STAIREISLLKEMQHGNIVRLQD 68

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILD-------DPENTYGLQEEEFLLVLEHLTAGMKH 128
           +   +    K + +       +F  LD       D    +          L  +  G+ +
Sbjct: 69  VVHSE----KRLYL-------VFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDM 187
              +R++HRDLKP N++    D  +   KL DFG AR      + F     T  Y  P++
Sbjct: 118 CHSHRVLHRDLKPQNLL---IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEI 174

Query: 188 YERAVLRKPVGKTFGATVDLWSIG 211
              +       + +   VD+WS+G
Sbjct: 175 LLGS-------RHYSTPVDIWSVG 191

Length = 294

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 42/213 (19%)

Query: 28  QGVNKNNGEP--VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK 85
           +G  + +G+P  VAVK           +  ++E +++ ++K+ NI++LL +    +    
Sbjct: 35  EGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL-- 92

Query: 86  VIVMELCTGGSLFNILDDPE---------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
            ++ E    G L   L   E         N   +     L +   + +GMK+L     VH
Sbjct: 93  CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVH 152

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           RDL   N +     +  TI K+ DFG +R         +LY  + Y    +  RAVL  P
Sbjct: 153 RDLATRNCL---VGNHYTI-KIADFGMSR---------NLYSGDYY---RIQGRAVL--P 194

Query: 197 V----------GKTFGATVDLWSIGVTLYHVAT 219
           +          GK F    D+W+ GVTL+ + T
Sbjct: 195 IRWMAWESILLGK-FTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 20/222 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           +LG G  G V +G+    G+    PVA+KT    S  +           +  + H  IV+
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL I     G    +V +L   GSL + +   ++   L  +  L     +  GM +L ++
Sbjct: 74  LLGI---CPGASLQLVTQLSPLGSLLDHVR--QHRDSLDPQRLLNWCVQIAKGMYYLEEH 128

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           R+VHR+L   NI+        +I ++ DFG A  L  D +    Y   E+  P  +    
Sbjct: 129 RMVHRNLAARNILL----KSDSIVQIADFGVADLLYPDDK---KYFYSEHKTPIKW--MA 179

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           L   +   +    D+WS GVT++ + +      PY G R  E
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMS--YGAEPYAGMRPHE 219

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 65/245 (26%), Positives = 103/245 (42%), Gaps = 58/245 (23%)

Query: 18  LGKGATGAVFQ----GVNK---NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+G  G V      G++K   N    VAVK     +  +     + E E++K + KH+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSL---------------FNILDDPENTYGLQEEE 114
           I+ LL     Q+G   VIV E  + G+L               +N    PE    L  ++
Sbjct: 86  IINLLG-ACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ--LSFKD 141

Query: 115 FLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM 174
            +     +  GM++L   + +HRDL   N++  + +D   + K+ DFG AR++       
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVL--VTED--NVMKIADFGLARDIH------ 191

Query: 175 SLYGTEEYLHPDMYERAVL-RKPV---------GKTFGATVDLWSIGVTLYHVATGNLPF 224
                    H D Y++    R PV          + +    D+WS GV L+ + T  L  
Sbjct: 192 ---------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGG 240

Query: 225 RPYGG 229
            PY G
Sbjct: 241 SPYPG 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 39/139 (28%), Positives = 66/139 (47%), Gaps = 16/139 (11%)

Query: 87  IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMK 146
           +V+E   GG L   +   +    L EE        +   +  L +  +++RDLK  N++ 
Sbjct: 73  LVIEYVNGGDLMFHM---QRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVL- 128

Query: 147 FICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATV 205
            +  DG    KLTD+G  +E L       +  GT  Y+ P+     +LR   G+ +G +V
Sbjct: 129 -LDADGHI--KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPE-----ILR---GEEYGFSV 177

Query: 206 DLWSIGVTLYHVATGNLPF 224
           D W++GV ++ +  G  PF
Sbjct: 178 DWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 43/231 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIVKL 73
           V+G+G  G V +   K +G  +  A+K   + +    H     E EVL K+ H  NI+ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNIL-------DDPE------NTYGLQEEEFLLVL 119
           L      E RG + + +E    G+L + L        DP           L  ++ L   
Sbjct: 62  LG---ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             +  GM +L   + +HRDL   NI+  + ++     K+ DFG +R            G 
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNIL--VGENYVA--KIADFGLSR------------GQ 162

Query: 180 EEYLHPDMYERAVLRKPVGKTFGATV-----DLWSIGVTLYHVAT-GNLPF 224
           E Y+   M  R  +R    ++   +V     D+WS GV L+ + + G  P+
Sbjct: 163 EVYVKKTM-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 36/226 (15%)

Query: 17  VLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           +L +G  G +F G+         E V VKT    +      + ++E  +L  + H+NI+ 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 73  LLAIEEEQEGRGKVIVMELCTG-GSLFNILDDP-----ENTYGLQEEEFLLVLEHLTAGM 126
           +L +    E      V+      G+L   L         N   L  ++ + +   +  GM
Sbjct: 73  ILHVC--IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY---GTEEYL 183
            +L    ++H+D+   N    + D+   + K+TD   +R+L     F   Y   G  E  
Sbjct: 131 SYLHKRGVIHKDIAARNC---VIDEELQV-KITDNALSRDL-----FPMDYHCLGDNEN- 180

Query: 184 HPDMYERAV----LRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
                 R V    L   V K + +  D+WS GV L+ + T G  P+
Sbjct: 181 ------RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 55/252 (21%), Positives = 93/252 (36%), Gaps = 67/252 (26%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTF--------NQLSHMRPHDVQMREFEVLKKVKHE 68
           V+G+GA G V     K+ G   A+K           Q++H+R       E ++L +    
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRA------ERDILVEADGA 61

Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +VK+      Q+ R   ++ME   GG +  +L   +    L EE     +      +  
Sbjct: 62  WVVKMFY--SFQDKRNLYLIMEFLPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDA 116

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE------------------- 169
           +     +HRD+KP N++     D     KL+DFG    L++                   
Sbjct: 117 IHQLGFIHRDIKPDNLLL----DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172

Query: 170 -----------------DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGV 212
                             Q   S  GT +Y+ P+++ +          +    D WS+GV
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--------GYNKLCDWWSLGV 224

Query: 213 TLYHVATGNLPF 224
            +Y +  G  PF
Sbjct: 225 IMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 41/230 (17%)

Query: 17  VLGKGATGAVFQGVNKNNG--EPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKL 73
           V+G+G  G V +   K +G     A+K   + +    H     E EVL K+  H NI+ L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNIL-------DDP------ENTYGLQEEEFLLVL 119
           L   E    RG + + +E    G+L + L        DP           L  ++ L   
Sbjct: 74  LGACEH---RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             +  GM +L   + +HRDL   NI+       + + K+ DFG +R            G 
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLSR------------GQ 174

Query: 180 EEYLHPDMYERAVLRKPVG----KTFGATVDLWSIGVTLYHVAT-GNLPF 224
           E Y+   M    V    +       +    D+WS GV L+ + + G  P+
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.8 bits (119), Expect = 5e-06
 Identities = 59/246 (23%), Positives = 102/246 (41%), Gaps = 49/246 (19%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF------NQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +GKG  G V+   +      VA+K        N L   R     +RE ++   + H  IV
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR----FLREAKIAADLIHPGIV 65

Query: 72  KLLAIEEEQEGRGKVI--VMELCTGGSLFNILDDPENTYGLQEE--------EFLLVLEH 121
            + +I  +    G  +   M    G +L ++L        L +E         FL +   
Sbjct: 66  PVYSICSD----GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121

Query: 122 LTAGMKHLRDNRLVHRDLKPGNIM--KFICDDGSTIYKLTDFGAA--RELEEDQQFMSLY 177
           + A ++++    ++HRDLKP NI+   F    G  +  + D+GAA  ++LEE+       
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLF----GEVV--ILDWGAAIFKKLEEEDLLDIDV 175

Query: 178 GTEEYLHPDMYERAVLRKPVG--------KTFGA----TVDLWSIGVTLYHVATGNLPFR 225
                 +  M    +  K VG        +  G     + D++++GV LY + T + P+R
Sbjct: 176 DERNICYSSM---TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232

Query: 226 PYGGRR 231
              GR+
Sbjct: 233 RKKGRK 238

Length = 932

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.9 bits (116), Expect = 6e-06
 Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 23/221 (10%)

Query: 7   STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK 66
           S N  +   +++G G+ G V++ +  +  E VA+K   Q    +      RE  ++K + 
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-----RELLIMKNLN 117

Query: 67  HENIVKLL------AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           H NI+ L         ++ ++     +VME         +     N + L      L   
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
            L   + ++    + HRDLKP N++    D  +   KL DFG+A+ L   Q+ +S   + 
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLL---IDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234

Query: 181 EYLHPDMYERAVLRKPVGKT-FGATVDLWSIGVTLYHVATG 220
            Y  P++         +G T +   +DLWS+G  +  +  G
Sbjct: 235 FYRAPELM--------LGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 18/149 (12%)

Query: 88  VMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMK 146
           V+E  +GG L F++    +    L EE        ++  +  L +  +++RDLK  N++ 
Sbjct: 74  VIEFVSGGDLMFHM----QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL 129

Query: 147 FICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVLRKPVGKTFGATV 205
               D     KLTD+G  +E        S + GT  Y+ P+     +LR   G+ +G +V
Sbjct: 130 ----DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPE-----ILR---GEDYGFSV 177

Query: 206 DLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           D W++GV ++ +  G  PF   G   N +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPD 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 48.1 bits (115), Expect = 7e-06
 Identities = 55/211 (26%), Positives = 85/211 (40%), Gaps = 45/211 (21%)

Query: 31  NKNNGEP--VAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV 86
           N N   P  VAVK    +   + R  +  ++E ++L ++   NI +LL +          
Sbjct: 40  NDNADAPVLVAVKVLRPDASDNAR--EDFLKEVKILSRLSDPNIARLLGVCTVDPP--LC 95

Query: 87  IVMELCTGGSLFNIL--------DDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRD 138
           ++ME    G L   L            N+  L     L +   + +GM++L     VHRD
Sbjct: 96  MIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD 155

Query: 139 LKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPV- 197
           L   N    +     TI K+ DFG +R          LY ++ Y    +  RA L  P+ 
Sbjct: 156 LATRNC---LVGKNYTI-KIADFGMSRN---------LYSSDYY---RVQGRAPL--PIR 197

Query: 198 ---------GKTFGATVDLWSIGVTLYHVAT 219
                    GK F    D+W+ GVTL+ + T
Sbjct: 198 WMAWESVLLGK-FTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 66/263 (25%), Positives = 102/263 (38%), Gaps = 79/263 (30%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPV-AVKTFNQLSHMRPHDVQMR--------EFEVLKKVK 66
             +G GA G V   V K +   + A+KT      +R  DV MR        E ++L +  
Sbjct: 7   KTIGIGAFGEVCL-VRKVDTNALYAMKT------LRKADVLMRNQAAHVKAERDILAEAD 59

Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL-LVLEHLTAG 125
           +E +VKL    ++++      VM+   GG + ++L       G+ EE+     +  LT  
Sbjct: 60  NEWVVKLYYSFQDKDNL--YFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCA 113

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG----------------------- 162
           ++ +     +HRD+KP NI+  I  DG    KLTDFG                       
Sbjct: 114 IESVHKMGFIHRDIKPDNIL--IDRDGHI--KLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169

Query: 163 -------------------AARELEEDQQFM--SLYGTEEYLHPDMYERAVLRKPVGKTF 201
                                R   + Q+ +  SL GT  Y+ P++  R          +
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--------TGY 221

Query: 202 GATVDLWSIGVTLYHVATGNLPF 224
               D WS+GV LY +  G  PF
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 64/239 (26%), Positives = 107/239 (44%), Gaps = 46/239 (19%)

Query: 18  LGKGATGAVFQ----GVNK---NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+G  G V      G++K   N    VAVK     +  +     + E E++K + KH+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNIL--------DDPENTYGLQEEEFLLVLEH 121
           I+ LL     Q+G   V+V E  + G+L   L        D   +T  L EE+  L  + 
Sbjct: 80  IINLLG-ACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ--LTFKD 135

Query: 122 LTA-------GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM 174
           L +       GM++L   + +HRDL   N++  + +D   + K+ DFG AR++     + 
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVL--VTED--NVMKIADFGLARDVHNIDYYK 191

Query: 175 SLYGTE---EYLHPD-MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
                    +++ P+ +++R    +          D+WS GV L+ + T  L   PY G
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQS---------DVWSFGVLLWEIFT--LGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 41/201 (20%)

Query: 38  VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSL 97
           VAVK   + ++    +  ++E +++ ++K  NI++LLA+    +     ++ E    G L
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL--CMITEYMENGDL 106

Query: 98  FNILD--DPENTYGLQEEEFL------LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFIC 149
              L   +P+      +   +       +   + +GMK+L     VHRDL   N     C
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN-----C 161

Query: 150 DDG-STIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPV----------G 198
             G +   K+ DFG +R         +LY  + Y    +  RAVL  P+          G
Sbjct: 162 LVGKNYTIKIADFGMSR---------NLYSGDYY---RIQGRAVL--PIRWMSWESILLG 207

Query: 199 KTFGATVDLWSIGVTLYHVAT 219
           K F    D+W+ GVTL+ + T
Sbjct: 208 K-FTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 68/286 (23%), Positives = 104/286 (36%), Gaps = 93/286 (32%)

Query: 17  VLGKGATGAVFQ----GVNKNNG-EPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENI 70
           VLG GA G V +    G++K +    VAVK   + +    H   M E ++L  +  H N+
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73

Query: 71  VKL-----------LAIEE--------------------------EQEGRGKVIV----- 88
           V L           + I E                          +Q GR + +V     
Sbjct: 74  VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133

Query: 89  ---MELCTGGSLFN--ILDDPENTYGLQEEEFL----LVLEHLTA-------GMKHLRDN 132
              +E      LF+        +T   QE + L    L +E L         GM+ L   
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           + +HRDL   NI+       + + K+ DFG AR++ +D              PD   +  
Sbjct: 194 KCIHRDLAARNILL----SENNVVKICDFGLARDIYKD--------------PDYVRKGS 235

Query: 193 LRKPV---------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
            R P+          K +    D+WS GV L+ + +  L   PY G
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS--LGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 62/263 (23%), Positives = 99/263 (37%), Gaps = 79/263 (30%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--------NQLSHMRPHDVQMREFEVLKKVKHEN 69
           LG GA G V      +     A+KT         NQ++H++       E ++L +  +E 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKA------ERDILAEADNEW 62

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           +VKL    ++++      VM+   GG + ++L   E      E      +  LT  ++ +
Sbjct: 63  VVKLYYSFQDKDNL--YFVMDYIPGGDMMSLLIRMEV---FPEVLARFYIAELTLAIESV 117

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG--------------------------- 162
                +HRD+KP NI+  I  DG    KLTDFG                           
Sbjct: 118 HKMGFIHRDIKPDNIL--IDLDGHI--KLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173

Query: 163 -------------------AARELEEDQQFM--SLYGTEEYLHPDMYERAVLRKPVGKTF 201
                                R  ++ Q+ +  SL GT  Y+ P++  R        K +
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--------KGY 225

Query: 202 GATVDLWSIGVTLYHVATGNLPF 224
               D WS+GV L+ +  G  PF
Sbjct: 226 TQLCDWWSVGVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.4 bits (110), Expect = 5e-05
 Identities = 50/170 (29%), Positives = 81/170 (47%), Gaps = 14/170 (8%)

Query: 20  KGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV-QMR-EFEVLKKVKHENIVKLLAIE 77
           +GA G V+ G  KNN +  AVK   +   +  + V Q++ E + L   K   IV L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY-- 71

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEF-LLVLEHLTAGMKHLRDNRLVH 136
             Q      +VME   GG + ++L    + YG  +EE  +  +  +   + +L  + ++H
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLL----HIYGYFDEEMAVKYISEVALALDYLHRHGIIH 127

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAAR-ELEEDQQFMSLYGTEEYLHP 185
           RDLKP N++  I ++G    KLTDFG ++  L  +   M +  T     P
Sbjct: 128 RDLKPDNML--ISNEGHI--KLTDFGLSKVTLNRELNMMDILTTPSMAKP 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 54/246 (21%), Positives = 92/246 (37%), Gaps = 55/246 (22%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV-QMR-EFEVLKKVKHENIVKLL 74
           V+G+GA G V     K+ G   A+K   +   +    V  +R E ++L +     +VK+ 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
                Q+     ++ME   GG +  +L   +    L EEE    +      +  +     
Sbjct: 68  Y--SFQDKLNLYLIMEFLPGGDMMTLLMKKDT---LTEEETQFYIAETVLAIDSIHQLGF 122

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE------------------------- 169
           +HRD+KP N++     D     KL+DFG    L++                         
Sbjct: 123 IHRDIKPDNLLL----DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 170 -----------DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVA 218
                       Q   S  GT +Y+ P+++ +          +    D WS+GV +Y + 
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--------TGYNKLCDWWSLGVIMYEML 230

Query: 219 TGNLPF 224
            G  PF
Sbjct: 231 IGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 45.1 bits (107), Expect = 6e-05
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 13/103 (12%)

Query: 125 GMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
            +++L     ++HRD+KP N++  I  +G    KL DFG +  L +        G + Y+
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVL--INRNGQ--VKLCDFGISGYLVDSVAKTIDAGCKPYM 170

Query: 184 HPDMYERAVLRKPVGKTFGATV--DLWSIGVTLYHVATGNLPF 224
            P   ER     P     G  V  D+WS+G+T+  +ATG  P+
Sbjct: 171 AP---ERI---NPELNQKGYDVKSDVWSLGITMIELATGRFPY 207

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 57/255 (22%), Positives = 94/255 (36%), Gaps = 70/255 (27%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTF--------NQLSHMRPHDVQMREFEVLKKVKHE 68
           V+G+GA G V     K+ G   A+K           Q++H+R       E ++L +  + 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRA------ERDILAEADNP 61

Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +VKL      Q+     ++ME   GG +  +L   ++T    EEE    +      +  
Sbjct: 62  WVVKLYY--SFQDENYLYLIMEYLPGGDMMTLLMK-KDT--FTEEETRFYIAETILAIDS 116

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-------------------- 168
           +     +HRD+KP N++     D     KL+DFG    L+                    
Sbjct: 117 IHKLGYIHRDIKPDNLLL----DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 169 -EDQQFM------------------SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWS 209
               + M                  S  GT +Y+ P+     V  +     +    D WS
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-----VFLQ---TGYNKECDWWS 224

Query: 210 IGVTLYHVATGNLPF 224
           +GV +Y +  G  PF
Sbjct: 225 LGVIMYEMLVGYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 16/99 (16%)

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEY 182
           +++L +NR++HRD+K  NI  FI   G     L DFGAA    ++  ++ +    GT   
Sbjct: 195 IQYLHENRIIHRDIKAENI--FINHPGDVC--LGDFGAACFPVDINANK-YYGWAGTIAT 249

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGN 221
             P++  R          +G  VD+WS G+ L+ +AT +
Sbjct: 250 NAPELLAR--------DPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 44.5 bits (105), Expect = 9e-05
 Identities = 52/228 (22%), Positives = 95/228 (41%), Gaps = 29/228 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           +LG G  G + +G  K   +   PVA+ T       +     + E   L +  H NIV+L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +     G   +IV E  + G+L + L   E    L   + + +L  L +GMK+L +  
Sbjct: 72  EGVI--TRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYLSEMG 127

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL--HPD--MYE 189
            VH+ L    ++     +   + K++ F   +E + +  + ++ G    L   P+   Y 
Sbjct: 128 YVHKGLAAHKVLV----NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRRNKETM 236
                      F +  D+WS G+ ++ V + G    RPY     ++ +
Sbjct: 184 H----------FSSASDVWSFGIVMWEVMSYGE---RPYWDMSGQDVI 218

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 45.4 bits (107), Expect = 9e-05
 Identities = 41/139 (29%), Positives = 58/139 (41%), Gaps = 24/139 (17%)

Query: 118 VLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY 177
           V+  +  G++ L    +VHRD+KP N++  +  DG    K+ DFGAA ++     F  LY
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLL--VTVDGQV--KIIDFGAAVDMCTGINFNPLY 369

Query: 178 GT--------EEYLHPDMYER------AVLRKPVGKTFGAT--VDLWSIGVTLYHVATGN 221
           G         EE + P    R      A L  P    +G     D ++ GV L  +    
Sbjct: 370 GMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPE 429

Query: 222 LPFRPYGGRR--NKETMYY 238
           L  RP    R  N E   Y
Sbjct: 430 L--RPVANIRLFNTELRQY 446

Length = 507

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 61/264 (23%), Positives = 99/264 (37%), Gaps = 81/264 (30%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--------NQLSHMRPHDVQMREFEVLKKVKHEN 69
           LG GA G V      +     A+KT         NQ++H++       E ++L +  +E 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKA------ERDILAEADNEW 62

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL-LVLEHLTAGMKH 128
           +V+L    ++++      VM+   GG + ++L       G+  E+     +  LT  ++ 
Sbjct: 63  VVRLYYSFQDKDNL--YFVMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVES 116

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA------------------------ 164
           +     +HRD+KP NI+  I  DG    KLTDFG                          
Sbjct: 117 VHKMGFIHRDIKPDNIL--IDRDGHI--KLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172

Query: 165 ----------------------RELEEDQQFM--SLYGTEEYLHPDMYERAVLRKPVGKT 200
                                 R   + Q+ +  SL GT  Y+ P++  R          
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--------G 224

Query: 201 FGATVDLWSIGVTLYHVATGNLPF 224
           +    D WS+GV LY +  G  PF
Sbjct: 225 YTQLCDWWSVGVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 57/237 (24%), Positives = 102/237 (43%), Gaps = 42/237 (17%)

Query: 18  LGKGATGAVFQ----GVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+G  G V      G++K+  +    VAVK     +  +     + E E++K + KH+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILD---DPENTYG----------LQEEEFL 116
           I+ LL     Q+G   VIV E  + G+L   L     P   Y           +  ++ +
Sbjct: 83  IINLLG-ACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL 176
                +  GM++L   + +HRDL   N++       + + K+ DFG AR++     +   
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLARDVNNIDYYKKT 196

Query: 177 YGTE---EYLHPD-MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
                  +++ P+ +++R    +          D+WS GV ++ + T  L   PY G
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQS---------DVWSFGVLMWEIFT--LGGSPYPG 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 15/168 (8%)

Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL 116
           RE ++LK + H  I+ L  I   +      +VM       LF  +D       L  E+ +
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKC-DLFTYVDRSGP---LPLEQAI 188

Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL 176
            +   L   + +L    ++HRD+K  NI  F+ +  + +  L DFGAA +L+        
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTENI--FLDEPENAV--LGDFGAACKLDAHPDTPQC 244

Query: 177 YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           YG    L  +  E   L       + A  D+WS G+ L+ ++  N+  
Sbjct: 245 YGWSGTLETNSPELLAL-----DPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 62/208 (29%)

Query: 58  EFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGL-QEEEFL 116
           E   L ++ HENI+K   IEE                     IL    NTY + Q+ +F 
Sbjct: 213 EILALGRLNHENILK---IEE---------------------ILRSEANTYMITQKYDFD 248

Query: 117 L----------------------VLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST 154
           L                      +++ L   ++++ D +L+HRD+K  NI  F+  DG  
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI--FLNCDGKI 306

Query: 155 IYKLTDFGAARELEEDQQFMSL--YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGV 212
           +  L DFG A   E++++       GT     P++          G  +    D+WS G+
Sbjct: 307 V--LGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL--------AGDGYCEITDIWSCGL 356

Query: 213 TLYHVATGNL-PFRPYGGRRNKETMYYI 239
            L  + + +  P    GG+  K+ +  I
Sbjct: 357 ILLDMLSHDFCPIGDGGGKPGKQLLKII 384

Length = 501

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.3 bits (92), Expect = 0.001
 Identities = 30/147 (20%), Positives = 53/147 (36%), Gaps = 16/147 (10%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
            +L  G T  V+  +     E   +K           D + RE  +L+ +  + +     
Sbjct: 4   KLLKGGLTNRVYL-L-GTKDEDYVLKINPSREK--GADRE-REVAILQLLARKGLPVPKV 58

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           +   +      ++ME   G +L       +     ++E+    L  L A +  L    L 
Sbjct: 59  LASGESDGWSYLLMEWIEGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFG 162
           H DL PGNI+     D   I  + D+ 
Sbjct: 112 HGDLHPGNILV----DDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 34/129 (26%), Positives = 52/129 (40%), Gaps = 36/129 (27%)

Query: 117 LVLEHL-------TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE 169
           L LE L         GM+ L   + +HRDL   NI+       + + K+ DFG AR++ +
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARDIYK 231

Query: 170 DQQFMSLYGTEEYLHPDMYERAVLRKPV---------GKTFGATVDLWSIGVTLYHVATG 220
           D              PD   +   R P+          + +    D+WS GV L+ + + 
Sbjct: 232 D--------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS- 276

Query: 221 NLPFRPYGG 229
            L   PY G
Sbjct: 277 -LGASPYPG 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 47/231 (20%), Positives = 88/231 (38%), Gaps = 30/231 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAV----KTFNQLSHMRP-HDVQMREFE---VLKKVKHEN 69
           LG+G    +++GV +   +   V    +    L  +   H   +  FE   ++ ++ H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           +VKL  +    E    ++V E    G L   L        +     L V + L + + +L
Sbjct: 63  LVKLYGVCVRDE---NIMVEEYVKFGPLDVFLH--REKNNVSLHWKLDVAKQLASALHYL 117

Query: 130 RDNRLVHRDLKPGNIM--KFICDDGSTIY-KLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
            D +LVH ++   NI+  ++  ++G   + KL+D G    +           + E     
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV----------LSREERVER 167

Query: 187 MYERAV--LRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKE 234
           +   A   +R        A  D WS G TL  + + G  P         + 
Sbjct: 168 IPWIAPECIRNGQASLTIAA-DKWSFGTTLLEICSNGEEPLSTLSSSEKER 217

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 16/104 (15%)

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT---EE 181
           GM+ L     VHRDL   N++  IC+    + K+ DFG AR++  D  ++S   T    +
Sbjct: 251 GMEFLASKNCVHRDLAARNVL--ICE--GKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306

Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
           ++ P+              +    D+WS G+ L+ + T G  P+
Sbjct: 307 WMAPESI--------FNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 49/215 (22%)

Query: 31  NKNNGEP--VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV 88
           N   G P  VAVK     ++    +  ++E ++L ++K  NI++LL +  +++     ++
Sbjct: 40  NVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL--CMI 97

Query: 89  MELCTGGSLFNILD--------------DPENTYGL--QEEEFLLVLEHLTAGMKHLRDN 132
            E    G L   L                P             L V   + +GMK+L   
Sbjct: 98  TEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
             VHRDL   N +       +   K+ DFG +R         +LY  + Y    +  RAV
Sbjct: 158 NFVHRDLATRNCLV----GENLTIKIADFGMSR---------NLYAGDYY---RIQGRAV 201

Query: 193 LRKPV----------GKTFGATVDLWSIGVTLYHV 217
           L  P+          GK F    D+W+ GVTL+ +
Sbjct: 202 L--PIRWMAWECILMGK-FTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 37/146 (25%), Positives = 61/146 (41%), Gaps = 18/146 (12%)

Query: 95  GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST 154
             + N+L D + + GL   + L     +  GM+ L     VHRDL   N++         
Sbjct: 220 SEVKNLLSD-DGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL----AQGK 274

Query: 155 IYKLTDFGAARELEEDQQFMSLYGT---EEYLHPDMYERAVLRKPVGKTFGATVDLWSIG 211
           I K+ DFG AR++  D  ++S   T    +++ P+              +    D+WS G
Sbjct: 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI--------FDNLYTTLSDVWSYG 326

Query: 212 VTLYHVATGNLPFRPYGGRRNKETMY 237
           + L+ + +  L   PY G     T Y
Sbjct: 327 ILLWEIFS--LGGTPYPGMIVDSTFY 350

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.5 bits (95), Expect = 0.003
 Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 3/34 (8%)

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL 167
           +VHRD+KP NI   I  +GS  +K+ D GAA +L
Sbjct: 276 IVHRDVKPQNI---IFSEGSGSFKIIDLGAAADL 306

Length = 566

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.2 bits (94), Expect = 0.003
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 35/163 (21%)

Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTF--------NQLSHMRPHDVQMREFEVLKKV 65
           T  V+GKGA G V     K+ G+  A+KT         +QL+H++       E +VL + 
Sbjct: 5   TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKA------ERDVLAES 58

Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEH 121
               +V L      Q+ +   ++ME   GG L  +L       E+       E +L +E 
Sbjct: 59  DSPWVVSLYY--SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEA 116

Query: 122 LTAGMKHLRDNRL--VHRDLKPGNIMKFICDDGSTIYKLTDFG 162
           +         ++L  +HRD+KP NI+    D G  I KL+DFG
Sbjct: 117 V---------HKLGFIHRDIKPDNIL---IDRGGHI-KLSDFG 146

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	708
KOG4250|consensus	732		100.0
KOG0615|consensus	475		100.0
KOG0575|consensus	592		100.0
KOG0595|consensus	429		100.0
KOG0581|consensus	364		100.0
KOG0593|consensus	396		100.0
KOG0598|consensus	357		100.0
KOG0661|consensus	538		100.0
KOG0600|consensus	560		100.0
KOG0583|consensus	370		100.0
KOG0660|consensus	359		100.0
KOG0659|consensus	318		100.0
KOG0663|consensus	419		100.0
KOG0591|consensus	375		100.0
KOG0592|consensus	604		100.0
KOG0198|consensus	313		100.0
KOG0597|consensus	808		100.0
KOG0033|consensus	355		100.0
KOG0585|consensus	576		100.0
KOG0578|consensus	550		100.0
KOG0605|consensus	550		100.0
KOG0588|consensus	786		100.0
KOG0658|consensus	364		100.0
KOG0616|consensus	355		100.0
KOG0582|consensus	516		100.0
KOG0032|consensus	382		100.0
KOG0192|consensus	362		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0594|consensus	323		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0694|consensus	694		100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0599|consensus	411		100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0611|consensus	668		100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0667|consensus	586		100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0197|consensus	468		100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0201|consensus	467		100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG4717|consensus	864		100.0
KOG0610|consensus	459		100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0589|consensus	426		100.0
KOG0580|consensus	281		100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG4721|consensus	904		100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0604|consensus	400		100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0612|consensus	1317		100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG1989|consensus	738		100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG2345|consensus	302		100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0690|consensus	516		100.0
KOG0579|consensus	1187		100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0574|consensus	502		100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0193|consensus	678		100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4645|consensus	1509		100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG4279|consensus	1226		100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0607|consensus	463		100.0
KOG1187|consensus	361		100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0577|consensus	948		100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0986|consensus	591		100.0
KOG4236|consensus	888		100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG1095|consensus	1025		100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0586|consensus	596		100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0584|consensus	632		100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0596|consensus	677		100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0194|consensus	474		100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0671|consensus	415		100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0983|consensus	391		100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0666|consensus	438		100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0662|consensus	292		100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1026|consensus	774		100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG4257|consensus	974		100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0696|consensus	683		100.0
KOG0669|consensus	376		100.0
KOG1035|consensus	1351		100.0
KOG1290|consensus	590		100.0
KOG0668|consensus	338		100.0
KOG1151|consensus	775		100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0603|consensus	612		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1006|consensus	361		100.0
KOG0196|consensus	996		99.98
KOG0587|consensus	953		99.98
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0199|consensus	1039		99.97
KOG0695|consensus	593		99.97
KOG0670|consensus	752		99.97
KOG0664|consensus	449		99.97
KOG1027|consensus	903		99.97
KOG4278|consensus	1157		99.97
KOG0608|consensus	1034		99.97
KOG0614|consensus	732		99.97
KOG0665|consensus	369		99.97
KOG1094|consensus	807		99.97
KOG2052|consensus	513		99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0984|consensus	282		99.96
KOG1025|consensus	1177		99.96
KOG0200|consensus	609		99.96
KOG1152|consensus	772		99.96
KOG1167|consensus	418		99.95
KOG3653|consensus	534		99.95
KOG0576|consensus	829		99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1345|consensus	378		99.94
KOG1024|consensus	563		99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG1164|consensus	322		99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG1163|consensus	341		99.89
KOG1165|consensus	449		99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG0590|consensus	601		99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
KOG4158|consensus	598		99.83
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.83
KOG1240|consensus	1431		99.83
KOG0603|consensus	612		99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
KOG0195|consensus	448		99.79
PRK10345	210	hypothetical protein; Provisional	99.78
KOG1166|consensus	974		99.77
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
KOG0606|consensus	1205		99.73
smart00090	237	RIO RIO-like kinase.	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
KOG1023|consensus	484		99.65
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.64
KOG1033|consensus	516		99.63
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.61
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.56
KOG0590|consensus	601		99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.49
KOG0601|consensus	524		99.38
KOG1243|consensus	690		99.25
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.23
KOG0601|consensus	524		99.19
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.18
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.16
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.15
KOG0606|consensus	1205		99.05
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.02
KOG1266|consensus	458		99.01
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.97
KOG3087|consensus	229		98.93
KOG3741|consensus	655		98.84
COG4248	637	Uncharacterized protein with protein kinase and he	98.82
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.73
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.65
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.62
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.45
KOG2137|consensus	700		98.35
PRK09902	216	hypothetical protein; Provisional	98.28
KOG0576|consensus	829		98.22
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.14
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.13
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.1
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.02
PF01636	239	APH: Phosphotransferase enzyme family This family	97.82
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.79
PLN02876	822	acyl-CoA dehydrogenase	97.77
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.73
KOG1235|consensus	538		97.73
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.68
KOG1035|consensus	1351		97.67
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.62
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.47
PRK10593	297	hypothetical protein; Provisional	97.29
KOG1826|consensus	2724		97.14
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.12
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.04
KOG2270|consensus	520		96.78
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.69
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.62
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.61
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.46
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.45
PRK05231	319	homoserine kinase; Provisional	95.95
KOG2268|consensus	465		95.62
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.23
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.19
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.18
KOG1093|consensus	725		94.94
PLN02236	344	choline kinase	94.66
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	94.17
PLN02756	418	S-methyl-5-thioribose kinase	94.09
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	94.03
PRK12396	409	5-methylribose kinase; Reviewed	93.66
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.84
KOG1236|consensus	565		92.47
PRK06148	1013	hypothetical protein; Provisional	91.96
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	91.52
PRK11768	325	serine/threonine protein kinase; Provisional	91.35
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	91.17
PTZ00384	383	choline kinase; Provisional	89.85
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	89.8
KOG1033|consensus	516		88.5
PTZ00296	442	choline kinase; Provisional	88.41
PHA03111	444	Ser/Thr kinase; Provisional	84.01

>KOG4250|consensus

Probab=100.00  E-value=4.7e-103  Score=867.68  Aligned_cols=685  Identities=35%  Similarity=0.528  Sum_probs=611.6

Q ss_pred             CCcccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEec
Q psy15481          1 MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ   80 (708)
Q Consensus         1 ms~l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~   80 (708)
                      |++++++.||-|...+.||+||||.||+|+++.||+.||||.++..+..++.+++.+|++++++|+|||||+++++.++.
T Consensus         4 ~~~l~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~   83 (732)
T KOG4250|consen    4 PPVLTSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETK   83 (732)
T ss_pred             CcccccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcc
Confidence            57899999999999999999999999999999999999999999999999999999999999999999999999998776


Q ss_pred             C----CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceE
Q psy15481         81 E----GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY  156 (708)
Q Consensus        81 ~----~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~v  156 (708)
                      .    .+..++|||||+||||+.++.+|+|.+|||+.+++.++.+++.||.|||++|||||||||+||+++++.||+.++
T Consensus        84 ~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~Iy  163 (732)
T KOG4250|consen   84 FLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIY  163 (732)
T ss_pred             ccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Confidence            6    667899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC-CChhhH
Q psy15481        157 KLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKET  235 (708)
Q Consensus       157 KL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g-~~~~e~  235 (708)
                      ||+|||+|+.+++++.+.+.+||+.|+|||++++       ++.|+..+|.|||||++||++||.+||.|+.+ +++.++
T Consensus       164 KLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~-------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~  236 (732)
T KOG4250|consen  164 KLTDFGAARELDDNSLFTSLVGTEEYLHPELYER-------QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEI  236 (732)
T ss_pred             eeecccccccCCCCCeeeeecCchhhcChHHHhh-------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchh
Confidence            9999999999999999999999999999999985       58899999999999999999999999999988 568999


Q ss_pred             HHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC--CHHHHHHHHHHHHhhhhc
Q psy15481        236 MYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW--SFERFFSEVTKTLNRKLV  313 (708)
Q Consensus       236 ~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp--sa~q~~~~l~~il~~~l~  313 (708)
                      ++.++++++.+++.+.+...+|+++|+..+|.++.+++.+...+.++|+.+|..||++||  ++.+||.++.+||+..+.
T Consensus       237 ~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vv  316 (732)
T KOG4250|consen  237 MWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVV  316 (732)
T ss_pred             hhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhee
Confidence            999999999999999999999999999999999999999999999999999999999999  999999999999999999


Q ss_pred             CcccCCcccccccccCCcccHHHHHHHHHhhcCCCccceEEEeeCCcc--c---ccCCCCCCCCCC--------------
Q psy15481        314 HLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHF--S---HIFPSSHQKNPS--------------  374 (708)
Q Consensus       314 h~~~~~~~~~~~~~i~~~e~~~~l~~~i~~~t~i~~~~q~~~~~~~~~--~---~~~~~~~~~~p~--------------  374 (708)
                      |.|...+...+.++++++++...|.+.|..+|||++.+|+++++++..  +   +..|++ -+.|+              
T Consensus       317 hiFs~~~~~~~~~~~~~~ntl~~~~~~I~~~Tgipe~~qeLL~e~~~~h~~~~~Q~~~dg-~~~~l~l~~~~~~~v~~~~  395 (732)
T KOG4250|consen  317 HIFSMVQATSHEYYVHADNTLHSLIERISKQTGIPEGKQELLFEGGLSHLEDSAQCIPDG-LDSPLYLVSDQDKNVDERK  395 (732)
T ss_pred             EEEeeccceEEEEecChhhhHHHHHHHHHHhhCCCCccceeeeecCccccCcccccCCCC-CCCceEEEecCCCcchhhc
Confidence            999999999999999999999999999999999999999999996655  2   245555 23333              


Q ss_pred             ---------CCcceeccchhHHhhhcC-chhHHHHHHHHhhhhhHHHHhHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHH
Q psy15481        375 ---------SYSVSVENDATLAKQACS-TGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQ  444 (708)
Q Consensus       375 ---------~~~~~~~~d~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (708)
                               ++.++.+.|+++||+.++ +|++|+|.++.+.+.++.+.+|.+|+++.|...+++..+....+...++.+.
T Consensus       396 ~~~r~~p~~~~~i~~d~k~~~aki~~~~vg~~~~~~i~~ll~~~~r~~qg~r~~~~~L~~~~s~~~k~~~t~~~~~~~~~  475 (732)
T KOG4250|consen  396 ILKRSLPKVVPYIDQDKKASLAKIQLRKVGLEALREIDTLLEDQERLFQGLRAVMELLVRTNSELLKVKTTSRSALQQLL  475 (732)
T ss_pred             ccccCCCCCccchhccchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence                     589999999999999999 9999999999999999999999999999999999999999988888888887


Q ss_pred             HHHHHHHhhhcccc--ccccccccchhhhHHHHhhhhhhhhhhhhhhHHHHHHhhccCchhhHHHhhccCCCCCCCCCch
Q psy15481        445 SLVDHISRSYNSIF--SLMEDKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRCVLDKTLSKEWTNATRPIICPGKVKV  522 (708)
Q Consensus       445 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  522 (708)
                      ..++.+........  .+..++..-+.+.+.+|.+..+ ....+...+++++......+.+..+|.+..   +++.++|.
T Consensus       476 a~~d~~~~~~~~~~~~~~e~~~i~~a~d~~~~l~r~ae-v~~~~~~~~~~i~~~~~~~~~l~~~~i~~~---~s~~~~r~  551 (732)
T KOG4250|consen  476 AKLDFMHSSIQIDLKKDSEQQEIGIASDKRTKLLREAE-VKSDIEACIKVIQWELEDLMSLDTEIIHSE---KSPYKRRQ  551 (732)
T ss_pred             HhhHHHHHHhhcchhccHHHHHHHHHHHHHHHHHHHHH-HhhHHHHHHHHHHHHhhhhhhhchHHHhcc---cCCccccc
Confidence            66655442222111  1111233345666777777676 678888888888888855556777777664   99999999


Q ss_pred             hhHHHHHHHHHHHHHHHHhhhhcc-CCCCCcccchhhhhhhhhhhhHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHHH
Q psy15481        523 PARAKTLTERLRDSWQHLLRDRAT-RTLSYNDEQFHVLERIKIGETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIY  601 (708)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~~~r~~-~~l~yn~eq~h~~~k~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~w~~~~~~~~  601 (708)
                      .+.|++|+++++++|+||+|+|++ |+++|||||+|||+|++..+.+++...++.++|+|+|.++++++++|+|.|++.+
T Consensus       552 ~~~l~~l~~~~~elyk~~~k~r~~~~~~~~n~e~~hkl~k~~~~~~~~~~~~s~~~~c~~k~~~~l~~~E~~~~~m~~~~  631 (732)
T KOG4250|consen  552 GAQLESLLERARELYKQLKKRRAEVRELGYNDEQIHKLQKQKNLHAALSQLLSNLDECKQKISEFLPKLEKWFRLMKETR  631 (732)
T ss_pred             HHHHHHHHHHHHHHHHHHHhchhhhhhcccchHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHhHHHHHHHHHHH
Confidence            999999999999999999999999 9999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHHHHHHHHHhhhhhHHHHhhhhhhhhhccccccCccCcc-ccchhhhhhhhhHHHHHHHHHHHHHH
Q psy15481        602 LQSNFLSKDMQTFAHSLAEFQTKVIDEDVKFHENLMNLSKIKFTNHLNSNVNK-LNNCLRIKSQDLKYIRTSIKDLSLIK  680 (708)
Q Consensus       602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  680 (708)
                      .++..+..++.+++..+.++++..++-.......+..  -+.++...+-|... ...+++       .+-..|++++++|
T Consensus       632 n~~~~lq~~r~~~~~~l~~i~~~~~~~~~~l~~~~~~--~~k~i~~~~~p~~~~~~~~l~-------~~~i~~~~~~ee~  702 (732)
T KOG4250|consen  632 NHVLQLQCSRFKEEESLLKIRCEFSEVQSELKQSLLQ--CTKGISALNPPIKLEGSNSLG-------DLLIPSQELSEEM  702 (732)
T ss_pred             HHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhhcchHh--hhhhhhccCCCccccccchHH-------HhhhhHHhhhhHH
Confidence            9999999999999999999999998777776665542  12233333333333 112222       2223489999999


Q ss_pred             HHHHHHHhhcchhHHHhhhhhcccCC
Q psy15481        681 NEFNQFLENNSHLVDDIKLLSEQSSS  706 (708)
Q Consensus       681 ~~v~~~l~~n~~~~~~~~~~~~~~~~  706 (708)
                      ..|+..|.+||+|+|++++++..+.|
T Consensus       703 ~~~~s~l~~~n~i~e~~~~~~~~~~~  728 (732)
T KOG4250|consen  703 DNLVSLLTENNHIIEQLNSLTNLDGS  728 (732)
T ss_pred             HhHHHHHHHHHHHHHHHhcccCCcch
Confidence            99999999999999999999986654

>KOG0615|consensus

Probab=100.00  E-value=2.8e-50  Score=423.58  Aligned_cols=269  Identities=28%  Similarity=0.401  Sum_probs=219.9

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC------chHHHHHHHHHHHhCCCCCccceeEEEEec
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR------PHDVQMREFEVLKKVKHENIVKLLAIEEEQ   80 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~------~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~   80 (708)
                      +++..|.+.+.||+|+||.|-+|..++||+.||||++++.....      ......+|+++|++|+|||||+++++|+.+
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            46788999999999999999999999999999999997653222      112235999999999999999999999987


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                      +.  .|+||||+.||+|++.+-....   +.+..-+.+++|++.|+.|||++||+||||||+|||+ -.++....+||+|
T Consensus       249 ds--~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl-~~~~e~~llKItD  322 (475)
T KOG0615|consen  249 DS--SYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILL-SNDAEDCLLKITD  322 (475)
T ss_pred             Cc--eEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEe-ccCCcceEEEecc
Confidence            75  8999999999999999877543   8999999999999999999999999999999999998 2333568999999


Q ss_pred             cCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcC-CccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        161 FGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       161 FGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~-s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      ||+|...++..-+.+.||||.|.|||++..-      |..+ ..++||||+||+||-+++|.+||...  ..+.....+|
T Consensus       323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~k------g~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~--~~~~sl~eQI  394 (475)
T KOG0615|consen  323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASK------GVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE--YTDPSLKEQI  394 (475)
T ss_pred             cchhhccccceehhhhcCCccccChhheecC------CeecccchheeeeccceEEEEeccCCCcccc--cCCccHHHHH
Confidence            9999999988888999999999999999731      3333 44899999999999999999999842  2223244445


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ..++.                 ....+.+..++    ....+||..||.+||++|||+++.           +.|||+..
T Consensus       395 ~~G~y-----------------~f~p~~w~~Is----eea~dlI~~mL~VdP~~R~s~~ea-----------L~hpW~~~  442 (475)
T KOG0615|consen  395 LKGRY-----------------AFGPLQWDRIS----EEALDLINWMLVVDPENRPSADEA-----------LNHPWFKD  442 (475)
T ss_pred             hcCcc-----------------cccChhhhhhh----HHHHHHHHHhhEeCcccCcCHHHH-----------hcChhhhc
Confidence            54321                 11223333444    455569999999999999999995           88999975


Q ss_pred             cc
Q psy15481        320 RL  321 (708)
Q Consensus       320 ~~  321 (708)
                      -+
T Consensus       443 ~~  444 (475)
T KOG0615|consen  443 AP  444 (475)
T ss_pred             cc
Confidence            44

>KOG0575|consensus

Probab=100.00  E-value=5.6e-47  Score=416.20  Aligned_cols=260  Identities=30%  Similarity=0.490  Sum_probs=224.6

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+....  ...+...+||++.+.|+|||||+++++|++.++  +||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n--VYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN--VYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc--eEE
Confidence            6899999999999999999999999999999999875433  234556799999999999999999999998765  999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |.|+|..++|..+++....   ++|.+++.+++||+.||.|||+++|+|||||.+|+|+    +++..|||+|||+|..+
T Consensus        96 vLELC~~~sL~el~Krrk~---ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL----~~~~~VKIgDFGLAt~l  168 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRRKP---LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL----NENMNVKIGDFGLATQL  168 (592)
T ss_pred             EEEecCCccHHHHHHhcCC---CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee----cCcCcEEecccceeeee
Confidence            9999999999999985443   9999999999999999999999999999999999999    88889999999999998


Q ss_pred             ccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 EED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ..+ +...+.||||.|+|||++.        ....+..+||||+||+||.|++|++||.   ..+-.+++.+|.....  
T Consensus       169 e~~~Erk~TlCGTPNYIAPEVl~--------k~gHsfEvDiWSlGcvmYtLL~G~PPFe---tk~vkety~~Ik~~~Y--  235 (592)
T KOG0575|consen  169 EYDGERKKTLCGTPNYIAPEVLN--------KSGHSFEVDIWSLGCVMYTLLVGRPPFE---TKTVKETYNKIKLNEY--  235 (592)
T ss_pred             cCcccccceecCCCcccChhHhc--------cCCCCCchhhhhhhhHHHhhhhCCCCcc---cchHHHHHHHHHhcCc--
Confidence            855 7788999999999999998        5778999999999999999999999997   3556777777765311  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcccccc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIR  325 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~~~  325 (708)
                                       .+|.  .+|.++++    ||.+||+.||.+|||++++           +.|+|+.....+..
T Consensus       236 -----------------~~P~--~ls~~A~d----LI~~lL~~~P~~Rpsl~~v-----------L~h~Ff~~g~~p~~  280 (592)
T KOG0575|consen  236 -----------------SMPS--HLSAEAKD----LIRKLLRPNPSERPSLDEV-----------LDHPFFKSGFTPAR  280 (592)
T ss_pred             -----------------cccc--ccCHHHHH----HHHHHhcCCcccCCCHHHH-----------hcCHhhhCCCcCCC
Confidence                             2333  56665555    8899999999999999997           67888855444433

>KOG0595|consensus

Probab=100.00  E-value=9.6e-47  Score=397.61  Aligned_cols=260  Identities=31%  Similarity=0.529  Sum_probs=216.6

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC-CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS-HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s-~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      .+..-+.|.+.+.||+|+||+||+|++++++..||||.+.+.. .....+....|+.+|+.++|||||.++++++..+  
T Consensus         5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~--   82 (429)
T KOG0595|consen    5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD--   82 (429)
T ss_pred             cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC--
Confidence            3455678889999999999999999999999999999998764 3344566689999999999999999999998766  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC--ceEEEecc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS--TIYKLTDF  161 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~--~~vKL~DF  161 (708)
                      .+|+|||||.||||..++.....   +++..++.++.||+.||++||+++||||||||.|||+.......  ..+||+||
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            59999999999999999988653   99999999999999999999999999999999999984432222  78999999


Q ss_pred             CccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        162 GAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       162 GlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      |+|+.+.++....+.||++-|||||++.        ...|+.|+|+||+|+++|+|++|..||.   ..+..+....+..
T Consensus       160 GfAR~L~~~~~a~tlcGSplYMAPEV~~--------~~~YdAKADLWSiG~Ilyq~l~g~~Pf~---a~t~~eL~~~~~k  228 (429)
T KOG0595|consen  160 GFARFLQPGSMAETLCGSPLYMAPEVIM--------SQQYDAKADLWSIGTILYQCLTGKPPFD---AETPKELLLYIKK  228 (429)
T ss_pred             chhhhCCchhHHHHhhCCccccCHHHHH--------hccccchhhHHHHHHHHHHHHhCCCCcc---ccCHHHHHHHHhc
Confidence            9999999888888999999999999998        6889999999999999999999999998   3555665554443


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      ...                   ..|.   ++..+..-..+++...|..||..|.++.++|.
T Consensus       229 ~~~-------------------~~~~---~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~  267 (429)
T KOG0595|consen  229 GNE-------------------IVPV---LPAELSNPLRELLISLLQRNPKDRISFEDFFD  267 (429)
T ss_pred             ccc-------------------ccCc---hhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence            210                   1111   11222223345778889999999999999854

>KOG0581|consensus

Probab=100.00  E-value=3.2e-46  Score=390.78  Aligned_cols=259  Identities=24%  Similarity=0.373  Sum_probs=222.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      ..+..+.||+|..|+||+++|+.|++.+|+|++.............+|++++++.+||+||.+++.|..... .++|+||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mE  158 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICME  158 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehh
Confidence            566788999999999999999999999999999554444444455799999999999999999999988764 6999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||.||||..++....   .++|..+..++.+|++||.|||. .+||||||||+|||+    +.++.|||||||.+..+..
T Consensus       159 YMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv----NskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV----NSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             hcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee----ccCCCEEeccccccHHhhh
Confidence            999999999998754   39999999999999999999996 899999999999999    8888999999999998766


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCC--CCCChhhHHHHHHhcccCCc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY--GGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~--~g~~~~e~~~~i~~~~~~~~  247 (708)
                      . ...+.+||..|||||.+.        +..|+.++||||||++++|+++|+.||.+.  +.....+.+..|..+.++  
T Consensus       232 S-~a~tfvGT~~YMsPERi~--------g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP--  300 (364)
T KOG0581|consen  232 S-IANTFVGTSAYMSPERIS--------GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP--  300 (364)
T ss_pred             h-hcccccccccccChhhhc--------CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC--
Confidence            6 567899999999999998        789999999999999999999999999874  224677788888865333  


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                      .+|..     .++..+.+|+..||++||.+|||++|+           +.|||+...
T Consensus       301 ----------------~lP~~-----~fS~ef~~FV~~CL~Kdp~~R~s~~qL-----------l~Hpfi~~~  341 (364)
T KOG0581|consen  301 ----------------RLPEG-----EFSPEFRSFVSCCLRKDPSERPSAKQL-----------LQHPFIKKF  341 (364)
T ss_pred             ----------------CCCcc-----cCCHHHHHHHHHHhcCCcccCCCHHHH-----------hcCHHHhhc
Confidence                            22322     244556669999999999999999998           679998643

>KOG0593|consensus

Probab=100.00  E-value=1.7e-46  Score=381.65  Aligned_cols=270  Identities=26%  Similarity=0.434  Sum_probs=216.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|+....+|+|+||.||+|+++.||+.||||.|..... +.-....+||+++|+.|+|||+|.++++|....  ..++|+
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr--klhLVF   80 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR--KLHLVF   80 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc--eeEEEe
Confidence            47778899999999999999999999999999964332 223344589999999999999999999997644  499999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc-
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-  168 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~-  168 (708)
                      |||. .++.+-+....+  |++++.++.+++|++.|++|||++++|||||||+|||+    ..++++||||||+|+.+. 
T Consensus        81 E~~d-hTvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi----t~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   81 EYCD-HTVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI----TQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             eecc-hHHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE----ecCCcEEeccchhhHhhcC
Confidence            9996 566666666444  49999999999999999999999999999999999999    778899999999999887 


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      +++.+...+.|.+|+|||.+.+       ...|+.++|||++||++.||++|.+.|.   |+++.++++.|...-..- +
T Consensus       154 pgd~YTDYVATRWYRaPELLvG-------DtqYG~pVDiWAiGCv~aEl~~G~pL~P---G~SDiDQLy~I~ktLG~L-~  222 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVG-------DTQYGKPVDIWAIGCVFAELLTGEPLWP---GRSDIDQLYLIRKTLGNL-I  222 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcc-------cCcCCCcccchhhhHHHHHHhcCCcCCC---CcchHHHHHHHHHHHccc-C
Confidence            6777888999999999999984       4789999999999999999999999997   789999999887532211 1


Q ss_pred             cccc-cCCCCcccccCCCCCcccC------ChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        249 SGTQ-TSENGEIDWCTDLPNNCQL------SLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       249 ~~~~-~~~~g~~~~~~~lp~~~~l------s~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      ..-+ .-..+++-..-.+|.....      -+.+...+.+++++||..||.+|++.+++
T Consensus       223 prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql  281 (396)
T KOG0593|consen  223 PRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL  281 (396)
T ss_pred             HHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH
Confidence            0000 0011111111133333222      23456678899999999999999999987

>KOG0598|consensus

Probab=100.00  E-value=8.8e-45  Score=379.82  Aligned_cols=243  Identities=30%  Similarity=0.445  Sum_probs=208.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ...|++.+.||+|+||.||.++.++|++.||+|++++......  ......|..+|.+++||.||+++..|.+.+  .+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~--kLy  101 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE--KLY  101 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC--eEE
Confidence            4579999999999999999999999999999999987654433  334579999999999999999999887655  499


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|+||+.||.|+..|++...   ++++.++-++..|+.||.|||++|||||||||+|||+    |.++.++|+|||+|..
T Consensus       102 lVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL----d~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL----DEQGHIKLTDFGLCKE  174 (357)
T ss_pred             EEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee----cCCCcEEEeccccchh
Confidence            99999999999999987554   9999999999999999999999999999999999999    8888999999999995


Q ss_pred             cc-ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LE-EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~-~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .. .+....+.|||++|||||++.        +..|+.++|.||||+++|+|++|.+||.   +.+......+|...+. 
T Consensus       175 ~~~~~~~t~tfcGT~eYmAPEil~--------~~gy~~~vDWWsLGillYeML~G~pPF~---~~~~~~~~~~I~~~k~-  242 (357)
T KOG0598|consen  175 DLKDGDATRTFCGTPEYMAPEILL--------GKGYDKAVDWWSLGILLYEMLTGKPPFY---AEDVKKMYDKILKGKL-  242 (357)
T ss_pred             cccCCCccccccCCccccChHHHh--------cCCCCcccchHhHHHHHHHHhhCCCCCc---CccHHHHHHHHhcCcC-
Confidence            43 445566789999999999998        6899999999999999999999999998   4666777777775431 


Q ss_pred             CcccccccCCCCcccccCCCCCccc-CChhHHHHHHHHHHhhcccCcccCCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQ-LSLGLKKLVTPILAGLLEVDSKKIWS  296 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~-ls~~l~~~l~~LL~~mL~~DP~kRps  296 (708)
                                          +.... ++.+.    .+++.++|..||++|+.
T Consensus       243 --------------------~~~p~~ls~~a----rdll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  243 --------------------PLPPGYLSEEA----RDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             --------------------CCCCccCCHHH----HHHHHHHhccCHHHhcC
Confidence                                12111 44444    45899999999999984

>KOG0661|consensus

Probab=100.00  E-value=7.8e-46  Score=395.90  Aligned_cols=288  Identities=22%  Similarity=0.348  Sum_probs=234.2

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .-.+|.+.+.||.|.||.||+|..+.+|..||||.+++.......-.-.||+..|++|+ |||||++.+++.+.+. .+|
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence            34578899999999999999999999999999999987655433334479999999998 9999999999987664 799


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||| ..+|+++++...  ..+++..++.|+.||+.||+|+|.+|+.|||+||+|||+    .+..++||+|||+|+.
T Consensus        87 fVfE~M-d~NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi----~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI----SGNDVIKIADFGLARE  159 (538)
T ss_pred             eeHHhh-hhhHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe----cccceeEecccccccc
Confidence            999999 589999999874  349999999999999999999999999999999999998    7788999999999999


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ......+...+.|.+|+|||++.+       ...|+.++|||++|||++|+.+-++.|.   |.+..+++++|..--..-
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLr-------s~~Ys~pvD~wA~GcI~aEl~sLrPLFP---G~sE~Dqi~KIc~VLGtP  229 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLR-------SGYYSSPVDMWAVGCIMAELYSLRPLFP---GASEIDQIYKICEVLGTP  229 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhh-------ccccCCchHHHHHHHHHHHHHHhcccCC---CCcHHHHHHHHHHHhCCC
Confidence            998889999999999999999986       6889999999999999999999999998   688889999988532111


Q ss_pred             cccccccC----CCCcccccCCCCCc-ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        247 VISGTQTS----ENGEIDWCTDLPNN-CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       247 ~i~~~~~~----~~g~~~~~~~lp~~-~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                      ........    ..-.+.|....|.. ..+-+.+.....++|..|+.+||.+||||+++           +.||||....
T Consensus       230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~a-----------l~~pffq~~~  298 (538)
T KOG0661|consen  230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQA-----------LQHPFFQVGR  298 (538)
T ss_pred             ccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHH-----------hcCccccccc
Confidence            11111000    00011111111111 11222366667789999999999999999997           7799997765


Q ss_pred             ccc
Q psy15481        322 QCI  324 (708)
Q Consensus       322 ~~~  324 (708)
                      ...
T Consensus       299 ~~~  301 (538)
T KOG0661|consen  299 ASG  301 (538)
T ss_pred             ccc
Confidence            543

>KOG0600|consensus

Probab=100.00  E-value=2.3e-44  Score=387.13  Aligned_cols=272  Identities=24%  Similarity=0.378  Sum_probs=226.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|+.+++||+|.||.||+|++..||+.||+|.++....... .-...|||.||++|+||||+++.++..+...+.+|+|+
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF  197 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF  197 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence            46778899999999999999999999999999987664333 33457999999999999999999999888666899999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||+ .||..++..+...  |++.+++.++.||+.||+|||++||+|||||.+|||+    |.++++||+|||+|+.+..
T Consensus       198 eYMd-hDL~GLl~~p~vk--ft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi----dn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  198 EYMD-HDLSGLLSSPGVK--FTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI----DNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             eccc-chhhhhhcCCCcc--cChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE----cCCCCEEeccccceeeccC
Confidence            9994 8999999887654  9999999999999999999999999999999999999    9999999999999997655


Q ss_pred             cc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        170 DQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       170 ~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..  .+.+.+.|.+|+|||++.+       ...|+.++|+||.||||.||++|++.|.   |+...++++.|+.      
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG-------~t~Yg~aVDlWS~GCIl~El~~gkPI~~---G~tEveQl~kIfk------  334 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLG-------ATSYGTAVDLWSVGCILAELFLGKPILQ---GRTEVEQLHKIFK------  334 (560)
T ss_pred             CCCcccccceEEeeccChHHhcC-------CcccccceeehhhhHHHHHHHcCCCCcC---CccHHHHHHHHHH------
Confidence            43  5778899999999999985       5789999999999999999999999998   6888899998886      


Q ss_pred             ccccccCCCCcccccCCCCCc------cc----C---ChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcC
Q psy15481        248 ISGTQTSENGEIDWCTDLPNN------CQ----L---SLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVH  314 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~------~~----l---s~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h  314 (708)
                      ++|......++   ...+|..      .+    +   ...++...++|+..||..||.+|.||.+.           +.+
T Consensus       335 lcGSP~e~~W~---~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~a-----------L~s  400 (560)
T KOG0600|consen  335 LCGSPTEDYWP---VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSA-----------LQS  400 (560)
T ss_pred             HhCCCChhccc---cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHH-----------hcC
Confidence            23333333332   1122211      11    1   12334456789999999999999999985           678


Q ss_pred             cccCC
Q psy15481        315 LFHIN  319 (708)
Q Consensus       315 ~~~~~  319 (708)
                      .||..
T Consensus       401 eyF~t  405 (560)
T KOG0600|consen  401 EYFTT  405 (560)
T ss_pred             ccccc
Confidence            88833

>KOG0583|consensus

Probab=100.00  E-value=7.5e-43  Score=381.60  Aligned_cols=258  Identities=28%  Similarity=0.478  Sum_probs=215.1

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC----CchHHHHHHHHHHHhCC-CCCccceeEEEEecC
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM----RPHDVQMREFEVLKKVK-HENIVKLLAIEEEQE   81 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~----~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~   81 (708)
                      .....|.+++.||+|+||.|+.|.+..+|+.||+|++++....    .......+|+.++++++ ||||+++++++..+.
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4566899999999999999999999999999999987664111    22334458999999998 999999999998876


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC-ceEEEec
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS-TIYKLTD  160 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~-~~vKL~D  160 (708)
                      .  +|+|||||.||+|++++.+..   .++|.+++.+++|++.|++|||++||+||||||+|||+    |+. +.+||+|
T Consensus        94 ~--~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill----d~~~~~~Kl~D  164 (370)
T KOG0583|consen   94 K--IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL----DGNEGNLKLSD  164 (370)
T ss_pred             e--EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe----cCCCCCEEEec
Confidence            5  999999999999999998733   39999999999999999999999999999999999998    666 8899999


Q ss_pred             cCccccc-cccccccccCCCCCcCChhhhhhhhhcCCCCCc-C-CccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH
Q psy15481        161 FGAAREL-EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKT-F-GATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       161 FGlA~~~-~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~-~-s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~  237 (708)
                      ||++... ..+....+.+||+.|+|||++.        +.. | +.++||||+||+||.|++|..||..   .+...+..
T Consensus       165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~--------~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~  233 (370)
T KOG0583|consen  165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLS--------GKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYR  233 (370)
T ss_pred             cccccccCCCCCcccCCCCCcccCCHHHhC--------CCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHH
Confidence            9999988 5667788899999999999998        444 5 6899999999999999999999973   33333443


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      +|....                   ..+|.+.. |+++.    +++.+||..||.+|+++.++           +.|||+
T Consensus       234 ki~~~~-------------------~~~p~~~~-S~~~~----~Li~~mL~~~P~~R~t~~~i-----------~~h~w~  278 (370)
T KOG0583|consen  234 KIRKGE-------------------FKIPSYLL-SPEAR----SLIEKMLVPDPSTRITLLEI-----------LEHPWF  278 (370)
T ss_pred             HHhcCC-------------------ccCCCCcC-CHHHH----HHHHHHcCCCcccCCCHHHH-----------hhChhh
Confidence            333221                   13344433 55554    48999999999999999997           569999


Q ss_pred             CC
Q psy15481        318 IN  319 (708)
Q Consensus       318 ~~  319 (708)
                      ..
T Consensus       279 ~~  280 (370)
T KOG0583|consen  279 QK  280 (370)
T ss_pred             cc
Confidence            87

>KOG0660|consensus

Probab=100.00  E-value=6.4e-44  Score=372.13  Aligned_cols=306  Identities=24%  Similarity=0.390  Sum_probs=233.5

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccC-CCCCchHHHHHHHHHHHhCCCCCccceeEEEEe---cCCc
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQL-SHMRPHDVQMREFEVLKKVKHENIVKLLAIEEE---QEGR   83 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~-s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~---~~~~   83 (708)
                      ..+.|...+.||.|+||.|+.+.++.||+.||||.+... .......+..||+.+|+.++|+||+.+.+++..   ...+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            455677789999999999999999999999999998632 333445566899999999999999999999875   2345


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|+|+|+| +.||.++++....   +++..+..+++|+++||+|+|+.||+|||+||+|+++    +.++.+||+|||+
T Consensus       100 DvYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~----n~~c~lKI~DFGL  171 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL----NADCDLKICDFGL  171 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhcccccccccchhheee----ccCCCEEeccccc
Confidence            699999999 7999999987654   9999999999999999999999999999999999999    8888899999999


Q ss_pred             cccccc---cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        164 ARELEE---DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       164 A~~~~~---~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      |+....   +......+.|.+|+|||++..       ...|+.++||||+||||.||++|++.|.   |.+...++..|.
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~-------~~~Yt~aiDiWSvGCI~AEmL~gkplFp---G~d~v~Ql~lI~  241 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLN-------SSEYTKAIDIWSVGCILAEMLTGKPLFP---GKDYVHQLQLIL  241 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhc-------cccccchhhhhhhhHHHHHHHcCCCCCC---CCchHHHHHHHH
Confidence            998764   344466789999999999975       6889999999999999999999999998   455555555555


Q ss_pred             hc---ccCCcccccccCCCCcccccCCCCCccc-----CChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhh
Q psy15481        241 TK---KASGVISGTQTSENGEIDWCTDLPNNCQ-----LSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKL  312 (708)
Q Consensus       241 ~~---~~~~~i~~~~~~~~g~~~~~~~lp~~~~-----ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l  312 (708)
                      .-   +....+..+...  ....|...+|...+     +-+.+.....+||.+||..||.+|+|+++.           +
T Consensus       242 ~~lGtP~~e~l~~i~s~--~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA-----------L  308 (359)
T KOG0660|consen  242 ELLGTPSEEDLQKIRSE--KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA-----------L  308 (359)
T ss_pred             HhcCCCCHHHHHHhccH--HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH-----------h
Confidence            32   222222221111  01123333333222     224556677889999999999999999995           6


Q ss_pred             cCcccCCccccc------ccc--cCCcccHHHHHHHHHhh
Q psy15481        313 VHLFHINRLQCI------RIY--LHPDDAYDQLQDLIQEQ  344 (708)
Q Consensus       313 ~h~~~~~~~~~~------~~~--i~~~e~~~~l~~~i~~~  344 (708)
                      .|||+..-....      ...  .....+.+.+.+.+.++
T Consensus       309 ~hPYl~~~hdp~dEP~~~~~~~~~~~~~~~~~~r~~i~~e  348 (359)
T KOG0660|consen  309 AHPYLAPYHDPEDEPVCQPIFDSFEHELTEEELRELIYKE  348 (359)
T ss_pred             cChhhhhhcCCccCCCCCCCCccccccccHHHHHHHHHHH
Confidence            677664322111      111  12224577777777665

>KOG0659|consensus

Probab=100.00  E-value=2.3e-43  Score=353.74  Aligned_cols=276  Identities=21%  Similarity=0.320  Sum_probs=225.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchH-HHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD-VQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~-~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ++|...+.||+|.||.||+|++..||+.||||.++......... ...||+..|+.++||||+.++++|...++  +.||
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~--l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN--LSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc--eEEE
Confidence            57888999999999999999999999999999998765443333 35799999999999999999999977654  9999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      +||++ .+|..++++...-  ++...++.++.++++|++|||++.|+||||||.|+|+    +.++.+||+|||+|+.+.
T Consensus        80 fEfm~-tdLe~vIkd~~i~--l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi----s~~g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   80 FEFMP-TDLEVVIKDKNII--LSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI----SSDGQLKIADFGLARFFG  152 (318)
T ss_pred             EEecc-ccHHHHhcccccc--cCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE----cCCCcEEeecccchhccC
Confidence            99995 8999999886654  9999999999999999999999999999999999998    777789999999999876


Q ss_pred             cc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 ED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      .. ......+.|.+|+|||.+.+       .+.|+..+||||.|||+.||+.|.+-|.   |.++.+++..|+..-    
T Consensus       153 ~p~~~~~~~V~TRWYRAPELLfG-------sr~Yg~~VDmWavGCI~AELllr~P~fp---G~sDidQL~~If~~L----  218 (318)
T KOG0659|consen  153 SPNRIQTHQVVTRWYRAPELLFG-------SRQYGTGVDMWAVGCIFAELLLRVPFFP---GDSDIDQLSKIFRAL----  218 (318)
T ss_pred             CCCcccccceeeeeccChHHhcc-------chhcCCcchhhhHHHHHHHHHccCCCCC---CCchHHHHHHHHHHc----
Confidence            44 34444589999999999985       5789999999999999999999987776   788888888887531    


Q ss_pred             ccccccCCCCc--------ccccCCCCC--cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        248 ISGTQTSENGE--------IDWCTDLPN--NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       248 i~~~~~~~~g~--------~~~~~~lp~--~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                        |..+...++        .++. ..|.  ...+-+.+...+.+|+.+||..||.+|+++.|.           +.|+||
T Consensus       219 --GTP~~~~WP~~~~lpdY~~~~-~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qa-----------L~~~yf  284 (318)
T KOG0659|consen  219 --GTPTPDQWPEMTSLPDYVKIQ-QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQA-----------LKHPYF  284 (318)
T ss_pred             --CCCCcccCccccccccHHHHh-cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHH-----------hcchhh
Confidence              222222211        0111 1111  122445566677899999999999999999996           668888


Q ss_pred             CCccc
Q psy15481        318 INRLQ  322 (708)
Q Consensus       318 ~~~~~  322 (708)
                      .+.+.
T Consensus       285 ~~~P~  289 (318)
T KOG0659|consen  285 KSLPL  289 (318)
T ss_pred             hcCCC
Confidence            76443

>KOG0663|consensus

Probab=100.00  E-value=1.7e-43  Score=363.85  Aligned_cols=288  Identities=24%  Similarity=0.341  Sum_probs=230.1

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch-HHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH-DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~-~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .+...|+..+.|++|.||.||+|++++|++.||+|.++........ -...|||.+|.+++|||||.+-++....+-+.+
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            4455788999999999999999999999999999999865433322 234699999999999999999999998888889


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|||||+ .||..++.....  .+...+++.++.|+++|++|||.+.|+|||+||+|+|+    ...+.+||+|||+|+
T Consensus       153 y~VMe~~E-hDLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm----~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  153 YIVMEYVE-HDLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL----SHKGILKIADFGLAR  225 (419)
T ss_pred             eeeHHHHH-hhHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee----ccCCcEEecccchhh
Confidence            99999995 899999988653  38999999999999999999999999999999999998    778899999999999


Q ss_pred             ccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH---h
Q psy15481        166 ELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT---T  241 (708)
Q Consensus       166 ~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~---~  241 (708)
                      .++.. ..+...+.|.+|+|||++..       ...|+.++||||+|||+.|++++.+.|.   |.+..+++.+|+   .
T Consensus       226 ~ygsp~k~~T~lVVTLWYRaPELLLG-------~~tyst~iDMWSvGCI~aE~l~~kPlf~---G~sE~dQl~~If~llG  295 (419)
T KOG0663|consen  226 EYGSPLKPYTPLVVTLWYRAPELLLG-------AKTYSTAVDMWSVGCIFAELLTQKPLFP---GKSEIDQLDKIFKLLG  295 (419)
T ss_pred             hhcCCcccCcceEEEeeecCHHHhcC-------CcccCcchhhhhHHHHHHHHHhcCCCCC---CCchHHHHHHHHHHhC
Confidence            98766 44667889999999999985       5789999999999999999999999998   455555665555   3


Q ss_pred             cccCCcccccccCCCC-cccccCCCCCc--ccCCh-hHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        242 KKASGVISGTQTSENG-EIDWCTDLPNN--CQLSL-GLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g-~~~~~~~lp~~--~~ls~-~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .+...+..|....... .+.+.....+.  ..+.. .+++.-.+|+.++|.+||.+|.||++.           +.|.||
T Consensus       296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~-----------L~h~~F  364 (419)
T KOG0663|consen  296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDG-----------LKHEYF  364 (419)
T ss_pred             CCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHh-----------hccccc
Confidence            3333333333322211 12222221111  00111 145667789999999999999999996           779999


Q ss_pred             CCccc
Q psy15481        318 INRLQ  322 (708)
Q Consensus       318 ~~~~~  322 (708)
                      ...+.
T Consensus       365 ~e~P~  369 (419)
T KOG0663|consen  365 RETPL  369 (419)
T ss_pred             ccCCC
Confidence            77655

>KOG0591|consensus

Probab=100.00  E-value=2.2e-44  Score=363.10  Aligned_cols=257  Identities=25%  Similarity=0.381  Sum_probs=209.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|++.+.||+|.||.||++.+..+|..||.|.++...... ..+....|+.+|+.|+|||||++++.....+...++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            4888999999999999999999999999999998443221 233447999999999999999999954444444589999


Q ss_pred             eccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         90 ELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRD--NR--LVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~--~g--IVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      |||.+|||.++++... ....+||..++.++.|++.||.+||+  ..  |+||||||.||++    ++++++||+|||++
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl----~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL----TANGVVKLGDFGLG  175 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE----cCCCceeeccchhH
Confidence            9999999999887522 12239999999999999999999999  44  9999999999999    88889999999999


Q ss_pred             ccccccccc-cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        165 RELEEDQQF-MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       165 ~~~~~~~~~-~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      +.+.....+ .+.+|||.||+||.+.        +..|+.++||||+||++|||+.-++||.   |++-.+...+|... 
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~--------~~~Y~~kSDiWslGCllyEMcaL~~PF~---g~n~~~L~~KI~qg-  243 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIH--------ESGYNFKSDIWSLGCLLYEMCALQSPFY---GDNLLSLCKKIEQG-  243 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHh--------cCCCCcchhHHHHHHHHHHHHhcCCCcc---cccHHHHHHHHHcC-
Confidence            998877665 4589999999999998        7899999999999999999999999998   45544444445432 


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCC-hhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLS-LGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls-~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                                          +.|   +++ .-.+..+..++..|+.+||..||+...++..+..
T Consensus       244 --------------------d~~---~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  244 --------------------DYP---PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             --------------------CCC---CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                                111   122 3344556669999999999999997666555433

>KOG0592|consensus

Probab=100.00  E-value=6.7e-43  Score=378.43  Aligned_cols=247  Identities=26%  Similarity=0.429  Sum_probs=207.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ...|.+++.||.|+|++|++|.++.+++.||||++.+.-.  ........+|-.+|.+| +||.|++++-.|.+...  +
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s--L  149 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES--L  149 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc--e
Confidence            4578999999999999999999999999999999865421  11123345788899999 99999999999987665  9


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|+||+++|+|.++|...+.   |++...+.++.+|+.||+|||++|||||||||+|||+    |+++.++|+|||.|.
T Consensus       150 YFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~GIIHRDlKPENILL----d~dmhikITDFGsAK  222 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL----DKDGHIKITDFGSAK  222 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE----cCCCcEEEeeccccc
Confidence            999999999999999988654   9999999999999999999999999999999999999    888899999999998


Q ss_pred             ccccccc--------------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCC
Q psy15481        166 ELEEDQQ--------------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR  231 (708)
Q Consensus       166 ~~~~~~~--------------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~  231 (708)
                      .+.+...              ..+.+||..|.+||++.        ....+..+|||+||||+|.|+.|.+||.   +.+
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~--------~~~~~~~sDiWAlGCilyQmlaG~PPFr---a~N  291 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN--------DSPAGPSSDLWALGCILYQMLAGQPPFR---AAN  291 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhc--------CCCCCcccchHHHHHHHHHHhcCCCCCc---ccc
Confidence            7643321              14578999999999998        6778999999999999999999999998   455


Q ss_pred             hhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        232 NKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       232 ~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      ..-+..+|..-               .+    .      ++++++..+.+|++++|..||.+|+|+.++
T Consensus       292 eyliFqkI~~l---------------~y----~------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI  335 (604)
T KOG0592|consen  292 EYLIFQKIQAL---------------DY----E------FPEGFPEDARDLIKKLLVRDPSDRLTSQQI  335 (604)
T ss_pred             HHHHHHHHHHh---------------cc----c------CCCCCCHHHHHHHHHHHccCccccccHHHH
Confidence            55566666642               11    1      233344567779999999999999999886

>KOG0198|consensus

Probab=100.00  E-value=1.4e-42  Score=367.51  Aligned_cols=264  Identities=28%  Similarity=0.454  Sum_probs=212.6

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|...+.||+|+||.||++.+.++|+..|||.+...+... .+...+|+.+|++|+|||||++++.........+++.
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            356899999999999999999999999999999987553322 4556799999999999999999997543332458999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC-CceEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG-STIYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~-~~~vKL~DFGlA~~~  167 (708)
                      |||++||||.+++.+...  .++++.++.+.+||+.||.|||++|||||||||+|||+    +. .+.+||+|||.+...
T Consensus        95 mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl----~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL----DPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE----eCCCCeEEeccCcccccc
Confidence            999999999999987553  39999999999999999999999999999999999998    55 578999999999876


Q ss_pred             cc----cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        168 EE----DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       168 ~~----~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ..    ........||+.|||||++..       +.....++|||||||++.||+||..||..+  ....+.+..+....
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~-------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~  239 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRN-------GEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED  239 (313)
T ss_pred             ccccccccccccccCCccccCchhhcC-------CCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC
Confidence            63    122345789999999999972       223345999999999999999999999853  23334444444321


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                          ..|   .++..++....++|.+|+..||++||||+++           +.|||......
T Consensus       240 --------------------~~P---~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eL-----------L~hpf~~~~~~  284 (313)
T KOG0198|consen  240 --------------------SLP---EIPDSLSDEAKDFLRKCFKRDPEKRPTAEEL-----------LEHPFLKQNSI  284 (313)
T ss_pred             --------------------CCC---CCCcccCHHHHHHHHHHhhcCcccCcCHHHH-----------hhChhhhcccc
Confidence                                122   3444566667779999999999999999998           66888866544

>KOG0597|consensus

Probab=100.00  E-value=1.2e-42  Score=376.00  Aligned_cols=258  Identities=28%  Similarity=0.466  Sum_probs=214.6

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|.+.+.||+|+||.||+|+.+.|++.||+|.+.+..... ......+|++++++++|||||.++++|+...  ++|+|+
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~--~~~vVt   80 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA--HLWVVT   80 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc--eEEEEe
Confidence            5788899999999999999999999999999997643322 2334579999999999999999999998755  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||.| +|+.++.....   +||+.+..+..+++.||.|||+++|+|||+||.|||+    ++.+.+|+||||+|+....
T Consensus        81 e~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl----~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL----EKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee----cCCCceeechhhhhhhccc
Confidence            99975 99999987655   9999999999999999999999999999999999999    8889999999999998776


Q ss_pred             ccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      +.. ..+..|||-|||||++.        +..|+..+|+||+||++||+++|++||..   ++-......|...      
T Consensus       153 ~t~vltsikGtPlYmAPElv~--------e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d------  215 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVE--------EQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKD------  215 (808)
T ss_pred             CceeeeeccCcccccCHHHHc--------CCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcC------
Confidence            644 34567999999999998        78999999999999999999999999972   3333333333321      


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcccccc
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIR  325 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~~~  325 (708)
                               +..|          +..++..+..+|.++|.+||.+|.+..++           +.|||.........
T Consensus       216 ---------~v~~----------p~~~S~~f~nfl~gLL~kdP~~RltW~~L-----------l~HpF~k~~~~~~~  262 (808)
T KOG0597|consen  216 ---------PVKP----------PSTASSSFVNFLQGLLIKDPAQRLTWTDL-----------LGHPFWKGKINIAE  262 (808)
T ss_pred             ---------CCCC----------cccccHHHHHHHHHHhhcChhhcccHHHH-----------hcChHHhhhhhhhc
Confidence                     1111          12445556679999999999999999987           67888766554443

>KOG0033|consensus

Probab=100.00  E-value=1.7e-43  Score=350.41  Aligned_cols=286  Identities=27%  Similarity=0.395  Sum_probs=239.7

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      +...|++.+.||+|+|+.|+++.+..||+.+|+|+++.... ....+...+|+++-+.|+||||+.+++...+..  ..|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~--~~y   86 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FHY   86 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc--eeE
Confidence            34568889999999999999999999999999999875432 234666789999999999999999999876544  589


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|+|++.|++|..-+....   -++|..+..+++||+.||+|+|.+||||||+||.|+++ -..+...-+||+|||+|..
T Consensus        87 lvFe~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllL-ASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLL-ASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EEEecccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheee-eeccCCCceeecccceEEE
Confidence            9999999999966554433   28999999999999999999999999999999999997 4555566899999999999


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ++.+......+|||+|||||++.        ...|+..+|||+-||+||-|+.|.+||.   +.+......+|..+.   
T Consensus       163 l~~g~~~~G~~GtP~fmaPEvvr--------kdpy~kpvDiW~cGViLfiLL~G~~PF~---~~~~~rlye~I~~g~---  228 (355)
T KOG0033|consen  163 VNDGEAWHGFAGTPGYLSPEVLK--------KDPYSKPVDIWACGVILYILLVGYPPFW---DEDQHRLYEQIKAGA---  228 (355)
T ss_pred             eCCccccccccCCCcccCHHHhh--------cCCCCCcchhhhhhHHHHHHHhCCCCCC---CccHHHHHHHHhccc---
Confidence            99777777889999999999998        6889999999999999999999999998   456666666666532   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccccccc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIRI  326 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~~~~  326 (708)
                                    +....|.+..++++.++    |+++||..||.+|+|+.+.           +.|||..++....+ 
T Consensus       229 --------------yd~~~~~w~~is~~Ak~----LvrrML~~dP~kRIta~EA-----------L~HpWi~~r~~~As-  278 (355)
T KOG0033|consen  229 --------------YDYPSPEWDTVTPEAKS----LIRRMLTVNPKKRITADEA-----------LKHPWICNRERVAS-  278 (355)
T ss_pred             --------------cCCCCcccCcCCHHHHH----HHHHHhccChhhhccHHHH-----------hCCchhcchHHHHH-
Confidence                          22244567778887776    8899999999999999984           88999988866544 


Q ss_pred             ccCCcccHHHHHHHHHh
Q psy15481        327 YLHPDDAYDQLQDLIQE  343 (708)
Q Consensus       327 ~i~~~e~~~~l~~~i~~  343 (708)
                      -+|-.++++.+..+-+.
T Consensus       279 ~~H~~dtvd~lrkfNar  295 (355)
T KOG0033|consen  279 AIHRQDTVDCLKKFNAR  295 (355)
T ss_pred             HhhhHHHHHHHHHhhHH
Confidence            57888888888766443

>KOG0585|consensus

Probab=100.00  E-value=1.1e-41  Score=363.64  Aligned_cols=263  Identities=25%  Similarity=0.429  Sum_probs=214.4

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-------------CCchHHHHHHHHHHHhCCCCCccceeEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-------------MRPHDVQMREFEVLKKVKHENIVKLLAI   76 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-------------~~~~~~~~~Ei~iL~kL~HpNIVkl~~v   76 (708)
                      ..|.+...||+|.||.|.+|++..+|+.||||++.+...             ..+.+...+||.+|+++.|||||+++++
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            378999999999999999999999999999999854311             1122455799999999999999999999


Q ss_pred             EEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceE
Q psy15481         77 EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY  156 (708)
Q Consensus        77 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~v  156 (708)
                      ..++..+.+|+|+|||..|.+...-   .....+++.+++.++++++.||.|||.+|||||||||+|+|+    ++.+++
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl----~~~g~V  249 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL----SSDGTV  249 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE----cCCCcE
Confidence            9999999999999999988775433   222228999999999999999999999999999999999998    666889


Q ss_pred             EEeccCccccc------cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC
Q psy15481        157 KLTDFGAAREL------EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR  230 (708)
Q Consensus       157 KL~DFGlA~~~------~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~  230 (708)
                      ||+|||.+...      +.+..+...+|||.|+|||......    .....+.+.||||+||+||.++.|+.||.   +.
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~----~~~~~g~a~DiWalGVTLYCllfG~~PF~---~~  322 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN----SFSYSGFALDIWALGVTLYCLLFGQLPFF---DD  322 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC----CccccchhhhhhhhhhhHHHhhhccCCcc---cc
Confidence            99999999866      3344455689999999999986311    12344788999999999999999999998   46


Q ss_pred             ChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        231 RNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       231 ~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      .-.++..+|.....                   .+|....+    ...+.+||.+||.+||.+|.+..++          
T Consensus       323 ~~~~l~~KIvn~pL-------------------~fP~~pe~----~e~~kDli~~lL~KdP~~Ri~l~~i----------  369 (576)
T KOG0585|consen  323 FELELFDKIVNDPL-------------------EFPENPEI----NEDLKDLIKRLLEKDPEQRITLPDI----------  369 (576)
T ss_pred             hHHHHHHHHhcCcc-------------------cCCCcccc----cHHHHHHHHHHhhcChhheeehhhh----------
Confidence            66777777775422                   34544433    4455669999999999999999886          


Q ss_pred             hhcCcccCCc
Q psy15481        311 KLVHLFHINR  320 (708)
Q Consensus       311 ~l~h~~~~~~  320 (708)
                       -.|||....
T Consensus       370 -k~Hpwvt~~  378 (576)
T KOG0585|consen  370 -KLHPWVTRD  378 (576)
T ss_pred             -eecceeccC
Confidence             578887665

>KOG0578|consensus

Probab=100.00  E-value=1.1e-41  Score=371.90  Aligned_cols=257  Identities=27%  Similarity=0.461  Sum_probs=221.2

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ++....|..-..||+|+.|.||.+....+++.||||.++... ....+...+|+.+|+..+|+|||.+++.|...+  .+
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d--eL  345 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD--EL  345 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccc--ee
Confidence            556677888899999999999999999999999999998543 444667789999999999999999999987654  49


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++||+|-+++....    ++|.++..|++.++.||+|||.+||+|||||.+|||+    +..+.+||+|||+|.
T Consensus       346 WVVMEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL----~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL----TMDGSVKLTDFGFCA  417 (550)
T ss_pred             EEEEeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe----ccCCcEEEeeeeeee
Confidence            99999999999999997644    9999999999999999999999999999999999997    555569999999999


Q ss_pred             cccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .+.... ...+.+|||.|||||++.        .+.|++++||||||++++||+-|.+||..   ++....++.|.+...
T Consensus       418 qi~~~~~KR~TmVGTPYWMAPEVvt--------rk~YG~KVDIWSLGIMaIEMveGEPPYln---E~PlrAlyLIa~ng~  486 (550)
T KOG0578|consen  418 QISEEQSKRSTMVGTPYWMAPEVVT--------RKPYGPKVDIWSLGIMAIEMVEGEPPYLN---ENPLRALYLIATNGT  486 (550)
T ss_pred             ccccccCccccccCCCCccchhhhh--------hcccCccccchhhhhHHHHHhcCCCCccC---CChHHHHHHHhhcCC
Confidence            887665 566789999999999998        68899999999999999999999999973   566666777765322


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      +                  .+.....+|+.+    .+||.+||+.||.+|++|.++           +.|||+
T Consensus       487 P------------------~lk~~~klS~~~----kdFL~~cL~~dv~~RasA~eL-----------L~HpFl  526 (550)
T KOG0578|consen  487 P------------------KLKNPEKLSPEL----KDFLDRCLVVDVEQRASAKEL-----------LEHPFL  526 (550)
T ss_pred             C------------------CcCCccccCHHH----HHHHHHHhhcchhcCCCHHHH-----------hcChhh
Confidence            2                  334444455555    459999999999999999998           679999

>KOG0605|consensus

Probab=100.00  E-value=1.9e-41  Score=367.55  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=213.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchH--HHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD--VQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~--~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ...|++...||+||||.||+|+.+.||..||+|++++.......+  ....|-.+|....+|.||+++..|.+.+  ++|
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~--~LY  217 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE--YLY  217 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC--eeE
Confidence            357899999999999999999999999999999998765433222  2357888899899999999999997765  499


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      |||||++|||+..+|.....   |++..++.++.+++.|+..+|+.|+|||||||+|+|+    |..|++||+|||++..
T Consensus       218 LiMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi----D~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI----DAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee----cCCCCEeeccccccch
Confidence            99999999999999987654   9999999999999999999999999999999999999    8899999999999853


Q ss_pred             ccc----------------------c--c------------------------cccccCCCCCcCChhhhhhhhhcCCCC
Q psy15481        167 LEE----------------------D--Q------------------------QFMSLYGTEEYLHPDMYERAVLRKPVG  198 (708)
Q Consensus       167 ~~~----------------------~--~------------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~  198 (708)
                      +..                      .  .                        ...+.+|||.|+|||++.        +
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll--------~  362 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL--------G  362 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh--------c
Confidence            211                      0  0                        011257999999999999        7


Q ss_pred             CcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCccccc--CCCCCcccCChhHH
Q psy15481        199 KTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWC--TDLPNNCQLSLGLK  276 (708)
Q Consensus       199 ~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~--~~lp~~~~ls~~l~  276 (708)
                      +.|+..+|.||||||+|||+.|.+||.   +.+..++..+|..                   |.  -..|....+++++ 
T Consensus       363 kgY~~~cDwWSLG~ImyEmLvGyPPF~---s~tp~~T~rkI~n-------------------wr~~l~fP~~~~~s~eA-  419 (550)
T KOG0605|consen  363 KGYGKECDWWSLGCIMYEMLVGYPPFC---SETPQETYRKIVN-------------------WRETLKFPEEVDLSDEA-  419 (550)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHH-------------------HhhhccCCCcCcccHHH-
Confidence            889999999999999999999999998   5778888888774                   32  1445555666554 


Q ss_pred             HHHHHHHHhhcccCcccCCC---HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        277 KLVTPILAGLLEVDSKKIWS---FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       277 ~~l~~LL~~mL~~DP~kRps---a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                         .|||.+||. ||++|..   ++|+           -.||||..
T Consensus       420 ---~DLI~rll~-d~~~RLG~~G~~EI-----------K~HPfF~~  450 (550)
T KOG0605|consen  420 ---KDLITRLLC-DPENRLGSKGAEEI-----------KKHPFFKG  450 (550)
T ss_pred             ---HHHHHHHhc-CHHHhcCcccHHHH-----------hcCCcccc
Confidence               458888888 9999987   4454           56898854

>KOG0588|consensus

Probab=100.00  E-value=1e-41  Score=375.59  Aligned_cols=258  Identities=27%  Similarity=0.448  Sum_probs=218.5

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .-..|.+++-||.|+.|.|.+|++..||+.+|||++.+.....  ......+|+-+|+.+.|||++.++++++...  ++
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~--~l   87 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ--HL   87 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc--eE
Confidence            3458999999999999999999999999999999998663221  1233469999999999999999999998755  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|.||++||-|++++...+.   +++.++..++.||+.|+.|||..+|+|||+||+|+|+    |..+.+||+|||.|.
T Consensus        88 ylvlEyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL----d~~~nIKIADFGMAs  160 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL----DVKNNIKIADFGMAS  160 (786)
T ss_pred             EEEEEecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh----hcccCEeeeccceee
Confidence            999999999999999987554   9999999999999999999999999999999999998    776679999999999


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcC-CccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~-s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .-.++....+.||+|.|.+||++.        |..| +.++||||.|||||.|+||.+||+   +.+-...+.++..+..
T Consensus       161 Le~~gklLeTSCGSPHYA~PEIV~--------G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~G~f  229 (786)
T KOG0588|consen  161 LEVPGKLLETSCGSPHYAAPEIVS--------GRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQRGVF  229 (786)
T ss_pred             cccCCccccccCCCcccCCchhhc--------CCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHcCcc
Confidence            777788888999999999999998        5555 889999999999999999999997   3444444444443211


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                         ++|  ..+++++.+    ||++||++||.+|+|.+++++           |||...-.
T Consensus       230 -------------------~MP--s~Is~eaQd----LLr~ml~VDp~~RiT~~eI~k-----------HP~l~g~~  270 (786)
T KOG0588|consen  230 -------------------EMP--SNISSEAQD----LLRRMLDVDPSTRITTEEILK-----------HPFLSGYT  270 (786)
T ss_pred             -------------------cCC--CcCCHHHHH----HHHHHhccCccccccHHHHhh-----------CchhhcCC
Confidence                               334  457777766    889999999999999999844           88886543

>KOG0658|consensus

Probab=100.00  E-value=6.6e-42  Score=357.63  Aligned_cols=284  Identities=21%  Similarity=0.303  Sum_probs=217.5

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc---e
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR---G   84 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~---~   84 (708)
                      ..-.|.-.+++|+|+||.||+|....+++.||||..-.+...     ..+|+.+|++++|||||++.-+|......   +
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            344788899999999999999999999999999998654332     23899999999999999999988765554   3


Q ss_pred             EEEEEeccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         85 KVIVMELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..+||||++ .+|.++++.. .+...++.-.++.+..||++||+|||+.||+||||||.|+|+   +...+.+||||||.
T Consensus        97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLv---D~~tg~LKicDFGS  172 (364)
T KOG0658|consen   97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLV---DPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEE---cCCCCeEEeccCCc
Confidence            458999996 8999988741 111238999999999999999999999999999999999998   33458999999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      |..+..++...+...|..|+|||.+.+       ...|+.+.||||.||++.||+-|++.|.+.++.+....+.++++.+
T Consensus       173 AK~L~~~epniSYicSRyYRaPELifg-------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P  245 (364)
T KOG0658|consen  173 AKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP  245 (364)
T ss_pred             ceeeccCCCceeEEEeccccCHHHHcC-------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence            999999988888999999999999985       5789999999999999999999999999544444444444444443


Q ss_pred             cCCcccccccCCCCcccccCCC-CCc-ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        244 ASGVISGTQTSENGEIDWCTDL-PNN-CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~l-p~~-~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ....|........ ...+..-. ..+ .-+.......+.+|+.++|.++|.+|.++-++           +.||||..
T Consensus       246 t~e~I~~mn~~y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~-----------l~h~fFde  311 (364)
T KOG0658|consen  246 TREDIKSMNPNYT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEA-----------LAHPFFDE  311 (364)
T ss_pred             CHHHHhhcCcccc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHH-----------hcchhhHH
Confidence            3333332221110 11111000 000 01333445567789999999999999999986           55676644

>KOG0616|consensus

Probab=100.00  E-value=2e-41  Score=344.20  Aligned_cols=239  Identities=28%  Similarity=0.439  Sum_probs=206.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|++...||.|+||.|.+++.+.+|..||+|++++...-+-  .+...+|..+|+.+.||.++++++.+.+.+  ++|+
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~--~lym  121 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS--NLYM  121 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC--eEEE
Confidence            368899999999999999999999999999999976543222  233468999999999999999999988755  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||.+||.|++++++...   +++..++-++.+|+.||.|||+++|++||+||+|||+    |.+|.+||+|||+|...
T Consensus       122 vmeyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl----D~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL----DQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EEeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee----ccCCcEEEEeccceEEe
Confidence            9999999999999988654   9999999999999999999999999999999999999    88899999999999987


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ...  ..+.||||.|+|||++.        .+.|+.++|.|+|||++|||+.|.+||..   .+...+..+|...+.   
T Consensus       195 ~~r--T~TlCGTPeYLAPEii~--------sk~ynkavDWWalGVLIYEMlaG~pPF~~---~~~~~iY~KI~~~~v---  258 (355)
T KOG0616|consen  195 SGR--TWTLCGTPEYLAPEIIQ--------SKGYNKAVDWWALGVLIYEMLAGYPPFYD---DNPIQIYEKILEGKV---  258 (355)
T ss_pred             cCc--EEEecCCccccChHHhh--------cCCCCcchhHHHHHHHHHHHHcCCCCCcC---CChHHHHHHHHhCcc---
Confidence            655  67899999999999998        79999999999999999999999999973   555777777776432   


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW  295 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp  295 (708)
                                      .+|.  .+++    .+.+||.++|++|-.+|.
T Consensus       259 ----------------~fP~--~fs~----~~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  259 ----------------KFPS--YFSS----DAKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             ----------------cCCc--ccCH----HHHHHHHHHHhhhhHhhh
Confidence                            2222  3444    455588999999999994

>KOG0582|consensus

Probab=100.00  E-value=7.4e-41  Score=355.44  Aligned_cols=270  Identities=24%  Similarity=0.368  Sum_probs=217.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+...||.|..+.||+|+...+++.||||+++-..+...-+...+|+..++.++||||++++..|....  .+|+|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~--~LWvV  102 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS--ELWVV  102 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc--eeEEe
Confidence            3579999999999999999999999999999999998877766677889999999999999999999998755  49999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |.||.+||+.++++..-+ .|++|..+..++++++.||.|||++|.||||||++|||+    ++.|.|||+|||.+..+.
T Consensus       103 mpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi----~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI----DSDGTVKLADFGVSASLF  177 (516)
T ss_pred             ehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE----cCCCcEEEcCceeeeeec
Confidence            999999999999987544 359999999999999999999999999999999999998    888889999999987654


Q ss_pred             ccc-----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        169 EDQ-----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       169 ~~~-----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ...     .+...+||++|||||++...      ...|+.|+||||||++..||++|..||..+.   ....+..-+.+.
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~------~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p---PmkvLl~tLqn~  248 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQ------LHGYDFKADIWSFGITACELAHGHAPFSKYP---PMKVLLLTLQND  248 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhc------ccCccchhhhhhhhHHHHHHhcCCCCcccCC---hHHHHHHHhcCC
Confidence            322     12456899999999996532      5789999999999999999999999998543   223333333332


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ++....+.             ++  ..-.......+..++..||..||.+||||.++           +.|+||...
T Consensus       249 pp~~~t~~-------------~~--~d~~k~~~ksf~e~i~~CL~kDP~kRptAskL-----------lkh~FFk~~  299 (516)
T KOG0582|consen  249 PPTLLTSG-------------LD--KDEDKKFSKSFREMIALCLVKDPSKRPTASKL-----------LKHAFFKKA  299 (516)
T ss_pred             CCCccccc-------------CC--hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHH-----------hccHHHhhc
Confidence            22111000             00  01112334467779999999999999999998           447777553

>KOG0032|consensus

Probab=100.00  E-value=1.2e-40  Score=364.60  Aligned_cols=266  Identities=30%  Similarity=0.457  Sum_probs=226.0

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCC-CCCccceeEEEEecCC
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVK-HENIVKLLAIEEEQEG   82 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~   82 (708)
                      ......|.+.+.||+|.||.||++.++.||+.||+|++.+.....  ..+...+|+.+|++++ |||||.+.+++++.. 
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-  109 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-  109 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-
Confidence            344557999999999999999999999999999999997654432  2355679999999998 999999999999876 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                       .+++|||+|.||.|++.+... +   +++..+..++.|++.|+.|||+.||+||||||+|+|+....++.+.+|++|||
T Consensus       110 -~~~lvmEL~~GGeLfd~i~~~-~---~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  110 -SVYLVMELCEGGELFDRIVKK-H---YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             -eEEEEEEecCCchHHHHHHHc-c---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence             499999999999999998776 2   99999999999999999999999999999999999984444445689999999


Q ss_pred             ccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        163 AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       163 lA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      +|.....+......+||+.|+|||++.        +..|+..+||||+||++|.|++|.+||.   +.+.......+...
T Consensus       185 la~~~~~~~~~~~~~Gtp~y~APEvl~--------~~~y~~~~DiWS~Gvi~yiLL~G~~PF~---~~~~~~~~~~i~~~  253 (382)
T KOG0032|consen  185 LAKFIKPGERLHTIVGTPEYVAPEVLG--------GRPYGDEVDVWSIGVILYILLSGVPPFW---GETEFEIFLAILRG  253 (382)
T ss_pred             CceEccCCceEeeecCCccccCchhhc--------CCCCCcccchhHHHHHHHHHhhCCCCCc---CCChhHHHHHHHcC
Confidence            999988877788899999999999997        6899999999999999999999999998   45555666666643


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      .+                 ....+.+..++..+++    ++++||..||.+|+++.++           +.|||....
T Consensus       254 ~~-----------------~f~~~~w~~is~~akd----~i~~ll~~dp~~R~ta~~~-----------L~HpWi~~~  299 (382)
T KOG0032|consen  254 DF-----------------DFTSEPWDDISESAKD----FIRKLLEFDPRKRLTAAQA-----------LQHPWIKSI  299 (382)
T ss_pred             CC-----------------CCCCCCccccCHHHHH----HHHHhcccCcccCCCHHHH-----------hcCccccCC
Confidence            22                 2234555556666555    8899999999999999997           569996543

>KOG0192|consensus

Probab=100.00  E-value=1.4e-40  Score=361.46  Aligned_cols=259  Identities=25%  Similarity=0.390  Sum_probs=209.7

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCce-EEEEEeccCCCCCc-hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGEP-VAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~~-VAIK~~~~~s~~~~-~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .+...||+|+||.||+|.++  |+. ||||.+........ ...+.+|+.+|.+++|||||++++++..+.. ..+||||
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtE  120 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTE  120 (362)
T ss_pred             hhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEE
Confidence            44566999999999999987  556 99999976433221 4567899999999999999999999987653 4899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCCCcEEEEEecCCCc-eEEEeccCcccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR-LVHRDLKPGNIMKFICDDGST-IYKLTDFGAARELE  168 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g-IVHrDIKP~NILl~~~~d~~~-~vKL~DFGlA~~~~  168 (708)
                      |+++|+|..++... ....++...+..++.+|++||.|||+++ ||||||||+|||+    +... ++||+|||+++...
T Consensus       121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv----~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV----DLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE----cCCCCEEEECCCccceeec
Confidence            99999999999774 1234999999999999999999999999 9999999999998    7775 99999999998766


Q ss_pred             cc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 ED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      .. .......||+.|||||++...      ...|+.++||||||+++|||+||..||..   ..+......+.....+. 
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~------~~~~~~K~DvySFgIvlWEl~t~~~Pf~~---~~~~~~~~~v~~~~~Rp-  265 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGE------KSPYTEKSDVYSFGIVLWELLTGEIPFED---LAPVQVASAVVVGGLRP-  265 (362)
T ss_pred             cccccccCCCCCccccChhhhcCC------CCcCCccchhhhHHHHHHHHHHCCCCCCC---CCHHHHHHHHHhcCCCC-
Confidence            54 334447899999999999721      35799999999999999999999999983   44455565555332211 


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                                      .+|.      .+...+..++..||..||..||++.+++..++.+....
T Consensus       266 ----------------~~p~------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  266 ----------------PIPK------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             ----------------CCCc------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence                            2222      23455666899999999999999999988877665543

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.2e-40  Score=351.64  Aligned_cols=274  Identities=26%  Similarity=0.363  Sum_probs=207.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||.|+||.||+|.+..++..||+|.+.............+|+.++++++||||+++++++...+  ..++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER--CLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC--eEEEEE
Confidence            358899999999999999999999999999999875443333445678999999999999999999987543  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+. ++|.+++.....  .+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.....
T Consensus        83 e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~----~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          83 EYLD-SDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI----NEKGELKLADFGLARAKSV  155 (288)
T ss_pred             eCCC-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----CCCCCEEECcCcceeeccC
Confidence            9996 599998865433  27999999999999999999999999999999999998    6667899999999976433


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh---cccC
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT---KKAS  245 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~---~~~~  245 (708)
                      .. ......|++.|+|||++..       +..++.++||||+||++|+|+||.+||.+   .+..+.+..+..   ....
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~pf~~---~~~~~~~~~~~~~~~~~~~  225 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLG-------STEYSTPIDMWGVGCILYEMATGRPMFPG---STVKEELHLIFRLLGTPTE  225 (288)
T ss_pred             CCccccCceecccccChHHhcC-------CcccCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHhCCCCh
Confidence            22 2334578999999999862       35688999999999999999999999974   444444444432   1111


Q ss_pred             CcccccccCCCCcccccC-CCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        246 GVISGTQTSENGEIDWCT-DLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~-~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ....+.....    .|.. .+|..     ....+.++..+.++|.+||.+||.+|||++++           +.|||+
T Consensus       226 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~-----------l~hp~f  288 (288)
T cd07871         226 ETWPGITSNE----EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA-----------LRHSYF  288 (288)
T ss_pred             HHhhccccch----hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH-----------hcCCCC
Confidence            1111111100    0000 01111     01112334456779999999999999999997           678886

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0594|consensus

Probab=100.00  E-value=1.2e-40  Score=348.52  Aligned_cols=283  Identities=24%  Similarity=0.342  Sum_probs=221.6

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCC-ccceeEEEEecC----CceE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHEN-IVKLLAIEEEQE----GRGK   85 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpN-IVkl~~v~~~~~----~~~~   85 (708)
                      |...++||.|+||.||+|+++.+|+.||+|.++-.... .......+|+.+++.|+|+| |+.+++++...+    ....
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            55567899999999999999999999999999866442 33444579999999999999 999999987654    2358


Q ss_pred             EEEEeccCCCCHHHHhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         86 VIVMELCTGGSLFNILDDPENT-YGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~-~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      ++|+||+ ..+|..++...... .+++...++.+++||+.||+|||++||+||||||.|||+    +..+.+||+|||+|
T Consensus        93 ~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi----~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   93 YLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI----SSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE----CCCCcEeeeccchH
Confidence            9999999 68999999875532 458889999999999999999999999999999999998    66888999999999


Q ss_pred             cccc-ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        165 RELE-EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       165 ~~~~-~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      +... +...+...++|..|+|||++..       ...|+..+||||+|||++||+++++.|.   |.++.+++.+|...-
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlG-------s~~Ys~~vDiWs~GcIfaEm~~~~~LFp---G~se~~ql~~If~~l  237 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLG-------STSYSTSVDIWSLGCIFAEMFTRRPLFP---GDSEIDQLFRIFRLL  237 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcC-------CCcCCCCcchHhHHHHHHHHHhCCCCCC---CCcHHHHHHHHHHHc
Confidence            9766 4445677889999999999884       4579999999999999999999999998   566677777777521


Q ss_pred             ---cCCcccccccCCCCcccccCCCCCc---ccCChhHH---HHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcC
Q psy15481        244 ---ASGVISGTQTSENGEIDWCTDLPNN---CQLSLGLK---KLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVH  314 (708)
Q Consensus       244 ---~~~~i~~~~~~~~g~~~~~~~lp~~---~~ls~~l~---~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h  314 (708)
                         ......++.....    |...+|.+   ..++..++   ....+++..||+.||.+|.|+...           +.|
T Consensus       238 GtP~e~~Wp~v~~~~~----~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~a-----------l~h  302 (323)
T KOG0594|consen  238 GTPNEKDWPGVSSLPD----YKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGA-----------LTH  302 (323)
T ss_pred             CCCCccCCCCcccccc----ccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHH-----------hcC
Confidence               1111122211111    11122221   12222222   367789999999999999999985           779


Q ss_pred             cccCCccccc
Q psy15481        315 LFHINRLQCI  324 (708)
Q Consensus       315 ~~~~~~~~~~  324 (708)
                      |||..-....
T Consensus       303 ~yf~~~~~~~  312 (323)
T KOG0594|consen  303 PYFSELPEKS  312 (323)
T ss_pred             hhhcccccch
Confidence            9987765443

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.6e-40  Score=347.50  Aligned_cols=258  Identities=24%  Similarity=0.376  Sum_probs=203.1

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      |.+.+.||+|+||.||+|.+..+|+.||+|.+......  .......+|+.++++++||||+++++++.+.+  ..++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~--~~~lv~   79 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD--ALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--eEEEEE
Confidence            67889999999999999999999999999998654322  22234568999999999999999999987654  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++||+|...+..... ..+++..+..++.|++.||.|||++||+||||||+|||+    +..+.++|+|||++.....
T Consensus        80 e~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill----~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          80 TIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL----DDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             EecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE----CCCCCEEEeeCCCcEEcCC
Confidence            99999999888754322 238999999999999999999999999999999999998    6667899999999987655


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      ........||..|+|||++.        +..++.++|||||||++|+|++|+.||.........+.+......       
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-------  219 (285)
T cd05631         155 GETVRGRVGTVGYMAPEVIN--------NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE-------  219 (285)
T ss_pred             CCeecCCCCCCCccCHhhhc--------CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc-------
Confidence            54455678999999999997        677899999999999999999999999742221111111111110       


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                             +.          ...+..++..+.+|+.+||..||.+||+     ++++           +.|||+..
T Consensus       220 -------~~----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~-----------~~h~~~~~  266 (285)
T cd05631         220 -------DQ----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV-----------KQHPIFKN  266 (285)
T ss_pred             -------cc----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH-----------hcCHhhcC
Confidence                   00          0112223445667999999999999997     6665           56888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.9e-40  Score=354.07  Aligned_cols=248  Identities=28%  Similarity=0.445  Sum_probs=199.3

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccC
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCT   93 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~   93 (708)
                      +.||+|+||.||++.++.+|+.||+|++......  .......+|+.++++++||||+++++++...+  ..|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEEEeCCC
Confidence            4699999999999999999999999998754221  22234568999999999999999999987654  5999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc-cccc
Q psy15481         94 GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQ  172 (708)
Q Consensus        94 ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~-~~~~  172 (708)
                      ||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.... ....
T Consensus        79 ~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll----~~~~~~kl~DfG~a~~~~~~~~~  151 (323)
T cd05571          79 GGELFFHLSRERV---FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML----DKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE----CCCCCEEEeeCCCCcccccCCCc
Confidence            9999999876433   8999999999999999999999999999999999998    667789999999997532 2233


Q ss_pred             ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccc
Q psy15481        173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ  252 (708)
Q Consensus       173 ~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~  252 (708)
                      ....+||+.|+|||++.        +..++.++|||||||++|+|+||..||..   .+.......+.....        
T Consensus       152 ~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltg~~Pf~~---~~~~~~~~~~~~~~~--------  212 (323)
T cd05571         152 MKTFCGTPEYLAPEVLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHEKLFELILMEEI--------  212 (323)
T ss_pred             ccceecCccccChhhhc--------CCCCCccccCcccchhhhhhhcCCCCCCC---CCHHHHHHHHHcCCC--------
Confidence            34567999999999987        67789999999999999999999999973   333333333332110        


Q ss_pred             cCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        253 TSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       253 ~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                 .+|  ..++    ..+.++|.+||..||++||     ++.++           +.|||+..
T Consensus       213 -----------~~p--~~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~l-----------l~h~~f~~  256 (323)
T cd05571         213 -----------RFP--RTLS----PEAKSLLAGLLKKDPKQRLGGGPEDAKEI-----------MEHRFFAS  256 (323)
T ss_pred             -----------CCC--CCCC----HHHHHHHHHHccCCHHHcCCCCCCCHHHH-----------HcCCCcCC
Confidence                       111  1233    4456699999999999999     68886           67999855

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.3e-40  Score=353.52  Aligned_cols=252  Identities=26%  Similarity=0.419  Sum_probs=206.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|.+.+.||+|+||.||+|.++.+|+.||+|++.....  ....+...+|+.++++++||||+++++++.+.+  ..|+
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~l   95 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN--RVYF   95 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC--EEEE
Confidence            468999999999999999999999999999999875321  122345678999999999999999999987654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++||+|.+++.....   +++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++...
T Consensus        96 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~~~~~  168 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAGR---FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL----DNKGHVKVTDFGFAKKV  168 (329)
T ss_pred             EEcCCCCChHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----CCCCCEEEeeccCceEc
Confidence            9999999999999876443   8999999999999999999999999999999999998    66778999999999865


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ...  .....||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +.+.......+.....   
T Consensus       169 ~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~elltg~~pf~---~~~~~~~~~~i~~~~~---  232 (329)
T PTZ00263        169 PDR--TFTLCGTPEYLAPEVIQ--------SKGHGKAVDWWTMGVLLYEFIAGYPPFF---DDTPFRIYEKILAGRL---  232 (329)
T ss_pred             CCC--cceecCChhhcCHHHHc--------CCCCCCcceeechHHHHHHHHcCCCCCC---CCCHHHHHHHHhcCCc---
Confidence            433  23467999999999987        6778999999999999999999999997   3444444444443210   


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                      .+|.  .++    ..+.++|.+||..||.+||+     ++++           +.|||+..
T Consensus       233 ----------------~~p~--~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~l-----------l~hp~f~~  276 (329)
T PTZ00263        233 ----------------KFPN--WFD----GRARDLVKGLLQTDHTKRLGTLKGGVADV-----------KNHPYFHG  276 (329)
T ss_pred             ----------------CCCC--CCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHH-----------hcCCccCC
Confidence                            1121  133    34567999999999999997     4665           67999865

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-40  Score=348.41  Aligned_cols=251  Identities=27%  Similarity=0.405  Sum_probs=204.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|.+..+|+.||+|++.....  ....+.+.+|+.++++++||||+++++++.+.+  .+|+|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv   79 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR--FLYML   79 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC--eEEEE
Confidence            57889999999999999999999999999999864321  122344578999999999999999999887644  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++||+|.+++.....   +++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++....
T Consensus        80 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli----~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          80 MEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL----DKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             EeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE----CCCCCEEEEecCcchhcc
Confidence            999999999999976443   8999999999999999999999999999999999998    666789999999998654


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      ..  .....||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .+..+....+.....    
T Consensus       153 ~~--~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~~l~~g~~pf~~---~~~~~~~~~i~~~~~----  215 (291)
T cd05612         153 DR--TWTLCGTPEYLAPEVIQ--------SKGHNKAVDWWALGILIYEMLVGYPPFFD---DNPFGIYEKILAGKL----  215 (291)
T ss_pred             CC--cccccCChhhcCHHHHc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhCCc----
Confidence            32  23467999999999987        56789999999999999999999999973   444454544443211    


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                     .+|.  .+    +..+.++|.+||+.||.+||+     ++++           +.|||+..
T Consensus       216 ---------------~~~~--~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~-----------l~h~~~~~  259 (291)
T cd05612         216 ---------------EFPR--HL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDV-----------KNHRWFKS  259 (291)
T ss_pred             ---------------CCCc--cC----CHHHHHHHHHHcCCCHHHccCCccCCHHHH-----------hcCccccC
Confidence                           1121  12    334667999999999999996     7775           67999854

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-39  Score=345.54  Aligned_cols=282  Identities=24%  Similarity=0.334  Sum_probs=205.6

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.+..+|+.||+|+++............+|+.+++.++||||+++++++.+..  ..|+||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~   82 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE--TLTLVF   82 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC--eEEEEE
Confidence            468899999999999999999999999999999976544333445678999999999999999999987654  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+. ++|.+++....  ..+++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++.....
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          83 EYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI----SDTGELKLADFGLARAKSV  155 (303)
T ss_pred             ECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEECCCCcceeccC
Confidence            9995 78887776533  238999999999999999999999999999999999998    6677899999999975432


Q ss_pred             c-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh---cccC
Q psy15481        170 D-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT---KKAS  245 (708)
Q Consensus       170 ~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~---~~~~  245 (708)
                      . .......||+.|+|||++..       ...++.++|||||||++|+|++|..||.+.  .+..+.+..+..   ....
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~  226 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLG-------STEYSTCLDMWGVGCIFVEMIQGVAAFPGM--KDIQDQLERIFLVLGTPNE  226 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--ccHHHHHHHHHHHhCCCCh
Confidence            2 23345678999999999862       345788999999999999999999999742  222233333321   1111


Q ss_pred             CcccccccC-CCCcccccCCCCCcc-c-C-ChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        246 GVISGTQTS-ENGEIDWCTDLPNNC-Q-L-SLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       246 ~~i~~~~~~-~~g~~~~~~~lp~~~-~-l-s~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ....+.... ...+..|....|... . . .....+.+.+++.+||+.||++|||+.++           +.|||+..-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~-----------l~h~~f~~~  294 (303)
T cd07869         227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA-----------LSHEYFSDL  294 (303)
T ss_pred             hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHH-----------hcCcccccC
Confidence            111110000 000000100000000 0 0 00112346679999999999999999997           679999654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.6e-40  Score=353.55  Aligned_cols=287  Identities=23%  Similarity=0.343  Sum_probs=204.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCC---ceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG---RGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~---~~~~   86 (708)
                      +|.+.+.||+|+||.||+|.+..+|..||||.+..... ........+|+.++++++||||+++++++...+.   ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            58999999999999999999999999999999864322 1223346789999999999999999998864432   3589


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||| +++|.+++.....   +++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++..
T Consensus        81 lv~e~~-~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll----~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELM-ESDLHQVIKANDD---LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA----NADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecC-CCCHHHHHHhccc---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCcEEEccCccccc
Confidence            999999 5799998876443   8999999999999999999999999999999999998    6677899999999986


Q ss_pred             ccccc----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        167 LEEDQ----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       167 ~~~~~----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .....    ......||+.|+|||++...      ...++.++|||||||++|+|+||++||.+.........+......
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~  226 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT  226 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhcc------ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence            43322    12345799999999998621      256889999999999999999999999743221112222222211


Q ss_pred             ccCCcccccccCCCCcc--cccCCCCC-cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        243 KASGVISGTQTSENGEI--DWCTDLPN-NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~--~~~~~lp~-~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      .+...+..+........  ......|. ....-+.....+.+++.+||..||++|||++++           +.|||+..
T Consensus       227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~-----------l~hp~f~~  295 (338)
T cd07859         227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA-----------LADPYFKG  295 (338)
T ss_pred             CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHH-----------hcCchhhh
Confidence            11111111000000000  00000000 000001223446679999999999999999997           66899865


Q ss_pred             ccc
Q psy15481        320 RLQ  322 (708)
Q Consensus       320 ~~~  322 (708)
                      ...
T Consensus       296 ~~~  298 (338)
T cd07859         296 LAK  298 (338)
T ss_pred             cCc
Confidence            433

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9.3e-40  Score=343.17  Aligned_cols=276  Identities=24%  Similarity=0.372  Sum_probs=203.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|.+.+.||+|+||.||+|.++.+++.||+|++..... ........+|+.+++.++||||+++++++...+  ..|+||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~   79 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG--KLYLVF   79 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC--EEEEEE
Confidence            58899999999999999999999999999999875432 223445678999999999999999999987644  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++++++..+.....   .+++..++.++.|++.||.|||+.|++||||||+||++    +..+.+||+|||++.....
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          80 EYVEKNMLELLEEMPN---GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI----SHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             ecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCcEEEeeccCcccccc
Confidence            9999877766554322   38999999999999999999999999999999999998    6667899999999987643


Q ss_pred             cc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh---ccc
Q psy15481        170 DQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT---KKA  244 (708)
Q Consensus       170 ~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~---~~~  244 (708)
                      ..  ......|++.|+|||++.        +..++.++|+|||||++|+|++|++||..   .+..+.+..+..   ..+
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslGvil~el~~g~~pf~~---~~~~~~~~~~~~~~~~~~  221 (287)
T cd07848         153 GSNANYTEYVATRWYRSPELLL--------GAPYGKAVDMWSVGCILGELSDGQPLFPG---ESEIDQLFTIQKVLGPLP  221 (287)
T ss_pred             cccccccccccccccCCcHHHc--------CCCCCCchhHHhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHhhCCCC
Confidence            32  223457899999999987        56689999999999999999999999974   333333332221   100


Q ss_pred             CCcccccc-cCCCCcccccC---CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        245 SGVISGTQ-TSENGEIDWCT---DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       245 ~~~i~~~~-~~~~g~~~~~~---~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ........ ........|..   ...........++..+.++|.+||++||++|||++++           +.||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~-----------l~hp~f  287 (287)
T cd07848         222 AEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC-----------LNHPAF  287 (287)
T ss_pred             HHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH-----------hcCCCC
Confidence            00000000 00000000000   0000001112245567889999999999999999997           568886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0694|consensus

Probab=100.00  E-value=3.7e-40  Score=366.06  Aligned_cols=242  Identities=25%  Similarity=0.411  Sum_probs=206.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch--HHHHHHHHHHHhC-CCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH--DVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~--~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|.+.++||+|+||+|+++..+.+++.||||++++.......  +..+.|-+|+... +||.++.++..|...+  ++|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~--~l~  445 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE--HLF  445 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC--eEE
Confidence            3688999999999999999999999999999999987654433  3457888888877 6999999999997655  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||+.||++..+.....    +++..++-++..|+.||.|||++||||||||.+|||+    |..|.+||+|||+++.
T Consensus       446 fvmey~~Ggdm~~~~~~~~----F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL----D~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHTDV----FSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL----DTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEecCCCcEEEEEeccc----ccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE----cccCcEEecccccccc
Confidence            9999999999665554332    9999999999999999999999999999999999999    8888999999999997


Q ss_pred             cc-ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LE-EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~-~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .- .+....+.||||.|||||++.        +..|+.++|.|||||+||||+.|+.||.   |.+..+....|....+ 
T Consensus       518 ~m~~g~~TsTfCGTpey~aPEil~--------e~~Yt~aVDWW~lGVLlyeML~Gq~PF~---gddEee~FdsI~~d~~-  585 (694)
T KOG0694|consen  518 GMGQGDRTSTFCGTPEFLAPEVLT--------EQSYTRAVDWWGLGVLLYEMLVGESPFP---GDDEEEVFDSIVNDEV-  585 (694)
T ss_pred             cCCCCCccccccCChhhcChhhhc--------cCcccchhhHHHHHHHHHHHHcCCCCCC---CCCHHHHHHHHhcCCC-
Confidence            64 556677899999999999998        7999999999999999999999999998   4666666666664211 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF  297 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa  297 (708)
                                        .      .+-.++....++++++|..||++|...
T Consensus       586 ------------------~------yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 ------------------R------YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ------------------C------CCCcccHHHHHHHHHHhccCcccccCC
Confidence                              1      222344556679999999999999976

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=349.67  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=206.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|.+..+|+.||+|++......  .......+|+.++..++||||+++++++...+  ..|+|
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~lv   79 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE--YLYLA   79 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC--EEEEE
Confidence            588999999999999999999999999999999754221  12334568999999999999999999987644  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++....
T Consensus        80 ~e~~~g~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGV---LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI----DASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             EeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----CCCCCEEEEeCcCCcccc
Confidence            999999999999976433   8999999999999999999999999999999999998    667789999999998654


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .  ......||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .+..+....+......  +
T Consensus       153 ~--~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~ell~g~~pf~~---~~~~~~~~~i~~~~~~--~  217 (333)
T cd05600         153 T--YANSVVGSPDYMAPEVLR--------GKGYDFTVDYWSLGCMLYEFLCGFPPFSG---STPNETWENLKYWKET--L  217 (333)
T ss_pred             c--ccCCcccCccccChhHhc--------CCCCCCccceecchHHHhhhhhCCCCCCC---CCHHHHHHHHHhcccc--c
Confidence            3  234567999999999987        56889999999999999999999999973   4444444433321100  0


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                     ..|........++..+.++|.+||..+|.+||++.++           +.|||+..
T Consensus       218 ---------------~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~l-----------l~h~~~~~  262 (333)
T cd05600         218 ---------------QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDI-----------KNHPFFKE  262 (333)
T ss_pred             ---------------cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHH-----------HhCcccCC
Confidence                           0111110012234456679999999999999999997           56888864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-39  Score=350.29  Aligned_cols=261  Identities=24%  Similarity=0.372  Sum_probs=201.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEE-----cCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCc
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVN-----KNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGR   83 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~   83 (708)
                      .+|.+.+.||+|+||.||+|.+     ..+++.||+|++...........+.+|+.++.++ +||||+++++++...+ .
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~   85 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN-G   85 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC-C
Confidence            4789999999999999999975     2456789999987544333345567999999999 8999999999886543 3


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCC---------------------------------------------------------
Q psy15481         84 GKVIVMELCTGGSLFNILDDPEN---------------------------------------------------------  106 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~---------------------------------------------------------  106 (708)
                      .+++||||++||+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            58999999999999998865321                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccc---cccCCCCC
Q psy15481        107 --TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF---MSLYGTEE  181 (708)
Q Consensus       107 --~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~---~~~~GT~~  181 (708)
                        ...+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+++....+...   ....++..
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~----~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE----cCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence              1237888999999999999999999999999999999998    66678999999999865433221   22346688


Q ss_pred             cCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCccc
Q psy15481        182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEID  260 (708)
Q Consensus       182 YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~  260 (708)
                      |+|||++.        +..++.++|||||||++|+|++ |..||..   ....+.+........                
T Consensus       242 y~aPE~~~--------~~~~~~~sDiwslG~il~el~~~g~~pf~~---~~~~~~~~~~~~~~~----------------  294 (338)
T cd05102         242 WMAPESIF--------DKVYTTQSDVWSFGVLLWEIFSLGASPYPG---VQINEEFCQRLKDGT----------------  294 (338)
T ss_pred             ccCcHHhh--------cCCCCcccCHHHHHHHHHHHHhCCCCCCCC---CCccHHHHHHHhcCC----------------
Confidence            99999987        5778999999999999999997 9999974   222222222221100                


Q ss_pred             ccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        261 WCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       261 ~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                         ..+.+...    +..+.+++.+||..||.+|||+.+++..+.+++.
T Consensus       295 ---~~~~~~~~----~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         295 ---RMRAPENA----TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             ---CCCCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               00111122    3346679999999999999999999999887765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0599|consensus

Probab=100.00  E-value=6.9e-41  Score=336.11  Aligned_cols=266  Identities=29%  Similarity=0.464  Sum_probs=220.6

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC----CCch---HHHHHHHHHHHhC-CCCCccceeEEEEecCC
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH----MRPH---DVQMREFEVLKKV-KHENIVKLLAIEEEQEG   82 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~----~~~~---~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~   82 (708)
                      -|.-.+.||.|..+.|.++.++.+|..+|+|++.....    ....   +...+|+.+|+++ .||+|+++.++++.+. 
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s-   96 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA-   96 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc-
Confidence            46667899999999999999999999999999854322    1222   2236899999998 8999999999998755 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                       ..++|+|.|+.|.|++++...-.   +++.+.+.+++|++.|+.|||.++|||||+||+|||+    |++..+||+|||
T Consensus        97 -F~FlVFdl~prGELFDyLts~Vt---lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl----ddn~~i~isDFG  168 (411)
T KOG0599|consen   97 -FVFLVFDLMPRGELFDYLTSKVT---LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL----DDNMNIKISDFG  168 (411)
T ss_pred             -hhhhhhhhcccchHHHHhhhhee---ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee----ccccceEEeccc
Confidence             58999999999999999987554   9999999999999999999999999999999999998    778889999999


Q ss_pred             ccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        163 AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       163 lA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      +|+.+.+++.....||||+|+|||.+.-  .+......|+..+|+|+.|||+|.++.|.+||-   .+...-.+..|..+
T Consensus       169 Fa~~l~~GekLrelCGTPgYLAPEtikC--~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw---HRkQmlMLR~ImeG  243 (411)
T KOG0599|consen  169 FACQLEPGEKLRELCGTPGYLAPETIKC--SMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW---HRKQMLMLRMIMEG  243 (411)
T ss_pred             eeeccCCchhHHHhcCCCcccChhheee--ecccCCCCccchhhHHHHHHHHHHHHcCCCchh---HHHHHHHHHHHHhc
Confidence            9999999999999999999999999863  223336789999999999999999999999996   23333333333332


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      +                 |....|.+..+|...++    ||.+||++||.+|.|++++           +.|||+.+-..
T Consensus       244 k-----------------yqF~speWadis~~~Kd----LIsrlLqVdp~~Ritake~-----------LaHpff~q~~~  291 (411)
T KOG0599|consen  244 K-----------------YQFRSPEWADISATVKD----LISRLLQVDPTKRITAKEA-----------LAHPFFIQIAQ  291 (411)
T ss_pred             c-----------------cccCCcchhhccccHHH----HHHHHHeeCchhcccHHHH-----------hcChHHHHHHH
Confidence            2                 22244677677776665    8899999999999999997           67999855433

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=346.00  Aligned_cols=247  Identities=27%  Similarity=0.396  Sum_probs=197.6

Q ss_pred             eecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCC
Q psy15481         18 LGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        18 LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~gg   95 (708)
                      ||+|+||.||+|.+..+++.||+|++.....  ........+|+.++++++||||+++++++...+  ..|+||||++||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--KLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--eEEEEEcCCCCC
Confidence            7999999999999999999999999864321  222344568999999999999999999887654  599999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc-cccc
Q psy15481         96 SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFM  174 (708)
Q Consensus        96 sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~-~~~~  174 (708)
                      +|.+++....   .+++..+..++.||+.||.|||++||+||||||+|||+    +..+.++|+|||++...... ....
T Consensus        79 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili----~~~~~~kl~Dfg~~~~~~~~~~~~~  151 (312)
T cd05585          79 ELFHHLQREG---RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL----DYQGHIALCDFGLCKLNMKDDDKTN  151 (312)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE----CCCCcEEEEECcccccCccCCCccc
Confidence            9999997643   28999999999999999999999999999999999998    66778999999999754322 2234


Q ss_pred             ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccC
Q psy15481        175 SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTS  254 (708)
Q Consensus       175 ~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~  254 (708)
                      ..+||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .+..+....+....           
T Consensus       152 ~~~gt~~y~aPE~~~--------~~~~~~~~DvwslGvil~el~tg~~pf~~---~~~~~~~~~~~~~~-----------  209 (312)
T cd05585         152 TFCGTPEYLAPELLL--------GHGYTKAVDWWTLGVLLYEMLTGLPPFYD---ENVNEMYRKILQEP-----------  209 (312)
T ss_pred             cccCCcccCCHHHHc--------CCCCCCccceechhHHHHHHHhCCCCcCC---CCHHHHHHHHHcCC-----------
Confidence            467999999999987        67789999999999999999999999973   33334333333211           


Q ss_pred             CCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC---HHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        255 ENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS---FERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       255 ~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps---a~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                          .    .+|      ..++..+.++|.+||..||.+||+   +.++           +.|||+...
T Consensus       210 ----~----~~~------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~-----------l~hp~~~~~  253 (312)
T cd05585         210 ----L----RFP------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEI-----------KNHPFFSQL  253 (312)
T ss_pred             ----C----CCC------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHH-----------HcCCCcCCC
Confidence                0    111      223345566999999999999986   4554           679998653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=352.07  Aligned_cols=256  Identities=23%  Similarity=0.394  Sum_probs=203.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|.+..+|+.||||++......  .......+|+.+++.++||||+++++++.+.+  .+|+|
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~lv   79 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN--YLYLI   79 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--eEEEE
Confidence            578899999999999999999999999999999753211  12234568999999999999999999988654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||+||+|.+++....   .+++..++.++.|++.||.|||++||+||||||+|||+    +..+.++|+|||++..+.
T Consensus        80 ~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~----~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          80 MEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL----DAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             ECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE----CCCCCEEEeecccceecc
Confidence            99999999999987643   28999999999999999999999999999999999998    677789999999987542


Q ss_pred             ccc---------------------------------------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchh
Q psy15481        169 EDQ---------------------------------------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWS  209 (708)
Q Consensus       169 ~~~---------------------------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWS  209 (708)
                      ...                                       ...+.+||+.|+|||++.        +..++.++||||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwS  224 (364)
T cd05599         153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL--------QTGYNKECDWWS  224 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc--------CCCCCCeeeeec
Confidence            211                                       011246999999999987        567899999999


Q ss_pred             hhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhccc
Q psy15481        210 IGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEV  289 (708)
Q Consensus       210 LGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~  289 (708)
                      |||++|+|++|.+||..   .+..+....+.....                 ...+|....+++.+    .++|.+||. 
T Consensus       225 lG~il~el~~G~~Pf~~---~~~~~~~~~i~~~~~-----------------~~~~~~~~~~s~~~----~~li~~ll~-  279 (364)
T cd05599         225 LGVIMYEMLVGYPPFCS---DNPQETYRKIINWKE-----------------TLQFPDEVPLSPEA----KDLIKRLCC-  279 (364)
T ss_pred             chhHHHHhhcCCCCCCC---CCHHHHHHHHHcCCC-----------------ccCCCCCCCCCHHH----HHHHHHHcc-
Confidence            99999999999999973   444444444432110                 01223333445544    458888996 


Q ss_pred             CcccCCC---HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        290 DSKKIWS---FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       290 DP~kRps---a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ||.+|++   +.++           +.|||+..
T Consensus       280 ~p~~R~~~~~~~~l-----------l~h~~~~~  301 (364)
T cd05599         280 EAERRLGNNGVNEI-----------KSHPFFKG  301 (364)
T ss_pred             CHhhcCCCCCHHHH-----------hcCCCcCC
Confidence            9999998   8886           77999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.9e-39  Score=351.20  Aligned_cols=257  Identities=23%  Similarity=0.369  Sum_probs=201.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|.+..+|+.||+|++......  .......+|+.++..++||||+++++.+.+..  .+|+|
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~--~~~lv   79 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL--NLYLI   79 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--eEEEE
Confidence            478899999999999999999999999999999753221  12234568999999999999999999987654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||+||+|.+++....   .+++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++....
T Consensus        80 ~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi----~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          80 MEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL----DSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             EcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE----CCCCCEEEeeccCccccc
Confidence            99999999999997643   38999999999999999999999999999999999998    666789999999987543


Q ss_pred             ccc------------------------------------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhh
Q psy15481        169 EDQ------------------------------------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGV  212 (708)
Q Consensus       169 ~~~------------------------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGv  212 (708)
                      ...                                    .....+||+.|+|||++.        +..++.++|||||||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--------~~~~~~~~DvwSlGv  224 (363)
T cd05628         153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM--------QTGYNKLCDWWSLGV  224 (363)
T ss_pred             ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc--------CCCCCCchhhhhhHH
Confidence            211                                    012357999999999987        677899999999999


Q ss_pred             HHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcc
Q psy15481        213 TLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSK  292 (708)
Q Consensus       213 iLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~  292 (708)
                      ++|+|++|..||.   +....+....+...+..                 ..+|....+++.+.+    ++.+|+. +|.
T Consensus       225 il~ell~G~~Pf~---~~~~~~~~~~i~~~~~~-----------------~~~p~~~~~s~~~~~----li~~l~~-~~~  279 (363)
T cd05628         225 IMYEMLIGYPPFC---SETPQETYKKVMNWKET-----------------LIFPPEVPISEKAKD----LILRFCC-EWE  279 (363)
T ss_pred             HHHHHHhCCCCCC---CCCHHHHHHHHHcCcCc-----------------ccCCCcCCCCHHHHH----HHHHHcC-Chh
Confidence            9999999999997   34455555555431110                 023444446666655    5555553 444


Q ss_pred             ---cCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        293 ---KIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       293 ---kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                         .||+++++           +.|||+...
T Consensus       280 ~r~~r~~~~ei-----------~~hp~f~~~  299 (363)
T cd05628         280 HRIGAPGVEEI-----------KTNPFFEGV  299 (363)
T ss_pred             hcCCCCCHHHH-----------hCCCCCCCC
Confidence               46888887           679998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.4e-39  Score=336.81  Aligned_cols=279  Identities=24%  Similarity=0.305  Sum_probs=204.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcC-CCceEEEEEeccCCCCC-chHHHHHHHHHHHhC---CCCCccceeEEEEec---CC
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKN-NGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKV---KHENIVKLLAIEEEQ---EG   82 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~-tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL---~HpNIVkl~~v~~~~---~~   82 (708)
                      +|.+.+.||+|+||.||+|.+.. +|+.||+|.+....... ......+|+.+++.+   +||||+++++++...   ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            68889999999999999999854 57889999987543222 223345777777766   699999999988532   23


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                      ..+++||||+. ++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|||
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~----~~~~~~kl~Dfg  155 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV----TSSGQIKLADFG  155 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE----cCCCCEEEcccc
Confidence            45899999995 689998865432 248999999999999999999999999999999999998    666789999999


Q ss_pred             ccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        163 AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       163 lA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      ++.............||+.|+|||++.        +..++.++|||||||++|+|++|.+||.   +..+.+.+..+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~g~~~f~---~~~~~~~~~~i~~~  224 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLL--------QSSYATPVDLWSVGCIFAEMFRRKPLFR---GSSDVDQLGKILDV  224 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHh--------CCCCCCccchHHHHHHHHHHHcCCCCcC---CCCHHHHHHHHHHH
Confidence            998765554445567999999999987        5678899999999999999999999997   35555666665542


Q ss_pred             ccCCcccccccCC-CCcccccCCCC-CcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        243 KASGVISGTQTSE-NGEIDWCTDLP-NNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       243 ~~~~~i~~~~~~~-~g~~~~~~~lp-~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .....-....... .....|....+ ....+.+.++..+.+++.+||..||++|||+.++           +.||||
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~-----------l~hp~f  290 (290)
T cd07862         225 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA-----------LSHPYF  290 (290)
T ss_pred             hCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHH-----------hcCCCC
Confidence            1100000000000 00000000000 0011223445567789999999999999999997           668886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.3e-39  Score=348.60  Aligned_cols=252  Identities=25%  Similarity=0.385  Sum_probs=203.6

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCC-ceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNG-EPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg-~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|.+.+.||+|+||.||+|.++.++ ..||+|.+.....  ....+.+.+|+.+++.++||||+++++++.+.+  ..|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~  107 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES--YLY  107 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC--EEE
Confidence            46899999999999999999876655 6899999864322  222345578999999999999999999987654  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++||+|.+++.....   +++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++..
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl----~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKR---FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL----DKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE----CCCCCEEEecCCCCee
Confidence            99999999999999976443   8999999999999999999999999999999999998    6677899999999986


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ....  .....||+.|+|||++.        +..++.++|||||||++|+|++|.+||..   .+.......+....   
T Consensus       181 ~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlGvil~ell~G~~Pf~~---~~~~~~~~~i~~~~---  244 (340)
T PTZ00426        181 VDTR--TYTLCGTPEYIAPEILL--------NVGHGKAADWWTLGIFIYEILVGCPPFYA---NEPLLIYQKILEGI---  244 (340)
T ss_pred             cCCC--cceecCChhhcCHHHHh--------CCCCCccccccchhhHHHHHhcCCCCCCC---CCHHHHHHHHhcCC---
Confidence            5432  34567999999999997        56788999999999999999999999973   44444444444211   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  .    .+|.  .+++    .+.+++++||+.||.+|+     +++++           +.|||+.+
T Consensus       245 ------------~----~~p~--~~~~----~~~~li~~~l~~dp~~R~~~~~~~~~~~-----------~~hp~f~~  289 (340)
T PTZ00426        245 ------------I----YFPK--FLDN----NCKHLMKKLLSHDLTKRYGNLKKGAQNV-----------KEHPWFGN  289 (340)
T ss_pred             ------------C----CCCC--CCCH----HHHHHHHHHcccCHHHcCCCCCCCHHHH-----------HcCCCcCC
Confidence                        0    1121  2333    455699999999999996     77776           67999865

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.3e-39  Score=346.38  Aligned_cols=248  Identities=29%  Similarity=0.452  Sum_probs=198.1

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccC
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCT   93 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~   93 (708)
                      +.||+|+||.||++.+..+|+.||+|++......  .......+|+.+++.++||||+++++++...+  ..|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--RLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--EEEEEEeCCC
Confidence            4699999999999999999999999999754322  22334568999999999999999999887654  5999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-ccc
Q psy15481         94 GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQQ  172 (708)
Q Consensus        94 ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~~  172 (708)
                      ||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++..... ...
T Consensus        79 ~g~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll----~~~~~~kL~DfG~~~~~~~~~~~  151 (328)
T cd05593          79 GGELFFHLSRERV---FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML----DKDGHIKITDFGLCKEGITDAAT  151 (328)
T ss_pred             CCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE----CCCCcEEEecCcCCccCCCcccc
Confidence            9999998866433   8999999999999999999999999999999999998    6677899999999876432 223


Q ss_pred             ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccc
Q psy15481        173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ  252 (708)
Q Consensus       173 ~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~  252 (708)
                      ....+||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .+..+....+....         
T Consensus       152 ~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslGvil~elltG~~Pf~~---~~~~~~~~~~~~~~---------  211 (328)
T cd05593         152 MKTFCGTPEYLAPEVLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHEKLFELILMED---------  211 (328)
T ss_pred             cccccCCcCccChhhhc--------CCCCCccCCccccchHHHHHhhCCCCCCC---CCHHHHHHHhccCC---------
Confidence            34567999999999987        56789999999999999999999999973   33333333332110         


Q ss_pred             cCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        253 TSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       253 ~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                            .    .+|  ..++    ..+.++|.+||..||.+|+     ++.++           +.|+|+..
T Consensus       212 ------~----~~p--~~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~i-----------l~h~~~~~  256 (328)
T cd05593         212 ------I----KFP--RTLS----ADAKSLLSGLLIKDPNKRLGGGPDDAKEI-----------MRHSFFTG  256 (328)
T ss_pred             ------c----cCC--CCCC----HHHHHHHHHHcCCCHHHcCCCCCCCHHHH-----------hcCCCcCC
Confidence                  0    111  1233    4456699999999999997     78886           56888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.3e-39  Score=352.53  Aligned_cols=256  Identities=23%  Similarity=0.363  Sum_probs=201.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|++..+++.||+|++......  .......+|+.+++.++||||+++++.+.+.+  .+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~--~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--EEEEE
Confidence            588999999999999999999999999999998753221  12234568999999999999999999987654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||+||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|....
T Consensus        80 ~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl----~~~g~~kL~DFGla~~~~  152 (382)
T cd05625          80 MDYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI----DRDGHIKLTDFGLCTGFR  152 (382)
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCEEEeECCCCcccc
Confidence            99999999999987643   38999999999999999999999999999999999998    667789999999975321


Q ss_pred             cc------------------------------------------------ccccccCCCCCcCChhhhhhhhhcCCCCCc
Q psy15481        169 ED------------------------------------------------QQFMSLYGTEEYLHPDMYERAVLRKPVGKT  200 (708)
Q Consensus       169 ~~------------------------------------------------~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~  200 (708)
                      ..                                                ....+.+||+.|+|||++.        +..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~  224 (382)
T cd05625         153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL--------RTG  224 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc--------CCC
Confidence            00                                                0012347999999999987        677


Q ss_pred             CCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHH
Q psy15481        201 FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVT  280 (708)
Q Consensus       201 ~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~  280 (708)
                      ++.++|||||||++|+|++|.+||..   .+..+....+.....                 ...+|....+++.+.+   
T Consensus       225 ~~~~~DiwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~-----------------~~~~p~~~~~s~~~~~---  281 (382)
T cd05625         225 YTQLCDWWSVGVILYEMLVGQPPFLA---QTPLETQMKVINWQT-----------------SLHIPPQAKLSPEASD---  281 (382)
T ss_pred             CCCeeeEEechHHHHHHHhCCCCCCC---CCHHHHHHHHHccCC-----------------CcCCCCcccCCHHHHH---
Confidence            89999999999999999999999973   444444444442110                 1133444456665555   


Q ss_pred             HHHHhhcccCcccCCC---HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        281 PILAGLLEVDSKKIWS---FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       281 ~LL~~mL~~DP~kRps---a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                       +|.+|+ .||.+|++   ++++           +.|||+..
T Consensus       282 -li~~l~-~~p~~R~~~~~~~ei-----------~~hp~f~~  310 (382)
T cd05625         282 -LIIKLC-RGPEDRLGKNGADEI-----------KAHPFFKT  310 (382)
T ss_pred             -HHHHHc-cCHhHcCCCCCHHHH-----------hcCCCcCC
Confidence             666665 59999997   7775           67898854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-39  Score=348.14  Aligned_cols=256  Identities=28%  Similarity=0.437  Sum_probs=206.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|.+..+|+.||+|+++....  ......+.+|+.++..++||||+++++++.+.+  ..|+|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv   79 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE--HLYLV   79 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC--eEEEE
Confidence            58899999999999999999999999999999975422  122344578999999999999999999987644  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++|++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++....
T Consensus        80 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll----~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          80 MEYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI----DADGHIKLADFGLCKKMN  152 (350)
T ss_pred             EcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE----CCCCCEEeecCCCCccCc
Confidence            99999999999997652   39999999999999999999999999999999999998    667789999999998655


Q ss_pred             ccc------------------------------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHh
Q psy15481        169 EDQ------------------------------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVA  218 (708)
Q Consensus       169 ~~~------------------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLl  218 (708)
                      ...                              ......||+.|+|||++.        +..++.++|||||||++|+|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~ell  224 (350)
T cd05573         153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR--------GTPYGLECDWWSLGVILYEML  224 (350)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc--------CCCCCCceeeEecchhhhhhc
Confidence            433                              223457999999999997        568899999999999999999


Q ss_pred             cCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-H
Q psy15481        219 TGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-F  297 (708)
Q Consensus       219 TG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-a  297 (708)
                      +|..||..   ....+....+......                 ..+|....+++    .+.++|.+||. ||.+||+ +
T Consensus       225 ~g~~Pf~~---~~~~~~~~~i~~~~~~-----------------~~~p~~~~~~~----~~~~li~~ll~-dp~~R~~s~  279 (350)
T cd05573         225 YGFPPFYS---DTLQETYNKIINWKES-----------------LRFPPDPPVSP----EAIDLICRLLC-DPEDRLGSF  279 (350)
T ss_pred             cCCCCCCC---CCHHHHHHHHhccCCc-----------------ccCCCCCCCCH----HHHHHHHHHcc-ChhhcCCCH
Confidence            99999974   3344444444431000                 02233333344    45558889997 9999999 9


Q ss_pred             HHHHHHHHHHHhhhhcCcccCC
Q psy15481        298 ERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       298 ~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      +++           +.|||+..
T Consensus       280 ~~l-----------l~hp~~~~  290 (350)
T cd05573         280 EEI-----------KSHPFFKG  290 (350)
T ss_pred             HHH-----------hcCCCcCC
Confidence            997           66898854

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0611|consensus

Probab=100.00  E-value=2.3e-40  Score=346.32  Aligned_cols=249  Identities=27%  Similarity=0.485  Sum_probs=213.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHH--HHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV--QMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~--~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..+|.+.+.||+|.||.|.+|...++|+.||||.+++.......+.  ..+|++|+..|+||||++++++|+..+.  ++
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK--Iv  129 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK--IV  129 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce--EE
Confidence            4589999999999999999999999999999999988765554444  3799999999999999999999987654  99


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      |||||..||.|++++.....   |++.+++.+++||++|+.|||.++++|||+|.+|||+    |.++.+||+|||++-.
T Consensus       130 ivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL----D~N~NiKIADFGLSNl  202 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL----DQNNNIKIADFGLSNL  202 (668)
T ss_pred             EEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhccceecccchhheee----cCCCCeeeeccchhhh
Confidence            99999999999999988664   9999999999999999999999999999999999999    8888999999999998


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCcC-CccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~-s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      +..+.-..+.||++-|.+||++.        |..| ++.+|-|||||+||.|+.|..||+   |.+....+.+|..+..+
T Consensus       203 y~~~kfLqTFCGSPLYASPEIvN--------G~PY~GPEVDsWsLGvLLYtLVyGtMPFD---G~Dhk~lvrQIs~GaYr  271 (668)
T KOG0611|consen  203 YADKKFLQTFCGSPLYASPEIVN--------GTPYKGPEVDSWSLGVLLYTLVYGTMPFD---GRDHKRLVRQISRGAYR  271 (668)
T ss_pred             hccccHHHHhcCCcccCCccccC--------CCCCCCCccchhhHHHHHHHHhhcccccC---CchHHHHHHHhhccccc
Confidence            88887788899999999999997        5555 788999999999999999999998   45555555555542111


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                                        +.+.    +.    ....||+.||.+||++|-|.+++..+
T Consensus       272 ------------------EP~~----PS----dA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  272 ------------------EPET----PS----DASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ------------------CCCC----Cc----hHHHHHHHHHhcCcccchhHHHHhhh
Confidence                              1111    11    23448999999999999999987554

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.4e-39  Score=346.11  Aligned_cols=248  Identities=28%  Similarity=0.449  Sum_probs=198.2

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccC
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCT   93 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~   93 (708)
                      +.||+|+||.||++.+..+|..||+|++......  .......+|+.+++.++||||+++++++...+  .+|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEEEeCCC
Confidence            4699999999999999999999999998754221  12234468999999999999999999987654  5999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-ccc
Q psy15481         94 GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQQ  172 (708)
Q Consensus        94 ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~~  172 (708)
                      ||+|..++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++..... ...
T Consensus        79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kL~Dfg~~~~~~~~~~~  151 (323)
T cd05595          79 GGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML----DKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE----cCCCCEEecccHHhccccCCCCc
Confidence            999999886643   28999999999999999999999999999999999998    6667899999999875422 233


Q ss_pred             ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccc
Q psy15481        173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ  252 (708)
Q Consensus       173 ~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~  252 (708)
                      .....||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .+.......+.....        
T Consensus       152 ~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlGvil~ell~g~~Pf~~---~~~~~~~~~~~~~~~--------  212 (323)
T cd05595         152 MKTFCGTPEYLAPEVLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEI--------  212 (323)
T ss_pred             cccccCCcCcCCccccc--------CCCCCchhchhhhHHHHHHHHhCCCCCCC---CCHHHHHHHHhcCCC--------
Confidence            34567999999999986        56789999999999999999999999973   333333333332110        


Q ss_pred             cCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        253 TSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       253 ~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                 .+|.  .++    ..+.++|.+||..||.+|+     ++.++           +.|+|+..
T Consensus       213 -----------~~p~--~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~-----------l~h~~~~~  256 (323)
T cd05595         213 -----------RFPR--TLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEV-----------MEHRFFLS  256 (323)
T ss_pred             -----------CCCC--CCC----HHHHHHHHHHccCCHHHhCCCCCCCHHHH-----------HcCCCcCC
Confidence                       1121  233    4456699999999999998     67775           66888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.1e-39  Score=351.50  Aligned_cols=257  Identities=24%  Similarity=0.355  Sum_probs=201.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|.+..+++.||+|++......  .....+.+|+.++++++||||+++++++.+.+  .+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--EEEEE
Confidence            478899999999999999999999999999999754322  22334578999999999999999999998654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++||+|.+++.....   +++..++.++.||+.||.|||+.||+||||||+|||+    +..+.+||+|||++....
T Consensus        80 ~E~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili----~~~~~~kL~DFGl~~~~~  152 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEV---FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI----DLDGHIKLTDFGLCTGFR  152 (381)
T ss_pred             EecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE----CCCCCEEEeeCcCCcccc
Confidence            999999999999876443   8999999999999999999999999999999999998    666789999999975321


Q ss_pred             ccc------------------------------------------------cccccCCCCCcCChhhhhhhhhcCCCCCc
Q psy15481        169 EDQ------------------------------------------------QFMSLYGTEEYLHPDMYERAVLRKPVGKT  200 (708)
Q Consensus       169 ~~~------------------------------------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~  200 (708)
                      ...                                                ...+.+||+.|+|||++.        +..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~  224 (381)
T cd05626         153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL--------RKG  224 (381)
T ss_pred             cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc--------CCC
Confidence            000                                                012357999999999987        567


Q ss_pred             CCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHH
Q psy15481        201 FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVT  280 (708)
Q Consensus       201 ~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~  280 (708)
                      ++.++|||||||++|+|+||..||..   ....+....+.....                 ...+|....+++++.+   
T Consensus       225 ~~~~~DiwSlG~il~elltG~~Pf~~---~~~~~~~~~i~~~~~-----------------~~~~~~~~~~s~~~~d---  281 (381)
T cd05626         225 YTQLCDWWSVGVILFEMLVGQPPFLA---PTPTETQLKVINWEN-----------------TLHIPPQVKLSPEAVD---  281 (381)
T ss_pred             CCCccceeehhhHHHHHHhCCCCCcC---CCHHHHHHHHHcccc-----------------ccCCCCCCCCCHHHHH---
Confidence            89999999999999999999999974   333444444432100                 0123444446666555   


Q ss_pred             HHHHhh--cccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        281 PILAGL--LEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       281 ~LL~~m--L~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                       +|.+|  +..+|..|++++++           +.|||+..
T Consensus       282 -li~~ll~~~~~~~~R~~~~~~-----------l~hp~f~~  310 (381)
T cd05626         282 -LITKLCCSAEERLGRNGADDI-----------KAHPFFSE  310 (381)
T ss_pred             -HHHHHccCcccccCCCCHHHH-----------hcCcccCC
Confidence             66664  45566669999997           66999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-39  Score=351.15  Aligned_cols=256  Identities=23%  Similarity=0.377  Sum_probs=200.6

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||++.+..+|+.||||++.....  ........+|+.+++.++||||+++++++.+.+  .+|+|
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~~lv   79 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ--YLYLI   79 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--eeEEE
Confidence            57889999999999999999999999999999864321  122334568999999999999999999987654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++||+|.+++....   .+++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|||+++...
T Consensus        80 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll----~~~~~~kl~DfGla~~~~  152 (377)
T cd05629          80 MEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI----DRGGHIKLSDFGLSTGFH  152 (377)
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE----CCCCCEEEeecccccccc
Confidence            99999999999997643   38999999999999999999999999999999999998    666789999999986321


Q ss_pred             ccc------------------------------------------------cccccCCCCCcCChhhhhhhhhcCCCCCc
Q psy15481        169 EDQ------------------------------------------------QFMSLYGTEEYLHPDMYERAVLRKPVGKT  200 (708)
Q Consensus       169 ~~~------------------------------------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~  200 (708)
                      ...                                                ...+.+||+.|+|||++.        +..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~  224 (377)
T cd05629         153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL--------QQG  224 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc--------cCC
Confidence            100                                                001246999999999987        677


Q ss_pred             CCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHH
Q psy15481        201 FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVT  280 (708)
Q Consensus       201 ~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~  280 (708)
                      ++.++|||||||++|+|+||.+||..   ....+....+.....                 ...+|....++..    +.
T Consensus       225 ~~~~~DiwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~-----------------~~~~p~~~~~s~~----~~  280 (377)
T cd05629         225 YGQECDWWSLGAIMFECLIGWPPFCS---ENSHETYRKIINWRE-----------------TLYFPDDIHLSVE----AE  280 (377)
T ss_pred             CCCceeeEecchhhhhhhcCCCCCCC---CCHHHHHHHHHccCC-----------------ccCCCCCCCCCHH----HH
Confidence            89999999999999999999999973   444444444442100                 0122333344544    45


Q ss_pred             HHHHhhcccCcccC---CCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        281 PILAGLLEVDSKKI---WSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       281 ~LL~~mL~~DP~kR---psa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ++|.+||. +|.+|   +++.++           +.|||+..
T Consensus       281 dli~~lL~-~~~~r~~r~~~~~~-----------l~hp~~~~  310 (377)
T cd05629         281 DLIRRLIT-NAENRLGRGGAHEI-----------KSHPFFRG  310 (377)
T ss_pred             HHHHHHhc-CHhhcCCCCCHHHH-----------hcCCCcCC
Confidence            58889997 77765   588887           67999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0667|consensus

Probab=100.00  E-value=4.8e-39  Score=357.13  Aligned_cols=285  Identities=24%  Similarity=0.334  Sum_probs=221.3

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CC-----CccceeEEEEec
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HE-----NIVKLLAIEEEQ   80 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-Hp-----NIVkl~~v~~~~   80 (708)
                      ...|+|.+.+.||+|+||.|.+|.+.+|++.||||++++..  ........|+.+|..|+ |.     |+|+++++|...
T Consensus       183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            45679999999999999999999999999999999997542  23344468999999996 53     899999999886


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                      +  +.|||+|.+ +.+|+++++...- .+++...++.++.||+.||.+||+.||||+||||+|||+  .+-++..+|++|
T Consensus       261 ~--HlciVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL--~~~~r~~vKVID  334 (586)
T KOG0667|consen  261 N--HLCIVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILL--KDPKRSRIKVID  334 (586)
T ss_pred             c--ceeeeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheee--ccCCcCceeEEe
Confidence            6  499999999 7999999987554 359999999999999999999999999999999999996  556667999999


Q ss_pred             cCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        161 FGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       161 FGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ||+|+.....  ..+.+.+..|+|||++.        |..|+.+.||||||||++||.+|.+.|.   |.+..+++..|.
T Consensus       335 FGSSc~~~q~--vytYiQSRfYRAPEVIL--------GlpY~~~IDmWSLGCIlAEL~tG~PLfp---G~ne~DQl~~I~  401 (586)
T KOG0667|consen  335 FGSSCFESQR--VYTYIQSRFYRAPEVIL--------GLPYDTAIDMWSLGCILAELFTGEPLFP---GDNEYDQLARII  401 (586)
T ss_pred             cccccccCCc--ceeeeeccccccchhhc--------cCCCCCccceeehhhhHHhHhcCccccC---CCCHHHHHHHHH
Confidence            9999974433  33778999999999999        8999999999999999999999988787   677788887776


Q ss_pred             hc---ccCCcccccc-----cCC-CCc----cccc--------------------CCCC-Cccc----CChhHHHHHHHH
Q psy15481        241 TK---KASGVISGTQ-----TSE-NGE----IDWC--------------------TDLP-NNCQ----LSLGLKKLVTPI  282 (708)
Q Consensus       241 ~~---~~~~~i~~~~-----~~~-~g~----~~~~--------------------~~lp-~~~~----ls~~l~~~l~~L  282 (708)
                      ..   .+...+....     ... .+.    .+|.                    ...| ....    +...-...+.++
T Consensus       402 e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~df  481 (586)
T KOG0667|consen  402 EVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDF  481 (586)
T ss_pred             HHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHH
Confidence            41   1111110000     000 000    0000                    1122 1111    111334567899


Q ss_pred             HHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcccc
Q psy15481        283 LAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQC  323 (708)
Q Consensus       283 L~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~  323 (708)
                      |++||++||.+|||+.+.           +.|||+......
T Consensus       482 lk~~L~~dP~~R~tp~qa-----------l~Hpfl~~~~~~  511 (586)
T KOG0667|consen  482 LKRCLEWDPAERITPAQA-----------LNHPFLTGTSLE  511 (586)
T ss_pred             HHHHhccCchhcCCHHHH-----------hcCccccccccc
Confidence            999999999999999985           789999755443

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.2e-39  Score=358.95  Aligned_cols=280  Identities=21%  Similarity=0.305  Sum_probs=205.1

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEec------C
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ------E   81 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~------~   81 (708)
                      ....|.+.+.||+|+||.||+|.+..+|+.||||.+....     ....+|+.+++.++||||+++++++...      .
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            4457999999999999999999999999999999885432     2234799999999999999999876432      1


Q ss_pred             CceEEEEEeccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC-ceEEEe
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS-TIYKLT  159 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~-~~vKL~  159 (708)
                      ...+++||||++ ++|..++... .....+++..++.++.||+.||.|||++||+||||||+|||+    +.. ..+||+
T Consensus       139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl----~~~~~~vkL~  213 (440)
T PTZ00036        139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI----DPNTHTLKLC  213 (440)
T ss_pred             ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEE----cCCCCceeee
Confidence            224679999996 5776665431 122348999999999999999999999999999999999998    433 479999


Q ss_pred             ccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        160 DFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       160 DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      |||+|+............||+.|+|||++..       ...|+.++|||||||++|+|+||.+||.   +.+..+.+..+
T Consensus       214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~elltG~~pf~---~~~~~~~~~~i  283 (440)
T PTZ00036        214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLG-------ATNYTTHIDLWSLGCIIAEMILGYPIFS---GQSSVDQLVRI  283 (440)
T ss_pred             ccccchhccCCCCcccCCCCcCccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCC---CCChHHHHHHH
Confidence            9999987765555556789999999999862       3468999999999999999999999997   45555555555


Q ss_pred             HhcccCC---cccccccCCCCcccccCCCCC--cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcC
Q psy15481        240 TTKKASG---VISGTQTSENGEIDWCTDLPN--NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVH  314 (708)
Q Consensus       240 ~~~~~~~---~i~~~~~~~~g~~~~~~~lp~--~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h  314 (708)
                      .......   .+.... .....+.|....+.  ...++...+..+.+||.+||.+||.+|||+.++           +.|
T Consensus       284 ~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~-----------l~h  351 (440)
T PTZ00036        284 IQVLGTPTEDQLKEMN-PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA-----------LAD  351 (440)
T ss_pred             HHHhCCCCHHHHHHhc-hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH-----------hCC
Confidence            4321100   000000 00000111100000  001122334567779999999999999999997           779


Q ss_pred             cccCC
Q psy15481        315 LFHIN  319 (708)
Q Consensus       315 ~~~~~  319 (708)
                      ||+..
T Consensus       352 p~f~~  356 (440)
T PTZ00036        352 PFFDD  356 (440)
T ss_pred             hhHHh
Confidence            99843

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.4e-39  Score=343.48  Aligned_cols=254  Identities=25%  Similarity=0.389  Sum_probs=198.4

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.++.+|+.||+|++.....  .........|..++..+ +||||+++++++...+  .+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD--RLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC--EEEEEEcCC
Confidence            369999999999999999999999999875321  22234456788888876 7999999999987654  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-cc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~  171 (708)
                      +||+|..++.....   +++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++..... ..
T Consensus        79 ~~g~L~~~i~~~~~---l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli----~~~~~~kL~DfG~~~~~~~~~~  151 (320)
T cd05590          79 NGGDLMFHIQKSRR---FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL----DHEGHCKLADFGMCKEGIFNGK  151 (320)
T ss_pred             CCchHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE----CCCCcEEEeeCCCCeecCcCCC
Confidence            99999998876443   8999999999999999999999999999999999998    6667899999999875432 22


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      ......||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .+..+....+.....       
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~g~~Pf~~---~~~~~~~~~i~~~~~-------  213 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQ--------EMLYGPSVDWWAMGVLLYEMLCGHAPFEA---ENEDDLFEAILNDEV-------  213 (320)
T ss_pred             cccccccCccccCHHHHc--------CCCCCCccchhhhHHHHHHHhhCCCCCCC---CCHHHHHHHHhcCCC-------
Confidence            334567999999999987        67789999999999999999999999973   444454444443110       


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  .+|.  .++    ..+.+++.+||..||.+||++.++ ..    ....+.|||+..
T Consensus       214 ------------~~~~--~~~----~~~~~li~~~L~~dP~~R~~~~~~-~~----~~~~~~h~~f~~  258 (320)
T cd05590         214 ------------VYPT--WLS----QDAVDILKAFMTKNPTMRLGSLTL-GG----EEAILRHPFFKE  258 (320)
T ss_pred             ------------CCCC--CCC----HHHHHHHHHHcccCHHHCCCCCCC-CC----HHHHHcCCCcCC
Confidence                        1111  233    445669999999999999998321 00    011267999854

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.5e-38  Score=333.86  Aligned_cols=279  Identities=23%  Similarity=0.289  Sum_probs=204.3

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-hHHHHHHHHHHHhC---CCCCccceeEEEEec---CCc
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKV---KHENIVKLLAIEEEQ---EGR   83 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-~~~~~~Ei~iL~kL---~HpNIVkl~~v~~~~---~~~   83 (708)
                      +|.+.+.||+|+||.||+|.++.+|+.||+|.+........ .....+|+.+++.+   +||||+++++++...   ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            48889999999999999999999999999999875432221 22344677777665   799999999987643   234


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+++||||+. ++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+||++    +..+.+||+|||+
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili----~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV----TSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCEEECccCc
Confidence            5899999996 589888865332 348999999999999999999999999999999999998    6667799999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      +.............||..|+|||++.        +..++.++||||+||++|+|++|.+||.+   ....+.+.++....
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~~l~~l~~g~~~f~~---~~~~~~~~~~~~~~  223 (288)
T cd07863         155 ARIYSCQMALTPVVVTLWYRAPEVLL--------QSTYATPVDMWSVGCIFAEMFRRKPLFCG---NSEADQLGKIFDLI  223 (288)
T ss_pred             cccccCcccCCCccccccccCchHhh--------CCCCCCcchhhhHHHHHHHHHhCCcCcCC---CCHHHHHHHHHHHh
Confidence            98765544445567899999999987        56789999999999999999999999974   34444444443311


Q ss_pred             cCCcccccccC-CCCcccccCCC-CCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        244 ASGVISGTQTS-ENGEIDWCTDL-PNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       244 ~~~~i~~~~~~-~~g~~~~~~~l-p~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ........... ......+.... .....+.+.++..+.+++.+||..||++|||+.++           +.||||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~-----------l~hp~f  288 (288)
T cd07863         224 GLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA-----------LQHPFF  288 (288)
T ss_pred             CCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH-----------hcCCCC
Confidence            00000000000 00000000000 00112223455667789999999999999999997           668886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.5e-38  Score=348.84  Aligned_cols=262  Identities=23%  Similarity=0.377  Sum_probs=207.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|.+.+.||+|+||.||++.++.+|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+.+  .+|+
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~--~~~l  120 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK--YLYM  120 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--EEEE
Confidence            468999999999999999999999999999999864321  122334568999999999999999999887644  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++||+|.+++....    +++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||.+...
T Consensus       121 v~Ey~~gg~L~~~l~~~~----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl----~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         121 VMEYMPGGDLVNLMSNYD----IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL----DKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE----cCCCCEEEEeccceeec
Confidence            999999999999986532    8999999999999999999999999999999999998    66778999999999865


Q ss_pred             ccccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        168 EEDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       168 ~~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .....  .....||+.|+|||++...    +....++.++|||||||++|+|++|.+||..   .+....+..+......
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~DiwSlGvilyelltG~~Pf~~---~~~~~~~~~i~~~~~~  265 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYA---DSLVGTYSKIMDHKNS  265 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccC----CCCCCCCCceeeeehhHHHHHHHhCCCCcCC---CCHHHHHHHHHcCCCc
Confidence            43322  2346799999999998631    1134578999999999999999999999973   4444444444432110


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCccc--CCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKK--IWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~k--Rpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                   .    .+|....+|..    +.++|.+||..+|.+  |++++++           +.|||+...
T Consensus       266 -------------~----~~~~~~~~s~~----~~~li~~~L~~~p~r~~R~s~~el-----------l~h~~~~~~  310 (370)
T cd05596         266 -------------L----TFPDDIEISKQ----AKDLICAFLTDREVRLGRNGVDEI-----------KSHPFFKND  310 (370)
T ss_pred             -------------C----CCCCcCCCCHH----HHHHHHHHccChhhccCCCCHHHH-----------hcCcccCCC
Confidence                         0    23333334544    455899999999998  9999997           679998653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.8e-39  Score=344.50  Aligned_cols=248  Identities=28%  Similarity=0.442  Sum_probs=197.6

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccC
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCT   93 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~   93 (708)
                      +.||+|+||.||++.+..+|+.||+|++......  .......+|+.+++.++||||+++++++...+  .+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~--~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC--EEEEEEeCCC
Confidence            3699999999999999999999999999754221  22234568999999999999999999887654  5999999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-cc
Q psy15481         94 GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQ  171 (708)
Q Consensus        94 ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~  171 (708)
                      ||+|..++.....   +++..+..++.||+.||.|||+ +||+||||||+|||+    +..+.+||+|||++..... ..
T Consensus        79 ~~~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll----~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          79 GGELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML----DKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             CCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE----CCCCCEEEecCCCCeecCCCCc
Confidence            9999998866433   8999999999999999999997 799999999999998    6677899999999875432 23


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      ......||+.|+|||++.        +..++.++|||||||++|+|+||..||..   .+.......+.....       
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~tG~~Pf~~---~~~~~~~~~i~~~~~-------  213 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHEKLFELILMEEI-------  213 (325)
T ss_pred             ccccccCCcccCCHHHHc--------cCCCCCccccccccceeeeeccCCCCCCC---CCHHHHHHHHhcCCC-------
Confidence            334567999999999987        67789999999999999999999999973   333333333332100       


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  .+|  ..+++    .+.++|.+||+.||++|+     ++.++           +.|+|+..
T Consensus       214 ------------~~p--~~~~~----~~~~li~~~L~~dP~~R~~~~~~~~~~i-----------l~h~~~~~  257 (325)
T cd05594         214 ------------RFP--RTLSP----EAKSLLSGLLKKDPKQRLGGGPDDAKEI-----------MQHKFFAG  257 (325)
T ss_pred             ------------CCC--CCCCH----HHHHHHHHHhhcCHHHhCCCCCCCHHHH-----------hcCCCcCC
Confidence                        112  12333    456699999999999997     78876           56888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.5e-39  Score=350.58  Aligned_cols=256  Identities=23%  Similarity=0.364  Sum_probs=200.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|.+..+|+.||+|++.....  ........+|+.+++.++||||+++++.+.+.+  .+|+|
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~lv   79 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYFV   79 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--EEEEE
Confidence            58899999999999999999999999999999864321  122344568999999999999999999987644  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||+||+|.+++....   .+++..++.++.||+.||+|||++||+||||||+|||+    +..+.+||+|||+|..+.
T Consensus        80 ~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill----~~~~~ikL~DFG~a~~~~  152 (376)
T cd05598          80 MDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI----DRDGHIKLTDFGLCTGFR  152 (376)
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE----CCCCCEEEEeCCCCcccc
Confidence            99999999999997643   38999999999999999999999999999999999998    666789999999975321


Q ss_pred             cc--------------------------------------------ccccccCCCCCcCChhhhhhhhhcCCCCCcCCcc
Q psy15481        169 ED--------------------------------------------QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGAT  204 (708)
Q Consensus       169 ~~--------------------------------------------~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~k  204 (708)
                      ..                                            ......+||+.|+|||++.        +..++.+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~  224 (376)
T cd05598         153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL--------RTGYTQL  224 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc--------CCCCCcc
Confidence            00                                            0011347999999999987        6778999


Q ss_pred             ccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHH
Q psy15481        205 VDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILA  284 (708)
Q Consensus       205 sDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~  284 (708)
                      +|||||||++|+|++|..||..   ....+....+.....                 ...+|....+++.+.+    +|.
T Consensus       225 ~DiwSlGvilyell~G~~Pf~~---~~~~~~~~~i~~~~~-----------------~~~~~~~~~~s~~~~~----li~  280 (376)
T cd05598         225 CDWWSVGVILYEMLVGQPPFLA---DTPAETQLKVINWET-----------------TLHIPSQAKLSREASD----LIL  280 (376)
T ss_pred             eeeeeccceeeehhhCCCCCCC---CCHHHHHHHHhccCc-----------------cccCCCCCCCCHHHHH----HHH
Confidence            9999999999999999999973   344444444332110                 0022333345555544    666


Q ss_pred             hhcccCcccCC---CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        285 GLLEVDSKKIW---SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       285 ~mL~~DP~kRp---sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      +|+ .||.+|+   ++.++           +.|||+..
T Consensus       281 ~l~-~~p~~R~~~~t~~el-----------l~h~~~~~  306 (376)
T cd05598         281 RLC-CGAEDRLGKNGADEI-----------KAHPFFKG  306 (376)
T ss_pred             HHh-cCHhhcCCCCCHHHH-----------hCCCCcCC
Confidence            765 5999999   88887           67999865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.7e-38  Score=341.23  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=198.0

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHH---HhCCCCCccceeEEEEecCCceEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVL---KKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL---~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      |.+.+.||+|+||.||+|.+..+|+.||||+++....  ....+...+|+.++   +.++||||+++++++...+  ..|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~--~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED--HVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC--EEE
Confidence            6788999999999999999999999999999975421  12233445565554   5678999999999987644  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++|++|...+...    .+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||++..
T Consensus        79 lv~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill----~~~~~~kL~Dfg~~~~  150 (324)
T cd05589          79 FVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL----DTEGFVKIADFGLCKE  150 (324)
T ss_pred             EEEcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE----CCCCcEEeCcccCCcc
Confidence            999999999999888653    28999999999999999999999999999999999998    6677899999999875


Q ss_pred             ccc-cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEE-DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~-~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ... .......+|++.|+|||++.        +..++.++|||||||++|+|++|..||..   .+..+....+..... 
T Consensus       151 ~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~G~~pf~~---~~~~~~~~~i~~~~~-  218 (324)
T cd05589         151 GMGFGDRTSTFCGTPEFLAPEVLT--------ETSYTRAVDWWGLGVLIYEMLVGESPFPG---DDEEEVFDSIVNDEV-  218 (324)
T ss_pred             CCCCCCcccccccCccccCHhHhc--------CCCCCcccchhhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhCCC-
Confidence            332 22334567999999999987        67789999999999999999999999973   444444444443211 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                        ..|      ..++..+.++|.+||..||.+||+     +.++           +.|||+..
T Consensus       219 ------------------~~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l-----------~~~~~f~~  262 (324)
T cd05589         219 ------------------RYP------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDV-----------KKQPFFRD  262 (324)
T ss_pred             ------------------CCC------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHH-----------hhCCCcCC
Confidence                              111      122344566999999999999995     5554           56888854

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=334.46  Aligned_cols=258  Identities=26%  Similarity=0.392  Sum_probs=203.3

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      |++.+.||+|+||.||++.+..+|+.||+|.+.......  ......+|+.+++.++||||+++++.+...+  ..|+||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~   79 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--eEEEEE
Confidence            778899999999999999999999999999986533221  1233468999999999999999999987654  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++||+|..++..... ..+++..+..++.|++.||.|||++|++||||||+||++    ++.+.++|+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          80 TLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL----DDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             eccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE----CCCCCEEEeeCCCceecCC
Confidence            99999999988754322 238999999999999999999999999999999999998    6667899999999987655


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      ........|+..|+|||++.        +..++.++|+||+||++|+|++|..||.+.   ........+......    
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Diws~G~~l~el~~g~~pf~~~---~~~~~~~~~~~~~~~----  219 (285)
T cd05605         155 GETIRGRVGTVGYMAPEVVK--------NERYTFSPDWWGLGCLIYEMIEGKSPFRQR---KEKVKREEVERRVKE----  219 (285)
T ss_pred             CCccccccCCCCccCcHHhc--------CCCCCccccchhHHHHHHHHHHCCCCCCCC---chhhHHHHHHHHhhh----
Confidence            44445567999999999986        567889999999999999999999999742   222222222211000    


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                    ..   ...+..++..+.+++.+||..||.+||     +++++           +.|+|+..
T Consensus       220 --------------~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l-----------~~~~~~~~  266 (285)
T cd05605         220 --------------DQ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEV-----------KAHPFFRT  266 (285)
T ss_pred             --------------cc---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHH-----------hcCcCccC
Confidence                          00   011223344566799999999999999     77776           66888854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.5e-38  Score=346.51  Aligned_cols=279  Identities=24%  Similarity=0.365  Sum_probs=205.1

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCC----
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG----   82 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~----   82 (708)
                      ...+|.+.+.||+|+||.||++.+..+|..||+|.+..... ........+|+.+++.++||||+++++++.....    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            34689999999999999999999999999999999865422 2223445689999999999999999999864432    


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                      ..+|+||||+. ++|...+..     .+++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||+|||
T Consensus        99 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~----~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMD-ANLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCC-cCHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----CCCCCEEEecCC
Confidence            34799999996 567666643     27899999999999999999999999999999999998    666789999999


Q ss_pred             ccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        163 AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       163 lA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      ++.............||+.|+|||++.        +..++.++|||||||++|+|+||..||.+   .+..+.+..+...
T Consensus       169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DiwSlG~il~el~tg~~pf~~---~~~~~~~~~~~~~  237 (359)
T cd07876         169 LARTACTNFMMTPYVVTRYYRAPEVIL--------GMGYKENVDIWSVGCIMGELVKGSVIFQG---TDHIDQWNKVIEQ  237 (359)
T ss_pred             CccccccCccCCCCcccCCCCCchhcc--------CCCCCcchhhHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHh
Confidence            998765554445567999999999987        67789999999999999999999999974   3333333322221


Q ss_pred             ccCCc---ccc--------c-ccCCCCcccccCCC-----CCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        243 KASGV---ISG--------T-QTSENGEIDWCTDL-----PNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       243 ~~~~~---i~~--------~-~~~~~g~~~~~~~l-----p~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                      .....   ...        . .......+.+...+     |............+.++|.+||..||++|||+.++     
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~-----  312 (359)
T cd07876         238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA-----  312 (359)
T ss_pred             cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH-----
Confidence            10000   000        0 00000000111111     11111122234556789999999999999999997     


Q ss_pred             HHHhhhhcCcccC
Q psy15481        306 KTLNRKLVHLFHI  318 (708)
Q Consensus       306 ~il~~~l~h~~~~  318 (708)
                            +.|||+.
T Consensus       313 ------l~hp~~~  319 (359)
T cd07876         313 ------LRHPYIT  319 (359)
T ss_pred             ------hcCchhh
Confidence                  6688774

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2e-38  Score=337.76  Aligned_cols=282  Identities=23%  Similarity=0.331  Sum_probs=208.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.++.+++.||+|.++............+|+.++++++||||+++++++...+  ..|+||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK--SLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC--eEEEEE
Confidence            468999999999999999999999999999999876544444445678999999999999999999987654  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+. ++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||++.....
T Consensus        84 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          84 EYLD-KDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI----NERGELKLADFGLARAKSV  156 (309)
T ss_pred             eCCC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEECccccceecCC
Confidence            9996 588888765433  28999999999999999999999999999999999998    6677899999999976433


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh---cccC
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT---KKAS  245 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~---~~~~  245 (708)
                      .. ......+++.|+|||++..       ...++.++|||||||++|+|+||.+||..   .+..+.+..+..   ....
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~tg~~pf~~---~~~~~~~~~~~~~~~~~~~  226 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLG-------SSEYSTQIDMWGVGCIFFEMASGRPLFPG---STVEDELHLIFRLLGTPTE  226 (309)
T ss_pred             CccccccccccccccCCHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHHHhCCCCH
Confidence            22 2334568999999999863       35678999999999999999999999974   333333333332   1111


Q ss_pred             CcccccccCCC-CcccccCCCCC-cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        246 GVISGTQTSEN-GEIDWCTDLPN-NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       246 ~~i~~~~~~~~-g~~~~~~~lp~-~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                      ........... ....+....+. .....+.++..+.++|.+||..||.+|||+.++           +.|||+....
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~-----------l~h~~~~~~~  293 (309)
T cd07872         227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA-----------MKHAYFRSLG  293 (309)
T ss_pred             HHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH-----------hcChhhhhcc
Confidence            11111000000 00000000000 001112334456679999999999999999997           6799997543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3e-38  Score=340.54  Aligned_cols=200  Identities=29%  Similarity=0.451  Sum_probs=173.4

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||++.+..+|..||+|.+...........+.+|++++++++||||+++++++...+  ..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEEEE
Confidence            3578999999999999999999999999999999875433333455679999999999999999999987654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||++|++|.+++.....   +++..+..++.|++.||.|||++ +|+||||||+|||+    +..+.++|+|||++...
T Consensus        82 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          82 MEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV----NSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             eecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE----cCCCcEEEccCcccccc
Confidence            999999999999976443   89999999999999999999986 69999999999998    66677999999999765


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCC
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP  226 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~  226 (708)
                      ... ......|++.|+|||++.        +..++.++|||||||++|+|+||+.||..
T Consensus       155 ~~~-~~~~~~g~~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         155 IDS-MANSFVGTRSYMSPERLQ--------GTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ccc-ccccCCCCcCcCCHhHhc--------CCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            432 234467999999999987        56789999999999999999999999974

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2e-38  Score=341.93  Aligned_cols=252  Identities=24%  Similarity=0.413  Sum_probs=196.6

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+|+.||+|+++.....  .......+|..++.++ +||||+++++++...+  .+|+|||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--RLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--EEEEEEeCC
Confidence            4699999999999999999999999999754322  2233456889999988 7999999999987654  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc-cccc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~-~~~~  171 (708)
                      +||+|..++....   .+++..++.++.||+.||.|||++|++||||||+|||+    +..+.+||+|||++... ....
T Consensus        79 ~~g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili----~~~~~~kL~Dfg~~~~~~~~~~  151 (329)
T cd05588          79 SGGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL----DAEGHIKLTDYGMCKEGIRPGD  151 (329)
T ss_pred             CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE----CCCCCEEECcCccccccccCCC
Confidence            9999998886543   39999999999999999999999999999999999998    66678999999998753 2233


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCC-----hhhHHHHHHhcccCC
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR-----NKETMYYITTKKASG  246 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~-----~~e~~~~i~~~~~~~  246 (708)
                      .....+||+.|+|||++.        +..++.++|+|||||++|+|+||..||...+...     ..+..........  
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--  221 (329)
T cd05588         152 TTSTFCGTPNYIAPEILR--------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--  221 (329)
T ss_pred             ccccccCCccccCHHHHc--------CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--
Confidence            344567999999999987        6778999999999999999999999996422111     1122222221100  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH------HHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF------ERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa------~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                      ..+|.  .++    ..+.++|.+||..||.+|+++      .++           +.|||+..
T Consensus       222 ----------------~~~p~--~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i-----------~~hp~~~~  267 (329)
T cd05588         222 ----------------IRIPR--SLS----VKASSVLKGFLNKDPKERLGCHPQTGFRDI-----------KSHPFFRN  267 (329)
T ss_pred             ----------------CCCCC--CCC----HHHHHHHHHHhccCHHHcCCCCCCCCHHHH-----------hcCCCCCC
Confidence                            01221  233    345669999999999999984      454           67999954

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2e-38  Score=340.38  Aligned_cols=248  Identities=26%  Similarity=0.397  Sum_probs=198.2

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+|+.||+|++......  ........|.+++..+ +||||+++++++...+  .+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--eEEEEEeCC
Confidence            3699999999999999999999999998754321  2233456788888876 8999999999997654  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-cc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~  171 (708)
                      +||+|...+.....   +++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++..... ..
T Consensus        79 ~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill----~~~~~~kL~Dfg~~~~~~~~~~  151 (321)
T cd05591          79 NGGDLMFQIQRSRK---FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL----DAEGHCKLADFGMCKEGILNGV  151 (321)
T ss_pred             CCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE----CCCCCEEEeecccceecccCCc
Confidence            99999998876443   8999999999999999999999999999999999998    6677899999999875432 22


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      ......||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +.+..+....+.....       
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~tg~~Pf~---~~~~~~~~~~i~~~~~-------  213 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQ--------ELEYGPSVDWWALGVLMYEMMAGQPPFE---ADNEDDLFESILHDDV-------  213 (321)
T ss_pred             cccccccCccccCHHHHc--------CCCCCCccceechhHHHHHHhcCCCCCC---CCCHHHHHHHHHcCCC-------
Confidence            334467999999999987        5778999999999999999999999997   3445555554443210       


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-------CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-------SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-------sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  .+|.  .++    ..+.++|.+||..||++|+       ++.++           +.|||+..
T Consensus       214 ------------~~p~--~~~----~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~-----------~~hp~~~~  259 (321)
T cd05591         214 ------------LYPV--WLS----KEAVSILKAFMTKNPNKRLGCVASQGGEDAI-----------KQHPFFKE  259 (321)
T ss_pred             ------------CCCC--CCC----HHHHHHHHHHhccCHHHcCCCCCCCCCHHHH-----------hcCCccCC
Confidence                        1121  233    3456699999999999999       66665           57888844

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.6e-38  Score=340.52  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=199.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEc---CCCceEEEEEeccCCC---CCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCc
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSH---MRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGR   83 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~~~~~s~---~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~   83 (708)
                      .|.+.+.||+|+||.||++++.   .+|+.||+|++.....   ....+...+|+.+++.+ +||||+++++++...+  
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA--   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--
Confidence            3788999999999999998864   4789999999864321   12233456899999999 5999999999887644  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|+||||++||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili----~~~~~~kl~DfG~  151 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL----DSEGHVVLTDFGL  151 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE----CCCCCEEEeeCcC
Confidence            59999999999999999876433   8999999999999999999999999999999999998    6667899999999


Q ss_pred             cccccccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH-HHH
Q psy15481        164 ARELEEDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY-YIT  240 (708)
Q Consensus       164 A~~~~~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~-~i~  240 (708)
                      +.......  .....+||+.|+|||++..       ...++.++|||||||++|+|+||..||...+.......+. .+.
T Consensus       152 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  224 (332)
T cd05614         152 SKEFLSEEKERTYSFCGTIEYMAPEIIRG-------KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL  224 (332)
T ss_pred             CccccccCCCccccccCCccccCHHHhcC-------CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh
Confidence            98653332  2234679999999999862       2347889999999999999999999997543333222222 222


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCc
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHL  315 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~  315 (708)
                      ..                     ..+    ++..++..+.+++.+||..||++||     +++++           +.||
T Consensus       225 ~~---------------------~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~-----------l~h~  268 (332)
T cd05614         225 KC---------------------DPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEI-----------KEHP  268 (332)
T ss_pred             cC---------------------CCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHH-----------HcCC
Confidence            11                     111    1122334556699999999999999     66675           6799


Q ss_pred             ccCC
Q psy15481        316 FHIN  319 (708)
Q Consensus       316 ~~~~  319 (708)
                      |+..
T Consensus       269 ~~~~  272 (332)
T cd05614         269 FFKG  272 (332)
T ss_pred             CcCC
Confidence            9865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.8e-38  Score=339.60  Aligned_cols=258  Identities=25%  Similarity=0.364  Sum_probs=200.6

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCC-CccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHE-NIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~Hp-NIVkl~~v~~~~~~~~~~L   87 (708)
                      .|.+.+.||+|+||.||+|.+..+++.||+|++.....  ....+....|..++..++|+ +|+.+++++.+.+  .+|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC--EEEE
Confidence            37889999999999999999999999999999875322  22234456889999999765 5788888887644  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++||+|..++.....   +++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++...
T Consensus        79 v~E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill----~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML----DAEGHIKIADFGMCKEN  151 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE----cCCCCEEEeecCcceec
Confidence            9999999999999876433   8999999999999999999999999999999999998    66678999999998753


Q ss_pred             c-ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 E-EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~-~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      . ........+||+.|+|||++.        +..++.++||||+||++|+|+||+.||.+   .+..+....+.....  
T Consensus       152 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslGvil~elltG~~pf~~---~~~~~~~~~i~~~~~--  218 (324)
T cd05587         152 IFGGKTTRTFCGTPDYIAPEIIA--------YQPYGKSVDWWAFGVLLYEMLAGQPPFDG---EDEDELFQSIMEHNV--  218 (324)
T ss_pred             CCCCCceeeecCCccccChhhhc--------CCCCCcccchhhhHHHHHHHHhCCCCCCC---CCHHHHHHHHHcCCC--
Confidence            2 222334567999999999987        67789999999999999999999999973   444444444442110  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                       .+|.  .++    ..+.+++.+||..||.+|++...-      .......|||+..
T Consensus       219 -----------------~~~~--~~~----~~~~~li~~~l~~~P~~R~~~~~~------~~~~~~~hp~~~~  262 (324)
T cd05587         219 -----------------SYPK--SLS----KEAVSICKGLLTKHPAKRLGCGPT------GERDIREHAFFRR  262 (324)
T ss_pred             -----------------CCCC--CCC----HHHHHHHHHHhhcCHHHcCCCCCC------CHHHHhcCCCcCC
Confidence                             1111  233    345669999999999999986210      0111267888854

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.4e-38  Score=343.50  Aligned_cols=278  Identities=23%  Similarity=0.344  Sum_probs=207.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecC----Cc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE----GR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~----~~   83 (708)
                      ..+|.+.+.||+|+||.||++.+..+++.||||.+..... ........+|+.+++.++||||+++++++....    ..
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            4689999999999999999999999999999999875432 222344568999999999999999999875432    23


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|+||||+. ++|...+..     .+++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kL~DfG~  172 (364)
T cd07875         103 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGL  172 (364)
T ss_pred             eEEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE----CCCCcEEEEeCCC
Confidence            5899999995 577777743     27899999999999999999999999999999999998    6667899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ++............||..|+|||++.        +..++.++|||||||++|+|++|..||.+   .+..+.+..+....
T Consensus       173 a~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DiwSlG~il~ell~g~~pf~~---~~~~~~~~~~~~~~  241 (364)
T cd07875         173 ARTAGTSFMMTPYVVTRYYRAPEVIL--------GMGYKENVDIWSVGCIMGEMIKGGVLFPG---TDHIDQWNKVIEQL  241 (364)
T ss_pred             ccccCCCCcccCCcccCCcCCHHHHh--------CCCCCchhhHHhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHhc
Confidence            98765544445567999999999987        67789999999999999999999999973   44455555444321


Q ss_pred             cCC---cccccc---------cCCCCcccccC-----CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        244 ASG---VISGTQ---------TSENGEIDWCT-----DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       244 ~~~---~i~~~~---------~~~~g~~~~~~-----~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                      ...   ......         ........+..     ..|.....+......+.++|.+||..||.+|||++++      
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~------  315 (364)
T cd07875         242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA------  315 (364)
T ss_pred             CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH------
Confidence            110   000000         00000000000     0111111122234567789999999999999999997      


Q ss_pred             HHhhhhcCcccC
Q psy15481        307 TLNRKLVHLFHI  318 (708)
Q Consensus       307 il~~~l~h~~~~  318 (708)
                           +.|||+.
T Consensus       316 -----L~hp~~~  322 (364)
T cd07875         316 -----LQHPYIN  322 (364)
T ss_pred             -----hcCcccc
Confidence                 5678774

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4e-38  Score=345.64  Aligned_cols=263  Identities=22%  Similarity=0.367  Sum_probs=205.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ...|.+.+.||+|+||.||++.+..+++.||+|++.+...  ........+|+.+++.++||||+++++++.+..  ..|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~--~~~  119 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK--YLY  119 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEE
Confidence            3578999999999999999999999999999999864321  122334568999999999999999999987644  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|||||+||+|.+++...    .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|..
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl----~~~~~~kL~DFG~a~~  191 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL----DKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE----CCCCCEEEEeccccee
Confidence            999999999999999653    28999999999999999999999999999999999998    6677899999999987


Q ss_pred             cccccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        167 LEEDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       167 ~~~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ......  ....+||+.|+|||++...    +....++.++|+||+||++|+|++|..||.+   .+....+..+.....
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~---~~~~~~~~~i~~~~~  264 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLFEMLVGDTPFYA---DSLVGTYSKIMDHKN  264 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhcc----CCCCCCCcccCEEeehHHHHHHHhCCCCCCC---CCHHHHHHHHHhCCc
Confidence            643322  2356799999999998631    1123478999999999999999999999973   444455555543211


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCccc--CCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKK--IWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~k--Rpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                   ..    .+|....++..    +.+++.+||..+|.+  |+++.++           +.|||+...
T Consensus       265 -------------~~----~~p~~~~~s~~----~~~li~~~L~~~~~r~~R~~~~e~-----------l~hp~~~~~  310 (370)
T cd05621         265 -------------SL----NFPEDVEISKH----AKNLICAFLTDREVRLGRNGVEEI-----------KQHPFFKND  310 (370)
T ss_pred             -------------cc----CCCCcccCCHH----HHHHHHHHccCchhccCCCCHHHH-----------hcCcccCCC
Confidence                         01    22333334444    445788888755544  8899987           669998653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.6e-38  Score=338.81  Aligned_cols=248  Identities=29%  Similarity=0.450  Sum_probs=197.2

Q ss_pred             eEeecCCceEEEEEEEc---CCCceEEEEEeccCCC---CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         16 SVLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSH---MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~---~tg~~VAIK~~~~~s~---~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +.||+|+||.||++++.   .+|+.||+|++.....   ........+|+.+++.++||||+++++++...+  .+|+||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~~lv~   79 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG--KLYLIL   79 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC--eEEEEE
Confidence            67999999999999864   4789999999875321   122234468999999999999999999987644  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++|++|..++.....   +++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          80 EYLSGGELFMHLEREGI---FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL----DAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             eCCCCchHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCCEEEeeCcCCeeccc
Confidence            99999999999876433   8899999999999999999999999999999999998    6677899999999875432


Q ss_pred             c-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 D-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      . .......||+.|+|||++.        +..++.++|||||||++|+|++|..||..   ......+..+.....    
T Consensus       153 ~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~G~~pf~~---~~~~~~~~~~~~~~~----  217 (323)
T cd05584         153 EGTVTHTFCGTIEYMAPEILM--------RSGHGKAVDWWSLGALMYDMLTGAPPFTA---ENRKKTIDKILKGKL----  217 (323)
T ss_pred             CCCcccccCCCccccChhhcc--------CCCCCCcceecccHHHHHHHhcCCCCCCC---CCHHHHHHHHHcCCC----
Confidence            2 2233467999999999987        56678999999999999999999999973   344444444443110    


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                     .+|      +.++..+.++|.+||..||++||     +++++           +.|||+..
T Consensus       218 ---------------~~~------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l-----------~~h~~~~~  261 (323)
T cd05584         218 ---------------NLP------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEV-----------QSHPFFRH  261 (323)
T ss_pred             ---------------CCC------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHH-----------hcCCCcCC
Confidence                           111      22334566799999999999999     67776           56888855

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.1e-38  Score=340.93  Aligned_cols=263  Identities=24%  Similarity=0.372  Sum_probs=206.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||++.++.+|+.||+|+++....  ......+.+|+.+++.++||||+++++++.+.+  ..|+|
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~--~~~lv   79 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD--NLYLV   79 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--eEEEE
Confidence            58899999999999999999999999999999975432  122344568999999999999999999887644  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++||+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++....
T Consensus        80 ~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll----~~~~~~kL~Dfg~a~~~~  153 (330)
T cd05601          80 MEYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI----DRTGHIKLADFGSAARLT  153 (330)
T ss_pred             ECCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE----CCCCCEEeccCCCCeECC
Confidence            999999999999976422  38999999999999999999999999999999999998    677789999999998765


Q ss_pred             ccccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        169 EDQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       169 ~~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      .....  ....||+.|+|||++.....  ..+..++.++|||||||++|+|++|..||..   ......+..+.....  
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~DiwslG~il~el~~g~~Pf~~---~~~~~~~~~i~~~~~--  226 (330)
T cd05601         154 ANKMVNSKLPVGTPDYIAPEVLTTMNG--DGKGTYGVECDWWSLGVIAYEMIYGRSPFHE---GTSAKTYNNIMNFQR--  226 (330)
T ss_pred             CCCceeeecccCCccccCHHHhccccc--cccCCCCCcceeecccceeeeeccCCCCCCC---CCHHHHHHHHHcCCC--
Confidence            44322  23479999999999863211  0135678999999999999999999999973   344444444443210  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                 .    ..+|....+++.    +.+++..||. ||.+||+++++           +.|||+..
T Consensus       227 -----------~----~~~~~~~~~~~~----~~~li~~ll~-~p~~R~t~~~l-----------~~h~~~~~  268 (330)
T cd05601         227 -----------F----LKFPEDPKVSSD----FLDLIQSLLC-GQKERLGYEGL-----------CCHPFFSK  268 (330)
T ss_pred             -----------c----cCCCCCCCCCHH----HHHHHHHHcc-ChhhCCCHHHH-----------hCCCCcCC
Confidence                       0    022332334444    5568899997 99999999987           67999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0197|consensus

Probab=100.00  E-value=2.9e-38  Score=344.25  Aligned_cols=251  Identities=28%  Similarity=0.398  Sum_probs=208.1

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      .+.+.||+|.||.||.|.+.. ...||+|.++..  ....+.+.+|+.+|++|+|+|||++++++....+  +||||||+
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p--iyIVtE~m  283 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP--IYIVTEYM  283 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcC-CCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc--eEEEEEec
Confidence            346789999999999999863 348999999865  2335567799999999999999999999987654  99999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ  172 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~  172 (708)
                      +.|+|.++|.... ...+...+.+.++.|||+||+||+++++|||||-..||||    +...++||+|||+|+...++.-
T Consensus       284 ~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV----~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  284 PKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV----DEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             ccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee----ccCceEEEcccccccccCCCce
Confidence            9999999998732 2348999999999999999999999999999999999999    7778999999999995544432


Q ss_pred             ccc--cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        173 FMS--LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       173 ~~~--~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      ...  .--...|.|||.+.        ...|+.++|||||||+|||++| |+.||.   +.++.+.+..+..+-      
T Consensus       359 ~~~~~~kfPIkWtAPEa~~--------~~~FS~kSDVWSFGVlL~E~fT~G~~py~---~msn~ev~~~le~Gy------  421 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALN--------YGKFSSKSDVWSFGVLLWELFTYGRVPYP---GMSNEEVLELLERGY------  421 (468)
T ss_pred             eecCCCCCCceecCHHHHh--------hCCcccccceeehhhhHHHHhccCCCCCC---CCCHHHHHHHHhccC------
Confidence            211  22356799999998        5779999999999999999999 999987   678888888777531      


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                                    .+|.+..    +++.+.+++..||+.+|++||||+.++..++++.
T Consensus       422 --------------Rlp~P~~----CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  422 --------------RLPRPEG----CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             --------------cCCCCCC----CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence                          4555443    3455666999999999999999998877766654

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.3e-38  Score=337.31  Aligned_cols=242  Identities=26%  Similarity=0.402  Sum_probs=194.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .|.+.+.||+|+||.||+|.+..+++.||+|++......  ........|..++..+ .||+|+++++++.+.+  ..|+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD--RLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC--EEEE
Confidence            378899999999999999999999999999999754322  1223345777888777 5889999999887654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++||+|...+.....   +++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++...
T Consensus        79 v~E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill----~~~~~~kL~DfG~~~~~  151 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML----DSEGHIKIADFGMCKEN  151 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE----CCCCcEEEccCCCceec
Confidence            9999999999998866433   8999999999999999999999999999999999998    66778999999999754


Q ss_pred             cc-cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 EE-DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~~-~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      .. .......+||+.|+|||++.        +..++.++|||||||++|+|+||..||.   +.+.......+.....  
T Consensus       152 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlGvil~elltg~~Pf~---~~~~~~~~~~i~~~~~--  218 (323)
T cd05616         152 MWDGVTTKTFCGTPDYIAPEIIA--------YQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDELFQSIMEHNV--  218 (323)
T ss_pred             CCCCCccccCCCChhhcCHHHhc--------CCCCCCccchhchhHHHHHHHhCCCCCC---CCCHHHHHHHHHhCCC--
Confidence            32 22334567999999999987        6778999999999999999999999997   3444555555543210  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF  297 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa  297 (708)
                                       .+|  ..++    ..+.+++.+||..||.+|+++
T Consensus       219 -----------------~~p--~~~s----~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 -----------------AYP--KSMS----KEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -----------------CCC--CcCC----HHHHHHHHHHcccCHHhcCCC
Confidence                             112  1233    345669999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.3e-38  Score=338.92  Aligned_cols=252  Identities=29%  Similarity=0.430  Sum_probs=196.1

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHH-HHHhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFE-VLKKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~-iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+|+.||+|++......  ........|.. +++.++||||+++++.+...+  ..|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~--~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--KLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC--EEEEEEcCC
Confidence            3699999999999999999999999998653221  11222334444 567899999999999987654  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-cc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~  171 (708)
                      +||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++..... ..
T Consensus        79 ~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll----~~~~~~kl~Dfg~~~~~~~~~~  151 (323)
T cd05575          79 NGGELFFHLQRERS---FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL----DSQGHVVLTDFGLCKEGIEHSK  151 (323)
T ss_pred             CCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE----CCCCcEEEeccCCCcccccCCC
Confidence            99999999876433   8999999999999999999999999999999999998    6677899999999875432 22


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      .....+||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .+..+....+.....       
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~ell~g~~pf~~---~~~~~~~~~i~~~~~-------  213 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLR--------KQPYDRTVDWWCLGAVLYEMLYGLPPFYS---RDTAEMYDNILNKPL-------  213 (323)
T ss_pred             ccccccCChhhcChhhhc--------CCCCCccccccccchhhhhhhcCCCCCCC---CCHHHHHHHHHcCCC-------
Confidence            233467999999999987        56789999999999999999999999973   444444444443210       


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  .      +.+.++..+.++|.+||+.||.+||++.+-+.+       .+.|||+..
T Consensus       214 ------------~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~-------il~~~~~~~  256 (323)
T cd05575         214 ------------R------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLE-------IKNHVFFSS  256 (323)
T ss_pred             ------------C------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHH-------HHcCCCcCC
Confidence                        1      112223456679999999999999998643222       257898854

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.5e-38  Score=336.59  Aligned_cols=201  Identities=22%  Similarity=0.355  Sum_probs=165.0

Q ss_pred             eeEeecCCceEEEEEEEc--CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         15 TSVLGKGATGAVFQGVNK--NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~--~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +..||+|+||.||+|.++  .+++.||+|.+.....   .....+|+.++++++||||+++++++........|++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            468999999999999975  4678999999864321   23456899999999999999999999776667799999999


Q ss_pred             CCCCHHHHhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         93 TGGSLFNILDDPE------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        93 ~ggsL~~~L~~~~------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                       +++|..++....      ....+++..++.++.||+.||.|||++||+||||||+|||+...++..+.+||+|||+|..
T Consensus        83 -~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 -EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             -CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence             568888775321      1123899999999999999999999999999999999999733334567899999999986


Q ss_pred             ccccc----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCC
Q psy15481        167 LEEDQ----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP  226 (708)
Q Consensus       167 ~~~~~----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~  226 (708)
                      .....    ......||+.|+|||++..       ...++.++||||+||++|+|++|.+||..
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcC-------CCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            54332    2234678999999999862       35689999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.7e-38  Score=343.76  Aligned_cols=256  Identities=23%  Similarity=0.389  Sum_probs=201.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||++.++.+|+.||+|+++....  ........+|+.++..++||||+++++.+.+.+  .+|+|
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~--~~~lv   79 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR--NLYLI   79 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEEE
Confidence            47889999999999999999999999999999974321  222344568999999999999999999987644  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||+||+|.+++.....   +++..++.++.|++.||.|||++||+||||||+|||+    +..+.++|+|||++....
T Consensus        80 ~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli----~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL----DAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             EeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE----CCCCCEEEeeccCCcccc
Confidence            999999999999876443   8999999999999999999999999999999999998    667789999999987542


Q ss_pred             ccc------------------------------------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhh
Q psy15481        169 EDQ------------------------------------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGV  212 (708)
Q Consensus       169 ~~~------------------------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGv  212 (708)
                      ...                                    .....+||+.|+|||++.        +..++.++|||||||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~--------~~~~~~~~DiwSlGv  224 (360)
T cd05627         153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM--------QTGYNKLCDWWSLGV  224 (360)
T ss_pred             cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc--------CCCCCCcceeccccc
Confidence            210                                    011357999999999987        677899999999999


Q ss_pred             HHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcc
Q psy15481        213 TLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSK  292 (708)
Q Consensus       213 iLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~  292 (708)
                      ++|+|+||.+||..   .........+...+.             .    ..+|....+++.+.+    +|.+|+ .||.
T Consensus       225 ilyel~tG~~Pf~~---~~~~~~~~~i~~~~~-------------~----~~~p~~~~~s~~~~~----li~~l~-~~p~  279 (360)
T cd05627         225 IMYEMLIGYPPFCS---ETPQETYRKVMNWKE-------------T----LVFPPEVPISEKAKD----LILRFC-TDSE  279 (360)
T ss_pred             eeeecccCCCCCCC---CCHHHHHHHHHcCCC-------------c----eecCCCCCCCHHHHH----HHHHhc-cChh
Confidence            99999999999973   444444444442110             0    023333345555555    667766 4999


Q ss_pred             cCCC---HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        293 KIWS---FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       293 kRps---a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      +|++   ++++           +.|||+..
T Consensus       280 ~R~~~~~~~ei-----------~~hp~f~~  298 (360)
T cd05627         280 NRIGSNGVEEI-----------KSHPFFEG  298 (360)
T ss_pred             hcCCCCCHHHH-----------hcCCCCCC
Confidence            9986   4554           67999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.1e-38  Score=338.86  Aligned_cols=258  Identities=23%  Similarity=0.370  Sum_probs=195.9

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+++.||+|++......  .......+|+.++.++ +||||+++++++...+  .+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--EEEEEEeCC
Confidence            4699999999999999999999999999764322  2233456788888777 8999999999987654  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc-ccc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~-~~~  171 (708)
                      +||+|..++....   .+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||++.... ...
T Consensus        79 ~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili----~~~~~~kL~DfG~~~~~~~~~~  151 (329)
T cd05618          79 NGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL----DSEGHIKLTDYGMCKEGLRPGD  151 (329)
T ss_pred             CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE----CCCCCEEEeeCCccccccCCCC
Confidence            9999998886543   38999999999999999999999999999999999998    666789999999997532 222


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCC-----hhhHHHHHHhcccCC
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR-----NKETMYYITTKKASG  246 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~-----~~e~~~~i~~~~~~~  246 (708)
                      ......||+.|+|||++.        +..++.++|+|||||++|+|++|..||...+...     ....+........  
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--  221 (329)
T cd05618         152 TTSTFCGTPNYIAPEILR--------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--  221 (329)
T ss_pred             ccccccCCccccCHHHHc--------CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--
Confidence            334567999999999987        6778999999999999999999999996322211     1112222211100  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                      ..+|      ..++..+.++|.+||..||.+||++..... +    ...+.|||+..
T Consensus       222 ----------------~~~p------~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~-~----~~i~~hp~f~~  267 (329)
T cd05618         222 ----------------IRIP------RSLSVKAASVLKSFLNKDPKERLGCHPQTG-F----ADIQGHPFFRN  267 (329)
T ss_pred             ----------------CCCC------CCCCHHHHHHHHHHhcCCHHHcCCCCCCCC-H----HHHhcCCCCCC
Confidence                            0122      223344567999999999999999531100 0    11267999854

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0201|consensus

Probab=100.00  E-value=6.7e-40  Score=348.17  Aligned_cols=252  Identities=22%  Similarity=0.406  Sum_probs=209.6

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .....|...+.||+|+||.||+|.+..+++.||+|+++-.......+...+|+.++..+++|||.++++.+....  .++
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~--~Lw   87 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT--KLW   87 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc--cHH
Confidence            345578888999999999999999999999999999987766555566679999999999999999999987654  499


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ++||||.||++.+.++....   +.+..+..++++++.||.|||..+.+|||||+.|||+    ...+.+||+|||.+..
T Consensus        88 iiMey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~----s~~g~vkl~DfgVa~q  160 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL----SESGDVKLADFGVAGQ  160 (467)
T ss_pred             HHHHHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhcceecccccccceeE----eccCcEEEEecceeee
Confidence            99999999999999976543   5899999999999999999999999999999999998    4446799999999998


Q ss_pred             ccccccc-cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEEDQQF-MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~~~~~-~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      +...... .+.+||+.|||||++.        +..|+.++||||||++.|||++|.+||....   +...++-|-...  
T Consensus       161 l~~~~~rr~tfvGTPfwMAPEVI~--------~~~Y~~KADIWSLGITaiEla~GePP~s~~h---PmrvlflIpk~~--  227 (467)
T KOG0201|consen  161 LTNTVKRRKTFVGTPFWMAPEVIK--------QSGYDTKADIWSLGITAIELAKGEPPHSKLH---PMRVLFLIPKSA--  227 (467)
T ss_pred             eechhhccccccccccccchhhhc--------cccccchhhhhhhhHHHHHHhcCCCCCcccC---cceEEEeccCCC--
Confidence            7766544 6789999999999998        7899999999999999999999999997432   222222122111  


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                                          |  +.+...++..+.+|+..||..||+.||+|.++++
T Consensus       228 --------------------P--P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  228 --------------------P--PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             --------------------C--CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence                                1  1233345555667999999999999999999855

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.1e-38  Score=342.30  Aligned_cols=278  Identities=23%  Similarity=0.344  Sum_probs=205.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecC----Cc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQE----GR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~----~~   83 (708)
                      ..+|.+.+.||+|+||.||++.+..+++.||+|.+...... .......+|+.+++.++||||+++++++....    ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            46899999999999999999999999999999998754322 22344568999999999999999999886432    23


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||+. ++|...+..     .+++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus        96 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill----~~~~~~kl~Dfg~  165 (355)
T cd07874          96 DVYLVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGL  165 (355)
T ss_pred             eeEEEhhhhc-ccHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE----CCCCCEEEeeCcc
Confidence            5799999996 567776643     28899999999999999999999999999999999998    6667899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ++............||+.|+|||++.        +..++.++|||||||++|+|++|..||.+   .+..+.+..+....
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~g~~pf~~---~~~~~~~~~~~~~~  234 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVIL--------GMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQL  234 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHh
Confidence            98765554455678999999999987        67789999999999999999999999974   33333333332211


Q ss_pred             cCC---cccccc--------cC-CCCccccc-----CCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        244 ASG---VISGTQ--------TS-ENGEIDWC-----TDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       244 ~~~---~i~~~~--------~~-~~g~~~~~-----~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                      ...   ......        .. ......+.     ...|.....+......+.++|.+||..||++|||+.++      
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el------  308 (355)
T cd07874         235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA------  308 (355)
T ss_pred             CCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH------
Confidence            000   000000        00 00000000     01111112222334567789999999999999999997      


Q ss_pred             HHhhhhcCcccC
Q psy15481        307 TLNRKLVHLFHI  318 (708)
Q Consensus       307 il~~~l~h~~~~  318 (708)
                           +.|||+.
T Consensus       309 -----l~hp~~~  315 (355)
T cd07874         309 -----LQHPYIN  315 (355)
T ss_pred             -----hcCcchh
Confidence                 5678774

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.3e-38  Score=336.76  Aligned_cols=248  Identities=26%  Similarity=0.399  Sum_probs=198.2

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+++.||+|++.+...  ........+|..++..+ +||||+++++++...+  .+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcCC
Confidence            469999999999999999999999999975421  22234456888888888 7999999999987654  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-cc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~  171 (708)
                      +||+|..++....   .+++..+..++.|++.||.|||++||+||||||+||++    +..+.++|+|||++..... ..
T Consensus        79 ~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~  151 (318)
T cd05570          79 NGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL----DSEGHIKIADFGMCKEGILGGV  151 (318)
T ss_pred             CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE----CCCCcEEecccCCCeecCcCCC
Confidence            9999999887643   38999999999999999999999999999999999998    6667899999999875322 22


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      .....+|++.|+|||++.        +..++.++|+|||||++|+|++|..||..   .+.......+.....       
T Consensus       152 ~~~~~~g~~~y~aPE~~~--------~~~~~~~~DiwslGvil~~l~~G~~pf~~---~~~~~~~~~i~~~~~-------  213 (318)
T cd05570         152 TTSTFCGTPDYIAPEILS--------YQPYGPAVDWWALGVLLYEMLAGQSPFEG---DDEDELFQSILEDEV-------  213 (318)
T ss_pred             cccceecCccccCHHHhc--------CCCCCcchhhhhHHHHHHHHhhCCCCCCC---CCHHHHHHHHHcCCC-------
Confidence            233457999999999987        67789999999999999999999999973   344444433332110       


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH-----HHHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF-----ERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa-----~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  .+|      ..++..+.++|.+||..||.+||++     .++           +.|||+..
T Consensus       214 ------------~~~------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~l-----------l~~~~~~~  257 (318)
T cd05570         214 ------------RYP------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDI-----------KGHPFFRE  257 (318)
T ss_pred             ------------CCC------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHH-----------hcCCCcCC
Confidence                        111      1223456679999999999999999     665           66888855

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.9e-38  Score=336.32  Aligned_cols=248  Identities=26%  Similarity=0.419  Sum_probs=194.6

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+++.||+|+++....  ....+....|..++..+ +||||+++++++...+  ..|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--HLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcCC
Confidence            369999999999999999999999999975422  12223345676677654 8999999999987644  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc-c
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-Q  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~-~  171 (708)
                      +||+|..++....   .+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++...... .
T Consensus        79 ~gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill----~~~~~~kL~Dfg~a~~~~~~~~  151 (316)
T cd05592          79 NGGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL----DKDGHIKIADFGMCKENMNGEG  151 (316)
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE----CCCCCEEEccCcCCeECCCCCC
Confidence            9999999987643   38999999999999999999999999999999999998    66678999999999764332 2


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      .....+||+.|+|||++.        +..++.++|||||||++|+|++|..||.+   .+..+....+....+       
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~ell~G~~Pf~~---~~~~~~~~~i~~~~~-------  213 (316)
T cd05592         152 KASTFCGTPDYIAPEILK--------GQKYNESVDWWSFGVLLYEMLIGQSPFHG---EDEDELFDSILNDRP-------  213 (316)
T ss_pred             ccccccCCccccCHHHHc--------CCCCCCcccchhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHcCCC-------
Confidence            334467999999999987        66789999999999999999999999973   444444443332100       


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHH-HHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-RFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~-q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  .+|      ..++..+.++|.+||..||.+||++. ++           ..|||+..
T Consensus       214 ------------~~~------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l-----------~~h~~~~~  253 (316)
T cd05592         214 ------------HFP------RWISKEAKDCLSKLFERDPTKRLGVDGDI-----------RQHPFFRG  253 (316)
T ss_pred             ------------CCC------CCCCHHHHHHHHHHccCCHHHcCCChHHH-----------HcCcccCC
Confidence                        112      12234456699999999999999875 43           45888754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.7e-38  Score=335.92  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=195.5

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.++.+|+.||+|.+.....  .........|..++..+ +||||+++++++.+.+  .+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--HLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC--EEEEEECCC
Confidence            469999999999999999999999999975422  12233446777787765 8999999999987644  699999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-cc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~  171 (708)
                      .||+|..++....   .+++..+..++.|++.||.|||++||+||||||+|||+    +..+.++|+|||++..... ..
T Consensus        79 ~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05620          79 NGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML----DRDGHIKIADFGMCKENVFGDN  151 (316)
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE----CCCCCEEeCccCCCeecccCCC
Confidence            9999999887643   28999999999999999999999999999999999998    6667899999999875322 22


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      .....+||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .+..+....+....        
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslGvil~el~~g~~Pf~~---~~~~~~~~~~~~~~--------  212 (316)
T cd05620         152 RASTFCGTPDYIAPEILQ--------GLKYTFSVDWWSFGVLLYEMLIGQSPFHG---DDEDELFESIRVDT--------  212 (316)
T ss_pred             ceeccCCCcCccCHHHHc--------CCCCCcccchhhhHHHHHHHHhCCCCCCC---CCHHHHHHHHHhCC--------
Confidence            234567999999999997        67789999999999999999999999973   33334333332210        


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHH-HHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-RFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~-q~~~~l~~il~~~l~h~~~~~  319 (708)
                                 ..+|.  .++.    .+.+++.+||..||.+|+++. ++           ..|||+..
T Consensus       213 -----------~~~~~--~~~~----~~~~li~~~l~~dP~~R~~~~~~~-----------~~h~~f~~  253 (316)
T cd05620         213 -----------PHYPR--WITK----ESKDILEKLFERDPTRRLGVVGNI-----------RGHPFFKT  253 (316)
T ss_pred             -----------CCCCC--CCCH----HHHHHHHHHccCCHHHcCCChHHH-----------HcCCCcCC
Confidence                       01222  1333    455699999999999999974 44           45888855

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.9e-38  Score=329.89  Aligned_cols=256  Identities=25%  Similarity=0.361  Sum_probs=198.3

Q ss_pred             eecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCC
Q psy15481         18 LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        18 LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~gg   95 (708)
                      ||+|+||.||++.++.+|+.||+|.+......  ........|++++++++||||+++++++....  ..|+||||++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT--HLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--eEEEEEecCCCC
Confidence            79999999999999999999999998643221  11233457999999999999999999987644  599999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccccc
Q psy15481         96 SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS  175 (708)
Q Consensus        96 sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~~  175 (708)
                      +|..++..... .++++..+..++.|++.||.|||+.|++||||||+||++    +..+.++|+|||++...........
T Consensus        79 ~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili----~~~~~~~l~Dfg~~~~~~~~~~~~~  153 (277)
T cd05607          79 DLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL----DDQGNCRLSDLGLAVELKDGKTITQ  153 (277)
T ss_pred             CHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE----cCCCCEEEeeceeeeecCCCceeec
Confidence            99988754332 238899999999999999999999999999999999998    6667899999999987655544455


Q ss_pred             cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH-HHHhcccCCcccccccC
Q psy15481        176 LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY-YITTKKASGVISGTQTS  254 (708)
Q Consensus       176 ~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~-~i~~~~~~~~i~~~~~~  254 (708)
                      ..|+..|+|||++.        +..++.++|+||+||++|+|++|..||.......+...+. .+...            
T Consensus       154 ~~~~~~y~aPE~~~--------~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------  213 (277)
T cd05607         154 RAGTNGYMAPEILK--------EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED------------  213 (277)
T ss_pred             cCCCCCccCHHHHc--------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc------------
Confidence            67999999999987        5668999999999999999999999997543322222221 11110            


Q ss_pred             CCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        255 ENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       255 ~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                               .++..   ...++..+.+++.+||..||++||++.+.+.       ..+.|+|+..
T Consensus       214 ---------~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~-------~~~~h~~f~~  259 (277)
T cd05607         214 ---------EVKFE---HQNFTEESKDICRLFLAKKPEDRLGSREKND-------DPRKHEFFKT  259 (277)
T ss_pred             ---------ccccc---cccCCHHHHHHHHHHhccCHhhCCCCccchh-------hhhcChhhcC
Confidence                     01100   0123345667999999999999999977532       3467888854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-38  Score=338.31  Aligned_cols=253  Identities=29%  Similarity=0.441  Sum_probs=199.2

Q ss_pred             eEeecCCceEEEEEEE---cCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEec
Q psy15481         16 SVLGKGATGAVFQGVN---KNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~---~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      +.||+|+||.||++++   ..+|+.||+|++...... .......+|+.++++++||||+++++++...+  .+|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--KLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--EEEEEEcC
Confidence            5799999999999876   357899999999754321 12234468999999999999999999987654  59999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc-
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-  170 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~-  170 (708)
                      ++||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++...... 
T Consensus        80 ~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          80 LRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL----DEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             CCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE----CCCCcEEEeeccCCcccCCCC
Confidence            999999999866433   8999999999999999999999999999999999998    66678999999999865443 


Q ss_pred             ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccc
Q psy15481        171 QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISG  250 (708)
Q Consensus       171 ~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~  250 (708)
                      .......||+.|+|||.+.        +..++.++|||||||++|+|++|..||..   ....+.+..+.....      
T Consensus       153 ~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~tg~~p~~~---~~~~~~~~~i~~~~~------  215 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVN--------RRGHTQSADWWSFGVLMFEMLTGSLPFQG---KDRKETMTMILKAKL------  215 (318)
T ss_pred             CceecccCChhhcCHHHHc--------CCCCCCccceeccceEeeeeccCCCCCCC---CCHHHHHHHHHcCCC------
Confidence            2334567999999999987        56778999999999999999999999973   444555544443210      


Q ss_pred             cccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        251 TQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       251 ~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                   .+|      ..++..+.++|.+||+.||.+||++.+.      .+...+.|+|+..
T Consensus       216 -------------~~p------~~~~~~~~~li~~~l~~~P~~R~~a~~~------~~~~~~~~~~~~~  259 (318)
T cd05582         216 -------------GMP------QFLSPEAQSLLRALFKRNPANRLGAGPD------GVEEIKRHPFFST  259 (318)
T ss_pred             -------------CCC------CCCCHHHHHHHHHHhhcCHhHcCCCCCC------CHHHHhCCCCcCC
Confidence                         111      2233445679999999999999996541      0111267888864

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.3e-37  Score=330.12  Aligned_cols=278  Identities=24%  Similarity=0.357  Sum_probs=208.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||.|+||.||+|.++.+++.||+|.+.............+|+.++++++||||+++++++...+  ..++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~--~~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK--SLTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC--eEEEEE
Confidence            468999999999999999999999999999999875544444445678999999999999999999987654  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+. ++|..++.....  .+++..+..++.|++.||.|||++|++|+||||+||++    +..+.++|+|||++.....
T Consensus        84 e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          84 EYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI----NERGELKLADFGLARAKSI  156 (301)
T ss_pred             eccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE----CCCCcEEECcCcchhccCC
Confidence            9996 689888865432  38999999999999999999999999999999999998    6667899999999976443


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh---cccC
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT---KKAS  245 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~---~~~~  245 (708)
                      .. ......+++.|+|||++..       ...++.++|||||||++|+|+||.+||..   .+..+.+..+..   ....
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~tg~~~f~~---~~~~~~~~~~~~~~~~~~~  226 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMSTGRPLFPG---STVEEQLHFIFRILGTPTE  226 (301)
T ss_pred             CCCcccccceeecccCcHHHhC-------CCCCccHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHcCCCCh
Confidence            22 2334567899999999863       34578899999999999999999999974   333333333322   1111


Q ss_pred             CcccccccCCCCcccc-cCCCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDW-CTDLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~-~~~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      .........    ..| ....|..     ....+.++..+.++|.+||..||.+|||++++           +.|||+..
T Consensus       227 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei-----------l~h~~f~~  291 (301)
T cd07873         227 ETWPGILSN----EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA-----------MKHPYFHC  291 (301)
T ss_pred             hhchhhhcc----ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH-----------hcCccccc
Confidence            111100000    000 0011111     11223345556779999999999999999997           77999965


Q ss_pred             cc
Q psy15481        320 RL  321 (708)
Q Consensus       320 ~~  321 (708)
                      -.
T Consensus       292 ~~  293 (301)
T cd07873         292 LG  293 (301)
T ss_pred             cc
Confidence            43

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.8e-38  Score=337.90  Aligned_cols=252  Identities=30%  Similarity=0.422  Sum_probs=195.5

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHH-HHHHhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREF-EVLKKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei-~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+++.||+|++......  ........|. .+++.++||||+++++++...+  ..|+||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--eEEEEEeCC
Confidence            3699999999999999999999999998753211  1112223343 3567889999999999987654  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-cc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~  171 (708)
                      +||+|..++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++..... ..
T Consensus        79 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili----~~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          79 NGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL----DSQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE----CCCCCEEEccCCCCcccccCCC
Confidence            9999999997643   28899999999999999999999999999999999998    6667899999999975432 22


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      .....+||+.|+|||++.        +..++.++|||||||++|+|++|.+||.   +.+..+.+..+....        
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~g~~pf~---~~~~~~~~~~i~~~~--------  212 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLH--------KQPYDRTVDWWCLGAVLYEMLYGLPPFY---SRNTAEMYDNILNKP--------  212 (325)
T ss_pred             CcccccCCccccCHHHHc--------CCCCCCccccccccHHHHHHhcCCCCCC---CCCHHHHHHHHHhCC--------
Confidence            334567999999999987        6778999999999999999999999997   344445444444321        


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                   .+    +.+.++..+.++|.+||+.||.+|+++.+.+.+       ...|+|+..
T Consensus       213 -------------~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~-------i~~~~~~~~  256 (325)
T cd05602         213 -------------LQ----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME-------IKNHIFFSP  256 (325)
T ss_pred             -------------cC----CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH-------HhcCcccCC
Confidence                         11    112233445669999999999999998764332       256777643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6e-38  Score=329.73  Aligned_cols=252  Identities=26%  Similarity=0.404  Sum_probs=194.6

Q ss_pred             eecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCC
Q psy15481         18 LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        18 LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~gg   95 (708)
                      ||+|+||.||++.+..+|+.||+|.+.......  ..+.+..|+.++++++||||+++.+++....  ..|+||||++||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT--DLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC--eEEEEEeCCCCC
Confidence            799999999999999999999999986532221  1234568999999999999999999887644  599999999999


Q ss_pred             CHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccc-c
Q psy15481         96 SLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ-F  173 (708)
Q Consensus        96 sL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~-~  173 (708)
                      +|...+... .....+++..++.++.||+.||.|||++||+||||||+||++    +..+.++|+|||.+........ .
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~~l~dfg~~~~~~~~~~~~  154 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL----DNDGNVRISDLGLAVELKDGQSKT  154 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEeeCccceecCCCCccc
Confidence            998877432 122348999999999999999999999999999999999998    6667899999999976544322 2


Q ss_pred             cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChh-hHHHHHHhcccCCcccccc
Q psy15481        174 MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK-ETMYYITTKKASGVISGTQ  252 (708)
Q Consensus       174 ~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~-e~~~~i~~~~~~~~i~~~~  252 (708)
                      ....||+.|+|||++.        +..++.++|+|||||++|+|++|..||...+..... .....+...          
T Consensus       155 ~~~~g~~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  216 (280)
T cd05608         155 KGYAGTPGFMAPELLQ--------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------  216 (280)
T ss_pred             cccCCCcCccCHHHhc--------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------
Confidence            3457999999999997        677889999999999999999999999753222111 111111110          


Q ss_pred             cCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        253 TSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       253 ~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                 ..    .++..++..+.+++.+||+.||++||     +++++           +.|||+..
T Consensus       217 -----------~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~-----------l~h~~~~~  262 (280)
T cd05608         217 -----------SV----TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGL-----------RTHPLFRD  262 (280)
T ss_pred             -----------CC----CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH-----------hcChhhhc
Confidence                       00    11222334566799999999999999     55565           56888854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG4717|consensus

Probab=100.00  E-value=1.3e-38  Score=340.99  Aligned_cols=251  Identities=27%  Similarity=0.449  Sum_probs=215.7

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ..-..|.+.+-||+|.|+.|.+|++..||+.||||++.+..... .......|++-|+..+|||||++|++...+..  +
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK--l   92 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK--L   92 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce--E
Confidence            44568999999999999999999999999999999998765432 23345699999999999999999999887665  9


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|+|.-.||+|++++.+.+.  |+.|+..+.++.||+.|+.|||+..+||||+||+|+.. +  ...+.|||+|||++-
T Consensus        93 yLiLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVF-F--EKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVF-F--EKLGLVKLTDFGFSN  167 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEE-e--eecCceEeeeccccc
Confidence            999999999999999987553  59999999999999999999999999999999999986 3  456689999999999


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcC-CccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~-s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .+.++.+..+.||+..|-|||++.        |..| .+++||||||||||-|++|++||.   ..++.+++..|..-+.
T Consensus       168 kf~PG~kL~TsCGSLAYSAPEILL--------GDsYDAPAVDiWSLGVILyMLVCGq~PFq---eANDSETLTmImDCKY  236 (864)
T KOG4717|consen  168 KFQPGKKLTTSCGSLAYSAPEILL--------GDSYDAPAVDIWSLGVILYMLVCGQPPFQ---EANDSETLTMIMDCKY  236 (864)
T ss_pred             cCCCcchhhcccchhhccCchhhh--------cCccCCcchhhhHHHHHHHHHHhCCCccc---cccchhhhhhhhcccc
Confidence            999999999999999999999998        5666 568999999999999999999998   4667788877775322


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                         .      ++..+++...+||.+||..||++|.+.+++
T Consensus       237 -------------------t------vPshvS~eCrdLI~sMLvRdPkkRAslEeI  267 (864)
T KOG4717|consen  237 -------------------T------VPSHVSKECRDLIQSMLVRDPKKRASLEEI  267 (864)
T ss_pred             -------------------c------CchhhhHHHHHHHHHHHhcCchhhccHHHH
Confidence                               2      223344445559999999999999999986

>KOG0610|consensus

Probab=100.00  E-value=1.7e-38  Score=335.22  Aligned_cols=257  Identities=26%  Similarity=0.371  Sum_probs=211.0

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||.|.-|+||++..+.++..+|+|++.+......  ..+...|-+||..++||.++.+++.++...  ..|+|
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~--~~cl~  155 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK--YSCLV  155 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc--eeEEE
Confidence            46678899999999999999999999999999986543221  123357889999999999999999998754  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||+||+|...++.... ..+++..++.++..|+.||.|||-.|||+|||||+|||+    ...|.+-|+||.++....
T Consensus       156 meyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv----redGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV----REDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             EecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE----ecCCcEEeeeccccccCC
Confidence            999999999998877544 449999999999999999999999999999999999998    555679999998874210


Q ss_pred             c---------------------------------c------------------------ccccccCCCCCcCChhhhhhh
Q psy15481        169 E---------------------------------D------------------------QQFMSLYGTEEYLHPDMYERA  191 (708)
Q Consensus       169 ~---------------------------------~------------------------~~~~~~~GT~~YlAPE~l~~~  191 (708)
                      -                                 .                        ....+.+||.+|+|||++.  
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~--  308 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR--  308 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee--
Confidence            0                                 0                        0112367999999999998  


Q ss_pred             hhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccC
Q psy15481        192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQL  271 (708)
Q Consensus       192 ~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~l  271 (708)
                            |..-+.++|.|+|||++|||+.|..||.   |.++.+++..|..+..                   .+|....+
T Consensus       309 ------G~GHgsAVDWWtfGIflYEmLyG~TPFK---G~~~~~Tl~NIv~~~l-------------------~Fp~~~~v  360 (459)
T KOG0610|consen  309 ------GEGHGSAVDWWTFGIFLYEMLYGTTPFK---GSNNKETLRNIVGQPL-------------------KFPEEPEV  360 (459)
T ss_pred             ------cCCCCchhhHHHHHHHHHHHHhCCCCcC---CCCchhhHHHHhcCCC-------------------cCCCCCcc
Confidence                  7788999999999999999999999999   6889999999987533                   44554444


Q ss_pred             ChhHHHHHHHHHHhhcccCcccCCC----HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        272 SLGLKKLVTPILAGLLEVDSKKIWS----FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       272 s~~l~~~l~~LL~~mL~~DP~kRps----a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      +.    .+.|||+++|.+||.+|..    |.++           =.||||..
T Consensus       361 s~----~akDLIr~LLvKdP~kRlg~~rGA~eI-----------K~HpFF~g  397 (459)
T KOG0610|consen  361 SS----AAKDLIRKLLVKDPSKRLGSKRGAAEI-----------KRHPFFEG  397 (459)
T ss_pred             hh----HHHHHHHHHhccChhhhhccccchHHh-----------hcCccccC
Confidence            44    4556999999999999998    6664           35787754

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.6e-38  Score=334.85  Aligned_cols=248  Identities=26%  Similarity=0.406  Sum_probs=196.0

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+++.||+|++.....  .........|..++..+ +||||+++++++.+.+  .+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--NLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--EEEEEEeCC
Confidence            469999999999999999999999999875421  12233445777788764 9999999999987654  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-cc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~  171 (708)
                      +||+|..++....   .+++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++..... ..
T Consensus        79 ~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05619          79 NGGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL----DTDGHIKIADFGMCKENMLGDA  151 (316)
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE----CCCCCEEEccCCcceECCCCCC
Confidence            9999999997643   28999999999999999999999999999999999998    6667899999999875322 22


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      ......||+.|+|||++.        +..++.++|+||+||++|+|++|..||..   .+..+....+....+       
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~~G~~pf~~---~~~~~~~~~i~~~~~-------  213 (316)
T cd05619         152 KTCTFCGTPDYIAPEILL--------GQKYNTSVDWWSFGVLLYEMLIGQSPFHG---HDEEELFQSIRMDNP-------  213 (316)
T ss_pred             ceeeecCCccccCHHHHc--------CCCCCchhhhhhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhCCC-------
Confidence            334567999999999987        67789999999999999999999999973   444444443332110       


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHH-HHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-RFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~-q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  .+|.  .++    ..+.+++.+||..||.+||++. ++           ..|||+..
T Consensus       214 ------------~~~~--~~~----~~~~~li~~~l~~~P~~R~~~~~~l-----------~~h~~~~~  253 (316)
T cd05619         214 ------------CYPR--WLT----REAKDILVKLFVREPERRLGVKGDI-----------RQHPFFRE  253 (316)
T ss_pred             ------------CCCc--cCC----HHHHHHHHHHhccCHhhcCCChHHH-----------HcCcccCC
Confidence                        1121  123    3456699999999999999986 44           56888755

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.1e-38  Score=343.45  Aligned_cols=261  Identities=24%  Similarity=0.362  Sum_probs=199.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|...+.||+|+||.||+|.+..+|+.||||++...........+.+|++++++++||||+++++++...+  .+|+||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~  151 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG--EIQVLL  151 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC--eEEEEE
Confidence            357788999999999999999999999999999865433333445679999999999999999999987644  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+.||+|....       ..++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.....
T Consensus       152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI----NSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE----cCCCCEEEcccccceeccc
Confidence            999999986532       15778889999999999999999999999999999998    6667899999999986543


Q ss_pred             c-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 D-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      . .......||..|+|||++.....   .+...+.++|||||||++|+|++|+.||...........+..+....     
T Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----  292 (353)
T PLN00034        221 TMDPCNSSVGTIAYMSPERINTDLN---HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-----  292 (353)
T ss_pred             ccccccccccCccccCccccccccc---cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-----
Confidence            3 22345679999999998752110   13345678999999999999999999997321111112222111110     


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                     ..    .....+...+.++|.+||..||++||++.++           +.|||+....
T Consensus       293 ---------------~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~el-----------l~hp~~~~~~  335 (353)
T PLN00034        293 ---------------PP----EAPATASREFRHFISCCLQREPAKRWSAMQL-----------LQHPFILRAQ  335 (353)
T ss_pred             ---------------CC----CCCCccCHHHHHHHHHHccCChhhCcCHHHH-----------hcCcccccCC
Confidence                           00    1112233456679999999999999999997           6699997753

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-38  Score=326.42  Aligned_cols=258  Identities=32%  Similarity=0.553  Sum_probs=203.9

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchH-HHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD-VQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~-~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      |++.+.||+|+||.||++.+..+++.||+|++.......... ...+|+.++++++||||+++++++....  ..++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN--YLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--EEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc--ccccccc
Confidence            789999999999999999999999999999997654322111 2246999999999999999999998744  5899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc-cc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EE  169 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~-~~  169 (708)
                      |+++++|.+++....   .+++..+..++.|++.||.+||++|++|+||||+||++    +..+.++|+|||.+... ..
T Consensus        79 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~----~~~~~~~l~Dfg~~~~~~~~  151 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL----DENGEVKLIDFGSSVKLSEN  151 (260)
T ss_dssp             EETTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE----STTSEEEESSGTTTEESTST
T ss_pred             ccccccccccccccc---cccccccccccccccccccccccccccccccccccccc----cccccccccccccccccccc
Confidence            999999999998322   28999999999999999999999999999999999998    67778999999999863 33


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      ........++..|+|||++..       +..++.++|+||+|+++|+|++|..||......+....+.........    
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~----  220 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQ-------GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP----  220 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTT-------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH----
T ss_pred             ccccccccccccccccccccc-------cccccccccccccccccccccccccccccccchhhhhhhhhccccccc----
Confidence            445556789999999999862       577899999999999999999999999843111223333322221100    


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                                       ............+.+++..||..||++||++.++           +.|||+
T Consensus       221 -----------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l-----------~~~~~~  260 (260)
T PF00069_consen  221 -----------------SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEEL-----------LKHPWF  260 (260)
T ss_dssp             -----------------HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHH-----------HTSGGG
T ss_pred             -----------------ccccccchhHHHHHHHHHHHccCChhHCcCHHHH-----------hcCCCC
Confidence                             0000011112567789999999999999999997           668885

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.8e-38  Score=337.90  Aligned_cols=252  Identities=31%  Similarity=0.409  Sum_probs=196.2

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHH-HHHhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFE-VLKKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~-iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+|+.||+|++......  ........|.. +++.++||||+++++++...+  ..|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~--~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--KLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC--EEEEEEcCC
Confidence            3699999999999999999999999998653221  12223345544 567789999999999987654  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-cc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~  171 (708)
                      +||+|..++....   .+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++..... ..
T Consensus        79 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll----~~~~~~kL~DfG~~~~~~~~~~  151 (325)
T cd05604          79 NGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL----DSQGHVVLTDFGLCKEGIAQSD  151 (325)
T ss_pred             CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE----CCCCCEEEeecCCcccCCCCCC
Confidence            9999998886543   38999999999999999999999999999999999998    6667899999999875432 22


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      .....+||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .+..+....+....        
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~~G~~pf~~---~~~~~~~~~~~~~~--------  212 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIR--------KQPYDNTVDWWCLGAVLYEMLYGLPPFYC---RDVAEMYDNILHKP--------  212 (325)
T ss_pred             CcccccCChhhCCHHHHc--------CCCCCCcCccccccceehhhhcCCCCCCC---CCHHHHHHHHHcCC--------
Confidence            334567999999999987        67788999999999999999999999973   44444444444311        


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                   +.    +.+..+..+.++|.+||+.||.+||++.+.+.+       .+.|||+..
T Consensus       213 -------------~~----~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~-------i~~h~~f~~  256 (325)
T cd05604         213 -------------LV----LRPGASLTAWSILEELLEKDRQRRLGAKEDFLE-------IQEHPFFES  256 (325)
T ss_pred             -------------cc----CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH-------HhcCCCcCC
Confidence                         11    111233445669999999999999998643322       367999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-37  Score=342.47  Aligned_cols=275  Identities=19%  Similarity=0.268  Sum_probs=201.4

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|....       ....+|+.++++++||||+++++++....  ..++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~lv  161 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNK--FTCLI  161 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECC--eeEEE
Confidence            3579999999999999999999999999999997532       23468999999999999999999987644  58999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||++ +++|..++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|....
T Consensus       162 ~e~~-~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll----~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        162 LPRY-KTDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI----NHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EecC-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE----cCCCCEEEEeCCcccccc
Confidence            9999 578988886643   38999999999999999999999999999999999998    666789999999997533


Q ss_pred             cc--ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC----ChhhHHHHHHhc
Q psy15481        169 ED--QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR----RNKETMYYITTK  242 (708)
Q Consensus       169 ~~--~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~----~~~e~~~~i~~~  242 (708)
                      ..  .......||+.|+|||++.        +..++.++|||||||++|+|+||..||....+.    .....+..+...
T Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~  305 (391)
T PHA03212        234 DINANKYYGWAGTIATNAPELLA--------RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR  305 (391)
T ss_pred             cccccccccccCccCCCChhhhc--------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence            22  2233467999999999987        567899999999999999999999887532211    112222222221


Q ss_pred             cc--CCccc-ccccCCCCc-----ccccC---CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        243 KA--SGVIS-GTQTSENGE-----IDWCT---DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       243 ~~--~~~i~-~~~~~~~g~-----~~~~~---~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      ..  +.... .........     ..+..   ..|.+..+ ..++..+.++|.+||..||.+|||+.++           
T Consensus       306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~Li~~mL~~dP~~Rpta~el-----------  373 (391)
T PHA03212        306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNL-YELPIDLEYLICKMLAFDAHHRPSAEAL-----------  373 (391)
T ss_pred             hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHH-hhhhhhHHHHHHHHhcCChhhCCCHHHH-----------
Confidence            10  00000 000000000     00000   00111111 1234567789999999999999999997           


Q ss_pred             hcCcccCCc
Q psy15481        312 LVHLFHINR  320 (708)
Q Consensus       312 l~h~~~~~~  320 (708)
                      +.|||+..-
T Consensus       374 L~hp~f~~~  382 (391)
T PHA03212        374 LDFAAFQDI  382 (391)
T ss_pred             hcChhhccC
Confidence            668998653

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.3e-38  Score=337.67  Aligned_cols=258  Identities=23%  Similarity=0.388  Sum_probs=197.2

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+++.||+|++......  .......+|+.++.++ +||||+.+++++...+  .+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--RLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--EEEEEEeCC
Confidence            4699999999999999999999999999754322  2233456888898888 6999999999987654  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc-ccc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~-~~~  171 (708)
                      +||+|..++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.... ...
T Consensus        79 ~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili----~~~~~~kl~Dfg~~~~~~~~~~  151 (327)
T cd05617          79 NGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL----DADGHIKLTDYGMCKEGLGPGD  151 (327)
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE----eCCCCEEEeccccceeccCCCC
Confidence            9999998886543   29999999999999999999999999999999999998    666779999999997532 233


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC---CChhhHHHHHHhcccCCcc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG---RRNKETMYYITTKKASGVI  248 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g---~~~~e~~~~i~~~~~~~~i  248 (708)
                      .....+||+.|+|||++.        +..++.++|||||||++|+|++|..||.....   ....+.........+    
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----  219 (327)
T cd05617         152 TTSTFCGTPNYIAPEILR--------GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----  219 (327)
T ss_pred             ceecccCCcccCCHHHHC--------CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----
Confidence            344567999999999987        67789999999999999999999999964322   122223333322110    


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                .    .+|.  .++    ..+.+++.+||..||.+|+++.+. ..    ......|||+..
T Consensus       220 ----------~----~~p~--~~~----~~~~~li~~~L~~dP~~R~~~~~~-~~----~~~i~~h~~f~~  265 (327)
T cd05617         220 ----------I----RIPR--FLS----VKASHVLKGFLNKDPKERLGCQPQ-TG----FSDIKSHTFFRS  265 (327)
T ss_pred             ----------C----CCCC--CCC----HHHHHHHHHHhccCHHHcCCCCCC-CC----HHHHHcCCCCCC
Confidence                      0    1121  233    345569999999999999985410 00    011267898855

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.7e-37  Score=340.67  Aligned_cols=263  Identities=23%  Similarity=0.379  Sum_probs=203.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ...|.+.+.||+|+||.||++.++.+++.||+|++.....  ......+.+|+.+++.++||||+++++++.+.  ...|
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~~  119 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYLY  119 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEEE
Confidence            3578999999999999999999999999999999864321  11233456899999999999999999998764  4599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++||+|.+++...    .+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++..
T Consensus       120 lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll----~~~~~ikL~DfG~a~~  191 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL----DKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE----CCCCCEEEEeCCceeE
Confidence            999999999999999653    28999999999999999999999999999999999998    6667899999999987


Q ss_pred             ccccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        167 LEEDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       167 ~~~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .....  .....+||+.|+|||++...    .....++.++|||||||++|+|++|.+||..   .+.......+.....
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~~---~~~~~~~~~i~~~~~  264 (371)
T cd05622         192 MNKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYA---DSLVGTYSKIMNHKN  264 (371)
T ss_pred             cCcCCcccccCcccCccccCHHHHhcc----CCCccCCCccceeehhHHHHHHHhCCCCCCC---CCHHHHHHHHHcCCC
Confidence            64332  22356799999999998631    1123478999999999999999999999973   444444444443211


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCccc--CCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKK--IWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~k--Rpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      .             .    .+|....++..    +.++|..||..+|.+  |++++++           +.|+|+.+.
T Consensus       265 ~-------------~----~~~~~~~~s~~----~~~li~~~L~~~~~r~~r~~~~ei-----------~~h~~~~~~  310 (371)
T cd05622         265 S-------------L----TFPDDNDISKE----AKNLICAFLTDREVRLGRNGVEEI-----------KRHLFFKND  310 (371)
T ss_pred             c-------------c----cCCCcCCCCHH----HHHHHHHHcCChhhhcCCCCHHHH-----------hcCcccCCC
Confidence            0             0    22333334444    455888999843433  6788886           568888653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-37  Score=323.13  Aligned_cols=256  Identities=21%  Similarity=0.337  Sum_probs=201.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc---CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      +..|.+.+.||+|+||.||+|.++   ..+..||+|.++..........+.+|+.++++++||||+++++++...+  ..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~   81 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN--TM   81 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC--Cc
Confidence            557999999999999999999765   4567899999876543333445678999999999999999999987644  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ++||||+++|+|.+++.....  .+++..++.++.|++.||+|||++|++||||||+||++    +.++.++++|||.+.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili----~~~~~~~l~dfg~~~  155 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV----NSDLVCKISGFRRLQ  155 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE----cCCCcEEECCCcccc
Confidence            999999999999999876432  38999999999999999999999999999999999998    666789999999887


Q ss_pred             ccccccccc--ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhc
Q psy15481        166 ELEEDQQFM--SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       166 ~~~~~~~~~--~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .........  ...++..|+|||.+.        +..++.++|||||||++|++++ |..||..   .+..+....+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~ell~~g~~p~~~---~~~~~~~~~~~~~  224 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAPEAIQ--------YHHFSSASDVWSFGIVMWEVMSYGERPYWD---MSGQDVIKAVEDG  224 (266)
T ss_pred             cccccchhcccCCCCceeecCHHHHh--------hCCccchhHHHHHHHHHHHHhcCCCCCcCc---CCHHHHHHHHHCC
Confidence            543322211  233567899999987        5778999999999999999775 9999973   3344444333321


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      .                    ..|.    +..++..+.+++..||..||.+||+++++++.+.++
T Consensus       225 ~--------------------~~~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 F--------------------RLPA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             C--------------------CCCC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            0                    1111    122334566799999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.9e-38  Score=335.91  Aligned_cols=252  Identities=29%  Similarity=0.424  Sum_probs=194.3

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHH-HHHHhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREF-EVLKKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei-~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+|+.||+|++......  ........|. .+++.++||||+++++++.+.+  ..|+||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEEEEcCC
Confidence            4699999999999999999999999998653221  1122233454 4678899999999999887654  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-cc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~  171 (708)
                      +||+|...+.....   +++..+..++.||+.||.|||++||+||||||+||++    +..+.+||+|||++..... ..
T Consensus        79 ~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~~~~~~~~~~  151 (321)
T cd05603          79 NGGELFFHLQRERC---FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL----DSQGHVVLTDFGLCKEGVEPEE  151 (321)
T ss_pred             CCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE----CCCCCEEEccCCCCccCCCCCC
Confidence            99999988865432   8999999999999999999999999999999999998    6677899999999875322 22


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      .....+||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .+.......+....        
T Consensus       152 ~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~g~~pf~~---~~~~~~~~~i~~~~--------  212 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLR--------KEPYDRTVDWWCLGAVLYEMLYGLPPFYS---RDVSQMYDNILHKP--------  212 (321)
T ss_pred             ccccccCCcccCCHHHhc--------CCCCCCcCcccccchhhhhhhcCCCCCCC---CCHHHHHHHHhcCC--------
Confidence            334467999999999986        56789999999999999999999999973   33333333333210        


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                   +    .+++.....+.+++.+||+.||.+||++..-+.       ..+.|+|+.+
T Consensus       213 -------------~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~-------~~~~~~~~~~  256 (321)
T cd05603         213 -------------L----QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFL-------EIKNHVFFSP  256 (321)
T ss_pred             -------------C----CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHH-------HHhCCCCcCC
Confidence                         0    112223345667999999999999998753222       1357888753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0589|consensus

Probab=100.00  E-value=1.4e-38  Score=345.57  Aligned_cols=253  Identities=24%  Similarity=0.366  Sum_probs=213.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..|..++.+|+|+||.++.++++..+..|++|.++-.... ........|+.+++++.|||||.+.++|...+ ...+||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEEEE
Confidence            3577889999999999999999999999999999755432 22335679999999999999999999998643 359999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |+||+||+|.+.+.... ..-++++.+..++.|++.|+.|||+++|+|||||+.|||+    .....|+|+|||+|+.+.
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl----tk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL----TKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc----cccCceeecchhhhhhcC
Confidence            99999999999998755 2239999999999999999999999999999999999997    444557999999999988


Q ss_pred             ccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 EDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      +.. ...+.+||+.|++||++.        +..|+.++|||||||++|||++-+++|.+   .+......+|....    
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~--------d~pYn~KSDiWsLGC~~yEm~~lk~aF~a---~~m~~Li~ki~~~~----  222 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILS--------DIPYNEKSDIWSLGCCLYEMCTLKPAFKA---SNMSELILKINRGL----  222 (426)
T ss_pred             CchhhhheecCCCcccCHHHhC--------CCCCCccCcchhhcchHHHHHhcccccCc---cchHHHHHHHhhcc----
Confidence            776 556789999999999998        89999999999999999999999999984   55556666666432    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                                          ..+++...+..+..+++.||..+|..||++.+++..
T Consensus       223 --------------------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 --------------------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --------------------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                                122344445556669999999999999999998664

>KOG0580|consensus

Probab=100.00  E-value=7.8e-39  Score=317.23  Aligned_cols=254  Identities=25%  Similarity=0.403  Sum_probs=214.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|.+++.||.|.||.||+|+.++++-.||+|++.+....  .......+|+++...|+||||.+++++|.+...  +|+
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r--iyL   99 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR--IYL   99 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce--eEE
Confidence            3688999999999999999999999999999998654211  112334699999999999999999999987654  999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ++||.++|+|+..|...... .+++.....++.|++.||.|+|.++++||||||+|+|+    +..+.+||+|||.+...
T Consensus       100 ilEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl----g~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL----GSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc----CCCCCeeccCCCceeec
Confidence            99999999999999864432 38999999999999999999999999999999999998    77778999999999854


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      . .....+.|||..|++||+..        +..++..+|+|++|++.||++.|.+||..   .+..++..+|.....   
T Consensus       175 p-~~kR~tlcgt~dyl~pEmv~--------~~~hd~~Vd~w~lgvl~yeflvg~ppFes---~~~~etYkrI~k~~~---  239 (281)
T KOG0580|consen  175 P-SNKRKTLCGTLDYLPPEMVE--------GRGHDKFVDLWSLGVLCYEFLVGLPPFES---QSHSETYKRIRKVDL---  239 (281)
T ss_pred             C-CCCceeeecccccCCHhhcC--------CCCccchhhHHHHHHHHHHHHhcCCchhh---hhhHHHHHHHHHccc---
Confidence            4 55667899999999999998        78899999999999999999999999983   445666666664211   


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                                      .+|  ..++.++.+    +|.+||..+|.+|.+..++           +.|||..
T Consensus       240 ----------------~~p--~~is~~a~d----lI~~ll~~~p~~r~~l~~v-----------~~hpwI~  277 (281)
T KOG0580|consen  240 ----------------KFP--STISGGAAD----LISRLLVKNPIERLALTEV-----------MDHPWIV  277 (281)
T ss_pred             ----------------cCC--cccChhHHH----HHHHHhccCccccccHHHH-----------hhhHHHH
Confidence                            223  446666655    8899999999999998886           6788864

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.5e-38  Score=344.56  Aligned_cols=280  Identities=23%  Similarity=0.361  Sum_probs=204.5

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCC---ceEEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG---RGKVI   87 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~---~~~~L   87 (708)
                      |++.+.||+|+||.||++.+..+|+.||+|.+..... ........+|+.+++.++||||+++++++...+.   ...|+
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            6788999999999999999999999999999864321 1223345789999999999999999999876541   25899


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||+. ++|...+....   .+++..++.++.||+.||.|||++|++||||||+|||+    +..+.+||+|||++...
T Consensus        82 v~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili----~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          82 VTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV----NSNCVLKICDFGLARVE  153 (372)
T ss_pred             Eeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE----CCCCCEEeccccceeec
Confidence            999995 78888886543   38999999999999999999999999999999999998    66778999999999865


Q ss_pred             cccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        168 EEDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       168 ~~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ....  ......+++.|+|||++..       ...++.++||||+||++|+|++|++||.+   .+....+..+......
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~---~~~~~~~~~i~~~~g~  223 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMG-------SRHYTSAVDIWSVGCIFAELLGRRILFQA---QSPIQQLDLITDLLGT  223 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcC-------CCCCCcHHHHHhHHHHHHHHHcCCCCCCC---CCHHHHHHHHHHHcCC
Confidence            4332  2234568999999999862       24578999999999999999999999974   3344444433321100


Q ss_pred             CcccccccCCCCcccc----cCCCC---CcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        246 GVISGTQTSENGEIDW----CTDLP---NNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~----~~~lp---~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      ...........+...+    ....|   ....++......+.++|.+||..||.+|||+.++           +.|||+.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~-----------l~hp~~~  292 (372)
T cd07853         224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA-----------LAHPYLD  292 (372)
T ss_pred             CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH-----------hcCHhhC
Confidence            0000000000000000    00000   0111223334566779999999999999999997           7799886


Q ss_pred             Cc
Q psy15481        319 NR  320 (708)
Q Consensus       319 ~~  320 (708)
                      ..
T Consensus       293 ~~  294 (372)
T cd07853         293 EG  294 (372)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.5e-37  Score=332.41  Aligned_cols=257  Identities=25%  Similarity=0.369  Sum_probs=199.9

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      |...+.||+|+||.||+|.++.+|+.||+|++.....  .........|..++..+. ||+|+++++++.+.+  .+|+|
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~lv   79 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD--RLYFV   79 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC--EEEEE
Confidence            6778999999999999999999999999999875422  122334567888888885 577888988887654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++||+|.+++.....   +++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++....
T Consensus        80 ~Ey~~~g~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill----~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML----DSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             EcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE----CCCCCEEEeccccccccC
Confidence            999999999999876443   8999999999999999999999999999999999998    666789999999987543


Q ss_pred             cc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 ED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      .. .......||+.|+|||++.        +..++.++|+||+||++|+|+||..||..   .........+.....   
T Consensus       153 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslGvil~elltG~~pf~~---~~~~~~~~~i~~~~~---  218 (323)
T cd05615         153 VDGVTTRTFCGTPDYIAPEIIA--------YQPYGKSVDWWAYGVLLYEMLAGQPPFDG---EDEDELFQSIMEHNV---  218 (323)
T ss_pred             CCCccccCccCCccccCHHHHc--------CCCCCCccchhhhHHHHHHHHhCCCCCCC---CCHHHHHHHHHhCCC---
Confidence            22 2234467999999999987        56789999999999999999999999973   444444444443210   


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                      .+|.  .++    ..+.+++.+||..||.+|++..+-      .......|||+..
T Consensus       219 ----------------~~p~--~~~----~~~~~li~~~l~~~p~~R~~~~~~------~~~~i~~h~~f~~  262 (323)
T cd05615         219 ----------------SYPK--SLS----KEAVSICKGLMTKHPSKRLGCGPE------GERDIREHAFFRR  262 (323)
T ss_pred             ----------------CCCc--cCC----HHHHHHHHHHcccCHhhCCCCCCC------CHHHHhcCcccCC
Confidence                            1121  233    345669999999999999985421      0111257888854

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.2e-37  Score=324.62  Aligned_cols=249  Identities=20%  Similarity=0.298  Sum_probs=197.7

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEe--cCCceEEEEEec
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEE--QEGRGKVIVMEL   91 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~--~~~~~~~LVmEy   91 (708)
                      ..||+|++|.||+|..  +|+.||+|.++.......  .+.+.+|+.++++++||||+++++++.+  .+....++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5799999999999987  689999999875432221  2445699999999999999999999876  444468999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      ++||+|.+++....   .+++.....++.+++.||.|||+. +++||||||+||++    +.++.+||+|||++......
T Consensus       104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill----~~~~~~kl~dfg~~~~~~~~  176 (283)
T PHA02988        104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV----TENYKLKIICHGLEKILSSP  176 (283)
T ss_pred             CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE----CCCCcEEEcccchHhhhccc
Confidence            99999999997643   388999999999999999999984 99999999999998    66778999999999865432


Q ss_pred             ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccc
Q psy15481        171 QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISG  250 (708)
Q Consensus       171 ~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~  250 (708)
                      .  ....|+..|+|||++...      ...++.++|||||||++|+|++|..||..   .+..+....+.....+     
T Consensus       177 ~--~~~~~~~~y~aPE~~~~~------~~~~~~k~Di~SlGvil~el~~g~~Pf~~---~~~~~~~~~i~~~~~~-----  240 (283)
T PHA02988        177 P--FKNVNFMVYFSYKMLNDI------FSEYTIKDDIYSLGVVLWEIFTGKIPFEN---LTTKEIYDLIINKNNS-----  240 (283)
T ss_pred             c--ccccCcccccCHHHhhhc------cccccchhhhhHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHhcCCC-----
Confidence            2  345689999999998631      25789999999999999999999999973   4444444444322110     


Q ss_pred             cccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        251 TQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       251 ~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                  ..+|      ...+..+.+++.+||+.||.+|||+.+++..+...
T Consensus       241 ------------~~~~------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        241 ------------LKLP------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             ------------CCCC------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence                        0112      12344566799999999999999999998876644

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.3e-37  Score=334.29  Aligned_cols=200  Identities=29%  Similarity=0.461  Sum_probs=172.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|++.+.||+|+||.||++.+..+|..+|+|.+...........+.+|+++++.++||||+++++++.+.+  ..|+|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--EEEEE
Confidence            3578899999999999999999999999999999875433333345679999999999999999999998754  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||++|++|.+++.....   +++..+..++.+++.||.|||++ +++||||||+|||+    +..+.+||+|||++...
T Consensus        82 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili----~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE----cCCCCEEEeeCCcchhh
Confidence            999999999999976432   89999999999999999999985 79999999999998    66667999999999765


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCC
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP  226 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~  226 (708)
                      ... ......|+..|+|||++.        +..++.++|+|||||++|+|++|..||.+
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         155 IDS-MANSFVGTRSYMSPERLQ--------GTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hhh-ccccCCCCccccCHHHhc--------CCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            332 223457899999999986        56788999999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.3e-37  Score=326.31  Aligned_cols=258  Identities=23%  Similarity=0.369  Sum_probs=202.4

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      |++.+.||+|+||.||++.+..+++.||+|.+........  .....+|+.++++++|+||+.+++.+.+.+  ..|+||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~   79 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLVL   79 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--EEEEEE
Confidence            6778999999999999999999999999999865432221  233468999999999999999999887644  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++|++|.+++..... ..+++..+..++.|++.||.|||+.||+||||||+||++    +..+.++|+|||++.....
T Consensus        80 e~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~----~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          80 TLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL----DDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             EecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE----CCCCCEEEeeccceeecCC
Confidence            99999999998854322 238999999999999999999999999999999999998    6667799999999986655


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      ........|+..|+|||++.        +..++.++|+||+||++|+|++|..||.........+..........     
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-----  221 (285)
T cd05630         155 GQTIKGRVGTVGYMAPEVVK--------NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-----  221 (285)
T ss_pred             CccccCCCCCccccChHHHc--------CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-----
Confidence            54445567999999999987        56789999999999999999999999974221111222222211100     


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                   ..      .+......+.+++.+||..||.+|||     ++++           +.|||+..
T Consensus       222 -------------~~------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~-----------~~h~~~~~  266 (285)
T cd05630         222 -------------EE------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREV-----------KEHPLFKQ  266 (285)
T ss_pred             -------------hh------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHH-----------HcChhhhc
Confidence                         01      11222344667999999999999999     6776           56888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG4721|consensus

Probab=100.00  E-value=1.3e-38  Score=344.25  Aligned_cols=237  Identities=29%  Similarity=0.518  Sum_probs=199.1

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCC
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~gg   95 (708)
                      +-||+|+-|.||+|+-.  ++.||||.++..        ...+|.-|++|+||||+.+.++|....  .+|||||||+.|
T Consensus       130 eWlGSGaQGAVF~Grl~--netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsP--cyCIiMEfCa~G  197 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH--NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSP--CYCIIMEFCAQG  197 (904)
T ss_pred             hhhccCcccceeeeecc--CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCc--eeEEeeeccccc
Confidence            45899999999999765  889999987632        236888999999999999999997654  599999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccccc
Q psy15481         96 SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS  175 (708)
Q Consensus        96 sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~~  175 (708)
                      -|..+|+....   ++...+..+..+|+.||+|||.+.|||||||.-||||    ....+|||+|||.++...+-.+..+
T Consensus       198 qL~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI----s~~d~VKIsDFGTS~e~~~~STkMS  270 (904)
T KOG4721|consen  198 QLYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI----SYDDVVKISDFGTSKELSDKSTKMS  270 (904)
T ss_pred             cHHHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe----eccceEEeccccchHhhhhhhhhhh
Confidence            99999988654   8999999999999999999999999999999999998    5556899999999999888888889


Q ss_pred             cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCC
Q psy15481        176 LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSE  255 (708)
Q Consensus       176 ~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~  255 (708)
                      ++||..|||||++.        +...+.++|||||||+||||+||..||...+      .+         .+|.|+-.  
T Consensus       271 FaGTVaWMAPEvIr--------nePcsEKVDIwSfGVVLWEmLT~EiPYkdVd------ss---------AIIwGVGs--  325 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIR--------NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD------SS---------AIIWGVGS--  325 (904)
T ss_pred             hhhhHhhhCHHHhh--------cCCcccccceehhHHHHHHHHhcCCCccccc------hh---------eeEEeccC--
Confidence            99999999999998        7888999999999999999999999997321      11         12222211  


Q ss_pred             CCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        256 NGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       256 ~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                           -+..+|-+...+++++-    |++.||.-.|..||||.+++.+++
T Consensus       326 -----NsL~LpvPstcP~Gfkl----L~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  326 -----NSLHLPVPSTCPDGFKL----LLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             -----CcccccCcccCchHHHH----HHHHHHhcCCCCCccHHHHHHHHh
Confidence                 12245555555566655    889999999999999999866643

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-37  Score=350.81  Aligned_cols=252  Identities=26%  Similarity=0.410  Sum_probs=202.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCC-CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNN-GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~t-g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ........+|+.+++.++||||+++++++...+  ..|+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDD--KLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC--EEEE
Confidence            44699999999999999999998877 7889999764332 222344568999999999999999999987654  5999


Q ss_pred             EEeccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         88 VMELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ||||++||+|.+++... .....+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++..
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL----MPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE----CCCCcEEEEeCcCcee
Confidence            99999999999887542 122348999999999999999999999999999999999998    6677899999999987


Q ss_pred             cccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        167 LEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       167 ~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ......   ....+||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +.+..+.+..+....
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~el~tg~~Pf~---~~~~~~~~~~~~~~~  287 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWE--------RKRYSKKADMWSLGVILYELLTLHRPFK---GPSQREIMQQVLYGK  287 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhC--------CCCCCcHHhHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHhCC
Confidence            644321   23457999999999987        5778999999999999999999999997   345555565555321


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      .                    .|.++.+++    .+.++|.+||..||++||++.+++.
T Consensus       288 ~--------------------~~~~~~~s~----~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        288 Y--------------------DPFPCPVSS----GMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             C--------------------CCCCccCCH----HHHHHHHHHhccChhhCcCHHHHHh
Confidence            1                    112223444    4566999999999999999998754

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.7e-37  Score=327.00  Aligned_cols=261  Identities=20%  Similarity=0.258  Sum_probs=194.6

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcC----------------CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKN----------------NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL   73 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~----------------tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl   73 (708)
                      .+|.+.+.||+|+||.||+|.+..                ++..||+|.+...........+.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            478899999999999999997532                3457999998754333333456789999999999999999


Q ss_pred             eEEEEecCCceEEEEEeccCCCCHHHHhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q psy15481         74 LAIEEEQEGRGKVIVMELCTGGSLFNILDDPE----------------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR  137 (708)
Q Consensus        74 ~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~----------------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHr  137 (708)
                      ++++.+.+  ..++||||+++|+|.+++....                ....+++..+..++.||+.||.|||+.||+||
T Consensus        85 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~  162 (304)
T cd05096          85 LGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR  162 (304)
T ss_pred             EEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99987654  4899999999999999886421                11236788999999999999999999999999


Q ss_pred             CCCCCcEEEEEecCCCceEEEeccCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHH
Q psy15481        138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTL  214 (708)
Q Consensus       138 DIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviL  214 (708)
                      ||||+|||+    +..+.+||+|||++.........   ....++..|+|||++.        +..++.++|||||||++
T Consensus       163 dlkp~Nill----~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~~l  230 (304)
T cd05096         163 DLATRNCLV----GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL--------MGKFTTASDVWAFGVTL  230 (304)
T ss_pred             CcchhheEE----cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh--------cCCCCchhhhHHHHHHH
Confidence            999999998    66678999999999865443221   2234578899999986        56689999999999999


Q ss_pred             HHHhc--CCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcc
Q psy15481        215 YHVAT--GNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSK  292 (708)
Q Consensus       215 yeLlT--G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~  292 (708)
                      |+|++  |..||..   .+..+.+..+.......          ....+. ..|      +.++..+.+++..||..||+
T Consensus       231 ~el~~~~~~~p~~~---~~~~~~~~~~~~~~~~~----------~~~~~~-~~~------~~~~~~~~~li~~cl~~~p~  290 (304)
T cd05096         231 WEILMLCKEQPYGE---LTDEQVIENAGEFFRDQ----------GRQVYL-FRP------PPCPQGLYELMLQCWSRDCR  290 (304)
T ss_pred             HHHHHccCCCCCCc---CCHHHHHHHHHHHhhhc----------cccccc-cCC------CCCCHHHHHHHHHHccCCch
Confidence            99987  5667763   33333333222100000          000000 011      12234566799999999999


Q ss_pred             cCCCHHHHHHHH
Q psy15481        293 KIWSFERFFSEV  304 (708)
Q Consensus       293 kRpsa~q~~~~l  304 (708)
                      +|||+.++...+
T Consensus       291 ~RPs~~~i~~~l  302 (304)
T cd05096         291 ERPSFSDIHAFL  302 (304)
T ss_pred             hCcCHHHHHHHH
Confidence            999999986654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.9e-37  Score=350.35  Aligned_cols=279  Identities=20%  Similarity=0.326  Sum_probs=198.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCC------CCccceeEEEEecCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH------ENIVKLLAIEEEQEG   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~H------pNIVkl~~v~~~~~~   82 (708)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||+++....  .......|+.+++.+.|      ++++.+++++... .
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~  204 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-T  204 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-C
Confidence            4679999999999999999999999999999999864321  12233467777777754      4588888888654 3


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCC---------
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDG---------  152 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~---------  152 (708)
                      ..+|+||+++ |++|.+++....   .+++..++.++.||+.||.|||+ .|||||||||+|||+  ..++         
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl--~~~~~~~~~~~~~  278 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILM--ETSDTVVDPVTNR  278 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE--ecCCccccccccc
Confidence            4689999999 788988886543   38999999999999999999998 599999999999997  2222         


Q ss_pred             -----CceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCC
Q psy15481        153 -----STIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY  227 (708)
Q Consensus       153 -----~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~  227 (708)
                           ...+||+|||.+....  ......+||+.|+|||++.        +..|+.++|||||||++|||++|++||.+ 
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~--------~~~~~~~~DiwSlGvil~elltG~~pf~~-  347 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVL--------GLGWMYSTDMWSMGCIIYELYTGKLLYDT-  347 (467)
T ss_pred             ccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhh--------cCCCCcHHHHHHHHHHHHHHHhCCCCCCC-
Confidence                 2359999999886432  2234568999999999997        67899999999999999999999999974 


Q ss_pred             CCCChhhHHHHHHhcc--cCCccccccc--------CCCCcccccCC------CCCcccCC-hhHHHHHHHHHHhhcccC
Q psy15481        228 GGRRNKETMYYITTKK--ASGVISGTQT--------SENGEIDWCTD------LPNNCQLS-LGLKKLVTPILAGLLEVD  290 (708)
Q Consensus       228 ~g~~~~e~~~~i~~~~--~~~~i~~~~~--------~~~g~~~~~~~------lp~~~~ls-~~l~~~l~~LL~~mL~~D  290 (708)
                        .++.+.+..+....  .+..+.+...        ...+.......      +.....+. ......+.+||.+||.+|
T Consensus       348 --~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  425 (467)
T PTZ00284        348 --HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD  425 (467)
T ss_pred             --CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence              44445444433211  0000000000        00000000000      00000000 011345778999999999


Q ss_pred             cccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        291 SKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       291 P~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      |.+|||++++           +.|||+..-
T Consensus       426 P~~R~ta~e~-----------L~Hp~~~~~  444 (467)
T PTZ00284        426 RQKRLNARQM-----------TTHPYVLKY  444 (467)
T ss_pred             hhhCCCHHHH-----------hcCcccccc
Confidence            9999999997           679999763

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=317.78  Aligned_cols=247  Identities=28%  Similarity=0.406  Sum_probs=197.3

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC----chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR----PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~----~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .|.+.+.||+|++|.||.|.+..+|+.||+|.+.......    ......+|+.++++++||||+++++++.+..  ..+
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~   80 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE--TLS   80 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC--eEE
Confidence            4888999999999999999999999999999986442211    1234568999999999999999999997654  699


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++|++|.+.+.....   +++..+..++.+++.||.|||+.|++||||+|+||++    +..+.++|+|||.+..
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv----~~~~~~~l~dfg~~~~  153 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR----DSAGNVKLGDFGASKR  153 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEeeccccee
Confidence            99999999999999876443   8999999999999999999999999999999999998    5566799999999976


Q ss_pred             ccccccc----cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        167 LEEDQQF----MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       167 ~~~~~~~----~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .......    ....|+..|+|||.+.        +..++.++|||||||++|++++|..||..   .+.......+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~g~~p~~~---~~~~~~~~~~~~~  222 (263)
T cd06625         154 LQTICSSGTGMKSVTGTPYWMSPEVIS--------GEGYGRKADVWSVGCTVVEMLTEKPPWAE---FEAMAAIFKIATQ  222 (263)
T ss_pred             ccccccccccccCCCcCccccCcceec--------cCCCCchhhhHHHHHHHHHHHhCCCCccc---cchHHHHHHHhcc
Confidence            5432211    2356888999999987        56688999999999999999999999973   2333333332211


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      .                       ....++......+.+++.+||..||.+||++.++
T Consensus       223 ~-----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  257 (263)
T cd06625         223 P-----------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEEL  257 (263)
T ss_pred             C-----------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            0                       0011222334456679999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-38  Score=338.59  Aligned_cols=278  Identities=24%  Similarity=0.372  Sum_probs=205.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecC----Cc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQE----GR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~----~~   83 (708)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|.+...... .......+|+.++++++||||+++++++....    ..
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            45788999999999999999999999999999998653221 22334568999999999999999999875332    13


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|++|+++ |++|..++...    .+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~----~~~~~~kl~Dfg~  164 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV----NEDCELRILDFGL  164 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE----CCCCCEEEcCCcc
Confidence            478999998 89999888643    28999999999999999999999999999999999998    6667899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc-
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK-  242 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~-  242 (708)
                      +......  .....||+.|+|||++..       ...++.++|||||||++|+|++|..||.+   .+..+.+..+... 
T Consensus       165 ~~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~---~~~~~~~~~~~~~~  232 (343)
T cd07878         165 ARQADDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLKGKALFPG---NDYIDQLKRIMEVV  232 (343)
T ss_pred             ceecCCC--cCCccccccccCchHhcC-------CccCCchhhhHhHHHHHHHHHHCCCCCCC---CCHHHHHHHHHHHh
Confidence            9865433  345679999999999862       35688999999999999999999999974   3333334333321 


Q ss_pred             --ccCCcccccccCCCCcccccCCCCCccc-----CChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCc
Q psy15481        243 --KASGVISGTQTSENGEIDWCTDLPNNCQ-----LSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHL  315 (708)
Q Consensus       243 --~~~~~i~~~~~~~~g~~~~~~~lp~~~~-----ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~  315 (708)
                        ........+..  .....+...+|....     +..+....+.++|.+||..||.+|||+.++           +.||
T Consensus       233 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el-----------l~hp  299 (343)
T cd07878         233 GTPSPEVLKKISS--EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA-----------LAHP  299 (343)
T ss_pred             CCCCHHHHHhcch--hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH-----------hcCc
Confidence              11110000000  000011111111110     111223456789999999999999999997           6689


Q ss_pred             ccCCc
Q psy15481        316 FHINR  320 (708)
Q Consensus       316 ~~~~~  320 (708)
                      |+...
T Consensus       300 ~~~~~  304 (343)
T cd07878         300 YFSQY  304 (343)
T ss_pred             chhcc
Confidence            88653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.7e-37  Score=323.13  Aligned_cols=259  Identities=25%  Similarity=0.385  Sum_probs=202.5

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      |...+.||+|+||.||+|.+..+|+.||+|.+.......  ......+|+.+++.++|+||+.+.+.+...+  ..++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~   79 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD--ALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--EEEEEE
Confidence            677899999999999999999999999999986543221  1233568999999999999999998887644  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++++|..++....+ ..+++..+..++.|++.||.|||++||+||||||+||++    +..+.++|+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili----~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          80 TIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL----DDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             EeccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE----CCCCCEEEecCCcceecCC
Confidence            99999999988865332 239999999999999999999999999999999999998    6667899999999976654


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      ........|+..|+|||.+.        +..++.++|+||+||++|+|++|..||..   ..+......+.......   
T Consensus       155 ~~~~~~~~g~~~~~aPE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~P~~~---~~~~~~~~~~~~~~~~~---  220 (285)
T cd05632         155 GESIRGRVGTVGYMAPEVLN--------NQRYTLSPDYWGLGCLIYEMIEGQSPFRG---RKEKVKREEVDRRVLET---  220 (285)
T ss_pred             CCcccCCCCCcCccChHHhc--------CCCCCcccchHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHhhhcc---
Confidence            44445567999999999986        56789999999999999999999999973   33333222222211100   


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                              .          ...++.++..+.+++.+||..||++||+     +.++           +.|+|+..-
T Consensus       221 --------~----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l-----------~~~~~~~~~  267 (285)
T cd05632         221 --------E----------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEV-----------KRHPFFRNM  267 (285)
T ss_pred             --------c----------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHH-----------HcChhhhcC
Confidence                    0          0112223445667999999999999999     5554           567777553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.2e-37  Score=329.83  Aligned_cols=201  Identities=22%  Similarity=0.362  Sum_probs=163.3

Q ss_pred             eeEeecCCceEEEEEEEcC--CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         15 TSVLGKGATGAVFQGVNKN--NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~--tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +..||+|+||.||+|.++.  ++..||+|.+.....   .....+|+.++++++||||+++++++........|+||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            4689999999999999754  668999999864321   23456899999999999999999998766666799999999


Q ss_pred             CCCCHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         93 TGGSLFNILDDP------ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        93 ~ggsL~~~L~~~------~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      . ++|.+++...      .....+++..++.++.||+.||.|||++||+||||||+|||+....+..+.+||+|||+++.
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            5 6887776421      11223899999999999999999999999999999999999733334567899999999986


Q ss_pred             ccccc----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCC
Q psy15481        167 LEEDQ----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP  226 (708)
Q Consensus       167 ~~~~~----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~  226 (708)
                      .....    ......||+.|+|||++..       ...++.++|||||||++|+|+||.+||..
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcC-------CCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            54332    2234578999999999862       35688999999999999999999999964

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0604|consensus

Probab=100.00  E-value=2.8e-38  Score=321.21  Aligned_cols=261  Identities=28%  Similarity=0.421  Sum_probs=212.6

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEe--cCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEE--QEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~--~~~~~~~LVmEy~   92 (708)
                      .+||-|-.|.|-.+.++.||+.+|+|++..      .....+|+++--.. .|||||.++++++.  .+..++.+|||.+
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLD------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhc------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            689999999999999999999999999753      23345888876555 79999999999864  2345688999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ  172 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~  172 (708)
                      +||.|++.+.+... ..++|.++..|++||+.|+.|||+.+|.||||||+|+|. .+...+..+||+|||+|........
T Consensus       142 eGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLy-t~t~~na~lKLtDfGFAK~t~~~~~  219 (400)
T KOG0604|consen  142 EGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLY-TTTSPNAPLKLTDFGFAKETQEPGD  219 (400)
T ss_pred             cchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheee-ecCCCCcceEecccccccccCCCcc
Confidence            99999999987553 459999999999999999999999999999999999996 5566678999999999998887777


Q ss_pred             ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH-HHHhcccCCccccc
Q psy15481        173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY-YITTKKASGVISGT  251 (708)
Q Consensus       173 ~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~-~i~~~~~~~~i~~~  251 (708)
                      ..+.+.||.|.|||++.        ...|+..+|+||+||++|-|++|.+||....|..-..-|. +|..          
T Consensus       220 L~TPc~TPyYvaPevlg--------~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~----------  281 (400)
T KOG0604|consen  220 LMTPCFTPYYVAPEVLG--------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT----------  281 (400)
T ss_pred             ccCCcccccccCHHHhC--------chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc----------
Confidence            88899999999999987        4669999999999999999999999998655533222222 2222          


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccccc
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCI  324 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~~  324 (708)
                           |.++|..  |.|..+|...    .++|+++|..+|.+|.|.+++           +.|||..+....-
T Consensus       282 -----gqy~FP~--pEWs~VSe~a----KdlIR~LLkt~PteRlTI~~~-----------m~hpwi~~~~~vp  332 (400)
T KOG0604|consen  282 -----GQYEFPE--PEWSCVSEAA----KDLIRKLLKTEPTERLTIEEV-----------MDHPWINQYEAVP  332 (400)
T ss_pred             -----cCccCCC--hhHhHHHHHH----HHHHHHHhcCCchhheeHHHh-----------hcCchhcccccCC
Confidence                 3333322  4455555554    458999999999999999998           7799987765443

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-37  Score=330.74  Aligned_cols=263  Identities=25%  Similarity=0.368  Sum_probs=200.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||++.+..+++.||+|++++...  ......+.+|+.++..++||||+++++++.+.+  .+|+|
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv   79 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN--NLYLV   79 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC--eEEEE
Confidence            58899999999999999999999999999999874221  122334568999999999999999999987654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++||+|.+++.....  .+++..++.++.||+.||+|||++||+||||||+|||+    +..+.+||+|||++....
T Consensus        80 ~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          80 MDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL----DKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             EecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE----CCCCCEEEEECCceeecC
Confidence            999999999999975322  38999999999999999999999999999999999998    666789999999997654


Q ss_pred             ccccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        169 EDQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       169 ~~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      .....  ....||+.|+|||++.....   ....++.++||||+||++|+|++|..||..   .+..+....+...... 
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~~l~el~~g~~Pf~~---~~~~~~~~~i~~~~~~-  226 (331)
T cd05597         154 ADGTVQSNVAVGTPDYISPEILQAMED---GKGRYGPECDWWSLGVCMYEMLYGETPFYA---ESLVETYGKIMNHKEH-  226 (331)
T ss_pred             CCCCccccceeccccccCHHHHhhccc---cccCCCCcceeehhhhHHHHHhhCCCCCCC---CCHHHHHHHHHcCCCc-
Confidence            43322  22469999999999863110   024578899999999999999999999973   4444444444432110 


Q ss_pred             cccccccCCCCcccccCCCCC-cccCChhHHHHHHHHHHhhcccCccc--CCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPN-NCQLSLGLKKLVTPILAGLLEVDSKK--IWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~-~~~ls~~l~~~l~~LL~~mL~~DP~k--Rpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  .    .+|. ...+++.    +.+++++||..++++  |+++.++           +.|||+..
T Consensus       227 ------------~----~~~~~~~~~~~~----~~~li~~ll~~~~~r~~r~~~~~~-----------l~hp~~~~  271 (331)
T cd05597         227 ------------F----QFPPDVTDVSEE----AKDLIRRLICSPETRLGRNGLQDF-----------KDHPFFEG  271 (331)
T ss_pred             ------------c----cCCCccCCCCHH----HHHHHHHHccCcccccCCCCHHHH-----------hcCCCCCC
Confidence                        0    1111 1123444    455777877654443  7898887           77999854

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.4e-37  Score=349.80  Aligned_cols=257  Identities=24%  Similarity=0.363  Sum_probs=203.7

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCC---
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG---   82 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~---   82 (708)
                      ....+|.+.+.||+|+||.||+|.+..+|+.||||++...... .......+|+..+..++|+||+++++.+.....   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3457999999999999999999999999999999998754332 222345689999999999999999887653321   


Q ss_pred             ---ceEEEEEeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEE
Q psy15481         83 ---RGKVIVMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKL  158 (708)
Q Consensus        83 ---~~~~LVmEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL  158 (708)
                         ..+++||||+++|+|.+++.... ....+++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl----~~~~~vkL  184 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL----CSNGLVKL  184 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE----eCCCCEEE
Confidence               13689999999999999886532 22348999999999999999999999999999999999998    66678999


Q ss_pred             eccCcccccccc---ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhH
Q psy15481        159 TDFGAARELEED---QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKET  235 (708)
Q Consensus       159 ~DFGlA~~~~~~---~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~  235 (708)
                      +|||+++.....   ......+||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +.+..+.
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--------~~~~s~k~DVwSlGvilyeLltG~~Pf~---~~~~~~~  253 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR--------RKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEEV  253 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhC--------CCCCCcHHHHHHHHHHHHHHHHCCCCCC---CCCHHHH
Confidence            999999765432   1223467999999999987        6778999999999999999999999997   3444555


Q ss_pred             HHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        236 MYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       236 ~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      +..+.....                    .|    +++.++..+.+++.+||..||.+||++.+++.
T Consensus       254 ~~~~~~~~~--------------------~~----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        254 MHKTLAGRY--------------------DP----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             HHHHhcCCC--------------------CC----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            554443211                    01    12223445667999999999999999999744

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1e-36  Score=314.18  Aligned_cols=250  Identities=24%  Similarity=0.388  Sum_probs=200.6

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|++.+.||.|+||.||++.+..++..||+|.++........+...+|+.+++.++||||+++++.+.+.+  .+|+|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG--HLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEEEEe
Confidence            47889999999999999999999999999999875444444455678999999999999999999987654  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||++    +..+.++|+|||.+......
T Consensus        79 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili----~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          79 YCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL----TQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             eCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE----CCCCcEEEcccCcceeeccc
Confidence            9999999998865322 238999999999999999999999999999999999998    66677999999999866443


Q ss_pred             cc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        171 QQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       171 ~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      .. .....|++.|+|||++.        +..++.++|+||||+++|+|++|..||..   .+.......+....      
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~---~~~~~~~~~~~~~~------  216 (255)
T cd08219         154 GAYACTYVGTPYYVPPEIWE--------NMPYNNKSDIWSLGCILYELCTLKHPFQA---NSWKNLILKVCQGS------  216 (255)
T ss_pred             ccccccccCCccccCHHHHc--------cCCcCchhhhhhhchhheehhhccCCCCC---CCHHHHHHHHhcCC------
Confidence            22 23456899999999987        56688999999999999999999999973   33333333332210      


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                                     .+   .++..++..+.+++.+||..||.+||++.+++.
T Consensus       217 ---------------~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  251 (255)
T cd08219         217 ---------------YK---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILS  251 (255)
T ss_pred             ---------------CC---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence                           00   012223345677999999999999999999755

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.9e-37  Score=320.62  Aligned_cols=277  Identities=19%  Similarity=0.340  Sum_probs=203.5

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      |.+.+.||+|+||.||+|.+..+++.||+|.++............+|+.+++++ +||||+++++++.+...+..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            678899999999999999999999999999987543322223345788899988 4999999999998765457999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+. ++|.+.+.....  .+++..+..++.|++.||.|||++|++||||+|+||++    +. +.+||+|||.+......
T Consensus        81 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l----~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGRKR--PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE----cC-CCeEEEecccccccccC
Confidence            996 588887765332  38999999999999999999999999999999999998    54 78999999999877655


Q ss_pred             ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc---ccCCc
Q psy15481        171 QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK---KASGV  247 (708)
Q Consensus       171 ~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~---~~~~~  247 (708)
                      .......++..|+|||.+..       +..++.++|+||+||++|+|++|.+||.+   .+..+....+...   .....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~el~~~~~p~~~---~~~~~~~~~~~~~~~~~~~~~  222 (282)
T cd07831         153 PPYTEYISTRWYRAPECLLT-------DGYYGPKMDIWAVGCVFFEILSLFPLFPG---TNELDQIAKIHDVLGTPDAEV  222 (282)
T ss_pred             CCcCCCCCCcccCChhHhhc-------CCCCCcchhHHHHHHHHHHHHcCCcCCCC---CCHHHHHHHHHHHcCCCCHHH
Confidence            55555678999999998752       45578899999999999999999999974   3333333332211   11000


Q ss_pred             ccccccCCCCcccccCCCCC-cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        248 ISGTQTSENGEIDWCTDLPN-NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~-~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .............|....+. ...+.+..+..+.+++.+||..||++||++.++           +.|||+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~-----------l~~~~~  282 (282)
T cd07831         223 LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA-----------LRHPYF  282 (282)
T ss_pred             HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHH-----------hhCCCC
Confidence            00000000011111111110 011122345667789999999999999999997           667875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=334.40  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=191.3

Q ss_pred             eecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhC---CCCCccceeEEEEecCCceEEEEEecc
Q psy15481         18 LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKV---KHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        18 LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL---~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      ||+|+||.||+|.+..+|+.||+|++.......  .......|..++..+   +||||+++++++...+  .+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--DLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--eEEEEEcCC
Confidence            799999999999999999999999986432111  112234566666655   7999999999987654  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-cc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQ  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~  171 (708)
                      +||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.++|+|||++..... ..
T Consensus        79 ~~g~L~~~l~~~~~---~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili----~~~~~~kl~Dfg~a~~~~~~~~  151 (330)
T cd05586          79 SGGELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL----DATGHIALCDFGLSKANLTDNK  151 (330)
T ss_pred             CCChHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE----CCCCCEEEecCCcCcCCCCCCC
Confidence            99999998876433   8999999999999999999999999999999999998    6667899999999875432 22


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      .....+||+.|+|||++..       ...++.++|||||||++|+|+||..||..   ....+.+..+.....       
T Consensus       152 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~-------  214 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLD-------EKGYTKHVDFWSLGVLVFEMCCGWSPFYA---EDTQQMYRNIAFGKV-------  214 (330)
T ss_pred             CccCccCCccccCHHHHcC-------CCCCCCccceeccccEEEEeccCCCCCCC---CCHHHHHHHHHcCCC-------
Confidence            3345679999999999862       34578999999999999999999999973   333343333332110       


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC----HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS----FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps----a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  .+|. ..++    ..+.+++.+||..||.+||+    +.++           +.|||+..
T Consensus       215 ------------~~~~-~~~~----~~~~~li~~~L~~~P~~R~~~~~~~~~l-----------l~h~~~~~  258 (330)
T cd05586         215 ------------RFPK-NVLS----DEGRQFVKGLLNRNPQHRLGAHRDAVEL-----------KEHPFFAD  258 (330)
T ss_pred             ------------CCCC-ccCC----HHHHHHHHHHcCCCHHHCCCCCCCHHHH-----------hcCccccC
Confidence                        1121 1133    34556999999999999995    4554           56888865

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.3e-36  Score=322.25  Aligned_cols=262  Identities=26%  Similarity=0.440  Sum_probs=208.6

Q ss_pred             ccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         4 l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      -.|+....|.+.+.||+|++|.||+|.+..+|+.||+|.+...... ..+...+|+.+++.++||||+++++.+....  
T Consensus        14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~--   90 (296)
T cd06654          14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGD--   90 (296)
T ss_pred             ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC--
Confidence            3577888999999999999999999999999999999998754332 2455678999999999999999999987643  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||++|++|.+++....    +++.++..++.|++.||.|||+.||+||||||+||++    +..+.++|+|||.
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill----~~~~~~kl~dfg~  162 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL----GMDGSVKLTDFGF  162 (296)
T ss_pred             EEEEeecccCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----cCCCCEEECcccc
Confidence            5999999999999999986532    7899999999999999999999999999999999998    5566899999999


Q ss_pred             ccccccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        164 ARELEEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       164 A~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      +........ .....|++.|+|||.+.        +..++.++|+|||||++|+|++|..||..   .........+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~---~~~~~~~~~~~~~  231 (296)
T cd06654         163 CAQITPEQSKRSTMVGTPYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLN---ENPLRALYLIATN  231 (296)
T ss_pred             chhccccccccCcccCCccccCHHHHc--------CCCCCccchHHHHHHHHHHHHhCCCCCCC---CCHHHhHHHHhcC
Confidence            886543322 23457899999999987        56678999999999999999999999973   2222222222210


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ..                  ..++.    +..+...+.+++.+||..||++||++.++           +.|+|+...
T Consensus       232 ~~------------------~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~ei-----------l~~~~~~~~  276 (296)
T cd06654         232 GT------------------PELQN----PEKLSAIFRDFLNRCLDMDVEKRGSAKEL-----------LQHQFLKIA  276 (296)
T ss_pred             CC------------------CCCCC----ccccCHHHHHHHHHHCcCCcccCcCHHHH-----------hhChhhhcc
Confidence            00                  01111    22334456779999999999999999997           557877543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.7e-37  Score=326.46  Aligned_cols=262  Identities=24%  Similarity=0.338  Sum_probs=205.1

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCce----EEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecC
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE   81 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~----VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~   81 (708)
                      .-....|.+.+.||+|+||.||+|.+..+|..    ||+|.++..........+.+|+.+++.++||||+++++++... 
T Consensus         3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            34566799999999999999999998766664    8999987544333345567899999999999999999998753 


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                        ..+++++|+++|+|.+++.....  .++...+..++.||+.||+|||++||+||||||+|||+    +..+.+||+||
T Consensus        82 --~~~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill----~~~~~~kl~Df  153 (316)
T cd05108          82 --TVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV----KTPQHVKITDF  153 (316)
T ss_pred             --CceeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe----cCCCcEEEccc
Confidence              37899999999999999976432  38899999999999999999999999999999999998    66667999999


Q ss_pred             Cccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHH
Q psy15481        162 GAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       162 GlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~  237 (708)
                      |++.........   ....++..|+|||.+.        +..++.++|||||||++|+|++ |..||..   ....+ +.
T Consensus       154 G~a~~~~~~~~~~~~~~~~~~~~y~apE~~~--------~~~~~~~~Di~slGv~l~el~t~g~~p~~~---~~~~~-~~  221 (316)
T cd05108         154 GLAKLLGADEKEYHAEGGKVPIKWMALESIL--------HRIYTHQSDVWSYGVTVWELMTFGSKPYDG---IPASE-IS  221 (316)
T ss_pred             cccccccCCCcceeccCCccceeecChHHhc--------cCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CCHHH-HH
Confidence            999876544322   2233467899999987        5778999999999999999998 9999973   33222 33


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      .+.....                   .+|.....    ...+..++..||..||.+||++.+++..+..+....
T Consensus       222 ~~~~~~~-------------------~~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         222 SILEKGE-------------------RLPQPPIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             HHHhCCC-------------------CCCCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            3332110                   11211112    234567999999999999999999999887776544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.3e-36  Score=316.20  Aligned_cols=275  Identities=24%  Similarity=0.420  Sum_probs=204.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|++...||+|++|.||+|.++.+|+.||+|.+..... ......+.+|+.++++++||||+++++++....  ..++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~v~   79 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR--KLHLVF   79 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC--EEEEEE
Confidence            58889999999999999999999999999999864432 222345578999999999999999999987644  589999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++++|..++....   .+++..++.++.|++.||.|||+.|++||||||+||++    +..+.++|+|||.+.....
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~----~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          80 EYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI----TKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             eccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE----cCCCcEEECccccceecCC
Confidence            9999988888776543   28999999999999999999999999999999999998    6667899999999987654


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .. ......++..|+|||.+..       +..++.++|+|||||++|+|++|.+||.+   ..+.+....+...... .+
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~i~~~l~~g~~p~~~---~~~~~~~~~~~~~~~~-~~  221 (286)
T cd07847         153 PGDDYTDYVATRWYRAPELLVG-------DTQYGPPVDVWAIGCVFAELLTGQPLWPG---KSDVDQLYLIRKTLGD-LI  221 (286)
T ss_pred             CcccccCcccccccCCHHHHhC-------CCCcCchhhhHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHHHhCC-CC
Confidence            43 2334567889999999862       35578899999999999999999999973   3344444433321100 00


Q ss_pred             cccccCCCCcccccC--CCCCcc------cCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        249 SGTQTSENGEIDWCT--DLPNNC------QLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~--~lp~~~------~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ...... .....|..  ..|...      ...+.++..+.+++.+||..||++||++.++           +.|||+
T Consensus       222 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei-----------l~~~~f  286 (286)
T cd07847         222 PRHQQI-FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL-----------LEHPYF  286 (286)
T ss_pred             hHHhhh-cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH-----------hcCCCC
Confidence            000000 00000100  011110      0112335567789999999999999999997           668885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0612|consensus

Probab=100.00  E-value=2.3e-35  Score=340.30  Aligned_cols=263  Identities=26%  Similarity=0.378  Sum_probs=216.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-Cc-hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RP-HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~-~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|.+.++||+|+||.|.+++++.|++.||+|++++-... ++ ...++.|-.+|..-+.+=|+.++-.|.+..  ++|+
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~--~LYl  152 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER--YLYL  152 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc--ceEE
Confidence            3688899999999999999999999999999999863222 22 344677888888888999999998887654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++||||..++.+...   +|++.++.++..|+.||+-||+.|+|||||||+|||+    |-.|++||+|||.|..+
T Consensus       153 VMdY~pGGDlltLlSk~~~---~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl----d~~GHikLADFGsClkm  225 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFDR---LPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL----DKSGHIKLADFGSCLKM  225 (1317)
T ss_pred             EEecccCchHHHHHhhcCC---ChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe----cccCcEeeccchhHHhc
Confidence            9999999999999987652   9999999999999999999999999999999999999    88899999999999988


Q ss_pred             cccccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        168 EEDQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       168 ~~~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ..+...  ...+|||.|++||++..--.   ....|++.+|.||+||++|||+.|..||.   ..+-.++..+|...+..
T Consensus       226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~---~~g~yG~ecDwWSlGV~~YEMlyG~TPFY---adslveTY~KIm~hk~~  299 (1317)
T KOG0612|consen  226 DADGTVRSSVAVGTPDYISPEVLQSQGD---GKGEYGRECDWWSLGVFMYEMLYGETPFY---ADSLVETYGKIMNHKES  299 (1317)
T ss_pred             CCCCcEEeccccCCCCccCHHHHHhhcC---CccccCCccchhhhHHHHHHHHcCCCcch---HHHHHHHHHHHhchhhh
Confidence            766543  34689999999999974211   12679999999999999999999999998   46777888888765322


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC---HHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS---FERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps---a~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                       ..+|....+|..+++++    .+++ .+|+.|.+   +++|           -.||||.+.
T Consensus       300 -----------------l~FP~~~~VSeeakdLI----~~ll-~~~e~RLgrngiedi-----------k~HpFF~g~  344 (1317)
T KOG0612|consen  300 -----------------LSFPDETDVSEEAKDLI----EALL-CDREVRLGRNGIEDI-----------KNHPFFEGI  344 (1317)
T ss_pred             -----------------cCCCcccccCHHHHHHH----HHHh-cChhhhcccccHHHH-----------HhCccccCC
Confidence                             15665566788777754    4443 47888887   7776           568888654

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9.2e-37  Score=335.24  Aligned_cols=259  Identities=21%  Similarity=0.364  Sum_probs=199.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCC-----CceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCc
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNN-----GEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGR   83 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~   83 (708)
                      ..|.+.+.||+|+||.||+|.+..+     +..||+|.++..........+.+|+.+++.+ +||||+++++.+...+  
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~--  115 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG--  115 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC--
Confidence            3588999999999999999986544     4579999997554333345567899999999 8999999999987654  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCC----------------------------------------------------------
Q psy15481         84 GKVIVMELCTGGSLFNILDDPE----------------------------------------------------------  105 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~----------------------------------------------------------  105 (708)
                      ..|+|||||++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            4999999999999999885321                                                          


Q ss_pred             ---------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccc---
Q psy15481        106 ---------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF---  173 (708)
Q Consensus       106 ---------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~---  173 (708)
                               ....+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.....+...   
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~----~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL----TDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE----eCCCeEEEeeceeeeeccCCcceeec
Confidence                     01237888999999999999999999999999999999998    56678999999999865443221   


Q ss_pred             cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCcccccc
Q psy15481        174 MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVISGTQ  252 (708)
Q Consensus       174 ~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~  252 (708)
                      ....++..|+|||++.        +..++.++|||||||++|+|++ |..||....   ....+........        
T Consensus       272 ~~~~~~~~y~aPE~~~--------~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~---~~~~~~~~~~~~~--------  332 (374)
T cd05106         272 GNARLPVKWMAPESIF--------DCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL---VNSKFYKMVKRGY--------  332 (374)
T ss_pred             cCCCCccceeCHHHhc--------CCCCCccccHHHHHHHHHHHHhCCCCCCcccc---ccHHHHHHHHccc--------
Confidence            1223556799999986        5678999999999999999997 999997422   2222333322110        


Q ss_pred             cCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        253 TSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       253 ~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                               ....|  ...+    ..+.+++..||..||.+||++.++...+.+++
T Consensus       333 ---------~~~~~--~~~~----~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         333 ---------QMSRP--DFAP----PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ---------CccCC--CCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                     00111  1123    34566999999999999999999988877654

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6e-37  Score=336.73  Aligned_cols=257  Identities=24%  Similarity=0.393  Sum_probs=198.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEE-----cCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCc
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVN-----KNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGR   83 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~   83 (708)
                      .+|.+.+.||+|+||.||+|.+     ..++..||+|+++........+.+.+|+.+++.+ +||||+++++++.+.+  
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~--  112 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG--  112 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC--
Confidence            3688999999999999999964     3567789999987544333445567899999999 8999999999987655  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCC---------------------------------------------------------
Q psy15481         84 GKVIVMELCTGGSLFNILDDPEN---------------------------------------------------------  106 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~---------------------------------------------------------  106 (708)
                      ..++|||||+||+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            48999999999999998864221                                                         


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc
Q psy15481        107 ---------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ  171 (708)
Q Consensus       107 ---------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~  171 (708)
                                     ...+++..+..++.||+.||.|||++||+||||||+|||+    +....+||+|||++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill----~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL----THGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE----ECCCcEEEecCccceeccCcc
Confidence                           1137888999999999999999999999999999999998    556689999999998654432


Q ss_pred             ccc---ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        172 QFM---SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       172 ~~~---~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ...   ...++..|+|||.+.        +..++.++|||||||++|+|++ |..||..   ........+......   
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDi~slG~~l~ellt~g~~p~~~---~~~~~~~~~~~~~~~---  334 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIF--------NCVYTFESDVWSYGILLWEIFSLGSSPYPG---MPVDSKFYKMIKEGY---  334 (375)
T ss_pred             cccccCCCCCCcceeChhHhc--------CCCCCCCCCHHHHHHHHHHHHhcCCCCCCC---CCchHHHHHHHHhCc---
Confidence            211   233566799999987        6778999999999999999998 8999974   222222223222110   


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                                    ....|.  ..    +..+.+++..||..||++||++.+++..++.
T Consensus       335 --------------~~~~~~--~~----~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         335 --------------RMLSPE--CA----PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             --------------cCCCCC--CC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                          001111  12    2356679999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.1e-37  Score=319.46  Aligned_cols=274  Identities=25%  Similarity=0.355  Sum_probs=201.2

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      |.+.+.||+|++|.||+|.+..+|..||+|.+...... .......+|+.++++++||||+++++++.+.+  ..|+|||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e   79 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES--RLYLIFE   79 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--eEEEEEe
Confidence            78899999999999999999999999999998654322 22345568999999999999999999987644  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+. ++|.+++........+++..++.++.||+.||.|||++|++|+||||+||++    +..+.++|+|||++......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~----~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI----DNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE----cCCCcEEECcccceeecCCC
Confidence            996 6888888654333348999999999999999999999999999999999998    66678999999999765433


Q ss_pred             c-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc---CC
Q psy15481        171 Q-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA---SG  246 (708)
Q Consensus       171 ~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~---~~  246 (708)
                      . ......+++.|+|||.+..       ...++.++|+|||||++|+|+||++||..   .........+.....   ..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~~~~~---~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLG-------SPRYSTPVDIWSIGTIFAEMATKKPLFHG---DSEIDQLFRIFRILGTPTED  224 (285)
T ss_pred             cccccCCcccccccChHHhcC-------CCCcCcHHHHHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHHHhCCCChh
Confidence            2 2233467899999998862       34578899999999999999999999973   333333333322100   00


Q ss_pred             cccccccCCCCcccccCCCCCcc-----cCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNC-----QLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~-----~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ........    ..|....+...     .....++..+.++|.+||..||.+|||+.++           +.|||+
T Consensus       225 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~l-----------l~~~~~  285 (285)
T cd07861         225 VWPGVTSL----PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA-----------LNHPYF  285 (285)
T ss_pred             hhhcchhh----HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHH-----------hcCCCC
Confidence            00000000    00111111100     0111233445679999999999999999997           668875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG1989|consensus

Probab=100.00  E-value=2.8e-37  Score=352.60  Aligned_cols=265  Identities=22%  Similarity=0.361  Sum_probs=211.6

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEE-EEec---C-C
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAI-EEEQ---E-G   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v-~~~~---~-~   82 (708)
                      +.++.+.+.|.+|||+.||+|.+...|..||+|++-.. .........+|+++|++|+ |||||.++|. ....   + .
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            56789999999999999999999888899999998654 3444556689999999995 9999999993 2211   2 2


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR--LVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g--IVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                      ..++|.||||.||+|-+++....... |++.+++.|+.++++|+.+||..+  |||||||-+|||+    ++.+.+||||
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl----s~~g~~KLCD  189 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL----SADGNYKLCD  189 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE----cCCCCEEeCc
Confidence            35789999999999999998755433 999999999999999999999986  9999999999998    7777899999


Q ss_pred             cCccccccccc----------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC
Q psy15481        161 FGAARELEEDQ----------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR  230 (708)
Q Consensus       161 FGlA~~~~~~~----------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~  230 (708)
                      ||.|..-....          .-...+-|+.|+|||++.-..     +...+.|+|||+|||+||-|+....||..   .
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys-----g~pI~eKsDIWALGclLYkLCy~t~PFe~---s  261 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS-----GLPIGEKSDIWALGCLLYKLCYFTTPFEE---S  261 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhc-----CCCCcchhHHHHHHHHHHHHHHhCCCcCc---C
Confidence            99997532221          112356899999999986322     67889999999999999999999999973   1


Q ss_pred             ChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        231 RNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       231 ~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ...    .|+..                   ...+|.....    .+.+.+||+.||+.||.+||++-|++.++..+...
T Consensus       262 g~l----aIlng-------------------~Y~~P~~p~y----s~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  262 GKL----AILNG-------------------NYSFPPFPNY----SDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             cce----eEEec-------------------cccCCCCccH----HHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence            111    22221                   1255665444    44566699999999999999999999998888776


Q ss_pred             hhcC
Q psy15481        311 KLVH  314 (708)
Q Consensus       311 ~l~h  314 (708)
                      .+--
T Consensus       315 ~~~~  318 (738)
T KOG1989|consen  315 PCPI  318 (738)
T ss_pred             CCCc
Confidence            5533

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-36  Score=317.24  Aligned_cols=269  Identities=25%  Similarity=0.339  Sum_probs=200.1

Q ss_pred             eE-EEeeEeecCCceEEEEEE----EcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         11 VW-CTTSVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        11 ~y-~i~~~LG~G~fG~Vy~a~----~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      +| .+.+.||+|+||.||++.    ...++..||+|.+...........+.+|++++++++||||+++++++...+....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            44 889999999999998764    3457889999998754333334556789999999999999999998876666678


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ++||||+++++|.+++...    .+++..++.++.|++.||.|||++|++||||||+||++    +..+.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~~l~dfg~~~  155 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL----DNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE----cCCCcEEEeeccccc
Confidence            9999999999999999653    28999999999999999999999999999999999998    566789999999998


Q ss_pred             cccccccc----cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        166 ELEEDQQF----MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       166 ~~~~~~~~----~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      ........    ....++..|+|||.+.        +..++.++|||||||++|+|+||..||.....  .   ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~--~---~~~~~~  222 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLK--------ENKFSYASDVWSFGVTLYELLTHCDSKQSPPK--K---FEEMIG  222 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhc--------ccCCCcccccHHHHHHHHHHHhCCCCCCCCcc--h---hhhhhc
Confidence            76543221    1234566799999886        56688999999999999999999999863211  1   111111


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ..... ......  ..........|    .+...+..+.+++..||..||++|||+++++..+..+
T Consensus       223 ~~~~~-~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         223 PKQGQ-MTVVRL--IELLERGMRLP----CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             ccccc-cchhhh--hhhhhcCCCCC----CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            00000 000000  00000001111    2233445677799999999999999999998877654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-36  Score=318.89  Aligned_cols=277  Identities=23%  Similarity=0.337  Sum_probs=200.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|.+....... ......+|+.++++++||||+++++++.+..  ..|+|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK--KLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--ceEEEE
Confidence            4788999999999999999999999999999986543221 2234568999999999999999999987654  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+. ++|.+++.....  .+++..++.++.||+.||.|||++|++||||||+||++    +..+.++|+|||++.....
T Consensus        79 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~----~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          79 EYCD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI----NKNGELKLADFGLARAFGI  151 (284)
T ss_pred             ecCC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE----cCCCcEEECccchhhccCC
Confidence            9996 688887764322  38999999999999999999999999999999999998    6667899999999986543


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC--
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG--  246 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~--  246 (708)
                      .. ......++..|+|||.+..       ...++.++|||||||++|+|+||..||.+  +.+..+.+..+.......  
T Consensus       152 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~tg~~p~~~--~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd07839         152 PVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTE  222 (284)
T ss_pred             CCCCcCCCccccCCcChHHHhC-------CcccCcHHHHHHHHHHHHHHHhcCCCCcC--CCCHHHHHHHHHHHhCCCCh
Confidence            32 2334567899999999862       34578999999999999999999888643  333333333332211000  


Q ss_pred             -cccccccCCCCcccccC--CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        247 -VISGTQTSENGEIDWCT--DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       247 -~i~~~~~~~~g~~~~~~--~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                       ........... ..+..  ....+....+.++..+.++|.+||..||.+|||+.++           +.|||+
T Consensus       223 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i-----------l~h~~f  284 (284)
T cd07839         223 ESWPGVSKLPDY-KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA-----------LQHPYF  284 (284)
T ss_pred             HHhHHhhhcccc-cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH-----------hcCCCC
Confidence             00000000000 00000  0000011122344556679999999999999999997           668885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-36  Score=318.50  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=200.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCC-----ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNG-----EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg-----~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .|.+.+.||+|+||.||+|.+...+     ..||+|.+...........+.+|+.++++++||||+++++++....  ..
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~   83 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ--PT   83 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC--ce
Confidence            5788999999999999999876555     6899999875433333445678999999999999999999987544  48


Q ss_pred             EEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC
Q psy15481         86 VIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG  152 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~  152 (708)
                      |++|||+++++|.+++.....             ...+++..+..++.|++.||.|||++|++|+||||+||++    +.
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~----~~  159 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV----GE  159 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE----cC
Confidence            999999999999999865321             1348899999999999999999999999999999999998    56


Q ss_pred             CceEEEeccCccccccccc---cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCC
Q psy15481        153 STIYKLTDFGAARELEEDQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYG  228 (708)
Q Consensus       153 ~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~  228 (708)
                      .+.++|+|||++.......   ......+++.|+|||.+.        +..++.++|+|||||++|+|++ |..||.+  
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDv~slG~il~el~~~g~~p~~~--  229 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL--------YGKFTTESDIWSFGVVLWEIFSYGLQPYYG--  229 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhc--------cCcCchhhhHHHHHHHHHHHHcCCCCCCCC--
Confidence            6789999999997653332   122345678899999886        5678999999999999999998 9999973  


Q ss_pred             CCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        229 GRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       229 g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                       .+..+....+.....                     +.   .+..++..+.+++.+||..||.+||++.++...+.
T Consensus       230 -~~~~~~~~~i~~~~~---------------------~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05048         230 -FSNQEVIEMIRSRQL---------------------LP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR  281 (283)
T ss_pred             -CCHHHHHHHHHcCCc---------------------CC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence             444444444432110                     11   12234456777999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-36  Score=327.87  Aligned_cols=263  Identities=25%  Similarity=0.374  Sum_probs=202.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||++.++.+++.||+|++.+...  ......+.+|+.++..++||||+++++.+.+.+  .+|+|
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv   79 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN--NLYLV   79 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC--EEEEE
Confidence            58889999999999999999999999999999864221  112234568889999999999999999987654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++||+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++....
T Consensus        80 ~ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili----~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623          80 MDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM----DMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             EeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE----CCCCCEEEeecchheecc
Confidence            999999999999976332  38999999999999999999999999999999999998    666789999999997654


Q ss_pred             cccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        169 EDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       169 ~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ....  ....+||+.|+|||++.....   ....++.++|||||||++|+|++|..||.   +.+..+....+...... 
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DvwSlGvil~ell~g~~Pf~---~~~~~~~~~~i~~~~~~-  226 (332)
T cd05623         154 EDGTVQSSVAVGTPDYISPEILQAMED---GKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHKER-  226 (332)
T ss_pred             cCCcceecccccCccccCHHHHhcccc---CCCCCCCcCCEEeeHHHHHHHhcCCCCCC---CCCHHHHHHHHhCCCcc-
Confidence            3322  223579999999999863211   13457899999999999999999999997   34555555555432110 


Q ss_pred             cccccccCCCCcccccCCCCCc-ccCChhHHHHHHHHHHhhcccCccc--CCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNN-CQLSLGLKKLVTPILAGLLEVDSKK--IWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~-~~ls~~l~~~l~~LL~~mL~~DP~k--Rpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  .    .+|.. ..+++    .+.+++++||..+|.+  |++++++           +.|||+..
T Consensus       227 ------------~----~~p~~~~~~s~----~~~~li~~ll~~~~~r~~r~~~~~~-----------~~h~~f~~  271 (332)
T cd05623         227 ------------F----QFPAQVTDVSE----DAKDLIRRLICSREHRLGQNGIEDF-----------KQHPFFTG  271 (332)
T ss_pred             ------------c----cCCCccccCCH----HHHHHHHHHccChhhhcCCCCHHHH-----------hCCCCcCC
Confidence                        0    11211 12344    4555888888665554  7888887           67999854

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-36  Score=319.54  Aligned_cols=268  Identities=21%  Similarity=0.332  Sum_probs=206.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|++.+.||+|+||.||++.+..+|..||+|.+...........+.+|+.++++++||||+++++.+...+  ..|+|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~e   79 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG--AVYMCME   79 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC--eEEEEEe
Confidence            57888999999999999999999999999999865432222345678999999999999999999887644  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |++|++|..++........+++..+..++.+++.||.|||+ .|++|+||||+||++    +..+.++|+|||.+.....
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~----~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV----NGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE----CCCCCEEEeecCCcccccC
Confidence            99999999998765333349999999999999999999997 599999999999998    5567899999999976533


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      . ......++..|+|||.+.....  ..+..++.++|+|||||++|+|++|..||...........+..+....+     
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----  227 (286)
T cd06622         156 S-LAKTNIGCQSYMAPERIKSGGP--NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP-----  227 (286)
T ss_pred             C-ccccCCCccCccCcchhcCCCC--CccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-----
Confidence            2 2234568889999998853211  0134568899999999999999999999974221111112222221110     


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                         ..+++.+...+.+++.+||..||.+||+++++           +.|||+.....
T Consensus       228 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l-----------~~~~~~~~~~~  270 (286)
T cd06622         228 -------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQL-----------LEHPWLVKYKN  270 (286)
T ss_pred             -------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHH-----------hcChhhhhccC
Confidence                               11223345556679999999999999999997           56898866543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.5e-36  Score=309.88  Aligned_cols=249  Identities=27%  Similarity=0.457  Sum_probs=199.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|.+.+.||.|++|.||++.++.+++.||+|.+...... ...+...+|+.++++++|||++++++.+... ...+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence            388999999999999999999999999999998654322 2234567899999999999999999887543 33589999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++++|.+++..... ..+++.+++.++.+++.|+.+||++|++||||||+||++    +..+.++|+|||++.....
T Consensus        80 e~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~----~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          80 GFCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL----TRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             cccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE----ecCCcEEEecccceEEecc
Confidence            99999999999875322 238999999999999999999999999999999999998    6667899999999986543


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .. ......+++.|+|||++.        +..++.++|+|||||++|++++|..||..   .+.......+....     
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~~l~~g~~~~~~---~~~~~~~~~~~~~~-----  218 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFS--------NKPYNYKSDVWALGCCVYEMATLKHAFNA---KDMNSLVYRIIEGK-----  218 (257)
T ss_pred             cCCccccccCCcCccChhHhc--------CCCCCchhhhHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHhcC-----
Confidence            32 223456899999999987        56788999999999999999999999973   33333333333211     


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                      +|.   ++...+..+.+++.+||..||.+||++.++
T Consensus       219 ----------------~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~  251 (257)
T cd08223         219 ----------------LPP---MPKDYSPELGELIATMLSKRPEKRPSVKSI  251 (257)
T ss_pred             ----------------CCC---CccccCHHHHHHHHHHhccCcccCCCHHHH
Confidence                            111   122344567779999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-36  Score=327.92  Aligned_cols=263  Identities=23%  Similarity=0.368  Sum_probs=200.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+++++.+++.||+|++.....  ......+.+|..++..++||||+++++++.+.+  ..|+|
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~--~~~lv   79 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN--YLYLV   79 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEEE
Confidence            58899999999999999999999999999999864321  112233567889999999999999999987654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++||+|.+++.....  .+++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++....
T Consensus        80 ~Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill----~~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          80 MDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL----DMNGHIRLADFGSCLKMN  153 (331)
T ss_pred             EeCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE----cCCCCEEEEeccceeecc
Confidence            999999999999976322  38999999999999999999999999999999999998    666789999999998665


Q ss_pred             ccccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        169 EDQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       169 ~~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      .....  ....||+.|+|||++....   .....++.++|+|||||++|+|++|..||..   .+..+....+.....  
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~---~~~~~~~~~i~~~~~--  225 (331)
T cd05624         154 QDGTVQSSVAVGTPDYISPEILQAME---DGMGKYGPECDWWSLGVCMYEMLYGETPFYA---ESLVETYGKIMNHEE--  225 (331)
T ss_pred             CCCceeeccccCCcccCCHHHHhccc---cCCCCCCCcccEEeeehhhhhhhhCCCCccC---CCHHHHHHHHHcCCC--
Confidence            43322  2357999999999986211   0014578899999999999999999999973   444444444442110  


Q ss_pred             cccccccCCCCcccccCCCCCc-ccCChhHHHHHHHHHHhhcccCccc--CCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNN-CQLSLGLKKLVTPILAGLLEVDSKK--IWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~-~~ls~~l~~~l~~LL~~mL~~DP~k--Rpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                 ..    .+|.. ..++    ..+.+++.+||..+|.+  |++++++           +.|+|+..
T Consensus       226 -----------~~----~~p~~~~~~~----~~~~~li~~ll~~~~~~~~~~~~~~~-----------~~h~~f~~  271 (331)
T cd05624         226 -----------RF----QFPSHITDVS----EEAKDLIQRLICSRERRLGQNGIEDF-----------KKHAFFEG  271 (331)
T ss_pred             -----------cc----cCCCccccCC----HHHHHHHHHHccCchhhcCCCCHHHH-----------hcCCCcCC
Confidence                       00    11111 1233    34556888998876654  4677776           66888854

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.7e-36  Score=321.01  Aligned_cols=260  Identities=22%  Similarity=0.324  Sum_probs=198.3

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCce--EEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEP--VAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~--VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .|++.+.||+|+||.||+|.+..+|..  +|+|.+...........+.+|+.++.++ +||||+++++++...+  .+|+
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~--~~~l   85 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYL   85 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC--CceE
Confidence            578889999999999999999887764  5777665433222334567899999999 8999999999987644  5999


Q ss_pred             EEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCc
Q psy15481         88 VMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST  154 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~  154 (708)
                      ||||+++++|.+++.....             ...+++..++.++.|++.|++|||++|++||||||+|||+    +..+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili----~~~~  161 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV----GENY  161 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe----cCCC
Confidence            9999999999999865321             1238899999999999999999999999999999999998    6667


Q ss_pred             eEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChh
Q psy15481        155 IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNK  233 (708)
Q Consensus       155 ~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~  233 (708)
                      .+||+|||++.............++..|+|||.+.        +..++.++|||||||++|+|+| |.+||..   .+..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~ellt~g~~p~~~---~~~~  230 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN--------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---MTCA  230 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHh--------ccCCcccccchhhhhHHHHHHhcCCCCccc---CChH
Confidence            89999999987433222222233467899999886        5668899999999999999998 9999963   3333


Q ss_pred             hHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        234 ETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       234 e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      +....+...                  +  ..+.....+    ..+.+++.+||..||++||++++++..+..++...
T Consensus       231 ~~~~~~~~~------------------~--~~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         231 ELYEKLPQG------------------Y--RLEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             HHHHHHhcC------------------C--cCCCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            322222110                  0  001111223    34567999999999999999999999887776543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.9e-36  Score=311.40  Aligned_cols=248  Identities=25%  Similarity=0.410  Sum_probs=199.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||+|.+..++..|++|.+.....   .+.+.+|++++++++||||+++++.+.+..  ..|++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~   76 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNT--DLWIV   76 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCC--cEEEE
Confidence            3568889999999999999999998899999999865422   456679999999999999999999987653  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      +||+++++|.+++.....  .+++..+..++.+++.||.|||+.|++|+||+|+||++    +..+.++|+|||.+....
T Consensus        77 ~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~----~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          77 MEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL----NEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             EecCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE----CCCCcEEEcccccchhcc
Confidence            999999999999865332  38999999999999999999999999999999999998    666689999999998765


Q ss_pred             ccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 EDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ... ......|+..|+|||++.        +..++.++|||||||++|+|++|..||..   ......+..+...     
T Consensus       151 ~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Di~s~G~il~~l~~g~~p~~~---~~~~~~~~~~~~~-----  214 (256)
T cd06612         151 DTMAKRNTVIGTPFWMAPEVIQ--------EIGYNNKADIWSLGITAIEMAEGKPPYSD---IHPMRAIFMIPNK-----  214 (256)
T ss_pred             cCccccccccCCccccCHHHHh--------cCCCCchhhHHHHHHHHHHHHhCCCCCCC---cchhhhhhhhccC-----
Confidence            443 223355889999999987        56788999999999999999999999973   2222222111110     


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                       .+.....+...+..+.+++.+||..||.+|||+.++
T Consensus       215 -----------------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~i  250 (256)
T cd06612         215 -----------------PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQL  250 (256)
T ss_pred             -----------------CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHH
Confidence                             001111122334556779999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.9e-36  Score=318.92  Aligned_cols=262  Identities=27%  Similarity=0.459  Sum_probs=209.4

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      |.....|.+.+.||.|++|.||+|.+..+|+.||+|.+..... ...+...+|+.+++.++||||+++++++...+  .+
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~   91 (296)
T cd06655          15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGD--EL   91 (296)
T ss_pred             CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCc--eE
Confidence            4556789999999999999999999999999999999865332 23455678999999999999999999987644  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|+||++|++|..++...    .+++..+..++.+++.||.|||++|++||||||+||++    +..+.++|+|||++.
T Consensus        92 ~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili----~~~~~~kl~dfg~~~  163 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL----GMDGSVKLTDFGFCA  163 (296)
T ss_pred             EEEEEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEccCccch
Confidence            9999999999999998653    28999999999999999999999999999999999998    556679999999988


Q ss_pred             ccccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ....... .....|+..|+|||.+.        +..++.++|+|||||++|++++|..||..   .+....+..+.....
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slGvil~~lltg~~pf~~---~~~~~~~~~~~~~~~  232 (296)
T cd06655         164 QITPEQSKRSTMVGTPYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLN---ENPLRALYLIATNGT  232 (296)
T ss_pred             hcccccccCCCcCCCccccCcchhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcCC
Confidence            6544322 23456889999999986        56688999999999999999999999973   333343433332110


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      +                  .+...    ..++..+.+++.+||..||.+||++.++           +.|+|+.....
T Consensus       233 ~------------------~~~~~----~~~~~~~~~li~~~l~~dp~~Rpt~~~i-----------l~~~~~~~~~~  277 (296)
T cd06655         233 P------------------ELQNP----EKLSPIFRDFLNRCLEMDVEKRGSAKEL-----------LQHPFLKLAKP  277 (296)
T ss_pred             c------------------ccCCc----ccCCHHHHHHHHHHhhcChhhCCCHHHH-----------hhChHhhhccc
Confidence            0                  11111    1233456679999999999999999997           56888865443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4e-36  Score=311.92  Aligned_cols=254  Identities=22%  Similarity=0.340  Sum_probs=201.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|++|.||+|.++++++.||+|.+....  .....+.+|+.++++++||||+++++++...+  .++++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~   81 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYIIT   81 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC--CcEEEE
Confidence            45888999999999999999999999999999986432  22345678999999999999999999987654  489999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+||++    +..+.+||+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~----~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          82 EFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE----cCCCcEEeCCCcccccccc
Confidence            99999999999865332 238999999999999999999999999999999999998    5667899999999987654


Q ss_pred             ccccc--ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQQFM--SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~~~~--~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      .....  ...++..|+|||.+.        +..++.++|||||||++|+|++ |..||.+   ....+....+...    
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~el~t~g~~p~~~---~~~~~~~~~~~~~----  221 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLA--------YNKFSIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYELLEKG----  221 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhc--------cCCCCchhHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHHHCC----
Confidence            32211  123456799999886        5678899999999999999998 9999973   3333333322211    


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                    +....      +...+..+.+++.+||..||++||++.++.+.++.+
T Consensus       222 --------------~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 --------------YRMER------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --------------CCCCC------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                          00011      122335567799999999999999999998876654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-36  Score=329.77  Aligned_cols=263  Identities=22%  Similarity=0.320  Sum_probs=202.3

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecC
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQE   81 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~   81 (708)
                      ...+|++.+.||+|+||.||+|.+.     .+++.||+|+++............+|+.++.++ +||||+++++++...+
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3458999999999999999999754     346889999987543322334456899999999 8999999999886543


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCC-------------------------------------------------------
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPEN-------------------------------------------------------  106 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~-------------------------------------------------------  106 (708)
                       ..++++|||++|++|.+++.....                                                       
T Consensus        85 -~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          85 -GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             -CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             358999999999999998854221                                                       


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccc---ccccCCCC
Q psy15481        107 ---TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTE  180 (708)
Q Consensus       107 ---~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~  180 (708)
                         ...+++..+..++.||+.||.|||++||+||||||+|||+    +..+.++|+|||++..+.....   .....++.
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill----~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE----eCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence               1247899999999999999999999999999999999998    5566799999999987643321   12345677


Q ss_pred             CcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcc
Q psy15481        181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEI  259 (708)
Q Consensus       181 ~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~  259 (708)
                      .|+|||++.        +..++.++|||||||++|+|++ |..||..   ....+.+.........              
T Consensus       240 ~y~aPE~~~--------~~~~~~~~Di~SlGv~l~el~t~g~~p~~~---~~~~~~~~~~~~~~~~--------------  294 (337)
T cd05054         240 KWMAPESIF--------DKVYTTQSDVWSFGVLLWEIFSLGASPYPG---VQIDEEFCRRLKEGTR--------------  294 (337)
T ss_pred             cccCcHHhc--------CCCCCccccHHHHHHHHHHHHHcCCCCCCC---CCccHHHHHHHhccCC--------------
Confidence            899999987        6778999999999999999998 9999963   2222222222211000              


Q ss_pred             cccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        260 DWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       260 ~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                         ...|      ......+.+++.+||..+|++||++.+++..+.+++.
T Consensus       295 ---~~~~------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         295 ---MRAP------EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ---CCCC------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               0111      1223446679999999999999999999999888765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.8e-36  Score=311.32  Aligned_cols=248  Identities=27%  Similarity=0.422  Sum_probs=196.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--C--chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--R--PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~--~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .|.+.+.||+|+||.||.|.+..+|+.||+|.+......  .  ....+.+|+.++++++||||+++++++.+.....++
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            578899999999999999999999999999988643211  1  123456899999999999999999988766555789


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ++|||++|++|.+++.....   +++..+..++.|++.||.|||++|++|+||||+||++    +..+.++|+|||.+..
T Consensus        83 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~----~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          83 IFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR----DSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEecCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe----cCCCCEEECcCccccc
Confidence            99999999999999875432   7899999999999999999999999999999999997    5666799999999986


Q ss_pred             cccc----ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        167 LEED----QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       167 ~~~~----~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      ....    .......|+..|+|||.+.        +..++.++|+|||||++|+|++|..||..   .........+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~el~~g~~p~~~---~~~~~~~~~~~~~  224 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVIS--------GEGYGRKADIWSVGCTVVEMLTEKPPWAE---FEAMAAIFKIATQ  224 (265)
T ss_pred             cccccccccccccCCCCccccChhhhc--------CCCCCcchhHHHHHHHHHHHhhCCCCCCc---cchHHHHHHHhcC
Confidence            5321    1223456889999999986        56678999999999999999999999973   2223333222211


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                             +....++......+.++|.+|+ .+|+.||+++++
T Consensus       225 -----------------------~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~i  258 (265)
T cd06652         225 -----------------------PTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADEL  258 (265)
T ss_pred             -----------------------CCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHH
Confidence                                   0111123445566777889998 499999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=328.31  Aligned_cols=290  Identities=22%  Similarity=0.346  Sum_probs=209.1

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecC---Cce
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE---GRG   84 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~---~~~   84 (708)
                      .+..|.+.+.||+|+||.||+|.+..+|+.||+|.+.............+|+.++++++||||+++++++....   ...
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            35679999999999999999999999999999999865433333455678999999999999999999876433   235


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||+. ++|..++....    +++..+..++.|++.||.|||++||+||||||+||++    +..+.++|+|||++
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~----l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill----~~~~~~kl~dfg~~  153 (336)
T cd07849          83 VYIVQELME-TDLYKLIKTQH----LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTNCDLKICDFGLA  153 (336)
T ss_pred             EEEEehhcc-cCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE----CCCCCEEECcccce
Confidence            799999995 68888886532    8999999999999999999999999999999999998    66778999999999


Q ss_pred             cccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        165 RELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       165 ~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ........    .....|+..|+|||.+..       ...++.++|+||+||++|+|++|+.||..   .+....+..+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGvil~el~~G~~~f~~---~~~~~~~~~~~  223 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKAIDIWSVGCILAEMLSNRPLFPG---KDYLHQLNLIL  223 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHH
Confidence            76543221    123568999999998752       35678999999999999999999999964   22222222221


Q ss_pred             ---hcccCCcccccccCCCCcccccCCCCCccc-----CChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhh
Q psy15481        241 ---TKKASGVISGTQTSENGEIDWCTDLPNNCQ-----LSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKL  312 (708)
Q Consensus       241 ---~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~-----ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l  312 (708)
                         ..............  ....|...++....     ..+..+..+.+++.+||+.||++|||+.++           +
T Consensus       224 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~-----------l  290 (336)
T cd07849         224 GVLGTPSQEDLNCIISL--RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA-----------L  290 (336)
T ss_pred             HHcCCCCHHHHHHhhch--hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH-----------h
Confidence               11111110000000  00001111111110     112234557789999999999999999997           6


Q ss_pred             cCcccCCcccccccccC
Q psy15481        313 VHLFHINRLQCIRIYLH  329 (708)
Q Consensus       313 ~h~~~~~~~~~~~~~i~  329 (708)
                      .|||+..-.......+.
T Consensus       291 ~hp~~~~~~~~~~~~~~  307 (336)
T cd07849         291 AHPYLEQYHDPSDEPVA  307 (336)
T ss_pred             cCccccccCCCCCcccC
Confidence            68888765544333333

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.5e-36  Score=310.93  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=205.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|.+.+.||.|+||.||+|.+..++..||+|++.............+|+.+++.++||||+++++.+...+  ..|+|||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~iv~e   79 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD--ELWLVMP   79 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC--EEEEEEe
Confidence            58889999999999999999998999999999875544334556679999999999999999999887644  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      +++|++|.+++........+++..+..++.|++.||.|||++|++||||+|+||++    +.++.++|+|||++......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~----~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL----GEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE----cCCCCEEEcccchHHHhccC
Confidence            99999999999764332348999999999999999999999999999999999998    55677999999999766543


Q ss_pred             ccc-----cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        171 QQF-----MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       171 ~~~-----~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ...     ....|+..|+|||++..       ...++.++|+|||||++|+|++|..||..   .+............+.
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~---~~~~~~~~~~~~~~~~  225 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQ-------VHGYDFKADIWSFGITAIELATGAAPYSK---YPPMKVLMLTLQNDPP  225 (267)
T ss_pred             ccccccccccccCChhhcChHHHcc-------ccCcCcccchHhHhHHHHHHHhCCCCccc---cChhhhHHHHhcCCCC
Confidence            222     23468999999999873       23688999999999999999999999973   2333333333322111


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                                        .++... -...++..+.+++.+||..||.+||++.++           +.|||+
T Consensus       226 ------------------~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l-----------l~~p~~  267 (267)
T cd06610         226 ------------------SLETGA-DYKKYSKSFRKMISLCLQKDPSKRPTAEEL-----------LKHKFF  267 (267)
T ss_pred             ------------------CcCCcc-ccccccHHHHHHHHHHcCCChhhCcCHHHH-----------hhCCCC
Confidence                              001100 011334456679999999999999999997           568885

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.9e-36  Score=311.75  Aligned_cols=246  Identities=26%  Similarity=0.418  Sum_probs=192.1

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCC
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~gg   95 (708)
                      +.||+|+||.||+|.++.+|+.||+|.+...........+.+|++++++++||||+++++++....  ..|+||||++|+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--CeEEEEeeccCC
Confidence            369999999999999999999999998764433333455679999999999999999999987654  499999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccccc-
Q psy15481         96 SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-  174 (708)
Q Consensus        96 sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~-  174 (708)
                      +|.+++.....  .+++..++.++.|++.||.|||++|++||||||+||++    +..+.+||+|||.+.......... 
T Consensus        79 ~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~----~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          79 DFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV----TEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             cHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE----cCCCcEEECccccCccccccccccc
Confidence            99999865332  38999999999999999999999999999999999998    566679999999998654321111 


Q ss_pred             --ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        175 --SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       175 --~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                        ...++..|+|||.+.        +..++.++|+|||||++|+|++ |.+||..   .........+....        
T Consensus       153 ~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~e~~~~~~~p~~~---~~~~~~~~~~~~~~--------  213 (252)
T cd05084         153 GGMKQIPVKWTAPEALN--------YGRYSSESDVWSFGILLWEAFSLGAVPYAN---LSNQQTREAIEQGV--------  213 (252)
T ss_pred             CCCCCCceeecCchhhc--------CCCCChHHHHHHHHHHHHHHHhCCCCCccc---cCHHHHHHHHHcCC--------
Confidence              112345699999986        5668899999999999999998 9999963   33333333332210        


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                                  ..+    .+...+..+.+++.+||..||++|||+.+++..+
T Consensus       214 ------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l  250 (252)
T cd05084         214 ------------RLP----CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL  250 (252)
T ss_pred             ------------CCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                        001    1112234567799999999999999999987754

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.8e-36  Score=312.62  Aligned_cols=255  Identities=28%  Similarity=0.431  Sum_probs=200.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC----chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR----PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~----~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .|...+.||+|+||.||+|.+..+|..||+|.+.......    ......+|+.+++.++||||+++++++........+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            4778899999999999999999999999999986543211    123456899999999999999999998765556789


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ++|||+++++|.+++.....   +++..++.++.|++.||.|||+.|++||||||+||++    +..+.++|+|||++..
T Consensus        83 l~~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~----~~~~~~~l~dfg~~~~  155 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR----DSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----CCCCCEEEccCCCccc
Confidence            99999999999999876433   8999999999999999999999999999999999997    6666799999999875


Q ss_pred             cccc----ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        167 LEED----QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       167 ~~~~----~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      ....    .......++..|+|||.+.        +..++.++|+||+||++|++++|..||..   .........+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~i~~el~~g~~pf~~---~~~~~~~~~~~~~  224 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVIS--------GEGYGRKADVWSLGCTVVEMLTEKPPWAE---YEAMAAIFKIATQ  224 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhC--------CCCCCchhhhHHHHHHHHHHHHCCCCccc---cchHHHHHHHhcC
Confidence            4321    1122345888999999986        56788999999999999999999999974   2333333332211


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      .                       ....++......+.+++ +||..||++||+++++           +.|||+.
T Consensus       225 ~-----------------------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~ei-----------l~hp~~~  265 (266)
T cd06651         225 P-----------------------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEEL-----------LRHPFAQ  265 (266)
T ss_pred             C-----------------------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHH-----------hcCcccc
Confidence            0                       00112223344556677 5777899999999997           6688874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-36  Score=318.32  Aligned_cols=254  Identities=22%  Similarity=0.351  Sum_probs=199.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.++++++||||+++++.+...+  ..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e   79 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--RISICTE   79 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--EEEEEEe
Confidence            46788999999999999999999999999999875433333345678999999999999999999998754  4899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+++++|..+.       .+++..+..++.|++.||.|||++||+|+||||+||++    +..+.++|+|||++......
T Consensus        80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill----~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV----NTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE----CCCCCEEEeeCCcceecccc
Confidence            99999996542       17889999999999999999999999999999999998    66778999999999865433


Q ss_pred             ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChh----hHHHHHHhcccCC
Q psy15481        171 QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK----ETMYYITTKKASG  246 (708)
Q Consensus       171 ~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~----e~~~~i~~~~~~~  246 (708)
                       ......|+..|+|||.+.        +..++.++|+|||||++|+|++|..||.........    .....+...... 
T Consensus       149 -~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  218 (279)
T cd06619         149 -IAKTYVGTNAYMAPERIS--------GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP-  218 (279)
T ss_pred             -cccCCCCChhhcCceeec--------CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC-
Confidence             233467999999999987        567889999999999999999999999753221111    111111110000 


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                       .++. ...    +..+.+++.+||..||++||+++++           +.|||+...
T Consensus       219 -----------------~~~~-~~~----~~~~~~li~~~l~~~P~~Rp~~~ei-----------l~~~~~~~~  259 (279)
T cd06619         219 -----------------VLPV-GQF----SEKFVHFITQCMRKQPKERPAPENL-----------MDHPFIVQY  259 (279)
T ss_pred             -----------------CCCC-CcC----CHHHHHHHHHHhhCChhhCCCHHHH-----------hcCcccccc
Confidence                             1111 112    2345679999999999999999997           668998554

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.4e-36  Score=308.63  Aligned_cols=248  Identities=25%  Similarity=0.409  Sum_probs=200.0

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      |.+.+.||+|++|.||+|.+..+|+.|++|.+..... ......+.+|++++++++||||+++++.+...+  ..|+|||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e   79 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG--KLNIVME   79 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--EEEEEEE
Confidence            7788999999999999999999999999999864322 233445678999999999999999999987643  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |++|++|.+++.... ...+++..+..++.+++.||.|||++|++|+||||+||++    +..+.++|+|||.+......
T Consensus        80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili----~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL----DAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE----eCCCCEEEcccccceeccCc
Confidence            999999999987642 2348999999999999999999999999999999999998    55667999999998866544


Q ss_pred             cc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        171 QQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       171 ~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      .. .....|++.|+|||++.        +..++.++|+|||||++|+|++|..||..   .++......+....      
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~~------  217 (256)
T cd08529         155 TNFANTIVGTPYYLSPELCE--------DKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALILKIIRGV------  217 (256)
T ss_pred             cchhhccccCccccCHHHhc--------CCCCCCccchHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHcCC------
Confidence            32 23456889999999987        56688999999999999999999999973   33444444333211      


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHH
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFF  301 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~  301 (708)
                                     .+.   ++..++..+.+++.+||..+|++||++.+++
T Consensus       218 ---------------~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll  251 (256)
T cd08529         218 ---------------FPP---VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLL  251 (256)
T ss_pred             ---------------CCC---CccccCHHHHHHHHHHccCCcccCcCHHHHh
Confidence                           111   1123344567799999999999999999973

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.3e-36  Score=312.23  Aligned_cols=246  Identities=26%  Similarity=0.469  Sum_probs=196.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--------hHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--------HDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--------~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      +|.+...||+|++|.||+|.+..+++.||+|.+........        .+...+|+.++++++||||+++++++...+ 
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD-   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence            48889999999999999999999999999999865432211        133568999999999999999999987654 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                       ..++||||+++++|.+++.....   +++..+..++.|++.||.|||++|++||||+|+||++    +..+.++|+|||
T Consensus        80 -~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~----~~~~~~~l~dfg  151 (267)
T cd06628          80 -HLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV----DNKGGIKISDFG  151 (267)
T ss_pred             -ccEEEEEecCCCCHHHHHHhccC---ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE----cCCCCEEecccC
Confidence             58999999999999999976433   8999999999999999999999999999999999998    666789999999


Q ss_pred             cccccccccc-------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhH
Q psy15481        163 AARELEEDQQ-------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKET  235 (708)
Q Consensus       163 lA~~~~~~~~-------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~  235 (708)
                      .+.....+..       .....|+..|+|||.+.        +..++.++|+||+||++|+|++|..||..   ......
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~--------~~~~~~~~Dv~slG~il~~l~~g~~p~~~---~~~~~~  220 (267)
T cd06628         152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK--------QTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQA  220 (267)
T ss_pred             CCcccccccccCCccccccccCCCcCccChhHhc--------cCCCCchhhhHHHHHHHHHHhhCCCCCCC---ccHHHH
Confidence            9986653211       11245888999999986        56678899999999999999999999973   233333


Q ss_pred             HHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        236 MYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       236 ~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      +..+....                     .|   .++...+..+.++|.+||..||.+||++.++
T Consensus       221 ~~~~~~~~---------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  261 (267)
T cd06628         221 IFKIGENA---------------------SP---EIPSNISSEAIDFLEKTFEIDHNKRPTAAEL  261 (267)
T ss_pred             HHHHhccC---------------------CC---cCCcccCHHHHHHHHHHccCCchhCcCHHHH
Confidence            33322210                     01   1122334556779999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.4e-36  Score=315.10  Aligned_cols=258  Identities=25%  Similarity=0.354  Sum_probs=200.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCc----eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~----~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ...|.+.+.||+|+||.||+|.+..+|.    .||+|++...........+.+|+.+++.++||||+++++++...   .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---T   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---C
Confidence            4678999999999999999999877776    48999987554433345567899999999999999999988643   3


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .+++|+|+++|+|.+++.....  .+++..+..++.|++.||.|||++|++||||||+|||+    +..+.+||+|||++
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~----~~~~~~kL~dfG~~  156 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV----KSPNHVKITDFGLA  156 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE----cCCCcEEECCCCce
Confidence            7899999999999999876432  38999999999999999999999999999999999998    55567999999999


Q ss_pred             ccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHH
Q psy15481        165 RELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       165 ~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~  240 (708)
                      +........   ....++..|+|||.+.        +..++.++|||||||++|+|++ |..||..   ....... ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Di~slG~~l~el~t~g~~p~~~---~~~~~~~-~~~  224 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESIL--------HRRFTHQSDVWSYGVTVWELMTFGAKPYDG---IPAREIP-DLL  224 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhc--------cCCCCchhHHHHHHHHHHHHHcCCCCCCCC---CCHHHHH-HHH
Confidence            876433221   1234567899999986        5678999999999999999998 9999963   2222222 222


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ....                   ..+....    .+..+.+++.+||..||+.||++.+++..+.++..+
T Consensus       225 ~~~~-------------------~~~~~~~----~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         225 EKGE-------------------RLPQPPI----CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             HCCC-------------------cCCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            2100                   1111112    234566799999999999999999999877666443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-36  Score=358.77  Aligned_cols=261  Identities=23%  Similarity=0.355  Sum_probs=204.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...|.+.+.||+|+||.||+|.+..++..||+|.+...... .....+..|+.+++.|+||||++++++|.......+||
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            35899999999999999999999999999999998754322 22345678999999999999999999987766667999


Q ss_pred             EEeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CCcccCCCCCcEEEEEe----------
Q psy15481         88 VMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDN-------RLVHRDLKPGNIMKFIC----------  149 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~-------gIVHrDIKP~NILl~~~----------  149 (708)
                      ||||+++|+|..++.... ....+++..++.++.||+.||.|||+.       +||||||||+|||+...          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            999999999999886521 112399999999999999999999984       49999999999997321          


Q ss_pred             ---cCCCceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCC
Q psy15481        150 ---DDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP  226 (708)
Q Consensus       150 ---~d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~  226 (708)
                         .++...+||+|||++.............||+.|+|||++...      ...++.++||||||||||+|+||..||..
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge------~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE------TKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc------CCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence               134456999999999876555444566899999999998621      34588999999999999999999999973


Q ss_pred             CCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        227 YGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       227 ~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                         ..+...+.......+                   .+|. ...    +..+.+||..||..||.+||++.+++.
T Consensus       246 ---~~~~~qli~~lk~~p-------------------~lpi-~~~----S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        246 ---ANNFSQLISELKRGP-------------------DLPI-KGK----SKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             ---CCcHHHHHHHHhcCC-------------------CCCc-CCC----CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence               233333333332111                   1111 112    344667999999999999999999854

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.1e-36  Score=308.83  Aligned_cols=249  Identities=24%  Similarity=0.390  Sum_probs=199.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|++.+.||+|++|.||++.+..++..||+|.+...... .....+.+|+.+++.++||||+++++.+...+  ..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK--ALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC--EEEEEE
Confidence            488999999999999999999999999999998754322 22345678999999999999999999886543  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++|++|.+++..... ..+++..+..++.+++.||.|||++|++|+||+|+||++  + +....++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~--~-~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          79 EYAPGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL--D-KHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             ecCCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--c-CCCCEEEEccCCCceecCC
Confidence            99999999999976432 238999999999999999999999999999999999997  2 2345789999999987765


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      ........|+..|+|||.+.        +..++.++|+||||+++|+|++|..||..   .+.......+.....     
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~---~~~~~~~~~~~~~~~-----  218 (256)
T cd08220         155 KSKAYTVVGTPCYISPELCE--------GKPYNQKSDIWALGCVLYELASLKRAFEA---ANLPALVLKIMSGTF-----  218 (256)
T ss_pred             CccccccccCCcccCchhcc--------CCCCCcccchHHHHHHHHHHHhCCCCccc---CchHHHHHHHHhcCC-----
Confidence            54444567899999999986        56678899999999999999999999973   333333333332110     


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                     .+    ++..++..+.+++..||..||.+|||+.++
T Consensus       219 ---------------~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l  250 (256)
T cd08220         219 ---------------AP----ISDRYSPDLRQLILSMLNLDPSKRPQLSQI  250 (256)
T ss_pred             ---------------CC----CCCCcCHHHHHHHHHHccCChhhCCCHHHH
Confidence                           01    112233446679999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.5e-36  Score=317.04  Aligned_cols=254  Identities=26%  Similarity=0.352  Sum_probs=200.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcC-----CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .|.+.+.||+|+||.||+|.+..     +++.||+|.++..........+.+|++++++++||||+++++++....  ..
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~   83 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD--PP   83 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC--Ce
Confidence            57788999999999999998753     467899999876544334556789999999999999999999987654  59


Q ss_pred             EEEEeccCCCCHHHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCc
Q psy15481         86 VIVMELCTGGSLFNILDDPE-----------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST  154 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~-----------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~  154 (708)
                      ++||||++|++|.+++....           ....+++..+..++.|++.|+.|||++|++||||||+||++    +..+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili----~~~~  159 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV----GYDL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE----cCCC
Confidence            99999999999999986532           12337899999999999999999999999999999999998    6667


Q ss_pred             eEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCC
Q psy15481        155 IYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGR  230 (708)
Q Consensus       155 ~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~  230 (708)
                      .++|+|||.+........   .....++..|+|||++.        +..++.++|||||||++|+|++ |..||..   .
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~e~~~~g~~p~~~---~  228 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM--------YRKFTTESDVWSFGVVLWEIFTYGKQPWYG---L  228 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhc--------cCCcchhhhHHHHHHHHHHHHhcCCCCCCC---C
Confidence            899999999976533221   12334578899999987        5778999999999999999998 9999963   3


Q ss_pred             ChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        231 RNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       231 ~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                      ...+....+.....                     +.   .+...+..+.+++.+||..||.+||++.++++.+.
T Consensus       229 ~~~~~~~~~~~~~~---------------------~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         229 SNEEVIECITQGRL---------------------LQ---RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CHHHHHHHHHcCCc---------------------CC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            34444433332110                     00   01123345677999999999999999999877653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.9e-36  Score=318.35  Aligned_cols=260  Identities=21%  Similarity=0.315  Sum_probs=200.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCc--eEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGE--PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~--~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .|++.+.||+|+||.||+|.+..+|.  .+++|.++..........+.+|+.++.++ +||||+++++++...+  .+|+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~~l   80 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG--YLYI   80 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC--cceE
Confidence            57889999999999999999887765  46888876433323334567899999999 7999999999987654  4999


Q ss_pred             EEeccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCc
Q psy15481         88 VMELCTGGSLFNILDDPE-------------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST  154 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~-------------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~  154 (708)
                      ||||+++++|.+++....             ....+++..++.++.|++.||+|||++|++||||||+|||+    +..+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill----~~~~  156 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV----GENL  156 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE----CCCC
Confidence            999999999999986522             11238899999999999999999999999999999999998    6667


Q ss_pred             eEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChh
Q psy15481        155 IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNK  233 (708)
Q Consensus       155 ~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~  233 (708)
                      .+||+|||++..............+..|+|||.+.        +..++.++|||||||++|+|++ |..||..   ....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwSlG~il~el~t~g~~pf~~---~~~~  225 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLN--------YSVYTTKSDVWSFGVLLWEIVSLGGTPYCG---MTCA  225 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhc--------cCCCCchhhHHHHHHHHHHHHcCCCCCCCC---CCHH
Confidence            89999999987533221222223355799999886        5678999999999999999998 9999963   3333


Q ss_pred             hHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        234 ETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       234 e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      +....+....                    ..+.    +..++..+.+++.+||..||.+||++++++..+..++...
T Consensus       226 ~~~~~~~~~~--------------------~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         226 ELYEKLPQGY--------------------RMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHHHHHhcCC--------------------CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            3333332110                    0111    1123345667999999999999999999999988887644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=311.16  Aligned_cols=259  Identities=23%  Similarity=0.405  Sum_probs=202.2

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecC----C
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQE----G   82 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~----~   82 (708)
                      .+.+|.+.+.||+|++|.||+|.++.+++.|++|++.....  ..+.+.+|+.+++++ +||||+++++++....    +
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            46789999999999999999999999999999999875432  245567899999999 7999999999986543    4


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                      ..+|+||||+++++|.+++.... ....+++..+..++.|++.||.|||+.|++|+||+|+||++    +..+.++|+||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~----~~~~~~~l~d~  157 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL----TKNAEVKLVDF  157 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE----ccCCeEEECCC
Confidence            56899999999999999886532 11238999999999999999999999999999999999998    66678999999


Q ss_pred             Cccccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        162 GAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       162 GlA~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      |.+....... ......|+..|+|||++.....   ....++.++|||||||++|+|++|..||..   .........+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slG~il~~l~~g~~p~~~---~~~~~~~~~~~  231 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQ---PDASYDARSDVWSLGITAIELADGKPPLCD---MHPMRALFKIP  231 (275)
T ss_pred             ccceecccchhhhcCccccccccCHhHhccccc---ccCCccccccHHHhHHHHHHHHhCCCCccc---cchHHHHHHhh
Confidence            9987654332 2234568999999998852111   134578899999999999999999999973   23333333333


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      .....                  .++    .+...+..+.+++.+||..||++|||+.++
T Consensus       232 ~~~~~------------------~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l  269 (275)
T cd06608         232 RNPPP------------------TLK----SPENWSKKFNDFISECLIKNYEQRPFMEEL  269 (275)
T ss_pred             ccCCC------------------CCC----chhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence            21100                  111    112234556779999999999999999997

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=315.36  Aligned_cols=255  Identities=24%  Similarity=0.404  Sum_probs=206.0

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      +|.+.+.||.|++|.||+|.+..+|+.||+|.+...........+.+|+.+++.++||||+++++.+.+.  ...|+|+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e   79 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWIIME   79 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEEEE
Confidence            5788899999999999999999999999999987654333345567899999999999999999988765  45999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+++++|.+++...    .+++..+..++.|++.||.|||++|++|+||+|+||++    +..+.++|+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i----~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          80 YCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL----SEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----CCCCCEEEcccccceeeccc
Confidence            99999999999764    38999999999999999999999999999999999998    66778999999999876544


Q ss_pred             -ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        171 -QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       171 -~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                       .......++..|+|||.+.        +..++.++|+|||||++|+|+||..||...   +.......+....      
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~--------~~~~~~~sDv~slG~il~~l~tg~~p~~~~---~~~~~~~~~~~~~------  214 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIK--------QSGYDEKADIWSLGITAIELAKGEPPLSDL---HPMRVLFLIPKNN------  214 (274)
T ss_pred             ccccccccCCccccChhhhc--------cCCCCchhhHHHHHHHHHHHHhCCCCcccC---chHHHHHHhhhcC------
Confidence             2233457889999999987        556899999999999999999999999742   2222222222210      


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                  ...++..     ..+..+.+++.+||..||++||++.++           +.|+|+...
T Consensus       215 ------------~~~~~~~-----~~~~~~~~~l~~~l~~~p~~Rpt~~~i-----------l~~~~~~~~  257 (274)
T cd06609         215 ------------PPSLEGN-----KFSKPFKDFVSLCLNKDPKERPSAKEL-----------LKHKFIKKA  257 (274)
T ss_pred             ------------CCCCccc-----ccCHHHHHHHHHHhhCChhhCcCHHHH-----------hhChhhcCC
Confidence                        0011111     033446679999999999999999997           568998664

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.6e-36  Score=320.16  Aligned_cols=265  Identities=26%  Similarity=0.423  Sum_probs=210.0

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      -|+.+.+|.+.+.||+|+||.||++.+..+|+.||+|.+..... ...+...+|+.+++.++||||+++++.+....  .
T Consensus        14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~   90 (297)
T cd06656          14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGD--E   90 (297)
T ss_pred             cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--E
Confidence            36778899999999999999999999999999999999864332 23455678999999999999999999987644  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||++|++|.+++....    +++..+..++.+++.||.|||+.|++||||||+|||+    +..+.++|+|||.+
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili----~~~~~~~l~Dfg~~  162 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL----GMDGSVKLTDFGFC  162 (297)
T ss_pred             EEEeecccCCCCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEECcCccc
Confidence            999999999999999986532    8999999999999999999999999999999999998    66678999999998


Q ss_pred             cccccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        165 RELEEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       165 ~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ........ .....+++.|+|||.+.        +..++.++|+|||||++|++++|..||...   +.......+... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slGvil~~l~tg~~pf~~~---~~~~~~~~~~~~-  230 (297)
T cd06656         163 AQITPEQSKRSTMVGTPYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNE---NPLRALYLIATN-  230 (297)
T ss_pred             eEccCCccCcCcccCCccccCHHHHc--------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CcchheeeeccC-
Confidence            76544322 23356889999999987        567889999999999999999999999642   211111111100 


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcccc
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQC  323 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~  323 (708)
                                          ..|. ...+..++..+.+++.+||..||.+||++.++           +.|||+......
T Consensus       231 --------------------~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i-----------l~~~~~~~~~~~  278 (297)
T cd06656         231 --------------------GTPE-LQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL-----------LQHPFLKLAKPL  278 (297)
T ss_pred             --------------------CCCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHH-----------hcCchhcccccc
Confidence                                0000 00122334556779999999999999999997           668998765443


Q ss_pred             c
Q psy15481        324 I  324 (708)
Q Consensus       324 ~  324 (708)
                      .
T Consensus       279 ~  279 (297)
T cd06656         279 S  279 (297)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.9e-36  Score=313.00  Aligned_cols=261  Identities=24%  Similarity=0.346  Sum_probs=201.5

Q ss_pred             cccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481          3 FLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus         3 ~l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      .++......|.+.+.||+|+||.||+|.+..+|+.||+|++..... .......+|+.++++++||||+++++++...+ 
T Consensus         2 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-   79 (267)
T cd06646           2 ILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-   79 (267)
T ss_pred             ccccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-
Confidence            3556677889999999999999999999999999999999864432 22344568999999999999999999987654 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                       .+|+||||+++++|.+++....   .+++..+..++.|++.||.|||+.||+||||||+||++    +..+.++|+|||
T Consensus        80 -~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill----~~~~~~~l~dfg  151 (267)
T cd06646          80 -KLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL----TDNGDVKLADFG  151 (267)
T ss_pred             -EEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----CCCCCEEECcCc
Confidence             5899999999999999886543   38999999999999999999999999999999999998    666779999999


Q ss_pred             ccccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        163 AARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       163 lA~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      .+....... ......|+..|+|||.+...     ....++.++|+||+||++|+|++|..||...   .+.+....+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~---~~~~~~~~~~~  223 (267)
T cd06646         152 VAAKITATIAKRKSFIGTPYWMAPEVAAVE-----KNGGYNQLCDIWAVGITAIELAELQPPMFDL---HPMRALFLMSK  223 (267)
T ss_pred             cceeecccccccCccccCccccCHhHcccc-----cCCCCcchhhHHHHHHHHHHHHhCCCCcccc---chhhhheeeec
Confidence            998654322 22345688999999987421     1345788999999999999999999999631   11111111110


Q ss_pred             cccCCcccccccCCCCcccccC-CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        242 KKASGVISGTQTSENGEIDWCT-DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~-~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      .                 .+.. .++...    .++..+.+++.+||..||++||++++++.
T Consensus       224 ~-----------------~~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~Rp~~~~il~  264 (267)
T cd06646         224 S-----------------NFQPPKLKDKT----KWSSTFHNFVKISLTKNPKKRPTAERLLT  264 (267)
T ss_pred             C-----------------CCCCCCCcccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence            0                 0000 111111    23345667999999999999999999744

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.2e-36  Score=317.03  Aligned_cols=290  Identities=22%  Similarity=0.266  Sum_probs=212.1

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ......|.+.+.||.|+||.||+|.+..+|+.||+|.+....... ......+|+.++++++||||+++++++.+...+.
T Consensus         3 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             cccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence            345667999999999999999999999999999999986543222 1223458999999999999999999987765567


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||+. ++|.+++....  ..+++..+..++.|++.||.|||+.|++||||||+||++    +..+.++|+|||.+
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~----~~~~~~kL~dfg~~  155 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL----TDKGCLKIADFGLA  155 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCEEECcccee
Confidence            899999995 68888886533  238999999999999999999999999999999999998    66678999999999


Q ss_pred             ccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        165 RELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       165 ~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ....... ......++..|+|||.+..       ...++.++|+|||||++|+|++|.+||..   .+..+....+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~~f~~---~~~~~~~~~~~~~~  225 (309)
T cd07845         156 RTYGLPAKPMTPKVVTLWYRAPELLLG-------CTTYTTAIDMWAVGCILAELLAHKPLLPG---KSEIEQLDLIIQLL  225 (309)
T ss_pred             eecCCccCCCCcccccccccChhhhcC-------CCCcCchHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHhc
Confidence            8765432 2233456788999999862       35678999999999999999999999973   44555555444321


Q ss_pred             cCCc---cccccc-CCCCcccccC-CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        244 ASGV---ISGTQT-SENGEIDWCT-DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       244 ~~~~---i~~~~~-~~~g~~~~~~-~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      ....   ...... ...+...... ............+..+.++|.+||.+||++|||++++           +.|||+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i-----------l~h~~f~  294 (309)
T cd07845         226 GTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA-----------LESSYFK  294 (309)
T ss_pred             CCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH-----------hcChhhc
Confidence            1100   000000 0000000000 0000000111234456679999999999999999997           6799997


Q ss_pred             Ccccc
Q psy15481        319 NRLQC  323 (708)
Q Consensus       319 ~~~~~  323 (708)
                      ..+.+
T Consensus       295 ~~~~~  299 (309)
T cd07845         295 EKPLP  299 (309)
T ss_pred             cCCCC
Confidence            66554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG2345|consensus

Probab=100.00  E-value=2.4e-37  Score=307.82  Aligned_cols=266  Identities=22%  Similarity=0.356  Sum_probs=207.5

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEe---cCCce
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEE---QEGRG   84 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~---~~~~~   84 (708)
                      .|.+|.+.+.||.|||+-||++.+..+++.||+|.+...+ .+..+..++|++..++++|||++++++....   .....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            4679999999999999999999999999999999987655 3445667899999999999999999986532   13345


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTY-GLQEEEFLLVLEHLTAGMKHLRDNR--LVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~-~L~e~~v~~il~qIl~aL~yLH~~g--IVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                      .||+++|+..|||.+.+......+ -+++.+++.++.+|++||.+||+..  +.||||||+|||+    .+.+.++|+||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl----s~~~~~vl~D~  173 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL----SDSGLPVLMDL  173 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe----cCCCceEEEec
Confidence            899999999999999887643222 3999999999999999999999998  9999999999998    55678999999


Q ss_pred             Ccccccccc----------ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCC
Q psy15481        162 GAARELEED----------QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR  231 (708)
Q Consensus       162 GlA~~~~~~----------~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~  231 (708)
                      |.++...-.          +....-..|..|+|||.+.-     +.+...+.++|||||||+||.|+.|..||...    
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v-----k~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~----  244 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV-----KSHCTITERTDIWSLGCTLYAMMFGESPFERI----  244 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheec-----ccCcccccccchhhhhHHHHHHHHcCCcchHH----
Confidence            999754211          11223457899999999863     22677899999999999999999999999731    


Q ss_pred             hhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        232 NKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       232 ~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                              .....+ .-..+   .++.+    .+|...+.|.    .+..+++.||++||.+||++.+++..+++.
T Consensus       245 --------~~~GgS-laLAv---~n~q~----s~P~~~~yse----~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  245 --------YQQGGS-LALAV---QNAQI----SIPNSSRYSE----ALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             --------hhcCCe-EEEee---ecccc----ccCCCCCccH----HHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                    110000 00001   11222    3455444444    455699999999999999999998887764

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.6e-36  Score=314.76  Aligned_cols=277  Identities=25%  Similarity=0.383  Sum_probs=207.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|.+..... ......+.+|+.++++++||||+++++++...  ...|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeEEEe
Confidence            48899999999999999999999999999999875442 22234567899999999999999999998764  3599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+ |++|.+++....  ..+++..++.++.||+.||.|||+.|++|+||||+||++    +..+.++|+|||.+.....
T Consensus        79 e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~----~~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832          79 EYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI----SADGVLKIADFGLARLFSE  151 (286)
T ss_pred             ccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE----cCCCcEEEeeeeecccccC
Confidence            999 999999986543  238999999999999999999999999999999999998    6677899999999987654


Q ss_pred             cc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        170 DQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       170 ~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..  ......|+..|+|||.+..       ...++.++||||+||++|+|+||.+||.   +..+......+........
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~---~~~~~~~~~~~~~~~~~~~  221 (286)
T cd07832         152 EEPRLYSHQVATRWYRAPELLYG-------ARKYDPGVDLWAVGCIFAELLNGSPLFP---GENDIEQLAIVFRTLGTPN  221 (286)
T ss_pred             CCCCccccccCcccccCceeeec-------cccCCchhHHHHHHHHHHHHHcCCcCcC---CCCHHHHHHHHHHHcCCCC
Confidence            43  2334578999999998752       3457899999999999999999988886   3444444444443211100


Q ss_pred             cccc---ccC-CCCcccccCCCCC-cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        248 ISGT---QTS-ENGEIDWCTDLPN-NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       248 i~~~---~~~-~~g~~~~~~~lp~-~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ....   ... .-+.+.|....+. .....+..+..+.++|.+||..||.+||+++++           +.|||+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~-----------l~h~~~  285 (286)
T cd07832         222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA-----------LRHPYF  285 (286)
T ss_pred             hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHH-----------hhCcCc
Confidence            0000   000 0001111111000 001112344677889999999999999999997           668887

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.7e-36  Score=310.47  Aligned_cols=259  Identities=22%  Similarity=0.335  Sum_probs=201.6

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|.+.+.||+|+||.||+|.+..+|+.||||.+......  .....+.+|+.+++.++||||+++++++.+.+  ..++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN--ELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC--eEEE
Confidence            3688999999999999999999999999999988643222  22234578999999999999999999987654  5899


Q ss_pred             EEeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         88 VMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ||||+++++|.+++.... ....+++..+..++.+++.||.|||++|++|+||||+||++    +..+.++|+|||.+..
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~----~~~~~~~l~d~g~~~~  155 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI----TATGVVKLGDLGLGRF  155 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE----cCCCCEEECcccccee
Confidence            999999999998885321 12238999999999999999999999999999999999998    5566799999999886


Q ss_pred             cccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ...... .....|++.|+|||.+.        +..++.++|+||+|+++|+|++|..||.... .+.......+...   
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Di~slG~~l~el~~g~~p~~~~~-~~~~~~~~~~~~~---  223 (267)
T cd08228         156 FSSKTTAAHSLVGTPYYMSPERIH--------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLFSLCQKIEQC---  223 (267)
T ss_pred             ccchhHHHhcCCCCccccChhhhc--------cCCCCchhhHHHHHHHHHHHhcCCCCCcccc-ccHHHHHHHHhcC---
Confidence            544322 23456889999999987        5667889999999999999999999996311 1222222222210   


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                                        ..|.  ..+...+..+.+++.+||..||.+||++.+++..+..
T Consensus       224 ------------------~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~  264 (267)
T cd08228         224 ------------------DYPP--LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ  264 (267)
T ss_pred             ------------------CCCC--CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence                              0011  0112344567789999999999999999998876653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-36  Score=315.97  Aligned_cols=278  Identities=24%  Similarity=0.324  Sum_probs=200.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|++|.||+|.++.+|+.||+|.+.............+|+.+++.++||||+++++++.+..  ..|+||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK--TLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC--eEEEEE
Confidence            468899999999999999999999999999999875443333344568999999999999999999987543  699999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+. ++|.+++.....  .+++..++.++.|++.||.|||++|++||||||+||++    +.++.++|+|||+++....
T Consensus        83 e~~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~----~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          83 EYLD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI----SERGELKLADFGLARAKSV  155 (291)
T ss_pred             ecCC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE----cCCCCEEECccccccccCC
Confidence            9996 599998865432  38999999999999999999999999999999999998    6677899999999875432


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh---cccC
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT---KKAS  245 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~---~~~~  245 (708)
                      .. ......++..|+|||++..       ...++.++||||+||++|+|++|..||...  ....+.+..+..   ....
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~--~~~~~~~~~~~~~~~~~~~  226 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLG-------STEYSTSLDMWGVGCIFYEMATGRPLFPGS--TDVEDQLHKIFRVLGTPTE  226 (291)
T ss_pred             CCccccccccccccCCcHHhhc-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCC--ccHHHHHHHHHHhcCCCCh
Confidence            21 1223457889999998862       345788999999999999999999999642  112233322221   1111


Q ss_pred             CcccccccCCCCcccccCCCCCccc---CChhHH--HHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQ---LSLGLK--KLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~---ls~~l~--~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .......... ....+.........   ..+.+.  ..+.+++.+||..||.+|||+.++           +.||||
T Consensus       227 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~-----------l~~~~f  291 (291)
T cd07844         227 ETWPGVSSNP-EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEA-----------MKHPYF  291 (291)
T ss_pred             hhhhhhhhcc-ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHH-----------hcCCCC
Confidence            1110000000 00000000000000   001111  445679999999999999999997           668875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.9e-36  Score=315.29  Aligned_cols=257  Identities=24%  Similarity=0.385  Sum_probs=197.5

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      ...+|.+.+.||+|+||.||+|.+.     .++..||+|.++..........+.+|+.+++.++||||+++++++.... 
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence            3457899999999999999999865     2457899999865433233344678999999999999999999986544 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCce
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPEN-------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTI  155 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~-------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~  155 (708)
                       ..++||||+++++|.+++.....       ...++...+..++.|++.||.|||++|++||||||+||++    ++.+.
T Consensus        83 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~----~~~~~  157 (277)
T cd05062          83 -PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFT  157 (277)
T ss_pred             -CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE----cCCCC
Confidence             59999999999999999865221       1236778899999999999999999999999999999998    66678


Q ss_pred             EEEeccCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCC
Q psy15481        156 YKLTDFGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRR  231 (708)
Q Consensus       156 vKL~DFGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~  231 (708)
                      ++|+|||++.........   ....++..|+|||.+.        +..++.++|+|||||++|+|++ |..||..   ..
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~~~~~~p~~~---~~  226 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK--------DGVFTTYSDVWSFGVVLWEIATLAEQPYQG---MS  226 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhh--------cCCcCchhHHHHHHHHHHHHHcCCCCCCCC---CC
Confidence            999999998765433221   1234577899999987        5678999999999999999999 7889863   33


Q ss_pred             hhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        232 NKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       232 ~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                      .......+....                     .+.   .+...+..+.+++.+||+.||++|||+.+++..+.
T Consensus       227 ~~~~~~~~~~~~---------------------~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         227 NEQVLRFVMEGG---------------------LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHHHHHcCC---------------------cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            333333332210                     000   11223345677999999999999999999877643

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.6e-36  Score=315.39  Aligned_cols=259  Identities=20%  Similarity=0.332  Sum_probs=201.0

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCC-----CceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNN-----GEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEG   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~   82 (708)
                      ...|.+.+.||+|+||.||++.+...     ...||+|.+.............+|+.+++++ +||||+++++++...+ 
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-   89 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG-   89 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC-
Confidence            45789999999999999999988643     3789999987543333334467899999999 8999999999987654 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEe
Q psy15481         83 RGKVIVMELCTGGSLFNILDDP-------------ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFIC  149 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~-------------~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~  149 (708)
                       .++++|||+++|+|..++...             .....+++..+..++.|++.||.|||++||+||||||+||++   
T Consensus        90 -~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~---  165 (293)
T cd05053          90 -PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV---  165 (293)
T ss_pred             -CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---
Confidence             499999999999999998642             112348999999999999999999999999999999999998   


Q ss_pred             cCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCC
Q psy15481        150 DDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFR  225 (708)
Q Consensus       150 ~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~  225 (708)
                       +..+.+||+|||.+........   .....++..|+|||.+.        +..++.++|||||||++|++++ |..||.
T Consensus       166 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~~g~~p~~  236 (293)
T cd05053         166 -TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF--------DRVYTHQSDVWSFGVLLWEIFTLGGSPYP  236 (293)
T ss_pred             -cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc--------cCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence             5667899999999987654322   11233456899999886        5778999999999999999998 999996


Q ss_pred             CCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        226 PYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       226 ~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                      .   ....+. ........                   ..+    .+......+.+++.+||..||++|||+.+++..+.
T Consensus       237 ~---~~~~~~-~~~~~~~~-------------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~  289 (293)
T cd05053         237 G---IPVEEL-FKLLKEGY-------------------RME----KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD  289 (293)
T ss_pred             C---CCHHHH-HHHHHcCC-------------------cCC----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence            3   333332 22222100                   001    11122345667999999999999999999999988


Q ss_pred             HHH
Q psy15481        306 KTL  308 (708)
Q Consensus       306 ~il  308 (708)
                      +++
T Consensus       290 ~~~  292 (293)
T cd05053         290 RML  292 (293)
T ss_pred             Hhh
Confidence            764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.5e-36  Score=309.71  Aligned_cols=251  Identities=26%  Similarity=0.427  Sum_probs=201.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|++.+.||.|+||.||++.+..+|..||+|.+...... ...+....|+.++++++||||+++++.+....+...|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            378899999999999999999999999999998754322 2234456899999999999999999988766666789999


Q ss_pred             eccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         90 ELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLR-----DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH-----~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ||+++++|.+++.... ....+++..++.++.+|+.||.|||     +.+++|+||+|+||++    +..+.++|+|||.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili----~~~~~~kl~d~g~  156 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL----DANNNVKLGDFGL  156 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE----ecCCCEEEecccc
Confidence            9999999999886531 1223899999999999999999999     8999999999999998    5667899999999


Q ss_pred             ccccccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        164 ARELEEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       164 A~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      +........ .....|++.|+|||.+.        +..++.++|+||||+++|+|++|..||..   .+.......+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~--------~~~~~~~~Dv~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~  225 (265)
T cd08217         157 AKILGHDSSFAKTYVGTPYYMSPEQLN--------HMSYDEKSDIWSLGCLIYELCALSPPFTA---RNQLQLASKIKEG  225 (265)
T ss_pred             cccccCCcccccccccCCCccChhhhc--------CCCCCchhHHHHHHHHHHHHHHCCCcccC---cCHHHHHHHHhcC
Confidence            987765543 34467899999999987        55688999999999999999999999974   3333322222211


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      .                     .+   .++...+..+.+++..||..||.+||++.++
T Consensus       226 ~---------------------~~---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~i  259 (265)
T cd08217         226 K---------------------FR---RIPYRYSSELNEVIKSMLNVDPDKRPSTEEL  259 (265)
T ss_pred             C---------------------CC---CCccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence            0                     01   1223344567779999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-36  Score=309.93  Aligned_cols=255  Identities=23%  Similarity=0.369  Sum_probs=201.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCC---CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNN---GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|.+.+.||+|+||.||+|.++.+   ...||+|.+...........+.+|+.++++++||||+++++++...+  ..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~   81 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR--PVM   81 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC--ceE
Confidence            3578899999999999999998654   45799999875443333445678999999999999999999987644  489


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||+++++|.+++.....  .+++..+..++.|++.||.|||++||+|+||||+||++    +..+.++|+|||++..
T Consensus        82 iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili----~~~~~~~l~dfg~~~~  155 (266)
T cd05033          82 IITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV----NSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE----cCCCCEEECccchhhc
Confidence            99999999999999876432  38999999999999999999999999999999999998    6677899999999987


Q ss_pred             cccc-cccc--ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhc
Q psy15481        167 LEED-QQFM--SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       167 ~~~~-~~~~--~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .... ....  ...++..|+|||.+.        +..++.++|+|||||++|+|++ |..||..   ..+......+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~--------~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~---~~~~~~~~~~~~~  224 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIA--------YRKFTSASDVWSFGIVMWEVMSYGERPYWD---MSNQDVIKAVEDG  224 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhc--------cCCCccccchHHHHHHHHHHHccCCCCCCC---CCHHHHHHHHHcC
Confidence            6522 1112  233467899999986        5678899999999999999998 9999963   3344444444321


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      .                    ..|...    ..+..+.+++..||..||++||++.++++.+.++
T Consensus       225 ~--------------------~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 Y--------------------RLPPPM----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C--------------------CCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0                    111111    2234566799999999999999999998887654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4e-36  Score=312.44  Aligned_cols=263  Identities=23%  Similarity=0.406  Sum_probs=202.0

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecC----C
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQE----G   82 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~----~   82 (708)
                      ....|.+.+.||+|+||.||+|.+..+++.||+|.+....  .......+|+.+++++ +||||+++++.+....    .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            3456888899999999999999999999999999986532  2334566899999998 7999999999986533    2


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                      ..+|+||||+++++|.+++..... ..+++..+..++.|++.||+|||++||+|+||||+||++    +.++.++|+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili----~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL----TENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE----CCCCCEEEccCC
Confidence            358999999999999999876432 238999999999999999999999999999999999998    666789999999


Q ss_pred             ccccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        163 AARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       163 lA~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      ++....... ......|+..|+|||++....   ..+..++.++|+||+||++|+|++|..||...   ........+..
T Consensus       157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~---~~~~~~~~~~~  230 (272)
T cd06637         157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEGAPPLCDM---HPMRALFLIPR  230 (272)
T ss_pred             CceecccccccCCcccccccccCHhHhcccc---CcCCCCCchhhHHHHHHHHHHHHhCCCCcccc---CHHHHHHHHhc
Confidence            998654322 233467899999999985211   11346788999999999999999999999642   22222211111


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ...                  ..+     .....+..+.+++.+||..||.+|||+.++           +.|||+
T Consensus       231 ~~~------------------~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i-----------l~~~~~  272 (272)
T cd06637         231 NPA------------------PRL-----KSKKWSKKFQSFIESCLVKNHSQRPTTEQL-----------MKHPFI  272 (272)
T ss_pred             CCC------------------CCC-----CCCCcCHHHHHHHHHHcCCChhhCCCHHHH-----------hhCCCC
Confidence            000                  000     111223456679999999999999999997           568875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.2e-36  Score=310.54  Aligned_cols=255  Identities=22%  Similarity=0.415  Sum_probs=201.1

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-----chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-----PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-----~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      |+..+.||+|++|.||++.+..+|+.||+|.+.......     ....+.+|+.++++++||||+++++++.+.+  ..+
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~   79 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS--HFN   79 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--eEE
Confidence            778899999999999999999999999999986433211     1234578999999999999999999987654  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC-ceEEEeccCccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS-TIYKLTDFGAAR  165 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~-~~vKL~DFGlA~  165 (708)
                      +||||++|++|.+++....   .+++..++.++.|++.||.|||++|++|+||+|+||++    +.. ..++|+|||.+.
T Consensus        80 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~----~~~~~~~~l~dfg~~~  152 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI----DSTGQRLRIADFGAAA  152 (268)
T ss_pred             EEEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEEccccccc
Confidence            9999999999999997643   38999999999999999999999999999999999997    443 369999999998


Q ss_pred             ccccccc-----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        166 ELEEDQQ-----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       166 ~~~~~~~-----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      .......     .....|+..|+|||.+.        +..++.++|+||+||++|++++|..||..............+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  224 (268)
T cd06630         153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLR--------GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA  224 (268)
T ss_pred             ccccccccCCccccccccccceeCHhHhc--------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh
Confidence            6643311     12246788999999986        5677899999999999999999999997433222222222221


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ..                       .....+++.++..+.+++..||..||.+||++.++           +.|||+
T Consensus       225 ~~-----------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l-----------l~~~~~  267 (268)
T cd06630         225 SA-----------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL-----------LKHPVF  267 (268)
T ss_pred             cc-----------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHH-----------hcCccc
Confidence            10                       00111333455567779999999999999999997           668886

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-36  Score=333.98  Aligned_cols=277  Identities=22%  Similarity=0.269  Sum_probs=204.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc--CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK--NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~--~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..+|.+.+.||.|+||.||++...  .++..||+|.+....      ...+|+.++++++||||+++++++....  ..|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKS--TVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCC--EEE
Confidence            346999999999999999999764  356889999875421      2348999999999999999999987644  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|||++ +++|..++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.++|+|||++..
T Consensus       163 lv~e~~-~~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill----~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        163 MVMPKY-KCDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL----DEPENAVLGDFGAACK  234 (392)
T ss_pred             EEehhc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----cCCCCEEEccCccccc
Confidence            999999 478888885433   38999999999999999999999999999999999998    6677899999999976


Q ss_pred             cccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        167 LEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       167 ~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ......   .....||+.|+|||++.        +..|+.++|||||||++|+|++|..||.+.........+..+....
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~  306 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLA--------LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM  306 (392)
T ss_pred             cCcccccccccccccccCccCHhHhc--------CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh
Confidence            544321   23457999999999987        6778999999999999999999999997644444444454444321


Q ss_pred             cCCcccccccCC----------CCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhc
Q psy15481        244 ASGVISGTQTSE----------NGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLV  313 (708)
Q Consensus       244 ~~~~i~~~~~~~----------~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~  313 (708)
                      ......-.....          .........+|.. .........+.++|.+||..||++|||+.++           +.
T Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~-----------l~  374 (392)
T PHA03207        307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPV-IRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI-----------LS  374 (392)
T ss_pred             ccCccccCCccchhHHHHHHhhcccccCCccccch-hhccCcchhHHHHHHHHhccChhhCCCHHHH-----------hh
Confidence            111000000000          0000000011110 0011223456679999999999999999997           67


Q ss_pred             CcccCCcc
Q psy15481        314 HLFHINRL  321 (708)
Q Consensus       314 h~~~~~~~  321 (708)
                      ||||...+
T Consensus       375 ~p~f~~~~  382 (392)
T PHA03207        375 LPLFTKEP  382 (392)
T ss_pred             Cchhhccc
Confidence            99996543

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4e-36  Score=317.30  Aligned_cols=284  Identities=21%  Similarity=0.287  Sum_probs=209.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC----CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM----RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~----~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      +|.+.+.||.|++|.||+|.+..+|+.||+|.+......    ........|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~   78 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK--SNIN   78 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--CEEE
Confidence            478889999999999999999999999999999755432    1123346799999999999999999999774  4599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||+ +++|.+++....  ..+++..+..++.||+.||.|||++|++|+||+|+||++    +..+.++|+|||.+..
T Consensus        79 lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill----~~~~~~~l~dfg~~~~  151 (298)
T cd07841          79 LVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI----ASDGVLKLADFGLARS  151 (298)
T ss_pred             EEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE----cCCCCEEEccceeeee
Confidence            999999 899999997654  138999999999999999999999999999999999998    5667899999999987


Q ss_pred             cccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .... .......++..|+|||.+..       ...++.++|+|||||++|+|++|.+||..   ..+.+.+.++......
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~e~~~g~~~~~~---~~~~~~~~~~~~~~~~  221 (298)
T cd07841         152 FGSPNRKMTHQVVTRWYRAPELLFG-------ARHYGVGVDMWSVGCIFAELLLRVPFLPG---DSDIDQLGKIFEALGT  221 (298)
T ss_pred             ccCCCccccccccceeeeCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHcCCccccC---CccHHHHHHHHHHcCC
Confidence            6543 22333457888999998852       35678999999999999999999888863   3344444444321100


Q ss_pred             CcccccccC--CCCcccccCCCCC-cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        246 GVISGTQTS--ENGEIDWCTDLPN-NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       246 ~~i~~~~~~--~~g~~~~~~~lp~-~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      .........  ......+....+. ...+....+..+.+++.+||.+||.+|||+.++           +.|+|+.+.+.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~-----------l~~~~~~~~~~  290 (298)
T cd07841         222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA-----------LEHPYFSNDPA  290 (298)
T ss_pred             CchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHH-----------hhCccccCCCC
Confidence            000000000  0000001000000 011123345567789999999999999999997           66999988766


Q ss_pred             cc
Q psy15481        323 CI  324 (708)
Q Consensus       323 ~~  324 (708)
                      +.
T Consensus       291 ~~  292 (298)
T cd07841         291 PT  292 (298)
T ss_pred             CC
Confidence            44

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.7e-36  Score=315.97  Aligned_cols=271  Identities=25%  Similarity=0.323  Sum_probs=201.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEE----cCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVN----KNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~----~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ++.|.+.+.||+|+||.||++..    +.++..||+|.+...........+.+|+.+++.++||||+++++++...+...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            45678899999999999999974    46788999999875544444456779999999999999999999988765566


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .++||||++|++|.+++.....  .+++..+..++.|++.||+|||++|++||||||+||++    +..+.++|+|||++
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~----~~~~~~~l~dfg~~  156 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV----ESEHQVKIGDFGLT  156 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE----cCCCCEEECCCccc
Confidence            8999999999999999865432  38999999999999999999999999999999999998    55667999999999


Q ss_pred             cccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        165 RELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       165 ~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ........    .....++..|+|||.+.        +..++.++|||||||++|+|+||+.|+...  .   .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~--------~~~~~~~~Di~slG~il~ellt~~~~~~~~--~---~~~~~~~  223 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLI--------QSKFYIASDVWSFGVTLYELLTYCDSESSP--M---TLFLKMI  223 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhc--------cCCCCccccchhhhhhhhhhhcCCCCCccc--c---chhhhhc
Confidence            87654322    12345677899999886        567889999999999999999988765321  0   0000000


Q ss_pred             hcccCC-ccc-ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        241 TKKASG-VIS-GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       241 ~~~~~~-~i~-~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ...... ... .......+     ...|..    ..++..+.+++.+||..||.+||++++++..++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~-----~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         224 GPTHGQMTVTRLVRVLEEG-----KRLPRP----PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccccccccHHHHHHHHHcC-----ccCCCC----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000000 000 00000000     011111    22344567799999999999999999999887765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.5e-36  Score=311.92  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=204.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|++.+.||.|+||.||+|.+..+|..||+|.+......  .....+.+|+.++++++||||+++++.+.+..  ..|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE--NMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--eEEEE
Confidence            388999999999999999999999999999999754322  23455678999999999999999999886544  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||+.|++|..++....   .+++..+..++.|++.||.|||++|++|+||+|+||++    +..+.++|+|||.+....
T Consensus        79 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~----~~~~~~~l~d~~~~~~~~  151 (258)
T cd05578          79 VDLLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL----DEQGHVHITDFNIATKVT  151 (258)
T ss_pred             EeCCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE----cCCCCEEEeecccccccC
Confidence            99999999999997652   38999999999999999999999999999999999998    666789999999998766


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .........|+..|+|||.+.        +..++.++|+||||+++|+|++|..||............ .....      
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~------  216 (258)
T cd05578         152 PDTLTTSTSGTPGYMAPEVLC--------RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-AKQET------  216 (258)
T ss_pred             CCccccccCCChhhcCHHHHc--------ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-HHhcc------
Confidence            554445567899999999987        456889999999999999999999999753222122221 11110      


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH--HHHHHHHHHHHhhhhcCccc
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF--ERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa--~q~~~~l~~il~~~l~h~~~  317 (708)
                                        .....++..+..+.++|.+||..||.+||++  .++           +.|||+
T Consensus       217 ------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l-----------~~~~~~  258 (258)
T cd05578         217 ------------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDL-----------KNHPYF  258 (258)
T ss_pred             ------------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHH-----------hcCCCC
Confidence                              0001122334567779999999999999999  665           567775

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=306.03  Aligned_cols=254  Identities=23%  Similarity=0.342  Sum_probs=200.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||.|+||.||+|.+..+++.+++|.+...... ......+|+.++++++||||+++++.+....  .+|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRD--KLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCC--EEEEEE
Confidence            4688999999999999999999999999999998754322 3455679999999999999999999887644  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++|++|.+++....  ..+++..+..++.|++.||.|||++|++|+||+|+||++    +..+.++|+|||.+.....
T Consensus        80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i----~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL----TEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE----CCCCCEEECccccchhhhh
Confidence            9999999999887642  238999999999999999999999999999999999998    6667799999999986544


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .. ......++..|+|||.+....     ...++.++|+|||||++|+|+||.+||..   .+.......+.....    
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~-----~~~~~~~~Di~slG~~l~~~~tg~~p~~~---~~~~~~~~~~~~~~~----  221 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVER-----KGGYDGKCDIWALGITAIELAELQPPMFD---LHPMRALFLISKSNF----  221 (262)
T ss_pred             hhhccccccCCccccCchhhcccc-----cCCcCchhhhHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhccC----
Confidence            32 233457889999999986210     12678899999999999999999999974   333333332222100    


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                      .+.........+..+.+++.+||..||..||++.++
T Consensus       222 ----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  257 (262)
T cd06613         222 ----------------PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKL  257 (262)
T ss_pred             ----------------CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence                            000011122334557789999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.8e-36  Score=314.34  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=202.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|++|.||++.+..+++.||+|++.....  ....+...+|++++++++||||+++++++.+.+  .+|+|
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v   79 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS--NLYLV   79 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--eEEEE
Confidence            58889999999999999999999999999999864322  222345678999999999999999999987644  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++|++|.+++....   .+++..+..++.|++.||.|||++|++|+||+|+||++    +..+.+||+|||++....
T Consensus        80 ~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili----~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          80 MEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL----DSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE----CCCCCEEEeeCCCccccC
Confidence            99999999999997653   38999999999999999999999999999999999998    666789999999998765


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      ..  .....|++.|+|||.+.        +..++.++|+||||+++|+|++|..||..   .........+....     
T Consensus       153 ~~--~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~~-----  214 (290)
T cd05580         153 GR--TYTLCGTPEYLAPEIIL--------SKGYGKAVDWWALGILIYEMLAGYPPFFD---DNPIQIYEKILEGK-----  214 (290)
T ss_pred             CC--CCCCCCCccccChhhhc--------CCCCCccccHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcCC-----
Confidence            44  33457899999999986        55678899999999999999999999974   22333333333210     


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                      .+    ++..++..+.++|.+||..||.+|+     +++++           +.|||+..
T Consensus       215 ----------------~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l-----------~~~~~~~~  259 (290)
T cd05580         215 ----------------VR----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDI-----------KNHPWFAG  259 (290)
T ss_pred             ----------------cc----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHH-----------HcCccccc
Confidence                            01    1122234566799999999999999     66665           56888744

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.8e-36  Score=323.24  Aligned_cols=279  Identities=18%  Similarity=0.192  Sum_probs=198.5

Q ss_pred             EeeEeecC--CceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         14 TTSVLGKG--ATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        14 i~~~LG~G--~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      +.++||+|  +||.||++.++.+|+.||+|.+....... ......+|+.+++.++||||+++++++...+  ..|+|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--EEEEEEe
Confidence            46789999  78999999999999999999987543322 2234568999999999999999999997654  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+++|+|.+++..... .++++..++.++.|++.||+|||++||+||||||+|||+    +..+.++++|||.+......
T Consensus        80 ~~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~----~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          80 FMAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI----SVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             ccCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE----ecCCcEEEcccchhhccccc
Confidence            9999999999865321 238999999999999999999999999999999999998    55667999999876443211


Q ss_pred             cc--------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        171 QQ--------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       171 ~~--------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      ..        .....++..|+|||++...      ...++.++|||||||++|+|++|..||..   .............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~---~~~~~~~~~~~~~  225 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQN------LQGYDAKSDIYSVGITACELANGHVPFKD---MPATQMLLEKLNG  225 (327)
T ss_pred             cccccccccccccccceecccChHHhhcc------cCCCCchhhHHHHHHHHHHHHHCCCCCCC---cchhHHHHHHhcC
Confidence            10        1123567789999998621      14588999999999999999999999973   2222222222211


Q ss_pred             ccCCcccccc---------cC---CCC-c--------ccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHH
Q psy15481        243 KASGVISGTQ---------TS---ENG-E--------IDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFF  301 (708)
Q Consensus       243 ~~~~~i~~~~---------~~---~~g-~--------~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~  301 (708)
                      ..+..+....         ..   ... .        .......+...+....++..+.+++.+||..||++|||++++ 
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~el-  304 (327)
T cd08227         226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTL-  304 (327)
T ss_pred             CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHH-
Confidence            1111000000         00   000 0        000000001111223445667789999999999999999997 


Q ss_pred             HHHHHHHhhhhcCcccCC
Q psy15481        302 SEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       302 ~~l~~il~~~l~h~~~~~  319 (708)
                                +.|||+..
T Consensus       305 ----------l~~p~f~~  312 (327)
T cd08227         305 ----------LNHSFFKQ  312 (327)
T ss_pred             ----------hcChhhhh
Confidence                      67899854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-36  Score=317.71  Aligned_cols=257  Identities=27%  Similarity=0.425  Sum_probs=204.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|++|.||+|.+..+|+.||+|.+.......  ....+.+|+++++.++||||+++++.+.+..  ..|+|
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv   79 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET--YLCLV   79 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC--EEEEE
Confidence            5889999999999999999999999999999997653332  2344578999999999999999999987643  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||+.|++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||||+||++    +.++.++|+|||.+....
T Consensus        80 ~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          80 MDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL----HESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE----cCCCCEEEeecchhhccc
Confidence            99999999999987532 2348999999999999999999999999999999999998    556779999999987543


Q ss_pred             cccc------------------------------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHh
Q psy15481        169 EDQQ------------------------------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVA  218 (708)
Q Consensus       169 ~~~~------------------------------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLl  218 (708)
                      ....                              .....|+..|+|||++.        +..++.++|||||||++|+|+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Di~slG~ll~~l~  226 (316)
T cd05574         155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS--------GDGHGSAVDWWTLGILLYEML  226 (316)
T ss_pred             ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc--------CCCCCchHHHHHHHHHHHHHh
Confidence            2211                              11236888999999987        566889999999999999999


Q ss_pred             cCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC--
Q psy15481        219 TGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS--  296 (708)
Q Consensus       219 TG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps--  296 (708)
                      +|..||..   .+....+..+.....                   .++....    ++..+.+++.+||..||++||+  
T Consensus       227 ~g~~pf~~---~~~~~~~~~~~~~~~-------------------~~~~~~~----~~~~~~~li~~~l~~~p~~R~s~~  280 (316)
T cd05574         227 YGTTPFKG---SNRDETFSNILKKEV-------------------TFPGSPP----VSSSARDLIRKLLVKDPSKRLGSK  280 (316)
T ss_pred             hCCCCCCC---CchHHHHHHHhcCCc-------------------cCCCccc----cCHHHHHHHHHHccCCHhHCCCch
Confidence            99999973   444444444442111                   1122111    3455677999999999999999  


Q ss_pred             --HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        297 --FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       297 --a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                        ++++           +.|||+..
T Consensus       281 ~~~~~l-----------l~~~~~~~  294 (316)
T cd05574         281 RGAAEI-----------KQHPFFRG  294 (316)
T ss_pred             hhHHHH-----------HcCchhhc
Confidence              7775           56888754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-36  Score=306.53  Aligned_cols=248  Identities=26%  Similarity=0.430  Sum_probs=199.0

Q ss_pred             eEeecCCceEEEEEEEcCC---CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNN---GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~t---g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+...   +..||+|.+.............+|+.+++.++||||+++++++..  ...+++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEec
Confidence            4699999999999999866   899999999765443334556789999999999999999999876  34599999999


Q ss_pred             CCCCHHHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         93 TGGSLFNILDDPEN------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        93 ~ggsL~~~L~~~~~------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|++|.+++.....      ...+++..+..++.|++.||.|||++|++|+||||+||++    +..+.++|+|||.+..
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili----~~~~~~~l~dfg~~~~  154 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV----GEDLVVKISDFGLSRD  154 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE----CCCCcEEEcccccccc
Confidence            99999999987521      1348999999999999999999999999999999999998    6667899999999987


Q ss_pred             ccccc---cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhc
Q psy15481        167 LEEDQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       167 ~~~~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .....   ......++..|+|||.+.        +..++.++|||||||++|+|++ |..||..   ....+....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~~g~~p~~~---~~~~~~~~~~~~~  223 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLK--------DGIFTSKSDVWSFGVLLWEIFTLGATPYPG---LSNEEVLEYLRKG  223 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhc--------cCCcchhhccHHHHHHHHHHHhcCCCCCCC---CCHHHHHHHHHcC
Confidence            65442   223456788999999887        4578999999999999999999 6999974   3334443333321


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      .                    ..+    .+..++..+.+++.+||..||.+|||+.++++.+
T Consensus       224 ~--------------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         224 Y--------------------RLP----KPEYCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             C--------------------CCC----CCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            0                    111    1122245567799999999999999999987754

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-36  Score=329.11  Aligned_cols=192  Identities=22%  Similarity=0.388  Sum_probs=163.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|+.....       ...|+.++++++||||+++++++....  ..++||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~  136 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGA--ITCMVL  136 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCC--eeEEEE
Confidence            45899999999999999999999999999999854321       236999999999999999999987654  589999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      +|+ .++|.+++....  ..+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.....
T Consensus       137 e~~-~~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill----~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        137 PHY-SSDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI----NDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             Ecc-CCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEEecCcccccccc
Confidence            999 468888876533  238999999999999999999999999999999999998    6677899999999986544


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC-CCCCC
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG-NLPFR  225 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG-~~PF~  225 (708)
                      ........||..|+|||++.        +..++.++|||||||++|+|+++ ..+|.
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlGvvl~ell~~~~~~f~  258 (357)
T PHA03209        210 APAFLGLAGTVETNAPEVLA--------RDKYNSKADIWSAGIVLFEMLAYPSTIFE  258 (357)
T ss_pred             CcccccccccccccCCeecC--------CCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence            44445567999999999987        56789999999999999999985 44444

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.4e-36  Score=311.99  Aligned_cols=275  Identities=25%  Similarity=0.368  Sum_probs=206.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|++.+.||.|++|.||+|.+..+|..||+|.+.............+|+.+++.++||||+++++.+.+.+  ..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN--KLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEEEEEe
Confidence            37889999999999999999999999999999976544444455678999999999999999999998754  4899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |++ ++|.+++........+++..+..++.|++.||.|||++|++||||||+||++    +..+.++|+|||.+......
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~----~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI----NKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE----CCCCcEEEeecchhhhhcCC
Confidence            997 5888887654433348999999999999999999999999999999999998    66678999999999765432


Q ss_pred             c-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc---CC
Q psy15481        171 Q-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA---SG  246 (708)
Q Consensus       171 ~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~---~~  246 (708)
                      . ......++..|++||.+..       +..++.++|+|||||++|+|++|..||.+   .+..+....+.....   ..
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~---~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLG-------SRTYSTSIDIWSVGCIMAEMITGRPLFPG---TNNEDQLLKIFRIMGTPTES  223 (284)
T ss_pred             ccccccccccccccChHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCcHHHHHHHHHHhCCCChh
Confidence            2 2234567889999998862       34578899999999999999999999974   344444444332110   00


Q ss_pred             cccccccCCCCcccccCCCCCcc-----cCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNC-----QLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~-----~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ......    ....|....|...     .+.+..+..+.+++.+||+.||.+||++.++           +.||||
T Consensus       224 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~-----------l~~~~f  284 (284)
T cd07836         224 TWPGIS----QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA-----------LQHPWF  284 (284)
T ss_pred             hHHHHh----cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH-----------hcCCCC
Confidence            000000    0011111222111     1112334567789999999999999999997           668875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-35  Score=311.45  Aligned_cols=268  Identities=28%  Similarity=0.388  Sum_probs=207.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|...+.||.|++|.||++.+..+++.||+|.+...........+.+|++++++++||||+++++++.+.....+|+|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            57889999999999999999999999999999876544334455679999999999999999999987666667999999


Q ss_pred             ccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         91 LCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        91 y~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |++|++|.+++... .....+++..+..++.|++.||.|||+.|++|+||+|+||++    +..+.++|+|||++.....
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~----~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL----TRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----ecCCeEEEeeccccccccc
Confidence            99999998876531 112338999999999999999999999999999999999998    5566799999999876543


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC--CChhhHHHHHHhcccCCc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG--RRNKETMYYITTKKASGV  247 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g--~~~~e~~~~i~~~~~~~~  247 (708)
                      .. .....++..|+|||.+.        +..++.++|+|||||++|+|++|..||.....  ....+....+.....+  
T Consensus       158 ~~-~~~~~~~~~y~~pE~~~--------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  226 (287)
T cd06621         158 SL-AGTFTGTSFYMAPERIQ--------GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP--  226 (287)
T ss_pred             cc-cccccCCccccCHHHhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch--
Confidence            22 22356788999999986        56788999999999999999999999975321  1222222222221100  


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                      .++............+.+++..||..||.+|||+.++           +.|+|+.+.
T Consensus       227 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ei-----------l~~~~~~~~  272 (287)
T cd06621         227 ----------------ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDM-----------LEHPWIKAQ  272 (287)
T ss_pred             ----------------hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHH-----------HhCcccccc
Confidence                            1111111112234567789999999999999999997           679998443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-36  Score=311.08  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=194.0

Q ss_pred             eEeecCCceEEEEEEEcCCCc--eEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGE--PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~--~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+|.  .+++|.++..........+.+|+.++.++ +||||+++++++...+  ..|+||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--CceEEEEeC
Confidence            368999999999999988876  46888876433333344567899999999 8999999999987654  489999999


Q ss_pred             CCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         93 TGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        93 ~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      ++|+|.+++.....             ...+++..+..++.|++.||+|||++|++||||||+||++    +..+.+||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili----~~~~~~kl~  154 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIA  154 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE----cCCCeEEEC
Confidence            99999999865321             1237899999999999999999999999999999999998    677789999


Q ss_pred             ccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHH
Q psy15481        160 DFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       160 DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~  238 (708)
                      |||++..............+..|+|||.+.        +..++.++|+|||||++|+|++ |..||..   .+..+....
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~--------~~~~~~~~Di~slG~il~el~~~g~~pf~~---~~~~~~~~~  223 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLN--------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---MTCAELYEK  223 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHc--------cCCCCchhhHHHHHHHHHHHHcCCCCCccc---cCHHHHHHH
Confidence            999986433221122233456799999886        5678999999999999999997 9999963   333333332


Q ss_pred             HHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                      +...                  +....+      ......+.+++.+||..||.+|||+.+++..+..++
T Consensus       224 ~~~~------------------~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         224 LPQG------------------YRLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HhCC------------------CCCCCC------CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            2210                  000111      112345667999999999999999999999887765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-36  Score=309.53  Aligned_cols=257  Identities=20%  Similarity=0.319  Sum_probs=197.9

Q ss_pred             EEEeeEeecCCceEEEEEEEcC---CCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCC----c
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKN---NGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG----R   83 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~---tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~----~   83 (708)
                      |.+.+.||+|+||.||.|....   ++..||+|.+...... ...+.+.+|+..++.++||||+++++++.....    .
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998764   3478999998754322 223456789999999999999999998764332    3


Q ss_pred             eEEEEEeccCCCCHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         84 GKVIVMELCTGGSLFNILDDPE---NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~---~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                      ..+++|||+++|+|..++....   ....+++..+..++.|++.||.|||++|++||||||+||++    +..+.+||+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~d  156 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML----REDMTVCVAD  156 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE----CCCCeEEECC
Confidence            4799999999999998874421   12248999999999999999999999999999999999998    6667899999


Q ss_pred             cCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHH
Q psy15481        161 FGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM  236 (708)
Q Consensus       161 FGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~  236 (708)
                      ||+++........   ....++..|+|||.+.        +..++.++|||||||++|+|++ |.+||..   ..+.+..
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~Dv~SlG~il~el~~~g~~p~~~---~~~~~~~  225 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA--------DRVYTSKSDVWAFGVTMWEIATRGQTPYPG---VENHEIY  225 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcc--------cCCCCcccchHHHHHHHHHHHhCCCCCCCC---CCHHHHH
Confidence            9999865433221   1123567899999886        5678999999999999999999 9999963   4444444


Q ss_pred             HHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        237 YYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       237 ~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ..+......                  ..      +......+.+++.+||..||.+||++.++.+.+.++
T Consensus       226 ~~~~~~~~~------------------~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         226 DYLRHGNRL------------------KQ------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHHcCCCC------------------CC------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            333321100                  11      122334567799999999999999999998887654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.3e-35  Score=305.79  Aligned_cols=250  Identities=22%  Similarity=0.345  Sum_probs=202.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|+..+.||.|+||.||.+++..+|+.|++|.+..... ......+.+|+.++++++||||+++++++.+.+  ..+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN--TLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC--eEEEEE
Confidence            48899999999999999999999999999999865432 223344678999999999999999999997644  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++|++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||++    +..+.+||+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~----~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          79 EYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL----TKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             EecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE----eCCCCEEECcCcceEEccc
Confidence            9999999999997643 2238999999999999999999999999999999999998    5566799999999986544


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .. ......|++.|+|||.+.        +..++.++|+|||||++|+|++|..||..   ....+....+.....+   
T Consensus       154 ~~~~~~~~~~~~~y~ape~~~--------~~~~~~~~Dv~slG~i~~~l~~g~~~~~~---~~~~~~~~~~~~~~~~---  219 (256)
T cd08221         154 EYSMAETVVGTPYYMSPELCQ--------GVKYNFKSDIWALGCVLYELLTLKRTFDA---TNPLNLVVKIVQGNYT---  219 (256)
T ss_pred             ccccccccCCCccccCHhhcC--------CCCCCCcchhHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHcCCCC---
Confidence            33 234467899999999986        55678899999999999999999999973   4444445444432110   


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                                       +    .....+..+.+++..||..||.+||++.++++
T Consensus       220 -----------------~----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~  252 (256)
T cd08221         220 -----------------P----VVSVYSSELISLVHSLLQQDPEKRPTADEVLD  252 (256)
T ss_pred             -----------------C----CccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence                             1    11223345667999999999999999999743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.4e-36  Score=306.17  Aligned_cols=247  Identities=28%  Similarity=0.481  Sum_probs=197.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC----CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM----RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~----~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      +|...+.||+|++|.||+|.+..+++.|++|.+......    .....+.+|+.++++++||||+++++++.+..  ..|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~   78 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED--NLY   78 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC--eEE
Confidence            477889999999999999999889999999998654321    12344678999999999999999999887544  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ++|||++|++|.+++....   .+++..+..++.|++.||.|||+.|++|+||+|+||++    +..+.+||+|||.+..
T Consensus        79 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~----~~~~~~kl~d~~~~~~  151 (258)
T cd06632          79 IFLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV----DTNGVVKLADFGMAKQ  151 (258)
T ss_pred             EEEEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEccCcccee
Confidence            9999999999999997643   28999999999999999999999999999999999998    5667899999999987


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCc-CCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKT-FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~-~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ...........|+..|+|||.+.        ... ++.++|+|||||++|++++|..||...   ........+....  
T Consensus       152 ~~~~~~~~~~~~~~~y~~pe~~~--------~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~---~~~~~~~~~~~~~--  218 (258)
T cd06632         152 VVEFSFAKSFKGSPYWMAPEVIA--------QQGGYGLAADIWSLGCTVLEMATGKPPWSQL---EGVAAVFKIGRSK--  218 (258)
T ss_pred             ccccccccccCCCcceeCHHHhc--------CCCCCCchhhhHHHHHHHHHHHhCCCCcccC---cHHHHHHHHHhcc--
Confidence            65544344567899999999986        333 889999999999999999999999742   2223232222100  


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                        ..+   .+++.++..+.+++.+||..||.+||++.++
T Consensus       219 ------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~  252 (258)
T cd06632         219 ------------------ELP---PIPDHLSDEAKDFILKCLQRDPSLRPTAAEL  252 (258)
T ss_pred             ------------------cCC---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHH
Confidence                              111   1222334556679999999999999999997

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0690|consensus

Probab=100.00  E-value=1.9e-37  Score=317.25  Aligned_cols=263  Identities=30%  Similarity=0.468  Sum_probs=211.3

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHH--HHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV--QMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~--~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|...++||+|.||+|-+++.+.+|+.||+|++++.-.....++  ...|-++|+..+||.+..+--.|...+  .+|+|
T Consensus       169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d--rlCFV  246 (516)
T KOG0690|consen  169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD--RLCFV  246 (516)
T ss_pred             hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc--eEEEE
Confidence            46677899999999999999999999999999987643333333  357889999999999999987776544  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc-
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~-  167 (708)
                      |||.+||.|+-++.....   ++++..+.+...|+.||.|||+++||+||+|.+|.|+    |..+.+||+|||++.+. 
T Consensus       247 MeyanGGeLf~HLsrer~---FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL----DkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERV---FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL----DKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeehhhhhc---ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee----ccCCceEeeecccchhcc
Confidence            999999999999977543   9999999999999999999999999999999999998    77888999999999864 


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..+....+.||||+|+|||++.        ...|+.++|.|.+||++|||++|++||..   . +.+.++.++...    
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVle--------DnDYgraVDWWG~GVVMYEMmCGRLPFyn---~-dh~kLFeLIl~e----  383 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLE--------DNDYGRAVDWWGVGVVMYEMMCGRLPFYN---K-DHEKLFELILME----  383 (516)
T ss_pred             cccceeccccCChhhcCchhhc--------cccccceeehhhhhHHHHHHHhccCcccc---c-chhHHHHHHHhh----
Confidence            4456677899999999999998        68899999999999999999999999973   3 334444433210    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HH-----HHHHHH--HHHHhhhhcCc
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FE-----RFFSEV--TKTLNRKLVHL  315 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~-----q~~~~l--~~il~~~l~h~  315 (708)
                                      ++.-+..++++++.    ||.++|..||.+|..     +.     +||..+  .+.+.+++..|
T Consensus       384 ----------------d~kFPr~ls~eAkt----LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PP  443 (516)
T KOG0690|consen  384 ----------------DLKFPRTLSPEAKT----LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPP  443 (516)
T ss_pred             ----------------hccCCccCCHHHHH----HHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCC
Confidence                            22223346666555    889999999999985     22     344433  45566666666


Q ss_pred             ccC
Q psy15481        316 FHI  318 (708)
Q Consensus       316 ~~~  318 (708)
                      |-.
T Consensus       444 fKP  446 (516)
T KOG0690|consen  444 FKP  446 (516)
T ss_pred             CCC
Confidence            553

>KOG0579|consensus

Probab=100.00  E-value=8.2e-38  Score=340.44  Aligned_cols=269  Identities=24%  Similarity=0.340  Sum_probs=215.7

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .+..|.|+.-||.|+||.||+|.++.++-..|.|++...+... .+.++-|++||..++||+||++++.|...+.  +||
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEE-LEDylVEIeILa~CdHP~ivkLl~ayy~enk--Lwi  106 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEE-LEDYLVEIEILAECDHPVIVKLLSAYYFENK--LWI  106 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhH-HhhhhhhhhhhhcCCChHHHHHHHHHhccCc--eEE
Confidence            4457899999999999999999999999999999987554333 3445689999999999999999998877655  999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ..|||.||-...++-.-..  +|+++++..+++|++.||+|||+++|||||+|.+|||+    .-.|.++|+|||.+-..
T Consensus       107 liEFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~----TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL----TLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             EEeecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE----EecCcEeeecccccccc
Confidence            9999999999998876543  39999999999999999999999999999999999997    33345999999997643


Q ss_pred             c-ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 E-EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~-~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      . .-....+..|||.|||||++.--..   ...+|+.++||||||++|.||+-|.+|-.   ..+..-.+.+|....++.
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~---KD~PYDykaDiWSlGITLIEMAqiEPPHh---elnpMRVllKiaKSePPT  254 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETF---KDQPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAKSEPPT  254 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccc---cCCCchhhhhHHhhhhHHHHHhccCCCcc---ccchHHHHHHHhhcCCCc
Confidence            2 3345567899999999998863221   15789999999999999999999999986   344555555555433322


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccccc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCI  324 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~~  324 (708)
                      .                      --+......+.++|.+||..||..||++.++           +.|||+.+-++..
T Consensus       255 L----------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaql-----------l~Hpfv~~~~SnK  299 (1187)
T KOG0579|consen  255 L----------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQL-----------LKHPFVQNAPSNK  299 (1187)
T ss_pred             c----------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHH-----------hhCcccccCCcch
Confidence            2                      1222334456679999999999999999998           5699998665543

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.6e-36  Score=309.94  Aligned_cols=257  Identities=24%  Similarity=0.371  Sum_probs=202.7

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCC---CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNN---GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ++.|.+.+.||+|+||.||+|.+...   ...||+|.+.........+.+.+|+.++++++||||+++++++.+.   ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~   81 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PV   81 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---Cc
Confidence            45788999999999999999987644   3469999886544333345667899999999999999999988653   37


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||+++++|.+++.....  .+++..+..++.+++.||.|||+.|++||||||+||++    +..+.++|+|||++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili----~~~~~~~l~d~g~~~  155 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV----SSPDCVKLGDFGLSR  155 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE----ecCCCeEEccCceee
Confidence            899999999999999976432  38999999999999999999999999999999999998    566789999999998


Q ss_pred             ccccccccc--ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhc
Q psy15481        166 ELEEDQQFM--SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       166 ~~~~~~~~~--~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .........  ...++..|+|||.+.        +..++.++|||||||++|++++ |..||..   ....+....+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~~g~~pf~~---~~~~~~~~~~~~~  224 (270)
T cd05056         156 YLEDESYYKASKGKLPIKWMAPESIN--------FRRFTSASDVWMFGVCMWEILMLGVKPFQG---VKNNDVIGRIENG  224 (270)
T ss_pred             ecccccceecCCCCccccccChhhhc--------cCCCCchhhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHcC
Confidence            654432221  223456899999886        5678899999999999999996 9999973   3444444433321


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      .                    .++.+    +.++..+.+++.+|+..+|.+|||+.++++.+.++..
T Consensus       225 ~--------------------~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         225 E--------------------RLPMP----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             C--------------------cCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1                    11111    2234456779999999999999999999998887654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8e-36  Score=312.99  Aligned_cols=254  Identities=21%  Similarity=0.340  Sum_probs=197.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEc----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNK----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .|++.+.||+|+||.||+|.+.    .++..||+|.+...........+.+|+.++++++||||+++++++....  ..|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~   83 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ--PVC   83 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC--ceE
Confidence            5788899999999999999853    4567899999875433333345678999999999999999999987654  489


Q ss_pred             EEEeccCCCCHHHHhcCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC
Q psy15481         87 IVMELCTGGSLFNILDDPEN--------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG  152 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~--------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~  152 (708)
                      +||||+++++|.+++.....              ...+++..+..++.+++.||.|||++|++||||||+|||+    +.
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili----~~  159 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI----GE  159 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE----cC
Confidence            99999999999998853210              1237889999999999999999999999999999999998    56


Q ss_pred             CceEEEeccCccccccccc---cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCC
Q psy15481        153 STIYKLTDFGAARELEEDQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYG  228 (708)
Q Consensus       153 ~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~  228 (708)
                      .+.+||+|||++.......   ......++..|+|||.+.        +..++.++|+|||||++|+|++ |.+||.+  
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~el~~~g~~p~~~--  229 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM--------YGKFSSDSDIWSFGVVLWEIFSFGLQPYYG--  229 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhc--------cCCCCchhhhHHHHHHHHHHHcCCCCCCCC--
Confidence            6679999999998654332   122344567899999886        5668999999999999999998 9999963  


Q ss_pred             CCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        229 GRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       229 g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                       .+....+..+.....                    ++.+    ..++..+.+++..||..||.+||++.++...+.
T Consensus       230 -~~~~~~~~~~~~~~~--------------------~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         230 -FSNQEVIEMVRKRQL--------------------LPCS----EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             -CCHHHHHHHHHcCCc--------------------CCCC----CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence             444444444443211                    1111    122345666999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=315.55  Aligned_cols=264  Identities=26%  Similarity=0.383  Sum_probs=206.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||.|+||.||++.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++++....  ..|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYEN--KLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC--eEEEE
Confidence            346889999999999999999999899999999986432 222345678999999999999999999987644  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++|++|.+++.....  .+++..++.++.|++.||.|||++||+|+||||+||++    +..+.++|+|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili----~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          81 IEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL----TLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             eeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE----CCCCCEEEccCccchhhc
Confidence            999999999999876432  38999999999999999999999999999999999998    667789999999987553


Q ss_pred             cc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 ED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      .. .......|++.|+|||.+....   ..+..++.++|+|||||++|+|++|.+||..   .+....+..+.....+  
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~~~sDi~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~~~~--  226 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACET---FKDNPYDYKADIWSLGITLIELAQMEPPHHE---LNPMRVLLKILKSEPP--  226 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcc---cCCCCCCccccHHHHHHHHHHHHhCCCCccc---CCHHHHHHHHhcCCCC--
Confidence            32 2223456899999999985211   1134578899999999999999999999974   3333334333321110  


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                      .+..    +..++..+.+++.+||..||.+||++.++           +.|+|+...
T Consensus       227 ----------------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~i-----------l~~~~~~~~  268 (280)
T cd06611         227 ----------------TLDQ----PSKWSSSFNDFLKSCLVKDPDDRPTAAEL-----------LKHPFVSDQ  268 (280)
T ss_pred             ----------------CcCC----cccCCHHHHHHHHHHhccChhhCcCHHHH-----------hcChhhccc
Confidence                            1111    12233456679999999999999999997           668988654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.7e-35  Score=305.65  Aligned_cols=249  Identities=23%  Similarity=0.371  Sum_probs=195.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||++.++ ++..+|+|.+....  .....+.+|+.++++++||||+++++++...+  ..++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~iv~   78 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK--PLYIVT   78 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC--CEEEEE
Confidence            35788899999999999999875 45689999876432  22345678999999999999999999987654  499999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++||+|.+++.....  .+++..+..++.+++.||.|||++|++||||||+||++    +..+.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i----~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          79 EFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV----SSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             EcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE----cCCCeEEECCCCCccccCC
Confidence            99999999999875332  38999999999999999999999999999999999998    6677899999999986543


Q ss_pred             cccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ....  ....++..|+|||.+.        +..++.++|+|||||++|+|++ |+.||..   .+..+....+.....  
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~s~G~~l~el~~~g~~p~~~---~~~~~~~~~i~~~~~--  219 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFN--------FSKYSSKSDVWSFGVLMWEVFTEGKMPFEK---KSNYEVVEMISRGFR--  219 (256)
T ss_pred             CceeccCCCCCchhhCChhhcc--------cCccchhhhhHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHHHCCCC--
Confidence            3222  1233556899999986        5678899999999999999999 9999973   444444444432110  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                                      ...|.  ..    +..+.+++.+||..||.+||++.+++..+
T Consensus       220 ----------------~~~~~--~~----~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 ----------------LYRPK--LA----SMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ----------------CCCCC--CC----CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                            01111  12    23567799999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-36  Score=311.03  Aligned_cols=254  Identities=25%  Similarity=0.377  Sum_probs=198.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCC-----CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNN-----GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ..|.+.+.||+|+||.||+|.+...     +..||+|.+...........+.+|+.+++.++||||+++++++....  .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~   83 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ--P   83 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC--C
Confidence            3688999999999999999988654     47899999865433333345678999999999999999999987654  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEE
Q psy15481         85 KVIVMELCTGGSLFNILDDPEN-------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYK  157 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~-------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vK  157 (708)
                      .|+||||+++|+|.+++.....       ...+++..+..++.|++.||.|||++|++||||||+||++    +..+.+|
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill----~~~~~~k  159 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV----AEDLTVK  159 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE----cCCCCEE
Confidence            9999999999999999865321       1236888999999999999999999999999999999998    6667899


Q ss_pred             EeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChh
Q psy15481        158 LTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNK  233 (708)
Q Consensus       158 L~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~  233 (708)
                      |+|||+++.......   .....++..|+|||.+.        +..++.++|||||||++|+++| |..||..   .+..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~t~g~~p~~~---~~~~  228 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK--------DGVFTTKSDVWSFGVVLWEMATLAEQPYQG---LSNE  228 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHh--------cCCCCcccchHHHHHHHHHhhccCCCCCcc---CCHH
Confidence            999999986544322   12345678999999986        5668899999999999999998 9999973   3444


Q ss_pred             hHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        234 ETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       234 e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      +....+.....                  ...|.      ..+..+.+++.+||..||++|||+.++++.+
T Consensus       229 ~~~~~~~~~~~------------------~~~~~------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l  275 (277)
T cd05032         229 EVLKFVIDGGH------------------LDLPE------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSL  275 (277)
T ss_pred             HHHHHHhcCCC------------------CCCCC------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence            43333331100                  01121      1244567799999999999999999987764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0574|consensus

Probab=100.00  E-value=2.2e-38  Score=321.15  Aligned_cols=275  Identities=25%  Similarity=0.413  Sum_probs=222.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+...||.|+||.||++.++.+|..+|||.+...+.   .+....|+.++..++.|++|++++.+.-...  +||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD---LQEIIKEISIMQQC~S~yVVKYYGSYFK~sD--LWIVM  107 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD---LQEIIKEISIMQQCKSKYVVKYYGSYFKHSD--LWIVM  107 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch---HHHHHHHHHHHHHcCCchhhhhhhhhccCCc--eEeeh
Confidence            456778899999999999999999999999999865432   4556799999999999999999998765444  99999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||..||..+++.....  .|++.++..+++.-+.||.|||...-+|||||.+|||+    +..++.||+|||.|..+.+
T Consensus       108 EYCGAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL----NT~G~AKLADFGVAGQLTD  181 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL----NTDGIAKLADFGVAGQLTD  181 (502)
T ss_pred             hhcCCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE----cccchhhhhhccccchhhh
Confidence            99999999999976543  39999999999999999999999999999999999998    7778899999999987765


Q ss_pred             c-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 D-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      . ....++.|||-|||||++.        .-.|..++||||||++..||+-|++||....   +...++.|-+       
T Consensus       182 TMAKRNTVIGTPFWMAPEVI~--------EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH---PMRAIFMIPT-------  243 (502)
T KOG0574|consen  182 TMAKRNTVIGTPFWMAPEVIE--------EIGYDTKADIWSLGITAIEMAEGRPPYSDIH---PMRAIFMIPT-------  243 (502)
T ss_pred             hHHhhCccccCcccccHHHHH--------HhccchhhhHhhhcchhhhhhcCCCCccccc---ccceeEeccC-------
Confidence            4 3455688999999999998        5789999999999999999999999997321   1111111112       


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccccccccc
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIRIYL  328 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~~~~~i  328 (708)
                                     ..|..-.-+...++.+.+++++||.++|++|-||.++           +.|||..+-+.+     
T Consensus       244 ---------------~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L-----------~~H~FiknA~g~-----  292 (502)
T KOG0574|consen  244 ---------------KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRL-----------CEHTFIKNAPGC-----  292 (502)
T ss_pred             ---------------CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHH-----------hhhhhhcCCCcc-----
Confidence                           2233333455677788999999999999999999997           779998765442     


Q ss_pred             CCcccHHHHHHHHHhhcCCCcc
Q psy15481        329 HPDDAYDQLQDLIQEQTDVTPN  350 (708)
Q Consensus       329 ~~~e~~~~l~~~i~~~t~i~~~  350 (708)
                            +-++..|.+..++...
T Consensus       293 ------~I~~~~I~~A~e~~~~  308 (502)
T KOG0574|consen  293 ------DIMQLMIQDAQEKAIL  308 (502)
T ss_pred             ------cHHHHHHHHHHHHHHh
Confidence                  3355556655544443

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1e-35  Score=308.60  Aligned_cols=247  Identities=23%  Similarity=0.419  Sum_probs=192.4

Q ss_pred             EeecCCceEEEEEEEc--CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCC
Q psy15481         17 VLGKGATGAVFQGVNK--NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTG   94 (708)
Q Consensus        17 ~LG~G~fG~Vy~a~~~--~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~g   94 (708)
                      .||+|+||.||+|.+.  .++..||+|++.........+.+.+|+.++++++||||+++++++..   ...++||||++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCCC
Confidence            3899999999999765  45667999998765443344557799999999999999999998753   248999999999


Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccccc
Q psy15481         95 GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM  174 (708)
Q Consensus        95 gsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~  174 (708)
                      ++|.+++.....  .+++..++.++.|++.||.|||++|++||||||+||++    +..+.+||+|||.+.....+....
T Consensus        79 ~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~----~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          79 GPLNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL----VNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE----cCCCcEEeccCCccccccCCccce
Confidence            999999875332  38999999999999999999999999999999999998    666789999999998654432211


Q ss_pred             ----ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        175 ----SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       175 ----~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                          ...++..|+|||.+.        +..++.++|||||||++|++++ |..||..   ....+....+.....     
T Consensus       153 ~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~~~g~~p~~~---~~~~~~~~~~~~~~~-----  216 (257)
T cd05115         153 KARSAGKWPLKWYAPECIN--------FRKFSSRSDVWSYGITMWEAFSYGQKPYKK---MKGPEVMSFIEQGKR-----  216 (257)
T ss_pred             eccCCCCCCcccCCHHHHc--------cCCCCchhhHHHHHHHHHHHhcCCCCCcCc---CCHHHHHHHHHCCCC-----
Confidence                122357899999986        5668899999999999999996 9999973   344444433332110     


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                   ...|      +..+..+.+++.+||..||++||++.++...+..+
T Consensus       217 -------------~~~~------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 -------------LDCP------AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -------------CCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                         0111      22334566799999999999999999997776543

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.8e-36  Score=315.74  Aligned_cols=264  Identities=26%  Similarity=0.377  Sum_probs=202.6

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .+..|++.+.||+|+||.||+|.+..+|..|++|.+.... ......+.+|+.+++.++||||+++++.+...+  .+|+
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l   86 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--KLWI   86 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--eEEE
Confidence            3456889999999999999999999999999999986532 222344568999999999999999999987654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++|++|..++.+...  .+++..+..++.|++.||.|||++|++||||||+||++    +..+.++|+|||.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL----TLDGDIKLADFGVSAKN  160 (292)
T ss_pred             EEecCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE----cCCCCEEEccCccceec
Confidence            9999999999888765332  38999999999999999999999999999999999998    56678999999998754


Q ss_pred             ccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 EED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ... .......++..|+|||.+....   .....++.++|+|||||++|+|++|.+||..   .+.......+.....+ 
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slG~il~el~~g~~p~~~---~~~~~~~~~~~~~~~~-  233 (292)
T cd06644         161 VKTLQRRDSFIGTPYWMAPEVVMCET---MKDTPYDYKADIWSLGITLIEMAQIEPPHHE---LNPMRVLLKIAKSEPP-  233 (292)
T ss_pred             cccccccceecCCccccCceeecccc---ccCCCCCchhhhHhHHHHHHHHhcCCCCCcc---ccHHHHHHHHhcCCCc-
Confidence            322 1223456889999999885211   0134578899999999999999999999964   2222222222211000 


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                       ..+.    +..++..+.+++.+||..||++||++.++           +.|||+..
T Consensus       234 -----------------~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i-----------l~~~~~~~  274 (292)
T cd06644         234 -----------------TLSQ----PSKWSMEFRDFLKTALDKHPETRPSAAQL-----------LEHPFVSS  274 (292)
T ss_pred             -----------------cCCC----CcccCHHHHHHHHHHhcCCcccCcCHHHH-----------hcCccccc
Confidence                             1111    12233446679999999999999999997           56888754

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.5e-36  Score=312.36  Aligned_cols=254  Identities=23%  Similarity=0.347  Sum_probs=195.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|.+..... .......+|+.+++.++||||+++++++...+  .+|+|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~--~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD--KLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--EEEEE
Confidence            3477888999999999999999999999999999865432 22344568999999999999999999987644  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||+++++|.+++.....   +++..++.++.|++.||.|||++|++|+||||+||++    +..+.++|+|||.+....
T Consensus        85 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili----~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL----TDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             EeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEECcceeeeEcc
Confidence            999999999999876443   8999999999999999999999999999999999998    666789999999987654


Q ss_pred             ccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 EDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ... ......|+..|+|||.+...     ....++.++|+|||||++|+|++|..||...   ...............  
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~---~~~~~~~~~~~~~~~--  227 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVE-----RKGGYNQLCDIWAVGITAIELAELQPPMFDL---HPMRALFLMTKSNFQ--  227 (267)
T ss_pred             CcccccccccCcccccChhhhccc-----cCCCCCchhhhHHHHHHHHHHhcCCCCcccc---cchhhHHhhhccCCC--
Confidence            321 22345789999999987421     1345788999999999999999999999631   122222211111000  


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                +.    .++....+    +..+.+++.+||..||++||+++++
T Consensus       228 ----------~~----~~~~~~~~----~~~~~~li~~~l~~~P~~R~~~~~l  262 (267)
T cd06645         228 ----------PP----KLKDKMKW----SNSFHHFVKMALTKNPKKRPTAEKL  262 (267)
T ss_pred             ----------CC----cccccCCC----CHHHHHHHHHHccCCchhCcCHHHH
Confidence                      00    00111112    2345679999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.4e-36  Score=310.44  Aligned_cols=256  Identities=21%  Similarity=0.342  Sum_probs=196.3

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCc--eEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecC----CceE
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGE--PVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQE----GRGK   85 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~--~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~----~~~~   85 (708)
                      .+.+.||+|+||.||+|.+..++.  .||+|.++..... .....+.+|+.+++.++||||+++++.+....    ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            467899999999999999887765  6999988654222 22345678999999999999999999764321    2347


Q ss_pred             EEEEeccCCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         86 VIVMELCTGGSLFNILDDP---ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~---~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                      +++|||+++|+|.+++...   .....+++..+..++.|++.||.|||++||+||||||+|||+    +..+.++|+|||
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg  157 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML----NENMNVCVADFG  157 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE----cCCCCEEECCCC
Confidence            8999999999999887421   112238999999999999999999999999999999999998    666789999999


Q ss_pred             ccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHH
Q psy15481        163 AARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       163 lA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~  238 (708)
                      ++.........   ....+++.|+|||.+.        +..++.++|||||||++|+|++ |.+||..   .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~Di~slG~il~el~~~g~~p~~~---~~~~~~~~~  226 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLA--------DRVYTTKSDVWSFGVTMWEIATRGQTPYPG---VENSEIYDY  226 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHcc--------CCCcChHHHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHH
Confidence            99876443221   1234677899999987        5678999999999999999999 8999973   344444443


Q ss_pred             HHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      +....                    ..+..    +.+...+.+++.+||..||++|||+.+++..++.+
T Consensus       227 ~~~~~--------------------~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         227 LRQGN--------------------RLKQP----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHcCC--------------------CCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            33210                    01111    12334466799999999999999999998887654

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-35  Score=311.22  Aligned_cols=258  Identities=26%  Similarity=0.460  Sum_probs=199.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcC-----CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      ...|.+.+.||+|++|.||+|.+..     ++..||+|.+...........+.+|+.++++++||||+++++++.+..  
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL--   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--
Confidence            3568899999999999999999987     778999998875443333445678999999999999999999887654  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         84 GKVIVMELCTGGSLFNILDDPEN----TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~----~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      ..++||||++|++|.+++.....    ...+++..+..++.||+.||.|||++|++||||||+||++. .......+||+
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~-~~~~~~~~kl~  161 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLT-CKGPGRVAKIA  161 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEe-ccCCCcceEec
Confidence            48999999999999999865321    12489999999999999999999999999999999999972 12223479999


Q ss_pred             ccCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhH
Q psy15481        160 DFGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKET  235 (708)
Q Consensus       160 DFGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~  235 (708)
                      |||.+.........   ....++..|+|||++.        +..++.++|||||||++|+|++ |..||.   +.+....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~~g~~pf~---~~~~~~~  230 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL--------DGIFTSKTDVWSFGVLLWEIFSLGYMPYP---GRTNQEV  230 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHh--------cCCcCchhHHHHHHHHHHHHHcCCCCCCC---CCCHHHH
Confidence            99999865332211   1223356899999987        5778999999999999999997 999997   3444444


Q ss_pred             HHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        236 MYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       236 ~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      +..+....              ..    ..|      ..++..+.+++.+||..||++||++.++++++
T Consensus       231 ~~~~~~~~--------------~~----~~~------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l  275 (277)
T cd05036         231 MEFVTGGG--------------RL----DPP------KGCPGPVYRIMTDCWQHTPEDRPNFATILERI  275 (277)
T ss_pred             HHHHHcCC--------------cC----CCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence            43333210              00    111      12234566799999999999999999987765

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-35  Score=308.24  Aligned_cols=253  Identities=32%  Similarity=0.494  Sum_probs=198.6

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-----chHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-----PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-----~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      +|.+.+.||+|+||.||+|.+ .+|+.+|+|.+.......     ....+.+|++++++++||||+++++++.+.  ...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   77 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTI   77 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeE
Confidence            488899999999999999987 478999999986543221     123356899999999999999999998765  469


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ++||||++|++|.+++.....   +++..+..++.|++.||.|||+.|++|+||+|+||++    +..+.++|+|||.+.
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~----~~~~~~~l~dfg~~~  150 (265)
T cd06631          78 SIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML----MPNGIIKLIDFGCAR  150 (265)
T ss_pred             EEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE----CCCCeEEeccchhhH
Confidence            999999999999999976432   8999999999999999999999999999999999998    666789999999987


Q ss_pred             ccccc-------ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHH
Q psy15481        166 ELEED-------QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       166 ~~~~~-------~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~  238 (708)
                      .....       .......|+..|+|||.+.        +..++.++|+|||||++|+|++|..||..   .+.......
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~Dv~slG~~~~~l~~g~~p~~~---~~~~~~~~~  219 (265)
T cd06631         151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN--------ESGYGRKSDIWSIGCTVFEMATGKPPLAS---MDRLAAMFY  219 (265)
T ss_pred             hhhhccccccccccccccCCCccccChhhhc--------CCCCcchhhHHHHHHHHHHHHhCCCcccc---CChHHHHHH
Confidence            64321       1123456899999999986        56688999999999999999999999973   222222222


Q ss_pred             HHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      +....  .                 ..|   .++...+..+.+++++||..||.+||++.++           +.|||+
T Consensus       220 ~~~~~--~-----------------~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~-----------l~~~~~  265 (265)
T cd06631         220 IGAHR--G-----------------LMP---RLPDSFSAAAIDFVTSCLTRDQHERPSALQL-----------LRHDFL  265 (265)
T ss_pred             hhhcc--C-----------------CCC---CCCCCCCHHHHHHHHHHhcCCcccCCCHHHH-----------hcCCCC
Confidence            22110  0                 011   1222344556779999999999999999997           567875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.8e-36  Score=312.83  Aligned_cols=259  Identities=22%  Similarity=0.366  Sum_probs=206.7

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|...+.||.|+||.||+|.+..++..||+|.+...........+.+|+.++++++||||+++++++.+.+  ..|+|
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv   80 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT--KLWII   80 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--EEEEE
Confidence            3567888999999999999999999999999999875433333455678999999999999999999987644  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++|++|.+++...    .+++..+..++.+++.||.|||++|++|+||+|+||++    +..+.++|+|||.+....
T Consensus        81 ~e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~----~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          81 MEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL----SEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE----cCCCCEEEcccccceecc
Confidence            9999999999998653    28999999999999999999999999999999999998    556679999999997654


Q ss_pred             cccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 EDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      .... .....++..|+|||.+.        +..++.++|+|||||++|+|+||..||..   .........+...     
T Consensus       153 ~~~~~~~~~~~~~~y~apE~~~--------~~~~~~~~Dv~slG~il~el~tg~~p~~~---~~~~~~~~~~~~~-----  216 (277)
T cd06640         153 DTQIKRNTFVGTPFWMAPEVIQ--------QSAYDSKADIWSLGITAIELAKGEPPNSD---MHPMRVLFLIPKN-----  216 (277)
T ss_pred             CCccccccccCcccccCHhHhc--------cCCCccHHHHHHHHHHHHHHHHCCCCCCC---cChHhHhhhhhcC-----
Confidence            3322 22346888999999986        56688999999999999999999999973   2222222211110     


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcccc
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQC  323 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~  323 (708)
                                      ..   ..+...++..+.+++.+||..||++||++.++           +.|+|+......
T Consensus       217 ----------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i-----------l~~~~~~~~~~~  262 (277)
T cd06640         217 ----------------NP---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKEL-----------LKHKFIVKNAKK  262 (277)
T ss_pred             ----------------CC---CCCchhhhHHHHHHHHHHcccCcccCcCHHHH-----------HhChHhhhcchh
Confidence                            00   11333455667789999999999999999997           568887665443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-35  Score=311.11  Aligned_cols=263  Identities=19%  Similarity=0.314  Sum_probs=199.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHH-HHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~i-L~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|.+.+.||+|+||.||++.+..+|+.||+|.++.............|+.+ ++.++||||+++++++...+  ..|++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~--~~~lv~   79 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG--DVWICM   79 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC--cEEEEh
Confidence            478899999999999999999999999999998754333223334456665 56679999999999987654  499999


Q ss_pred             eccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         90 ELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||++ |+|.+++... .....+++..++.++.|++.||.|||++ +++||||||+||++    +..+.+||+|||.+...
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~----~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI----NRNGQVKLCDFGISGYL  154 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE----CCCCCEEEeeccccccc
Confidence            9995 7887776542 1223489999999999999999999998 99999999999998    66778999999999876


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..........|+..|+|||.+....    ....++.++|+|||||++|+|++|+.||...  ....+.+..+......  
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~--  226 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPEL----NQKGYDVKSDVWSLGITMIELATGRFPYDSW--KTPFQQLKQVVEEPSP--  226 (283)
T ss_pred             ccccccccccCCccccChhhcCCcc----cccccCccccchhhHHHHHHHHhCCCCCCcc--ccCHHHHHHHHhcCCC--
Confidence            5443333456899999999886311    1255788999999999999999999999642  2222333333221100  


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                      .+|.     ...+..+.+++.+||..||.+||++.++           +.|||+...
T Consensus       227 ----------------~~~~-----~~~~~~l~~li~~~l~~~p~~Rp~~~~i-----------l~~~~~~~~  267 (283)
T cd06617         227 ----------------QLPA-----EKFSPEFQDFVNKCLKKNYKERPNYPEL-----------LQHPFFELH  267 (283)
T ss_pred             ----------------CCCc-----cccCHHHHHHHHHHccCChhhCcCHHHH-----------hcCchhhhc
Confidence                            1111     1123456679999999999999999997           668888765

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.4e-35  Score=312.45  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=201.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcC-----CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      ..+|.+.+.||+|+||.||+|.++.     .+..||+|.++..........+.+|+.+++.++||||+++++++.+.+  
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   82 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ--   82 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC--
Confidence            4579999999999999999997652     355899998865433222334578999999999999999999987654  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceE
Q psy15481         84 GKVIVMELCTGGSLFNILDDPEN-------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY  156 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~-------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~v  156 (708)
                      ..|+||||+++|+|.+++.....       ...++...+..++.|++.||.|||++|++||||||+||++    ++.+.+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili----~~~~~~  158 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV----AHDFTV  158 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE----cCCCcE
Confidence            48999999999999999964211       1225677899999999999999999999999999999998    666789


Q ss_pred             EEeccCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCCh
Q psy15481        157 KLTDFGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRN  232 (708)
Q Consensus       157 KL~DFGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~  232 (708)
                      +|+|||+++........   ....++..|+|||.+.        +..++.++|+|||||++|+|++ |..||.+   ...
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~--------~~~~~~~~DvwslG~~l~el~~~~~~p~~~---~~~  227 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK--------DGVFTTSSDMWSFGVVLWEITSLAEQPYQG---LSN  227 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhc--------cCCCChHhHHHHHHHHHHHHHhCCCCCCCC---CCH
Confidence            99999999865332211   1234567899999987        5678999999999999999998 7889963   444


Q ss_pred             hhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhh
Q psy15481        233 KETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKL  312 (708)
Q Consensus       233 ~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l  312 (708)
                      .+....+......                  ..+      ...+..+.+++.+||..||++|||+.++++.+.+.     
T Consensus       228 ~~~~~~~~~~~~~------------------~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~-----  278 (288)
T cd05061         228 EQVLKFVMDGGYL------------------DQP------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD-----  278 (288)
T ss_pred             HHHHHHHHcCCCC------------------CCC------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh-----
Confidence            4443333321000                  111      12234567799999999999999999998766544     


Q ss_pred             cCcccC
Q psy15481        313 VHLFHI  318 (708)
Q Consensus       313 ~h~~~~  318 (708)
                      .||++.
T Consensus       279 ~~~~~~  284 (288)
T cd05061         279 LHPSFP  284 (288)
T ss_pred             cCCCCC
Confidence            477664

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.5e-36  Score=317.53  Aligned_cols=274  Identities=22%  Similarity=0.329  Sum_probs=203.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|.+.+.||+|+||.||++.+..+|..||+|.+.............+|++++++++||||+++++++.+.+  .+|+|||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e   79 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG--EISICME   79 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--EEEEEee
Confidence            48899999999999999999999999999999875432222344578999999999999999999997654  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |++|++|.+++....   .+++..+..++.|++.||.|||+ .|++|+||||+||++    +..+.++|+|||.+.....
T Consensus        80 y~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~----~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          80 HMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             ccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE----ecCCcEEEccCCCcccccc
Confidence            999999999997643   28999999999999999999997 599999999999998    5566799999999876533


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      . ......|+..|+|||.+.        +..++.++|+|||||++|+|++|..||.+..    .................
T Consensus       153 ~-~~~~~~~~~~~~aPE~~~--------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~  219 (308)
T cd06615         153 S-MANSFVGTRSYMSPERLQ--------GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD----AKELEAMFGRPVSEGEA  219 (308)
T ss_pred             c-ccccCCCCcCccChhHhc--------CCCCCccchHHHHHHHHHHHHhCCCCCCCcc----hhhHHHhhcCccccccc
Confidence            2 223467899999999886        5668899999999999999999999996421    22222222211110000


Q ss_pred             ccc--------cCCCCccc------c--cCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhc
Q psy15481        250 GTQ--------TSENGEID------W--CTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLV  313 (708)
Q Consensus       250 ~~~--------~~~~g~~~------~--~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~  313 (708)
                      ...        ........      +  ....|..+  ...++..+.+++.+||..||++||++.++           +.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~l-----------l~  286 (308)
T cd06615         220 KESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKEL-----------TK  286 (308)
T ss_pred             cCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHH-----------hc
Confidence            000        00000000      0  00000000  01134456779999999999999999997           67


Q ss_pred             CcccCC
Q psy15481        314 HLFHIN  319 (708)
Q Consensus       314 h~~~~~  319 (708)
                      |||+..
T Consensus       287 ~~~~~~  292 (308)
T cd06615         287 HPFIKR  292 (308)
T ss_pred             Chhhhh
Confidence            898854

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.8e-36  Score=313.85  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=203.3

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|++.+.||+|+||.||+|.+..++..+++|.+..... .....+.+|+.+++.++||||+++++.+...+  ..|+|||
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~~~~v~e   82 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWILIE   82 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC--EEEEEEE
Confidence            46788999999999999999999999999999864332 22344578999999999999999999987644  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+++++|..++....  ..+++..+..++.|++.||.|||+.|++||||||+||++    +.++.++|+|||++......
T Consensus        83 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili----~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          83 FCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF----TLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             ecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE----ccCCCEEEcccccccccccc
Confidence            999999998876432  238999999999999999999999999999999999998    66678999999998764332


Q ss_pred             c-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        171 Q-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       171 ~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      . ......++..|+|||++....   ..+..++.++|+||+||++|+|++|.+||..   .+..+....+......    
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvil~el~~g~~p~~~---~~~~~~~~~~~~~~~~----  226 (282)
T cd06643         157 IQRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIEMAQIEPPHHE---LNPMRVLLKIAKSEPP----  226 (282)
T ss_pred             ccccccccccccccCHhhccccC---CCCCCCCccchhhhHHHHHHHHccCCCCccc---cCHHHHHHHHhhcCCC----
Confidence            1 223456899999999975211   1145678899999999999999999999974   3333443333321110    


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                    .++.+    ...+..+.+++.+||..||.+||++.++           +.|||+...
T Consensus       227 --------------~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i-----------l~~~~~~~~  268 (282)
T cd06643         227 --------------TLAQP----SRWSSEFKDFLKKCLEKNVDARWTTTQL-----------LQHPFVTVN  268 (282)
T ss_pred             --------------CCCCc----cccCHHHHHHHHHHccCChhhCcCHHHH-----------hcCCCEecc
Confidence                          11111    1223456679999999999999999987           679998654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-35  Score=305.64  Aligned_cols=248  Identities=25%  Similarity=0.427  Sum_probs=199.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|.+.+.||+|+||.||++.+..+|+.||+|.+..... ........+|+.++++++||||+++++++...+  ..|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG--NLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC--eEEEEE
Confidence            48899999999999999999999999999999864322 222345678999999999999999999987644  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++|++|.+++..... ..+++..+..++.|++.||.|||++|++|+||+|+||++    +.++.++|+|||.+.....
T Consensus        79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~----~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          79 DYCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL----TKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             ecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE----cCCCCEEEeeccceeecCc
Confidence            99999999998865322 237999999999999999999999999999999999998    6666799999999986544


Q ss_pred             ccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      ... .....|+..|+|||.+.        +..++.++|+|||||++|+|++|..||..   ....+....+.....    
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~Dv~slG~i~~~l~~g~~~~~~---~~~~~~~~~~~~~~~----  218 (256)
T cd08218         154 TVELARTCIGTPYYLSPEICE--------NRPYNNKSDIWALGCVLYEMCTLKHAFEA---GNMKNLVLKIIRGSY----  218 (256)
T ss_pred             chhhhhhccCCccccCHHHhC--------CCCCCCccchhHHHHHHHHHHcCCCCccC---CCHHHHHHHHhcCCC----
Confidence            322 22356889999999986        56678899999999999999999999973   334444444432210    


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                       +.   .+..++..+.+++.+||+.||.+||++.++
T Consensus       219 -----------------~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~v  250 (256)
T cd08218         219 -----------------PP---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSI  250 (256)
T ss_pred             -----------------CC---CcccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence                             10   122334456779999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.5e-36  Score=313.00  Aligned_cols=250  Identities=29%  Similarity=0.463  Sum_probs=193.3

Q ss_pred             EEeeEeecCCceEEEEEEEc----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         13 CTTSVLGKGATGAVFQGVNK----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .+.+.||.|+||.||+|...    ..+..|+||.++........+.+.+|++.+++++||||+++++++...+.  .++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~--~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP--LFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS--EEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc--cccc
Confidence            57889999999999999987    45678999999654333335667899999999999999999999984443  9999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||+++|+|.+++.... ...+++..+..++.||+.||.|||+++++|+||+|+||++    +..+.+||+|||++....
T Consensus        80 ~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill----~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL----DSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----ETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc----cccccccccccccccccc
Confidence            99999999999998761 2238999999999999999999999999999999999998    667799999999998763


Q ss_pred             ccc---cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        169 EDQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       169 ~~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ...   ......+...|+|||.+.        +..++.++||||||+++||+++ |..||..   .++.+....+.... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~ksDVysfG~~l~ei~~~~~~p~~~---~~~~~~~~~~~~~~-  222 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLK--------DGEYTKKSDVYSFGMLLYEILTLGKFPFSD---YDNEEIIEKLKQGQ-  222 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHH--------HSEESHHHHHHHHHHHHHHHHTTSSGTTTT---SCHHHHHHHHHTTE-
T ss_pred             cccccccccccccccccccccccc--------cccccccccccccccccccccccccccccc---cccccccccccccc-
Confidence            221   122345778899999998        4568999999999999999999 7899873   45555555554321 


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                                         .++.    +..++..+.+++..||..||.+||++.+++..|
T Consensus       223 -------------------~~~~----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 -------------------RLPI----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -------------------ETTS----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -------------------ccee----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                               1111    122344566799999999999999999987653

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.1e-35  Score=306.94  Aligned_cols=253  Identities=23%  Similarity=0.354  Sum_probs=198.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..+|.+.+.||+|+||.||+|.+..+ ..||+|.+....  ...+.+.+|+.++++++||||+++++.+..   ...|+|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv   78 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV   78 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEE
Confidence            35699999999999999999988765 459999987432  223456789999999999999999988643   247999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||+++|+|.+++..... ..+++..+..++.+++.||.|||++|++||||||+||++    +..+.++|+|||.+....
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill----~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADFGLARLIE  153 (262)
T ss_pred             EEcCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE----cCCCcEEeccCCceeecc
Confidence            999999999999975321 237899999999999999999999999999999999998    556679999999998664


Q ss_pred             ccccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .....  ....++..|+|||...        +..++.++|+|||||++|+++| |.+||..   ..+.+.+..+....  
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~DvwslG~~l~ellt~g~~p~~~---~~~~~~~~~~~~~~--  220 (262)
T cd05071         154 DNEYTARQGAKFPIKWTAPEAAL--------YGRFTIKSDVWSFGILLTELTTKGRVPYPG---MVNREVLDQVERGY--  220 (262)
T ss_pred             ccccccccCCcccceecCHhHhc--------cCCCCchhhHHHHHHHHHHHHcCCCCCCCC---CChHHHHHHHhcCC--
Confidence            43321  2234667899999876        5678999999999999999999 8989963   34444444333210  


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                        ..+.    +..++..+.+++.+||+.||++||++.++...+++.
T Consensus       221 ------------------~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 ------------------RMPC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ------------------CCCC----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                              1111    223344567799999999999999999988766543

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-35  Score=308.36  Aligned_cols=253  Identities=25%  Similarity=0.456  Sum_probs=196.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc---------hHHHHHHHHHHHhCCCCCccceeEEEEecC
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP---------HDVQMREFEVLKKVKHENIVKLLAIEEEQE   81 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~---------~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~   81 (708)
                      .|.+.+.||+|+||.||+|.+..+|+.||+|.+........         .+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            68899999999999999999999999999998864321111         123467999999999999999999987654


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                        ..++||||++|++|.+++....   .+++..++.++.|++.||.|||++|++||||+|+||++    +..+.++|+||
T Consensus        82 --~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~----~~~~~~~l~d~  152 (272)
T cd06629          82 --YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV----DADGICKISDF  152 (272)
T ss_pred             --ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE----cCCCeEEEeec
Confidence              5999999999999999997653   38999999999999999999999999999999999998    66778999999


Q ss_pred             Cccccccccc---cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHH
Q psy15481        162 GAARELEEDQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       162 GlA~~~~~~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~  238 (708)
                      |.+.......   ......|+..|+|||.+...      ...++.++|+||||+++|++++|..||..   ....+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~---~~~~~~~~~  223 (272)
T cd06629         153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY------SQGYSAKVDIWSLGCVVLEMFAGRRPWSD---EEAIAAMFK  223 (272)
T ss_pred             cccccccccccccccccccCCccccCHHHhccc------cCCCCccchhHHHHHHHHHHHhCCCCCcC---cchHHHHHH
Confidence            9997643321   12234688999999998621      13478999999999999999999999962   333333332


Q ss_pred             HHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      +.......                 .++  ....+.++..+.+++.+||..||.+||+++++
T Consensus       224 ~~~~~~~~-----------------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  266 (272)
T cd06629         224 LGNKRSAP-----------------PIP--PDVSMNLSPVALDFLNACFTINPDNRPTAREL  266 (272)
T ss_pred             hhccccCC-----------------cCC--ccccccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence            22110000                 011  11222344566779999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0193|consensus

Probab=100.00  E-value=9.7e-37  Score=334.07  Aligned_cols=258  Identities=24%  Similarity=0.404  Sum_probs=207.3

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      ..+...||+|.||+||+|++-.   .||||+++...-. .-.+.+.+|+.++++-+|.||+-+.+++..++   +.||+.
T Consensus       394 v~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AIiTq  467 (678)
T KOG0193|consen  394 VLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAIITQ  467 (678)
T ss_pred             hhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eeeeeh
Confidence            3678999999999999999974   4999999864322 23456789999999999999999999998665   599999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc---
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL---  167 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~---  167 (708)
                      ||+|.+|+.++...+..  |.....+.|++||+.||.|||.++|||||||..|||+    ++.+.|||+|||++..-   
T Consensus       468 wCeGsSLY~hlHv~etk--fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl----~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETK--FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL----HEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             hccCchhhhhccchhhh--hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE----ccCCcEEEecccceeeeeee
Confidence            99999999999876643  8999999999999999999999999999999999998    55578999999999642   


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ....+.....|...|||||++...     ....|++.+|||||||++|||+||.+||..   .....+++.+    .+|.
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmq-----d~nPfS~qSDVYaFGiV~YELltg~lPysi---~~~dqIifmV----GrG~  609 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQ-----DDNPFSFQSDVYAFGIVWYELLTGELPYSI---QNRDQIIFMV----GRGY  609 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhc-----ccCCCCcccchhhhhHHHHHHHhCcCCcCC---CChhheEEEe----cccc
Confidence            223344556789999999999732     156799999999999999999999999971   2222222222    2221


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                                      -.|....+...++..+.+|+..||.++|++||.|.+++..+..++.
T Consensus       610 ----------------l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  610 ----------------LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ----------------cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence                            1233333445567778889999999999999999999998877765

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.6e-35  Score=311.97  Aligned_cols=257  Identities=25%  Similarity=0.370  Sum_probs=200.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .|.+.+.||+|+||.||++.+.     .++..||+|.+.... ......+.+|+.++++++||||+++++++...+  .+
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~   82 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD--PL   82 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--cc
Confidence            5788999999999999999853     345679999886433 222345678999999999999999999987644  59


Q ss_pred             EEEEeccCCCCHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCce
Q psy15481         86 VIVMELCTGGSLFNILDDPE----------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTI  155 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~----------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~  155 (708)
                      ++||||+++++|.+++....          ....+++..+..++.|++.||.|||++|++||||||+||++    +..+.
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili----~~~~~  158 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV----GENLL  158 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE----ccCCc
Confidence            99999999999999986422          11238999999999999999999999999999999999998    66778


Q ss_pred             EEEeccCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCC
Q psy15481        156 YKLTDFGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRR  231 (708)
Q Consensus       156 vKL~DFGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~  231 (708)
                      ++|+|||.+.........   ....++..|+|||++.        +..++.++|+|||||++|+|+| |.+||..   ..
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDiwslG~il~~l~t~g~~p~~~---~~  227 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--------YRKFTTESDVWSLGVVLWEIFTYGKQPWYQ---LS  227 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CC
Confidence            999999999865433211   2234577899999986        5778999999999999999998 9999963   34


Q ss_pred             hhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        232 NKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       232 ~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      ..+....+......                  ..+  ...+    ..+.+++.+||..||.+|||+.++++.+.++..
T Consensus       228 ~~~~~~~i~~~~~~------------------~~~--~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         228 NNEVIECITQGRVL------------------QRP--RTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHHHHHHHcCCcC------------------CCC--CCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            44444444432110                  011  1122    346779999999999999999999888877653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.1e-36  Score=313.95  Aligned_cols=276  Identities=25%  Similarity=0.410  Sum_probs=204.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|.+.+.||+|+||.||+|.+..+|+.||+|.+....... ..+...+|+++++.++||||+++++++....  ..|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~   79 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK--RLYLVF   79 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC--eEEEEE
Confidence            5888999999999999999999999999999986543322 2345678999999999999999999987543  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++++|..+.....   .+++..++.++.|++.||.|||+.|++|+||+|+||++    +.++.++|+|||++.....
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~----~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          80 EFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV----SQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             ecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----CCCCcEEEEeeeeeeeccC
Confidence            9999999988775533   28999999999999999999999999999999999998    6667899999999986543


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .. ......++..|+|||++..       ...++.++|||||||++|+|++|.+||..   ....+....+...... ..
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el~~g~~~~~~---~~~~~~~~~~~~~~~~-~~  221 (286)
T cd07846         153 PGEVYTDYVATRWYRAPELLVG-------DTKYGRAVDIWAVGCLVTEMLTGEPLFPG---DSDIDQLYHIIKCLGN-LI  221 (286)
T ss_pred             CccccCcccceeeccCcHHhcc-------ccccCchHhHHHHHHHHHHHHcCCCCCCC---CchHHHHHHHHHHhCC-Cc
Confidence            32 2234568899999999862       34577899999999999999999999963   3444444444421110 00


Q ss_pred             ccccc-CCCC------cccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        249 SGTQT-SENG------EIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       249 ~~~~~-~~~g------~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ..... ....      ...+...........+.++..+.+++.+||..||.+||++.++           +.|+|+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i-----------l~~~~~  286 (286)
T cd07846         222 PRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL-----------LHHEFF  286 (286)
T ss_pred             hhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH-----------hcCCCC
Confidence            00000 0000      0000000000011123445667789999999999999999997           667775

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.4e-35  Score=309.41  Aligned_cols=266  Identities=25%  Similarity=0.413  Sum_probs=203.5

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecC---C
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQE---G   82 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~---~   82 (708)
                      .....|.+...||+|+||.||++.+..+|+.||+|.+....  .......+|+.+++++ +|||++++++++...+   +
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            45677999999999999999999999999999999986432  2234456899999999 8999999999986543   2


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                      +..|+||||++|++|.+++.... ....+++..++.++.|++.||.|||+.|++||||||+||++    +..+.++|+||
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili----~~~~~~kl~df  172 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL----TTEGGVKLVDF  172 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE----cCCCCEEEeec
Confidence            46899999999999999886321 12238999999999999999999999999999999999998    55667999999


Q ss_pred             Cccccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        162 GAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       162 GlA~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      |.+....... ......|+..|+|||.+....   ..+..++.++|+|||||++|+|++|++||..   .........+.
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slGvi~~el~~g~~p~~~---~~~~~~~~~~~  246 (291)
T cd06639         173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QYDYSYDARCDVWSLGITAIELGDGDPPLFD---MHPVKTLFKIP  246 (291)
T ss_pred             ccchhcccccccccCccCCccccChhhhcCCC---CcccccCCccchHHHHHHHHHHhhCCCCCCC---CcHHHHHHHHh
Confidence            9998654332 123456889999999975311   1123468999999999999999999999973   23333333332


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .....                  .+.    .+......+.+++.+||..||++||++.++           +.|||+
T Consensus       247 ~~~~~------------------~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~i-----------l~~~~~  290 (291)
T cd06639         247 RNPPP------------------TLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHL-----------LEHPFI  290 (291)
T ss_pred             cCCCC------------------CCC----cccccCHHHHHHHHHHhhcChhhCcCHHHH-----------hcCccc
Confidence            21110                  011    112233456779999999999999999997           668886

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.7e-36  Score=313.78  Aligned_cols=254  Identities=21%  Similarity=0.320  Sum_probs=197.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCC-----CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNN-----GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .|.+.+.||.|+||.||+|.+..+     +..||+|.++........+.+.+|+.++..++||||+++++++...+.  .
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~--~   83 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP--L   83 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc--e
Confidence            466788999999999999987643     578999998754332223456789999999999999999999876554  8


Q ss_pred             EEEEeccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC
Q psy15481         86 VIVMELCTGGSLFNILDDPE-------------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG  152 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~-------------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~  152 (708)
                      +++++|+.+++|..++....             ....+++..+..++.|++.||.|||++|++||||||+||++    +.
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~----~~  159 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV----FD  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe----cC
Confidence            99999999999999885311             01237888999999999999999999999999999999998    55


Q ss_pred             CceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCC
Q psy15481        153 STIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYG  228 (708)
Q Consensus       153 ~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~  228 (708)
                      .+.+||+|||+++.......   .....+++.|+|||.+.        +..++.++|||||||++|+|++ |..||.+  
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~--  229 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM--------YGKFSIDSDIWSYGVVLWEVFSYGLQPYCG--  229 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHh--------cCCCCcchhHHHHHHHHHHHHcCCCCCCCC--
Confidence            56799999999886543321   22344678999999986        5668899999999999999998 8888873  


Q ss_pred             CCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        229 GRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       229 g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                       ....+....+.....                    .+    .+.+++..+.+++..||+.||.+||+++++...++
T Consensus       230 -~~~~~~~~~i~~~~~--------------------~~----~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         230 -YSNQDVIEMIRNRQV--------------------LP----CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             -CCHHHHHHHHHcCCc--------------------CC----CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence             444444444443211                    01    12234455677999999999999999999877653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.1e-35  Score=350.82  Aligned_cols=261  Identities=21%  Similarity=0.305  Sum_probs=198.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|+++.....  .....+.+|++++++++||||+++++++.+.+  ..|+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~--~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD--PVYY   79 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC--EEEE
Confidence            4799999999999999999999999999999998754322  22345678999999999999999999987644  5999


Q ss_pred             EEeccCCCCHHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         88 VMELCTGGSLFNILDDPE--------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~--------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      ||||++||+|.+++....        ....++...+..++.||+.||.|||++||+||||||+||++    +..+.++|+
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL----d~dg~vKLi  155 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL----GLFGEVVIL  155 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE----cCCCCEEEE
Confidence            999999999999886421        11225677889999999999999999999999999999998    666779999


Q ss_pred             ccCccccccccc-------------------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC
Q psy15481        160 DFGAARELEEDQ-------------------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG  220 (708)
Q Consensus       160 DFGlA~~~~~~~-------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG  220 (708)
                      |||++.......                   .....+||+.|+|||++.        +..++.++|||||||++|+|+||
T Consensus       156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~--------g~~~S~kSDIWSLGVILyELLTG  227 (932)
T PRK13184        156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL--------GVPASESTDIYALGVILYQMLTL  227 (932)
T ss_pred             ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc--------CCCCCcHhHHHHHHHHHHHHHHC
Confidence            999998652110                   011246999999999987        67789999999999999999999


Q ss_pred             CCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-HHH
Q psy15481        221 NLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-FER  299 (708)
Q Consensus       221 ~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-a~q  299 (708)
                      ..||....   ...........              .+.    ..+....++    ..+.+++.+||..||++|++ +++
T Consensus       228 ~~PF~~~~---~~ki~~~~~i~--------------~P~----~~~p~~~iP----~~L~~LI~rcL~~DP~kR~ss~ee  282 (932)
T PRK13184        228 SFPYRRKK---GRKISYRDVIL--------------SPI----EVAPYREIP----PFLSQIAMKALAVDPAERYSSVQE  282 (932)
T ss_pred             CCCCCCcc---hhhhhhhhhcc--------------Chh----hccccccCC----HHHHHHHHHHccCChhhCcCHHHH
Confidence            99997422   11211111100              000    111111233    44566999999999999975 556


Q ss_pred             HHHHHHHHHh
Q psy15481        300 FFSEVTKTLN  309 (708)
Q Consensus       300 ~~~~l~~il~  309 (708)
                      +...+...+.
T Consensus       283 Ll~~Le~~lq  292 (932)
T PRK13184        283 LKQDLEPHLQ  292 (932)
T ss_pred             HHHHHHHHHh
Confidence            6666665544

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.5e-36  Score=330.22  Aligned_cols=259  Identities=24%  Similarity=0.348  Sum_probs=199.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCC-----CceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNN-----GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEG   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~   82 (708)
                      .+.|.+.+.||+|+||.||+|.+...     +..||||++.........+.+.+|+.++++++ ||||+++++++.+.+ 
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~-  114 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG-  114 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-
Confidence            45788999999999999999987533     34799999976544444556789999999996 999999999987644 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCC--------------------------------------------------------
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPEN--------------------------------------------------------  106 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~--------------------------------------------------------  106 (708)
                       ..|+|||||++|+|.+++.....                                                        
T Consensus       115 -~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         115 -PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             -ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence             49999999999999988754210                                                        


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEe
Q psy15481        107 -------------------------------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFIC  149 (708)
Q Consensus       107 -------------------------------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~  149 (708)
                                                           ...+++..+..++.|++.||.|||++||+||||||+|||+   
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill---  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL---  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---
Confidence                                                 1237888899999999999999999999999999999998   


Q ss_pred             cCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCC
Q psy15481        150 DDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFR  225 (708)
Q Consensus       150 ~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~  225 (708)
                       +..+.+||+|||++........   .....++..|+|||.+.        +..++.++|||||||++|+|++ |..||.
T Consensus       271 -~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwSlGvil~ellt~g~~P~~  341 (400)
T cd05105         271 -AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF--------DNLYTTLSDVWSYGILLWEIFSLGGTPYP  341 (400)
T ss_pred             -eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc--------CCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence             5667899999999986543322   12345678899999986        5678999999999999999997 999997


Q ss_pred             CCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        226 PYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       226 ~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                      ..   ..............                   .++..    ..++..+.+++.+||..||++||++.++.+.+.
T Consensus       342 ~~---~~~~~~~~~~~~~~-------------------~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~  395 (400)
T cd05105         342 GM---IVDSTFYNKIKSGY-------------------RMAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE  395 (400)
T ss_pred             cc---chhHHHHHHHhcCC-------------------CCCCC----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence            32   11222222221100                   11111    223345667999999999999999999888766


Q ss_pred             HH
Q psy15481        306 KT  307 (708)
Q Consensus       306 ~i  307 (708)
                      ..
T Consensus       396 ~l  397 (400)
T cd05105         396 SL  397 (400)
T ss_pred             HH
Confidence            54

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.6e-36  Score=311.69  Aligned_cols=256  Identities=26%  Similarity=0.399  Sum_probs=196.4

Q ss_pred             eecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCC
Q psy15481         18 LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        18 LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~gg   95 (708)
                      ||+|+||.||++.+..+|+.||+|.+......  .....+.+|+.++++++||||+++++++...+  ..|+||||++|+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--DLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC--eEEEEEecCCCC
Confidence            69999999999999999999999998653221  22334468999999999999999999987654  599999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccccc
Q psy15481         96 SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS  175 (708)
Q Consensus        96 sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~~  175 (708)
                      +|.+++..... ..+++..+..++.|++.||.|||++|++||||+|+||++    +..+.++|+|||.+...........
T Consensus        79 ~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~----~~~~~~~l~dfg~~~~~~~~~~~~~  153 (277)
T cd05577          79 DLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL----DDHGNVRISDLGLAVELKGGKKIKG  153 (277)
T ss_pred             cHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----CCCCCEEEccCcchhhhccCCcccc
Confidence            99998876432 248999999999999999999999999999999999998    6667899999999987655444455


Q ss_pred             cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCC
Q psy15481        176 LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSE  255 (708)
Q Consensus       176 ~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~  255 (708)
                      ..++..|+|||.+.        +..++.++|+|||||++|+|++|..||...........+.....              
T Consensus       154 ~~~~~~y~~PE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------  211 (277)
T cd05577         154 RAGTPGYMAPEVLQ--------GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL--------------  211 (277)
T ss_pred             ccCCCCcCCHHHhc--------CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc--------------
Confidence            67889999999986        45588999999999999999999999975332222222211110              


Q ss_pred             CCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHH-HHHHHHHHHhhhhcCcccCC
Q psy15481        256 NGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFER-FFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       256 ~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q-~~~~l~~il~~~l~h~~~~~  319 (708)
                                ......++..+..+.++|.+||..||.+||++.+ ...+       .+.|||+..
T Consensus       212 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~-------ll~h~~~~~  259 (277)
T cd05577         212 ----------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADE-------VREHPLFKD  259 (277)
T ss_pred             ----------cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHH-------HHhChhhhc
Confidence                      0011122233445667999999999999994443 2111       156888853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-35  Score=308.68  Aligned_cols=258  Identities=25%  Similarity=0.368  Sum_probs=203.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCc----eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~----~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ...|.+.+.||+|+||.||+|.++.+|.    .||+|.+...........+.+|+.++++++||||+++++++..   ..
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~   82 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQ   82 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cc
Confidence            4578999999999999999999877765    5899988765443334556789999999999999999999876   34


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .++||||+++|+|.+++.....  .+++..+..++.|++.||.|||++|++||||||+||++    +..+.+||+|||.+
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~----~~~~~~kL~dfg~~  156 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV----KTPQHVKITDFGLA  156 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE----cCCCeEEECCCccc
Confidence            8999999999999999976433  28999999999999999999999999999999999998    66678999999999


Q ss_pred             ccccccccccc---cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHH
Q psy15481        165 RELEEDQQFMS---LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       165 ~~~~~~~~~~~---~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~  240 (708)
                      +..........   ..++..|+|||.+.        +..++.++|+|||||++|++++ |..||..   ....+....+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Di~slG~~l~el~~~g~~p~~~---~~~~~~~~~~~  225 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESIL--------HRIYTHKSDVWSYGVTVWELMTFGAKPYEG---IPAVEIPDLLE  225 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhh--------cCCcCchhhHHHHHHHHHHHhcCCCCCCCC---CCHHHHHHHHh
Confidence            87654332211   22356899999886        5678899999999999999999 9999974   33333333332


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ...                    ..+.+...    ...+.+++.+||..||..||++.++++.+.+++..
T Consensus       226 ~~~--------------------~~~~~~~~----~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         226 KGE--------------------RLPQPPIC----TIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             CCC--------------------CCCCCCCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            210                    11111112    23456799999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.9e-35  Score=310.39  Aligned_cols=257  Identities=23%  Similarity=0.334  Sum_probs=197.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCce----EEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~----VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ..|.+.+.||.|+||.||+|.+..+|+.    |++|.+...........+..|+..+++++||||+++++++..   ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Ccc
Confidence            4678899999999999999999877774    677776543322223445677888899999999999998753   237


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ++++||+++|+|.+++.....  .+++..+..++.||+.||.|||++|++||||||+||++    +..+.+||+|||.++
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili----~~~~~~kl~Dfg~~~  157 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL----KSDSIVQIADFGVAD  157 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE----cCCCcEEEcCCccce
Confidence            899999999999999975332  38999999999999999999999999999999999998    667789999999998


Q ss_pred             ccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHh
Q psy15481        166 ELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       166 ~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      .......   .....++..|+|||.+.        +..++.++|||||||++|++++ |..||.+   ..... +..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~--------~~~~~~~~Dv~slG~il~el~t~g~~p~~~---~~~~~-~~~~~~  225 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMALESIL--------FGRYTHQSDVWSYGVTVWEMMSYGAEPYAG---MRPHE-VPDLLE  225 (279)
T ss_pred             eccCCCcccccCCCCCcccccCHHHhc--------cCCcCchhhHHHHHHHHHHHHcCCCCCCCC---CCHHH-HHHHHH
Confidence            6543321   22345677899999987        5678999999999999999998 9999973   22222 222222


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ...                   .++....    ....+..++.+||..||.+|||+.+++..+..+...
T Consensus       226 ~~~-------------------~~~~~~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         226 KGE-------------------RLAQPQI----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCC-------------------cCCCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            110                   0111111    123456689999999999999999998887776543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.9e-35  Score=314.58  Aligned_cols=259  Identities=23%  Similarity=0.358  Sum_probs=201.0

Q ss_pred             CCceEEEeeEeecCCceEEEEEEE-----cCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecC
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVN-----KNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQE   81 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~   81 (708)
                      ....|.+.+.||+|+||.||++.+     ..++..||+|.++........+.+.+|+.+++++ +||||+++++.+...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            345789999999999999999975     3456689999987544333345567899999999 8999999999987654


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                        ..|+||||+++|+|.+++..... ..+++..+..++.+++.||.|||++|++|+||||+||++    +..+.++|+||
T Consensus       113 --~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~~l~df  185 (302)
T cd05055         113 --PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL----THGKIVKICDF  185 (302)
T ss_pred             --ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE----cCCCeEEECCC
Confidence              49999999999999999975332 238999999999999999999999999999999999998    56678999999


Q ss_pred             Ccccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHH
Q psy15481        162 GAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       162 GlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~  237 (708)
                      |.+........   .....++..|+|||.+.        +..++.++||||+||++|+|++ |..||..   ....+...
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslGvil~el~t~g~~p~~~---~~~~~~~~  254 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIF--------NCVYTFESDVWSYGILLWEIFSLGSNPYPG---MPVDSKFY  254 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhc--------cCCCCcHhHHHHHHHHHHHHHhCCCCCcCC---CCchHHHH
Confidence            99986543321   11234677899999986        5678899999999999999998 9999973   22222233


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ......                 +  ..+..    ...+..+.+++.+||..||++||++.+++..+.+.
T Consensus       255 ~~~~~~-----------------~--~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         255 KLIKEG-----------------Y--RMAQP----EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHcC-----------------C--cCCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            332210                 0  00111    11234566799999999999999999998877653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.4e-36  Score=309.36  Aligned_cols=256  Identities=27%  Similarity=0.422  Sum_probs=204.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|.+.+.||+|++|.||++.++.+++.||+|.+...........+.+|++++++++||||+++++.+...  +..++++|
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e   79 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICME   79 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEEE
Confidence            4677789999999999999999999999999987654444445567899999999999999999998765  45999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |++|++|.+++....  ..+++..+..++.|++.||.|||+ .|++|+||||+||++    +..+.++|+|||.+.....
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~----~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          80 YMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV----NSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             ecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE----CCCCCEEEeecccchhhHH
Confidence            999999999997643  238999999999999999999999 999999999999998    5567899999999986644


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC--CChhhHHHHHHhcccCCc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG--RRNKETMYYITTKKASGV  247 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g--~~~~e~~~~i~~~~~~~~  247 (708)
                      .... ...++..|+|||.+.        +..++.++|+|||||++|+|++|..||...+.  ....+.+..+.....   
T Consensus       154 ~~~~-~~~~~~~y~~PE~~~--------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---  221 (265)
T cd06605         154 SLAK-TFVGTSSYMAPERIQ--------GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP---  221 (265)
T ss_pred             HHhh-cccCChhccCHHHHc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC---
Confidence            3222 277899999999987        56789999999999999999999999964321  112222222221100   


Q ss_pred             ccccccCCCCcccccCCCCCcccCChh-HHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLG-LKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~-l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                                        |.   ++.. ++..+.++|..||..||.+|||+.++           +.|||+.
T Consensus       222 ------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l-----------l~~~~~~  261 (265)
T cd06605         222 ------------------PR---LPSGKFSPDFQDFVNLCLIKDPRERPSYKEL-----------LEHPFIK  261 (265)
T ss_pred             ------------------CC---CChhhcCHHHHHHHHHHcCCCchhCcCHHHH-----------hhCchhh
Confidence                              01   1111 44456779999999999999999997           5688884

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.6e-35  Score=308.95  Aligned_cols=261  Identities=25%  Similarity=0.427  Sum_probs=196.8

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEe---cCCc
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEE---QEGR   83 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~---~~~~   83 (708)
                      ....|.+.+.||+|+||.||++.+..+|+.||+|++....  .......+|+.+++++ +||||+++++++..   .++.
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            4567899999999999999999999999999999876422  2234456899999999 79999999998743   2345


Q ss_pred             eEEEEEeccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         84 GKVIVMELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                      .+++||||++|++|.+++... .....+++..+..++.|++.||.|||++|++||||||+||++    +..+.++|+|||
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili----~~~~~~kl~dfg  169 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL----TTEGGVKLVDFG  169 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE----CCCCCEEEccCC
Confidence            689999999999999887532 112238999999999999999999999999999999999998    556679999999


Q ss_pred             ccccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        163 AARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       163 lA~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      ++....... ......|++.|+|||.+....   ..+..++.++|+||+||++|+|++|..||..   ......+..+..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~---~~~~~~~~~~~~  243 (286)
T cd06638         170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QLDSTYDARCDVWSLGITAIELGDGDPPLAD---LHPMRALFKIPR  243 (286)
T ss_pred             ceeecccCCCccccccCCCcccChhhhchhh---hccccccchhhhhhHHHHHHHHhcCCCCCCC---CchhHHHhhccc
Confidence            998654332 223456899999999885211   1135578999999999999999999999973   222222221111


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      ....                  .+.    .+......+.+++.+||..||++|||+.+++.
T Consensus       244 ~~~~------------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~  282 (286)
T cd06638         244 NPPP------------------TLH----QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ  282 (286)
T ss_pred             cCCC------------------ccc----CCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0000                  000    11112334667999999999999999999733

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=305.54  Aligned_cols=247  Identities=24%  Similarity=0.377  Sum_probs=194.4

Q ss_pred             eEeecCCceEEEEEEEcCCC---ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNG---EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg---~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|....++   ..||+|.+.............+|+.+++.++||||+++++++..   ..+++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEeC
Confidence            46999999999999876554   78999998765443344556789999999999999999998753   2489999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ  172 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~  172 (708)
                      ++++|.+++....   .+++..+..++.|++.||.|||..|++|+||||+|||+    +.++.+||+|||.+........
T Consensus        78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili----~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL----VNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE----cCCCcEEeccccccceeecCCc
Confidence            9999999997654   38999999999999999999999999999999999998    6667899999999987654432


Q ss_pred             cc-c---cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        173 FM-S---LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       173 ~~-~---~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      .. .   ..++..|+|||.+.        +..++.++|||||||++|++++ |.+||..   .+..+....+....    
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~~~~~g~~p~~~---~~~~~~~~~~~~~~----  215 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECIN--------YGKFSSKSDVWSYGVTLWEAFSYGAKPYGE---MKGAEVIAMLESGE----  215 (257)
T ss_pred             ccccccCccccccccCHHHhc--------CCCCCccchHHHHHHHHHHHHcCCCCCccc---CCHHHHHHHHHcCC----
Confidence            21 1   22346799999886        5678999999999999999998 9999974   33333333332210    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                      ..+..    ...+..+.+++.+||..||.+||++.++.+.+.++
T Consensus       216 ----------------~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 ----------------RLPRP----EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ----------------cCCCC----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                            01111    12234566799999999999999999998876654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.6e-35  Score=321.97  Aligned_cols=271  Identities=24%  Similarity=0.369  Sum_probs=200.4

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecC----Cc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE----GR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~----~~   83 (708)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|.+..... ........+|+.++++++||||+++++++....    ..
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            4679999999999999999999999999999999864322 222344568999999999999999999886432    23


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||+. ++|.+.+...     +++..+..++.|++.||.|||++|++||||||+||++    +..+.+||+|||.
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~----~~~~~~kL~Dfg~  164 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGL  164 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----CCCCCEEEccCcc
Confidence            4799999995 6888887542     7899999999999999999999999999999999998    6677899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      +.............++..|+|||.+.        +..++.++|||||||++|+|++|..||..   .+....+..+....
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~~l~~l~~g~~pf~~---~~~~~~~~~~~~~~  233 (353)
T cd07850         165 ARTAGTSFMMTPYVVTRYYRAPEVIL--------GMGYKENVDIWSVGCIMGEMIRGTVLFPG---TDHIDQWNKIIEQL  233 (353)
T ss_pred             ceeCCCCCCCCCCcccccccCHHHHh--------CCCCCCchhhHhHHHHHHHHHHCCCCCCC---CCHHHHHHHHHHhc
Confidence            98765544444567899999999987        67789999999999999999999999974   33333333332210


Q ss_pred             cCC---cccc--------cc-cCCCCcccccCCCCC-----cc-cCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        244 ASG---VISG--------TQ-TSENGEIDWCTDLPN-----NC-QLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       244 ~~~---~i~~--------~~-~~~~g~~~~~~~lp~-----~~-~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      ...   ....        .. ........|...++.     .. .........+.++|.+||..||++|||+.++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei  308 (353)
T cd07850         234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA  308 (353)
T ss_pred             CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH
Confidence            000   0000        00 000000111111111     00 0012335567789999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.6e-35  Score=306.26  Aligned_cols=244  Identities=23%  Similarity=0.385  Sum_probs=190.4

Q ss_pred             EeecCCceEEEEEEE--cCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccC
Q psy15481         17 VLGKGATGAVFQGVN--KNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCT   93 (708)
Q Consensus        17 ~LG~G~fG~Vy~a~~--~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~   93 (708)
                      .||+|+||.||+|.+  ..++..||+|++...... ...+.+.+|+.++++++||||+++++++...   ..++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE---SWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CcEEEEecCC
Confidence            589999999999964  467889999998654322 2234567899999999999999999987532   4799999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccc
Q psy15481         94 GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF  173 (708)
Q Consensus        94 ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~  173 (708)
                      +++|.+++.....   +++..+..++.|++.||.|||++|++||||||+||++    +..+.++|+|||.+.........
T Consensus        79 ~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill----~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          79 LGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL----VTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             CCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE----cCCCeEEECCCccccccCCCCCe
Confidence            9999999976432   8999999999999999999999999999999999998    56678999999999866443221


Q ss_pred             ----cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        174 ----MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       174 ----~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                          ....++..|+|||.+.        +..++.++|+|||||++|+|++ |..||..   ....+....+....     
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~t~g~~p~~~---~~~~~~~~~i~~~~-----  215 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMN--------YYKFSSKSDVWSFGVLMWEAFSYGQKPYKG---MKGNEVTQMIESGE-----  215 (257)
T ss_pred             eeecCCCCCCccccCHhHhc--------cCCcCchhHHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHCCC-----
Confidence                1223457899999886        5668889999999999999998 9999974   33334444333210     


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                                   ....|.  ..+    ..+.+++..||..||++||+++.+...+.
T Consensus       216 -------------~~~~~~--~~~----~~l~~li~~~~~~~p~~Rp~~~~i~~~l~  253 (257)
T cd05116         216 -------------RMECPQ--RCP----PEMYDLMKLCWTYGVDERPGFAVVELRLR  253 (257)
T ss_pred             -------------CCCCCC--CCC----HHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence                         001111  233    44567999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.5e-35  Score=303.88  Aligned_cols=252  Identities=23%  Similarity=0.371  Sum_probs=198.4

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.+. ++..||+|.+....  ...+.+.+|+.++++++||||+++++.+.+.+  ..+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~   80 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE--PIYIIT   80 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC--CcEEEE
Confidence            46899999999999999999874 56789999876432  22456678999999999999999999886544  489999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++++|.+++.... ...++...+..++.+++.||.|||++|++||||||+||++    +..+.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili----~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          81 EYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV----SESLMCKIADFGLARVIED  155 (261)
T ss_pred             ecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe----cCCCcEEECCCccceecCC
Confidence            9999999999986532 2238899999999999999999999999999999999998    6667899999999986544


Q ss_pred             ccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ...  .....++..|+|||.+.        +..++.++|+|||||++|+|+| |..||..   .........+....   
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~l~t~g~~p~~~---~~~~~~~~~~~~~~---  221 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAIN--------FGSFTIKSDVWSFGILLYEIVTYGKIPYPG---MSNSDVMSALQRGY---  221 (261)
T ss_pred             CceeccCCCccceecCCHHHhc--------cCCCChhhhhhhhHHHHHHHHccCCCCCCC---CCHHHHHHHHHcCC---
Confidence            321  12234567899999986        5668889999999999999998 9999973   34444444433210   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                                       ..|....    ++..+.+++.+||..||++||+++++.+.+++
T Consensus       222 -----------------~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         222 -----------------RMPRMEN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -----------------CCCCCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                             1111112    23446679999999999999999998776553

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4e-35  Score=308.94  Aligned_cols=277  Identities=25%  Similarity=0.322  Sum_probs=199.4

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.+..+|..||+|.+.............+|+.+++.++||||+++++++....  ..|+||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~lv~   82 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE--TLTFVF   82 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC--eEEEEE
Confidence            578899999999999999999999999999999875443333334568999999999999999999987543  589999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+. ++|...+....  ..+++..+..++.|++.||.|||+.|++|+||||+||++    +..+.++|+|||++.....
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~----~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI----SYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE----cCCCcEEEeccccccccCC
Confidence            9995 77777665432  237889999999999999999999999999999999998    5667899999999875432


Q ss_pred             c-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc--c-C
Q psy15481        170 D-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK--A-S  245 (708)
Q Consensus       170 ~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~--~-~  245 (708)
                      . .......++..|+|||.+..       ...++.++|+|||||++|+|++|..||...  ....+.+..+....  + .
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~--~~~~~~~~~~~~~~~~~~~  226 (291)
T cd07870         156 PSQTYSSEVVTLWYRPPDVLLG-------ATDYSSALDIWGAGCIFIEMLQGQPAFPGV--SDVFEQLEKIWTVLGVPTE  226 (291)
T ss_pred             CCCCCCCccccccccCCceeec-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCc--hhHHHHHHHHHHHcCCCCh
Confidence            2 22234567899999998862       245788999999999999999999999742  22333333322110  0 0


Q ss_pred             CcccccccCCCCcccccC-CCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        246 GVISGTQTSENGEIDWCT-DLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~-~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ...............|.. ..+..     ..++  .+..+.+++.+||..||.+|||++++           +.|||+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ll~~~l~~dp~~R~t~~~~-----------l~h~~~  291 (291)
T cd07870         227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLS--RPPKAEDLASQMLMMFPKDRISAQDA-----------LLHPYF  291 (291)
T ss_pred             hhhhhhhhcccccchhccccCCcchhhhccccC--CChHHHHHHHHHhCcCcccCcCHHHH-----------hcCCCC
Confidence            000000000000001100 00000     0011  13456679999999999999999997           678885

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG4645|consensus

Probab=100.00  E-value=1.8e-37  Score=361.42  Aligned_cols=256  Identities=29%  Similarity=0.513  Sum_probs=215.0

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC-CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS-HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s-~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      +-..+|+-+..||.|.||.||-|.+..||+..|+|-++-.. .........+|..++..|+|||+|+++++....+.  .
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek--v 1309 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK--V 1309 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH--H
Confidence            34568999999999999999999999999999999876432 22333445689999999999999999999887665  8


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      +|.||||.||+|.+.+.....   .++...+.+..|++.|++|||+.|||||||||.||++    +.++.+|++|||.|.
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L----d~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL----DFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee----ecCCcEEeeccccee
Confidence            999999999999999987655   7888888999999999999999999999999999998    777899999999999


Q ss_pred             cccccc-----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        166 ELEEDQ-----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       166 ~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      .+..+.     ......||+.|||||++.+..     ++.-..++|||||||+..||+||+.||..+  +++..+|+++.
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~-----~kG~~~A~DiWslGCVVlEM~tGkrPW~~~--dne~aIMy~V~ 1455 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTK-----GKGHGGAADIWSLGCVVLEMATGKRPWAEL--DNEWAIMYHVA 1455 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccc-----cCCCCcchhhhcccceEEEeecCCCchhhc--cchhHHHhHHh
Confidence            876553     233568999999999998532     456677899999999999999999999854  56788888887


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      .+..                        ++++..++..-.++|..||+.||++||++.|+++
T Consensus      1456 ~gh~------------------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1456 AGHK------------------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             ccCC------------------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            5321                        1234446666777999999999999999998744

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-35  Score=307.71  Aligned_cols=259  Identities=23%  Similarity=0.358  Sum_probs=200.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|++|.||++.+..+|+.||+|.+.......  ....+.+|+.+++.++||||+++++.+...+  ..+++
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~v   80 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNIV   80 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC--eEEEE
Confidence            5778899999999999999999999999999886533222  2234568999999999999999999987644  59999


Q ss_pred             EeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||++|++|.+++.... ....+++..+..++.+|+.||.|||++|++|+||||+||++    +..+.++|+|||.+...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili----~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI----TATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCCEEECcchhhhcc
Confidence            99999999999886421 12348999999999999999999999999999999999998    66678999999998865


Q ss_pred             ccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 EEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ..... .....|+..|+|||.+.        +..++.++|+||||+++|+|++|..||.+.. .........+...    
T Consensus       157 ~~~~~~~~~~~~~~~~~ape~~~--------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~----  223 (267)
T cd08229         157 SSKTTAAHSLVGTPYYMSPERIH--------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKIEQC----  223 (267)
T ss_pred             ccCCcccccccCCcCccCHHHhc--------CCCccchhhHHHHHHHHHHHHhCCCCccccc-chHHHHhhhhhcC----
Confidence            44322 23456899999999986        5668889999999999999999999996311 1111111111110    


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                       ..|..  .+...+..+.+++.+||..||.+|||+.+++..+.+.
T Consensus       224 -----------------~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         224 -----------------DYPPL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             -----------------CCCCC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                             00100  1122444567799999999999999999988876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3e-35  Score=306.04  Aligned_cols=255  Identities=25%  Similarity=0.382  Sum_probs=198.7

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCc---eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|.+.+.||+|+||.||+|.+..++.   .||+|.+...........+.+|+.+++.++||||+++++++...+  ..|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK--PVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--ccE
Confidence            367889999999999999999865543   799998865432223345678999999999999999999987544  589


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++|++|.+++.....  .+++..+..++.|++.||.|||++|++||||||+||++    +..+.++|+|||.+..
T Consensus        82 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili----~~~~~~~l~dfg~~~~  155 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV----NSNLVCKVSDFGLSRV  155 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE----CCCCeEEeCCCCcccc
Confidence            99999999999999976432  38999999999999999999999999999999999998    6677899999999986


Q ss_pred             ccccccc----cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHh
Q psy15481        167 LEEDQQF----MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       167 ~~~~~~~----~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      .......    ....++..|+|||.+.        +..++.++|+|||||++|++++ |..||..   ....+....+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~--------~~~~~~~~Dv~slG~~l~ell~~g~~p~~~---~~~~~~~~~~~~  224 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIA--------YRKFTSASDVWSYGIVMWEVMSYGERPYWE---MSNQDVIKAIEE  224 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhc--------cCccCchhhhHHHHHHHHHHhcCCCCCccc---CCHHHHHHHHhC
Confidence            5443221    1122356899999987        5678999999999999999887 9999973   333333333332


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ..                    ..|.....+    ..+.+++.+||..+|.+||++.+++..+.++
T Consensus       225 ~~--------------------~~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 GY--------------------RLPAPMDCP----AALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CC--------------------cCCCCCCCC----HHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            10                    112222233    3456799999999999999999998877654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=305.04  Aligned_cols=248  Identities=25%  Similarity=0.426  Sum_probs=197.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC----CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH----MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~----~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .|.+.+.||+|+||.||+|.+..+|..||+|.+.....    ......+.+|+.++++++||||+++++.+.+.....++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            58889999999999999999999999999998754321    12223456899999999999999999998776666789


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ++|||++|++|.+++.....   +++..++.++.|++.||.|||++|++|+||||+||++    +.++.++|+|||.+..
T Consensus        83 ~v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i----~~~~~~~l~dfg~~~~  155 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR----DSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE----cCCCCEEECccccccc
Confidence            99999999999999875432   8999999999999999999999999999999999998    5666799999999986


Q ss_pred             cccc----ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        167 LEED----QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       167 ~~~~----~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      ....    .......|+..|+|||.+.        +..++.++|+|||||++|++++|..||..   .........+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~  224 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVIS--------GEGYGRKADVWSVACTVVEMLTEKPPWAE---YEAMAAIFKIATQ  224 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhc--------CCCCCccccHHHHHHHHHHHHhCCCCCCc---cCHHHHHHHHHcC
Confidence            5321    1122356889999999987        56678999999999999999999999963   2233333333211


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                             +....+++.+.+.+.+++..||. +|.+||++.++
T Consensus       225 -----------------------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~  258 (264)
T cd06653         225 -----------------------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFL  258 (264)
T ss_pred             -----------------------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHH
Confidence                                   11112334455667779999999 57999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.5e-35  Score=306.60  Aligned_cols=254  Identities=24%  Similarity=0.396  Sum_probs=198.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCc---eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .|.+.+.||+|+||.||+|.++.+|+   .||+|.+...........+..|+.+++.++||||+++++++....  ..++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~l   82 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR--PVMI   82 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC--ceEE
Confidence            58899999999999999999887665   599999865433223345678999999999999999999986544  4899


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||+++++|.+++.....  .+++..+..++.|++.||.|||++|++|+||||+||++    ++.+.++|+|||.+...
T Consensus        83 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili----~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          83 ITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV----NSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE----cCCCcEEECCCcccccc
Confidence            9999999999999876432  38999999999999999999999999999999999998    67778999999998765


Q ss_pred             ccccc---ccccC---CCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHH
Q psy15481        168 EEDQQ---FMSLY---GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       168 ~~~~~---~~~~~---GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~  240 (708)
                      .....   .....   .+..|+|||.+.        +..++.++|+||+||++|++++ |..||..   .+..+....+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~DvwslG~~l~e~l~~g~~p~~~---~~~~~~~~~i~  225 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIA--------YRKFTSASDVWSYGIVMWEVMSYGERPYWD---MSNQDVINAIE  225 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhc--------cCcccchhhhhhhHHHHHHHhcCCCCCCCC---CCHHHHHHHHH
Confidence            43321   11111   245799999987        5678899999999999999886 9999963   33334333332


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ..                  +  .+|....    ++..+.+++.+||..||.+||++.+++..++.+
T Consensus       226 ~~------------------~--~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 QD------------------Y--RLPPPMD----CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cC------------------C--cCCCccc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11                  0  1122122    234466799999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.7e-35  Score=302.85  Aligned_cols=259  Identities=22%  Similarity=0.360  Sum_probs=202.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|.+..+|+.||+|.++....  ........+|++++++++|+||+++++.+...+  ..++|
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~--~~~lv   80 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN--ELNIV   80 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--eEEEE
Confidence            68889999999999999999999999999999864322  222445678999999999999999999987654  58999


Q ss_pred             EeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||++|++|.+++.... ....+++..+..++.+++.||.|||+.|++||||+|+||++    +..+.++|+|||.+...
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~----~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI----TATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE----CCCCcEEEeccceeeec
Confidence            99999999999886422 12338999999999999999999999999999999999998    56677999999998765


Q ss_pred             cccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 EEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      .... ......++..|+|||.+.        +..++.++|+|||||++|+|++|..||.... .+.......+.....  
T Consensus       157 ~~~~~~~~~~~~~~~y~apE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~--  225 (267)
T cd08224         157 SSKTTAAHSLVGTPYYMSPERIH--------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKIEKCDY--  225 (267)
T ss_pred             cCCCcccceecCCccccCHHHhc--------cCCCCchhcHHHHHHHHHHHHHCCCCcccCC-ccHHHHHhhhhcCCC--
Confidence            4332 223356889999999986        5678899999999999999999999996321 111122222211100  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                      ...|     ....+..+.+++.+||..+|++||++.+++..+..+
T Consensus       226 ----------------~~~~-----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         226 ----------------PPLP-----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ----------------CCCC-----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                            0111     113345567799999999999999999998876654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.7e-36  Score=313.92  Aligned_cols=279  Identities=23%  Similarity=0.329  Sum_probs=204.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|.+.+.||.|+||.||+|.+..+|+.||+|.++...... ......+|+.++++++||||+++++++...+....|+||
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            5778899999999999999999999999999987543322 122346899999999999999999998776556799999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+. ++|.+++.....  .+++..++.++.||+.||.|||++|++|+||||+||++    +..+.++|+|||.+.....
T Consensus        86 e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili----~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          86 EYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL----NNRGILKICDFGLAREYGS  158 (293)
T ss_pred             hhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE----CCCCcEEEeecCceeeccC
Confidence            9996 599988865432  38999999999999999999999999999999999998    6677899999999987654


Q ss_pred             c-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC---
Q psy15481        170 D-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS---  245 (708)
Q Consensus       170 ~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~---  245 (708)
                      . .......+++.|+|||.+..       ...++.++|+||+||++|+|++|.+||..   ....+.+.++......   
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~f~~---~~~~~~~~~~~~~~~~~~~  228 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLG-------AKEYSTAIDMWSVGCIFAELLTKKPLFPG---KSEIDQLNKIFKLLGTPTE  228 (293)
T ss_pred             CccccccccccccccCchhhcC-------CccccchhhHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHHHhCCCch
Confidence            4 23334567889999998862       34468899999999999999999999974   3334444443321110   


Q ss_pred             CcccccccCCC-CcccccCCCC--CcccCChh-HHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        246 GVISGTQTSEN-GEIDWCTDLP--NNCQLSLG-LKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       246 ~~i~~~~~~~~-g~~~~~~~lp--~~~~ls~~-l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ....+...... ....|....+  ....++.. +...+.++|.+||..||++|||+.++           +.|+|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~el-----------l~~~~f  293 (293)
T cd07843         229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA-----------LKHPYF  293 (293)
T ss_pred             HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHH-----------hcCCCC
Confidence            00000000000 0000000000  00011111 35567779999999999999999997           667775

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=311.28  Aligned_cols=267  Identities=25%  Similarity=0.391  Sum_probs=199.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|.+.+.||+|++|.||+|.++.+++.||+|.++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~iv~   79 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG--RLYLVF   79 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC--EEEEEE
Confidence            58999999999999999999999999999999865322 233456679999999999999999999997644  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++++.+..+.....   .+++..+..++.+|+.||.|||++|++|+||+|+||++    +..+.++|+|||.+.....
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~----~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          80 EYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV----SESGVLKLCDFGFARALRA  152 (288)
T ss_pred             ecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCCEEEEeeecccccCC
Confidence            9998877766665433   38999999999999999999999999999999999998    6677899999999987655


Q ss_pred             cc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh---ccc
Q psy15481        170 DQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT---KKA  244 (708)
Q Consensus       170 ~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~---~~~  244 (708)
                      ..  ......++..|+|||++..       ...++.++|+||||+++|+|++|.+||..   ....+....+..   ...
T Consensus       153 ~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~---~~~~~~~~~~~~~~~~~~  222 (288)
T cd07833         153 RPASPLTDYVATRWYRAPELLVG-------DTNYGKPVDVWAIGCIMAELLDGEPLFPG---DSDIDQLYLIQKCLGPLP  222 (288)
T ss_pred             CccccccCcccccCCcCCchhcC-------CCCcCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHhCCCC
Confidence            43  3344668899999999872       22788999999999999999999999974   223333322221   000


Q ss_pred             CCcccccccCCCCcccccC-CCCCc-------ccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        245 SGVISGTQTSENGEIDWCT-DLPNN-------CQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~-~lp~~-------~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      +........  .  ..+.. .++..       ...+..++..+.+++++||..||++||+++++
T Consensus       223 ~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  282 (288)
T cd07833         223 PSHQELFSS--N--PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDEL  282 (288)
T ss_pred             HHHhhhccc--C--ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHH
Confidence            000000000  0  00000 01100       01112235567789999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.2e-35  Score=311.06  Aligned_cols=258  Identities=20%  Similarity=0.328  Sum_probs=198.5

Q ss_pred             EEEeeEeecCCceEEEEEEEcC-----CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      |++...||+|+||.||+|.+..     .+..+++|.+...........+.+|+.+++.++||||+++++.+...+  ..+
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~   79 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG--PLL   79 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC--CcE
Confidence            6788999999999999998753     335799998865443333345678999999999999999999987654  489


Q ss_pred             EEEeccCCCCHHHHhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q psy15481         87 IVMELCTGGSLFNILDDPE---------------------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIM  145 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~---------------------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NIL  145 (708)
                      ++|||+.+++|.+++....                     ....+++..++.++.|++.||.|||++|++||||||+||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            9999999999999876421                     1123789999999999999999999999999999999999


Q ss_pred             EEEecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CC
Q psy15481        146 KFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GN  221 (708)
Q Consensus       146 l~~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~  221 (708)
                      +    +..+.++|+|||+++.......   .....++..|+|||.+.        +..++.++|||||||++|+|+| |.
T Consensus       160 l----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~--------~~~~~~~~Di~slG~~l~el~t~g~  227 (290)
T cd05045         160 V----AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF--------DHIYTTQSDVWSFGVLLWEIVTLGG  227 (290)
T ss_pred             E----cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc--------cCCcchHhHHHHHHHHHHHHHhcCC
Confidence            8    5567899999999986533221   12234567899999886        5678999999999999999999 99


Q ss_pred             CCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHH
Q psy15481        222 LPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFF  301 (708)
Q Consensus       222 ~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~  301 (708)
                      .||.+   ........ .....                 +  ..+..    ...+..+.+++..||+.||.+||++.+++
T Consensus       228 ~p~~~---~~~~~~~~-~~~~~-----------------~--~~~~~----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~  280 (290)
T cd05045         228 NPYPG---IAPERLFN-LLKTG-----------------Y--RMERP----ENCSEEMYNLMLTCWKQEPDKRPTFADIS  280 (290)
T ss_pred             CCCCC---CCHHHHHH-HHhCC-----------------C--CCCCC----CCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence            99963   33333332 22210                 0  01111    12234566799999999999999999999


Q ss_pred             HHHHHHHhh
Q psy15481        302 SEVTKTLNR  310 (708)
Q Consensus       302 ~~l~~il~~  310 (708)
                      +.+++++.+
T Consensus       281 ~~l~~~~~~  289 (290)
T cd05045         281 KELEKMMVK  289 (290)
T ss_pred             HHHHHHHhc
Confidence            998887643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5e-35  Score=302.17  Aligned_cols=252  Identities=31%  Similarity=0.508  Sum_probs=198.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.++++++||||+++++++...+  .+++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE--KVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC--EEEEEE
Confidence            588999999999999999999989999999998754332 23445679999999999999999999876543  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++++|.+++.....   +++..+..++.+++.||.|||+.|++|+||+|+||++    +..+.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~----~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          79 EYCSGGTLEELLEHGRI---LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL----DHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             ecCCCCcHHHHHhhcCC---CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEcccccccccCC
Confidence            99999999999976432   7899999999999999999999999999999999998    6677899999999987644


Q ss_pred             ccc-----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        170 DQQ-----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       170 ~~~-----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ...     .....++..|+|||.+....     ...++.++||||||+++|++++|+.||...  .........+.... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~-  223 (264)
T cd06626         152 NTTTMGEEVQSLAGTPAYMAPEVITGGK-----GKGHGRAADIWSLGCVVLEMATGKRPWSEL--DNEFQIMFHVGAGH-  223 (264)
T ss_pred             CCCcccccccCCcCCcCccChhhccCCC-----CCCCCcccchHHHHHHHHHHHhCCCCccCC--cchHHHHHHHhcCC-
Confidence            322     22356889999999986211     134789999999999999999999999742  22233332222210 


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                       ...+|....++    ..+.+++.+||..||.+||++.++
T Consensus       224 -----------------~~~~~~~~~~~----~~~~~li~~~l~~~p~~R~~~~~i  258 (264)
T cd06626         224 -----------------KPPIPDSLQLS----PEGKDFLDRCLESDPKKRPTASEL  258 (264)
T ss_pred             -----------------CCCCCcccccC----HHHHHHHHHHccCCcccCCCHHHH
Confidence                             01223322223    345569999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG4279|consensus

Probab=100.00  E-value=2.2e-36  Score=332.26  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=208.8

Q ss_pred             EeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCCC
Q psy15481         17 VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGS   96 (708)
Q Consensus        17 ~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggs   96 (708)
                      +||.|.||+||-|++..|...+|||-+.... .+..+....|+.+-+.|+|.|||++++.+..  ++++-|.||-++|||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCCCc
Confidence            7999999999999999999999999986433 2334456789999999999999999999754  336789999999999


Q ss_pred             HHHHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-cccc
Q psy15481         97 LFNILDDPENTYGL--QEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQQF  173 (708)
Q Consensus        97 L~~~L~~~~~~~~L--~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-~~~~  173 (708)
                      |.+++...-..  +  .|..+-.+.+||+.||.|||++.|||||||.+|+|+   +.-.|++||+|||.+..+-. ++-.
T Consensus       659 LSsLLrskWGP--lKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLv---NTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  659 LSSLLRSKWGP--LKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLV---NTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             HHHHHHhccCC--CccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEE---eeccceEEecccccchhhccCCccc
Confidence            99999875432  5  789999999999999999999999999999999998   34567999999999987643 3444


Q ss_pred             cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccccc
Q psy15481        174 MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQT  253 (708)
Q Consensus       174 ~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~  253 (708)
                      .+..||..|||||++..+      ...|+.++|||||||++.||+||++||...  .+....|+++.-            
T Consensus       734 ETFTGTLQYMAPEvIDqG------~RGYG~aADIWS~GCT~vEMATGrPPF~El--gspqAAMFkVGm------------  793 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQG------PRGYGKAADIWSFGCTMVEMATGRPPFVEL--GSPQAAMFKVGM------------  793 (1226)
T ss_pred             cccccchhhhChHhhccC------CcCCCchhhhhhccceeEeeccCCCCeeec--CChhHhhhhhcc------------
Confidence            567899999999999753      367999999999999999999999999743  344555665542            


Q ss_pred             CCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        254 SENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       254 ~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                 +...++++.+++.....+|.+|+++||.+||+|.++           +..||....
T Consensus       794 -----------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~L-----------L~DpFlq~~  838 (1226)
T KOG4279|consen  794 -----------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDL-----------LQDPFLQHN  838 (1226)
T ss_pred             -----------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHh-----------ccCcccccC
Confidence                       122334566677777779999999999999999997           556776655

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.4e-35  Score=304.20  Aligned_cols=249  Identities=26%  Similarity=0.429  Sum_probs=201.3

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|++.+.||.|++|.||+|.+..+|+.|++|.+...........+.+|+..+.+++||||+++++++...  ...++|||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e   79 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVLE   79 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEEE
Confidence            4788899999999999999999999999999987654333345567999999999999999999998765  35999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |++|++|.+++....   .+++..+..++.|++.|+.|||+ .|++|+||+|+||++    +..+.++|+|||.+.....
T Consensus        80 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~----~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          80 YMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI----NSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE----CCCCCEEEccCccceeccc
Confidence            999999999997643   38999999999999999999999 999999999999998    6677899999999987654


Q ss_pred             ccccc-ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQQFM-SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~~~~-~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      ..... ...++..|+|||.+.        +..++.++|+||||+++|+|+||..||...+.....+....+....     
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~--------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----  219 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPERIQ--------GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP-----  219 (264)
T ss_pred             CCCcccceeecccccCHhhhC--------CCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC-----
Confidence            43322 456889999999986        5678899999999999999999999997532212223332222110     


Q ss_pred             cccccCCCCcccccCCCCCcccCChh-HHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLG-LKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~-l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                      .+.   ++.. .+..+.+++..||..+|++||++.++
T Consensus       220 ----------------~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l  253 (264)
T cd06623         220 ----------------PPS---LPAEEFSPEFRDFISACLQKDPKKRPSAAEL  253 (264)
T ss_pred             ----------------CCC---CCcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence                            011   1112 34456679999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.5e-35  Score=305.14  Aligned_cols=250  Identities=26%  Similarity=0.419  Sum_probs=199.3

Q ss_pred             eecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCC
Q psy15481         18 LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        18 LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~gg   95 (708)
                      ||.|++|.||++.+..+++.||+|++......  .....+.+|+.+++.++||||+++++.+.+..  ..|+||||++|+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK--YIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--ccEEEEecCCCC
Confidence            69999999999999999999999999754322  23345678999999999999999999887654  599999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccccc
Q psy15481         96 SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS  175 (708)
Q Consensus        96 sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~~  175 (708)
                      +|.+++.....   +++..+..++.||+.||.|||++|++|+||+|+||++    +..+.++|+|||.+...........
T Consensus        79 ~L~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv----~~~~~~~l~df~~~~~~~~~~~~~~  151 (262)
T cd05572          79 ELWTILRDRGL---FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL----DSNGYVKLVDFGFAKKLKSGQKTWT  151 (262)
T ss_pred             cHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE----cCCCCEEEeeCCcccccCccccccc
Confidence            99999976433   8999999999999999999999999999999999998    6667899999999987655433344


Q ss_pred             cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCC
Q psy15481        176 LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSE  255 (708)
Q Consensus       176 ~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~  255 (708)
                      ..|++.|+|||.+.        +..++.++|+||+|+++|+|++|..||..... +....+..+......          
T Consensus       152 ~~~~~~~~~PE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~----------  212 (262)
T cd05572         152 FCGTPEYVAPEIIL--------NKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGK----------  212 (262)
T ss_pred             ccCCcCccChhHhc--------CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCC----------
Confidence            67899999999986        56678999999999999999999999974321 133333333311000          


Q ss_pred             CCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        256 NGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       256 ~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                             ...|      ...+..+.+++.+||..||.+||+     +.++           +.|||+.+
T Consensus       213 -------~~~~------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l-----------~~~~~~~~  257 (262)
T cd05572         213 -------LEFP------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDI-----------KKHKWFNG  257 (262)
T ss_pred             -------CCCC------cccCHHHHHHHHHHccCChhhCcCCcccCHHHH-----------hcChhhhC
Confidence                   0111      122445677999999999999999     7775           66888853

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.7e-36  Score=312.62  Aligned_cols=273  Identities=26%  Similarity=0.372  Sum_probs=201.5

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      |...+.||.|++|.||+|.+..+|..||||.+...... .....+.+|++++++++||||+++++++.+..  ..++|||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e   79 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYLVFE   79 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC--cEEEEee
Confidence            77889999999999999999999999999998654322 22345678999999999999999999987544  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+. ++|..++..... ..+++..++.++.|++.||+|||++|++|+||+|+||++    +..+.++|+|||++......
T Consensus        80 ~~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill----~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          80 FLH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI----NTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             ccc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEEeeccchhhcccC
Confidence            995 689888865432 348999999999999999999999999999999999998    66678999999998765433


Q ss_pred             c-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC---C
Q psy15481        171 Q-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS---G  246 (708)
Q Consensus       171 ~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~---~  246 (708)
                      . ......++..|+|||.+..       ...++.++|+|||||++|+|+||..||..   .+......++......   .
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~p~~~---~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEV  223 (284)
T ss_pred             ccccccccccccccCCeEEec-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHHHhCCCChh
Confidence            2 2233457889999998762       34468899999999999999999999974   3334444443321110   0


Q ss_pred             cccccccCCCCcccccCCCCCcc-----cCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNC-----QLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~-----~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ...+...    ...+...++...     .+.+.++..+.++|.+||..||.+||++.++           +.||||
T Consensus       224 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~-----------l~~~~f  284 (284)
T cd07860         224 VWPGVTS----LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA-----------LAHPFF  284 (284)
T ss_pred             hhhhhhH----HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHH-----------hcCCCC
Confidence            0000000    000000111110     1112233446679999999999999999997           678886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.5e-35  Score=312.50  Aligned_cols=260  Identities=19%  Similarity=0.322  Sum_probs=201.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcC-------CCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecC
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKN-------NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQE   81 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~-------tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~   81 (708)
                      ..|.+.+.||+|+||.||++.+..       ++..||+|.+.............+|+.+++++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            468999999999999999998643       33579999987543333334566899999999 8999999999987654


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEE
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFI  148 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~  148 (708)
                        ..|+||||+++|+|.+++.....             ...++...++.++.|++.||.|||++|++||||||+||++  
T Consensus        98 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill--  173 (307)
T cd05098          98 --PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--  173 (307)
T ss_pred             --ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE--
Confidence              48999999999999999975321             1238899999999999999999999999999999999998  


Q ss_pred             ecCCCceEEEeccCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCC
Q psy15481        149 CDDGSTIYKLTDFGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF  224 (708)
Q Consensus       149 ~~d~~~~vKL~DFGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF  224 (708)
                        +..+.++|+|||.+.........   ....++..|+|||.+.        +..++.++|+|||||++|+|++ |..||
T Consensus       174 --~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~~l~el~~~g~~p~  243 (307)
T cd05098         174 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--------DRIYTHQSDVWSFGVLLWEIFTLGGSPY  243 (307)
T ss_pred             --cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc--------cCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence              56678999999999865432211   1223456899999886        5678899999999999999998 88998


Q ss_pred             CCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        225 RPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       225 ~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      ..   ... +.+........                   ..+.    +..++..+.+++.+||..+|.+||++.+++..+
T Consensus       244 ~~---~~~-~~~~~~~~~~~-------------------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l  296 (307)
T cd05098         244 PG---VPV-EELFKLLKEGH-------------------RMDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  296 (307)
T ss_pred             Cc---CCH-HHHHHHHHcCC-------------------CCCC----CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            62   333 33333222110                   0111    122334566799999999999999999999999


Q ss_pred             HHHHhh
Q psy15481        305 TKTLNR  310 (708)
Q Consensus       305 ~~il~~  310 (708)
                      ..++..
T Consensus       297 ~~~~~~  302 (307)
T cd05098         297 DRILAL  302 (307)
T ss_pred             HHHHHH
Confidence            888765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.7e-36  Score=316.53  Aligned_cols=263  Identities=22%  Similarity=0.372  Sum_probs=204.4

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      +.....|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+  ..
T Consensus        18 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~~   94 (292)
T cd06658          18 GDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD--EL   94 (292)
T ss_pred             CchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC--eE
Confidence            344445555678999999999999999999999999986432 223445678999999999999999999987644  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++|++|.+++....    +++..+..++.||+.||.|||++||+||||||+||++    +.++.++|+|||++.
T Consensus        95 ~lv~e~~~~~~L~~~~~~~~----l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill----~~~~~~kL~dfg~~~  166 (292)
T cd06658          95 WVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL----TSDGRIKLSDFGFCA  166 (292)
T ss_pred             EEEEeCCCCCcHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE----cCCCCEEEccCcchh
Confidence            99999999999999886532    8999999999999999999999999999999999998    556689999999987


Q ss_pred             cccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ...... ......|+..|+|||.+.        +..++.++|+|||||++|+|++|..||..   .+....+..+.....
T Consensus       167 ~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slGvil~el~~g~~p~~~---~~~~~~~~~~~~~~~  235 (292)
T cd06658         167 QVSKEVPKRKSLVGTPYWMAPEVIS--------RLPYGTEVDIWSLGIMVIEMIDGEPPYFN---EPPLQAMRRIRDNLP  235 (292)
T ss_pred             hcccccccCceeecCccccCHHHHc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcCC
Confidence            543322 223456899999999986        56688999999999999999999999973   333333333222100


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcccc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQC  323 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~  323 (708)
                                        ..++...    ..+..+.+++..||..||.+|||+.++           +.|+|+......
T Consensus       236 ------------------~~~~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~i-----------l~~~~~~~~~~~  281 (292)
T cd06658         236 ------------------PRVKDSH----KVSSVLRGFLDLMLVREPSQRATAQEL-----------LQHPFLKLAGPP  281 (292)
T ss_pred             ------------------Ccccccc----ccCHHHHHHHHHHccCChhHCcCHHHH-----------hhChhhhccCCc
Confidence                              0111111    233456679999999999999999997           558888655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-35  Score=306.64  Aligned_cols=253  Identities=26%  Similarity=0.385  Sum_probs=201.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||.|+||.||+|.+.. +..+|+|.+..... .......+|+.+++.++||||+++++++.+..  ..++||
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~   81 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGE--PVYIIT   81 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCC--CeEEEE
Confidence            357788999999999999999977 89999999875432 22445678999999999999999999987654  489999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++++|.+++..... ..+++..+..++.+++.||.|||++|++|+||||+||++    ++.+.+||+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv----~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          82 ELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV----GEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             eecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE----cCCceEEEccccchhhcCC
Confidence            99999999999976432 348999999999999999999999999999999999998    6667899999999986543


Q ss_pred             ccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        170 DQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       170 ~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ... .....++..|+|||.+.        +..++.++|+|||||++|+|++ |..||..   .+..+....+....    
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~--------~~~~~~~~DiwslG~~l~~l~~~g~~p~~~---~~~~~~~~~~~~~~----  221 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAAS--------HGTFSTKSDVWSFGILLYEMFTYGQVPYPG---MNNHEVYDQITAGY----  221 (261)
T ss_pred             ccccccCCCCceEecCHHHHc--------cCCCCchhhHHHHHHHHHHHHcCCCCCCCc---CCHHHHHHHHHhCC----
Confidence            321 12334567899999986        5678899999999999999998 8999963   44444444443210    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                                      ..+.+    ..++..+.+++.+||..||.+|||+.++.+.|+.
T Consensus       222 ----------------~~~~~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 ----------------RMPCP----AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ----------------cCCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                            11111    2223456679999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=313.15  Aligned_cols=210  Identities=23%  Similarity=0.390  Sum_probs=169.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcC--CCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKN--NGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~--tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .|.+.+.||+|+||.||+|.+..  +|..||+|.+....  .........+|+.++++++||||+++++++.+.....+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47889999999999999999988  89999999987632  112234456899999999999999999999877556799


Q ss_pred             EEEeccCCCCHHHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         87 IVMELCTGGSLFNILDDPEN--TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~--~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      +||||++ ++|.+.+.....  ...+++..++.++.|++.||.|||++|++||||||+||++..+++..+.+||+|||++
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            9999996 577776643211  1248999999999999999999999999999999999998221222789999999999


Q ss_pred             cccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCC
Q psy15481        165 RELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG  228 (708)
Q Consensus       165 ~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~  228 (708)
                      ........    .....++..|+|||.+..       ...++.++|||||||++|+|++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            86543321    223467899999998862       3567899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=308.51  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=201.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC---CCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK---HENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~---HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .|...+.||+|+||.||+|.+..+|+.||+|.++............+|+.++++++   |||++++++++...+  .+|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~--~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP--RLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC--EEEE
Confidence            46778899999999999999999999999999876544444455668999999996   999999999887543  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++|++|.+++...    .+++..+..++.+++.||.|||+.|++|+||+|+||++    +..+.++|+|||.+...
T Consensus        80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i----~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV----TNTGNVKLCDFGVAALL  151 (277)
T ss_pred             EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE----cCCCCEEEccCCceeec
Confidence            99999999999998653    38999999999999999999999999999999999998    55778999999999876


Q ss_pred             ccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 EEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ..... .....|+..|+|||.+..       +..++.++|+|||||++|+|++|..||..   .........+...    
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~---~~~~~~~~~~~~~----  217 (277)
T cd06917         152 NQNSSKRSTFVGTPYWMAPEVITE-------GKYYDTKADIWSLGITIYEMATGNPPYSD---VDAFRAMMLIPKS----  217 (277)
T ss_pred             CCCccccccccCCcceeCHHHhcc-------CCccccchhHHHHHHHHHHHHhCCCCCCC---CChhhhhhccccC----
Confidence            54332 234568999999998863       45678899999999999999999999973   2221111111100    


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                       ..|...  .......+.+++.+||..||.+||++.++           +.|+|+....
T Consensus       218 -----------------~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~i-----------l~~~~~~~~~  262 (277)
T cd06917         218 -----------------KPPRLE--DNGYSKLLREFVAACLDEEPKERLSAEEL-----------LKSKWIKAHS  262 (277)
T ss_pred             -----------------CCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHH-----------hhChHhhccc
Confidence                             001100  01134456779999999999999999997           4588885543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-35  Score=311.21  Aligned_cols=263  Identities=22%  Similarity=0.330  Sum_probs=205.4

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      +..|.+.+.||+|+||.||++.+..+|+.||+|++...........+.+|+++++.++||||+++++.+...+  .+|+|
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv   81 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN--NICMC   81 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC--EEEEE
Confidence            3568888999999999999999999999999999875544444556679999999999999999999987654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||+++++|..++....   .+++..+..++.+++.||.|||+ .|++||||||+||++    +..+.++|+|||++...
T Consensus        82 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~----~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          82 MEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV----NSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             EecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE----CCCCcEEEccCCcccch
Confidence            99999999999887643   38999999999999999999997 699999999999998    66678999999998754


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCCh--------hhHHHHH
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--------KETMYYI  239 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~--------~e~~~~i  239 (708)
                      ... ......|+..|+|||++.        +..++.++|+|||||++|+++||..||........        .+....+
T Consensus       155 ~~~-~~~~~~~~~~~~aPE~~~--------~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd06620         155 INS-IADTFVGTSTYMSPERIQ--------GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI  225 (284)
T ss_pred             hhh-ccCccccCcccCCHHHHc--------cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence            322 223457899999999986        56788999999999999999999999974322100        0111111


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      .....                  ..++.     ..++..+.+++.+||..||.+||+++++           +.|+|+..
T Consensus       226 ~~~~~------------------~~~~~-----~~~~~~~~~li~~~l~~dp~~Rpt~~e~-----------~~~~~~~~  271 (284)
T cd06620         226 VQEPP------------------PRLPS-----SDFPEDLRDFVDACLLKDPTERPTPQQL-----------CAMPPFIQ  271 (284)
T ss_pred             hhccC------------------CCCCc-----hhcCHHHHHHHHHHhcCCcccCcCHHHH-----------hcCccccc
Confidence            11000                  01111     1133456779999999999999999997           55777766


Q ss_pred             cccc
Q psy15481        320 RLQC  323 (708)
Q Consensus       320 ~~~~  323 (708)
                      ....
T Consensus       272 ~~~~  275 (284)
T cd06620         272 ALRA  275 (284)
T ss_pred             cccc
Confidence            5443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.5e-35  Score=311.03  Aligned_cols=260  Identities=20%  Similarity=0.329  Sum_probs=201.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc-------CCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEec
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK-------NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQ   80 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~-------~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~   80 (708)
                      ...|.+.+.||+|+||.||+|.+.       .++..||+|.+.............+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            346889999999999999999753       235579999986543333344567899999999 899999999998765


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEE
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKF  147 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~  147 (708)
                      .  ..|+||||+++|+|.+++.....             ...++...+..++.||+.||.|||++|++||||||+||++ 
T Consensus        94 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili-  170 (304)
T cd05101          94 G--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV-  170 (304)
T ss_pred             C--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE-
Confidence            4  48999999999999999875321             1237888999999999999999999999999999999998 


Q ss_pred             EecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCC
Q psy15481        148 ICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLP  223 (708)
Q Consensus       148 ~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~P  223 (708)
                         +..+.+||+|||.+........   .....++..|+|||++.        +..++.++|||||||++|++++ |..|
T Consensus       171 ---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~~~g~~p  239 (304)
T cd05101         171 ---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF--------DRVYTHQSDVWSFGVLMWEIFTLGGSP  239 (304)
T ss_pred             ---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc--------cCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence               5667899999999986643321   12234567899999986        5678899999999999999998 8888


Q ss_pred             CCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        224 FRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       224 F~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                      |.   +.+..+....+.....                  ...|      ...+..+.+++.+||..+|.+||++.+++..
T Consensus       240 ~~---~~~~~~~~~~~~~~~~------------------~~~~------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         240 YP---GIPVEELFKLLKEGHR------------------MDKP------ANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             cc---cCCHHHHHHHHHcCCc------------------CCCC------CCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            86   3444443333322100                  0111      1233456679999999999999999999998


Q ss_pred             HHHHHh
Q psy15481        304 VTKTLN  309 (708)
Q Consensus       304 l~~il~  309 (708)
                      +.+++.
T Consensus       293 l~~~~~  298 (304)
T cd05101         293 LDRILT  298 (304)
T ss_pred             HHHHHH
Confidence            877764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.9e-35  Score=309.39  Aligned_cols=250  Identities=22%  Similarity=0.396  Sum_probs=190.6

Q ss_pred             EeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHh---CCCCCccceeEEEEecCCceEEEEEec
Q psy15481         17 VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKK---VKHENIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        17 ~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~k---L~HpNIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      .||+|+||.||++.+..+|+.||+|.+........  .....+|..+++.   .+||||+.+++.+...+  ..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEEEEEec
Confidence            48999999999999999999999999875432211  2223344444433   47999999999887654  58999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ  171 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~  171 (708)
                      ++|++|..++.....   +++..+..++.|++.||.|||++|++||||||+||++    +.++.++|+|||++.......
T Consensus        79 ~~~~~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~----~~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          79 MNGGDLHYHLSQHGV---FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL----DEHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             CCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE----CCCCCEEEccCCcceeccccC
Confidence            999999998875432   8999999999999999999999999999999999998    666789999999997554332


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                       .....|+..|+|||.+..       +..++.++|+||+||++|+|++|..||.......... ......          
T Consensus       152 -~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~----------  212 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQK-------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL----------  212 (279)
T ss_pred             -ccCcCCCcCccCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhh----------
Confidence             233568999999998752       4567899999999999999999999997543322221 111110          


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                              .+...      +++.++..+.++|.+||..||.+||     ++.++           +.|||+..
T Consensus       213 --------~~~~~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~-----------~~h~~~~~  260 (279)
T cd05633         213 --------TVNVE------LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEV-----------KEHVFFKG  260 (279)
T ss_pred             --------cCCcC------CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH-----------HhCccccC
Confidence                    00011      2233445566799999999999999     47776           67999966

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.4e-35  Score=298.74  Aligned_cols=256  Identities=29%  Similarity=0.495  Sum_probs=206.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|...+.||+|++|.||+|.+..+|+.|++|++..... ....+.+.+|+.++++++||||+++++.+.....+.+++||
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            37788999999999999999999999999999875432 12345567999999999999999999998876335699999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++++|.+++....   .+++..+..++.+++.||.|||+.|++|+||+|+||++    +..+.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i----~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV----DSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----cCCCCEEEcccccEEeccc
Confidence            9999999999997654   38999999999999999999999999999999999998    5567899999999987765


Q ss_pred             ccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ...   .....++..|+|||.+.        +..++.++|+||||+++|+|++|..||...+  .....+..+...    
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~--------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~----  219 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIR--------GEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSS----  219 (260)
T ss_pred             ccccccccCCCCCccccCHhhhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhcccc----
Confidence            543   44567899999999986        4558999999999999999999999997532  122222222110    


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                                         .....++...+..+.+++.+||..||.+||++.++           +.|||+
T Consensus       220 -------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~l-----------l~~~~~  260 (260)
T cd06606         220 -------------------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADEL-----------LQHPFL  260 (260)
T ss_pred             -------------------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHH-----------hhCCCC
Confidence                               01111233335567779999999999999999998           567875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.9e-35  Score=304.68  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=200.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCc---eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|...+.||+|+||.||+|.++.++.   .+|+|.+.........+.+..|+.++++++||||+++++++...+  ..|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~   82 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK--PAM   82 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC--CcE
Confidence            467889999999999999999876665   799998865433333455678999999999999999999987654  489


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||+++++|..++....  ..+++..+..++.+++.|+.|||+.|++|+||||+||++    +..+.++|+|||++..
T Consensus        83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili----~~~~~~kl~dfg~~~~  156 (268)
T cd05063          83 IITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV----NSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE----cCCCcEEECCCcccee
Confidence            9999999999999986533  238999999999999999999999999999999999998    5667899999999986


Q ss_pred             cccccc--cc--ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHh
Q psy15481        167 LEEDQQ--FM--SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       167 ~~~~~~--~~--~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      ......  ..  ....+..|+|||.+.        +..++.++|+|||||++|++++ |..||..   .+..+....+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Dv~slG~il~ell~~g~~p~~~---~~~~~~~~~i~~  225 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIA--------YRKFTSASDVWSFGIVMWEVMSFGERPYWD---MSNHEVMKAIND  225 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhh--------cCCcChHhHHHHHHHHHHHHHhCCCCCCCc---CCHHHHHHHHhc
Confidence            543221  11  122345799999986        5678899999999999999997 9999963   334444444432


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ..                    ..|....    .+..+.+++..||..||.+||++.+++..+.++
T Consensus       226 ~~--------------------~~~~~~~----~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         226 GF--------------------RLPAPMD----CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CC--------------------CCCCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10                    1122112    234566799999999999999999998887665

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-35  Score=331.10  Aligned_cols=274  Identities=19%  Similarity=0.257  Sum_probs=198.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....       ....+|+.++++++||||+++++++...+  ..++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~--~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGG--LTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECC--EEEEE
Confidence            4568999999999999999999999999999996432       22458999999999999999999987644  58999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |+++ +++|..++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.++|+|||+++...
T Consensus       239 ~e~~-~~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl----~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        239 LPKY-RSDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV----NGPEDICLGDFGAACFAR  311 (461)
T ss_pred             EEcc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE----CCCCCEEEcccCCceecc
Confidence            9999 5788888865332  38999999999999999999999999999999999998    666779999999998654


Q ss_pred             cccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC----CChhhHHHHHHh
Q psy15481        169 EDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG----RRNKETMYYITT  241 (708)
Q Consensus       169 ~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g----~~~~e~~~~i~~  241 (708)
                      ....   .....||..|+|||++.        +..++.++|||||||++|||++|..|+.....    ......+.+++.
T Consensus       312 ~~~~~~~~~~~~GT~~Y~APE~~~--------~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~  383 (461)
T PHA03211        312 GSWSTPFHYGIAGTVDTNAPEVLA--------GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR  383 (461)
T ss_pred             cccccccccccCCCcCCcCHHHHc--------CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence            3221   12356999999999987        67789999999999999999998876543211    111222333332


Q ss_pred             cccCCcccccccCCCCc-------ccccC-----CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        242 KKASGVISGTQTSENGE-------IDWCT-----DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~-------~~~~~-----~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      ...... ..........       .....     ..+.+..+. .+...+.+||.+||..||.+|||+.++         
T Consensus       384 ~~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~dli~~mL~~DP~~RPsa~el---------  452 (461)
T PHA03211        384 QAQVHV-DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYY-KLDLDVEYLVCRALTFDGARRPSAAEL---------  452 (461)
T ss_pred             hhcccc-ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhc-cccchHHHHHHHHcccChhhCcCHHHH---------
Confidence            111000 0000000000       00000     001111000 122346679999999999999999997         


Q ss_pred             hhhcCcccCC
Q psy15481        310 RKLVHLFHIN  319 (708)
Q Consensus       310 ~~l~h~~~~~  319 (708)
                        +.||||.+
T Consensus       453 --L~hp~f~~  460 (461)
T PHA03211        453 --LRLPLFQS  460 (461)
T ss_pred             --hhCcccCC
Confidence              66999865

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.7e-35  Score=306.40  Aligned_cols=261  Identities=20%  Similarity=0.277  Sum_probs=202.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcC----CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKN----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~----tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ...|.+.+.||+|+||.||+|.+..    ++..|++|.+...........+.+|+.++++++||||+++++++... +..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~   83 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GEP   83 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCC
Confidence            4578899999999999999999875    36889999886443333345567899999999999999999987654 335


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         85 KVIVMELCTGGSLFNILDDPENT-----YGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~-----~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      .+++++|+++++|..++......     ..+++..+..++.+++.||.|||++|++||||||+||++    +..+.+||+
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~----~~~~~~kl~  159 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI----DEELQVKIT  159 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE----cCCCcEEEC
Confidence            89999999999999998764321     348999999999999999999999999999999999998    566789999


Q ss_pred             ccCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhH
Q psy15481        160 DFGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKET  235 (708)
Q Consensus       160 DFGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~  235 (708)
                      |||+++.+......   ....++..|+|||.+.        +..++.++|||||||++|++++ |.+||..   .+..+.
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~--------~~~~~~~~Di~slG~~l~el~~~g~~p~~~---~~~~~~  228 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLV--------NKEYSSASDVWSFGVLLWELMTLGQTPYVE---IDPFEM  228 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHh--------cCCCCchhhHHHhHHHHHHHhcCCCCCcCc---CCHHHH
Confidence            99999865433211   2234677899999987        5678999999999999999999 9999973   333333


Q ss_pred             HHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        236 MYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       236 ~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      ...+... .                   .++....    ++..+.+++.+||..||++|||+.+++..+.++..
T Consensus       229 ~~~~~~~-~-------------------~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         229 AAYLKDG-Y-------------------RLAQPIN----CPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHHHcC-C-------------------CCCCCCc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            2222211 0                   1111111    23456679999999999999999999988877654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.2e-35  Score=309.18  Aligned_cols=263  Identities=23%  Similarity=0.400  Sum_probs=201.3

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEec----CC
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQ----EG   82 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~----~~   82 (708)
                      ....|.+.+.||+|+||.||+|.+..+++.||+|++....  ........|+.+++++ +||||+++++++...    ..
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            4567889999999999999999999999999999986432  2233456888999998 799999999988532    23


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                      ..+|++|||+++|+|.+++..... ..+++..+..++.||+.||.|||+.|++|+||+|+||++    +..+.++|+|||
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili----~~~~~~~l~dfg  166 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL----TENAEVKLVDFG  166 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEeeCc
Confidence            568999999999999999876332 238899999999999999999999999999999999998    566679999999


Q ss_pred             cccccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        163 AARELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       163 lA~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      .+...... .......|+..|+|||.+....   ..+..++.++|+|||||++|+|++|..||..   ..+......+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~---~~~~~~~~~~DvwslG~~l~el~~g~~p~~~---~~~~~~~~~~~~  240 (282)
T cd06636         167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDYRSDIWSLGITAIEMAEGAPPLCD---MHPMRALFLIPR  240 (282)
T ss_pred             chhhhhccccCCCcccccccccCHhhcCccc---CcCcCCCcccchhHHHHHHHHHHhCCCCccc---cCHHhhhhhHhh
Confidence            98765422 2233466899999999875211   1135678899999999999999999999963   222222222211


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ...                     +.  ......+..+.++|.+||..||.+||++.++           +.|||+
T Consensus       241 ~~~---------------------~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~el-----------l~~~~~  282 (282)
T cd06636         241 NPP---------------------PK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL-----------LKHPFI  282 (282)
T ss_pred             CCC---------------------CC--CcccccCHHHHHHHHHHhCCChhhCcCHHHH-----------hcCCCC
Confidence            100                     00  0111233456779999999999999999997           668875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0607|consensus

Probab=100.00  E-value=2.1e-36  Score=309.46  Aligned_cols=279  Identities=24%  Similarity=0.392  Sum_probs=214.2

Q ss_pred             ccCCCCceEE-EeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecC
Q psy15481          4 LRGSTNYVWC-TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQE   81 (708)
Q Consensus         4 l~~~~n~~y~-i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~   81 (708)
                      ++|.+.-.|. ..+.||+|+||.|--+....||..||||++.+.. .....+..+|++++... .|+||++++++|++..
T Consensus        71 ~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   71 LSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             ccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            3444444443 3578999999999999999999999999997653 23344556999999998 7999999999999866


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                      .  +|+|||-+.||+|...+.....   +++.++..+.++|+.||+|||.+||.|||+||+|||. ...+.-.-+|||||
T Consensus       150 ~--FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC-~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  150 R--FYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILC-ESPNKVSPVKICDF  223 (463)
T ss_pred             e--EEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceee-cCCCCcCceeeecc
Confidence            5  9999999999999999987654   9999999999999999999999999999999999997 55566678999999


Q ss_pred             Ccccccccc--------ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC---
Q psy15481        162 GAARELEED--------QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR---  230 (708)
Q Consensus       162 GlA~~~~~~--------~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~---  230 (708)
                      .++.....+        +...+.+|+.+|||||+....+.   ....|+.++|.||||||+|-|++|.+||.+.-|.   
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~---qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG  300 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVD---QATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG  300 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhcc---ccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence            998654322        22445789999999999874432   2467999999999999999999999999864321   


Q ss_pred             ----ChhhHH-HHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        231 ----RNKETM-YYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       231 ----~~~e~~-~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                          .+-... ..++...        |   .|.++|..  ..|..+|.+.++    ++..+|..||..|.++.++     
T Consensus       301 WdrGe~Cr~CQ~~LFesI--------Q---EGkYeFPd--kdWahIS~eakd----lisnLlvrda~~rlsa~~v-----  358 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFESI--------Q---EGKYEFPD--KDWAHISSEAKD----LISNLLVRDAKQRLSAAQV-----  358 (463)
T ss_pred             ccCCCccHHHHHHHHHHH--------h---ccCCcCCh--hhhHHhhHHHHH----HHHHHHhccHHhhhhhhhc-----
Confidence                111111 1111111        1   22232322  234456665555    7888899999999999997     


Q ss_pred             HHHhhhhcCcccCCc
Q psy15481        306 KTLNRKLVHLFHINR  320 (708)
Q Consensus       306 ~il~~~l~h~~~~~~  320 (708)
                            +.|||+..-
T Consensus       359 ------lnhPw~~~~  367 (463)
T KOG0607|consen  359 ------LNHPWVQRC  367 (463)
T ss_pred             ------cCCcccccc
Confidence                  779998543

>KOG1187|consensus

Probab=100.00  E-value=4.7e-35  Score=319.45  Aligned_cols=266  Identities=25%  Similarity=0.341  Sum_probs=202.7

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEec
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      |.-...||+|+||.||+|.-. +|..||||.+...+... ...+.+|+.++.+++|||+|+++++|.+.+. ..++|+||
T Consensus        77 Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEy  153 (361)
T KOG1187|consen   77 FSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEY  153 (361)
T ss_pred             CchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEc
Confidence            444579999999999999875 45899999887655432 3348899999999999999999999987653 58999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN---RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~---gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      +++|||.+++...... .+++.....|+.+++.||+|||..   .||||||||+|||+    |.+..+||+|||+|+...
T Consensus       154 m~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL----D~~~~aKlsDFGLa~~~~  228 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL----DEDFNAKLSDFGLAKLGP  228 (361)
T ss_pred             cCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE----CCCCCEEccCccCcccCC
Confidence            9999999999886543 599999999999999999999985   39999999999999    888899999999997655


Q ss_pred             c-ccccccc-CCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCC--CCChhhHH-HHHHhcc
Q psy15481        169 E-DQQFMSL-YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG--GRRNKETM-YYITTKK  243 (708)
Q Consensus       169 ~-~~~~~~~-~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~--g~~~~e~~-~~i~~~~  243 (708)
                      . ....... .||.+|++||.+.        ....+.++|||||||++.|++||+.|...-.  +..+...+ .......
T Consensus       229 ~~~~~~~~~~~gt~gY~~PEy~~--------~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~  300 (361)
T KOG1187|consen  229 EGDTSVSTTVMGTFGYLAPEYAS--------TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG  300 (361)
T ss_pred             ccccceeeecCCCCccCChhhhc--------cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence            4 3333333 8999999999997        5678999999999999999999998887422  11111111 1111111


Q ss_pred             -cCCcccccccCCCCcccccCCCCCcccCCh-hHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        244 -ASGVISGTQTSENGEIDWCTDLPNNCQLSL-GLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       244 -~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~-~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                       ...++             ...+.. ...+. ..-..+..+...|++.+|..||++.++++.+..+
T Consensus       301 ~~~eii-------------D~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  301 KLREIV-------------DPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             chhhee-------------CCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence             10000             011111 11221 2333467799999999999999999987776433

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.3e-35  Score=300.94  Aligned_cols=245  Identities=24%  Similarity=0.368  Sum_probs=191.2

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCC
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~gg   95 (708)
                      ++||+|+||.||+|... ++..||+|.++..........+.+|+.++++++||||+++++++...+  ..++||||++|+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEECCCCC
Confidence            36899999999999864 688999999875543333345678999999999999999999987654  489999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccc--
Q psy15481         96 SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF--  173 (708)
Q Consensus        96 sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~--  173 (708)
                      +|.+++.....  .+++..+..++.+++.||.|||++|++||||||+||++    +..+.++|+|||++.........  
T Consensus        78 ~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili----~~~~~~~l~d~g~~~~~~~~~~~~~  151 (250)
T cd05085          78 DFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV----GENNVLKISDFGMSRQEDDGIYSSS  151 (250)
T ss_pred             cHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE----cCCCeEEECCCccceeccccccccC
Confidence            99999865432  38899999999999999999999999999999999998    66678999999999754332211  


Q ss_pred             cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCcccccc
Q psy15481        174 MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVISGTQ  252 (708)
Q Consensus       174 ~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~  252 (708)
                      ....++..|+|||++.        +..++.++|+|||||++|++++ |..||..   .........+... .        
T Consensus       152 ~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~ll~~~~~~g~~p~~~---~~~~~~~~~~~~~-~--------  211 (250)
T cd05085         152 GLKQIPIKWTAPEALN--------YGRYSSESDVWSYGILLWETFSLGVCPYPG---MTNQQAREQVEKG-Y--------  211 (250)
T ss_pred             CCCCCcccccCHHHhc--------cCCCCchhHHHHHHHHHHHHhcCCCCCCCC---CCHHHHHHHHHcC-C--------
Confidence            1123456799999986        5668889999999999999998 9999973   3333333333221 0        


Q ss_pred             cCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        253 TSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       253 ~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                               ....      +..++..+.+++.+||..||++||++.++.+++
T Consensus       212 ---------~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l  248 (250)
T cd05085         212 ---------RMSC------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL  248 (250)
T ss_pred             ---------CCCC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence                     0011      112334567799999999999999999987764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.2e-35  Score=309.75  Aligned_cols=261  Identities=20%  Similarity=0.244  Sum_probs=198.8

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCC----------------ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNG----------------EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL   73 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg----------------~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl   73 (708)
                      .+|.+.+.||+|+||.||+|.+..++                ..||+|.+.........+.+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            47889999999999999999876544                56899998765443334556789999999999999999


Q ss_pred             eEEEEecCCceEEEEEeccCCCCHHHHhcCCCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q psy15481         74 LAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN--------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIM  145 (708)
Q Consensus        74 ~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~--------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NIL  145 (708)
                      ++++...+  ..+++|||+++++|.+++.....        ...+++..++.++.|++.||.|||++|++||||||+||+
T Consensus        85 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          85 LGVCTVDP--PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            99987653  58999999999999999876431        113899999999999999999999999999999999999


Q ss_pred             EEEecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc--C
Q psy15481        146 KFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT--G  220 (708)
Q Consensus       146 l~~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT--G  220 (708)
                      +    +..+.++|+|||.+........   .....++..|+|||.+.        +..++.++|||||||++|+|++  |
T Consensus       163 i----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~el~~~~~  230 (296)
T cd05051         163 V----GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL--------LGKFTTKSDVWAFGVTLWEILTLCR  230 (296)
T ss_pred             e----cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh--------cCCCCccchhhhhHHHHHHHHhcCC
Confidence            8    6667899999999986543321   22345678899999987        5668999999999999999998  6


Q ss_pred             CCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        221 NLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       221 ~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      ..||..   .+..+.+..+.......             .....++..    ...+..+.+++.+||..||.+|||+.++
T Consensus       231 ~~p~~~---~~~~~~~~~~~~~~~~~-------------~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rpt~~el  290 (296)
T cd05051         231 EQPYEH---LTDQQVIENAGHFFRDD-------------GRQIYLPRP----PNCPKDIYELMLECWRRDEEDRPTFREI  290 (296)
T ss_pred             CCCCCC---cChHHHHHHHHhccccc-------------cccccCCCc----cCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence            778753   33344333332210000             000011111    1223457779999999999999999998


Q ss_pred             HHHH
Q psy15481        301 FSEV  304 (708)
Q Consensus       301 ~~~l  304 (708)
                      +..|
T Consensus       291 ~~~L  294 (296)
T cd05051         291 HLFL  294 (296)
T ss_pred             HHHh
Confidence            7754

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.1e-35  Score=309.03  Aligned_cols=282  Identities=22%  Similarity=0.332  Sum_probs=201.4

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-hHHHHHHHHHHHhCCCCCccceeEEEEecCC---
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAIEEEQEG---   82 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~---   82 (708)
                      ..-..|.+.+.||+|+||.||+|.+..+|+.||+|.+........ .....+|+.++++++||||+++++++.....   
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            344579999999999999999999999999999999865432222 2334689999999999999999998865432   


Q ss_pred             ---ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         83 ---RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        83 ---~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                         ...++||||+. ++|.+.+....  ..+++.+++.++.|++.||.|||++|++|+||||+||++    +..+.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~----~~~~~~kl~  161 (310)
T cd07865          89 RYKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI----TKDGILKLA  161 (310)
T ss_pred             CCCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE----CCCCcEEEC
Confidence               35799999995 68888886543  238999999999999999999999999999999999998    667789999


Q ss_pred             ccCcccccccccc-----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhh
Q psy15481        160 DFGAARELEEDQQ-----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE  234 (708)
Q Consensus       160 DFGlA~~~~~~~~-----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e  234 (708)
                      |||.+........     .....++..|+|||.+..       ...++.++|+||||+++|+|+||++||..........
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~  234 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT  234 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcC-------CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999976543221     123457889999998752       3446889999999999999999999997432222222


Q ss_pred             HHHHHHhcccCCcccccccCCCCccccc-CCCCCcc--cCCh-----hHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        235 TMYYITTKKASGVISGTQTSENGEIDWC-TDLPNNC--QLSL-----GLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       235 ~~~~i~~~~~~~~i~~~~~~~~g~~~~~-~~lp~~~--~ls~-----~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                      .+..+....++........    ...|. ..+|...  ..+.     .....+.++|.+||..||.+|||++++      
T Consensus       235 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~------  304 (310)
T cd07865         235 LISQLCGSITPEVWPGVDK----LELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA------  304 (310)
T ss_pred             HHHHHhCCCChhhcccccc----hhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHH------
Confidence            2222222111111110000    00000 0001100  0000     012345679999999999999999997      


Q ss_pred             HHhhhhcCccc
Q psy15481        307 TLNRKLVHLFH  317 (708)
Q Consensus       307 il~~~l~h~~~  317 (708)
                           +.||||
T Consensus       305 -----l~h~~f  310 (310)
T cd07865         305 -----LNHDFF  310 (310)
T ss_pred             -----hcCCCC
Confidence                 668886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.1e-35  Score=311.70  Aligned_cols=259  Identities=23%  Similarity=0.363  Sum_probs=200.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||++.+..+++.||+|.+......  .....+.+|+.+++.++||||+++++.+...+  .+|+|
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv   79 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR--HLCMV   79 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC--EEEEE
Confidence            477889999999999999999999999999998754321  12234568999999999999999999887644  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++|++|.+++....   .+++..+..++.+++.||.|||++|++||||||+||++    +..+.++|+|||.+....
T Consensus        80 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll----~~~~~~~l~dfg~~~~~~  152 (305)
T cd05609          80 MEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI----TSMGHIKLTDFGLSKIGL  152 (305)
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE----CCCCCEEEeeCCCccccC
Confidence            99999999999997643   28999999999999999999999999999999999998    666789999999986321


Q ss_pred             ccc----------------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCCh
Q psy15481        169 EDQ----------------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN  232 (708)
Q Consensus       169 ~~~----------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~  232 (708)
                      ...                ......|+..|+|||.+.        +..++.++|+|||||++|++++|..||.   +...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~vl~el~~g~~pf~---~~~~  221 (305)
T cd05609         153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL--------RQGYGKPVDWWAMGIILYEFLVGCVPFF---GDTP  221 (305)
T ss_pred             cCccccccccccccchhhccccCCccCccccCchhcc--------CCCCCchhhHHHHHHHHHHHHhCCCCCC---CCCH
Confidence            110                001235788999999986        5678999999999999999999999997   3444


Q ss_pred             hhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhh
Q psy15481        233 KETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKL  312 (708)
Q Consensus       233 ~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l  312 (708)
                      .+....+.....                   ..|..   ...++..+.+++.+||..||++||++.+.+.        .+
T Consensus       222 ~~~~~~~~~~~~-------------------~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~--------ll  271 (305)
T cd05609         222 EELFGQVISDDI-------------------EWPEG---DEALPADAQDLISRLLRQNPLERLGTGGAFE--------VK  271 (305)
T ss_pred             HHHHHHHHhccc-------------------CCCCc---cccCCHHHHHHHHHHhccChhhccCccCHHH--------HH
Confidence            444444432110                   01110   1123345667999999999999999644322        26


Q ss_pred             cCcccCC
Q psy15481        313 VHLFHIN  319 (708)
Q Consensus       313 ~h~~~~~  319 (708)
                      .|||+..
T Consensus       272 ~~~~~~~  278 (305)
T cd05609         272 QHRFFLG  278 (305)
T ss_pred             hCccccC
Confidence            7888855

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.7e-36  Score=313.12  Aligned_cols=247  Identities=23%  Similarity=0.383  Sum_probs=195.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|...+.||+|+||.||+|.+..+|+.||+|.+.........+.+.+|+.++++++||||+++++.+...+  ..|+|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT--KLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC--ceEEEEE
Confidence            45667889999999999999999999999999875443333455678999999999999999999987644  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |++|++|.+++...    .+++..+..++.+++.|+.|||++|++|+||+|+||++    +..+.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i----~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          83 YLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL----SEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE----eCCCCEEEccccccccccCc
Confidence            99999999988643    28999999999999999999999999999999999998    55667999999999765443


Q ss_pred             cc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        171 QQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       171 ~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      .. .....|+..|+|||.+.        +..++.++|+|||||++|+|++|..||..   .........+...       
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~el~tg~~p~~~---~~~~~~~~~~~~~-------  216 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIK--------QSAYDFKADIWSLGITAIELAKGEPPNSD---LHPMRVLFLIPKN-------  216 (277)
T ss_pred             chhhhcccCcccccCHHHhC--------cCCCchhhhHHHHHHHHHHHHhCCCCCcc---cchhhHHhhhhcC-------
Confidence            22 22346889999999987        56788999999999999999999999963   2222222111110       


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                                    ..+   .+....+..+.+++.+||..+|.+||++.+++.
T Consensus       217 --------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         217 --------------SPP---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             --------------CCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                          001   112223445677999999999999999999844

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.2e-35  Score=302.05  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=194.8

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||++...  |..||+|.+....   ..+.+.+|+.++++++|||++++++++...+ ...|+||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-CceEEEE
Confidence            36788899999999999999764  7889999986432   2445678999999999999999999765432 3589999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||++    +.++.+||+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~----~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV----SEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE----cCCCcEEecCCccceeccc
Confidence            99999999999876432 238899999999999999999999999999999999998    6667899999999886443


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      ..  ....++..|+|||++.        +..++.++|||||||++|+|++ |.+||..   .........+...      
T Consensus       155 ~~--~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~---~~~~~~~~~~~~~------  215 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALR--------EKKFSTKSDVWSFGILLWEIYSFGRVPYPR---IPLKDVVPRVEKG------  215 (256)
T ss_pred             cC--CCCccceeecCHHHHc--------cCCCCchhhhHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHhcC------
Confidence            32  2334567899999886        5678899999999999999998 9999963   2222222222211      


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                                  +....      ++.++..+.+++.+||..||.+|||+.++++.+..
T Consensus       216 ------------~~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         216 ------------YKMDA------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ------------CCCCC------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                        00011      12234456679999999999999999999877653

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-35  Score=302.00  Aligned_cols=251  Identities=26%  Similarity=0.374  Sum_probs=197.4

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|++|.||+|.+. +++.||+|.+.....  ....+.+|+.++++++||||+++++++...+  ..|+||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~   80 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE--PIYIVT   80 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCC--Ceeeee
Confidence            46889999999999999999875 567899999865332  2345678999999999999999999887654  489999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++|++|.+++.... ...+++..+..++.+++.|+.|||++|++||||||+||++    +..+.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV----GENNICKVADFGLARVIKE  155 (261)
T ss_pred             ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE----cCCCCEEECCcceEEEccC
Confidence            9999999999997643 2238999999999999999999999999999999999998    6667799999999987653


Q ss_pred             cccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ....  ....++..|+|||.+.        +..++.++|+|||||++|+|+| |+.||.+   .........+....   
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~t~g~~p~~~---~~~~~~~~~~~~~~---  221 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAAL--------YNRFSIKSDVWSFGILLTEIVTYGRMPYPG---MTNAEVLQQVDQGY---  221 (261)
T ss_pred             CcccccCCCcCceeccCccccc--------cCCCCchhhHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHHHHcCC---
Confidence            2211  1122345799999886        5678899999999999999999 9999973   44444444433210   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                                       .++.    +...+..+.+++.+||..||.+||+++++...++
T Consensus       222 -----------------~~~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~  259 (261)
T cd05068         222 -----------------RMPC----PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE  259 (261)
T ss_pred             -----------------CCCC----CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence                             0111    1123345677999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.6e-35  Score=302.67  Aligned_cols=249  Identities=24%  Similarity=0.359  Sum_probs=195.8

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||.|.+. .+..||+|.+....  ...+.+.+|+.++++++||||+++++++...+  ..|+||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~   78 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR--PIYIVT   78 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC--CcEEEE
Confidence            35888999999999999999875 34569999886432  22455678999999999999999999987654  489999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+.+|+|.+++.....  .+++..+..++.||+.||.|||+.|++|+||||+||++    ++.+.+||+|||.+.....
T Consensus        79 e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili----~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          79 EYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV----DDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             EcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE----cCCCCEEECCCccceecCC
Confidence            99999999999876432  38999999999999999999999999999999999998    6667899999999886544


Q ss_pred             cccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      +...  ....++..|+|||.+.        +..++.++|+|||||++|+|++ |..||..   ....+....+.....  
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~--------~~~~~~~~Di~slG~~l~~l~~~g~~p~~~---~~~~~~~~~~~~~~~--  219 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLL--------YSKFSSKSDVWAFGVLMWEVYSLGKMPYER---FNNSETVEKVSQGLR--  219 (256)
T ss_pred             CceeecCCCccChhhCCHHHHh--------cCcccchhHHHHHHHHHHHHhcCCCCCcCc---CCHHHHHHHHhcCCC--
Confidence            3221  1233567899999986        5668899999999999999999 9999973   334444444433211  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                                        .+....    .+..+.+++.+||..||.+||++.+++..+
T Consensus       220 ------------------~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         220 ------------------LYRPHL----ASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             ------------------CCCCCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence                              011111    234566799999999999999999987653

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.4e-35  Score=308.50  Aligned_cols=259  Identities=24%  Similarity=0.332  Sum_probs=201.7

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      ...|.+.+.||+|+||.||+|.+.     .++..+++|.+..... .....+.+|+.++++++||||+++++++...+  
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   80 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGD--   80 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC--
Confidence            346889999999999999999864     3456799998764322 22344678999999999999999999987644  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec
Q psy15481         84 GKVIVMELCTGGSLFNILDDPE-------------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD  150 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~-------------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~  150 (708)
                      ..++||||+++++|.+++....             ....+++..++.++.||+.||.|||++|++||||||+||++    
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~----  156 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV----  156 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE----
Confidence            4999999999999999986532             11238899999999999999999999999999999999998    


Q ss_pred             CCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCC
Q psy15481        151 DGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRP  226 (708)
Q Consensus       151 d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~  226 (708)
                      +..+.++|+|||++........   .....++..|+|||.+.        +..++.++|||||||++|+|+| |..||..
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~t~g~~p~~~  228 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--------YRKFTTESDVWSFGVILWEIFTYGKQPWFQ  228 (291)
T ss_pred             ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            6677899999999976543321   12345678899999887        5778899999999999999999 9999863


Q ss_pred             CCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        227 YGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       227 ~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                         .+..+.+..+......                  ..+      ...+..+.+++.+||..||.+||++.++++.+.+
T Consensus       229 ---~~~~~~~~~~~~~~~~------------------~~~------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~  281 (291)
T cd05094         229 ---LSNTEVIECITQGRVL------------------ERP------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHA  281 (291)
T ss_pred             ---CCHHHHHHHHhCCCCC------------------CCC------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence               3344433333221100                  011      1123456679999999999999999999999888


Q ss_pred             HHh
Q psy15481        307 TLN  309 (708)
Q Consensus       307 il~  309 (708)
                      +..
T Consensus       282 ~~~  284 (291)
T cd05094         282 LGK  284 (291)
T ss_pred             HHh
Confidence            754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.2e-35  Score=302.75  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=196.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..+|++.+.||+|+||.||+|.+. ++..||+|.+.....  ..+.+.+|+.++++++||||+++++++..   ...|++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv   78 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIV   78 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEE
Confidence            347889999999999999999875 566799999875332  24557799999999999999999998743   247999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||+++++|.+++..... ..+++..+..++.+++.||.|||++|++||||||+||++    +..+.++|+|||.+....
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili----~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV----GDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE----eCCceEEeCCceeeeecc
Confidence            999999999999875332 238999999999999999999999999999999999998    566789999999998654


Q ss_pred             ccccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .....  ....++..|+|||.+.        +..++.++|+|||||++|+|++ |.+||..   ....+....+....  
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~l~~~g~~p~~~---~~~~~~~~~~~~~~--  220 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAAL--------YGRFTIKSDVWSFGILLTELVTKGRVPYPG---MNNREVLEQVERGY--  220 (260)
T ss_pred             CcccccccCCCCCccccChHHHh--------cCCCcchhhhHHHHHHHHHHHhcCCCCCCC---CCHHHHHHHHHcCC--
Confidence            43221  1233556799999886        5668899999999999999999 9999973   34444444433210  


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                                        ..+    .+...+..+.+++.+||..||.+|||+.++.+.++
T Consensus       221 ------------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         221 ------------------RMP----CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE  258 (260)
T ss_pred             ------------------CCC----CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence                              011    11233445777999999999999999998866543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-35  Score=301.92  Aligned_cols=249  Identities=25%  Similarity=0.381  Sum_probs=197.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||.|+||.||+|...  |+.||+|.+.....  ....+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v   78 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQG--NPLYIV   78 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCC--CCeEEE
Confidence            346788999999999999999864  88999999875433  345567899999999999999999998764  359999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||+++++|.+++..... ..+++..++.++.|++.||.|||++|++|+||||+||++    +.++.++|+|||.+....
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili----~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV----SEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE----eCCCCEEEcccccccccc
Confidence            999999999999976442 238999999999999999999999999999999999998    667789999999998764


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ...  ....++..|+|||.+.        +..++.++|+|||||++|++++ |..||..   ....+....+...     
T Consensus       154 ~~~--~~~~~~~~~~ape~~~--------~~~~~~~~Di~slG~il~~l~~~g~~p~~~---~~~~~~~~~~~~~-----  215 (256)
T cd05039         154 QGQ--DSGKLPVKWTAPEALR--------EKKFSTKSDVWSFGILLWEIYSFGRVPYPR---IPLKDVVPHVEKG-----  215 (256)
T ss_pred             ccc--ccCCCcccccCchhhc--------CCcCCcHHHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHHHhcC-----
Confidence            332  2344567899999886        5667889999999999999997 9999973   3333333222211     


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                                   +....|      ...+..+.+++.+||..||++||++.+++..+.
T Consensus       216 -------------~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  254 (256)
T cd05039         216 -------------YRMEAP------EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA  254 (256)
T ss_pred             -------------CCCCCc------cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence                         000111      122345667999999999999999999988764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.6e-35  Score=302.81  Aligned_cols=251  Identities=22%  Similarity=0.365  Sum_probs=190.4

Q ss_pred             eEeecCCceEEEEEEEcC---CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKN---NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~---tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..   .+..||+|.+.........+.+.+|+.+++.++||||+++++++...+ +..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEEecC
Confidence            368999999999998653   345799998754332223445678999999999999999999775433 3478999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc-
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-  171 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~-  171 (708)
                      .+|+|.+++.....  .+++..+..++.+++.||.|||++|++||||||+|||+    +..+.+||+|||+++...... 
T Consensus        80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili----~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          80 KHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML----DESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE----cCCCcEEECCccccccccCCcc
Confidence            99999999976432  26788889999999999999999999999999999998    566679999999997653321 


Q ss_pred             ----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        172 ----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       172 ----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                          ......++..|+|||.+.        +..++.++|||||||++|+|++ |.+||..   .+..+....+....   
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~~~~~~~~~~---~~~~~~~~~~~~~~---  219 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQ--------TQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VDSFDITVYLLQGR---  219 (262)
T ss_pred             eeecccccCcCCccccChhHhc--------cCccchHHHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHHhcCC---
Confidence                112334677899999886        5678899999999999999999 5666752   33333333332210   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                                       ..+...    ..+..+.+++.+||..||++||++.+++..+.++.
T Consensus       220 -----------------~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 -----------------RLLQPE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -----------------CCCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                             111111    12345667999999999999999999999887764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.4e-35  Score=302.06  Aligned_cols=251  Identities=23%  Similarity=0.370  Sum_probs=197.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      +..|++.+.||+|+||.||+|..+ +++.||+|.+....  .....+.+|+.++++++||||+++++++..   ...+++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v   78 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYII   78 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEE
Confidence            457899999999999999999864 67889999987433  224556789999999999999999998643   248999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||+.+++|.+++..... ..+++..+..++.+++.||.|||+.|++||||||+||++    +..+.++|+|||.+....
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i----~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          79 TEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV----SETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE----cCCCCEEEccCcceeecC
Confidence            999999999998865332 348999999999999999999999999999999999998    666789999999998665


Q ss_pred             cccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ....  .....++..|+|||.+.        +..++.++|||||||++|++++ |.+||..   .+..+....+....  
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~--------~~~~~~~~Di~slG~~l~el~~~g~~p~~~---~~~~~~~~~~~~~~--  220 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAIN--------YGTFTIKSDVWSFGILLTEIVTYGRIPYPG---MTNPEVIQNLERGY--  220 (260)
T ss_pred             CCCcccccCCcccccccCHHHhc--------cCCcCcccchHHHHHHHHHHHhCCCCCCCC---CChHHHHHHHHcCC--
Confidence            3221  12234567899999886        5668899999999999999999 9999973   34444443332210  


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                                        ..+..    ...+..+.+++.+||..||++||++++++..++
T Consensus       221 ------------------~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         221 ------------------RMPRP----DNCPEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             ------------------CCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence                              11111    122345777999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0577|consensus

Probab=100.00  E-value=1.4e-36  Score=329.76  Aligned_cols=258  Identities=23%  Similarity=0.377  Sum_probs=209.6

Q ss_pred             cccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch--HHHHHHHHHHHhCCCCCccceeEEEEec
Q psy15481          3 FLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH--DVQMREFEVLKKVKHENIVKLLAIEEEQ   80 (708)
Q Consensus         3 ~l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~--~~~~~Ei~iL~kL~HpNIVkl~~v~~~~   80 (708)
                      |........|.-.+-||.|+||.||-|++..+.+.||||.++........  .....|+..|++++|||+|.+.+.|.-.
T Consensus        19 F~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre   98 (948)
T KOG0577|consen   19 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE   98 (948)
T ss_pred             HccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence            34455666788888999999999999999999999999999754332211  2346899999999999999999998654


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                      ..  .|+|||||- ||-.+++.-..  .++.+.++..|..+.+.||.|||+.+.||||||.+|||+    ...+.|||+|
T Consensus        99 ~T--aWLVMEYCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL----se~g~VKLaD  169 (948)
T KOG0577|consen   99 HT--AWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL----SEPGLVKLAD  169 (948)
T ss_pred             ch--HHHHHHHHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe----cCCCeeeecc
Confidence            43  899999995 66666554322  238999999999999999999999999999999999998    7788999999


Q ss_pred             cCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        161 FGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       161 FGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ||.|....+.   .+++|||.|||||++..--     .+.|+-++||||||++..||+-.++|+-.   .+....++.|.
T Consensus       170 FGSAsi~~PA---nsFvGTPywMAPEVILAMD-----EGqYdgkvDvWSLGITCIELAERkPPlFn---MNAMSALYHIA  238 (948)
T KOG0577|consen  170 FGSASIMAPA---NSFVGTPYWMAPEVILAMD-----EGQYDGKVDVWSLGITCIELAERKPPLFN---MNAMSALYHIA  238 (948)
T ss_pred             ccchhhcCch---hcccCCccccchhHheecc-----ccccCCccceeeccchhhhhhhcCCCccC---chHHHHHHHHH
Confidence            9999866544   4678999999999986321     46789999999999999999999999763   44555667676


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                      .+..                     |..  -+++.++.+..|+..||.+-|.+|||.+++|++
T Consensus       239 QNes---------------------PtL--qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  239 QNES---------------------PTL--QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             hcCC---------------------CCC--CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            5322                     221  256778889999999999999999999987653

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.5e-35  Score=308.52  Aligned_cols=276  Identities=22%  Similarity=0.348  Sum_probs=201.0

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhC-CCCCccceeEEEEecCC---ceE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKV-KHENIVKLLAIEEEQEG---RGK   85 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~---~~~   85 (708)
                      .|.+.+.||+|+||.||+|.+..+|+.||+|.+....... ......+|+.+++++ +||||+++++++...+.   ...
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            4889999999999999999999999999999986543221 234456899999999 46999999998865432   247


Q ss_pred             EEEEeccCCCCHHHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC-CceEEEeccC
Q psy15481         86 VIVMELCTGGSLFNILDDPEN--TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG-STIYKLTDFG  162 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~--~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~-~~~vKL~DFG  162 (708)
                      |+||||+++ +|.+++.....  ...+++..++.++.||+.||.|||++|++||||||+||++    +. .+.++|+|||
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~----~~~~~~~kl~dfg  156 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV----DKQKGLLKIADLG  156 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE----ecCCCeEEEeecc
Confidence            999999974 88887764321  2348999999999999999999999999999999999998    44 6789999999


Q ss_pred             cccccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        163 AARELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       163 lA~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      .+...... .......+++.|+|||.+..       ...++.++|+|||||++|+|++|.+||..   .++......+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~~~~---~~~~~~~~~~~~  226 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLG-------STHYSTPVDIWSVGCIFAEMSRKQPLFPG---DSELQQLLHIFK  226 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhC-------CCCCCchHHHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHH
Confidence            98765332 22233457889999998862       35678999999999999999999999973   444444444432


Q ss_pred             ccc--CC-cccccccCCCCcccccCCCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhc
Q psy15481        242 KKA--SG-VISGTQTSENGEIDWCTDLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLV  313 (708)
Q Consensus       242 ~~~--~~-~i~~~~~~~~g~~~~~~~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~  313 (708)
                      ...  .. ........    ..|. ..|..     ....+.++..+.++|.+||..||.+||+++++           +.
T Consensus       227 ~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei-----------l~  290 (295)
T cd07837         227 LLGTPTEQVWPGVSKL----RDWH-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA-----------LT  290 (295)
T ss_pred             HhCCCChhhCcchhhc----cchh-hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH-----------hc
Confidence            110  00 00000000    0000 01110     01112345557779999999999999999997           67


Q ss_pred             Cccc
Q psy15481        314 HLFH  317 (708)
Q Consensus       314 h~~~  317 (708)
                      |||+
T Consensus       291 ~~~~  294 (295)
T cd07837         291 HPYF  294 (295)
T ss_pred             CCCc
Confidence            8886

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0986|consensus

Probab=100.00  E-value=2e-36  Score=321.48  Aligned_cols=249  Identities=26%  Similarity=0.404  Sum_probs=209.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|..-++||+||||.||-+..+.||+.||+|.+.+...  .......++|-.+|.+++.|.||.+--.|+..+.  +|+|
T Consensus       186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~--LClV  263 (591)
T KOG0986|consen  186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA--LCLV  263 (591)
T ss_pred             ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc--eEEE
Confidence            46677899999999999999999999999998854321  1223445789999999999999999888887665  9999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |..|+||||.-+|.+..+ .++++..++.++.+|+.||.+||+.+||+||+||+|||+    |+.+.+.|+|+|+|..+.
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL----Dd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL----DDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee----ccCCCeEeeccceEEecC
Confidence            999999999999988665 469999999999999999999999999999999999999    888999999999999999


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .+......+||.+|||||++.        +..|+..+|.|||||++|+|+.|+.||+.+......+-+.+.+..      
T Consensus       339 ~g~~~~~rvGT~GYMAPEvl~--------ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~------  404 (591)
T KOG0986|consen  339 EGKPIRGRVGTVGYMAPEVLQ--------NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE------  404 (591)
T ss_pred             CCCccccccCcccccCHHHHc--------CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc------
Confidence            999888899999999999998        566999999999999999999999999975544333233332211      


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE  298 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~  298 (708)
                                        ....+|..++....++++.+|..||.+|....
T Consensus       405 ------------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  405 ------------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ------------------chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                              11223445555666799999999999998754

>KOG4236|consensus

Probab=100.00  E-value=2.1e-36  Score=324.61  Aligned_cols=258  Identities=27%  Similarity=0.439  Sum_probs=210.5

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch-HHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEec
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH-DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~-~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      --.+.||+|-||+||-|+++++|+.||||++.+....... +...+|+.||.++.||.||.+--.|+.++.  +++|||-
T Consensus       567 f~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er--vFVVMEK  644 (888)
T KOG4236|consen  567 FADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER--VFVVMEK  644 (888)
T ss_pred             hhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce--EEEEehh
Confidence            3468899999999999999999999999999876655443 445789999999999999999998887765  9999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ  171 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~  171 (708)
                      +. |+...++-..+ .+.|++...+.++.||+.||.|||.++|||+|+||+|||+ -..+.-..+||||||+|+..++..
T Consensus       645 l~-GDMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLL-as~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  645 LH-GDMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLL-ASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             hc-chHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheee-ccCCCCCceeeccccceeecchhh
Confidence            95 55555443433 2349999999999999999999999999999999999998 445666789999999999999888


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                      -..+.+|||.|+|||++.        ++.|...-||||.|||+|--++|..||..     +.++-.+|...         
T Consensus       722 FRrsVVGTPAYLaPEVLr--------nkGyNrSLDMWSVGVIiYVsLSGTFPFNE-----dEdIndQIQNA---------  779 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLR--------NKGYNRSLDMWSVGVIIYVSLSGTFPFNE-----DEDINDQIQNA---------  779 (888)
T ss_pred             hhhhhcCCccccCHHHHh--------hccccccccceeeeEEEEEEecccccCCC-----ccchhHHhhcc---------
Confidence            888999999999999998        79999999999999999999999999973     22223333321         


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                              .|......+..++++    ..+||.++|++.-.+|.|.++.           +.|||...-
T Consensus       780 --------aFMyPp~PW~eis~~----AidlIn~LLqVkm~kRysvdk~-----------lsh~Wlq~y  825 (888)
T KOG4236|consen  780 --------AFMYPPNPWSEISPE----AIDLINNLLQVKMRKRYSVDKS-----------LSHPWLQDY  825 (888)
T ss_pred             --------ccccCCCchhhcCHH----HHHHHHHHHHHHHHHhcchHhh-----------ccchhhhcc
Confidence                    122233344555554    4558899999999999999875           668887554

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.6e-35  Score=306.57  Aligned_cols=255  Identities=23%  Similarity=0.400  Sum_probs=202.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|...+.||.|+||.||+|.+..+++.||+|.+...........+.+|+.++++++||||+++++.+...+  ..|+||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~   81 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--KLWIIM   81 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--eEEEEE
Confidence            357788999999999999999999999999999865433333455678999999999999999999987644  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++++|..++...    .+++..+..++.+++.|+.|||++|++|+||+|+||++    +..+.++|+|||++.....
T Consensus        82 e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i----~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          82 EYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL----SEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE----CCCCCEEEeecccceeccc
Confidence            999999999998653    28999999999999999999999999999999999998    6667899999999876543


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .. ......++..|+|||.+.        +..++.++|+|||||++|+|++|..||..   .........+....     
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~---~~~~~~~~~~~~~~-----  217 (277)
T cd06641         154 TQIKRNTFVGTPFWMAPEVIK--------QSAYDSKADIWSLGITAIELAKGEPPHSE---LHPMKVLFLIPKNN-----  217 (277)
T ss_pred             chhhhccccCCccccChhhhc--------cCCCCchhhHHHHHHHHHHHHcCCCCCCc---cchHHHHHHHhcCC-----
Confidence            32 223356888999999986        56678899999999999999999999973   22222222221110     


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                      .|   .+....+..+.+++.+||..||.+||++.++           +.|||+...
T Consensus       218 ----------------~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~-----------l~~~~~~~~  259 (277)
T cd06641         218 ----------------PP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKEL-----------LKHKFIVRF  259 (277)
T ss_pred             ----------------CC---CCCcccCHHHHHHHHHHccCChhhCcCHHHH-----------HhCHHHhhh
Confidence                            01   1122233456679999999999999999997           557887664

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.9e-35  Score=310.66  Aligned_cols=259  Identities=20%  Similarity=0.322  Sum_probs=199.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcC-------CCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecC
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKN-------NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQE   81 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~-------tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~   81 (708)
                      .+|.+.+.||+|+||.||++.+..       .+..||+|.++..........+.+|+.+++.+ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            468899999999999999997642       34579999987543333334567899999999 6999999999987644


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEE
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFI  148 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~  148 (708)
                        .+|+||||+++|+|.+++.....             ...++...+..++.|++.||.|||++|++||||||+|||+  
T Consensus        92 --~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill--  167 (314)
T cd05099          92 --PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV--  167 (314)
T ss_pred             --ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE--
Confidence              48999999999999999865321             1238899999999999999999999999999999999998  


Q ss_pred             ecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCC
Q psy15481        149 CDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF  224 (708)
Q Consensus       149 ~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF  224 (708)
                        +..+.+||+|||.++.......   .....++..|+|||.+.        +..++.++|||||||++|+|++ |..||
T Consensus       168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~~l~el~~~g~~p~  237 (314)
T cd05099         168 --TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF--------DRVYTHQSDVWSFGILMWEIFTLGGSPY  237 (314)
T ss_pred             --cCCCcEEEccccccccccccccccccccCCCCccccCHHHHc--------cCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence              5566799999999986543221   11223456799999986        5678999999999999999999 89999


Q ss_pred             CCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        225 RPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       225 ~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      ..   ....+....+....                  ....|      ...+..+.+++.+||..||++||++.+++..+
T Consensus       238 ~~---~~~~~~~~~~~~~~------------------~~~~~------~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l  290 (314)
T cd05099         238 PG---IPVEELFKLLREGH------------------RMDKP------SNCTHELYMLMRECWHAVPTQRPTFKQLVEAL  290 (314)
T ss_pred             CC---CCHHHHHHHHHcCC------------------CCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            63   33333333332210                  00111      12234566799999999999999999999988


Q ss_pred             HHHHh
Q psy15481        305 TKTLN  309 (708)
Q Consensus       305 ~~il~  309 (708)
                      ..+..
T Consensus       291 ~~~~~  295 (314)
T cd05099         291 DKVLA  295 (314)
T ss_pred             HHHHH
Confidence            77654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.6e-35  Score=307.05  Aligned_cols=271  Identities=27%  Similarity=0.329  Sum_probs=197.8

Q ss_pred             ceEEEeeEeecCCceEEEEEE----EcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~----~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ..|.+.+.||+|+||.||++.    +..+|..||+|.+.... ......+.+|+.++++++||||+++++++...+...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            478889999999999999997    44678999999986432 2223455789999999999999999998866655569


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ++||||+++++|.+++.....  .+++..+..++.|++.||.|||++|++||||||+||++    +..+.++|+|||++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili----~~~~~~~l~dfg~~~  156 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV----ESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE----CCCCeEEECCCcccc
Confidence            999999999999999865432  38999999999999999999999999999999999998    666789999999998


Q ss_pred             cccccccc----cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        166 ELEEDQQF----MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       166 ~~~~~~~~----~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      ........    ....++..|+|||++.        +..++.++|||||||++|+|++|..|+...    ....+..+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~~~~~~~~~~----~~~~~~~~~~  224 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYSDKSCSP----PAEFMRMMGN  224 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhc--------cCCcChHHHHHHHHHHHHHHhhcCCcCCCc----chhhhhhccc
Confidence            76443221    1122345699999986        567889999999999999999998776421    1111111111


Q ss_pred             cccCCcc-cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        242 KKASGVI-SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       242 ~~~~~~i-~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ....... .....    ...-...+|.    ...++..+.+++.+||..||++|||+.++...++.+
T Consensus       225 ~~~~~~~~~~~~~----~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         225 DKQGQMIVYHLIE----LLKNNGRLPA----PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             ccccccchHHHHH----HHhcCCcCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000000 00000    0000001122    223344567799999999999999999998876643

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-35  Score=301.89  Aligned_cols=248  Identities=25%  Similarity=0.360  Sum_probs=194.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|.+.+.||+|+||.||++.++ ++..+|+|.+.....  ..+.+.+|+.+++.++||||+++++++...+  ..|+|||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e   79 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR--PIFIVTE   79 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--ceEEEEe
Confidence            5788999999999999999886 567899999864322  2345678999999999999999999887554  5899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |++|++|.+++.....  .+++..+..++.|++.||.|||++|++||||||+||++    +..+.+||+|||.++.....
T Consensus        80 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i----~~~~~~kl~dfg~~~~~~~~  153 (256)
T cd05059          80 YMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV----GEDNVVKVSDFGLARYVLDD  153 (256)
T ss_pred             cCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE----CCCCcEEECCcccceecccc
Confidence            9999999999875332  38999999999999999999999999999999999998    66778999999999865433


Q ss_pred             cccc--ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        171 QQFM--SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       171 ~~~~--~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ....  ...++..|+|||.+.        +..++.++|+|||||++|++++ |.+||..   .++.+....+....    
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~--------~~~~~~~~Di~slG~il~~l~~~g~~p~~~---~~~~~~~~~~~~~~----  218 (256)
T cd05059         154 QYTSSQGTKFPVKWAPPEVFD--------YSRFSSKSDVWSFGVLMWEVFSEGKMPYER---FSNSEVVESVSAGY----  218 (256)
T ss_pred             cccccCCCCCCccccCHHHhc--------cCCCCchhhHHHHHHHHHHHhccCCCCCCC---CCHHHHHHHHHcCC----
Confidence            2211  112345799999987        5678899999999999999999 8999973   33444444333210    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                                      ..+.+    ...+..+.+++.+||..+|++|||+.++++.+
T Consensus       219 ----------------~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         219 ----------------RLYRP----KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ----------------cCCCC----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                            01111    11234566799999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.3e-35  Score=318.15  Aligned_cols=286  Identities=21%  Similarity=0.364  Sum_probs=209.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEec--CCceE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ--EGRGK   85 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~--~~~~~   85 (708)
                      ...|.+.+.||+|++|.||+|.+..+|+.||+|.+..... ........+|+.++++++||||+++++++...  .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            3678899999999999999999999999999999875432 22334456899999999999999999987543  33468


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||+. ++|.+++.....   +++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||.+.
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~----~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV----NEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCcEEecccccce
Confidence            99999994 789999865433   8999999999999999999999999999999999998    666789999999997


Q ss_pred             ccccccc-----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        166 ELEEDQQ-----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       166 ~~~~~~~-----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      .......     .....|+..|+|||.+..       ...++.++|+|||||++|+|++|+.||.+   .+....+..+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~l~el~~g~~pf~~---~~~~~~~~~~~  225 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLS-------LPEYTTAIDMWSVGCIFAEMLGRRQLFPG---KNYVHQLKLIL  225 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcC-------CcccccccchHHHHHHHHHHHcCCCccCC---CChHHHHHHHH
Confidence            6543221     123468999999999862       34578999999999999999999999974   22222222222


Q ss_pred             h---cccCCcccccccCCCCcccccCCCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhh
Q psy15481        241 T---KKASGVISGTQTSENGEIDWCTDLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKL  312 (708)
Q Consensus       241 ~---~~~~~~i~~~~~~~~g~~~~~~~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l  312 (708)
                      .   ..+...+.......  ...+....+..     ..+.+..+..+.++|.+||..||.+||++.++           +
T Consensus       226 ~~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~-----------l  292 (334)
T cd07855         226 SVLGSPSEEVLNRIGSDR--VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA-----------L  292 (334)
T ss_pred             HHhCCChhHhhhhhchhh--HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHH-----------H
Confidence            1   11111111100000  00000011111     11123345567789999999999999999987           6


Q ss_pred             cCcccCCcccccc
Q psy15481        313 VHLFHINRLQCIR  325 (708)
Q Consensus       313 ~h~~~~~~~~~~~  325 (708)
                      .|||+........
T Consensus       293 ~~~~~~~~~~~~~  305 (334)
T cd07855         293 QHPFLAQYHDPDD  305 (334)
T ss_pred             hChhhhhccCCcc
Confidence            6899876555443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5e-35  Score=309.83  Aligned_cols=280  Identities=24%  Similarity=0.344  Sum_probs=200.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCC-----
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEG-----   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~-----   82 (708)
                      -..|.+.+.||+|+||.||+|.+..+|+.||+|.+....... ......+|+++++.++||||+++++++.....     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            458999999999999999999999999999999986543222 22345689999999999999999998754332     


Q ss_pred             -ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         83 -RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        83 -~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                       ..+|+||+|+. ++|...+....  ..+++..++.++.|++.||.|||++|++|+||||+||++    +..+.++|+||
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~----~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI----DNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCEEECcC
Confidence             35799999995 57877776532  239999999999999999999999999999999999998    66778999999


Q ss_pred             Ccccccccccc------------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC
Q psy15481        162 GAARELEEDQQ------------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG  229 (708)
Q Consensus       162 GlA~~~~~~~~------------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g  229 (708)
                      |++........            +....+++.|+|||.+..       ...++.++|||||||++|+|++|.+||.+   
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~~g~~~~~~---  229 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-------ERRYTTAVDIWGIGCVFAEMFTRRPILQG---  229 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhC-------CCccCchhHhHHHHHHHHHHHhCCCCCCC---
Confidence            99976543221            123456888999998862       34578899999999999999999999974   


Q ss_pred             CChhhHHHHHHhc---ccCCcccccccCCCCcc--cccCCCCC-cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        230 RRNKETMYYITTK---KASGVISGTQTSENGEI--DWCTDLPN-NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       230 ~~~~e~~~~i~~~---~~~~~i~~~~~~~~g~~--~~~~~lp~-~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                      .+.......+...   ..+.......... ...  ......+. .......+...+.+++.+||..||.+|||+.++   
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el---  305 (311)
T cd07866         230 KSDIDQLHLIFKLCGTPTEETWPGWRSLP-GCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA---  305 (311)
T ss_pred             CCHHHHHHHHHHHhCCCChhhchhhhhcc-cccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH---
Confidence            3333333333321   0000000000000 000  00000000 000011222456789999999999999999997   


Q ss_pred             HHHHHhhhhcCccc
Q psy15481        304 VTKTLNRKLVHLFH  317 (708)
Q Consensus       304 l~~il~~~l~h~~~  317 (708)
                              +.||||
T Consensus       306 --------l~~~~f  311 (311)
T cd07866         306 --------LEHPYF  311 (311)
T ss_pred             --------hcCCCC
Confidence                    668885

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.2e-34  Score=295.00  Aligned_cols=248  Identities=29%  Similarity=0.490  Sum_probs=200.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|...+.||+|++|.||++.+..+|..|++|.+..... .......+|+.++++++||||+++++++....  ..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKD--ELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--eEEEEEe
Confidence            37788999999999999999998999999999876443 23455679999999999999999999987654  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |++|++|.+++....  ..+++..+..++.+++.||.+||++|++||||+|+||++    +..+.++|+|||.+......
T Consensus        78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i----~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL----TSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE----ccCCeEEEeecccccccccc
Confidence            999999999987642  238999999999999999999999999999999999998    55678999999999876654


Q ss_pred             ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccc
Q psy15481        171 QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISG  250 (708)
Q Consensus       171 ~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~  250 (708)
                      .......++..|+|||.+.        +..++.++|+||||+++|+|++|..||..   .+....+........+     
T Consensus       152 ~~~~~~~~~~~~~~PE~~~--------~~~~~~~~Dv~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~~~~-----  215 (253)
T cd05122         152 KARNTMVGTPYWMAPEVIN--------GKPYDYKADIWSLGITAIELAEGKPPYSE---LPPMKALFKIATNGPP-----  215 (253)
T ss_pred             ccccceecCCcccCHHHHc--------CCCCCccccHHHHHHHHHHHHhCCCCCCC---CchHHHHHHHHhcCCC-----
Confidence            4344567899999999986        45588999999999999999999999974   2223333332221110     


Q ss_pred             cccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        251 TQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       251 ~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                   .++....    .+..+.+++.+||..||++|||+.++
T Consensus       216 -------------~~~~~~~----~~~~~~~~i~~~l~~~p~~R~t~~~~  248 (253)
T cd05122         216 -------------GLRNPEK----WSDEFKDFLKKCLQKNPEKRPTAEQL  248 (253)
T ss_pred             -------------CcCcccc----cCHHHHHHHHHHccCChhhCCCHHHH
Confidence                         1111111    23456779999999999999999997

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.5e-35  Score=317.25  Aligned_cols=283  Identities=22%  Similarity=0.332  Sum_probs=204.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC-CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC---ce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS-HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG---RG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s-~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~---~~   84 (708)
                      +.+|.+...||.|+||.||+|.+..+|+.||||.+.... .........+|+.+++.++||||+++++++.....   ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457999999999999999999999999999999986532 12223345689999999999999999998764432   35


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||+ +++|.+++.....   +++..+..++.|++.||.|||++|++||||||+||++    +..+.+||+|||++
T Consensus        84 ~~lv~e~~-~~~L~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~----~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELM-DTDLHQIIRSSQT---LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCC-CCCHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE----cCCCCEEECcCccc
Confidence            89999999 5789998876433   9999999999999999999999999999999999998    66678999999999


Q ss_pred             ccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        165 RELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       165 ~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ....... ......++..|+|||.+..       +..++.++|+|||||++|+|++|.+||...+...............
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  228 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELLLN-------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP  228 (337)
T ss_pred             cccCCCcccccccccccCccChHHHhc-------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence            8664432 2234568899999999863       3458899999999999999999999997422111111111111111


Q ss_pred             cCCcccccccCCCCcccccCCCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      ...........  ....|...++..     ....+.++..+.+++.+||..||++|||+.++           +.|||+.
T Consensus       229 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el-----------l~h~~~~  295 (337)
T cd07858         229 SEEDLGFIRNE--KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA-----------LAHPYLA  295 (337)
T ss_pred             ChHHhhhcCch--hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH-----------HcCcchh
Confidence            11100000000  000011111111     11123345566789999999999999999997           5677774


Q ss_pred             C
Q psy15481        319 N  319 (708)
Q Consensus       319 ~  319 (708)
                      .
T Consensus       296 ~  296 (337)
T cd07858         296 S  296 (337)
T ss_pred             h
Confidence            4

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.9e-35  Score=310.56  Aligned_cols=262  Identities=27%  Similarity=0.461  Sum_probs=206.9

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      |....+|.+.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+  ..
T Consensus        15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~   91 (293)
T cd06647          15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGD--EL   91 (293)
T ss_pred             cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC--cE
Confidence            556678999999999999999999998899999999986432 223455678999999999999999999987654  49


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|+||++|++|.+++....    +++..+..++.+++.||.|||++|++|+||||+||++    +..+.++|+|||++.
T Consensus        92 ~lv~e~~~~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili----~~~~~~kL~dfg~~~  163 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL----GMDGSVKLTDFGFCA  163 (293)
T ss_pred             EEEEecCCCCcHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE----cCCCCEEEccCccee
Confidence            99999999999999997532    7899999999999999999999999999999999998    556679999999987


Q ss_pred             ccccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ....... .....|++.|+|||.+.        +..++.++|+|||||++|++++|..||..   .+....+..+...  
T Consensus       164 ~~~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Dv~slG~ll~~ll~g~~pf~~---~~~~~~~~~~~~~--  230 (293)
T cd06647         164 QITPEQSKRSTMVGTPYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLN---ENPLRALYLIATN--  230 (293)
T ss_pred             cccccccccccccCChhhcCchhhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCC---CChhhheeehhcC--
Confidence            6544332 23346889999999986        45678899999999999999999999973   2222222111110  


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                  +.    ..++.    +..+...+.+++.+||..||.+||+++++           +.|+|+.....
T Consensus       231 ------------~~----~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~i-----------l~h~~~~~~~~  277 (293)
T cd06647         231 ------------GT----PELQN----PEKLSAIFRDFLNRCLEMDVEKRGSAKEL-----------LQHPFLKIAKP  277 (293)
T ss_pred             ------------CC----CCCCC----ccccCHHHHHHHHHHccCChhhCcCHHHH-----------hcCHHHhcCcc
Confidence                        00    01111    22234456679999999999999999997           67888876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-35  Score=316.83  Aligned_cols=262  Identities=21%  Similarity=0.342  Sum_probs=199.4

Q ss_pred             CceEEEeeEeecCCceEEEEEEE-----cCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVN-----KNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEG   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~   82 (708)
                      ..+|.+.+.||+|+||.||+|.+     ..+++.||||.++............+|+.++.++ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-
Confidence            34799999999999999999984     3567899999997543333344567899999999 7899999999886543 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCC--------------------------------------------------------
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPEN--------------------------------------------------------  106 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~--------------------------------------------------------  106 (708)
                      ...++|||||++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            358999999999999998864210                                                        


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccc---cc
Q psy15481        107 --------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF---MS  175 (708)
Q Consensus       107 --------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~---~~  175 (708)
                              ...++...+..++.|++.||.|||++||+||||||+||++    +..+.+||+|||++.........   ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE----cCCCcEEEEecccccccccCcchhhcCC
Confidence                    1126788889999999999999999999999999999998    56678999999999865333221   12


Q ss_pred             cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCcccccccC
Q psy15481        176 LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVISGTQTS  254 (708)
Q Consensus       176 ~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~  254 (708)
                      ..++..|+|||.+.        +..++.++|||||||++|+|++ |..||....  ........+....           
T Consensus       241 ~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~-----------  299 (343)
T cd05103         241 ARLPLKWMAPETIF--------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--IDEEFCRRLKEGT-----------  299 (343)
T ss_pred             CCCCcceECcHHhc--------CCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc--ccHHHHHHHhccC-----------
Confidence            34567899999986        5778999999999999999997 999996421  1122222221110           


Q ss_pred             CCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        255 ENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       255 ~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                             ....|.  ..++    .+.+++..||..||++||++.+++.++..+++
T Consensus       300 -------~~~~~~--~~~~----~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         300 -------RMRAPD--YTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             -------CCCCCC--CCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                   001111  1223    45668899999999999999999999888765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.9e-35  Score=301.13  Aligned_cols=247  Identities=23%  Similarity=0.337  Sum_probs=195.2

Q ss_pred             eEeecCCceEEEEEEEcC-CCc--eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKN-NGE--PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~-tg~--~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|++|.||+|.+.. +++  .||+|.+...........+.+|+.++++++||||+++++++.+   ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence            368999999999999865 333  6999998765443334556789999999999999999999876   4599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ  172 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~  172 (708)
                      ++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||++    +..+.+||+|||.+........
T Consensus        78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~----~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL----ASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE----ecCCEEEecccccccccccccc
Confidence            99999999976542 348999999999999999999999999999999999998    5567899999999987644321


Q ss_pred             ----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        173 ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       173 ----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                          .....++..|+|||.+.        +..++.++|||||||++|+|++ |..||..   .+..+.+..+.....   
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~--------~~~~~~~~Di~slG~~l~el~t~g~~p~~~---~~~~~~~~~~~~~~~---  218 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLR--------TRTFSHASDVWMFGVTLWEMFTYGEEPWAG---LSGSQILKKIDKEGE---  218 (257)
T ss_pred             ceecccCCCCCceecCHHHhc--------ccCcCchhhhHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHhcCC---
Confidence                11245778899999886        5678999999999999999999 9999963   344444444432100   


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                                      ..+.    +...+..+.+++..||..+|++||++.+++..+
T Consensus       219 ----------------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l  255 (257)
T cd05040         219 ----------------RLER----PEACPQDIYNVMLQCWAHNPADRPTFAALREFL  255 (257)
T ss_pred             ----------------cCCC----CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence                            1111    122334567799999999999999999987654

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-34  Score=300.04  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=196.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .+|.+...||+|++|.||+|.+..+ ..+|+|.+....  ...+.+.+|+.++++++|||++++++++..   ...++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~   79 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIVT   79 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEEE
Confidence            4699999999999999999987654 469999876432  224556789999999999999999988743   2479999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+.+++|.+++..... ..+++..+..++.+++.||.|||+.|++|+||||+||++    +..+.++|+|||.+.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill----~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          80 EFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV----GDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EcCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE----cCCCeEEECCCccceEccC
Confidence            99999999999976432 237899999999999999999999999999999999998    6677899999999976543


Q ss_pred             ccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ...  .....++..|+|||...        +..++.++|+|||||++|+|+| |.+||..   ..+.+....+....   
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~--------~~~~~~~~Di~slG~~l~el~t~g~~p~~~---~~~~~~~~~~~~~~---  220 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAAL--------YGRFTIKSDVWSFGILLTELVTKGRVPYPG---MVNREVLEQVERGY---  220 (260)
T ss_pred             CcccccCCCccchhhCCHHHhc--------cCCcChHHHHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHcCC---
Confidence            321  12234667899999876        5668899999999999999999 9999973   44444444433210   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                                       ..+    .+...+..+.+++.+||..||.+||+++++.+.++
T Consensus       221 -----------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  258 (260)
T cd05069         221 -----------------RMP----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE  258 (260)
T ss_pred             -----------------CCC----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence                             001    11233455677999999999999999999877554

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-34  Score=298.27  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=199.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||+|.+. ++..||+|.+....  .....+.+|+.++++++||||+++++++....  ..++|
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v   79 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE--PIYIV   79 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC--ceEEE
Confidence            357889999999999999999975 55789999987433  23455678999999999999999999987544  48999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||+++++|.+++..... ..++...+..++.+++.|+.|||++|++|+||||+||++    +..+.++|+|||.+....
T Consensus        80 ~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili----~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV----GENLVCKIADFGLARLIE  154 (261)
T ss_pred             EeccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE----cCCCCEEECccccceecc
Confidence            999999999999976432 238999999999999999999999999999999999998    666789999999998665


Q ss_pred             cccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .+..  .....++..|+|||.+.        +..++.++|+|||||++|+++| |+.||.   +......+..+....  
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Di~slG~il~~l~t~g~~p~~---~~~~~~~~~~~~~~~--  221 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAAN--------YGRFTIKSDVWSFGILLTEIVTYGRVPYP---GMTNREVLEQVERGY--  221 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhc--------cCCcCchhHHHHHHHHHHHHHhCCCCCCC---CCCHHHHHHHHHcCC--
Confidence            3321  11233567899999887        5678899999999999999999 999996   344444454443210  


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                                        ..+..    ...+..+.+++.+||..||.+||++++++..++
T Consensus       222 ------------------~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         222 ------------------RMPRP----PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             ------------------CCCCC----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence                              11111    112345677999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.5e-35  Score=312.84  Aligned_cols=256  Identities=23%  Similarity=0.406  Sum_probs=201.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|.....||+|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+  ..|+|||
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~iv~e   98 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE--ELWVLME   98 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCC--eEEEEEe
Confidence            34455689999999999999999999999999865432 23455678999999999999999999987644  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+++++|..++....    +++..+..++.|++.||.|||++|++||||||+||++    +..+.++|+|||++.....+
T Consensus        99 ~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill----~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          99 FLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL----TLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             cCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE----ccCCcEEEeechhHhhcccc
Confidence            999999999886532    8999999999999999999999999999999999998    66678999999998755433


Q ss_pred             c-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        171 Q-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       171 ~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      . ......|+..|+|||++.        +..++.++|+|||||++|+|++|..||..   ....+.+..+......    
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~el~~g~~p~~~---~~~~~~~~~~~~~~~~----  235 (297)
T cd06659         171 VPKRKSLVGTPYWMAPEVIS--------RTPYGTEVDIWSLGIMVIEMVDGEPPYFS---DSPVQAMKRLRDSPPP----  235 (297)
T ss_pred             cccccceecCccccCHHHHc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhccCCC----
Confidence            2 233467899999999986        56688999999999999999999999973   3334444333221100    


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                    ...    ........+.+++..||..||.+||++.++           +.|+|+....
T Consensus       236 --------------~~~----~~~~~~~~l~~~i~~~l~~~P~~Rps~~~l-----------l~~~~~~~~~  278 (297)
T cd06659         236 --------------KLK----NAHKISPVLRDFLERMLTREPQERATAQEL-----------LDHPFLLQTG  278 (297)
T ss_pred             --------------Ccc----ccCCCCHHHHHHHHHHhcCCcccCcCHHHH-----------hhChhhccCC
Confidence                          001    111223446679999999999999999997           5578776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG1095|consensus

Probab=100.00  E-value=4.1e-35  Score=344.07  Aligned_cols=275  Identities=24%  Similarity=0.378  Sum_probs=223.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCc-----eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~-----~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      ...-.+.+.||+|+||.||.|.-....-     .||+|.+++.........+.+|..++++++|||||++++++.+..  
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~--  768 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG--  768 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC--
Confidence            4456788999999999999998764322     399999988776666777899999999999999999999998744  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         84 GKVIVMELCTGGSLFNILDDPEN----TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~----~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      ..+|++|||+||||..+|++...    ...++..+.+.++.+|++|+.||+++++|||||-..|+|+    +...+|||+
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL----~~~r~VKIa  844 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL----DERRVVKIA  844 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee----cccCcEEEc
Confidence            49999999999999999998611    2239999999999999999999999999999999999999    778999999


Q ss_pred             ccCccccccccccccc---cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhH
Q psy15481        160 DFGAARELEEDQQFMS---LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKET  235 (708)
Q Consensus       160 DFGlA~~~~~~~~~~~---~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~  235 (708)
                      |||+|+.+...+-+..   ..-...|||||.+.        ...|+.++|||||||++||++| |..||.   +.+|.++
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~--------d~iFtskSDvWsFGVllWEifslG~~PY~---~~~n~~v  913 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK--------DGIFTSKSDVWSFGVLLWEIFSLGATPYP---SRSNFEV  913 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHh--------hcccccccchhhhHHHHHHHHhCCCCCCC---CcchHHH
Confidence            9999995443332221   12235899999998        6889999999999999999999 999987   6888998


Q ss_pred             HHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCc
Q psy15481        236 MYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHL  315 (708)
Q Consensus       236 ~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~  315 (708)
                      +......-                  +...|..      +++.+.+++..||+.+|++||+|..+++.+..+.+-.+-.+
T Consensus       914 ~~~~~~gg------------------RL~~P~~------CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~  969 (1025)
T KOG1095|consen  914 LLDVLEGG------------------RLDPPSY------CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI  969 (1025)
T ss_pred             HHHHHhCC------------------ccCCCCC------CChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence            88666431                  1122333      34556679999999999999999999998888887766665


Q ss_pred             ccCCccccc
Q psy15481        316 FHINRLQCI  324 (708)
Q Consensus       316 ~~~~~~~~~  324 (708)
                      +..-...-.
T Consensus       970 ~~~~~a~~~  978 (1025)
T KOG1095|consen  970 YGPLPADYE  978 (1025)
T ss_pred             ccccccccC
Confidence            554444433

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-34  Score=312.77  Aligned_cols=259  Identities=20%  Similarity=0.325  Sum_probs=199.4

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCC-------CceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecC
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNN-------GEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQE   81 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~t-------g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~   81 (708)
                      .+|.+.+.||+|+||.||+|.+...       +..||+|.+...........+.+|+.+++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            4689999999999999999986432       2368999887543333344567899999999 8999999999987654


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEE
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFI  148 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~  148 (708)
                        ..+++|||+++|+|.+++.....             ...++...+..++.|++.||.|||++|++||||||+||++  
T Consensus        92 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill--  167 (334)
T cd05100          92 --PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV--  167 (334)
T ss_pred             --ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE--
Confidence              48999999999999999875321             1237788899999999999999999999999999999998  


Q ss_pred             ecCCCceEEEeccCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCC
Q psy15481        149 CDDGSTIYKLTDFGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF  224 (708)
Q Consensus       149 ~~d~~~~vKL~DFGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF  224 (708)
                        +..+.+||+|||+++........   ....++..|+|||++.        +..++.++|||||||++|+|++ |..||
T Consensus       168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~~g~~p~  237 (334)
T cd05100         168 --TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF--------DRVYTHQSDVWSFGVLLWEIFTLGGSPY  237 (334)
T ss_pred             --cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc--------cCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence              55668999999999865443221   1233456799999987        5778899999999999999998 89999


Q ss_pred             CCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        225 RPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       225 ~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      ..   .+..+....+.....                  ...|      ......+.+++.+||..+|.+||++.+++..+
T Consensus       238 ~~---~~~~~~~~~~~~~~~------------------~~~~------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         238 PG---IPVEELFKLLKEGHR------------------MDKP------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             CC---CCHHHHHHHHHcCCC------------------CCCC------CCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            63   343443333322100                  0111      12234566799999999999999999999988


Q ss_pred             HHHHh
Q psy15481        305 TKTLN  309 (708)
Q Consensus       305 ~~il~  309 (708)
                      ..+..
T Consensus       291 ~~~~~  295 (334)
T cd05100         291 DRVLT  295 (334)
T ss_pred             HHHhh
Confidence            77753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-35  Score=309.64  Aligned_cols=262  Identities=19%  Similarity=0.256  Sum_probs=195.4

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCC--------------ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCcccee
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNG--------------EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL   74 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg--------------~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~   74 (708)
                      ..+|++.+.||+|+||.||++.+..++              ..||+|.++........+.+.+|++++++++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            357999999999999999999875432              358999987543333344567899999999999999999


Q ss_pred             EEEEecCCceEEEEEeccCCCCHHHHhcCCCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q psy15481         75 AIEEEQEGRGKVIVMELCTGGSLFNILDDPEN---------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIM  145 (708)
Q Consensus        75 ~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~---------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NIL  145 (708)
                      +++...+  ..++||||+++++|.+++.....         ...+++..+..++.+++.||.|||++|++||||||+||+
T Consensus        84 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          84 GVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEcCCC--ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9987654  48999999999999998865321         112688899999999999999999999999999999999


Q ss_pred             EEEecCCCceEEEeccCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc--C
Q psy15481        146 KFICDDGSTIYKLTDFGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT--G  220 (708)
Q Consensus       146 l~~~~d~~~~vKL~DFGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT--G  220 (708)
                      +    +..+.+||+|||++.........   ....++..|+|||.+.        +..++.++|+|||||++|+|++  |
T Consensus       162 l----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwSlG~~l~el~~~~~  229 (295)
T cd05097         162 V----GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL--------LGKFTTASDVWAFGVTLWEMFTLCK  229 (295)
T ss_pred             E----cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc--------cCCcCchhhHHHHHHHHHHHHHcCC
Confidence            8    55667999999999765433221   1234567899999886        5668999999999999999988  6


Q ss_pred             CCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        221 NLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       221 ~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      ..||..   .+..+....+......          .+...+.   .    .++..+..+.+++.+||..||.+|||++++
T Consensus       230 ~~p~~~---~~~~~~~~~~~~~~~~----------~~~~~~~---~----~~~~~~~~l~~li~~~l~~~p~~RPs~~~i  289 (295)
T cd05097         230 EQPYSL---LSDEQVIENTGEFFRN----------QGRQIYL---S----QTPLCPSPVFKLMMRCWSRDIKDRPTFNKI  289 (295)
T ss_pred             CCCCcc---cChHHHHHHHHHhhhh----------ccccccC---C----CCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            778863   3333333322210000          0000000   0    111123456779999999999999999998


Q ss_pred             HHHH
Q psy15481        301 FSEV  304 (708)
Q Consensus       301 ~~~l  304 (708)
                      +..+
T Consensus       290 ~~~l  293 (295)
T cd05097         290 HHFL  293 (295)
T ss_pred             HHHH
Confidence            7654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.7e-35  Score=298.56  Aligned_cols=249  Identities=27%  Similarity=0.444  Sum_probs=198.7

Q ss_pred             EEeeEeecCCceEEEEEEEcCCC----ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNG----EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg----~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .+.+.||.|+||.||++.+..++    ..||+|.+...........+..|+.+++.++||||+++++++.+.+  ..+++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~i   79 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE--PLMIV   79 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--eeEEE
Confidence            56789999999999999998766    8999999875543334456678999999999999999999987654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++|++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||++    +..+.++|+|||.+....
T Consensus        80 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~----~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV----GENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE----ccCCeEEEcccCCceecc
Confidence            999999999999876432 128999999999999999999999999999999999998    666789999999998765


Q ss_pred             ccccccc--cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQQFMS--LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~~~~~--~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .......  ..++..|+|||.+.        +..++.++|+||+||++|+|++ |.+||..   .+.......+..... 
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~--------~~~~~~~~Di~slG~i~~~l~~~g~~p~~~---~~~~~~~~~~~~~~~-  222 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLK--------DGKFTSKSDVWSFGVLLWEIFTLGESPYPG---MSNEEVLEYLKKGYR-  222 (258)
T ss_pred             cccccccccCCCcccccChHHhc--------cCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHhcCCC-
Confidence            5432222  33678999999885        5778999999999999999998 8888863   444444444432110 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                                         .+.    +...+..+.+++.+||..||.+|||+.+++..
T Consensus       223 -------------------~~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  257 (258)
T smart00219      223 -------------------LPK----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEI  257 (258)
T ss_pred             -------------------CCC----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence                               011    11134456679999999999999999998653

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1e-34  Score=298.58  Aligned_cols=248  Identities=25%  Similarity=0.488  Sum_probs=196.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|.+.+.||+|+||.||++.++.+|..||+|.+...... ...+...+|+.+++.++||||+++++.+...+  ..|+|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG--RLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC--eEEEEE
Confidence            478899999999999999999999999999998654221 22345568999999999999999999887644  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC-ceEEEeccCcccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS-TIYKLTDFGAARELE  168 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~-~~vKL~DFGlA~~~~  168 (708)
                      ||+++++|.+++..... ..+++..+..++.+++.||.|||++|++|+||||+||++    +.. ..++|+|||.+....
T Consensus        79 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~----~~~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          79 EYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFL----SKNGMVAKLGDFGIARQLN  153 (257)
T ss_pred             ecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE----cCCCCeEEecccccchhcc
Confidence            99999999999865332 237999999999999999999999999999999999997    333 467999999998765


Q ss_pred             ccccc-cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 EDQQF-MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~~~~-~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..... ....|+..|+|||.+.        +..++.++|+|||||++|++++|..||..   .........+....    
T Consensus       154 ~~~~~~~~~~~~~~~~ape~~~--------~~~~~~~~Dv~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~~----  218 (257)
T cd08225         154 DSMELAYTCVGTPYYLSPEICQ--------NRPYNNKTDIWSLGCVLYELCTLKHPFEG---NNLHQLVLKICQGY----  218 (257)
T ss_pred             CCcccccccCCCccccCHHHHc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCC---ccHHHHHHHHhccc----
Confidence            44322 2346899999999886        55688999999999999999999999963   33333333222210    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                       ++   .+++..+..+.+++.+||..+|++|||++++
T Consensus       219 -----------------~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l  251 (257)
T cd08225         219 -----------------FA---PISPNFSRDLRSLISQLFKVSPRDRPSITSI  251 (257)
T ss_pred             -----------------CC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence                             00   1122334456779999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0586|consensus

Probab=100.00  E-value=1.7e-35  Score=326.08  Aligned_cols=253  Identities=26%  Similarity=0.434  Sum_probs=211.6

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-hHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .....|.+...||+|.|+.|.++++..||..||||.+.+...... .....+|+.+++.|+|||||+++.+.+.+..  +
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~--l  130 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT--L  130 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce--e
Confidence            345679999999999999999999999999999999987654332 2445799999999999999999999987664  9


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||+.+|.+++++.+...   +.+..++.++.|+++|++|||+++|||||||++|||+    +....+||+|||++.
T Consensus       131 ylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL----~~~mnikIaDfgfS~  203 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL----DENMNIKIADFGFST  203 (596)
T ss_pred             EEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc----ccccceeeeccccce
Confidence            999999999999999987554   7889999999999999999999999999999999999    888889999999999


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .+..+....+.||++.|.|||++..       ....++.+|+||+|+++|-|+.|.+||.+   ..-.+.-.+.+..+. 
T Consensus       204 ~~~~~~~lqt~cgsppyAaPEl~~g-------~~y~gpe~D~Wslgvvly~LV~GsLPFDG---~~lk~Lr~rvl~gk~-  272 (596)
T KOG0586|consen  204 FFDYGLMLQTFCGSPPYAAPELFNG-------KKYDGPEVDIWSLGVVLYALVEGSLPFDG---QNLKELRPRVLRGKY-  272 (596)
T ss_pred             eecccccccccCCCCCccChHhhcC-------cccCCcceehhhhhhhheeeeecccccCC---cccccccchheeeee-
Confidence            9998888899999999999999983       23458899999999999999999999983   333332222222211 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                                        .+|.  .++.++.    ++|+++|..+|.+|++.+++.+.
T Consensus       273 ------------------rIp~--~ms~dce----~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  273 ------------------RIPF--YMSCDCE----DLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ------------------cccc--eeechhH----HHHHHhhccCccccCCHHHhhhh
Confidence                              2233  2344444    48899999999999999997443

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-34  Score=301.82  Aligned_cols=253  Identities=28%  Similarity=0.443  Sum_probs=193.3

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCC
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~gg   95 (708)
                      ..||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++++++||||+++++++...+  ..++|+||++|+
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~   90 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG--FFKIFMEQVPGG   90 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC--EEEEEEecCCCC
Confidence            57999999999999999999999999886433 222345679999999999999999999987644  599999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC-CceEEEeccCcccccccccc-c
Q psy15481         96 SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG-STIYKLTDFGAARELEEDQQ-F  173 (708)
Q Consensus        96 sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~-~~~vKL~DFGlA~~~~~~~~-~  173 (708)
                      +|.+++.........++..+..++.||+.||.|||++||+||||||+||++    +. .+.++|+|||.+........ .
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~----~~~~~~~~l~dfg~~~~~~~~~~~~  166 (268)
T cd06624          91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV----NTYSGVVKISDFGTSKRLAGINPCT  166 (268)
T ss_pred             CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE----cCCCCeEEEecchhheecccCCCcc
Confidence            999998754221112888999999999999999999999999999999997    33 45799999999876543222 2


Q ss_pred             cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccccc
Q psy15481        174 MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQT  253 (708)
Q Consensus       174 ~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~  253 (708)
                      ....|+..|+|||.+...      ...++.++|+||+||++|+|++|..||...+  .....+......           
T Consensus       167 ~~~~~~~~~~aPE~~~~~------~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~--~~~~~~~~~~~~-----------  227 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKG------PRGYGAPADIWSLGCTIVEMATGKPPFIELG--EPQAAMFKVGMF-----------  227 (268)
T ss_pred             ccCCCCccccChhhhccc------cccCCchhhhHHHHHHHHHHHhCCCCCcccc--ChhhhHhhhhhh-----------
Confidence            234688999999998521      2347889999999999999999999996421  111111111100           


Q ss_pred             CCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        254 SENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       254 ~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                               ...|   .++..+...+.+++.+||..+|.+|||+.++           +.|||+
T Consensus       228 ---------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l-----------l~~~~~  268 (268)
T cd06624         228 ---------KIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDL-----------LQDPFL  268 (268)
T ss_pred             ---------ccCC---CCCcccCHHHHHHHHHHcCCCchhCCCHHHH-----------HhCCCC
Confidence                     0011   1223344556779999999999999999997           568875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-34  Score=296.04  Aligned_cols=249  Identities=27%  Similarity=0.434  Sum_probs=201.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|.+.+.||.|++|.||++.+..++..||+|.+...... .......+|+++++.++|||++++++.+...  ...++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence            478899999999999999999999999999998754332 3344567899999999999999999998765  4699999


Q ss_pred             eccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         90 ELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||++|++|.+++.... ....+++..+..++.+++.||.|||++|++|+||+|+||++    +..+.++|+|||.+....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~----~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL----TSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE----cCCCcEEECCccceeecc
Confidence            9999999999987642 12348999999999999999999999999999999999998    666789999999998765


Q ss_pred             ccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 EDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ... ......|++.|+|||.+.        +..++.++|+||+|+++|+|++|..||..   .+............    
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~--------~~~~~~~~Dv~slG~~~~~l~~g~~p~~~---~~~~~~~~~~~~~~----  219 (258)
T cd08215         155 STVDLAKTVVGTPYYLSPELCQ--------NKPYNYKSDIWSLGCVLYELCTLKHPFEG---ENLLELALKILKGQ----  219 (258)
T ss_pred             cCcceecceeeeecccChhHhc--------cCCCCccccHHHHHHHHHHHHcCCCCCCC---CcHHHHHHHHhcCC----
Confidence            443 223457899999999876        56688999999999999999999999973   33333333332211    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                       .+   .++..+...+.+++..||..||.+||++.++
T Consensus       220 -----------------~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l  252 (258)
T cd08215         220 -----------------YP---PIPSQYSSELRNLVSSLLQKDPEERPSIAQI  252 (258)
T ss_pred             -----------------CC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                             01   1222344567779999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.2e-34  Score=321.36  Aligned_cols=259  Identities=22%  Similarity=0.341  Sum_probs=200.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCc
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGR   83 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~   83 (708)
                      ..|.+.+.||+|+||.||+|.+.     .++..||+|+++........+.+.+|+.++.++. ||||+++++++...+  
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~--  114 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG--  114 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC--
Confidence            35778899999999999999864     3567899999976543333445779999999997 999999999987654  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCC---------------------------------------------------------
Q psy15481         84 GKVIVMELCTGGSLFNILDDPEN---------------------------------------------------------  106 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~---------------------------------------------------------  106 (708)
                      ..++|||||.+|+|.+++.....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            49999999999999998864211                                                         


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEE
Q psy15481        107 --------------------------------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFI  148 (708)
Q Consensus       107 --------------------------------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~  148 (708)
                                                            ...+++..+..++.||+.||.|||++|++||||||+|||+  
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl--  272 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI--  272 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE--
Confidence                                                  1236778889999999999999999999999999999998  


Q ss_pred             ecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCC
Q psy15481        149 CDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF  224 (708)
Q Consensus       149 ~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF  224 (708)
                        +..+.++|+|||++........   .....++..|+|||.+.        +..++.++|||||||++|+|++ |..||
T Consensus       273 --~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslGvil~e~l~~g~~P~  342 (401)
T cd05107         273 --CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF--------NNLYTTLSDVWSFGILLWEIFTLGGTPY  342 (401)
T ss_pred             --eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc--------CCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence              5567899999999986543221   22345788999999986        5668899999999999999998 89999


Q ss_pred             CCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        225 RPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       225 ~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      ..   ....+..........                   .++.+..    ....+.+++.+||..||.+||++.+++..+
T Consensus       343 ~~---~~~~~~~~~~~~~~~-------------------~~~~p~~----~~~~l~~li~~cl~~~P~~RPs~~ell~~L  396 (401)
T cd05107         343 PE---LPMNEQFYNAIKRGY-------------------RMAKPAH----ASDEIYEIMQKCWEEKFEIRPDFSQLVHLV  396 (401)
T ss_pred             CC---CCchHHHHHHHHcCC-------------------CCCCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            63   233333333322110                   1111112    234566799999999999999999999988


Q ss_pred             HHHH
Q psy15481        305 TKTL  308 (708)
Q Consensus       305 ~~il  308 (708)
                      ++++
T Consensus       397 ~~~~  400 (401)
T cd05107         397 GDLL  400 (401)
T ss_pred             HHHh
Confidence            7654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-34  Score=304.19  Aligned_cols=260  Identities=23%  Similarity=0.380  Sum_probs=205.2

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ...+.|..-+.||+|++|.||++.+..+++.|++|.+..... ...+...+|+.+++.++||||+++++.+...+  ..+
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~--~~~   92 (285)
T cd06648          16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD--ELW   92 (285)
T ss_pred             cchHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--eEE
Confidence            333466677899999999999999999999999999864322 22345678999999999999999999887644  589


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|+||+.|++|.+++...    .+++..+..++.|++.||.|||++|++||||+|+||++    +..+.++|+|||.+..
T Consensus        93 ~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~~l~d~g~~~~  164 (285)
T cd06648          93 VVMEFLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL----TSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             EEEeccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE----cCCCcEEEcccccchh
Confidence            999999999999998762    28999999999999999999999999999999999998    6667899999998875


Q ss_pred             ccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ..... ......|+..|+|||.+.        +..++.++|+||+||++|+|++|..||..   .+....+..+.....+
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slGv~l~ell~g~~p~~~---~~~~~~~~~~~~~~~~  233 (285)
T cd06648         165 VSKEVPRRKSLVGTPYWMAPEVIS--------RLPYGTEVDIWSLGIMVIEMVDGEPPYFN---EPPLQAMKRIRDNLPP  233 (285)
T ss_pred             hccCCcccccccCCccccCHHHhc--------CCCCCCcccHHHHHHHHHHHHhCCCCCcC---CCHHHHHHHHHhcCCC
Confidence            44332 223356899999999986        56688999999999999999999999963   3334444433321100


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                        .++..    ...+..+.+++.+||..||++||++.++           +.|+|+....
T Consensus       234 ------------------~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~i-----------l~~~~~~~~~  276 (285)
T cd06648         234 ------------------KLKNL----HKVSPRLRSFLDRMLVRDPAQRATAAEL-----------LNHPFLAKAG  276 (285)
T ss_pred             ------------------CCccc----ccCCHHHHHHHHHHcccChhhCcCHHHH-----------ccCcccccCC
Confidence                              11111    1133456779999999999999999997           6689886644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-34  Score=306.38  Aligned_cols=262  Identities=20%  Similarity=0.293  Sum_probs=195.4

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcC----------------CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKN----------------NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK   72 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~----------------tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVk   72 (708)
                      ..+|.+.+.||+|+||.||++.+..                ++..||+|.+...........+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            4568999999999999999986432                345799999875433333455678999999999999999


Q ss_pred             eeEEEEecCCceEEEEEeccCCCCHHHHhcCCCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q psy15481         73 LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN--------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNI  144 (708)
Q Consensus        73 l~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~--------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NI  144 (708)
                      +++++...+  ..++||||+++++|.+++.....        ...+++..+..++.|++.||.|||++|++||||||+||
T Consensus        84 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999987654  48999999999999999875321        12377889999999999999999999999999999999


Q ss_pred             EEEEecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc--
Q psy15481        145 MKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT--  219 (708)
Q Consensus       145 Ll~~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT--  219 (708)
                      ++    +..+.++|+|||++........   .....++..|++||...        +..++.++|+|||||++|+|++  
T Consensus       162 li----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~DiwSlG~~l~el~~~~  229 (296)
T cd05095         162 LV----GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL--------LGKFTTASDVWAFGVTLWEILTLC  229 (296)
T ss_pred             EE----cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh--------cCCccchhhhhHHHHHHHHHHHhC
Confidence            98    5567899999999986543321   11233467899999876        5668999999999999999998  


Q ss_pred             CCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHH
Q psy15481        220 GNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFER  299 (708)
Q Consensus       220 G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q  299 (708)
                      |..||..   .+..+.+.........          .+.   ...+|....    ++..+.+++..||..||.+||++.+
T Consensus       230 ~~~p~~~---~~~~~~~~~~~~~~~~----------~~~---~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~  289 (296)
T cd05095         230 KEQPYSQ---LSDEQVIENTGEFFRD----------QGR---QVYLPKPAL----CPDSLYKLMLSCWRRNAKERPSFQE  289 (296)
T ss_pred             CCCCccc---cChHHHHHHHHHHHhh----------ccc---cccCCCCCC----CCHHHHHHHHHHcCCCcccCCCHHH
Confidence            7788863   3333333222110000          000   001122222    2345667999999999999999999


Q ss_pred             HHHHH
Q psy15481        300 FFSEV  304 (708)
Q Consensus       300 ~~~~l  304 (708)
                      +.+.+
T Consensus       290 i~~~l  294 (296)
T cd05095         290 IHATL  294 (296)
T ss_pred             HHHHH
Confidence            87754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.5e-35  Score=307.80  Aligned_cols=263  Identities=23%  Similarity=0.329  Sum_probs=196.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|.....||+|+||.||++.+..+|+.||+|.+...........+.+|+.++.++. ||||+++++++...+  ..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~--~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG--DCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC--cEEEEE
Confidence            45566789999999999999999999999999875443333445678999999995 999999999887644  489999


Q ss_pred             eccCCCCHHHHhc---CCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         90 ELCTGGSLFNILD---DPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        90 Ey~~ggsL~~~L~---~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ||+. +++.++..   ... ...+++..+..++.+++.||+|||+. |++||||||+||++    +..+.++|+|||++.
T Consensus        83 e~~~-~~l~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~----~~~~~~kl~dfg~~~  156 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVL-KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL----DRNGNIKLCDFGISG  156 (288)
T ss_pred             eccc-CCHHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE----ccCCcEEEeecchhH
Confidence            9985 56554332   111 12389999999999999999999985 99999999999998    556789999999998


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ............|+..|+|||++....     +..++.++|+||+||++|+|++|.+||....  ...+.+..+.....+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~  229 (288)
T cd06616         157 QLVDSIAKTRDAGCRPYMAPERIDPSA-----RDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPP  229 (288)
T ss_pred             HhccCCccccccCccCccCHHHhcccc-----ccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCC
Confidence            665443334457899999999986310     1468899999999999999999999997432  112222222211100


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                        .++..  .....+..+.+++.+||..||++|||++++           +.|||+..
T Consensus       230 ------------------~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i-----------~~~~~~~~  272 (288)
T cd06616         230 ------------------ILSNS--EEREFSPSFVNFINLCLIKDESKRPKYKEL-----------LEHPFIKD  272 (288)
T ss_pred             ------------------cCCCc--CCCccCHHHHHHHHHHccCChhhCcCHHHH-----------hcChhhhc
Confidence                              01110  112234456779999999999999999997           66888854

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0584|consensus

Probab=100.00  E-value=5.6e-36  Score=330.07  Aligned_cols=266  Identities=21%  Similarity=0.318  Sum_probs=215.7

Q ss_pred             ccCCCCceE-EEeeEeecCCceEEEEEEEcCCCceEEE---EEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEe
Q psy15481          4 LRGSTNYVW-CTTSVLGKGATGAVFQGVNKNNGEPVAV---KTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEE   79 (708)
Q Consensus         4 l~~~~n~~y-~i~~~LG~G~fG~Vy~a~~~~tg~~VAI---K~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~   79 (708)
                      +-.+.+.+| .....||+|+|-+||+|.|..+|..||=   |.-.........+++..|+.+|+.|+||||+++++++.+
T Consensus        33 ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d  112 (632)
T KOG0584|consen   33 VEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD  112 (632)
T ss_pred             cccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence            344555555 6778999999999999999999999983   322222233334778899999999999999999999998


Q ss_pred             cCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCCCcEEEEEecCCCceEE
Q psy15481         80 QEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN--RLVHRDLKPGNIMKFICDDGSTIYK  157 (708)
Q Consensus        80 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~--gIVHrDIKP~NILl~~~~d~~~~vK  157 (708)
                      .....+.+|+|.|.+|+|+.|+++...   +....++.+++||+.||.|||++  .|||||||-+|||+   +...|.||
T Consensus       113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFi---nG~~G~VK  186 (632)
T KOG0584|consen  113 TDNKTINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFV---NGNLGEVK  186 (632)
T ss_pred             CCCceeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEE---cCCcCcee
Confidence            888889999999999999999988654   89999999999999999999987  69999999999998   23457899


Q ss_pred             EeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH
Q psy15481        158 LTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       158 L~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~  237 (708)
                      |+|+|+|...... ...+..|||+|||||+|+         ..|+..+||||||+++.||+|+..||.-  -.+...+..
T Consensus       187 IGDLGLAtl~r~s-~aksvIGTPEFMAPEmYE---------E~YnE~VDVYaFGMCmLEMvT~eYPYsE--C~n~AQIYK  254 (632)
T KOG0584|consen  187 IGDLGLATLLRKS-HAKSVIGTPEFMAPEMYE---------ENYNELVDVYAFGMCMLEMVTSEYPYSE--CTNPAQIYK  254 (632)
T ss_pred             ecchhHHHHhhcc-ccceeccCccccChHHHh---------hhcchhhhhhhhhHHHHHHHhccCChhh--hCCHHHHHH
Confidence            9999999876544 334589999999999996         6799999999999999999999999973  245556666


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      +++.++.+..++.+.                       ...+..||.+||.. ...|+|+.++           +.|+||
T Consensus       255 KV~SGiKP~sl~kV~-----------------------dPevr~fIekCl~~-~~~R~sa~eL-----------L~d~Ff  299 (632)
T KOG0584|consen  255 KVTSGIKPAALSKVK-----------------------DPEVREFIEKCLAT-KSERLSAKEL-----------LKDPFF  299 (632)
T ss_pred             HHHcCCCHHHhhccC-----------------------CHHHHHHHHHHhcC-chhccCHHHH-----------hhChhh
Confidence            666655544433321                       12356699999999 9999999998           557777


Q ss_pred             CCccc
Q psy15481        318 INRLQ  322 (708)
Q Consensus       318 ~~~~~  322 (708)
                      .....
T Consensus       300 ~~d~g  304 (632)
T KOG0584|consen  300 DEDGG  304 (632)
T ss_pred             ccccc
Confidence            66533

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.6e-35  Score=305.91  Aligned_cols=256  Identities=22%  Similarity=0.285  Sum_probs=197.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcC-----CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      ...|.+.+.||+|+||.||++.+..     ++..||+|.+...........+.+|+.++++++||||+++++++....  
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~--   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK--   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--
Confidence            3578889999999999999998753     678999999865432222345678999999999999999999887644  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q psy15481         84 GKVIVMELCTGGSLFNILDDPE-------------------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNI  144 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~-------------------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NI  144 (708)
                      ..++||||+++|+|.+++....                   ....+++..+..++.|++.||.|||++|++||||||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            4899999999999999986321                   112378899999999999999999999999999999999


Q ss_pred             EEEEecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-C
Q psy15481        145 MKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-G  220 (708)
Q Consensus       145 Ll~~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G  220 (708)
                      ++    +..+.++|+|||.+........   .....++..|+|||.+.        +..++.++|+|||||++|+|++ |
T Consensus       162 l~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~el~~~~  229 (288)
T cd05050         162 LV----GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF--------YNRYTTESDVWAYGVVLWEIFSYG  229 (288)
T ss_pred             Ee----cCCCceEECccccceecccCccccccCCCccChhhcCHHHHh--------cCCCCchhHHHHHHHHHHHHHhCC
Confidence            98    6667899999999876543321   11233466799999886        5678999999999999999998 8


Q ss_pred             CCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        221 NLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       221 ~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      ..||.+   ....+....+....                    ..+.    +..++..+.+++.+||..||.+|||+.++
T Consensus       230 ~~p~~~---~~~~~~~~~~~~~~--------------------~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~el  282 (288)
T cd05050         230 MQPYYG---MAHEEVIYYVRDGN--------------------VLSC----PDNCPLELYNLMRLCWSKLPSDRPSFASI  282 (288)
T ss_pred             CCCCCC---CCHHHHHHHHhcCC--------------------CCCC----CCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence            888863   33444443333211                    0111    11233456779999999999999999998


Q ss_pred             HHHHH
Q psy15481        301 FSEVT  305 (708)
Q Consensus       301 ~~~l~  305 (708)
                      +..+.
T Consensus       283 ~~~l~  287 (288)
T cd05050         283 NRILQ  287 (288)
T ss_pred             HHHhh
Confidence            77543

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-34  Score=305.82  Aligned_cols=277  Identities=21%  Similarity=0.333  Sum_probs=201.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|.+.+.||.|++|.||+|.+..+|+.||+|.+...... .....+.+|+.++++++||||+++++++.+..  .+|+||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~   80 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK--RLYLVF   80 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC--eEEEEE
Confidence            588999999999999999999999999999998654322 22345668999999999999999999987644  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++ ++|...+..... ..+++..+..++.||+.||.|||++|++|+||+|+||++  +. ....+||+|||++.....
T Consensus        81 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill--~~-~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLI--DR-RTNALKLADFGLARAFGI  155 (294)
T ss_pred             eccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEE--EC-CCCEEEEcccccccccCC
Confidence            9995 688887755332 236889999999999999999999999999999999997  21 334689999999976543


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc---ccC
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK---KAS  245 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~---~~~  245 (708)
                      .. ......+++.|+|||.+..       +..++.++|+||+||++|+|+||.+||..   ....+...++...   ...
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~---~~~~~~~~~~~~~~~~~~~  225 (294)
T PLN00009        156 PVRTFTHEVVTLWYRAPEILLG-------SRHYSTPVDIWSVGCIFAEMVNQKPLFPG---DSEIDELFKIFRILGTPNE  225 (294)
T ss_pred             CccccccCceeecccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHhCCCCh
Confidence            32 2234567899999998862       35678899999999999999999999974   3333444433321   110


Q ss_pred             CcccccccCCCCcccccCCCCCcc-----cCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNC-----QLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~-----~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ....+...    ...|....+...     ...+..+..+.+++.+||..||++||++.++           +.|||+.+
T Consensus       226 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~-----------l~~~~~~~  289 (294)
T PLN00009        226 ETWPGVTS----LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA-----------LEHEYFKD  289 (294)
T ss_pred             hhcccccc----chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH-----------hcCchHhH
Confidence            00000000    000111111110     1122344556779999999999999999997           56888754

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.7e-35  Score=304.84  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=196.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      .+.|.+.+.||+|+||.||++...     .++..+|+|.+.... ......+.+|+++++.++||||+++++++...+  
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR--   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC--
Confidence            356788999999999999999743     356789999876432 223445678999999999999999999887644  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecC
Q psy15481         84 GKVIVMELCTGGSLFNILDDPEN------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDD  151 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d  151 (708)
                      ..+++|||+++++|.+++.....            ...+++..+..++.|++.|+.|||++|++||||||+|||+    +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~----~  156 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV----G  156 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE----c
Confidence            48999999999999999865321            1238899999999999999999999999999999999998    5


Q ss_pred             CCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCC
Q psy15481        152 GSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPY  227 (708)
Q Consensus       152 ~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~  227 (708)
                      ..+.++|+|||++........   .....+++.|+|||.+.        +..++.++|||||||++|+|++ |.+||.. 
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~~g~~p~~~-  227 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL--------YRKFTTESDIWSFGVVLWEIFTYGKQPWYQ-  227 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhc--------cCCcCchhhHHHHHHHHHHHHcCCCCCCcc-
Confidence            567899999999976543321   11233567899999886        5678999999999999999998 9999963 


Q ss_pred             CCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        228 GGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       228 ~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                        ....+.+..+....                    ..+....++    ..+.+++.+||..||.+||+++++...+
T Consensus       228 --~~~~~~~~~~~~~~--------------------~~~~~~~~~----~~~~~li~~cl~~~P~~Rp~~~~l~~~l  278 (280)
T cd05092         228 --LSNTEAIECITQGR--------------------ELERPRTCP----PEVYAIMQGCWQREPQQRMVIKDIHSRL  278 (280)
T ss_pred             --CCHHHHHHHHHcCc--------------------cCCCCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence              33344443333211                    011111223    3456799999999999999999987754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-34  Score=312.34  Aligned_cols=305  Identities=22%  Similarity=0.323  Sum_probs=214.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCC--CceEEEEEeccCCCC-CchHHHHHHHHHHHhC-CCCCccceeEEEEec--CCce
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNN--GEPVAVKTFNQLSHM-RPHDVQMREFEVLKKV-KHENIVKLLAIEEEQ--EGRG   84 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~t--g~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~--~~~~   84 (708)
                      .|.+.+.||+|+||.||++.+..+  +..||+|.+...... .......+|+.+++++ +||||+++++.+...  ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            478899999999999999999888  999999998643222 2234456899999999 699999999875432  2345


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|++|+|+ +++|..++....   .+++..++.++.||+.||.|||++|++||||||+|||+    +..+.++|+|||.+
T Consensus        81 ~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili----~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELM-EADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV----NADCELKICDFGLA  152 (332)
T ss_pred             EEEEEecc-cCCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE----cCCCCEEeCcCCCc
Confidence            78999998 478999886543   38999999999999999999999999999999999998    66678999999999


Q ss_pred             cccccccc-----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        165 RELEEDQQ-----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       165 ~~~~~~~~-----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      ........     .....|+..|+|||.+..       +..++.++|+||+||++|+|++|.+||..   .+....+..+
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~~l~~g~~pf~~---~~~~~~~~~~  222 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLS-------FQSYTKAIDVWSVGCILAELLGRKPVFKG---KDYVDQLNQI  222 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCcCCCC---CCHHHHHHHH
Confidence            86543221     223568999999998762       35678999999999999999999999974   3323333222


Q ss_pred             Hhcc---cCCcccccccCCCCccccc---CCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhc
Q psy15481        240 TTKK---ASGVISGTQTSENGEIDWC---TDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLV  313 (708)
Q Consensus       240 ~~~~---~~~~i~~~~~~~~g~~~~~---~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~  313 (708)
                      ....   ...................   ...+......+..+..+.+++.+||..||.+|||+.++           +.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l-----------l~  291 (332)
T cd07857         223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA-----------LE  291 (332)
T ss_pred             HHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH-----------hc
Confidence            2210   0000000000000000000   00000011122234567789999999999999999997           45


Q ss_pred             CcccCC------c---ccccccccCCcccHHHHHHHHHhh
Q psy15481        314 HLFHIN------R---LQCIRIYLHPDDAYDQLQDLIQEQ  344 (708)
Q Consensus       314 h~~~~~------~---~~~~~~~i~~~e~~~~l~~~i~~~  344 (708)
                      |||+..      .   .....+....+++.+++...|.++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (332)
T cd07857         292 HPYLAIWHDPDDEPVCQKPFDFSFESEDSMEELRDMIIEE  331 (332)
T ss_pred             ChhhhhhcCccccccccccccCCccccccHHHHHHHHhhc
Confidence            666631      1   112235667788899998888764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-35  Score=303.27  Aligned_cols=276  Identities=23%  Similarity=0.355  Sum_probs=206.4

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      |.+.+.||+|++|.||+|.+..+|+.+++|.+...... .......+|+.++++++||||+++++++.+.+  ..++|||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG--DLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC--CEEEEEe
Confidence            56678999999999999999999999999998754332 23345678999999999999999999987654  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |++ ++|.+++....  ..+++..+..++.+++.||.|||++|++|+||||+||++    +..+.++|+|||.+......
T Consensus        79 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili----~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          79 FMD-TDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI----NTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             ccC-CCHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE----CCCCcEEEeeeeeeEecCCC
Confidence            996 58888876643  238999999999999999999999999999999999998    66678999999999876554


Q ss_pred             c-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        171 Q-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       171 ~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      . ......++..|+|||.+..       ...++.++|+|||||++|+|+||+.||..   .+..+.+..+..........
T Consensus       152 ~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~~---~~~~~~~~~~~~~~~~~~~~  221 (283)
T cd05118         152 VRPYTHYVVTRWYRAPELLLG-------DKGYSTPVDIWSVGCIFAELLSRRPLFPG---KSEIDQLFKIFRTLGTPDPE  221 (283)
T ss_pred             cccccCccCcccccCcHHHhc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHcCCCchH
Confidence            3 2334568889999999862       23688999999999999999999999963   44455554444321111000


Q ss_pred             ccccC----CCCcccccC-CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        250 GTQTS----ENGEIDWCT-DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       250 ~~~~~----~~g~~~~~~-~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .....    ......+.. .......+.+.++..+.+++.+||.+||.+||++.++           +.|||+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l-----------l~~~~~  283 (283)
T cd05118         222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA-----------LAHPYF  283 (283)
T ss_pred             hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH-----------hhCCCC
Confidence            00000    000000000 0011112334566778889999999999999999997           567875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=302.86  Aligned_cols=268  Identities=24%  Similarity=0.411  Sum_probs=200.4

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      |.+.+.||+|++|.||+|....+++.||||.+.............+|+..+++++ ||||+++++++.+.  ...|+|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN--DELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--CcEEEEEe
Confidence            6788999999999999999999999999999875433222334457999999998 99999999998774  35999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+ +|+|.+.+.... ...+++..+..++.|++.||.|||++|++|+||+|+||++    +..+.++|+|||.+......
T Consensus        79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i----~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV----SGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE----cCCCCEEEeecccceeccCC
Confidence            99 789998887643 1238999999999999999999999999999999999998    66778999999999876655


Q ss_pred             ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc---ccCCc
Q psy15481        171 QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK---KASGV  247 (708)
Q Consensus       171 ~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~---~~~~~  247 (708)
                      .......++..|+|||++..       +..++.++|+||||+++|+|++|.+||..   ....+....+...   .....
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~s~G~~l~el~~g~~~~~~---~~~~~~~~~~~~~~~~~~~~~  222 (283)
T cd07830         153 PPYTDYVSTRWYRAPEILLR-------STSYSSPVDIWALGCIMAELYTLRPLFPG---SSEIDQLYKICSVLGTPTKQD  222 (283)
T ss_pred             CCcCCCCCcccccCceeeec-------CcCcCCccchhhHHHHHHHHHhCCCccCC---CChHHHHHHHHHhcCCCChhh
Confidence            55555678999999998853       45578899999999999999999999974   3333333333321   11000


Q ss_pred             ccccccCCCCcccccCCCCCcc-----cCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNC-----QLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~-----~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      ..... .......|  .++...     ...+.....+.+++.+||..||++||++.++
T Consensus       223 ~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  277 (283)
T cd07830         223 WPEGY-KLASKLGF--RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA  277 (283)
T ss_pred             hhhHh-hhhccccc--cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHH
Confidence            00000 00000111  111110     1111124567789999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.2e-35  Score=313.11  Aligned_cols=288  Identities=22%  Similarity=0.298  Sum_probs=207.0

Q ss_pred             CCCceEE-EeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-------------hHHHHHHHHHHHhCCCCCccc
Q psy15481          7 STNYVWC-TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-------------HDVQMREFEVLKKVKHENIVK   72 (708)
Q Consensus         7 ~~n~~y~-i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-------------~~~~~~Ei~iL~kL~HpNIVk   72 (708)
                      +...+|. +.+.||+|+||.||+|.+..+|+.||+|.+........             .....+|+++++.++||||++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            3445665 56789999999999999999999999999865432210             113468999999999999999


Q ss_pred             eeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC
Q psy15481         73 LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG  152 (708)
Q Consensus        73 l~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~  152 (708)
                      +++++...+  ..++||||+. |+|.+++.....   +++..+..++.|++.||.|||++|++|+||+|+||++    +.
T Consensus        85 ~~~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill----~~  154 (335)
T PTZ00024         85 LVDVYVEGD--FINLVMDIMA-SDLKKVVDRKIR---LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI----NS  154 (335)
T ss_pred             eeEEEecCC--cEEEEEeccc-cCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE----CC
Confidence            999987644  5999999996 699998865433   8999999999999999999999999999999999998    66


Q ss_pred             CceEEEeccCcccccccc---------------ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHH
Q psy15481        153 STIYKLTDFGAARELEED---------------QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHV  217 (708)
Q Consensus       153 ~~~vKL~DFGlA~~~~~~---------------~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeL  217 (708)
                      .+.++|+|||.+......               .......++..|+|||.+..       ...++.++|+|||||++|+|
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el  227 (335)
T PTZ00024        155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-------AEKYHFAVDMWSVGCIFAEL  227 (335)
T ss_pred             CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc-------CCCCCcHHHHHHHHHHHHHH
Confidence            678999999999765411               11223456888999998862       34578899999999999999


Q ss_pred             hcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCc--ccccCCC-CCcccCChhHHHHHHHHHHhhcccCcccC
Q psy15481        218 ATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGE--IDWCTDL-PNNCQLSLGLKKLVTPILAGLLEVDSKKI  294 (708)
Q Consensus       218 lTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~--~~~~~~l-p~~~~ls~~l~~~l~~LL~~mL~~DP~kR  294 (708)
                      +||.+||..   ..+.+.+..+..................+  ..+.... +......+.....+.++|.+||..||++|
T Consensus       228 ~tg~~p~~~---~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  304 (335)
T PTZ00024        228 LTGKPLFPG---ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER  304 (335)
T ss_pred             HhCCCCCCC---CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhc
Confidence            999999974   34444444443311100000000000000  0000000 00111112234557789999999999999


Q ss_pred             CCHHHHHHHHHHHHhhhhcCcccCCcccccc
Q psy15481        295 WSFERFFSEVTKTLNRKLVHLFHINRLQCIR  325 (708)
Q Consensus       295 psa~q~~~~l~~il~~~l~h~~~~~~~~~~~  325 (708)
                      |+++++           +.|+|+........
T Consensus       305 ~s~~~~-----------l~~~~~~~~~~~~~  324 (335)
T PTZ00024        305 ISAKEA-----------LKHEYFKSDPLPCD  324 (335)
T ss_pred             cCHHHH-----------hcCcccCCCCCCCC
Confidence            999997           67999987765433

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=300.85  Aligned_cols=270  Identities=26%  Similarity=0.395  Sum_probs=199.3

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC-CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS-HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s-~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      |.+.+.||+|++|.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++|||++++++++........++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999999999999999998653 2222344668999999999999999999997663356999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |++ ++|..++....  ..+++..++.++.||+.||.|||+.|++|+||+|+||++    +.++.++|+|||.+......
T Consensus        81 ~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~----~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI----NNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE----cCCCCEEEccccceeeccCC
Confidence            996 58998886643  238999999999999999999999999999999999998    66778999999999876544


Q ss_pred             c--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        171 Q--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       171 ~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .  ......++..|+|||.+..       ...++.++|||||||++|+|+||..||..   ......+..+.........
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~t~~~p~~~---~~~~~~~~~~~~~~~~~~~  223 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLG-------ATRYGPEVDMWSVGCILAELFLGKPIFQG---STELEQLEKIFELCGSPTD  223 (287)
T ss_pred             CcccccccccccccCCceeeEc-------cccCChHHHHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHHHhCCCch
Confidence            3  2334567889999997752       34578999999999999999999999974   3333444443321110000


Q ss_pred             cccccCCCCcccccCCCCCcccCC-------hh-HHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLS-------LG-LKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls-------~~-l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      ......  ....+...........       .. .+..+.+++.+||..||.+||++.++
T Consensus       224 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~  281 (287)
T cd07840         224 ENWPGV--SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA  281 (287)
T ss_pred             hhcccc--ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            000000  0000000000000000       11 24567789999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.5e-34  Score=300.69  Aligned_cols=257  Identities=19%  Similarity=0.269  Sum_probs=187.5

Q ss_pred             EeecCCceEEEEEEEcC--CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCC
Q psy15481         17 VLGKGATGAVFQGVNKN--NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTG   94 (708)
Q Consensus        17 ~LG~G~fG~Vy~a~~~~--tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~g   94 (708)
                      .||+|+||.||+|....  ....+|+|.+...........+.+|+.+++.++||||+++++.+....  ..|+||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~--~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC--ceEEEEEeCCC
Confidence            58999999999996533  445788888764433333345678999999999999999999887654  49999999999


Q ss_pred             CCHHHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccc
Q psy15481         95 GSLFNILDDPEN--TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ  172 (708)
Q Consensus        95 gsL~~~L~~~~~--~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~  172 (708)
                      |+|.+++.....  ....++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill----~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL----TADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe----cCCCcEEEeccccccccccchh
Confidence            999999876432  1225678889999999999999999999999999999998    6677899999999875433221


Q ss_pred             ---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        173 ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       173 ---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                         .....++..|+|||++..... ...+..++.++|||||||++|+|++ |.+||..   ..+.+.+..+......   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~---~~~~~~~~~~~~~~~~---  228 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQ-DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD---LSDEQVLKQVVREQDI---  228 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccc-cccccccchhhHHHHHHHHHHHHHhCCCCCCCc---CCHHHHHHHHhhccCc---
Confidence               122345678999999863211 0113467889999999999999999 8888863   3444444444332110   


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                                     .+|.. .++...+..+..++..|+ .||++||+++++.+.
T Consensus       229 ---------------~~~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         229 ---------------KLPKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             ---------------cCCCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence                           11111 122334445556778887 599999999998664

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.9e-34  Score=306.63  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=199.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCc----eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~----~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ..|...+.||+|+||.||+|.+..+|.    .||+|.+...........+.+|+.+++.++||||+++++++...   ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---Cc
Confidence            467888999999999999999987776    46888876544333334567899999999999999999988643   26


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      +++++|+++|+|.+++.....  .+++..+..++.|++.||.|||++||+||||||+||++    +..+.+||+|||++.
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill----~~~~~~kL~Dfg~~~  157 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV----KSPNHVKITDFGLAR  157 (303)
T ss_pred             eeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee----cCCCceEEccccccc
Confidence            799999999999999876432  38999999999999999999999999999999999998    556679999999998


Q ss_pred             ccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHh
Q psy15481        166 ELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       166 ~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      .......   .....++..|+|||.+.        +..++.++|||||||++|++++ |..||..   ... .....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~DiwslG~~l~el~t~g~~p~~~---~~~-~~~~~~~~  225 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIH--------YRKFTHQSDVWSYGVTIWELMTFGGKPYDG---IPT-REIPDLLE  225 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhc--------cCCCChHHHHHHHHHHHHHHHhCCCCCCCC---CCH-HHHHHHHH
Confidence            6543322   12234577899999986        6778999999999999999997 9999963   222 22222222


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ...                   .+|.....    +..+.+++..||..||++||++.+++..+..+...
T Consensus       226 ~~~-------------------~~~~~~~~----~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         226 KGE-------------------RLPQPPIC----TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCC-------------------CCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            110                   11111112    23456799999999999999999999988776543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.5e-35  Score=302.00  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=192.0

Q ss_pred             eEeecCCceEEEEEEEcCCC------ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         16 SVLGKGATGAVFQGVNKNNG------EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg------~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +.||+|+||.||+|.+...+      ..||+|.+...........+.+|+.+++.++||||+++++++....  ..++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE--PQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--CeEEEE
Confidence            36899999999999886543      6899998865433333455678999999999999999999987654  489999


Q ss_pred             eccCCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec-CCCceEEEeccCcc
Q psy15481         90 ELCTGGSLFNILDDPE----NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD-DGSTIYKLTDFGAA  164 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~----~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~-d~~~~vKL~DFGlA  164 (708)
                      ||++|++|.+++....    ....+++..+..++.+++.||.|||++|++|+||||+||++.... +....++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999999986421    122378999999999999999999999999999999999972111 12237999999999


Q ss_pred             ccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHH
Q psy15481        165 RELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       165 ~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~  240 (708)
                      .........   ....++..|+|||.+.        +..++.++|||||||++|+|+| |..||..   .++.+....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~ellt~g~~p~~~---~~~~~~~~~~~  227 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLL--------DGKFTTQSDVWSFGVLMWEILTLGQQPYPA---LNNQEVLQHVT  227 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHc--------cCCcccchhHHHHHHHHHHHHHcCCCCCcc---cCHHHHHHHHh
Confidence            765433211   1234578899999987        5678999999999999999998 9999963   34444443332


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      ...                    .++    .+...+..+.+++.+||..+|.+||+++++.+.+
T Consensus       228 ~~~--------------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  267 (269)
T cd05044         228 AGG--------------------RLQ----KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL  267 (269)
T ss_pred             cCC--------------------ccC----CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            210                    011    1122345567799999999999999999987765

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.5e-35  Score=308.28  Aligned_cols=267  Identities=24%  Similarity=0.372  Sum_probs=206.5

Q ss_pred             CCcccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEec
Q psy15481          1 MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ   80 (708)
Q Consensus         1 ms~l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~   80 (708)
                      |++..+.....|.....||+|+||.||++.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++.+...
T Consensus        11 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   89 (292)
T cd06657          11 MVVDPGDPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG   89 (292)
T ss_pred             EeecCCChHHHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeC
Confidence            44445544445555678999999999999999999999999885432 22344567899999999999999999998765


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                      +  ..++||||+++++|.+++....    +++..+..++.|++.||.|||++|++||||+|+||++    +.++.++|+|
T Consensus        90 ~--~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv----~~~~~~~l~d  159 (292)
T cd06657          90 D--ELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL----THDGRVKLSD  159 (292)
T ss_pred             C--EEEEEEecCCCCcHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEEcc
Confidence            4  5999999999999999886532    8999999999999999999999999999999999998    6666799999


Q ss_pred             cCccccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        161 FGAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       161 FGlA~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      ||.+....... ......|+..|+|||.+.        +..++.++|+||+||++|+|++|..||..   ......+..+
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~~pE~~~--------~~~~~~~~Dv~slGvil~el~tg~~p~~~---~~~~~~~~~~  228 (292)
T cd06657         160 FGFCAQVSKEVPRRKSLVGTPYWMAPELIS--------RLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKMI  228 (292)
T ss_pred             cccceecccccccccccccCccccCHHHhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHH
Confidence            99987654332 233456899999999886        56678899999999999999999999973   3333333322


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ....+.                  .++....+++    .+.+++.+||..||.+||++.++           +.|+|+..
T Consensus       229 ~~~~~~------------------~~~~~~~~~~----~l~~li~~~l~~~P~~R~~~~~l-----------l~~~~~~~  275 (292)
T cd06657         229 RDNLPP------------------KLKNLHKVSP----SLKGFLDRLLVRDPAQRATAAEL-----------LKHPFLAK  275 (292)
T ss_pred             HhhCCc------------------ccCCcccCCH----HHHHHHHHHHhCCcccCcCHHHH-----------hcChHHhc
Confidence            221110                  1111122333    45669999999999999999997           66888766


Q ss_pred             ccc
Q psy15481        320 RLQ  322 (708)
Q Consensus       320 ~~~  322 (708)
                      ...
T Consensus       276 ~~~  278 (292)
T cd06657         276 AGP  278 (292)
T ss_pred             cCC
Confidence            543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-34  Score=313.65  Aligned_cols=281  Identities=23%  Similarity=0.317  Sum_probs=203.4

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC-----
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG-----   82 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~-----   82 (708)
                      ...+|.+.+.||.|+||.||+|.+..+|..||+|.+..... .......+|++++++++||||+++++++.....     
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            35789999999999999999999999999999999865443 333445689999999999999999987654332     


Q ss_pred             -------ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCce
Q psy15481         83 -------RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTI  155 (708)
Q Consensus        83 -------~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~  155 (708)
                             ...|+||||+. ++|.+++...    .+++..++.++.||+.||.|||+.|++||||||+||++  + .....
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili--~-~~~~~  153 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI--N-TEDLV  153 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--c-CCCce
Confidence                   24799999996 6999888643    28999999999999999999999999999999999997  2 13457


Q ss_pred             EEEeccCcccccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCC
Q psy15481        156 YKLTDFGAARELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR  231 (708)
Q Consensus       156 vKL~DFGlA~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~  231 (708)
                      ++|+|||.+........    .....++..|+|||.+..       +..++.++|||||||++|+|++|+.||.+   ..
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~~---~~  223 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAEMLTGKPLFAG---AH  223 (342)
T ss_pred             EEECCcccceecCCccccccccccccccccccCHHHHhC-------ccccCchhhHHHHHHHHHHHHhCCCCCCC---CC
Confidence            89999999976532211    122457889999998752       35678899999999999999999999973   33


Q ss_pred             hhhHHHHHHhcccCCcccccccCCCC-c-----ccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        232 NKETMYYITTKKASGVISGTQTSENG-E-----IDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       232 ~~e~~~~i~~~~~~~~i~~~~~~~~g-~-----~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                      ..+.+..+....+............. +     ..+....|. ..+.+.+...+.+++.+||..||.+|||+.++     
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el-----  297 (342)
T cd07854         224 ELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPL-RDLLPGVNPEALDFLEQILTFNPMDRLTAEEA-----  297 (342)
T ss_pred             HHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCH-HHHccCCCHHHHHHHHHHhCCCchhccCHHHH-----
Confidence            34444443332111000000000000 0     000001110 01112344556779999999999999999997     


Q ss_pred             HHHhhhhcCcccCC
Q psy15481        306 KTLNRKLVHLFHIN  319 (708)
Q Consensus       306 ~il~~~l~h~~~~~  319 (708)
                            +.|+|+..
T Consensus       298 ------l~h~~~~~  305 (342)
T cd07854         298 ------LMHPYMSC  305 (342)
T ss_pred             ------hCCCcccc
Confidence                  66898863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0596|consensus

Probab=100.00  E-value=1.8e-35  Score=320.54  Aligned_cols=269  Identities=25%  Similarity=0.341  Sum_probs=202.8

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEecc-CCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ-LSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~-~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .+..|++.+.||+||.+.||++...+. +.||+|.+.. .......+-+.+|+.+|.+| +|.+||+++++....  +.+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--~~l  435 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--GYL  435 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--ceE
Confidence            356899999999999999999987544 4566665543 22333345678999999999 799999999998763  469


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||- ..||..+|+.....  ++...++.+..|++.|++++|..||||.||||.|+|+     -.|.+||+|||.|.
T Consensus       436 YmvmE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-----VkG~LKLIDFGIA~  507 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-----VKGRLKLIDFGIAN  507 (677)
T ss_pred             EEEeecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-----EeeeEEeeeechhc
Confidence            9999997 58999999875532  5556899999999999999999999999999999996     34579999999999


Q ss_pred             ccccccc---ccccCCCCCcCChhhhhhhhhcCCCC---CcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        166 ELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVG---KTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       166 ~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~---~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      ....+..   ..+.+||+.||+||.+.........+   -..+.++||||||||||+|+-|+.||..+  .+....+..|
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aKl~aI  585 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAKLHAI  585 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHHHHhh
Confidence            8776643   24578999999999997443221111   12688999999999999999999999632  1222333333


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ...             +-.++|....+.         ..+.++++.||..||++||+..++           +.|||...
T Consensus       586 ~~P-------------~~~Iefp~~~~~---------~~li~~mK~CL~rdPkkR~si~eL-----------LqhpFl~~  632 (677)
T KOG0596|consen  586 TDP-------------NHEIEFPDIPEN---------DELIDVMKCCLARDPKKRWSIPEL-----------LQHPFLQI  632 (677)
T ss_pred             cCC-------------CccccccCCCCc---------hHHHHHHHHHHhcCcccCCCcHHH-----------hcCccccc
Confidence            321             112223221111         126789999999999999999997           77999876


Q ss_pred             ccc
Q psy15481        320 RLQ  322 (708)
Q Consensus       320 ~~~  322 (708)
                      .+-
T Consensus       633 ~~i  635 (677)
T KOG0596|consen  633 QPI  635 (677)
T ss_pred             ccc
Confidence            433

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.6e-34  Score=300.78  Aligned_cols=258  Identities=19%  Similarity=0.310  Sum_probs=186.5

Q ss_pred             eEeecCCceEEEEEEEc--CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccC
Q psy15481         16 SVLGKGATGAVFQGVNK--NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCT   93 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~--~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~   93 (708)
                      +.||+|+||.||+|.+.  .++..+|+|.++..........+.+|+.+++.++||||+++++.+.+..  ..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcEEEEECCC
Confidence            36899999999999764  3566899998875543333345678999999999999999999887654  4899999999


Q ss_pred             CCCHHHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc
Q psy15481         94 GGSLFNILDDPE--NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ  171 (708)
Q Consensus        94 ggsL~~~L~~~~--~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~  171 (708)
                      +|+|.+++....  .....++..++.++.|++.||.|||++|++|+||||+||++    +..+.++|+|||.+.......
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~----~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL----TADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE----cCCCcEEECCccccccccCcc
Confidence            999999986422  11235677888999999999999999999999999999998    566789999999997543322


Q ss_pred             cc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        172 QF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       172 ~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..   ....++..|+|||++.... .......++.++|+|||||++|+|++ |..||..   ..+.+...........  
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~---~~~~~~~~~~~~~~~~--  228 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVH-GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH---LSDEQVLTYTVREQQL--  228 (269)
T ss_pred             eeecCCCcCCcccccCHhHhcccc-ccccccCCCccchhHHHHHHHHHHHhCCCCCCCC---CChHHHHHHHhhcccC--
Confidence            11   2345788899999986211 00001246889999999999999996 9999964   2233322222211000  


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                                      .++.+ .+.......+.+++..|+ .||++|||++++...
T Consensus       229 ----------------~~~~~-~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~  266 (269)
T cd05087         229 ----------------KLPKP-RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLL  266 (269)
T ss_pred             ----------------CCCCC-ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHH
Confidence                            11111 111223344666889998 689999999998654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-34  Score=296.38  Aligned_cols=246  Identities=28%  Similarity=0.404  Sum_probs=192.1

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCC
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~gg   95 (708)
                      +.||+|+||.||++.+.. |+.||+|.+...........+.+|+.++++++||||+++++++....  ..++||||++|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEEcCCCC
Confidence            369999999999999877 99999998875443323445678999999999999999999987654  489999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccc--
Q psy15481         96 SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF--  173 (708)
Q Consensus        96 sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~--  173 (708)
                      +|.+++.....  .+++..+..++.+++.||.|||++|++||||||+||++    +..+.++|+|||.+.........  
T Consensus        78 ~l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili----~~~~~~~l~d~g~~~~~~~~~~~~~  151 (251)
T cd05041          78 SLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV----GENNVLKISDFGMSREEEGGIYTVS  151 (251)
T ss_pred             cHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE----cCCCcEEEeeccccccccCCcceec
Confidence            99999865432  38899999999999999999999999999999999998    66678999999999865422111  


Q ss_pred             -cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        174 -MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       174 -~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                       ....++..|+|||.+.        +..++.++|+|||||++|+|+| |..||..   .........+... .       
T Consensus       152 ~~~~~~~~~y~~PE~~~--------~~~~~~~~Di~slG~i~~~l~t~~~~p~~~---~~~~~~~~~~~~~-~-------  212 (251)
T cd05041         152 DGLKQIPIKWTAPEALN--------YGRYTSESDVWSYGILLWETFSLGDTPYPG---MSNQQTRERIESG-Y-------  212 (251)
T ss_pred             cccCcceeccCChHhhc--------cCCCCcchhHHHHHHHHHHHHhccCCCCcc---CCHHHHHHHHhcC-C-------
Confidence             1123456799999986        5678899999999999999999 8899863   2222222222210 0       


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                                  .++.    +..++..+.+++.+||..+|.+||++.+++..+.
T Consensus       213 ------------~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         213 ------------RMPA----PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ------------CCCC----CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                        1111    1223445777999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-35  Score=305.38  Aligned_cols=273  Identities=25%  Similarity=0.377  Sum_probs=201.3

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      |++.+.||.|++|.||+|.+..+|..||+|.+....... ......+|+.++++++||||+++++++.+.  ...|++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEEe
Confidence            567889999999999999999999999999987543222 234566899999999999999999998764  45999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+ +++|.+++..... ..+++..+..++.|++.||.|||++|++||||+|+||++    +..+.++|+|||.+......
T Consensus        79 ~~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~----~~~~~~~l~df~~~~~~~~~  152 (283)
T cd07835          79 FL-DLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI----DREGALKLADFGLARAFGVP  152 (283)
T ss_pred             cc-CcCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE----cCCCcEEEeecccccccCCC
Confidence            99 4789998866442 238999999999999999999999999999999999998    55678999999999765432


Q ss_pred             c-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC---C
Q psy15481        171 Q-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS---G  246 (708)
Q Consensus       171 ~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~---~  246 (708)
                      . ......++..|+|||.+..       +..++.++|+|||||++|+|++|.+||..   .+....+..+......   .
T Consensus       153 ~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~---~~~~~~~~~~~~~~~~~~~~  222 (283)
T cd07835         153 VRTYTHEVVTLWYRAPEILLG-------SRQYSTPVDIWSIGCIFAEMVNRRPLFPG---DSEIDQLFRIFRTLGTPDED  222 (283)
T ss_pred             ccccCccccccCCCCCceeec-------CcccCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHhCCCChH
Confidence            2 2233457889999998752       34578899999999999999999999973   3333333333321000   0


Q ss_pred             cccccccCCCCcccccCCCC-----CcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        247 VISGTQTSENGEIDWCTDLP-----NNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp-----~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .........    .+...++     ......+..+..+.+++.+||..||.+||++.++           +.|+|+
T Consensus       223 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i-----------l~~~~~  283 (283)
T cd07835         223 VWPGVTSLP----DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA-----------LQHPYF  283 (283)
T ss_pred             Hhhhhhhch----hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHH-----------hcCCCC
Confidence            000000000    0000111     1111123344567779999999999999999997           567775

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=299.64  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=191.6

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHH-HhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVL-KKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL-~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +.||+|+||.||+|.+..+|+.||+|.+.......  .......|..++ ...+||||+++++++...+  .+|+||||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD--YLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC--eEEEEEecc
Confidence            56899999999999999999999999986543211  111223444443 4458999999999987644  599999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ  172 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~  172 (708)
                      +|++|.+++.....   +++..+..++.|++.||.|||+.|++||||+|+||++    +..+.++|+|||.+......  
T Consensus        80 ~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~----~~~~~~~l~dfg~~~~~~~~--  150 (260)
T cd05611          80 NGGDCASLIKTLGG---LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI----DQTGHLKLTDFGLSRNGLEN--  150 (260)
T ss_pred             CCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCcEEEeecccceecccc--
Confidence            99999999976433   8999999999999999999999999999999999998    56678999999998754332  


Q ss_pred             ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccc
Q psy15481        173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ  252 (708)
Q Consensus       173 ~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~  252 (708)
                       ....|+..|+|||.+.        +..++.++|+||+|+++|+|++|..||.+   .+.......+...          
T Consensus       151 -~~~~~~~~y~~pe~~~--------~~~~~~~~Dv~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~----------  208 (260)
T cd05611         151 -KKFVGTPDYLAPETIL--------GVGDDKMSDWWSLGCVIFEFLFGYPPFHA---ETPDAVFDNILSR----------  208 (260)
T ss_pred             -ccCCCCcCccChhhhc--------CCCCcchhhhHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHhc----------
Confidence             2346889999999987        45588999999999999999999999973   3333333333221          


Q ss_pred             cCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        253 TSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       253 ~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                           ...|...      ....++..+.+++.+||..||++||++.++.+        .+.|||+..
T Consensus       209 -----~~~~~~~------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~--------~l~~~~~~~  256 (260)
T cd05611         209 -----RINWPEE------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQE--------IKSHPFFKS  256 (260)
T ss_pred             -----ccCCCCc------ccccCCHHHHHHHHHHccCCHHHccCCCcHHH--------HHcChHhhc
Confidence                 1111111      11233455677999999999999998764322        267888854

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.8e-34  Score=301.57  Aligned_cols=251  Identities=22%  Similarity=0.397  Sum_probs=190.1

Q ss_pred             EeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHH---HHHHhCCCCCccceeEEEEecCCceEEEEEec
Q psy15481         17 VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREF---EVLKKVKHENIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        17 ~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei---~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      .||+|+||.||++.+..+|+.||+|.+........  ......|.   ..++...||||+.+++.+...+  .+|+||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--EEEEEEec
Confidence            48999999999999999999999999875432211  11223333   3444568999999999987654  59999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ  171 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~  171 (708)
                      +.|++|..++....   .+++..++.++.|++.||.|||++|++||||||+||++    +.++.++|+|||++.......
T Consensus        79 ~~g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili----~~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          79 MNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL----DEHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE----CCCCCEEEccCcCccccCccC
Confidence            99999999886543   38999999999999999999999999999999999998    666789999999987654322


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccccc
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT  251 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~  251 (708)
                       .....|+..|+|||.+..       +..++.++|+||+||++|+|++|..||..............+...         
T Consensus       152 -~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  214 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------  214 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcC-------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc---------
Confidence             234579999999999863       345889999999999999999999999753222222211111100         


Q ss_pred             ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       252 ~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                ...+|.      ..+..+.+++.+||..||.+||     ++.++           +.|||+...
T Consensus       215 ----------~~~~~~------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~l-----------l~~~~~~~~  261 (278)
T cd05606         215 ----------AVELPD------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV-----------KEHPFFRSL  261 (278)
T ss_pred             ----------CCCCCC------cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHH-----------HhCccccCC
Confidence                      001121      2234566699999999999999     88886           458888553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-34  Score=293.40  Aligned_cols=246  Identities=26%  Similarity=0.440  Sum_probs=199.3

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|.+.+.||+|++|.||++.+..+|+.|++|.+...... ...+.+.+|++++++++|||++++++++.+.  +..+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEE
Confidence            478899999999999999999999999999999765322 2334567999999999999999999998764  4599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||++|++||||+|+||++    +..+.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i----~~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627          79 EYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT----TKDGVVKLADFGVATKLND  151 (254)
T ss_pred             ecCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE----CCCCCEEEeccccceecCC
Confidence            9999999999987643   38999999999999999999999999999999999998    5567899999999987654


Q ss_pred             ccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      ... .....++..|+|||.+.        +..++.++|+||+|+++|+|++|..||..   ......+..+....     
T Consensus       152 ~~~~~~~~~~~~~y~~pe~~~--------~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~---~~~~~~~~~~~~~~-----  215 (254)
T cd06627         152 VSKDDASVVGTPYWMAPEVIE--------MSGASTASDIWSLGCTVIELLTGNPPYYD---LNPMAALFRIVQDD-----  215 (254)
T ss_pred             CcccccccccchhhcCHhhhc--------CCCCCcchhHHHHHHHHHHHHhCCCCCCC---ccHHHHHHHHhccC-----
Confidence            432 23456899999999886        45578999999999999999999999974   23333333333210     


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                     . +   .++......+.+++.+||..||++||++.++
T Consensus       216 ---------------~-~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~  248 (254)
T cd06627         216 ---------------H-P---PLPEGISPELKDFLMQCFQKDPNLRPTAKQL  248 (254)
T ss_pred             ---------------C-C---CCCCCCCHHHHHHHHHHHhCChhhCcCHHHH
Confidence                           0 0   1222334556679999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.1e-34  Score=295.77  Aligned_cols=248  Identities=23%  Similarity=0.409  Sum_probs=199.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|.+.+.||.|++|.||++.+..+|+.||+|.+...... .......+|+.+++.++||||+++++++.+.  ...|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence            478899999999999999999999999999998754322 2233456899999999999999999998764  4699999


Q ss_pred             eccCCCCHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         90 ELCTGGSLFNILDDPEN-TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~-~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||+++++|..++..... ...+++..+..++.+++.||.|||++|++|+||+|+||++    +..+.++|+|||.+....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~----~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL----VANDLVKIGDLGISKVLK  154 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE----ecCCcEEEeeccchhhhc
Confidence            99999999998865211 1238999999999999999999999999999999999998    456679999999998765


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .. ......++..|+|||.+.        +..++.++|+||||+++|++++|..||..   .+..+....+...      
T Consensus       155 ~~-~~~~~~~~~~~~~Pe~~~--------~~~~~~~~D~~slG~~~~~l~~g~~p~~~---~~~~~~~~~~~~~------  216 (256)
T cd08530         155 KN-MAKTQIGTPHYMAPEVWK--------GRPYSYKSDIWSLGCLLYEMATFAPPFEA---RSMQDLRYKVQRG------  216 (256)
T ss_pred             cC-CcccccCCccccCHHHHC--------CCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcC------
Confidence            54 333456899999999986        56788899999999999999999999974   3333333333221      


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                     ..+   .++......+.+++.+||..||.+||++.++
T Consensus       217 ---------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~  250 (256)
T cd08530         217 ---------------KYP---PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI  250 (256)
T ss_pred             ---------------CCC---CCchhhCHHHHHHHHHHcCCCcccCCCHHHH
Confidence                           111   1223445567789999999999999999997

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.9e-34  Score=295.73  Aligned_cols=251  Identities=24%  Similarity=0.356  Sum_probs=196.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||++.+. .+..||+|.+....  ...+.+.+|+.++++++|+||+++++++..   ...+++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v   78 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYII   78 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEE
Confidence            457999999999999999999864 45679999876432  224456789999999999999999999865   348999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||+++++|.+++..... ..++...+..++.+++.||.|||+.|++|+||||+||++    +..+.++|+|||.+....
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i----~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV----SASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEeCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE----cCCCcEEECCCcceeecc
Confidence            999999999999976432 237889999999999999999999999999999999998    667789999999997654


Q ss_pred             ccccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .....  ....++..|+|||.+.        +..++.++|+|||||++|+++| |.+||..   .+.......+....  
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Di~slG~~l~~l~t~g~~p~~~---~~~~~~~~~~~~~~--  220 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAIN--------FGSFTIKSDVWSFGILLMEIVTYGRIPYPG---MSNPEVIRALERGY--  220 (260)
T ss_pred             CCCcccccCCcccccccCHhHhc--------cCCcCccccchHHHHHHHHHHhcCCCCCCC---CCHHHHHHHHhCCC--
Confidence            33211  1234567799999986        5668899999999999999999 9999973   44444443333210  


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                                        .++..    ...+..+.+++.+||..||++||+++++.+.|+
T Consensus       221 ------------------~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         221 ------------------RMPRP----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             ------------------CCCCc----ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence                              11111    223345667999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3e-34  Score=305.41  Aligned_cols=262  Identities=24%  Similarity=0.360  Sum_probs=203.8

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      ......|.+.+.||+|+||.||+|.+..+|+.||+|.+........  ...+.+|+.+++.++||||+++++++.+.+  
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~--   88 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH--   88 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC--
Confidence            4556679999999999999999999999999999999865432222  234568999999999999999999998654  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||+. |+|.+.+.....  .+++..+..++.|++.||.|||++|++||||+|+||++    +..+.++|+|||+
T Consensus        89 ~~~lv~e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~----~~~~~~kL~dfg~  161 (307)
T cd06607          89 TAWLVMEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL----TEPGTVKLADFGS  161 (307)
T ss_pred             eEEEEHHhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE----CCCCCEEEeecCc
Confidence            4899999996 677776654322  38999999999999999999999999999999999998    6667899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      +......   ....++..|+|||++...     ....++.++||||||+++|+|+||..||..   .+.......+....
T Consensus       162 ~~~~~~~---~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~s~G~il~el~tg~~p~~~---~~~~~~~~~~~~~~  230 (307)
T cd06607         162 ASLVSPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFN---MNAMSALYHIAQND  230 (307)
T ss_pred             ceecCCC---CCccCCccccCceeeecc-----CCCCCCcccchHHHHHHHHHHHcCCCCCCC---ccHHHHHHHHhcCC
Confidence            8754433   235688899999987421     135578899999999999999999999963   33333333332211


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                      .                     |..  .....+..+.+++.+||..||++||++.++           +.|+|+....
T Consensus       231 ~---------------------~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i-----------l~~~~~~~~~  274 (307)
T cd06607         231 S---------------------PTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEEL-----------LKHRFVLRER  274 (307)
T ss_pred             C---------------------CCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHH-----------hcChhhcccC
Confidence            0                     110  012234557789999999999999999997           5688887653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.2e-34  Score=304.32  Aligned_cols=274  Identities=21%  Similarity=0.301  Sum_probs=196.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecC-------
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQE-------   81 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~-------   81 (708)
                      ..|.+.+.||.|+||.||+|.++.+|+.||+|.++..... .......+|+.++++++||||+++++++.+..       
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            4688899999999999999999999999999998754322 22234568999999999999999999886543       


Q ss_pred             -CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         82 -GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        82 -~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                       ...+++|+||+++ ++...+....  ..+++..+..++.|++.||.|||++||+|+||||+||++    +..+.+||+|
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili----~~~~~~kl~d  159 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL----NNKGQIKLAD  159 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCcEEeCc
Confidence             2368999999975 7777776542  238999999999999999999999999999999999998    6777899999


Q ss_pred             cCccccccccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHH
Q psy15481        161 FGAARELEEDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       161 FGlA~~~~~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~  238 (708)
                      ||.+.......  ......++..|+|||.+..       ...++.++|||||||++|+|++|++||..   .+..+.+..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~~~el~~g~~~~~~---~~~~~~~~~  229 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLG-------EERYGPAIDVWSCGCILGELFTKKPIFQA---NQELAQLEL  229 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCC---CChHHHHHH
Confidence            99998654432  1223456788999998852       34568899999999999999999999974   333333333


Q ss_pred             HHh---cccCCcccccccCC-CCcccccCCC-CCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        239 ITT---KKASGVISGTQTSE-NGEIDWCTDL-PNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       239 i~~---~~~~~~i~~~~~~~-~g~~~~~~~l-p~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      +..   ...+.......... .......... .........++..+.+++..||..||.+||++.++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  296 (302)
T cd07864         230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA  296 (302)
T ss_pred             HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            322   11111100000000 0000000000 00000011234456779999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-34  Score=298.52  Aligned_cols=278  Identities=23%  Similarity=0.288  Sum_probs=203.9

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhC---CCCCccceeEEEEecCC---ce
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKV---KHENIVKLLAIEEEQEG---RG   84 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL---~HpNIVkl~~v~~~~~~---~~   84 (708)
                      |.+.+.||+|+||.||+|.++.+|+.||+|.+....... ......+|+.+++++   +||||+++++++...+.   ..
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999999899999999987433221 123345677777666   69999999999876442   34


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      ++++|||+. ++|.+++..... ..+++..++.++.|++.||.|||++|++|+||+|+||++    +..+.++|+|||.+
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili----~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV----TSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE----ccCCCEEEeccCcc
Confidence            899999996 589888865332 248999999999999999999999999999999999998    66678999999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .............++..|+|||.+.        +..++.++|+|||||++|+|++|.+||..   ....+...++.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~~~~Di~s~G~~l~~l~~~~~~~~~---~~~~~~~~~~~~~~~  223 (287)
T cd07838         155 RIYSFEMALTSVVVTLWYRAPEVLL--------QSSYATPVDMWSVGCIFAELFRRRPLFRG---TSEADQLDKIFDVIG  223 (287)
T ss_pred             eeccCCcccccccccccccChHHhc--------cCCCCCcchhhhHHHHHHHHHhCCCcccC---CChHHHHHHHHHHcC
Confidence            8776555445566889999999987        56688999999999999999999999973   444555555443211


Q ss_pred             C-CcccccccCCCCcccccCCC-CCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        245 S-GVISGTQTSENGEIDWCTDL-PNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       245 ~-~~i~~~~~~~~g~~~~~~~l-p~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      . ...............+.... +......+.....+.+++.+||..||.+||++.++           +.|||+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~i-----------l~~~~~  287 (287)
T cd07838         224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA-----------LQHPYF  287 (287)
T ss_pred             CCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHH-----------hcCcCC
Confidence            0 00000000000000000000 00111223455667889999999999999999997           568875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2e-34  Score=296.73  Aligned_cols=250  Identities=27%  Similarity=0.444  Sum_probs=195.9

Q ss_pred             eecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCC
Q psy15481         18 LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        18 LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~gg   95 (708)
                      ||.|+||.||++.+..+|+.|++|.+......  .......+|+.++++++||||+++++.+...  +..|++|||++|+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC--cEEEEEEecCCCC
Confidence            68999999999999999999999998654321  2344567899999999999999999988654  4599999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc----
Q psy15481         96 SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ----  171 (708)
Q Consensus        96 sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~----  171 (708)
                      +|.+++....   .+++..+..++.||+.||.|||++|++|+||+|+||++    +..+.++|+|||++.......    
T Consensus        79 ~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~----~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          79 DLASLLENVG---SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI----DSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE----cCCCCEEEEecccchhcccCccccc
Confidence            9999997644   38999999999999999999999999999999999998    666789999999987643331    


Q ss_pred             -----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        172 -----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       172 -----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                           ......++..|+|||...        +..++.++|+||||+++|++++|..||..   ....+....+...    
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~--------~~~~~~~~Dv~slG~~~~~l~~g~~p~~~---~~~~~~~~~~~~~----  216 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVIL--------GQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNILNG----  216 (265)
T ss_pred             ccccccccCcccCccccCHHHhc--------CCCCCcchhhHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcC----
Confidence                 123356888999999987        45578899999999999999999999973   3333333333221    


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                                 ..    ..|..+.+    +..+.+++.+||..||.+||++..+.+        .+.|||+.
T Consensus       217 -----------~~----~~~~~~~~----~~~~~~~i~~~l~~~p~~Rpt~~~~~~--------~l~~~~~~  261 (265)
T cd05579         217 -----------KI----EWPEDVEV----SDEAIDLISKLLVPDPEKRLGAKSIEE--------IKNHPFFK  261 (265)
T ss_pred             -----------Cc----CCCccccC----CHHHHHHHHHHhcCCHhhcCCCccHHH--------HhcCcccc
Confidence                       01    11222222    345567999999999999999943221        26789885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-34  Score=300.50  Aligned_cols=261  Identities=27%  Similarity=0.376  Sum_probs=200.8

Q ss_pred             ceEEEeeEeecCCceEEEEEEEc----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNK----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ..|.+.+.||+|+||.||++...    .++..||+|.+...........+.+|+.++++++||||+++++++...+....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45778899999999999999864    35889999998754332234556799999999999999999999887666679


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ++||||+++++|.+++.....  .+++..+..++.|++.||.|||++|++|+||||+||++    +..+.++|+|||.+.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~----~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV----ESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE----cCCCCEEEccccccc
Confidence            999999999999999976442  38999999999999999999999999999999999998    666789999999998


Q ss_pred             cccccccc----cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCC----------
Q psy15481        166 ELEEDQQF----MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR----------  231 (708)
Q Consensus       166 ~~~~~~~~----~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~----------  231 (708)
                      ........    ....++..|+|||.+.        +..++.++|+|||||++|+|+||..||.......          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~--------~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  229 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLR--------TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ  229 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHc--------cCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence            76533221    1123456799999886        5678899999999999999999999986421110          


Q ss_pred             -hhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        232 -NKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       232 -~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                       ....+......                   ....+.    +...+..+.+++.+||..||.+||++.++...+..+
T Consensus       230 ~~~~~~~~~~~~-------------------~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         230 MIVTRLLELLKE-------------------GERLPR----PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ccHHHHHHHHHc-------------------CCcCCC----CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence             01111111110                   001111    122335577799999999999999999998877654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0194|consensus

Probab=100.00  E-value=6.7e-35  Score=322.17  Aligned_cols=257  Identities=25%  Similarity=0.346  Sum_probs=206.9

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCc---e-EEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGE---P-VAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~---~-VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .+.++||+|+||.||+|.-+..+.   . ||+|..+...  .......+++|.++++.++|||||+++|+......  ++
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P--l~  237 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP--LM  237 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc--cE
Confidence            345899999999999998875422   3 8999987422  22234456899999999999999999999887665  99


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|||+|+||+|.++|+....  .++..+...++.+.+.||+|||+++++||||-..|+|+    +...++||+|||+++.
T Consensus       238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~----~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY----SKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee----cCCCeEEeCccccccC
Confidence            99999999999999988654  39999999999999999999999999999999999998    6666799999999986


Q ss_pred             cccccccc-ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        167 LEEDQQFM-SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       167 ~~~~~~~~-~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ...-.... ...-...|+|||.+.        ...|+.++|||||||++||+.+ |..||.   |..+.+...+|.....
T Consensus       312 ~~~~~~~~~~~klPirWLAPEtl~--------~~~~s~kTDV~sfGV~~~Eif~~g~~Py~---g~~~~~v~~kI~~~~~  380 (474)
T KOG0194|consen  312 GSQYVMKKFLKKLPIRWLAPETLN--------TGIFSFKTDVWSFGVLLWEIFENGAEPYP---GMKNYEVKAKIVKNGY  380 (474)
T ss_pred             CcceeeccccccCcceecChhhhc--------cCccccccchhheeeeEEeeeccCCCCCC---CCCHHHHHHHHHhcCc
Confidence            54211111 123567899999998        5689999999999999999999 888887   5777777777754321


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      +                 ..      .+...+..+..++..|+..||+.||++.++...+..+....
T Consensus       381 r-----------------~~------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  381 R-----------------MP------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             c-----------------CC------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence            1                 12      22244566777889999999999999999988877765543

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.8e-34  Score=295.23  Aligned_cols=245  Identities=28%  Similarity=0.404  Sum_probs=193.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||++.  .+++.||+|.+....   ..+.+.+|+.++++++||||+++++++...   ..++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcEEEE
Confidence            468999999999999999985  468899999986432   245567899999999999999999987643   379999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++|++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||++    +..+.++|+|||.+.....
T Consensus        78 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili----~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          78 ELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV----SEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             ECCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE----cCCCcEEECCCccceeccc
Confidence            99999999999976432 238999999999999999999999999999999999998    6667899999999976433


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .  ......+..|+|||.+.        +..++.++|+|||||++|+|++ |.+||..   .+..+....+...      
T Consensus       153 ~--~~~~~~~~~y~~pe~~~--------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~---~~~~~~~~~~~~~------  213 (254)
T cd05083         153 G--VDNSKLPVKWTAPEALK--------HKKFSSKSDVWSYGVLLWEVFSYGRAPYPK---MSLKEVKECVEKG------  213 (254)
T ss_pred             c--CCCCCCCceecCHHHhc--------cCCcCchhhHHHHHHHHHHHHhCCCCCCcc---CCHHHHHHHHhCC------
Confidence            2  22334567899999886        5678899999999999999998 9999973   3333333222210      


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                                  +  ..+.    +...+..+.+++.+||..+|.+||++++++..+
T Consensus       214 ------------~--~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l  251 (254)
T cd05083         214 ------------Y--RMEP----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKL  251 (254)
T ss_pred             ------------C--CCCC----CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                        0  0111    112334566799999999999999999987754

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.5e-34  Score=298.72  Aligned_cols=256  Identities=23%  Similarity=0.380  Sum_probs=197.8

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcC-----CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ..|.+...||+|+||.||+|+++.     +.+.|++|.+.........+.+.+|+.++++++||||+++++++.+.+  .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE--P   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC--c
Confidence            467889999999999999999764     356799998765433223455678999999999999999999886644  4


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEE
Q psy15481         85 KVIVMELCTGGSLFNILDDPENT------YGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKL  158 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~------~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL  158 (708)
                      .|+||||+++|+|.+++......      ..+++..+..++.|++.||.|||++||+||||||+||++    +..+.++|
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili----~~~~~~~l  158 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV----SSQREVKV  158 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE----eCCCcEEE
Confidence            89999999999999998754311      148999999999999999999999999999999999998    55667999


Q ss_pred             eccCccccccccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhH
Q psy15481        159 TDFGAARELEEDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKET  235 (708)
Q Consensus       159 ~DFGlA~~~~~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~  235 (708)
                      +|||++.......  ......++..|+|||.+.        +..++.++|||||||++|++++ |..||..   ......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Di~slG~~l~~l~~~~~~p~~~---~~~~~~  227 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ--------EDDFSTKSDVWSFGVLMWEVFTQGELPFYG---LSDEEV  227 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCccc---cchHHH
Confidence            9999987543221  223345677899999886        4567889999999999999999 8899963   333343


Q ss_pred             HHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        236 MYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       236 ~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                      +..+...               ...|.    .    +..++..+.+++.+||..||.+||++.++++.+.
T Consensus       228 ~~~~~~~---------------~~~~~----~----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         228 LNRLQAG---------------KLELP----V----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHHHcC---------------CcCCC----C----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            3333321               11111    1    1123345777999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-34  Score=309.85  Aligned_cols=282  Identities=24%  Similarity=0.397  Sum_probs=209.0

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecC---CceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE---GRGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~---~~~~~   86 (708)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++||||+++++++....   .+..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            58899999999999999999999999999999875432 223345678999999999999999999987653   23589


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||+|++ ++|.+++....   .+++..++.++.+|+.||.|||++|++||||||+|||+    +..+.++|+|||.+..
T Consensus        81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili----~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV----NSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEcccCceEe
Confidence            9999996 68999887644   39999999999999999999999999999999999998    6667899999999987


Q ss_pred             ccccc----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        167 LEEDQ----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       167 ~~~~~----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .....    ......++..|+|||.+..       ...++.++|+|||||++|+|++|.+||..   ....+.+..+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~il~~l~~g~~pf~~---~~~~~~~~~i~~~  222 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLS-------SSRYTKAIDIWSVGCIFAELLTRKPLFPG---RDYIDQLNLIVEV  222 (330)
T ss_pred             ecccccccccccccccccCcCCceeeec-------ccCCCcchhHHHHHHHHHHHHcCCCCcCC---CCHHHHHHHHHHh
Confidence            65543    2334568899999999872       22788999999999999999999999973   4444444443331


Q ss_pred             ccCCcccccc-cCCCCcccccCCCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcc
Q psy15481        243 KASGVISGTQ-TSENGEIDWCTDLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLF  316 (708)
Q Consensus       243 ~~~~~i~~~~-~~~~g~~~~~~~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~  316 (708)
                      .......... ........+....+..     ..+.+.++..+.+++.+||.+||.+||+++++           +.|||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l-----------l~~~~  291 (330)
T cd07834         223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA-----------LAHPY  291 (330)
T ss_pred             cCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH-----------HhCcc
Confidence            1100000000 0000001111111111     11122345567789999999999999999997           56888


Q ss_pred             cCCcc
Q psy15481        317 HINRL  321 (708)
Q Consensus       317 ~~~~~  321 (708)
                      +....
T Consensus       292 ~~~~~  296 (330)
T cd07834         292 LAQLH  296 (330)
T ss_pred             HHhhc
Confidence            86543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4e-34  Score=300.59  Aligned_cols=262  Identities=27%  Similarity=0.439  Sum_probs=207.9

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      +.....|.....||+|++|.||+|.+..++..|++|++.....  ....+.+|+++++.++||||+++++.+...+  ..
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~   90 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGD--EL   90 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC--EE
Confidence            4455678888999999999999999998999999999875432  3445678999999999999999999987754  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|+||++|++|.+++....  ..++...+..++.+++.||.|||+.|++|+||+|+||++    +..+.++|+|||.+.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i----~~~~~~~l~d~~~~~  164 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL----SKDGSVKLADFGFAA  164 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE----cCCCCEEECccchhh
Confidence            99999999999999998754  238999999999999999999999999999999999998    666679999999987


Q ss_pred             cccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ...... ......++..|+|||.+.        +..++.++|+|||||++|+|++|..||..   .++...+..+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Dv~slGvil~~l~~g~~p~~~---~~~~~~~~~~~~~~~  233 (286)
T cd06614         165 QLTKEKSKRNSVVGTPYWMAPEVIK--------RKDYGPKVDIWSLGIMCIEMAEGEPPYLR---EPPLRALFLITTKGI  233 (286)
T ss_pred             hhccchhhhccccCCcccCCHhHhc--------CCCCCCccccHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcCC
Confidence            654332 223345788999999886        56688999999999999999999999973   333333333332110


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                      .                  .++..    ..++..+.+++..||..||.+||++.++           +.|+|+....
T Consensus       234 ~------------------~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~i-----------l~~~~~~~~~  277 (286)
T cd06614         234 P------------------PLKNP----EKWSPEFKDFLNKCLVKDPEKRPSAEEL-----------LQHPFLKKAC  277 (286)
T ss_pred             C------------------CCcch----hhCCHHHHHHHHHHhccChhhCcCHHHH-----------hhChHhhccC
Confidence            0                  11111    1133456679999999999999999997           5578776643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0671|consensus

Probab=100.00  E-value=1.3e-35  Score=310.86  Aligned_cols=284  Identities=25%  Similarity=0.328  Sum_probs=222.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC--CC----CccceeEEEEecCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK--HE----NIVKLLAIEEEQEG   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~--Hp----NIVkl~~v~~~~~~   82 (708)
                      ..+|.+.+.+|+|.||.|..+.+..++..||+|+++..  ....+..+-|++++.++.  -|    -+|++.++|...+ 
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg-  164 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG-  164 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC-
Confidence            56899999999999999999999999999999999754  333455668999999993  23    3678888887755 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecC-----------
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDD-----------  151 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d-----------  151 (708)
                       +.|||+|.+ |-|+++++..... -++|...++.+..|++.+++|||+++++|.|+||+|||+ +..+           
T Consensus       165 -hiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILf-vss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  165 -HICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILF-VSSEYFKTYNPKKKV  240 (415)
T ss_pred             -ceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEE-eccceEEEeccCCcc
Confidence             499999999 7899999987443 349999999999999999999999999999999999996 2221           


Q ss_pred             ------CCceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCC
Q psy15481        152 ------GSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR  225 (708)
Q Consensus       152 ------~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~  225 (708)
                            ....++++|||.|+.....  ....+.|..|+|||++.        +-.++.++||||+||||+|+.||...|.
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViL--------gLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVIL--------GLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchhee--------ccCcCCccCceeeeeEEEEeeccceecc
Confidence                  1346899999999875443  36778999999999998        7889999999999999999999999999


Q ss_pred             CCCCCChhhHHHHHHhcccCCccccc---ccCCCCcccccCC-----------CCCcc----cCChhHHHHHHHHHHhhc
Q psy15481        226 PYGGRRNKETMYYITTKKASGVISGT---QTSENGEIDWCTD-----------LPNNC----QLSLGLKKLVTPILAGLL  287 (708)
Q Consensus       226 ~~~g~~~~e~~~~i~~~~~~~~i~~~---~~~~~g~~~~~~~-----------lp~~~----~ls~~l~~~l~~LL~~mL  287 (708)
                      ..+.......|.+|.+..+...+...   ..-..|.+.|...           .+.+.    .-.+.....+.+||++||
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            76655556688888876555544333   1112234555322           11110    011233445789999999


Q ss_pred             ccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        288 EVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       288 ~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      .+||.+|+|+.+.           +.||||...
T Consensus       391 ~fDP~~RiTl~EA-----------L~HpFF~~~  412 (415)
T KOG0671|consen  391 EFDPARRITLREA-----------LSHPFFARL  412 (415)
T ss_pred             ccCccccccHHHH-----------hcCHHhhcC
Confidence            9999999999985           789999654

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.5e-34  Score=295.04  Aligned_cols=242  Identities=20%  Similarity=0.296  Sum_probs=185.7

Q ss_pred             eEeecCCceEEEEEEEcCCC----------ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         16 SVLGKGATGAVFQGVNKNNG----------EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg----------~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      +.||+|+||.||+|.+..++          ..|++|.+......  ...+.+|+.++++++||||+++++++.. .  ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-D--EN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-C--Cc
Confidence            36899999999999998777          35788876543322  4566789999999999999999998876 3  37


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC-----CceEEEec
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG-----STIYKLTD  160 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~-----~~~vKL~D  160 (708)
                      ++||||+++|+|.+++.....  .++...+..++.||+.||.|||++||+||||||+|||+  +.++     ...++|+|
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill--~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILV--ARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEE--ecCccccCCceeEEeCC
Confidence            999999999999999976443  38999999999999999999999999999999999997  2222     22799999


Q ss_pred             cCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHH
Q psy15481        161 FGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       161 FGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i  239 (708)
                      ||++......   ....++..|+|||.+...      ...++.++|||||||++|++++ |..||....   ..+.....
T Consensus       152 fg~a~~~~~~---~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~---~~~~~~~~  219 (259)
T cd05037         152 PGIPITVLSR---EERVERIPWIAPECIRNG------QASLTIAADKWSFGTTLLEICSNGEEPLSTLS---SSEKERFY  219 (259)
T ss_pred             CCcccccccc---cccccCCCccChhhhcCC------CCCcchhhHHHHHHHHHHHHHhCCCCCcccCC---chhHHHHH
Confidence            9999865442   234577889999998621      1368899999999999999999 688886422   11111111


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      ..                    ....|...      ...+.+++.+||..||.+||++.+++..+
T Consensus       220 ~~--------------------~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         220 QD--------------------QHRLPMPD------CAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             hc--------------------CCCCCCCC------chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            10                    00111111      14677899999999999999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=299.68  Aligned_cols=272  Identities=26%  Similarity=0.387  Sum_probs=203.8

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      |.+.+.||+|++|.||+|.+..+|+.||+|.+..... .........|+.++++++||||+++++++.+.+  ..++|||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER--KLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC--ceEEEec
Confidence            5677899999999999999999999999999976542 222345568999999999999999999987654  5999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |++ ++|.+++....  ..+++..+..++.+++.||.|||++|++||||+|+||++    +..+.++|+|||.+......
T Consensus        79 ~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~----~~~~~~~l~d~g~~~~~~~~  151 (282)
T cd07829          79 YCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI----NRDGVLKLADFGLARAFGIP  151 (282)
T ss_pred             CcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE----cCCCCEEEecCCcccccCCC
Confidence            996 69999997652  238999999999999999999999999999999999998    66778999999999865443


Q ss_pred             c-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc---CC
Q psy15481        171 Q-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA---SG  246 (708)
Q Consensus       171 ~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~---~~  246 (708)
                      . ......++..|+|||.+..       ...++.++|+|||||++|++++|.+||..   ....+.+..+.....   ..
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  221 (282)
T cd07829         152 LRTYTHEVVTLWYRAPEILLG-------SKHYSTAVDIWSVGCIFAEMITGKPLFPG---DSEIDQLFKIFQILGTPTEE  221 (282)
T ss_pred             ccccCccccCcCcCChHHhcC-------CcCCCccccHHHHHHHHHHHHhCCCCCCC---ccHHHHHHHHHHHhCCCcHH
Confidence            2 2334556788999999862       33788999999999999999999999973   444444443332110   00


Q ss_pred             cccccccCCCCcccccCCCCCcc-----cCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNC-----QLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~-----~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .........    .|...++...     ...+.....+.+++.+||..||++||++.++           +.|||+
T Consensus       222 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~-----------l~~p~~  282 (282)
T cd07829         222 SWPGVTKLP----DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA-----------LKHPYF  282 (282)
T ss_pred             HHHhhcccc----cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH-----------hhCcCC
Confidence            000000000    0111111111     1112235567889999999999999999997           668885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.2e-33  Score=291.31  Aligned_cols=248  Identities=22%  Similarity=0.357  Sum_probs=194.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|.+.+.||+|+||.||++.+. ++..+|+|.+.....  ..+.+.+|++++++++||||+++++++....  ..++|||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e   79 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS--PICLVFE   79 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC--ceEEEEE
Confidence            6788999999999999999875 477899998864322  2345678999999999999999999987654  4899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |++|++|.+++.....  .+++..+..++.+++.|+.|||+.|++|+||||+||++    +..+.++|+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i----~~~~~~~l~d~g~~~~~~~~  153 (256)
T cd05112          80 FMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV----GENQVVKVSDFGMTRFVLDD  153 (256)
T ss_pred             cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE----cCCCeEEECCCcceeecccC
Confidence            9999999999875432  27899999999999999999999999999999999998    66678999999998765433


Q ss_pred             cc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        171 QQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       171 ~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..  .....++..|+|||.+.        +..++.++|+|||||++|+|++ |..||..   .........+...     
T Consensus       154 ~~~~~~~~~~~~~~~aPe~~~--------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~---~~~~~~~~~~~~~-----  217 (256)
T cd05112         154 QYTSSTGTKFPVKWSSPEVFS--------FSKYSSKSDVWSFGVLMWEVFSEGKTPYEN---RSNSEVVETINAG-----  217 (256)
T ss_pred             cccccCCCccchhhcCHhHhc--------cCCcChHHHHHHHHHHHHHHHcCCCCCCCc---CCHHHHHHHHhCC-----
Confidence            21  11233567899999886        5678889999999999999998 9999963   3333333332211     


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                                   +....|.  .    .+..+.+++.+||..||++||++.+++..+
T Consensus       218 -------------~~~~~~~--~----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         218 -------------FRLYKPR--L----ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -------------CCCCCCC--C----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                         0001111  1    234577799999999999999999987653

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.3e-34  Score=298.64  Aligned_cols=241  Identities=21%  Similarity=0.366  Sum_probs=183.8

Q ss_pred             eecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEeccCCCC
Q psy15481         18 LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELCTGGS   96 (708)
Q Consensus        18 LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggs   96 (708)
                      ||+|+||.||++.++.+|..+|+|.+.......      .|+.....+ +||||+++++.+...+  ..|+||||++|++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~--~~~iv~e~~~~~~   95 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLK--GHVLIMDYIKDGD   95 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCC--eeEEEEEcCCCCc
Confidence            599999999999999999999999986532211      123222223 7999999999997755  5999999999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCc-eEEEeccCccccccccccccc
Q psy15481         97 LFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMS  175 (708)
Q Consensus        97 L~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~-~vKL~DFGlA~~~~~~~~~~~  175 (708)
                      |.+++....   .+++..++.++.|++.||.|||+.|++||||||+||++    +..+ .++|+|||.+......   ..
T Consensus        96 L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~----~~~~~~~~l~dfg~~~~~~~~---~~  165 (267)
T PHA03390         96 LFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY----DRAKDRIYLCDYGLCKIIGTP---SC  165 (267)
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----eCCCCeEEEecCccceecCCC---cc
Confidence            999997643   38999999999999999999999999999999999997    4444 7999999998765433   23


Q ss_pred             cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCC
Q psy15481        176 LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSE  255 (708)
Q Consensus       176 ~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~  255 (708)
                      ..|+..|+|||.+.        +..++.++|+||+||++|+|++|..||.......  .......... .          
T Consensus       166 ~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~-~----------  224 (267)
T PHA03390        166 YDGTLDYFSPEKIK--------GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ-Q----------  224 (267)
T ss_pred             CCCCCcccChhhhc--------CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh-c----------
Confidence            46899999999987        5668899999999999999999999997321111  0011111100 0          


Q ss_pred             CCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        256 NGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       256 ~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                             ...+...    ..+..+.++|.+||+.||.+||+ ++++           +.|||+.+
T Consensus       225 -------~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~-----------l~h~~~~~  267 (267)
T PHA03390        225 -------KKLPFIK----NVSKNANDFVQSMLKYNINYRLTNYNEI-----------IKHPFLKI  267 (267)
T ss_pred             -------ccCCccc----ccCHHHHHHHHHHhccChhhCCchHHHH-----------hcCCcccC
Confidence                   0111111    23344566999999999999996 5886           67999853

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.4e-34  Score=296.27  Aligned_cols=258  Identities=17%  Similarity=0.221  Sum_probs=188.9

Q ss_pred             EeecCCceEEEEEEEcCC--CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCC
Q psy15481         17 VLGKGATGAVFQGVNKNN--GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTG   94 (708)
Q Consensus        17 ~LG~G~fG~Vy~a~~~~t--g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~g   94 (708)
                      .||+|+||.||+|....+  ...+++|.+...........+.+|+.+++.++||||+++++.+....  ..|+||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--PYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC--ccEEEEecCCC
Confidence            589999999999975433  33567777665443334556789999999999999999999987654  48999999999


Q ss_pred             CCHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc--
Q psy15481         95 GSLFNILDDPEN-TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ--  171 (708)
Q Consensus        95 gsL~~~L~~~~~-~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~--  171 (708)
                      |+|.+++..... ...+++..++.++.||+.||.|||++|++||||||+|||+    +..+.++|+|||++.......  
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~----~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL----TSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE----cCCccEEecccccccccCcchhh
Confidence            999999875321 1236778889999999999999999999999999999998    667789999999986432211  


Q ss_pred             -cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        172 -QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       172 -~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                       .....+++..|+|||++.... .+.....++.++|||||||++|+|++ |..||.   ..++.+.+..+.......   
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~---~~~~~~~~~~~~~~~~~~---  228 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFH-GGLITAEQTKPSNVWALGVTLWELFENAAQPYS---HLSDREVLNHVIKDQQVK---  228 (268)
T ss_pred             hcccCCcCcccccCchhccccc-CccccCCCCCcchhHHHHHHHHHHHhCCCCCCC---CCCHHHHHHHHHhhcccc---
Confidence             123456889999999875211 11113456889999999999999997 577886   344555555544322111   


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                                     ++. ..+.......+.+++..|+ .||.+||+++++++.+
T Consensus       229 ---------------~~~-~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         229 ---------------LFK-PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             ---------------cCC-CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence                           011 1112223455666888999 6899999999987654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.8e-34  Score=302.36  Aligned_cols=270  Identities=16%  Similarity=0.204  Sum_probs=193.5

Q ss_pred             CceEEEEEEEcCCCceEEEEEeccCC-CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCCCHHHH
Q psy15481         22 ATGAVFQGVNKNNGEPVAVKTFNQLS-HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNI  100 (708)
Q Consensus        22 ~fG~Vy~a~~~~tg~~VAIK~~~~~s-~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~  100 (708)
                      ++|.||.+++..+|+.||+|.++... .......+.+|+.+++.++||||+++++++...+  ..|++|||+++|+|.++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~~~e~~~~~~l~~~   89 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYVVSPLMAYGSCEDL   89 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEEEEeccCCCCHHHH
Confidence            45666777777799999999997642 2333456679999999999999999999987654  48999999999999999


Q ss_pred             hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccc--------
Q psy15481        101 LDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ--------  172 (708)
Q Consensus       101 L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~--------  172 (708)
                      +..... ..+++..+..++.|++.||.|||++||+||||||+||++    +..+.++|+|||.+........        
T Consensus        90 l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili----~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          90 LKTHFP-EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL----SGDGKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             HHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE----ecCCceEEecCccceeeccccccccccccc
Confidence            976432 248999999999999999999999999999999999998    5566799999999875532211        


Q ss_pred             ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccc
Q psy15481        173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ  252 (708)
Q Consensus       173 ~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~  252 (708)
                      .....++..|+|||++...      ...++.++|+||+||++|+|++|..||...  ........++... .+..+....
T Consensus       165 ~~~~~~~~~y~aPE~~~~~------~~~~~~~~Diws~G~il~el~~g~~pf~~~--~~~~~~~~~~~~~-~~~~~~~~~  235 (314)
T cd08216         165 PKSSVKNLPWLSPEVLQQN------LQGYNEKSDIYSVGITACELANGHVPFKDM--PATQMLLEKVRGT-VPCLLDKST  235 (314)
T ss_pred             cccccccccccCHHHhcCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcc-CccccccCc
Confidence            1234577889999998621      245788999999999999999999999742  1222222222211 111111000


Q ss_pred             c-CCCCcccc--------cCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        253 T-SENGEIDW--------CTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       253 ~-~~~g~~~~--------~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      . ...+....        ....+........+...+.+++..||..||++|||++++           +.|||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l-----------l~~p~~~  299 (314)
T cd08216         236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL-----------LNHSFFK  299 (314)
T ss_pred             hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH-----------hcCchHh
Confidence            0 00000000        001111122344556678889999999999999999997           6688875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.6e-34  Score=299.04  Aligned_cols=251  Identities=25%  Similarity=0.444  Sum_probs=199.6

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .|.+.+.||+|++|.||+|.+..+|..||+|++.....  ........+|+.++++++ ||||+++++++.+.+  ..++
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--~~~l   79 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE--NLYF   79 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc--eEEE
Confidence            58899999999999999999999999999999875322  122344568999999998 999999999887644  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||+.|++|+||+|+||++    +..+.++|+|||.+...
T Consensus        80 v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i----~~~~~~~l~df~~~~~~  152 (280)
T cd05581          80 VLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL----DKDMHIKITDFGTAKVL  152 (280)
T ss_pred             EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE----CCCCCEEecCCcccccc
Confidence            999999999999997654   39999999999999999999999999999999999998    55567999999998865


Q ss_pred             cccc---------------------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCC
Q psy15481        168 EEDQ---------------------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP  226 (708)
Q Consensus       168 ~~~~---------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~  226 (708)
                      ....                     ......++..|+|||.+.        +..++.++|+||||+++|++++|..||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~--------~~~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN--------EKPAGKSSDLWALGCIIYQMLTGKPPFRG  224 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhC--------CCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            4322                     112345789999999886        45688899999999999999999999974


Q ss_pred             CCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH----HHHHH
Q psy15481        227 YGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF----ERFFS  302 (708)
Q Consensus       227 ~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa----~q~~~  302 (708)
                         .........+...                 .|  .      ++..++..+.+++.+||..||.+||++    .++  
T Consensus       225 ---~~~~~~~~~~~~~-----------------~~--~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~l--  274 (280)
T cd05581         225 ---SNEYLTFQKILKL-----------------EY--S------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDEL--  274 (280)
T ss_pred             ---ccHHHHHHHHHhc-----------------CC--C------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHH--
Confidence               2222222222211                 00  1      112234456679999999999999999    775  


Q ss_pred             HHHHHHhhhhcCccc
Q psy15481        303 EVTKTLNRKLVHLFH  317 (708)
Q Consensus       303 ~l~~il~~~l~h~~~  317 (708)
                               +.|||+
T Consensus       275 ---------l~~~~~  280 (280)
T cd05581         275 ---------KAHPFF  280 (280)
T ss_pred             ---------hcCCCC
Confidence                     668875

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0983|consensus

Probab=100.00  E-value=7.1e-35  Score=293.13  Aligned_cols=277  Identities=22%  Similarity=0.344  Sum_probs=219.7

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEec
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      +....||+|..|.||+++.+++|...|||.+....+.....+....+.++.+- +.|.||+.+++|.....  ++|.||.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V~IcMel  172 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--VFICMEL  172 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--HHHHHHH
Confidence            45678999999999999999999999999998776665556666777776655 58999999999976554  8999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      | +.-+..+++.-..  ++||..+-.+...++.||.||..+ ||+|||+||+|||+    |..+.+||||||.+..+.+.
T Consensus       173 M-s~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl----De~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  173 M-STCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL----DERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             H-HHHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE----ccCCCEEeecccccceeecc
Confidence            8 4555555554322  389999999999999999999975 99999999999999    88999999999999988777


Q ss_pred             ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccc
Q psy15481        171 QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISG  250 (708)
Q Consensus       171 ~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~  250 (708)
                      .......|.+.|||||.+.-     +....|+..+|+||||++++||+||+.||.+  -..+.+++.++....++     
T Consensus       246 kAhtrsAGC~~YMaPERidp-----~~~~kYDiRaDVWSlGITlveLaTg~yPy~~--c~tdFe~ltkvln~ePP-----  313 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDP-----PDKPKYDIRADVWSLGITLVELATGQYPYKG--CKTDFEVLTKVLNEEPP-----  313 (391)
T ss_pred             cccccccCCccccCccccCC-----CCCCccchhhhhhhhccchhhhhcccCCCCC--CCccHHHHHHHHhcCCC-----
Confidence            66667789999999999862     1256799999999999999999999999984  36778888888864332     


Q ss_pred             cccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcccccccccCC
Q psy15481        251 TQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHP  330 (708)
Q Consensus       251 ~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~~~~~i~~  330 (708)
                                   .+|....+|+    .+.+++..||..|+.+||...++           +.|||...--...      
T Consensus       314 -------------~L~~~~gFSp----~F~~fv~~CL~kd~r~RP~Y~~L-----------l~h~Fi~~ye~a~------  359 (391)
T KOG0983|consen  314 -------------LLPGHMGFSP----DFQSFVKDCLTKDHRKRPKYNKL-----------LEHPFIKRYETAE------  359 (391)
T ss_pred             -------------CCCcccCcCH----HHHHHHHHHhhcCcccCcchHHH-----------hcCcceeecchhh------
Confidence                         3344444444    55669999999999999999997           6789885532221      


Q ss_pred             cccHHHHHHHHHhh
Q psy15481        331 DDAYDQLQDLIQEQ  344 (708)
Q Consensus       331 ~e~~~~l~~~i~~~  344 (708)
                      .+-.++|...+...
T Consensus       360 ~dVa~WF~dV~~~~  373 (391)
T KOG0983|consen  360 VDVASWFKDVMAKT  373 (391)
T ss_pred             ccHHHHHHHHHhcc
Confidence            33455666665543

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-34  Score=311.81  Aligned_cols=280  Identities=23%  Similarity=0.374  Sum_probs=206.1

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCC---
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG---   82 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~---   82 (708)
                      +...+|.+.+.||+|+||.||++.+..+|..||+|.+..... ........+|+.++++++||||+++++++.....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            456689999999999999999999999999999999864322 1223445689999999999999999998865432   


Q ss_pred             -ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         83 -RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        83 -~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                       ..+++||+|+ |++|..++...    .+++..++.++.|++.||.|||+.||+||||||+||++    +..+.++|+||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill----~~~~~~kl~df  162 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV----NEDCELKILDF  162 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEeec
Confidence             2468999999 78999888642    28999999999999999999999999999999999998    56677999999


Q ss_pred             CccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        162 GAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       162 GlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      |.+......  .....+++.|+|||.+..       ...++.++|+|||||++|++++|.+||..   .........+..
T Consensus       163 g~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~ll~~l~~g~~pf~~---~~~~~~~~~~~~  230 (343)
T cd07880         163 GLARQTDSE--MTGYVVTRWYRAPEVILN-------WMHYTQTVDIWSVGCIMAEMLTGKPLFKG---HDHLDQLMEIMK  230 (343)
T ss_pred             ccccccccC--ccccccCCcccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHH
Confidence            999865432  234567899999999862       24578899999999999999999999973   333333333322


Q ss_pred             cccCC---cccccccCCCCcccccCCCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhc
Q psy15481        242 KKASG---VISGTQTSENGEIDWCTDLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLV  313 (708)
Q Consensus       242 ~~~~~---~i~~~~~~~~g~~~~~~~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~  313 (708)
                      .....   ........  ....+...+|..     ..+.+.+...+.++|.+||..||.+|||+.++           +.
T Consensus       231 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~-----------l~  297 (343)
T cd07880         231 VTGTPSKEFVQKLQSE--DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA-----------LA  297 (343)
T ss_pred             hcCCCCHHHHHhhcch--hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHH-----------hc
Confidence            11100   00000000  000011111111     11122344557789999999999999999997           56


Q ss_pred             CcccCCc
Q psy15481        314 HLFHINR  320 (708)
Q Consensus       314 h~~~~~~  320 (708)
                      |||+...
T Consensus       298 ~~~~~~~  304 (343)
T cd07880         298 HPYFEEF  304 (343)
T ss_pred             CccHhhh
Confidence            8888654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.2e-34  Score=296.14  Aligned_cols=257  Identities=20%  Similarity=0.329  Sum_probs=195.6

Q ss_pred             EEEeeEeecCCceEEEEEEEc---CCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCc----
Q psy15481         12 WCTTSVLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR----   83 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~----   83 (708)
                      |.+.+.||+|+||.||+|.+.   .+|..||+|++...... ...+...+|+.++++++||||+++++++......    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999864   36789999998654322 2234457899999999999999999988654321    


Q ss_pred             eEEEEEeccCCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         84 GKVIVMELCTGGSLFNILDDP---ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~---~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                      ..+++++|+.+|+|..++...   .....++...++.++.|++.||.|||++||+||||||+||++    ++.+.+||+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili----~~~~~~kl~d  156 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML----NENMTVCVAD  156 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE----cCCCCEEECc
Confidence            247899999999998876421   122348999999999999999999999999999999999998    6667799999


Q ss_pred             cCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHH
Q psy15481        161 FGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM  236 (708)
Q Consensus       161 FGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~  236 (708)
                      ||.++.......   .....+++.|++||.+.        +..++.++|||||||++|+|++ |.+||..   ....+..
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~sDi~slG~il~el~~~g~~p~~~---~~~~~~~  225 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLA--------DNVYTTHSDVWAFGVTMWEIMTRGQTPYAG---VENSEIY  225 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHh--------cCccchhhhhHHHHHHHHHHhhCCCCCCCC---CCHHHHH
Confidence            999986543321   12234567899999987        5678899999999999999999 8999863   3333333


Q ss_pred             HHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        237 YYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       237 ~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ..+....                    .++.    ++.....+.+++..||..+|.+|||+.++...+..+
T Consensus       226 ~~~~~~~--------------------~~~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         226 NYLIKGN--------------------RLKQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHHcCC--------------------cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            3333210                    0111    112334567799999999999999999998877654

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-34  Score=299.71  Aligned_cols=243  Identities=18%  Similarity=0.306  Sum_probs=184.9

Q ss_pred             eEeecCCceEEEEEEEcCCCce-------EEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEP-------VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~-------VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      +.||+|+||.||+|.+..++..       ||+|.+.... ....+.+..|+.+++.++||||+++++++....  ..++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--CcEEE
Confidence            3689999999999998765544       8888875322 222345678999999999999999999987654  48999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC------CceEEEeccC
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG------STIYKLTDFG  162 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~------~~~vKL~DFG  162 (708)
                      |||+++|+|..++.....  .+++..++.++.||+.||.|||++||+||||||+||++  +.++      ...++++|||
T Consensus        78 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili--~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLL--IREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             EecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE--ecccccccCCCceEEecccc
Confidence            999999999999976443  38999999999999999999999999999999999997  2222      2358999999


Q ss_pred             ccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC-CCCCCCCCCCChhhHHHHHHh
Q psy15481        163 AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG-NLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       163 lA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG-~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      .+......   ....++..|+|||.+..       ...++.++|||||||++|+|++| .+||..   .+...... ...
T Consensus       154 ~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~---~~~~~~~~-~~~  219 (258)
T cd05078         154 ISITVLPK---EILLERIPWVPPECIEN-------PQNLSLAADKWSFGTTLWEIFSGGDKPLSA---LDSQKKLQ-FYE  219 (258)
T ss_pred             cccccCCc---hhccccCCccCchhccC-------CCCCCchhhHHHHHHHHHHHHcCCCCChhh---ccHHHHHH-HHH
Confidence            98765433   23468889999999862       34578999999999999999998 466652   22222211 111


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      ..                   ..+|.      .....+.+++.+||+.||++|||+++++..+
T Consensus       220 ~~-------------------~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         220 DR-------------------HQLPA------PKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             cc-------------------ccCCC------CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            10                   01221      1223466799999999999999999987754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-34  Score=312.94  Aligned_cols=282  Identities=23%  Similarity=0.376  Sum_probs=207.2

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCC-
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG-   82 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~-   82 (708)
                      .......|.+...||+|++|.||+|.+..+++.||+|.+..... ........+|+.++++++||||+++++++...+. 
T Consensus        10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            34455678999999999999999999999999999999864321 1222344689999999999999999987754332 


Q ss_pred             ---ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         83 ---RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        83 ---~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                         ...|+|+||+ |++|.+++...    .+++..+..++.|++.||.|||++||+||||||+||++    +..+.++|+
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill----~~~~~~kL~  160 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV----NEDCELKIL  160 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCCEEEc
Confidence               3489999999 78999998753    28999999999999999999999999999999999998    556779999


Q ss_pred             ccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        160 DFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       160 DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      |||.+......  .....++..|+|||.+..       ...++.++|+|||||++|++++|+.||..   ......+..+
T Consensus       161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGv~l~elltg~~pf~~---~~~~~~~~~i  228 (343)
T cd07851         161 DFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGKTLFPG---SDHIDQLKRI  228 (343)
T ss_pred             ccccccccccc--ccCCcccccccCHHHHhC-------CCCCCchHhHHHHHHHHHHHHhCCCCCCC---CChHHHHHHH
Confidence            99999865433  334568899999999862       24678899999999999999999999973   3444444444


Q ss_pred             Hhccc---CCcccccccCCCCcccccCCCCC-----cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        240 TTKKA---SGVISGTQTSENGEIDWCTDLPN-----NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       240 ~~~~~---~~~i~~~~~~~~g~~~~~~~lp~-----~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      .....   +....+...  .+...|...++.     ...+....+..+.+++.+||..||.+|||+.++           
T Consensus       229 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el-----------  295 (343)
T cd07851         229 MNLVGTPDEELLQKISS--ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA-----------  295 (343)
T ss_pred             HHhcCCCCHHHHhhccc--hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH-----------
Confidence            33211   000000000  000001000110     011111234567779999999999999999997           


Q ss_pred             hcCcccCCc
Q psy15481        312 LVHLFHINR  320 (708)
Q Consensus       312 l~h~~~~~~  320 (708)
                      +.|||+..-
T Consensus       296 l~h~~~~~~  304 (343)
T cd07851         296 LAHPYLAEY  304 (343)
T ss_pred             hcCCCcccc
Confidence            678888654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.6e-34  Score=301.45  Aligned_cols=263  Identities=23%  Similarity=0.354  Sum_probs=200.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..|.+.+.||+|+||.||+|.+..+|+.||||.++............+|+.++.+. +||||+++++++.+..  ..|+|
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v   92 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS--DVFIC   92 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC--eEEEE
Confidence            46788999999999999999999899999999997543333333445677766666 5999999999987654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||+ +++|.+++.....  .+++..+..++.+++.||.|||+ .||+||||+|+||++    +..+.++|+|||.+...
T Consensus        93 ~e~~-~~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill----~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          93 MELM-STCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL----DASGNVKLCDFGISGRL  165 (296)
T ss_pred             eecc-CcCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE----cCCCCEEECccccchhc
Confidence            9998 4678777765332  38999999999999999999997 599999999999998    66678999999999876


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..........++..|+|||.+...    .....++.++|+|||||++|+|++|..||...  ..+.+.+..+......  
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~~--  237 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPP----DPNPKYDIRADVWSLGISLVELATGQFPYKNC--KTEFEVLTKILQEEPP--  237 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCC----CCccccccchhHHHHHHHHHHHHhCCCCCCcc--hhHHHHHHHHhcCCCC--
Confidence            544444445688899999998621    11234788999999999999999999999642  2233444443332110  


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                      .++.....    +..+.+++.+||..||.+||+++++           +.|+|+...
T Consensus       238 ----------------~~~~~~~~----~~~l~~li~~~l~~~p~~Rp~~~~i-----------l~~~~~~~~  279 (296)
T cd06618         238 ----------------SLPPNEGF----SPDFCSFVDLCLTKDHRKRPKYREL-----------LQHPFIRRY  279 (296)
T ss_pred             ----------------CCCCCCCC----CHHHHHHHHHHccCChhhCCCHHHH-----------hcChhhhcc
Confidence                            11111122    3346679999999999999999997           668887653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0666|consensus

Probab=100.00  E-value=1.2e-35  Score=303.16  Aligned_cols=284  Identities=21%  Similarity=0.295  Sum_probs=212.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCc----eEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~----~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .|.+...||+|.||.||+|..++++.    .||||.|+..+.. .......||+.+++.++|||++.+..++... ...+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~v  103 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DKKV  103 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-CceE
Confidence            58889999999999999997665543    7999999765433 2234456999999999999999999998764 4569


Q ss_pred             EEEEeccCCCCHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         86 VIVMELCTGGSLFNILDDP--ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~--~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ++++||.+ .||+.+++-.  .....+|...++.++.||+.|++|||++-|+|||+||.|||+..+...++.|||+|||+
T Consensus       104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            99999995 7999988642  12234999999999999999999999999999999999999855455679999999999


Q ss_pred             ccccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC------CChh
Q psy15481        164 ARELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG------RRNK  233 (708)
Q Consensus       164 A~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g------~~~~  233 (708)
                      |+.+...-.    ...++.|.+|+|||++.+       ...|+.++|||++|||+.||+|-.+.|.+...      .-..
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLG-------a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~  255 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLG-------ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH  255 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcc-------cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence            998765422    234678999999999985       57899999999999999999999999975321      1123


Q ss_pred             hHHHHHHhcccCCcccccccCCCCcccccCCCCCc--------------ccCCh------hHHHHHHHHHHhhcccCccc
Q psy15481        234 ETMYYITTKKASGVISGTQTSENGEIDWCTDLPNN--------------CQLSL------GLKKLVTPILAGLLEVDSKK  293 (708)
Q Consensus       234 e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~--------------~~ls~------~l~~~l~~LL~~mL~~DP~k  293 (708)
                      +++.+|+.-      -|..+...++  .....|..              +.+..      .-++...+||.+||..||.+
T Consensus       256 dQl~rIf~v------LG~Pt~~~Wp--~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~k  327 (438)
T KOG0666|consen  256 DQLDRIFEV------LGTPTDKDWP--DLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIK  327 (438)
T ss_pred             HHHHHHHHH------cCCCccccch--hhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchh
Confidence            445555531      2222222221  00111211              10100      01122567999999999999


Q ss_pred             CCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        294 IWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       294 Rpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      |.|+++.           +.|+||.....
T Consensus       328 RIta~qA-----------leh~yF~~d~l  345 (438)
T KOG0666|consen  328 RITAEQA-----------LEHPYFTEDPL  345 (438)
T ss_pred             hccHHHH-----------hcccccccCCC
Confidence            9999984           78999977643

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-34  Score=310.59  Aligned_cols=277  Identities=23%  Similarity=0.375  Sum_probs=201.7

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCC----c
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG----R   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~----~   83 (708)
                      ..+|.+...||+|+||.||+|.+..+|+.||+|.+..... ........+|+.+++.++||||+++++++.....    .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            3578899999999999999999999999999999865322 2223345689999999999999999999865432    3


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|+||+|+. .+|..++..     .+++..+..++.|++.||.|||++|++||||||+||++    +..+.++|+|||+
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll----~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV----NEDCELKILDFGL  163 (342)
T ss_pred             eEEEEecccc-cCHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEeeCCC
Confidence            5799999995 578776632     28999999999999999999999999999999999998    6667899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      +......  .....++..|+|||.+..       +..++.++|+|||||++|+|++|+.||.+   .+....+..+....
T Consensus       164 ~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slGvil~el~~g~~pf~~---~~~~~~~~~~~~~~  231 (342)
T cd07879         164 ARHADAE--MTGYVVTRWYRAPEVILN-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKG---KDYLDQLTQILKVT  231 (342)
T ss_pred             CcCCCCC--CCCceeeecccChhhhcC-------ccccCchHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHhc
Confidence            9864322  234567889999999862       24578899999999999999999999973   33334444433211


Q ss_pred             c---CCcccccccCCCCcccccCCCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCc
Q psy15481        244 A---SGVISGTQTSENGEIDWCTDLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHL  315 (708)
Q Consensus       244 ~---~~~i~~~~~~~~g~~~~~~~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~  315 (708)
                      .   +.........  ....|...+|..     ....+.....+.++|.+||..||.+||++.++           +.||
T Consensus       232 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~-----------l~h~  298 (342)
T cd07879         232 GVPGPEFVQKLEDK--AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA-----------LEHP  298 (342)
T ss_pred             CCCCHHHHHHhccc--chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH-----------hcCc
Confidence            0   0000000000  000111111110     00112234456779999999999999999997           6688


Q ss_pred             ccCCc
Q psy15481        316 FHINR  320 (708)
Q Consensus       316 ~~~~~  320 (708)
                      |+..-
T Consensus       299 ~f~~~  303 (342)
T cd07879         299 YFDSF  303 (342)
T ss_pred             chhhc
Confidence            87543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.5e-34  Score=300.70  Aligned_cols=261  Identities=17%  Similarity=0.234  Sum_probs=186.2

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCC---CceEEEEEeccCCCCCchHH----------HHHHHHHHHhCCCCCccce
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNN---GEPVAVKTFNQLSHMRPHDV----------QMREFEVLKKVKHENIVKL   73 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~~~~~s~~~~~~~----------~~~Ei~iL~kL~HpNIVkl   73 (708)
                      ..+.+|.+.+.||+|+||.||+|.+..+   +..+|+|+..........+.          ...+...+..+.|+||+.+
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4567999999999999999999998877   67788887543322111111          1223344556789999999


Q ss_pred             eEEEEecCC--ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecC
Q psy15481         74 LAIEEEQEG--RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDD  151 (708)
Q Consensus        74 ~~v~~~~~~--~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d  151 (708)
                      ++.......  ...+++++++ ..++.+.+.....   .++..++.++.|++.||.|||++||+||||||+|||+    +
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill----~  160 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKC---KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV----D  160 (294)
T ss_pred             EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhcc---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----c
Confidence            987654432  2357888988 4677777654322   6788899999999999999999999999999999998    6


Q ss_pred             CCceEEEeccCccccccccc--------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCC
Q psy15481        152 GSTIYKLTDFGAARELEEDQ--------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP  223 (708)
Q Consensus       152 ~~~~vKL~DFGlA~~~~~~~--------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~P  223 (708)
                      ..+.++|+|||+|+....+.        ......||+.|+|||++.        +..++.++|||||||++|+|++|.+|
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~--------~~~~~~~~DiwSlG~~l~el~~g~~P  232 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN--------GACVTRRGDLESLGYCMLKWAGIKLP  232 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC--------CCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            66779999999998654321        112346999999999987        67789999999999999999999999


Q ss_pred             CCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        224 FRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       224 F~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                      |......  ..........    .+...   ..+..    .+       +..+..+.+++..|+..+|++||+++++...
T Consensus       233 ~~~~~~~--~~~~~~~~~~----~~~~~---~~~~~----~~-------~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~  292 (294)
T PHA02882        233 WKGFGHN--GNLIHAAKCD----FIKRL---HEGKI----KI-------KNANKFIYDFIECVTKLSYEEKPDYDALIKI  292 (294)
T ss_pred             CCccccc--hHHHHHhHHH----HHHHh---hhhhh----cc-------CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence            9854222  2212111100    00000   00000    01       1123567789999999999999999997654

>KOG0662|consensus

Probab=100.00  E-value=8.3e-35  Score=277.11  Aligned_cols=278  Identities=24%  Similarity=0.339  Sum_probs=212.8

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      |.-.+.||+|.||+||+|+++.+++.||+|.++.....+. .....+|+-+++.++|.|||+++++.....  .+-+|+|
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk--kltlvfe   81 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLVFE   81 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc--eeEEeHH
Confidence            4456789999999999999999999999999986544332 345579999999999999999999986544  4899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      || ..+|..+......  .++...++.++.|+++||.|+|+.++.|||+||.|.++    +.++.+||+|||+|+.++-+
T Consensus        82 ~c-dqdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli----n~ngelkladfglarafgip  154 (292)
T KOG0662|consen   82 FC-DQDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI----NRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             Hh-hHHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe----ccCCcEEecccchhhhcCCc
Confidence            99 6899998876543  29999999999999999999999999999999999998    78889999999999977655


Q ss_pred             cc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhc---ccC
Q psy15481        171 QQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTK---KAS  245 (708)
Q Consensus       171 ~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~---~~~  245 (708)
                      -. +...+.|..|++|+++-.       .+-|+...|+||.|||+.|+.. |++.|.   |.+..+++.+|...   ...
T Consensus       155 vrcysaevvtlwyrppdvlfg-------akly~tsidmwsagcifaelanagrplfp---g~dvddqlkrif~~lg~p~e  224 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFP---GNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_pred             eEeeeceeeeeeccCcceeee-------eehhccchHhhhcchHHHHHhhcCCCCCC---CCcHHHHHHHHHHHhCCCcc
Confidence            33 334578999999999875       4678999999999999999998 887787   45556666666542   111


Q ss_pred             CcccccccCCCCcccccCCCCC---cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPN---NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~---~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                      .-..++....+  +.--...|.   +..+-+.+...-.++++++|..+|..|++++..           +.||+|....
T Consensus       225 d~wps~t~lpd--yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaa-----------lqhpyf~d~s  290 (292)
T KOG0662|consen  225 DQWPSMTKLPD--YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAA-----------LQHPYFSDFS  290 (292)
T ss_pred             ccCCccccCCC--CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHH-----------hcCccccccC
Confidence            11111110000  000001111   122334445556789999999999999999984           8899987643

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.6e-34  Score=293.69  Aligned_cols=248  Identities=24%  Similarity=0.357  Sum_probs=194.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC----CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH----MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~----~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      +|.+.+.||+|+||.||++.+..++..+++|+++....    ........+|+.++++++||||+++++.+.+..  ..+
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~   78 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD--AFC   78 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ceE
Confidence            58899999999999999999988888888887754321    111223457899999999999999999887654  489


Q ss_pred             EEEeccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         87 IVMELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      +||||+++++|.+++... .....+++..++.++.|++.||.|||++|++|+||+|+||++    +. +.++|+|||.+.
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili----~~-~~~~l~d~g~~~  153 (260)
T cd08222          79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL----KN-NLLKIGDFGVSR  153 (260)
T ss_pred             EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEe----ec-CCEeecccCcee
Confidence            999999999999887541 122348999999999999999999999999999999999997    22 358999999987


Q ss_pred             cccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ...... ......|++.|+|||.+.        +..++.++|+||+|+++|+|++|..||.+   .........+...  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~Dv~slG~~~~~l~~~~~~~~~---~~~~~~~~~~~~~--  220 (260)
T cd08222         154 LLMGSCDLATTFTGTPYYMSPEALK--------HQGYDSKSDIWSLGCILYEMCCLAHAFEG---QNFLSVVLRIVEG--  220 (260)
T ss_pred             ecCCCcccccCCCCCcCccCHHHHc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCC---ccHHHHHHHHHcC--
Confidence            654332 223456889999999886        56678899999999999999999999963   3333333333221  


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                         ..|.   ++...+..+.+++.+||..||++||++.++
T Consensus       221 -------------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  254 (260)
T cd08222         221 -------------------PTPS---LPETYSRQLNSIMQSMLNKDPSLRPSAAEI  254 (260)
T ss_pred             -------------------CCCC---CcchhcHHHHHHHHHHhcCChhhCcCHHHH
Confidence                               1111   233445567789999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.3e-34  Score=306.18  Aligned_cols=277  Identities=17%  Similarity=0.211  Sum_probs=194.3

Q ss_pred             eEeecC--CceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKG--ATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G--~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      ..||.|  +||.||++.+..+|+.||+|++....... ..+.+.+|+.+++.++||||+++++++...+  ..++||||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEEEEecc
Confidence            356666  99999999999999999999987543222 2345578999999999999999999998754  489999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ  172 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~  172 (708)
                      .+++|.+++..... .++++..+..++.|++.||+|||++|++||||||+||++    +..+.++++|||.+........
T Consensus        82 ~~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill----~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          82 AYGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI----SGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             cCCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----eCCCcEEEechHHHhhhhccCc
Confidence            99999999876432 238999999999999999999999999999999999998    5566799999986543322111


Q ss_pred             c--------cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        173 F--------MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       173 ~--------~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .        ....++..|+|||++...      ...++.++||||+||++|+|++|.+||..   ......+.......+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~DiwslG~~l~el~~g~~p~~~---~~~~~~~~~~~~~~~  227 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQD------LYGYNVKSDIYSVGITACELATGRVPFQD---MLRTQMLLQKLKGPP  227 (328)
T ss_pred             cccccccccccccCccCccChhhhcCC------CCCCCchhhHHHHHHHHHHHHhCCCCCCC---cChHHHHHHHhcCCC
Confidence            0        012345679999998621      14478999999999999999999999974   222222222222111


Q ss_pred             CCccc-c-----cccCCCCccc-------------ccCCC---CCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        245 SGVIS-G-----TQTSENGEID-------------WCTDL---PNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       245 ~~~i~-~-----~~~~~~g~~~-------------~~~~l---p~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      ..... .     ......+...             +....   ......+...+..+.+++++||..||++|||++++  
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~--  305 (328)
T cd08226         228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL--  305 (328)
T ss_pred             CCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHH--
Confidence            00000 0     0000000000             00000   00011234466778889999999999999999997  


Q ss_pred             HHHHHHhhhhcCcccCC
Q psy15481        303 EVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       303 ~l~~il~~~l~h~~~~~  319 (708)
                               +.|+|+..
T Consensus       306 ---------l~~~~~~~  313 (328)
T cd08226         306 ---------LSHAFFKQ  313 (328)
T ss_pred             ---------hhCHHHHH
Confidence                     55777643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-33  Score=297.36  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=197.2

Q ss_pred             EEEeeEeecCCceEEEEEEEc---CCCceEEEEEeccCCC---CCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCce
Q psy15481         12 WCTTSVLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSH---MRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~~~~~s~---~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~   84 (708)
                      |++.+.||.|+||.||.+.+.   .+|..||+|++.....   ....+...+|+.+++++ +||||+++++.+....  .
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~--~   79 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT--K   79 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--e
Confidence            778999999999999999874   4789999999875322   12234456899999999 6999999999887643  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||++|++|.+++....   .+++..+..++.|++.||.|||++|++||||+|+|||+    +..+.++|+|||++
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~----~~~~~~kl~dfg~~  152 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL----DSNGHVVLTDFGLS  152 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE----CCCCCEEEeeCccc
Confidence            899999999999999987643   38999999999999999999999999999999999998    56678999999999


Q ss_pred             ccccccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        165 RELEEDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       165 ~~~~~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .......  ......|+..|+|||.+...      ...++.++|+|||||++|+|++|..||...+.......+......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~  226 (290)
T cd05613         153 KEFHEDEVERAYSFCGTIEYMAPDIVRGG------DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK  226 (290)
T ss_pred             eecccccccccccccCCcccCChhhccCC------CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc
Confidence            8654432  22245689999999998621      234678999999999999999999999632222121212111110


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCccc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .                    ..|    .+..++..+.+++.+||..||.+||     +++++           +.|||+
T Consensus       227 ~--------------------~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l-----------~~~~~~  271 (290)
T cd05613         227 S--------------------EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEI-----------KKHPFF  271 (290)
T ss_pred             c--------------------CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH-----------HcCccc
Confidence            0                    001    1222344566799999999999998     56665           668887


Q ss_pred             CCc
Q psy15481        318 INR  320 (708)
Q Consensus       318 ~~~  320 (708)
                      ...
T Consensus       272 ~~~  274 (290)
T cd05613         272 QKI  274 (290)
T ss_pred             ccC
Confidence            553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7e-34  Score=306.54  Aligned_cols=280  Identities=23%  Similarity=0.317  Sum_probs=201.9

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .+.+|.+.+.||.|+||.||++.+..+|+.||+|.+..... ........+|+.+++.++||||+++++++.... ...|
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-EDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-CcEE
Confidence            45679999999999999999999999999999998864322 222344568999999999999999999886533 3589


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ++|||+ +++|..++...    .+++..+..++.|++.||.|||++|++||||+|+||++    +..+.++|+|||.+..
T Consensus        87 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili----~~~~~~~l~dfg~~~~  157 (328)
T cd07856          87 FVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI----NENCDLKICDFGLARI  157 (328)
T ss_pred             EEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE----CCCCCEEeCccccccc
Confidence            999999 67999888643    27889999999999999999999999999999999998    6677899999999975


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ....  .....++..|+|||.+..       +..++.++|+|||||++|+|+||.+||...........+.......+..
T Consensus       158 ~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  228 (328)
T cd07856         158 QDPQ--MTGYVSTRYYRAPEIMLT-------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD  228 (328)
T ss_pred             cCCC--cCCCcccccccCceeeec-------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            4322  234567889999998752       3568899999999999999999999997422111111111111111100


Q ss_pred             cccccccCCCCcccccCCCCCcc-----cCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNC-----QLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~-----~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ........  ....+...++...     ...+.++..+.+++.+||..||++||+++++           +.|+|+..
T Consensus       229 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el-----------l~~~~~~~  293 (328)
T cd07856         229 VINTICSE--NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA-----------LAHPYLAP  293 (328)
T ss_pred             HHHhccch--hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH-----------hcCCcccc
Confidence            00000000  0000000111100     0112334567779999999999999999997           66888854

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.1e-34  Score=308.54  Aligned_cols=276  Identities=23%  Similarity=0.308  Sum_probs=201.5

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC-CCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCce
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS-HMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s-~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~   84 (708)
                      .....|.+.+.||+|+||.||+|.+..+|+.||+|.+.... .........+|+.+++++ +||||+++++++...+...
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            34457888999999999999999999999999999885421 122233456899999999 9999999999987666667


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||+. ++|..++...    .+++..+..++.|++.||.|||++||+||||||+||++    +..+.++|+|||.+
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill----~~~~~~kl~d~g~~  154 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL----NSDCRVKLADFGLA  154 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCcEEEeeccch
Confidence            899999996 6999988664    28899999999999999999999999999999999998    77778999999999


Q ss_pred             ccccccc------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHH
Q psy15481        165 RELEEDQ------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       165 ~~~~~~~------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~  238 (708)
                      .......      ......|+..|+|||.+..       ...++.++|+|||||++|+|+||++||.+   ....+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~~l~el~tg~~pf~~---~~~~~~~~~  224 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLG-------STRYTKGVDMWSVGCILGEMLLGKPLFPG---TSTLNQLEK  224 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeec-------cccccccchHHHHHHHHHHHHhCCCCCCC---CChHHHHHH
Confidence            8654332      2223568999999998752       35678899999999999999999999973   333444444


Q ss_pred             HHhcccCCc---ccccccCCCC----cccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        239 ITTKKASGV---ISGTQTSENG----EIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       239 i~~~~~~~~---i~~~~~~~~g----~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      +........   +.........    .+... ..+......+.++..+.+++.+||..||.+|||+.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         225 IIEVIGPPSAEDIESIKSPFAATMLDSLPSR-PRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             HHHHhCCCCHHHHHHHHhhhHHHhhhhcccc-cccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence            332211000   0000000000    00000 000111112224556777999999999999999999733

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=288.58  Aligned_cols=244  Identities=32%  Similarity=0.499  Sum_probs=195.5

Q ss_pred             eecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCC
Q psy15481         18 LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        18 LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~gg   95 (708)
                      ||.|+||.||++.+..+|+.||+|.+.......  ..+...+|+.++++++||||+++++.+....  ..|+||||++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE--KLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC--eeEEEEecCCCC
Confidence            699999999999999899999999987653322  2345678999999999999999999887544  599999999999


Q ss_pred             CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc-cccc
Q psy15481         96 SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFM  174 (708)
Q Consensus        96 sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~-~~~~  174 (708)
                      +|.+++....   .+++..+..++.|++.||.|||+.|++|+||+|+||++    +..+.++|+|||.+...... ....
T Consensus        79 ~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~----~~~~~~~l~d~~~~~~~~~~~~~~~  151 (250)
T cd05123          79 ELFSHLSKEG---RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL----DADGHIKLTDFGLAKELSSEGSRTN  151 (250)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE----cCCCcEEEeecCcceecccCCCccc
Confidence            9999997654   28999999999999999999999999999999999998    56667999999999875443 2334


Q ss_pred             ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccC
Q psy15481        175 SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTS  254 (708)
Q Consensus       175 ~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~  254 (708)
                      ...++..|+|||...        +...+.++|+||||+++|++++|..||..   .+.......+...            
T Consensus       152 ~~~~~~~~~~Pe~~~--------~~~~~~~~D~~slG~~~~~l~~g~~p~~~---~~~~~~~~~~~~~------------  208 (250)
T cd05123         152 TFCGTPEYLAPEVLL--------GKGYGKAVDWWSLGVLLYEMLTGKPPFYA---EDRKEIYEKILKD------------  208 (250)
T ss_pred             CCcCCccccChHHhC--------CCCCCchhhHHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHhcC------------
Confidence            567899999999986        45678899999999999999999999963   3333333222211            


Q ss_pred             CCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH---HHHHHHHHHHHhhhhcCccc
Q psy15481        255 ENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF---ERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       255 ~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa---~q~~~~l~~il~~~l~h~~~  317 (708)
                               .++    ++..++..+.+++.+||..||++||++   +++           ..||||
T Consensus       209 ---------~~~----~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l-----------~~~~~f  250 (250)
T cd05123         209 ---------PLR----FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEI-----------KAHPFF  250 (250)
T ss_pred             ---------CCC----CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHH-----------HhCCCC
Confidence                     111    122224456679999999999999999   554           568875

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-34  Score=326.03  Aligned_cols=284  Identities=19%  Similarity=0.240  Sum_probs=191.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCC-ceEEEEEecc--------------C--CCCCchHHHHHHHHHHHhCCCCCccc
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNG-EPVAVKTFNQ--------------L--SHMRPHDVQMREFEVLKKVKHENIVK   72 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg-~~VAIK~~~~--------------~--s~~~~~~~~~~Ei~iL~kL~HpNIVk   72 (708)
                      ..|.+.+.||+|+||.||+|..+... ..+++|.++.              .  ........+.+|+.++++++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            57999999999999999998765432 2222221110              0  01111233568999999999999999


Q ss_pred             eeEEEEecCCceEEEEEeccCCCCHHHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec
Q psy15481         73 LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN--TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD  150 (708)
Q Consensus        73 l~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~--~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~  150 (708)
                      +++++...+  ..|+|++++ +++|..++.....  ........++.++.||+.||.|||++|||||||||+|||+    
T Consensus       228 l~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl----  300 (501)
T PHA03210        228 IEEILRSEA--NTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL----  300 (501)
T ss_pred             EeEEEEECC--eeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----
Confidence            999998765  489999999 5677777654221  1124467788999999999999999999999999999998    


Q ss_pred             CCCceEEEeccCcccccccccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCC
Q psy15481        151 DGSTIYKLTDFGAARELEEDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG  228 (708)
Q Consensus       151 d~~~~vKL~DFGlA~~~~~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~  228 (708)
                      +..+.+||+|||++........  .....||..|+|||++.        +..++.++|||||||++|+|++|..|+.+..
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlGvil~ell~~~~~p~~~~  372 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA--------GDGYCEITDIWSCGLILLDMLSHDFCPIGDG  372 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhc--------CCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence            6667899999999987654322  22457999999999987        6778999999999999999999876544333


Q ss_pred             CCChhhHHHHHHhcccCCcccccccCCCCcccccC--CCCCc-ccCC-----hhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        229 GRRNKETMYYITTKKASGVISGTQTSENGEIDWCT--DLPNN-CQLS-----LGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       229 g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~--~lp~~-~~ls-----~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      +......+..++....... ............|..  .++.. ..++     ..++..+.++|.+||.+||.+|||+.++
T Consensus       373 ~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el  451 (501)
T PHA03210        373 GGKPGKQLLKIIDSLSVCD-EEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL  451 (501)
T ss_pred             CCCHHHHHHHHHHhcccCh-hhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence            3333344444433111000 000000000000000  00000 0000     1123345678999999999999999997


Q ss_pred             HHHHHHHHhhhhcCcccCCc
Q psy15481        301 FSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       301 ~~~l~~il~~~l~h~~~~~~  320 (708)
                                 +.||||...
T Consensus       452 -----------L~hp~f~~~  460 (501)
T PHA03210        452 -----------LALPLFSAE  460 (501)
T ss_pred             -----------hhChhhhcC
Confidence                       669998554

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-33  Score=294.55  Aligned_cols=245  Identities=18%  Similarity=0.263  Sum_probs=181.7

Q ss_pred             eEeecCCceEEEEEEEcC------------CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481         16 SVLGKGATGAVFQGVNKN------------NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~------------tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      +.||.|+||.||+|....            ....|++|.+.... ......+..|+.+++.++||||+++++++....  
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~--   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV--   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--
Confidence            368999999999998532            23358899875432 222334567889999999999999999987654  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec---CCCceEEEec
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD---DGSTIYKLTD  160 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~---d~~~~vKL~D  160 (708)
                      ..++||||+++|+|..++.....  .+++..++.++.||+.||.|||++||+||||||+|||+....   .....++++|
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            47999999999999988865332  289999999999999999999999999999999999972111   1122489999


Q ss_pred             cCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHh-cCCCCCCCCCCCChhhHHHHH
Q psy15481        161 FGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVA-TGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       161 FGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLl-TG~~PF~~~~g~~~~e~~~~i  239 (708)
                      ||.+......   ....++..|+|||.+..       +..++.++|||||||++|+|+ +|..||..   ....+ ....
T Consensus       156 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~el~~~~~~p~~~---~~~~~-~~~~  221 (262)
T cd05077         156 PGIPITVLSR---QECVERIPWIAPECVED-------SKNLSIAADKWSFGTTLWEICYNGEIPLKD---KTLAE-KERF  221 (262)
T ss_pred             CCCCccccCc---ccccccccccChhhhcC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCC---cchhH-HHHH
Confidence            9998754322   23467889999998752       466889999999999999998 58888863   22111 1111


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      ...                     ..+...+    ....+.+++.+||..||.+||++.+++.++
T Consensus       222 ~~~---------------------~~~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         222 YEG---------------------QCMLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             Hhc---------------------CccCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            110                     0011111    123466799999999999999999987653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.1e-33  Score=300.33  Aligned_cols=263  Identities=24%  Similarity=0.345  Sum_probs=203.0

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      +...+..|...+.||+|+||.||+|.+..+|+.|++|.+........  .....+|+.+++.++|||++++++++.+.. 
T Consensus        16 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   94 (313)
T cd06633          16 KDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-   94 (313)
T ss_pred             cCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-
Confidence            34445567778899999999999999999999999999875433222  234568999999999999999999987754 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                       ..|+||||+. |+|.+++....  ..+++..+..++.|++.|+.|||++|++|+||+|+||++    +..+.++|+|||
T Consensus        95 -~~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili----~~~~~~kL~dfg  166 (313)
T cd06633          95 -TAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL----TEPGQVKLADFG  166 (313)
T ss_pred             -EEEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE----CCCCCEEEeecC
Confidence             5899999995 67777775432  238999999999999999999999999999999999998    556679999999


Q ss_pred             ccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        163 AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       163 lA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .+.....   .....|+..|+|||.+....     +..++.++|+|||||++|+|++|..||..   .+.......+...
T Consensus       167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~-----~~~~~~~sDv~slGvil~el~~g~~p~~~---~~~~~~~~~~~~~  235 (313)
T cd06633         167 SASKSSP---ANSFVGTPYWMAPEVILAMD-----EGQYDGKVDVWSLGITCIELAERKPPLFN---MNAMSALYHIAQN  235 (313)
T ss_pred             CCcccCC---CCCccccccccChhhccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHhc
Confidence            9865332   23457899999999985211     34578899999999999999999999973   3334444443321


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                      ..                     |..  ..+..+..+.+++.+||..+|.+||++.++           +.|||+....
T Consensus       236 ~~---------------------~~~--~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~-----------l~~~~~~~~~  280 (313)
T cd06633         236 DS---------------------PTL--QSNEWTDSFRGFVDYCLQKIPQERPASAEL-----------LRHDFVRRDR  280 (313)
T ss_pred             CC---------------------CCC--CccccCHHHHHHHHHHccCChhhCcCHHHH-----------hcCcccCCCc
Confidence            11                     110  111223346679999999999999999997           6789987644

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.6e-33  Score=299.91  Aligned_cols=255  Identities=23%  Similarity=0.359  Sum_probs=197.5

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      .......|...+.||+|+||.||++.+..+|..||+|.+.......  ....+.+|+.++++++|||++++++++.+.. 
T Consensus        20 ~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-   98 (317)
T cd06635          20 KEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-   98 (317)
T ss_pred             CCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-
Confidence            3444456888999999999999999999999999999987543322  1234568999999999999999999987654 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                       ..|+||||+. |+|.+.+....  ..+++..+..++.+++.||.|||++|++||||+|+||++    +..+.++|+|||
T Consensus        99 -~~~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~----~~~~~~kl~dfg  170 (317)
T cd06635          99 -TAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL----TEPGQVKLADFG  170 (317)
T ss_pred             -eEEEEEeCCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE----CCCCCEEEecCC
Confidence             4899999996 57777765432  238999999999999999999999999999999999998    666789999999


Q ss_pred             ccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        163 AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       163 lA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      ++......   ....|+..|+|||.+....     +..++.++|+|||||++|+|++|..||..   .........+...
T Consensus       171 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~-----~~~~~~~~Dv~slGvil~el~~g~~p~~~---~~~~~~~~~~~~~  239 (317)
T cd06635         171 SASIASPA---NSFVGTPYWMAPEVILAMD-----EGQYDGKVDVWSLGITCIELAERKPPLFN---MNAMSALYHIAQN  239 (317)
T ss_pred             CccccCCc---ccccCCccccChhhhhcCC-----CCCCCccccHHHHHHHHHHHHhCCCCCCC---ccHHHHHHHHHhc
Confidence            98754432   2456889999999975211     35578899999999999999999999973   3333444444321


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      ..                     +.  ..+...+..+.+++.+||..||.+||++.+++.
T Consensus       240 ~~---------------------~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  276 (317)
T cd06635         240 ES---------------------PT--LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK  276 (317)
T ss_pred             cC---------------------CC--CCCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence            10                     00  011223445677999999999999999999843

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9e-34  Score=294.62  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=195.1

Q ss_pred             EEEeeEeecCCceEEEEEEEcC-CCceEEEEEeccCCC---------CCchHHHHHHHHHHHh-CCCCCccceeEEEEec
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKN-NGEPVAVKTFNQLSH---------MRPHDVQMREFEVLKK-VKHENIVKLLAIEEEQ   80 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~-tg~~VAIK~~~~~s~---------~~~~~~~~~Ei~iL~k-L~HpNIVkl~~v~~~~   80 (708)
                      |.+.+.||+|+||.||+|.+.. +++.+|+|.+.....         ........+|+.++.+ ++||||+++++++.+.
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            6788999999999999999987 788999998853211         1112234578887765 7999999999998764


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCCCceEEE
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDGSTIYKL  158 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~~~~vKL  158 (708)
                      +  ..++||||++|++|.+++... .....+++..++.++.|++.||.|||+ .|++|+||+|+||++    +..+.++|
T Consensus        82 ~--~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~----~~~~~~~l  155 (269)
T cd08528          82 D--RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML----GEDDKVTI  155 (269)
T ss_pred             C--eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE----CCCCcEEE
Confidence            4  599999999999999887431 112348999999999999999999996 789999999999998    66678999


Q ss_pred             eccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHH
Q psy15481        159 TDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       159 ~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~  238 (708)
                      +|||.+.............|+..|+|||.+.        +..++.++|+||||+++|+|++|.+||..   .........
T Consensus       156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~--------~~~~~~~~Dv~slG~ll~~l~~g~~p~~~---~~~~~~~~~  224 (269)
T cd08528         156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVK--------NEPYGEKADVWAFGCILYQMCTLQPPFYS---TNMLSLATK  224 (269)
T ss_pred             ecccceeecccccccccccCcccCcChhhhc--------CCCCchHHHHHHHHHHHHHHHhCCCcccc---cCHHHHHHH
Confidence            9999998766554445567899999999987        56689999999999999999999999963   233333333


Q ss_pred             HHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      +......                  ..+ .    ...+..+.+++.+||..||++||++.++..++
T Consensus       225 ~~~~~~~------------------~~~-~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~  267 (269)
T cd08528         225 IVEAVYE------------------PLP-E----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMI  267 (269)
T ss_pred             HhhccCC------------------cCC-c----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence            3221100                  001 0    11234466799999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1026|consensus

Probab=100.00  E-value=2.1e-34  Score=327.82  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=211.4

Q ss_pred             EEEeeEeecCCceEEEEEEEcC-----CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ....+.||+|+||.||+|+...     ....||||.++..........|.||++++..|+|||||++++++...+.  .|
T Consensus       488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P--~~  565 (774)
T KOG1026|consen  488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP--LC  565 (774)
T ss_pred             eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe--eE
Confidence            3456789999999999997643     3457999999877665566778899999999999999999999987554  99


Q ss_pred             EEEeccCCCCHHHHhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCce
Q psy15481         87 IVMELCTGGSLFNILDDPEN-----------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTI  155 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~-----------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~  155 (708)
                      +|+|||..|||.++|....+           ...|+..+++.|+.||+.||.||-++.+|||||-..|+||    ..+.+
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV----ge~l~  641 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV----GENLV  641 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee----ccceE
Confidence            99999999999999875221           1228899999999999999999999999999999999999    88889


Q ss_pred             EEEeccCccccccccccccc---cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCC
Q psy15481        156 YKLTDFGAARELEEDQQFMS---LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRR  231 (708)
Q Consensus       156 vKL~DFGlA~~~~~~~~~~~---~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~  231 (708)
                      |||+|||+++..-..+-+..   ..-..+|||||.+.        ...|+.++||||+||+|||+++ |..||.   |.+
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl--------y~kFTteSDVWs~GVvLWEIFsyG~QPy~---glS  710 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL--------YGKFTTESDVWSFGVVLWEIFSYGKQPYY---GLS  710 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhh--------cCcccchhhhhhhhhhhhhhhccccCccc---ccc
Confidence            99999999986533322221   22356899999998        6789999999999999999999 998887   688


Q ss_pred             hhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        232 NKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       232 ~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      |.+.+..|..+..                    ++    .+..++..+..|+..||..+|++||+|.++-..|.....
T Consensus       711 n~EVIe~i~~g~l--------------------L~----~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  711 NQEVIECIRAGQL--------------------LS----CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             hHHHHHHHHcCCc--------------------cc----CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            8999988886432                    11    233445667779999999999999999998776665543

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-33  Score=296.50  Aligned_cols=244  Identities=19%  Similarity=0.293  Sum_probs=181.9

Q ss_pred             EeecCCceEEEEEEEcCC------------------------CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccc
Q psy15481         17 VLGKGATGAVFQGVNKNN------------------------GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK   72 (708)
Q Consensus        17 ~LG~G~fG~Vy~a~~~~t------------------------g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVk   72 (708)
                      .||+|+||.||+|....+                        ...|++|++.... ......+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            589999999999975322                        2358888875432 122334568889999999999999


Q ss_pred             eeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEe---
Q psy15481         73 LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFIC---  149 (708)
Q Consensus        73 l~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~---  149 (708)
                      +++++...+  ..++||||+++|+|..++.....  .+++..+..++.||+.||.|||++||+||||||+|||+.-.   
T Consensus        81 ~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          81 VHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            999987654  48999999999999999865332  38999999999999999999999999999999999997211   


Q ss_pred             cCCCceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHh-cCCCCCCCCC
Q psy15481        150 DDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVA-TGNLPFRPYG  228 (708)
Q Consensus       150 ~d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLl-TG~~PF~~~~  228 (708)
                      ++....++++|||.+......   ....++..|+|||.+..       +..++.++|+|||||++|+++ +|..||..  
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~-------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~--  224 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG-------GNSLSTAADKWSFGTTLLEICFDGEVPLKE--  224 (274)
T ss_pred             cCccceeeecCCccccccccc---cccccCCcccCchhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCccc--
Confidence            112345899999998654322   23457888999998862       356789999999999999985 69999973  


Q ss_pred             CCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        229 GRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       229 g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                       ....+.. .......                   .+|.  ..+    ..+.+++.+||..||++|||+.+++..+
T Consensus       225 -~~~~~~~-~~~~~~~-------------------~~~~--~~~----~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         225 -RTPSEKE-RFYEKKH-------------------RLPE--PSC----KELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             -cChHHHH-HHHHhcc-------------------CCCC--CCC----hHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence             2222221 1111100                   1111  112    2466799999999999999999987754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-33  Score=307.22  Aligned_cols=277  Identities=24%  Similarity=0.400  Sum_probs=200.7

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecC----Cc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQE----GR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~----~~   83 (708)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|.+...... .......+|+.++++++||||+++++++....    ..
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            35688999999999999999999999999999998753221 22344568999999999999999999885432    23


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|++++++ |++|.+++...    .+++..+..++.|++.||.|||++|++||||||+||++    +..+.++|+|||+
T Consensus        96 ~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll----~~~~~~kl~dfg~  166 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGL  166 (345)
T ss_pred             cEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE----cCCCCEEEecccc
Confidence            478888887 89999888653    28999999999999999999999999999999999998    5666899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      +......  .....++..|+|||.+..       ...++.++|+|||||++|+|++|.+||..   .+.......+....
T Consensus       167 ~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~pf~~---~~~~~~~~~~~~~~  234 (345)
T cd07877         167 ARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLV  234 (345)
T ss_pred             ccccccc--ccccccCCCccCHHHHhC-------ccCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHh
Confidence            9865332  334568899999998862       25678899999999999999999999963   33333333222211


Q ss_pred             ---cCCcccccccCCCCcccccCCC---CCc--ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCc
Q psy15481        244 ---ASGVISGTQTSENGEIDWCTDL---PNN--CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHL  315 (708)
Q Consensus       244 ---~~~~i~~~~~~~~g~~~~~~~l---p~~--~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~  315 (708)
                         ...........  ....+...+   |..  .......+..+.++|.+||..||.+||++.++           +.||
T Consensus       235 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~-----------l~h~  301 (345)
T cd07877         235 GTPGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA-----------LAHA  301 (345)
T ss_pred             CCCCHHHHhhcccH--hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH-----------hcCh
Confidence               00000000000  000000000   100  00001223456789999999999999999987           6678


Q ss_pred             ccCC
Q psy15481        316 FHIN  319 (708)
Q Consensus       316 ~~~~  319 (708)
                      |+..
T Consensus       302 ~f~~  305 (345)
T cd07877         302 YFAQ  305 (345)
T ss_pred             hhhh
Confidence            8764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.6e-33  Score=297.71  Aligned_cols=264  Identities=23%  Similarity=0.361  Sum_probs=202.5

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      .......|...+.||+|+||.||+|++..++..||+|.+......  .....+.+|+.+++.++|||++++++++.... 
T Consensus        10 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   88 (308)
T cd06634          10 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-   88 (308)
T ss_pred             cCCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-
Confidence            344556788889999999999999999999999999998643222  12234568999999999999999999987654 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                       ..++||||+. |+|.+.+....  ..+++..+..++.+++.||.|||++|++||||+|+||++    +..+.++|+|||
T Consensus        89 -~~~lv~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~----~~~~~~kl~dfg  160 (308)
T cd06634          89 -TAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL----SEPGLVKLGDFG  160 (308)
T ss_pred             -eeEEEEEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE----CCCCcEEECCcc
Confidence             5899999996 67877765432  238999999999999999999999999999999999998    556789999999


Q ss_pred             ccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        163 AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       163 lA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      ++......   ....|+..|+|||.+....     ...++.++|||||||++|+|++|..||..   ....+....+...
T Consensus       161 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~---~~~~~~~~~~~~~  229 (308)
T cd06634         161 SASIMAPA---NXFVGTPYWMAPEVILAMD-----EGQYDGKVDVWSLGITCIELAERKPPLFN---MNAMSALYHIAQN  229 (308)
T ss_pred             cceeecCc---ccccCCccccCHHHHhhcc-----cCCCCcccchHHHHHHHHHHHcCCCCCcc---ccHHHHHHHHhhc
Confidence            98765433   2346889999999975211     34578899999999999999999999964   2233333333321


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      .                     .|..  .+...+..+.++|.+||..+|.+||+++++           +.|+|+.....
T Consensus       230 ~---------------------~~~~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l-----------l~~~~~~~~~~  275 (308)
T cd06634         230 E---------------------SPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL-----------LKHRFVLRERP  275 (308)
T ss_pred             C---------------------CCCc--CcccccHHHHHHHHHHhhCCcccCCCHHHH-----------hhCccccccCC
Confidence            0                     0110  112334556779999999999999999997           56888766433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG4257|consensus

Probab=100.00  E-value=5.5e-34  Score=311.17  Aligned_cols=253  Identities=25%  Similarity=0.419  Sum_probs=212.3

Q ss_pred             EEeeEeecCCceEEEEEEEcC----CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         13 CTTSVLGKGATGAVFQGVNKN----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~----tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .+.++||.|-||.||.|.-..    ..--||||.++.+......+.++.|..++++++|||||++++++.+.+   .|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P---~Wiv  468 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP---MWIV  468 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc---eeEE
Confidence            467789999999999997642    233599999998777777888999999999999999999999998765   8999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||.++-|.|..+++...+  .++......++.||+.||.|||+..+|||||-..|||+    .....|||+|||+++.+.
T Consensus       469 mEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV----sSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV----SSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee----cCcceeeecccchhhhcc
Confidence            999999999999988654  49999999999999999999999999999999999998    666689999999999988


Q ss_pred             ccccccccCC--CCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQQFMSLYG--TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~~~~~~~G--T~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ++.-+....|  ...|||||.+.        -..|+.++|+|-|||.+||++. |.-||.   |-.|.+.+-++..    
T Consensus       543 d~~yYkaS~~kLPIKWmaPESIN--------fRrFTtASDVWMFgVCmWEIl~lGvkPfq---gvkNsDVI~~iEn----  607 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESIN--------FRRFTTASDVWMFGVCMWEILSLGVKPFQ---GVKNSDVIGHIEN----  607 (974)
T ss_pred             ccchhhccccccceeecCccccc--------hhcccchhhHHHHHHHHHHHHHhcCCccc---cccccceEEEecC----
Confidence            7765544333  45799999987        5789999999999999999998 999997   4445444433332    


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                                      ...+|.+...+    ..+..++.+||.+||.+||.|.++...+.++++
T Consensus       608 ----------------GeRlP~P~nCP----p~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  608 ----------------GERLPCPPNCP----PALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ----------------CCCCCCCCCCC----hHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                            12455544444    455569999999999999999999999999887

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.3e-33  Score=292.30  Aligned_cols=261  Identities=26%  Similarity=0.362  Sum_probs=196.6

Q ss_pred             EEEeeEeecCCceEEEEEEEc---CCCceEEEEEeccCCC---CCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCce
Q psy15481         12 WCTTSVLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSH---MRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~~~~~s~---~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~   84 (708)
                      |.+.+.||+|++|.||++.+.   .+++.||+|++.....   ........+|+.++.++ +||||+++++.+....  .
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~--~   79 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT--K   79 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--E
Confidence            788999999999999999864   4678999999864321   12233456899999999 6999999999886543  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||++|++|..++....   .+++..++.++.|++.||.|||+.|++||||+|+||++    +..+.++|+|||++
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~----~~~~~~~l~dfg~~  152 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL----DSEGHVVLTDFGLS  152 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE----CCCCCEEEEECccc
Confidence            899999999999999886533   28999999999999999999999999999999999998    66677999999998


Q ss_pred             ccccccccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCC-hhhHHHHHHh
Q psy15481        165 RELEEDQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR-NKETMYYITT  241 (708)
Q Consensus       165 ~~~~~~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~-~~e~~~~i~~  241 (708)
                      .........  ....|+..|+|||.+...      ....+.++|+||||+++|+|++|..||...+... ..+....+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  226 (288)
T cd05583         153 KEFLAEEEERAYSFCGTIEYMAPEVIRGG------SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK  226 (288)
T ss_pred             cccccccccccccccCCccccCHHHhcCC------CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc
Confidence            765443221  234689999999997621      1236789999999999999999999996422221 1121111111


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      .                     ..+.    +..++..+.+++.+||..||++|||+.++..        .+.|||+.+.
T Consensus       227 ~---------------------~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~--------~l~~~~~~~~  272 (288)
T cd05583         227 S---------------------KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADE--------IKNHPFFQGI  272 (288)
T ss_pred             c---------------------CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHH--------HhcCcccccC
Confidence            0                     1111    1223344567999999999999999876533        2678887554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0696|consensus

Probab=100.00  E-value=2.7e-34  Score=301.42  Aligned_cols=242  Identities=27%  Similarity=0.412  Sum_probs=203.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHH--HHHHHHHHHhC-CCCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV--QMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~--~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .|....+||.|+||.|-+|..+.|.+.||||++++.-.....++  .+.|-++|... +-|.+++++..|...+.  +|+
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR--LyF  427 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR--LYF  427 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh--eee
Confidence            57788999999999999999999999999999987654333333  36787777766 56788999988876554  999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||+.||+|...++....   +.+..+..++..|+-||-+||++||++||||.+|||+    |+.+.+||+|||.+.+.
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL----d~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML----DSEGHIKIADFGMCKEN  500 (683)
T ss_pred             EEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe----ccCCceEeeeccccccc
Confidence            9999999999999987554   8999999999999999999999999999999999999    88889999999999864


Q ss_pred             -cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 -EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 -~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                       .++.+..+.+|||.|+|||++.        -..|+.++|.||+||+||||+.|++||.   |.+..+....|...+.  
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~--------YqPYgksvDWWa~GVLLyEmlaGQpPFd---GeDE~elF~aI~ehnv--  567 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIA--------YQPYGKSVDWWAFGVLLYEMLAGQPPFD---GEDEDELFQAIMEHNV--  567 (683)
T ss_pred             ccCCcceeeecCCCcccccceEE--------ecccccchhHHHHHHHHHHHHcCCCCCC---CCCHHHHHHHHHHccC--
Confidence             3455677899999999999998        5889999999999999999999999998   5666666666665422  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF  297 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa  297 (708)
                                             ..+..++....++.++.|.+.|.+|...
T Consensus       568 -----------------------syPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  568 -----------------------SYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             -----------------------cCcccccHHHHHHHHHHhhcCCccccCC
Confidence                                   1233445566679999999999999763

>KOG0669|consensus

Probab=100.00  E-value=6e-35  Score=290.66  Aligned_cols=280  Identities=24%  Similarity=0.376  Sum_probs=211.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEec---C---Cc
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQ---E---GR   83 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~---~---~~   83 (708)
                      .|.-...||+|.||.||+|+.+.+|+.||+|.+-..+.. .......+|+.+|..|+|+|++.+++++...   .   ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            455567899999999999999999999999876433322 2233456999999999999999999877432   1   12


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|+|+++|+ .+|..++.++...  ++..+++.++.++..||.|+|++.|+|||+||.|+|+    ++.+++||+|||+
T Consensus        98 t~ylVf~~ce-hDLaGlLsn~~vr--~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI----t~dgilklADFGl  170 (376)
T KOG0669|consen   98 TFYLVFDFCE-HDLAGLLSNRKVR--FSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI----TKDGILKLADFGL  170 (376)
T ss_pred             eeeeeHHHhh-hhHHHHhcCcccc--ccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE----cCCceEEeecccc
Confidence            4899999995 8999999876433  8999999999999999999999999999999999998    8888999999999


Q ss_pred             ccccccc-----ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHH
Q psy15481        164 ARELEED-----QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       164 A~~~~~~-----~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~  238 (708)
                      |+.+...     +.+...+.|..|++||.+.+       ...|+++.|||..|||+.+|+||++.|.   |..+..+++.
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG-------~r~yg~~iDiWgAgCimaeMwtrspimq---gnteqqql~~  240 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG-------DREYGPPIDIWGAGCIMAEMWTRSPIMQ---GNTEQQQLHL  240 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhc-------ccccCCcchhHhHHHHHHHHHccCcccc---CChHHHHHHH
Confidence            9765432     23445677999999999985       6789999999999999999999999887   4566666665


Q ss_pred             HHhcccCCcccccccCCCCcc-----ccc-CCCC---Cc--ccCChhHH-----HHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        239 ITTKKASGVISGTQTSENGEI-----DWC-TDLP---NN--CQLSLGLK-----KLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~-----~~~-~~lp---~~--~~ls~~l~-----~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      |..-      .|..+.+.+|.     -|. -+++   ..  ..+...++     +...+|+..||..||.+|+++++.  
T Consensus       241 Is~L------cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~a--  312 (376)
T KOG0669|consen  241 ISQL------CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQA--  312 (376)
T ss_pred             HHHH------hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhh--
Confidence            5431      11111111110     010 0111   10  00111111     246689999999999999999996  


Q ss_pred             HHHHHHhhhhcCcccCCccccc
Q psy15481        303 EVTKTLNRKLVHLFHINRLQCI  324 (708)
Q Consensus       303 ~l~~il~~~l~h~~~~~~~~~~  324 (708)
                               +.|.||+..+.+.
T Consensus       313 ---------lnh~~F~kdp~pq  325 (376)
T KOG0669|consen  313 ---------LNHDFFWKDPMPQ  325 (376)
T ss_pred             ---------hchhhhhcCCcch
Confidence                     7799999887764

>KOG1035|consensus

Probab=100.00  E-value=3.7e-34  Score=332.75  Aligned_cols=255  Identities=25%  Similarity=0.398  Sum_probs=189.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEe-----------
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEE-----------   79 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~-----------   79 (708)
                      .|+....||+||||.||+++++-+|+.||||.+.............+|+..+.+|+|||||+++..+.+           
T Consensus       480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~  559 (1351)
T KOG1035|consen  480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV  559 (1351)
T ss_pred             hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence            456778999999999999999999999999999765433444556799999999999999999743211           


Q ss_pred             --------------------------------------------c---------------------C-------------
Q psy15481         80 --------------------------------------------Q---------------------E-------------   81 (708)
Q Consensus        80 --------------------------------------------~---------------------~-------------   81 (708)
                                                                  .                     +             
T Consensus       560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~  639 (1351)
T KOG1035|consen  560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS  639 (1351)
T ss_pred             ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence                                                        0                     0             


Q ss_pred             --------------------C--------ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy15481         82 --------------------G--------RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR  133 (708)
Q Consensus        82 --------------------~--------~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g  133 (708)
                                          .        ..+||-||||+...|.+++.....  .-.....++++++|+.||.|+|++|
T Consensus       640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~--~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF--NSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc--chhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                0        236899999998888888876431  1247889999999999999999999


Q ss_pred             CcccCCCCCcEEEEEecCCCceEEEeccCcccccc-------------------ccccccccCCCCCcCChhhhhhhhhc
Q psy15481        134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-------------------EDQQFMSLYGTEEYLHPDMYERAVLR  194 (708)
Q Consensus       134 IVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~-------------------~~~~~~~~~GT~~YlAPE~l~~~~~~  194 (708)
                      ||||||||.|||+    |..+.|||+|||+|....                   ++....+.+||.-|+|||++....  
T Consensus       718 iIHRDLKP~NIFL----d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~--  791 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFL----DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS--  791 (1351)
T ss_pred             eeeccCCcceeEE----cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc--
Confidence            9999999999998    778889999999998621                   011234568999999999997421  


Q ss_pred             CCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChh
Q psy15481        195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLG  274 (708)
Q Consensus       195 ~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~  274 (708)
                         ...|+.|+||||||||||||+-   ||..     ..+....+.. -..           |      .+|.+..+...
T Consensus       792 ---~~~Yn~KiDmYSLGIVlFEM~y---PF~T-----sMERa~iL~~-LR~-----------g------~iP~~~~f~~~  842 (1351)
T KOG1035|consen  792 ---SNKYNSKIDMYSLGIVLFEMLY---PFGT-----SMERASILTN-LRK-----------G------SIPEPADFFDP  842 (1351)
T ss_pred             ---cccccchhhhHHHHHHHHHHhc---cCCc-----hHHHHHHHHh-ccc-----------C------CCCCCcccccc
Confidence               2369999999999999999975   5753     1222222221 111           1      23333222222


Q ss_pred             HHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        275 LKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       275 l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      -...-..+|+.||..||.+||||.+++.
T Consensus       843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  843 EHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             cchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            2222345999999999999999999743

>KOG1290|consensus

Probab=100.00  E-value=8.9e-33  Score=296.17  Aligned_cols=291  Identities=22%  Similarity=0.326  Sum_probs=225.5

Q ss_pred             CC-ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-----CC---CccceeEEEE
Q psy15481          8 TN-YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-----HE---NIVKLLAIEE   78 (708)
Q Consensus         8 ~n-~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-----Hp---NIVkl~~v~~   78 (708)
                      ++ .+|.+.++||.|.|++||+|.|..+.+.||+|+.+.  .....+..+.||.+|+.++     |+   .||++++.|.
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS--AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS--AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh--hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            44 799999999999999999999999999999999863  3445566789999999982     33   6999999995


Q ss_pred             --ecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEec-----
Q psy15481         79 --EQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICD-----  150 (708)
Q Consensus        79 --~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~-----  150 (708)
                        .+++.++|+|+|++ |.+|..+|..... .|+|...++.|++||+.||+|||+. ||||.||||+|||+..++     
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~  230 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAK  230 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhh
Confidence              45677899999999 8999999977554 4699999999999999999999975 999999999999863110     


Q ss_pred             -------------------------------------------------------------------------------C
Q psy15481        151 -------------------------------------------------------------------------------D  151 (708)
Q Consensus       151 -------------------------------------------------------------------------------d  151 (708)
                                                                                                     +
T Consensus       231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n  310 (590)
T KOG1290|consen  231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN  310 (590)
T ss_pred             hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence                                                                                           0


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15481        152 ------------------------------------------------------------------------------GS  153 (708)
Q Consensus       152 ------------------------------------------------------------------------------~~  153 (708)
                                                                                                    ..
T Consensus       311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d  390 (590)
T KOG1290|consen  311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD  390 (590)
T ss_pred             ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence                                                                                          00


Q ss_pred             ceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC---
Q psy15481        154 TIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR---  230 (708)
Q Consensus       154 ~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~---  230 (708)
                      ..+||+|||.|++..  ..|..-..|..|+|||++.        |..|+..+||||++|++|||+||...|.|..|.   
T Consensus       391 i~vKIaDlGNACW~~--khFT~DIQTRQYRapEVll--------GsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~  460 (590)
T KOG1290|consen  391 IRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLL--------GSGYSTSADIWSTACMAFELATGDYLFEPHSGENYS  460 (590)
T ss_pred             eeEEEeeccchhhhh--hhhchhhhhhhccCcceee--------cCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCC
Confidence            136778888887643  3456667899999999998        899999999999999999999999999987653   


Q ss_pred             ChhhHHHHHHh---cccCCc-----ccccccCCCCcccccCCCCCcc---------cCChhHHHHHHHHHHhhcccCccc
Q psy15481        231 RNKETMYYITT---KKASGV-----ISGTQTSENGEIDWCTDLPNNC---------QLSLGLKKLVTPILAGLLEVDSKK  293 (708)
Q Consensus       231 ~~~e~~~~i~~---~~~~~~-----i~~~~~~~~g~~~~~~~lp~~~---------~ls~~l~~~l~~LL~~mL~~DP~k  293 (708)
                      .+.+.+..|..   ..++.+     .+...+...|...-...+..+.         ..|.+-...+.+||.-||+.+|++
T Consensus       461 rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeK  540 (590)
T KOG1290|consen  461 RDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEK  540 (590)
T ss_pred             ccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccc
Confidence            34555555442   333222     1222223344433333333332         356667778999999999999999


Q ss_pred             CCCHHHHHHHHHHHHhhhhcCcccCCcccc
Q psy15481        294 IWSFERFFSEVTKTLNRKLVHLFHINRLQC  323 (708)
Q Consensus       294 Rpsa~q~~~~l~~il~~~l~h~~~~~~~~~  323 (708)
                      ||||.++           +.|||+.+-+..
T Consensus       541 R~tA~~c-----------l~hPwLn~~~~~  559 (590)
T KOG1290|consen  541 RPTAAQC-----------LKHPWLNPVAGP  559 (590)
T ss_pred             cccHHHH-----------hcCccccCCCCC
Confidence            9999998           679999876664

>KOG0668|consensus

Probab=100.00  E-value=1.7e-34  Score=284.21  Aligned_cols=278  Identities=19%  Similarity=0.334  Sum_probs=224.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..|++.+.+|+|.++.||.|.+..+++.++||+++...    .....+|+.+|..|. ||||++++++..++.+..+.+|
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            35788899999999999999999999999999987543    445679999999995 9999999999999988889999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      +||+++.+...+-..      ++...++.++.+++.||+|||++||+|||+||.|+|+   +.....++|+|+|+|.++.
T Consensus       114 FE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI---dh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee---chhhceeeeeecchHhhcC
Confidence            999998888776644      8889999999999999999999999999999999997   2345579999999999999


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      ++......+.+..|--||.+..       -..|+.+-|||||||+|..|+..+-||-  .|.+|.+++.+|..--....+
T Consensus       185 p~~eYnVRVASRyfKGPELLVd-------y~~YDYSLD~WS~GcmlA~miFrkepFF--hG~dN~DQLVkIakVLGt~el  255 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFF--HGHDNYDQLVKIAKVLGTDEL  255 (338)
T ss_pred             CCceeeeeeehhhcCCchheee-------chhccccHHHHHHHHHHHHHHhccCccc--CCCCCHHHHHHHHHHhChHHH
Confidence            9988888899999999999974       4678899999999999999999999984  488888888887642111100


Q ss_pred             ----------cccc-cC---CCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcC
Q psy15481        249 ----------SGTQ-TS---ENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVH  314 (708)
Q Consensus       249 ----------~~~~-~~---~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h  314 (708)
                                ...+ ..   ......|..-++.....  -..+.+.++|.++|..|-.+|+||.+.           +.|
T Consensus       256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h--l~~peaiDlldklLrYDHqeRlTakEa-----------m~H  322 (338)
T KOG0668|consen  256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQH--LVSPEAIDLLDKLLRYDHQERLTAKEA-----------MAH  322 (338)
T ss_pred             HHHHHHHccCCChhHhhHhhccccccHHHhCCccccc--cCChHHHHHHHHHHhhccccccchHHH-----------hcC
Confidence                      0000 00   11234555444433211  112456679999999999999999995           889


Q ss_pred             cccCCccc
Q psy15481        315 LFHINRLQ  322 (708)
Q Consensus       315 ~~~~~~~~  322 (708)
                      |||.+...
T Consensus       323 pyF~~~~~  330 (338)
T KOG0668|consen  323 PYFAPVRE  330 (338)
T ss_pred             chHHHHHH
Confidence            99966543

>KOG1151|consensus

Probab=100.00  E-value=3.5e-34  Score=302.48  Aligned_cols=272  Identities=24%  Similarity=0.375  Sum_probs=212.4

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC------chHHHHHHHHHHHhCCCCCccceeEEEEec
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR------PHDVQMREFEVLKKVKHENIVKLLAIEEEQ   80 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~------~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~   80 (708)
                      +.|.+|.+..+||+|||+.||+|.+....++||+|+-......+      ......+|.+|-+.|+||.||+++++|.-.
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            35678889999999999999999999999999999753222111      122346999999999999999999999654


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCCCcEEEEEecCCCceEEE
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN--RLVHRDLKPGNIMKFICDDGSTIYKL  158 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~--gIVHrDIKP~NILl~~~~d~~~~vKL  158 (708)
                      . ..+|-|+|||+|.+|.-+++....   +++.+++.|+.||+.||.||...  .|||-|+||.|||+ +.....+.+||
T Consensus       540 t-dsFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILL-v~GtacGeIKI  614 (775)
T KOG1151|consen  540 T-DSFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILL-VNGTACGEIKI  614 (775)
T ss_pred             c-ccceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEE-ecCcccceeEe
Confidence            3 358999999999999999987554   99999999999999999999975  79999999999997 77777889999


Q ss_pred             eccCccccccccc--------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC
Q psy15481        159 TDFGAARELEEDQ--------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR  230 (708)
Q Consensus       159 ~DFGlA~~~~~~~--------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~  230 (708)
                      +|||++...+++.        ......||-+|++||.+...   +. ....+.++||||+|||||.++.|+-||..  ..
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg---ke-PPKIsnKVDVWSvGVIFyQClYGrKPFGh--nq  688 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG---KE-PPKISNKVDVWSVGVIFYQCLYGRKPFGH--NQ  688 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecC---CC-CCccccceeeEeeehhhhhhhccCCCCCC--ch
Confidence            9999998765442        12336799999999998632   11 35679999999999999999999999963  22


Q ss_pred             ChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        231 RNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       231 ~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      +..+++....--+...                ..+|..+.+++++.+    +|++||.+.-+.|....++          
T Consensus       689 sQQdILqeNTIlkAtE----------------VqFP~KPvVsseAka----FIRRCLaYRKeDR~DV~qL----------  738 (775)
T KOG1151|consen  689 SQQDILQENTILKATE----------------VQFPPKPVVSSEAKA----FIRRCLAYRKEDRIDVQQL----------  738 (775)
T ss_pred             hHHHHHhhhchhccee----------------ccCCCCCccCHHHHH----HHHHHHHhhhhhhhhHHHH----------
Confidence            3333333221111111                145666667776666    8999999999999998886          


Q ss_pred             hhcCcccCCc
Q psy15481        311 KLVHLFHINR  320 (708)
Q Consensus       311 ~l~h~~~~~~  320 (708)
                       -.||++.+.
T Consensus       739 -A~dpyllPh  747 (775)
T KOG1151|consen  739 -ACDPYLLPH  747 (775)
T ss_pred             -ccCccccch
Confidence             457777653

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2e-32  Score=322.00  Aligned_cols=147  Identities=27%  Similarity=0.364  Sum_probs=127.7

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++........  ...+.+|+.+++.++||||+++++++...+  .+|+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~l   81 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN--NVYL   81 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC--EEEE
Confidence            368899999999999999999999999999999975432211  244568999999999999999998887644  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ||||+.|++|..++.....   +++..++.++.||+.||.|||.+||+||||||+|||+    +..+.+||+|||+++
T Consensus        82 VmEy~~g~~L~~li~~~~~---l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl----~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI----SNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE----cCCCCEEEEeCCCCc
Confidence            9999999999999975432   8999999999999999999999999999999999998    556689999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0603|consensus

Probab=100.00  E-value=3.5e-33  Score=309.24  Aligned_cols=244  Identities=27%  Similarity=0.326  Sum_probs=197.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      -.|.+...+|.|+||.|..+.+..+++.+++|++.+....    . .+|+.++... +||||+++++++.+.-  +.|+|
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~-~~e~~~~~~~~~h~niv~~~~v~~~~~--~~~~v  394 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----N-QDEIPISLLVRDHPNIVKSHDVYEDGK--EIYLV  394 (612)
T ss_pred             hhhccccccCCCCccceeeeeccccccchhheeccccccc----c-ccccchhhhhcCCCcceeecceecCCc--eeeee
Confidence            4677778899999999999999999999999999765211    1 1566666655 8999999999998744  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||.+.|+-+.+.+.....   +. .++..|+.+|+.|+.|||++|+||||+||+|||+  . ++.+.++|+|||.++...
T Consensus       395 ~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~--~-~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILL--D-GSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             ehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheee--c-CCCCcEEEEEechhhhCc
Confidence            999999888776655432   33 7888899999999999999999999999999997  1 355679999999999876


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      ..  ..+.+-|..|.|||++.        ...|++++|+||||++||+|++|+.||...+  ...+++.++...      
T Consensus       468 ~~--~~tp~~t~~y~APEvl~--------~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P--~~~ei~~~i~~~------  529 (612)
T KOG0603|consen  468 RS--CDTPALTLQYVAPEVLA--------IQEYTEACDWWSLGVLLYEMLTGRTLFAAHP--AGIEIHTRIQMP------  529 (612)
T ss_pred             hh--hcccchhhcccChhhhc--------cCCCCcchhhHHHHHHHHHHHhCCCccccCC--chHHHHHhhcCC------
Confidence            66  56678899999999997        6889999999999999999999999998532  224444433321      


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                                        .   .+..+++...+||..||++||.+|++++++           ..|+|+
T Consensus       530 ------------------~---~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i-----------~~h~w~  566 (612)
T KOG0603|consen  530 ------------------K---FSECVSDEAKDLLQQLLQVDPALRLGADEI-----------GAHPWF  566 (612)
T ss_pred             ------------------c---cccccCHHHHHHHHHhccCChhhCcChhhh-----------ccCcch
Confidence                              1   123344455569999999999999999997           678888

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.6e-33  Score=284.91  Aligned_cols=234  Identities=20%  Similarity=0.246  Sum_probs=179.2

Q ss_pred             CCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCCCHHHH
Q psy15481         21 GATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNI  100 (708)
Q Consensus        21 G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~  100 (708)
                      |.+|.||++.++.+|+.||+|.+...+.      ..+|...+....||||+++++++....  ..|+||||++||+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------YSRERLTIIPHCVPNMVCLHKYIVSED--SVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh------hhhHHHHHHhcCCCceeehhhheecCC--eEEEEEecCCCCCHHHH
Confidence            8999999999999999999999875431      124445555668999999999987644  59999999999999998


Q ss_pred             hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccccccCCCC
Q psy15481        101 LDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE  180 (708)
Q Consensus       101 L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~  180 (708)
                      +.....   +++..+..++.|++.||.|||++|++||||||+||++    +..+.++++|||.+......  .....++.
T Consensus        76 l~~~~~---l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~~l~df~~~~~~~~~--~~~~~~~~  146 (237)
T cd05576          76 ISKFLN---IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL----DDRGHIQLTYFSRWSEVEDS--CDGEAVEN  146 (237)
T ss_pred             HHHhcC---CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE----cCCCCEEEecccchhccccc--cccCCcCc
Confidence            866432   8999999999999999999999999999999999998    66677999999988655432  23455678


Q ss_pred             CcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCccc
Q psy15481        181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEID  260 (708)
Q Consensus       181 ~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~  260 (708)
                      .|+|||.+.        +..++.++|+||+||++|+|++|..||....    ..    +..              .  . 
T Consensus       147 ~y~aPE~~~--------~~~~~~~~DvwslG~il~el~~g~~~~~~~~----~~----~~~--------------~--~-  193 (237)
T cd05576         147 MYCAPEVGG--------ISEETEACDWWSLGAILFELLTGKTLVECHP----SG----INT--------------H--T-  193 (237)
T ss_pred             cccCCcccC--------CCCCCchhhHHHHHHHHHHHHHCcchhhcCc----hh----ccc--------------c--c-
Confidence            899999875        5667889999999999999999998885311    00    000              0  0 


Q ss_pred             ccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        261 WCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       261 ~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                       ...+|      +.++..+.++|.+||..||++||++.+.      .+...+.|||+
T Consensus       194 -~~~~~------~~~~~~~~~li~~~l~~dp~~R~~~~~~------~~~~~~~h~~~  237 (237)
T cd05576         194 -TLNIP------EWVSEEARSLLQQLLQFNPTERLGAGVA------GVEDIKSHPFF  237 (237)
T ss_pred             -ccCCc------ccCCHHHHHHHHHHccCCHHHhcCCCcc------chHHHHcCCCC
Confidence             00122      2233456679999999999999997321      01112678885

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006|consensus

Probab=100.00  E-value=6.8e-34  Score=285.27  Aligned_cols=251  Identities=24%  Similarity=0.347  Sum_probs=198.4

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEeccC
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELCT   93 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~~   93 (708)
                      ...||.|+||+|++..++.+|+..|||.++..........+..|.+...+- +.||||+++++....+.  -||.||.| 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--cWiCMELM-  145 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--CWICMELM-  145 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--eeeeHHHH-
Confidence            457999999999999999999999999998766544455566777765544 89999999998876554  89999999 


Q ss_pred             CCCHHHHhc---CCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         94 GGSLFNILD---DPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        94 ggsL~~~L~---~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ..||..+-+   .... ..++|..+-.|.-..+.||+||... .||||||||+|||+    |..+.+||||||.+..+.+
T Consensus       146 d~SlDklYk~vy~vq~-~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl----dr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  146 DISLDKLYKRVYSVQK-SRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL----DRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             hhhHHHHHHHHHHHHh-ccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE----ecCCCEeeecccchHhHHH
Confidence            577755332   1111 2289999999999999999999975 99999999999999    8899999999999998877


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      .-......|...|||||.+..      .+..|..++|+||||++|||++||..|++.|+.  ..+++..+..+.++....
T Consensus       221 SiAkT~daGCrpYmAPERi~p------~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDP------SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLF  292 (361)
T ss_pred             HHHhhhccCCccccChhccCC------ccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecC
Confidence            665566789999999999873      356799999999999999999999999997643  566666666544333211


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      ..               ..-+.    ...+..++.-||.+|-..||.++++
T Consensus       293 ~~---------------~~~~~----s~~~~~fintCl~Kd~~~Rpky~~L  324 (361)
T KOG1006|consen  293 DK---------------ECVHY----SFSMVRFINTCLIKDRSDRPKYDDL  324 (361)
T ss_pred             cc---------------ccccc----CHHHHHHHHHHhhcccccCcchhhh
Confidence            10               01112    3345669999999999999999987

>KOG0196|consensus

Probab=99.98  E-value=1.2e-32  Score=307.66  Aligned_cols=256  Identities=24%  Similarity=0.384  Sum_probs=216.6

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCc---eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...+.++||.|.||.||+|+-+..|+   .||||.++..........|..|..||..++||||+.+-++.....  .+.|
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~--PvMI  707 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK--PVMI  707 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc--eeEE
Confidence            45788999999999999999887664   699999987766665666789999999999999999999987644  4999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |+|||++|+|..+|....  +.++.-++..+++.|+.||+||-++|+|||||-..|||+    +.+.+.|++|||+++.+
T Consensus       708 iTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV----NsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV----NSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             EhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee----ccceEEEeccccceeec
Confidence            999999999999998755  349999999999999999999999999999999999999    99999999999999988


Q ss_pred             cccc-cccc-cC--CCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhc
Q psy15481        168 EEDQ-QFMS-LY--GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       168 ~~~~-~~~~-~~--GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .++. ...+ .-  -...|.|||.+.        ...++.++|+||+|++|||.++ |..||-   .-+|.+.+..|...
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa--------~RKFTsASDVWSyGIVmWEVmSyGERPYW---dmSNQdVIkaIe~g  850 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIA--------YRKFTSASDVWSYGIVMWEVMSYGERPYW---DMSNQDVIKAIEQG  850 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhh--------hcccCchhhccccceEEEEecccCCCccc---ccchHHHHHHHHhc
Confidence            7664 2222 21  236899999998        6889999999999999999998 999986   46788888777652


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                                          ..+|.+-..+.    .+..|+..||++|-.+||.|.|++..+++++.
T Consensus       851 --------------------yRLPpPmDCP~----aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  851 --------------------YRLPPPMDCPA----ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             --------------------cCCCCCCCCcH----HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence                                25666544444    45558889999999999999999998887754

>KOG0587|consensus

Probab=99.98  E-value=2.5e-31  Score=301.33  Aligned_cols=266  Identities=24%  Similarity=0.427  Sum_probs=215.7

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEe---cCCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEE---QEGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~---~~~~~   84 (708)
                      .-.|++...||.|.+|.||+++++++|+..|+|+.......  .+....|+++++.+ .|||++.+++++.-   ..++.
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            34689999999999999999999999999999998654332  34455788899988 79999999998843   33567


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      +|+|||||.|||.-+++++.. ...+.|..+.+|++.++.|+.|||.+.++|||||-.|||+    ...+.|||+|||.+
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL----T~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL----TENAEVKLVDFGVS  170 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE----eccCcEEEeeeeee
Confidence            999999999999999998765 4559999999999999999999999999999999999998    66667999999999


Q ss_pred             ccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        165 RELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       165 ~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ..+...- ...+..|||.|||||++....   .....|+..+|+||||++..||.-|.+|+..   ....-.++.|... 
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e---~~d~tyd~R~D~WsLGITaIEladG~PPl~D---mHPmraLF~IpRN-  243 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDE---SPDATYDYRSDLWSLGITAIEMAEGAPPLCD---MHPMRALFLIPRN-  243 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeeccc---CCCCCcccccchhhccceeehhcCCCCCccC---cchhhhhccCCCC-
Confidence            8776543 345678999999999986322   1246788999999999999999999999973   2233334433322 


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                           .|....-+......+.++|..||.+|-.+||+..++           +.|||....
T Consensus       244 ---------------------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l-----------l~hpFi~e~  288 (953)
T KOG0587|consen  244 ---------------------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL-----------LKHPFITEQ  288 (953)
T ss_pred             ---------------------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhh-----------ccCCccccc
Confidence                                 222222345667778889999999999999999997           779999743

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=4.7e-31  Score=323.04  Aligned_cols=257  Identities=19%  Similarity=0.268  Sum_probs=189.9

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEec
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      +...+.||+|+||.||+|.+..+|..||+|.+.....     ....|++.+++++|||||++++++.+.+  ..|+||||
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv~Ey  764 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLIHEY  764 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEEEeC
Confidence            3456789999999999999999999999999864322     1125688999999999999999997654  48999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR---DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH---~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ++||+|.+++..      +++.....++.+++.||+|||   +.+|+||||||+||++    ++....++. ||.+....
T Consensus       765 ~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~----~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        765 IEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII----DGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             CCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE----CCCCceEEE-eccccccc
Confidence            999999999963      889999999999999999999   6799999999999997    544445554 55543322


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC-ChhhHHHHHHhcccCCc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-RNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~-~~~e~~~~i~~~~~~~~  247 (708)
                      .+   ....||+.|+|||++.        +..++.++|||||||++|||+||+.||....+. .....+.+.....  . 
T Consensus       834 ~~---~~~~~t~~y~aPE~~~--------~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~-  899 (968)
T PLN00113        834 TD---TKCFISSAYVAPETRE--------TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD--C-  899 (968)
T ss_pred             cC---CCccccccccCccccc--------CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc--c-
Confidence            11   2336889999999986        677899999999999999999999999642221 1111111110000  0 


Q ss_pred             ccccccCCCCcccccC-CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        248 ISGTQTSENGEIDWCT-DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~-~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                               ....|.+ .++............+.+++.+||..||++||++.+++..++.+..
T Consensus       900 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        900 ---------HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ---------chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence                     0001111 1111112233444567789999999999999999999998877654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=8.5e-31  Score=264.31  Aligned_cols=239  Identities=32%  Similarity=0.550  Sum_probs=192.0

Q ss_pred             CceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCCCHHHHh
Q psy15481         22 ATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNIL  101 (708)
Q Consensus        22 ~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L  101 (708)
                      +||.||+|.+..+|+.||+|++.........+.+.+|+..+++++|+||+++++.+....  ..+++|||+++++|..++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED--KLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC--EEEEEEeCCCCCCHHHHH
Confidence            689999999998999999999976544332566779999999999999999999987643  599999999999999998


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccccccCCCCC
Q psy15481        102 DDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE  181 (708)
Q Consensus       102 ~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~  181 (708)
                      .....   ++...+..++.+++.++.|||+.|++|+||+|+||++    +..+.++|+|||.+.............++..
T Consensus        79 ~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  151 (244)
T smart00220       79 KKRGR---LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL----DEDGHVKLADFGLARQLDPGGLLTTFVGTPE  151 (244)
T ss_pred             HhccC---CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE----CCCCcEEEccccceeeeccccccccccCCcC
Confidence            76443   8999999999999999999999999999999999998    5567899999999998766555566778999


Q ss_pred             cCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccc
Q psy15481        182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDW  261 (708)
Q Consensus       182 YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~  261 (708)
                      |++||.+.        +..++.++|+||+|+++|++++|..||...   .+...+.........                
T Consensus       152 ~~~pE~~~--------~~~~~~~~Di~slG~~l~~l~~~~~p~~~~---~~~~~~~~~~~~~~~----------------  204 (244)
T smart00220      152 YMAPEVLL--------GKGYGKAVDVWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKP----------------  204 (244)
T ss_pred             CCCHHHHc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHhccCC----------------
Confidence            99999986        566788999999999999999999999631   223333333321100                


Q ss_pred             cCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHH
Q psy15481        262 CTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFF  301 (708)
Q Consensus       262 ~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~  301 (708)
                          +. ......++..+.+++.+||..||++||++.+++
T Consensus       205 ----~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~  239 (244)
T smart00220      205 ----PF-PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEAL  239 (244)
T ss_pred             ----CC-ccccccCCHHHHHHHHHHccCCchhccCHHHHh
Confidence                00 000001334567799999999999999999973

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=4.5e-31  Score=304.29  Aligned_cols=280  Identities=16%  Similarity=0.208  Sum_probs=181.0

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCC----CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEE----e
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNN----GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEE----E   79 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~t----g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~----~   79 (708)
                      ....|.+.+.||+|+||.||+|.+..+    +..||+|.+.....   .+....+  .++...+.++..+...+.    .
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            345799999999999999999999988    99999998764221   1222121  222223333333322211    1


Q ss_pred             cCCceEEEEEeccCCCCHHHHhcCCCCCCC-----------------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q psy15481         80 QEGRGKVIVMELCTGGSLFNILDDPENTYG-----------------LQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPG  142 (708)
Q Consensus        80 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~-----------------L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~  142 (708)
                      ......++||||+.+++|.+++......+.                 .....+..++.||+.||.|||++||+||||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            234468999999999999999875432110                 123456789999999999999999999999999


Q ss_pred             cEEEEEecCCCceEEEeccCccccccccc--cccccCCCCCcCChhhhhhhhhcCCC--------------CCcCCcccc
Q psy15481        143 NIMKFICDDGSTIYKLTDFGAARELEEDQ--QFMSLYGTEEYLHPDMYERAVLRKPV--------------GKTFGATVD  206 (708)
Q Consensus       143 NILl~~~~d~~~~vKL~DFGlA~~~~~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~--------------~~~~s~ksD  206 (708)
                      |||+  + +..+.+||+|||+|.......  ......+++.|+|||.+.........              +..++.++|
T Consensus       285 NILl--~-~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        285 NIIF--S-EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HEEE--e-CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            9997  1 134679999999998654332  22346789999999977532110000              123456779


Q ss_pred             chhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCc--------ccCChhHHHH
Q psy15481        207 LWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNN--------CQLSLGLKKL  278 (708)
Q Consensus       207 IWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~--------~~ls~~l~~~  278 (708)
                      ||||||+||+|++|..|+.     .+...+..+......           ....|...++..        ..+.......
T Consensus       362 VwSlGviL~el~~~~~~~~-----~~~~~~~~~l~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  425 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSD-----SNLIQFNRQLKRNDY-----------DLVAWRKLVEPRASPDLRRGFEVLDLDGGA  425 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCc-----hHHHHHHHHHHhcCC-----------cHHHHHHhhccccchhhhhhhhhccccchH
Confidence            9999999999999776653     223333333321110           011222111111        0000111123


Q ss_pred             HHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        279 VTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       279 l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      ..+||.+||..||++|||+.++           +.|||+.....
T Consensus       426 ~~dLi~~mL~~dP~kR~ta~e~-----------L~Hpff~~~~~  458 (566)
T PLN03225        426 GWELLKSMMRFKGRQRISAKAA-----------LAHPYFDREGL  458 (566)
T ss_pred             HHHHHHHHccCCcccCCCHHHH-----------hCCcCcCCCCc
Confidence            4579999999999999999997           77999976543

>KOG0199|consensus

Probab=99.97  E-value=1.6e-31  Score=295.21  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=207.0

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCC-Cc--eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNN-GE--PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~t-g~--~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...+.+.||+|.||.|++|.|... |+  .||||+++........+.+.+|+.+|.+|+|||++++|+++.++.   ..+
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp---~mM  187 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP---AMM  187 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch---hhH
Confidence            345668899999999999998753 33  599999987766556777899999999999999999999998744   789


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||.+++|||.+.|.+ .....|....+..++.||+.||.||.++++||||+-..|+++    .....|||+|||+.+.+
T Consensus       188 V~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll----asprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL----ASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             HhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee----cccceeeeecccceecc
Confidence            9999999999999987 333458999999999999999999999999999999999998    44668999999999998


Q ss_pred             ccccccccc----CCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhc
Q psy15481        168 EEDQQFMSL----YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       168 ~~~~~~~~~----~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      ..++.....    --...|+|||.+.        ...|+.++|+|++||++|||+| |..||.   |.+...+++.|-.+
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLr--------h~kFShaSDvWmyGVTiWEMFtyGEePW~---G~~g~qIL~~iD~~  331 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLR--------HRKFSHASDVWMYGVTIWEMFTYGEEPWV---GCRGIQILKNIDAG  331 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhc--------cccccccchhhhhhhhHHhhhccCCCCCC---CCCHHHHHHhcccc
Confidence            877655432    2345799999998        6889999999999999999999 999998   56666777666521


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                       .                   .+|.+    +.++..|.+++..||..+|++||+|..+..
T Consensus       332 -e-------------------rLpRP----k~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  332 -E-------------------RLPRP----KYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             -c-------------------cCCCC----CCChHHHHHHHHHhccCCccccccHHHHHH
Confidence             0                   34443    344566778999999999999999987643

>KOG0695|consensus

Probab=99.97  E-value=1.5e-31  Score=274.77  Aligned_cols=247  Identities=23%  Similarity=0.396  Sum_probs=200.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|.+..+||+|+|++|.+++.++|.+.||+|++++.-..  +..+-...|-.+...- +||.+|-++..|....  .++
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes--rlf  327 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES--RLF  327 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc--eEE
Confidence            4688999999999999999999999999999999865322  2233334566666655 8999999999887655  499


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|.||++||+|.-.++....   +|++.++.+...|+.||+|||+.|||+||+|.+|+|+    |..+.+||+|+|.+.+
T Consensus       328 fvieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rgiiyrdlkldnvll----daeghikltdygmcke  400 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL----DAEGHIKLTDYGMCKE  400 (593)
T ss_pred             EEEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE----ccCCceeecccchhhc
Confidence            99999999999877766543   9999999999999999999999999999999999999    8888999999999986


Q ss_pred             c-cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCC----CCChhhHHHHHHh
Q psy15481        167 L-EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG----GRRNKETMYYITT  241 (708)
Q Consensus       167 ~-~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~----g~~~~e~~~~i~~  241 (708)
                      . .++....+.+|||.|.|||++.        +..|+..+|.|+|||+++||+.|+.||.-.+    ..+..+.+++++-
T Consensus       401 ~l~~gd~tstfcgtpnyiapeilr--------geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil  472 (593)
T KOG0695|consen  401 GLGPGDTTSTFCGTPNYIAPEILR--------GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL  472 (593)
T ss_pred             CCCCCcccccccCCCcccchhhhc--------ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh
Confidence            4 5556677899999999999998        8999999999999999999999999997432    2334455555554


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF  297 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa  297 (708)
                      .+.-                  .+|.  .+|-.    ...+|++.|.+||.+|...
T Consensus       473 ekqi------------------ripr--slsvk----as~vlkgflnkdp~erlgc  504 (593)
T KOG0695|consen  473 EKQI------------------RIPR--SLSVK----ASHVLKGFLNKDPKERLGC  504 (593)
T ss_pred             hhcc------------------cccc--eeehh----hHHHHHHhhcCCcHHhcCC
Confidence            3211                  1222  23333    3448899999999999763

>KOG0670|consensus

Probab=99.97  E-value=7.4e-32  Score=290.01  Aligned_cols=280  Identities=23%  Similarity=0.371  Sum_probs=213.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCC------CCccceeEEEEecCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH------ENIVKLLAIEEEQEG   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~H------pNIVkl~~v~~~~~~   82 (708)
                      ..+|.+....|+|-||+|..|.+..-|..||||+++....+  ...=.+|+++|++|+.      -|++.++..|...+ 
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn-  507 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN-  507 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc-
Confidence            45788888999999999999999999999999999753221  2222589999999952      38899998887655 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                       ++|+|+|-+ ..+|..+|+..+..-||....++.++.|+..||..|...||+|.||||+|||+   +.+..++||||||
T Consensus       508 -HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLV---NE~k~iLKLCDfG  582 (752)
T KOG0670|consen  508 -HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILV---NESKNILKLCDFG  582 (752)
T ss_pred             -eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEe---ccCcceeeeccCc
Confidence             599999999 68999999997777789999999999999999999999999999999999997   4567799999999


Q ss_pred             ccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh-
Q psy15481        163 AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT-  241 (708)
Q Consensus       163 lA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~-  241 (708)
                      .|....+++. ..+..+..|.|||++.        |..|+...|+||.||+||||.||...|.   |..|..++..... 
T Consensus       583 SA~~~~enei-tPYLVSRFYRaPEIiL--------G~~yd~~iD~WSvgctLYElYtGkIlFp---G~TNN~MLrl~me~  650 (752)
T KOG0670|consen  583 SASFASENEI-TPYLVSRFYRAPEIIL--------GLPYDYPIDTWSVGCTLYELYTGKILFP---GRTNNQMLRLFMEL  650 (752)
T ss_pred             cccccccccc-cHHHHHHhccCcceee--------cCcccCCccceeeceeeEEeeccceecC---CCCcHHHHHHHHHh
Confidence            9998777653 3455678899999998        8999999999999999999999999998   5666555443332 


Q ss_pred             -cccCC-cccc-----cccCCC------------C--cccccCCCCC----------cccCC---hhHHHHHHHHHHhhc
Q psy15481        242 -KKASG-VISG-----TQTSEN------------G--EIDWCTDLPN----------NCQLS---LGLKKLVTPILAGLL  287 (708)
Q Consensus       242 -~~~~~-~i~~-----~~~~~~------------g--~~~~~~~lp~----------~~~ls---~~l~~~l~~LL~~mL  287 (708)
                       ++.+. .+-.     -.+..+            +  .+.-...+.+          ...++   +..-..+.+||.+||
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence             11111 0000     000000            0  0000001111          01122   234556889999999


Q ss_pred             ccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        288 EVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       288 ~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ..||++|.|..+.           +.|||+..
T Consensus       731 ~LdP~KRit~nqA-----------L~HpFi~~  751 (752)
T KOG0670|consen  731 ILDPEKRITVNQA-----------LKHPFITE  751 (752)
T ss_pred             ccChhhcCCHHHH-----------hcCCcccC
Confidence            9999999999984           88999864

>KOG0664|consensus

Probab=99.97  E-value=6.2e-33  Score=278.67  Aligned_cols=270  Identities=22%  Similarity=0.382  Sum_probs=199.3

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCceEEEEEeccC-CCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc---eEEEE
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQL-SHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR---GKVIV   88 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~-s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~---~~~LV   88 (708)
                      +-.+-||.|+||.||.+.++++|+.||+|.+... ..........+|+.+|..++|.|+...+++...+..+   .+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3457899999999999999999999999987532 1222334456999999999999999999987654432   26889


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      +|.+ ..+|..++..+..   ++.+.++.+++||++||+|||+.||.||||||+|.|+    +.++++||||||+|+.-+
T Consensus       136 TELm-QSDLHKIIVSPQ~---Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV----NSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVSPQA---LTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV----NSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHH-HhhhhheeccCCC---CCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe----ccCceEEecccccccccc
Confidence            9999 5899999988775   9999999999999999999999999999999999999    899999999999999755


Q ss_pred             ccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        169 EDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       169 ~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      .++  .+...+.|..|+|||++.+       ...|+.++||||.|||+.|++..+..|..   .+..+.+.-|+.--...
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMG-------aRhYs~AvDiWSVGCIFaELLgRrILFQA---q~PiqQL~lItdLLGTP  277 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMG-------ARRYTGAVDIWSVGCIFAELLQRKILFQA---AGPIEQLQMIIDLLGTP  277 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhc-------chhhcCccceehhhHHHHHHHhhhhhhhc---cChHHHHHHHHHHhCCC
Confidence            443  2344567889999999985       57799999999999999999999999985   34444444443211000


Q ss_pred             cccccccCCCCcc----ccc---CCCCCcccCCh--hHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        247 VISGTQTSENGEI----DWC---TDLPNNCQLSL--GLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       247 ~i~~~~~~~~g~~----~~~---~~lp~~~~ls~--~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      ..........|..    +-.   ..++..-.++.  ........++..||.+||.+|.+..+.
T Consensus       278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A  340 (449)
T KOG0664|consen  278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA  340 (449)
T ss_pred             cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence            0000000000100    000   01111111222  233445668899999999999997764

>KOG1027|consensus

Probab=99.97  E-value=1.2e-31  Score=302.78  Aligned_cols=261  Identities=27%  Similarity=0.432  Sum_probs=199.1

Q ss_pred             eEEEeeEeecCCce-EEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATG-AVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG-~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.-.+++|.|+.| .||+|.-  .|+.||||.+-...    .+...+|+..|+.- .|||||++++...+  ....||+
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d--~qF~YIa  581 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQD--RQFLYIA  581 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccC--CceEEEE
Confidence            45667889999987 6899975  58999999875332    45567999999987 79999999987655  4469999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCH-HHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEe-cCCCceEEEeccCcccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQE-EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFIC-DDGSTIYKLTDFGAARE  166 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e-~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~-~d~~~~vKL~DFGlA~~  166 (708)
                      .|.| ..+|.++++.......... ...+.++.|++.||+|||+.+||||||||.|||+... .++...++|+|||++..
T Consensus       582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            9999 5899999987411111111 4567899999999999999999999999999998332 24557899999999998


Q ss_pred             cccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC-CCCCCCCCCCChhhHHHHHHh
Q psy15481        167 LEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG-NLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       167 ~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG-~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      +..+..    .....||.+|+|||++.        ...-+.++||||+||++|++++| ..||..     +.+.-..|..
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~--------~~~~~~avDiFslGCvfyYvltgG~HpFGd-----~~~R~~NIl~  727 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLR--------EDRKTQAVDIFSLGCVFYYVLTGGSHPFGD-----SLERQANILT  727 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHh--------ccccCcccchhhcCceEEEEecCCccCCCc-----hHHhhhhhhc
Confidence            766543    33467999999999998        34456699999999999999995 999952     2333333443


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                      ....                   +   ..+.+.-.....+||.+|+.+||..||+|.++           +.||+||+..
T Consensus       728 ~~~~-------------------L---~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~V-----------L~HPlFW~~e  774 (903)
T KOG1027|consen  728 GNYT-------------------L---VHLEPLPDCEAKDLISRMLNPDPQLRPSATDV-----------LNHPLFWDSE  774 (903)
T ss_pred             Cccc-------------------e---eeeccCchHHHHHHHHHhcCCCcccCCCHHHH-----------hCCCccCChH
Confidence            2211                   1   11111111267789999999999999999997           7899999987


Q ss_pred             ccccc
Q psy15481        322 QCIRI  326 (708)
Q Consensus       322 ~~~~~  326 (708)
                      ....+
T Consensus       775 krL~F  779 (903)
T KOG1027|consen  775 KRLSF  779 (903)
T ss_pred             HHHHH
Confidence            76665

>KOG4278|consensus

Probab=99.97  E-value=4.5e-31  Score=287.61  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=206.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      ...+.+.||-|.||.||.|.|++-.-.||||.++.+.  ...+.+..|..+|+.++|||+|+++++|.....  +|||+|
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP--FYIiTE  343 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP--FYIITE  343 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC--eEEEEe
Confidence            4567889999999999999999999999999987543  345678899999999999999999999987665  999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      ||..|+|.++|..... .-++.-.+++++.||..||.||..+++|||||-..|+|+    ..+.+||++|||+++....+
T Consensus       344 fM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV----gEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             cccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc----cccceEEeeccchhhhhcCC
Confidence            9999999999987643 237888889999999999999999999999999999998    77789999999999987655


Q ss_pred             cccc--ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        171 QQFM--SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       171 ~~~~--~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      .-..  ..-....|.|||.+.        -..|+.++|+|+|||+|||++| |..||.+.    +...++.++.+.    
T Consensus       419 TYTAHAGAKFPIKWTAPEsLA--------yNtFSiKSDVWAFGVLLWEIATYGMsPYPGi----dlSqVY~LLEkg----  482 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLA--------YNTFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYGLLEKG----  482 (1157)
T ss_pred             ceecccCccCcccccCccccc--------ccccccchhhHHHHHHHHHHHhcCCCCCCCc----cHHHHHHHHhcc----
Confidence            3211  122456899999987        4678999999999999999999 99999743    244555565532    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                   |+..-|.      +++..+..|++.||.++|..||+|.++-..++.+
T Consensus       483 -------------yRM~~Pe------GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  483 -------------YRMDGPE------GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             -------------ccccCCC------CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence                         2223333      3345566799999999999999999765555444

>KOG0608|consensus

Probab=99.97  E-value=2.9e-31  Score=290.15  Aligned_cols=242  Identities=25%  Similarity=0.433  Sum_probs=194.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHH--HHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV--QMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~--~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|..++-||-|+||.|++++..+|...||.|.+++.......++  ...|-.||..-+.+=||+++-.|.+.+.  +|+|
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn--LYFV  707 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN--LYFV  707 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc--eEEE
Confidence            57788999999999999999999999999999876543322222  3578889999999999999999877654  9999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc-
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~-  167 (708)
                      |||++||++..+|-+.+.   ++|+.++.++..+.+|+++.|..|+|||||||+||||    |-.+.+||+|||++.-+ 
T Consensus       708 MdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI----DrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI----DRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE----ccCCceeeeeccccccce
Confidence            999999999999877654   9999999999999999999999999999999999998    77788999999998532 


Q ss_pred             --------cccc----------------------------------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccc
Q psy15481        168 --------EEDQ----------------------------------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATV  205 (708)
Q Consensus       168 --------~~~~----------------------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ks  205 (708)
                              ..+.                                  .--+.+||+.|+|||++.        ...|+..+
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~--------r~g~~q~c  852 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA--------RTGYTQLC  852 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc--------ccCccccc
Confidence                    1110                                  011357999999999998        57899999


Q ss_pred             cchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccC--CCCCcccCChhHHHHHHHHH
Q psy15481        206 DLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCT--DLPNNCQLSLGLKKLVTPIL  283 (708)
Q Consensus       206 DIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~--~lp~~~~ls~~l~~~l~~LL  283 (708)
                      |.||.|||||||+.|++||..   ....++.++++                   +|..  .+|....+|.++.+++..|+
T Consensus       853 dwws~gvil~em~~g~~pf~~---~tp~~tq~kv~-------------------nw~~~l~~~~~~~ls~e~~~li~kLc  910 (1034)
T KOG0608|consen  853 DWWSVGVILYEMLVGQPPFLA---DTPGETQYKVI-------------------NWRNFLHIPYQGNLSKEALDLIQKLC  910 (1034)
T ss_pred             hhhHhhHHHHHHhhCCCCccC---CCCCcceeeee-------------------ehhhccccccccccCHHHHHHHHHHh
Confidence            999999999999999999974   44444444443                   3433  45555678888877655443


Q ss_pred             HhhcccCcccCCC
Q psy15481        284 AGLLEVDSKKIWS  296 (708)
Q Consensus       284 ~~mL~~DP~kRps  296 (708)
                           .+++.|..
T Consensus       911 -----~sad~RLG  918 (1034)
T KOG0608|consen  911 -----CSADSRLG  918 (1034)
T ss_pred             -----cChhhhhc
Confidence                 45667764

>KOG0614|consensus

Probab=99.97  E-value=3.4e-32  Score=291.97  Aligned_cols=243  Identities=23%  Similarity=0.397  Sum_probs=202.3

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ....+.-||-||||.|=++........+|+|++++...  ....+....|-.+|...+.|.||+++-.|.+..  ++|++
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k--yvYmL  498 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK--YVYML  498 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch--hhhhh
Confidence            34566789999999999998776666699999876422  222334458889999999999999999987754  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||.|-||.|+.++.....   +.+...+.++.+++.|++|||++|||+||+||+|.|+    |.++-+||.|||+|..+.
T Consensus       499 mEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL----d~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL----DNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             HHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcCceeccCChhheee----ccCCceEEeehhhHHHhc
Confidence            999999999999988664   9999999999999999999999999999999999998    888899999999999999


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .+....+.||||+|.|||++.        ++.-+.++|.||||+++|||+||.+||.   +.++..+...|+.+..    
T Consensus       572 ~g~KTwTFcGTpEYVAPEIIL--------nKGHD~avDyWaLGIli~ELL~G~pPFs---~~dpmktYn~ILkGid----  636 (732)
T KOG0614|consen  572 SGRKTWTFCGTPEYVAPEIIL--------NKGHDRAVDYWALGILIYELLTGSPPFS---GVDPMKTYNLILKGID----  636 (732)
T ss_pred             cCCceeeecCCcccccchhhh--------ccCcchhhHHHHHHHHHHHHHcCCCCCC---CCchHHHHHHHHhhhh----
Confidence            999999999999999999998        6778899999999999999999999998   4555555555554211    


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS  296 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps  296 (708)
                               .+.|...          +.....++++++-..+|.+|..
T Consensus       637 ---------~i~~Pr~----------I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 ---------KIEFPRR----------ITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ---------hhhcccc----------cchhHHHHHHHHHhcCcHhhhc
Confidence                     1222222          2334556889999999999987

>KOG0665|consensus

Probab=99.97  E-value=1.8e-31  Score=274.23  Aligned_cols=279  Identities=26%  Similarity=0.407  Sum_probs=212.3

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC-CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC---
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS-HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG---   82 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s-~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~---   82 (708)
                      +...+|.-...+|.|+- .|..+.|.-+++.||+|.....- ......+..+|..++..+.|+||++++.+|.....   
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            34568888899999998 89999999999999999875431 12223445699999999999999999999864322   


Q ss_pred             -ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         83 -RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        83 -~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                       ...|+|||++ ..+|...+.. +    ++=..+..++.|+++|++|||+.||+||||||+||++    ...+.+||.||
T Consensus        93 ~~e~y~v~e~m-~~nl~~vi~~-e----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv----~~~~~lKi~df  162 (369)
T KOG0665|consen   93 FQEVYLVMELM-DANLCQVILM-E----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV----NSDCTLKILDF  162 (369)
T ss_pred             HHhHHHHHHhh-hhHHHHHHHH-h----cchHHHHHHHHHHHHHHHHHHhcceeecccCccccee----cchhheeeccc
Confidence             3489999999 6899888762 2    6778999999999999999999999999999999998    77788999999


Q ss_pred             CccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        162 GAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       162 GlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      |+|+.-+.+-.....+.|..|+|||++.        +..|.+.+||||+||++.||++|...|.   |.+..+.+.++..
T Consensus       163 g~ar~e~~~~~mtpyVvtRyyrapevil--------~~~~ke~vdiwSvGci~gEli~~~Vlf~---g~d~idQ~~ki~~  231 (369)
T KOG0665|consen  163 GLARTEDTDFMMTPYVVTRYYRAPEVIL--------GMGYKENVDIWSVGCIMGELILGTVLFP---GKDHIDQWNKIIE  231 (369)
T ss_pred             hhhcccCcccccCchhheeeccCchhee--------ccCCcccchhhhhhhHHHHHhhceEEec---CchHHHHHHHHHH
Confidence            9999766554455678999999999998        6669999999999999999999999998   5556666666553


Q ss_pred             c---ccCCccccccc---------CCCCcccccCCCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        242 K---KASGVISGTQT---------SENGEIDWCTDLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       242 ~---~~~~~i~~~~~---------~~~g~~~~~~~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      .   ..+.+....+.         .....+.+...+|..     ..-++.-...+.+++.+||..||++|.|++++    
T Consensus       232 ~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da----  307 (369)
T KOG0665|consen  232 QLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA----  307 (369)
T ss_pred             HhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH----
Confidence            2   11111111110         000013333333332     11222334567889999999999999999986    


Q ss_pred             HHHHhhhhcCcccC
Q psy15481        305 TKTLNRKLVHLFHI  318 (708)
Q Consensus       305 ~~il~~~l~h~~~~  318 (708)
                             +.||++.
T Consensus       308 -------L~HPY~~  314 (369)
T KOG0665|consen  308 -------LRHPYIK  314 (369)
T ss_pred             -------hcCCeee
Confidence                   6677774

>KOG1094|consensus

Probab=99.97  E-value=9.7e-31  Score=284.73  Aligned_cols=259  Identities=21%  Similarity=0.278  Sum_probs=202.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ....+++.||+|-||.|.+|.-. .+..||+|.++..........+.+|+++|.+|+||||+.++++|...+.  +++|+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP--icmI~  614 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP--LCMIT  614 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc--hHHHH
Confidence            45678899999999999999753 4799999999987776666778899999999999999999999986655  99999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++.|+|.+++...+... +.......++.||++||+||.+.++|||||.|.|+|+    |+...+||+|||.++.+-.
T Consensus       615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv----~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV----DGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhchhhccccccceee----cCcccEEecCccccccccc
Confidence            9999999999998764332 3455667799999999999999999999999999999    9999999999999996654


Q ss_pred             ccccc---ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc--CCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        170 DQQFM---SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT--GNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       170 ~~~~~---~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT--G~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ++-+.   ..+-...|||||.+.        ...++.++|+|+||+++||+++  ...||.   ...+.........-  
T Consensus       690 g~yy~vqgr~vlpiRwmawEsil--------lgkFttaSDvWafgvTlwE~~~~C~e~Py~---~lt~e~vven~~~~--  756 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESIL--------LGKFTTASDVWAFGVTLWEVFMLCREQPYS---QLTDEQVVENAGEF--  756 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHH--------hccccchhhhhhhHHHHHHHHHHHhhCchh---hhhHHHHHHhhhhh--
Confidence            43322   134567999999988        5779999999999999999876  778886   34444433322211  


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                         +.     ..+.-.   -++    .++-++..+..++.+||..|.++||||+++...+
T Consensus       757 ---~~-----~~~~~~---~l~----~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l  801 (807)
T KOG1094|consen  757 ---FR-----DQGRQV---VLS----RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFL  801 (807)
T ss_pred             ---cC-----CCCcce---ecc----CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence               00     001101   111    1223344566789999999999999999975544

>KOG2052|consensus

Probab=99.97  E-value=8.8e-30  Score=271.10  Aligned_cols=269  Identities=23%  Similarity=0.376  Sum_probs=204.1

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHh--CCCCCccceeEEEEecCC--
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK--VKHENIVKLLAIEEEQEG--   82 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~k--L~HpNIVkl~~v~~~~~~--   82 (708)
                      +...+..+.+.||+|.||.||+|.++  |+.||||+|...    .+..+.+|.++...  |+|+||..+++.-...++  
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc--CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            44567889999999999999999997  899999999743    24556688888876  499999999987533322  


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccCCCCCcEEEEEecCCCc
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN--------RLVHRDLKPGNIMKFICDDGST  154 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~--------gIVHrDIKP~NILl~~~~d~~~  154 (708)
                      .++|+|++|.+.|||+++|....    ++.+..+.++..++.||+|||-.        .|.|||||..|||+    ..++
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV----Kkn~  353 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----KKNG  353 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE----ccCC
Confidence            36899999999999999998732    99999999999999999999963        59999999999998    7777


Q ss_pred             eEEEeccCccccccccc-----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC---------
Q psy15481        155 IYKLTDFGAARELEEDQ-----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG---------  220 (708)
Q Consensus       155 ~vKL~DFGlA~~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG---------  220 (708)
                      ..-|+|+|+|.....+.     .....+||..|||||++......+.- .. -..+||||||.++||++..         
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~F-es-yk~ADIYafgLVlWEiarRc~~ggi~ee  431 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHF-ES-YKRADIYAFGLVLWEIARRCESGGIVEE  431 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhh-hh-hhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence            89999999998765542     34557899999999999754432211 11 2357999999999999863         


Q ss_pred             -CCCCCCCCC-CChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHH
Q psy15481        221 -NLPFRPYGG-RRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE  298 (708)
Q Consensus       221 -~~PF~~~~g-~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~  298 (708)
                       ++||...-. +...+.|.++.-.         +.       .+..+|+.=. +..+-..+..+++.||..||.-|.||-
T Consensus       432 y~~Pyyd~Vp~DPs~eeMrkVVCv---------~~-------~RP~ipnrW~-s~~~l~~m~klMkeCW~~Np~aRltAL  494 (513)
T KOG2052|consen  432 YQLPYYDVVPSDPSFEEMRKVVCV---------QK-------LRPNIPNRWK-SDPALRVMAKLMKECWYANPAARLTAL  494 (513)
T ss_pred             hcCCcccCCCCCCCHHHHhcceee---------cc-------cCCCCCcccc-cCHHHHHHHHHHHHhhcCCchhhhHHH
Confidence             688876533 5566666654421         10       1112222211 233344466799999999999999999


Q ss_pred             HHHHHHHHHH
Q psy15481        299 RFFSEVTKTL  308 (708)
Q Consensus       299 q~~~~l~~il  308 (708)
                      .+-+.+.++.
T Consensus       495 riKKtl~~l~  504 (513)
T KOG2052|consen  495 RIKKTLAKLS  504 (513)
T ss_pred             HHHHHHHHHh
Confidence            8877666554

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.9e-29  Score=283.74  Aligned_cols=282  Identities=18%  Similarity=0.181  Sum_probs=183.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc----------------CCCceEEEEEeccCCCCC-------------chHHHHHHH
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK----------------NNGEPVAVKTFNQLSHMR-------------PHDVQMREF   59 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~----------------~tg~~VAIK~~~~~s~~~-------------~~~~~~~Ei   59 (708)
                      +..|.+.++||+|+||.||+|...                ..++.||||.++......             ..+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            457899999999999999999752                345689999986432111             112234577


Q ss_pred             HHHHhCCCCCc-----cceeEEEEec------CCceEEEEEeccCCCCHHHHhcCCCCC---------------------
Q psy15481         60 EVLKKVKHENI-----VKLLAIEEEQ------EGRGKVIVMELCTGGSLFNILDDPENT---------------------  107 (708)
Q Consensus        60 ~iL~kL~HpNI-----Vkl~~v~~~~------~~~~~~LVmEy~~ggsL~~~L~~~~~~---------------------  107 (708)
                      .++.+++|.++     +.+++++...      .....++||||+++++|.+++......                     
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77788876654     5666665432      123589999999999999988642211                     


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccccc--cCCCCCcCCh
Q psy15481        108 YGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS--LYGTEEYLHP  185 (708)
Q Consensus       108 ~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~~--~~GT~~YlAP  185 (708)
                      ..+++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++.....+.....  ..+|+.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl----~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV----TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE----CCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            124567888999999999999999999999999999998    5566899999999976544332222  3458999999


Q ss_pred             hhhhhhhhcCCC------------C--CcCCccccchhhhhHHHHHhcCCC-CCCCCCCCChhhHHHHHHhcccCCcccc
Q psy15481        186 DMYERAVLRKPV------------G--KTFGATVDLWSIGVTLYHVATGNL-PFRPYGGRRNKETMYYITTKKASGVISG  250 (708)
Q Consensus       186 E~l~~~~~~~~~------------~--~~~s~ksDIWSLGviLyeLlTG~~-PF~~~~g~~~~e~~~~i~~~~~~~~i~~  250 (708)
                      |.+.........            .  .....+.|+||+||++|+|++|.+ ||.....   ........    ......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~---f~~~~~~~----~~~~~~  452 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRL---FNTELRQY----DNDLNR  452 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhh---hhhHHhhc----cchHHH
Confidence            998531100000            0  011235799999999999999886 7753111   10000000    000000


Q ss_pred             cccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCc---ccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        251 TQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDS---KKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       251 ~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP---~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      +.......+    .++.....    +....+++.+||..+|   .+|+|+.++           +.|||+.+.
T Consensus       453 ~r~~~~~~~----~~~~~d~~----s~~~~dLi~~LL~~~~~~~~~RlSa~ea-----------L~Hp~f~~~  506 (507)
T PLN03224        453 WRMYKGQKY----DFSLLDRN----KEAGWDLACKLITKRDQANRGRLSVGQA-----------LSHRFFLPE  506 (507)
T ss_pred             HHhhcccCC----Cccccccc----ChHHHHHHHHHhccCCCCcccCCCHHHH-----------hCCCCcCCC
Confidence            000011111    12222223    3445668889999766   689999996           779999653

>KOG0984|consensus

Probab=99.96  E-value=5.9e-30  Score=249.07  Aligned_cols=219  Identities=19%  Similarity=0.297  Sum_probs=179.5

Q ss_pred             EeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEecc
Q psy15481         14 TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        14 i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      .+..||+|++|.|-+.++..+|...|+|.+...-.........+|+.+..+. .+|.+|.+++.......  +||.||.|
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd--vwIcME~M  127 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD--VWICMELM  127 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc--EEEeHHHh
Confidence            3567999999999999999999999999997655444445556788876665 79999999998776554  99999999


Q ss_pred             CCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         93 TGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        93 ~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                       ..||..+-... .....+||..+-+++..++.||.|||++ .++|||+||+|||+    +..+.+|+||||.+..+.+.
T Consensus       128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI----n~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI----NYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE----ccCCcEEEcccccceeehhh
Confidence             58886644331 1112389999999999999999999987 89999999999998    77788999999999887665


Q ss_pred             ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        171 QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       171 ~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      -......|...|||||.+....    .++.|+.++||||||++++||++|+.||..  .....+++.++.+..++
T Consensus       203 iAkt~daGCkpYmaPEri~~e~----n~~gY~vksDvWSLGItmiElA~lr~PY~~--w~tpF~qLkqvVeep~P  271 (282)
T KOG0984|consen  203 IAKTMDAGCKPYMAPERINPEL----NQKGYSVKSDVWSLGITMIEMAILRFPYES--WGTPFQQLKQVVEEPSP  271 (282)
T ss_pred             hHHHHhcCCCccCChhhcCccc----Ccccceeehhhhhhhhhhhhhhhccccccc--cCCHHHHHHHHhcCCCC
Confidence            4444467999999999987433    245899999999999999999999999986  46788889888876544

>KOG1025|consensus

Probab=99.96  E-value=7.8e-30  Score=285.93  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=207.4

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCc----eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~----~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ......++||+|+||.||+|.+.-.|+    +||||++...........+..|.-+|.+++|||++++++++....   +
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~  772 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST---L  772 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---H
Confidence            344567899999999999999865554    799999987777777778889999999999999999999987544   7


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      .||++|+++|.|.++++....  .+-....+.+..||++||.|||.+++|||||-..|+|+    ..-..+||+|||+|+
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV----ksP~hvkitdfgla~  846 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV----KSPNHVKITDFGLAK  846 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee----cCCCeEEEEecchhh
Confidence            899999999999999987433  38889999999999999999999999999999999998    666789999999999


Q ss_pred             cccccccccc---cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHh
Q psy15481        166 ELEEDQQFMS---LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       166 ~~~~~~~~~~---~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      .+..++.-.+   ....+.|||-|.+.        ...|+.++|||||||++||++| |.-|+.   |.+..+ +...+.
T Consensus       847 ll~~d~~ey~~~~gK~pikwmale~i~--------~~~~thqSDVWsfGVtiWElmTFGa~Py~---gi~~~e-I~dlle  914 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGKVPIKWMALESIR--------IRKYTHQSDVWSFGVTIWELMTFGAKPYD---GIPAEE-IPDLLE  914 (1177)
T ss_pred             ccCcccccccccccccCcHHHHHHHhh--------ccCCCchhhhhhhhhhHHHHHhcCCCccC---CCCHHH-hhHHHh
Confidence            8776654332   22345678888776        6889999999999999999999 999987   344333 333332


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      ...                   .++.    ++.+.-.+..++-+||..|+..||+|.++..++.+.+...
T Consensus       915 ~ge-------------------RLsq----PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  915 KGE-------------------RLSQ----PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             ccc-------------------cCCC----CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            211                   2222    2333445666889999999999999999999988877543

>KOG0200|consensus

Probab=99.96  E-value=1.2e-28  Score=286.50  Aligned_cols=257  Identities=24%  Similarity=0.398  Sum_probs=203.6

Q ss_pred             EEeeEeecCCceEEEEEEEc----C---CCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCce
Q psy15481         13 CTTSVLGKGATGAVFQGVNK----N---NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~----~---tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~   84 (708)
                      .+.+.||+|+||.|++|.-.    .   ....||||.++..........+..|+.+++.+ .||||+.+++.+...  +.
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~--~~  376 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD--GP  376 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC--Cc
Confidence            45569999999999999743    1   14579999998766655566778999999999 699999999999873  35


Q ss_pred             EEEEEeccCCCCHHHHhcCCC-----CC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecC
Q psy15481         85 KVIVMELCTGGSLFNILDDPE-----NT--------YGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDD  151 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~-----~~--------~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d  151 (708)
                      .++|+||+..|+|.+++....     ..        ..++...+..+..||+.||.||++.++||||+-..|||+    .
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi----~  452 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI----T  452 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe----c
Confidence            999999999999999998755     00        128999999999999999999999999999999999998    6


Q ss_pred             CCceEEEeccCccccccccccccc--cCC--CCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCC
Q psy15481        152 GSTIYKLTDFGAARELEEDQQFMS--LYG--TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRP  226 (708)
Q Consensus       152 ~~~~vKL~DFGlA~~~~~~~~~~~--~~G--T~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~  226 (708)
                      .+.++||+|||+|+.......+..  ..|  ...|||||.+.        ...|+.++||||+||+|||++| |..||.+
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~--------~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF--------DRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc--------cCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            678999999999996555544432  222  23599999998        6789999999999999999999 9999974


Q ss_pred             CCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        227 YGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       227 ~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                      .  ....+.+..+..+.                  +...|..|      ...+.++++.||+.+|++||+|.++...+..
T Consensus       525 ~--~~~~~l~~~l~~G~------------------r~~~P~~c------~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  525 I--PPTEELLEFLKEGN------------------RMEQPEHC------SDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             C--CcHHHHHHHHhcCC------------------CCCCCCCC------CHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            1  22444444333321                  12334443      3556679999999999999999999888877


Q ss_pred             HHh
Q psy15481        307 TLN  309 (708)
Q Consensus       307 il~  309 (708)
                      .+.
T Consensus       579 ~l~  581 (609)
T KOG0200|consen  579 HLQ  581 (609)
T ss_pred             HHH
Confidence            554

>KOG1152|consensus

Probab=99.96  E-value=3.6e-29  Score=272.43  Aligned_cols=198  Identities=31%  Similarity=0.519  Sum_probs=171.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch---H----HHHHHHHHHHhCC---CCCccceeEEEEec
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH---D----VQMREFEVLKKVK---HENIVKLLAIEEEQ   80 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~---~----~~~~Ei~iL~kL~---HpNIVkl~~v~~~~   80 (708)
                      .|.+...+|.|+||.|++|.++.+...|+||.+.+.......   +    ..--|+.||..++   |+||++++++|++.
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            489999999999999999999999999999998764321110   1    1136999999996   99999999999986


Q ss_pred             CCceEEEEEecc-CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         81 EGRGKVIVMELC-TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        81 ~~~~~~LVmEy~-~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      +  ++||+||-. +|-+|++++....+   ++|.+++.|++||+.|+++||+.||||||||-+|+.+    |+++.+||+
T Consensus       642 d--~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv----d~~g~~kli  712 (772)
T KOG1152|consen  642 D--YYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV----DSNGFVKLI  712 (772)
T ss_pred             C--eeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccCceecccccccEEE----ecCCeEEEe
Confidence            6  499999975 56799999987665   9999999999999999999999999999999999999    999999999


Q ss_pred             ccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCC
Q psy15481        160 DFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR  225 (708)
Q Consensus       160 DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~  225 (708)
                      |||.|... .+.++...+||..|.|||++.+       .+..+..-|||+||++||.++....||.
T Consensus       713 dfgsaa~~-ksgpfd~f~gtv~~aapevl~g-------~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYT-KSGPFDVFVGTVDYAAPEVLGG-------EKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhh-cCCCcceeeeeccccchhhhCC-------CccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999854 4556888999999999999973       3444778899999999999999999985

>KOG1167|consensus

Probab=99.95  E-value=1e-28  Score=262.36  Aligned_cols=276  Identities=23%  Similarity=0.311  Sum_probs=202.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcC---CCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKN---NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~---tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~   84 (708)
                      ...|...++||.|.|++||++.+..   .++.||+|.+...+.+   ....+|+++|..+ .+.||+++.+.+...+  .
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd--~  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNND--Q  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCC--e
Confidence            3467889999999999999999887   7889999999766553   3456999999999 7999999999987654  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .++||||++..+..++...      ++..+++.+++.++.||.++|.+|||||||||+|+|.   +...+...|+|||+|
T Consensus       110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~---n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLY---NRRTQRGVLVDFGLA  180 (418)
T ss_pred             eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccc---ccccCCceEEechhH
Confidence            9999999999999998866      7889999999999999999999999999999999995   233446789999999


Q ss_pred             ccccccc---------------------------------------------cccccCCCCCcCChhhhhhhhhcCCCCC
Q psy15481        165 RELEEDQ---------------------------------------------QFMSLYGTEEYLHPDMYERAVLRKPVGK  199 (708)
Q Consensus       165 ~~~~~~~---------------------------------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~  199 (708)
                      ...+...                                             ...+..||++|+|||++.+       ..
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k-------~~  253 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR-------CP  253 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh-------cc
Confidence            7211000                                             0012469999999999986       45


Q ss_pred             cCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc----------ccCCccccccc-----CCCCcccccCC
Q psy15481        200 TFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK----------KASGVISGTQT-----SENGEIDWCTD  264 (708)
Q Consensus       200 ~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~----------~~~~~i~~~~~-----~~~g~~~~~~~  264 (708)
                      ..+.++||||.|||+..+++++.||-.  ..++.+.+..+..-          ...|.+.-.+.     ...-...|..-
T Consensus       254 ~QttaiDiws~GVI~Lslls~~~PFf~--a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~  331 (418)
T KOG1167|consen  254 RQTTAIDIWSAGVILLSLLSRRYPFFK--AKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL  331 (418)
T ss_pred             CcCCccceeeccceeehhhcccccccc--CccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence            668899999999999999999999853  23333333333211          11111000110     00001111111


Q ss_pred             C-------C----CcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        265 L-------P----NNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       265 l-------p----~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      .       .    ..+..++..+..+.++|.+||+.||.+|.||++.           +.||||.
T Consensus       332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeA-----------LkHpFF~  385 (418)
T KOG1167|consen  332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDA-----------LKHPFFD  385 (418)
T ss_pred             ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHH-----------hcCcCCc
Confidence            0       0    0111223334478899999999999999999985           7899996

>KOG3653|consensus

Probab=99.95  E-value=9.7e-29  Score=264.88  Aligned_cols=261  Identities=21%  Similarity=0.326  Sum_probs=191.6

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHh--CCCCCccceeEEEEecC--CceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK--VKHENIVKLLAIEEEQE--GRGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~k--L~HpNIVkl~~v~~~~~--~~~~~   86 (708)
                      -.++..+||+|.||.||+|.-  +++.||||+|....    .+.+.+|-+|.+.  ++|+||+++++..+..+  .-.++
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            345678999999999999965  47999999997432    4455566666664  58999999999876443  33599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCcccCCCCCcEEEEEecCCCceEE
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN---------RLVHRDLKPGNIMKFICDDGSTIYK  157 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~---------gIVHrDIKP~NILl~~~~d~~~~vK  157 (708)
                      ||++|.+.|||.++|+..-    +++....+++..+++||+|||+.         +|+|||||..|||+    ....+.-
T Consensus       285 LVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv----K~DlTcc  356 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV----KNDLTCC  356 (534)
T ss_pred             EEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE----ccCCcEE
Confidence            9999999999999998744    89999999999999999999973         59999999999998    5566789


Q ss_pred             EeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCC--------
Q psy15481        158 LTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP--------  226 (708)
Q Consensus       158 L~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~--------  226 (708)
                      |+|||+|..+.++..   ....+||..|||||+++++..-..  ...-.+.||||+|.+|||+++...-+.+        
T Consensus       357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d--~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql  434 (534)
T KOG3653|consen  357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD--RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL  434 (534)
T ss_pred             eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc--HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence            999999998765532   334789999999999997653321  2222468999999999999986544321        


Q ss_pred             ----C-CCCChhhHHHHH-HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        227 ----Y-GGRRNKETMYYI-TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       227 ----~-~g~~~~e~~~~i-~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                          . +.....+.|... ..++.+-.         .+-.|...         .-...+.+.+..||+.||+-|.||.=+
T Consensus       435 pfe~evG~hPt~e~mq~~VV~kK~RP~---------~p~~W~~h---------~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  435 PFEAEVGNHPTLEEMQELVVRKKQRPK---------IPDAWRKH---------AGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             chhHHhcCCCCHHHHHHHHHhhccCCC---------ChhhhhcC---------ccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence                1 122333333332 22222111         01122221         123457789999999999999999876


Q ss_pred             HHHHH
Q psy15481        301 FSEVT  305 (708)
Q Consensus       301 ~~~l~  305 (708)
                      ...+.
T Consensus       497 ~eR~~  501 (534)
T KOG3653|consen  497 EERMA  501 (534)
T ss_pred             HHHHH
Confidence            66554

>KOG0576|consensus

Probab=99.95  E-value=9.1e-29  Score=273.16  Aligned_cols=265  Identities=24%  Similarity=0.359  Sum_probs=207.8

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      +.--.|.+..++|+|.||.||+++++.+|+..|+|+++-..... ......|+-+++..+|||||.+++.+.-...  .|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~dk--lw   88 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK--LW   88 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhcC--cE
Confidence            45568999999999999999999999999999999998654433 2334579999999999999999999866554  99


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      |+||||.||+|.+.-....   .+++.++..+.+..+.||+|||++|-+|||||-.||++    ...+.+|+.|||.+-.
T Consensus        89 icMEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~gk~hRdiKGanill----td~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL----TDEGDVKLADFGVSAQ  161 (829)
T ss_pred             EEEEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCCcccccccccceee----cccCceeecccCchhh
Confidence            9999999999998765433   39999999999999999999999999999999999998    6677899999999876


Q ss_pred             cccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      +... .+..+..||+.|||||+-.-..     ...|...+|||++|++..|+.--++|...   ......++-+.+.   
T Consensus       162 itati~KrksfiGtpywmapEvaaver-----kggynqlcdiwa~gitAiel~eLqpplfd---lhpmr~l~LmTkS---  230 (829)
T KOG0576|consen  162 ITATIAKRKSFIGTPYWMAPEVAAVER-----KGGYNQLCDIWALGITAIELGELQPPLFD---LHPMRALFLMTKS---  230 (829)
T ss_pred             hhhhhhhhhcccCCccccchhHHHHHh-----cccccccccccccccchhhhhhcCCcccc---cchHHHHHHhhcc---
Confidence            6543 3456788999999999875332     46789999999999999999988888642   2222222222221   


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                          +.+..         .+..    .......+-+|++.+|..+|++||+++.+           +.|||....
T Consensus       231 ----~~qpp---------~lkD----k~kws~~fh~fvK~altknpKkRptaekl-----------L~h~fvs~~  277 (829)
T KOG0576|consen  231 ----GFQPP---------TLKD----KTKWSEFFHNFVKGALTKNPKKRPTAEKL-----------LQHPFVSQT  277 (829)
T ss_pred             ----CCCCC---------cccC----CccchHHHHHHHHHHhcCCCccCCChhhh-----------eeceeeccc
Confidence                11100         1111    12334556779999999999999999975           668888665

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=6.9e-27  Score=229.08  Aligned_cols=211  Identities=34%  Similarity=0.594  Sum_probs=178.0

Q ss_pred             eecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCCCH
Q psy15481         18 LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSL   97 (708)
Q Consensus        18 LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL   97 (708)
                      ||+|++|.||++.+..+|+.+++|++.........+.+.+|+..++.++|++|+++++++...  ...+++|||+.|++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCcH
Confidence            689999999999998889999999987554322245677999999999999999999998765  359999999999999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC-CceEEEeccCccccccccc-cccc
Q psy15481         98 FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG-STIYKLTDFGAARELEEDQ-QFMS  175 (708)
Q Consensus        98 ~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~-~~~vKL~DFGlA~~~~~~~-~~~~  175 (708)
                      .+++....  ..++...+..++.+++.++.+||+.|++|+||+|.||++    +. .+.++|+|||.+....... ....
T Consensus        79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~----~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL----DSDNGKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE----eCCCCcEEEecCCceEEccCCcchhhc
Confidence            99997652  238999999999999999999999999999999999998    44 5679999999998654432 2334


Q ss_pred             cCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCC
Q psy15481        176 LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSE  255 (708)
Q Consensus       176 ~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~  255 (708)
                      ..+...|++||.+..       ...++.++|+||+|++++++                                      
T Consensus       153 ~~~~~~~~~pe~~~~-------~~~~~~~~D~~~lg~~~~~l--------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLG-------KGYYSEKSDIWSLGVILYEL--------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcc-------cCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence            668899999999862       12778999999999999999                                      


Q ss_pred             CCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        256 NGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       256 ~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                                           ..+.+++..|+..||.+||++.++++
T Consensus       188 ---------------------~~~~~~l~~~l~~~p~~R~~~~~l~~  213 (215)
T cd00180         188 ---------------------PELKDLIRKMLQKDPEKRPSAKEILE  213 (215)
T ss_pred             ---------------------HHHHHHHHHHhhCCcccCcCHHHHhh
Confidence                                 12456899999999999999999754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.5e-26  Score=231.90  Aligned_cols=199  Identities=39%  Similarity=0.635  Sum_probs=170.0

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEec
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+...........+.+|++.+++++|+|++++++.+....  ..++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE--PLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC--ceEEEEec
Confidence            5678899999999999999998899999999875433213456678999999999999999999887654  48999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ  171 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~  171 (708)
                      +++++|.+++......  +++..+..++.+++.++.+||+.|++|+||+|+||++    +..+.++|+|||.+.......
T Consensus        79 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v----~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       79 CEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL----GMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             cCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEeeCceeeEecCcc
Confidence            9999999999764321  7899999999999999999999999999999999998    556789999999998765543


Q ss_pred             --cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCC
Q psy15481        172 --QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR  225 (708)
Q Consensus       172 --~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~  225 (708)
                        ......++..|++||.+..       ...++.++|+||||+++|+|++|+.||.
T Consensus       153 ~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      153 AALLKTVKGTPFYLAPEVLLG-------GKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccccceeccCCcCCHhHhcC-------CCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence              3345678889999999831       5677789999999999999999999995

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345|consensus

Probab=99.94  E-value=1.1e-26  Score=234.11  Aligned_cols=205  Identities=22%  Similarity=0.385  Sum_probs=163.2

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..-.|.+.+.||.|.||.+-++.++.+.+.+++|.+...-.  ....+.+|+..--.| .|.||+.-+++-... .+.++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~Yv   98 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYV   98 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEE
Confidence            34578899999999999999999999999999999865422  233456777655555 589999998865433 33689


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +++||++-|||.+-+..    .|+.|...+.++.|+++|+.|+|++++||||||.+|||+ ++.|.. .+||||||+.+.
T Consensus        99 F~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLi-f~~df~-rvKlcDFG~t~k  172 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILI-FDADFY-RVKLCDFGLTRK  172 (378)
T ss_pred             EeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEE-ecCCcc-EEEeeecccccc
Confidence            99999999999987754    348999999999999999999999999999999999998 455544 899999999986


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP  226 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~  226 (708)
                      .+..  ....-.+..|.+||....-+.   ..-...+.+|+|.||+++|.++||.+||..
T Consensus       173 ~g~t--V~~~~~~~~y~~pe~~~~~~n---e~~~~~ps~D~WqfGIi~f~cltG~~PWQk  227 (378)
T KOG1345|consen  173 VGTT--VKYLEYVNNYHAPELCDTVVN---EKLVVNPSTDIWQFGIIFFYCLTGKFPWQK  227 (378)
T ss_pred             cCce--ehhhhhhcccCCcHHHhhccc---cceEecccccchheeeeeeeeecCCCcchh
Confidence            4432  223345678999998864321   123357889999999999999999999974

>KOG1024|consensus

Probab=99.93  E-value=2.4e-25  Score=233.53  Aligned_cols=256  Identities=21%  Similarity=0.338  Sum_probs=201.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCC-----ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNG-----EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg-----~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ++++...+-+|.||.||.|.++...     +.|-+|.++...++-....+..|.-++..+.|||+.++.++..+. ....
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~~~P  363 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-YATP  363 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-cCcc
Confidence            5777888999999999999887532     346677766555444455667888889999999999999987653 3458


Q ss_pred             EEEEeccCCCCHHHHhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         86 VIVMELCTGGSLFNILD-----DPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~-----~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                      ++++.+..-|+|..++.     ++.....++..+...++.|++.||.|||+.|+||.||-..|.++    |+.-.+||+|
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI----dd~LqVkltD  439 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI----DDQLQVKLTD  439 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee----hhheeEEecc
Confidence            89999998999999998     55555568888999999999999999999999999999999998    8889999999


Q ss_pred             cCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHH
Q psy15481        161 FGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM  236 (708)
Q Consensus       161 FGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~  236 (708)
                      =.+++.+.+..-.   .+-.....||+||.+.        +..|+.++|+|||||+||||+| |..|+.   .-++.+..
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~--------n~~yssasDvWsfGVllWELmtlg~~Pya---eIDPfEm~  508 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQ--------NSHYSSASDVWSFGVLLWELMTLGKLPYA---EIDPFEME  508 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHh--------hhhhcchhhhHHHHHHHHHHHhcCCCCcc---ccCHHHHH
Confidence            9999876544211   1223456899999998        6889999999999999999999 999997   34555555


Q ss_pred             HHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        237 YYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       237 ~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                      +.+..+.                  +-.-|.+|      ++.+..++..||..+|++||+++|+..-+.+
T Consensus       509 ~ylkdGy------------------RlaQP~NC------PDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  509 HYLKDGY------------------RLAQPFNC------PDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             HHHhccc------------------eecCCCCC------cHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            4444321                  11223333      4667779999999999999999987655443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=2.8e-25  Score=266.74  Aligned_cols=206  Identities=18%  Similarity=0.226  Sum_probs=144.6

Q ss_pred             HhCCC-CCccceeEEEEec-----CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q psy15481         63 KKVKH-ENIVKLLAIEEEQ-----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH  136 (708)
Q Consensus        63 ~kL~H-pNIVkl~~v~~~~-----~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVH  136 (708)
                      +.++| +||+.+++.+...     ....++.++||+ +++|.+++..+.  ..+++.+++.++.||+.||+|||++||+|
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~gIvH  103 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQGIVV  103 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            34556 5888888876221     123477889988 789999997643  23999999999999999999999999999


Q ss_pred             cCCCCCcEEEEE---------------ecCCCceEEEeccCccccccccc-----------------cccccCCCCCcCC
Q psy15481        137 RDLKPGNIMKFI---------------CDDGSTIYKLTDFGAARELEEDQ-----------------QFMSLYGTEEYLH  184 (708)
Q Consensus       137 rDIKP~NILl~~---------------~~d~~~~vKL~DFGlA~~~~~~~-----------------~~~~~~GT~~YlA  184 (708)
                      |||||+|||+.-               ..+..+.+|++|||+++......                 ......||+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999721               01334567888888886432100                 0112458999999


Q ss_pred             hhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCC
Q psy15481        185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTD  264 (708)
Q Consensus       185 PE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~  264 (708)
                      ||++.        +..|+.++|||||||+||||++|.+||..     ....+..+....                     
T Consensus       184 PE~~~--------~~~~~~~sDVwSlGviL~ELl~~~~~~~~-----~~~~~~~~~~~~---------------------  229 (793)
T PLN00181        184 PEEDN--------GSSSNCASDVYRLGVLLFELFCPVSSREE-----KSRTMSSLRHRV---------------------  229 (793)
T ss_pred             hhhhc--------cCCCCchhhhhhHHHHHHHHhhCCCchhh-----HHHHHHHHHHhh---------------------
Confidence            99987        67789999999999999999999888752     111222221110                     


Q ss_pred             CCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        265 LPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       265 lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      +|..  ...... ...+++..||.+||.+||++.++           +.|||+..
T Consensus       230 ~~~~--~~~~~~-~~~~~~~~~L~~~P~~Rps~~ei-----------l~h~~~~~  270 (793)
T PLN00181        230 LPPQ--ILLNWP-KEASFCLWLLHPEPSCRPSMSEL-----------LQSEFINE  270 (793)
T ss_pred             cChh--hhhcCH-HHHHHHHHhCCCChhhCcChHHH-----------hhchhhhh
Confidence            0100  000111 23457889999999999999997           55788754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=1.3e-23  Score=204.90  Aligned_cols=169  Identities=17%  Similarity=0.238  Sum_probs=125.3

Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccccc
Q psy15481         95 GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM  174 (708)
Q Consensus        95 gsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~  174 (708)
                      |||.+++....  ..+++..++.++.||+.||.|||+++      ||+|||+    +.++.+++  ||.+......    
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~----~~~~~~~~--fG~~~~~~~~----   62 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL----TWDGLLKL--DGSVAFKTPE----   62 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE----cCccceee--ccceEeeccc----
Confidence            68999997533  23999999999999999999999999      9999997    66667888  9999865443    


Q ss_pred             ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccC
Q psy15481        175 SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTS  254 (708)
Q Consensus       175 ~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~  254 (708)
                      ...||+.|+|||++.        +..++.++|||||||++|+|+||..||....  .....+..+......         
T Consensus        63 ~~~g~~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltg~~p~~~~~--~~~~~~~~~~~~~~~---------  123 (176)
T smart00750       63 QSRVDPYFMAPEVIQ--------GQSYTEKADIYSLGITLYEALDYELPYNEER--ELSAILEILLNGMPA---------  123 (176)
T ss_pred             cCCCcccccChHHhc--------CCCCcchhhHHHHHHHHHHHHhCCCCccccc--hhcHHHHHHHHHhcc---------
Confidence            236899999999997        6778999999999999999999999996421  112223233221111         


Q ss_pred             CCCcccccCCCCCcccCChhHHH--HHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        255 ENGEIDWCTDLPNNCQLSLGLKK--LVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       255 ~~g~~~~~~~lp~~~~ls~~l~~--~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                               ..+...........  .+.+++.+||..||.+||++.+++.+...+..
T Consensus       124 ---------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      124 ---------DDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             ---------CCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence                     00111111122333  47889999999999999999999887665543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164|consensus

Probab=99.90  E-value=2.2e-22  Score=217.08  Aligned_cols=265  Identities=22%  Similarity=0.229  Sum_probs=194.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCC-ceEEEEEeccCCCCCchHHHHHHHHHHHhCCC----CCccceeEEEEecCCceE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNG-EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH----ENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg-~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~H----pNIVkl~~v~~~~~~~~~   85 (708)
                      .|.+...||+|+||.||.+.+..++ ..+|+|+-......... ....|..++..+..    +++..+++... ......
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCcee
Confidence            8999999999999999999988774 68999987765443333 56688899998863    68888888874 234468


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec-CCCceEEEeccCcc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD-DGSTIYKLTDFGAA  164 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~-d~~~~vKL~DFGlA  164 (708)
                      |+||+.+ |.+|.++..... ...++...+..++.|++.+|.++|+.|++||||||+|+++.... .....+.|.|||+|
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            9999999 899999886544 34599999999999999999999999999999999999973322 12257999999999


Q ss_pred             c--ccc-ccc-------c-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChh
Q psy15481        165 R--ELE-EDQ-------Q-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK  233 (708)
Q Consensus       165 ~--~~~-~~~-------~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~  233 (708)
                      +  ..- ...       . .....||..|.++....        +...+.+.|+||++.++.++..|.+||.........
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~--------~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~  246 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL--------GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK  246 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhC--------CCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence            8  321 111       1 12345999999999877        788899999999999999999999999754333232


Q ss_pred             hHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        234 ETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       234 e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ..+........                    .+..+...   +..+..+...+-..+...+|....+...+......
T Consensus       247 ~~~~~~~~~~~--------------------~~~~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  247 SKFEKDPRKLL--------------------TDRFGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHHHHhhhhc--------------------cccccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            22222222110                    00011111   22344455555568899999999887776655544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=4.4e-22  Score=205.38  Aligned_cols=262  Identities=27%  Similarity=0.402  Sum_probs=194.7

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCCCC-CccceeEEEEecCCceEEEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHE-NIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~Hp-NIVkl~~v~~~~~~~~~~LV   88 (708)
                      |.+...||.|+||.||.+.+.   ..+++|.+.......  ....+.+|+.++..+.|+ +|+++.+.+....  ..+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~   76 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--SLYLV   76 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--EEEEE
Confidence            778899999999999999887   789999987655444  255677999999999988 7999999985433  38999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCc-eEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST-IYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~-~vKL~DFGlA~~~  167 (708)
                      ++++.|+++..++........+++.....++.|++.++.|+|+.|++|||+||+||++    +... .++++|||.+...
T Consensus        77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~----~~~~~~~~l~dfg~~~~~  152 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL----DRDGRVVKLIDFGLAKLL  152 (384)
T ss_pred             EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee----cCCCCeEEEeccCcceec
Confidence            9999999999777664311138999999999999999999999999999999999998    5555 7999999999855


Q ss_pred             cccc-------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        168 EEDQ-------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       168 ~~~~-------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ....       ......|+..|++||.+....     ...++...|+||+|++++++++|..||................
T Consensus       153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~-----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  227 (384)
T COG0515         153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS-----LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII  227 (384)
T ss_pred             CCCCccccccccccccccccccCCHHHhcCCC-----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH
Confidence            4432       245678999999999987200     0578889999999999999999999986432110122222222


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      .......             .......  .........+.+++..++..+|..|.+......
T Consensus       228 ~~~~~~~-------------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         228 LELPTPS-------------LASPLSP--SNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             HhcCCcc-------------cccccCc--cccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            2111110             0000000  000222345677999999999999999887544

>KOG1163|consensus

Probab=99.89  E-value=2.2e-22  Score=200.26  Aligned_cols=268  Identities=22%  Similarity=0.287  Sum_probs=198.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCC-CCccceeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH-ENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~H-pNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..|.+.+.||+|+||.+|.|....+|+.||||+-+..   ........|..+.+.|++ ..|+.+.-+..+  ..+-++|
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlV   89 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLV   89 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhccc--cccceee
Confidence            4689999999999999999999999999999985432   223344578888888854 566666655544  3357999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||.+ |-||.++..-....  ++...++-++.|++.-+.|+|.+++|||||||+|+|+.++.. ...+.|+|||+|..+.
T Consensus        90 MdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh-~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRH-CNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccc-cceEEEEeccchhhhc
Confidence            9999 89998887765543  899999999999999999999999999999999999866544 3478999999998765


Q ss_pred             cccc--------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        169 EDQQ--------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       169 ~~~~--------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      +...        -....||..|.+--...        +...+...|+=|+|.+|.+.--|.+||.+....+......+|.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~--------g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~  237 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHL--------GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS  237 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhh--------hhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence            4322        23467999998876655        5667888999999999999999999999776666666677777


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCc
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHL  315 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~  315 (708)
                      +++.+..+                    ..+..+++..+.-.+.-|-..--++-|... ++..+..+|.+.+.|.
T Consensus       238 EkK~s~~i--------------------e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~-ylrqlFriLfr~ln~~  291 (341)
T KOG1163|consen  238 EKKMSTPI--------------------EVLCKGFPAEFAMYLNYCRGLGFEEKPDYM-YLRQLFRILFRTLNHQ  291 (341)
T ss_pred             HhhcCCCH--------------------HHHhCCCcHHHHHHHHHHhhcCCCCCCcHH-HHHHHHHHHHhhcccc
Confidence            66543211                    112334445555566666555555556543 3344445566666554

>KOG1165|consensus

Probab=99.88  E-value=3.7e-22  Score=206.36  Aligned_cols=263  Identities=23%  Similarity=0.323  Sum_probs=202.6

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      -.|.+++.||.|+||..+.|.+.-++++||||.-...+.   ......|++..+.| ..++|+..+-+  .+.+-+-.+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYF--GqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYF--GQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeee--ccccchhhhh
Confidence            468999999999999999999999999999997543221   23345788888887 67899888755  3455567899


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec-CCCceEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD-DGSTIYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~-d~~~~vKL~DFGlA~~~  167 (708)
                      ||.+ |-||.++.+=+...  ++...+..++.|++.-+.|+|++.+|.|||||+|+||.... .....+.++|||+|..+
T Consensus       103 idLL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            9999 89998888766544  89999999999999999999999999999999999984432 22458899999999987


Q ss_pred             ccccc--------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        168 EEDQQ--------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       168 ~~~~~--------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      .+..+        ..+..||..||+--...        |...+...|+=|||-+|.+.+-|.+||.+.....+++...+|
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHl--------GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI  251 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHL--------GREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI  251 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccc--------cchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence            66543        34578999999987665        788899999999999999999999999988888899999988


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                      ..++....+                    ..+..+++..+..-++-.=..+-.+-|..+=+-.-+.++|
T Consensus       252 Ge~Kr~T~i--------------------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl  300 (449)
T KOG1165|consen  252 GETKRSTPI--------------------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL  300 (449)
T ss_pred             ccccccCCH--------------------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            876653321                    1123344445555555555566666677653333333333

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=3e-22  Score=218.17  Aligned_cols=160  Identities=21%  Similarity=0.218  Sum_probs=124.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcC-CCceEEEEEeccCCC----CCchHHHHHHHHHHHhCCCCCccc-eeEEEEecCCc
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKN-NGEPVAVKTFNQLSH----MRPHDVQMREFEVLKKVKHENIVK-LLAIEEEQEGR   83 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~-tg~~VAIK~~~~~s~----~~~~~~~~~Ei~iL~kL~HpNIVk-l~~v~~~~~~~   83 (708)
                      ..|.+.+.||+|+||.||+|.++. +|+.||||.+.....    ......+.+|++++++++|+||+. +++.    +  
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~--   91 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G--   91 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C--
Confidence            469999999999999999999876 788889998753211    112345679999999999999985 4332    2  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC-CCCcEEEEEecCCCceEEEeccC
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDL-KPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDI-KP~NILl~~~~d~~~~vKL~DFG  162 (708)
                      ..|+|||||+|++|.. + .+     ..   ...++.+++.||.|||++||+|||| ||+|||+    +..+.+||+|||
T Consensus        92 ~~~LVmE~~~G~~L~~-~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv----~~~~~ikLiDFG  157 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-A-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM----GPDGEAAVIDFQ  157 (365)
T ss_pred             CcEEEEEccCCCCHHH-h-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE----cCCCCEEEEECc
Confidence            3799999999999973 2 11     11   1467899999999999999999999 9999998    555679999999


Q ss_pred             ccccccccc---------cccccCCCCCcCChhhhh
Q psy15481        163 AARELEEDQ---------QFMSLYGTEEYLHPDMYE  189 (708)
Q Consensus       163 lA~~~~~~~---------~~~~~~GT~~YlAPE~l~  189 (708)
                      +|+......         ......++..|+|||.+.
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            998654332         123456888899999886

>KOG0590|consensus

Probab=99.88  E-value=1.9e-23  Score=241.21  Aligned_cols=253  Identities=26%  Similarity=0.362  Sum_probs=185.8

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCceEEEEEeccC----CCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQL----SHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~----s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ....++|.|++|.|+.+........++.|.+...    .... .......|+-+-.+|.|||++..++.+.....  .+-
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~--~~~  398 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG--ILQ  398 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc--chh
Confidence            4567899999999998888777776777765421    1111 11113467777788899999888776654433  444


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      .||||++ ||+.++.....   ++..++..++.|++.|++|+|+.||.|||+||+|+++    ...+.+||+|||.+...
T Consensus       399 ~mE~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~----~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV----TENGILKIIDFGAASVF  470 (601)
T ss_pred             hhhcccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE----ecCCceEEeecCcceee
Confidence            4999998 99999987522   8999999999999999999999999999999999998    66668999999999865


Q ss_pred             ccc-----ccccccCCCCCcCChhhhhhhhhcCCCCCcC-CccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        168 EED-----QQFMSLYGTEEYLHPDMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       168 ~~~-----~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~-s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      ..+     ......+|+..|+|||.+.        +..| ...+||||.|++++.|++|+.||.......+.-  .... 
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~--------~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~~~-  539 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLT--------GKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KTNN-  539 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCccccc--------ccccCcchhhhhhccceEEEEecCCCccccccccccch--hhhc-
Confidence            432     2234578999999999998        4444 557899999999999999999998643222211  0011 


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                                      ...|......+..+...++..-..+|.+||++||.+|.++++++.
T Consensus       540 ----------------~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  540 ----------------YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ----------------cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence                            111222222233344455666677999999999999999999744

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=1.9e-20  Score=191.26  Aligned_cols=173  Identities=16%  Similarity=0.189  Sum_probs=130.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch--HH------HHHHHHHHHhCCCCCccceeEEEEec
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH--DV------QMREFEVLKKVKHENIVKLLAIEEEQ   80 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~--~~------~~~Ei~iL~kL~HpNIVkl~~v~~~~   80 (708)
                      +++|.+.+.||.|+||.||++..  ++..+|+|+++........  ..      +.+|+..+.++.||+|+.+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            67899999999999999999654  4778999999754322211  11      46888999999999999999886644


Q ss_pred             CC------ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCc
Q psy15481         81 EG------RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST  154 (708)
Q Consensus        81 ~~------~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~  154 (708)
                      ..      +..++||||++|.+|.++..       +++.    .+.+++.++..+|+.|++|||+||+||++    +..+
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili----~~~g  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIV----SKNG  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEE----eCCC
Confidence            31      24789999999999988732       3432    46699999999999999999999999997    3334


Q ss_pred             eEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHh
Q psy15481        155 IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVA  218 (708)
Q Consensus       155 ~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLl  218 (708)
                       ++|+|||.......+...            +.+..       ...|+.++|+||||+++.-..
T Consensus       173 -i~liDfg~~~~~~e~~a~------------d~~vl-------er~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK------------DRIDL-------ERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhH------------HHHHH-------HhHhcccccccceeEeehHHH
Confidence             999999998765333211            22211       345667899999999987553

>KOG4158|consensus

Probab=99.83  E-value=2.3e-20  Score=196.78  Aligned_cols=218  Identities=22%  Similarity=0.273  Sum_probs=156.4

Q ss_pred             CCCCccceeEEEEec-------------------------CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15481         66 KHENIVKLLAIEEEQ-------------------------EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE  120 (708)
Q Consensus        66 ~HpNIVkl~~v~~~~-------------------------~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~  120 (708)
                      +|||||.+..+|.+.                         .+...|+||.-+ ..+|..++....    .+......++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence            599999998766431                         124579999988 489999998754    67788899999


Q ss_pred             HHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc-------cccccccCCCCCcCChhhhhhhhh
Q psy15481        121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-------DQQFMSLYGTEEYLHPDMYERAVL  193 (708)
Q Consensus       121 qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~-------~~~~~~~~GT~~YlAPE~l~~~~~  193 (708)
                      |+++|+.|||++||.|||+|.+|||+..++|+...+.++|||.+-.-+.       .......-|...-||||+...-  
T Consensus       349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~--  426 (598)
T KOG4158|consen  349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV--  426 (598)
T ss_pred             HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC--
Confidence            9999999999999999999999999999999999999999999853211       1222345688899999998631  


Q ss_pred             cCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCCh
Q psy15481        194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSL  273 (708)
Q Consensus       194 ~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~  273 (708)
                      .++.....-.++|.|+.|.+.||+++...||..- |.-..+.-..-                      ..++|.   ++.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~r~Yq----------------------e~qLPa---lp~  480 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDTRTYQ----------------------ESQLPA---LPS  480 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCccccc-chheechhhhh----------------------hhhCCC---Ccc
Confidence            1111222345789999999999999999999741 11111110000                      013443   455


Q ss_pred             hHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcccccc
Q psy15481        274 GLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCIR  325 (708)
Q Consensus       274 ~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~~~  325 (708)
                      .++..+.+++..+|..||.+|+|++-.-         .++|.+.|.......
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~iAA---------Nvl~LsLw~~~~~vk  523 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPNIAA---------NVLNLSLWRMGEDVK  523 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCccHHH---------hHHHHHHhcCchHHH
Confidence            5566677788899999999999977322         245566655544333

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.83  E-value=3.5e-20  Score=194.67  Aligned_cols=249  Identities=20%  Similarity=0.267  Sum_probs=151.6

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCC----------CCCcccee
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVK----------HENIVKLL   74 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~----------HpNIVkl~   74 (708)
                      ........+..||.|+++.||.+.+..||+.+|+|++.......  ..+...+|.-....+.          |-.++..+
T Consensus         9 ~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~   88 (288)
T PF14531_consen    9 QRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL   88 (288)
T ss_dssp             --EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred             CCceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence            33446678899999999999999999999999999986554221  1223334433333322          22333333


Q ss_pred             EEEEecC----------Cc-----eEEEEEeccCCCCHHHHhcC---CCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q psy15481         75 AIEEEQE----------GR-----GKVIVMELCTGGSLFNILDD---PENT-YGLQEEEFLLVLEHLTAGMKHLRDNRLV  135 (708)
Q Consensus        75 ~v~~~~~----------~~-----~~~LVmEy~~ggsL~~~L~~---~~~~-~~L~e~~v~~il~qIl~aL~yLH~~gIV  135 (708)
                      +....++          .+     +.+++|+-+ .+||..++..   .... .++.......+..|++..+++||+.|+|
T Consensus        89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV  167 (288)
T PF14531_consen   89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV  167 (288)
T ss_dssp             EEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence            4332211          11     246788888 5888877542   1111 1122333345568999999999999999


Q ss_pred             ccCCCCCcEEEEEecCCCceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHH
Q psy15481        136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLY  215 (708)
Q Consensus       136 HrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLy  215 (708)
                      |+||+|+|+++    +.++.++|+||+.....+.....  ...+..|.|||.........+..-.++.+.|.|+||+++|
T Consensus       168 Hgdi~~~nfll----~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly  241 (288)
T PF14531_consen  168 HGDIKPENFLL----DQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY  241 (288)
T ss_dssp             EST-SGGGEEE-----TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred             ecccceeeEEE----cCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence            99999999998    77788999999998765544322  3456889999987643211112346789999999999999


Q ss_pred             HHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccC
Q psy15481        216 HVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKI  294 (708)
Q Consensus       216 eLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kR  294 (708)
                      .+++|.+||.-......                          ..|     ....+. .+++.+..||+++|+.||.+|
T Consensus       242 ~lWC~~lPf~~~~~~~~--------------------------~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  242 SLWCGRLPFGLSSPEAD--------------------------PEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHSS-STCCCGGGST--------------------------SGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHccCCCCCCCcccc--------------------------ccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999973111000                          000     111223 667778889999999999988

>KOG1240|consensus

Probab=99.83  E-value=4.2e-21  Score=222.25  Aligned_cols=253  Identities=17%  Similarity=0.234  Sum_probs=178.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC---CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM---RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~---~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .+...+.||++.|=+|.+|+++ .|. |+||+|-+..-.   ++......|++ ...++|||.+.+.-+...  .+..|+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl   98 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL   98 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence            6777899999999999999875 454 999998654422   22233345555 555699999998766443  334789


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |-+|+ ..+|++.+...+-   +..-+.+-|++|++.||.-+|..||+|||||.+|||+    ..-+.+.|+||...+..
T Consensus        99 vRqyv-khnLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi----TSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen   99 VRQYV-KHNLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI----TSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             HHHHH-hhhhhhhhccchH---HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE----eeechhhhhcccccCCc
Confidence            99998 5899999977553   7888999999999999999999999999999999999    77778999999887642


Q ss_pred             --ccc--cc----ccccCCCCCcCChhhhhhhhhcCC--C-CCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhH
Q psy15481        168 --EED--QQ----FMSLYGTEEYLHPDMYERAVLRKP--V-GKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKET  235 (708)
Q Consensus       168 --~~~--~~----~~~~~GT~~YlAPE~l~~~~~~~~--~-~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~  235 (708)
                        .++  ..    |.+...-.+|+|||.+..+....+  . ....+++-||||+||+++|+++ |++||.       ..+
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-------LSQ  243 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-------LSQ  243 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-------HHH
Confidence              222  11    233445678999999976431111  1 1226789999999999999999 899996       111


Q ss_pred             HHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        236 MYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       236 ~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                      +..-..+.   ..        .+..-...++.     .    -+.++|..|++.||.+|.||++++..
T Consensus       244 L~aYr~~~---~~--------~~e~~Le~Ied-----~----~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  244 LLAYRSGN---AD--------DPEQLLEKIED-----V----SLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhHhccC---cc--------CHHHHHHhCcC-----c----cHHHHHHHHHccCchhccCHHHHHHh
Confidence            11111100   00        00000001111     1    25568999999999999999988776

>KOG0603|consensus

Probab=99.82  E-value=3.1e-21  Score=214.56  Aligned_cols=227  Identities=25%  Similarity=0.362  Sum_probs=185.6

Q ss_pred             eecCCceEEEEEEE---cCCCceEEEEEeccCCCCCc-hHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEEEEecc
Q psy15481         18 LGKGATGAVFQGVN---KNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        18 LG~G~fG~Vy~a~~---~~tg~~VAIK~~~~~s~~~~-~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      +|+|+||.|++++.   .+.|..||+|+.++...... ......|-.++...+ ||.++.++..+.....  .++++++.
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k--l~l~ld~~   79 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK--LYLILDFL   79 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc--hhHhhhhc
Confidence            79999999998643   35688899999876543221 113345777888885 9999999998876654  99999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccccc
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ  172 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~  172 (708)
                      .||+|...+.....   +++..+..+...++-|++++|+.||+|||+||+||++    +..|++++.|||+++..-+.+.
T Consensus        80 rgg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill----d~~Ghi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL----LLEGHIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             ccchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee----cccCccccCCchhhhHhHhhhh
Confidence            99999998877665   8899999999999999999999999999999999999    8888999999999997655543


Q ss_pred             ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccc
Q psy15481        173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ  252 (708)
Q Consensus       173 ~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~  252 (708)
                      .   |||..|||||++.          ....++|.||+|+++|+|+||..||.+       +++..|...          
T Consensus       153 ~---cgt~eymApEI~~----------gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~----------  202 (612)
T KOG0603|consen  153 A---CGTYEYRAPEIIN----------GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKA----------  202 (612)
T ss_pred             c---ccchhhhhhHhhh----------ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhh----------
Confidence            3   9999999999985          346789999999999999999999973       777777753          


Q ss_pred             cCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHH
Q psy15481        253 TSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE  298 (708)
Q Consensus       253 ~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~  298 (708)
                                 .++    .+..+...+.+++..++..+|.+|....
T Consensus       203 -----------~~~----~p~~l~~~a~~~~~~l~~r~p~nrLg~~  233 (612)
T KOG0603|consen  203 -----------ELE----MPRELSAEARSLFRQLFKRNPENRLGAG  233 (612)
T ss_pred             -----------ccC----CchhhhHHHHHHHHHHHhhCHHHHhccC
Confidence                       222    3445566666799999999999998763

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=5.7e-20  Score=183.69  Aligned_cols=140  Identities=21%  Similarity=0.221  Sum_probs=107.6

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch-------------------------HHHHHHHHHHHhCCCCC
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH-------------------------DVQMREFEVLKKVKHEN   69 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~-------------------------~~~~~Ei~iL~kL~HpN   69 (708)
                      ...||+|+||.||+|.+. +|+.||+|+++........                         ....+|+.++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999987 8999999999754211000                         11235999999998888


Q ss_pred             ccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCcEEEEE
Q psy15481         70 IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL-RDNRLVHRDLKPGNIMKFI  148 (708)
Q Consensus        70 IVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yL-H~~gIVHrDIKP~NILl~~  148 (708)
                      +.....+.. . .  .+|||||++|+++.......   .+++...+..++.|++.+|.++ |+.||+||||||+|||+  
T Consensus        81 v~~p~~~~~-~-~--~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli--  151 (190)
T cd05147          81 IPCPEPILL-K-S--HVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY--  151 (190)
T ss_pred             CCCCcEEEe-c-C--CEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE--
Confidence            754443321 1 2  48999999988776543222   2389999999999999999999 69999999999999998  


Q ss_pred             ecCCCceEEEeccCccccc
Q psy15481        149 CDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus       149 ~~d~~~~vKL~DFGlA~~~  167 (708)
                        + .+.++|+|||+|...
T Consensus       152 --~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         152 --H-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             --E-CCcEEEEEccccccC
Confidence              3 246999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=3.8e-19  Score=177.47  Aligned_cols=141  Identities=26%  Similarity=0.320  Sum_probs=110.2

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC---------------------c----hHHHHHHHHHHHhCCCCC
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR---------------------P----HDVQMREFEVLKKVKHEN   69 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~---------------------~----~~~~~~Ei~iL~kL~HpN   69 (708)
                      ...||+|++|.||+|.+. +|+.||||+++......                     .    .....+|++.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 89999999997642110                     0    111247899999999998


Q ss_pred             ccceeEEEEecCCceEEEEEeccCCCCHHH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEE
Q psy15481         70 IVKLLAIEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKF  147 (708)
Q Consensus        70 IVkl~~v~~~~~~~~~~LVmEy~~ggsL~~-~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~  147 (708)
                      +.....+...  .  .|+||||++|+++.. .+..    ..++...+..++.+++.++.++|+ .||+||||||+||++ 
T Consensus        81 i~~p~~~~~~--~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll-  151 (190)
T cd05145          81 VPVPEPILLK--K--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY-  151 (190)
T ss_pred             CCCceEEEec--C--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE-
Confidence            8655544332  2  489999998885543 3432    237889999999999999999999 999999999999998 


Q ss_pred             EecCCCceEEEeccCccccccc
Q psy15481        148 ICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus       148 ~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                         + .+.++|+|||+|.....
T Consensus       152 ---~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 ---H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             ---E-CCCEEEEEcccceecCC
Confidence               3 35699999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195|consensus

Probab=99.79  E-value=9.6e-20  Score=183.90  Aligned_cols=254  Identities=18%  Similarity=0.269  Sum_probs=182.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ....+.-+|.....|..|+|++.  |..+++|+++.... .+....+..|+-.|+-+.||||..+++.+..+++  ++++
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn--lv~i  265 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN--LVII  265 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC--ceEe
Confidence            34455567888899999999997  44577787764332 2223345678889999999999999999987765  9999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCc-ccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLV-HRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIV-HrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ..|++.|||++++....+ ...+-.++..++.++++|++|||+. .++ ---+....+++  ++|-...+..+|--++..
T Consensus       266 sq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi--dedltarismad~kfsfq  342 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI--DEDLTARISMADTKFSFQ  342 (448)
T ss_pred             eeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe--cchhhhheecccceeeee
Confidence            999999999999987543 3367789999999999999999986 333 33567778886  344333444444333321


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                            ......+|.|++||.+.+.    + ....-.++|||||++++||+.|...||..   -++.+.--+|.-+    
T Consensus       343 ------e~gr~y~pawmspealqrk----p-ed~n~raadmwsfaillwel~trevpfad---lspmecgmkiale----  404 (448)
T KOG0195|consen  343 ------EVGRAYSPAWMSPEALQRK----P-EDLNIRAADMWSFAILLWELNTREVPFAD---LSPMECGMKIALE----  404 (448)
T ss_pred             ------ccccccCcccCCHHHHhcC----c-hhcchhhhhHHHHHHHHHHhhcccccccc---CCchhhhhhhhhc----
Confidence                  2234568999999998743    2 23445688999999999999999999974   3333332232211    


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                         |                -...++++.+..+..++.-|+..||.+||.|+.++--++++
T Consensus       405 ---g----------------lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  405 ---G----------------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ---c----------------ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence               1                11235566677777899999999999999999876655443

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=2.3e-18  Score=174.61  Aligned_cols=141  Identities=18%  Similarity=0.240  Sum_probs=109.6

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-----CCCCccceeEEEEecCC-ceEE-E
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-----KHENIVKLLAIEEEQEG-RGKV-I   87 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-----~HpNIVkl~~v~~~~~~-~~~~-L   87 (708)
                      ...||+|+||.||.  ++.++.. +||++...... ..+...+|+.+++.+     +||||+++++++++..+ +.++ +
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            46899999999995  7777766 69988654322 345567999999999     57999999999987653 2334 7


Q ss_pred             EEec--cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         88 VMEL--CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM-KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        88 VmEy--~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL-~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      ||||  +.+++|.+++++..    +++.  ..++.+++.++ .|||+++|+||||||+|||+....++...++|+||+-+
T Consensus        83 I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            8999  55799999997632    6665  35688888887 89999999999999999998433445568999995444


Q ss_pred             c
Q psy15481        165 R  165 (708)
Q Consensus       165 ~  165 (708)
                      .
T Consensus       157 ~  157 (210)
T PRK10345        157 S  157 (210)
T ss_pred             c
Confidence            3

>KOG1166|consensus

Probab=99.77  E-value=2.6e-18  Score=203.10  Aligned_cols=197  Identities=21%  Similarity=0.361  Sum_probs=160.6

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC---CCCccceeEEEEecCCce
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK---HENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~---HpNIVkl~~v~~~~~~~~   84 (708)
                      .|..|.|...||.|+||+||+|.+.+ |+.||+|+-+..+..+..    --.+++.+|+   -+.|+.+...+...++  
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY----I~~q~~~RLk~~~~~~~~~~~~a~~~~~~--  768 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY----ICLQVMERLKPQMLPSIMHISSAHVFQNA--  768 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee----ehHHHHHhhchhhhcchHHHHHHHccCCc--
Confidence            35678999999999999999999876 999999997665443222    1223555665   2345555555555554  


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEe---cCCCceEEEecc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFIC---DDGSTIYKLTDF  161 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~---~d~~~~vKL~DF  161 (708)
                      -++|++|.+.|+|.+++....   .+++..+..++.|++.-+++||..||||+||||+|.|+...   +.+...++|+||
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             ceeeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence            799999999999999998433   39999999999999999999999999999999999997332   334568999999


Q ss_pred             Cccccc---cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCC
Q psy15481        162 GAAREL---EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNL  222 (708)
Q Consensus       162 GlA~~~---~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~  222 (708)
                      |.+..+   .++..|...++|-.+-.+|+..        |+.++..+|.|.|+.+++-|+.|+.
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~--------grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE--------GRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhc--------CCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999753   4456788899999999999998        8999999999999999999999963

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=2.8e-18  Score=172.35  Aligned_cols=185  Identities=14%  Similarity=0.115  Sum_probs=137.6

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC---CchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEEE
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM---RPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~---~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .....|++|+||.|+.+..  .+.+++.+.+......   .....+.+|+++|++|. |++|++++++    +  ..|++
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~--~~~lv   76 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D--GRHLD   76 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c--CEEEE
Confidence            3567899999999998754  5788887777543321   11124578999999994 5889999886    2  27999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC-CCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDL-KPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDI-KP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |+|+.|.+|...+..         . ...++.+++.+|.++|++||+|||| ||+|||+    +..+.++|+|||+|...
T Consensus        77 meyI~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv----~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         77 RSYLAGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV----QEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             EeeecCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE----cCCCCEEEEECCCceec
Confidence            999999999754321         1 1357889999999999999999999 7999997    44557999999999865


Q ss_pred             cccccc----c----------ccCCCCCcCChhhhhhhhhcCCCCCcCC-ccccchhhhhHHHHHhcCCCCCCC
Q psy15481        168 EEDQQF----M----------SLYGTEEYLHPDMYERAVLRKPVGKTFG-ATVDLWSIGVTLYHVATGNLPFRP  226 (708)
Q Consensus       168 ~~~~~~----~----------~~~GT~~YlAPE~l~~~~~~~~~~~~~s-~ksDIWSLGviLyeLlTG~~PF~~  226 (708)
                      ......    .          -...++.|++|+.-.-       -...+ ...+.++-|+-+|.++||.+|+-.
T Consensus       143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~-------l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRV-------LKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhh-------hccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            443311    0          1237889999986542       11223 556888999999999999998753

>KOG0606|consensus

Probab=99.73  E-value=4.2e-18  Score=197.75  Aligned_cols=209  Identities=26%  Similarity=0.444  Sum_probs=151.1

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ....|..++.|..|+||.||..+|+.+.+.+|+| +++.+.            |++.     |..+-      ++  .+.
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------------ilRn-----ilt~a------~n--pfv  134 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------------ILRN-----ILTFA------GN--PFV  134 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch------------hhhc-----ccccc------CC--cce
Confidence            3457889999999999999999999999999995 443221            2221     22211      11  233


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |      ||-...++....   ++...        +.++.|||+.||+|||+||+|.++    ..-+.+|++|||++...
T Consensus       135 v------gDc~tllk~~g~---lPvdm--------vla~Eylh~ygivhrdlkpdnllI----T~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  135 V------GDCATLLKNIGP---LPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI----TSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             e------chhhhhcccCCC---Ccchh--------hHHhHhhccCCeecCCCCCCccee----eecccccccchhhhhhh
Confidence            3      455555555332   44433        889999999999999999999998    77788999999998642


Q ss_pred             ccc--------------c--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCC
Q psy15481        168 EED--------------Q--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR  231 (708)
Q Consensus       168 ~~~--------------~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~  231 (708)
                      ...              .  .-..++||+.|+|||++.        .+.|+..+|.|++|+|+|+.+.|..||.   |+.
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil--------rqgygkpvdwwamGiIlyeFLVgcvpff---Gdt  262 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL--------RQGYGKPVDWWAMGIILYEFLVGCVPFF---GDT  262 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhh--------hhccCCCccHHHHHHHHHHHheeeeecc---CCC
Confidence            111              0  112368999999999998        5889999999999999999999999997   566


Q ss_pred             hhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC
Q psy15481        232 NKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS  296 (708)
Q Consensus       232 ~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps  296 (708)
                      ..+.+..++.               ..++|...-+   .+++++    .+++..+|+.+|..|..
T Consensus       263 peelfg~vis---------------d~i~wpE~de---a~p~Ea----~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  263 PEELFGQVIS---------------DDIEWPEEDE---ALPPEA----QDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             HHHHHhhhhh---------------hhccccccCc---CCCHHH----HHHHHHHHHhChHhhcc
Confidence            6666655553               2345544422   234444    44888999999999964

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=2.3e-17  Score=170.55  Aligned_cols=148  Identities=22%  Similarity=0.290  Sum_probs=112.6

Q ss_pred             CCceEEEeeEeecCCceEEEEEE-EcCCCceEEEEEeccCCCC-------------------Cc----hHHHHHHHHHHH
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGV-NKNNGEPVAVKTFNQLSHM-------------------RP----HDVQMREFEVLK   63 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~-~~~tg~~VAIK~~~~~s~~-------------------~~----~~~~~~Ei~iL~   63 (708)
                      .++.|.+.+.||+|++|.||+|. +..+|+.||+|+++.....                   .+    .....+|+.++.
T Consensus        26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~  105 (237)
T smart00090       26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ  105 (237)
T ss_pred             cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            34568889999999999999998 6779999999998754210                   00    012357999999


Q ss_pred             hCCCCC--ccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCC
Q psy15481         64 KVKHEN--IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR-LVHRDLK  140 (708)
Q Consensus        64 kL~HpN--IVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g-IVHrDIK  140 (708)
                      ++.+.+  ++++++.   .   ..++||||++|++|........   .+....+..++.|++.++.+||+.| ++|||||
T Consensus       106 ~L~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik  176 (237)
T smart00090      106 RLYEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEGELVHGDLS  176 (237)
T ss_pred             HHHhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence            997533  3344432   2   2589999999888876542222   2667778899999999999999999 9999999


Q ss_pred             CCcEEEEEecCCCceEEEeccCccccccc
Q psy15481        141 PGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus       141 P~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |+||++    + .+.++|+|||.|.....
T Consensus       177 p~NIli----~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      177 EYNILV----H-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             hhhEEE----E-CCCEEEEEChhhhccCC
Confidence            999998    3 45699999999875443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=3.7e-16  Score=157.33  Aligned_cols=135  Identities=20%  Similarity=0.268  Sum_probs=109.8

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-------hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-------HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-------~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      +.||+|++|.||+|.+  .|..|++|..........       .....+|+.++..+.|++|+....++...+  ..+++
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv   77 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIV   77 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEE
Confidence            5799999999999986  678899998764332211       123568999999999999887777665544  37899


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      |||++|++|.+++...      .. ....++.+++.+|.++|+.|++|||++|+|||+    + .+.++|+|||.+..
T Consensus        78 ~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~----~-~~~~~liDf~~a~~  143 (211)
T PRK14879         78 MEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL----S-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE----E-CCCEEEEECCcccC
Confidence            9999999999998642      22 788999999999999999999999999999998    3 45689999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=5.5e-16  Score=154.80  Aligned_cols=132  Identities=22%  Similarity=0.335  Sum_probs=103.5

Q ss_pred             EeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-------hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         17 VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-------HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        17 ~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-------~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .||+|+||.||+|..  +|..|++|..........       .....+|+.+++.+.|+++.....++...+  ..++||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~   76 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVM   76 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEE
Confidence            489999999999984  578999998754332211       133468999999999887655554444333  368999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||++|++|.+.+....    .      .++.+++.+|.+||+.|++|||++|+||++    + .+.++++|||.+...
T Consensus        77 e~~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~----~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        77 EYIEGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV----R-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EEECCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCCeecCCCCcceEEE----E-CCcEEEEECCCCcCC
Confidence            9999999998875421    1      789999999999999999999999999997    3 457999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023|consensus

Probab=99.65  E-value=7.2e-16  Score=171.79  Aligned_cols=220  Identities=21%  Similarity=0.322  Sum_probs=161.0

Q ss_pred             HHhCCCCCccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-cccCCC
Q psy15481         62 LKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL-VHRDLK  140 (708)
Q Consensus        62 L~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gI-VHrDIK  140 (708)
                      |+.+.|.|+.++++.+.+.+  ..++|.+||..|+|.+.+.....  .++......++++|+.||.|+|...| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~--~~~~i~~~c~rGsl~D~i~~~~~--~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGP--EMIVIWEYCSRGSLLDILSNEDI--KLDYFFILSFIRDISKGLAYLHNSPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCC--ceEEEEeeecCccHHhHHhcccc--CccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence            35689999999999998764  59999999999999999987432  38888889999999999999998765 999999


Q ss_pred             CCcEEEEEecCCCceEEEeccCcccccccc---ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHH
Q psy15481        141 PGNIMKFICDDGSTIYKLTDFGAARELEED---QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHV  217 (708)
Q Consensus       141 P~NILl~~~~d~~~~vKL~DFGlA~~~~~~---~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeL  217 (708)
                      +.|.++    |.+-.+||+|||+.......   .......-..-|.|||.+....... .....+.+.|+||+|++++|+
T Consensus        77 s~nClv----d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~-~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   77 SSNCLV----DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQS-LESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             ccccee----eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccc-ccccccccCCeehHHHHHHHH
Confidence            999999    89999999999998765421   1111122345689999997532111 113367889999999999999


Q ss_pred             hcCCCCCCCCCC-CChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC
Q psy15481        218 ATGNLPFRPYGG-RRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS  296 (708)
Q Consensus       218 lTG~~PF~~~~g-~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps  296 (708)
                      ++..-||.-... .+..+.+.++...              +...+.+.++...    ++.+.+..+++.||..+|..||+
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~~--------------~~~~~rP~i~~~~----e~~~~l~~l~~~cw~e~P~~rPs  213 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKKG--------------GSNPFRPSIELLN----ELPPELLLLVARCWEEIPEKRPS  213 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHhc--------------CCCCcCcchhhhh----hcchHHHHHHHHhcccChhhCcc
Confidence            999999974222 2234555554430              1111122222211    33445677999999999999999


Q ss_pred             HHHHHHHHHHHH
Q psy15481        297 FERFFSEVTKTL  308 (708)
Q Consensus       297 a~q~~~~l~~il  308 (708)
                      ++++...+..+.
T Consensus       214 ~~~i~~~~~~~~  225 (484)
T KOG1023|consen  214 IEQIRSKLLTIN  225 (484)
T ss_pred             HHHHHhhhhhhc
Confidence            999877655443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.64  E-value=8.8e-16  Score=153.91  Aligned_cols=139  Identities=22%  Similarity=0.298  Sum_probs=106.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--C-------------------chHHHHHHHHHHHhCCCCC
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--R-------------------PHDVQMREFEVLKKVKHEN   69 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~-------------------~~~~~~~Ei~iL~kL~HpN   69 (708)
                      .|.+.+.||+|+||.||++.+. +|+.||||+++.....  .                   ......+|+.++.++.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4778899999999999999875 8999999997643210  0                   0112357888999998874


Q ss_pred             --ccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEE
Q psy15481         70 --IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKF  147 (708)
Q Consensus        70 --IVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~  147 (708)
                        ++..++.      ...++||||++|++|......         .....++.+++.++.++|+.|++||||||+||++ 
T Consensus        95 i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill-  158 (198)
T cd05144          95 FPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV-  158 (198)
T ss_pred             CCCCceeec------CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE-
Confidence              3433331      236899999999998765421         2356788999999999999999999999999998 


Q ss_pred             EecCCCceEEEeccCccccccc
Q psy15481        148 ICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus       148 ~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                         +..+.++|+|||.+.....
T Consensus       159 ---~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         159 ---DDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             ---cCCCcEEEEECCccccCCC
Confidence               5567899999999975443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033|consensus

Probab=99.63  E-value=1.3e-16  Score=175.05  Aligned_cols=121  Identities=25%  Similarity=0.435  Sum_probs=106.7

Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      +.||.|++|...+|.+++..+......+....+.++.|++.|++|   +|.+|+|+||.||+.    .....+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~----~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF----SDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc----ccchhhhhhhhhh
Confidence            478999999999999999876666668889999999999999999   999999999999995    2333799999999


Q ss_pred             cccccccc-------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc
Q psy15481        164 ARELEEDQ-------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT  219 (708)
Q Consensus       164 A~~~~~~~-------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT  219 (708)
                      .......+       ......||..||+||.+.        +..|+.++||||||++|||++.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~--------g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR--------GQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHh--------hhhhhhhcchhhHHHHHHHHHH
Confidence            98766555       445578999999999998        7899999999999999999998

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.61  E-value=5.3e-15  Score=170.47  Aligned_cols=137  Identities=20%  Similarity=0.280  Sum_probs=106.2

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-------chHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-------PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-------~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      |...+.||+|+||.||++.+.  +..+++|.........       ..+.+.+|+++++.++|++++....+.....  .
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~  410 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--E  410 (535)
T ss_pred             cCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--C
Confidence            456789999999999999875  3445555432211111       1234578999999999999988776655543  3


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .++||||++|++|.+++.           ....++.+++.+|.+||+.|++||||||+|||+    + .+.++|+|||+|
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~-~~~~~liDFGla  474 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----R-DDRLYLIDFGLG  474 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----E-CCcEEEEeCccc
Confidence            789999999999998885           346789999999999999999999999999997    2 235899999999


Q ss_pred             cccc
Q psy15481        165 RELE  168 (708)
Q Consensus       165 ~~~~  168 (708)
                      +...
T Consensus       475 ~~~~  478 (535)
T PRK09605        475 KYSD  478 (535)
T ss_pred             ccCC
Confidence            8654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.56  E-value=1.7e-14  Score=142.46  Aligned_cols=138  Identities=27%  Similarity=0.376  Sum_probs=97.1

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-hHH----------------------HHHHHHHHHhCCCCC--
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDV----------------------QMREFEVLKKVKHEN--   69 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-~~~----------------------~~~Ei~iL~kL~HpN--   69 (708)
                      .+.||+|+||.||+|.+. +|+.||||+++....... ...                      ...|...+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            468999999999999986 899999999875322110 010                      124555666664332  


Q ss_pred             ccceeEEEEecCCceEEEEEeccCCCCHHH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEE
Q psy15481         70 IVKLLAIEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKF  147 (708)
Q Consensus        70 IVkl~~v~~~~~~~~~~LVmEy~~ggsL~~-~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~  147 (708)
                      +++.++.      ...++||||++|+++.. .+....    .. ..+..++.+++.++.++|. .||+|+||||+||++ 
T Consensus        81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili-  148 (187)
T cd05119          81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV-  148 (187)
T ss_pred             CCceEec------CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE-
Confidence            3444432      12689999999854321 121111    11 6678999999999999999 999999999999998 


Q ss_pred             EecCCCceEEEeccCccccccc
Q psy15481        148 ICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus       148 ~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                         + .+.++|+|||.+.....
T Consensus       149 ---~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         149 ---D-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             ---E-CCcEEEEECcccccccC
Confidence               3 55799999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590|consensus

Probab=99.56  E-value=4.2e-16  Score=180.40  Aligned_cols=263  Identities=22%  Similarity=0.348  Sum_probs=190.7

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcC-CCceEEEEEeccCCC-CCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKN-NGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~-tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~   85 (708)
                      +..|.+..-||+|+|+.|-...... +...+|.|.++.... .........|..+-+.+. |+|++.+++....++  ..
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~--~~   96 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR--SY   96 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc--cc
Confidence            6778888999999999999987743 344566776654431 122222345777778886 999999999877655  48


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCcEEEEEecCCCc-eEEEeccCc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR-DNRLVHRDLKPGNIMKFICDDGST-IYKLTDFGA  163 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH-~~gIVHrDIKP~NILl~~~~d~~~-~vKL~DFGl  163 (708)
                      +++++|..|++++..+..+. ..+.+......++.|+..++.|+| ..++.|+||||+|.++    ++.+ ..+++|||+
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l----~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL----DESGSALKIADFGL  171 (601)
T ss_pred             ccccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh----ccCCCcccCCCchh
Confidence            99999999999999884222 124788899999999999999999 9999999999999998    6666 899999999


Q ss_pred             cccccc-cc---cccccCC-CCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHH
Q psy15481        164 ARELEE-DQ---QFMSLYG-TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       164 A~~~~~-~~---~~~~~~G-T~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~  238 (708)
                      |..+.. +.   .....+| ++.|.|||...+       .....+..|+||.|+++..+++|..|+........ . ...
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~-------~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~-~~~  242 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSG-------KAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-R-YSS  242 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccc-------hhhcCCCcccccccccccccccCCCCccccccccc-c-cee
Confidence            987655 22   2344678 999999999873       13457889999999999999999999974322210 0 000


Q ss_pred             HHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      ....+             +    ......+.    .+.....+++.+++..+|..|.+.+++           -.++|..
T Consensus       243 ~~~~~-------------~----~~~~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~-----------~~d~~~~  290 (601)
T KOG0590|consen  243 WKSNK-------------G----RFTQLPWN----SISDQAHDLLHKILKENPSNRLSIEEL-----------KLDNWLS  290 (601)
T ss_pred             ecccc-------------c----ccccCccc----cCChhhhhcccccccCCchhccccccc-----------ccccccc
Confidence            00000             0    00111222    233345568889999999999998886           4466665


Q ss_pred             C
Q psy15481        319 N  319 (708)
Q Consensus       319 ~  319 (708)
                      .
T Consensus       291 ~  291 (601)
T KOG0590|consen  291 S  291 (601)
T ss_pred             c
Confidence            5

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=6.1e-14  Score=145.24  Aligned_cols=138  Identities=20%  Similarity=0.289  Sum_probs=104.0

Q ss_pred             eeEee-cCCceEEEEEEEcCCCceEEEEEeccCCC------------CCchHHHHHHHHHHHhCCCCCc--cceeEEEEe
Q psy15481         15 TSVLG-KGATGAVFQGVNKNNGEPVAVKTFNQLSH------------MRPHDVQMREFEVLKKVKHENI--VKLLAIEEE   79 (708)
Q Consensus        15 ~~~LG-~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~------------~~~~~~~~~Ei~iL~kL~HpNI--Vkl~~v~~~   79 (708)
                      ...|| .||.|+||.+...  |..+++|.+.....            ........+|+.++.+|.|++|  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35688 8999999999764  78899998854211            0112345689999999998875  666766443


Q ss_pred             cCCc--eEEEEEeccCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceE
Q psy15481         80 QEGR--GKVIVMELCTG-GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY  156 (708)
Q Consensus        80 ~~~~--~~~LVmEy~~g-gsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~v  156 (708)
                      ..+.  ..++|||+++| .+|.+++....    +++.    .+.+++.++.+||++||+||||||.|||+    +..+.+
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~----l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv----~~~~~v  181 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEAP----LSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL----DPDGKF  181 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcCC----CCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE----cCCCCE
Confidence            3221  23599999997 69998886532    5554    36789999999999999999999999998    444579


Q ss_pred             EEeccCcccc
Q psy15481        157 KLTDFGAARE  166 (708)
Q Consensus       157 KL~DFGlA~~  166 (708)
                      +|+|||.+..
T Consensus       182 ~LIDfg~~~~  191 (239)
T PRK01723        182 WLIDFDRGEL  191 (239)
T ss_pred             EEEECCCccc
Confidence            9999999875

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.49  E-value=1.9e-13  Score=127.75  Aligned_cols=132  Identities=27%  Similarity=0.309  Sum_probs=106.9

Q ss_pred             EeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCC--CCccceeEEEEecCCceEEEEEec
Q psy15481         14 TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH--ENIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        14 i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~H--pNIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      +.+.||+|.++.||++...  +..+++|.+.....   .....+|+.+++.++|  +++++++.+....  +..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEEe
Confidence            3578999999999999875  37899999865432   3456689999999976  5888888877654  358999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN---RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~---gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ++|+++..+          +......++.+++.++.++|..   +++|+|++|+||++    +..+.++++|||.+..
T Consensus        75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~----~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV----DDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE----ECCcEEEEEecccccC
Confidence            988777543          4456677899999999999984   79999999999998    4457899999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601|consensus

Probab=99.38  E-value=6.5e-13  Score=148.50  Aligned_cols=201  Identities=26%  Similarity=0.317  Sum_probs=163.5

Q ss_pred             CCCceEEEeeEeec--CCceEEEEEEE--cCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhC-CCCCccceeEEEEec
Q psy15481          7 STNYVWCTTSVLGK--GATGAVFQGVN--KNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQ   80 (708)
Q Consensus         7 ~~n~~y~i~~~LG~--G~fG~Vy~a~~--~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~   80 (708)
                      ...+.+.+...+|.  |.+|.||.+..  ..++..+|+|.-..... ........+|+...+++ .|+|.++.+..+++.
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence            44567788999999  99999999998  88999999998543222 11122345788888887 699999988887765


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHHCCCcccCCCCCcEEEEEecCCC-ce
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA----GMKHLRDNRLVHRDLKPGNIMKFICDDGS-TI  155 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~----aL~yLH~~gIVHrDIKP~NILl~~~~d~~-~~  155 (708)
                      +  ..|+-+|+| |.+|..+.....+.  ++...++..+.+...    ||.++|+.+++|-|+||.||+.    .++ ..
T Consensus       191 ~--~lfiqtE~~-~~sl~~~~~~~~~~--~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~----~~~~~s  261 (524)
T KOG0601|consen  191 G--ILFIQTELC-GESLQSYCHTPCNF--LPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT----TSDWTS  261 (524)
T ss_pred             C--cceeeeccc-cchhHHhhhccccc--CCchhhhhHHhhhhhcccccccccCCCcccccccchhheec----ccccce
Confidence            5  489999999 68998888776543  899999999999999    9999999999999999999996    333 78


Q ss_pred             EEEeccCccccccccccc------cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCC
Q psy15481        156 YKLTDFGAARELEEDQQF------MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR  225 (708)
Q Consensus       156 vKL~DFGlA~~~~~~~~~------~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~  225 (708)
                      .+++|||+...+.++.-.      ...-|...|++||...         ..++.+.|++|+|-++.+..+|..++.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~---------~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN---------GLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc---------cccchHhhhcchhhhhHhhHhhccccc
Confidence            899999999887665421      1125788899999985         678999999999999999999987775

>KOG1243|consensus

Probab=99.25  E-value=6.8e-11  Score=133.70  Aligned_cols=192  Identities=22%  Similarity=0.326  Sum_probs=141.0

Q ss_pred             cccCCCCc--eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEec
Q psy15481          3 FLRGSTNY--VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ   80 (708)
Q Consensus         3 ~l~~~~n~--~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~   80 (708)
                      |+.+..+.  .|.+ ...+-++.+..--|..+.++.+|.|......+. ...+...+-+.-++.++||||+++++.++..
T Consensus         4 ~f~~~~~~~fpY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~   81 (690)
T KOG1243|consen    4 FFSRDSSSQFPYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEE   81 (690)
T ss_pred             eecccccccCCccc-ccccCCCcccccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhccc
Confidence            44444444  3444 333333333222456677899999998876554 3345567888999999999999999998876


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR-DNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH-~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      +  ..|||+|-+  ..|..++++      +....+...++||+.||.||| +.+++|++|.-+.|++    +..+..||+
T Consensus        82 ~--~~ylvTErV--~Pl~~~lk~------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV----n~~GeWkLg  147 (690)
T KOG1243|consen   82 G--TLYLVTERV--RPLETVLKE------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV----NESGEWKLG  147 (690)
T ss_pred             C--ceEEEeecc--ccHHHHHHH------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE----cCCCcEEEe
Confidence            5  499999998  467777876      668889999999999999998 5699999999999998    777789999


Q ss_pred             ccCcccccccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC
Q psy15481        160 DFGAARELEEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG  220 (708)
Q Consensus       160 DFGlA~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG  220 (708)
                      +|.++........ ....+--..|..|+.+.          .-....|.|-|||+++|++.|
T Consensus       148 gle~v~~~~~~~~~~~~~~~~~s~~~P~~~~----------~s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  148 GLELVSKASGFNAPAKSLYLIESFDDPEEID----------PSEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             eeEEEeccccCCcccccchhhhcccChhhcC----------ccccchhhhhHHHHHHHHhCc
Confidence            9999875433221 12223334567776543          112567999999999999999

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.23  E-value=3.7e-11  Score=135.09  Aligned_cols=144  Identities=24%  Similarity=0.248  Sum_probs=95.0

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch--------------------------H-------------HH
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH--------------------------D-------------VQ   55 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~--------------------------~-------------~~   55 (708)
                      .+.||+|++|.||+|.. .+|+.||||+.+........                          +             .+
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            35799999999999986 47999999998654211000                          0             01


Q ss_pred             HHHHHHHHhC----CCCCccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q psy15481         56 MREFEVLKKV----KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA-GMKHLR  130 (708)
Q Consensus        56 ~~Ei~iL~kL----~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~-aL~yLH  130 (708)
                      .+|...+.++    +|.+-+.+-.++.+..+ ..++||||++|++|.++......  +.+   ...++..++. .+..+|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~-~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTS-ERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC-CceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHH
Confidence            2344444444    23322333233322222 36999999999999887643211  122   2345555555 467899


Q ss_pred             HCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481        131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus       131 ~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ..|++|+|+||+||++    +..+.++++|||++..+.+
T Consensus       275 ~~g~~H~D~hPgNilv----~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 RDGFFHADLHPGNIFV----LKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             hCCceeCCCCcccEEE----CCCCcEEEEeCCCeeECCH
Confidence            9999999999999998    5556799999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601|consensus

Probab=99.19  E-value=2.1e-11  Score=136.47  Aligned_cols=243  Identities=21%  Similarity=0.230  Sum_probs=172.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEc-CCCceEEEEEeccCCCCCchHHH-HHHHHHHHhC-CCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNK-NNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKV-KHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~-~tg~~VAIK~~~~~s~~~~~~~~-~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|..+..||.|.|+.|+..... .++..|++|-..+.......+.+ ..|+.+...+ .|.+++..+..+....+  .|
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--~~  342 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--GY  342 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc--cc
Confidence            35678889999999999987755 67889999987765544433332 5677777766 68888888877754433  67


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +--|||+|+++.-.+.....   +.+...+.+..|++.++.++|++.++|+|+||+||++  ..++ +..+++|||.+..
T Consensus       343 ip~e~~~~~s~~l~~~~~~~---~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i--~~~~-~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQM---LDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILI--SNDG-FFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhhHHHHh---cCcchhhhhHHHHHhccccccchhhhcccccccceee--ccch-hhhhccccccccc
Confidence            99999999988766644333   8889999999999999999999999999999999996  3333 7789999999864


Q ss_pred             ccccccccccCCCCCcC-ChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEEDQQFMSLYGTEEYL-HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~Yl-APE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      +.-..  ....+...+. .+|++..       ...+..++|++|||..+++.++|.. +..     +....+.+..+   
T Consensus       417 ~~~~~--~~~~~~~r~~p~~~~~~e-------~~~~~~~~~~~sl~~~~~e~~~~~~-ls~-----~~~~~~~i~~~---  478 (524)
T KOG0601|consen  417 LAFSS--GVFHHIDRLYPIAEILLE-------DYPHLSKADIFSLGLSVDEAITGSP-LSE-----SGVQSLTIRSG---  478 (524)
T ss_pred             cceec--ccccccccccccchhhcc-------ccccccccccccccccccccccCcc-cCc-----ccccceeeecc---
Confidence            21111  1122333344 2444432       6778899999999999999999864 321     11112222211   


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                        ..|.    .++....+..+.+.++..|+..|+.+.++
T Consensus       479 ------------------~~p~----~~~~~~~~q~~~kv~~~~~~~~~~l~~~l  511 (524)
T KOG0601|consen  479 ------------------DTPN----LPGLKLQLQVLLKVMINPDRKRRPSAVEL  511 (524)
T ss_pred             ------------------cccC----CCchHHhhhhhhhhhcCCccccchhhhhh
Confidence                              2222    22333556668889999999999998875

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.18  E-value=2.2e-10  Score=114.83  Aligned_cols=139  Identities=20%  Similarity=0.289  Sum_probs=100.1

Q ss_pred             eeEeecCCceEEEEEEEcC------CCceEEEEEeccCC------------C---------CCchHHH----HHHHHHHH
Q psy15481         15 TSVLGKGATGAVFQGVNKN------NGEPVAVKTFNQLS------------H---------MRPHDVQ----MREFEVLK   63 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~------tg~~VAIK~~~~~s------------~---------~~~~~~~----~~Ei~iL~   63 (708)
                      ...||.|.-+.||.|....      .+..+|||+++...            .         ..+....    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998654      35799999974211            0         0111122    38999999


Q ss_pred             hCC--CCCccceeEEEEecCCceEEEEEeccCCCCHH-HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCC
Q psy15481         64 KVK--HENIVKLLAIEEEQEGRGKVIVMELCTGGSLF-NILDDPENTYGLQEEEFLLVLEHLTAGMKHL-RDNRLVHRDL  139 (708)
Q Consensus        64 kL~--HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~-~~L~~~~~~~~L~e~~v~~il~qIl~aL~yL-H~~gIVHrDI  139 (708)
                      ++.  .-+++..+++   .   .-+|||||+.++.+. ..+++.    .+++.....++.+++.+|..+ |+.|+||+|+
T Consensus        82 rl~~~Gv~vP~pi~~---~---~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL---K---KHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECNLVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe---c---CCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            984  3566777764   1   258999999765442 223322    156667788899999999998 8999999999


Q ss_pred             CCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481        140 KPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus       140 KP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      +|.||++    + .+.++|+|||.|...+
T Consensus       152 s~~NIL~----~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLW----H-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEE----E-CCcEEEEECCCceeCC
Confidence            9999997    2 2358999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.16  E-value=1.4e-10  Score=112.22  Aligned_cols=128  Identities=24%  Similarity=0.234  Sum_probs=93.2

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCc-cceeEEEEecCCceEEEEEeccC
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI-VKLLAIEEEQEGRGKVIVMELCT   93 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNI-Vkl~~v~~~~~~~~~~LVmEy~~   93 (708)
                      .+.|+.|.++.||++...  |..|++|+......  ......+|+.+++.+.+.++ ++++....  ..  .++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~--~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ET--GVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CC--CeEEEEecC
Confidence            457899999999999764  78899998754321  12224589999998865554 44544432  22  479999999


Q ss_pred             CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----cccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         94 GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL-----VHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        94 ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gI-----VHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      |.++...    .    ..   ...++.+++.+|..||+.++     +|+|++|+||++    + .+.++++|||.+..
T Consensus        75 G~~l~~~----~----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~----~-~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE----D----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL----D-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc----c----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE----E-CCeEEEEecccccC
Confidence            9887543    0    11   13457899999999999985     999999999997    3 23589999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.15  E-value=3.4e-11  Score=137.46  Aligned_cols=147  Identities=21%  Similarity=0.279  Sum_probs=92.4

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--------------------------CchH-------H------HH
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--------------------------RPHD-------V------QM   56 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--------------------------~~~~-------~------~~   56 (708)
                      ..||+|++|.||+|+.+.+|+.||||+.+.....                          ...+       .      +.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            6799999999999999888999999999754210                          0010       0      12


Q ss_pred             HHHHHHHhC----CCCCccceeEEEEecCCceEEEEEeccCCCCHHHH--hcCCC-CCCCCCHHHHHHHHHHHHHHHHHH
Q psy15481         57 REFEVLKKV----KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNI--LDDPE-NTYGLQEEEFLLVLEHLTAGMKHL  129 (708)
Q Consensus        57 ~Ei~iL~kL----~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~--L~~~~-~~~~L~e~~v~~il~qIl~aL~yL  129 (708)
                      +|...+.++    .+.+.+.+-.++.+-. +..++||||+.|+.+.++  +.... +...+.+..+..++.|++      
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence            344333333    2444444444443322 237899999999999774  22211 000133444444555544      


Q ss_pred             HHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481        130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus       130 H~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                       ..|++|+|+||+||++..+....+.++++|||.+..+.+.
T Consensus       278 -~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        278 -RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence             5899999999999998222222348999999999865443

>KOG0606|consensus

Probab=99.05  E-value=5.5e-11  Score=139.36  Aligned_cols=246  Identities=21%  Similarity=0.290  Sum_probs=165.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch--HHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH--DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~--~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .+.+.+-+.+|++|.++.+.-..+|...++|+..........  +....+-.++-.-.+|-++.....+  +.....+++
T Consensus       805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L~  882 (1205)
T KOG0606|consen  805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPLV  882 (1205)
T ss_pred             cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCcchh
Confidence            345556889999999999988888877777765433221111  1111111111112334444443332  223348999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ++|..|++|...+....   ..+++..+..+..+..++++||...++|+|++|.|++.    ...+..+++|||......
T Consensus       883 ~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~----~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI----AYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccchhhcccccccchhh----cccCCcccCccccccccc
Confidence            99999999999987754   27778888999999999999999999999999999997    555678999997432110


Q ss_pred             ---------------------cc-----------ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHH
Q psy15481        169 ---------------------ED-----------QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYH  216 (708)
Q Consensus       169 ---------------------~~-----------~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLye  216 (708)
                                           ..           .......||+.|++||...        +..-+.++|+|+.|+++++
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l--------g~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL--------GRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc--------cccCCCcchhhhhhhhhhh
Confidence                                 00           0012356899999999987        6777889999999999999


Q ss_pred             HhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC
Q psy15481        217 VATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS  296 (708)
Q Consensus       217 LlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps  296 (708)
                      .++|.+||..   ....    +++....           ++.+.|..       .+........+++..+|..+|.+|..
T Consensus      1028 ~l~g~pp~na---~tpq----~~f~ni~-----------~~~~~~p~-------g~~~~s~~aq~~~~~ll~~~~~qr~~ 1082 (1205)
T KOG0606|consen 1028 VLTGIPPFNA---ETPQ----QIFENIL-----------NRDIPWPE-------GPEEGSYEAQDLINRLLTEEPTQRLG 1082 (1205)
T ss_pred             hhcCCCCCCC---cchh----hhhhccc-----------cCCCCCCC-------CccccChhhhhhhhhhhccCchhccC
Confidence            9999999974   2222    2222211           22233322       22223333445778899999999988


Q ss_pred             HH
Q psy15481        297 FE  298 (708)
Q Consensus       297 a~  298 (708)
                      +.
T Consensus      1083 a~ 1084 (1205)
T KOG0606|consen 1083 AK 1084 (1205)
T ss_pred             cc
Confidence            76

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=2.9e-09  Score=104.31  Aligned_cols=133  Identities=23%  Similarity=0.322  Sum_probs=95.0

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--h-----HHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--H-----DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~-----~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..+++|+-+.+|.+...  |..+++|.-.+.....+  .     +...+|+.++.++.--.|....-++.+++.  ..|+
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~--~~I~   77 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN--GLIV   77 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CEEE
Confidence            45789999999999664  55677776433332221  1     223689999998865444333333334443  7899


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||.+|..|.+.+...      .    ..++..+-.-+.-||..||||+|+.++||++    .+. .+.++|||++...
T Consensus        78 me~I~G~~lkd~l~~~------~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl----~~~-~i~~IDfGLg~~s  141 (204)
T COG3642          78 MEYIEGELLKDALEEA------R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIIL----SGG-RIYFIDFGLGEFS  141 (204)
T ss_pred             EEEeCChhHHHHHHhc------c----hHHHHHHHHHHHHHHhcCeecCCCccceEEE----eCC-cEEEEECCccccc
Confidence            9999999999888764      1    3466777777778999999999999999997    322 2899999999753

>KOG1266|consensus

Probab=99.01  E-value=1e-10  Score=122.15  Aligned_cols=199  Identities=16%  Similarity=0.192  Sum_probs=133.8

Q ss_pred             HHHHhCCCCCccceeEEEEecCC---ceEEEEEeccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHC--C
Q psy15481         60 EVLKKVKHENIVKLLAIEEEQEG---RGKVIVMELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDN--R  133 (708)
Q Consensus        60 ~iL~kL~HpNIVkl~~v~~~~~~---~~~~LVmEy~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~--g  133 (708)
                      .-+-.+-|.|||+++.++.+...   ....+++||+..|++..+|++. .+...+.....++++.||+.||.|||+.  -
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            34555679999999998865432   3478999999999999999863 2334488999999999999999999986  6


Q ss_pred             CcccCCCCCcEEEEEecCCCceEEEeccCcccc-----ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccch
Q psy15481        134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-----LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLW  208 (708)
Q Consensus       134 IVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~-----~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIW  208 (708)
                      |+|+++..+.|++    ..++.+|++--.....     ...........+-++|.+||.-.        ....+.++|||
T Consensus       199 iihgnlTc~tifi----q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~--------~tn~~~a~dIy  266 (458)
T KOG1266|consen  199 IIHGNLTCDTIFI----QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT--------TTNTTGASDIY  266 (458)
T ss_pred             cccCCcchhheee----cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc--------ccccccchhhh
Confidence            9999999999997    4555666653221110     00001111234678899998744        34557789999


Q ss_pred             hhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcc
Q psy15481        209 SIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLE  288 (708)
Q Consensus       209 SLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~  288 (708)
                      ++|....+|..|..--.  .+.+..+.-..+..     .+.+                    ++.++.   .+++.+||+
T Consensus       267 ~fgmcAlemailEiq~t--nseS~~~~ee~ia~-----~i~~--------------------len~lq---r~~i~kcl~  316 (458)
T KOG1266|consen  267 KFGMCALEMAILEIQST--NSESKVEVEENIAN-----VIIG--------------------LENGLQ---RGSITKCLE  316 (458)
T ss_pred             hhhHHHHHHHHheeccC--CCcceeehhhhhhh-----heee--------------------ccCccc---cCcCccccc
Confidence            99999999998875322  12222111111110     1111                    111111   247789999


Q ss_pred             cCcccCCCHHHH
Q psy15481        289 VDSKKIWSFERF  300 (708)
Q Consensus       289 ~DP~kRpsa~q~  300 (708)
                      ..|..||++..+
T Consensus       317 ~eP~~rp~ar~l  328 (458)
T KOG1266|consen  317 GEPNGRPDARLL  328 (458)
T ss_pred             CCCCCCcchhhh
Confidence            999999999986

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.97  E-value=4.8e-09  Score=105.64  Aligned_cols=144  Identities=22%  Similarity=0.235  Sum_probs=105.1

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCC--CCccceeEEEEecC-CceEEEEEecc
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH--ENIVKLLAIEEEQE-GRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~H--pNIVkl~~v~~~~~-~~~~~LVmEy~   92 (708)
                      ..||.|.++.||++... +|+.|++|...............+|+.+++.+.+  .++++++.+..... .+..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            56899999999999764 3688999997654322234456789999999965  44677777654322 12468999999


Q ss_pred             CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q psy15481         93 TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-----------------------------------------  131 (708)
Q Consensus        93 ~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-----------------------------------------  131 (708)
                      +|.++...+..    ..+++.....++.+++.+|..||+                                         
T Consensus        83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99988775532    126777778888888888888874                                         


Q ss_pred             ---------------CCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481        132 ---------------NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       132 ---------------~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                                     ..++|+|++|+||++  ++++.+.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~--~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLF--HPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEE--cCCCCcEEEEEecccccc
Confidence                           235899999999997  221156789999999874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087|consensus

Probab=98.93  E-value=1.2e-08  Score=99.60  Aligned_cols=147  Identities=22%  Similarity=0.270  Sum_probs=103.8

Q ss_pred             EeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-------hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         14 TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-------HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        14 i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-------~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ....+-+|+-+.|+++.+  .|+.++||.-.......+       ..+..+|.+++.++.--.|....-++.+..+  -.
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~--~~   86 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG--GQ   86 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC--Ce
Confidence            567889999999999965  588888886432222111       1233689999998865455444434444443  57


Q ss_pred             EEEeccCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         87 IVMELCTG-GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        87 LVmEy~~g-gsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|||++| .++.+++...-.. .........+++.|-..+.-||.++|+|+|+..+||++ ..++++-.+.++|||++.
T Consensus        87 i~ME~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill-~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   87 IYMEFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILL-RSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEEEeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEE-ecCCCcCceEEEeecchh
Confidence            99999976 3677776553322 13333447899999999999999999999999999997 444455567999999986


Q ss_pred             c
Q psy15481        166 E  166 (708)
Q Consensus       166 ~  166 (708)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>KOG3741|consensus

Probab=98.84  E-value=1.2e-07  Score=104.85  Aligned_cols=171  Identities=19%  Similarity=0.280  Sum_probs=128.1

Q ss_pred             ceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEe--cCCceEEEEEeccCC-CCHHH
Q psy15481         23 TGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEE--QEGRGKVIVMELCTG-GSLFN   99 (708)
Q Consensus        23 fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~--~~~~~~~LVmEy~~g-gsL~~   99 (708)
                      ..+.|++....+|..|++|+++-.. .........-++.++++.|+|||++.+++..  -+...+++|++|+++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r-~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDR-DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeecccc-ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4588999999999999999994222 2222223467889999999999999998852  223458999999875 56766


Q ss_pred             HhcC-CC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481        100 ILDD-PE-----------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus       100 ~L~~-~~-----------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      .--. +.           .....+|..++.++.|+..||.++|+.|+.-+-+.|.+|++    +|...++|..-|....+
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv----~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV----TGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe----eCcceEEEecccceeee
Confidence            4322 11           12237899999999999999999999999999999999998    77777888887777665


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCC
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNL  222 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~  222 (708)
                      .++.           .  +.++.           ..+-|.=-||.++..|.||..
T Consensus       444 ~~d~-----------~--~~le~-----------~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  444 QEDP-----------T--EPLES-----------QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             cCCC-----------C--cchhH-----------HhhhhHHHHHHHHHHHhhccc
Confidence            5443           1  11221           234588899999999999965

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.82  E-value=3.2e-07  Score=99.26  Aligned_cols=275  Identities=12%  Similarity=0.100  Sum_probs=161.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEE----EEecC-Cce
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAI----EEEQE-GRG   84 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v----~~~~~-~~~   84 (708)
                      ....+.-||+|+-+.+|-.-.   -..-+.|++....-  ....  .-+..|.+. .||-+-.-+.+    ....+ +..
T Consensus        12 ~i~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Ppp--a~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          12 PIPPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPP--AAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             ccCCCccccCCccceeeecch---hhchhheeecCCCc--hHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            344567899999999997522   22234577764321  1222  223333333 66644331211    11122 222


Q ss_pred             EEEEEeccCCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         85 KVIVMELCTGGSLFNILDDPE----NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~----~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                      +-+.|..+.|..--..+.++.    ...-..+...+++.+.++.+.+-||..|.+-+|+.++|+|+    .+.+.|.|.|
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV----sd~~~V~LVd  160 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV----SDDSKVVLVD  160 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee----ecCceEEEEc
Confidence            668888887753333332321    11115688899999999999999999999999999999998    4455688887


Q ss_pred             cCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC-CCCCCCCCCCC-hhhHHH-
Q psy15481        161 FGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG-NLPFRPYGGRR-NKETMY-  237 (708)
Q Consensus       161 FGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG-~~PF~~~~g~~-~~e~~~-  237 (708)
                      =.....-.++..+...+|..+|++||.-.-   ....+..-+...|.|.|||++|+++.| +.||.+..... ...... 
T Consensus       161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~---~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         161 SDSFQINANGTLHLCPVGVSEFTPPELQTL---PSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             ccceeeccCCceEecccCccccCCHHHhcc---ccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            555444445556677889999999997641   112255567889999999999999996 99998642211 111111 


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhccc--CcccCCCHHHHHHHHHHHH
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEV--DSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~--DP~kRpsa~q~~~~l~~il  308 (708)
                      .|...    .+........|...- ..-+.+.-+++.+..    +...|+..  +|.-|||++-++..+...-
T Consensus       238 ~Ia~g----~f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqA----lF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         238 DIAHG----RFAYASDQRRGLKPP-PRSIPLSMLPPDVQA----LFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             hhhcc----eeeechhccCCCCCC-CCCCChhhcCHHHHH----HHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            12211    111111111111000 011222335555555    44455543  3678999998888775443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.73  E-value=2.1e-07  Score=98.08  Aligned_cols=141  Identities=13%  Similarity=0.098  Sum_probs=95.7

Q ss_pred             CceEEEEEEEcCCCceEEEEEeccCCCC----------CchHHHHHHHHHHHhCCCCCc--cceeEEEEecC---CceEE
Q psy15481         22 ATGAVFQGVNKNNGEPVAVKTFNQLSHM----------RPHDVQMREFEVLKKVKHENI--VKLLAIEEEQE---GRGKV   86 (708)
Q Consensus        22 ~fG~Vy~a~~~~tg~~VAIK~~~~~s~~----------~~~~~~~~Ei~iL~kL~HpNI--Vkl~~v~~~~~---~~~~~   86 (708)
                      ....|+++..  .|+.|.||........          .+.....+|+..+.+|..-+|  +..+++.+...   ....+
T Consensus        34 ~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~  111 (268)
T PRK15123         34 EGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF  111 (268)
T ss_pred             CCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence            3344666543  5788999977433210          122235688888888743333  33344443221   23478


Q ss_pred             EEEeccCCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEe---cCCCceEEEeccC
Q psy15481         87 IVMELCTGG-SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFIC---DDGSTIYKLTDFG  162 (708)
Q Consensus        87 LVmEy~~gg-sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~---~d~~~~vKL~DFG  162 (708)
                      +|||+++|. +|.+++..... ...+......++.+++..+.-||..||+|+|++|+|||+...   .++...+.|+||+
T Consensus       112 LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        112 IITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             EEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            999999876 89988853211 125667788999999999999999999999999999998311   1345689999999


Q ss_pred             ccc
Q psy15481        163 AAR  165 (708)
Q Consensus       163 lA~  165 (708)
                      .+.
T Consensus       191 r~~  193 (268)
T PRK15123        191 RAQ  193 (268)
T ss_pred             ccc
Confidence            885

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.65  E-value=4.3e-07  Score=91.99  Aligned_cols=110  Identities=25%  Similarity=0.357  Sum_probs=82.4

Q ss_pred             HHHHHHHHHHHhCCCC--CccceeEEEEecCC--ceEEEEEeccCCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q psy15481         53 DVQMREFEVLKKVKHE--NIVKLLAIEEEQEG--RGKVIVMELCTGG-SLFNILDDPENTYGLQEEEFLLVLEHLTAGMK  127 (708)
Q Consensus        53 ~~~~~Ei~iL~kL~Hp--NIVkl~~v~~~~~~--~~~~LVmEy~~gg-sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~  127 (708)
                      ....+|...+..|..-  ..+..+++.+...+  ...++|||+++|. +|.+++.....   ++......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            3456888887777432  24455555443222  3468999999874 89999876333   567778899999999999


Q ss_pred             HHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481        128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       128 yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      -||.+||+|+|++|.|||+ ..+++...+.++||+.+..
T Consensus       133 ~lH~~gi~H~Dl~~~NILv-~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDAGIYHGDLNPSNILV-DPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHCcCCCCCCCcccEEE-eCCCCceeEEEEcchhcee
Confidence            9999999999999999998 2233456899999998875

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.62  E-value=2.3e-07  Score=92.63  Aligned_cols=127  Identities=30%  Similarity=0.399  Sum_probs=80.7

Q ss_pred             EEEEEEEcCCCceEEEEEeccCC------------CCC--------ch-----HHHHHHHHHHHhCCCC--CccceeEEE
Q psy15481         25 AVFQGVNKNNGEPVAVKTFNQLS------------HMR--------PH-----DVQMREFEVLKKVKHE--NIVKLLAIE   77 (708)
Q Consensus        25 ~Vy~a~~~~tg~~VAIK~~~~~s------------~~~--------~~-----~~~~~Ei~iL~kL~Hp--NIVkl~~v~   77 (708)
                      .||.|.. .+|..+|+|+.+...            ..+        ..     ....+|++.|.++..-  ++++.+++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899987 467899999974321            001        00     1125899999999655  567776552


Q ss_pred             EecCCceEEEEEeccC--CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHHCCCcccCCCCCcEEEEEecCCCc
Q psy15481         78 EEQEGRGKVIVMELCT--GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH-LRDNRLVHRDLKPGNIMKFICDDGST  154 (708)
Q Consensus        78 ~~~~~~~~~LVmEy~~--ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~y-LH~~gIVHrDIKP~NILl~~~~d~~~  154 (708)
                         .   -+|||||++  |..+..+....     ++......++.+++..+.. +|..||||+|+.+.||++    ++. 
T Consensus        80 ---~---~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv----~~~-  143 (188)
T PF01163_consen   80 ---R---NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILV----DDG-  143 (188)
T ss_dssp             ---T---TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEE----ETT-
T ss_pred             ---C---CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEe----ecc-
Confidence               2   479999998  65555444332     2234566778888886655 579999999999999997    222 


Q ss_pred             eEEEeccCcccccc
Q psy15481        155 IYKLTDFGAARELE  168 (708)
Q Consensus       155 ~vKL~DFGlA~~~~  168 (708)
                      .+.|+|||.|....
T Consensus       144 ~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 KVYIIDFGQAVDSS  157 (188)
T ss_dssp             CEEE--GTTEEETT
T ss_pred             eEEEEecCcceecC
Confidence            69999999997644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.45  E-value=6.7e-07  Score=92.69  Aligned_cols=138  Identities=24%  Similarity=0.294  Sum_probs=99.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccC-----------CC------C----CchHHHHHHHHHHHhCCCC-
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQL-----------SH------M----RPHDVQMREFEVLKKVKHE-   68 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~-----------s~------~----~~~~~~~~Ei~iL~kL~Hp-   68 (708)
                      .+.++..||-|.-|.||.|.++ .|.++|||.=+..           +.      .    .+.....+|+++|.+|... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            3457789999999999999986 7899999963211           00      0    0011235899999999655 


Q ss_pred             -CccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEE
Q psy15481         69 -NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKF  147 (708)
Q Consensus        69 -NIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~  147 (708)
                       .+++.+++-      .-++|||+..|..|...-        ++......++..|+.-+..+-..|+||+|+.+=||++ 
T Consensus       171 ~~VP~P~~~n------RHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV-  235 (304)
T COG0478         171 VKVPKPIAWN------RHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV-  235 (304)
T ss_pred             CCCCCccccc------cceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE-
Confidence             788877652      258999999987665433        1234455566677777766668999999999999998 


Q ss_pred             EecCCCceEEEeccCccccc
Q psy15481        148 ICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus       148 ~~~d~~~~vKL~DFGlA~~~  167 (708)
                         ++.+.+.++||--+...
T Consensus       236 ---~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         236 ---TEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             ---ecCCCEEEEeCcccccC
Confidence               55556999999877654

>KOG2137|consensus

Probab=98.35  E-value=1.9e-07  Score=106.65  Aligned_cols=143  Identities=22%  Similarity=0.361  Sum_probs=97.9

Q ss_pred             HHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccc----------cccCCCCCcCChhhhhh
Q psy15481        122 LTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF----------MSLYGTEEYLHPDMYER  190 (708)
Q Consensus       122 Il~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~----------~~~~GT~~YlAPE~l~~  190 (708)
                      ++.||.|+|.. ++||++|.|++|.+    ++.+.+||+.|+++....++..+          ........|.|||.+. 
T Consensus       108 v~dgl~flh~sAk~VH~ni~p~~i~~----na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~-  182 (700)
T KOG2137|consen  108 VADGLAFLHRSAKVVHGNIQPEAIVV----NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL-  182 (700)
T ss_pred             ccchhhhhccCcceeecccchhheee----ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc-
Confidence            44899999965 99999999999998    88889999999998765442111          1123567899999987 


Q ss_pred             hhhcCCCCCcCCccccchhhhhHHHHHh-cCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcc
Q psy15481        191 AVLRKPVGKTFGATVDLWSIGVTLYHVA-TGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNC  269 (708)
Q Consensus       191 ~~~~~~~~~~~s~ksDIWSLGviLyeLl-TG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~  269 (708)
                             +...+.++|+||+||++|.+. .|..-|...++..    .+.......          ..+...         
T Consensus       183 -------~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~----~~~~~~~~~----------~~~~~~---------  232 (700)
T KOG2137|consen  183 -------GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL----SYSFSRNLL----------NAGAFG---------  232 (700)
T ss_pred             -------cccccccccceeeeeEEEEEecCCcchhhccCCcc----hhhhhhccc----------cccccc---------
Confidence                   566789999999999999999 5666665432211    111111000          001111         


Q ss_pred             cCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        270 QLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       270 ~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                       .|..++..+.+=|.+++..|+.-||++..+
T Consensus       233 -~s~~~p~el~~~l~k~l~~~~~~rp~~~~l  262 (700)
T KOG2137|consen  233 -YSNNLPSELRESLKKLLNGDSAVRPTLDLL  262 (700)
T ss_pred             -ccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence             122333445557789999999999987764

>PRK09902 hypothetical protein; Provisional

Probab=98.28  E-value=2.4e-05  Score=79.31  Aligned_cols=143  Identities=15%  Similarity=0.127  Sum_probs=101.3

Q ss_pred             ecCCceEEEEEEEcCCCceEEEEEeccCC-----CCCchHHHHHHHHHHHhCCCCC--ccceeE--EEEecCCceEEEEE
Q psy15481         19 GKGATGAVFQGVNKNNGEPVAVKTFNQLS-----HMRPHDVQMREFEVLKKVKHEN--IVKLLA--IEEEQEGRGKVIVM   89 (708)
Q Consensus        19 G~G~fG~Vy~a~~~~tg~~VAIK~~~~~s-----~~~~~~~~~~Ei~iL~kL~HpN--IVkl~~--v~~~~~~~~~~LVm   89 (708)
                      |+||-+.|+....  .|..|-+|.-....     .+.+...+.+|+..+.+|..-+  +++...  ....+.....+||+
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            6789999998754  35568888764111     1334566789999999884322  444432  22223334578999


Q ss_pred             eccCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         90 ELCTG-GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        90 Ey~~g-gsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      |-++| .||.+++.+..- ...++.....++.+|+..+.-||+.|+.|+|+-|.||++  ..++...+.++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll--~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYV--KTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheee--cCCCCeeEEEEEhhccch
Confidence            98754 689888865321 226777788999999999999999999999999999997  333445699999988764

>KOG0576|consensus

Probab=98.22  E-value=5e-07  Score=102.19  Aligned_cols=184  Identities=24%  Similarity=0.229  Sum_probs=135.0

Q ss_pred             EeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCC-ccceeEEEEecCCceEEEEEecc
Q psy15481         14 TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHEN-IVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        14 i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpN-IVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      .-+-+++|+++++++.+...+...+ .+++...      ....-++++|.+++||| .+..++-+  ......+++|+++
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPMRIC  316 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccC--Ccccccchhhhhh
Confidence            3345678999999998766554333 5655432      22335888999999999 44444433  3344589999999


Q ss_pred             CCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc
Q psy15481         93 TGG-SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ  171 (708)
Q Consensus        93 ~gg-sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~  171 (708)
                      .++ +-.......+  -.+...++..+.+.-+++++++|+..-+|+|    ||+.     ..+..+.+||+.+..+....
T Consensus       317 s~~rs~~~~~~~se--~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~-----s~~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  317 STGRSSALEMTVSE--IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG-----SEEEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             cCCccccccCChhh--HhhhhhhhhhhhhhhcccccccccccccCcc----cccc-----cccccccccccCCcccCccc
Confidence            776 2222121111  1256667778888899999999998878998    8883     34568999999998887766


Q ss_pred             cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCC
Q psy15481        172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR  225 (708)
Q Consensus       172 ~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~  225 (708)
                      ...+..+++.++|||+..        +..+....|.||+|+-..++.-|-+|-.
T Consensus       386 ~~~t~~~~~~~~~pev~~--------~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQ--------ENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccccCCCCCCCCCchhhc--------ccccccCCCccCCCcchhhcCCCCCCCC
Confidence            667788999999999887        6778889999999998888888877764

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.14  E-value=2.2e-05  Score=80.79  Aligned_cols=139  Identities=24%  Similarity=0.270  Sum_probs=96.9

Q ss_pred             EeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC------------------ch-H----HHHHHHHHHHhC--CCC
Q psy15481         14 TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR------------------PH-D----VQMREFEVLKKV--KHE   68 (708)
Q Consensus        14 i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~------------------~~-~----~~~~Ei~iL~kL--~Hp   68 (708)
                      +...|++|.-+.||+|.. .++..||+|+++.....-                  .. .    -...|+.-|+++  .+-
T Consensus        52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            344788888899999975 578999999985432110                  00 0    014788888887  344


Q ss_pred             CccceeEEEEecCCceEEEEEeccCCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEE
Q psy15481         69 NIVKLLAIEEEQEGRGKVIVMELCTGG-SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMK  146 (708)
Q Consensus        69 NIVkl~~v~~~~~~~~~~LVmEy~~gg-sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl  146 (708)
                      .+++.+++..      -++||||+... .-...|+..    ++...+...+..+++..+.-|-. .|+||+|+..=|||+
T Consensus       131 rvP~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~  200 (268)
T COG1718         131 RVPEPIAFRN------NVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV  200 (268)
T ss_pred             CCCCceeecC------CeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence            5566665532      48999999533 112223222    14455788899999999998887 899999999999997


Q ss_pred             EEecCCCceEEEeccCcccccc
Q psy15481        147 FICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus       147 ~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                          . .+.+.++|||-|....
T Consensus       201 ----~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         201 ----H-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             ----E-CCeEEEEECccccccC
Confidence                3 4468999999998654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.13  E-value=8.4e-06  Score=93.11  Aligned_cols=144  Identities=24%  Similarity=0.306  Sum_probs=89.2

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch-H-------------------------H-------------HH
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH-D-------------------------V-------------QM   56 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~-~-------------------------~-------------~~   56 (708)
                      .-|+.++-|.||+|.-+ +|+.||||+.+.+-..... +                         .             ..
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            56789999999999975 5999999997543211100 0                         0             01


Q ss_pred             HHHHHHHhC-----CCCCccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q psy15481         57 REFEVLKKV-----KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD  131 (708)
Q Consensus        57 ~Ei~iL~kL-----~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~  131 (708)
                      +|...+.++     +.|++.-- .++.+-. +.-+++|||+.|..+.+...-...  +.+.+.+...+.++.  +..+-.
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP-~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~ia~~~~~~f--~~q~~~  283 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVP-KVYWEYT-TRRVLTMEWIDGIKISDIAALKSA--GIDRKELAELLVRAF--LRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEec-eeehhcc-CCcEEEEEeeCCEecccHHHHHhc--CCCHHHHHHHHHHHH--HHHHHh
Confidence            344334433     23332211 2222211 136899999999988887432221  255444443333322  334445


Q ss_pred             CCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481        132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus       132 ~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      .|+.|.|.+|+||++    +..+.+.+.|||....+.+.
T Consensus       284 dgffHaDpHpGNi~v----~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         284 DGFFHADPHPGNILV----RSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cCccccCCCccceEE----ecCCcEEEEcCcceecCCHH
Confidence            899999999999998    66678999999998765543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.10  E-value=4.1e-05  Score=77.99  Aligned_cols=139  Identities=19%  Similarity=0.216  Sum_probs=88.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHH---------HHHHHHHHhC---CCCCccceeEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ---------MREFEVLKKV---KHENIVKLLAI   76 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~---------~~Ei~iL~kL---~HpNIVkl~~v   76 (708)
                      ++.|.+.+++-......|.+..  -+|..+++|..+... ..+...+         .+++..+.++   .-..+..++.+
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~-~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREEN-RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhh-hhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4567777888777777777664  457899999876533 2222111         2334333344   33334443333


Q ss_pred             EEecCC---ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC
Q psy15481         77 EEEQEG---RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS  153 (708)
Q Consensus        77 ~~~~~~---~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~  153 (708)
                      .+-...   ...+++|||++|..|.+...       +++    .+...+..++.-+|+.|++|+|.+|+|+++  .++  
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv--~~~--  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV--SNN--  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE--ECC--
Confidence            322111   23568999999988866542       333    244667788999999999999999999997  222  


Q ss_pred             ceEEEeccCcccc
Q psy15481        154 TIYKLTDFGAARE  166 (708)
Q Consensus       154 ~~vKL~DFGlA~~  166 (708)
                       .++++||+..+.
T Consensus       172 -~i~iID~~~k~~  183 (229)
T PF06176_consen  172 -GIRIIDTQGKRM  183 (229)
T ss_pred             -cEEEEECccccc
Confidence             289999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.02  E-value=6.8e-05  Score=77.19  Aligned_cols=72  Identities=19%  Similarity=0.263  Sum_probs=50.5

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCC--ccceeEEEEecCCceEEEEEeccC
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHEN--IVKLLAIEEEQEGRGKVIVMELCT   93 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpN--IVkl~~v~~~~~~~~~~LVmEy~~   93 (708)
                      ..||+|.++.||+.    .|..+++|......   ......+|.++++.+..-.  +++.+++....+  ...+||++++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~--~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGG--RLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCC--eeeeeeeecC
Confidence            46899999999984    25568889876422   2334568999999885433  466666665433  3678999998


Q ss_pred             CCC
Q psy15481         94 GGS   96 (708)
Q Consensus        94 ggs   96 (708)
                      |.+
T Consensus        78 G~~   80 (226)
T TIGR02172        78 GKR   80 (226)
T ss_pred             Ccc
Confidence            863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.82  E-value=0.0002  Score=72.09  Aligned_cols=80  Identities=19%  Similarity=0.280  Sum_probs=54.9

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCC--CccceeEEEEecC-CceEEEEEec
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE--NIVKLLAIEEEQE-GRGKVIVMEL   91 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~Hp--NIVkl~~v~~~~~-~~~~~LVmEy   91 (708)
                      ...|+.|..+.||+.....  ..+++|.....   .......+|..+++.+...  .++.++....... ....+++|++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            4678999999999998754  58999996543   2244556888888888432  3566666443222 2347999999


Q ss_pred             cCCCCHHH
Q psy15481         92 CTGGSLFN   99 (708)
Q Consensus        92 ~~ggsL~~   99 (708)
                      ++|.++..
T Consensus        77 i~g~~~~~   84 (239)
T PF01636_consen   77 IPGRPLDD   84 (239)
T ss_dssp             ESSEEHHH
T ss_pred             eccccccc
Confidence            99987776

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.79  E-value=0.0005  Score=69.38  Aligned_cols=133  Identities=23%  Similarity=0.308  Sum_probs=91.5

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCC---------------CCCchHHHHHHHHHHHhCC------CCCccce
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS---------------HMRPHDVQMREFEVLKKVK------HENIVKL   73 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s---------------~~~~~~~~~~Ei~iL~kL~------HpNIVkl   73 (708)
                      ...||+|+.-.||.-  + .+....||+.....               .........+|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            357999999999975  3 34557889987654               0111233456766655555      7899999


Q ss_pred             eEEEEecCCceEEEEEeccC------CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEE
Q psy15481         74 LAIEEEQEGRGKVIVMELCT------GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKF  147 (708)
Q Consensus        74 ~~v~~~~~~~~~~LVmEy~~------ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~  147 (708)
                      +++.++.-+  .-+|+|...      +-+|.+++....    +++ .+...+.   .-..||-+.+|+.+|++|.||++.
T Consensus        83 ~G~veT~~G--~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETNLG--LGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecCCc--eEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEE
Confidence            999987665  677776543      236888886543    555 3333333   344688999999999999999986


Q ss_pred             EecCCCceEEEec
Q psy15481        148 ICDDGSTIYKLTD  160 (708)
Q Consensus       148 ~~~d~~~~vKL~D  160 (708)
                      ..+++...+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            6666665777887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.77  E-value=0.00028  Score=85.94  Aligned_cols=82  Identities=18%  Similarity=0.277  Sum_probs=57.0

Q ss_pred             eeEeecCCceEEEEEEEcCCC--ceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCc--cceeEEEEecC-CceEEEE
Q psy15481         15 TSVLGKGATGAVFQGVNKNNG--EPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENI--VKLLAIEEEQE-GRGKVIV   88 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg--~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNI--Vkl~~v~~~~~-~~~~~LV   88 (708)
                      ...++.|.+..+|+......+  ..+++|+..............+|+.+++.+. |+++  ++++.++.+.. .+..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            467899999999998764332  4678887654333333445679999999995 6665  77777765532 1347899


Q ss_pred             EeccCCCC
Q psy15481         89 MELCTGGS   96 (708)
Q Consensus        89 mEy~~ggs   96 (708)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998764

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.73  E-value=0.00017  Score=70.81  Aligned_cols=132  Identities=22%  Similarity=0.194  Sum_probs=92.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccc-eeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK-LLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVk-l~~v~~~~~~~~~~LV   88 (708)
                      |.-.....||.|.+|.||+|.+.  |..+|+|+-+.++.   ...+..|.++|..+.-.++.+ ++.+-+      .++.
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~------~~i~   90 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGE------DFIR   90 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeecc--CceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEech------hhhh
Confidence            44456778999999999999886  66999998765443   445668999999887766643 333321      3566


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC-CCcEEEEEecCCCceEEEeccCcccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLK-PGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIK-P~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      |||..|-.|...-..      .+.    .-+..++.+---|-..||-|+.|. |..+++    -+...+.|+||..|+.
T Consensus        91 me~i~G~~L~~~~~~------~~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vl----v~~~~~~iIDFd~At~  155 (201)
T COG2112          91 MEYIDGRPLGKLEIG------GDR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVL----VNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhcCcchhhhhhc------ccH----HHHHHHHHHHHHHHHhccchhhhcCCceeEE----ecCCcEEEEEccchhh
Confidence            999998888776543      122    334445555555667899999998 555554    2223689999999984

>KOG1235|consensus

Probab=97.73  E-value=0.00012  Score=83.69  Aligned_cols=143  Identities=21%  Similarity=0.268  Sum_probs=88.2

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-hHH-----------------------------------HHHHH
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDV-----------------------------------QMREF   59 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-~~~-----------------------------------~~~Ei   59 (708)
                      .-||..+.|.|++|+-+ +|+.||||+-+..-.... .+.                                   +.+|.
T Consensus       167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            56888999999999876 599999999654321110 010                                   01232


Q ss_pred             HH----HHhCCCCC------ccceeEEEEecCCceEEEEEeccCCCCHHHH--hcCCCCCCCCCHHHHHHHHHHHHHHH-
Q psy15481         60 EV----LKKVKHEN------IVKLLAIEEEQEGRGKVIVMELCTGGSLFNI--LDDPENTYGLQEEEFLLVLEHLTAGM-  126 (708)
Q Consensus        60 ~i----L~kL~HpN------IVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~--L~~~~~~~~L~e~~v~~il~qIl~aL-  126 (708)
                      +-    .+.+.|-+      |++++   .+-. ...+++||||+|..+.+.  +++..    ++...+   +..+..+. 
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy---~~~s-t~RVLtME~~~G~~i~Dl~~i~~~g----i~~~~i---~~~l~~~~~  314 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVY---WDLS-TKRVLTMEYVDGIKINDLDAIDKRG----ISPHDI---LNKLVEAYL  314 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeeh---hhcC-cceEEEEEecCCccCCCHHHHHHcC----CCHHHH---HHHHHHHHH
Confidence            22    22234444      33333   2221 137999999999866543  33322    565544   33444332 


Q ss_pred             HHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481        127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus       127 ~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      .-+-..|++|+|-+|+||++.-..++...+.+-|||+.......
T Consensus       315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            23345789999999999998333356788999999998765443

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.68  E-value=0.00042  Score=71.61  Aligned_cols=76  Identities=12%  Similarity=0.094  Sum_probs=51.1

Q ss_pred             EeecCCc-eEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEEEEeccCC
Q psy15481         17 VLGKGAT-GAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVIVMELCTG   94 (708)
Q Consensus        17 ~LG~G~f-G~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~LVmEy~~g   94 (708)
                      .|..|.+ +.||+....  +..+.+|+.....    .....+|+.+++.+. +--+++++++....  +..++||++++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCC
Confidence            3555665 788998643  4678889875432    223457999988883 44466777766543  347899999999


Q ss_pred             CCHHHH
Q psy15481         95 GSLFNI  100 (708)
Q Consensus        95 gsL~~~  100 (708)
                      .+|...
T Consensus        77 ~~l~~~   82 (244)
T cd05150          77 VPAAAL   82 (244)
T ss_pred             ccHhHh
Confidence            877643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1035|consensus

Probab=97.67  E-value=0.00017  Score=86.99  Aligned_cols=200  Identities=21%  Similarity=0.253  Sum_probs=136.1

Q ss_pred             HHHHHHHHhCCCCCccceeEEEEecCCce--EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy15481         56 MREFEVLKKVKHENIVKLLAIEEEQEGRG--KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR  133 (708)
Q Consensus        56 ~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~--~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g  133 (708)
                      ..|+..+.++.|+|++.++.+....-..+  ..+..++|.+.++...+.....   .+...++.+..++..||.|+|+..
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHHHhc
Confidence            35667788889999999998865443333  2345678999999998877543   899999999999999999999985


Q ss_pred             CcccCCCCCcEEEEEecCCCceEEEe--ccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhh
Q psy15481        134 LVHRDLKPGNIMKFICDDGSTIYKLT--DFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIG  211 (708)
Q Consensus       134 IVHrDIKP~NILl~~~~d~~~~vKL~--DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLG  211 (708)
                      ..|.-+..+-.. ..+.++.+.+.++  ||+....+.......+..-+..+.+||.....      ....+...|+|++|
T Consensus       307 l~~v~L~~s~~~-~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~------~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  307 LEHVVLSASSSK-ESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKEN------TAKKSRLTDLWCLG  379 (1351)
T ss_pred             cceeEEeccccc-ccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccc------cchhhhhhHHHHHH
Confidence            555544433221 1122455566666  99999887776665566667778888877621      12234447999999


Q ss_pred             hHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCc
Q psy15481        212 VTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDS  291 (708)
Q Consensus       212 viLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP  291 (708)
                      ..+.-+..|..+-..      ...+...                         ++.   .+..   ...+.+.+|+.-|+
T Consensus       380 ll~~~~~~~~~i~~~------~~~~~~~-------------------------l~~---~~~~---~~~d~~~~~~~~~~  422 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEK------SAVPVSL-------------------------LDV---LSTS---ELLDALPKCLDEDS  422 (1351)
T ss_pred             HHHhhhhhcCccccc------ccchhhh-------------------------hcc---ccch---hhhhhhhhhcchhh
Confidence            999999887654321      1111111                         111   1111   34567889999999


Q ss_pred             ccCCCHHHHHH
Q psy15481        292 KKIWSFERFFS  302 (708)
Q Consensus       292 ~kRpsa~q~~~  302 (708)
                      ++|+++.++++
T Consensus       423 ~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  423 EERLSALELLT  433 (1351)
T ss_pred             hhccchhhhhh
Confidence            99999999744

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.62  E-value=0.0011  Score=66.90  Aligned_cols=128  Identities=26%  Similarity=0.281  Sum_probs=88.7

Q ss_pred             ceEEEeeEeecCCc-eEEEEEEEcCCCceEEEEEeccCCCC--------------------CchHHHHHHHHHHHhC---
Q psy15481         10 YVWCTTSVLGKGAT-GAVFQGVNKNNGEPVAVKTFNQLSHM--------------------RPHDVQMREFEVLKKV---   65 (708)
Q Consensus        10 ~~y~i~~~LG~G~f-G~Vy~a~~~~tg~~VAIK~~~~~s~~--------------------~~~~~~~~Ei~iL~kL---   65 (708)
                      ..++..+.||.|.- |.||++..  .|+.||+|++..-...                    ...+.+..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            57888999999999 99999976  4889999994321000                    0112345676666666   


Q ss_pred             CCCCc--cceeEEEEecC----------------CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q psy15481         66 KHENI--VKLLAIEEEQE----------------GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK  127 (708)
Q Consensus        66 ~HpNI--Vkl~~v~~~~~----------------~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~  127 (708)
                      .+.++  |+++++..-..                .....||.||.+...            .++...    +.+|.+-|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence            45566  89988873221                112457888876433            134343    456666677


Q ss_pred             HHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481        128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus       128 yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .+|..||+-+|+++.|..     +|    +|+|||.+
T Consensus       179 ~~~k~gI~~~Dv~~~ny~-----~G----~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLGIVPRDVKPRNYR-----GG----KLVDFSSS  206 (207)
T ss_pred             HHHHCCeeeccCcccccc-----CC----EEEecccC
Confidence            899999999999999998     54    79999975

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.47  E-value=0.00062  Score=70.15  Aligned_cols=75  Identities=19%  Similarity=0.163  Sum_probs=45.8

Q ss_pred             eEeecCCce-EEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCC---CccceeEEEEecCC-ceEEEEEe
Q psy15481         16 SVLGKGATG-AVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE---NIVKLLAIEEEQEG-RGKVIVME   90 (708)
Q Consensus        16 ~~LG~G~fG-~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~Hp---NIVkl~~v~~~~~~-~~~~LVmE   90 (708)
                      ..|+.|+.. .||+.     +..+++|....   ........+|.++++.+...   .++.+++.....+. ...+++|+
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~---~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSA---AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCc---cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            457777776 48876     23477787543   12244567899999888532   34455544332222 23588999


Q ss_pred             ccCCCCHH
Q psy15481         91 LCTGGSLF   98 (708)
Q Consensus        91 y~~ggsL~   98 (708)
                      +++|.++.
T Consensus        75 ~i~G~~l~   82 (235)
T cd05155          75 WLEGETAT   82 (235)
T ss_pred             eecCCCCC
Confidence            99987663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.29  E-value=0.0034  Score=67.33  Aligned_cols=81  Identities=11%  Similarity=0.119  Sum_probs=56.6

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCC---CCccceeEEEEecC-CceEEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH---ENIVKLLAIEEEQE-GRGKVI   87 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~H---pNIVkl~~v~~~~~-~~~~~L   87 (708)
                      -.-...||.|..+.||..... +| .+.+|..+.   ..+...+.+|...++.|.-   ..++++++++.... .+..++
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS-QG-NPMPLMARS---FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             hheeeecCCccceeEEEEEcC-CC-CEEEEEecc---cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            344568999999999998542 23 577787432   1134567789999998842   46788888775432 234899


Q ss_pred             EEeccCCCCH
Q psy15481         88 VMELCTGGSL   97 (708)
Q Consensus        88 VmEy~~ggsL   97 (708)
                      |||+++|+++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998754

>KOG1826|consensus

Probab=97.14  E-value=4.1e-05  Score=93.78  Aligned_cols=157  Identities=18%  Similarity=0.043  Sum_probs=117.9

Q ss_pred             HHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCC-CCCHHHHHHHHHHHHHHHHHHHHC-C-
Q psy15481         57 REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY-GLQEEEFLLVLEHLTAGMKHLRDN-R-  133 (708)
Q Consensus        57 ~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~-~L~e~~v~~il~qIl~aL~yLH~~-g-  133 (708)
                      .|...++...|+++.....=..+......|.+++|+.+|.+++.+-++.... .+...-+.....+.+.+..-+|+. + 
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            4555666678999887766555445556799999999999999887643322 244455555555557777777764 2 


Q ss_pred             ---CcccCCCCCcEEEEEecCCCceEEEeccCcccc-ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchh
Q psy15481        134 ---LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWS  209 (708)
Q Consensus       134 ---IVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~-~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWS  209 (708)
                         -+|+++|+-|.++    .++..+|++++|+.+. ......+....+++.|++|++..        .-.++.++|+|+
T Consensus      1358 g~T~v~~~Lkf~lpmI----Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N--------~ik~t~rsdilr 1425 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMI----VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN--------EIKFTKRSDILR 1425 (2724)
T ss_pred             Cccchhhhhhhhccce----ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH--------HHhhhhHHHHHH
Confidence               6899999999998    7777799999999993 33333445577889999999887        355777899999


Q ss_pred             hhhHHHHHhcCCCCCC
Q psy15481        210 IGVTLYHVATGNLPFR  225 (708)
Q Consensus       210 LGviLyeLlTG~~PF~  225 (708)
                      .|+-+|...-|..||.
T Consensus      1426 ~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1426 RSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             HHHHHHHHhcccHHHH
Confidence            9999999998888875

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.12  E-value=0.0028  Score=66.12  Aligned_cols=136  Identities=17%  Similarity=0.211  Sum_probs=74.7

Q ss_pred             eecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCc-cceeEEEEecCCceEEEEEeccCCCC
Q psy15481         18 LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI-VKLLAIEEEQEGRGKVIVMELCTGGS   96 (708)
Q Consensus        18 LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNI-Vkl~~v~~~~~~~~~~LVmEy~~ggs   96 (708)
                      +..|-++.+|+..  .+|..+++|........-..+ ..+|+.+++.+....+ ++++...  .    -++||+|++|..
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~-r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVD-RQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCc-HHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCcc
Confidence            4567778888875  456788888754332211112 3578899998854333 3444332  1    268999999866


Q ss_pred             HHH--------------H---hcCCC-CCCCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCCcccCCC
Q psy15481         97 LFN--------------I---LDDPE-NTYGLQE-EEFLLVLEHL---------TAGMKHLRD--------NRLVHRDLK  140 (708)
Q Consensus        97 L~~--------------~---L~~~~-~~~~L~e-~~v~~il~qI---------l~aL~yLH~--------~gIVHrDIK  140 (708)
                      +..              .   +.... ....++. ..+..+..++         ...+..+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            531              1   11111 1111121 1122222111         111222222        258999999


Q ss_pred             CCcEEEEEecCCCceEEEeccCccccc
Q psy15481        141 PGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus       141 P~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |+||++    ++.+ +.|+||+.|...
T Consensus       155 ~~Nil~----~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       155 AYNLVV----TPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cCcEEE----eCCC-CEEEeccccCcC
Confidence            999997    3333 689999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.04  E-value=0.0065  Score=62.19  Aligned_cols=75  Identities=23%  Similarity=0.303  Sum_probs=47.5

Q ss_pred             eeEeecCCceEEEEEEEcC-CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCC-ccceeEEEEecCCceEEEEEecc
Q psy15481         15 TSVLGKGATGAVFQGVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHEN-IVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~-tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpN-IVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      ...|+.|-+..+|+..... .+..|++|+...... ...+ ..+|+.+++.+...+ .++++....  +    .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d-~~~E~~~~~~l~~~gl~P~v~~~~~--~----~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIID-RERELRIHKLLSKHGLAPKLYATFQ--N----GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceec-HHHHHHHHHHHHhCCCCCeEEEEeC--C----cEEEEee
Confidence            3567788889999986543 356899997754321 1122 237888888884433 344443321  2    3799999


Q ss_pred             CCCCH
Q psy15481         93 TGGSL   97 (708)
Q Consensus        93 ~ggsL   97 (708)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2270|consensus

Probab=96.78  E-value=0.011  Score=64.24  Aligned_cols=143  Identities=21%  Similarity=0.290  Sum_probs=98.5

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--------------------CC-CchHH----HHHHHHHHHhCC
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--------------------HM-RPHDV----QMREFEVLKKVK   66 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--------------------~~-~~~~~----~~~Ei~iL~kL~   66 (708)
                      -.+...|..|.-+.||.+.. .+|..+|||+++...                    +. .+...    ...|++-|++|.
T Consensus       146 ~~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~  224 (520)
T KOG2270|consen  146 VEINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN  224 (520)
T ss_pred             eecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence            35677889999999999975 578889999974321                    01 11111    136788888886


Q ss_pred             CCCccceeEEEEecCCceEEEEEeccCCCCHHH--HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCc
Q psy15481         67 HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFN--ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGN  143 (708)
Q Consensus        67 HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~--~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~N  143 (708)
                      ...|+-.--+..    +.-+|||+|+ |.+=+.  .|+.    ..++...+..+-.+++.-|.-|.+ .++||.||.-=|
T Consensus       225 ~aGIP~PePIlL----k~hVLVM~Fl-Grdgw~aPkLKd----~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN  295 (520)
T KOG2270|consen  225 NAGIPCPEPILL----KNHVLVMEFL-GRDGWAAPKLKD----ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN  295 (520)
T ss_pred             hcCCCCCCceee----ecceEeeeec-cCCCCcCccccc----ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence            655443322222    1258999999 443322  2332    238888899999999999987765 599999999999


Q ss_pred             EEEEEecCCCceEEEeccCccccccc
Q psy15481        144 IMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus       144 ILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      +|+     ..+.+.++|-+-+.....
T Consensus       296 ~Ly-----hdG~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  296 LLY-----HDGKLYIIDVSQSVEHDH  316 (520)
T ss_pred             heE-----ECCEEEEEEccccccCCC
Confidence            997     234699999988876543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.69  E-value=0.0045  Score=61.94  Aligned_cols=102  Identities=21%  Similarity=0.161  Sum_probs=77.8

Q ss_pred             HHHHHHHHhCCC-CCccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---
Q psy15481         56 MREFEVLKKVKH-ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD---  131 (708)
Q Consensus        56 ~~Ei~iL~kL~H-pNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~---  131 (708)
                      ..|.-+++.+.+ +++++++|++-      -++|+||...+++......-..-...++.....++.+++..+.+++.   
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            368889999966 69999999872      47799999877765321110111226899999999999999999998   


Q ss_pred             CCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481        132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus       132 ~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ..+.-.|++|+|+-+    +..+.+|++|...+...
T Consensus        81 ~~~~lcDv~~~nfgv----~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGV----NDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEE----eCCCcEEEEechhcchh
Confidence            357788999999997    45556999999887643

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.62  E-value=0.015  Score=61.70  Aligned_cols=142  Identities=13%  Similarity=0.131  Sum_probs=80.3

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCC--CccceeEEEE----ecCCceEEEE
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE--NIVKLLAIEE----EQEGRGKVIV   88 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~Hp--NIVkl~~v~~----~~~~~~~~LV   88 (708)
                      ...|+.|....+|+...  ++..+++|++..    ...+....|+.++..+.+.  .+++++....    ....+..++|
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            55677788889998854  345788998764    2234455788888877432  2444443210    0112247899


Q ss_pred             EeccCCCCHHH-----------H---hcCCCCCCC------CCHHHHH------------HHHHHHHHHHHHHHH-----
Q psy15481         89 MELCTGGSLFN-----------I---LDDPENTYG------LQEEEFL------------LVLEHLTAGMKHLRD-----  131 (708)
Q Consensus        89 mEy~~ggsL~~-----------~---L~~~~~~~~------L~e~~v~------------~il~qIl~aL~yLH~-----  131 (708)
                      ++|++|.++..           .   +........      .......            .....+..++.++..     
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99999876421           0   000000000      0000000            011122334444443     


Q ss_pred             --CCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481        132 --NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       132 --~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                        .+++|+|+.|+||++    ++...+.|+||+.+..
T Consensus       173 ~~~~l~HgD~~~~Nil~----~~~~~~~iIDfe~a~~  205 (296)
T cd05153         173 LPRGVIHADLFRDNVLF----DGDELSGVIDFYFACT  205 (296)
T ss_pred             CCCcCCccCcCcccEEE----eCCceEEEeehhhhcC
Confidence              479999999999998    5556678999998863

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.61  E-value=0.046  Score=61.02  Aligned_cols=78  Identities=26%  Similarity=0.222  Sum_probs=54.3

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCC------CCCchHHHHHHHHHHHhCC---CCCccceeEEEEecCCceE
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS------HMRPHDVQMREFEVLKKVK---HENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s------~~~~~~~~~~Ei~iL~kL~---HpNIVkl~~v~~~~~~~~~   85 (708)
                      .+.||.|.+..||++.....++.|+||.-....      .....+....|.+.|+.+.   ..++++++.+..  +  ..
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~--~~  106 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--E--LA  106 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--C--CC
Confidence            367899999999999986444689999854211      1234556678888888762   346777777632  2  36


Q ss_pred             EEEEeccCCCC
Q psy15481         86 VIVMELCTGGS   96 (708)
Q Consensus        86 ~LVmEy~~ggs   96 (708)
                      ++||||+++..
T Consensus       107 ~lVME~L~~~~  117 (401)
T PRK09550        107 VTVMEDLSDHK  117 (401)
T ss_pred             EEEEecCCCcc
Confidence            89999997643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.46  E-value=0.022  Score=60.81  Aligned_cols=75  Identities=21%  Similarity=0.201  Sum_probs=45.7

Q ss_pred             eEeecCCceEEEEEEEcC------CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCC-ccceeEEEEecCCceEEEE
Q psy15481         16 SVLGKGATGAVFQGVNKN------NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHEN-IVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~------tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpN-IVkl~~v~~~~~~~~~~LV   88 (708)
                      +.|..|-...+|+.....      +++.|++|+...... . .....+|+.+++.+.... .++++..+.  +    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~-~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-L-LIDRERELVVFARLSERNLGPKLYGIFP--N----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-c-eechHHHHHHHHHHHhCCCCCceEEEeC--C----Cch
Confidence            455566677888776432      367899999764321 1 122347888888884333 345555442  2    258


Q ss_pred             EeccCCCCHH
Q psy15481         89 MELCTGGSLF   98 (708)
Q Consensus        89 mEy~~ggsL~   98 (708)
                      ++|++|..+.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9999887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.45  E-value=0.02  Score=61.47  Aligned_cols=144  Identities=13%  Similarity=0.154  Sum_probs=79.0

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCC--CccceeEEEE----ecCCceEE
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE--NIVKLLAIEE----EQEGRGKV   86 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~Hp--NIVkl~~v~~----~~~~~~~~   86 (708)
                      .....++.|....+|+... .+| .+++|+.+...   ..+....|++++..|...  .+++++....    ....+..+
T Consensus        25 ~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~---~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV---KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             eeccccCCccccceEEEEe-CCC-cEEEEEecCCC---CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            3356677787789998854 334 68889875421   123344677777777322  2344433211    11123578


Q ss_pred             EEEeccCCCCHH-----------H---HhcCCCCCCCC------CHHH---H-H-----------HHHHHHHHHHHHHHH
Q psy15481         87 IVMELCTGGSLF-----------N---ILDDPENTYGL------QEEE---F-L-----------LVLEHLTAGMKHLRD  131 (708)
Q Consensus        87 LVmEy~~ggsL~-----------~---~L~~~~~~~~L------~e~~---v-~-----------~il~qIl~aL~yLH~  131 (708)
                      ++++|++|.++.           .   .+......+..      ....   . .           .....+...++++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999999885431           0   01110011000      0000   0 0           011223334555542


Q ss_pred             -------CCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481        132 -------NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus       132 -------~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                             .+++|+|+.++||++    ++.+.+.|+||+.+.
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~----~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLF----DGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEE----ECCceEEEeeccccc
Confidence                   589999999999997    444567899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=95.95  E-value=0.11  Score=55.84  Aligned_cols=31  Identities=26%  Similarity=0.409  Sum_probs=25.8

Q ss_pred             CCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481        132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       132 ~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      .|+||+|+.|+||++    ++....-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~----~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLF----EGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEE----ECCceEEEEecccccC
Confidence            389999999999997    4555678999999863

>KOG2268|consensus

Probab=95.62  E-value=0.011  Score=63.27  Aligned_cols=136  Identities=20%  Similarity=0.258  Sum_probs=91.0

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccC-------CCCC----------c----hHHHHHHHHHHHhCCC--
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQL-------SHMR----------P----HDVQMREFEVLKKVKH--   67 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~-------s~~~----------~----~~~~~~Ei~iL~kL~H--   67 (708)
                      .+.+++.||-|.-+.+|.+-+. .|++.++|.=+..       ...+          +    .-...+|+..|+.|..  
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            5678899999999999999874 6889999862110       0000          0    0112488888988832  


Q ss_pred             CCccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEE
Q psy15481         68 ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKF  147 (708)
Q Consensus        68 pNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~  147 (708)
                      --+++.++..      .-++|||++.|..|..+-.-.      ..   ..+...+..-+.-|-.+|+||+|..--||++ 
T Consensus       172 fpVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v~------d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv-  235 (465)
T KOG2268|consen  172 FPVPKPIDHN------RHCVVMELVDGYPLRQVRHVE------DP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMV-  235 (465)
T ss_pred             CCCCCccccc------ceeeHHHhhcccceeeeeecC------Ch---HHHHHHHHHHHHHHHHcCceecccchheeEE-
Confidence            2355555442      268999999888876644221      11   2234444444567788999999999999998 


Q ss_pred             EecCCCceEEEeccCcccc
Q psy15481        148 ICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       148 ~~~d~~~~vKL~DFGlA~~  166 (708)
                         +..+.++++||--...
T Consensus       236 ---~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  236 ---KDDDKIVVIDFPQMVS  251 (465)
T ss_pred             ---ecCCCEEEeechHhhc
Confidence               4445689999966543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.23  E-value=0.16  Score=54.08  Aligned_cols=29  Identities=21%  Similarity=0.271  Sum_probs=23.8

Q ss_pred             CCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481        132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus       132 ~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      .+++|+|+.++||++    ++ +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~----~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILL----KD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEE----eC-CcEEEEECcccc
Confidence            478999999999997    33 347899998775

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.19  E-value=0.21  Score=54.95  Aligned_cols=74  Identities=20%  Similarity=0.150  Sum_probs=48.8

Q ss_pred             EeecCCceEEEEEEEcCCCceEEEEEecc------CCCCCchHHHHHHHHHHHhCC--CC-CccceeEEEEecCCceEEE
Q psy15481         17 VLGKGATGAVFQGVNKNNGEPVAVKTFNQ------LSHMRPHDVQMREFEVLKKVK--HE-NIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        17 ~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~------~s~~~~~~~~~~Ei~iL~kL~--Hp-NIVkl~~v~~~~~~~~~~L   87 (708)
                      .||.|....||++.+...++.|+||.-..      .+.+-+.++...|.+.|+...  -| .+++++.+-  ++  ...+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e--~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TE--MAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cc--ccee
Confidence            46889999999999864446899997531      122444556667888887763  24 455665542  22  3679


Q ss_pred             EEeccCC
Q psy15481         88 VMELCTG   94 (708)
Q Consensus        88 VmEy~~g   94 (708)
                      |||+++.
T Consensus        78 vMEdL~~   84 (370)
T TIGR01767        78 VMEDLSH   84 (370)
T ss_pred             hHhhCcc
Confidence            9999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.18  E-value=0.15  Score=55.32  Aligned_cols=144  Identities=18%  Similarity=0.227  Sum_probs=79.9

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEecc-CCCCCchHHHHHHHHHHHhCCCC--CccceeEEEEecCCceEEEEEec
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ-LSHMRPHDVQMREFEVLKKVKHE--NIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~-~s~~~~~~~~~~Ei~iL~kL~Hp--NIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      .+.+..|-.-.+|.....  ++.+++. ... ...........+|+.+++.+.--  -+...++.+.+..-...|.||+|
T Consensus        30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             eeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            334433433445555443  7888888 331 22223344456899999887432  23334444443322347999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHH-HHHHHHHHHHHH---------------------------------------
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVL-EHLTAGMKHLRD---------------------------------------  131 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il-~qIl~aL~yLH~---------------------------------------  131 (708)
                      +.|..+.+.+....    .+    ..++ ..+...|.-||+                                       
T Consensus       107 veGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p  178 (321)
T COG3173         107 VEGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP  178 (321)
T ss_pred             ecceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence            99854433221110    01    1111 234444444443                                       


Q ss_pred             -----------C--------CCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccc
Q psy15481        132 -----------N--------RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF  173 (708)
Q Consensus       132 -----------~--------gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~  173 (708)
                                 +        .++|+|..+.||++    ++..-+-+.||+.+...++...+
T Consensus       179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii----~~~~~~gVlDwe~~~lGDP~~Dl  235 (321)
T COG3173         179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLII----DPGRPTGVLDWELATLGDPLEDL  235 (321)
T ss_pred             hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEE----eCCCeeEEEeccccccCCcHHHH
Confidence                       2        26999999999998    44444899999999865554433

>KOG1093|consensus

Probab=94.94  E-value=0.019  Score=64.74  Aligned_cols=49  Identities=29%  Similarity=0.455  Sum_probs=40.1

Q ss_pred             HHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCC
Q psy15481         55 QMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPE  105 (708)
Q Consensus        55 ~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~  105 (708)
                      ..-.+.+++.+.|+|...++++-.....+ ..+|||++ +.||.+.+....
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r-~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHER-VIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccce-EEEEehhh-ccchHHHHHhcc
Confidence            44667889999999999999987765544 88999999 799999887644

>PLN02236 choline kinase

Probab=94.66  E-value=0.3  Score=53.53  Aligned_cols=141  Identities=20%  Similarity=0.166  Sum_probs=78.8

Q ss_pred             eeEeecCCceEEEEEEEcC----CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCc-cceeEEEEecCCceEEEEE
Q psy15481         15 TSVLGKGATGAVFQGVNKN----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI-VKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~----tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNI-Vkl~~v~~~~~~~~~~LVm   89 (708)
                      ...|..|-+-.+|++....    +++.|++|+..... ....++ .+|+.+++.+..-++ +++++.+  +++    .|+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR-~~E~~~~~~l~~~gl~P~~~~~~--~~g----~v~  112 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDR-DDEIRTFECMSRHGQGPRLLGRF--PNG----RVE  112 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceeech-HHHHHHHHHHHHcCCCCceEEEE--CCc----eEE
Confidence            3455558888999986432    34689999876543 222222 478889888854333 4555554  222    478


Q ss_pred             eccCCCCHHHH-----------------hcCCC---CCCCCCHHHHHHHHHHH-----------------HHHHHHH---
Q psy15481         90 ELCTGGSLFNI-----------------LDDPE---NTYGLQEEEFLLVLEHL-----------------TAGMKHL---  129 (708)
Q Consensus        90 Ey~~ggsL~~~-----------------L~~~~---~~~~L~e~~v~~il~qI-----------------l~aL~yL---  129 (708)
                      +|++|.+|...                 +....   .........+..++.++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99887665311                 11111   00011123333333221                 1112222   


Q ss_pred             -H----HCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481        130 -R----DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       130 -H----~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                       .    ...++|+|++++|||+  + ++.+.+.++||..|..
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~--~-~~~~~~~lID~Eya~~  231 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMI--D-EETRAITIIDYEYASY  231 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEE--e-CCCCcEEEEeehhccc
Confidence             1    1258999999999997  2 2235799999988863

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=94.17  E-value=0.35  Score=51.31  Aligned_cols=32  Identities=38%  Similarity=0.592  Sum_probs=25.4

Q ss_pred             CCcccCCCCCcEEEEEecCC-CceEEEeccCcccccc
Q psy15481        133 RLVHRDLKPGNIMKFICDDG-STIYKLTDFGAARELE  168 (708)
Q Consensus       133 gIVHrDIKP~NILl~~~~d~-~~~vKL~DFGlA~~~~  168 (708)
                      .++|+|++|+|||+    ++ ....-|+||+.+...+
T Consensus       186 ~lvHGD~~~~Nilv----~~~~~~~gviDWe~a~iGD  218 (276)
T cd05152         186 VLVHGDLHPGHILI----DEDARVTGLIDWTEAKVGD  218 (276)
T ss_pred             eeEeCCCCCCcEEE----eCCCCEEEEECcHhcccCC
Confidence            48999999999997    33 3456799999987543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.09  E-value=0.78  Score=51.45  Aligned_cols=75  Identities=12%  Similarity=0.124  Sum_probs=50.8

Q ss_pred             EeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC------CCchHHHHHHHHHHHhCC---CCCccceeEEEEecCCce
Q psy15481         14 TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH------MRPHDVQMREFEVLKKVK---HENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        14 i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~------~~~~~~~~~Ei~iL~kL~---HpNIVkl~~v~~~~~~~~   84 (708)
                      ..+.||.|....||+..+.  +..|+||.-.....      +-..++...|.+.|+.+.   ..++++++.+..+    .
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~  109 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----M  109 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----C
Confidence            3567899999999998763  45699998642211      113344456777777663   3478888887653    2


Q ss_pred             EEEEEeccCC
Q psy15481         85 KVIVMELCTG   94 (708)
Q Consensus        85 ~~LVmEy~~g   94 (708)
                      .+++|||+++
T Consensus       110 ~vlvME~L~~  119 (418)
T PLN02756        110 ALIGMRYLEP  119 (418)
T ss_pred             CEEEEeecCC
Confidence            5889999976

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=94.03  E-value=0.48  Score=51.61  Aligned_cols=78  Identities=19%  Similarity=0.288  Sum_probs=46.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCC---CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCc-cceeEEEEecCCceEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNN---GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI-VKLLAIEEEQEGRGKV   86 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNI-Vkl~~v~~~~~~~~~~   86 (708)
                      ...+ ..|..|=+-.+|+......   +..|++|+...... ...++ .+|..+++.+..-++ +++++++  .++    
T Consensus        16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR-~~E~~il~~l~~~gl~P~~l~~~--~~G----   86 (330)
T PLN02421         16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDR-ERELQAIKYLSAAGFGAKLLGVF--GNG----   86 (330)
T ss_pred             ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEech-HHHHHHHHHHHhcCCCCceeEEe--CCc----
Confidence            3344 3444478888998864432   34799998764332 22222 378888888855444 4555554  232    


Q ss_pred             EEEeccCCCCH
Q psy15481         87 IVMELCTGGSL   97 (708)
Q Consensus        87 LVmEy~~ggsL   97 (708)
                      +|.+|++|..|
T Consensus        87 ~i~~fi~g~~l   97 (330)
T PLN02421         87 MIQSFINARTL   97 (330)
T ss_pred             EeehhhcCCCC
Confidence            48888877654

>PRK12396 5-methylribose kinase; Reviewed

Probab=93.66  E-value=0.55  Score=52.38  Aligned_cols=76  Identities=18%  Similarity=0.137  Sum_probs=51.7

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEecc-----CCCCCchHHHHHHHHHHHhCC--CC-CccceeEEEEecCCceEE
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ-----LSHMRPHDVQMREFEVLKKVK--HE-NIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~-----~s~~~~~~~~~~Ei~iL~kL~--Hp-NIVkl~~v~~~~~~~~~~   86 (708)
                      ...||.|.-.-||++.+...++.|+||.-..     .+-+-+.++...|.+.|+...  -| .+++++.+-.  .  ...
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e--~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--V--MNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--H--Hhh
Confidence            5678999999999998854466799997521     122344566678888888763  34 4666665532  2  267


Q ss_pred             EEEeccCC
Q psy15481         87 IVMELCTG   94 (708)
Q Consensus        87 LVmEy~~g   94 (708)
                      +|||+++.
T Consensus       110 ~vMEdL~~  117 (409)
T PRK12396        110 CVMEDLSD  117 (409)
T ss_pred             HHHHhCcc
Confidence            89999854

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.84  E-value=0.99  Score=48.47  Aligned_cols=30  Identities=23%  Similarity=0.205  Sum_probs=25.9

Q ss_pred             CCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481        133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       133 gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +++|+|+.++|+++    ++.+.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~----~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLY----DETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEE----cCCCCEEEEEhhhccc
Confidence            79999999999997    6666788999998874

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1236|consensus

Probab=92.47  E-value=0.5  Score=52.49  Aligned_cols=61  Identities=21%  Similarity=0.219  Sum_probs=47.0

Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCcEEEEEe
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL-RDNRLVHRDLKPGNIMKFIC  149 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yL-H~~gIVHrDIKP~NILl~~~  149 (708)
                      .+++-+|..|-++..+++...    .++...+.+..--+.|+.-+ --.+.+|.|+.|+||++...
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            467778999999999997654    67777777777777776543 34689999999999998443

>PRK06148 hypothetical protein; Provisional

Probab=91.96  E-value=1.9  Score=54.13  Aligned_cols=33  Identities=33%  Similarity=0.462  Sum_probs=25.1

Q ss_pred             CCCcccCCCCCcEEEEEecCCC-ceEEEeccCcccc
Q psy15481        132 NRLVHRDLKPGNIMKFICDDGS-TIYKLTDFGAARE  166 (708)
Q Consensus       132 ~gIVHrDIKP~NILl~~~~d~~-~~vKL~DFGlA~~  166 (708)
                      .++||+|+.+.||++  +.++. .+.-|+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv--~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILV--DADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEE--cCCCCcceEEEEECccccc
Confidence            479999999999997  22221 3456999999875

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=91.52  E-value=1.9  Score=46.20  Aligned_cols=76  Identities=18%  Similarity=0.221  Sum_probs=46.2

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC---CCCCccceeEEEEecCCceEEEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV---KHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL---~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..-...+|.|....+|+..  .+++.+.+|+-..    .....+..|.+-|+.|   .--.+++.+++....+.  .|+|
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fLl   90 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFLL   90 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceEE
Confidence            3456778889999999986  6788899998652    2234566788888887   33457788887765443  5999


Q ss_pred             EeccCCC
Q psy15481         89 MELCTGG   95 (708)
Q Consensus        89 mEy~~gg   95 (708)
                      |||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9998766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=91.35  E-value=2.1  Score=46.45  Aligned_cols=71  Identities=14%  Similarity=0.136  Sum_probs=39.7

Q ss_pred             CceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCC--Ccccee---E-EEEecCCceEEEEEeccCCC
Q psy15481         22 ATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE--NIVKLL---A-IEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        22 ~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~Hp--NIVkl~---~-v~~~~~~~~~~LVmEy~~gg   95 (708)
                      .-..||+... .+|..|++|+.+...  ........|.+++..|...  .++...   + ..... ++..+.++++++|.
T Consensus        37 ~eN~vy~v~~-~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~-~g~~~~l~~~~~G~  112 (325)
T PRK11768         37 YENRVYQFGD-EDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEH-QGFRFALFPRRGGR  112 (325)
T ss_pred             ccceEEEEec-CCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEE-CCEEEEEEeeeCCC
Confidence            4456888754 456779999875322  2344445777777766321  122222   1 11111 23578899999876


Q ss_pred             C
Q psy15481         96 S   96 (708)
Q Consensus        96 s   96 (708)
                      .
T Consensus       113 ~  113 (325)
T PRK11768        113 A  113 (325)
T ss_pred             C
Confidence            4

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=91.17  E-value=0.77  Score=47.21  Aligned_cols=103  Identities=17%  Similarity=0.262  Sum_probs=63.2

Q ss_pred             eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHH
Q psy15481         37 PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL  116 (708)
Q Consensus        37 ~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~  116 (708)
                      +..+|.+......-....+..+++++.++.  .|+++.   -+ ++..+-++.|+|-         .+..   ++..   
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~---ND-n~~~yGvIlE~Cy---------~~~i---~~~N---  145 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK---ND-NNYKYGVILERCY---------KIKI---NFSN---  145 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee---cC-CCceeEEEEeecc---------Cccc---chhH---
Confidence            344555554333323334567888888763  355555   22 3445779999994         1111   1111   


Q ss_pred             HHHHHHHHHHHHHHH--CCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481        117 LVLEHLTAGMKHLRD--NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus       117 ~il~qIl~aL~yLH~--~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                       ++.-=+.+|.-.|+  .+.+|+|-.|+|||-    |..+-+||.|-+.-.
T Consensus       146 -~i~agi~~L~~fH~~~~~~lHGD~np~NiM~----D~~G~lKlVDP~~Ll  191 (308)
T PF07387_consen  146 -FITAGIKDLMDFHSENQHCLHGDCNPDNIMC----DKFGYLKLVDPVCLL  191 (308)
T ss_pred             -HHHHhHHHHHHhhccCCCeecCCCChhheee----cCCCCEEecChhhhh
Confidence             22222345667784  489999999999997    888889999977643

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=89.85  E-value=2.8  Score=46.75  Aligned_cols=78  Identities=15%  Similarity=0.224  Sum_probs=45.3

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCC-Cce-----EEEEEeccCCCCCchHHHHHHHHHHHhCCCCCc-cceeEEEEecCCc
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNN-GEP-----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI-VKLLAIEEEQEGR   83 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~t-g~~-----VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNI-Vkl~~v~~~~~~~   83 (708)
                      .+.+. .|..|-+..+|++..... +..     |.++...... ....+ ..+|+.+++.+...++ +++++.+.     
T Consensus        52 ~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~-----  123 (383)
T PTZ00384         52 FIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVID-NDLQYNIAKLLGDNNFGPKIIGRFG-----  123 (383)
T ss_pred             cEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEec-cHHHHHHHHHHHhCCCCCeEEEecC-----
Confidence            34444 555588999999865432 122     4444322111 11122 2378999999965544 55555542     


Q ss_pred             eEEEEEeccCCCCH
Q psy15481         84 GKVIVMELCTGGSL   97 (708)
Q Consensus        84 ~~~LVmEy~~ggsL   97 (708)
                       -+++.||++|..|
T Consensus       124 -~g~l~efIeGr~l  136 (383)
T PTZ00384        124 -DFTIQEWVEGNTM  136 (383)
T ss_pred             -CEEEEEEeccccC
Confidence             2589999988765

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=89.80  E-value=1.3  Score=48.82  Aligned_cols=130  Identities=19%  Similarity=0.251  Sum_probs=82.3

Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      ++.+.|++|++. |+++.. ++.      -..+++..++.+.+..++-+..+ ..-|||+...||++    + .|.|.|+
T Consensus       297 e~~y~yl~~kdh-gt~is~-ik~------~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d-~GnvtLI  363 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISI-IKA------DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----D-EGNVTLI  363 (488)
T ss_pred             CceEEEEEEecC-Cceeee-eec------ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----e-cCceEEE
Confidence            344678899986 666543 222      45678899999999888888866 78999999999998    5 6779999


Q ss_pred             ccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        160 DFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       160 DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      ||-+++. ..+..   .......-+|..+.        |.. +..-+||-+-   --|+.|+.  ..|....|.-.++..
T Consensus       364 DfklsRl-~~~q~---~isy~rldhp~lF~--------G~d-d~QFeIYrlM---r~l~~g~w--a~F~P~TNvlWL~yL  425 (488)
T COG5072         364 DFKLSRL-SYSQG---IISYNRLDHPDLFN--------GVD-DYQFEIYRLM---RRLLKGRW--AQFEPITNVLWLYYL  425 (488)
T ss_pred             Eeeeeec-ccCCc---eeeccccCchhhhc--------Ccc-ceeeeHHHHH---HHHhcCcH--HhcccchhhHHHHHH
Confidence            9999983 22211   12223345676665        222 4455666543   33333432  223345566666555


Q ss_pred             Hh
Q psy15481        240 TT  241 (708)
Q Consensus       240 ~~  241 (708)
                      ..
T Consensus       426 s~  427 (488)
T COG5072         426 SH  427 (488)
T ss_pred             HH
Confidence            43

>KOG1033|consensus

Probab=88.50  E-value=0.093  Score=59.26  Aligned_cols=71  Identities=24%  Similarity=0.324  Sum_probs=61.0

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecC
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE   81 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~   81 (708)
                      .+..+..+|.|+||+|+.+..+.++..+|||.+.............+|+..+.++.|++++.++-.|...+
T Consensus        50 ~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~  120 (516)
T KOG1033|consen   50 DFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYERP  120 (516)
T ss_pred             cccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecCC
Confidence            56778899999999999999988888999999987777666777789999999999999999988776543

>PTZ00296 choline kinase; Provisional

Probab=88.41  E-value=3.3  Score=47.08  Aligned_cols=76  Identities=21%  Similarity=0.206  Sum_probs=46.6

Q ss_pred             EeeEeecCCceEEEEEEEcC--------CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCc-cceeEEEEecCCce
Q psy15481         14 TTSVLGKGATGAVFQGVNKN--------NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI-VKLLAIEEEQEGRG   84 (708)
Q Consensus        14 i~~~LG~G~fG~Vy~a~~~~--------tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNI-Vkl~~v~~~~~~~~   84 (708)
                      -...|..|=+-.+|++....        .++.|.+++.......- .+ ..+|..+++.+..-+| +++++.+  .+   
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-Id-R~~E~~v~~~ls~~gi~P~l~~~f--~g---  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-YN-PISEFEVYKTMSKYRIAPQLLNTF--SG---  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-eC-HHHHHHHHHHHHHCCCCCceEEEe--CC---
Confidence            45566667788888886542        25679999876543221 12 2368888888754444 3455543  22   


Q ss_pred             EEEEEeccCCCCH
Q psy15481         85 KVIVMELCTGGSL   97 (708)
Q Consensus        85 ~~LVmEy~~ggsL   97 (708)
                       +.|.+|++|..|
T Consensus       182 -g~I~efi~g~~l  193 (442)
T PTZ00296        182 -GRIEEWLYGDPL  193 (442)
T ss_pred             -CEEEEeeCCccC
Confidence             357899987643

>PHA03111 Ser/Thr kinase; Provisional

Probab=84.01  E-value=1.9  Score=46.80  Aligned_cols=47  Identities=21%  Similarity=0.323  Sum_probs=31.2

Q ss_pred             HHHHHHHHHHHHHHHHHHHH----CCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481        112 EEEFLLVLEHLTAGMKHLRD----NRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus       112 e~~v~~il~qIl~aL~yLH~----~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      .+-++-++.||+.-.-.+..    .+.+|-||||+|||+ ++.+..-.++++
T Consensus       278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILi-Fds~~~i~I~~~  328 (444)
T PHA03111        278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILI-FDSDEPISITLK  328 (444)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEE-ecCCCcEEEEEC
Confidence            45566777888765534433    368999999999998 455544444433

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	708
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-123
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-113
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-26
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-26
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-21
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-20
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-20
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-20
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-20
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-20
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-20
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-20
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-20
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-20
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-20
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-20
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-19
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-19
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-19
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-19
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-19
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-19
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-18
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-18
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-18
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-18
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-18
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-18
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-18
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-18
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-18
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-18
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-18
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-18
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-18
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-18
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-18
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-18
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-18
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-18
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-18
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-18
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-18
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-18
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-18
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-18
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-18
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-18
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-18
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-17
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-17
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-17
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-17
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-17
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-17
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-17
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-17
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-17
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-17
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-17
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-17
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-17
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-17
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-17
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-17
3soa_A	444	Full-Length Human Camkii Length = 444		4e-17
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-17
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-17
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-17
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-17
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-17
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-17
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-16
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-16
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-16
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-16
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-16
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-16
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-16
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-15
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-15
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-15
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-15
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-15
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-15
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-15
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-15
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-15
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-15
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-15
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-15
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-15
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-15
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-15
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-15
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-15
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-13
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-13
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-13
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-13
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		6e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-11
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-10
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		9e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-07
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-07
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		3e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-06
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		3e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-06
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-06
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-06
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-06
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-05
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-05
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-05
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-05
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-05
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		7e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-05

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score =  438 bits (1127), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 205/386 (53%), Positives = 278/386 (72%), Gaps = 9/386 (2%)
Query: 7   STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK 66
           ++N++W  + +LG+GAT  VF+G +K  G+  A+K FN +S +RP DVQMREFEVLKK+ 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM 126
           H+NIVKL AIEEE   R KV++ME C  GSL+ +L++P N YGL E EFL+VL  +  GM
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
            HLR+N +VHR++KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+SLYGTEEYLHPD
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY-GGRRNKETMYYITTKKAS 245
           MYERAVLRK   K +GATVDLWSIGVT YH ATG+LPFRP+ G RRNKE MY I T K S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT 305
           G ISG Q +ENG IDW  D+P +C LS GL+ L+TP+LA +LE D +K W F++FF+E +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 306 KTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKN------- 358
             L+R ++H+F + ++   +IY+H  +      +L+ +QT +  + Q L+Y+        
Sbjct: 306 DILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEP 365
Query: 359 THFSHIFPSSHQKNPSSYSVSVENDA 384
              +  FP + ++NP  + VS E ++
Sbjct: 366 GRLAQHFPKTTEENP-IFVVSREGNS 390

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score =  406 bits (1044), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 186/305 (60%), Positives = 236/305 (77%), Gaps = 1/305 (0%)
Query: 7   STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK 66
           ++N++W  + +LG+GAT  VF+G +K  G+  A+K FN +S +RP DVQMREFEVLKK+ 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM 126
           H+NIVKL AIEEE   R KV++ME C  GSL+ +L++P N YGL E EFL+VL  +  GM
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
            HLR+N +VHR++KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+ LYGTEEYLHPD
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY-GGRRNKETMYYITTKKAS 245
           MYERAVLRK   K +GATVDLWSIGVT YH ATG+LPFRP+ G RRNKE MY I T K S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT 305
           G ISG Q +ENG IDW  D+P +C LS GL+ L+TP+LA +LE D +K W F++FF+E +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 306 KTLNR 310
             L+R
Sbjct: 306 DILHR 310

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 121/251 (48%), Gaps = 26/251 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG G  G V + ++++ GE VA+K   Q    +  +    E +++KK+ H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 72  KLLAIEEEQEGRGKV-------IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
              +  E  +G  K+       + ME C GG L   L+  EN  GL+E     +L  +++
Sbjct: 77  ---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
            +++L +NR++HRDLKP NI+         I+K+ D G A+EL++ +      GT +YL 
Sbjct: 134 ALRYLHENRIIHRDLKPENIV-LQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP-------YGGRRNKETMY 237
           P++ E+        K +  TVD WS G   +   TG  PF P       +G  R K   +
Sbjct: 193 PELLEQ--------KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 244
Query: 238 YITTKKASGVI 248
            +     +G +
Sbjct: 245 IVVYDDLTGAV 255

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score =  117 bits (292), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 121/251 (48%), Gaps = 26/251 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG G  G V + ++++ GE VA+K   Q    +  +    E +++KK+ H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 72  KLLAIEEEQEGRGKV-------IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
              +  E  +G  K+       + ME C GG L   L+  EN  GL+E     +L  +++
Sbjct: 76  ---SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
            +++L +NR++HRDLKP NI+         I+K+ D G A+EL++ +      GT +YL 
Sbjct: 133 ALRYLHENRIIHRDLKPENIV-LQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP-------YGGRRNKETMY 237
           P++ E+        K +  TVD WS G   +   TG  PF P       +G  R K   +
Sbjct: 192 PELLEQ--------KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243
Query: 238 YITTKKASGVI 248
            +     +G +
Sbjct: 244 IVVYDDLTGAV 254

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/209 (35%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           VLG GA   VF    +  G+  A+K   +    R   ++  E  VLKK+KHENIV L  I
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-NEIAVLKKIKHENIVTLEDI 74
Query: 77  EEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
            E        +VM+L +GG LF+ IL+    T    E++  LV++ + + +K+L +N +V
Sbjct: 75  YESTTHY--YLVMQLVSGGELFDRILERGVYT----EKDASLVIQQVLSAVKYLHENGIV 128
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRDLKP N++    ++ S I  +TDFG ++ +E++    +  GT  Y+ P++    + +K
Sbjct: 129 HRDLKPENLLYLTPEENSKI-MITDFGLSK-MEQNGIMSTACGTPGYVAPEV----LAQK 182
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P  K     VD WSIGV  Y +  G  PF
Sbjct: 183 PYSK----AVDCWSIGVITYILLCGYPPF 207

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 13/223 (5%)
Query: 3   FLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVL 62
           + +G+ + ++     LG GA G V     +++G    +KT N+     P +    E EVL
Sbjct: 15  YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVL 74
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEH 121
           K + H NI+K+  + E+       IVME C GG L   I+        L E     +++ 
Sbjct: 75  KSLDHPNIIKIFEVFEDY--HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE 181
           +   + +     +VH+DLKP NI+       S I K+ DFG A   + D+   +  GT  
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI-KIIDFGLAELFKSDEHSTNAAGTAL 191
Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           Y+ P++++R V  K          D+WS GV +Y + TG LPF
Sbjct: 192 YMAPEVFKRDVTFK---------CDIWSAGVVMYFLLTGCLPF 225

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/229 (31%), Positives = 117/229 (51%), Gaps = 21/229 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMR---PHDVQMREFEVLKKVKHENIVK 72
           LG G    V +   K  G+  A K   +  LS  R     +   RE  +L++++H NI+ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L  I E +     V+++EL +GG LF+ L + E+   L E+E    L+ +  G+ +L   
Sbjct: 80  LHDIFENK--TDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSK 134
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           R+ H DLKP NIM    +  +   KL DFG A ++E   +F +++GT E++ P++    V
Sbjct: 135 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI----V 190
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
             +P+    G   D+WSIGV  Y + +G  PF    G   +ET+  I+ 
Sbjct: 191 NYEPL----GLEADMWSIGVITYILLSGASPFL---GETKQETLTNISA 232

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/229 (31%), Positives = 117/229 (51%), Gaps = 21/229 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMR---PHDVQMREFEVLKKVKHENIVK 72
           LG G    V +   K  G+  A K   +  LS  R     +   RE  +L++++H NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L  I E +     V+++EL +GG LF+ L + E+   L E+E    L+ +  G+ +L   
Sbjct: 73  LHDIFENKTD--VVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSK 127
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           R+ H DLKP NIM    +  +   KL DFG A ++E   +F +++GT E++ P++    V
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI----V 183
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
             +P+    G   D+WSIGV  Y + +G  PF    G   +ET+  I+ 
Sbjct: 184 NYEPL----GLEADMWSIGVITYILLSGASPFL---GETKQETLTNISA 225

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/185 (33%), Positives = 102/185 (55%), Gaps = 16/185 (8%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL 116
           RE  +L++++H NI+ L  I E +     V+++EL +GG LF+ L + E+   L E+E  
Sbjct: 78  REVNILREIRHPNIITLHDIFENK--TDVVLILELVSGGELFDFLAEKES---LTEDEAT 132
Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL 176
             L+ +  G+ +L   R+ H DLKP NIM    +  +   KL DFG A ++E   +F ++
Sbjct: 133 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 192
Query: 177 YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
           +GT E++ P++    V  +P+    G   D+WSIGV  Y + +G  PF    G   +ET+
Sbjct: 193 FGTPEFVAPEI----VNYEPL----GLEADMWSIGVITYILLSGASPFL---GETKQETL 241
Query: 237 YYITT 241
             I+ 
Sbjct: 242 TNISA 246

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/187 (34%), Positives = 103/187 (55%), Gaps = 20/187 (10%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL 116
           RE  +L++V H N++ L  + E +     V+++EL +GG LF+ L   E+   L EEE  
Sbjct: 64  REVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFDFLAQKES---LSEEEAT 118
Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTI--YKLTDFGAARELEEDQQFM 174
             ++ +  G+ +L   ++ H DLKP NIM  + D    I   KL DFG A E+E+  +F 
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIM--LLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 175 SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           +++GT E++ P++    V  +P+    G   D+WSIGV  Y + +G  PF    G   +E
Sbjct: 177 NIFGTPEFVAPEI----VNYEPL----GLEADMWSIGVITYILLSGASPFL---GDTKQE 225
Query: 235 TMYYITT 241
           T+  IT+
Sbjct: 226 TLANITS 232

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/187 (34%), Positives = 99/187 (52%), Gaps = 20/187 (10%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL 116
           RE  +L++V H NI+ L  + E +     V+++EL +GG LF+ L   E+   L EEE  
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTD--VVLILELVSGGELFDFLAQKES---LSEEEAT 118
Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTI--YKLTDFGAARELEEDQQFM 174
             ++ +  G+ +L   ++ H DLKP NIM  + D    I   KL DFG A E+E+  +F 
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIM--LLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 175 SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           +++GT E++ P++     L        G   D+WSIGV  Y + +G  PF    G   +E
Sbjct: 177 NIFGTPEFVAPEIVNYEPL--------GLEADMWSIGVITYILLSGASPFL---GDTKQE 225
Query: 235 TMYYITT 241
           T+  IT 
Sbjct: 226 TLANITA 232

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/187 (34%), Positives = 103/187 (55%), Gaps = 20/187 (10%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL 116
           RE  +L++V H N++ L  + E +     V+++EL +GG LF+ L   E+   L EEE  
Sbjct: 64  REVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFDFLAQKES---LSEEEAT 118
Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTI--YKLTDFGAARELEEDQQFM 174
             ++ +  G+ +L   ++ H DLKP NIM  + D    I   KL DFG A E+E+  +F 
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIM--LLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 175 SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           +++GT E++ P++    V  +P+    G   D+WSIGV  Y + +G  PF    G   +E
Sbjct: 177 NIFGTPEFVAPEI----VNYEPL----GLEADMWSIGVITYILLSGASPFL---GDTKQE 225
Query: 235 TMYYITT 241
           T+  IT+
Sbjct: 226 TLANITS 232

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/187 (34%), Positives = 102/187 (54%), Gaps = 20/187 (10%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL 116
           RE  +L++V H N++ L  + E +     V+++EL +GG LF+ L   E+   L EEE  
Sbjct: 64  REVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFDFLAQKES---LSEEEAT 118
Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTI--YKLTDFGAARELEEDQQFM 174
             ++ +  G+ +L   ++ H DLKP NIM  + D    I   KL DFG A E+E+  +F 
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIM--LLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 175 SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           +++GT E++ P++    V  +P+    G   D+WSIGV  Y + +G  PF    G   +E
Sbjct: 177 NIFGTPEFVAPEI----VNYEPL----GLEADMWSIGVITYILLSGASPFL---GDTKQE 225
Query: 235 TMYYITT 241
           T+  IT 
Sbjct: 226 TLANITA 232

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 115/231 (49%), Gaps = 26/231 (11%)
Query: 3   FLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEV 61
           + +G+    +    +LGKG+ G V +  ++   +  AVK  N+ S   +     +RE E+
Sbjct: 15  YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL 74
Query: 62  LKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEH 121
           LKK+ H NI+KL  I E+       IV EL TGG LF   D+        E +   +++ 
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSF--YIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQ 129
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIM----KFICDDGSTIYKLTDFGAARELEEDQQFMSLY 177
           + +G+ ++  + +VHRDLKP NI+    +  CD      K+ DFG +   +++ +     
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCD-----IKIIDFGLSTCFQQNTKMKDRI 184
Query: 178 GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
           GT  Y+ P+     VLR     T+    D+WS GV LY + +G  PF  YG
Sbjct: 185 GTAYYIAPE-----VLR----GTYDEKCDVWSAGVILYILLSGTPPF--YG 224

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/187 (34%), Positives = 103/187 (55%), Gaps = 20/187 (10%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL 116
           RE  +L++V H N++ L  + E +     V+++EL +GG LF+ L   E+   L EEE  
Sbjct: 64  REVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFDFLAQKES---LSEEEAT 118
Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTI--YKLTDFGAARELEEDQQFM 174
             ++ +  G+ +L   ++ H DLKP NIM  + D    I   KL DFG A E+E+  +F 
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIM--LLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 175 SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           +++GT E++ P++    V  +P+    G   D+WSIGV  Y + +G  PF    G   +E
Sbjct: 177 NIFGTPEFVAPEI----VNYEPL----GLEADMWSIGVITYILLSGASPFL---GDTKQE 225
Query: 235 TMYYITT 241
           T+  IT+
Sbjct: 226 TLANITS 232

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/187 (34%), Positives = 102/187 (54%), Gaps = 20/187 (10%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL 116
           RE  +L++V H N++ L  + E +     V+++EL +GG LF+ L   E+   L EEE  
Sbjct: 64  REVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFDFLAQKES---LSEEEAT 118
Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTI--YKLTDFGAARELEEDQQFM 174
             ++ +  G+ +L   ++ H DLKP NIM  + D    I   KL DFG A E+E+  +F 
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIM--LLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 175 SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           +++GT E++ P++    V  +P+    G   D+WSIGV  Y + +G  PF    G   +E
Sbjct: 177 NIFGTPEFVAPEI----VNYEPL----GLEADMWSIGVITYILLSGASPFL---GDTKQE 225
Query: 235 TMYYITT 241
           T+  IT 
Sbjct: 226 TLANITA 232

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 114/227 (50%), Gaps = 18/227 (7%)
Query: 3   FLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEV 61
           + +G+    +    +LGKG+ G V +  ++   +  AVK  N+ S   +     +RE E+
Sbjct: 15  YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL 74
Query: 62  LKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEH 121
           LKK+ H NI+KL  I E+       IV EL TGG LF   D+        E +   +++ 
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSF--YIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQ 129
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE 181
           + +G+ ++  + +VHRDLKP NI+    +    I K+ DFG +   +++ +     GT  
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
           Y+ P+     VLR     T+    D+WS GV LY + +G  PF  YG
Sbjct: 189 YIAPE-----VLR----GTYDEKCDVWSAGVILYILLSGTPPF--YG 224

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 114/227 (50%), Gaps = 18/227 (7%)
Query: 3   FLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEV 61
           + +G+    +    +LGKG+ G V +  ++   +  AVK  N+ S   +     +RE E+
Sbjct: 15  YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL 74
Query: 62  LKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEH 121
           LKK+ H NI+KL  I E+       IV EL TGG LF   D+        E +   +++ 
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSF--YIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQ 129
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE 181
           + +G+ ++  + +VHRDLKP NI+    +    I K+ DFG +   +++ +     GT  
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
           Y+ P+     VLR     T+    D+WS GV LY + +G  PF  YG
Sbjct: 189 YIAPE-----VLR----GTYDEKCDVWSAGVILYILLSGTPPF--YG 224

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/211 (36%), Positives = 105/211 (49%), Gaps = 20/211 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL- 74
           LGKGA   V + +    G+  A K  N  +LS  R H    RE  + + +KH NIV+L  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
           +I EE       +V +L TGG LF   D     Y   E +    ++ +   + H   N +
Sbjct: 71  SISEEG---FHYLVFDLVTGGELFE--DIVAREY-YSEADASHCIQQILESVNHCHLNGI 124
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ-FMSLYGTEEYLHPDMYERAVL 193
           VHRDLKP N++      G+ + KL DFG A E++ DQQ +    GT  YL P+     VL
Sbjct: 125 VHRDLKPENLLLASKSKGAAV-KLADFGLAIEVQGDQQAWFGFAGTPGYLSPE-----VL 178
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           RK     +G  VD+W+ GV LY +  G  PF
Sbjct: 179 RK---DPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/211 (36%), Positives = 105/211 (49%), Gaps = 20/211 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL- 74
           LGKGA   V + +    G+  A K  N  +LS  R H    RE  + + +KH NIV+L  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
           +I EE       +V +L TGG LF   D     Y   E +    ++ +   + H   N +
Sbjct: 71  SISEEG---FHYLVFDLVTGGELFE--DIVAREY-YSEADASHCIQQILESVNHCHLNGI 124
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ-FMSLYGTEEYLHPDMYERAVL 193
           VHRDLKP N++      G+ + KL DFG A E++ DQQ +    GT  YL P+     VL
Sbjct: 125 VHRDLKPENLLLASKSKGAAV-KLADFGLAIEVQGDQQAWFGFAGTPGYLSPE-----VL 178
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           RK     +G  VD+W+ GV LY +  G  PF
Sbjct: 179 RK---DPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL-AI 76
           LG GA G V +   +  G   A K F    H    +   +E + +  ++H  +V L  A 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAK-FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
           E++ E    V++ E  +GG LF  + D  N   + E+E +  +  +  G+ H+ +N  VH
Sbjct: 118 EDDNE---MVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENNYVH 172
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
            DLKP NIM       S   KL DFG    L+  Q      GT E+  P++ E       
Sbjct: 173 LDLKPENIM--FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE------- 223
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
            GK  G   D+WS+GV  Y + +G     P+GG  + ET+
Sbjct: 224 -GKPVGYYTDMWSVGVLSYILLSG---LSPFGGENDDETL 259

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL-AI 76
           LG GA G V +   +  G   A K F    H    +   +E + +  ++H  +V L  A 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAK-FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
           E++ E    V++ E  +GG LF  + D  N   + E+E +  +  +  G+ H+ +N  VH
Sbjct: 224 EDDNE---MVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENNYVH 278
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
            DLKP NIM       S   KL DFG    L+  Q      GT E+  P++ E       
Sbjct: 279 LDLKPENIM--FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE------- 329
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
            GK  G   D+WS+GV  Y + +G     P+GG  + ET+
Sbjct: 330 -GKPVGYYTDMWSVGVLSYILLSG---LSPFGGENDDETL 365

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 71
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 72  QHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++    V  +P+    G   D+WSIGV  Y + +G  PF
Sbjct: 187 EI----VNYEPL----GLEADMWSIGVITYILLSGASPF 217

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/211 (35%), Positives = 105/211 (49%), Gaps = 20/211 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL- 74
           LGKGA   V + V K   +  A K  N  +LS  R H    RE  + + +KH NIV+L  
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHD 97
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
           +I EE       +V +L TGG LF  +   E      E +    +  +   + H+  + +
Sbjct: 98  SISEEG---FHYLVFDLVTGGELFEDIVAREY---YSEADASHCIHQILESVNHIHQHDI 151
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ-FMSLYGTEEYLHPDMYERAVL 193
           VHRDLKP N++      G+ + KL DFG A E++ +QQ +    GT  YL P+     VL
Sbjct: 152 VHRDLKPENLLLASKCKGAAV-KLADFGLAIEVQGEQQAWFGFAGTPGYLSPE-----VL 205
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           RK     +G  VD+W+ GV LY +  G  PF
Sbjct: 206 RK---DPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           LGKGA   V + V+K  G   A K  N    +   D Q   RE  + +K++H NIV+L  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLH- 71
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
            +  QE     +V +L TGG LF   +D        E +    ++ +   + +   N +V
Sbjct: 72  -DSIQEESFHYLVFDLVTGGELF---EDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HR+LKP N++      G+ + KL DFG A E+ + + +    GT  YL P++ ++    K
Sbjct: 128 HRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P        VD+W+ GV LY +  G  PF
Sbjct: 187 P--------VDIWACGVILYILLVGYPPF 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           LGKGA   V + V+K  G   A K  N    +   D Q   RE  + +K++H NIV+L  
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLH- 70
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
            +  QE     +V +L TGG LF   +D        E +    ++ +   + +   N +V
Sbjct: 71  -DSIQEESFHYLVFDLVTGGELF---EDIVAREFYSEADASHCIQQILESIAYCHSNGIV 126
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HR+LKP N++      G+ + KL DFG A E+ + + +    GT  YL P++ ++    K
Sbjct: 127 HRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 185
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P        VD+W+ GV LY +  G  PF
Sbjct: 186 P--------VDIWACGVILYILLVGYPPF 206

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/211 (36%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL- 74
           LGKGA   V + V    G+  A K  N  +LS  R H    RE  + + +KH NIV+L  
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
           +I EE       ++ +L TGG LF   D     Y   E +    ++ +   + H     +
Sbjct: 89  SISEEGH---HYLIFDLVTGGELFE--DIVAREY-YSEADASHCIQQILEAVLHCHQMGV 142
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ-FMSLYGTEEYLHPDMYERAVL 193
           VHRDLKP N++      G+ + KL DFG A E+E +QQ +    GT  YL P+     VL
Sbjct: 143 VHRDLKPENLLLASKLKGAAV-KLADFGLAIEVEGEQQAWFGFAGTPGYLSPE-----VL 196
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           RK     +G  VDLW+ GV LY +  G  PF
Sbjct: 197 RK---DPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/211 (35%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL- 74
           +GKGA   V + V    G   A K  N  +LS  R H    RE  + + +KH NIV+L  
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLS-ARDHQKLEREARICRLLKHSNIVRLHD 70
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
           +I EE       +V +L TGG LF   D     Y   E +    ++ +   + H     +
Sbjct: 71  SISEEG---FHYLVFDLVTGGELFE--DIVAREY-YSEADASHCIQQILEAVLHCHQMGV 124
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ-FMSLYGTEEYLHPDMYERAVL 193
           VHRDLKP N++      G+ + KL DFG A E++ DQQ +    GT  YL P+     VL
Sbjct: 125 VHRDLKPENLLLASKCKGAAV-KLADFGLAIEVQGDQQAWFGFAGTPGYLSPE-----VL 178
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           RK   + +G  VD+W+ GV LY +  G  PF
Sbjct: 179 RK---EAYGKPVDIWACGVILYILLVGYPPF 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 71
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 72  QHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++     L        G   D+WSIGV  Y + +G  PF
Sbjct: 187 EIVNYEPL--------GLEADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 71
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 72  QHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++    V  +P+    G   D+WSIGV  Y + +G  PF
Sbjct: 187 EI----VNYEPL----GLEADMWSIGVITYILLSGASPF 217

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           LGKGA   V + V+K  G   A K  N    +   D Q   RE  + +K++H NIV+L  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLH- 71
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
            +  QE     +V +L TGG LF   +D        E +    ++ +   + +   N +V
Sbjct: 72  -DSIQEESFHYLVFDLVTGGELF---EDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HR+LKP N++      G+ + KL DFG A E+ + + +    GT  YL P++ ++    K
Sbjct: 128 HRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P        VD+W+ GV LY +  G  PF
Sbjct: 187 P--------VDIWACGVILYILLVGYPPF 207

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 71
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 72  QHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++    V  +P+    G   D+WSIGV  Y + +G  PF
Sbjct: 187 EI----VNYEPL----GLEADMWSIGVITYILLSGASPF 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 70
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 71  QHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 125
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++     L        G   D+WSIGV  Y + +G  PF
Sbjct: 186 EIVNYEPL--------GLEADMWSIGVITYILLSGASPF 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 71
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 72  QHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++    V  +P+    G   D+WSIGV  Y + +G  PF
Sbjct: 187 EI----VNYEPL----GLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 71
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 72  QHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++    V  +P+    G   D+WSIGV  Y + +G  PF
Sbjct: 187 EI----VNYEPL----GLEADMWSIGVITYILLSGASPF 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 70
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 71  QHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 125
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++    V  +P+    G   D+WSIGV  Y + +G  PF
Sbjct: 186 EI----VNYEPL----GLEADMWSIGVITYILLSGASPF 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 71
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 72  QHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++    V  +P+    G   D+WSIGV  Y + +G  PF
Sbjct: 187 EI----VNYEPL----GLEADMWSIGVITYILLSGASPF 217

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           LGKGA   V + V+K  G   A K  N    +   D Q   RE  + +K++H NIV+L  
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLH- 94
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
            +  QE     +V +L TGG LF   +D        E +    ++ +   + +   N +V
Sbjct: 95  -DSIQEESFHYLVFDLVTGGELF---EDIVAREFYSEADASHCIQQILESIAYCHSNGIV 150
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HR+LKP N++      G+ + KL DFG A E+ + + +    GT  YL P++ ++    K
Sbjct: 151 HRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 209
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P        VD+W+ GV LY +  G  PF
Sbjct: 210 P--------VDIWACGVILYILLVGYPPF 230

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 71
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 72  QHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++     L        G   D+WSIGV  Y + +G  PF
Sbjct: 187 EIVNYEPL--------GLEADMWSIGVITYILLSGASPF 217

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 71
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 72  QHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++    V  +P+    G   D+WSIGV  Y + +G  PF
Sbjct: 187 EI----VNYEPL----GLEADMWSIGVITYILLSGASPF 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 93/168 (55%), Gaps = 13/168 (7%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL 116
           RE  +LK+++H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE  
Sbjct: 63  REVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL 176
             L+ +  G+ +L   ++ H DLKP NIM    +      K+ DFG A +++   +F ++
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 177 YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +GT E++ P++    V  +P+    G   D+WSIGV  Y + +G  PF
Sbjct: 178 FGTPEFVAPEI----VNYEPL----GLEADMWSIGVITYILLSGASPF 217

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 118/239 (49%), Gaps = 24/239 (10%)
Query: 5   RGSTN--YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVL 62
           +G+ N  Y    T +LG G  G V +      G  +A K   +   M+  +    E  V+
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII-KTRGMKDKEEVKNEISVM 140
Query: 63  KKVKHENIVKLL-AIEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLE 120
            ++ H N+++L  A E + +    V+VME   GG LF+ I+D+   +Y L E + +L ++
Sbjct: 141 NQLDHANLIQLYDAFESKND---IVLVMEYVDGGELFDRIIDE---SYNLTELDTILFMK 194
Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
            +  G++H+    ++H DLKP NI+  +  D   I K+ DFG AR  +  ++    +GT 
Sbjct: 195 QICEGIRHMHQMYILHLDLKPENIL-CVNRDAKQI-KIIDFGLARRYKPREKLKVNFGTP 252
Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           E+L P++     +  P         D+WS+GV  Y + +G     P+ G  + ET+  I
Sbjct: 253 EFLAPEVVNYDFVSFP--------TDMWSVGVIAYMLLSG---LSPFLGDNDAETLNNI 300

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 20/222 (9%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S LG+GAT  V++   K   +P A+K   +    +   +   E  VL ++ H NI+KL  
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK---IVRTEIGVLLRLSHPNIIKLKE 115
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           I E        +V+EL TGG LF+ +   E  Y   E +    ++ +   + +L +N +V
Sbjct: 116 IFETPTEIS--LVLELVTGGELFDRI--VEKGY-YSERDAADAVKQILEAVAYLHENGIV 170
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRDLKP N++ +         K+ DFG ++ +E      ++ GT  Y  P+     +LR 
Sbjct: 171 HRDLKPENLL-YATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE-----ILR- 223
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
             G  +G  VD+WS+G+  Y +  G   F P+   R  + M+
Sbjct: 224 --GCAYGPEVDMWSVGIITYILLCG---FEPFYDERGDQFMF 260

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 15/214 (7%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           VLGKG  G V+ G + +N   +A+K   +        +   E  + K +KH+NIV+ L  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH-EEIALHKHLKHKNIVQYLGS 87
Query: 77  EEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E    G + I ME   GGSL  +L          E+      + +  G+K+L DN++V
Sbjct: 88  FSEN---GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVLR 194
           HRD+K  N++    +  S + K++DFG ++ L         + GT +Y+ P++ ++    
Sbjct: 145 HRDIKGDNVL---INTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG--- 198
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
            P G  +G   D+WS+G T+  +ATG  PF   G
Sbjct: 199 -PRG--YGKAADIWSLGCTIIEMATGKPPFYELG 229

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +GKG    V    +   G  VAVK  ++ + + P  +Q   RE  ++K + H NIVKL  
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNRL 134
           + E +  +   +VME  +GG +F+ L      +G ++E+E       + + +++     +
Sbjct: 82  VIETE--KTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQIVSAVQYCHQKYI 135
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLK  N++     DG    K+ DFG + E     +  +  G+  Y  P++++     
Sbjct: 136 VHRDLKAENLLL----DGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQ----- 186
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS+GV LY + +G+LPF
Sbjct: 187 ---GKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 71
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     ++++EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 72  QHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT  ++ P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAP 186
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++    V  +P+    G   D+WSIGV  Y + +G  PF
Sbjct: 187 EI----VNYEPL----GLEADMWSIGVITYILLSGASPF 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           VLG GA   V    +K   + VA+K   + +          E  VL K+KH NIV L  I
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
            E   G    ++M+L +GG LF+ +   E  +  + +   L+ + L A +K+L D  +VH
Sbjct: 85  YES--GGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDA-VKYLHDLGIVH 139
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           RDLKP N++ +  D+ S I  ++DFG ++  +      +  GT  Y+ P++    + +KP
Sbjct: 140 RDLKPENLLYYSLDEDSKIM-ISDFGLSKMEDPGSVLSTACGTPGYVAPEV----LAQKP 194
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K     VD WSIGV  Y +  G  PF
Sbjct: 195 YSK----AVDCWSIGVIAYILLCGYPPF 218

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENI 70
           W     LG+GA G V   VN+   E VAVK  +    +  P +++ +E  + K + HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEIXINKMLNHENV 66
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           VK       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L 
Sbjct: 67  VKFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDM 187
              + HRD+KP N++    D+   + K++DFG A   R    ++    + GT  Y+ P++
Sbjct: 122 GIGITHRDIKPENLL---LDERDNL-KISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 188 YERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
            +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 178 LKR--------REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENI 70
           W     LG+GA G V   VN+   E VAVK  +    +  P +++ +E  + K + HEN+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEIXINKMLNHENV 67
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           VK       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L 
Sbjct: 68  VKFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDM 187
              + HRD+KP N++    D+   + K++DFG A   R    ++    + GT  Y+ P++
Sbjct: 123 GIGITHRDIKPENLL---LDERDNL-KISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 188 YERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
            +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 179 LKR--------REFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           VLG GA   V    +K   + VA+K   + +          E  VL K+KH NIV L  I
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
            E   G    ++M+L +GG LF+ +   E  +  + +   L+ + L A +K+L D  +VH
Sbjct: 85  YES--GGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDA-VKYLHDLGIVH 139
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           RDLKP N++ +  D+ S I  ++DFG ++  +      +  GT  Y+ P++    + +KP
Sbjct: 140 RDLKPENLLYYSLDEDSKIM-ISDFGLSKMEDPGSVLSTACGTPGYVAPEV----LAQKP 194
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K     VD WSIGV  Y +  G  PF
Sbjct: 195 YSK----AVDCWSIGVIAYILLCGYPPF 218

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENI 70
           W     LG+GA G V   VN+   E VAVK  +    +  P +++ +E  + K + HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEIXINKMLNHENV 66
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           VK       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L 
Sbjct: 67  VKFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDM 187
              + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++
Sbjct: 122 GIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 188 YERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
            +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 178 LKR--------REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 15/217 (6%)
Query: 9   NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE 68
           N VW     LG GA G V++  NK  G   A K     S     D  + E E+L    H 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY-IVEIEILATCDHP 76
Query: 69  NIVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            IVKLL         GK+ I++E C GG++  I+   E   GL E +  +V   +   + 
Sbjct: 77  YIVKLLGAYYHD---GKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQVVCRQMLEALN 131
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPD 186
            L   R++HRDLK GN++  +  D     +L DFG +A+ L+  Q+  S  GT  ++ P+
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
           +     ++      +    D+WS+G+TL  +A    P
Sbjct: 188 VVMCETMKD---TPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L  
Sbjct: 68  KFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 123 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 179 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 15/214 (7%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           VLGKG  G V+ G + +N   +A+K   +        +   E  + K +KH+NIV+ L  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH-EEIALHKHLKHKNIVQYLGS 73
Query: 77  EEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E    G + I ME   GGSL  +L          E+      + +  G+K+L DN++V
Sbjct: 74  FSEN---GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVLR 194
           HRD+K  N++    +  S + K++DFG ++ L         + GT +Y+ P++ ++    
Sbjct: 131 HRDIKGDNVL---INTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG--- 184
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
            P G  +G   D+WS+G T+  +ATG  PF   G
Sbjct: 185 -PRG--YGKAADIWSLGCTIIEMATGKPPFYELG 215

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           VLG GA   V    +K   + VA+K   + +          E  VL K+KH NIV L  I
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
            E   G    ++M+L +GG LF+ +   E  +  + +   L+ + L A +K+L D  +VH
Sbjct: 85  YES--GGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDA-VKYLHDLGIVH 139
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           RDLKP N++ +  D+ S I  ++DFG ++  +      +  GT  Y+ P++    + +KP
Sbjct: 140 RDLKPENLLYYSLDEDSKIM-ISDFGLSKMEDPGSVLSTACGTPGYVAPEV----LAQKP 194
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K     VD WSIGV  Y +  G  PF
Sbjct: 195 YSK----AVDCWSIGVIAYILLCGYPPF 218

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 15/217 (6%)
Query: 9   NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE 68
           N VW     LG GA G V++  NK  G   A K     S     D  + E E+L    H 
Sbjct: 10  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY-IVEIEILATCDHP 68
Query: 69  NIVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            IVKLL         GK+ I++E C GG++  I+   E   GL E +  +V   +   + 
Sbjct: 69  YIVKLLGAYYHD---GKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQVVCRQMLEALN 123
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPD 186
            L   R++HRDLK GN++  +  D     +L DFG +A+ L+  Q+  S  GT  ++ P+
Sbjct: 124 FLHSKRIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 179
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
           +     ++      +    D+WS+G+TL  +A    P
Sbjct: 180 VVMCETMKD---TPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           VLG GA   V    +K   + VA+K   + +          E  VL K+KH NIV L  I
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
            E   G    ++M+L +GG LF+ +   E  +  + +   L+ + L A +K+L D  +VH
Sbjct: 85  YES--GGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDA-VKYLHDLGIVH 139
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           RDLKP N++ +  D+ S I  ++DFG ++  +      +  GT  Y+ P++    + +KP
Sbjct: 140 RDLKPENLLYYSLDEDSKIM-ISDFGLSKMEDPGSVLSTACGTPGYVAPEV----LAQKP 194
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K     VD WSIGV  Y +  G  PF
Sbjct: 195 YSK----AVDCWSIGVIAYILLCGYPPF 218

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN---------QLSHMRPHDVQMREFEVLKKVK- 66
           V+G+G +  V + V++  G   AVK            QL  +R  +   RE  +L++V  
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVR--EATRRETHILRQVAG 158
Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM 126
           H +I+ L  I+  +      +V +L   G LF+ L +      L E+E   ++  L   +
Sbjct: 159 HPHIITL--IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAV 213
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
             L  N +VHRDLKP NI+    DD   I +L+DFG +  LE  ++   L GT  YL P+
Sbjct: 214 SFLHANNIVHRDLKPENIL---LDDNMQI-RLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + + ++     G  +G  VDLW+ GV L+ +  G+ PF
Sbjct: 270 ILKCSMDETHPG--YGKEVDLWACGVILFTLLAGSPPF 305

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 20/219 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK------TFNQLSHMRPHDVQMREFEVLKKV 65
           + T   LG G    V +   K+ G   A K      T +    +   D++ RE  +LK++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-REVSILKEI 71
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +H N++ L  + E +     +++ EL  GG LF+ L + E+   L EEE    L+ +  G
Sbjct: 72  QHPNVITLHEVYENK--TDVILIGELVAGGELFDFLAEKES---LTEEEATEFLKQILNG 126
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L   ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++    V  +P+    G   D+WSIGV  Y + +G  PF
Sbjct: 187 EI----VNYEPL----GLEADMWSIGVITYILLSGASPF 217

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENI 70
           W     LG+GA G V   VN+   E VAVK  +    +  P +++ +E  + K + HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENV 66
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           VK       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L 
Sbjct: 67  VKFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDM 187
              + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++
Sbjct: 122 GIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 188 YERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
            +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 178 LKR--------REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENI 70
           W     LG+GA G V   VN+   E VAVK  +    +  P +++ +E  + K + HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENV 66
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           VK       +EG  + + +E C+GG LF   D  E   G+ E +       L AG+ +L 
Sbjct: 67  VKFYG--HRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDM 187
              + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++
Sbjct: 122 GIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 188 YERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
            +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 178 LKR--------REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENI 70
           W     LG+GA G V   VN+   E VAVK  +    +  P +++ +E  + K + HEN+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENV 66
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           VK       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L 
Sbjct: 67  VKFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDM 187
              + HRD+KP N++    D+   + K++DFG A   R    ++    + GT  Y+ P++
Sbjct: 122 GIGITHRDIKPENLL---LDERDNL-KISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 188 YERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
            +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 178 LKR--------REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF   D  E   G+ E +       L AG+ +L  
Sbjct: 68  KFYG--HRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 123 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 179 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF   D  E   G+ E +       L AG+ +L  
Sbjct: 68  KFYG--HRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 123 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 179 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF   D  E   G+ E +       L AG+ +L  
Sbjct: 69  KFYG--HRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 124 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 180 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           VLGKG+ G V    +K  G+  AVK  +  Q+      +  +RE ++LK++ H NI+KL 
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              E+   +G   +V E+ TGG LF   D+  +     E +   ++  + +G+ ++  N+
Sbjct: 99  EFFED---KGYFYLVGEVYTGGELF---DEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +VHRDLKP N++       + I ++ DFG +   E  ++     GT  Y+ P++      
Sbjct: 153 IVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASKKMKDKIGTAYYIAPEV------ 205
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              +  T+    D+WS GV LY + +G  PF
Sbjct: 206 ---LHGTYDEKCDVWSTGVILYILLSGCPPF 233

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L  
Sbjct: 67  KFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 122 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 178 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 22/221 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL-AI 76
           LG GA G V + V K  G     K  N    +  + V+  E  ++ ++ H  ++ L  A 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK-NEISIMNQLHHPKLINLHDAF 117
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
           E++ E    V+++E  +GG LF+ +      Y + E E +  +     G+KH+ ++ +VH
Sbjct: 118 EDKYE---MVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172
Query: 137 RDLKPGNIMKFICD-DGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
            D+KP NIM   C+   ++  K+ DFG A +L  D+       T E+  P++    V R+
Sbjct: 173 LDIKPENIM---CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI----VDRE 225
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
           PV    G   D+W+IGV  Y + +G     P+ G  + ET+
Sbjct: 226 PV----GFYTDMWAIGVLGYVLLSG---LSPFAGEDDLETL 259

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L  
Sbjct: 68  KFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 123 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 179 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 9   NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVK 66
           NY    T  +GKG    V    +   G  VA+K  ++ + + P  +Q   RE  ++K + 
Sbjct: 16  NYRLLKT--IGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILN 72
Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAG 125
           H NIVKL  + E +  +   ++ME  +GG +F+ L      +G ++E+E       + + 
Sbjct: 73  HPNIVKLFEVIETE--KTLYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVSA 126
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           +++    R+VHRDLK  N++     D     K+ DFG + E     +  +  G   Y  P
Sbjct: 127 VQYCHQKRIVHRDLKAENLLL----DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182
Query: 186 DMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
           ++++        GK + G  VD+WS+GV LY + +G+LPF
Sbjct: 183 ELFQ--------GKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF   D  E   G+ E +       L AG+ +L  
Sbjct: 68  KFYG--HRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 123 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 179 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 25/220 (11%)
Query: 9   NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVK 66
           NY    T  +GKG    V    +   G  VA+K  ++ + + P  +Q   RE  ++K + 
Sbjct: 13  NYRLLKT--IGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILN 69
Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAG 125
           H NIVKL  + E +  +   ++ME  +GG +F+ L      +G ++E+E       + + 
Sbjct: 70  HPNIVKLFEVIETE--KTLYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVSA 123
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           +++    R+VHRDLK  N++     D     K+ DFG + E     +  +  G+  Y  P
Sbjct: 124 VQYCHQKRIVHRDLKAENLLL----DADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAP 179
Query: 186 DMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
           ++++        GK + G  VD+WS+GV LY + +G+LPF
Sbjct: 180 ELFQ--------GKKYDGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L  
Sbjct: 69  KFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 124 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 180 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF   D  E   G+ E +       L AG+ +L  
Sbjct: 68  KFYG--HRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 123 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 179 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L  
Sbjct: 68  KFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 123 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 179 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ----LSHMRPHDVQMR---EFEVLKK 64
           +  +  LG GA G V     +   + VA+K  ++    +   R  D  +    E E+LKK
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 65  VKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           + H  I+K   I+   +     IV+EL  GG LF   D       L+E    L    +  
Sbjct: 72  LNHPCIIK---IKNFFDAEDYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 125
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
            +++L +N ++HRDLKP N++     +   + K+TDFG ++ L E     +L GT  YL 
Sbjct: 126 AVQYLHENGIIHRDLKPENVL-LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P+     VL       +   VD WS+GV L+   +G  PF
Sbjct: 185 PE-----VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L  
Sbjct: 69  KFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 124 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 180 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L  
Sbjct: 69  KFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 124 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 180 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L  
Sbjct: 69  KFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 124 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 180 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ----LSHMRPHDVQMR---EFEVLKK 64
           +  +  LG GA G V     +   + VA+K  ++    +   R  D  +    E E+LKK
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 70
Query: 65  VKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           + H  I+K   I+   +     IV+EL  GG LF   D       L+E    L    +  
Sbjct: 71  LNHPCIIK---IKNFFDAEDYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 124
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
            +++L +N ++HRDLKP N++     +   + K+TDFG ++ L E     +L GT  YL 
Sbjct: 125 AVQYLHENGIIHRDLKPENVL-LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 183
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P+     VL       +   VD WS+GV L+   +G  PF
Sbjct: 184 PE-----VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 218

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L  
Sbjct: 69  KFYG--HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 124 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 180 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ----LSHMRPHDVQMR---EFEVLKK 64
           +  +  LG GA G V     +   + VA+K  ++    +   R  D  +    E E+LKK
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 65  VKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           + H  I+K   I+   +     IV+EL  GG LF   D       L+E    L    +  
Sbjct: 72  LNHPCIIK---IKNFFDAEDYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 125
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
            +++L +N ++HRDLKP N++     +   + K+TDFG ++ L E     +L GT  YL 
Sbjct: 126 AVQYLHENGIIHRDLKPENVL-LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P+     VL       +   VD WS+GV L+   +G  PF
Sbjct: 185 PE-----VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ----LSHMRPHDVQMR---EFEVLKK 64
           +  +  LG GA G V     +   + VA+K  ++    +   R  D  +    E E+LKK
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 65  VKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           + H  I+K   I+   +     IV+EL  GG LF   D       L+E    L    +  
Sbjct: 72  LNHPCIIK---IKNFFDAEDYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 125
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
            +++L +N ++HRDLKP N++     +   + K+TDFG ++ L E     +L GT  YL 
Sbjct: 126 AVQYLHENGIIHRDLKPENVL-LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P+     VL       +   VD WS+GV L+   +G  PF
Sbjct: 185 PE-----VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           VLGKG+ G V    +K  G+  AVK  +  Q+      +  +RE ++LK++ H NI+KL 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              E+   +G   +V E+ TGG LF   D+  +     E +   ++  + +G+ ++  N+
Sbjct: 93  EFFED---KGYFYLVGEVYTGGELF---DEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +VHRDLKP N++       + I ++ DFG +   E  ++     GT  Y+ P++      
Sbjct: 147 IVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASKKMKDKIGTAYYIAPEV------ 199
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              +  T+    D+WS GV LY + +G  PF
Sbjct: 200 ---LHGTYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 19/240 (7%)
Query: 5   RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLK 63
           +G  + ++     LG GA G V    +K      A+K   + S     + ++  E  VLK
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK 91
Query: 64  KVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
            + H NI+KL    E++  R   +VME   GG LF   D+  +     E +  ++++ + 
Sbjct: 92  LLDHPNIMKLYDFFEDK--RNYYLVMECYKGGELF---DEIIHRMKFNEVDAAVIIKQVL 146
Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
           +G+ +L  + +VHRDLKP N++     +   + K+ DFG +   E  ++     GT  Y+
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLL-LESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
            P+     VLR    K +    D+WSIGV L+ +  G   + P+GG+ ++E +  +   K
Sbjct: 206 APE-----VLR----KKYDEKCDVWSIGVILFILLAG---YPPFGGQTDQEILRKVEKGK 253

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 118/234 (50%), Gaps = 29/234 (12%)
Query: 17  VLGKGATGAVF---QGVNKNNGEPVAVKTFNQLSHMRPHDVQMR-EFEVLKKVKHENIVK 72
           VLG+G+ G VF   +    ++G   A+K   + +      V+ + E ++L  V H  +VK
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 73  L-LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           L  A + E    GK+ ++++   GG LF  L          EE+    L  L  G+ HL 
Sbjct: 95  LHYAFQTE----GKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYE 189
              +++RDLKP NI+    D+   I KLTDFG ++E ++ +++  S  GT EY+ P++  
Sbjct: 148 SLGIIYRDLKPENIL---LDEEGHI-KLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN 203
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
           R        +    + D WS GV ++ + TG+LPF+   G+  KETM  I   K
Sbjct: 204 R--------QGHSHSADWWSYGVLMFEMLTGSLPFQ---GKDRKETMTLILKAK 246

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ----LSHMRPHDVQMR---EFEVLKK 64
           +  +  LG GA G V     +   + VA++  ++    +   R  D  +    E E+LKK
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 210
Query: 65  VKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           + H  I+K   I+   +     IV+EL  GG LF   D       L+E    L    +  
Sbjct: 211 LNHPCIIK---IKNFFDAEDYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 264
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
            +++L +N ++HRDLKP N++     +   + K+TDFG ++ L E     +L GT  YL 
Sbjct: 265 AVQYLHENGIIHRDLKPENVL-LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 323
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P+     VL       +   VD WS+GV L+   +G  PF
Sbjct: 324 PE-----VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 115/227 (50%), Gaps = 16/227 (7%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +GKG+ G V      +  +  A+K  N+   +  ++V+   +E ++++ ++H  +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              +++E     +V++L  GG L   L   +     +EE   L +  L   + +L++ R+
Sbjct: 82  YSFQDEEDM--FMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           +HRD+KP NI+    D+   ++ +TDF  A  L  + Q  ++ GT+ Y+ P+M+     R
Sbjct: 137 IHRDMKPDNIL---LDEHGHVH-ITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS---R 189
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           K  G +F   VD WS+GVT Y +  G  P+       +KE ++   T
Sbjct: 190 KGAGYSFA--VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET 234

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ----LSHMRPHDVQMR---EFEVLKK 64
           +  +  LG GA G V     +   + VA+K  ++    +   R  D  +    E E+LKK
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 77
Query: 65  VKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           + H  I+K   I+   +     IV+EL  GG LF   D       L+E    L    +  
Sbjct: 78  LNHPCIIK---IKNFFDAEDYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 131
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
            +++L +N ++HRDLKP N++     +   + K+TDFG ++ L E     +L GT  YL 
Sbjct: 132 AVQYLHENGIIHRDLKPENVL-LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 190
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P+     VL       +   VD WS+GV L+   +G  PF
Sbjct: 191 PE-----VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/211 (35%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL- 74
           LGKGA   V + V    G+  A    N  +LS  R H    RE  + + +KH NIV+L  
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
           +I EE       ++ +L TGG LF   D     Y   E +    ++ +   + H     +
Sbjct: 78  SISEEGH---HYLIFDLVTGGELFE--DIVAREY-YSEADASHCIQQILEAVLHCHQMGV 131
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ-FMSLYGTEEYLHPDMYERAVL 193
           VHR+LKP N++      G+ + KL DFG A E+E +QQ +    GT  YL P+     VL
Sbjct: 132 VHRNLKPENLLLASKLKGAAV-KLADFGLAIEVEGEQQAWFGFAGTPGYLSPE-----VL 185
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           RK     +G  VDLW+ GV LY +  G  PF
Sbjct: 186 RK---DPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 15  TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ----LSHMRPHDVQMR---EFEVLKKVKH 67
           +  LG GA G V     +   + VA++  ++    +   R  D  +    E E+LKK+ H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
             I+K   I+   +     IV+EL  GG LF   D       L+E    L    +   ++
Sbjct: 200 PCIIK---IKNFFDAEDYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           +L +N ++HRDLKP N++     +   + K+TDFG ++ L E     +L GT  YL P+ 
Sbjct: 254 YLHENGIIHRDLKPENVL-LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE- 311
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               VL       +   VD WS+GV L+   +G  PF
Sbjct: 312 ----VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           VLGKG+ G V    +K  G+  AVK  +  Q+      +  +RE ++LK++ H NI+KL 
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              E+   +G   +V E+ TGG LF   D+  +     E +   ++  + +G+ ++  N+
Sbjct: 116 EFFED---KGYFYLVGEVYTGGELF---DEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +VHRDLKP N++       + I ++ DFG +   E  ++     GT  Y+ P++      
Sbjct: 170 IVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASKKMKDKIGTAYYIAPEV------ 222
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              +  T+    D+WS GV LY + +G  PF
Sbjct: 223 ---LHGTYDEKCDVWSTGVILYILLSGCPPF 250

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           VLGKG+ G V    +K  G+  AVK  +  Q+      +  +RE ++LK++ H NI+KL 
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              E+   +G   +V E+ TGG LF   D+  +     E +   ++  + +G+ ++  N+
Sbjct: 117 EFFED---KGYFYLVGEVYTGGELF---DEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +VHRDLKP N++       + I ++ DFG +   E  ++     GT  Y+ P++      
Sbjct: 171 IVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASKKMKDKIGTAYYIAPEV------ 223
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              +  T+    D+WS GV LY + +G  PF
Sbjct: 224 ---LHGTYDEKCDVWSTGVILYILLSGCPPF 251

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 20/230 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD--VQMREFEVLKKVKHENIVKLLA 75
           LG GA G V    +K  G   A+K   + S     +    + E  VLK++ H NI+KL  
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E++  R   +VME+  GG LF   D+        E +  ++++ + +G  +L  + +V
Sbjct: 89  FFEDK--RNYYLVMEVYRGGELF---DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIV 143
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRDLKP N++         + K+ DFG +   E   +     GT  Y+ P+     VLR 
Sbjct: 144 HRDLKPENLL-LESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE-----VLR- 196
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS 245
              K +    D+WS GV LY +  G   + P+GG+ ++E +  +   K S
Sbjct: 197 ---KKYDEKCDVWSCGVILYILLCG---YPPFGGQTDQEILKRVEKGKFS 240

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 20/230 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD--VQMREFEVLKKVKHENIVKLLA 75
           LG GA G V    +K  G   A+K   + S     +    + E  VLK++ H NI+KL  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E++  R   +VME+  GG LF   D+        E +  ++++ + +G  +L  + +V
Sbjct: 72  FFEDK--RNYYLVMEVYRGGELF---DEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIV 126
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRDLKP N++         + K+ DFG +   E   +     GT  Y+ P+     VLRK
Sbjct: 127 HRDLKPENLL-LESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE-----VLRK 180
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS 245
                +    D+WS GV LY +  G   + P+GG+ ++E +  +   K S
Sbjct: 181 K----YDEKCDVWSCGVILYILLCG---YPPFGGQTDQEILKRVEKGKFS 223

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG+GA G V   VN+   E VAVK  +    +   +   +E  +   + HEN+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVV 68
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K       +EG  + + +E C+GG LF   D  E   G+ E +       L AG+ +L  
Sbjct: 69  KFYG--HRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMY 188
             + HRD+KP N++     D     K++DFG A   R    ++    + GT  Y+ P++ 
Sbjct: 124 IGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 189 ERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPF 224
           +R        + F A  VD+WS G+ L  +  G LP+
Sbjct: 180 KR--------REFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 15/214 (7%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG GA G V++  NK      A K  +  S     D  M E ++L    H NIV
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY-MVEIDILASCDHPNIV 97
Query: 72  KLL-AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           KLL A   E       I++E C GG++  ++ + E    L E +  +V +     + +L 
Sbjct: 98  KLLDAFYYEN---NLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLH 152
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYE 189
           DN+++HRDLK GNI+  +  DG    KL DFG +A+     Q+  S  GT  ++ P   E
Sbjct: 153 DNKIIHRDLKAGNILFTL--DGDI--KLADFGVSAKNTRXIQRRDSFIGTPYWMAP---E 205
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
             +      + +    D+WS+G+TL  +A    P
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 114/237 (48%), Gaps = 34/237 (14%)
Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ---LSHMRPHDVQMR 57
           ++   G  +  + T S LG GA G V+  V+K   + V VK   +   L      D ++ 
Sbjct: 15  LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 58  ----EFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNI------LDDPENT 107
               E  +L +V+H NI+K+L I E Q G  ++++ +  +G  LF        LD+P  +
Sbjct: 75  KVTLEIAILSRVEHANIIKVLDIFENQ-GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 108 YGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL 167
           Y         +   L + + +LR   ++HRD+K  NI+  I +D +   KL DFG+A  L
Sbjct: 134 Y---------IFRQLVSAVGYLRLKDIIHRDIKDENIV--IAEDFTI--KLIDFGSAAYL 180
Query: 168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           E  + F +  GT EY  P++      R P        +++WS+GVTLY +     PF
Sbjct: 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGP-------ELEMWSLGVTLYTLVFEENPF 230

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G+ G      +  +G    +K  N +S M  +  +   RE  VL  +KH NIV+   
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEIN-ISRMSSKEREESRREVAVLANMKHPNIVQYR- 89
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
            E  +E     IVM+ C GG LF  ++  +     QE++ L     +   +KH+ D +++
Sbjct: 90  -ESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHDRKIL 147
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYERAVLR 194
           HRD+K  NI  F+  DG+   +L DFG AR L    +   +  GT  YL P++ E     
Sbjct: 148 HRDIKSQNI--FLTKDGTV--QLGDFGIARVLNSTVELARACIGTPYYLSPEICE----- 198
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT 219
               K +    D+W++G  LY + T
Sbjct: 199 ---NKPYNNKSDIWALGCVLYELCT 220

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 15/214 (7%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG GA G V++  NK      A K  +  S     D  M E ++L    H NIV
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY-MVEIDILASCDHPNIV 97
Query: 72  KLL-AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           KLL A   E       I++E C GG++  ++ + E    L E +  +V +     + +L 
Sbjct: 98  KLLDAFYYEN---NLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLH 152
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYE 189
           DN+++HRDLK GNI+  +  DG    KL DFG +A+     Q+  S  GT  ++ P   E
Sbjct: 153 DNKIIHRDLKAGNILFTL--DGDI--KLADFGVSAKNTRTIQRRDSFIGTPYWMAP---E 205
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
             +      + +    D+WS+G+TL  +A    P
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+GA+G V+  ++   G+ VA++  N L      ++ + E  V+++ K+ NIV  L  +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYL--D 84
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GGSL +++ +      + E +   V       ++ L  N+++HR
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYERAVLRKP 196
           D+K  NI+  +  DGS   KLTDFG   ++  +Q   S + GT  ++ P++  R      
Sbjct: 141 DIKSDNIL--LGMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------ 190
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K +G  VD+WS+G+    +  G  P+
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           VLGKG+ G V    +K  G+  AVK  +  Q+      +  +RE ++LK++ H NI KL 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              E+   +G   +V E+ TGG LF   D+  +     E +   ++  + +G+ +   N+
Sbjct: 93  EFFED---KGYFYLVGEVYTGGELF---DEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +VHRDLKP N++       + I ++ DFG +   E  ++     GT  Y+ P++      
Sbjct: 147 IVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASKKXKDKIGTAYYIAPEV------ 199
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              +  T+    D+WS GV LY + +G  PF
Sbjct: 200 ---LHGTYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+GA+G V+  ++   G+ VA++  N L      ++ + E  V+++ K+ NIV  L  +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYL--D 84
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GGSL +++ +      + E +   V       ++ L  N+++HR
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYERAVLRKP 196
           D+K  NI+  +  DGS   KLTDFG   ++  +Q   S + GT  ++ P++  R      
Sbjct: 141 DIKSDNIL--LGMDGSV--KLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTR------ 190
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K +G  VD+WS+G+    +  G  P+
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+GA+G V+  ++   G+ VA++  N L      ++ + E  V+++ K+ NIV  L  +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYL--D 84
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GGSL +++ +      + E +   V       ++ L  N+++HR
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYERAVLRKP 196
           D+K  NI+  +  DGS   KLTDFG   ++  +Q   S + GT  ++ P++  R      
Sbjct: 141 DIKSDNIL--LGMDGSV--KLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR------ 190
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K +G  VD+WS+G+    +  G  P+
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+GA+G V+  ++   G+ VA++  N L      ++ + E  V+++ K+ NIV  L  +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYL--D 85
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GGSL +++ +      + E +   V       ++ L  N+++HR
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYERAVLRKP 196
           D+K  NI+  +  DGS   KLTDFG   ++  +Q   S + GT  ++ P++  R      
Sbjct: 142 DIKSDNIL--LGMDGSV--KLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR------ 191
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K +G  VD+WS+G+    +  G  P+
Sbjct: 192 --KAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 116/241 (48%), Gaps = 31/241 (12%)
Query: 9   NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ---MREFEVLKKV 65
           N+   T+  LG+G    V Q ++K+ G+  A K   +    R  D +   + E  VL+  
Sbjct: 28  NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK--RRRGQDCRAEILHEIAVLELA 85
Query: 66  KHENIVKLLAIEEEQEGRGKVI-VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           K  +  +++ + E  E   ++I ++E   GG +F+ L  PE    + E + + +++ +  
Sbjct: 86  K--SCPRVINLHEVYENTSEIILILEYAAGGEIFS-LCLPELAEMVSENDVIRLIKQILE 142
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY-----KLTDFGAARELEEDQQFMSLYGT 179
           G+ +L  N +VH DLKP NI+       S+IY     K+ DFG +R++    +   + GT
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILL------SSIYPLGDIKIVDFGMSRKIGHACELREIMGT 196
Query: 180 EEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
            EYL P++        P+        D+W+IG+  Y + T   PF    G  N+ET   I
Sbjct: 197 PEYLAPEILN----YDPI----TTATDMWNIGIIAYMLLTHTSPFV---GEDNQETYLNI 245
Query: 240 T 240
           +
Sbjct: 246 S 246

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG GA G V++  NK      A K  +  S     D  M E ++L    H NIV
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY-MVEIDILASCDHPNIV 97
Query: 72  KLL-AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           KLL A   E       I++E C GG++  ++ + E    L E +  +V +     + +L 
Sbjct: 98  KLLDAFYYEN---NLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLH 152
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYE 189
           DN+++HRDLK GNI+  +  DG    KL DFG +A+     Q+     GT  ++ P   E
Sbjct: 153 DNKIIHRDLKAGNILFTL--DGDI--KLADFGVSAKNTRXIQRRDXFIGTPYWMAP---E 205
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
             +      + +    D+WS+G+TL  +A    P
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 20/217 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVK--------TFNQLSHMRPHDVQMREFEVLKKVK-H 67
           +LG+G +  V + ++K   +  AVK        +F+        +  ++E ++L+KV  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            NI++L    E        +V +L   G LF+ L +      L E+E   ++  L   + 
Sbjct: 84  PNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVIC 138
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
            L    +VHRDLKP NI+    DD   I KLTDFG + +L+  ++  S+ GT  YL P++
Sbjct: 139 ALHKLNIVHRDLKPENIL---LDDDMNI-KLTDFGFSCQLDPGEKLRSVCGTPSYLAPEI 194
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            E ++     G  +G  VD+WS GV +Y +  G+ PF
Sbjct: 195 IECSMNDNHPG--YGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/235 (33%), Positives = 117/235 (49%), Gaps = 31/235 (13%)
Query: 17  VLGKGATGAVFQGVNKNNGEPV----AVKTFNQLS-HMRPHDVQMREFEVLKKVKHENIV 71
           VLG+G+ G VF  V K +G       A+K   + +  +R       E ++L +V H  IV
Sbjct: 32  VLGQGSFGKVFL-VKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 72  KL-LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           KL  A + E    GK+ ++++   GG LF  L          EE+    L  L   + HL
Sbjct: 91  KLHYAFQTE----GKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHL 143
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMY 188
               +++RDLKP NI+    D+   I KLTDFG ++E ++ +++  S  GT EY+ P++ 
Sbjct: 144 HSLGIIYRDLKPENIL---LDEEGHI-KLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 199
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
            R       G T   + D WS GV ++ + TG LPF+   G+  KETM  I   K
Sbjct: 200 NRR------GHT--QSADWWSFGVLMFEMLTGTLPFQ---GKDRKETMTMILKAK 243

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/235 (33%), Positives = 117/235 (49%), Gaps = 31/235 (13%)
Query: 17  VLGKGATGAVFQGVNKNNGEPV----AVKTFNQLS-HMRPHDVQMREFEVLKKVKHENIV 71
           VLG+G+ G VF  V K +G       A+K   + +  +R       E ++L +V H  IV
Sbjct: 31  VLGQGSFGKVFL-VKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 72  KL-LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           KL  A + E    GK+ ++++   GG LF  L          EE+    L  L   + HL
Sbjct: 90  KLHYAFQTE----GKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHL 142
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMY 188
               +++RDLKP NI+    D+   I KLTDFG ++E ++ +++  S  GT EY+ P++ 
Sbjct: 143 HSLGIIYRDLKPENIL---LDEEGHI-KLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
            R       G T   + D WS GV ++ + TG LPF+   G+  KETM  I   K
Sbjct: 199 NRR------GHT--QSADWWSFGVLMFEMLTGTLPFQ---GKDRKETMTMILKAK 242

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 16/220 (7%)
Query: 5   RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK 64
           +G  N  +   + +G+G+ G V   V K      A K   +   +   D   +E E++K 
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY-FVEDVDRFKQEIEIMKS 62
Query: 65  VKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           + H NI++L   E  ++     +VMELCTGG LF  +    +    +E +   +++ + +
Sbjct: 63  LDHPNIIRLY--ETFEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLS 117
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
            + +     + HRDLKP N + F+ D   +  KL DFG A   +  +   +  GT  Y+ 
Sbjct: 118 AVAYCHKLNVAHRDLKPENFL-FLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P + E           +G   D WS GV +Y +  G  PF
Sbjct: 177 PQVLE---------GLYGPECDEWSAGVMMYVLLCGYPPF 207

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/235 (33%), Positives = 117/235 (49%), Gaps = 31/235 (13%)
Query: 17  VLGKGATGAVFQGVNKNNGEPV----AVKTFNQLS-HMRPHDVQMREFEVLKKVKHENIV 71
           VLG+G+ G VF  V K +G       A+K   + +  +R       E ++L +V H  IV
Sbjct: 31  VLGQGSFGKVFL-VKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 72  KL-LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           KL  A + E    GK+ ++++   GG LF  L          EE+    L  L   + HL
Sbjct: 90  KLHYAFQTE----GKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHL 142
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMY 188
               +++RDLKP NI+    D+   I KLTDFG ++E ++ +++  S  GT EY+ P++ 
Sbjct: 143 HSLGIIYRDLKPENIL---LDEEGHI-KLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
            R       G T   + D WS GV ++ + TG LPF+   G+  KETM  I   K
Sbjct: 199 NRR------GHT--QSADWWSFGVLMFEMLTGTLPFQ---GKDRKETMTMILKAK 242

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +GKG    V    +   G+ VAVK  ++ + +    +Q   RE  ++K + H NIVKL  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNRL 134
           + E +  +   +VME  +GG +F+ L      +G ++E+E       + + +++     +
Sbjct: 81  VIETE--KTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQIVSAVQYCHQKFI 134
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLK  N++     D     K+ DFG + E     +  +  G+  Y  P++++     
Sbjct: 135 VHRDLKAENLLL----DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQ----- 185
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS+GV LY + +G+LPF
Sbjct: 186 ---GKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 16/220 (7%)
Query: 5   RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK 64
           +G  N  +   + +G+G+ G V   V K      A K   +   +   D   +E E++K 
Sbjct: 21  KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY-FVEDVDRFKQEIEIMKS 79
Query: 65  VKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           + H NI++L   E  ++     +VMELCTGG LF  +    +    +E +   +++ + +
Sbjct: 80  LDHPNIIRLY--ETFEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLS 134
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
            + +     + HRDLKP N + F+ D   +  KL DFG A   +  +   +  GT  Y+ 
Sbjct: 135 AVAYCHKLNVAHRDLKPENFL-FLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 193
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P + E           +G   D WS GV +Y +  G  PF
Sbjct: 194 PQVLE---------GLYGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +GKG    V    +   G+ VAVK  ++ + +    +Q   RE  ++K + H NIVKL  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNRL 134
           + E +  +   +VME  +GG +F+ L      +G ++E+E       + + +++     +
Sbjct: 81  VIETE--KTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQIVSAVQYCHQKFI 134
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLK  N++     D     K+ DFG + E     +  +  G+  Y  P++++     
Sbjct: 135 VHRDLKAENLLL----DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQ----- 185
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS+GV LY + +G+LPF
Sbjct: 186 ---GKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 14/207 (6%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG GA   V     K  G+  AVK   + +          E  VL+K+KHENIV L  I 
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIY 89
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
           E        +VM+L +GG LF+ +   E  +  +++   L+ + L A + +L    +VHR
Sbjct: 90  ESPNHL--YLVMQLVSGGELFDRI--VEKGFYTEKDASTLIRQVLDA-VYYLHRMGIVHR 144
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPV 197
           DLKP N++ +  D+ S I  ++DFG ++   +     +  GT  Y+ P++    + +KP 
Sbjct: 145 DLKPENLLYYSQDEESKIM-ISDFGLSKMEGKGDVMSTACGTPGYVAPEV----LAQKPY 199
Query: 198 GKTFGATVDLWSIGVTLYHVATGNLPF 224
            K     VD WSIGV  Y +  G  PF
Sbjct: 200 SK----AVDCWSIGVIAYILLCGYPPF 222

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +GKG    V    +   G+ VAVK  ++ + +    +Q   RE  ++K + H NIVKL  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNRL 134
           + E +  +   +VME  +GG +F+ L      +G ++E+E       + + +++     +
Sbjct: 74  VIETE--KTLYLVMEYASGGEVFDYL----VAHGWMKEKEARAKFRQIVSAVQYCHQKFI 127
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLK  N++     D     K+ DFG + E     +  +  G+  Y  P++++     
Sbjct: 128 VHRDLKAENLLL----DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQ----- 178
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS+GV LY + +G+LPF
Sbjct: 179 ---GKKYDGPEVDVWSLGVILYTLVSGSLPF 206

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +GKG    V    +   G+ VAVK  ++ + +    +Q   RE  ++K + H NIVKL  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNRL 134
           + E +  +   +VME  +GG +F+ L      +G ++E+E       + + +++     +
Sbjct: 81  VIETE--KTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQIVSAVQYCHQKFI 134
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLK  N++     D     K+ DFG + E     +  +  G   Y  P++++     
Sbjct: 135 VHRDLKAENLLL----DADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQ----- 185
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS+GV LY + +G+LPF
Sbjct: 186 ---GKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 115/248 (46%), Gaps = 33/248 (13%)
Query: 11  VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKT-----FNQLSHMRPHDVQMREFEVLKKV 65
           V+    V+GKGA   V + +N+  G+  AVK      F     +   D++ RE  +   +
Sbjct: 25  VYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHML 83
Query: 66  KHENIVKLLAIEEEQEGRGKV-IVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLT 123
           KH +IV+LL   E     G + +V E   G  L F I+   +  +   E      +  + 
Sbjct: 84  KHPHIVELL---ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEY 182
             +++  DN ++HRD+KP N++     + S   KL DFG A +L E         GT  +
Sbjct: 141 EALRYCHDNNIIHRDVKPENVL-LASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHF 199
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK 242
           + P++    V R+P GK     VD+W  GV L+ + +G LPF  YG    KE ++     
Sbjct: 200 MAPEV----VKREPYGK----PVDVWGCGVILFILLSGCLPF--YG---TKERLF----- 241
Query: 243 KASGVISG 250
              G+I G
Sbjct: 242 --EGIIKG 247

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+GA+G V+  ++   G+ VA++  N L      ++ + E  V+++ K+ NIV  L  +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYL--D 85
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GGSL +++ +      + E +   V       ++ L  N+++HR
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYERAVLRKP 196
           ++K  NI+  +  DGS   KLTDFG   ++  +Q   S + GT  ++ P++  R      
Sbjct: 142 NIKSDNIL--LGMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------ 191
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K +G  VD+WS+G+    +  G  P+
Sbjct: 192 --KAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +GKG    V    +   G+ VAV+  ++ + +    +Q   RE  ++K + H NIVKL  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNRL 134
           + E +  +   +VME  +GG +F+ L      +G ++E+E       + + +++     +
Sbjct: 81  VIETE--KTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQIVSAVQYCHQKFI 134
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLK  N++     D     K+ DFG + E     +  +  G+  Y  P++++     
Sbjct: 135 VHRDLKAENLLL----DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQ----- 185
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS+GV LY + +G+LPF
Sbjct: 186 ---GKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 116/234 (49%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++GV K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLE---HLTAG 125
           LL +    +G+  +++MEL T G L + L     + EN   L       +++    +  G
Sbjct: 86  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L  N+ VHRDL   N M  + +D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 144 MAYLNANKFVHRDLAARNCM--VAEDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 197
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V  T+    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 198 RWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFV 246

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 116/234 (49%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++GV K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLE---HLTAG 125
           LL +    +G+  +++MEL T G L + L     + EN   L       +++    +  G
Sbjct: 84  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 141
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L  N+ VHRDL   N M  + +D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 142 MAYLNANKFVHRDLAARNCM--VAEDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 195
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V  T+    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 196 RWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFV 244

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 116/234 (49%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++GV K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLE---HLTAG 125
           LL +    +G+  +++MEL T G L + L     + EN   L       +++    +  G
Sbjct: 86  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L  N+ VHRDL   N M  + +D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 144 MAYLNANKFVHRDLAARNCM--VAEDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 197
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V  T+    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 198 RWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFV 246

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 116/234 (49%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++GV K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLE---HLTAG 125
           LL +    +G+  +++MEL T G L + L     + EN   L       +++    +  G
Sbjct: 87  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L  N+ VHRDL   N M  + +D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 145 MAYLNANKFVHRDLAARNCM--VAEDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 198
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V  T+    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 199 RWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFV 247

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 116/234 (49%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++GV K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLE---HLTAG 125
           LL +    +G+  +++MEL T G L + L     + EN   L       +++    +  G
Sbjct: 115 LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 172
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L  N+ VHRDL   N M  + +D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 173 MAYLNANKFVHRDLAARNCM--VAEDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 226
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V  T+    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 227 RWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFV 275

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 116/234 (49%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++GV K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLE---HLTAG 125
           LL +    +G+  +++MEL T G L + L     + EN   L       +++    +  G
Sbjct: 93  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 150
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L  N+ VHRDL   N M  + +D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 151 MAYLNANKFVHRDLAARNCM--VAEDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 204
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V  T+    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 205 RWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFV 253

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ---MREFEVLKKVKHENIVKLL 74
           LG G  G V  G ++  G  VAVK  N+   +R  DV     RE + LK  +H +I+KL 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +          +VME  +GG LF+ +        L E+E   + + + +G+ +   + +
Sbjct: 83  QVISTPSD--IFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLKP N++     D     K+ DFG +  + + +      G+  Y  P++       
Sbjct: 138 VHRDLKPENVLL----DAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVIS----- 188
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              G+ + G  VD+WS GV LY +  G LPF
Sbjct: 189 ---GRLYAGPEVDIWSSGVILYALLCGTLPF 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVK--------TFNQLSHMRPHDVQMREFEVLKKVK-H 67
           +LG+G +  V + ++K   +  AVK        +F+        +  ++E ++L+KV  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            NI++L    E        +V +L   G LF+ L +      L E+E   ++  L   + 
Sbjct: 84  PNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVIC 138
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
            L    +VHRDLKP NI+    DD   I KLTDFG + +L+  ++   + GT  YL P++
Sbjct: 139 ALHKLNIVHRDLKPENIL---LDDDMNI-KLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            E ++     G  +G  VD+WS GV +Y +  G+ PF
Sbjct: 195 IECSMNDNHPG--YGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVK--------TFNQLSHMRPHDVQMREFEVLKKVK-H 67
           +LG+G +  V + ++K   +  AVK        +F+        +  ++E ++L+KV  H
Sbjct: 11  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 70
Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            NI++L    E        +V +L   G LF+ L +      L E+E   ++  L   + 
Sbjct: 71  PNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVIC 125
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
            L    +VHRDLKP NI+    DD   I KLTDFG + +L+  ++   + GT  YL P++
Sbjct: 126 ALHKLNIVHRDLKPENIL---LDDDMNI-KLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            E ++     G  +G  VD+WS GV +Y +  G+ PF
Sbjct: 182 IECSMNDNHPG--YGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 116/234 (49%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++GV K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLE---HLTAG 125
           LL +    +G+  +++MEL T G L + L     + EN   L       +++    +  G
Sbjct: 80  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L  N+ VHRDL   N M  + +D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 138 MAYLNANKFVHRDLAARNCM--VAEDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 191
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V  T+    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 192 RWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFV 240

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +GKG    V    +   G+ VAV+  ++ + +    +Q   RE  ++K + H NIVKL  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNRL 134
           + E +  +   +VME  +GG +F+ L      +G ++E+E       + + +++     +
Sbjct: 81  VIETE--KTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQIVSAVQYCHQKFI 134
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLK  N++     D     K+ DFG + E     +     G+  Y  P++++     
Sbjct: 135 VHRDLKAENLLL----DADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQ----- 185
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS+GV LY + +G+LPF
Sbjct: 186 ---GKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G   +   K++G+ +  K  +  S M   + QM   E  +L+++KH NIV+   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMK--HLRDN 132
              ++      IVME C GG L +++          +EEF+L V+  LT  +K  H R +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 133 ---RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMY 188
               ++HRDLKP N+  F+  DG    KL DFG AR L  D  F   + GT  Y+ P+  
Sbjct: 133 GGHTVLHRDLKPANV--FL--DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 188
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
            R         ++    D+WS+G  LY +     PF  +
Sbjct: 189 NRM--------SYNEKSDIWSLGCLLYELCALMPPFTAF 219

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL- 73
           VLG+G  G VF    K  G+  A K  N+    +    Q  M E ++L KV    IV L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 74  LAIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
            A E + +     +VM +  GG + ++I +  E+  G QE   +     + +G++HL   
Sbjct: 252 YAFETKTD---LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERA 191
            +++RDLKP N++  + DDG+   +++D G A EL+  Q     Y GT  ++ P++    
Sbjct: 309 NIIYRDLKPENVL--LDDDGNV--RISDLGLAVELKAGQTKTKGYAGTPGFMAPELL--- 361
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-RNKE 234
                +G+ +  +VD +++GVTLY +     PFR  G +  NKE
Sbjct: 362 -----LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 400

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K  H+NIV+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I+MEL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 98  CIGVSLQSLPR--FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 156 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 215 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 260

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G   +   K++G+ +  K  +  S M   + QM   E  +L+++KH NIV+   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMK--HLRDN 132
              ++      IVME C GG L +++          +EEF+L V+  LT  +K  H R +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 133 ---RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMY 188
               ++HRDLKP N+  F+  DG    KL DFG AR L  D  F   + GT  Y+ P+  
Sbjct: 133 GGHTVLHRDLKPANV--FL--DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
            R         ++    D+WS+G  LY +     PF  +
Sbjct: 189 NRM--------SYNEKSDIWSLGCLLYELCALMPPFTAF 219

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 106/219 (48%), Gaps = 22/219 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G   +   K++G+ +  K  +  S M   + QM   E  +L+++KH NIV+   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMK--HLRDN 132
              ++      IVME C GG L +++          +EEF+L V+  LT  +K  H R +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 133 ---RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMY 188
               ++HRDLKP N+  F+  DG    KL DFG AR L  D+ F   + GT  Y+ P+  
Sbjct: 133 GGHTVLHRDLKPANV--FL--DGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM 188
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
            R         ++    D+WS+G  LY +     PF  +
Sbjct: 189 NRM--------SYNEKSDIWSLGCLLYELCALMPPFTAF 219

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL- 73
           VLG+G  G VF    K  G+  A K  N+    +    Q  M E ++L KV    IV L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 74  LAIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
            A E + +     +VM +  GG + ++I +  E+  G QE   +     + +G++HL   
Sbjct: 252 YAFETKTD---LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERA 191
            +++RDLKP N++  + DDG+   +++D G A EL+  Q     Y GT  ++ P++    
Sbjct: 309 NIIYRDLKPENVL--LDDDGNV--RISDLGLAVELKAGQTKTKGYAGTPGFMAPELL--- 361
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-RNKE 234
                +G+ +  +VD +++GVTLY +     PFR  G +  NKE
Sbjct: 362 -----LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 400

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL- 73
           VLG+G  G VF    K  G+  A K  N+    +    Q  M E ++L KV    IV L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 74  LAIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
            A E + +     +VM +  GG + ++I +  E+  G QE   +     + +G++HL   
Sbjct: 252 YAFETKTD---LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERA 191
            +++RDLKP N++  + DDG+   +++D G A EL+  Q     Y GT  ++ P++    
Sbjct: 309 NIIYRDLKPENVL--LDDDGNV--RISDLGLAVELKAGQTKTKGYAGTPGFMAPELL--- 361
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-RNKE 234
                +G+ +  +VD +++GVTLY +     PFR  G +  NKE
Sbjct: 362 -----LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 400

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL- 73
           VLG+G  G VF    K  G+  A K  N+    +    Q  M E ++L KV    IV L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 74  LAIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
            A E + +     +VM +  GG + ++I +  E+  G QE   +     + +G++HL   
Sbjct: 252 YAFETKTD---LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERA 191
            +++RDLKP N++  + DDG+   +++D G A EL+  Q     Y GT  ++ P++    
Sbjct: 309 NIIYRDLKPENVL--LDDDGNV--RISDLGLAVELKAGQTKTKGYAGTPGFMAPELL--- 361
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-RNKE 234
                +G+ +  +VD +++GVTLY +     PFR  G +  NKE
Sbjct: 362 -----LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 400

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K  H+NIV+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I+MEL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 113 CIGVSLQSLPR--FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 171 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 230 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 275

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 115/234 (49%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++GV K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLE---HLTAG 125
           LL +    +G+  +++MEL T G L + L     + EN   L       +++    +  G
Sbjct: 87  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L  N+ VHRDL   N M  + +D +   K+ DFG  R++ E        G +  L  
Sbjct: 145 MAYLNANKFVHRDLAARNCM--VAEDFTV--KIGDFGMTRDIXETDXXRK--GGKGLLPV 198
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V  T+    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 199 RWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFV 247

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 115/234 (49%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++GV K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLE---HLTAG 125
           LL +    +G+  +++MEL T G L + L     + EN   L       +++    +  G
Sbjct: 78  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L  N+ VHRDL   N M  + +D +   K+ DFG  R++ E        G +  L  
Sbjct: 136 MAYLNANKFVHRDLAARNCM--VAEDFTV--KIGDFGMTRDIXETDXXRK--GGKGLLPV 189
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V  T+    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 190 RWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFV 238

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K+ H+NIV+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I++EL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 99  CIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 157 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 216 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 261

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K  H+NIV+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I++EL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 105 CIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 163 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 222 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 267

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVR 119
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IVME   GG LF+ + D        E E   +++ +   +++L 
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              + HRD+KP N++ +     + I KLTDFG A+E        +   T  Y+ P++   
Sbjct: 179 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG- 236
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   + +  + D+WS+GV +Y +  G  PF
Sbjct: 237 -------PEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K+ H+NIV+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I++EL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 113 CIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 171 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 230 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 275

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL--- 73
           V+G GAT  V         E VA+K  N        D  ++E + + +  H NIV     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILD----DPENTYG-LQEEEFLLVLEHLTAGMKH 128
             +++E       +VM+L +GGS+ +I+       E+  G L E     +L  +  G+++
Sbjct: 82  FVVKDEL-----WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR------ELEEDQQFMSLYGTEEY 182
           L  N  +HRD+K GNI+  + +DGS   ++ DFG +       ++  ++   +  GT  +
Sbjct: 137 LHKNGQIHRDVKAGNIL--LGEDGSV--QIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
           + P++ E+        + +    D+WS G+T   +ATG  P+  Y
Sbjct: 193 MAPEVMEQV-------RGYDFKADIWSFGITAIELATGAAPYHKY 230

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAI 76
           LG+G+     + V+K + +  AVK  ++    R      +E   LK  + H NIVKL  +
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             +Q      +VMEL  GG LF  +   ++     E E   ++  L + + H+ D  +VH
Sbjct: 75  FHDQ--LHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ------FMSLYGTEEYLHPDMYER 190
           RDLKP N++ F  ++ +   K+ DFG AR    D Q      F   Y   E L+ + Y+ 
Sbjct: 130 RDLKPENLL-FTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDE 188
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
                        + DLWS+GV LY + +G +PF+ +
Sbjct: 189 -------------SCDLWSLGVILYTMLSGQVPFQSH 212

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K  H+NIV+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I++EL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 125 CIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 183 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 242 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 287

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVR 75
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IVME   GG LF+ + D        E E   +++ +   +++L 
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              + HRD+KP N++ +     + I KLTDFG A+E        +   T  Y+ P++   
Sbjct: 135 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG- 192
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   + +  + D+WS+GV +Y +  G  PF
Sbjct: 193 -------PEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K  H+NIV+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I++EL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 115 CIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 173 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 232 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 277

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 21  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVR 74
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IVME   GG LF+ + D        E E   +++ +   +++L 
Sbjct: 75  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH 133
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              + HRD+KP N++ +     + I KLTDFG A+E        +   T  Y+ P++   
Sbjct: 134 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG- 191
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   + +  + D+WS+GV +Y +  G  PF
Sbjct: 192 -------PEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K  H+NIV+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I++EL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 99  CIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 157 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 216 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 261

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 72  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVR 125
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IVME   GG LF+ + D        E E   +++ +   +++L 
Sbjct: 126 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH 184
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              + HRD+KP N++ +     + I KLTDFG A+E        +   T  Y+ P++   
Sbjct: 185 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG- 242
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   + +  + D+WS+GV +Y +  G  PF
Sbjct: 243 -------PEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVR 75
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IVME   GG LF+ + D        E E   +++ +   +++L 
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              + HRD+KP N++ +     + I KLTDFG A+E        +   T  Y+ P++   
Sbjct: 135 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG- 192
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   + +  + D+WS+GV +Y +  G  PF
Sbjct: 193 -------PEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 20  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVR 73
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IVME   GG LF+ + D        E E   +++ +   +++L 
Sbjct: 74  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              + HRD+KP N++ +     + I KLTDFG A+E        +   T  Y+ P++   
Sbjct: 133 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG- 190
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   + +  + D+WS+GV +Y +  G  PF
Sbjct: 191 -------PEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K  H+NIV+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I++EL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 90  CIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 148 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 207 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 252

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 27  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVR 80
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IVME   GG LF+ + D        E E   +++ +   +++L 
Sbjct: 81  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH 139
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              + HRD+KP N++ +     + I KLTDFG A+E        +   T  Y+ P++   
Sbjct: 140 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG- 197
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   + +  + D+WS+GV +Y +  G  PF
Sbjct: 198 -------PEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 20  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVR 73
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IVME   GG LF+ + D        E E   +++ +   +++L 
Sbjct: 74  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-----DQQFMSLYGTEEYLHP 185
              + HRD+KP N++ +     + I KLTDFG A+E        +  +   Y   E L P
Sbjct: 133 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGP 191
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + Y++             + D+WS+GV +Y +  G  PF
Sbjct: 192 EKYDK-------------SCDMWSLGVIMYILLCGYPPF 217

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL--- 73
           V+G GAT  V         E VA+K  N        D  ++E + + +  H NIV     
Sbjct: 17  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 76
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILD----DPENTYG-LQEEEFLLVLEHLTAGMKH 128
             +++E       +VM+L +GGS+ +I+       E+  G L E     +L  +  G+++
Sbjct: 77  FVVKDEL-----WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR------ELEEDQQFMSLYGTEEY 182
           L  N  +HRD+K GNI+  + +DGS   ++ DFG +       ++  ++   +  GT  +
Sbjct: 132 LHKNGQIHRDVKAGNIL--LGEDGSV--QIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
           + P++ E+        + +    D+WS G+T   +ATG  P+  Y
Sbjct: 188 MAPEVMEQV-------RGYDFKADIWSFGITAIELATGAAPYHKY 225

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 28  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVR 81
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IVME   GG LF+ + D        E E   +++ +   +++L 
Sbjct: 82  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH 140
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              + HRD+KP N++ +     + I KLTDFG A+E        +   T  Y+ P++   
Sbjct: 141 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG- 198
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   + +  + D+WS+GV +Y +  G  PF
Sbjct: 199 -------PEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 26  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVR 79
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IVME   GG LF+ + D        E E   +++ +   +++L 
Sbjct: 80  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH 138
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              + HRD+KP N++ +     + I KLTDFG A+E        +   T  Y+ P++   
Sbjct: 139 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG- 196
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   + +  + D+WS+GV +Y +  G  PF
Sbjct: 197 -------PEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K  H+NIV+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I++EL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 98  CIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 156 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 215 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 260

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           V+G+GA G V +   K   + VA+K     S  +   V++R+   L +V H NIVKL   
Sbjct: 15  VVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAFIVELRQ---LSRVNHPNIVKLYGA 69
Query: 77  EEEQEGRGKVIVMELCTGGSLFNIL--DDPENTY-GLQEEEFLLVLEHLTAGMKHLRDNR 133
                     +VME   GGSL+N+L   +P   Y       + L      A +  ++   
Sbjct: 70  CLNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           L+HRDLKP N++      G T+ K+ DFG A +++      +  G+  ++ P+++E    
Sbjct: 126 LIHRDLKPPNLLLVA---GGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFE---- 176
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               G  +    D++S G+ L+ V T   PF   GG
Sbjct: 177 ----GSNYSEKCDVFSWGIILWEVITRRKPFDEIGG 208

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           V+G+GA G V +   K   + VA+K     S  +   V++R+   L +V H NIVKL   
Sbjct: 16  VVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAFIVELRQ---LSRVNHPNIVKLYGA 70
Query: 77  EEEQEGRGKVIVMELCTGGSLFNIL--DDPENTY-GLQEEEFLLVLEHLTAGMKHLRDNR 133
                     +VME   GGSL+N+L   +P   Y       + L      A +  ++   
Sbjct: 71  CLNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           L+HRDLKP N++      G T+ K+ DFG A +++      +  G+  ++ P+++E    
Sbjct: 127 LIHRDLKPPNLLLVA---GGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFE---- 177
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               G  +    D++S G+ L+ V T   PF   GG
Sbjct: 178 ----GSNYSEKCDVFSWGIILWEVITRRKPFDEIGG 209

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 115/240 (47%), Gaps = 37/240 (15%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++GV K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFN-------------ILDDPENTYGLQEEEFLLVL 119
           LL +    +G+  +++MEL T G L +             +L  P  +  +Q      + 
Sbjct: 83  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ------MA 134
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             +  GM +L  N+ VHRDL   N M  + +D +   K+ DFG  R++ E   +    G 
Sbjct: 135 GEIADGMAYLNANKFVHRDLAARNCM--VAEDFTV--KIGDFGMTRDIYETDYYRK--GG 188
Query: 180 EEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           +  L         L+  V  T+    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 189 KGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFV 243

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K  H+NIV+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I++EL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 116 CIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 174 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 233 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 278

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K  H+NIV+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I++EL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 139 CIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 197 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 256 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 301

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++GV K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLE---HLTAG 125
           LL +    +G+  +++MEL T G L + L     + EN   L       +++    +  G
Sbjct: 80  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L  N+ VHRDL   N    + +D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 138 MAYLNANKFVHRDLAARNCX--VAEDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 191
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V  T+    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 192 RWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFV 240

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 17  VLGKGATGAVFQG---VNKNNGEPVAVKTFNQLSHMR-PHDVQMREFE--VLKKVKHENI 70
           VLGKG  G VFQ       N G+  A+K   +   +R   D    + E  +L++VKH  I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           V L  I   Q G    +++E  +GG LF  L   E      E+     L  ++  + HL 
Sbjct: 84  VDL--IYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALGHLH 138
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYE 189
              +++RDLKP NIM  +   G    KLTDFG  +E   D      + GT EY+ P++  
Sbjct: 139 QKGIIYRDLKPENIM--LNHQGHV--KLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           R+   +         VD WS+G  +Y + TG  PF
Sbjct: 195 RSGHNR--------AVDWWSLGALMYDMLTGAPPF 221

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 17  VLGKGATGAVFQG---VNKNNGEPVAVKTFNQLSHMR-PHDVQMREFE--VLKKVKHENI 70
           VLGKG  G VFQ       N G+  A+K   +   +R   D    + E  +L++VKH  I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           V L  I   Q G    +++E  +GG LF  L   E      E+     L  ++  + HL 
Sbjct: 84  VDL--IYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALGHLH 138
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYE 189
              +++RDLKP NIM  +   G    KLTDFG  +E   D      + GT EY+ P++  
Sbjct: 139 QKGIIYRDLKPENIM--LNHQGHV--KLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           R+   +         VD WS+G  +Y + TG  PF
Sbjct: 195 RSGHNR--------AVDWWSLGALMYDMLTGAPPF 221

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 115/240 (47%), Gaps = 37/240 (15%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++GV K     EP   VA+KT N+ + MR     + E  V+K+    ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFN-------------ILDDPENTYGLQEEEFLLVL 119
           LL +    +G+  +++MEL T G L +             +L  P  +  +Q      + 
Sbjct: 93  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ------MA 144
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             +  GM +L  N+ VHRDL   N M  + +D +   K+ DFG  R++ E   +    G 
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCM--VAEDFTV--KIGDFGMTRDIYETDYYRK--GG 198
Query: 180 EEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           +  L         L+  V  T+    D+WS GV L+ +AT  L  +PY G  N++ + ++
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT--LAEQPYQGLSNEQVLRFV 253

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 29/219 (13%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 36  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVR 89
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IVME   GG LF+ + D        E E   +++ +   +++L 
Sbjct: 90  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH 148
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ-----FMSLYGTEEYLHP 185
              + HRD+KP N++ +     + I KLTDFG A+E           +   Y   E L P
Sbjct: 149 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 207
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + Y++             + D+WS+GV +Y +  G  PF
Sbjct: 208 EKYDK-------------SCDMWSLGVIMYILLCGYPPF 233

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K  H+NIV+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I++EL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 113 CIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG AR++     +          +++ P
Sbjct: 171 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 230 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 275

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 32  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              + +     IV + C G SL++ L   E  + +++   + +      GM +L    ++
Sbjct: 88  YSTKPQ---LAIVTQWCEGSSLYHHLHASETKFEMKK--LIDIARQTARGMDYLHAKSII 142
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARE---LEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A E        QF  L G+  ++ P+     V
Sbjct: 143 HRDLKSNNI--FLHEDNTV--KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-----V 193
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 104/234 (44%), Gaps = 41/234 (17%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-------------------------PH 52
           +GKG+ G V    N+N+    A+K  ++   +R                         P 
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 53  DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
           +   +E  +LKK+ H N+VKL+ + ++       +V EL   G +  +         L E
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----PTLKPLSE 136
Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
           ++     + L  G+++L   +++HRD+KP N++  + +DG    K+ DFG + E +    
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL--VGEDGHI--KIADFGVSNEFKGSDA 192
Query: 173 FMS-LYGTEEYLHPDMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
            +S   GT  ++ P+            K F G  +D+W++GVTLY    G  PF
Sbjct: 193 LLSNTVGTPAFMAPESLSET------RKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 109/236 (46%), Gaps = 25/236 (10%)
Query: 18  LGKGATGAVFQG-VNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG GA G V++G V+    +P    VAVKT  ++   +     + E  ++ K  H+NIV+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
            + +  +   R   I++EL  GG L + L +    P     L   + L V   +  G ++
Sbjct: 99  CIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHP 185
           L +N  +HRD+   N +   C     + K+ DFG A+++     +          +++ P
Sbjct: 157 LEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + +   +        F +  D WS GV L+ + +  L + PY  + N+E + ++T+
Sbjct: 216 EAFMEGI--------FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLEFVTS 261

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 32  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     IV + C G SL++ L   E  + +++   + +      GM +L    ++
Sbjct: 88  YSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKK--LIDIARQTARGMDYLHAKSII 142
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARE---LEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A E        QF  L G+  ++ P+     V
Sbjct: 143 HRDLKSNNI--FLHEDNTV--KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-----V 193
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVL--KKVKHENIVKLLA 75
           LGKG     F+  + +  E  A K   +   ++PH  +    E+   + + H+++V    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E+ +     +V+ELC   SL  +    +    L E E    L  +  G ++L  NR++
Sbjct: 85  FFEDNDF--VFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLR 194
           HRDLK GN+  F+ +D     K+ DFG A ++E D ++  +L GT  Y+ P++  +    
Sbjct: 140 HRDLKLGNL--FLNEDLEV--KIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK--- 192
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              G +F   VD+WSIG  +Y +  G  PF
Sbjct: 193 ---GHSF--EVDVWSIGCIMYTLLVGKPPF 217

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVL--KKVKHENIVKLLA 75
           LGKG     F+  + +  E  A K   +   ++PH  +    E+   + + H+++V    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E+ +     +V+ELC   SL  +    +    L E E    L  +  G ++L  NR++
Sbjct: 89  FFEDNDF--VFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNRVI 143
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLR 194
           HRDLK GN+  F+ +D     K+ DFG A ++E D ++  +L GT  Y+ P++  +    
Sbjct: 144 HRDLKLGNL--FLNEDLEV--KIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK--- 196
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              G +F   VD+WSIG  +Y +  G  PF
Sbjct: 197 ---GHSF--EVDVWSIGCIMYTLLVGKPPF 221

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +GKG    V    +   G+ VAVK  ++ + +    +Q   RE  + K + H NIVKL  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNRL 134
           + E +  +   +V E  +GG +F+ L      +G  +E+E       + + +++     +
Sbjct: 81  VIETE--KTLYLVXEYASGGEVFDYL----VAHGRXKEKEARAKFRQIVSAVQYCHQKFI 134
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLK  N++     D     K+ DFG + E     +  +  G   Y  P++++     
Sbjct: 135 VHRDLKAENLLL----DADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQ----- 185
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS+GV LY + +G+LPF
Sbjct: 186 ---GKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVL--KKVKHENIVKLLA 75
           LGKG     F+  + +  E  A K   +   ++PH  +    E+   + + H+++V    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E+ +     +V+ELC   SL  +    +    L E E    L  +  G ++L  NR++
Sbjct: 85  FFEDNDF--VFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLR 194
           HRDLK GN+  F+ +D     K+ DFG A ++E D ++  +L GT  Y+ P++  +    
Sbjct: 140 HRDLKLGNL--FLNEDLEV--KIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK--- 192
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              G +F   VD+WSIG  +Y +  G  PF
Sbjct: 193 ---GHSF--EVDVWSIGCIMYTLLVGKPPF 217

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 192 LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 249 SEEP---IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 305 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 357 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 391

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 192 LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 249 SEEP---IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 305 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 357 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 391

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 24/210 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG+G+ G+V++ ++K  G+ VA+K     S     D+Q  ++E  ++++    ++VK   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     IVME C  GS+ +I+     T  L E+E   +L+    G+++L   R +
Sbjct: 92  --SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLR 194
           HRD+K GNI+  +  +G    KL DFG A +L +   +   + GT  ++ P++ +     
Sbjct: 148 HRDIKAGNIL--LNTEGHA--KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQE---- 199
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             +G  +    D+WS+G+T   +A G  P+
Sbjct: 200 --IG--YNCVADIWSLGITAIEMAEGKPPY 225

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 20  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              + +     IV + C G SL++ L   E  + +++   + +      GM +L    ++
Sbjct: 76  YSTKPQ---LAIVTQWCEGSSLYHHLHASETKFEMKK--LIDIARQTARGMDYLHAKSII 130
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A          QF  L G+  ++ P+     V
Sbjct: 131 HRDLKSNNI--FLHEDNTV--KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-----V 181
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 182 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 192 LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 249 SEEP---IYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 305 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 357 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 391

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVL--KKVKHENIVKLLA 75
           LGKG     F+  + +  E  A K   +   ++PH  +    E+   + + H+++V    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E+ +     +V+ELC   SL  +    +    L E E    L  +  G ++L  NR++
Sbjct: 107 FFEDNDF--VFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNRVI 161
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLR 194
           HRDLK GN+  F+ +D     K+ DFG A ++E D ++   L GT  Y+ P++  +    
Sbjct: 162 HRDLKLGNL--FLNEDLEV--KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK--- 214
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              G +F   VD+WSIG  +Y +  G  PF
Sbjct: 215 ---GHSF--EVDVWSIGCIMYTLLVGKPPF 239

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVL--KKVKHENIVKLLA 75
           LGKG     F+  + +  E  A K   +   ++PH  +    E+   + + H+++V    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNI------LDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
             E+ +     +V+ELC   SL  +      L +PE  Y L++         +  G ++L
Sbjct: 83  FFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ---------IVLGCQYL 131
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMY 188
             NR++HRDLK GN+  F+ +D     K+ DFG A ++E D ++   L GT  Y+ P++ 
Sbjct: 132 HRNRVIHRDLKLGNL--FLNEDLEV--KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL 187
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +       G +F   VD+WSIG  +Y +  G  PF
Sbjct: 188 SKK------GHSF--EVDVWSIGCIMYTLLVGKPPF 215

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ---MREFEVLKKVKHE 68
           +     LG G  G V  G ++  G  VAVK  N+   +R  DV     RE + LK  +H 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMK 127
           +I+KL  +          +VME  +GG LF+ +      +G ++E E   + + + + + 
Sbjct: 72  HIIKLYQVISTPTDF--FMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVD 125
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           +   + +VHRDLKP N++     D     K+ DFG +  + + +   +  G+  Y  P++
Sbjct: 126 YCHRHMVVHRDLKPENVLL----DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181
Query: 188 YERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
                     G+ + G  VD+WS GV LY +  G LPF
Sbjct: 182 IS--------GRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVL--KKVKHENIVKLLA 75
           LGKG     F+  + +  E  A K   +   ++PH  +    E+   + + H+++V    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E+ +     +V+ELC   SL  +    +    L E E    L  +  G ++L  NR++
Sbjct: 109 FFEDNDF--VFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNRVI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLR 194
           HRDLK GN+  F+ +D     K+ DFG A ++E D ++   L GT  Y+ P++  +    
Sbjct: 164 HRDLKLGNL--FLNEDLEV--KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK--- 216
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              G +F   VD+WSIG  +Y +  G  PF
Sbjct: 217 ---GHSF--EVDVWSIGCIMYTLLVGKPPF 241

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LG+G  G V    +   N   GE VAVK   +    +      RE E+L+ + HE+IVK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
               E+Q  +   +VME    GSL + L  P +  GL   + LL  + +  GM +L    
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLA--QLLLFAQQICEGMAYLHAQH 132
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            +HR L   N++     D   + K+ DFG A+ + E  ++  +   E+   P  +     
Sbjct: 133 YIHRALAARNVLL----DNDRLVKIGDFGLAKAVPEGHEYYRV--REDGDSPVFWYAPEC 186
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVAT 219
            K     F    D+WS GVTLY + T
Sbjct: 187 LKEC--KFYYASDVWSFGVTLYELLT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT  +   M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 275 LGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 332 SEEP---IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 387
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 388 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 440 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 474

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G    N + VA+KT      M P    + E +++KK+KH+ +V+L A+ 
Sbjct: 17  LGNGQFGEVWMGTWNGNTK-VAIKTLKP-GTMSPESF-LEEAQIMKKLKHDKLVQLYAVV 73
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E    GSL + L D E    L+    + +   + AGM ++     +HR
Sbjct: 74  SEEP---IYIVTEYMNKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPV 197
           DL+  NI+         I K+ DFG AR L ED +  +  G +  +     E A+  +  
Sbjct: 130 DLRSANILV----GNGLICKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGR-- 182
Query: 198 GKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
              F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 183 ---FTIKSDVWSFGILLTELVTKGRV---PYPGMNNREVL 216

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LG+G  G V    +   N   GE VAVK   +    +      RE E+L+ + HE+IVK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
               E+Q  +   +VME    GSL + L  P +  GL   + LL  + +  GM +L    
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLA--QLLLFAQQICEGMAYLHAQH 131
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            +HR L   N++     D   + K+ DFG A+ + E  ++  +   E+   P  +     
Sbjct: 132 YIHRALAARNVLL----DNDRLVKIGDFGLAKAVPEGHEYYRV--REDGDSPVFWYAPEC 185
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVAT 219
            K     F    D+WS GVTLY + T
Sbjct: 186 LKEC--KFYYASDVWSFGVTLYELLT 209

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 26  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV+E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 83  SEEP---IYIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 139 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 191 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 225

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 26  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKIRHEKLVQLYAVV 82
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 83  SEEP---IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 139 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 191 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 225

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 26  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IVME  + G L + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 83  SEEP---IYIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 139 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 191 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 225

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT     +M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 193 LGQGCFGEVWMGT-WNGTTRVAIKTLKP-GNMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 249
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 250 SEEP---IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 305
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG  R L ED ++ +  G +  +     E A+  
Sbjct: 306 DLRAANILVGENLVC-------KVADFGLGR-LIEDNEYTARQGAKFPIKWTAPEAALYG 357
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 358 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 392

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ---MREFEVLKKVKHE 68
           +     LG G  G V  G ++  G  VAVK  N+   +R  DV     RE + LK  +H 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMK 127
           +I+KL  +          +VME  +GG LF+ +      +G ++E E   + + + + + 
Sbjct: 72  HIIKLYQVISTPTDF--FMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVD 125
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           +   + +VHRDLKP N++     D     K+ DFG +  + + +      G+  Y  P++
Sbjct: 126 YCHRHMVVHRDLKPENVLL----DAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEV 181
Query: 188 YERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
                     G+ + G  VD+WS GV LY +  G LPF
Sbjct: 182 IS--------GRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 19  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 75
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 76  SEEP---IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 131
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 132 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 183
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 184 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 218

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 17  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 73
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 74  SEEP---IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 129
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 130 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 181
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 182 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 216

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 15  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 71
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 72  SEEP---IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 127
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 128 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 179
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 180 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 214

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+TG V     K++G  VAVK  +     R  ++   E  +++  +H N+V++   +
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHFNVVEMY--K 109
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    ++ME   GG+L +I+    +   L EE+   V E +   + +L    ++HR
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  +I+  +  DG    KL+DFG   ++ +D  +   L GT  ++ P++  R++    
Sbjct: 166 DIKSDSIL--LTLDGRV--KLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSL---- 217
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +   VD+WS+G+ +  +  G  P+
Sbjct: 218 ----YATEVDIWSLGIMVIEMVDGEPPY 241

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 26  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 83  SEEP---IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 139 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 191 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 225

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 26  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 83  SEEP---IYIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 139 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 191 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 225

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRP----------HDVQMREFEVLKKV 65
           LG GA G V     KN     A+K    +Q    R           H+    E  +LK +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
            H NI+KL  + E++  +   +V E   GG LF   +   N +   E +   +++ + +G
Sbjct: 104 DHPNIIKLFDVFEDK--KYFYLVTEFYEGGELF---EQIINRHKFDECDAANIMKQILSG 158
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTI-YKLTDFGAARELEEDQQFMSLYGTEEYLH 184
           + +L  + +VHRD+KP NI+  + +  S +  K+ DFG +    +D +     GT  Y+ 
Sbjct: 159 ICYLHKHNIVHRDIKPENIL--LENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
           P+     VL+K     +    D+WS GV +Y +  G   + P+GG+ +++ +
Sbjct: 217 PE-----VLKKK----YNEKCDVWSCGVIMYILLCG---YPPFGGQNDQDII 256

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 123/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
             A+        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNAM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 124/290 (42%), Gaps = 30/290 (10%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHEN 69
           T S +G GA G+V    +  +G  +AVK     F  + H +      RE  +LK +KHEN
Sbjct: 55  TLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHEN 111
Query: 70  IVKLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM 126
           ++ LL +       E    V ++    G  L NI+        L ++    ++  +  G+
Sbjct: 112 VIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGL 167
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
           K++    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P+
Sbjct: 168 KYIHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPE 221
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG 246
           +    +        +  TVD+WS+G  +  + TG   F         + +  +T    + 
Sbjct: 222 IMLNWM-------HYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPAS 274
Query: 247 VISGTQTSE-NGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           VIS   + E    I+    +P  N   + +G   L   +L  +L +D+ K
Sbjct: 275 VISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDK 324

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 112/248 (45%), Gaps = 33/248 (13%)
Query: 11  VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKT-----FNQLSHMRPHDVQMREFEVLKKV 65
           V+    V+GKG    V + +N+  G+  AVK      F     +   D++ RE  +   +
Sbjct: 27  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHML 85
Query: 66  KHENIVKLLAIEEEQEGRGKV-IVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLT 123
           KH +IV+LL   E     G + +V E   G  L F I+   +  +   E      +  + 
Sbjct: 86  KHPHIVELL---ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEY 182
             +++  DN ++HRD+KP  ++     + S   KL  FG A +L E         GT  +
Sbjct: 143 EALRYCHDNNIIHRDVKPHCVL-LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 201
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK 242
           + P++    V R+P GK     VD+W  GV L+ + +G LPF  YG    KE ++     
Sbjct: 202 MAPEV----VKREPYGKP----VDVWGCGVILFILLSGCLPF--YG---TKERLF----- 243
Query: 243 KASGVISG 250
              G+I G
Sbjct: 244 --EGIIKG 249

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 112/248 (45%), Gaps = 33/248 (13%)
Query: 11  VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKT-----FNQLSHMRPHDVQMREFEVLKKV 65
           V+    V+GKG    V + +N+  G+  AVK      F     +   D++ RE  +   +
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHML 83
Query: 66  KHENIVKLLAIEEEQEGRGKV-IVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLT 123
           KH +IV+LL   E     G + +V E   G  L F I+   +  +   E      +  + 
Sbjct: 84  KHPHIVELL---ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEY 182
             +++  DN ++HRD+KP  ++     + S   KL  FG A +L E         GT  +
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVL-LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK 242
           + P++    V R+P GK     VD+W  GV L+ + +G LPF  YG    KE ++     
Sbjct: 200 MAPEV----VKREPYGKP----VDVWGCGVILFILLSGCLPF--YG---TKERLF----- 241
Query: 243 KASGVISG 250
              G+I G
Sbjct: 242 --EGIIKG 247

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 36  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              + +     IV + C G SL++ L   E  + + +   + +      GM +L    ++
Sbjct: 92  YSTKPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIK--LIDIARQTAQGMDYLHAKSII 146
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARE---LEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A E        QF  L G+  ++ P+     V
Sbjct: 147 HRDLKSNNI--FLHEDLTV--KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-----V 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 198 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 23  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E    GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 80  SEEP---IYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVERMNYVHR 135
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 136 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 187
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 188 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 222

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 16  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              + +     IV + C G SL++ L   E  +  +  + + +      GM +L    ++
Sbjct: 72  YSTKPQ---LAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHAKSII 126
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARE---LEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A E        QF  L G+  ++ P+     V
Sbjct: 127 HRDLKSNNI--FLHEDLTV--KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-----V 177
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 48/230 (20%)
Query: 17  VLGKGATGAVFQGV---NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+GKG  G V+ G       N    A+K+ ++++ M+  +  +RE  +++ + H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN--------TYGLQEEEFLLVLEHLTAG 125
           + I    EG   V++  +C  G L   +  P+         ++GLQ          +  G
Sbjct: 88  IGIMLPPEGLPHVLLPYMCH-GDLLQFIRSPQRNPTVKDLISFGLQ----------VARG 136
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M++L + + VHRDL   N M     D S   K+ DFG AR++  D+++   Y  +++ H 
Sbjct: 137 MEYLAEQKFVHRDLAARNCML----DESFTVKVADFGLARDI-LDREY---YSVQQHRH- 187
Query: 186 DMYERAVLRKPVGKT---------FGATVDLWSIGVTLYHVAT-GNLPFR 225
                   R PV  T         F    D+WS GV L+ + T G  P+R
Sbjct: 188 -------ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR 230

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 44  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              + +     IV + C G SL++ L   E  + + +   + +      GM +L    ++
Sbjct: 100 YSTKPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIK--LIDIARQTAQGMDYLHAKSII 154
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARE---LEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A E        QF  L G+  ++ P+     V
Sbjct: 155 HRDLKSNNI--FLHEDLTV--KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-----V 205
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 206 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 26  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 83  SEEP---IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL   NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 139 DLAAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 191 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 225

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMAGFVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P    ++E +V+KK++HE +V+L A+ 
Sbjct: 23  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSPEAF-LQEAQVMKKLRHEKLVQLYAVV 79
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E    GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 80  SEEP---IYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVERMNYVHR 135
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 136 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEWTARQGAKFPIKWTAPEAALYG 187
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 188 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 222

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKAR------REVELHWRASQCPHIVR 119
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IV E   GG LF+ + D        E E   + + +   +++L 
Sbjct: 120 IVDVYENLYAGRKCLLIVXECLDGGELFSRIQD-RGDQAFTEREASEIXKSIGEAIQYLH 178
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              + HRD+KP N++ +     + I KLTDFG A+E        +   T  Y+ P++   
Sbjct: 179 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG- 236
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   + +  + D WS+GV  Y +  G  PF
Sbjct: 237 -------PEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 26  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV+E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 83  SEEP---IYIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED +  +  G +  +     E A+  
Sbjct: 139 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYG 190
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 191 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 225

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 16  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 72
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 73  SEEP---IXIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 128
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED +  +  G +  +     E A+  
Sbjct: 129 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYG 180
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 181 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 215

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 50/232 (21%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM------REFEVLKKV 65
           + + + +G GA G+V   ++K +GE VA+K  +     RP   ++      RE  +LK +
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-----RPFQSEIFAKRAYRELLLLKHM 80
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILD----------DPENTYGLQ--EE 113
           +HEN++ LL +                   SL N  D          D +   GL+  EE
Sbjct: 81  QHENVIGLLDV--------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE 126
Query: 114 EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF 173
           +   ++  +  G+K++    +VHRDLKPGN+   + +D     K+ DFG AR    D + 
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA--VNEDCEL--KILDFGLAR--HADAEM 180
Query: 174 MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                T  Y  P++    +        +  TVD+WS+G  +  + TG   F+
Sbjct: 181 TGYVVTRWYRAPEVILSWM-------HYNQTVDIWSVGCIMAEMLTGKTLFK 225

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +GKG+ G VF+G++    + VA+K  +        +   +E  VL +     + K     
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG-- 88
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
              +G    I+ME   GGS  ++L          E +   +L+ +  G+ +L   + +HR
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHSEKKIHR 144
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  N++  + + G    KL DFG A +L + Q +  +  GT  ++ P++ +++     
Sbjct: 145 DIKAANVL--LSEQGDV--KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS----- 195
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLP 223
               + +  D+WS+G+T   +A G  P
Sbjct: 196 ---AYDSKADIWSLGITAIELAKGEPP 219

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G  G V+ G   N    VA+KT      M P +  ++E +V+KK++HE +V+L A+ 
Sbjct: 26  LGQGCFGEVWMG-TWNGTTRVAIKTLKP-GTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E+      IV E  + G L + L      Y L+  + + +   + +GM ++     VHR
Sbjct: 83  SEEP---IYIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 138 DLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           DL+  NI+     +C       K+ DFG AR L ED ++ +  G +  +     E A+  
Sbjct: 139 DLRAANILVGENLVC-------KVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
           +     F    D+WS G+ L  + T G +   PY G  N+E +
Sbjct: 191 R-----FTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 225

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 27/232 (11%)
Query: 1   MSFLRGSTNY--------VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH 52
           M+ LRG  N         ++     +GKG+ G V++G++ +  E VA+K  +        
Sbjct: 2   MAHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEI 61
Query: 53  DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
           +   +E  VL +     I +        +     I+ME   GGS  ++L        L+E
Sbjct: 62  EDIQQEITVLSQCDSPYITRYFG--SYLKSTKLWIIMEYLGGGSALDLL----KPGPLEE 115
Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
                +L  +  G+ +L   R +HRD+K  N++  + + G    KL DFG A +L + Q 
Sbjct: 116 TYIATILREILKGLDYLHSERKIHRDIKAANVL--LSEQGDV--KLADFGVAGQLTDTQI 171
Query: 173 FMSLY-GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
             + + GT  ++ P++ +++         +    D+WS+G+T   +A G  P
Sbjct: 172 KRNXFVGTPFWMAPEVIKQSA--------YDFKADIWSLGITAIELAKGEPP 215

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 20/224 (8%)
Query: 15  TSVLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI 70
             VLG GA G V++G+    GE    PVA+K  N+ +  + +   M E  ++  + H ++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           V+LL +      +   +V +L   G L   + + ++  G Q    L     +  GM +L 
Sbjct: 80  VRLLGVCLSPTIQ---LVTQLMPHGCLLEYVHEHKDNIGSQL--LLNWCVQIAKGMMYLE 134
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
           + RLVHRDL   N++           K+TDFG AR LE D++  +  G +  +     E 
Sbjct: 135 ERRLVHRDLAARNVLV----KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
              RK     F    D+WS GVT++ + T     +PY G   +E
Sbjct: 191 IHYRK-----FTHQSDVWSYGVTIWELMT--FGGKPYDGIPTRE 227

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 18  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              + +     IV + C G SL++ L   E  +  +  + + +      GM +L    ++
Sbjct: 74  YSTKPQ---LAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHAKSII 128
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A          QF  L G+  ++ P+     V
Sbjct: 129 HRDLKSNNI--FLHEDLTV--KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-----V 179
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 180 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  + + G  VA+K               +RE  +LK++ H NIV L+ +
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +  R   +V E      L  +LD  EN  GLQ+ +  + L  L  G+ H   +R++H
Sbjct: 88  IHSE--RCLTLVFEFMEK-DLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  DG+   KL DFG AR      + +     T  Y  PD+   +    
Sbjct: 143 RDLKPQNLL--INSDGAL--KLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS---- 194
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
              K +  +VD+WSIG     + TG  P  P
Sbjct: 195 ---KKYSTSVDIWSIGCIFAEMITGK-PLFP 221

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  + + G  VA+K               +RE  +LK++ H NIV L+ +
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +  R   +V E      L  +LD  EN  GLQ+ +  + L  L  G+ H   +R++H
Sbjct: 88  IHSE--RCLTLVFEFMEK-DLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  DG+   KL DFG AR      + +     T  Y  PD+   +    
Sbjct: 143 RDLKPQNLL--INSDGAL--KLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS---- 194
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
              K +  +VD+WSIG     + TG  P  P
Sbjct: 195 ---KKYSTSVDIWSIGCIFAEMITGK-PLFP 221

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G+     + ++K      AVK  ++       ++++    +L+  +H NI+ L  + 
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI----LLRYGQHPNIITLKDVY 85
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
           ++  G+   +V EL  GG L   LD         E E   VL  +T  +++L    +VHR
Sbjct: 86  DD--GKYVYVVTELMKGGEL---LDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHR 140
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DLKP NI+           ++ DFG A++L  E+   M+   T  ++ P++ ER      
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER------ 194
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             + + A  D+WS+GV LY + TG  PF
Sbjct: 195 --QGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 90
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 146
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 147 IHSADIIHRDLKPSNLA--VNEDSEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 200
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 201 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 252
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 253 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 301

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 21  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              + +     IV + C G SL++ L   E  +  +  + + +      GM +L    ++
Sbjct: 77  YSTKPQ---LAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHAKSII 131
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A          QF  L G+  ++ P+     V
Sbjct: 132 HRDLKSNNI--FLHEDLTV--KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-----V 182
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 183 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 33  SPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 89
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 145
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 146 IHSADIIHRDLKPSNLA--VNEDXEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 199
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 200 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 251
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 252 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 300

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 90
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 146
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 147 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 200
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 201 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 252
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 253 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 301

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 16  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              + +     IV + C G SL++ L   E  +  +  + + +      GM +L    ++
Sbjct: 72  YSTKPQ---LAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHAKSII 126
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A          QF  L G+  ++ P+     V
Sbjct: 127 HRDLKSNNI--FLHEDLTV--KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-----V 177
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G    V++     +G PVA+K       M  +     ++E ++LK++ H N++K  A
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 76  --IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRDN 132
             IE+ +      IV+EL   G L  ++   +    L  E  +      L + ++H+   
Sbjct: 100 SFIEDNELN----IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYERA 191
           R++HRD+KP N+  FI   G  + KL D G  R          SL GT  Y+ P+     
Sbjct: 156 RVMHRDIKPANV--FITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
                 G  F +  D+WS+G  LY +A    PF  YG + N
Sbjct: 212 ------GYNFKS--DIWSLGCLLYEMAALQSPF--YGDKMN 242

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 21  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              + +     IV + C G SL++ L   E  +  +  + + +      GM +L    ++
Sbjct: 77  YSTKPQ---LAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHAKSII 131
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A          QF  L G+  ++ P+     V
Sbjct: 132 HRDLKSNNI--FLHEDLTV--KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-----V 182
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 183 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 86
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 142
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 143 IHSADIIHRDLKPSNLA--VNEDSEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 196
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 197 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 248
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 249 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 297

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 43  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              + +     IV + C G SL++ L   E  + + +   + +      GM +L    ++
Sbjct: 99  YSTKPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIK--LIDIARQTAQGMDYLHAKSII 153
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A          QF  L G+  ++ P+     V
Sbjct: 154 HRDLKSNNI--FLHEDLTV--KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-----V 204
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 205 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 20/222 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K  N+ +  + +   M E  ++  + H ++V+
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL +      +   +V +L   G L   + + ++  G Q    L     +  GM +L + 
Sbjct: 105 LLGVCLSPTIQ---LVTQLMPHGCLLEYVHEHKDNIGSQL--LLNWCVQIAKGMMYLEER 159
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           RLVHRDL   N++           K+TDFG AR LE D++  +  G +  +     E   
Sbjct: 160 RLVHRDLAARNVLV----KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
            RK     F    D+WS GVT++ + T     +PY G   +E
Sbjct: 216 YRK-----FTHQSDVWSYGVTIWELMT--FGGKPYDGIPTRE 250

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 3   FLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFN---QLSHMRPHDVQMREF 59
           F +     ++     +G G+ GAV+   +  N E VA+K  +   + S+ +  D+ ++E 
Sbjct: 8   FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-IKEV 66
Query: 60  EVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGS--LFNILDDPENTYGLQEEEFLL 117
             L+K++H N ++       +      +VME C G +  L  +   P     LQE E   
Sbjct: 67  RFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKP-----LQEVEIAA 119
Query: 118 VLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY 177
           V      G+ +L  + ++HRD+K GNI+  + + G  + KL DFG+A  +     F+   
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNIL--LSEPG--LVKLGDFGSASIMAPANXFV--- 172
Query: 178 GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           GT  ++ P++    +L    G+ +   VD+WS+G+T   +A    P            +Y
Sbjct: 173 GTPYWMAPEV----ILAMDEGQ-YDGKVDVWSLGITCIELAERKPPLF---NMNAMSALY 224
Query: 238 YITTKKASGVISG 250
           +I   ++  + SG
Sbjct: 225 HIAQNESPALQSG 237

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 50/232 (21%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM------REFEVLKKV 65
           + + + +G GA G+V   ++K +GE VA+K  +     RP   ++      RE  +LK +
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-----RPFQSEIFAKRAYRELLLLKHM 98
Query: 66  KHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILD----------DPENTYGLQ--EE 113
           +HEN++ LL +                   SL N  D          D +   G++  EE
Sbjct: 99  QHENVIGLLDV--------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEE 144
Query: 114 EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF 173
           +   ++  +  G+K++    +VHRDLKPGN+   + +D     K+ DFG AR    D + 
Sbjct: 145 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA--VNEDCEL--KILDFGLAR--HADAEM 198
Query: 174 MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                T  Y  P++    +        +  TVD+WS+G  +  + TG   F+
Sbjct: 199 TGYVVTRWYRAPEVILSWM-------HYNQTVDIWSVGCIMAEMLTGKTLFK 243

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 33  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 89
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 145
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 146 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 199
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 200 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 251
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 252 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 300

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 44  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              + +     IV + C G SL++ L   E  +  +  + + +      GM +L    ++
Sbjct: 100 YSTKPQ---LAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHAKSII 154
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A          QF  L G+  ++ P+     V
Sbjct: 155 HRDLKSNNI--FLHEDLTV--KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-----V 205
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 206 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 109/227 (48%), Gaps = 23/227 (10%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLL 74
            ++G+G+ G V +  NK+ G  VA+K F +    +    + MRE ++LK+++HEN+V LL
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            + +++  +   +V E         ILDD E    GL  +     L  +  G+     + 
Sbjct: 91  EVCKKK--KRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ-FMSLYGTEEYLHPDMYERAV 192
           ++HRD+KP NI+       S + KL DFG AR L    + +     T  Y  P++    V
Sbjct: 145 IIHRDIKPENILV----SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                   +G  VD+W+IG  +  +  G  P  P  G  + + +Y+I
Sbjct: 201 -------KYGKAVDVWAIGCLVTEMFMGE-PLFP--GDSDIDQLYHI 237

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LG+G  G V    +   N   GE VAVK        +      +E ++L+ + HE+I+K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
               E+Q  +   +VME    GSL + L  P ++ GL   + LL  + +  GM +L    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLA--QLLLFAQQICEGMAYLHSQH 137
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM-YERAV 192
            +HR+L   N++     D   + K+ DFG A+ + E  ++  +   E+   P   Y    
Sbjct: 138 YIHRNLAARNVLL----DNDRLVKIGDFGLAKAVPEGHEYYRV--REDGDSPVFWYAPEC 191
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT 219
           L++     F    D+WS GVTLY + T
Sbjct: 192 LKE---YKFYYASDVWSFGVTLYELLT 215

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +   G  VAVK  ++    + H  +  RE  +LK V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKTLEEFQDVYLVMEL-MDANLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR    +        T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTACTNFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
               +G  + A VD+WS+G  +  +  G + F+
Sbjct: 198 ----LGMGYAANVDIWSVGCIMGELVKGCVIFQ 226

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KXQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDXEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 80
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 136
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 137 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMAGFVATRWYRAPEIM 190
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 191 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 242
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I     +P  N   + +G   L   +L  +L +DS K
Sbjct: 243 LKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 33  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 89
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 145
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 146 IHSADIIHRDLKPSNLA--VNEDXEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 199
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 200 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 251
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 252 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 300

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 76
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   ++   +   + L     +  GM++L   R
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++F  +    E    +  P+   
Sbjct: 135 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 191 ES--------KFSVASDVWSFGVVLYELFT 212

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 112/234 (47%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++G  ++   GE    VAVKT N+ + +R     + E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQE---EEFLLVLEHLTAG 125
           LL +    +G+  ++VMEL   G L + L     + EN  G      +E + +   +  G
Sbjct: 85  LLGV--VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L   + VHRDL   N M  +  D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 143 MAYLNAKKFVHRDLAARNCM--VAHDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 196
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V   F  + D+WS GV L+ + +  L  +PY G  N++ + ++
Sbjct: 197 RWMAPESLKDGV---FTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQVLKFV 245

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 40/214 (18%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-LKKVKHENIVK 72
           T+ VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVR 75
Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           ++ + E      K  +IVME   GG LF+ + D        E E   +++ +   +++L 
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              + HRD+KP N++ +     + I KLTDFG A+E                        
Sbjct: 135 SINIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKET----------------------- 170
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                  G+ +  + D+WS+GV +Y +  G  PF
Sbjct: 171 ------TGEKYDKSCDMWSLGVIMYILLCGYPPF 198

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 80
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 136
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 137 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 190
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 191 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 242
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMAGFVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I     +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 112/234 (47%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++G  ++   GE    VAVKT N+ + +R     + E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQE---EEFLLVLEHLTAG 125
           LL +    +G+  ++VMEL   G L + L     + EN  G      +E + +   +  G
Sbjct: 85  LLGV--VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L   + VHRDL   N M  +  D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 143 MAYLNAKKFVHRDLAARNCM--VAHDFTV--KIGDFGMTRDIYETAYYRK--GGKGLLPV 196
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V   F  + D+WS GV L+ + +  L  +PY G  N++ + ++
Sbjct: 197 RWMAPESLKDGV---FTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQVLKFV 245

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 90
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 146
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 147 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 200
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 201 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 252
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 253 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 301

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGXVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 25  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 81
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 82  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 137
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 138 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 191
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 192 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 243
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 244 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 292

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLLA 75
           +G G+ G V++G  K +G+ VAVK  N ++   P  +Q    E  VL+K +H NI+  + 
Sbjct: 16  IGSGSFGTVYKG--KWHGD-VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     IV + C G SL++ L   E  +  +  + + +      GM +L    ++
Sbjct: 72  YSTAPQ---LAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHAKSII 126
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDLK  NI  F+ +D +   K+ DFG A          QF  L G+  ++ P+     V
Sbjct: 127 HRDLKSNNI--FLHEDLTV--KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-----V 177
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +R      +    D+++ G+ LY + TG LP+
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KXQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR--EFEVLKKVKHENIVKLLA 75
           LGKG     ++  + +  E  A K   +   ++PH  +    E  + K + + ++V    
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E+ +     +V+E+C   SL  +    +    + E E    +     G+++L +NR++
Sbjct: 110 FFEDDDF--VYVVLEICRRRSLLELH---KRRKAVTEPEARYFMRQTIQGVQYLHNNRVI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLR 194
           HRDLK GN+  F+ DD     K+ DFG A ++E D ++  +L GT  Y+ P++  +    
Sbjct: 165 HRDLKLGNL--FLNDDMDV--KIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKK--- 217
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              G +F   VD+WS+G  LY +  G  PF
Sbjct: 218 ---GHSF--EVDIWSLGCILYTLLVGKPPF 242

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 25  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 81
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 82  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 137
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 138 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 191
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 192 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 243
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 244 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 292

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 42/261 (16%)
Query: 18  LGKGATGAVFQGV---NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G+G  G V QG+    +N    VA+KT    +     +  ++E   +++  H +IVKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +  E       I+MELCT G L + L      Y L     +L    L+  + +L   R 
Sbjct: 78  GVITENP---VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKRF 132
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG--TEEYLHPDMYERAV 192
           VHRD+   N++       +   KL DFG +R +E+   + +  G    +++ P   E   
Sbjct: 133 VHRDIAARNVLV----SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP---ESIN 185
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
            R+     F +  D+W  GV ++ +    +  +P+ G +N + +  I             
Sbjct: 186 FRR-----FTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRI------------- 225
Query: 253 TSENGEIDWCTDLPNNCQLSL 273
             ENGE      +P NC  +L
Sbjct: 226 --ENGER---LPMPPNCPPTL 241

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 33  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 89
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 145
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 146 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 199
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 200 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 251
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 252 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 300

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 27  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 83
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 84  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 139
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 140 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 193
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 194 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 245
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 246 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 294

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 91
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 147
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 148 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 201
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 202 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 253
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 302

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 19/224 (8%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           ++G G +G V  G  +  G+   PVA+K        R     + E  ++ +  H NI++L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +     GR  +IV E    GSL   L   +  + + +   + +L  + AGM++L D  
Sbjct: 116 EGVV--TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ--LVGMLRGVGAGMRYLSDLG 171
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            VHRDL   N++     D + + K++DFG +R LE+D    + Y T     P  +     
Sbjct: 172 YVHRDLAARNVLV----DSNLVCKVSDFGLSRVLEDDPD--AAYTTTGGKIPIRW--TAP 223
Query: 194 RKPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRRNKETM 236
                +TF +  D+WS GV ++ V A G    RPY    N++ +
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGE---RPYWNMTNRDVI 264

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+TG V     K+ G+ VAVK  +     R  ++   E  +++   H+N+V + +  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR-RELLFNEVVIMRDYHHDNVVDMYS-- 109
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GG+L +I+        + EE+   V   +   + +L +  ++HR
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQGVIHR 165
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  +I+  +  DG    KL+DFG  A+  +E  +   L GT  ++ P++  R      
Sbjct: 166 DIKSDSIL--LTSDGRI--KLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRL----- 216
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  VD+WS+G+ +  +  G  P+
Sbjct: 217 ---PYGTEVDIWSLGIMVIEMIDGEPPY 241

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 31/237 (13%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++G  ++   GE    VAVKT N+ + +R     + E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQE---EEFLLVLEHLTAG 125
           LL +    +G+  ++VMEL   G L + L     + EN  G      +E + +   +  G
Sbjct: 85  LLGV--VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQQFMSLYG--TEEY 182
           M +L   + VHRDL   N M  +  D +   K+ DFG  R++ E D       G     +
Sbjct: 143 MAYLNAKKFVHRDLAARNCM--VAHDFTV--KIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           + P+  +  V        F  + D+WS GV L+ + +  L  +PY G  N++ + ++
Sbjct: 199 MAPESLKDGV--------FTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQVLKFV 245

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 31/237 (13%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++G  ++   GE    VAVKT N+ + +R     + E  V+K     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQE---EEFLLVLEHLTAG 125
           LL +    +G+  ++VMEL   G L + L     + EN  G      +E + +   +  G
Sbjct: 82  LLGV--VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQQFMSLYG--TEEY 182
           M +L   + VHRDL   N M  +  D +   K+ DFG  R++ E D       G     +
Sbjct: 140 MAYLNAKKFVHRDLAARNCM--VAHDFTV--KIGDFGMTRDIXETDXXRKGGKGLLPVRW 195
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           + P+  +  V        F  + D+WS GV L+ + +  L  +PY G  N++ + ++
Sbjct: 196 MAPESLKDGV--------FTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQVLKFV 242

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 42/261 (16%)
Query: 18  LGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G+G  G V QG+  +   P   VA+KT    +     +  ++E   +++  H +IVKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +  E       I+MELCT G L + L      Y L     +L    L+  + +L   R 
Sbjct: 78  GVITENP---VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKRF 132
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG--TEEYLHPDMYERAV 192
           VHRD+   N++       +   KL DFG +R +E+   + +  G    +++ P   E   
Sbjct: 133 VHRDIAARNVLV----SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP---ESIN 185
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
            R+     F +  D+W  GV ++ +    +  +P+ G +N + +  I             
Sbjct: 186 FRR-----FTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRI------------- 225
Query: 253 TSENGEIDWCTDLPNNCQLSL 273
             ENGE      +P NC  +L
Sbjct: 226 --ENGER---LPMPPNCPPTL 241

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 31/237 (13%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++G  ++   GE    VAVKT N+ + +R     + E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQE---EEFLLVLEHLTAG 125
           LL +    +G+  ++VMEL   G L + L     + EN  G      +E + +   +  G
Sbjct: 85  LLGV--VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQQFMSLYG--TEEY 182
           M +L   + VHRDL   N M  +  D +   K+ DFG  R++ E D       G     +
Sbjct: 143 MAYLNAKKFVHRDLAARNCM--VAHDFTV--KIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           + P+  +  V        F  + D+WS GV L+ + +  L  +PY G  N++ + ++
Sbjct: 199 MAPESLKDGV--------FTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQVLKFV 245

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 26  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 82
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 83  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 138
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 139 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 192
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 193 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 244
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 245 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 293

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 86
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 142
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 143 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 196
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 197 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 248
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 249 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 297

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 90
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 146
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 147 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 200
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 201 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 252
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I     +P  N   + +G   L   +L  +L +DS K
Sbjct: 253 LKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 301

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           +G GA G+V    +    + VAVK     F  L H R      RE  +LK +KHEN++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR---RTYRELRLLKHLKHENVIGL 92
Query: 74  LAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           L +       E   +V ++    G  L NI+     +  L +E    ++  L  G+K++ 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              ++HRDLKP N+   + +D     ++ DFG AR  + D++      T  Y  P++   
Sbjct: 149 SAGIIHRDLKPSNVA--VNEDSEL--RILDFGLAR--QADEEMTGYVATRWYRAPEIMLN 202
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +        +  TVD+WS+G  +  +  G   F
Sbjct: 203 WM-------HYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 86
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 142
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 143 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 196
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 197 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 248
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 249 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 297

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 39  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 95
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 96  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 151
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 152 IHSADIIHRDLKPSNLA--VNEDXEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 205
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 206 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 257
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 258 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 306

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LG+G  G V    +   N   GE VAVK        +      +E ++L+ + HE+I+K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
               E+Q  +   +VME    GSL + L  P ++ GL   + LL  + +  GM +L    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLA--QLLLFAQQICEGMAYLHAQH 137
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM-YERAV 192
            +HR+L   N++     D   + K+ DFG A+ + E  ++  +   E+   P   Y    
Sbjct: 138 YIHRNLAARNVLL----DNDRLVKIGDFGLAKAVPEGHEYYRV--REDGDSPVFWYAPEC 191
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT 219
           L++     F    D+WS GVTLY + T
Sbjct: 192 LKE---YKFYYASDVWSFGVTLYELLT 215

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 51  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 107
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 108 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 163
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 164 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMXGYVATRWYRAPEIM 217
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 218 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 269
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 270 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 318

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
           M  L+     ++     +GKG+ G VF+G++    + VA+K  +        +   +E  
Sbjct: 13  MQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEIT 72
Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           VL +     + K        +     I+ME   GGS  ++L+       L E +   +L 
Sbjct: 73  VLSQCDSPYVTKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILR 126
Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GT 179
            +  G+ +L   + +HRD+K  N++  + + G    KL DFG A +L + Q   + + GT
Sbjct: 127 EILKGLDYLHSEKKIHRDIKAANVL--LSEHGEV--KLADFGVAGQLTDTQIKRNXFVGT 182
Query: 180 EEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
             ++ P++ +++         + +  D+WS+G+T   +A G  P
Sbjct: 183 PFWMAPEVIKQS--------AYDSKADIWSLGITAIELARGEPP 218

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 28/238 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN---QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G G+ GAV+   +  N E VA+K  +   + S+ +  D+ ++E   L+K++H N ++  
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-IKEVRFLQKLRHPNTIQYR 120
Query: 75  AIEEEQEGRGKVIVMELCTGGS--LFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
                +      +VME C G +  L  +   P     LQE E   V      G+ +L  +
Sbjct: 121 GCYLREHT--AWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLHSH 173
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRD+K GNI+  + + G  + KL DFG+A  +     F+   GT  ++ P++    +
Sbjct: 174 NMIHRDVKAGNIL--LSEPG--LVKLGDFGSASIMAPANXFV---GTPYWMAPEV----I 222
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISG 250
           L    G+ +   VD+WS+G+T   +A    P            +Y+I   ++  + SG
Sbjct: 223 LAMDEGQ-YDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESPALQSG 276

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 86
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 142
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 143 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 196
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 197 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 248
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 249 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 297

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 112/234 (47%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++G  ++   GE    VAVKT N+ + +R     + E  V+K     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQE---EEFLLVLEHLTAG 125
           LL +    +G+  ++VMEL   G L + L     + EN  G      +E + +   +  G
Sbjct: 84  LLGV--VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L   + VHRDL   N M  +  D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 142 MAYLNAKKFVHRDLAARNCM--VAHDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 195
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V   F  + D+WS GV L+ + +  L  +PY G  N++ + ++
Sbjct: 196 RWMAPESLKDGV---FTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQVLKFV 244

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+     +  L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KSQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG  R    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDSEL--KILDFGLCR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 87/188 (46%), Gaps = 26/188 (13%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL 116
           RE     ++ H+NIV ++ ++EE +     +VME   G +L   +   E+   L  +  +
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCY--YLVMEYIEGPTLSEYI---ESHGPLSVDTAI 114
Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ--QFM 174
                +  G+KH  D R+VHRD+KP NI+     D +   K+ DFG A+ L E    Q  
Sbjct: 115 NFTNQILDGIKHAHDMRIVHRDIKPQNILI----DSNKTLKIFDFGIAKALSETSLTQTN 170
Query: 175 SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
            + GT +Y  P+  +        G+      D++SIG+ LY +  G  PF       N E
Sbjct: 171 HVLGTVQYFSPEQAK--------GEATDECTDIYSIGIVLYEMLVGEPPF-------NGE 215
Query: 235 TMYYITTK 242
           T   I  K
Sbjct: 216 TAVSIAIK 223

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVKHE 68
           +     LG+G+ G V    +    + VA+K F     ++  D+ MR   E   LK ++H 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALK-FISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           +I+KL  +         V+V+E   GG LF+ + + +    + E+E     + +   +++
Sbjct: 70  HIIKLYDVITTPTD--IVMVIEY-AGGELFDYIVEKKR---MTEDEGRRFFQQIICAIEY 123
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
              +++VHRDLKP N++    DD   + K+ DFG +  + +     +  G+  Y  P++ 
Sbjct: 124 CHRHKIVHRDLKPENLL---LDDNLNV-KIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 189 ERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
                    GK + G  VD+WS G+ LY +  G LPF
Sbjct: 180 N--------GKLYAGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 42/261 (16%)
Query: 18  LGKGATGAVFQGV---NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G+G  G V QG+    +N    VA+KT    +     +  ++E   +++  H +IVKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +  E       I+MELCT G L + L      + L     +L    L+  + +L   R 
Sbjct: 78  GVITENP---VWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLESKRF 132
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG--TEEYLHPDMYERAV 192
           VHRD+   N++    D      KL DFG +R +E+   + +  G    +++ P   E   
Sbjct: 133 VHRDIAARNVLVSATD----CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP---ESIN 185
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
            R+     F +  D+W  GV ++ +    +  +P+ G +N + +  I             
Sbjct: 186 FRR-----FTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRI------------- 225
Query: 253 TSENGEIDWCTDLPNNCQLSL 273
             ENGE      +P NC  +L
Sbjct: 226 --ENGER---LPMPPNCPPTL 241

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 42/261 (16%)
Query: 18  LGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G+G  G V QG+  +   P   VA+KT    +     +  ++E   +++  H +IVKL+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +  E       I+MELCT G L + L      Y L     +L    L+  + +L   R 
Sbjct: 106 GVITENP---VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKRF 160
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG--TEEYLHPDMYERAV 192
           VHRD+   N++       +   KL DFG +R +E+   + +  G    +++ P   E   
Sbjct: 161 VHRDIAARNVLV----SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP---ESIN 213
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
            R+     F +  D+W  GV ++ +    +  +P+ G +N + +  I             
Sbjct: 214 FRR-----FTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRI------------- 253
Query: 253 TSENGEIDWCTDLPNNCQLSL 273
             ENGE      +P NC  +L
Sbjct: 254 --ENGER---LPMPPNCPPTL 269

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR--EFEVLKKVKHENIVKLLA 75
           LGKG     ++  + +  E  A K   +   ++PH  +    E  + K + + ++V    
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E+ +     +V+E+C   SL  +    +    + E E    +     G+++L +NR++
Sbjct: 94  FFEDDDF--VYVVLEICRRRSLLELH---KRRKAVTEPEARYFMRQTIQGVQYLHNNRVI 148
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLR 194
           HRDLK GN+  F+ DD     K+ DFG A ++E D ++   L GT  Y+ P++  +    
Sbjct: 149 HRDLKLGNL--FLNDDMDV--KIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKK--- 201
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              G +F   VD+WS+G  LY +  G  PF
Sbjct: 202 ---GHSF--EVDIWSLGCILYTLLVGKPPF 226

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 40  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 96
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 97  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 152
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 153 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 206
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 207 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 258
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 259 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 307

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 39  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 95
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 96  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 151
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 152 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 205
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 206 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 257
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 258 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 306

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 40  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 96
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 97  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 152
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 153 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 206
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 207 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 258
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 259 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 307

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 80
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 136
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 137 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 190
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 191 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 242
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I     +P  N   + +G   L   +L  +L +DS K
Sbjct: 243 LKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 21/225 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           ++G G +G V  G  +  G+   PVA+K        R     + E  ++ +  H NI++L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +     GR  +IV E    GSL   L   +  + + +   + +L  + AGM++L D  
Sbjct: 116 EGVV--TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ--LVGMLRGVGAGMRYLSDLG 171
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-QFMSLYGTEEYLHPDMYERAV 192
            VHRDL   N++     D + + K++DFG +R LE+D     +  G +  +     E   
Sbjct: 172 YVHRDLAARNVLV----DSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIA 227
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRRNKETM 236
            R     TF +  D+WS GV ++ V A G    RPY    N++ +
Sbjct: 228 FR-----TFSSASDVWSFGVVMWEVLAYGE---RPYWNMTNRDVI 264

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +GKG+ G VF+G++    + VA+K  +        +   +E  VL +     + K     
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-- 72
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
              +     I+ME   GGS  ++L+       L E +   +L  +  G+ +L   + +HR
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSEKKIHR 128
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  N++  + + G    KL DFG A +L + Q +  +  GT  ++ P++ +++     
Sbjct: 129 DIKAANVL--LSEHGEV--KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA---- 180
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLP 223
               + +  D+WS+G+T   +A G  P
Sbjct: 181 ----YDSKADIWSLGITAIELARGEPP 203

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I     +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 40  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAK---RTYRELRLLKHMKHENVI 96
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 97  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 152
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 153 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 206
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 207 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 258
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 259 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 307

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 80
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCAKLTDDHVQFLIYQILRGLKY 136
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 137 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 190
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 191 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 242
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I     +P  N   + +G   L   +L  +L +DS K
Sbjct: 243 LKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR--EFEVLKKVKHENIVKLLA 75
           LGKG     ++  + +  E  A K   +   ++PH  +    E  + K + + ++V    
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E+ +     +V+E+C   SL  +    +    + E E    +     G+++L +NR++
Sbjct: 110 FFEDDDF--VYVVLEICRRRSLLELH---KRRKAVTEPEARYFMRQTIQGVQYLHNNRVI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLR 194
           HRDLK GN+  F+ DD     K+ DFG A ++E D ++   L GT  Y+ P++  +    
Sbjct: 165 HRDLKLGNL--FLNDDMDV--KIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKK--- 217
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              G +F   VD+WS+G  LY +  G  PF
Sbjct: 218 ---GHSF--EVDIWSLGCILYTLLVGKPPF 242

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 104
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 160
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 161 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 214
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 215 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 266
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 267 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 315

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR--EFEVLKKVKHENIVKLLA 75
           LGKG     ++  + +  E  A K   +   ++PH  +    E  + K + + ++V    
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
             E+ +     +V+E+C   SL  +    +    + E E    +     G+++L +NR++
Sbjct: 110 FFEDDDF--VYVVLEICRRRSLLELH---KRRKAVTEPEARYFMRQTIQGVQYLHNNRVI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLR 194
           HRDLK GN+  F+ DD     K+ DFG A ++E D ++   L GT  Y+ P++  +    
Sbjct: 165 HRDLKLGNL--FLNDDMDV--KIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKK--- 217
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              G +F   VD+WS+G  LY +  G  PF
Sbjct: 218 ---GHSF--EVDIWSLGCILYTLLVGKPPF 242

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V ++    G  L+ +L     T  L  +     L  +  G+K++
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLL----KTQHLSNDHICYFLYQILRGLKYI 160
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLHP 185
               ++HRDLKP N++     D     K+ DFG AR  + D     F++ Y  T  Y  P
Sbjct: 161 HSANVLHRDLKPSNLLLNTTXD----LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           ++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 217 EIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 249

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 42/261 (16%)
Query: 18  LGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G+G  G V QG+  +   P   VA+KT    +     +  ++E   +++  H +IVKL+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +  E       I+MELCT G L + L      Y L     +L    L+  + +L   R 
Sbjct: 75  GVITENP---VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKRF 129
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG--TEEYLHPDMYERAV 192
           VHRD+   N++       +   KL DFG +R +E+   + +  G    +++ P   E   
Sbjct: 130 VHRDIAARNVLV----SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP---ESIN 182
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
            R+     F +  D+W  GV ++ +    +  +P+ G +N + +  I             
Sbjct: 183 FRR-----FTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRI------------- 222
Query: 253 TSENGEIDWCTDLPNNCQLSL 273
             ENGE      +P NC  +L
Sbjct: 223 --ENGER---LPMPPNCPPTL 238

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 42/261 (16%)
Query: 18  LGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G+G  G V QG+  +   P   VA+KT    +     +  ++E   +++  H +IVKL+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +  E       I+MELCT G L + L      Y L     +L    L+  + +L   R 
Sbjct: 83  GVITENP---VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG--TEEYLHPDMYERAV 192
           VHRD+   N++       +   KL DFG +R +E+   + +  G    +++ P   E   
Sbjct: 138 VHRDIAARNVLV----SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP---ESIN 190
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
            R+     F +  D+W  GV ++ +    +  +P+ G +N + +  I             
Sbjct: 191 FRR-----FTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRI------------- 230
Query: 253 TSENGEIDWCTDLPNNCQLSL 273
             ENGE      +P NC  +L
Sbjct: 231 --ENGER---LPMPPNCPPTL 246

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 42/261 (16%)
Query: 18  LGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G+G  G V QG+  +   P   VA+KT    +     +  ++E   +++  H +IVKL+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +  E       I+MELCT G L + L      Y L     +L    L+  + +L   R 
Sbjct: 80  GVITENP---VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKRF 134
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG--TEEYLHPDMYERAV 192
           VHRD+   N++       +   KL DFG +R +E+   + +  G    +++ P   E   
Sbjct: 135 VHRDIAARNVLV----SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP---ESIN 187
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
            R+     F +  D+W  GV ++ +    +  +P+ G +N + +  I             
Sbjct: 188 FRR-----FTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRI------------- 227
Query: 253 TSENGEIDWCTDLPNNCQLSL 273
             ENGE      +P NC  +L
Sbjct: 228 --ENGER---LPMPPNCPPTL 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 47  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 103
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 104 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 159
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 160 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 213
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 214 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 265
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 266 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 314

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           +G GA G+V    +    + VAVK     F  L H R      RE  +LK +KHEN++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR---RTYRELRLLKHLKHENVIGL 92
Query: 74  LAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           L +       E   +V ++    G  L NI+        L +E    ++  L  G+K++ 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              ++HRDLKP N+   + +D     ++ DFG AR  + D++      T  Y  P++   
Sbjct: 149 SAGIIHRDLKPSNVA--VNEDSEL--RILDFGLAR--QADEEMTGYVATRWYRAPEIMLN 202
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +        +  TVD+WS+G  +  +  G   F
Sbjct: 203 WM-------HYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 42/261 (16%)
Query: 18  LGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G+G  G V QG+  +   P   VA+KT    +     +  ++E   +++  H +IVKL+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +  E       I+MELCT G L + L      Y L     +L    L+  + +L   R 
Sbjct: 81  GVITENP---VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKRF 135
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG--TEEYLHPDMYERAV 192
           VHRD+   N++       +   KL DFG +R +E+   + +  G    +++ P   E   
Sbjct: 136 VHRDIAARNVLV----SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP---ESIN 188
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
            R+     F +  D+W  GV ++ +    +  +P+ G +N + +  I             
Sbjct: 189 FRR-----FTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRI------------- 228
Query: 253 TSENGEIDWCTDLPNNCQLSL 273
             ENGE      +P NC  +L
Sbjct: 229 --ENGER---LPMPPNCPPTL 244

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           +G GA G+V    +    + VAVK     F  L H R      RE  +LK +KHEN++ L
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR---RTYRELRLLKHLKHENVIGL 84
Query: 74  LAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           L +       E   +V ++    G  L NI+        L +E    ++  L  G+K++ 
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              ++HRDLKP N+   + +D     ++ DFG AR  + D++      T  Y  P++   
Sbjct: 141 SAGIIHRDLKPSNVA--VNEDCEL--RILDFGLAR--QADEEMTGYVATRWYRAPEIMLN 194
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +        +  TVD+WS+G  +  +  G   F
Sbjct: 195 WM-------HYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 51  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 107
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 108 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 163
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 164 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 217
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 218 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 269
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 270 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 318

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 27  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 84  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED ++ +  G +   ++  P+        
Sbjct: 140 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG--- 191
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 192 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 226

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 21  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 78  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED ++ +  G +   ++  P+        
Sbjct: 134 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG--- 185
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 186 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 220

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 16  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 73  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED ++ +  G +   ++  P+        
Sbjct: 129 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG--- 180
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 181 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 215

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 47  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 103
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 104 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 159
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 160 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 213
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 214 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 265
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I     +P  N   + +G   L   +L  +L +DS K
Sbjct: 266 LKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 314

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 26  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 83  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 138
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED ++ +  G +   ++  P+        
Sbjct: 139 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG--- 190
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 191 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 225

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +GKG+ G VF+G++    + VA+K  +        +   +E  VL +     + K     
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-- 92
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
              +     I+ME   GGS  ++L+       L E +   +L  +  G+ +L   + +HR
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSEKKIHR 148
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  N++  + + G    KL DFG A +L + Q +  +  GT  ++ P++ +++     
Sbjct: 149 DIKAANVL--LSEHGEV--KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA---- 200
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLP 223
               + +  D+WS+G+T   +A G  P
Sbjct: 201 ----YDSKADIWSLGITAIELARGEPP 223

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ D+G AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDYGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +GKG+ G VF+G++    + VA+K  +        +   +E  VL +     + K     
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-- 72
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
              +     I+ME   GGS  ++L+       L E +   +L  +  G+ +L   + +HR
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSEKKIHR 128
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVLRKP 196
           D+K  N++  + + G    KL DFG A +L + Q   + + GT  ++ P++ +++     
Sbjct: 129 DIKAANVL--LSEHGEV--KLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS----- 179
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLP 223
               + +  D+WS+G+T   +A G  P
Sbjct: 180 ---AYDSKADIWSLGITAIELARGEPP 203

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 104
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 160
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 161 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIM 214
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 215 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 266
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I     +P  N   + +G   L   +L  +L +DS K
Sbjct: 267 LKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 315

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 110/236 (46%), Gaps = 26/236 (11%)
Query: 13  CTT--SVLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVK 66
           C T   V+G G  G V++G+ K +      PVA+KT       +     + E  ++ +  
Sbjct: 45  CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM 126
           H NI++L  +  +   +  +I+ E    G+L   L + +  + + +   + +L  + AGM
Sbjct: 105 HHNIIRLEGVISKY--KPMMIITEYMENGALDKFLREKDGEFSVLQ--LVGMLRGIAAGM 160
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
           K+L +   VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P 
Sbjct: 161 KYLANMNYVHRDLAARNILV----NSNLVCKVSDFGLSRVLEDDPE--ATYTTSGGKIPI 214
Query: 187 MY---ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
            +   E    RK     F +  D+WS G+ ++ V T     RPY    N E M  I
Sbjct: 215 RWTAPEAISYRK-----FTSASDVWSFGIVMWEVMTYGE--RPYWELSNHEVMKAI 263

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LG+G  G V    +     N GE VAVK+    S         +E E+L+ + HENIVK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             I  E  G G  ++ME    GSL   L   +N   L+++  L     +  GM +L   +
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ--LKYAVQICKGMDYLGSRQ 134
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            VHRDL   N++     +     K+ DFG  + +E D++  ++    +    +  P+   
Sbjct: 135 YVHRDLAARNVLV----ESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
           ++         F    D+WS GVTL+ + T
Sbjct: 191 QS--------KFYIASDVWSFGVTLHELLT 212

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +   G  VAVK  ++    + H  +  RE  +LK V H+NI+ LL +
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 90  FTPQKTLEEFQDVYLVMEL-MDANLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA 143
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR    +        T  Y  P++     
Sbjct: 144 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTASTNFMMTPYVVTRYYRAPEVI---- 195
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
               +G  +   VD+WS+G  +  +  G++ F+
Sbjct: 196 ----LGMGYKENVDIWSVGCIMGELVKGSVIFQ 224

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 104
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 160
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++ 
Sbjct: 161 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMXGXVATRWYRAPEIM 214
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 215 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 266
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I     +P  N   + +G   L   +L  +L +DS K
Sbjct: 267 LKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 315

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LG+G  G V    +     N GE VAVK+    S         +E E+L+ + HENIVK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             I  E  G G  ++ME    GSL   L   +N   L+++  L     +  GM +L   +
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ--LKYAVQICKGMDYLGSRQ 146
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            VHRDL   N++     +     K+ DFG  + +E D++  ++    +    +  P+   
Sbjct: 147 YVHRDLAARNVLV----ESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
           ++         F    D+WS GVTL+ + T
Sbjct: 203 QS--------KFYIASDVWSFGVTLHELLT 224

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 90/173 (52%), Gaps = 19/173 (10%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDD-PENTYGLQEEEF 115
           +E ++L++++H+N+++L+ +   +E +   +VME C  G +  +LD  PE  + + +   
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHG 113
Query: 116 LLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE---DQQ 172
                 L  G+++L    +VH+D+KPGN++      G T+ K++  G A  L     D  
Sbjct: 114 YFC--QLIDGLEYLHSQGIVHKDIKPGNLL---LTTGGTL-KISALGVAEALHPFAADDT 167
Query: 173 FMSLYGTEEYLHPDMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
             +  G+  +  P++            TF G  VD+WS GVTLY++ TG  PF
Sbjct: 168 CRTSQGSPAFQPPEIANGL-------DTFSGFKVDIWSAGVTLYNITTGLYPF 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 31  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 88  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 143
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED ++ +  G +   ++  P+        
Sbjct: 144 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG--- 195
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 196 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 230

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 32/287 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++ L
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVIGL 96
Query: 74  LAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           L +       E    V ++    G  L NI+        L ++    ++  +  G+K++ 
Sbjct: 97  LDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIH 152
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              ++HRDLKP N+   + +D     K+ DFG AR    D +      T  Y  P++   
Sbjct: 153 SADIIHRDLKPSNLA--VNEDCEL--KILDFGLAR--HTDDEMTGYVATRWYRAPEIMLN 206
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASGVI 248
            +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  + 
Sbjct: 207 WM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLK 258
Query: 249 SGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
             +  S    I     +P  N   + +G   L   +L  +L +DS K
Sbjct: 259 KISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 305

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 25/226 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLA 75
           +G+G+ G VF+  N++ G+ VA+K F + S   P    + +RE  +LK++KH N+V LL 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLE-SEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           +   +  R   +V E C   ++ + LD  +   G+ E     +       +     +  +
Sbjct: 70  VFRRK--RRLHLVFEYCD-HTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYERAVLR 194
           HRD+KP NI+        ++ KL DFG AR L     +      T  Y  P++       
Sbjct: 125 HRDVKPENILI----TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL------ 174
Query: 195 KPVGKT-FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
             VG T +G  VD+W+IG     + +G +P  P  G+ + + +Y I
Sbjct: 175 --VGDTQYGPPVDVWAIGCVFAELLSG-VPLWP--GKSDVDQLYLI 215

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+TG V     +++G+ VAVK  +     R  ++   E  +++  +HEN+V++    
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMY--N 84
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GG+L +I+        + EE+   V   +   +  L    ++HR
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVIHR 140
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  +I+  +  DG    KL+DFG  A+  +E  +   L GT  ++ P++  R      
Sbjct: 141 DIKSDSIL--LTHDGRV--KLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL----- 191
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  VD+WS+G+ +  +  G  P+
Sbjct: 192 ---PYGPEVDIWSLGIMVIEMVDGEPPY 216

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++G  ++   GE    VAVKT N+ + +R     + E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQE---EEFLLVLEHLTAG 125
           LL +    +G+  ++VMEL   G L + L     + EN  G      +E + +   +  G
Sbjct: 85  LLGV--VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L   + VHR+L   N M  +  D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 143 MAYLNAKKFVHRNLAARNCM--VAHDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 196
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V   F  + D+WS GV L+ + +  L  +PY G  N++ + ++
Sbjct: 197 RWMAPESLKDGV---FTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQVLKFV 245

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 42/261 (16%)
Query: 18  LGKGATGAVFQGV---NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G+G  G V QG+    +N    VA+KT    +     +  ++E   +++  H +IVKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +  E       I+MELCT G L + L      + L     +L    L+  + +L   R 
Sbjct: 458 GVITENP---VWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG--TEEYLHPDMYERAV 192
           VHRD+   N++    D      KL DFG +R +E+   + +  G    +++ P   E   
Sbjct: 513 VHRDIAARNVLVSATD----CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP---ESIN 565
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
            R+     F +  D+W  GV ++ +    +  +P+ G +N + +  I             
Sbjct: 566 FRR-----FTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRI------------- 605
Query: 253 TSENGEIDWCTDLPNNCQLSL 273
             ENGE      +P NC  +L
Sbjct: 606 --ENGER---LPMPPNCPPTL 621

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+TG V     +++G+ VAVK  +     R  ++   E  +++  +HEN+V++    
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMY--N 93
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GG+L +I+        + EE+   V   +   +  L    ++HR
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 149
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  +I+  +  DG    KL+DFG  A+  +E  +   L GT  ++ P++  R      
Sbjct: 150 DIKSDSIL--LTHDGRV--KLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL----- 200
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  VD+WS+G+ +  +  G  P+
Sbjct: 201 ---PYGPEVDIWSLGIMVIEMVDGEPPY 225

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+GA G+V + V+K +G+ +AVK        +     + + +V+ +      +      
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 78  EEQEGRGKVIVMELCTGG------SLFNILDD--PENTYGLQEEEFLLVLEHLTAGMKHL 129
             +EG    I MEL +         ++++LDD  PE   G       + L  + A + HL
Sbjct: 90  LFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPEEILGK------ITLATVKA-LNHL 141
Query: 130 RDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           ++N +++HRD+KP NI+     D S   KL DFG + +L +        G   Y+ P+  
Sbjct: 142 KENLKIIHRDIKPSNILL----DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 197
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + +  R+     +    D+WS+G+TLY +ATG  P+
Sbjct: 198 DPSASRQ----GYDVRSDVWSLGITLYELATGRFPY 229

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 25/234 (10%)
Query: 18  LGKGATGAVFQGVNKN--NGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G+ G V++G  ++   GE    VAVKT N+ + +R     + E  V+K     ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQE---EEFLLVLEHLTAG 125
           LL +    +G+  ++VMEL   G L + L     + EN  G      +E + +   +  G
Sbjct: 86  LLGV--VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M +L   + VHR+L   N M  +  D +   K+ DFG  R++ E   +    G +  L  
Sbjct: 144 MAYLNAKKFVHRNLAARNCM--VAHDFTV--KIGDFGMTRDIYETDYYRK--GGKGLLPV 197
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  L+  V   F  + D+WS GV L+ + +  L  +PY G  N++ + ++
Sbjct: 198 RWMAPESLKDGV---FTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQVLKFV 246

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 140
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 141 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 196 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 229

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+TG V     +++G+ VAVK  +     R  ++   E  +++  +HEN+V++    
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMY--N 95
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GG+L +I+        + EE+   V   +   +  L    ++HR
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 151
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  +I+  +  DG    KL+DFG  A+  +E  +   L GT  ++ P++  R      
Sbjct: 152 DIKSDSIL--LTHDGRV--KLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL----- 202
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  VD+WS+G+ +  +  G  P+
Sbjct: 203 ---PYGPEVDIWSLGIMVIEMVDGEPPY 227

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G+     + ++K      AVK  ++       ++++    +L+  +H NI+ L  + 
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI----LLRYGQHPNIITLKDVY 85
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
           ++  G+   +V EL  GG L   LD         E E   VL  +T  +++L    +VHR
Sbjct: 86  DD--GKYVYVVTELXKGGEL---LDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHR 140
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DLKP NI+           ++ DFG A++L  E+    +   T  ++ P++ ER      
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLER------ 194
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             + + A  D+WS+GV LY   TG  PF
Sbjct: 195 --QGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 142
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 143 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 198 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 231

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 34/290 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 91
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 147
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDM 187
           +    ++HRDLKP N+   + +D     K+ DFG AR   ++   M+ Y  T  Y  P++
Sbjct: 148 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLARHTADE---MTGYVATRWYRAPEI 200
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKAS 245
               +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A 
Sbjct: 201 MLNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAE 252
Query: 246 GVISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
            +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 302

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 34/290 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 91
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 147
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDM 187
           +    ++HRDLKP N+   + +D     K+ DFG AR   ++   M+ Y  T  Y  P++
Sbjct: 148 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLARHTADE---MTGYVATRWYRAPEI 200
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKAS 245
               +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A 
Sbjct: 201 MLNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAE 252
Query: 246 GVISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
            +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 302

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 148
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 149 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 204 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 237

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 140
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 141 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 196 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 229

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 34/290 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 91
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 147
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDM 187
           +    ++HRDLKP N+   + +D     K+ DFG AR   ++   M+ Y  T  Y  P++
Sbjct: 148 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFGLARHTADE---MTGYVATRWYRAPEI 200
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKAS 245
               +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A 
Sbjct: 201 MLNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAE 252
Query: 246 GVISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
            +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 302

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHENIVKL 73
           LG G  G V+ G   NN   VAVKT      ++P  + ++ F     ++K ++H+ +V+L
Sbjct: 21  LGAGQFGEVWMGYY-NNSTKVAVKT------LKPGTMSVQAFLEEANLMKTLQHDKLVRL 73
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A+   +E     I+ E    GSL + L   E    L  +  +     +  GM ++    
Sbjct: 74  YAVVTREEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPK-LIDFSAQIAEGMAYIERKN 130
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            +HRDL+  N++       S + K+ DFG AR + ED ++ +  G +    P  +     
Sbjct: 131 YIHRDLRAANVLV----SESLMCKIADFGLARVI-EDNEYTAREGAK---FPIKW----- 177
Query: 194 RKPVGKTFGATV---DLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
             P    FG      D+WS G+ LY + T G +   PY GR N + M
Sbjct: 178 TAPEAINFGCFTIKSDVWSFGILLYEIVTYGKI---PYPGRTNADVM 221

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ DF  AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDFYLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+TG V     +++G+ VAVK  +     R  ++   E  +++  +HEN+V++    
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMY--N 88
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GG+L +I+        + EE+   V   +   +  L    ++HR
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVIHR 144
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  +I+  +  DG    KL+DFG  A+  +E  +   L GT  ++ P++  R      
Sbjct: 145 DIKSDSIL--LTHDGRV--KLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL----- 195
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  VD+WS+G+ +  +  G  P+
Sbjct: 196 ---PYGPEVDIWSLGIMVIEMVDGEPPY 220

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 145
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 201 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 234

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 146
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 147 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 202 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 235

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 137
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 138 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 193 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 226

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 144
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 200 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 233

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 45  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 104
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 105 KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 161
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK+L   + VHRDL   N M    D+  T+ K+ DFG AR++  D+++ S++     
Sbjct: 162 AKGMKYLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEYYSVHNKTGA 216
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 217 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+TG V     +++G+ VAVK  +     R  ++   E  +++  +HEN+V++    
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMY--N 215
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GG+L +I+        + EE+   V   +   +  L    ++HR
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 271
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  +I+  +  DG    KL+DFG  A+  +E  +   L GT  ++ P++  R      
Sbjct: 272 DIKSDSIL--LTHDGRV--KLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL----- 322
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  VD+WS+G+ +  +  G  P+
Sbjct: 323 ---PYGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 21  LGAGQAGEVWMGYY-NGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 78  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED +  +  G +   ++  P+        
Sbjct: 134 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAINYG--- 185
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 186 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 220

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 25  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 84
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 85  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 141
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK+L   + VHRDL   N M    D+  T+ K+ DFG AR++  D+++ S++     
Sbjct: 142 AKGMKYLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEYYSVHNKTGA 196
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 197 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 26  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 86  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 142
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK+L   + VHRDL   N M    D+  T+ K+ DFG AR++  D+++ S++     
Sbjct: 143 AKGMKYLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEYYSVHNKTGA 197
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 198 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 26  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 86  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 142
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK+L   + VHRDL   N M    D+  T+ K+ DFG AR++  D+++ S++     
Sbjct: 143 AKGMKYLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEYYSVHNKTGA 197
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 198 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 138
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 194 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 227

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 18  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 77
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 78  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 134
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK+L   + VHRDL   N M    D+  T+ K+ DFG AR++  D+++ S++     
Sbjct: 135 AKGMKYLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEYYSVHNKTGA 189
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 190 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 21  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 81  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 137
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK+L   + VHRDL   N M    D+  T+ K+ DFG AR++  D+++ S++     
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEYYSVHNKTGA 192
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 193 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 160
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 161 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 216 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 249

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 140
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLHP 185
               ++HRDLKP N++     D     K+ DFG AR  + D     F++ Y  T  Y  P
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXD----LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           ++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 197 EIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 138
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 194 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 227

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 23  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 83  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 139
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK+L   + VHRDL   N M    D+  T+ K+ DFG AR++  D+++ S++     
Sbjct: 140 AKGMKYLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEYYSVHNKTGA 194
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 195 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 77
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   +    +   + L     +  GM++L   R
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKR 135
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            +HR+L   NI+     +     K+ DFG  + L +D+++   Y  +E     ++  A  
Sbjct: 136 YIHRNLATRNILV----ENENRVKIGDFGLTKVLPQDKEY---YKVKEPGESPIFWYAPE 188
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVAT 219
                K F    D+WS GV LY + T
Sbjct: 189 SLTESK-FSVASDVWSFGVVLYELFT 213

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 144
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLHP 185
               ++HRDLKP N++     D     K+ DFG AR  + D     F++ Y  T  Y  P
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXD----LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           ++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 201 EIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 24  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 83
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 84  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 140
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK+L   + VHRDL   N M    D+  T+ K+ DFG AR++  D+++ S++     
Sbjct: 141 AKGMKYLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEYYSVHNKTGA 195
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 196 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 42/261 (16%)
Query: 18  LGKGATGAVFQGV---NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G+G  G V QG+    +N    VA+KT    +     +  ++E   +++  H +IVKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +  E       I+MELCT G L + L      + L     +L    L+  + +L   R 
Sbjct: 458 GVITENP---VWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG--TEEYLHPDMYERAV 192
           VHRD+   N++       +   KL DFG +R +E+   + +  G    +++ P   E   
Sbjct: 513 VHRDIAARNVLV----SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP---ESIN 565
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
            R+     F +  D+W  GV ++ +    +  +P+ G +N + +  I             
Sbjct: 566 FRR-----FTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRI------------- 605
Query: 253 TSENGEIDWCTDLPNNCQLSL 273
             ENGE      +P NC  +L
Sbjct: 606 --ENGER---LPMPPNCPPTL 621

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 22  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 79  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 134
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED +  +  G +   ++  P+        
Sbjct: 135 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYG--- 186
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 187 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 221

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 44  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 103
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 104 KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 160
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK+L   + VHRDL   N M    D+  T+ K+ DFG AR++  D+++ S++     
Sbjct: 161 AKGMKYLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEYYSVHNKTGA 215
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 216 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 75
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   ++   +   + L     +  GM++L   R
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 133
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 134 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 190 ES--------KFSVASDVWSFGVVLYELFT 211

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LG+G  G V    +   N   GE VAVK     +  +      +E ++L+ + HE+I+K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
               E+       +VME    GSL + L  P ++ GL   + LL  + +  GM +L    
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLA--QLLLFAQQICEGMAYLHAQH 154
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM-YERAV 192
            +HRDL   N++     D   + K+ DFG A+ + E  +   +   E+   P   Y    
Sbjct: 155 YIHRDLAARNVLL----DNDRLVKIGDFGLAKAVPEGHEXYRV--REDGDSPVFWYAPEC 208
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT 219
           L++     F    D+WS GVTLY + T
Sbjct: 209 LKE---YKFYYASDVWSFGVTLYELLT 232

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 23  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 80  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 135
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED +  +  G +   ++  P+        
Sbjct: 136 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYG--- 187
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 188 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 222

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 21  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 78  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED +  +  G +   ++  P+        
Sbjct: 134 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYG--- 185
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 186 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 220

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 140
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLHP 185
               ++HRDLKP N++     D     K+ DFG AR  + D     F++ Y  T  Y  P
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXD----LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           ++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 197 EIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 229

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 112/261 (42%), Gaps = 42/261 (16%)
Query: 18  LGKGATGAVFQGV---NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           +G+G  G V QG+    +N    VA+KT    +     +  ++E   +++  H +IVKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +  E       I+MELCT G L + L      + L     +L    L+  + +L   R 
Sbjct: 78  GVITENP---VWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLESKRF 132
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG--TEEYLHPDMYERAV 192
           VHRD+   N++       +   KL DFG +R +E+     +  G    +++ P   E   
Sbjct: 133 VHRDIAARNVLV----SSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAP---ESIN 185
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
            R+     F +  D+W  GV ++ +    +  +P+ G +N + +  I             
Sbjct: 186 FRR-----FTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRI------------- 225
Query: 253 TSENGEIDWCTDLPNNCQLSL 273
             ENGE      +P NC  +L
Sbjct: 226 --ENGER---LPMPPNCPPTL 241

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L   +HENI+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 142
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 143 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 198 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 231

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 112/224 (50%), Gaps = 30/224 (13%)
Query: 12  WCTTSVLGKGATGA-VFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKV-KH 67
           +C   VLG GA G  V++G+  N    VAVK       + P       RE ++L++  +H
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRD--VAVK------RILPECFSFADREVQLLRESDEH 77
Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY-GLQEEEFLLVLEHLTAGM 126
            N+++    E++++   + I +ELC   +L   ++  +  + GL   E + +L+  T+G+
Sbjct: 78  PNVIRYFCTEKDRQF--QYIAIELC-AATLQEYVEQKDFAHLGL---EPITLLQQTTSGL 131
Query: 127 KHLRDNRLVHRDLKPGNIMKFICD-DGSTIYKLTDFGAARELEEDQQFMS----LYGTEE 181
            HL    +VHRDLKP NI+  + +  G     ++DFG  ++L   +   S    + GTE 
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
           ++ P+M        P       TVD++S G   Y+V + G+ PF
Sbjct: 192 WIAPEMLSEDCKENPT-----YTVDIFSAGCVFYYVISEGSHPF 230

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+  FG AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILGFGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 76
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   ++   +   + L     +  GM++L   R
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 135 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 191 ES--------KFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 74
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   ++   +   + L     +  GM++L   R
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 132
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 133 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 189 ES--------KFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 80
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   ++   +   + L     +  GM++L   R
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 138
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 139 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 195 ES--------KFSVASDVWSFGVVLYELFT 216

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 140
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLHP 185
               ++HRDLKP N++     D     K+ DFG AR  + D     F++ Y  T  Y  P
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXD----LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           ++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 197 EIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 229

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA++  +   H       +RE ++L + +HENI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 144
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 200 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 233

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 81
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   ++   +   + L     +  GM++L   R
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 139
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 140 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 196 ES--------KFSVASDVWSFGVVLYELFT 217

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 24  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 83
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 84  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 140
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK L   + VHRDL   N M    D+  T+ K+ DFG AR++  D++F S++     
Sbjct: 141 AKGMKFLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEFDSVHNKTGA 195
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 196 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 21  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 78  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED +  +  G +   ++  P+        
Sbjct: 134 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYG--- 185
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 186 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 220

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+TG V     +++G+ VAVK  +     R  ++   E  +++  +HEN+V++    
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMY--N 138
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GG+L +I+        + EE+   V   +   +  L    ++HR
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 194
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  +I+  +  DG    KL+DFG  A+  +E  +   L GT  ++ P++  R      
Sbjct: 195 DIKSDSIL--LTHDGRV--KLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL----- 245
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  VD+WS+G+ +  +  G  P+
Sbjct: 246 ---PYGPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 79
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL   L   ++   +   + L     +  GM++L   R
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 138 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 194 ES--------KFSVASDVWSFGVVLYELFT 215

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 144
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLHP 185
               ++HRDLKP N++     D     K+ DFG AR  + D     F++ Y  T  Y  P
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXD----LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           ++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 201 EIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 233

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 79
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   ++   +   + L     +  GM++L   R
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 138 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 194 ES--------KFSVASDVWSFGVVLYELFT 215

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 17  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 74  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 129
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           +L+  NI+  + D  S   K+ DFG AR L ED ++ +  G +   ++  P+        
Sbjct: 130 NLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG--- 181
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 182 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 76
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   ++   +   + L     +  GM++L   R
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 135 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 191 ES--------KFSVASDVWSFGVVLYELFT 212

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE--VLKKVKHENIVKLLA 75
           LG G+ G V    +++NG   A+K   +   +R   V+    E  +L  V H  I+++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKHLRD 131
               Q+ +   ++M+   GG LF++L      P         E  L LE+L     H +D
Sbjct: 74  TF--QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL-----HSKD 126
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
             +++RDLKP NI+    D    I K+TDFG A+ + +      L GT +Y+ P++    
Sbjct: 127 --IIYRDLKPENIL---LDKNGHI-KITDFGFAKYVPDVT--YXLCGTPDYIAPEV---- 174
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           V  KP  K+    +D WS G+ +Y +  G  PF
Sbjct: 175 VSTKPYNKS----IDWWSFGILIYEMLAGYTPF 203

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 107
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   ++   +   + L     +  GM++L   R
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 166 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 222 ES--------KFSVASDVWSFGVVLYELFT 243

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 29  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 86  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 141
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED +  +  G +   ++  P+        
Sbjct: 142 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYG--- 193
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 194 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 228

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 83
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   ++   +   + L     +  GM++L   R
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 141
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 142 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 198 ES--------KFSVASDVWSFGVVLYELFT 219

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ D G AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDAGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 79
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L    +   +   + L     +  GM++L   R
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--AHAERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 138 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 194 ES--------KFSVASDVWSFGVVLYELFT 215

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 27  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 84  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED +  +  G +   ++  P+        
Sbjct: 140 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYG--- 191
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 192 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 226

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVKHENIVKLL 74
           LG+G+ G V    +   G+ VA+K  N+   +   D+Q R   E   L+ ++H +I+KL 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLRLLRHPHIIKLY 79
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            + + ++   ++I++    G  LF+ +   +    + E+E     + + + +++   +++
Sbjct: 80  DVIKSKD---EIIMVIEYAGNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRHKI 133
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLKP N++    D+   + K+ DFG +  + +     +  G+  Y  P++       
Sbjct: 134 VHRDLKPENLL---LDEHLNV-KIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS----- 184
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS GV LY +    LPF
Sbjct: 185 ---GKLYAGPEVDVWSCGVILYVMLCRRLPF 212

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ G   N    VAVK+  Q S M P D  + E  ++K+++H+ +V+L A+ 
Sbjct: 30  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGS-MSP-DAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +HR
Sbjct: 87  TQEP---IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNYIHR 142
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL+  NI+  + D  S   K+ DFG AR L ED +  +  G +   ++  P+        
Sbjct: 143 DLRAANIL--VSDTLSC--KIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYG--- 194
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                TF    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 195 -----TFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 229

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 82
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   ++   +   + L     +  GM++L   R
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 140
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 141 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 197 ES--------KFSVASDVWSFGVVLYELFT 218

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 34/227 (14%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHENIVKL 73
           LG G  G V+ G   NN   VAVKT      ++P  + ++ F     ++K ++H+ +V+L
Sbjct: 20  LGAGQFGEVWMGYY-NNSTKVAVKT------LKPGTMSVQAFLEEANLMKTLQHDKLVRL 72
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A+  ++E     I+ E    GSL + L   E    L  +  +     +  GM ++    
Sbjct: 73  YAVVTKEEPI--YIITEFMAKGSLLDFLKSDEGGKVLLPK-LIDFSAQIAEGMAYIERKN 129
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            +HRDL+  N++       S + K+ DFG AR + ED ++ +  G +    P  +     
Sbjct: 130 YIHRDLRAANVLV----SESLMCKIADFGLARVI-EDNEYTAREGAK---FPIKW----- 176
Query: 194 RKPVGKTFGATV---DLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
             P    FG      ++WS G+ LY + T G +   PY GR N + M
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVTYGKI---PYPGRTNADVM 220

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 26  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 86  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 142
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK L   + VHRDL   N M    D+  T+ K+ DFG AR++  D++F S++     
Sbjct: 143 AKGMKFLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEFDSVHNKTGA 197
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 198 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVKHENIVKLL 74
           LG+G+ G V    +   G+ VA+K  N+   +   D+Q R   E   L+ ++H +I+KL 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLRLLRHPHIIKLY 80
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            + + ++   ++I++    G  LF+ +   +    + E+E     + + + +++   +++
Sbjct: 81  DVIKSKD---EIIMVIEYAGNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRHKI 134
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLKP N++    D+   + K+ DFG +  + +     +  G+  Y  P++       
Sbjct: 135 VHRDLKPENLL---LDEHLNV-KIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS----- 185
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS GV LY +    LPF
Sbjct: 186 ---GKLYAGPEVDVWSCGVILYVMLCRRLPF 213

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVKHENIVKLL 74
           +G+G  G V++G   N    VAVK    +  +   +++ +   E +V+ K +HEN+V+LL
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
                 +G    +V      GSL + L   + T  L       + +    G+  L +N  
Sbjct: 91  GFS--SDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 148
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYERA 191
           +HRD+K  NI+     D +   K++DFG AR  E+  Q +    + GT  Y+ P+     
Sbjct: 149 IHRDIKSANILL----DEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGE 204
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
           +  K          D++S GV L  + TG LP
Sbjct: 205 ITPKS---------DIYSFGVVLLEIITG-LP 226

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVKHENIVKLL 74
           LG+G+ G V    +   G+ VA+K  N+   +   D+Q R   E   L+ ++H +I+KL 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLRLLRHPHIIKLY 70
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            + + ++   ++I++    G  LF+ +   +    + E+E     + + + +++   +++
Sbjct: 71  DVIKSKD---EIIMVIEYAGNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRHKI 124
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLKP N++    D+   + K+ DFG +  + +     +  G+  Y  P++       
Sbjct: 125 VHRDLKPENLL---LDEHLNV-KIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS----- 175
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS GV LY +    LPF
Sbjct: 176 ---GKLYAGPEVDVWSCGVILYVMLCRRLPF 203

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQ-----MELDHERMSYLLYQMLVGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +    +T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDATL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   VD+WS+GV +  +  G + F
Sbjct: 198 ----LGMGYKENVDIWSVGVIMGEMIKGGVLF 225

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 40/224 (17%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE----- 68
           +  VLG G  G V +  ++  G+  A+K        R            ++V H      
Sbjct: 14  SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR------------QEVDHHWQASG 61
Query: 69  --NIVKLLAIEEEQE--GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
             +IV +L + E      R  +I+ME   GG LF+ + +        E E   ++  +  
Sbjct: 62  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE-RGDQAFTEREAAEIMRDIGT 120
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ----FMSLYGTE 180
            ++ L  + + HRD+KP N++ +   +   + KLTDFG A+E  ++      +   Y   
Sbjct: 121 AIQFLHSHNIAHRDVKPENLL-YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAP 179
Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           E L P+ Y++             + D+WS+GV +Y +  G  PF
Sbjct: 180 EVLGPEKYDK-------------SCDMWSLGVIMYILLCGFPPF 210

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 22/238 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ---MREFEVLKKVKHENIVKLL 74
           LGKG  G V+    K +   VA+K   + S +    V+    RE E+   + H NI++L 
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFK-SQIEKEGVEHQLRREIEIQAHLHHPNILRLY 89
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
               ++  R   +++E    G L+  L   + +    E+    ++E L   + +    ++
Sbjct: 90  NYFYDR--RRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYCHGKKV 144
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           +HRD+KP N++           K+ DFG +      ++  ++ GT +YL P+M E     
Sbjct: 145 IHRDIKPENLLL----GLKGELKIADFGWSVHAPSLRR-KTMCGTLDYLPPEMIE----- 194
Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
              G+     VDLW IGV  Y +  GN PF           +  +  K  + V +G Q
Sbjct: 195 ---GRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQ 249

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ D G AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDRGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 94
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   ++   +   + L     +  GM++L   R
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKR 152
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 153 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 209 ES--------KFSVASDVWSFGVVLYELFT 230

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVKHENIVKLL 74
           +G+G  G V++G   N    VAVK    +  +   +++ +   E +V+ K +HEN+V+LL
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
                 +G    +V      GSL + L   + T  L       + +    G+  L +N  
Sbjct: 97  GFS--SDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYERA 191
           +HRD+K  NI+     D +   K++DFG AR  E+  Q +    + GT  Y+ P+     
Sbjct: 155 IHRDIKSANILL----DEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGE 210
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
           +  K          D++S GV L  + TG LP
Sbjct: 211 ITPKS---------DIYSFGVVLLEIITG-LP 232

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE----VLKKVKHENIVKL 73
           +G G+ G V++G  K +G+ VAVK    L  + P   Q + F     VL+K +H NI+  
Sbjct: 44  IGSGSFGTVYKG--KWHGD-VAVKI---LKVVDPTPEQFQAFRNEVAVLRKTRHVNILLF 97
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           +    +       IV + C G SL+  L   E  +  Q  + + +      GM +L    
Sbjct: 98  MGYMTKDN---LAIVTQWCEGSSLYKHLHVQETKF--QMFQLIDIARQTAQGMDYLHAKN 152
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAA---RELEEDQQFMSLYGTEEYLHPDMYER 190
           ++HRD+K  NI      +G T+ K+ DFG A         QQ     G+  ++ P+    
Sbjct: 153 IIHRDMKSNNI---FLHEGLTV-KIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE---- 204
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            V+R      F    D++S G+ LY + TG LP+
Sbjct: 205 -VIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 31  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 90
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 91  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 147
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK L   + VHRDL   N M    D+  T+ K+ DFG AR++  D++F S++     
Sbjct: 148 AKGMKFLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEFDSVHNKTGA 202
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 203 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 18  LGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           LGKG  G+V    +  +  N GE VAVK     +     D + RE E+LK ++H+NIVK 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE-REIEILKSLQHDNIVKY 94
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +      R   ++ME    GSL + L   +    +   + L     +  GM++L   R
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTKR 152
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDMYE 189
            +HRDL   NI+     +     K+ DFG  + L +D++   +    E    +  P+   
Sbjct: 153 YIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
            +         F    D+WS GV LY + T
Sbjct: 209 ES--------KFSVASDVWSFGVVLYELFT 230

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 27  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 86
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 87  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 143
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK L   + VHRDL   N M    D+  T+ K+ DFG AR++  D++F S++     
Sbjct: 144 AKGMKFLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEFDSVHNKTGA 198
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 199 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L   +HENI+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 142
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLHP 185
               ++HRDLKP N++     D     K+ DFG AR  + D     F++ Y  T  Y  P
Sbjct: 143 HSANVLHRDLKPSNLLLNTTSD----LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           ++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 199 EIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 231

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 26  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 86  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 142
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK L   + VHRDL   N M    D+  T+ K+ DFG AR++  D++F S++     
Sbjct: 143 AKGMKFLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEFDSVHNKTGA 197
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 198 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH-ENIVKLLA 75
           ++G G  G V++G +   G+  A+K  +          Q  E  +LKK  H  NI     
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ--EINMLKKYSHHRNIATYYG 88
Query: 76  --IEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYG--LQEEEFLLVLEHLTAGMKHL 129
             I++   G      +VME C  GS+ +++   +NT G  L+EE    +   +  G+ HL
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMY 188
             ++++HRD+K  N++  + ++     KL DFG + +L+    +  +  GT  ++ P++ 
Sbjct: 146 HQHKVIHRDIKGQNVL--LTENAEV--KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             A    P   T+    DLWS+G+T   +A G  P 
Sbjct: 202 --ACDENP-DATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVKHENIVKLL 74
           +G+G  G V++G   N    VAVK    +  +   +++ +   E +V+ K +HEN+V+LL
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
                 +G    +V      GSL + L   + T  L       + +    G+  L +N  
Sbjct: 97  GFS--SDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYERA 191
           +HRD+K  NI+     D +   K++DFG AR  E+  Q +    + GT  Y+ P+     
Sbjct: 155 IHRDIKSANILL----DEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGE 210
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
           +  K          D++S GV L  + TG LP
Sbjct: 211 ITPKS---------DIYSFGVVLLEIITG-LP 232

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVKHENIVKLL 74
           LG+G+ G V    +   G+ VA+K  N+   +   D+Q R   E   L+ ++H +I+KL 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLRLLRHPHIIKLY 74
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            + + ++   ++I++    G  LF+ +   +    + E+E     + + + +++   +++
Sbjct: 75  DVIKSKD---EIIMVIEYAGNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRHKI 128
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLKP N++     D     K+ DFG +  + +     +  G+  Y  P++       
Sbjct: 129 VHRDLKPENLLL----DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS----- 179
Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS GV LY +    LPF
Sbjct: 180 ---GKLYAGPEVDVWSCGVILYVMLCRRLPF 207

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM------REFEVLKKVKHENI 70
           ++G G  G V++      G+ VAVK      H    D+        +E ++   +KH NI
Sbjct: 14  IIGIGGFGKVYRAFWI--GDEVAVKAAR---HDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLV--LEHLTAGMKH 128
           + L  +  ++      +VME   GG L  +L       G +    +LV     +  GM +
Sbjct: 69  IALRGVCLKEPNL--CLVMEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNY 120
Query: 129 LRDNRLV---HRDLKPGNIMKFI----CDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE 181
           L D  +V   HRDLK  NI+        D  + I K+TDFG ARE     + MS  G   
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYA 179
Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
           ++ P+     V+R      F    D+WS GV L+ + TG +PFR   G
Sbjct: 180 WMAPE-----VIR---ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 85  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 145 KDFSHPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 201
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK L   + VHRDL   N M    D+  T+ K+ DFG AR++  D++F S++     
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEFDSVHNKTGA 256
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 257 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 27  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 86
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 87  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 143
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK L   + VHRDL   N M    D+  T+ K+ DFG AR++  D++F S++     
Sbjct: 144 AKGMKFLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-LDKEFDSVHNKTGA 198
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 199 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L        L  +     L  +  G+K++
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KCQHLSNDHICYFLYQILRGLKYI 144
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D     F++ Y  T  Y  
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 200 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 233

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S +G GA G+V    +   G  VAVK     F  + H +      RE  +LK +KHEN++
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVI 84
Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            LL +       E    V ++    G  L NI+        L ++    ++  +  G+K+
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQILRGLKY 140
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+   + +D     K+ D G AR    D +      T  Y  P++ 
Sbjct: 141 IHSADIIHRDLKPSNLA--VNEDCEL--KILDGGLAR--HTDDEMTGYVATRWYRAPEIM 194
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN--KETMYYITTKKASG 246
              +        +  TVD+WS+G  +  + TG   F P     +  K  +  + T  A  
Sbjct: 195 LNWM-------HYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL 246
Query: 247 VISGTQTSENGEIDWCTDLP--NNCQLSLGLKKLVTPILAGLLEVDSKK 293
           +   +  S    I   T +P  N   + +G   L   +L  +L +DS K
Sbjct: 247 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 295

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 37/221 (16%)
Query: 17  VLGKGATGAVFQGVNKNN-GEP--VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           +LG+G  G V++GV  N+ GE   VAVKT  +   +   +  M E  ++K + H +IVKL
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           + I EE+      I+MEL   G L + L+  +N+  L+    +L    +   M +L    
Sbjct: 75  IGIIEEEP---TWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLESIN 129
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            VHRD+   NI+           KL DFG +R +E++               D Y+ +V 
Sbjct: 130 CVHRDIAVRNILV----ASPECVKLGDFGLSRYIEDE---------------DYYKASVT 170
Query: 194 RKPVG---------KTFGATVDLWSIGVTLYHVAT-GNLPF 224
           R P+          + F    D+W   V ++ + + G  PF
Sbjct: 171 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 40/224 (17%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH------ 67
           +  VLG G  G V +  ++  G+  A+K        R            ++V H      
Sbjct: 33  SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR------------QEVDHHWQASG 80
Query: 68  -ENIVKLLAIEEEQE--GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
             +IV +L + E      R  +I+ME   GG LF+ + +        E E   ++  +  
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE-RGDQAFTEREAAEIMRDIGT 139
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ----FMSLYGTE 180
            ++ L  + + HRD+KP N++ +   +   + KLTDFG A+E  ++      +   Y   
Sbjct: 140 AIQFLHSHNIAHRDVKPENLL-YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAP 198
Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           E L P+ Y++             + D+WS+GV +Y +  G  PF
Sbjct: 199 EVLGPEKYDK-------------SCDMWSLGVIMYILLCGFPPF 229

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G    V++G+NK  G  VA+K     S        +RE  ++K++KHENIV+L  + 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDD---PENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
             +    K+ ++       L   +D         GL+          L  G+    +N++
Sbjct: 73  HTEN---KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI 129
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVL 193
           +HRDLKP N++  I   G    KL DFG AR        F S   T  Y  PD+   +  
Sbjct: 130 LHRDLKPQNLL--INKRGQ--LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS-- 183
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
                +T+  ++D+WS G  L  + TG  P  P
Sbjct: 184 -----RTYSTSIDIWSCGCILAEMITGK-PLFP 210

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 6   GSTNYVWCTTSVLGKGATGAVFQG-VNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVL 62
           G ++ +     V+G+G  G V+ G +  N+G+ +  AVK+ N+++ +      + E  ++
Sbjct: 25  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 84
Query: 63  KKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
           K   H N++ LL I    EG   ++V+     G L N + +   T+    ++ +     +
Sbjct: 85  KDFSHPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQV 141
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GMK+L   + VHRDL   N M    D+  T+ K+ DFG AR++  D++  S++     
Sbjct: 142 AKGMKYLASKKFVHRDLAARNCM---LDEKFTV-KVADFGLARDM-YDKEXXSVHNKTGA 196
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             P  +    L     + F    D+WS GV L+ + T   P  P
Sbjct: 197 KLPVKW--MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 20/222 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+   +GE    PVA+K   + +  + +   + E  V+  V    + +
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL I      +   +V +L   G L + +   EN   L  ++ L     +  GM +L D 
Sbjct: 84  LLGICLTSTVQ---LVTQLMPYGCLLDHVR--ENRGRLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           RLVHRDL   N++           K+TDFG AR L+ D+      G +  +   M   ++
Sbjct: 139 RLVHRDLAARNVLV----KSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-WMALESI 193
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           LR    + F    D+WS GVT++ + T     +PY G   +E
Sbjct: 194 LR----RRFTHQSDVWSYGVTVWELMT--FGAKPYDGIPARE 229

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 38/220 (17%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV-QMREFEVLKKVKHENIVKLLAI 76
           +G+G  G VF+  ++  G+ VA+K     +      +  +RE ++L+ +KHEN+V L+ I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 77  EEEQEG-----RGKV-IVMELCT---GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
              +       +G + +V + C     G L N+L            E   V++ L  G+ 
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLY 139
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           ++  N+++HRD+K  N++  I  DG  + KL DFG AR           +   +   P+ 
Sbjct: 140 YIHRNKILHRDMKAANVL--ITRDG--VLKLADFGLARA----------FSLAKNSQPNR 185
Query: 188 YERAVL----RKP---VG-KTFGATVDLWSIGVTLYHVAT 219
           Y   V+    R P   +G + +G  +DLW  G  +  + T
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              +  +      VME   GG LF  L   E  +   EE        + + +++L    +
Sbjct: 72  YAFQTHDRL--CFVMEYANGGELFFHLSR-ERVF--TEERARFYGAEIVSALEYLHSRDV 126
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           V+RD+K  N+M  +  DG    K+TDFG  +E   D   M  + GT EYL P++ E    
Sbjct: 127 VYRDIKLENLM--LDKDGHI--KITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE---- 178
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                  +G  VD W +GV +Y +  G LPF
Sbjct: 179 ----DNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              +  +      VME   GG LF  L   E  +   EE        + + +++L    +
Sbjct: 72  YAFQTHDRL--CFVMEYANGGELFFHLSR-ERVF--TEERARFYGAEIVSALEYLHSRDV 126
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           V+RD+K  N+M  +  DG    K+TDFG  +E   D   M  + GT EYL P++ E    
Sbjct: 127 VYRDIKLENLM--LDKDGHI--KITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE---- 178
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                  +G  VD W +GV +Y +  G LPF
Sbjct: 179 ----DNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQ-----MELDHERMSYLLYQMLVGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +    +T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDATL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   VD+WS+GV +  +  G + F
Sbjct: 198 ----LGMGYKENVDIWSVGVIMGEMIKGGVLF 225

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              +  +      VME   GG LF  L   E  +   EE        + + +++L    +
Sbjct: 72  YAFQTHDRL--CFVMEYANGGELFFHLSR-ERVF--TEERARFYGAEIVSALEYLHSRDV 126
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           V+RD+K  N+M  +  DG    K+TDFG  +E   D   M  + GT EYL P++ E    
Sbjct: 127 VYRDIKLENLM--LDKDGHI--KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---- 178
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                  +G  VD W +GV +Y +  G LPF
Sbjct: 179 ----DNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 37/221 (16%)
Query: 17  VLGKGATGAVFQGVNKNN-GEP--VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           +LG+G  G V++GV  N+ GE   VAVKT  +   +   +  M E  ++K + H +IVKL
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           + I EE+      I+MEL   G L + L+  +N+  L+    +L    +   M +L    
Sbjct: 91  IGIIEEEP---TWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLESIN 145
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            VHRD+   NI+           KL DFG +R +E++               D Y+ +V 
Sbjct: 146 CVHRDIAVRNILV----ASPECVKLGDFGLSRYIEDE---------------DYYKASVT 186
Query: 194 RKPVG---------KTFGATVDLWSIGVTLYHVAT-GNLPF 224
           R P+          + F    D+W   V ++ + + G  PF
Sbjct: 187 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 15  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 74
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              +  +      VME   GG LF  L   E  +   EE        + + +++L    +
Sbjct: 75  YAFQTHDRL--CFVMEYANGGELFFHLSR-ERVF--TEERARFYGAEIVSALEYLHSRDV 129
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           V+RD+K  N+M  +  DG    K+TDFG  +E   D   M  + GT EYL P++ E    
Sbjct: 130 VYRDIKLENLM--LDKDGHI--KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---- 181
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                  +G  VD W +GV +Y +  G LPF
Sbjct: 182 ----DNDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKSLEEFQDVYIVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR            GT   + P++  R  
Sbjct: 146 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTA----------GTSFMMEPEVVTR-Y 190
Query: 193 LRKP---VGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
            R P   +G  +   VDLWS+G  +  +    +  P R Y  + NK
Sbjct: 191 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNK 236

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 37/221 (16%)
Query: 17  VLGKGATGAVFQGVNKNN-GEP--VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           +LG+G  G V++GV  N+ GE   VAVKT  +   +   +  M E  ++K + H +IVKL
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           + I EE+      I+MEL   G L + L+  +N+  L+    +L    +   M +L    
Sbjct: 79  IGIIEEEP---TWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLESIN 133
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            VHRD+   NI+           KL DFG +R +E++               D Y+ +V 
Sbjct: 134 CVHRDIAVRNILV----ASPECVKLGDFGLSRYIEDE---------------DYYKASVT 174
Query: 194 RKPVG---------KTFGATVDLWSIGVTLYHVAT-GNLPF 224
           R P+          + F    D+W   V ++ + + G  PF
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 27/233 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEP--VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LG G  G+V QGV +   +   VA+K   Q +     +  MRE +++ ++ +  IV+L+ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEE----EFLLVLEHLTAGMKHLRD 131
           + + +     ++VME+  GG L   L       G +EE        +L  ++ GMK+L +
Sbjct: 78  VCQAE---ALMLVMEMAGGGPLHKFL------VGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY-LHPDMYER 190
              VHRDL   N++           K++DFG ++ L  D  + +     ++ L     E 
Sbjct: 129 KNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
              RK     F +  D+WS GVT++   +     +PY   +  E M +I   K
Sbjct: 185 INFRK-----FSSRSDVWSYGVTMWEALSYGQ--KPYKKMKGPEVMAFIEQGK 230

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 144
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ----FMSLYGTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D            T  Y  
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 200 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 233

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 24/222 (10%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +   S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 72  KLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  I      E    V +++      L+ +L     T  L  +     L  +  G+K++
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLL----KTQHLSNDHICYFLYQILRGLKYI 145
Query: 130 RDNRLVHRDLKPGN-IMKFICDDGSTIYKLTDFGAARELEEDQQ----FMSLYGTEEYLH 184
               ++HRDLKP N ++   CD      K+ DFG AR  + D            T  Y  
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           P++   +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 201 PEIMLNS-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 234

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 119/274 (43%), Gaps = 59/274 (21%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMRPHDVQMREFEV--LKKVKHENIV 71
             +G+G+ G V   +        A+K  N+  +  + P DV+  + EV  +KK+ H NI 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFN----ILDD-----------------PE----- 105
           +L  + E+++     +VMELC GG L +     +DD                 PE     
Sbjct: 92  RLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 106 ---NTYGLQE------EEFLL--VLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST 154
              + +G +E       E L+  ++  + + + +L +  + HRD+KP N +     + S 
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL--FSTNKSF 207
Query: 155 IYKLTDFGAAREL-----EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWS 209
             KL DFG ++E       E     +  GT  ++ P++           +++G   D WS
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT------NESYGPKCDAWS 261
Query: 210 IGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
            GV L+ +  G +PF    G  + +T+  +  KK
Sbjct: 262 AGVLLHLLLMGAVPFP---GVNDADTISQVLNKK 292

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 38/220 (17%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV-QMREFEVLKKVKHENIVKLLAI 76
           +G+G  G VF+  ++  G+ VA+K     +      +  +RE ++L+ +KHEN+V L+ I
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 77  EEEQEG-----RGKV-IVMELCT---GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
              +       +G + +V + C     G L N+L            E   V++ L  G+ 
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLY 138
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           ++  N+++HRD+K  N++  I  DG  + KL DFG AR           +   +   P+ 
Sbjct: 139 YIHRNKILHRDMKAANVL--ITRDG--VLKLADFGLARA----------FSLAKNSQPNR 184
Query: 188 YERAVL----RKP---VG-KTFGATVDLWSIGVTLYHVAT 219
           Y   V+    R P   +G + +G  +DLW  G  +  + T
Sbjct: 185 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              +  +      VME   GG LF  L   E  +   EE        + + +++L    +
Sbjct: 72  YAFQTHDRL--CFVMEYANGGELFFHLSR-ERVF--TEERARFYGAEIVSALEYLHSRDV 126
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           V+RD+K  N+M  +  DG    K+TDFG  +E   D   M  + GT EYL P++ E    
Sbjct: 127 VYRDIKLENLM--LDKDGHI--KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---- 178
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                  +G  VD W +GV +Y +  G LPF
Sbjct: 179 ----DNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKL- 73
           V+G+GA G V     KN  +  A+K  N+   ++  +      E +VL     + I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A    Q+     +VM+   GG L  +L   E+   L EE     L  +   +  +    
Sbjct: 141 YAF---QDDNNLYLVMDYYVGGDLLTLLSKFEDR--LPEEMARFYLAEMVIAIDSVHQLH 195
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS--LYGTEEYLHPDMYERA 191
            VHRD+KP NI+     D +   +L DFG+  +L ED    S    GT +Y+ P++ +  
Sbjct: 196 YVHRDIKPDNILM----DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ-- 249
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +    G+ +G   D WS+GV +Y +  G  PF
Sbjct: 250 AMEGGKGR-YGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 23/175 (13%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKV--IVMELCTGGSLFNILDDPENTYG-LQEE 113
           RE +    + H  IV + A  E +   G +  IVME   G +L +I+    +T G +  +
Sbjct: 61  REAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPK 116
Query: 114 EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED--- 170
             + V+      +     N ++HRD+KP NIM       +   K+ DFG AR + +    
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMI----SATNAVKVMDFGIARAIADSGNS 172
Query: 171 -QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             Q  ++ GT +YL P+           G +  A  D++S+G  LY V TG  PF
Sbjct: 173 VTQTAAVIGTAQYLSPEQAR--------GDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           V+G+GA G V    +K+  +  A+K  ++   ++  D      E +++       +V+L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL---DDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
                Q+ R   +VME   GG L N++   D PE        E +L L+ + +       
Sbjct: 136 YAF--QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS------- 186
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM--SLYGTEEYLHPDMYE 189
              +HRD+KP N++     D S   KL DFG   ++ ++      +  GT +Y+ P+   
Sbjct: 187 MGFIHRDVKPDNMLL----DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE--- 239
Query: 190 RAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
             VL+   G  + G   D WS+GV LY +  G+ PF
Sbjct: 240 --VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           V+G+GA G V    +K+  +  A+K  ++   ++  D      E +++       +V+L 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL---DDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
                Q+ R   +VME   GG L N++   D PE        E +L L+ + +       
Sbjct: 141 Y--AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS------- 191
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM--SLYGTEEYLHPDMYE 189
              +HRD+KP N++     D S   KL DFG   ++ ++      +  GT +Y+ P+   
Sbjct: 192 MGFIHRDVKPDNMLL----DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE--- 244
Query: 190 RAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
             VL+   G  + G   D WS+GV LY +  G+ PF
Sbjct: 245 --VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              +  +      VME   GG LF  L   E  +   EE        + + +++L    +
Sbjct: 72  YAFQTHDRL--CFVMEYANGGELFFHLSR-ERVF--TEERARFYGAEIVSALEYLHSRDV 126
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           V+RD+K  N+M  +  DG    K+TDFG  +E   D   M  + GT EYL P++ E    
Sbjct: 127 VYRDIKLENLM--LDKDGHI--KITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE---- 178
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                  +G  VD W +GV +Y +  G LPF
Sbjct: 179 ----DNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIV 71
              V+G+GA G V    +K+  +  A+K  ++   ++  D      E +++       +V
Sbjct: 78  VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 137
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNIL---DDPENTYGLQEEEFLLVLEHLTAGMKH 128
           +L      Q+ R   +VME   GG L N++   D PE        E +L L+ + +    
Sbjct: 138 QLFY--AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS---- 191
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM--SLYGTEEYLHPD 186
                 +HRD+KP N++     D S   KL DFG   ++ ++      +  GT +Y+ P+
Sbjct: 192 ---MGFIHRDVKPDNMLL----DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 244
Query: 187 MYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
                VL+   G  + G   D WS+GV LY +  G+ PF
Sbjct: 245 -----VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 38/220 (17%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV-QMREFEVLKKVKHENIVKLLAI 76
           +G+G  G VF+  ++  G+ VA+K     +      +  +RE ++L+ +KHEN+V L+ I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 77  EEEQEG-----RGKV-IVMELCT---GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
              +       +G + +V + C     G L N+L            E   V++ L  G+ 
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLY 139
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           ++  N+++HRD+K  N++  I  DG  + KL DFG AR           +   +   P+ 
Sbjct: 140 YIHRNKILHRDMKAANVL--ITRDG--VLKLADFGLARA----------FSLAKNSQPNR 185
Query: 188 YERAVL----RKP---VG-KTFGATVDLWSIGVTLYHVAT 219
           Y   V+    R P   +G + +G  +DLW  G  +  + T
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 17  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 76
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              +  +      VME   GG LF  L   E  +   EE        + + +++L    +
Sbjct: 77  YAFQTHDRL--CFVMEYANGGELFFHLSR-ERVF--TEERARFYGAEIVSALEYLHSRDV 131
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           V+RD+K  N+M  +  DG    K+TDFG  +E   D   M  + GT EYL P++ E    
Sbjct: 132 VYRDIKLENLM--LDKDGHI--KITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE---- 183
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                  +G  VD W +GV +Y +  G LPF
Sbjct: 184 ----DNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM------REFEVLKKVKHENIV 71
           +G GA GAV   V+   G  VA+K        RP   ++      RE  +LK ++HEN++
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKL-----YRPFQSELFAKRAYRELRLLKHMRHENVI 87
Query: 72  KLLAIEEEQEGRGKV----IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            LL +    E         +VM    G  L  ++   +    L E+    ++  +  G++
Sbjct: 88  GLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLKGLR 142
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           ++    ++HRDLKPGN+   + +D     K+ DFG AR  + D +      T  Y  P++
Sbjct: 143 YIHAAGIIHRDLKPGNLA--VNEDCEL--KILDFGLAR--QADSEMXGXVVTRWYRAPEV 196
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
               +        +  TVD+WS+G  +  + TG   F+
Sbjct: 197 ILNWM-------RYTQTVDIWSVGCIMAEMITGKTLFK 227

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 37/233 (15%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ---MREFEVLKKVKHENIVKLL 74
           +G+G  G VF G  + +   VAVK+  +     P D++   ++E  +LK+  H NIV+L+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRE---TLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG--LQEEEFLLVLEHLTAGMKHLRDN 132
            +  +++     IVMEL  GG     L     T G  L+ +  L ++    AGM++L   
Sbjct: 179 GVCTQKQ--PIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDM- 187
             +HRDL   N +         + K++DFG +RE E D  + +  G  +    +  P+  
Sbjct: 233 CCIHRDLAARNCLV----TEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAPEAL 287
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
            Y R          + +  D+WS G+ L+   T +L   PY    N++T  ++
Sbjct: 288 NYGR----------YSSESDVWSFGILLWE--TFSLGASPYPNLSNQQTREFV 328

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 76
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +  V+ + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 77  RLRYFFYSSGEKKDVVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 186 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 101/231 (43%), Gaps = 37/231 (16%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVL-KKVKHENIVKL 73
           V+GKG+ G V    +K      AVK   + + ++  + +  M E  VL K VKH  +V L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL------VLEHLTAGMK 127
                 Q       V++   GG LF         Y LQ E   L          + + + 
Sbjct: 105 HF--SFQTADKLYFVLDYINGGELF---------YHLQRERCFLEPRARFYAAEIASALG 153
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPD 186
           +L    +V+RDLKP NI+  +   G  +  LTDFG  +E +E +    +  GT EYL P+
Sbjct: 154 YLHSLNIVYRDLKPENIL--LDSQGHIV--LTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
                VL K   + +  TVD W +G  LY +  G  PF      RN   MY
Sbjct: 210 -----VLHK---QPYDRTVDWWCLGAVLYEMLYGLPPFY----SRNTAEMY 248

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKSLEEFQDVYIVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR            GT   + P++  R  
Sbjct: 146 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTA----------GTSFMMEPEVVTR-Y 190
Query: 193 LRKP---VGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
            R P   +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNK 236

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKSLEEFQDVYIVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR            GT   + P++  R  
Sbjct: 146 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTA----------GTSFMMTPEVVTR-Y 190
Query: 193 LRKP---VGKTFGATVDLWSIGVTLYHVATGNLPF 224
            R P   +G  +   VD+WS+G  +  +  G + F
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 38/220 (17%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV-QMREFEVLKKVKHENIVKLLAI 76
           +G+G  G VF+  ++  G+ VA+K     +      +  +RE ++L+ +KHEN+V L+ I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 77  ---EEEQEGRGKV---IVMELCT---GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
              +     R K    +V + C     G L N+L            E   V++ L  G+ 
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLY 139
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           ++  N+++HRD+K  N++  I  DG  + KL DFG AR           +   +   P+ 
Sbjct: 140 YIHRNKILHRDMKAANVL--ITRDG--VLKLADFGLARA----------FSLAKNSQPNR 185
Query: 188 YERAVL----RKP---VG-KTFGATVDLWSIGVTLYHVAT 219
           Y   V+    R P   +G + +G  +DLW  G  +  + T
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 21/231 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G      +K   E VAVK   + + +   +VQ RE    + ++H NIV+   + 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQ-REIINHRSLRHPNIVRFKEVI 85
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
                    I+ME  +GG L+  +    N     E+E     + L +G+ +    ++ HR
Sbjct: 86  LTPTHLA--IIMEYASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQICHR 140
Query: 138 DLKPGNIMKFICDDGSTI--YKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           DLK  N +     DGS     K+ DFG ++      Q  S  GT  Y+ P++    +LR+
Sbjct: 141 DLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV----LLRQ 192
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFR-PYGGRRNKETMYYITTKKAS 245
              +  G   D+WS GVTLY +  G  PF  P   R  ++T+  I + K S
Sbjct: 193 ---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    KN+   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    +++
Sbjct: 76  YF--HDSTRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKKVI 130
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 131 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-AALCGTLDYLPPEMIE------ 179
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 180 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENI 70
           +     +G G+     + V+K      AVK  ++ S   P +    E E+L +  +H NI
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDK-SKRDPSE----EIEILLRYGQHPNI 83
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           + L  + ++  G+   +V EL  GG L   LD         E E   VL  +   +++L 
Sbjct: 84  ITLKDVYDD--GKHVYLVTELMRGGEL---LDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYE 189
              +VHRDLKP NI+           ++ DFG A++L  E+   M+   T  ++ P++ +
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           R        + +    D+WS+G+ LY +  G  PF
Sbjct: 199 R--------QGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +     +G G+     + V+K      AVK  ++       ++++    +L+  +H NI+
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI----LLRYGQHPNII 84
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
            L  + ++  G+   +V EL  GG L   LD         E E   VL  +   +++L  
Sbjct: 85  TLKDVYDD--GKHVYLVTELMRGGEL---LDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYER 190
             +VHRDLKP NI+           ++ DFG A++L  E+   M+   T  ++ P++ +R
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKR 199
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   + +    D+WS+G+ LY +  G  PF
Sbjct: 200 --------QGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 94  FTPQKSLEEFQDVYIVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 147
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR        +    T  Y  P++     
Sbjct: 148 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMVPFVVTRYYRAPEVI---- 199
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   VD+WS+G  +  +  G + F
Sbjct: 200 ----LGMGYKENVDIWSVGCIMGEMIKGGVLF 227

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL 73
           ++LGKG+   V++  + + G  VA+K  ++ +  +   VQ    E ++  ++KH +I++L
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
               E+       +V+E+C  G +   L +    +   E E    +  +  GM +L  + 
Sbjct: 77  YNYFEDSN--YVYLVLEMCHNGEMNRYLKNRVKPF--SENEARHFMHQIITGMLYLHSHG 132
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAV 192
           ++HRDL   N++       +   K+ DFG A +L+   ++  +L GT  Y+ P++  R+ 
Sbjct: 133 ILHRDLTLSNLLL----TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS- 187
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                    G   D+WS+G   Y +  G  PF
Sbjct: 188 -------AHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 13  CTT--SVLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKH 67
           C T   V+G G  G V  G  K  G+   PVA+KT       +     + E  ++ +  H
Sbjct: 23  CITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 82
Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            NI+ L  +  +   +  +IV E    GSL   L   +  + + +   + +L  ++AGMK
Sbjct: 83  PNIIHLEGVVTKS--KPVMIVTEYMENGSLDTFLKKNDGQFTVIQ--LVGMLRGISAGMK 138
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           +L D   VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  
Sbjct: 139 YLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIR 192
Query: 188 Y---ERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
           +   E    RK     F +  D+WS G+ ++ V + G  P+
Sbjct: 193 WTAPEAIAFRK-----FTSASDVWSYGIVMWEVVSYGERPY 228

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 79  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 134 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 182
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 183 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 108/250 (43%), Gaps = 29/250 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S+LG+GA G V    +K  GE VA+K              +RE ++LK  KHENI+ +  
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 76  IEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           I+     E   +V +++      L  ++    +T  L ++     +      +K L  + 
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRAVKVLHGSN 132
Query: 134 LVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQFMS-----LYGTEEYLHPDM 187
           ++HRDLKP N++    CD      K+ DFG AR ++E     S       G  EY+    
Sbjct: 133 VIHRDLKPSNLLINSNCD-----LKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRW 187
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP-YGGRRNKETMYYITTKKASG 246
           Y RA         +   +D+WS G  L  +       RP + GR  +  +  I      G
Sbjct: 188 Y-RAPEVMLTSAKYSRAMDVWSCGCILAELFLR----RPIFPGRDYRHQLLLIF-----G 237
Query: 247 VISGTQTSEN 256
           +I GT  S+N
Sbjct: 238 II-GTPHSDN 246

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 16  SVLGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRP---HDVQMREFEVLKKVKHE 68
           S LGKG  G+V    +  +  N G  VAVK   QL H  P    D Q RE ++LK +  +
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVK---QLQHSGPDQQRDFQ-REIQILKALHSD 71
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            IVK   +      +   +VME    G L + L    +   L     LL    +  GM++
Sbjct: 72  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEY 129
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           L   R VHRDL   NI+     +     K+ DFG A+ L  D+ +   Y   E     ++
Sbjct: 130 LGSRRCVHRDLAARNILV----ESEAHVKIADFGLAKLLPLDKDY---YVVREPGQSPIF 182
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
             A         F    D+WS GV LY + T
Sbjct: 183 WYAP-ESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 81  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 136 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 184
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 185 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 19  GKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR---EFEVLKKVKHENIVKLLA 75
           G+G  G V++G   N    VAVK    +  +   +++ +   E +V  K +HEN+V+LL 
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +G    +V      GSL + L   + T  L       + +    G+  L +N  +
Sbjct: 89  FS--SDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHI 146
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS---LYGTEEYLHPDMYERAV 192
           HRD+K  NI+     D +   K++DFG AR  E+  Q +    + GT  Y  P+     +
Sbjct: 147 HRDIKSANILL----DEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEI 202
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
             K          D++S GV L  + TG LP
Sbjct: 203 TPKS---------DIYSFGVVLLEIITG-LP 223

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 86  FTPQKSLEEFQDVYIVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 139
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 140 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 191
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VDLWS+G  +  +    +  P R Y  + NK
Sbjct: 192 ----LGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNK 230

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G ++  L   +      E+     +  L   + +    R++
Sbjct: 81  YF--HDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 136 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 184
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 185 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 76  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 131 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-AALCGTLDYLPPEMIE------ 179
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 180 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKSLEEFQDVYIVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   VD+WS+G  +  +  G + F
Sbjct: 198 ----LGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 93  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 147
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 148 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 196
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 197 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 223

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 75  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 129
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 130 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 178
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 179 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 205

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 79  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 134 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-AALCGTLDYLPPEMIE------ 182
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 183 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQ-----MELDHERMSYLLYQMLVGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +    +T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDATL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   VD+WS+G  +  +  G + F
Sbjct: 198 ----LGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 99/240 (41%), Gaps = 49/240 (20%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN---TYGLQEEEF---LLVLEHLTA- 124
            LL    +  G   VIV E C  G+L   L    N    Y +  E+     L LEHL   
Sbjct: 86  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 125 ------GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG 178
                 GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D        
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIXKD-------- 192
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
                 PD   +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 193 ------PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 244

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 83
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I++E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 84  TREPPF--YIIIEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 141 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 193
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 194 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 220

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 76  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 131 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 179
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 180 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 77  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 131
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 132 HRDIKPENLL--LGSAGEL--KIADFGWSCHAPSSRR-TTLSGTLDYLPPEMIE------ 180
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 181 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +    +T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDATL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   VD+WS+G  +  +  G + F
Sbjct: 198 ----LGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 79  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 134 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 182
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 183 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 16  SVLGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRP---HDVQMREFEVLKKVKHE 68
           S LGKG  G+V    +  +  N G  VAVK   QL H  P    D Q RE ++LK +  +
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVK---QLQHSGPDQQRDFQ-REIQILKALHSD 84
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            IVK   +      +   +VME    G L + L    +   L     LL    +  GM++
Sbjct: 85  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEY 142
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           L   R VHRDL   NI+     +     K+ DFG A+ L  D+ +   Y   E     ++
Sbjct: 143 LGSRRCVHRDLAARNILV----ESEAHVKIADFGLAKLLPLDKDY---YVVREPGQSPIF 195
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
             A         F    D+WS GV LY + T
Sbjct: 196 WYAP-ESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN---TYGLQEEEF---LLVLEHLTA- 124
            LL    +  G   VIV E C  G+L   L    N    Y +  E+     L LEHL   
Sbjct: 95  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 125 ------GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG 178
                 GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D        
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIXKD-------- 201
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
                 PD   +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 202 ------PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 253
Query: 230 RRNKE 234
            +  E
Sbjct: 254 VKIDE 258

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G ++  L   +      E+     +  L   + +    R++
Sbjct: 81  YF--HDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++   L GT +YL P+M E      
Sbjct: 136 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-XXLXGTLDYLPPEMIE------ 184
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 185 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 77  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 131
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++   L GT +YL P+M E      
Sbjct: 132 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIE------ 180
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 181 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 78  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 132
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++   L GT +YL P+M E      
Sbjct: 133 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-XXLCGTLDYLPPEMIE------ 181
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 182 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K  G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 110 --SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N+M     D     K+TDFG A+ ++   +   L GT EYL P++        
Sbjct: 165 YRDLKPENLMI----DQQGYIKVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 211
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 212 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 18  LGKGATGAVFQGVNKNN-----GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+G  G V + V  ++      + V VK  +Q+       +  +E  +L   +H NI+ 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-------LVKKEISILNIARHRNILH 65
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L    E  E    V++ E  +G  +F  ++   + + L E E +  +  +   ++ L  +
Sbjct: 66  LHESFESMEEL--VMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            + H D++P NI+ +     STI K+ +FG AR+L+    F  L+   EY  P++++  V
Sbjct: 122 NIGHFDIRPENII-YQTRRSSTI-KIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +            D+WS+G  +Y + +G  PF
Sbjct: 180 V--------STATDMWSLGTLVYVLLSGINPF 203

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 93  FTPQKSLEEFQDVYIVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 146
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 147 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 198
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   VD+WS+G  +  +  G + F
Sbjct: 199 ----LGMGYKENVDIWSVGCIMGEMIKGGVLF 226

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 16  SVLGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRP---HDVQMREFEVLKKVKHE 68
           S LGKG  G+V    +  +  N G  VAVK   QL H  P    D Q RE ++LK +  +
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVK---QLQHSGPDQQRDFQ-REIQILKALHSD 72
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            IVK   +      +   +VME    G L + L    +   L     LL    +  GM++
Sbjct: 73  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEY 130
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           L   R VHRDL   NI+     +     K+ DFG A+ L  D+ +   Y   E     ++
Sbjct: 131 LGSRRCVHRDLAARNILV----ESEAHVKIADFGLAKLLPLDKDY---YVVREPGQSPIF 183
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
             A         F    D+WS GV LY + T
Sbjct: 184 WYAP-ESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDA-NLSQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +    +T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDATL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   VD+WS+G  +  +  G + F
Sbjct: 198 ----LGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 78
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I++E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 79  TREPPF--YIIIEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 136 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 188
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 189 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 215

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 97  FTPQKSLEEFQDVYIVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 150
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 151 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 202
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VDLWS+G  +  +    +  P R Y  + NK
Sbjct: 203 ----LGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNK 241

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 106/244 (43%), Gaps = 36/244 (14%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G    V++G +K     VA+K              +RE  +LK +KH NIV L  I 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +  +   +V E      L   LDD  N   +   +  L    L  G+ +    +++HR
Sbjct: 70  HTE--KSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLF--QLLRGLAYCHRQKVLHR 124
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELE-----EDQQFMSLYGTEEYLHPDMYERAV 192
           DLKP N++  I + G    KL DFG AR         D + ++L+    Y  PD+     
Sbjct: 125 DLKPQNLL--INERGEL--KLADFGLARAKSIPTKTYDNEVVTLW----YRPPDIL---- 172
Query: 193 LRKPVGKT-FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT 251
               +G T +   +D+W +G   Y +ATG  P  P  G   +E +++I        I GT
Sbjct: 173 ----LGSTDYSTQIDMWGVGCIFYEMATGR-PLFP--GSTVEEQLHFIFR------ILGT 219
Query: 252 QTSE 255
            T E
Sbjct: 220 PTEE 223

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 27/233 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEP--VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LG G  G+V QGV +   +   VA+K   Q +     +  MRE +++ ++ +  IV+L+ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEE----EFLLVLEHLTAGMKHLRD 131
           + + +     ++VME+  GG L   L       G +EE        +L  ++ GMK+L +
Sbjct: 404 VCQAE---ALMLVMEMAGGGPLHKFL------VGKREEIPVSNVAELLHQVSMGMKYLEE 454
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY-LHPDMYER 190
              VHR+L   N++           K++DFG ++ L  D  + +     ++ L     E 
Sbjct: 455 KNFVHRNLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
              RK     F +  D+WS GVT++   +     +PY   +  E M +I   K
Sbjct: 511 INFRK-----FSSRSDVWSYGVTMWEALSYGQ--KPYKKMKGPEVMAFIEQGK 556

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 102 YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 156
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 157 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 205
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 206 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 76
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 77  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  F +  G +  +     E     K 
Sbjct: 134 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TFTAHAGAKFPIKWTAPESLAYNK- 186
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 187 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 213

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKSLEEFQDVYIVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   VD+WS+G  +  +  G + F
Sbjct: 198 ----LGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++M+L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 86  LLGICLTSTVQ---LIMQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 139
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 140 RRLVHRDLAARNVLV----KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-----KWM 190
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 76  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++   L GT +YL P+M E      
Sbjct: 131 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIE------ 179
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 180 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 77  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 131
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 132 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-DTLCGTLDYLPPEMIE------ 180
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 181 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 99/238 (41%), Gaps = 47/238 (19%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL----LVLEHL----- 122
            LL    +  G   VIV E C  G+L   L    N +   + E L    L LEHL     
Sbjct: 97  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSF 155
Query: 123 --TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
               GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D          
Sbjct: 156 QVAKGMEFLASRKXIHRDLAARNILL----SEKNVVKICDFGLARDIXKD---------- 201
Query: 181 EYLHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
               PD   +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 202 ----PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 253

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 101/244 (41%), Gaps = 48/244 (19%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN---TYGLQEEEF--LLVLEHLTA-- 124
            LL    +  G   VIV E C  G+L   L    N    Y   E+ +   L LEHL    
Sbjct: 96  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYS 154
Query: 125 -----GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
                GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D         
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIXKD--------- 201
Query: 180 EEYLHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGGR 230
                PD   +   R P+      T+         D+WS GV L+ + +  L   PY G 
Sbjct: 202 -----PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGV 254
Query: 231 RNKE 234
           +  E
Sbjct: 255 KIDE 258

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKTLEEFQDVYLVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDXTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 198 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++M+L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 84  LLGICLTSTVQ---LIMQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 137
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 138 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 188
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKTLEEFQDVYLVMEL-MDANLXQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDXTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 198 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 101/241 (41%), Gaps = 45/241 (18%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEF--LLVLEHLTA----- 124
            LL    +  G   VIV E C  G+L   L    N +   ++ +   L LEHL       
Sbjct: 95  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 125 --GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D            
Sbjct: 154 AKGMEFLASRKXIHRDLAARNILL----SEKNVVKICDFGLARDIYKD------------ 197
Query: 183 LHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGGRRNK 233
             PD   +   R P+      T+         D+WS GV L+ + +  L   PY G +  
Sbjct: 198 --PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID 253
Query: 234 E 234
           E
Sbjct: 254 E 254

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++M+L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 83  LLGICLTSTVQ---LIMQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 136
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 137 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 187
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
            L   + + +    D+WS GVT++ + T     +PY G
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMT--FGSKPYDG 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++M+L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 84  LLGICLTSTVQ---LIMQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 137
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 138 RRLVHRDLAARNVLV----KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-----KWM 188
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN---TYGLQEEEF---LLVLEHLTA- 124
            LL    +  G   VIV E C  G+L   L    N    Y +  E+     L LEHL   
Sbjct: 95  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 125 ------GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG 178
                 GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D        
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKD-------- 201
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
                 PD   +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 202 ------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 253
Query: 230 RRNKE 234
            +  E
Sbjct: 254 VKIDE 258

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 78
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I++E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 79  TREPPF--YIIIEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 136 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 188
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 189 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 215

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 25/228 (10%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVK-HENIV 71
           T+ +LG+GA   V   V+  NG+  AVK    Q  H R      RE E L + + ++NI+
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSR--VFREVETLYQCQGNKNIL 74
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           +L+   E+       +V E   GGS   IL   +      E E   V+  + A +  L  
Sbjct: 75  ELIEFFEDDTRF--YLVFEKLQGGS---ILAHIQKQKHFNEREASRVVRDVAAALDFLHT 129
Query: 132 NRLVHRDLKPGNIMKFICDDGSTI--YKLTDF--GAARELEED------QQFMSLYGTEE 181
             + HRDLKP NI+   C+    +   K+ DF  G+  +L          +  +  G+ E
Sbjct: 130 KGIAHRDLKPENIL---CESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
           Y+ P++ E   +       +    DLWS+GV LY + +G  PF  + G
Sbjct: 187 YMAPEVVE---VFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCG 231

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++M+L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 82  LLGICLTSTVQ---LIMQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 135
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 136 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 186
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 81  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++   L GT +YL P+M E      
Sbjct: 136 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIE------ 184
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 185 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 76  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++   L GT +YL P+M E      
Sbjct: 131 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIE------ 179
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 180 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++M+L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 86  LLGICLTSTVQ---LIMQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 139
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 140 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 190
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K     +A+K     QL          RE E+   ++H NI++L  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 73  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 127
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 128 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 176
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 177 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 203

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN---TYGLQEEEF---LLVLEHLTA- 124
            LL    +  G   VIV E C  G+L   L    N    Y +  E+     L LEHL   
Sbjct: 95  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 125 ------GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG 178
                 GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D        
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKD-------- 201
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
                 PD   +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 202 ------PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 253
Query: 230 RRNKE 234
            +  E
Sbjct: 254 VKIDE 258

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 76  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++   L GT +YL P+M E      
Sbjct: 131 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TELCGTLDYLPPEMIE------ 179
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 180 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 130 FTPQKTLEEFQDVYLVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 183
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 184 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 235
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 236 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 274

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++M+L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 85  LLGICLTSTVQ---LIMQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 138
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 139 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 189
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N+   I D    I ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENL---IIDQQGYI-QVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -ISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 80  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 134
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 135 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 183
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 184 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 210

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++M+L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 84  LLGICLTSTVQ---LIMQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 137
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 138 RRLVHRDLAARNVLV----KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-----KWM 188
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ---MREFEVLKKVKHENIVKLL 74
           +G+G  G VF G  + +   VAVK+  +     P D++   ++E  +LK+  H NIV+L+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRE---TLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG--LQEEEFLLVLEHLTAGMKHLRDN 132
            +  +++     IVMEL  GG     L     T G  L+ +  L ++    AGM++L   
Sbjct: 179 GVCTQKQ--PIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE----YLHPDM- 187
             +HRDL   N +         + K++DFG +RE E D    +  G  +    +  P+  
Sbjct: 233 CCIHRDLAARNCLV----TEKNVLKISDFGMSRE-EADGVXAASGGLRQVPVKWTAPEAL 287
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
            Y R          + +  D+WS G+ L+   T +L   PY    N++T  ++
Sbjct: 288 NYGR----------YSSESDVWSFGILLWE--TFSLGASPYPNLSNQQTREFV 328

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 79  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++   L GT +YL P+M E      
Sbjct: 134 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-XXLCGTLDYLPPEMIE------ 182
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 183 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   IVMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKSLEEFQDVYIVMEL-MDANLSQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   VD+WS+G  +  +  G + F
Sbjct: 198 ----LGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++M+L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 83  LLGICLTSTVQ---LIMQLMPFGXLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 136
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 137 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 187
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 79
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 80  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 136
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 137 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAYNK- 189
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 190 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 216

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 83
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 84  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 141 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 193
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 194 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 220

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K N   +A+K    +QL          RE E+   ++H NI+++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 76  IEEEQEGRGKVIVM-ELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNR 133
              +   R ++ +M E    G L+  L      +G   E+     +E L   + +  + +
Sbjct: 82  YFHD---RKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP N++  +   G    K+ DFG +      ++   + GT +YL P+M E    
Sbjct: 135 VIHRDIKPENLL--MGYKGEL--KIADFGWSVHAPSLRR-RXMCGTLDYLPPEMIE---- 185
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               GKT    VDLW  GV  Y    G  PF
Sbjct: 186 ----GKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 91  FTPQKTLEEFQDVYLVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 144
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 145 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 196
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 197 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 235

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKL- 73
           V+G+GA G V     KN     A+K  N+   ++  +      E +VL     + I  L 
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 156
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A ++E       +VM+   GG L  +L   E+   L E+     +  +   +  +    
Sbjct: 157 YAFQDENH---LYLVMDYYVGGDLLTLLSKFEDK--LPEDMARFYIGEMVLAIDSIHQLH 211
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS--LYGTEEYLHPDMYERA 191
            VHRD+KP N++     D +   +L DFG+  ++ +D    S    GT +Y+ P++ +  
Sbjct: 212 YVHRDIKPDNVLL----DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ-- 265
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +   +GK +G   D WS+GV +Y +  G  PF
Sbjct: 266 AMEDGMGK-YGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    + +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 80  YF--HDATRVYLILEYAPLGTVYREL---QKLSRFDEQRTATYITELANALSYCHSKRVI 134
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +  +G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 135 HRDIKPENLL--LGSNGEL--KIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 183
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 184 --GRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKL- 73
           V+G+GA G V     KN     A+K  N+   ++  +      E +VL     + I  L 
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 140
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A ++E       +VM+   GG L  +L   E+   L E+     +  +   +  +    
Sbjct: 141 YAFQDENH---LYLVMDYYVGGDLLTLLSKFEDK--LPEDMARFYIGEMVLAIDSIHQLH 195
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS--LYGTEEYLHPDMYERA 191
            VHRD+KP N++     D +   +L DFG+  ++ +D    S    GT +Y+ P++ +  
Sbjct: 196 YVHRDIKPDNVLL----DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ-- 249
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +   +GK +G   D WS+GV +Y +  G  PF
Sbjct: 250 AMEDGMGK-YGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 78
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 79  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 136 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 188
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 189 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 215

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 78
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 79  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 136 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 188
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 189 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 215

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 80
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 81  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 138 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAYNK- 190
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 191 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 217

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 93  FTPQKTLEEFQDVYLVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 146
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 147 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 198
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 199 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 237

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKTLEEFQDVYLVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 198 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 76  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++   L GT +YL P+M E      
Sbjct: 131 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-XXLCGTLDYLPPEMIE------ 179
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 180 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 76  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 130
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++   L GT +YL P+M E      
Sbjct: 131 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TXLCGTLDYLPPEMIE------ 179
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 180 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 42/246 (17%)
Query: 13  CTTSVLGKGATG-AVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENI 70
            +  +LG G++G  VFQG  +  G PVAVK       +   D+ + E ++L +   H N+
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRM----LIDFCDIALMEIKLLTESDDHPNV 89
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILD-------DPENTYGLQEEEFLLVLEHLT 123
           ++      E   R   I +ELC      N+ D         EN    +E   + +L  + 
Sbjct: 90  IRYYC--SETTDRFLYIALELCN----LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 124 AGMKHLRDNRLVHRDLKPGNIM-----KFICDDGSTIYKL----TDFGAARELEEDQQFM 174
           +G+ HL   +++HRDLKP NI+     +F  D  +    L    +DFG  ++L+  Q   
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 175 SL-----YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
                   GT  +  P++ E +  R+        ++D++S+G   Y++ +      P+G 
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRR-----LTRSIDIFSMGCVFYYILSKGK--HPFGD 256
Query: 230 RRNKET 235
           + ++E+
Sbjct: 257 KYSRES 262

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKV--IVMELCTGGSLFNILDDPENTYG-LQEE 113
           RE +    + H  IV +    E +   G +  IVME   G +L +I+    +T G +  +
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPK 116
Query: 114 EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED--- 170
             + V+      +     N ++HRD+KP NIM       +   K+ DFG AR + +    
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMI----SATNAVKVMDFGIARAIADSGNS 172
Query: 171 -QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             Q  ++ GT +YL P+           G +  A  D++S+G  LY V TG  PF
Sbjct: 173 VTQTAAVIGTAQYLSPEQAR--------GDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKV--IVMELCTGGSLFNILDDPENTYG-LQEE 113
           RE +    + H  IV +    E +   G +  IVME   G +L +I+    +T G +  +
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPK 116
Query: 114 EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED--- 170
             + V+      +     N ++HRD+KP NIM       +   K+ DFG AR + +    
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMI----SATNAVKVMDFGIARAIADSGNS 172
Query: 171 -QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             Q  ++ GT +YL P+           G +  A  D++S+G  LY V TG  PF
Sbjct: 173 VTQTAAVIGTAQYLSPEQAR--------GDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K N   +A+K    +QL          RE E+   ++H NI+++  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 76  IEEEQEGRGKVIVM-ELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNR 133
              +   R ++ +M E    G L+  L      +G   E+     +E L   + +  + +
Sbjct: 83  YFHD---RKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHERK 135
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP N++  +   G    K+ DFG +      ++   + GT +YL P+M E    
Sbjct: 136 VIHRDIKPENLL--MGYKGEL--KIADFGWSVHAPSLRR-RXMCGTLDYLPPEMIE---- 186
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               GKT    VDLW  GV  Y    G  PF
Sbjct: 187 ----GKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKTLEEFQDVYLVMELM-DANLXQVIQ-----MELDHERMSYLLYQMLXGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDXTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 198 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 42/246 (17%)
Query: 13  CTTSVLGKGATG-AVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENI 70
            +  +LG G++G  VFQG  +  G PVAVK       +   D+ + E ++L +   H N+
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRM----LIDFCDIALMEIKLLTESDDHPNV 89
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILD-------DPENTYGLQEEEFLLVLEHLT 123
           ++      E   R   I +ELC      N+ D         EN    +E   + +L  + 
Sbjct: 90  IRYYC--SETTDRFLYIALELCN----LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 124 AGMKHLRDNRLVHRDLKPGNIM-----KFICDDGSTIYKL----TDFGAARELEEDQQFM 174
           +G+ HL   +++HRDLKP NI+     +F  D  +    L    +DFG  ++L+  Q   
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 175 SL-----YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
                   GT  +  P++ E +  R+        ++D++S+G   Y++ +      P+G 
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRR-----LTRSIDIFSMGCVFYYILSKGK--HPFGD 256
Query: 230 RRNKET 235
           + ++E+
Sbjct: 257 KYSRES 262

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKTLEEFQDVYLVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 198 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKV--IVMELCTGGSLFNILDDPENTYG-LQEE 113
           RE +    + H  IV +    E +   G +  IVME   G +L +I+    +T G +  +
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPK 116
Query: 114 EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED--- 170
             + V+      +     N ++HRD+KP NIM       +   K+ DFG AR + +    
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMI----SATNAVKVMDFGIARAIADSGNS 172
Query: 171 -QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             Q  ++ GT +YL P+           G +  A  D++S+G  LY V TG  PF
Sbjct: 173 VTQTAAVIGTAQYLSPEQAR--------GDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 86  FTPQKTLEEFQDVYLVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 139
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 140 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 191
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 192 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 230

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 130 FTPQKTLEEFQDVYLVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 183
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 184 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 235
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 236 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 274

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN---TYGLQEEEF---LLVLEHLTA- 124
            LL    +  G   VIV E C  G+L   L    N    Y +  E+     L LEHL   
Sbjct: 132 NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190
Query: 125 ------GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG 178
                 GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D        
Sbjct: 191 SFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKD-------- 238
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
                 PD   +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 239 ------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 290
Query: 230 RRNKE 234
            +  E
Sbjct: 291 VKIDE 295

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 110/249 (44%), Gaps = 28/249 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S LG G  G VF+  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NR 133
                   G++ I ME   GGSL  +L   +    + E+    V   +  G+ +LR+ ++
Sbjct: 72  AFYSD---GEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+  +   G    KL DFG + +L  D    S  GT  Y+ P+  +    
Sbjct: 126 IMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ---- 176
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK-------ETMYYITTKKASG 246
               G  +    D+WS+G++L  +A G  P  P   + +        E + YI  +    
Sbjct: 177 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPK 232
Query: 247 VISGTQTSE 255
           + SG  + E
Sbjct: 233 LPSGVFSLE 241

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 78
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 79  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 136 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 188
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 189 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 215

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 14  TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIV 71
              V+G+GA G V    +K + +  A+K  ++   ++  D      E +++       +V
Sbjct: 79  VVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 138
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNIL---DDPENTYGLQEEEFLLVLEHLTAGMKH 128
           +L      Q+ +   +VME   GG L N++   D PE        E +L L+ + +    
Sbjct: 139 QLFC--AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHS---- 192
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM--SLYGTEEYLHPD 186
                L+HRD+KP N++     D     KL DFG   +++E       +  GT +Y+ P+
Sbjct: 193 ---MGLIHRDVKPDNMLL----DKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPE 245
Query: 187 MYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
                VL+   G  + G   D WS+GV L+ +  G+ PF
Sbjct: 246 -----VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 96  --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 150
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++    D+   I ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 151 YRDLKPENLL---IDEQGYI-QVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 197
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 198 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 86  FTPQKTLEEFQDVYLVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 139
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 140 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 191
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 192 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 230

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 101/241 (41%), Gaps = 45/241 (18%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEF--LLVLEHL------- 122
            LL    +  G   VIV E C  G+L   L    N +   ++ +   L LEHL       
Sbjct: 95  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQV 153
Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
             GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D            
Sbjct: 154 AKGMEFLASRKXIHRDLAARNILL----SEKNVVKIXDFGLARDIYKD------------ 197
Query: 183 LHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGGRRNK 233
             PD   +   R P+      T+         D+WS GV L+ + +  L   PY G +  
Sbjct: 198 --PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKID 253
Query: 234 E 234
           E
Sbjct: 254 E 254

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 85  FTPQKTLEEFQDVYLVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 138
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 139 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 190
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 191 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 82
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 83  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 139
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 140 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 192
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 193 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 219

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 78  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 132
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ +FG +      ++  +L GT +YL P+M E      
Sbjct: 133 HRDIKPENLL--LGSAGEL--KIANFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 181
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 182 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 78
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 79  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 136 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 188
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 189 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 215

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 80
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 81  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 138 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 190
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 191 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 217

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 93  FTPQKTLEEFQDVYLVMEL-MDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA 146
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 147 GIIHRDLKPSNI---VVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 198
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 199 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 237

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G      +K + E VAVK   +   +   +V+ RE    + ++H NIV+   + 
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKID-ENVK-REIINHRSLRHPNIVRFKEVI 83
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
                    IVME  +GG LF  +    N     E+E     + L +G+ +    ++ HR
Sbjct: 84  LTPTHLA--IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 138
Query: 138 DLKPGNIMKFICDDGSTI--YKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           DLK  N +     DGS     K+ DFG ++      Q  S  GT  Y+ P++    +L+K
Sbjct: 139 DLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV----LLKK 190
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFR-PYGGRRNKETMYYI 239
              +  G   D+WS GVTLY +  G  PF  P   +  ++T++ I
Sbjct: 191 ---EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 232

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 83
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 84  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 141 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 193
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 194 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 220

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 80
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 81  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 137
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 138 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 190
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 191 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 217

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G      +K + E VAVK   +   +  +    RE    + ++H NIV+   + 
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAAN--VKREIINHRSLRHPNIVRFKEVI 84
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
                    IVME  +GG LF  +    N     E+E     + L +G+ +    ++ HR
Sbjct: 85  LTPTHLA--IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 139
Query: 138 DLKPGNIMKFICDDGSTI--YKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           DLK  N +     DGS     K+ DFG ++      Q  S  GT  Y+ P++    +L+K
Sbjct: 140 DLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV----LLKK 191
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              +  G   D+WS GVTLY +  G  PF
Sbjct: 192 ---EYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 29/250 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S+LG+GA G V    +K  GE VA+K              +RE ++LK  KHENI+ +  
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 76  IEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           I+     E   +V +++      L  ++    +T  L ++     +      +K L  + 
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRAVKVLHGSN 132
Query: 134 LVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQFMS-----LYGTEEYLHPDM 187
           ++HRDLKP N++    CD      K+ DFG AR ++E     S       G  E++    
Sbjct: 133 VIHRDLKPSNLLINSNCD-----LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP-YGGRRNKETMYYITTKKASG 246
           Y RA         +   +D+WS G  L  +       RP + GR  +  +  I      G
Sbjct: 188 Y-RAPEVMLTSAKYSRAMDVWSCGCILAELFLR----RPIFPGRDYRHQLLLIF-----G 237
Query: 247 VISGTQTSEN 256
           +I GT  S+N
Sbjct: 238 II-GTPHSDN 246

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 49/240 (20%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN---TYGLQEEEF---LLVLEHLTA- 124
            LL     + G   +++ E C  G+L   L    N    Y +  E+     L LEHL   
Sbjct: 86  NLLG-ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 125 ------GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG 178
                 GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D        
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIXKD-------- 192
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
                 PD   +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 193 ------PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 244

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 49/240 (20%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN---TYGLQEEEF---LLVLEHLTA- 124
            LL     + G   +++ E C  G+L   L    N    Y +  E+     L LEHL   
Sbjct: 86  NLLG-ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 125 ------GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG 178
                 GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D        
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKD-------- 192
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
                 PD   +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 193 ------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 244

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 83
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 84  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 141 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 193
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 194 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 220

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 91
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 92  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 148
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 149 DLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 201
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 202 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 228

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 76
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I++E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 77  TREPPF--YIIIEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D    +  G +  +     E     K 
Sbjct: 134 DLAARN-----CLVGENHLVKVADFGLSRLMTGDTX-TAHAGAKFPIKWTAPESLAYNK- 186
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 187 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 213

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++  +++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N+M     D     K+TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLMI----DQQGYIKVTDFGLAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    + +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 80  YF--HDATRVYLILEYAPLGTVYREL---QKLSRFDEQRTATYITELANALSYCHSKRVI 134
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +  +G    K+ DFG +      ++  +L GT +YL P+M E      
Sbjct: 135 HRDIKPENLL--LGSNGEL--KIADFGWSVHAPSSRR-DTLCGTLDYLPPEMIE------ 183
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 184 --GRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKV--IVMELCTGGSLFNILDDPENTYG-LQEE 113
           RE +    + H  IV +    E +   G +  IVME   G +L +I+    +T G +  +
Sbjct: 78  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPK 133
Query: 114 EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED--- 170
             + V+      +     N ++HRD+KP NIM       +   K+ DFG AR + +    
Sbjct: 134 RAIEVIADACQALNFSHQNGIIHRDVKPANIMI----SATNAVKVMDFGIARAIADSGNS 189
Query: 171 -QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             Q  ++ GT +YL P+           G +  A  D++S+G  LY V TG  PF
Sbjct: 190 VTQTAAVIGTAQYLSPEQAR--------GDSVDARSDVYSLGCVLYEVLTGEPPF 236

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 76
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 186 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 49/240 (20%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPEN---TYGLQEEEF---LLVLEHLTA- 124
            LL     + G   +++ E C  G+L   L    N    Y +  E+     L LEHL   
Sbjct: 86  NLLG-ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 125 ------GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG 178
                 GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D        
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKD-------- 192
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
                 PD   +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 193 ------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 244

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 76
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 186 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 102 YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 156
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++   L GT +YL P+M E      
Sbjct: 157 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-DDLCGTLDYLPPEMIE------ 205
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 206 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLXGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 77
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 78  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 129
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 130 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 186
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 187 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 220

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 79
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I++E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 80  TREPPF--YIIIEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 136
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D    +  G +  +     E     K 
Sbjct: 137 DLAARN-----CLVGENHLVKVADFGLSRLMTGDTX-TAHAGAKFPIKWTAPESLAYNK- 189
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 190 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 216

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 15  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 74
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL-------DDPENTYGLQEEEFLLVLEHLTAGMK 127
              +  +      VME   GG LF  L       +D    YG    E +  L++L +   
Sbjct: 75  YSFQTHDRL--CFVMEYANGGELFFHLSRERVFSEDRARFYG---AEIVSALDYLHS--- 126
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPD 186
              +  +V+RDLK  N+M  +  DG    K+TDFG  +E  +D   M  + GT EYL P+
Sbjct: 127 ---EKNVVYRDLKLENLM--LDKDGHI--KITDFGLCKEGIKDGATMKXFCGTPEYLAPE 179
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + E           +G  VD W +GV +Y +  G LPF
Sbjct: 180 VLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 79  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ +FG +      ++  +L GT +YL P+M E      
Sbjct: 134 HRDIKPENLL--LGSAGEL--KIANFGWSVHAPSSRR-TTLCGTLDYLPPEMIE------ 182
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 183 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 76
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 186 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL-------DDPENTYGLQEEEFLLVLEHLTAGMK 127
              +  +      VME   GG LF  L       +D    YG    E +  L++L +   
Sbjct: 215 YSFQTHDRL--CFVMEYANGGELFFHLSRERVFSEDRARFYGA---EIVSALDYLHS--- 266
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPD 186
              +  +V+RDLK  N+M  +  DG    K+TDFG  +E  +D   M  + GT EYL P+
Sbjct: 267 ---EKNVVYRDLKLENLM--LDKDGHI--KITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + E           +G  VD W +GV +Y +  G LPF
Sbjct: 320 VLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 84
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 85  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 136
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 137 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 193
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 194 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 227

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 92  FTPQKTLEEFQDVYLVMEL-MDANLXQVIQ-----MELDHERMSYLLYQMLXGIKHLHSA 145
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 146 GIIHRDLKPSNI---VVKSDXTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 197
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 198 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 16  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 75
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL-------DDPENTYGLQEEEFLLVLEHLTAGMK 127
              +  +      VME   GG LF  L       +D    YG    E +  L++L +   
Sbjct: 76  YSFQTHDRL--CFVMEYANGGELFFHLSRERVFSEDRARFYG---AEIVSALDYLHS--- 127
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPD 186
              +  +V+RDLK  N+M  +  DG    K+TDFG  +E  +D   M  + GT EYL P+
Sbjct: 128 ---EKNVVYRDLKLENLM--LDKDGHI--KITDFGLCKEGIKDGATMKXFCGTPEYLAPE 180
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + E           +G  VD W +GV +Y +  G LPF
Sbjct: 181 VLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-REFEVLKKVKHENIVKLLAI 76
           +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 77  EEEQ----EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              Q    E +   +VMEL    +L  ++        L  E    +L  +  G+KHL   
Sbjct: 85  FTPQKTLEEFQDVYLVMEL-MDANLXQVIQ-----MELDHERMSYLLYQMLXGIKHLHSA 138
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRDLKP NI   +     T+ K+ DFG AR             T  Y  P++     
Sbjct: 139 GIIHRDLKPSNI---VVKSDXTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI---- 190
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNL--PFRPYGGRRNK 233
               +G  +   VD+WS+G  +  +    +  P R Y  + NK
Sbjct: 191 ----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 88
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 89  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 140
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 141 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 197
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 198 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 95
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 96  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 147
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 148 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 204
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 205 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 17  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 76
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL-------DDPENTYGLQEEEFLLVLEHLTAGMK 127
              +  +      VME   GG LF  L       +D    YG    E +  L++L +   
Sbjct: 77  YSFQTHDRL--CFVMEYANGGELFFHLSRERVFSEDRARFYG---AEIVSALDYLHS--- 128
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPD 186
              +  +V+RDLK  N+M  +  DG    K+TDFG  +E  +D   M  + GT EYL P+
Sbjct: 129 ---EKNVVYRDLKLENLM--LDKDGHI--KITDFGLCKEGIKDGATMKXFCGTPEYLAPE 181
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + E           +G  VD W +GV +Y +  G LPF
Sbjct: 182 VLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLAGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKV--IVMELCTGGSLFNILDDPENTYG-LQEE 113
           RE +    + H  IV +    E +   G +  IVME   G +L +I+    +T G +  +
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPK 116
Query: 114 EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED--- 170
             + V+      +     N ++HRD+KP NI+       +   K+ DFG AR + +    
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANILI----SATNAVKVVDFGIARAIADSGNS 172
Query: 171 -QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             Q  ++ GT +YL P+           G +  A  D++S+G  LY V TG  PF
Sbjct: 173 VXQTAAVIGTAQYLSPEQAR--------GDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEE------EFLLVLEHLTA- 124
            LL    +  G   VIV E C  G+L   L    N +   +E      +  L LEHL   
Sbjct: 97  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 125 ------GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG 178
                 GM+ L   + +HRDL   NI+         + K+ DFG AR++ +D        
Sbjct: 156 SFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKD-------- 203
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
                 PD   +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 204 ------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 255
Query: 230 RRNKE 234
            +  E
Sbjct: 256 VKIDE 260

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 25/221 (11%)
Query: 12  WCTTSV---LGKGATGAVFQGVNKNNGEPVAVKTF-NQLSHMRPHDVQMREFEVLKKVKH 67
           WC  ++   +G G+ G V +   + +G  VAVK    Q  H    +  +RE  ++K+++H
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            NIV  +    +       IV E  + GSL+ +L        L E   L +   +  GM 
Sbjct: 94  PNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 128 HL--RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS--LYGTEEYL 183
           +L  R+  +VHRDLK  N++    D   T+ K+ DFG +R L+      S    GT E++
Sbjct: 152 YLHNRNPPIVHRDLKSPNLL---VDKKYTV-KVCDFGLSR-LKASXFLXSKXAAGTPEWM 206
Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            P+     VLR    +      D++S GV L+ +AT   P+
Sbjct: 207 APE-----VLRD---EPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 89
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 90  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 141
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 142 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 198
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 199 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 232

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 45/230 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 104
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 105 RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 156
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 157 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 213
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATGNLPF 224
             Y  P++             FGAT     +D+WS G  L  +  G   F
Sbjct: 214 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL--- 74
           LG+G  G VF+  NK +    A+K     +     +  MRE + L K++H  IV+     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 75  ----AIEEEQEGRGKV---IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
                 E+ Q    KV   I M+LC   +L + ++        +    L +   +   ++
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ------FMSLY---- 177
            L    L+HRDLKP NI  F  DD   + K+ DFG    +++D++       M  Y    
Sbjct: 133 FLHSKGLMHRDLKPSNIF-FTMDD---VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 178 ---GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHV 217
              GT+ Y+ P+           G ++   VD++S+G+ L+ +
Sbjct: 189 GQVGTKLYMSPEQIH--------GNSYSHKVDIFSLGLILFEL 223

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 81  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 135
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++  +L GT +YL P+  E      
Sbjct: 136 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-TTLCGTLDYLPPEXIE------ 184
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 185 --GRXHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 217
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL-------DDPENTYGLQEEEFLLVLEHLTAGMK 127
              +  +      VME   GG LF  L       +D    YG    E +  L++L +   
Sbjct: 218 YSFQTHDRL--CFVMEYANGGELFFHLSRERVFSEDRARFYGA---EIVSALDYLHS--- 269
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPD 186
              +  +V+RDLK  N+M  +  DG    K+TDFG  +E  +D   M  + GT EYL P+
Sbjct: 270 ---EKNVVYRDLKLENLM--LDKDGHI--KITDFGLCKEGIKDGATMKTFCGTPEYLAPE 322
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + E           +G  VD W +GV +Y +  G LPF
Sbjct: 323 VLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 104 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 158
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 159 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 205
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 206 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-----NRELQIMRKLDHCNIV 76
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 186 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K  G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 102 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 156
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 157 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 203
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 204 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 110 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 165 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 211
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 212 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 88
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 89  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 140
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 141 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 197
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 198 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                +     +++E    G+++  L   +      E+     +  L   + +    R++
Sbjct: 79  YF--HDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKRVI 133
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N++  +   G    K+ DFG +      ++   L GT +YL P+M E      
Sbjct: 134 HRDIKPENLL--LGSAGEL--KIADFGWSVHAPSSRR-DDLCGTLDYLPPEMIE------ 182
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             G+     VDLWS+GV  Y    G  PF
Sbjct: 183 --GRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 92/214 (42%), Gaps = 27/214 (12%)
Query: 16  SVLGKGATGAV----FQGVNKNNGEPVAVKTFNQLSHMRP---HDVQMREFEVLKKVKHE 68
           S LGKG  G+V    +  +  N G  VAVK   QL H  P    D Q RE ++LK +  +
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVK---QLQHSGPDQQRDFQ-REIQILKALHSD 68
Query: 69  NIVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            IVK   +     GR ++ +VME    G L + L    +   L     LL    +  GM+
Sbjct: 69  FIVKYRGVSY-GPGRPELRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGME 125
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR--ELEEDQQFMSLYGTEEYLHP 185
           +L   R VHRDL   NI+     +     K+ DFG A+   L++D   +   G       
Sbjct: 126 YLGSRRCVHRDLAARNILV----ESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIF-- 179
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT 219
             Y    L       F    D+WS GV LY + T
Sbjct: 180 -WYAPESLSD---NIFSRQSDVWSFGVVLYELFT 209

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 110
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 220 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 80
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 81  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 132
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 133 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 189
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 190 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 223

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-----NRELQIMRKLDHCNIV 76
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 186 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G      +K   E VAVK   +   +   +V+ RE    + ++H NIV+   + 
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKID-ENVK-REIINHRSLRHPNIVRFKEVI 84
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
                    IVME  +GG LF  +    N     E+E     + L +G+ +    ++ HR
Sbjct: 85  LTPTHLA--IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSYAHAMQVAHR 139
Query: 138 DLKPGNIMKFICDDGSTI--YKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           DLK  N +     DGS     K+ DFG ++      Q  S  GT  Y+ P++    +L+K
Sbjct: 140 DLKLENTLL----DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEV----LLKK 191
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              +  G   D+WS GVTLY +  G  PF
Sbjct: 192 ---EYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N+M     D     K+TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLMI----DQQGYIKVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 81
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 82  RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 133
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 134 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 190
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 191 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 224

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFAEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 102/245 (41%), Gaps = 51/245 (20%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAV-KTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLA 75
           LGKGA G V++ +++  GE VAV K F+   +        RE  +L ++  HENIV LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 76  IEEEQEGRGKVIV---MELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           +      R   +V   ME      +  NIL+     Y         V+  L   +K+L  
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY---------VVYQLIKVIKYLHS 127
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE---------------------LEED 170
             L+HRD+KP NI+     +     K+ DFG +R                       ++D
Sbjct: 128 GGLLHRDMKPSNILL----NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 171 QQFMSLY-GTEEYLHPDMYERAVLRKPVGKT-FGATVDLWSIGVTLYHVATGNLPFRPYG 228
           Q  ++ Y  T  Y  P++         +G T +   +D+WS+G  L  +  G  P  P  
Sbjct: 184 QPILTDYVATRWYRAPEIL--------LGSTKYTKGIDMWSLGCILGEILCGK-PIFPGS 234
Query: 229 GRRNK 233
              N+
Sbjct: 235 STMNQ 239

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 130 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 184
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++      +L GT EYL P++        
Sbjct: 185 YRDLKPENLLI----DQQGYIQVTDFGFAKRVKGAT--WTLCGTPEYLAPEII------- 231
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 232 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 106/249 (42%), Gaps = 27/249 (10%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S+LG+GA G V    +K  GE VA+K              +RE ++LK  KHENI+ +  
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 76  IEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           I+     E   +V +++      L  ++    +T  L ++     +      +K L  + 
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVI----STQMLSDDHIQYFIYQTLRAVKVLHGSN 132
Query: 134 LVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           ++HRDLKP N++    CD      K+ DFG AR ++E     S    ++    +      
Sbjct: 133 VIHRDLKPSNLLINSNCD-----LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRW 187
Query: 193 LRKP----VGKTFGATVDLWSIGVTLYHVATGNLPFRP-YGGRRNKETMYYITTKKASGV 247
            R P        +   +D+WS G  L  +       RP + GR  +  +  I      G+
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLR----RPIFPGRDYRHQLLLIF-----GI 238
Query: 248 ISGTQTSEN 256
           I GT  S+N
Sbjct: 239 I-GTPHSDN 246

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K  G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 102 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 156
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 157 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 203
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 204 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 110
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 219
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 220 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 76  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 129
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 130 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 180
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
            L   + + +    D+WS GVT++ + T     +PY G
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMT--FGSKPYDG 216

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S LG G  G VF+  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NR 133
                   G++ I ME   GGSL  +L   +    + E+    V   +  G+ +LR+ ++
Sbjct: 72  AFYSD---GEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+  +   G    KL DFG + +L  D    S  GT  Y+ P+  +    
Sbjct: 126 IMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ---- 176
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
               G  +    D+WS+G++L  +A G  P  P
Sbjct: 177 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 83
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 84  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 140
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D    +  G +  +     E     K 
Sbjct: 141 DLAARN-----CLVGENHLVKVADFGLSRLMTGDTX-TAHAGAKFPIKWTAPESLAYNK- 193
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 194 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 220

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 112
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 113 RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 164
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 165 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 221
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 222 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 255

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S LG G  G VF+  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NR 133
                   G++ I ME   GGSL  +L   +    + E+    V   +  G+ +LR+ ++
Sbjct: 72  AFYSD---GEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+  +   G    KL DFG + +L  D    S  GT  Y+ P+  +    
Sbjct: 126 IMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ---- 176
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
               G  +    D+WS+G++L  +A G  P  P
Sbjct: 177 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S LG G  G VF+  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NR 133
                   G++ I ME   GGSL  +L   +    + E+    V   +  G+ +LR+ ++
Sbjct: 72  AFYSD---GEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+  +   G    KL DFG + +L  D    S  GT  Y+ P+  +    
Sbjct: 126 IMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ---- 176
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
               G  +    D+WS+G++L  +A G  P  P
Sbjct: 177 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S LG G  G VF+  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NR 133
                   G++ I ME   GGSL  +L   +    + E+    V   +  G+ +LR+ ++
Sbjct: 72  AFYSD---GEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+  +   G    KL DFG + +L  D    S  GT  Y+ P+  +    
Sbjct: 126 IMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ---- 176
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
               G  +    D+WS+G++L  +A G  P  P
Sbjct: 177 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S LG G  G VF+  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 74  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 133
Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NR 133
                   G++ I ME   GGSL  +L   +    + E+    V   +  G+ +LR+ ++
Sbjct: 134 AFYSD---GEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+  +   G    KL DFG + +L  D    S  GT  Y+ P+  +    
Sbjct: 188 IMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ---- 238
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
               G  +    D+WS+G++L  +A G  P  P
Sbjct: 239 ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 114
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 115 RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 166
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 167 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 223
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 224 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 257

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N+M     D     K+TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLMI----DQQGYIKVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K  G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 21/230 (9%)
Query: 1   MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQM 56
           M+ LR      +    VLG GA G V++G+    GE    PVA+K   + +  + +   +
Sbjct: 3   MALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 62
Query: 57  REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL 116
            E  V+  V + ++ +LL I      +   ++ +L   G L + + + ++  G Q   +L
Sbjct: 63  DEAYVMASVDNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YL 116
Query: 117 L-VLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS 175
           L     +  GM +L D RLVHRDL   N++           K+TDFG A+ L  +++   
Sbjct: 117 LNWCVQIAEGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYH 172
Query: 176 LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
             G +  +     +   L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 173 AEGGKVPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 217

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K  G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K  G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           VLGKG+ G V     K  G+  AVK   +   ++  DV+  M E  +L   ++   +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 75  AIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
               +   R    VME   GG L F+I    + +    E         + + +  L D  
Sbjct: 90  FCCFQTPDR-LFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAV 192
           +++RDLK  N++     D     KL DFG  +E +       +  GT +Y+ P++ +  +
Sbjct: 145 IIYRDLKLDNVLL----DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   +G  VD W++GV LY +  G+ PF
Sbjct: 201 --------YGPAVDWWAMGVLLYEMLCGHAPF 224

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  N N GE  A+K    +          +RE  +LK++KH NIVKL  +
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +  +  V+V E      L  +LD  E   GL+       L  L  G+ +  D R++H
Sbjct: 69  IHTK--KRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAAREL-----EEDQQFMSLYGTEEYLHPDMYERA 191
           RDLKP N++  I  +G    K+ DFG AR       +   + ++L+    Y  PD+   +
Sbjct: 124 RDLKPQNLL--INREGEL--KIADFGLARAFGIPVRKYTHEIVTLW----YRAPDVLMGS 175
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
                  K +  T+D+WS+G     +  G  P  P
Sbjct: 176 -------KKYSTTIDIWSVGCIFAEMVNGT-PLFP 202

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 92  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 145
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 146 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 196
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 197 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 230

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 27/222 (12%)
Query: 12  WCTTSV---LGKGATGAVFQGVNKNNGEPVAVKTF-NQLSHMRPHDVQMREFEVLKKVKH 67
           WC  ++   +G G+ G V +   + +G  VAVK    Q  H    +  +RE  ++K+++H
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            NIV  +    +       IV E  + GSL+ +L        L E   L +   +  GM 
Sbjct: 94  PNIVLFMGAVTQPPNLS--IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 128 HL--RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEY 182
           +L  R+  +VHR+LK  N++    D   T+ K+ DFG +R   +   F+   S  GT E+
Sbjct: 152 YLHNRNPPIVHRNLKSPNLL---VDKKYTV-KVCDFGLSR--LKASTFLSSKSAAGTPEW 205
Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + P+     VLR    +      D++S GV L+ +AT   P+
Sbjct: 206 MAPE-----VLRD---EPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 84  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 137
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 138 RRLVHRDLAARNVLV----KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-----KWM 188
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 85  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 138
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 139 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 189
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 130 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 184
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 185 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 231
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 232 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K  G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 110 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 165 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 211
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 212 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 29/217 (13%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S LG G  G VF+  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKHLR 130
                   G++ I ME   GGSL  +L      PE   G        V   +  G+ +LR
Sbjct: 99  AFYSD---GEISICMEHMDGGSLDQVLKKAGRIPEQILGK-------VSIAVIKGLTYLR 148
Query: 131 D-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
           + ++++HRD+KP NI+  +   G    KL DFG + +L  D    S  GT  Y+ P+  +
Sbjct: 149 EKHKIMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ 203
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
                   G  +    D+WS+G++L  +A G  P  P
Sbjct: 204 --------GTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 84  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 137
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 138 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 188
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 82  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 135
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 136 RRLVHRDLAARNVLV----KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-----KWM 186
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 82  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 135
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 136 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 186
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
            L   + + +    D+WS GVT++ + T     +PY G
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT--FGSKPYDG 222

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++  +++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N+M     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLMI----DQQGYIQVTDFGLAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  N N GE  A+K    +          +RE  +LK++KH NIVKL  +
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +  +  V+V E      L  +LD  E   GL+       L  L  G+ +  D R++H
Sbjct: 69  IHTK--KRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G    K+ DFG AR      +++     T  Y  PD+   +    
Sbjct: 124 RDLKPQNLL--INREGEL--KIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS---- 175
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
              K +  T+D+WS+G     +  G  P  P
Sbjct: 176 ---KKYSTTIDIWSVGCIFAEMVNGT-PLFP 202

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K  G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 110 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 165 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 211
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 212 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K  G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 110 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 165 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 211
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 212 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 82  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 135
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 136 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 186
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           VLGKG  G V     +  G+  A K   +    +     M   E ++L+KV    +V L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 75  AIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              E ++     +V+ L  GG L F+I        G  E   +     +  G++ L   R
Sbjct: 251 YAYETKDAL--CLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +V+RDLKP NI+    DD   I +++D G A  + E Q      GT  Y+ P++ +    
Sbjct: 307 IVYRDLKPENIL---LDDHGHI-RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK---- 358
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                + +  + D W++G  LY +  G  PF+
Sbjct: 359 ----NERYTFSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 76
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 77  TREPPF--YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 133
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D    +  G +  +     E     K 
Sbjct: 134 DLAARN-----CLVGENHLVKVADFGLSRLMTGDTX-TAHAGAKFPIKWTAPESLAYNK- 186
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 187 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 213

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 88  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 141
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 142 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 192
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 193 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 226

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 85  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 138
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 139 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 189
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 107 LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 160
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 161 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 211
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 212 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 245

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           VLGKG  G V     +  G+  A K   +    +     M   E ++L+KV    +V L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 75  AIEEEQEGRGKVIVMELCTGGSL-FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              E ++     +V+ L  GG L F+I        G  E   +     +  G++ L   R
Sbjct: 251 YAYETKDAL--CLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +V+RDLKP NI+    DD   I +++D G A  + E Q      GT  Y+ P++ +    
Sbjct: 307 IVYRDLKPENIL---LDDHGHI-RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK---- 358
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                + +  + D W++G  LY +  G  PF+
Sbjct: 359 ----NERYTFSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 85  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 138
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 139 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 189
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P     A++  
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAP-----AII-- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 32/228 (14%)
Query: 18  LGKGATGAVFQ----GVNKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIV 71
           LG GA G V +    G+ K +    VAVK     +H    +  M E +++  + +HENIV
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-------DPENTYGLQEEEFLLVLEHLTA 124
            LL       G   +++ E C  G L N L        D E+   L+  + L     +  
Sbjct: 106 NLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---E 181
           GM  L     +HRD+   N++         + K+ DFG AR++  D  ++         +
Sbjct: 164 GMAFLASKNCIHRDVAARNVLL----TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
           ++ P+     V        +    D+WS G+ L+ + +  L   PY G
Sbjct: 220 WMAPESIFDCV--------YTVQSDVWSYGILLWEIFS--LGLNPYPG 257

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIV 155
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-DPENTYGL-----QEEEFL------LVL 119
           +L         +   + + L        +LD  PE  Y +     + ++ L      L +
Sbjct: 156 RLRYFFYSSGEKKDEVYLNL--------VLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 207
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             L   + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +
Sbjct: 208 YQLFRSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 264
Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
             Y  P++             FGAT     +D+WS G  L  +  G
Sbjct: 265 RYYRAPEL------------IFGATDYTSSIDVWSAGCVLAELLLG 298

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VL  GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++M+L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 89  LLGICLTSTVQ---LIMQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 142
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 143 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 193
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 89  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 142
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 143 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 193
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G+ G V +  +K  G   AVK       +R    ++ E      +    IV L    
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKK------VRLEVFRVEELVACAGLSSPRIVPLYGAV 133
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +EG    I MEL  GGSL  ++   +    L E+  L  L     G+++L   R++H 
Sbjct: 134 --REGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 188
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY------GTEEYLHPDMYERA 191
           D+K  N++  +  DGS    L DFG A  L+ D    SL       GTE ++ P++    
Sbjct: 189 DVKADNVL--LSSDGSRA-ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV--- 242
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
                +GK   A VD+WS    + H+  G  P+  Y
Sbjct: 243 -----MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 273

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 32/228 (14%)
Query: 18  LGKGATGAVFQ----GVNKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIV 71
           LG GA G V +    G+ K +    VAVK     +H    +  M E +++  + +HENIV
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILD-------DPENTYGLQEEEFLLVLEHLTA 124
            LL       G   +++ E C  G L N L        D E+   L+  + L     +  
Sbjct: 114 NLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---E 181
           GM  L     +HRD+   N++         + K+ DFG AR++  D  ++         +
Sbjct: 172 GMAFLASKNCIHRDVAARNVLL----TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
           ++ P+     V        +    D+WS G+ L+ + +  L   PY G
Sbjct: 228 WMAPESIFDCV--------YTVQSDVWSYGILLWEIFS--LGLNPYPG 265

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 82  LLGICLTSTVQ---LITQLMPFGXLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 135
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 136 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 186
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 89  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 142
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 143 RRLVHRDLAARNVLV----KTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-----KWM 193
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  N N GE  A+K    +          +RE  +LK++KH NIVKL  +
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +  +  V+V E      L  +LD  E   GL+       L  L  G+ +  D R++H
Sbjct: 69  IHTK--KRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G    K+ DFG AR      +++     T  Y  PD+   +    
Sbjct: 124 RDLKPQNLL--INREGEL--KIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS---- 175
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
              K +  T+D+WS+G     +  G  P  P
Sbjct: 176 ---KKYSTTIDIWSVGCIFAEMVNGA-PLFP 202

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 107/247 (43%), Gaps = 30/247 (12%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S LG G  G VF+  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 31  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 90
Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKHLR 130
                   G++ I ME   GGSL  +L      PE   G        V   +  G+ +LR
Sbjct: 91  AFYSD---GEISICMEHMDGGSLDQVLKKAGRIPEQILGK-------VSIAVIKGLTYLR 140
Query: 131 D-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
           + ++++HRD+KP NI+  +   G    KL DFG + +L  D    S  GT  Y+ P+  +
Sbjct: 141 EKHKIMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ 195
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK-ETMYYITTKKASGVI 248
                   G  +    D+WS+G++L  +A G  P     G     E + YI  +    + 
Sbjct: 196 --------GTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLP 247
Query: 249 SGTQTSE 255
           SG  + E
Sbjct: 248 SGVFSLE 254

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +GKG  G V  G  + N   VAVK     +  +     + E  V+ +++H N+V+LL + 
Sbjct: 201 IGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAF---LAEASVMTQLRHSNLVQLLGVI 255
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E++G G  IV E    GSL + L     +  L  +  L     +   M++L  N  VHR
Sbjct: 256 VEEKG-GLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNFVHR 313
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPV 197
           DL   N++  + +D   + K++DFG  +E    Q    L    ++  P+      LR+  
Sbjct: 314 DLAARNVL--VSED--NVAKVSDFGLTKEASSTQDTGKL--PVKWTAPE-----ALRE-- 360
Query: 198 GKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            K F    D+WS G+ L+ + + G +P+
Sbjct: 361 -KKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +GKG  G V  G  + N   VAVK     +  +     + E  V+ +++H N+V+LL + 
Sbjct: 29  IGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAF---LAEASVMTQLRHSNLVQLLGVI 83
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E++G G  IV E    GSL + L     +  L  +  L     +   M++L  N  VHR
Sbjct: 84  VEEKG-GLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNFVHR 141
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPV 197
           DL   N++  + +D   + K++DFG  +E    Q    L    ++  P+      LR+  
Sbjct: 142 DLAARNVL--VSED--NVAKVSDFGLTKEASSTQDTGKL--PVKWTAPE-----ALRE-- 188
Query: 198 GKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            K F    D+WS G+ L+ + + G +P+
Sbjct: 189 -KKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 25/231 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V +G  K  G+    VA+KT       R     + E  ++ + +H NI++L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 74  LAIEEEQEGRGKVIVMELCTGGSL--FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
             +         +I+ E    G+L  F  L+D + T      + + +L  + +GM++L +
Sbjct: 81  EGVVTNS--MPVMILTEFMENGALDSFLRLNDGQFTV----IQLVGMLRGIASGMRYLAE 134
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE---DQQFMSLYGTEEYLHPDMY 188
              VHRDL   NI+     + + + K++DFG +R LEE   D  + S  G +  +     
Sbjct: 135 MSYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           E    RK     F +  D WS G+ ++ V +     RPY    N++ +  I
Sbjct: 191 EAIAFRK-----FTSASDAWSYGIVMWEVMS--FGERPYWDMSNQDVINAI 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K  G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 130 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 184
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 185 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 231
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 232 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N+M     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLMI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +GKG  G V  G  + N   VAVK     +  +     + E  V+ +++H N+V+LL + 
Sbjct: 14  IGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAF---LAEASVMTQLRHSNLVQLLGVI 68
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E++G G  IV E    GSL + L     +  L  +  L     +   M++L  N  VHR
Sbjct: 69  VEEKG-GLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNFVHR 126
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPV 197
           DL   N++  + +D   + K++DFG  +E    Q    L    ++  P+      LR+  
Sbjct: 127 DLAARNVL--VSED--NVAKVSDFGLTKEASSTQDTGKL--PVKWTAPE-----ALRE-- 173
Query: 198 GKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            K F    D+WS G+ L+ + + G +P+
Sbjct: 174 -KKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  + + M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEF-LKEAAVMKEIKHPNLVQLLGVC 285
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 286 TREPPF--YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           +L   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 343 NLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 395
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 396 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 422

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 38/242 (15%)
Query: 17  VLGKGATG-AVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLL 74
           +LG G++G  VFQG  +  G PVAVK       +   D+ + E ++L +   H N+++  
Sbjct: 22  ILGYGSSGTVVFQGSFQ--GRPVAVKRM----LIDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILD-------DPENTYGLQEEEFLLVLEHLTAGMK 127
               E   R   I +ELC      N+ D         EN    +E   + +L  + +G+ 
Sbjct: 76  C--SETTDRFLYIALELCN----LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 128 HLRDNRLVHRDLKPGNIM-----KFICDDGSTIYKL----TDFGAARELEEDQQFMSL-- 176
           HL   +++HRDLKP NI+     +F  D  +    L    +DFG  ++L+  Q       
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 177 ---YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK 233
               GT  +  P++ E +   +   +    ++D++S+G   Y++ +      P+G + ++
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQ-TKRRLTRSIDIFSMGCVFYYILSKGK--HPFGDKYSR 246
Query: 234 ET 235
           E+
Sbjct: 247 ES 248

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 112/242 (46%), Gaps = 38/242 (15%)
Query: 17  VLGKGATG-AVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLL 74
           +LG G++G  VFQG  +  G PVAVK       +   D+ + E ++L +   H N+++  
Sbjct: 22  ILGYGSSGTVVFQGSFQ--GRPVAVKRM----LIDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILD-------DPENTYGLQEEEFLLVLEHLTAGMK 127
               E   R   I +ELC      N+ D         EN    +E   + +L  + +G+ 
Sbjct: 76  C--SETTDRFLYIALELCN----LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 128 HLRDNRLVHRDLKPGNIM-----KFICDDGSTIYKL----TDFGAARELEEDQ-----QF 173
           HL   +++HRDLKP NI+     +F  D  +    L    +DFG  ++L+  Q       
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 174 MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK 233
            +  GT  +  P++ E +   +   +    ++D++S+G   Y++ +      P+G + ++
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQ-TKRRLTRSIDIFSMGCVFYYILSKGK--HPFGDKYSR 246
Query: 234 ET 235
           E+
Sbjct: 247 ES 248

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVKL 73
           +LGKG+ G VF    K   +  A+K   +   +   DV+  M E  VL    +H  +  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
               + +E      VME   GG L   +    + + L    F      +  G++ L    
Sbjct: 84  FCTFQTKENL--FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAA--EIILGLQFLHSKG 138
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAV 192
           +V+RDLK  NI+  +  DG    K+ DFG  +E +  D +     GT +Y+ P++     
Sbjct: 139 IVYRDLKLDNIL--LDKDGHI--KIADFGMCKENMLGDAKTNXFCGTPDYIAPEIL---- 190
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G+ +  +VD WS GV LY +  G  PF
Sbjct: 191 ----LGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 95  --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 149
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +  +L GT EYL P++        
Sbjct: 150 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWTLCGTPEYLAPEII------- 196
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 197 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 97/222 (43%), Gaps = 37/222 (16%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +  T V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-----NRELQIMRKLDHCNIV 76
Query: 72  KLLAIEEEQEGRGKVIVMELC---TGGSLFNILDDPENTYGLQEEEFLLV-----LEHLT 123
           +L         +   + + L       +++ +       Y   ++   ++     +  L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRV----ARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
             + ++    + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +  Y 
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 184 HPDMYERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
            P++             FGAT     +D+WS G  L  +  G
Sbjct: 190 APEL------------IFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    + KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 110 --SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N+M     D     K+TDFG A+ ++   +   L GT EYL P++        
Sbjct: 165 YRDLKPENLMI----DQQGYIKVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 211
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 212 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    + KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 110 --SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N+M     D     K+TDFG A+ ++   +   L GT EYL P++        
Sbjct: 165 YRDLKPENLMI----DQQGYIKVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 211
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 212 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 21/229 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K  G+    VA+KT       +     + E  ++ +  H N++ L
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +      +I+ E    GSL + L   +  + + +   + +L  + AGMK+L D  
Sbjct: 100 EGVVTKSTP--VMIITEFMENGSLDSFLRQNDGQFTVIQ--LVGMLRGIAAGMKYLADMN 155
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYER 190
            VHRDL   NI+     + + + K++DFG +R LE+D     + S  G +  +     E 
Sbjct: 156 YVHRDLAARNILV----NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
              RK     F +  D+WS G+ ++ V +     RPY    N++ +  I
Sbjct: 212 IQYRK-----FTSASDVWSYGIVMWEVMSYGE--RPYWDMTNQDVINAI 253

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVKL 73
           +LGKG+ G VF    K   +  A+K   +   +   DV+  M E  VL    +H  +  +
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 84
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
               + +E      VME   GG L   +    + + L    F      +  G++ L    
Sbjct: 85  FCTFQTKENL--FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAA--EIILGLQFLHSKG 139
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAV 192
           +V+RDLK  NI+  +  DG    K+ DFG  +E +  D +     GT +Y+ P++     
Sbjct: 140 IVYRDLKLDNIL--LDKDGHI--KIADFGMCKENMLGDAKTNEFCGTPDYIAPEIL---- 191
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G+ +  +VD WS GV LY +  G  PF
Sbjct: 192 ----LGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHENIVKL 73
           LG G  G V+     N    VAVKT      M+P  + +  F     V+K ++H+ +VKL
Sbjct: 23  LGAGQFGEVWMATY-NKHTKVAVKT------MKPGSMSVEAFLAEANVMKTLQHDKLVKL 75
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A+  ++      I+ E    GSL + L   E +      + +     +  GM  +    
Sbjct: 76  HAVVTKEP---IYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRN 131
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            +HRDL+  NI+       S + K+ DFG AR + ED ++ +  G +  +          
Sbjct: 132 YIHRDLRAANILV----SASLVCKIADFGLARVI-EDNEYTAREGAKFPIK--------W 178
Query: 194 RKPVGKTFGATV---DLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
             P    FG+     D+WS G+ L  + T G +   PY G  N E +
Sbjct: 179 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI---PYPGMSNPEVI 222

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    + KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 110 --SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N+M     D     K+TDFG A+ ++   +   L GT EYL P++        
Sbjct: 165 YRDLKPENLMI----DQQGYIKVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 211
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 212 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+ G V +  +K  G   AVK       +R    ++ E      +    IV L    
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKK------VRLEVFRVEELVACAGLSSPRIVPLYGAV 119
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +EG    I MEL  GGSL  ++   +    L E+  L  L     G+++L   R++H 
Sbjct: 120 --REGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 174
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY------GTEEYLHPDMYERA 191
           D+K  N++  +  DGS    L DFG A  L+ D    SL       GTE ++ P++    
Sbjct: 175 DVKADNVL--LSSDGSRA-ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV--- 228
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
                +GK   A VD+WS    + H+  G  P+  Y
Sbjct: 229 -----MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 259

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V++GV K     VAVKT  + + M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEF-LKEAAVMKEIKHPNLVQLLGVC 324
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 325 TREPPF--YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 381
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           +L   N     C  G   + K+ DFG +R +  D  + +  G +  +     E     K 
Sbjct: 382 NLAARN-----CLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNK- 434
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               F    D+W+ GV L+ +AT  +   PY G
Sbjct: 435 ----FSIKSDVWAFGVLLWEIATYGM--SPYPG 461

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 112 EGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 167
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG AR LE+D +  + Y T     P  +   E 
Sbjct: 168 YVHRDLAARNILI----NSNLVCKVSDFGLARVLEDDPE--AAYTTRGGKIPIRWTSPEA 221
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 222 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 260

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G      +K + E VAVK   +   +   +V+ RE    + ++H NIV+   + 
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKID-ENVK-REIINHRSLRHPNIVRFKEVI 84
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
                    IVME  +GG LF  +    N     E+E     + L +G+ +    ++ HR
Sbjct: 85  LTPTHLA--IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 139
Query: 138 DLKPGNIMKFICDDGSTI--YKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           DLK  N +     DGS     K+  FG ++      Q  S  GT  Y+ P++    +L+K
Sbjct: 140 DLKLENTLL----DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEV----LLKK 191
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              +  G   D+WS GVTLY +  G  PF
Sbjct: 192 ---EYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF-NQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +G GA G V     +  G+ VA+K   N    +      +RE ++LK  KH+NI+ +  I
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 77  EEEQEGRGKV----IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
                  G+     +V++L     L  I+    ++  L  E     L  L  G+K++   
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMES-DLHQII---HSSQPLTLEHVRYFLYQLLRGLKYMHSA 177
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL----EEDQQFMSLY-GTEEYLHPDM 187
           +++HRDLKP N++     + +   K+ DFG AR L     E Q FM+ Y  T  Y  P++
Sbjct: 178 QVIHRDLKPSNLLV----NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 188 YERAVLRKPVGKTFGATVDLWSIG 211
                        +   +DLWS+G
Sbjct: 234 MLSL-------HEYTQAIDLWSVG 250

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 35/227 (15%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHENIVKL 73
           LG G  G V+     N    VAVKT      M+P  + +  F     V+K ++H+ +VKL
Sbjct: 196 LGAGQFGEVWMATY-NKHTKVAVKT------MKPGSMSVEAFLAEANVMKTLQHDKLVKL 248
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A+  ++      I+ E    GSL + L   E +      + +     +  GM  +    
Sbjct: 249 HAVVTKEP---IYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYER 190
            +HRDL+  NI+       S + K+ DFG AR + ED ++ +  G +   ++  P+    
Sbjct: 305 YIHRDLRAANILV----SASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINF 359
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                    +F    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 360 G--------SFTIKSDVWSFGILLMEIVTYGRI---PYPGMSNPEVI 395

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +GKG  G V  G  + N   VAVK     +  +     + E  V+ +++H N+V+LL + 
Sbjct: 20  IGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAF---LAEASVMTQLRHSNLVQLLGVI 74
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            E++G G  IV E    GSL + L     +  L  +  L     +   M++L  N  VHR
Sbjct: 75  VEEKG-GLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNFVHR 132
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPV 197
           DL   N++  + +D   + K++DFG  +E    Q    L    ++  P+    A      
Sbjct: 133 DLAARNVL--VSED--NVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREA------ 180
Query: 198 GKTFGATVDLWSIGVTLYHVAT-GNLPF 224
              F    D+WS G+ L+ + + G +P+
Sbjct: 181 --AFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 110 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +  +L GT EYL P++        
Sbjct: 165 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWTLCGTPEYLAPEII------- 211
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 212 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+ G V +  +K  G   AVK       +R    ++ E      +    IV L    
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKK------VRLEVFRVEELVACAGLSSPRIVPLYGAV 135
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +EG    I MEL  GGSL  ++   +    L E+  L  L     G+++L   R++H 
Sbjct: 136 --REGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 190
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY------GTEEYLHPDMYERA 191
           D+K  N++  +  DGS    L DFG A  L+ D    SL       GTE ++ P++    
Sbjct: 191 DVKADNVL--LSSDGSRA-ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV--- 244
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
                +GK   A VD+WS    + H+  G  P+  Y
Sbjct: 245 -----MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 275

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S LG G  G VF+  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 15  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NR 133
                   G++ I ME   GGSL  +L   +    + E+    V   +  G+ +LR+ ++
Sbjct: 75  AFYSD---GEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKHK 128
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+  +   G    KL DFG + +L  D+      GT  Y+ P+  +    
Sbjct: 129 IMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DEMANEFVGTRSYMSPERLQ---- 179
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
               G  +    D+WS+G++L  +A G  P  P
Sbjct: 180 ----GTHYSVQSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 83  EGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 138
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 139 YVHRDLAARNILI----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEA 192
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 193 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 231

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 82
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 83  EGVVTKS--KPVMIVTEXMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 138
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 139 YVHRDLAARNILI----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEA 192
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 193 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 231

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+GA G V    +      VA+K  +   H       +RE ++L + +HEN++ +  I 
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 78  EEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
                E    V +++      L+ +L     +  L  +     L  +  G+K++    ++
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLL----KSQQLSNDHICYFLYQILRGLKYIHSANVL 166
Query: 136 HRDLKPGNIM-KFICDDGSTIYKLTDFGAAR--ELEEDQQ--FMSLYGTEEYLHPDMYER 190
           HRDLKP N++    CD      K+ DFG AR  + E D          T  Y  P++   
Sbjct: 167 HRDLKPSNLLINTTCD-----LKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           +       K +  ++D+WS+G  L  + + N P  P
Sbjct: 222 S-------KGYTKSIDIWSVGCILAEMLS-NRPIFP 249

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 112 EGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 167
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 168 FVHRDLAARNILI----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEA 221
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 222 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 260

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF-NQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +G GA G V     +  G+ VA+K   N    +      +RE ++LK  KH+NI+ +  I
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 77  EEEQEGRGKV----IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
                  G+     +V++L     L  I+    ++  L  E     L  L  G+K++   
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMES-DLHQII---HSSQPLTLEHVRYFLYQLLRGLKYMHSA 178
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL----EEDQQFMSLY-GTEEYLHPDM 187
           +++HRDLKP N++     + +   K+ DFG AR L     E Q FM+ Y  T  Y  P++
Sbjct: 179 QVIHRDLKPSNLLV----NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 234
Query: 188 YERAVLRKPVGKTFGATVDLWSIG 211
                        +   +DLWS+G
Sbjct: 235 MLSL-------HEYTQAIDLWSVG 251

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VL  GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 82  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 135
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 136 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 186
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 12  WCTTSV-LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI 70
           W T  + LG+G+ G V +  +K  G   AVK       +R    +  E      +    I
Sbjct: 94  WATHQLRLGRGSFGEVHRMEDKQTGFQCAVKK------VRLEVFRAEELMACAGLTSPRI 147
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           V L      +EG    I MEL  GGSL  ++ +      L E+  L  L     G+++L 
Sbjct: 148 VPLYGAV--REGPWVNIFMELLEGGSLGQLVKE---QGCLPEDRALYYLGQALEGLEYLH 202
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY------GTEEYLH 184
             R++H D+K  N++  +  DGS    L DFG A  L+ D    SL       GTE ++ 
Sbjct: 203 SRRILHGDVKADNVL--LSSDGSHA-ALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMA 259
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P++         +G++  A VD+WS    + H+  G  P+
Sbjct: 260 PEVV--------LGRSCDAKVDVWSSCCMMLHMLNGCHPW 291

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 110 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 165 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 211
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 212 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 40  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 99
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 100 EGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 155
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 156 YVHRDLAARNILI----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEA 209
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 210 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 248

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 23/229 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K  G+    VA+KT       +     + E  ++ +  H N+V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +     G+  +IV+E    G+L   L   +  + + +   + +L  + AGM++L D  
Sbjct: 110 EGVV--TRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQ--LVGMLRGIAAGMRYLADMG 165
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R +E+D +  ++Y T     P  +   E 
Sbjct: 166 YVHRDLAARNILV----NSNLVCKVSDFGLSRVIEDDPE--AVYTTTGGKIPVRWTAPEA 219
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
              RK     F +  D+WS G+ ++ V +     RPY    N++ +  I
Sbjct: 220 IQYRK-----FTSASDVWSYGIVMWEVMSYGE--RPYWDMSNQDVIKAI 261

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 50  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 109
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 110 EGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 165
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 166 YVHRDLAARNILI----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEA 219
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 220 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 258

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 110 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT EYL P++        
Sbjct: 165 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEYLAPEII------- 211
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 212 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 109/240 (45%), Gaps = 28/240 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK-KVKHENIVKLLAI 76
            GK   G +F        + VA+KT    +   P   + R   +L+ +++H N+V LL +
Sbjct: 39  FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGV 97
Query: 77  EEEQEGRGKVIVMELCTGGSL--FNILDDPENTYG-----------LQEEEFLLVLEHLT 123
             + +     ++   C+ G L  F ++  P +  G           L+  +F+ ++  + 
Sbjct: 98  VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIA 155
Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
           AGM++L  + +VH+DL   N++ +   D   + K++D G  RE+     +  L G     
Sbjct: 156 AGMEYLSSHHVVHKDLATRNVLVY---DKLNV-KISDLGLFREVYA-ADYYKLLGNSLLP 210
Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
              M   A++    GK F    D+WS GV L+ V +  L  +PY G  N++ +  I  ++
Sbjct: 211 IRWMAPEAIM---YGK-FSIDSDIWSYGVVLWEVFSYGL--QPYCGYSNQDVVEMIRNRQ 264

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 112 EGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 167
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 168 YVHRDLAARNILI----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEA 221
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 222 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 260

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 112 EGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 167
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 168 YVHRDLAARNILI----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEA 221
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 222 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 260

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     ++TDFG A+ ++   +   L GT E L P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIQVTDFGFAKRVK--GRTWXLCGTPEALAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+    + +  + +   + E  V+  V + ++ +
Sbjct: 56  VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 116 LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 169
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 170 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 220
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 221 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 254

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 17  VLGKGATGAVF---QGVNKNNGEPVAVKTFNQ---LSHMRPHDVQMREFEVLKKVKHENI 70
           VLG GA G VF   +    + G+  A+K   +   +   +  +    E +VL+ ++    
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           +  L    + E +  +I ++   GG LF  L   E      E E  + +  +   ++HL 
Sbjct: 121 LVTLHYAFQTETKLHLI-LDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLH 176
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL--EEDQQFMSLYGTEEYLHPDMY 188
              +++RD+K  NI+  +  +G  +  LTDFG ++E   +E ++     GT EY+ PD+ 
Sbjct: 177 KLGIIYRDIKLENIL--LDSNGHVV--LTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 189 ERAVLRKPVGKTFG--ATVDLWSIGVTLYHVATGNLPF 224
                    G   G    VD WS+GV +Y + TG  PF
Sbjct: 233 R--------GGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 112 EGVVTKS--KPVMIVTEXMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 167
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 168 YVHRDLAARNILI----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEA 221
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 222 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 260

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 112 EGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 167
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 168 YVHRDLAARNILI----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEA 221
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 222 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 260

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 112 EGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 167
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 168 YVHRDLAARNILI----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEA 221
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 222 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 260

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           VLG+GA   V   +N    +  AVK    Q  H+R      RE E+L + +    V  L 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVLELI 77
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              E+E R   +V E   GGS   IL          E E  +V++ + + +  L +  + 
Sbjct: 78  EFFEEEDR-FYLVFEKMRGGS---ILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 136 HRDLKPGNIMKFICDDGSTI--YKLTDFGAARELE--------EDQQFMSLYGTEEYLHP 185
           HRDLKP NI+   C+  + +   K+ DFG    ++           + ++  G+ EY+ P
Sbjct: 134 HRDLKPENIL---CEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++ E       +   +    DLWS+GV LY + +G  PF
Sbjct: 191 EVVEAFSEEASI---YDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 112 EGVVTKS--KPVMIVTEXMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 167
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 168 AVHRDLAARNILI----NSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTSPEA 221
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 222 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 260

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VL  GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL-VLEHLTAGMKHLRD 131
           LL I      +   ++ +L   G L + + + ++  G Q   +LL     +  GM +L D
Sbjct: 89  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQ---YLLNWCVQIAKGMNYLED 142
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            RLVHRDL   N++           K+TDFG A+ L  +++     G +  +     +  
Sbjct: 143 RRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWM 193
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            L   + + +    D+WS GVT++ + T G+ P+
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 23/219 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           VLG+GA   V   +N    +  AVK    Q  H+R      RE E+L + +    V  L 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVLELI 77
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
              E+E R   +V E   GGS   IL          E E  +V++ + + +  L +  + 
Sbjct: 78  EFFEEEDR-FYLVFEKMRGGS---ILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 136 HRDLKPGNIMKFICDDGSTI--YKLTDF--GAARELEED------QQFMSLYGTEEYLHP 185
           HRDLKP NI+   C+  + +   K+ DF  G+  +L  D       + ++  G+ EY+ P
Sbjct: 134 HRDLKPENIL---CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++ E       +   +    DLWS+GV LY + +G  PF
Sbjct: 191 EVVEAFSEEASI---YDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 23/226 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +   +  +IV E    GSL + L   +  + + +   + +L  + +GMK+L D  
Sbjct: 112 EGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMG 167
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG  R LE+D +  + Y T     P  +   E 
Sbjct: 168 YVHRDLAARNILI----NSNLVCKVSDFGLGRVLEDDPE--AAYTTRGGKIPIRWTSPEA 221
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
              RK     F +  D+WS G+ L+ V +     RPY    N++ +
Sbjct: 222 IAYRK-----FTSASDVWSYGIVLWEVMSYGE--RPYWEMSNQDVI 260

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V+ GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL + 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGVC 97
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
             +      IV E    G+L + L +  N   +     L +   +++ M++L     +HR
Sbjct: 98  TLEPPF--YIVTEYMPYGNLLDYLREC-NREEVTAVVLLYMATQISSAMEYLEKKNFIHR 154
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           DL   N     C  G   + K+ DFG +R +  D  + +  G +  +     E       
Sbjct: 155 DLAARN-----CLVGENHVVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-- 206
Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
              TF    D+W+ GV L+ +AT  +   PY G
Sbjct: 207 ---TFSIKSDVWAFGVLLWEIATYGM--SPYPG 234

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 23/229 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K  G+    VA+KT       +     + E  ++ +  H NI+ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +    + +  +I+ E    GSL   L   +  + + +   + +L  + +GMK+L D  
Sbjct: 75  EGVV--TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQ--LVGMLRGIGSGMKYLSDMS 130
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 131 YVHRDLAARNILV----NSNLVCKVSDFGMSRVLEDDPE--AAYTTRGGKIPIRWTAPEA 184
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
              RK     F +  D+WS G+ ++ V +     RPY    N++ +  I
Sbjct: 185 IAYRK-----FTSASDVWSYGIVMWEVMSYGE--RPYWDMSNQDVIKAI 226

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 36/232 (15%)
Query: 18  LGKGATGAVFQ----GVNKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIV 71
           LG GA G V +    G+ K +    VAVK     +H    +  M E +++  + +HENIV
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNIL--------DDPENTYG---LQEEEFLLVLE 120
            LL       G   +++ E C  G L N L         DP        L   + L    
Sbjct: 114 NLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
            +  GM  L     +HRD+   N++         + K+ DFG AR++  D  ++      
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLL----TNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 181 ---EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
              +++ P+     V        +    D+WS G+ L+ + +  L   PY G
Sbjct: 228 LPVKWMAPESIFDCV--------YTVQSDVWSYGILLWEIFS--LGLNPYPG 269

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 23/229 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K  G+    VA+KT       +     + E  ++ +  H NI+ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +    + +  +I+ E    GSL   L   +  + + +   + +L  + +GMK+L D  
Sbjct: 81  EGVV--TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQ--LVGMLRGIGSGMKYLSDMS 136
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 137 YVHRDLAARNILV----NSNLVCKVSDFGMSRVLEDDPE--AAYTTRGGKIPIRWTAPEA 190
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
              RK     F +  D+WS G+ ++ V +     RPY    N++ +  I
Sbjct: 191 IAYRK-----FTSASDVWSYGIVMWEVMSYGE--RPYWDMSNQDVIKAI 232

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 109/240 (45%), Gaps = 28/240 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLK-KVKHENIVKLLAI 76
            GK   G +F        + VA+KT    +   P   + R   +L+ +++H N+V LL +
Sbjct: 22  FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGV 80
Query: 77  EEEQEGRGKVIVMELCTGGSL--FNILDDPENTYG-----------LQEEEFLLVLEHLT 123
             + +     ++   C+ G L  F ++  P +  G           L+  +F+ ++  + 
Sbjct: 81  VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIA 138
Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
           AGM++L  + +VH+DL   N++ +   D   + K++D G  RE+     +  L G     
Sbjct: 139 AGMEYLSSHHVVHKDLATRNVLVY---DKLNV-KISDLGLFREVYA-ADYYKLLGNSLLP 193
Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
              M   A++    GK F    D+WS GV L+ V +  L  +PY G  N++ +  I  ++
Sbjct: 194 IRWMAPEAIM---YGK-FSIDSDIWSYGVVLWEVFSYGL--QPYCGYSNQDVVEMIRNRQ 247

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 23/229 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K  G+    VA+KT       +     + E  ++ +  H NI+ L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +    + +  +I+ E    GSL   L   +  + + +   + +L  + +GMK+L D  
Sbjct: 96  EGVV--TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQ--LVGMLRGIGSGMKYLSDMS 151
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY---ER 190
            VHRDL   NI+     + + + K++DFG +R LE+D +  + Y T     P  +   E 
Sbjct: 152 AVHRDLAARNILV----NSNLVCKVSDFGMSRVLEDDPE--AAYTTRGGKIPIRWTAPEA 205
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
              RK     F +  D+WS G+ ++ V +     RPY    N++ +  I
Sbjct: 206 IAYRK-----FTSASDVWSYGIVMWEVMSYGE--RPYWDMSNQDVIKAI 247

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 36/214 (16%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA- 75
           ++G G  G VF+  ++ +G+   +K          ++   RE + L K+ H NIV     
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKY-----NNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 76  ---------IEEEQEGRGKV----IVMELCTGGSLFNILDDPENTYGLQEEEFLLV--LE 120
                       +   R K     I ME C  G+L   +   E   G + ++ L +   E
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDKVLALELFE 129
Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
            +T G+ ++   +L++RDLKP NI  F+ D  +   K+ DFG    L+ D +     GT 
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNI--FLVD--TKQVKIGDFGLVTSLKNDGKRXRSKGTL 185
Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTL 214
            Y+ P+            + +G  VDL+++G+ L
Sbjct: 186 RYMSPEQIS--------SQDYGKEVDLYALGLIL 211

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G      +K + E VAVK   +   +   +V+ RE    + ++H NIV+   + 
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKID-ENVK-REIINHRSLRHPNIVRFKEVI 84
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
                    IVME  +GG LF  +    N     E+E     + L +G+ +    ++ HR
Sbjct: 85  LTPTHLA--IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 139
Query: 138 DLKPGNIMKFICDDGSTI--YKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           DLK  N +     DGS     K+  FG ++      Q     GT  Y+ P++    +L+K
Sbjct: 140 DLKLENTLL----DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEV----LLKK 191
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              +  G   D+WS GVTLY +  G  PF
Sbjct: 192 ---EYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 21/229 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K  G+    VA+KT       +     + E  ++ +  H N++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +      +I+ E    GSL + L   +  + + +   + +L  + AGMK+L D  
Sbjct: 74  EGVVTKSTP--VMIITEFMENGSLDSFLRQNDGQFTVIQ--LVGMLRGIAAGMKYLADMN 129
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYER 190
            VHR L   NI+     + + + K++DFG +R LE+D     + S  G +  +     E 
Sbjct: 130 YVHRALAARNILV----NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
              RK     F +  D+WS G+ ++ V +     RPY    N++ +  I
Sbjct: 186 IQYRK-----FTSASDVWSYGIVMWEVMSYGE--RPYWDMTNQDVINAI 227

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S LG G  G V +  ++ +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 22  SELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 81
Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NR 133
                   G++ I ME   GGSL  +L + +    + EE    V   +  G+ +LR+ ++
Sbjct: 82  AFYSD---GEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+  +   G    KL DFG + +L  D    S  GT  Y+ P+  +    
Sbjct: 136 IMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLI-DSMANSFVGTRSYMAPERLQ---- 186
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
               G  +    D+WS+G++L  +A G  P  P
Sbjct: 187 ----GTHYSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 29/229 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G V  G   N  + VA+KT  +   M   D  + E EV+ K+ H  +V+L  + 
Sbjct: 15  IGSGQFGLVHLGYWLNK-DKVAIKTIRE-GAMSEEDF-IEEAEVMMKLSHPKLVQLYGVC 71
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            EQ      +V E    G L + L      +    E  L +   +  GM +L +  ++HR
Sbjct: 72  LEQAP--ICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEEASVIHR 127
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVL 193
           DL   N     C  G   + K++DFG  R + +D Q+ S  GT+   ++  P+++  +  
Sbjct: 128 DLAARN-----CLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFS-- 179
Query: 194 RKPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRRNKETMYYITT 241
                  + +  D+WS GV ++ V + G +   PY  R N E +  I+T
Sbjct: 180 ------RYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST 219

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +G G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     K+ DFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIKVADFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD----VQMREFEVLKKVKHENIVKL 73
           LG+G    V++  +KN  + VA+K           D      +RE ++L+++ H NI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA-------GM 126
           L    +  G    I +       +F+ ++       +++   +L   H+ A       G+
Sbjct: 78  L----DAFGHKSNISL-------VFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMSLYGTEEYLHP 185
           ++L  + ++HRDLKP N++     D + + KL DFG A+     ++ +     T  Y  P
Sbjct: 126 EYLHQHWILHRDLKPNNLLL----DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAP 181
Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           ++   A       + +G  VD+W++G  L  +    +PF P
Sbjct: 182 ELLFGA-------RMYGVGVDMWAVGCILAELLL-RVPFLP 214

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 25/231 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEP---VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V +G  K  G+    VA+KT       R     + E  ++ + +H NI++L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 74  LAIEEEQEGRGKVIVMELCTGGSL--FNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
             +         +I+ E    G+L  F  L+D + T      + + +L  + +GM++L +
Sbjct: 83  EGVVTNS--MPVMILTEFMENGALDSFLRLNDGQFTV----IQLVGMLRGIASGMRYLAE 136
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE---DQQFMSLYGTEEYLHPDMY 188
              VHRDL   NI+     + + + K++DFG +R LEE   D    S  G +  +     
Sbjct: 137 MSYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           E    RK     F +  D WS G+ ++ V +     RPY    N++ +  I
Sbjct: 193 EAIAFRK-----FTSASDAWSYGIVMWEVMS--FGERPYWDMSNQDVINAI 236

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 23/232 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G  G VF  V+ +  + VA+K   ++    P  V+  +RE ++++++ H+NIVK+  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHDNIVKVFE 75
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-------LQEEEFLLVLEHLTAGMKH 128
           I      +    V  L    S++ + +  E           L EE   L +  L  G+K+
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKY 135
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           +    ++HRDLKP N+  FI  +   + K+ DFG AR +  D  +       E L    Y
Sbjct: 136 IHSANVLHRDLKPANL--FINTE-DLVLKIGDFGLARIM--DPHYSHKGHLSEGLVTKWY 190
Query: 189 ERA-VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
               +L  P    +   +D+W+ G     + TG   F    G    E M  I
Sbjct: 191 RSPRLLLSP--NNYTKAIDMWAAGCIFAEMLTGKTLF---AGAHELEQMQLI 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +G G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYMPGGDMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     K+ DFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIKVADFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKL- 73
           V+G+GA   V     K  G+  A+K  N+   ++  +V     E +VL       I +L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG--LQEEEFLLVLEHLTAGMKHLRD 131
            A ++E       +VME   GG L  +L    + +G  +  E     L  +   +  +  
Sbjct: 128 FAFQDENY---LYLVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY--GTEEYLHPDMYE 189
              VHRD+KP NI+   C       +L DFG+  +L  D    SL   GT +YL P++ +
Sbjct: 181 LGYVHRDIKPDNILLDRCGH----IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            AV   P   ++G   D W++GV  Y +  G  PF
Sbjct: 237 -AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMRPHDVQMR---EFEVLKKVK---- 66
            +LGKG  G VF G    +   VA+K    N++    P    +    E  +L KV     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM 126
           H  +++LL   E QEG   V+   L     LF+ + +      L E         + A +
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPL-PAQDLFDYITE---KGPLGEGPSRCFFGQVVAAI 152
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
           +H     +VHRD+K  NI+    D      KL DFG+   L  D+ +    GT  Y  P+
Sbjct: 153 QHCHSRGVVHRDIKDENIL---IDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRVYSPPE 208
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              R            ATV  WS+G+ LY +  G++PF
Sbjct: 209 WISRHQYH-----ALPATV--WSLGILLYDMVCGDIPF 239

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           +G G+ G V    +   G   A+K  ++   ++   ++  + E  +L+ V    +VKL  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +VME   GG +F+ L          E         +    ++L    L+
Sbjct: 109 --SFKDNSNLYMVMEYMPGGDMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     K+ DFG A+ ++   +   L GT EYL P++        
Sbjct: 164 YRDLKPENLLI----DQQGYIKVADFGFAKRVK--GRTWXLCGTPEYLAPEII------- 210
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G+ G V    +K  G   A+K  ++   ++   ++  + E  + + V    +VKL  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
               ++     +V+E   GG +F+ L          E         +    ++L    L+
Sbjct: 110 --SFKDNSNLYMVLEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           +RDLKP N++     D     K+ DFG A+ ++   +   L GT EYL P++        
Sbjct: 165 YRDLKPENLLI----DQQGYIKVADFGFAKRVK--GRTWXLCGTPEYLAPEII------- 211
Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            + K +   VD W++GV +Y +A G  PF
Sbjct: 212 -LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 26/226 (11%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDV---------QMREFEV 61
           +     +  G+ GAV  GV+ + G PVA+K  FN +S  R  ++          +RE  +
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 62  LKKVKHENIVKL--LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVL 119
           L    H NI+ L  + +  E+    K+ ++       L  ++ D       Q  ++ +  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY- 141
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
            H+  G+  L +  +VHRDL PGNI+  + D+      + DF  ARE   D         
Sbjct: 142 -HILLGLHVLHEAGVVHRDLHPGNIL--LADNNDI--TICDFNLAREDTADANKTHYVTH 196
Query: 180 EEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
             Y  P++  +        K F   VD+WS G  +  +      FR
Sbjct: 197 RWYRAPELVMQF-------KGFTKLVDMWSAGCVMAEMFNRKALFR 235

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 29/229 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G V  G   N  + VA+KT  +   M   D  + E EV+ K+ H  +V+L  + 
Sbjct: 13  IGSGQFGLVHLGYWLNK-DKVAIKTIRE-GAMSEEDF-IEEAEVMMKLSHPKLVQLYGVC 69
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            EQ      +V E    G L + L      +    E  L +   +  GM +L +  ++HR
Sbjct: 70  LEQAP--ICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 138 DLKPGNIMKFICDDG-STIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVL 193
           DL   N     C  G + + K++DFG  R + +D Q+ S  GT+   ++  P+++  +  
Sbjct: 126 DLAARN-----CLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFS-- 177
Query: 194 RKPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRRNKETMYYITT 241
                  + +  D+WS GV ++ V + G +   PY  R N E +  I+T
Sbjct: 178 ------RYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST 217

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 12  WCTTSV-LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI 70
           W T  + LG+G+ G V +  +K  G   AVK       +R    +  E      +    I
Sbjct: 75  WATHQLRLGRGSFGEVHRMEDKQTGFQCAVKK------VRLEVFRAEELMACAGLTSPRI 128
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           V L      +EG    I MEL  GGSL  ++ +      L E+  L  L     G+++L 
Sbjct: 129 VPLYGAV--REGPWVNIFMELLEGGSLGQLVKE---QGCLPEDRALYYLGQALEGLEYLH 183
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY------GTEEYLH 184
             R++H D+K  N++  +  DGS    L DFG A  L+ D     L       GTE ++ 
Sbjct: 184 SRRILHGDVKADNVL--LSSDGSHA-ALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMA 240
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P++         +G++  A VD+WS    + H+  G  P+
Sbjct: 241 PEVV--------LGRSCDAKVDVWSSCCMMLHMLNGCHPW 272

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVK---HENIVKL 73
           +G GA G V++  + ++G  VA+K+    +      +  +RE  +L++++   H N+V+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY-------GLQEEEFLLVLEHLTAGM 126
           + +        ++ V        +F  +D    TY       GL  E    ++     G+
Sbjct: 72  MDVCATSRTDREIKVT------LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
             L  N +VHRDLKP NI+      G T+ KL DFG AR          +  T  Y  P+
Sbjct: 126 DFLHANCIVHRDLKPENIL---VTSGGTV-KLADFGLARIYSYQMALFPVVVTLWYRAPE 181
Query: 187 MYERAVLRKPVGKTFGATVDLWSIG 211
           +         +  T+   VD+WS+G
Sbjct: 182 VL--------LQSTYATPVDMWSVG 198

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 29/229 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G V  G   N  + VA+KT  +   M   D  + E EV+ K+ H  +V+L  + 
Sbjct: 15  IGSGQFGLVHLGYWLNK-DKVAIKTIRE-GAMSEEDF-IEEAEVMMKLSHPKLVQLYGVC 71
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            EQ      +V E    G L + L      +    E  L +   +  GM +L +  ++HR
Sbjct: 72  LEQAP--ICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEEACVIHR 127
Query: 138 DLKPGNIMKFICDDG-STIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVL 193
           DL   N     C  G + + K++DFG  R + +D Q+ S  GT+   ++  P+++  +  
Sbjct: 128 DLAARN-----CLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFS-- 179
Query: 194 RKPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRRNKETMYYITT 241
                  + +  D+WS GV ++ V + G +   PY  R N E +  I+T
Sbjct: 180 ------RYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST 219

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +      +V E  +   L + +D    T G+        L  L  G+     +R++H
Sbjct: 73  IHTENKL--YLVFEFLSM-DLKDFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 128
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 129 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 180
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 181 ---KYYSTAVDIWSLGCIFAEMVT 201

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 26/226 (11%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDV---------QMREFEV 61
           +     +  G+ GAV  GV+ + G PVA+K  FN +S  R  ++          +RE  +
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 62  LKKVKHENIVKL--LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVL 119
           L    H NI+ L  + +  E+    K+ ++       L  ++ D       Q  ++ +  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY- 141
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
            H+  G+  L +  +VHRDL PGNI+  + D+      + DF  ARE   D         
Sbjct: 142 -HILLGLHVLHEAGVVHRDLHPGNIL--LADNNDI--TICDFNLAREDTADANKTHYVTH 196
Query: 180 EEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
             Y  P++  +        K F   VD+WS G  +  +      FR
Sbjct: 197 RWYRAPELVMQF-------KGFTKLVDMWSAGCVMAEMFNRKALFR 235

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +      +V E  +   L + +D    T G+        L  L  G+     +R++H
Sbjct: 74  IHTENKL--YLVFEFLSM-DLKDFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 129
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 130 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 181
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 182 ---KYYSTAVDIWSLGCIFAEMVT 202

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 29/229 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G V  G   N  + VA+KT  +   M   D  + E EV+ K+ H  +V+L  + 
Sbjct: 18  IGSGQFGLVHLGYWLNK-DKVAIKTIRE-GAMSEEDF-IEEAEVMMKLSHPKLVQLYGVC 74
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            EQ      +V E    G L + L      +    E  L +   +  GM +L +  ++HR
Sbjct: 75  LEQAP--ICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEEACVIHR 130
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVL 193
           DL   N     C  G   + K++DFG  R + +D Q+ S  GT+   ++  P+++  +  
Sbjct: 131 DLAARN-----CLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFS-- 182
Query: 194 RKPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRRNKETMYYITT 241
                  + +  D+WS GV ++ V + G +   PY  R N E +  I+T
Sbjct: 183 ------RYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST 222

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 29/229 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G V  G   N  + VA+KT  + S     D  + E EV+ K+ H  +V+L  + 
Sbjct: 35  IGSGQFGLVHLGYWLNK-DKVAIKTIKEGS--MSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            EQ      +V E    G L + L      +    E  L +   +  GM +L +  ++HR
Sbjct: 92  LEQAP--ICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEEACVIHR 147
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVL 193
           DL   N     C  G   + K++DFG  R + +D Q+ S  GT+   ++  P+++  +  
Sbjct: 148 DLAARN-----CLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFS-- 199
Query: 194 RKPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRRNKETMYYITT 241
                  + +  D+WS GV ++ V + G +   PY  R N E +  I+T
Sbjct: 200 ------RYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST 239

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVK---HENIVKL 73
           +G GA G V++  + ++G  VA+K+    +      +  +RE  +L++++   H N+V+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY-------GLQEEEFLLVLEHLTAGM 126
           + +        ++ V        +F  +D    TY       GL  E    ++     G+
Sbjct: 72  MDVCATSRTDREIKVT------LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
             L  N +VHRDLKP NI+      G T+ KL DFG AR          +  T  Y  P+
Sbjct: 126 DFLHANCIVHRDLKPENIL---VTSGGTV-KLADFGLARIYSYQMALAPVVVTLWYRAPE 181
Query: 187 MYERAVLRKPVGKTFGATVDLWSIG 211
           +         +  T+   VD+WS+G
Sbjct: 182 VL--------LQSTYATPVDMWSVG 198

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 18  LGKGATGAVFQGVN-KNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVK---HENIVK 72
           +G+GA G VF+  + KN G  VA+K    Q          +RE  VL+ ++   H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 73  LLAI--EEEQEGRGKVIVMELCTGGSLFNILDD-PENTYGLQEEEFLLVLEHLTAGMKHL 129
           L  +      +   K+ ++       L   LD  PE   G+  E    ++  L  G+  L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFL 136
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
             +R+VHRDLKP NI+  +   G    KL DFG AR         S+  T  Y  P++  
Sbjct: 137 HSHRVVHRDLKPQNIL--VTSSGQI--KLADFGLARIYSFQMALTSVVVTLWYRAPEVL- 191
Query: 190 RAVLRKPVGKTFGATVDLWSIG 211
                  +  ++   VDLWS+G
Sbjct: 192 -------LQSSYATPVDLWSVG 206

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 29/229 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G V  G   N  + VA+KT  +   M   D  + E EV+ K+ H  +V+L  + 
Sbjct: 16  IGSGQFGLVHLGYWLNK-DKVAIKTIRE-GAMSEEDF-IEEAEVMMKLSHPKLVQLYGVC 72
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            EQ      +V E    G L + L      +    E  L +   +  GM +L +  ++HR
Sbjct: 73  LEQAP--ICLVTEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 138 DLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVL 193
           DL   N     C  G   + K++DFG  R + +D Q+ S  GT+   ++  P+++  +  
Sbjct: 129 DLAARN-----CLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFS-- 180
Query: 194 RKPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRRNKETMYYITT 241
                  + +  D+WS GV ++ V + G +   PY  R N E +  I+T
Sbjct: 181 ------RYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST 220

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 18  LGKGATGAVFQGVN-KNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVK---HENIVK 72
           +G+GA G VF+  + KN G  VA+K     +      +  +RE  VL+ ++   H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 73  LLAI--EEEQEGRGKVIVMELCTGGSLFNILDD-PENTYGLQEEEFLLVLEHLTAGMKHL 129
           L  +      +   K+ ++       L   LD  PE   G+  E    ++  L  G+  L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFL 136
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
             +R+VHRDLKP NI+  +   G    KL DFG AR         S+  T  Y  P++  
Sbjct: 137 HSHRVVHRDLKPQNIL--VTSSGQI--KLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 190 RAVLRKPVGKTFGATVDLWSIG 211
           ++        ++   VDLWS+G
Sbjct: 193 QS--------SYATPVDLWSVG 206

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           VLGKG+ G V     K   E  AVK   +   ++  DV+  M E  VL        +  L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
               +   R    VME   GG L   +   +     +E   +     +  G+  L+   +
Sbjct: 408 HSCFQTMDR-LYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           ++RDLK  N+M     D     K+ DFG  +E   D      + GT +Y+ P++    + 
Sbjct: 464 IYRDLKLDNVML----DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEI----IA 515
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +P GK+    VD W+ GV LY +  G  PF
Sbjct: 516 YQPYGKS----VDWWAFGVLLYEMLAGQAPF 542

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 19/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           VLGKG+ G V     K   E  A+K   +   ++  DV+  M E  VL  +     +  L
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
               +   R    VME   GG L   +   +     +E + +     ++ G+  L    +
Sbjct: 86  HSCFQTVDR-LYFVMEYVNGGDLMYHI---QQVGKFKEPQAVFYAAEISIGLFFLHKRGI 141
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++RDLK  N+M     D     K+ DFG  +E + +        GT +Y+ P++    + 
Sbjct: 142 IYRDLKLDNVML----DSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEI----IA 193
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +P GK+    VD W+ GV LY +  G  PF
Sbjct: 194 YQPYGKS----VDWWAYGVLLYEMLAGQPPF 220

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 18  LGKGATGAVFQGVN-KNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVK---HENIVK 72
           +G+GA G VF+  + KN G  VA+K     +      +  +RE  VL+ ++   H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 73  LLAI--EEEQEGRGKVIVMELCTGGSLFNILDD-PENTYGLQEEEFLLVLEHLTAGMKHL 129
           L  +      +   K+ ++       L   LD  PE   G+  E    ++  L  G+  L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFL 136
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
             +R+VHRDLKP NI+  +   G    KL DFG AR         S+  T  Y  P++  
Sbjct: 137 HSHRVVHRDLKPQNIL--VTSSGQI--KLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 190 RAVLRKPVGKTFGATVDLWSIG 211
           ++        ++   VDLWS+G
Sbjct: 193 QS--------SYATPVDLWSVG 206

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG G  G V  G  K   + VAVK   + S     D   +E + + K+ H  +VK   + 
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-VAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
            ++      IV E  + G L N L    +  GL+  + L +   +  GM  L  ++ +HR
Sbjct: 73  SKE--YPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE---EYLHPDMYERAVLR 194
           DL   N +     D     K++DFG  R + +D Q++S  GT+   ++  P+++      
Sbjct: 129 DLAARNCLV----DRDLCVKVSDFGMTRYVLDD-QYVSSVGTKFPVKWSAPEVFHYF--- 180
Query: 195 KPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPY 227
                 + +  D+W+ G+ ++ V + G +P+  Y
Sbjct: 181 -----KYSSKSDVWAFGILMWEVFSLGKMPYDLY 209

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 92/232 (39%), Gaps = 36/232 (15%)
Query: 18  LGKGATGAVFQ----GVNKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIV 71
           LG GA G V +    G+ K +    VAVK     +H    +  M E +++  + +HENIV
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNIL--------DDPENTYG---LQEEEFLLVLE 120
            LL       G   +++ E C  G L N L         DP            + L    
Sbjct: 114 NLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
            +  GM  L     +HRD+   N++         + K+ DFG AR++  D  ++      
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLL----TNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 181 ---EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
              +++ P+     V        +    D+WS G+ L+ + +  L   PY G
Sbjct: 228 LPVKWMAPESIFDCV--------YTVQSDVWSYGILLWEIFS--LGLNPYPG 269

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +      +V E  +   L   +D    T G+        L  L  G+     +R++H
Sbjct: 72  IHTENKL--YLVFEFLSM-DLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 127
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 128 RDLKPENLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 179
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 180 ---KYYSTAVDIWSLGCIFAEMVT 200

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           VLGKG+ G V     K   E  AVK   +   ++  DV+  M E  VL        +  L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
               +   R    VME   GG L   +   +     +E   +     +  G+  L+   +
Sbjct: 87  HSCFQTMDR-LYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           ++RDLK  N+M     D     K+ DFG  +E   D      + GT +Y+ P++    + 
Sbjct: 143 IYRDLKLDNVML----DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEI----IA 194
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +P GK+    VD W+ GV LY +  G  PF
Sbjct: 195 YQPYGKS----VDWWAFGVLLYEMLAGQAPF 221

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +      +V E  +   L   +D    T G+        L  L  G+     +R++H
Sbjct: 74  IHTENKL--YLVFEFLSM-DLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 129
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 130 RDLKPENLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 181
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 182 ---KYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLV---LEHLTAGMKHLRDNR 133
              +      +V E      L   L D  +   L      L+   L  L  G+     +R
Sbjct: 71  IHTENKL--YLVFEF-----LHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAV 192
           ++HRDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++     
Sbjct: 124 VLHRDLKPENLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC- 178
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT 219
                 K +   VD+WS+G     + T
Sbjct: 179 ------KYYSTAVDIWSLGCIFAEMVT 199

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 42/236 (17%)
Query: 18  LGKGATGAVFQ----GVNKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIV 71
           LG GA G V +    G+ K +    VAVK     +H    +  M E +++  + +HENIV
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNIL---------------DDPENTYGLQEEEFL 116
            LL       G   +++ E C  G L N L                +PE    L   + L
Sbjct: 114 NLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ--LSSRDLL 169
Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL 176
                +  GM  L     +HRD+   N++         + K+ DFG AR++  D  ++  
Sbjct: 170 HFSSQVAQGMAFLASKNCIHRDVAARNVLL----TNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 177 YGTE---EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
                  +++ P+     V        +    D+WS G+ L+ + +  L   PY G
Sbjct: 226 GNARLPVKWMAPESIFDCV--------YTVQSDVWSYGILLWEIFS--LGLNPYPG 271

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 71  IHTE---NKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 127 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 178
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 179 ---KYYSTAVDIWSLGCIFAEMVT 199

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +    V+G G+ G VFQ     + E VA+K   Q    +      RE ++++ VKH N+V
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK-----NRELQIMRIVKHPNVV 95
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE----HLTAGMK 127
            L A       +   + + L        +     +   L++   +L+++     L   + 
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           ++    + HRD+KP N++    D  S + KL DFG+A+ L   +  +S   +  Y  P++
Sbjct: 156 YIHSIGICHRDIKPQNLL---LDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPEL 212
Query: 188 YERAVLRKPVGKTFGAT-----VDLWSIGVTLYHVATG 220
                        FGAT     +D+WS G  +  +  G
Sbjct: 213 ------------IFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 71  IHTE---NKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLSFCHSHRVLH 126
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 127 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC---- 178
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 179 ---KYYSTAVDIWSLGCIFAEMVT 199

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 71  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP--DMYERAVLR 194
           RDLKP N++  I  +G+   KL DFG AR                Y H    ++ RA   
Sbjct: 127 RDLKPQNLL--INTEGAI--KLADFGLARAFG--------VPVRTYXHEVVTLWYRAPEI 174
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT 219
               K +   VD+WS+G     + T
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 71  IHTE---NKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 127 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC---- 178
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 179 ---KYYSTAVDIWSLGCIFAEMVT 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 72  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 127
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 128 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 179
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 180 ---KYYSTAVDIWSLGCIFAEMVT 200

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 70  IHTE---NKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 126 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC---- 177
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 178 ---KYYSTAVDIWSLGCIFAEMVT 198

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKT--FNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G  G V++  NK  GE VA+K    +  +   P    +RE  +LK++ H NIVKLL 
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP-STAIREISLLKELNHPNIVKLLD 68
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           +   +    K+ ++       L   +D    T G+        L  L  G+     +R++
Sbjct: 69  VIHTE---NKLYLVFEHVHQDLKTFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLR 194
           HRDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++       
Sbjct: 125 HRDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC--- 177
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT 219
               K +   VD+WS+G     + T
Sbjct: 178 ----KYYSTAVDIWSLGCIFAEMVT 198

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKT--FNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G  G VF+  N+   E VA+K    +      P    +RE  +LK++KH+NIV+L  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-LREICLLKELKHKNIVRLHD 68
Query: 76  IEEEQEGRGKVIVMELC----------TGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +      +   +V E C            G L     DPE       + FL     L  G
Sbjct: 69  VLHSD--KKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIV-----KSFLF---QLLKG 113
Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLH 184
           +       ++HRDLKP N++  I  +G    KL DFG AR      + + +   T  Y  
Sbjct: 114 LGFCHSRNVLHRDLKPQNLL--INRNGEL--KLADFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           PD+   A       K +  ++D+WS G     +A    P  P
Sbjct: 170 PDVLFGA-------KLYSTSIDMWSAGCIFAELANAARPLFP 204

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 71  IHTE---NKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 127 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 178
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 179 ---KYYSTAVDIWSLGCIFAEMVT 199

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 70  IHTE---NKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 126 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC---- 177
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 178 ---KYYSTAVDIWSLGCIFAEMVT 198

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 70  IHTE---NKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 126 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 177
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 178 ---KYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 73  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 128
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 129 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 180
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 181 ---KYYSTAVDIWSLGCIFAEMVT 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 71  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 127 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 178
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 179 ---KYYSTAVDIWSLGCIFAEMVT 199

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 49/227 (21%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV----- 71
           ++G G  G VF+  ++ +G+   ++          ++   RE + L K+ H NIV     
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKY-----NNEKAEREVKALAKLDHVNIVHYNGC 73
Query: 72  -------------KLLAIEEEQE-----GRGKV----IVMELCTGGSLFNILDDPENTYG 109
                         L + + + E      R K     I ME C  G+L   +   E   G
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRG 130
Query: 110 LQEEEFLLV--LEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL 167
            + ++ L +   E +T G+ ++   +L+HRDLKP NI  F+ D  +   K+ DFG    L
Sbjct: 131 EKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNI--FLVD--TKQVKIGDFGLVTSL 186
Query: 168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTL 214
           + D +     GT  Y+ P+            + +G  VDL+++G+ L
Sbjct: 187 KNDGKRTRSKGTLRYMSPEQIS--------SQDYGKEVDLYALGLIL 225

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 96/241 (39%), Gaps = 45/241 (18%)
Query: 18  LGKGATGAVFQ----GVNKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIV 71
           LG GA G V +    G+ K +    VAVK     +H    +  M E +++  + +HENIV
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNIL---------------DDPE-----NTYGLQ 111
            LL       G   +++ E C  G L N L                DPE     +   L+
Sbjct: 99  NLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 112 EEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ 171
             + L     +  GM  L     +HRD+   N++         + K+ DFG AR++  D 
Sbjct: 157 LRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL----TNGHVAKIGDFGLARDIMNDS 212
Query: 172 QFMSLYGTE---EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
            ++         +++ P+     V        +    D+WS G+ L+ + +  L   PY 
Sbjct: 213 NYIVKGNARLPVKWMAPESIFDCV--------YTVQSDVWSYGILLWEIFS--LGLNPYP 262
Query: 229 G 229
           G
Sbjct: 263 G 263

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 74  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 129
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 130 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 181
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 182 ---KYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 73  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 128
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 129 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 180
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 181 ---KYYSTAVDIWSLGCIFAEMVT 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 71  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 127 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC---- 178
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 179 ---KYYSTAVDIWSLGCIFAEMVT 199

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 70  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 126 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 177
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 178 ---KYYSTAVDIWSLGCIFAEMVT 198

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 74  IHTEN---KLYLVFEHVDQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 129
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 130 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 181
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 182 ---KYYSTAVDIWSLGCIFAEMVT 202

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 72  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 127
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 128 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC---- 179
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 180 ---KYYSTAVDIWSLGCIFAEMVT 200

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 32/208 (15%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF---NQLSHMRPHDVQ-MREFEVLKKVK---HENI 70
           +G GA G V++  + ++G  VA+K+    N         +  +RE  +L++++   H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY-------GLQEEEFLLVLEHLT 123
           V+L+ +        ++ V        +F  +D    TY       GL  E    ++    
Sbjct: 77  VRLMDVCATSRTDREIKVT------LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
            G+  L  N +VHRDLKP NI+      G T+ KL DFG AR          +  T  Y 
Sbjct: 131 RGLDFLHANCIVHRDLKPENIL---VTSGGTV-KLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIG 211
            P++  ++        T+   VD+WS+G
Sbjct: 187 APEVLLQS--------TYATPVDMWSVG 206

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 72  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 127
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 128 RDLKPENLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 179
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 180 ---KYYSTAVDIWSLGCIFAEMVT 200

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVK---HENIVKL 73
           +G GA G V++  + ++G  VA+K+    +      +  +RE  +L++++   H N+V+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY-------GLQEEEFLLVLEHLTAGM 126
           + +        ++ V        +F  +D    TY       GL  E    ++     G+
Sbjct: 72  MDVCATSRTDREIKVT------LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
             L  N +VHRDLKP NI+      G T+ KL DFG AR          +  T  Y  P+
Sbjct: 126 DFLHANCIVHRDLKPENIL---VTSGGTV-KLADFGLARIYSYQMALDPVVVTLWYRAPE 181
Query: 187 MYERAVLRKPVGKTFGATVDLWSIG 211
           +         +  T+   VD+WS+G
Sbjct: 182 VL--------LQSTYATPVDMWSVG 198

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 74  IHTEN---KLYLVFEFLHQDLKTFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 129
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 130 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 181
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 182 ---KYYSTAVDIWSLGCIFAEMVT 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 75  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 130
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 131 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 182
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 183 ---KYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 73  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 128
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 129 RDLKPENLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 180
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 181 ---KYYSTAVDIWSLGCIFAEMVT 201

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 71  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP--DMYERAVLR 194
           RDLKP N++  I  +G+   KL DFG AR                Y H    ++ RA   
Sbjct: 127 RDLKPQNLL--INTEGAI--KLADFGLARAFG--------VPVRTYTHEVVTLWYRAPEI 174
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT 219
               K +   VD+WS+G     + T
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 10/158 (6%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQL-SHMRPHDVQMREFEVLKKVKHENIVKL-- 73
           ++G+G+ G V+   +KN  + VA+K  N++   +      +RE  +L ++K + I++L  
Sbjct: 35  LIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHD 94
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           L I E+     ++ ++       L  +   P     L E+    +L +L  G K + ++ 
Sbjct: 95  LIIPEDLLKFDELYIVLEIADSDLKKLFKTP---IFLTEQHVKTILYNLLLGEKFIHESG 151
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ 171
           ++HRDLKP N +  +  D S   K+ DFG AR +  D+
Sbjct: 152 IIHRDLKPANCL--LNQDCSV--KICDFGLARTINSDK 185

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 74  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 129
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 130 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC---- 181
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 182 ---KYYSTAVDIWSLGCIFAEMVT 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKT--FNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G  G V++  NK  GE VA+K    +  +   P    +RE  +LK++ H NIVKLL 
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP-STAIREISLLKELNHPNIVKLLD 70
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           +   +    K+ ++       L   +D    T G+        L  L  G+     +R++
Sbjct: 71  VIHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVL 126
Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLR 194
           HRDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++       
Sbjct: 127 HRDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC--- 179
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT 219
               K +   VD+WS+G     + T
Sbjct: 180 ----KYYSTAVDIWSLGCIFAEMVT 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 75  IHTE---NKLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 130
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 131 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC---- 182
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 183 ---KYYSTAVDIWSLGCIFAEMVT 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 78  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 133
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 134 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC---- 185
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 186 ---KYYSTAVDIWSLGCIFAEMVT 206

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 70  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 126 CHNXGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 181
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                     +  G +  +WS+G+ LY +  G++PF
Sbjct: 182 RYH-------RYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 101/243 (41%), Gaps = 47/243 (19%)
Query: 17  VLGKGATGAVFQ----GVNKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENI 70
           VLG GA G V      G++K      VAVK   + +     +  M E +++ ++  HENI
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 71  VKLLAIEEEQEGRGKV-IVMELCTGGSLFNILD-----------DPENTYGLQEEEFLLV 118
           V LL         G + ++ E C  G L N L            + EN   L+EEE L V
Sbjct: 112 VNLLGA---CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 119 LE---------HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE 169
           L           +  GM+ L     VHRDL   N++      G  + K+ DFG AR++  
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL---VTHGKVV-KICDFGLARDIMS 224
Query: 170 DQQFMSLYGTE---EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           D  ++         +++ P+     +        +    D+WS G+ L+ + +  L   P
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGI--------YTIKSDVWSYGILLWEIFS--LGVNP 274
Query: 227 YGG 229
           Y G
Sbjct: 275 YPG 277

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 42  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 102 GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 158 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 213
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 214 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL +
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 78  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 133
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP--DMYERAVLR 194
           RDLKP N++  I  +G+   KL DFG AR                Y H    ++ RA   
Sbjct: 134 RDLKPQNLL--INTEGAI--KLADFGLARAFG--------VPVRTYTHEVVTLWYRAPEI 181
Query: 195 KPVGKTFGATVDLWSIGVTLYHVAT 219
               K +   VD+WS+G     + T
Sbjct: 182 LLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 70  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 126 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 181
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                     +  G +  +WS+G+ LY +  G++PF
Sbjct: 182 RYH-------RYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 14  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 73
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 74  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 130 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 185
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                     +  G +  +WS+G+ LY +  G++PF
Sbjct: 186 RYH-------RYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 95/232 (40%), Gaps = 44/232 (18%)
Query: 18  LGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+GA G VF       + + +   VAVK   + S     D Q RE E+L  ++H++IV+
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ-REAELLTMLQHQHIVR 84
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL--------------DDPENTYGLQEEEFLLV 118
              +    EGR  ++V E    G L   L              D      GL +   L V
Sbjct: 85  FFGVC--TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ--LLAV 140
Query: 119 LEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG-STIYKLTDFGAARELEEDQQFMSLY 177
              + AGM +L     VHRDL   N     C  G   + K+ DFG +R+         +Y
Sbjct: 141 ASQVAAGMVYLAGLHFVHRDLATRN-----CLVGQGLVVKIGDFGMSRD---------IY 186
Query: 178 GTEEYLHPDMYERAVLRKP----VGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            T+ Y         +   P    + + F    D+WS GV L+ + T G  P+
Sbjct: 187 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 238

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 108/288 (37%), Gaps = 69/288 (23%)
Query: 18  LGKGATGAVFQGVNKN--NGEPVAVKTFNQLSHMRPHDVQM---REFEVLKKVKHENIVK 72
           +G+GA G VFQ         EP  +     L      D+Q    RE  ++ +  + NIVK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDD--PENTYGLQEEEF--------------- 115
           LL +     G+   ++ E    G L   L    P     L   +                
Sbjct: 115 LLGVC--AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 116 ----LLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG-STIYKLTDFGAARELEED 170
               L +   + AGM +L + + VHRDL   N     C  G + + K+ DFG +R +   
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRN-----CLVGENMVVKIADFGLSRNIY-- 225
Query: 171 QQFMSLYGTEEYLHPDMYERAVLR-KPVGKTF----GATVDLWSIGVTLYHVATGNLPFR 225
                   + +Y   D  +   +R  P    F        D+W+ GV L+ + +  L  +
Sbjct: 226 --------SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL--Q 275
Query: 226 PYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSL 273
           PY G  ++E +YY+                +G I  C   P NC L L
Sbjct: 276 PYYGMAHEEVIYYV---------------RDGNILAC---PENCPLEL 305

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 15  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 75  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 131 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 186
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                     +  G +  +WS+G+ LY +  G++PF
Sbjct: 187 RYH-------RYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HEN 69
           +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H 
Sbjct: 104 VIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM-- 187
            +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+   
Sbjct: 160 HNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 216 YHR---------YHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HEN 69
           +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H 
Sbjct: 118 VIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 173
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM-- 187
            +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+   
Sbjct: 174 HNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 230 YHR---------YHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 70  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 126 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 181
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                     +  G +  +WS+G+ LY +  G++PF
Sbjct: 182 RYH-------RYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 106/237 (44%), Gaps = 29/237 (12%)
Query: 17  VLGKGATGAVFQG-VNKNNGEP--VAVKTFN-QLSHMRPHDVQMREFEVLKKVKHENIVK 72
           +LG+G  G+V +G + + +G    VAVKT     S  R  +  + E   +K   H N+++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 73  LLAIEEEQEGRG---KVIVMELCTGGSLFNILDDPENTYG---LQEEEFLLVLEHLTAGM 126
           LL +  E   +G    ++++     G L   L       G   +  +  L  +  +  GM
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
           ++L +   +HRDL   N M  + DD +    + DFG ++++         Y  + Y    
Sbjct: 161 EYLSNRNFLHRDLAARNCM--LRDDMTVC--VADFGLSKKI---------YSGDYYRQGR 207
Query: 187 MYERAV----LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           + +  V    +     + + +  D+W+ GVT++ +AT  +   PY G +N E   Y+
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM--TPYPGVQNHEMYDYL 262

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQL-SHMRPHDVQMREFEVLKKVKHENI 70
           +    ++G+G+ G V+   +KN  + VA+K  N++   +      +RE  +L ++K + I
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 71  VKL--LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           ++L  L I ++     ++ ++       L  +   P     L EE    +L +L  G   
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP---IFLTEEHIKTILYNLLLGENF 144
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           + ++ ++HRDLKP N +  +  D S   K+ DFG AR +  ++    +   EE   P  +
Sbjct: 145 IHESGIIHRDLKPANCL--LNQDCSV--KVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 189 ERAV------------LRKP----VGKTFGATVDLWSIG 211
            + +             R P    + + +  ++D+WS G
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 30  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 89
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 90  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 146 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 201
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 202 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 42  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 102 GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 158 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 213
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 214 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 43  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 103 GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 159 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 214
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 215 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 29  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 88
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 89  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 145 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 200
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 201 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 13  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 72
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 73  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 129 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 184
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                     +  G +  +WS+G+ LY +  G++PF
Sbjct: 185 RYH-------RYHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HEN 69
           +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H 
Sbjct: 104 VIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM-- 187
            +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+   
Sbjct: 160 HNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 216 YHR---------YHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 15  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 75  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 131 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 186
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 187 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 43  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 103 GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 158
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 159 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 214
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 215 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 42  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 102 GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 158 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 213
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 214 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HEN 69
           +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H 
Sbjct: 76  VIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
            +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+   
Sbjct: 132 HNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                    +  G +  +WS+G+ LY +  G++PF
Sbjct: 188 YH-------RYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 29  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 88
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 89  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 145 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 200
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 201 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 42  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 102 GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 157
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 158 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 213
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 214 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 95/232 (40%), Gaps = 44/232 (18%)
Query: 18  LGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+GA G VF       + + +   VAVK   + S     D Q RE E+L  ++H++IV+
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ-REAELLTMLQHQHIVR 78
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL--------------DDPENTYGLQEEEFLLV 118
              +    EGR  ++V E    G L   L              D      GL +   L V
Sbjct: 79  FFGVC--TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ--LLAV 134
Query: 119 LEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG-STIYKLTDFGAARELEEDQQFMSLY 177
              + AGM +L     VHRDL   N     C  G   + K+ DFG +R+         +Y
Sbjct: 135 ASQVAAGMVYLAGLHFVHRDLATRN-----CLVGQGLVVKIGDFGMSRD---------IY 180
Query: 178 GTEEYLHPDMYERAVLRKP----VGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            T+ Y         +   P    + + F    D+WS GV L+ + T G  P+
Sbjct: 181 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 232

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 57  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 116
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 117 GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 173 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 228
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 229 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 30  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 89
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 90  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 146 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 201
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 202 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 30  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 89
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 90  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 146 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 201
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 202 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 14  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 73
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 74  GVIRLLDWFE----RPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 130 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 185
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                     +  G +  +WS+G+ LY +  G++PF
Sbjct: 186 RYH-------RYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKT--FNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G  G VF+  N+   E VA+K    +      P    +RE  +LK++KH+NIV+L  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-LREICLLKELKHKNIVRLHD 68
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILD------DPENTYGLQEEEFLLVLEHLTAGMKHL 129
           +      +   +V E C    L    D      DPE       + FL     L  G+   
Sbjct: 69  VLHSD--KKLTLVFEFCD-QDLKKYFDSCNGDLDPEIV-----KSFLF---QLLKGLGFC 117
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMY 188
               ++HRDLKP N++  I  +G    KL +FG AR      + + +   T  Y  PD+ 
Sbjct: 118 HSRNVLHRDLKPQNLL--INRNGEL--KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
             A       K +  ++D+WS G     +A    P  P
Sbjct: 174 FGA-------KLYSTSIDMWSAGCIFAELANAGRPLFP 204

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 62  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 121
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 122 GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 177
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 178 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 233
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 234 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 262

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 40/236 (16%)
Query: 18  LGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIV 71
           LG GA G V +      +  +    VAVK     +H+   +  M E +VL  +  H NIV
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE----------- 120
            LL       G   +++ E C  G L N L    +++   +    ++ +           
Sbjct: 91  NLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 121 ----HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL 176
                +  GM  L     +HRDL   NI+         I K+ DFG AR+++ D  ++  
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILL----THGRITKICDFGLARDIKNDSNYVVK 204
Query: 177 YGTE---EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
                  +++ P+     V       TF +  D+WS G+ L+ + +  L   PY G
Sbjct: 205 GNARLPVKWMAPESIFNCVY------TFES--DVWSYGIFLWELFS--LGSSPYPG 250

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 95/230 (41%), Gaps = 42/230 (18%)
Query: 18  LGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+GA G VF     N     +   VAVKT    S     D   RE E+L  ++HE+IVK
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-REAELLTNLQHEHIVK 79
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL------------DDPENTYGLQEEEFLLVLE 120
              +    EG   ++V E    G L   L             +P     L + + L + +
Sbjct: 80  FYGVC--VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE--LTQSQMLHIAQ 135
Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYGT 179
            + AGM +L     VHRDL   N     C  G   + K+ DFG +R+         +Y T
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRN-----CLVGENLLVKIGDFGMSRD---------VYST 181
Query: 180 EEYLHPDMYERAVLRKP----VGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
           + Y         +   P    + + F    D+WS+GV L+ + T G  P+
Sbjct: 182 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 231

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 40/236 (16%)
Query: 18  LGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIV 71
           LG GA G V +      +  +    VAVK     +H+   +  M E +VL  +  H NIV
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE----------- 120
            LL       G   +++ E C  G L N L    +++   +    ++ +           
Sbjct: 107 NLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 164
Query: 121 ----HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL 176
                +  GM  L     +HRDL   NI+         I K+ DFG AR+++ D  ++  
Sbjct: 165 SFSYQVAKGMAFLASKNCIHRDLAARNILL----THGRITKICDFGLARDIKNDSNYVVK 220
Query: 177 YGTE---EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
                  +++ P+     V       TF +  D+WS G+ L+ + +  L   PY G
Sbjct: 221 GNARLPVKWMAPESIFNCVY------TFES--DVWSYGIFLWELFS--LGSSPYPG 266

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 39/224 (17%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHENIVKL 73
           LG G  G V+     N    VAVKT      M+P  + +  F     V+K ++H+ +VKL
Sbjct: 190 LGAGQFGEVWMATY-NKHTKVAVKT------MKPGSMSVEAFLAEANVMKTLQHDKLVKL 242
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A+  ++      I+ E    GSL + L   E +      + +     +  GM  +    
Sbjct: 243 HAVVTKEP---IYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRN 298
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            +HRDL+  NI+       S + K+ DFG AR      +F   +   E ++         
Sbjct: 299 YIHRDLRAANILV----SASLVCKIADFGLAR---VGAKFPIKWTAPEAIN--------- 342
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM 236
                 +F    D+WS G+ L  + T G +   PY G  N E +
Sbjct: 343 ----FGSFTIKSDVWSFGILLMEIVTYGRI---PYPGMSNPEVI 379

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 40/236 (16%)
Query: 18  LGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIV 71
           LG GA G V +      +  +    VAVK     +H+   +  M E +VL  +  H NIV
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE----------- 120
            LL       G   +++ E C  G L N L    +++   +    ++ +           
Sbjct: 109 NLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 166
Query: 121 ----HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL 176
                +  GM  L     +HRDL   NI+         I K+ DFG AR+++ D  ++  
Sbjct: 167 SFSYQVAKGMAFLASKNCIHRDLAARNILL----THGRITKICDFGLARDIKNDSNYVVK 222
Query: 177 YGTE---EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
                  +++ P+     V       TF +  D+WS G+ L+ + +  L   PY G
Sbjct: 223 GNARLPVKWMAPESIFNCVY------TFES--DVWSYGIFLWELFS--LGSSPYPG 268

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQMR-EFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 109 GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM- 187
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 165 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 220
Query: 188 -YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            Y R           G +  +WS+G+ LY +  G++PF
Sbjct: 221 RYHR---------YHGRSAAVWSLGILLYDMVCGDIPF 249

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF--NQLSHMR--PHDVQM-REFEVLKKVK--HE 68
            +LG G  G+V+ G+  ++  PVA+K    +++S     P+  ++  E  +LKKV     
Sbjct: 37  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 96
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
            +++LL   E    R    V+ L     + ++ D       LQEE        +   ++H
Sbjct: 97  GVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
             +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 153 CHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 208
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                     +  G +  +WS+G+ LY +  G++PF
Sbjct: 209 RYH-------RYHGRSAAVWSLGILLYDMVCGDIPF 237

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+      +         +RE  +LK++ H NIVKLL +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 71  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 126
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 127 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC---- 178
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 179 ---KYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-HDVQMREFEVLKKVKHENIVKLLAI 76
           +G+G  G V++  NK  GE VA+      +         +RE  +LK++ H NIVKLL +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +    K+ ++       L   +D    T G+        L  L  G+     +R++H
Sbjct: 70  IHTEN---KLYLVFEFLHQDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRK 195
           RDLKP N++  I  +G+   KL DFG AR      + +     T  Y  P++        
Sbjct: 126 RDLKPQNLL--INTEGAI--KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC---- 177
Query: 196 PVGKTFGATVDLWSIGVTLYHVAT 219
              K +   VD+WS+G     + T
Sbjct: 178 ---KYYSTAVDIWSLGCIFAEMVT 198

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 94/228 (41%), Gaps = 36/228 (15%)
Query: 18  LGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+GA G VF       + + +   VAVK   + S     D Q RE E+L  ++H++IV+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ-REAELLTMLQHQHIVR 107
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL--------------DDPENTYGLQEEEFLLV 118
              +    EGR  ++V E    G L   L              D      GL +   L V
Sbjct: 108 FFGVC--TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ--LLAV 163
Query: 119 LEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG-STIYKLTDFGAARELEEDQQFMSLY 177
              + AGM +L     VHRDL   N     C  G   + K+ DFG +R++     +    
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRN-----CLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218
Query: 178 GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
            T   +     E  + RK     F    D+WS GV L+ + T G  P+
Sbjct: 219 RTMLPIRWMPPESILYRK-----FTTESDVWSFGVVLWEIFTYGKQPW 261

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 15  TSVLGKGATGAVFQGVN-KNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH---ENI 70
            S LG+G  G V Q V+ +  G  VA+K    +   +  +    E  VL+K+     +N 
Sbjct: 38  VSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYK--EAARLEINVLEKINEKDPDNK 95
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGM 126
              + + +  +  G + +     G S F+ L D    P   + ++   F      L   +
Sbjct: 96  NLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAF-----QLCQAV 150
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDD----------------GSTIYKLTDFGAARELEED 170
           K L DN+L H DLKP NI+ F+  D                 ST  ++ DFG+A    + 
Sbjct: 151 KFLHDNKLTHTDLKPENIL-FVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSA--TFDH 207
Query: 171 QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR 230
           +   ++  T  Y  P++       +P         D+WSIG  ++    G   F+ +  R
Sbjct: 208 EHHSTIVSTRHYRAPEVILELGWSQP--------CDVWSIGCIIFEYYVGFTLFQTHDNR 259
Query: 231 RNKETMYYITTKKASGVISGTQTSE---NGEIDW 261
            +   M  I     S +I  T+  +    G +DW
Sbjct: 260 EHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDW 293

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 40/236 (16%)
Query: 18  LGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIV 71
           LG GA G V +      +  +    VAVK     +H+   +  M E +VL  +  H NIV
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE----------- 120
            LL       G   +++ E C  G L N L    +++   +    ++ +           
Sbjct: 114 NLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 121 ----HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL 176
                +  GM  L     +HRDL   NI+         I K+ DFG AR+++ D  ++  
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILL----THGRITKICDFGLARDIKNDSNYVVK 227
Query: 177 YGTE---EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
                  +++ P+     V       TF +  D+WS G+ L+ + +  L   PY G
Sbjct: 228 GNARLPVKWMAPESIFNCVY------TFES--DVWSYGIFLWELFS--LGSSPYPG 273

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 16/149 (10%)
Query: 87  IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMK 146
            V+E   GG L   +   +    L EE        ++  + +L +  +++RDLK  N++ 
Sbjct: 130 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 147 FICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATV 205
               D     KLTD+G  +E L       +  GT  Y+ P+     +LR   G+ +G +V
Sbjct: 187 ----DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE-----ILR---GEDYGFSV 234
Query: 206 DLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           D W++GV ++ +  G  PF   G   N +
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPD 263

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 7/92 (7%)
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP NI+    D+   I KL DFG +  L +D+      G   Y+ P   ER   
Sbjct: 146 VIHRDVKPSNIL---LDERGQI-KLCDFGISGRLVDDKAKDRSAGCAAYMAP---ERIDP 198
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
             P    +    D+WS+G++L  +ATG  P++
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYK 230

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 16/149 (10%)
Query: 87  IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMK 146
            V+E   GG L   +   +    L EE        ++  + +L +  +++RDLK  N++ 
Sbjct: 98  FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 154
Query: 147 FICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATV 205
               D     KLTD+G  +E L          GT  Y+ P+     +LR   G+ +G +V
Sbjct: 155 ----DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-----ILR---GEDYGFSV 202
Query: 206 DLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           D W++GV ++ +  G  PF   G   N +
Sbjct: 203 DWWALGVLMFEMMAGRSPFDIVGSSDNPD 231

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 40/236 (16%)
Query: 18  LGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIV 71
           LG GA G V +      +  +    VAVK     +H+   +  M E +VL  +  H NIV
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE----------- 120
            LL       G   +++ E C  G L N L    +++   +    ++ +           
Sbjct: 114 NLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 121 ----HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL 176
                +  GM  L     +HRDL   NI+         I K+ DFG AR ++ D  ++  
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILL----THGRITKICDFGLARHIKNDSNYVVK 227
Query: 177 YGTE---EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
                  +++ P+     V       TF +  D+WS G+ L+ + +  L   PY G
Sbjct: 228 GNARLPVKWMAPESIFNCVY------TFES--DVWSYGIFLWELFS--LGSSPYPG 273

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 16/149 (10%)
Query: 87  IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMK 146
            V+E   GG L   +   +    L EE        ++  + +L +  +++RDLK  N++ 
Sbjct: 83  FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 139
Query: 147 FICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATV 205
               D     KLTD+G  +E L          GT  Y+ P+     +LR   G+ +G +V
Sbjct: 140 ----DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-----ILR---GEDYGFSV 187
Query: 206 DLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           D W++GV ++ +  G  PF   G   N +
Sbjct: 188 DWWALGVLMFEMMAGRSPFDIVGSSDNPD 216

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 101/235 (42%), Gaps = 24/235 (10%)
Query: 17  VLGKGATGAVFQG-VNKNNGE--PVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIV 71
           +LGKG  G+V +  + + +G    VAVK   +   +   D++  +RE   +K+  H ++ 
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 72  KLLAIEEEQEGRGKV----IVMELCTGGSLFNILDDP---ENTYGLQEEEFLLVLEHLTA 124
           KL+ +      +G++    +++     G L   L      EN + L  +  +  +  +  
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
           GM++L     +HRDL   N M  + +D +    + DFG +R++     +    G    L 
Sbjct: 149 GMEYLSSRNFIHRDLAARNCM--LAEDMTVC--VADFGLSRKIYSGDYYRQ--GCASKLP 202
Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
               +   L       +    D+W+ GVT++ + T      PY G  N E   Y+
Sbjct: 203 ---VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ--TPYAGIENAEIYNYL 252

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 16/149 (10%)
Query: 87  IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMK 146
            V+E   GG L   +   +    L EE        ++  + +L +  +++RDLK  N++ 
Sbjct: 87  FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143
Query: 147 FICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATV 205
               D     KLTD+G  +E L          GT  Y+ P+     +LR   G+ +G +V
Sbjct: 144 ----DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-----ILR---GEDYGFSV 191
Query: 206 DLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           D W++GV ++ +  G  PF   G   N +
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPD 220

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +G G+ G ++ G N  +GE VA+K    +  H + H ++ + +++++       +K    
Sbjct: 17  IGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLH-IESKFYKMMQGGVGIPSIKWCG- 74
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
               EG   V+VMEL  G SL ++ +     + L+    LL+ + + + ++++     +H
Sbjct: 75  ---AEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKT--VLLLADQMISRIEYIHSKNFIH 128
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED--------QQFMSLYGTEEYLHPDMY 188
           RD+KP N +  +   G+ +Y + DFG A++  +         ++  +L GT  Y      
Sbjct: 129 RDVKPDNFLMGLGKKGNLVY-IIDFGLAKKYRDARTHQHIPYRENKNLTGTARY------ 181
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI 248
             A +   +G       DL S+G  L +   G+LP++       ++    I+ KK S  I
Sbjct: 182 --ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239
Query: 249 ----SGTQTSENGEIDWCTDL 265
                G  +  +  +++C  L
Sbjct: 240 EVLCKGYPSEFSTYLNFCRSL 260

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 56/107 (52%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  + +     S  G
Sbjct: 141 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANSFVG 196
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 197 TAQYVSPELLTE--------KSASKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           ++G+G  G V+     + G+  A+K  ++  +   +   + + E  +L  V   +   ++
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGL-QEEEFLLVLEHLTAGMKHLRDN 132
            +        K+  +++L  GG L   L    + +G+  E +       +  G++H+ + 
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            +V+RDLKP NI+    D+   + +++D G A +  + +   S+ GT  Y+ P++ ++ V
Sbjct: 312 FVVYRDLKPANIL---LDEHGHV-RISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGV 366
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                   + ++ D +S+G  L+ +  G+ PFR
Sbjct: 367 -------AYDSSADWFSLGCMLFKLLRGHSPFR 392

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           ++G+G  G V+     + G+  A+K  ++  +   +   + + E  +L  V   +   ++
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGL-QEEEFLLVLEHLTAGMKHLRDN 132
            +        K+  +++L  GG L   L    + +G+  E +       +  G++H+ + 
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            +V+RDLKP NI+    D+   + +++D G A +  + +   S+ GT  Y+ P++ ++ V
Sbjct: 312 FVVYRDLKPANIL---LDEHGHV-RISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGV 366
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                   + ++ D +S+G  L+ +  G+ PFR
Sbjct: 367 -------AYDSSADWFSLGCMLFKLLRGHSPFR 392

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           ++G+G  G V+     + G+  A+K  ++  +   +   + + E  +L  V   +   ++
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGL-QEEEFLLVLEHLTAGMKHLRDN 132
            +        K+  +++L  GG L   L    + +G+  E +       +  G++H+ + 
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            +V+RDLKP NI+    D+   + +++D G A +  + +   S+ GT  Y+ P++ ++ V
Sbjct: 312 FVVYRDLKPANIL---LDEHGHV-RISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGV 366
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                   + ++ D +S+G  L+ +  G+ PFR
Sbjct: 367 -------AYDSSADWFSLGCMLFKLLRGHSPFR 392

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           ++G+G  G V+     + G+  A+K  ++  +   +   + + E  +L  V   +   ++
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 254
Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGL-QEEEFLLVLEHLTAGMKHLRDN 132
            +        K+  +++L  GG L   L    + +G+  E +       +  G++H+ + 
Sbjct: 255 CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR 310
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            +V+RDLKP NI+    D+   + +++D G A +  + +   S+ GT  Y+ P++ ++ V
Sbjct: 311 FVVYRDLKPANIL---LDEHGHV-RISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGV 365
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                   + ++ D +S+G  L+ +  G+ PFR
Sbjct: 366 -------AYDSSADWFSLGCMLFKLLRGHSPFR 391

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 18/198 (9%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLA 75
           LG+G  G V++ ++    E VA+K   +L H         +RE  +LK+++H NI++L +
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           +        ++ ++       L   +D   +      + FL     L  G+      R +
Sbjct: 101 VIHHNH---RLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLY---QLINGVNFCHSRRCL 154
Query: 136 HRDLKPGNIMKFICDDGST-IYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAVL 193
           HRDLKP N++  + D   T + K+ DFG AR      +QF     T  Y  P++   +  
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGS-- 212
Query: 194 RKPVGKTFGATVDLWSIG 211
                + +  +VD+WSI 
Sbjct: 213 -----RHYSTSVDIWSIA 225

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 22/214 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           +LG+G+   V            A+K   +   ++ + V    RE +V+ ++ H   VKL 
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 95
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              ++ E       +     G L   +          E         + + +++L    +
Sbjct: 96  FTFQDDEKL--YFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYERA 191
           +HRDLKP NI+  + +D     ++TDFG A+ L  + +     S  GT +Y+ P++    
Sbjct: 151 IHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE- 205
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                  K+   + DLW++G  +Y +  G  PFR
Sbjct: 206 -------KSACKSSDLWALGCIIYQLVAGLPPFR 232

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 56/107 (52%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  + +     S  G
Sbjct: 142 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANSFVG 197
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 198 TAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFR 236

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 11/91 (12%)
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           + HRD+KP NI+     D +   KL+DFG + E   D++     GT E++ P+ +     
Sbjct: 173 ICHRDVKPSNILM----DKNGRVKLSDFGES-EYMVDKKIKGSRGTYEFMPPEFFSNE-- 225
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   GA VD+WS+G+ LY +    +PF
Sbjct: 226 ----SSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 19  GKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVKHENIVKLLAI- 76
           G+G  G V  G  K+ G  VA+K   Q    R  ++Q M++  VL    H NIV+L +  
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH---HPNIVQLQSYF 88
Query: 77  ----EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL------TAGM 126
               E ++      +VME     +L        N Y  Q     ++++        + G 
Sbjct: 89  YTLGERDRRDIYLNVVMEY-VPDTLHRCC---RNYYRRQVAPPPILIKVFLFQLIRSIGC 144
Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
            HL    + HRD+KP N++    ++     KL DFG+A++L   +  ++   +  Y  P+
Sbjct: 145 LHLPSVNVCHRDIKPHNVL---VNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPE 201
Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           +           + +   VD+WS+G     +  G   FR
Sbjct: 202 LIFG-------NQHYTTAVDIWSVGCIFAEMMLGEPIFR 233

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 108/226 (47%), Gaps = 42/226 (18%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           ++G+G  GAV++G    +  PVAVK F+  +  R + +  +    +  ++H+NI + +  
Sbjct: 20  LIGRGRYGAVYKG--SLDERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 77  EEEQEGRGKV---IVMELCTGGSLFNILDDPENTYGLQEEEFL--LVLEH-LTAGMKHLR 130
           +E     G++   +VME    GSL   L        L   +++    L H +T G+ +L 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYL-------SLHTSDWVSSCRLAHSVTRGLAYLH 128
Query: 131 DN---------RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL---------EEDQQ 172
                       + HRDL   N++  + +DG+ +  ++DFG +  L         EED  
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVL--VKNDGTCV--ISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 173 FMSLYGTEEYLHPDMYERAV-LRKPVGKTFGATVDLWSIGVTLYHV 217
            +S  GT  Y+ P++ E AV LR    ++    VD++++G+  + +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRD--XESALKQVDMYALGLIYWEI 228

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           +LG+G+   V            A+K   +   ++ + V    RE +V+ ++ H   VKL 
Sbjct: 17  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 76
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              ++ E       +     G L   +          E         + + +++L    +
Sbjct: 77  FTFQDDEKL--YFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKGI 131
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMS--LYGTEEYLHPDMYERA 191
           +HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    GT +Y+ P++    
Sbjct: 132 IHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE- 186
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                  K+   + DLW++G  +Y +  G  PFR
Sbjct: 187 -------KSACKSSDLWALGCIIYQLVAGLPPFR 213

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           +LG+G+   V            A+K   +   ++ + V    RE +V+ ++ H   VKL 
Sbjct: 14  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 73
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              ++ E       +     G L   +          E         + + +++L    +
Sbjct: 74  FTFQDDEKL--YFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKGI 128
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMS--LYGTEEYLHPDMYERA 191
           +HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    GT +Y+ P++    
Sbjct: 129 IHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE- 183
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                  K+   + DLW++G  +Y +  G  PFR
Sbjct: 184 -------KSACKSSDLWALGCIIYQLVAGLPPFR 210

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 37/226 (16%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +VLG+GA G V +  N  +    A+K    T  +LS +      + E  +L  + H+ +V
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI------LSEVMLLASLNHQYVV 65
Query: 72  KLLAIEEEQEGRGK-----------VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           +  A   E+    K            I ME C  G+L++++   EN    Q +E+  +  
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENL-NQQRDEYWRLFR 123
Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-----S 175
            +   + ++    ++HRDLKP NI  FI  D S   K+ DFG A+ +      +     +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNI--FI--DESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 176 LYGTEEYLHP----DMYERAVLRKPVGKTFGATVDLWSIGVTLYHV 217
           L G+ + L       MY    +    G  +   +D++S+G+  + +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEM 224

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           +LG+G+   V            A+K   +   ++ + V    RE +V+ ++ H   VKL 
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              ++ E       +     G L   +          E         + + +++L    +
Sbjct: 75  FTFQDDEKL--YFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMS--LYGTEEYLHPDMYERA 191
           +HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    GT +Y+ P++    
Sbjct: 130 IHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE- 184
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                  K+   + DLW++G  +Y +  G  PFR
Sbjct: 185 -------KSACKSSDLWALGCIIYQLVAGLPPFR 211

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           +LG+G+   V            A+K   +   ++ + V    RE +V+ ++ H   VKL 
Sbjct: 21  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 80
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              ++ E       +     G L   +          E         + + +++L    +
Sbjct: 81  FTFQDDEKL--YFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMS--LYGTEEYLHPDMYERA 191
           +HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    GT +Y+ P++    
Sbjct: 136 IHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE- 190
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                  K+   + DLW++G  +Y +  G  PFR
Sbjct: 191 -------KSACKSSDLWALGCIIYQLVAGLPPFR 217

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           +LG+G+   V            A+K   +   ++ + V    RE +V+ ++ H   VKL 
Sbjct: 16  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 75
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              ++ E       +     G L   +          E         + + +++L    +
Sbjct: 76  FTFQDDEKL--YFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKGI 130
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMS--LYGTEEYLHPDMYERA 191
           +HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    GT +Y+ P++    
Sbjct: 131 IHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE- 185
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                  K+   + DLW++G  +Y +  G  PFR
Sbjct: 186 -------KSACKSSDLWALGCIIYQLVAGLPPFR 212

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVL---KKVKHENIV 71
           S LG G+ G VF+  +K +G   AVK    +S  R P D   +  EV    K  +H   V
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVK--RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV 120
Query: 72  KLLAIEEEQEGRGKVIVM--ELCTGGSLFNILDDPENTYG--LQEEEFLLVLEHLTAGMK 127
           +L    EE    G ++ +  ELC G SL    +     +G  L E +    L      + 
Sbjct: 121 RLEQAWEE----GGILYLQTELC-GPSLQQHCE----AWGASLPEAQVWGYLRDTLLALA 171
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           HL    LVH D+KP NI  F+   G    KL DFG   EL          G   Y+ P++
Sbjct: 172 HLHSQGLVHLDVKPANI--FLGPRGRC--KLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
            +          ++G   D++S+G+T+  VA  N+   P+GG
Sbjct: 228 LQ---------GSYGTAADVFSLGLTILEVAC-NMEL-PHGG 258

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 56/107 (52%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  + +     +  G
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANAFVG 194
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 195 TAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFR 233

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 10  YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTF-NQLSHMRPHDVQMREFEVLKKVKHE 68
           Y +    V+GKG+ G V +  +    + VA+K   N+    R    ++R  E L+K   +
Sbjct: 97  YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEH-LTAGMK 127
           N + ++ + E    R  + +       +L+ ++   +N +       +    H +   + 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIK--KNKFQGFSLPLVRKFAHSILQCLD 214
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
            L  NR++H DLKP NI+  +   G +  K+ DFG++    E Q+  +   +  Y  P++
Sbjct: 215 ALHKNRIIHCDLKPENIL--LKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEV 270
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
                    +G  +G  +D+WS+G  L  + TG  P  P
Sbjct: 271 I--------LGARYGMPIDMWSLGCILAELLTG-YPLLP 300

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           +LG+G+   V            A+K   +   ++ + V    RE +V+ ++ H   VKL 
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 95
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              ++ E       +     G L   +          E         + + +++L    +
Sbjct: 96  FTFQDDEKL--YFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMS--LYGTEEYLHPDMYERA 191
           +HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    GT +Y+ P++    
Sbjct: 151 IHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE- 205
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                  K+   + DLW++G  +Y +  G  PFR
Sbjct: 206 -------KSACKSSDLWALGCIIYQLVAGLPPFR 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMS--LYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    G
Sbjct: 141 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVG 196
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 197 TAQYVSPELLTE--------KSAXKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 10  YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTF-NQLSHMRPHDVQMREFEVLKKVKHE 68
           Y +    V+GKG+ G V +  +    + VA+K   N+    R    ++R  E L+K   +
Sbjct: 97  YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEH-LTAGMK 127
           N + ++ + E    R  + +       +L+ ++   +N +       +    H +   + 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIK--KNKFQGFSLPLVRKFAHSILQCLD 214
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
            L  NR++H DLKP NI+  +   G +  K+ DFG++    E Q+  +   +  Y  P++
Sbjct: 215 ALHKNRIIHCDLKPENIL--LKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEV 270
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
                    +G  +G  +D+WS+G  L  + TG  P  P
Sbjct: 271 I--------LGARYGMPIDMWSLGCILAELLTG-YPLLP 300

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMS--LYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    G
Sbjct: 141 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVG 196
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 197 TAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 92/227 (40%), Gaps = 33/227 (14%)
Query: 18  LGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+GA G VF     N     +   VAVK     +     D Q RE E+L  ++HE+IVK
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-REAELLTNLQHEHIVK 81
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNIL------------DDPENTYG-LQEEEFLLVL 119
              +    +G   ++V E    G L   L              P    G L   + L + 
Sbjct: 82  FYGVC--GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST-IYKLTDFGAARELEEDQQFMSLYG 178
             + +GM +L     VHRDL   N     C  G+  + K+ DFG +R++     +     
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRN-----CLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
           T   +     E  + RK     F    D+WS GV L+ + T G  P+
Sbjct: 195 TMLPIRWMPPESIMYRK-----FTTESDVWSFGVILWEIFTYGKQPW 236

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMS--LYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    G
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVG 194
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 195 TAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFR 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMS--LYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    G
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVG 194
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 195 TAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFR 233

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMS--LYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    G
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVG 194
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 195 TAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFR 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMS--LYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    G
Sbjct: 146 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVG 201
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 202 TAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFR 240

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMS--LYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    G
Sbjct: 141 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVG 196
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 197 TAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMS--LYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    G
Sbjct: 142 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVG 197
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 198 TAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFR 236

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMS--LYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    G
Sbjct: 141 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVG 196
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 197 TAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMS--LYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    G
Sbjct: 144 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVG 199
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 200 TAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFR 238

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 15/107 (14%)
Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMS--LYG 178
           + + +++L    ++HRDLKP NI+  + +D     ++TDFG A+ L  E +Q  +    G
Sbjct: 141 IVSALEYLHGKGIIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANXFVG 196
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           T +Y+ P++           K+   + DLW++G  +Y +  G  PFR
Sbjct: 197 TAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFR 235

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 58/245 (23%)
Query: 18  LGKGATGAVF--QGVNKNNGEP-----VAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+GA G V   + +  +  +P     VAVK     +  +     + E E++K + KH+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSL---------------FNILDDPENTYGLQEEE 114
           I+ LL     Q+G   VIV E  + G+L               +N   +PE    L  ++
Sbjct: 85  IINLLGACT-QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ--LSSKD 140
Query: 115 FLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM 174
            +     +  GM++L   + +HRDL   N++  + +D   + K+ DFG AR++       
Sbjct: 141 LVSCAYQVARGMEYLASKKCIHRDLAARNVL--VTED--NVMKIADFGLARDIH------ 190
Query: 175 SLYGTEEYLHPDMYERAV-LRKPV---------GKTFGATVDLWSIGVTLYHVATGNLPF 224
                    H D Y++    R PV          + +    D+WS GV L+ + T  L  
Sbjct: 191 ---------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGG 239
Query: 225 RPYGG 229
            PY G
Sbjct: 240 SPYPG 244

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 58/245 (23%)
Query: 18  LGKGATGAVF--QGVNKNNGEP-----VAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+GA G V   + +  +  +P     VAVK     +  +     + E E++K + KH+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSL---------------FNILDDPENTYGLQEEE 114
           I+ LL     Q+G   VIV E  + G+L               +N   +PE    L  ++
Sbjct: 81  IINLLGACT-QDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ--LSSKD 136
Query: 115 FLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM 174
            +     +  GM++L   + +HRDL   N++  + +D   + K+ DFG AR++       
Sbjct: 137 LVSCAYQVARGMEYLASKKCIHRDLAARNVL--VTED--NVMKIADFGLARDIH------ 186
Query: 175 SLYGTEEYLHPDMYERAV-LRKPV---------GKTFGATVDLWSIGVTLYHVATGNLPF 224
                    H D Y++    R PV          + +    D+WS GV L+ + T  L  
Sbjct: 187 ---------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGG 235
Query: 225 RPYGG 229
            PY G
Sbjct: 236 SPYPG 240

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 110/240 (45%), Gaps = 26/240 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +G G+ G ++ G +   GE VA+K    +  H + H ++ + +++++       ++    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH-IESKIYKMMQGGVGIPTIRWCG- 74
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
               EG   V+VMEL  G SL ++ +     + L+    LL+ + + + ++++     +H
Sbjct: 75  ---AEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKT--VLLLADQMISRIEYIHSKNFIH 128
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEED--------QQFMSLYGTEEYLHPDMY 188
           RD+KP N +  +   G+ +Y + DFG A++  +         ++  +L GT  Y      
Sbjct: 129 RDVKPDNFLMGLGKKGNLVY-IIDFGLAKKYRDARTHQHIPYRENKNLTGTARY------ 181
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI 248
             A +   +G       DL S+G  L +   G+LP++       ++    I+ KK S  I
Sbjct: 182 --ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 58/245 (23%)
Query: 18  LGKGATGAVF--QGVNKNNGEP-----VAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+GA G V   + +  +  +P     VAVK     +  +     + E E++K + KH+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSL---------------FNILDDPENTYGLQEEE 114
           I+ LL     Q+G   VIV E  + G+L               +N   +PE    L  ++
Sbjct: 89  IINLLG-ACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ--LSSKD 144
Query: 115 FLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM 174
            +     +  GM++L   + +HRDL   N++  + +D   + K+ DFG AR++       
Sbjct: 145 LVSCAYQVARGMEYLASKKCIHRDLAARNVL--VTED--NVMKIADFGLARDIH------ 194
Query: 175 SLYGTEEYLHPDMYERAV-LRKPV---------GKTFGATVDLWSIGVTLYHVATGNLPF 224
                    H D Y++    R PV          + +    D+WS GV L+ + T  L  
Sbjct: 195 ---------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGG 243
Query: 225 RPYGG 229
            PY G
Sbjct: 244 SPYPG 248

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYER 190
           +VH DLKP N   F+  DG  + KL DFG A +++ D   +   S  GT  Y+ P+  + 
Sbjct: 148 IVHSDLKPAN---FLIVDG--MLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKD 202
Query: 191 AVLRKPVGKTFGATV---DLWSIGVTLYHVATGNLPFR 225
               +  GK+        D+WS+G  LY++  G  PF+
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 58/245 (23%)
Query: 18  LGKGATGAVF--QGVNKNNGEP-----VAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+GA G V   + +  +  +P     VAVK     +  +     + E E++K + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSL---------------FNILDDPENTYGLQEEE 114
           I+ LL     Q+G   VIV E  + G+L               +N   +PE    L  ++
Sbjct: 96  IINLLG-ACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ--LSSKD 151
Query: 115 FLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM 174
            +     +  GM++L   + +HRDL   N++  + +D   + K+ DFG AR++       
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVL--VTED--NVMKIADFGLARDIH------ 201
Query: 175 SLYGTEEYLHPDMYERAV-LRKPV---------GKTFGATVDLWSIGVTLYHVATGNLPF 224
                    H D Y++    R PV          + +    D+WS GV L+ + T  L  
Sbjct: 202 ---------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGG 250
Query: 225 RPYGG 229
            PY G
Sbjct: 251 SPYPG 255

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 58/245 (23%)
Query: 18  LGKGATGAVF--QGVNKNNGEP-----VAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+GA G V   + +  +  +P     VAVK     +  +     + E E++K + KH+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSL---------------FNILDDPENTYGLQEEE 114
           I+ LL     Q+G   VIV E  + G+L               +N   +PE    L  ++
Sbjct: 88  IINLLGACT-QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ--LSSKD 143
Query: 115 FLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM 174
            +     +  GM++L   + +HRDL   N++  + +D   + K+ DFG AR++       
Sbjct: 144 LVSCAYQVARGMEYLASKKCIHRDLAARNVL--VTED--NVMKIADFGLARDIH------ 193
Query: 175 SLYGTEEYLHPDMYERAV-LRKPV---------GKTFGATVDLWSIGVTLYHVATGNLPF 224
                    H D Y++    R PV          + +    D+WS GV L+ + T  L  
Sbjct: 194 ---------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGG 242
Query: 225 RPYGG 229
            PY G
Sbjct: 243 SPYPG 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 58/245 (23%)
Query: 18  LGKGATGAVF--QGVNKNNGEP-----VAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+GA G V   + +  +  +P     VAVK     +  +     + E E++K + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSL---------------FNILDDPENTYGLQEEE 114
           I+ LL     Q+G   VIV E  + G+L               +N   +PE    L  ++
Sbjct: 96  IINLLGACT-QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ--LSSKD 151
Query: 115 FLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM 174
            +     +  GM++L   + +HRDL   N++  + +D   + K+ DFG AR++       
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVL--VTED--NVMKIADFGLARDIH------ 201
Query: 175 SLYGTEEYLHPDMYERAV-LRKPV---------GKTFGATVDLWSIGVTLYHVATGNLPF 224
                    H D Y++    R PV          + +    D+WS GV L+ + T  L  
Sbjct: 202 ---------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGG 250
Query: 225 RPYGG 229
            PY G
Sbjct: 251 SPYPG 255

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 109/240 (45%), Gaps = 26/240 (10%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +G G+ G ++ G +   GE VA+K    +  H + H ++ + +++++       ++    
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH-IESKIYKMMQGGVGIPTIRWCG- 72
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
               EG   V+VMEL  G SL ++ +     + L+    LL+ + + + ++++     +H
Sbjct: 73  ---AEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKT--VLLLADQMISRIEYIHSKNFIH 126
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM--------SLYGTEEYLHPDMY 188
           RD+KP N +  +   G+ +Y + DFG A++  + +           +L GT  Y      
Sbjct: 127 RDVKPDNFLMGLGKKGNLVY-IIDFGLAKKYRDARTHQHIPYRENKNLTGTARY------ 179
Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI 248
             A +   +G       DL S+G  L +   G+LP++       ++    I+ KK S  I
Sbjct: 180 --ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 58/245 (23%)
Query: 18  LGKGATGAVF--QGVNKNNGEP-----VAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+GA G V   + +  +  +P     VAVK     +  +     + E E++K + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSL---------------FNILDDPENTYGLQEEE 114
           I+ LL     Q+G   VIV E  + G+L               +N   +PE    L  ++
Sbjct: 96  IINLLGACT-QDGPLYVIV-EYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ--LSSKD 151
Query: 115 FLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM 174
            +     +  GM++L   + +HRDL   N++  + +D   + K+ DFG AR++       
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVL--VTED--NVMKIADFGLARDIH------ 201
Query: 175 SLYGTEEYLHPDMYERAV-LRKPV---------GKTFGATVDLWSIGVTLYHVATGNLPF 224
                    H D Y++    R PV          + +    D+WS GV L+ + T  L  
Sbjct: 202 ---------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGG 250
Query: 225 RPYGG 229
            PY G
Sbjct: 251 SPYPG 255

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 46/239 (19%)
Query: 18  LGKGATGAVF--QGVNKNNGEP-----VAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+GA G V   + +  +  +P     VAVK     +  +     + E E++K + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSL---------------FNILDDPENTYGLQEEE 114
           I+ LL     Q+G   VIV E  + G+L               FN   +PE    L  ++
Sbjct: 96  IINLLG-ACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ--LSSKD 151
Query: 115 FLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE-DQQF 173
            +     +  GM++L   + +HRDL   N++  + +D   + K+ DFG AR++   D   
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVL--VTED--NVMKIADFGLARDIHHIDXXK 207
Query: 174 MSLYG--TEEYLHPD-MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
            +  G    +++ P+ +++R          +    D+WS GV L+ + T  L   PY G
Sbjct: 208 KTTNGRLPVKWMAPEALFDR---------IYTHQSDVWSFGVLLWEIFT--LGGSPYPG 255

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 17  VLGKGATGAVFQGVNKNNG--EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIVKL 73
           V+G+G  G V +   K +G     A+K   + +    H     E EVL K+ H  NI+ L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNIL-------DDPENTYG------LQEEEFLLVL 119
           L   E    RG + + +E    G+L + L        DP           L  ++ L   
Sbjct: 82  LGACEH---RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             +  GM +L   + +HRDL   NI+       + + K+ DFG +R            G 
Sbjct: 139 ADVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLSR------------GQ 182
Query: 180 EEYLHPDMYERAVLRKPVGKTFGATV-----DLWSIGVTLYHVAT-GNLPF 224
           E Y+   M  R  +R    ++   +V     D+WS GV L+ + + G  P+
Sbjct: 183 EVYVKKTM-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYER 190
           +VH DLKP N   F+  DG  + KL DFG A +++ D   +   S  GT  Y+ P+  + 
Sbjct: 129 IVHSDLKPAN---FLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 191 AVLRKPVGKTFGATV---DLWSIGVTLYHVATGNLPFR 225
               +  GK+        D+WS+G  LY++  G  PF+
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 106/250 (42%), Gaps = 63/250 (25%)
Query: 18  LGKGATGAVFQGV-----NKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENI 70
           LG+G  G V +        +     VAVK   +  +  P +++  + EF VLK+V H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE--NASPSELRDLLSEFNVLKQVNHPHV 88
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNIL----------------------DDPENTY 108
           +KL      Q+G   ++++E    GSL   L                      D P+   
Sbjct: 89  IKLYG-ACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER- 145
Query: 109 GLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE 168
            L   + +     ++ GM++L + +LVHRDL   NI+     +G  + K++DFG +R++ 
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL---VAEGRKM-KISDFGLSRDVY 201
Query: 169 EDQQFMSLYGTEEYLHPDMYERAVLRKPV---------GKTFGATVDLWSIGVTLYHVAT 219
           E+  ++              +R+  R PV            +    D+WS GV L+ + T
Sbjct: 202 EEDSYV--------------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 220 GNLPFRPYGG 229
             L   PY G
Sbjct: 248 --LGGNPYPG 255

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 17  VLGKGATGAVFQGVNKNNG--EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIVKL 73
           V+G+G  G V +   K +G     A+K   + +    H     E EVL K+ H  NI+ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNIL-------DDPENTYG------LQEEEFLLVL 119
           L   E    RG + + +E    G+L + L        DP           L  ++ L   
Sbjct: 92  LGACEH---RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             +  GM +L   + +HRDL   NI+       + + K+ DFG +R            G 
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLSR------------GQ 192
Query: 180 EEYLHPDMYERAVLRKPVGKTFGATV-----DLWSIGVTLYHVAT-GNLPF 224
           E Y+   M  R  +R    ++   +V     D+WS GV L+ + + G  P+
Sbjct: 193 EVYVKKTM-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYER 190
           +VH DLKP N   F+  DG  + KL DFG A +++ D   +   S  GT  Y+ P+  + 
Sbjct: 132 IVHSDLKPAN---FLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 186
Query: 191 AVLRKPVGKTFGATV---DLWSIGVTLYHVATGNLPFR 225
               +  GK+        D+WS+G  LY++  G  PF+
Sbjct: 187 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 224

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYER 190
           +VH DLKP N   F+  DG  + KL DFG A +++ D   +   S  GT  Y+ P+  + 
Sbjct: 148 IVHSDLKPAN---FLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 191 AVLRKPVGKTFGATV---DLWSIGVTLYHVATGNLPFR 225
               +  GK+        D+WS+G  LY++  G  PF+
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYER 190
           +VH DLKP N   F+  DG  + KL DFG A +++ D   +   S  GT  Y+ P+  + 
Sbjct: 176 IVHSDLKPAN---FLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 191 AVLRKPVGKTFGATV---DLWSIGVTLYHVATGNLPFR 225
               +  GK+        D+WS+G  LY++  G  PF+
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYER 190
           +VH DLKP N   F+  DG  + KL DFG A +++ D   +   S  GT  Y+ P+  + 
Sbjct: 176 IVHSDLKPAN---FLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 191 AVLRKPVGKTFGATV---DLWSIGVTLYHVATGNLPFR 225
               +  GK+        D+WS+G  LY++  G  PF+
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 58/245 (23%)
Query: 18  LGKGATGAVF--QGVNKNNGEP-----VAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           LG+GA G V   + +  +  +P     VAVK     +  +     + E E++K + KH+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSL---------------FNILDDPENTYGLQEEE 114
           I+ LL     Q+G   VIV E  + G+L               +N   +PE    L  ++
Sbjct: 137 IINLLG-ACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ--LSSKD 192
Query: 115 FLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM 174
            +     +  GM++L   + +HRDL   N++  + +D   + K+ DFG AR++       
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVL--VTED--NVMKIADFGLARDIH------ 242
Query: 175 SLYGTEEYLHPDMYERAV-LRKPV---------GKTFGATVDLWSIGVTLYHVATGNLPF 224
                    H D Y++    R PV          + +    D+WS GV L+ + T  L  
Sbjct: 243 ---------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGG 291
Query: 225 RPYGG 229
            PY G
Sbjct: 292 SPYPG 296

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 17/219 (7%)
Query: 10  YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTF-NQLSHMRPHDVQMREFEVLKKVKHE 68
           Y +    V+GKG  G V +  +    + VA+K   N+    R    ++R  E L+K   +
Sbjct: 97  YRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEH-LTAGMK 127
           N + ++ + E    R  + +       +L+ ++   +N +       +    H +   + 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIK--KNKFQGFSLPLVRKFAHSILQCLD 214
Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
            L  NR++H DLKP NI+  +   G +  K+ DFG++    E Q+      +  Y  P++
Sbjct: 215 ALHKNRIIHCDLKPENIL--LKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEV 270
Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
                    +G  +G  +D+WS+G  L  + TG  P  P
Sbjct: 271 I--------LGARYGMPIDMWSLGCILAELLTG-YPLLP 300

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/290 (21%), Positives = 120/290 (41%), Gaps = 45/290 (15%)
Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           VLGKG  G   +  ++  GE + +K   +          ++E +V++ ++H N++K + +
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-ETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             + +      + E   GG+L  I+   ++ Y   +   +   + + +GM +L    ++H
Sbjct: 76  LYKDKRLN--FITEYIKGGTLRGIIKSMDSQYPWSQR--VSFAKDIASGMAYLHSMNIIH 131
Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER-AVLRK 195
           RDL   N +  + ++ + +  + DFG AR + +++      G      PD  +R  V+  
Sbjct: 132 RDLNSHNCL--VRENKNVV--VADFGLARLMVDEKT--QPEGLRSLKKPDRKKRYTVVGN 185
Query: 196 PV--------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV 247
           P         G+++   VD++S G+ L  +           GR N +  Y   T      
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEII----------GRVNADPDYLPRTMDFGLN 235
Query: 248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF 297
           + G          +C   P NC  S        PI     ++D +K  SF
Sbjct: 236 VRGFLDR------YC---PPNCPPSF------FPITVRCCDLDPEKRPSF 270

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYER 190
           +VH DLKP N   F+  DG  + KL DFG A +++ D   +   S  GT  Y+ P+  + 
Sbjct: 128 IVHSDLKPAN---FLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 182
Query: 191 AVLRKPVGKTFGATV---DLWSIGVTLYHVATGNLPFR 225
               +  GK+        D+WS+G  LY++  G  PF+
Sbjct: 183 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 220

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMRE-FEVLKKVKHENIVKLLAI 76
           +G+G+   V++G++      VA          +    + +E  E LK ++H NIV+    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD- 92
Query: 77  EEEQEGRGK---VIVMELCTGGSLFNILDDPENTYGLQEEEFLLV-LEHLTAGMK--HLR 130
             E   +GK   V+V EL T G+L   L      + + + + L      +  G++  H R
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYL----KRFKVXKIKVLRSWCRQILKGLQFLHTR 148
Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              ++HRDLK  NI  FI     ++ K+ D G A  L+      ++ GT E+  P+ YE 
Sbjct: 149 TPPIIHRDLKCDNI--FITGPTGSV-KIGDLGLAT-LKRASFAKAVIGTPEFXAPEXYE- 203
Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   + +  +VD+++ G      AT   P+
Sbjct: 204 --------EKYDESVDVYAFGXCXLEXATSEYPY 229

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQG-VNKNNGE--PVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG G+ G V +G  +  +G+   VAVK      LS     D  +RE   +  + H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L  +      +   +V EL   GSL + L   +  + L       V   +  GM +L   
Sbjct: 80  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           R +HRDL   N++    D    + K+ DFG  R L ++      Y  +E+     +    
Sbjct: 135 RFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDH---YVMQEHRKVP-FAWCA 186
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
                 +TF    D W  GVTL+ + T G  P+
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQG-VNKNNGE--PVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG G+ G V +G  +  +G+   VAVK      LS     D  +RE   +  + H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L  +      +   +V EL   GSL + L   +  + L       V   +  GM +L   
Sbjct: 76  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           R +HRDL   N++    D    + K+ DFG  R L ++      Y  +E+     +    
Sbjct: 131 RFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDH---YVMQEHRKVP-FAWCA 182
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
                 +TF    D W  GVTL+ + T G  P+
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQG-VNKNNGE--PVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG G+ G V +G  +  +G+   VAVK      LS     D  +RE   +  + H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L  +      +   +V EL   GSL + L   +  + L       V   +  GM +L   
Sbjct: 80  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           R +HRDL   N++    D    + K+ DFG  R L ++      Y  +E+     +    
Sbjct: 135 RFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDH---YVMQEHRKVP-FAWCA 186
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
                 +TF    D W  GVTL+ + T G  P+
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF------NQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +GKG  G V +G    +   VA+K+        +   +       RE  ++  + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           KL  +          +VME    G L++ L D    + ++    L ++  +  G++++++
Sbjct: 87  KLYGLMHNP----PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 132 NR--LVHRDLKPGNIMKFICDDGSTI-YKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
               +VHRDL+  NI     D+ + +  K+ DFG +++         L G  +++ P+  
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ--SVHSVSGLLGNFQWMAPET- 197
Query: 189 ERAVLRKPVG---KTFGATVDLWSIGVTLYHVATGNLPFRPY 227
                   +G   +++    D +S  + LY + TG  PF  Y
Sbjct: 198 --------IGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQG-VNKNNGE--PVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG G+ G V +G  +  +G+   VAVK      LS     D  +RE   +  + H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L  +      +   +V EL   GSL + L   +  + L       V   +  GM +L   
Sbjct: 76  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           R +HRDL   N++    D    + K+ DFG  R L ++      Y  +E+     +    
Sbjct: 131 RFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDH---YVMQEHRKVP-FAWCA 182
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
                 +TF    D W  GVTL+ + T G  P+
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAI 76
           LG+G    VF+ +N  N E V VK    L  ++ + ++ RE ++L+ ++   NI+ L  I
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKI---LKPVKKNKIK-REIKILENLRGGPNIITLADI 100
Query: 77  EEEQEGRGKVIVMELCTG---GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            ++   R   +V E         L+  L D +  + + E         +   + +     
Sbjct: 101 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE---------ILKALDYCHSMG 151
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP N+M    D      +L D+G A      Q++     +  +  P++      
Sbjct: 152 IMHRDVKPHNVM---IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY-- 206
Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                + +  ++D+WS+G  L  +     PF
Sbjct: 207 -----QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF------NQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +GKG  G V +G    +   VA+K+        +   +       RE  ++  + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           KL  +          +VME    G L++ L D    + ++    L ++  +  G++++++
Sbjct: 87  KLYGLMHNP----PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 132 NR--LVHRDLKPGNIMKFICDDGSTI-YKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
               +VHRDL+  NI     D+ + +  K+ DFG +++         L G  +++ P+  
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--SVHSVSGLLGNFQWMAPET- 197
Query: 189 ERAVLRKPVG---KTFGATVDLWSIGVTLYHVATGNLPFRPY 227
                   +G   +++    D +S  + LY + TG  PF  Y
Sbjct: 198 --------IGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 37/226 (16%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +VLG+GA G V +  N  +    A+K    T  +LS +      + E  +L  + H+ +V
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI------LSEVMLLASLNHQYVV 65
Query: 72  KLLAIEEEQEGRGK-----------VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           +  A   E+    K            I ME C   +L++++   EN    Q +E+  +  
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHS-ENL-NQQRDEYWRLFR 123
Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-----S 175
            +   + ++    ++HRDLKP NI  FI  D S   K+ DFG A+ +      +     +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNI--FI--DESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 176 LYGTEEYLHP----DMYERAVLRKPVGKTFGATVDLWSIGVTLYHV 217
           L G+ + L       MY    +    G  +   +D++S+G+  + +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEM 224

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQG-VNKNNGE--PVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG G+ G V +G  +  +G+   VAVK      LS     D  +RE   +  + H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L  +      +   +V EL   GSL + L   +  + L       V   +  GM +L   
Sbjct: 76  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           R +HRDL   N++    D    + K+ DFG  R L ++     +   E    P  +    
Sbjct: 131 RFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHXVM--QEHRKVP--FAWCA 182
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
                 +TF    D W  GVTL+ + T G  P+
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF-NQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           S++GKG+ G V +  ++   E VA+K   N+ + +    +++R  E++ K   E    ++
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            ++     R  + ++      +L+++L +  N  G+         + +   +  L    L
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSYNLYDLLRN-TNFRGVSLNLTRKFAQQMCTALLFLATPEL 178
Query: 135 --VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
             +H DLKP NI+  +C+   +  K+ DFG++ +L   Q+      +  Y  P++     
Sbjct: 179 SIIHCDLKPENIL--LCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRSPEVL---- 230
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   +D+WS+G  L  + TG   F
Sbjct: 231 ----LGMPYDLAIDMWSLGCILVEMHTGEPLF 258

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 53  DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
           D  + E  V++++ +  IV+++ I E +     ++VME+   G L   L   +N + +++
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGICEAESW---MLVMEMAELGPLNKYLQ--QNRH-VKD 468
Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
           +  + ++  ++ GMK+L ++  VHRDL   N++           K++DFG ++ L  D+ 
Sbjct: 469 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT----QHYAKISDFGLSKALRADEN 524
Query: 173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRR 231
           +     T        Y    +       F +  D+WS GV ++   + G  P+R   G +
Sbjct: 525 YYKAQ-THGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMK 577
Query: 232 NKETMYYITTKKASGVISG 250
             E    +   +  G  +G
Sbjct: 578 GSEVTAMLEKGERMGCPAG 596

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 53  DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
           D  + E  V++++ +  IV+++ I E +     ++VME+   G L   L   +N + +++
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGICEAESW---MLVMEMAELGPLNKYLQ--QNRH-VKD 469
Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
           +  + ++  ++ GMK+L ++  VHRDL   N++           K++DFG ++ L  D+ 
Sbjct: 470 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT----QHYAKISDFGLSKALRADEN 525
Query: 173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHV-ATGNLPFRPYGGRR 231
           +     T        Y    +       F +  D+WS GV ++   + G  P+R   G +
Sbjct: 526 YYKAQ-THGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMK 578
Query: 232 NKETMYYITTKKASGVISG 250
             E    +   +  G  +G
Sbjct: 579 GSEVTAMLEKGERMGCPAG 597

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF-NQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           S++GKG+ G V +  ++   E VA+K   N+ + +    +++R  E++ K   E    ++
Sbjct: 41  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 100
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            ++     R  + ++      +L+++L +  N  G+         + +   +  L    L
Sbjct: 101 HLKRHFMFRNHLCLVFEMLSYNLYDLLRN-TNFRGVSLNLTRKFAQQMCTALLFLATPEL 159
Query: 135 --VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
             +H DLKP NI+  +C+   +  K+ DFG++ +L   Q+      +  Y  P++     
Sbjct: 160 SIIHCDLKPENIL--LCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRSPEVL---- 211
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   +D+WS+G  L  + TG   F
Sbjct: 212 ----LGMPYDLAIDMWSLGCILVEMHTGEPLF 239

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 31/214 (14%)
Query: 18  LGKGATGAVFQGVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           +  G  G ++  +++N NG PV +K            + M E + L +V H +IV++   
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 77  EEEQEGRG---KVIVMELCTGGSLFNILDDPENTYG--LQEEEFLLVLEHLTAGMKHLRD 131
            E  +  G     IVME   G SL       + + G  L   E +  L  +   + +L  
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSL-------KRSKGQKLPVAEAIAYLLEILPALSYLHS 200
Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
             LV+ DLKP NIM  + ++     KL D GA   +     F  LYGT  +  P++    
Sbjct: 201 IGLVYNDLKPENIM--LTEEQ---LKLIDLGAVSRI---NSFGYLYGTPGFQAPEIVR-- 250
Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                 G T     D++++G TL  + T +LP R
Sbjct: 251 -----TGPTV--ATDIYTVGRTLAAL-TLDLPTR 276

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQG-VNKNNGE--PVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG G+ G V +G  +  +G+   VAVK      LS     D  +RE   +  + H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L  +      +   +V EL   GSL + L   +  + L       V   +  GM +L   
Sbjct: 86  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           R +HRDL   N++    D    + K+ DFG  R L ++      Y  +E+     +    
Sbjct: 141 RFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDH---YVMQEHRKVP-FAWCA 192
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
                 +TF    D W  GVTL+ + T G  P+
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 11/98 (11%)
Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYER 190
           +VH DLKP N   F+  DG  + KL DFG A +++ D   +   S  G   Y+ P+  + 
Sbjct: 176 IVHSDLKPAN---FLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 191 AVLRKPVGKTFGATV---DLWSIGVTLYHVATGNLPFR 225
               +  GK+        D+WS+G  LY++  G  PF+
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 101/290 (34%), Gaps = 99/290 (34%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 28  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY----------------------- 108
            LL    +  G   VIV E C  G+L   L    N +                       
Sbjct: 88  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 146
Query: 109 -----------------GLQEEEFL----------------LVLEHLTA-------GMKH 128
                            G  EE+ L                L LEHL         GM+ 
Sbjct: 147 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 206
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           L   + +HRDL   NI+         + K+ DFG AR++ +D              PD  
Sbjct: 207 LASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKD--------------PDYV 248
Query: 189 ERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
            +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 249 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 296

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 17  VLGKGATGAVFQGVNKNNG--EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIVKL 73
           V+G+G  G V +   K +G     A+K   + +    H     E EVL K+ H  NI+ L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNIL-------DDPENTYG------LQEEEFLLVL 119
           L   E    RG + + +E    G+L + L        DP           L  ++ L   
Sbjct: 89  LGACEH---RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
             +  GM +L   + +HR+L   NI+       + + K+ DFG +R            G 
Sbjct: 146 ADVARGMDYLSQKQFIHRNLAARNILV----GENYVAKIADFGLSR------------GQ 189
Query: 180 EEYLHPDMYERAVLRKPVGKTFGATV-----DLWSIGVTLYHVAT-GNLPF 224
           E Y+   M  R  +R    ++   +V     D+WS GV L+ + + G  P+
Sbjct: 190 EVYVKKTM-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 239

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 87/198 (43%), Gaps = 16/198 (8%)
Query: 53  DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
           D  + E  V++++ +  IV+++ I    E    ++VME+   G L   L   +    +++
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGI---CEAESWMLVMEMAELGPLNKYL---QQNRHVKD 126
Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
           +  + ++  ++ GMK+L ++  VHRDL   N++           K++DFG ++ L  D+ 
Sbjct: 127 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT----QHYAKISDFGLSKALRADEN 182
Query: 173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
           +     T        Y    +       F +  D+WS GV ++   +     +PY G + 
Sbjct: 183 YYKA-QTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQ--KPYRGMKG 236
Query: 233 KETMYYITTKKASGVISG 250
            E    +   +  G  +G
Sbjct: 237 SEVTAMLEKGERMGCPAG 254

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 87/198 (43%), Gaps = 16/198 (8%)
Query: 53  DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
           D  + E  V++++ +  IV+++ I    E    ++VME+   G L   L   +    +++
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGI---CEAESWMLVMEMAELGPLNKYL---QQNRHVKD 126
Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
           +  + ++  ++ GMK+L ++  VHRDL   N++           K++DFG ++ L  D+ 
Sbjct: 127 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT----QHYAKISDFGLSKALRADEN 182
Query: 173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
           +     T        Y    +       F +  D+WS GV ++   +     +PY G + 
Sbjct: 183 YYKA-QTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQ--KPYRGMKG 236
Query: 233 KETMYYITTKKASGVISG 250
            E    +   +  G  +G
Sbjct: 237 SEVTAMLEKGERMGCPAG 254

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 101/290 (34%), Gaps = 99/290 (34%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY----------------------- 108
            LL    +  G   VIV E C  G+L   L    N +                       
Sbjct: 90  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 109 -----------------GLQEEEFL----------------LVLEHLTA-------GMKH 128
                            G  EE+ L                L LEHL         GM+ 
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           L   + +HRDL   NI+         + K+ DFG AR++ +D              PD  
Sbjct: 209 LASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKD--------------PDYV 250
Query: 189 ERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
            +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 298

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 53  DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
           D  + E  V++++ +  IV+++ I E +     ++VME+   G L   L    +   +++
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGICEAESW---MLVMEMAELGPLNKYLQQNRH---VKD 106
Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
           +  + ++  ++ GMK+L ++  VHRDL   N++           K++DFG ++ L  D+ 
Sbjct: 107 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT----QHYAKISDFGLSKALRADEN 162
Query: 173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
           +     T        Y    +       F +  D+WS GV ++   +     +PY G + 
Sbjct: 163 YYKA-QTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQ--KPYRGMKG 216
Query: 233 KETMYYITTKKASGVISG 250
            E    +   +  G  +G
Sbjct: 217 SEVTAMLEKGERMGCPAG 234

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 63/250 (25%)
Query: 18  LGKGATGAVFQGV-----NKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENI 70
           LG+G  G V +        +     VAVK   +  +  P +++  + EF VLK+V H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE--NASPSELRDLLSEFNVLKQVNHPHV 88
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNIL----------------------DDPENTY 108
           +KL      Q+G   ++++E    GSL   L                      D P+   
Sbjct: 89  IKLYG-ACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER- 145
Query: 109 GLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE 168
            L   + +     ++ GM++L + +LVHRDL   NI+     +G  + K++DFG +R++ 
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL---VAEGRKM-KISDFGLSRDVY 201
Query: 169 EDQQFMSLYGTEEYLHPDMYERAVLRKPV---------GKTFGATVDLWSIGVTLYHVAT 219
           E+   +              +R+  R PV            +    D+WS GV L+ + T
Sbjct: 202 EEDSXV--------------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 220 GNLPFRPYGG 229
             L   PY G
Sbjct: 248 --LGGNPYPG 255

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 53  DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
           D  + E  V++++ +  IV+++ I E +     ++VME+   G L   L    +   +++
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESW---MLVMEMAELGPLNKYLQQNRH---VKD 110
Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
           +  + ++  ++ GMK+L ++  VHRDL   N++           K++DFG ++ L  D+ 
Sbjct: 111 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT----QHYAKISDFGLSKALRADEN 166
Query: 173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
           +     T        Y    +       F +  D+WS GV ++   +     +PY G + 
Sbjct: 167 YYKA-QTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQ--KPYRGMKG 220
Query: 233 KETMYYITTKKASGVISG 250
            E    +   +  G  +G
Sbjct: 221 SEVTAMLEKGERMGCPAG 238

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 53  DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
           D  + E  V++++ +  IV+++ I E +     ++VME+   G L   L    +   +++
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGICEAESW---MLVMEMAELGPLNKYLQQNRH---VKD 104
Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
           +  + ++  ++ GMK+L ++  VHRDL   N++           K++DFG ++ L  D+ 
Sbjct: 105 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT----QHYAKISDFGLSKALRADEN 160
Query: 173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
           +     T        Y    +       F +  D+WS GV ++   +     +PY G + 
Sbjct: 161 YYKA-QTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQ--KPYRGMKG 214
Query: 233 KETMYYITTKKASGVISG 250
            E    +   +  G  +G
Sbjct: 215 SEVTAMLEKGERMGCPAG 232

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 53  DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
           D  + E  V++++ +  IV+++ I E +     ++VME+   G L   L    +   +++
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGICEAESW---MLVMEMAELGPLNKYLQQNRH---VKD 124
Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
           +  + ++  ++ GMK+L ++  VHRDL   N++           K++DFG ++ L  D+ 
Sbjct: 125 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT----QHYAKISDFGLSKALRADEN 180
Query: 173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
           +     T        Y    +       F +  D+WS GV ++   +     +PY G + 
Sbjct: 181 YYKA-QTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQ--KPYRGMKG 234
Query: 233 KETMYYITTKKASGVISG 250
            E    +   +  G  +G
Sbjct: 235 SEVTAMLEKGERMGCPAG 252

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 101/290 (34%), Gaps = 99/290 (34%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY----------------------- 108
            LL    +  G   VIV E C  G+L   L    N +                       
Sbjct: 95  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 153
Query: 109 -----------------GLQEEEFL----------------LVLEHLTA-------GMKH 128
                            G  EE+ L                L LEHL         GM+ 
Sbjct: 154 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 213
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           L   + +HRDL   NI+         + K+ DFG AR++ +D              PD  
Sbjct: 214 LASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKD--------------PDYV 255
Query: 189 ERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
            +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 256 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 303

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 19/213 (8%)
Query: 18  LGKGATGAVFQG-VNKNNGE--PVAVKTFNQ--LSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG G+ G V +G  +  +G+   VAVK      LS     D  +RE   +  + H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L  +      +   +V EL   GSL + L   +  + L       V   +  GM +L   
Sbjct: 86  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           R +HRDL   N++    D    + K+ DFG  R L ++     +   E    P  +    
Sbjct: 141 RFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHXVM--QEHRKVP--FAWCA 192
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF 224
                 +TF    D W  GVTL+ + T G  P+
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 96/212 (45%), Gaps = 16/212 (7%)
Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTF-NQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           S++GKG+ G V +  ++   E VA+K   N+ + +    +++R  E++ K   E    ++
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            ++     R  + ++      +L+++L +  N  G+         + +   +  L    L
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSYNLYDLLRN-TNFRGVSLNLTRKFAQQMCTALLFLATPEL 178
Query: 135 --VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
             +H DLKP NI+  +C+      K+ DFG++ +L   Q+      +  Y  P++     
Sbjct: 179 SIIHCDLKPENIL--LCNPKRXAIKIVDFGSSCQL--GQRIYQXIQSRFYRSPEVL---- 230
Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +G  +   +D+WS+G  L  + TG   F
Sbjct: 231 ----LGMPYDLAIDMWSLGCILVEMHTGEPLF 258

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 102/256 (39%), Gaps = 36/256 (14%)
Query: 18  LGKGATGAVFQGVNKNNGEP-VAVKTFNQLSHMRPHDVQMREFEVLKKVKH---ENIVKL 73
           LG+G  G V + ++   G+  VA+K    +   R  +    E  VLKK+K    EN    
Sbjct: 36  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR--EAARLEINVLKKIKEKDKENKFLC 93
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           + + +     G + +     G + F  L +     Y L     +     L   ++ L +N
Sbjct: 94  VLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAY--QLCHALRFLHEN 151
Query: 133 RLVHRDLKPGNIMKFICDDGSTIY----------------KLTDFGAARELEEDQQFMSL 176
           +L H DLKP NI+ F+  +  T+Y                ++ DFG+A    + +   ++
Sbjct: 152 QLTHTDLKPENIL-FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTI 208
Query: 177 YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
             T  Y  P++       +P         D+WSIG  L+    G   F+ +  R +   M
Sbjct: 209 VATRHYRPPEVILELGWAQP--------CDVWSIGCILFEYYRGFTLFQTHENREHLVMM 260
Query: 237 YYITTKKASGVISGTQ 252
             I     S +I  T+
Sbjct: 261 EKILGPIPSHMIHRTR 276

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 101/290 (34%), Gaps = 99/290 (34%)
Query: 18  LGKGATGAVFQ----GVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-NIV 71
           LG+GA G V +    G++K      VAVK   + +    H   M E ++L  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY----------------------- 108
            LL    +  G   VIV E C  G+L   L    N +                       
Sbjct: 97  NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 155
Query: 109 -----------------GLQEEEFL----------------LVLEHLTA-------GMKH 128
                            G  EE+ L                L LEHL         GM+ 
Sbjct: 156 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 215
Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           L   + +HRDL   NI+         + K+ DFG AR++ +D              PD  
Sbjct: 216 LASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKD--------------PDYV 257
Query: 189 ERAVLRKPVGKTFGATV---------DLWSIGVTLYHVATGNLPFRPYGG 229
            +   R P+      T+         D+WS GV L+ + +  L   PY G
Sbjct: 258 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPG 305

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 88/198 (44%), Gaps = 16/198 (8%)
Query: 53  DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
           D  + E  V++++ +  IV+++ I E +     ++VME+   G L   L    +   +++
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGICEAESW---MLVMEMAELGPLNKYLQQNRH---VKD 116
Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
           +  + ++  ++ GMK+L ++  VHRDL   N++           K++DFG ++ L  D+ 
Sbjct: 117 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT----QHYAKISDFGLSKALRADEN 172
Query: 173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
           +     T        Y    +       F +  D+WS GV ++   +     +PY G + 
Sbjct: 173 YYKA-QTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQ--KPYRGMKG 226
Query: 233 KETMYYITTKKASGVISG 250
            E    +   +  G  +G
Sbjct: 227 SEVTAMLEKGERMGCPAG 244

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 102/256 (39%), Gaps = 36/256 (14%)
Query: 18  LGKGATGAVFQGVNKNNGEP-VAVKTFNQLSHMRPHDVQMREFEVLKKVKH---ENIVKL 73
           LG+G  G V + ++   G+  VA+K    +   R  +    E  VLKK+K    EN    
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR--EAARLEINVLKKIKEKDKENKFLC 84
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           + + +     G + +     G + F  L +     Y L     +     L   ++ L +N
Sbjct: 85  VLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAY--QLCHALRFLHEN 142
Query: 133 RLVHRDLKPGNIMKFICDDGSTIY----------------KLTDFGAARELEEDQQFMSL 176
           +L H DLKP NI+ F+  +  T+Y                ++ DFG+A    + +   ++
Sbjct: 143 QLTHTDLKPENIL-FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTI 199
Query: 177 YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
             T  Y  P++       +P         D+WSIG  L+    G   F+ +  R +   M
Sbjct: 200 VATRHYRPPEVILELGWAQP--------CDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251
Query: 237 YYITTKKASGVISGTQ 252
             I     S +I  T+
Sbjct: 252 EKILGPIPSHMIHRTR 267

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/266 (21%), Positives = 105/266 (39%), Gaps = 35/266 (13%)
Query: 18  LGKGATGAVFQGVN-KNNGEPVAVKTFNQLS-HMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LG+GA G V + ++ K  G  VAVK    +  +      +++  E L      +  + + 
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81
Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTY-GLQEEEFLLVLEHLTAGMKHLRDNRL 134
           + E  E  G + ++    G S ++ +   EN +   + +    +   +   +  L  N+L
Sbjct: 82  MLEWFEHHGHICIVFELLGLSTYDFIK--ENGFLPFRLDHIRKMAYQICKSVNFLHSNKL 139
Query: 135 VHRDLKPGNIMKFICDDGSTIY----------------KLTDFGAARELEEDQQFMSLYG 178
            H DLKP NI+ F+  D +  Y                K+ DFG+A    +D+   +L  
Sbjct: 140 THTDLKPENIL-FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVS 196
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY 238
           T  Y  P++         +   +    D+WSIG  L     G   F  +  + +   M  
Sbjct: 197 TRHYRAPEVI--------LALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 239 ITTKKASGVISGTQTSE---NGEIDW 261
           I       +I  T+  +   +  +DW
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDW 274

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 102/256 (39%), Gaps = 36/256 (14%)
Query: 18  LGKGATGAVFQGVNKNNGEP-VAVKTFNQLSHMRPHDVQMREFEVLKKVKH---ENIVKL 73
           LG+G  G V + ++   G+  VA+K    +   R  +    E  VLKK+K    EN    
Sbjct: 59  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR--EAARLEINVLKKIKEKDKENKFLC 116
Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           + + +     G + +     G + F  L +     Y L     +     L   ++ L +N
Sbjct: 117 VLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAY--QLCHALRFLHEN 174
Query: 133 RLVHRDLKPGNIMKFICDDGSTIY----------------KLTDFGAARELEEDQQFMSL 176
           +L H DLKP NI+ F+  +  T+Y                ++ DFG+A    + +   ++
Sbjct: 175 QLTHTDLKPENIL-FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTI 231
Query: 177 YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
             T  Y  P++       +P         D+WSIG  L+    G   F+ +  R +   M
Sbjct: 232 VATRHYRPPEVILELGWAQP--------CDVWSIGCILFEYYRGFTLFQTHENREHLVMM 283
Query: 237 YYITTKKASGVISGTQ 252
             I     S +I  T+
Sbjct: 284 EKILGPIPSHMIHRTR 299

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 104/250 (41%), Gaps = 63/250 (25%)
Query: 18  LGKGATGAVFQGV-----NKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENI 70
           LG+G  G V +        +     VAVK   +  +  P +++  + EF VLK+V H ++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE--NASPSELRDLLSEFNVLKQVNHPHV 88
Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNIL----------------------DDPENTY 108
           +KL      Q+G   ++++E    GSL   L                      D P+   
Sbjct: 89  IKLYG-ACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER- 145
Query: 109 GLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE 168
            L   + +     ++ GM++L +  LVHRDL   NI+     +G  + K++DFG +R++ 
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNIL---VAEGRKM-KISDFGLSRDVY 201
Query: 169 EDQQFMSLYGTEEYLHPDMYERAVLRKPV---------GKTFGATVDLWSIGVTLYHVAT 219
           E+   +              +R+  R PV            +    D+WS GV L+ + T
Sbjct: 202 EEDSXV--------------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 220 GNLPFRPYGG 229
             L   PY G
Sbjct: 248 --LGGNPYPG 255

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 37/220 (16%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV--KHENIVKLLA 75
           +GKG  G V++G     GE VAVK F+     R      RE E+   V  +HENI+  +A
Sbjct: 16  VGKGRYGEVWRG--SWQGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 76  IEEEQEGRGKVIVMELCTG----GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR- 130
              +   R     + L T     GSL++ L        L     L ++  + +G+ HL  
Sbjct: 70  --SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 131 -------DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL-----YG 178
                     + HRDLK  NI+  +  +G     + D G A    +    + +      G
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNIL--VKKNGQCC--IADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVA 218
           T+ Y+ P++ +  +            VD+W+ G+ L+ VA
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSY--KRVDIWAFGLVLWEVA 217

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 94/226 (41%), Gaps = 26/226 (11%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG G  G V +GV    GE    PV +K     S  +           +  + H +IV+
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE---HLTAGMKHL 129
           LL +     G    +V +    GSL + +       G Q     L+L     +  GM +L
Sbjct: 98  LLGL---CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQ-----LLLNWGVQIAKGMYYL 149
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
            ++ +VHR+L   N++        +  ++ DFG A  L  D + + LY   E   P  + 
Sbjct: 150 EEHGMVHRNLAARNVLL----KSPSQVQVADFGVADLLPPDDKQL-LY--SEAKTPIKW- 201
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKET 235
            A+     GK +    D+WS GVT++ + T      PY G R  E 
Sbjct: 202 MALESIHFGK-YTHQSDVWSYGVTVWELMT--FGAEPYAGLRLAEV 244

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 37/220 (16%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV--KHENIVKLLA 75
           +GKG  G V++G     GE VAVK F+     R      RE E+   V  +HENI+  +A
Sbjct: 16  VGKGRYGEVWRG--SWQGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 76  IEEEQEGRGKVIVMELCTG----GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR- 130
              +   R     + L T     GSL++ L        L     L ++  + +G+ HL  
Sbjct: 70  --SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 131 -------DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL-----YG 178
                     + HRDLK  NI+  +  +G     + D G A    +    + +      G
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNIL--VKKNGQCC--IADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVA 218
           T+ Y+ P++ +  +            VD+W+ G+ L+ VA
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSY--KRVDIWAFGLVLWEVA 217

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 87/198 (43%), Gaps = 16/198 (8%)
Query: 53  DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
           D  + E  V++++ +  IV+++ I E +     ++VME+   G L   L    +   +++
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESW---MLVMEMAELGPLNKYLQQNRH---VKD 110
Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
           +  + ++  ++ GMK+L ++  VHRDL   N++           K++DFG ++ L  D+ 
Sbjct: 111 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT----QHYAKISDFGLSKALRADEN 166
Query: 173 FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
                 T        Y    +       F +  D+WS GV ++   +     +PY G + 
Sbjct: 167 XYKA-QTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQ--KPYRGMKG 220
Query: 233 KETMYYITTKKASGVISG 250
            E    +   +  G  +G
Sbjct: 221 SEVTAMLEKGERMGCPAG 238

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTF------NQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +GKG  G V +G    +   VA+K+        +   +       RE  ++  + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           KL  +          +VME    G L++ L D    + ++    L ++  +  G++++++
Sbjct: 87  KLYGLMHNP----PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 132 NR--LVHRDLKPGNIMKFICDDGSTI-YKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
               +VHRDL+  NI     D+ + +  K+ DF  +++         L G  +++ P+  
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ--SVHSVSGLLGNFQWMAPET- 197
Query: 189 ERAVLRKPVG---KTFGATVDLWSIGVTLYHVATGNLPFRPY 227
                   +G   +++    D +S  + LY + TG  PF  Y
Sbjct: 198 --------IGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 94/226 (41%), Gaps = 26/226 (11%)
Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG G  G V +GV    GE    PV +K     S  +           +  + H +IV+
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE---HLTAGMKHL 129
           LL +     G    +V +    GSL + +       G Q     L+L     +  GM +L
Sbjct: 80  LLGL---CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQ-----LLLNWGVQIAKGMYYL 131
Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
            ++ +VHR+L   N++        +  ++ DFG A  L  D + + LY   E   P  + 
Sbjct: 132 EEHGMVHRNLAARNVLL----KSPSQVQVADFGVADLLPPDDKQL-LY--SEAKTPIKW- 183
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKET 235
            A+     GK +    D+WS GVT++ + T      PY G R  E 
Sbjct: 184 MALESIHFGK-YTHQSDVWSYGVTVWELMT--FGAEPYAGLRLAEV 226

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 37/220 (16%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV--KHENIVKLLA 75
           +GKG  G V++G     GE VAVK F+     R      RE E+   V  +HENI+  +A
Sbjct: 45  VGKGRYGEVWRG--SWQGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIA 98
Query: 76  IEEEQEGRGKVIVMELCTG----GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR- 130
              +   R     + L T     GSL++ L        L     L ++  + +G+ HL  
Sbjct: 99  --SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 152
Query: 131 -------DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL-----YG 178
                     + HRDLK  NI+  +  +G     + D G A    +    + +      G
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNIL--VKKNGQCC--IADLGLAVMHSQSTNQLDVGNNPRVG 208
Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVA 218
           T+ Y+ P++ +  +            VD+W+ G+ L+ VA
Sbjct: 209 TKRYMAPEVLDETIQVDCFDSY--KRVDIWAFGLVLWEVA 246

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/255 (23%), Positives = 111/255 (43%), Gaps = 29/255 (11%)
Query: 4   LRGSTNYVWCTTSV---LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE 60
           + G  N V     V   +G+G+ G +F+G N  N + VA+K   + S       + R ++
Sbjct: 1   MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYK 60
Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
           +L        V        QEG   V+V++L  G SL ++LD     + ++     +  +
Sbjct: 61  LLAGCTGIPNVYYFG----QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVK--TVAMAAK 113
Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIM--KFICDDGSTIYKLTDFGAARELEED-------- 170
            + A ++ + +  LV+RD+KP N +  +    + + IY + DFG  +   +         
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFYRDPVTKQHIPY 172
Query: 171 QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR 230
           ++  +L GT  Y+  + +        +G+      DL ++G    +   G+LP++     
Sbjct: 173 REKKNLSGTARYMSINTH--------LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224
Query: 231 RNKETMYYITTKKAS 245
            NK+    I  KK S
Sbjct: 225 TNKQKYERIGEKKQS 239

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 14/125 (11%)
Query: 104 PENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA 163
           PE+  G      +  LEHL + +       ++HRD+KP N++  I   G    K+ DFG 
Sbjct: 107 PEDILGKIAVSIVKALEHLHSKLS------VIHRDVKPSNVL--INALGQV--KMCDFGI 156
Query: 164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
           +  L +D       G + Y+ P+     + +K     +    D+WS+G+T+  +A    P
Sbjct: 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQK----GYSVKSDIWSLGITMIELAILRFP 212
Query: 224 FRPYG 228
           +  +G
Sbjct: 213 YDSWG 217

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 103/268 (38%), Gaps = 80/268 (29%)
Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL--- 74
           +G+G  G VF+  NK +    A+K     +     +  MRE + L K++H  IV+     
Sbjct: 14  MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 73
Query: 75  ---AIEEEQEGRGKVIVMELCTGGSLFNI--LDDP------------ENTYG-------- 109
                E+ QE   ++ + +  T   L +   +D P            +NT G        
Sbjct: 74  LETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPK 133
Query: 110 ------------------------LQEEEF---LLVLEHLTAGMKHLRDNRLVHRDLKPG 142
                                   L++ E    L +   +   ++ L    L+HRDLKP 
Sbjct: 134 VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPS 193
Query: 143 NIMKFICDDGSTIYKLTDFGAARELEEDQQ------FMSLY-------GTEEYLHPDMYE 189
           NI  F  DD   + K+ DFG    +++D++       M  Y       GT+ Y+ P+   
Sbjct: 194 NIF-FTMDD---VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIH 249
Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHV 217
                   G  +   VD++S+G+ L+ +
Sbjct: 250 --------GNNYSHKVDIFSLGLILFEL 269

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 57  REFEVLKKVKHENIVKLLA--IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEE 113
           RE ++ +   H NI++L+A  + E        +++     G+L+N ++  ++    L E+
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 114 EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG----AARELEE 169
           + L +L  +  G++ +      HRDLKP NI+  + D+G  +  L D G    A   +E 
Sbjct: 135 QILWLLLGICRGLEAIHAKGYAHRDLKPTNIL--LGDEGQPV--LMDLGSMNQACIHVEG 190
Query: 170 DQQFMSLYG------TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
            +Q ++L        T  Y  P+++  +V    V        D+WS+G  LY +  G  P
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELF--SVQSHCV---IDERTDVWSLGCVLYAMMFGEGP 245
Query: 224 F 224
           +
Sbjct: 246 Y 246
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	708
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-141
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-127
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-118
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-41
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-40
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-40
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-40
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-39
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-39
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-39
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-39
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-39
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-38
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-38
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-38
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-38
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-38
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-38
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-38
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-38
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-38
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-38
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-38
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-37
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-37
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-37
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-37
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-37
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-36
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-36
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-36
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-35
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-35
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-34
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-34
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-33
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-33
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-33
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-33
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-32
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-32
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-32
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-31
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-31
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-31
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-30
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-30
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-30
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-29
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-28
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-28
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-28
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-28
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-27
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-27
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-27
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-27
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-27
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-27
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-26
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-26
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-26
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-26
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-26
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-25
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-24
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-24
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-24
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-24
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-24
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-24
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-24
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-23
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-23
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-23
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-23
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-23
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-22
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-19
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-19
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-19
4efo_A	94	Serine/threonine-protein kinase TBK1; ubiquitin li	1e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-14
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-11
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-11
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-08
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-07
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-05

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  418 bits (1076), Expect = e-141
 Identities = 198/358 (55%), Positives = 265/358 (74%), Gaps = 1/358 (0%)

Query: 5   RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK 64
           + ++N++W  + +LG+GAT  VF+G +K  G+  A+K FN +S +RP DVQMREFEVLKK
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 65  VKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           + H+NIVKL AIEEE   R KV++ME C  GSL+ +L++P N YGL E EFL+VL  +  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
           GM HLR+N +VHR++KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+SLYGTEEYLH
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY-GGRRNKETMYYITTKK 243
           PDMYERAVLRK   K +GATVDLWSIGVT YH ATG+LPFRP+ G RRNKE MY I T K
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE 303
            SG ISG Q +ENG IDW  D+P +C LS GL+ L+TP+LA +LE D +K W F++FF+E
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

Query: 304 VTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHF 361
            +  L+R ++H+F + ++   +IY+H  +      +L+ +QT +  + Q L+Y+    
Sbjct: 304 TSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRL 361

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  380 bits (978), Expect = e-127
 Identities = 189/316 (59%), Positives = 241/316 (76%), Gaps = 1/316 (0%)

Query: 5   RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK 64
           + ++N++W  + +LG+GAT  VF+G +K  G+  A+K FN +S +RP DVQMREFEVLKK
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 65  VKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           + H+NIVKL AIEEE   R KV++ME C  GSL+ +L++P N YGL E EFL+VL  +  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
           GM HLR+N +VHR++KPGNIM+ I +DG ++YKLTDFGAARELE+D+QF+SLYGTEEYLH
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY-GGRRNKETMYYITTKK 243
           PDMYERAVLRK   K +GATVDLWSIGVT YH ATG+LPFRP+ G RRNKE MY I T K
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE 303
            SG ISG Q +ENG IDW  D+P +C LS GL+ L+TP+LA +LE D +K W F++FF+E
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

Query: 304 VTKTLNRKLVHLFHIN 319
            +  L+R   H  H +
Sbjct: 304 TSDILHRGNSHHHHHH 319

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  367 bits (943), Expect = e-118
 Identities = 124/660 (18%), Positives = 243/660 (36%), Gaps = 66/660 (10%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           W     LG G  G V + ++++ GE VA+K   Q    +  +    E +++KK+ H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75

Query: 72  KLLAIEEEQE----GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
               + +  +        ++ ME C GG L   L+  EN  GL+E     +L  +++ ++
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           +L +NR++HRDLKP NI+         I+K+ D G A+EL++ +      GT +YL P++
Sbjct: 136 YLHENRIIHRDLKPENIV-LQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV 247
            E         K +  TVD WS G   +   TG  PF P      +   ++   ++ S  
Sbjct: 195 LE--------QKKYTVTVDYWSFGTLAFECITGFRPFLP----NWQPVQWHGKVREKSNE 242

Query: 248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFER-----FFS 302
                    G + + + LP    LS  L   +   L  +L    ++  +  +      F 
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302

Query: 303 EVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFS 362
            +   L+ KL+ + ++   +     +  ++    L+  +Q+ T +   +Q LL  +    
Sbjct: 303 ALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLAL 362

Query: 363 HIFPSSHQKNPSSY------------------SVSVENDATLAKQACSTGHVCKRRIEKL 404
           +      Q                            E   +L     S   V +     L
Sbjct: 363 NSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPAHPESVSIVLQDPKRPL 422

Query: 405 SKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQSLVDHISRSYNSIFSLMEDK 464
           + +     +        +     + +  +   +     +      +S+  NS+ S  E  
Sbjct: 423 TYTHLRRVWGQIWQ--TIRALKEDCARLLQGQRTSMVNLLRYNTELSKKKNSMTSECEQL 480

Query: 465 SNNANDFKDEI------------DSLRTNQLNSLSLNVEQLYQRC-------VLDKTLSK 505
               + F+  I              + + +L S    +EQ  + C        L   +  
Sbjct: 481 KAKLDFFRSSIQIDLEKYSEQMEFGITSEKLLSAWREMEQAVELCGREREVQALVDKMMA 540

Query: 506 EWTNATRPIICPGKVKVPARAKTLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIKIG 565
             T++      P   K       L E+ RD ++  LR+R     +  D    V   I   
Sbjct: 541 LQTDSVDLQRNPLGRKHRGTLDDLEEQARDLYRR-LRERPRDQRTPGDSNDMVRLLILAI 599

Query: 566 ETGKRIKCLLDDDTYPHVLQLSDCLADWYKMAQTIYLQSNFLSKDMQTFAHSLAEFQTKV 625
           ++ ++   L+ D     + +   C     +++  +    N + +D +       + Q ++
Sbjct: 600 QSFEKRVILIYD----QLSKTVVCKRKALELSPKVKEVMNLMREDEKIVVRRQEKRQQEL 655

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  151 bits (385), Expect = 2e-41
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 21/212 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
            LGKGA   V + V+K  G   A K  N    +   D Q   RE  + +K++H NIV+L 
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRL- 70

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              +  +      +V +L TGG LF  I+      Y   E +    ++ +   + +   N
Sbjct: 71  --HDSIQEESFHYLVFDLVTGGELFEDIVA--REFY--SEADASHCIQQILESIAYCHSN 124

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            +VHR+LKP N++      G+ + KL DFG A E+ + + +    GT  YL P+     V
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFAGTPGYLSPE-----V 178

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           L+K     +   VD+W+ GV LY +  G  PF
Sbjct: 179 LKK---DPYSKPVDIWACGVILYILLVGYPPF 207

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  152 bits (385), Expect = 1e-40
 Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 24/234 (10%)

Query: 10  YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHEN 69
           Y    T +LG G  G V +      G  +A K       M+  +    E  V+ ++ H N
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT-RGMKDKEEVKNEISVMNQLDHAN 147

Query: 70  IVKLL-AIEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMK 127
           +++L  A E + +    V+VME   GG LF+ I+D+   +Y L E + +L ++ +  G++
Sbjct: 148 LIQLYDAFESKND---IVLVMEYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIR 201

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           H+    ++H DLKP NI+  +  D   I K+ DFG AR  +  ++    +GT E+L P+ 
Sbjct: 202 HMHQMYILHLDLKPENIL-CVNRDAKQI-KIIDFGLARRYKPREKLKVNFGTPEFLAPE- 258

Query: 188 YERAVL-RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
               V+    V        D+WS+GV  Y + +G  PF    G  + ET+  I 
Sbjct: 259 ----VVNYDFVSF----PTDMWSVGVIAYMLLSGLSPFL---GDNDAETLNNIL 301

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  149 bits (378), Expect = 1e-40
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 15/210 (7%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG GA G V     +++G    +KT N+     P +    E EVLK + H NI+K+  +
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 77  EEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            E+      + IVME C GG L   I+        L E     +++ +   + +     +
Sbjct: 89  FEDYH---NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VH+DLKP NI+       S I K+ DFG A   + D+   +  GT  Y+ P+     V +
Sbjct: 146 VHKDLKPENILFQDTSPHSPI-KIIDFGLAELFKSDEHSTNAAGTALYMAPE-----VFK 199

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + V        D+WS GV +Y + TG LPF
Sbjct: 200 RDVTF----KCDIWSAGVVMYFLLTGCLPF 225

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  149 bits (379), Expect = 4e-40
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 21/213 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +G+G+ G      +  +G    +K  N +S M   + +   RE  VL  +KH NIV+  
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEIN-ISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 75  -AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            + EE        IVM+ C GG LF  ++  +     QE++ L     +   +KH+ D +
Sbjct: 90  ESFEENGSL---YIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHDRK 145

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF-MSLYGTEEYLHPDMYERAV 192
           ++HRD+K  NI  F+  DG    +L DFG AR L    +   +  GT  YL P++ E   
Sbjct: 146 ILHRDIKSQNI--FLTKDG--TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE--- 198

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                 K +    D+W++G  LY + T    F 
Sbjct: 199 -----NKPYNNKSDIWALGCVLYELCTLKHAFE 226

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  147 bits (374), Expect = 5e-40
 Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 22/212 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           +LGKG+ G V +  ++   +  AVK  N+ +  +  D     RE E+LKK+ H NI+KL 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINK-ASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
            I E+        IV EL TGG LF+ I+      +   E +   +++ + +G+ ++  +
Sbjct: 88  EILEDSS---SFYIVGELYTGGELFDEIIK--RKRF--SEHDAARIIKQVFSGITYMHKH 140

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            +VHRDLKP NI+    +    I K+ DFG +   +++ +     GT  Y+ P+     V
Sbjct: 141 NIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-----V 194

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           LR    +      D+WS GV LY + +G  PF
Sbjct: 195 LRGTYDE----KCDVWSAGVILYILLSGTPPF 222

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  147 bits (372), Expect = 9e-40
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 22/218 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +G G+ G   +   K++G+ +  K  +    M   + Q  + E  +L+++KH NIV+  
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHL---- 129
               ++      IVME C GG L + I    +    L EE  L V+  LT  +K      
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 130 -RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDM 187
              + ++HRDLKP N+  F+        KL DFG AR L  D  F   + GT  Y+ P+ 
Sbjct: 132 DGGHTVLHRDLKPANV--FLDGKQ--NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                       ++    D+WS+G  LY +     PF 
Sbjct: 188 MN--------RMSYNEKSDIWSLGCLLYELCALMPPFT 217

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  147 bits (374), Expect = 1e-39
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 29/229 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
            LG+G  G V + V  ++ +    K        +  D  +  +E  +L   +H NI+ L 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHRNILHLH 67

Query: 75  -AIEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
            + E  +E    V++ E  +G  +F  I       + L E E +  +  +   ++ L  +
Sbjct: 68  ESFESMEE---LVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH 121

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            + H D++P NI+ +     STI K+ +FG AR+L+    F  L+   EY  P+     V
Sbjct: 122 NIGHFDIRPENII-YQTRRSSTI-KIIEFGQARQLKPGDNFRLLFTAPEYYAPE-----V 174

Query: 193 L-RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
                V        D+WS+G  +Y + +G  PF       N++ +  I 
Sbjct: 175 HQHDVVST----ATDMWSLGTLVYVLLSGINPFL---AETNQQIIENIM 216

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  149 bits (378), Expect = 1e-39
 Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 22/226 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL-A 75
            LG GA G V + V K  G     K  N    +  + V+  E  ++ ++ H  ++ L  A
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK-NEISIMNQLHHPKLINLHDA 116

Query: 76  IEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            E++ E    V+++E  +GG LF+ I  +    Y + E E +  +     G+KH+ ++ +
Sbjct: 117 FEDKYE---MVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHSI 170

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VH D+KP NIM       S++ K+ DFG A +L  D+       T E+  P++    V R
Sbjct: 171 VHLDIKPENIM-CETKKASSV-KIIDFGLATKLNPDEIVKVTTATAEFAAPEI----VDR 224

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           +PVG       D+W+IGV  Y + +G  PF    G  + ET+  + 
Sbjct: 225 EPVGF----YTDMWAIGVLGYVLLSGLSPFA---GEDDLETLQNVK 263

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  147 bits (372), Expect = 2e-39
 Identities = 70/231 (30%), Positives = 112/231 (48%), Gaps = 25/231 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN---QLSHMRPHDVQM--REFEVLKKVKHENIV 71
            LG G    V +   K+ G   A K        +  R    +   RE  +L++V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 72  KLL-AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
            L    E   +    V+++EL +GG LF+ L   E+   L EEE    ++ +  G+ +L 
Sbjct: 79  TLHDVYENRTD---VVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLH 132

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
             ++ H DLKP NIM    +      KL DFG A E+E+  +F +++GT E++ P+    
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE---- 188

Query: 191 AVL-RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
            ++  +P+G       D+WSIGV  Y + +G  PF    G   +ET+  IT
Sbjct: 189 -IVNYEPLGL----EADMWSIGVITYILLSGASPFL---GDTKQETLANIT 231

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  146 bits (371), Expect = 2e-39
 Identities = 67/244 (27%), Positives = 95/244 (38%), Gaps = 32/244 (13%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVKL 73
            LG G+ G VF+  +K +G   AVK         P D    + E    +KV +H   V+L
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSM-SPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
               EE    G + +  ELC G SL    +    +  L E +    L      + HL   
Sbjct: 123 EQAWEE---GGILYLQTELC-GPSLQQHCEAWGAS--LPEAQVWGYLRDTLLALAHLHSQ 176

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            LVH D+KP NI  F+   G    KL DFG   EL          G   Y+ P   E  +
Sbjct: 177 GLVHLDVKPANI--FLGPRG--RCKLGDFGLLVELGTAGAGEVQEGDPRYMAP---E--L 227

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGN-LPFRPYGGRRNKETMYYITTKKASGVISGT 251
           L+      +G   D++S+G+T+  VA    LP          E    +         +  
Sbjct: 228 LQGS----YGTAADVFSLGLTILEVACNMELPH-------GGEGWQQLRQGYLPPEFTAG 276

Query: 252 QTSE 255
            +SE
Sbjct: 277 LSSE 280

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  147 bits (374), Expect = 3e-39
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
            LGKGA   V + V+K  G   A K  N    +   D Q   RE  + +K++H NIV+L 
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              +  +      +V +L TGG LF  I+      Y   E +    ++ +   + +   N
Sbjct: 95  ---DSIQEESFHYLVFDLVTGGELFEDIVA--REFY--SEADASHCIQQILESIAYCHSN 147

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            +VHR+LKP N++      G+ + KL DFG A E+ + + +    GT  YL P+     V
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFAGTPGYLSPE-----V 201

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           L+K     +   VD+W+ GV LY +  G  PF 
Sbjct: 202 LKK---DPYSKPVDIWACGVILYILLVGYPPFW 231

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  144 bits (366), Expect = 6e-39
 Identities = 71/230 (30%), Positives = 115/230 (50%), Gaps = 23/230 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN---QLSHMRPHDVQM--REFEVLKKVKHENIV 71
            LG G    V +   K  G+  A K        S  R    +   RE  +L++++H NI+
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
            L  I E +     V+++EL +GG LF+ L + E+   L E+E    L+ +  G+ +L  
Sbjct: 72  TLHDIFENK--TDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHS 126

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            R+ H DLKP NIM    +  +   KL DFG A ++E   +F +++GT E++ P+     
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE----- 181

Query: 192 VL-RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           ++  +P+G       D+WSIGV  Y + +G  PF    G   +ET+  I+
Sbjct: 182 IVNYEPLGL----EADMWSIGVITYILLSGASPFL---GETKQETLTNIS 224

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  145 bits (367), Expect = 8e-39
 Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 20/214 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +G+G    V++     +G PVA+K       M        ++E ++LK++ H N++K  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNIL-DDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           A   E     ++ IV+EL   G L  ++    +    + E         L + ++H+   
Sbjct: 99  ASFIE---DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYERA 191
           R++HRD+KP N+  FI   G  + KL D G  R          SL GT  Y+ P+     
Sbjct: 156 RVMHRDIKPANV--FITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-- 209

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                    +    D+WS+G  LY +A    PF 
Sbjct: 210 ------ENGYNFKSDIWSLGCLLYEMAALQSPFY 237

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  145 bits (367), Expect = 1e-38
 Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 25/230 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKH-ENIVKL 73
            LG+G    V Q ++K+ G+  A K   +              E  VL+  K    ++ L
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKK-RRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 74  L-AIEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
               E   E    ++++E   GG +F+  L +        E + + +++ +  G+ +L  
Sbjct: 95  HEVYENTSE---IILILEYAAGGEIFSLCLPELAEMVS--ENDVIRLIKQILEGVYYLHQ 149

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
           N +VH DLKP NI+         I K+ DFG +R++    +   + GT EYL P+     
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDI-KIVDFGMSRKIGHACELREIMGTPEYLAPE----- 203

Query: 192 VL-RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           +L   P+        D+W+IG+  Y + T   PF    G  N+ET   I+
Sbjct: 204 ILNYDPITT----ATDMWNIGIIAYMLLTHTSPF---VGEDNQETYLNIS 246

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  145 bits (369), Expect = 1e-38
 Identities = 71/231 (30%), Positives = 112/231 (48%), Gaps = 25/231 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN---QLSHMRPHDVQM--REFEVLKKVKHENIV 71
            LG G    V +   K+ G   A K        +  R    +   RE  +L++V H NI+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 72  KLL-AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
            L    E   +    V+++EL +GG LF+ L   E+   L EEE    ++ +  G+ +L 
Sbjct: 79  TLHDVYENRTD---VVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLH 132

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
             ++ H DLKP NIM    +      KL DFG A E+E+  +F +++GT E++ P+    
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE---- 188

Query: 191 AVL-RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
            ++  +P+G       D+WSIGV  Y + +G  PF    G   +ET+  IT
Sbjct: 189 -IVNYEPLGL----EADMWSIGVITYILLSGASPFL---GDTKQETLANIT 231

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  145 bits (368), Expect = 1e-38
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 19/215 (8%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQ--MREFEVLKKVKHENIVK 72
           V+GKG    V + +N+  G+  AVK  +  + +       +   RE  +   +KH +IV+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 73  LLAIEEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           LL         G + +V E   G  L   I+   +  +   E      +  +   +++  
Sbjct: 91  LLETYSS---DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYE 189
           DN ++HRD+KP  ++    ++ + + KL  FG A +L E         GT  ++ P+   
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPV-KLGGFGVAIQLGESGLVAGGRVGTPHFMAPE--- 203

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             V+++   + +G  VD+W  GV L+ + +G LPF
Sbjct: 204 --VVKR---EPYGKPVDVWGCGVILFILLSGCLPF 233

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  148 bits (376), Expect = 2e-38
 Identities = 65/230 (28%), Positives = 110/230 (47%), Gaps = 22/230 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           VLGKG+ G V    +K  G+  AVK  ++    +  D +   RE ++LK++ H NI+KL 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              E++       +V E+ TGG LF   D+  +     E +   ++  + +G+ ++  N+
Sbjct: 93  EFFEDKG---YFYLVGEVYTGGELF---DEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +VHRDLKP N++       + I ++ DFG +   E  ++     GT  Y+ P+     VL
Sbjct: 147 IVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASKKMKDKIGTAYYIAPE-----VL 200

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
                +      D+WS GV LY + +G  PF    G    + +  +   K
Sbjct: 201 HGTYDE----KCDVWSTGVILYILLSGCPPFN---GANEYDILKKVEKGK 243

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  144 bits (365), Expect = 2e-38
 Identities = 55/290 (18%), Positives = 111/290 (38%), Gaps = 48/290 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL-A 75
            LG+G    V      ++G   A+K        +  +   RE ++ +   H NI++L+  
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRIL-CHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDD-PENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              E+  + +  +++     G+L+N ++   +    L E++ L +L  +  G++ +    
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFG----------AARELEEDQQFMSLYGTEEYL 183
             HRDLKP NI   + D+G     L D G           +R+    Q + +   T  Y 
Sbjct: 155 YAHRDLKPTNI--LLGDEGQ--PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
            P+++                 D+WS+G  LY +  G  P+      +  +++      +
Sbjct: 211 APELFS-----VQSHCVIDERTDVWSLGCVLYAMMFGEGPY--DMVFQKGDSVALAVQNQ 263

Query: 244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKK 293
            S                   +P + + S  L +L+      ++ VD  +
Sbjct: 264 LS-------------------IPQSPRHSSALWQLL----NSMMTVDPHQ 290

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  143 bits (364), Expect = 2e-38
 Identities = 74/211 (35%), Positives = 113/211 (53%), Gaps = 20/211 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           VLG GA   VF    +  G+  A+K   +    R   ++  E  VLKK+KHENIV L   
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-NEIAVLKKIKHENIVTL--- 71

Query: 77  EEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
           E+  E      +VM+L +GG LF+ IL+     Y   E++  LV++ + + +K+L +N +
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILE--RGVY--TEKDASLVIQQVLSAVKYLHENGI 127

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLKP N++    ++ S I  +TDFG ++ +E++    +  GT  Y+ P+     VL 
Sbjct: 128 VHRDLKPENLLYLTPEENSKI-MITDFGLSK-MEQNGIMSTACGTPGYVAPE-----VLA 180

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           +   K +   VD WSIGV  Y +  G  PF 
Sbjct: 181 Q---KPYSKAVDCWSIGVITYILLCGYPPFY 208

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  146 bits (371), Expect = 2e-38
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 21/216 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQ-----MREFEVLKKVKHEN 69
            LG GA G V     +   + VA++  +  + +     +         E E+LKK+ H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           I+K+    + ++     IV+EL  GG LF+ ++    N   L+E    L    +   +++
Sbjct: 202 IIKIKNFFDAED---YYIVLELMEGGELFDKVV---GNKR-LKEATCKLYFYQMLLAVQY 254

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           L +N ++HRDLKP N++    ++   I K+TDFG ++ L E     +L GT  YL P+  
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLCGTPTYLAPE-- 311

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              VL       +   VD WS+GV L+   +G  PF
Sbjct: 312 ---VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  147 bits (374), Expect = 3e-38
 Identities = 70/230 (30%), Positives = 112/230 (48%), Gaps = 23/230 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
           +LGKG+ G V +  ++   +  AVK  N  +  +  D     RE E+LKK+ H NI+KL 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            I E+        IV EL TGG LF   D+        E +   +++ + +G+ ++  + 
Sbjct: 88  EILEDSS---SFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +VHRDLKP NI+    +    I K+ DFG +   +++ +     GT  Y+ P+     VL
Sbjct: 142 IVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-----VL 195

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
           R    +      D+WS GV LY + +G  PF    G+   + +  + T K
Sbjct: 196 RGTYDE----KCDVWSAGVILYILLSGTPPFY---GKNEYDILKRVETGK 238

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  147 bits (374), Expect = 3e-38
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 23/230 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
            LG GA G V    +K      A+K     + +          E  VLK + H NI+KL 
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIR-KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              E++       +VME   GG LF   D+  +     E +  ++++ + +G+ +L  + 
Sbjct: 103 DFFEDKR---NYYLVMECYKGGELF---DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +VHRDLKP N++    +  + I K+ DFG +   E  ++     GT  Y+ P+     VL
Sbjct: 157 IVHRDLKPENLLLESKEKDALI-KIVDFGLSAVFENQKKMKERLGTAYYIAPE-----VL 210

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
           RK   +      D+WSIGV L+ +  G  PF   GG+ ++E +  +   K
Sbjct: 211 RKKYDE----KCDVWSIGVILFILLAGYPPF---GGQTDQEILRKVEKGK 253

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  143 bits (362), Expect = 5e-38
 Identities = 66/231 (28%), Positives = 113/231 (48%), Gaps = 25/231 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN---QLSHMRPHDVQM--REFEVLKKVKHENIV 71
            LG G    V +   K+ G   A K        S  R    +   RE  +LK+++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 72  KLL-AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
            L    E + +    ++++EL  GG LF+ L + E+   L EEE    L+ +  G+ +L 
Sbjct: 78  TLHEVYENKTD---VILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLH 131

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
             ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P+    
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE---- 187

Query: 191 AVL-RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
            ++  +P+G       D+WSIGV  Y + +G  PF    G   +ET+  ++
Sbjct: 188 -IVNYEPLGL----EADMWSIGVITYILLSGASPFL---GDTKQETLANVS 230

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  142 bits (359), Expect = 5e-38
 Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 32/222 (14%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL-A 75
           ++G G  G VF+  ++ +G+   +K     ++ +      RE + L K+ H NIV     
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEK----AEREVKALAKLDHVNIVHYNGC 72

Query: 76  IEEEQEGRGKV-------------IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
            +                      I ME C  G+L   ++       L +   L + E +
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALELFEQI 131

Query: 123 TAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEY 182
           T G+ ++   +L++RDLKP NI  F+ D      K+ DFG    L+ D +     GT  Y
Sbjct: 132 TKGVDYIHSKKLINRDLKPSNI--FLVDTK--QVKIGDFGLVTSLKNDGKRTRSKGTLRY 187

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           + P+            + +G  VDL+++G+ L  +       
Sbjct: 188 MSPEQIS--------SQDYGKEVDLYALGLILAELLHVCDTA 221

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  142 bits (361), Expect = 7e-38
 Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 21/216 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN-------QLSHMRPHDVQMREFEVLKKVKHEN 69
            LG GA G V     +   + VA+K  +             P      E E+LKK+ H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           I+K+    + ++     IV+EL  GG LF+ ++    N   L+E    L    +   +++
Sbjct: 77  IIKIKNFFDAED---YYIVLELMEGGELFDKVV---GNKR-LKEATCKLYFYQMLLAVQY 129

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           L +N ++HRDLKP N++    ++   I K+TDFG ++ L E     +L GT  YL P+  
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLCGTPTYLAPE-- 186

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              VL       +   VD WS+GV L+   +G  PF
Sbjct: 187 ---VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  141 bits (357), Expect = 9e-38
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 20/210 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            +G+G+ G V   V K      A K   +   +   D   +E E++K + H NI++L   
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 77  EEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            E+      + +VMELCTGG LF  ++   +  +  +E +   +++ + + + +     +
Sbjct: 75  FEDNT---DIYLVMELCTGGELFERVVH--KRVF--RESDAARIMKDVLSAVAYCHKLNV 127

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
            HRDLKP N +       S + KL DFG A   +  +   +  GT  Y+ P      VL 
Sbjct: 128 AHRDLKPENFLFLTDSPDSPL-KLIDFGLAARFKPGKMMRTKVGTPYYVSPQ-----VLE 181

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
              G       D WS GV +Y +  G  PF
Sbjct: 182 GLYGP----ECDEWSAGVMMYVLLCGYPPF 207

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  147 bits (373), Expect = 1e-37
 Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 24/227 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
            LG GA G V +   +  G   A K    +      D +   +E + +  ++H  +V L 
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKF---VMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220

Query: 75  -AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
            A E++ E    V++ E  +GG LF  + D  N     E+E +  +  +  G+ H+ +N 
Sbjct: 221 DAFEDDNE---MVMIYEFMSGGELFEKVADEHNKM--SEDEAVEYMRQVCKGLCHMHENN 275

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            VH DLKP NIM F     + + KL DFG    L+  Q      GT E+  P++      
Sbjct: 276 YVHLDLKPENIM-FTTKRSNEL-KLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV----AE 329

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
            KPVG       D+WS+GV  Y + +G  PF    G  + ET+  + 
Sbjct: 330 GKPVGY----YTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVK 369

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  141 bits (358), Expect = 1e-37
 Identities = 65/297 (21%), Positives = 115/297 (38%), Gaps = 50/297 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKH--ENIVK 72
            +G G +  VFQ +N+   +  A+K  N L       +     E   L K++   + I++
Sbjct: 35  QIGSGGSSKVFQVLNEK-KQIYAIKYVN-LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 73  LLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           L   E   +    + +VME C    L + L   ++   +   E     +++   +  +  
Sbjct: 93  LYDYEITDQ---YIYMVME-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ 145

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY---GTEEYLHPDMY 188
           + +VH DLKP N +     DG    KL DFG A +++ D   +      GT  Y+ P+  
Sbjct: 146 HGIVHSDLKPANFL---IVDGM--LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

Query: 189 ERAVLRKPVGKT---FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS 245
           +     +  GK+        D+WS+G  LY++  G  PF           ++ I      
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDP--- 255

Query: 246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS 302
                     N EI++    P+       L+ +    L   L+ D K+  S     +
Sbjct: 256 ----------NHEIEF----PDI--PEKDLQDV----LKCCLKRDPKQRISIPELLA 292

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  141 bits (358), Expect = 2e-37
 Identities = 73/385 (18%), Positives = 140/385 (36%), Gaps = 73/385 (18%)

Query: 9   NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVK 66
             ++     +G G +  VFQ +N+   +  A+K  N L       +     E   L K++
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVN-LEEADNQTLDSYRNEIAYLNKLQ 65

Query: 67  H--ENIVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
              + I++L   E   +    + +VME C    L + L   ++   +   E     +++ 
Sbjct: 66  QHSDKIIRLYDYEITDQ---YIYMVME-CGNIDLNSWLKKKKS---IDPWERKSYWKNML 118

Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY---GTE 180
             +  +  + +VH DLKP N +     DG  + KL DFG A +++ D   +      GT 
Sbjct: 119 EAVHTIHQHGIVHSDLKPANFL---IVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTV 173

Query: 181 EYLHPDMYER---AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
            Y+ P+  +    +              D+WS+G  LY++  G  PF           ++
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLH 231

Query: 238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF 297
            I                N EI++    P+       L+ +    L   L+ D K+  S 
Sbjct: 232 AIIDP-------------NHEIEF----PDI--PEKDLQDV----LKCCLKRDPKQRISI 268

Query: 298 ERFFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDD-----AYDQLQDLIQEQTDVTPNKQ 352
               +           H +       ++I  HP +       ++++ ++ +   +     
Sbjct: 269 PELLA-----------HPY-------VQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNS 310

Query: 353 ILLYKNTHFSHIFPSSHQKNPSSYS 377
           IL    T + H        + SS +
Sbjct: 311 ILKAAKTLYEHYSGGESHNSSSSKT 335

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  140 bits (355), Expect = 3e-37
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 26/220 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQ------MREFEVLKKVK-H 67
           +LG+G +  V + ++K   +  AVK  +          +VQ      ++E ++L+KV  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            NI++L   +  +      +V +L   G LF+ L +      L E+E   ++  L   + 
Sbjct: 84  PNIIQL--KDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVIC 138

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
            L    +VHRDLKP NI+    DD   I KLTDFG + +L+  ++   + GT  YL P+ 
Sbjct: 139 ALHKLNIVHRDLKPENIL---LDDDMNI-KLTDFGFSCQLDPGEKLREVCGTPSYLAPE- 193

Query: 188 YERAVLRKPVG---KTFGATVDLWSIGVTLYHVATGNLPF 224
               ++   +      +G  VD+WS GV +Y +  G+ PF
Sbjct: 194 ----IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  143 bits (363), Expect = 4e-37
 Identities = 70/214 (32%), Positives = 99/214 (46%), Gaps = 22/214 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
            LGKGA   V + V    G+  A    N    +   D Q   RE  + + +KH NIV+L 
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              +     G   ++ +L TGG LF  I+      Y   E +    ++ +   + H    
Sbjct: 77  ---DSISEEGHHYLIFDLVTGGELFEDIVA--REYYS--EADASHCIQQILEAVLHCHQM 129

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYERA 191
            +VHR+LKP N++      G+ + KL DFG A E+E +QQ      GT  YL P+     
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAV-KLADFGLAIEVEGEQQAWFGFAGTPGYLSPE----- 183

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           VLRK     +G  VDLW+ GV LY +  G  PF 
Sbjct: 184 VLRK---DPYGKPVDLWACGVILYILLVGYPPFW 214

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  141 bits (358), Expect = 7e-37
 Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 21/225 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLA 75
           VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+++ 
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVRIVD 122

Query: 76  I-EEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           + E    GR  + IVME   GG LF+ I D  +  +   E E   +++ +   +++L   
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSIGEAIQYLHSI 180

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            + HRD+KP N++ +     + I KLTDFG A+E        +   T  Y+ P+     V
Sbjct: 181 NIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-----V 234

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           L     + +  + D+WS+GV +Y +  G  PF    G      M 
Sbjct: 235 LGP---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  140 bits (354), Expect = 7e-37
 Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 22/225 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLA 75
           VLG G  G V +  ++  G+  A+K             + +E +   +     +IV +L 
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKAR-QEVDHHWQASGGPHIVCILD 89

Query: 76  I-EEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           + E    G+  + I+ME   GG LF+ I +  +  +   E E   ++  +   ++ L  +
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF--TEREAAEIMRDIGTAIQFLHSH 147

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            + HRD+KP N++ +   +   + KLTDFG A+E  +     +   T  Y+ P+     V
Sbjct: 148 NIAHRDVKPENLL-YTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPE-----V 200

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           L     + +  + D+WS+GV +Y +  G  PF    G+     M 
Sbjct: 201 LGP---EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  142 bits (359), Expect = 1e-36
 Identities = 59/238 (24%), Positives = 109/238 (45%), Gaps = 25/238 (10%)

Query: 9   NYVWCTTSVLGKGATGA-VFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-K 66
              +C   VLG GA G  V++G    +   VAVK               RE ++L++  +
Sbjct: 23  KISFCPKDVLGHGAEGTIVYRG--MFDNRDVAVKRILP----ECFSFADREVQLLRESDE 76

Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM 126
           H N+++    E++++ +   I +ELC   +L   ++  +  +     E + +L+  T+G+
Sbjct: 77  HPNVIRYFCTEKDRQFQ--YIAIELC-AATLQEYVEQKDFAH--LGLEPITLLQQTTSGL 131

Query: 127 KHLRDNRLVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQFMS----LYGTEE 181
            HL    +VHRDLKP NI+       G     ++DFG  ++L   +   S    + GTE 
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           ++ P+     +L +   +    TVD++S G   Y+V +      P+G    ++    +
Sbjct: 192 WIAPE-----MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--PFGKSLQRQANILL 242

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  142 bits (360), Expect = 3e-36
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 32/240 (13%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKT----------FNQLSHMRPHDVQM--REFEVLKK 64
            LG GA G V     KN     A+K           ++  +       +    E  +LK 
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102

Query: 65  VKHENIVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
           + H NI+KL  + E+++      +V E   GG LF   +   N +   E +   +++ + 
Sbjct: 103 LDHPNIIKLFDVFEDKK---YFYLVTEFYEGGELF---EQIINRHKFDECDAANIMKQIL 156

Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
           +G+ +L  + +VHRD+KP NI+    +    I K+ DFG +    +D +     GT  Y+
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNI-KIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
            P+     VL+K   +      D+WS GV +Y +  G  PF    G+ +++ +  +   K
Sbjct: 216 APE-----VLKKKYNE----KCDVWSCGVIMYILLCGYPPFG---GQNDQDIIKKVEKGK 263

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  138 bits (349), Expect = 4e-36
 Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 35/230 (15%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+ G V +  +K  G   AVK       +R    ++ E      +    IV L    
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVK------KVRLEVFRVEELVACAGLSSPRIVPLYGAV 119

Query: 78  EEQEGRGKV-IVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNRLV 135
            E      V I MEL  GGSL  ++       G L E+  L  L     G+++L   R++
Sbjct: 120 REGP---WVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ------QFMSLYGTEEYLHPDMYE 189
           H D+K  N++  +  DGS    L DFG A  L+ D           + GTE ++ P+   
Sbjct: 173 HGDVKADNVL--LSSDGSRA-ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE--- 226

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
             V+    GK   A VD+WS    + H+  G     P+           I
Sbjct: 227 --VVM---GKPCDAKVDIWSSCCMMLHMLNGC---HPWTQYFRGPLCLKI 268

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  137 bits (348), Expect = 6e-36
 Identities = 65/223 (29%), Positives = 111/223 (49%), Gaps = 24/223 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG+GAT  V++   K   +P A+K   +        V+  E  VL ++ H NI+KL   
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVR-TEIGVLLRLSHPNIIKL--- 113

Query: 77  EEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
           +E  E   ++ +V+EL TGG LF+ I++  +  Y   E +    ++ +   + +L +N +
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVE--KGYY--SERDAADAVKQILEAVAYLHENGI 169

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLKP N++       + + K+ DFG ++ +E      ++ GT  Y  P+     +LR
Sbjct: 170 VHRDLKPENLLYATPAPDAPL-KIADFGLSKIVEHQVLMKTVCGTPGYCAPE-----ILR 223

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
                 +G  VD+WS+G+  Y +  G  PF      R  + M+
Sbjct: 224 G---CAYGPEVDMWSVGIITYILLCGFEPFY---DERGDQFMF 260

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  137 bits (347), Expect = 1e-35
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 29/221 (13%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN-------QLSHMRPHDVQMREFEVLKKVK-HE 68
           V+G+G +  V + V++  G   AVK                  +   RE  +L++V  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 69  NIVKLLAIEEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGM 126
           +I+ L    +  E    + +V +L   G LF+ +    E    L E+E   ++  L   +
Sbjct: 161 HIITL---IDSYESSSFMFLVFDLMRKGELFDYLT---EKVA-LSEKETRSIMRSLLEAV 213

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
             L  N +VHRDLKP N    + DD   I +L+DFG +  LE  ++   L GT  YL P+
Sbjct: 214 SFLHANNIVHRDLKPEN---ILLDDNMQI-RLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269

Query: 187 MYERAVLRK---PVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                +L+         +G  VDLW+ GV L+ +  G+ PF
Sbjct: 270 -----ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  137 bits (347), Expect = 2e-35
 Identities = 74/382 (19%), Positives = 139/382 (36%), Gaps = 73/382 (19%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKH--ENIVK 72
            +G G +  VFQ +N+   +  A+K  N L       +     E   L K++   + I++
Sbjct: 63  QIGSGGSSKVFQVLNEK-KQIYAIKYVN-LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 73  LLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           L   E   +    + +VME C    L + L   +    +   E     +++   +  +  
Sbjct: 121 LYDYEITDQ---YIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY---GTEEYLHPDMY 188
           + +VH DLKP N +     DG    KL DFG A +++ D   +      G   Y+ P+  
Sbjct: 174 HGIVHSDLKPANFL---IVDGM--LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 189 ERAVLRKPVGKT---FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS 245
           +     +  GK+        D+WS+G  LY++  G  PF           ++ I      
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDP--- 283

Query: 246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT 305
                     N EI++    P+       L+ +    L   L+ D K+  S     +   
Sbjct: 284 ----------NHEIEF----PDI--PEKDLQDV----LKCCLKRDPKQRISIPELLA--- 320

Query: 306 KTLNRKLVHLFHINRLQCIRIYLHPDD-----AYDQLQDLIQEQTDVTPNKQILLYKNTH 360
                   H +       ++I  HP +       ++++ ++ +   +     IL    T 
Sbjct: 321 --------HPY-------VQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTL 365

Query: 361 FSHIFPSSHQKNPSSYSVSVEN 382
           + H        + SS +   + 
Sbjct: 366 YEHYSGGESHNSSSSKTFEKKR 387

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  136 bits (343), Expect = 3e-35
 Identities = 68/324 (20%), Positives = 124/324 (38%), Gaps = 82/324 (25%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQM--REFEVLKKVKHENIVK 72
            +G+G+ G V   +        A+K  N  ++  + P DV+    E  ++KK+ H NI +
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 73  LLAIEEEQEGRGKV-IVMELCTGGSLF--------------------------------- 98
           L  + E+      + +VMELC GG L                                  
Sbjct: 93  LYEVYED---EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 99  ----NILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST 154
                        +  +E+    ++  + + + +L +  + HRD+KP N + F  +    
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL-FSTNKSFE 208

Query: 155 IYKLTDFGAARELE-----EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWS 209
           I KL DFG ++E       E     +  GT  ++ P+     VL     +++G   D WS
Sbjct: 209 I-KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-----VLN-TTNESYGPKCDAWS 261

Query: 210 IGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNC 269
            GV L+ +  G +PF    G  + +T+  +                N ++ +  + PN  
Sbjct: 262 AGVLLHLLLMGAVPFP---GVNDADTISQVL---------------NKKLCF--ENPNYN 301

Query: 270 QLSLGLKKLVTPILAGLLEVDSKK 293
            LS   + L++     LL  +  +
Sbjct: 302 VLSPLARDLLS----NLLNRNVDE 321

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  134 bits (339), Expect = 1e-34
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 24/212 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK-VKHENIVKLLA 75
            +G G+     + ++K      AVK  ++       D    E E+L +  +H NI+ L  
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVKIIDK----SKRDPT-EEIEILLRYGQHPNIITLKD 83

Query: 76  IEEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           + ++ +    V +V EL  GG L + IL   +  +   E E   VL  +T  +++L    
Sbjct: 84  VYDDGK---YVYVVTELMKGGELLDKILR--QKFF--SEREASAVLFTITKTVEYLHAQG 136

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYERAV 192
           +VHRDLKP NI+           ++ DFG A++L  +   +     T  ++ P+     V
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE-----V 191

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           L +   + + A  D+WS+GV LY + TG  PF
Sbjct: 192 LER---QGYDAACDIWSLGVLLYTMLTGYTPF 220

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  135 bits (340), Expect = 2e-34
 Identities = 33/241 (13%), Positives = 70/241 (29%), Gaps = 39/241 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN---------------------------QLSHM 49
           VLG+    A  +  ++  GE   V                                    
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 50  RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMEL--CTGGSLFNILDDPENT 107
           + H   +  F+++K  + + ++++   E +     +  +         +   +L    +T
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 108 YG-LQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE 166
           +  L     L +   +   +  L    LVH  L+P +I+  +   G     LT F     
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV--LDQRGGV--FLTGFEHLVR 260

Query: 167 LEEDQQFM--SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                       +   E             +          D W++G+ +Y +   +LP 
Sbjct: 261 DGASAVSPIGRGFAPPETTAE---RMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317

Query: 225 R 225
            
Sbjct: 318 T 318

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  131 bits (332), Expect = 3e-34
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)

Query: 12  WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHEN 69
                VLGKG  G V+ G + +N   +A+K   ++        Q    E  + K +KH+N
Sbjct: 24  NGDRVVLGKGTYGIVYAGRDLSNQVRIAIK---EIPERDSRYSQPLHEEIALHKHLKHKN 80

Query: 70  IVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           IV+ L    E    G + I ME   GGSL  +L          E+      + +  G+K+
Sbjct: 81  IVQYLGSFSE---NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF-MSLYGTEEYLHPDM 187
           L DN++VHRD+K  N++    +  S + K++DFG ++ L        +  GT +Y+ P++
Sbjct: 138 LHDNQIVHRDIKGDNVL---INTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEI 194

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
               + + P G  +G   D+WS+G T+  +ATG  PF
Sbjct: 195 ----IDKGPRG--YGKAADIWSLGCTIIEMATGKPPF 225

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  131 bits (332), Expect = 3e-34
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL-A 75
            LG+G  G VF+  NK +    A+K     +     +  MRE + L K++H  IV+   A
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 76  IEEEQEGRGKV---------IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM 126
             E+                I M+LC   +L + ++        +    L +   +   +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY--------- 177
           + L    L+HRDLKP NI  F   D   + K+ DFG    +++D++  ++          
Sbjct: 132 EFLHSKGLMHRDLKPSNI--FFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 178 ----GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLY 215
               GT+ Y+ P+           G ++   VD++S+G+ L+
Sbjct: 188 TGQVGTKLYMSPEQIH--------GNSYSHKVDIFSLGLILF 221

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  131 bits (331), Expect = 3e-34
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 38/231 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVKL 73
            +G G  G+VF+ V + +G   A+K           D Q  +RE      + +H ++V+ 
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSK-KPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRD 131
            +   E      + I  E C GGSL + + +        +E E   +L  +  G++++  
Sbjct: 77  FSAWAE---DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133

Query: 132 NRLVHRDLKPGNIMKFICDDG-----------------STIYKLTDFGAARELEEDQQFM 174
             LVH D+KP NI  FI                       ++K+ D G    +   Q   
Sbjct: 134 MSLVHMDIKPSNI--FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--- 188

Query: 175 SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
              G   +L     E  VL++       A  D++++ +T+   A      R
Sbjct: 189 VEEGDSRFLAN---E--VLQENYTHLPKA--DIFALALTVVCAAGAEPLPR 232

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  137 bits (347), Expect = 5e-34
 Identities = 57/222 (25%), Positives = 87/222 (39%), Gaps = 42/222 (18%)

Query: 16  SVLGKGATGAVFQGVNKN-NGEPVAVKTFNQLSHMRP-HDVQ-----MREFEVLKKVKHE 68
             +  G  G ++  +++N NG PV +K       +    D +     M E + L +V H 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKG------LVHSGDAEAQAMAMAERQFLAEVVHP 139

Query: 69  NIVKLLAIEEEQEGRGKV---IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           +IV++    E  +  G     IVME   G SL            L   E +  L  +   
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPA 194

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           + +L    LV+ DLKP NIM  + ++     KL D GA   +     F  LYGT  +  P
Sbjct: 195 LSYLHSIGLVYNDLKPENIM--LTEEQ---LKLIDLGAVSRIN---SFGYLYGTPGFQAP 246

Query: 186 DMYERAVLRKPVGKTFGATV--DLWSIGVTLYHVATGNLPFR 225
              E            G TV  D++++G TL  +        
Sbjct: 247 ---EIV--------RTGPTVATDIYTVGRTLAALTLDLPTRN 277

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  130 bits (330), Expect = 7e-34
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LGKG     F+  + +  E  A K   +   ++PH  +    E  + + + H+++V    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-- 80

Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
                E    V +V+ELC   SL  +    +    L E E    L  +  G ++L  NR+
Sbjct: 81  -HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNRV 136

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF-MSLYGTEEYLHPDMYERAVL 193
           +HRDLK GN+  F+ +D     K+ DFG A ++E D +    L GT  Y+ P++      
Sbjct: 137 IHRDLKLGNL--FLNEDLEV--KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS---- 188

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                K     VD+WSIG  +Y +  G  PF
Sbjct: 189 ----KKGHSFEVDVWSIGCIMYTLLVGKPPF 215

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  129 bits (327), Expect = 2e-33
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 25/216 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           V+G+GA G V +   K   + VA+K     S  +     + E   L +V H NIVKL   
Sbjct: 15  VVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAF---IVELRQLSRVNHPNIVKLYGA 69

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL---RDNR 133
                     +VME   GGSL+N+L   E          +      + G+ +L   +   
Sbjct: 70  CLNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           L+HRDLKP N++      G T+ K+ DFG A ++       +  G+  ++ P+++E    
Sbjct: 126 LIHRDLKPPNLL---LVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFE---- 176

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
               G  +    D++S G+ L+ V T   PF   GG
Sbjct: 177 ----GSNYSEKCDVFSWGIILWEVITRRKPFDEIGG 208

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  130 bits (329), Expect = 2e-33
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LGKG     F+  + +  E  A K   +   ++PH  +    E  + + + H+++V    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-- 106

Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
                E    V +V+ELC   SL  +    +    L E E    L  +  G ++L  NR+
Sbjct: 107 -HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRNRV 162

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF-MSLYGTEEYLHPDMYERAVL 193
           +HRDLK GN+  F+ +D     K+ DFG A ++E D +    L GT  Y+ P++      
Sbjct: 163 IHRDLKLGNL--FLNEDLEV--KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS---- 214

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                K     VD+WSIG  +Y +  G  PF
Sbjct: 215 ----KKGHSFEVDVWSIGCIMYTLLVGKPPF 241

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  128 bits (324), Expect = 2e-33
 Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 21/211 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LGKG+   V++  + + G  VA+K  ++ +  +   VQ    E ++  ++KH +I++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
             E+      V +V+E+C  G +   L +        E E    +  +  GM +L  + +
Sbjct: 79  YFEDSN---YVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQIITGMLYLHSHGI 133

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFG-AARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +HRDL   N+   +  + +   K+ DFG A +     ++  +L GT  Y+ P++      
Sbjct: 134 LHRDLTLSNL--LLTRNMNI--KIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT---- 185

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                   G   D+WS+G   Y +  G  PF
Sbjct: 186 ----RSAHGLESDVWSLGCMFYTLLIGRPPF 212

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  129 bits (326), Expect = 4e-33
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 24/212 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLA 75
            LG+G+     + V+K + +  AVK    +S     + Q +E   LK  + H NIVKL  
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKI---ISKRMEANTQ-KEITALKLCEGHPNIVKLHE 73

Query: 76  IEEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           +  +Q       +VMEL  GG LF  I    +  +   E E   ++  L + + H+ D  
Sbjct: 74  VFHDQL---HTFLVMELLNGGELFERIKK--KKHF--SETEASYIMRKLVSAVSHMHDVG 126

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-LYGTEEYLHPDMYERAV 192
           +VHRDLKP N++ F  ++ +   K+ DFG AR    D Q +     T  Y  P+     +
Sbjct: 127 VVHRDLKPENLL-FTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-----L 180

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           L +     +  + DLWS+GV LY + +G +PF
Sbjct: 181 LNQ---NGYDESCDLWSLGVILYTMLSGQVPF 209

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  128 bits (324), Expect = 6e-33
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 27/221 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLA 75
           VLG+GA   V   +N    +  AVK   +        V  RE E+L + + H N+++L+ 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-REVEMLYQCQGHRNVLELIE 78

Query: 76  IEEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             EE++   +  +V E   GGS+ + I       +   E E  +V++ + + +  L +  
Sbjct: 79  FFEEED---RFYLVFEKMRGGSILSHIHK--RRHF--NELEASVVVQDVASALDFLHNKG 131

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY--------GTEEYLHP 185
           + HRDLKP NI+    +  S + K+ DF     ++ +     +         G+ EY+ P
Sbjct: 132 IAHRDLKPENILCEHPNQVSPV-KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 186 DMYERAVLRKPVG--KTFGATVDLWSIGVTLYHVATGNLPF 224
           +     V+         +    DLWS+GV LY + +G  PF
Sbjct: 191 E-----VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  125 bits (317), Expect = 2e-32
 Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 29/220 (13%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHENIVK 72
           ++G G  G V++      G+ VAVK              +       ++   +KH NI+ 
Sbjct: 14  IIGIGGFGKVYRA--FWIGDEVAVKAARH-DPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL--- 129
           L  +  ++      +VME   GG L  +L        +  +  +     +  GM +L   
Sbjct: 71  LRGVCLKEPNL--CLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDE 124

Query: 130 RDNRLVHRDLKPGNI----MKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
               ++HRDLK  NI         D  + I K+TDFG ARE     + MS  G   ++ P
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYAWMAP 183

Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           ++             F    D+WS GV L+ + TG +PFR
Sbjct: 184 EVIR--------ASMFSKGSDVWSYGVLLWELLTGEVPFR 215

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  128 bits (323), Expect = 2e-32
 Identities = 50/306 (16%), Positives = 88/306 (28%), Gaps = 60/306 (19%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHEN----- 69
            L  G    VF   +    E  A+K F   +     +++          ++  E+     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 70  -------------------IVKLLAIEEEQEGRGKVIVMELCTG--GSLFNILDDPENTY 108
                                +L   +++      +++M   +     LF+ LD      
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 109 GLQEEEFLLVLEH-LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL 167
           G +    L +L   L     +L+   LVH    P N+  FI  DG     L D  A  + 
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNL--FIMPDGR--LMLGDVSALWK- 243

Query: 168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
               +  +      Y                 TF   ++ W +G+++Y V    LPF   
Sbjct: 244 -VGTRGPASSVPVTYAPR------EFLNASTATFTHALNAWQLGLSIYRVWCLFLPF--- 293

Query: 228 GGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLL 287
                      + T    G          G         +   L   +K L+       L
Sbjct: 294 ----------GLVTPGIKGSWKRPSLRVPGTDSL--AFGSCTPLPDFVKTLIG----RFL 337

Query: 288 EVDSKK 293
             D ++
Sbjct: 338 NFDRRR 343

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  126 bits (319), Expect = 2e-32
 Identities = 49/225 (21%), Positives = 91/225 (40%), Gaps = 41/225 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           VLG+GA G V +  N  +    A+K              + E  +L  + H+ +V+  A 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST--ILSEVMLLASLNHQYVVRYYAA 70

Query: 77  EEEQEGRGKV-----------IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
             E+    K            I ME C  G+L++++   EN    Q +E+  +   +   
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLN-QQRDEYWRLFRQILEA 128

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-------- 177
           + ++    ++HRDLKP NI  FI +  +   K+ DFG A+ +      + L         
Sbjct: 129 LSYIHSQGIIHRDLKPMNI--FIDESRNV--KIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 178 -------GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLY 215
                  GT  Y+  ++ +           +   +D++S+G+  +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGT-------GHYNEKIDMYSLGIIFF 222

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  125 bits (316), Expect = 4e-32
 Identities = 61/239 (25%), Positives = 98/239 (41%), Gaps = 38/239 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +G+G+   V++G++      VA     Q   +   + Q    E E+LK ++H NIV+  
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 75  AIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEE--------EFLLVLEHLTA 124
              E      K  V+V EL T G+L   L      + + +         + L  L+ L  
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFL-- 145

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
              H R   ++HRDLK  NI  FI    +   K+ D G A          ++ GT E++ 
Sbjct: 146 ---HTRTPPIIHRDLKCDNI--FI-TGPTGSVKIGDLGLATLKRASFA-KAVIGTPEFMA 198

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
           P+MYE               VD+++ G+ +  +AT      PY   +N   +Y   T  
Sbjct: 199 PEMYEEKYDES---------VDVYAFGMCMLEMATSE---YPYSECQNAAQIYRRVTSG 245

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  125 bits (315), Expect = 5e-32
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 42/225 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLA 75
           VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+++ 
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVRIVD 78

Query: 76  I-EEEQEGRGKV-IVMELCTGGSLFN-ILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           + E    GR  + IVME   GG LF+ I D  +  +   E E   +++ +   +++L   
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT--EREASEIMKSIGEAIQYLHSI 136

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            + HRD+KP N++ +     + I KLTDFG A+E                          
Sbjct: 137 NIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKE-------------------------T 170

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
             +   K    + D+WS+GV +Y +  G  PF    G      M 
Sbjct: 171 TGEKYDK----SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  124 bits (314), Expect = 6e-32
 Identities = 48/218 (22%), Positives = 95/218 (43%), Gaps = 23/218 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM------REFEVLKKVKHENI 70
            +GKG  G V +G    +   VA+K+          ++        RE  ++  + H NI
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL- 129
           VKL  +          +VME    G L++ L D  +   ++    L ++  +  G++++ 
Sbjct: 86  VKLYGLMHNP----PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQ 139

Query: 130 -RDNRLVHRDLKPGNI-MKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
            ++  +VHRDL+  NI ++ + ++     K+ DFG ++  +       L G  +++ P+ 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                      +++    D +S  + LY + TG  PF 
Sbjct: 198 IGAE------EESYTEKADTYSFAMILYTILTGEGPFD 229

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  124 bits (314), Expect = 9e-32
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 22/214 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
            +G G+ G V +   + +G  VAVK   +        V    RE  ++K+++H NIV  +
Sbjct: 44  KIGAGSFGTVHRA--EWHGSDVAVKILME-QDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL--RDN 132
               +       IV E  + GSL+ +L        L E   L +   +  GM +L  R+ 
Sbjct: 101 GAVTQPPNL--SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYERA 191
            +VHR+LK  N++    D   T+ K+ DFG +R          S  GT E++ P++    
Sbjct: 159 PIVHRNLKSPNLL---VDKKYTV-KVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR-- 212

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                  +      D++S GV L+ +AT   P+ 
Sbjct: 213 ------DEPSNEKSDVYSFGVILWELATLQQPWG 240

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  123 bits (310), Expect = 2e-31
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 25/214 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL- 74
           +G G+ G V++G  K +G+ VAVK  N  +   P  +Q    E  VL+K +H NI+  + 
Sbjct: 32  IGSGSFGTVYKG--KWHGD-VAVKMLNV-TAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
                Q      IV + C G SL++ L   E     + ++ + +      GM +L    +
Sbjct: 88  YSTAPQ----LAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKSI 141

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARE---LEEDQQFMSLYGTEEYLHPDMYERA 191
           +HRDLK  NI  F+ +D     K+ DFG A E        QF  L G+  ++ P   E  
Sbjct: 142 IHRDLKSNNI--FLHEDN--TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP---E-- 192

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           V+R      +    D+++ G+ LY + TG LP+ 
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  123 bits (310), Expect = 6e-31
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 26/216 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQM-----REFEVLKKVKHENI 70
           LG GA G V+  V+K   + V VK     ++      +         E  +L +V+H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 71  VKLLAIEEEQEGRGKVIVMEL-CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           +K+L I E Q      +VME   +G  LF  +D       L E     +   L + + +L
Sbjct: 92  IKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYL 146

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
           R   ++HRD+K  NI   +  +  TI KL DFG+A  LE  + F +  GT EY  P++  
Sbjct: 147 RLKDIIHRDIKDENI---VIAEDFTI-KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202

Query: 190 RAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
                   G  + G  +++WS+GVTLY +     PF
Sbjct: 203 --------GNPYRGPELEMWSLGVTLYTLVFEENPF 230

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  120 bits (303), Expect = 1e-30
 Identities = 37/213 (17%), Positives = 78/213 (36%), Gaps = 21/213 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REFEVLKKVKHENIVKLL 74
            L +  +G +++G  +  G  + VK             +    E   L+   H N++ +L
Sbjct: 17  KLNENHSGELWKG--RWQGNDIVVKVLKV-RDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL--RDN 132
              +        ++      GSL+N+L +  N + + + + +     +  GM  L   + 
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEP 132

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            +    L   ++M    D+  T  +++        +             ++ P   E   
Sbjct: 133 LIPRHALNSRSVM---IDEDMTA-RISMADVKFSFQS----PGRMYAPAWVAP---E--A 179

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           L+K    T   + D+WS  V L+ + T  +PF 
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  124 bits (313), Expect = 1e-30
 Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 32/238 (13%)

Query: 17  VLGKGATGAV-FQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLL 74
           +LG G++G V FQG     G PVAVK           D+ + E ++L +   H N+++  
Sbjct: 22  ILGYGSSGTVVFQG--SFQGRPVAVKRMLI----DFCDIALMEIKLLTESDDHPNVIRYY 75

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDP----ENTYGLQEEEFLLVLEHLTAGMKHLR 130
             E         I +ELC   +L ++++      EN    +E   + +L  + +G+ HL 
Sbjct: 76  CSETTDRFL--YIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 131 DNRLVHRDLKPGNIM---------KFICDDGSTIYKLTDFGAARELEEDQQFMS-----L 176
             +++HRDLKP NI+                +    ++DFG  ++L+  Q          
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 177 YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
            GT  +  P++ E +   +   +    ++D++S+G   Y++ +      P+G + ++E
Sbjct: 193 SGTSGWRAPELLEESNNLQT-KRRLTRSIDIFSMGCVFYYILSKGKH--PFGDKYSRE 247

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  122 bits (308), Expect = 2e-30
 Identities = 36/241 (14%), Positives = 77/241 (31%), Gaps = 40/241 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN------------------QLSHMRP------- 51
           VLG+    A  +  ++  GE   V                      +L  +R        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 52  --HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTG--GSLFNILDDPENT 107
             H   +  F+++K  + + ++++   E +     +  +         +   +L    +T
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 108 YG-LQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE 166
           +  L     L +   +   +  L    LVH  L+P +I   +   G     LT F     
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI--VLDQRGGV--FLTGFEHLVR 255

Query: 167 LEEDQQFMSLYGTEEYLHPDMYERAVL---RKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
                       +  +  P++  R       +        + D W++G+ +Y +   +LP
Sbjct: 256 DGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

Query: 224 F 224
            
Sbjct: 313 I 313

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (306), Expect = 2e-30
 Identities = 49/234 (20%), Positives = 97/234 (41%), Gaps = 41/234 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-----REFEVLKKVK-HENI 70
           VL +G    V++  +  +G   A+K       +  ++ +      +E   +KK+  H NI
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALK------RLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 71  VKLLA-----IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           V+  +      EE   G+ + +++     G L   L   E+   L  +  L +       
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 126 MKHLRDNR--LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED------------- 170
           ++H+   +  ++HRDLK  N+   + + G+   KL DFG+A  +                
Sbjct: 149 VQHMHRQKPPIIHRDLKVENL--LLSNQGT--IKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 171 QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           ++ ++   T  Y  P++ +      P+G+      D+W++G  LY +     PF
Sbjct: 205 EEEITRNTTPMYRTPEIIDL-YSNFPIGEK----QDIWALGCILYLLCFRQHPF 253

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  120 bits (302), Expect = 3e-30
 Identities = 44/245 (17%), Positives = 88/245 (35%), Gaps = 48/245 (19%)

Query: 17  VLGKGATGAVFQGVNKNNGE-------PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHEN 69
            LG+G    +F+GV +  G+        V +K  ++ +H    +       ++ K+ H++
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMMSKLSHKH 73

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           +V    +    +    ++V E    GSL   L   +N   +     L V + L A M  L
Sbjct: 74  LVLNYGVCVCGDEN--ILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQLAAAMHFL 129

Query: 130 RDNRLVHRDLKPGNIM----KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
            +N L+H ++   NI+    +          KL+D G +  +                  
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------------- 174

Query: 186 DMYERAVLRKPV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKET 235
           D+      ++ +           K      D WS G TL+ + +     +P     ++  
Sbjct: 175 DIL-----QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS--GGDKPLSALDSQRK 227

Query: 236 MYYIT 240
           + +  
Sbjct: 228 LQFYE 232

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  119 bits (300), Expect = 5e-30
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 26/224 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
            LGKG  G V+    K +   +A+K     QL          RE E+   ++H NI++L 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
               +     +V +++E    G+++  L   +      E+     +  L   + +    R
Sbjct: 76  GYFHDAT---RVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKR 129

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRD+KP N++         + K+ DFG +      ++   L GT +YL P+M E    
Sbjct: 130 VIHRDIKPENLL---LGSAGEL-KIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIE---- 180

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
               G+     VDLWS+GV  Y    G  PF         +  Y
Sbjct: 181 ----GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----NTYQETY 216

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  118 bits (299), Expect = 8e-30
 Identities = 64/255 (25%), Positives = 95/255 (37%), Gaps = 56/255 (21%)

Query: 16  SVLGKGATGAVFQGV----NKNNGEPVAVKTFNQ-LSHMRPHDVQMREFEVLKKVKHENI 70
             LG+G  G V          N GE VAVK+           D+  +E E+L+ + HENI
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL-KKEIEILRNLYHENI 85

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           VK   I  E  G G  ++ME    GSL   L   +N   +  ++ L     +  GM +L 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLG 143

Query: 131 DNRLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
             + VHRDL   N++   +          K+ DFG  + +E D+              + 
Sbjct: 144 SRQYVHRDLAARNVLVESEHQV-------KIGDFGLTKAIETDK--------------EY 182

Query: 188 YERAVLRK-PV----------GKTFGATVDLWSIGVTLYHVAT------------GNLPF 224
           Y     R  PV           K F    D+WS GVTL+ + T              +  
Sbjct: 183 YTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241

Query: 225 RPYGGRRNKETMYYI 239
             +G       +  +
Sbjct: 242 PTHGQMTVTRLVNTL 256

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  116 bits (294), Expect = 3e-29
 Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 46/240 (19%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           +LG+G  G V++GV  N+      VAVKT  +   +   +  M E  ++K + H +IVKL
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           + I EE+      I+MEL   G L + L+  +N+  L+    +L    +   M +L    
Sbjct: 79  IGIIEEEP---TWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLESIN 133

Query: 134 LVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
            VHRD+   NI+              KL DFG +R +E++          +Y     Y+ 
Sbjct: 134 CVHRDIAVRNILVASPECV-------KLGDFGLSRYIEDE----------DY-----YKA 171

Query: 191 AVLRKPV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           +V R P+           + F    D+W   V ++ + +     +P+    NK+ +  + 
Sbjct: 172 SVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILS--FGKQPFFWLENKDVIGVLE 228

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  117 bits (295), Expect = 5e-29
 Identities = 55/248 (22%), Positives = 95/248 (38%), Gaps = 46/248 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIV 71
           +LGKG  G+V +   K        VAVK       +   D++  +RE   +K+  H ++ 
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-DIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 72  KLLAI----EEEQEGRGKVIVMELCTGGSLFNIL---DDPENTYGLQEEEFLLVLEHLTA 124
           KL+ +      +      ++++     G L   L      EN + L  +  +  +  +  
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
           GM++L     +HRDL   N M  + +D      + DFG +R++                 
Sbjct: 149 GMEYLSSRNFIHRDLAARNCM--LAEDM--TVCVADFGLSRKIYSG-------------- 190

Query: 185 PDMYERAVLRK-PV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK 233
            D Y +    K PV             +    D+W+ GVT++ + T      PY G  N 
Sbjct: 191 -DYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMT--RGQTPYAGIENA 246

Query: 234 ETMYYITT 241
           E   Y+  
Sbjct: 247 EIYNYLIG 254

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  116 bits (292), Expect = 5e-29
 Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 28/225 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
            LGKG  G V+    K N   +A+K     QL          RE E+   ++H NI+++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDN 132
               +++   ++ +++E    G L+  L      +G   E+     +E L   + +  + 
Sbjct: 81  NYFHDRK---RIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHER 133

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           +++HRD+KP N++         + K+ DFG +      ++  ++ GT +YL P+M E   
Sbjct: 134 KVIHRDIKPENLL---MGYKGEL-KIADFGWSVHAPSLRR-RTMCGTLDYLPPEMIE--- 185

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
                GKT    VDLW  GV  Y    G  PF       +    +
Sbjct: 186 -----GKTHDEKVDLWCAGVLCYEFLVGMPPFDS----PSHTETH 221

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  116 bits (292), Expect = 8e-29
 Identities = 61/302 (20%), Positives = 116/302 (38%), Gaps = 65/302 (21%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFN--------------------QLSHMRPHDVQM- 56
           +GKG+ G V    N+N+    A+K  +                                 
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 57  ----REFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQE 112
               +E  +LKK+ H N+VKL+ + ++       +V EL   G +  +         L E
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSE 136

Query: 113 EEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ 172
           ++     + L  G+++L   +++HRD+KP N++     +   I K+ DFG + E +    
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL---VGEDGHI-KIADFGVSNEFKGSDA 192

Query: 173 FMSLY-GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR 231
            +S   GT  ++ P+      L +      G  +D+W++GVTLY    G  PF       
Sbjct: 193 LLSNTVGTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM----DE 243

Query: 232 NKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDS 291
               ++     K            +  +    + P+   ++  LK L    +  +L+ + 
Sbjct: 244 RIMCLH----SKIK----------SQAL----EFPDQPDIAEDLKDL----ITRMLDKNP 281

Query: 292 KK 293
           + 
Sbjct: 282 ES 283

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  115 bits (289), Expect = 1e-28
 Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 46/239 (19%)

Query: 17  VLGKGATGAVFQGV--NKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
            +G+G  G V QG+  +  N    VA+KT    +     +  ++E   +++  H +IVKL
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           + +  E       I+MELCT G L + L   + +  L     +L    L+  + +L   R
Sbjct: 82  IGVITENP---VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESKR 136

Query: 134 LVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
            VHRD+   N++              KL DFG +R +E+            Y     Y+ 
Sbjct: 137 FVHRDIAARNVLVSSNDCV-------KLGDFGLSRYMEDS----------TY-----YKA 174

Query: 191 AVLRKPV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           +  + P+           + F +  D+W  GV ++ +       +P+ G +N + +  I
Sbjct: 175 SKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRI 230

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  115 bits (290), Expect = 1e-28
 Identities = 54/241 (22%), Positives = 100/241 (41%), Gaps = 41/241 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+GKG  G V+ G   +  +     A+K+ ++++ M+  +  +RE  +++ + H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           + I    EG    +++     G L   +  P+       ++ +     +  GM++L + +
Sbjct: 88  IGIMLPPEGL-PHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYLAEQK 144

Query: 134 LVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
            VHRDL   N M    F         K+ DFG AR++ +           EY     +  
Sbjct: 145 FVHRDLAARNCMLDESFTV-------KVADFGLARDILDR----------EYYSVQQHRH 187

Query: 191 AVLRKPV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           A L  PV           + F    D+WS GV L+ + T      PY      +  +++ 
Sbjct: 188 ARL--PVKWTALESLQTYR-FTTKSDVWSFGVLLWELLT--RGAPPYRHIDPFDLTHFLA 242

Query: 241 T 241
            
Sbjct: 243 Q 243

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  115 bits (289), Expect = 2e-28
 Identities = 60/256 (23%), Positives = 93/256 (36%), Gaps = 56/256 (21%)

Query: 16  SVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
             LGKG  G+V          N GE VAVK     S         RE E+LK ++H+NIV
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIV 74

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K   +      R   ++ME    GSL + L   ++   +   + L     +  GM++L  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 132 NRLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
            R +HRDL   NI+   +          K+ DFG  + L +D+              + +
Sbjct: 133 KRYIHRDLATRNILVENENRV-------KIGDFGLTKVLPQDK--------------EFF 171

Query: 189 ERAVLRK-PV----------GKTFGATVDLWSIGVTLYHVATGNLPFR------------ 225
           +     + P+           K F    D+WS GV LY + T     +            
Sbjct: 172 KVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230

Query: 226 -PYGGRRNKETMYYIT 240
              G       +  + 
Sbjct: 231 DKQGQMIVFHLIELLK 246

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  115 bits (290), Expect = 2e-28
 Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 45/247 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIV 71
           +LG+G  G+V +G  K        VAVKT    +     +++  + E   +K   H N++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVI 99

Query: 72  KLLAI---EEEQEGRGKVIVMELCTGGSLFNIL---DDPENTYGLQEEEFLLVLEHLTAG 125
           +LL +      Q     ++++     G L   L           +  +  L  +  +  G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHP 185
           M++L +   +HRDL   N M  + DD      + DFG ++++                  
Sbjct: 160 MEYLSNRNFLHRDLAARNCM--LRDDM--TVCVADFGLSKKIYSG--------------- 200

Query: 186 DMYERAVLRK-PV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
           D Y +  + K PV             + +  D+W+ GVT++ +AT      PY G +N E
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNHE 257

Query: 235 TMYYITT 241
              Y+  
Sbjct: 258 MYDYLLH 264

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  115 bits (289), Expect = 2e-28
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 13/214 (6%)

Query: 11  VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI 70
           VW     LG GA G V++  NK  G   A K     S     D    E E+L    H  I
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI-VEIEILATCDHPYI 78

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           VKL  +          I++E C GG++  I+ + +    L E +  +V   +   +  L 
Sbjct: 79  VKL--LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLH 134

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYE 189
             R++HRDLK GN++  +  +G    +L DFG + +  +  Q   S  GT  ++ P   E
Sbjct: 135 SKRIIHRDLKAGNVL--MTLEGDI--RLADFGVSAKNLKTLQKRDSFIGTPYWMAP---E 187

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP 223
             +        +    D+WS+G+TL  +A    P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  115 bits (291), Expect = 2e-28
 Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 44/239 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL I          ++ +L   G L + + + ++  G Q    L     +  GM +L D 
Sbjct: 82  LLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYLEDR 136

Query: 133 RLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
           RLVHRDL   N++              K+TDFG A+ L  +         E+      Y 
Sbjct: 137 RLVHRDLAARNVLVKTPQHV-------KITDFGLAKLLGAE---------EKE-----YH 175

Query: 190 RAVLRKPVG---------KTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
               + P+          + +    D+WS GVT++ + T     +PY G    E    +
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT--FGSKPYDGIPASEISSIL 232

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  115 bits (289), Expect = 2e-28
 Identities = 44/230 (19%), Positives = 94/230 (40%), Gaps = 27/230 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           VLGKG  G   +  ++  GE + +K   +          ++E +V++ ++H N++K + +
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF-LKEVKVMRCLEHPNVLKFIGV 75

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             + +      + E   GG+L  I+   ++       + +   + + +GM +L    ++H
Sbjct: 76  LYKDKRL--NFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHSMNIIH 131

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA----- 191
           RDL   N +       +    + DFG AR + +++      G      PD  +R      
Sbjct: 132 RDLNSHNCLV----RENKNVVVADFGLARLMVDEK--TQPEGLRSLKKPDRKKRYTVVGN 185

Query: 192 -------VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE 234
                  ++    G+++   VD++S G+ L  +        P    R  +
Sbjct: 186 PYWMAPEMIN---GRSYDEKVDVFSFGIVLCEIIGRVNAD-PDYLPRTMD 231

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  115 bits (289), Expect = 2e-28
 Identities = 50/222 (22%), Positives = 100/222 (45%), Gaps = 30/222 (13%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREF--EV--LKKVKHENIVK 72
           ++GKG  G V+ G  + +GE VA++  +     R ++ Q++ F  EV   ++ +HEN+V 
Sbjct: 40  LIGKGRFGQVYHG--RWHGE-VAIRLIDIE---RDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 73  LLA--IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
            +   +          I+  LC G +L++++ D +    L   +   + + +  GM +L 
Sbjct: 94  FMGACMSPPH----LAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLH 147

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR------ELEEDQQFMSLYGTEEYLH 184
              ++H+DLK  N+  F  D+G     +TDFG             + +     G   +L 
Sbjct: 148 AKGILHKDLKSKNV--FY-DNGKV--VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 185 PDMY-ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
           P++  + +   +     F    D++++G   Y +     PF+
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  114 bits (287), Expect = 4e-28
 Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 40/233 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LG+G+   V            A+K   +   ++ + V    RE +V+ ++ H   VKL 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDD----PENT---YGLQEEEFLLVLEHLTAGMK 127
                Q+       +     G L   +       E     Y     E +  LE+L     
Sbjct: 97  F--TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT---AEIVSALEYL----- 146

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLH 184
           H +   ++HRDLKP NI+  + +D     ++TDFG A+ L  + +     S  GT +Y+ 
Sbjct: 147 HGKG--IIHRDLKPENIL--LNEDMHI--QITDFGTAKVLSPESKQARANSFVGTAQYVS 200

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           P++    +  K   K+     DLW++G  +Y +  G  PFR      N+  ++
Sbjct: 201 PEL----LTEKSACKS----SDLWALGCIIYQLVAGLPPFR----AGNEYLIF 241

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  115 bits (290), Expect = 4e-28
 Identities = 71/290 (24%), Positives = 119/290 (41%), Gaps = 29/290 (10%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL- 74
           S LG G  G VF+  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           A   +    G++ I ME   GGSL  +L        + E+    V   +  G+ +LR+  
Sbjct: 99  AFYSD----GEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH 151

Query: 134 -LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRD+KP NI+  +   G    KL DFG + +L +     S  GT  Y+ P   ER  
Sbjct: 152 KIMHRDVKPSNIL--VNSRGEI--KLCDFGVSGQLIDSMA-NSFVGTRSYMSP---ERLQ 203

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
                G  +    D+WS+G++L  +A G  P  P   +  +          A+      +
Sbjct: 204 -----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258

Query: 253 TSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS--FERF 300
           T       +  D     +  + + +L+  I+          ++S  F+ F
Sbjct: 259 TPGRPLNKFGMDS----RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 304

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  112 bits (283), Expect = 5e-28
 Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 43/236 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            +G G  G V  G   N    VA+KT  +   M   D  + E EV+ K+ H  +V+L  +
Sbjct: 15  EIGSGQFGLVHLGYWLNKD-KVAIKTIRE-GAMSEEDF-IEEAEVMMKLSHPKLVQLYGV 71

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             EQ      +V E    G L + L           E  L +   +  GM +L +  ++H
Sbjct: 72  CLEQAPI--CLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIH 127

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK- 195
           RDL   N +  + ++   + K++DFG  R + +DQ                Y  +   K 
Sbjct: 128 RDLAARNCL--VGENQ--VIKVSDFGMTRFVLDDQ----------------YTSSTGTKF 167

Query: 196 PV----------GKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYIT 240
           PV           + + +  D+WS GV ++ V + G     PY  R N E +  I+
Sbjct: 168 PVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGK---IPYENRSNSEVVEDIS 219

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  113 bits (284), Expect = 5e-28
 Identities = 65/281 (23%), Positives = 108/281 (38%), Gaps = 48/281 (17%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71

Query: 78  EEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             +       + +E C+GG LF+ +   E   G+ E +       L AG+ +L    + H
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY---GTEEYLHPDMYERAVL 193
           RD+KP N++    D+   + K++DFG A     + +   L    GT  Y+ P++ +    
Sbjct: 129 RDIKPENLL---LDERDNL-KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK---- 180

Query: 194 RKPVGKTF-GATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
                + F    VD+WS G+ L  +  G LP+       +    Y               
Sbjct: 181 ----RREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYS---DWKEKKTY--- 227

Query: 253 TSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKK 293
                       L    ++      L    L  +L  +   
Sbjct: 228 ------------LNPWKKIDSAPLAL----LHKILVENPSA 252

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  113 bits (286), Expect = 5e-28
 Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 24/217 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM---REFEVLKKVKHENIVKL 73
           +LG+G+ G V + ++       AVK   +    R  + +    +E ++L++++H+N+++L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 74  LAIEEEQEGRGKVIVMELCTGGS--LFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           + +   +E +   +VME C  G   + + + +          +       L  G+++L  
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----RFPVCQAHGYFCQLIDGLEYLHS 127

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY---GTEEYLHPDMY 188
             +VH+D+KPGN++      G T+ K++  G A  L       +     G+  +  P++ 
Sbjct: 128 QGIVHKDIKPGNLL---LTTGGTL-KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183

Query: 189 ERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
                      TF G  VD+WS GVTLY++ TG  PF
Sbjct: 184 NGL-------DTFSGFKVDIWSAGVTLYNITTGLYPF 213

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  114 bits (287), Expect = 9e-28
 Identities = 42/225 (18%), Positives = 87/225 (38%), Gaps = 28/225 (12%)

Query: 17  VLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           +LG+GA   V++    +     N +   +K     ++     +  +  E LK       +
Sbjct: 72  LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG--LQEEEFLLVLEHLTAGMKHL 129
           K  +    Q G   V+V EL + G+L N ++  +NT    + +   +     +   ++ +
Sbjct: 131 KFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 130 RDNRLVHRDLKPGNIM-------KFICDDGSTIYKLTDFGAARELE---EDQQFMSLYGT 179
            D  ++H D+KP N +       +   DD S    L D G + +++   +   F +   T
Sbjct: 189 HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248

Query: 180 EEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
             +   +M           K +   +D + +  T+Y +  G    
Sbjct: 249 SGFQCVEMLS--------NKPWNYQIDYFGVAATVYCMLFGTYMK 285

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  113 bits (285), Expect = 1e-27
 Identities = 61/256 (23%), Positives = 93/256 (36%), Gaps = 56/256 (21%)

Query: 16  SVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
             LGKG  G+V          N GE VAVK     S         RE E+LK ++H+NIV
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIV 105

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K   +      R   ++ME    GSL + L   ++   +   + L     +  GM++L  
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 132 NRLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
            R +HRDL   NI+   +          K+ DFG  + L +D+              + Y
Sbjct: 164 KRYIHRDLATRNILVENENRV-------KIGDFGLTKVLPQDK--------------EYY 202

Query: 189 ERAVLRK-PV----------GKTFGATVDLWSIGVTLYHVATGNLPFR------------ 225
           +     + P+           K F    D+WS GV LY + T     +            
Sbjct: 203 KVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261

Query: 226 -PYGGRRNKETMYYIT 240
              G       +  + 
Sbjct: 262 DKQGQMIVFHLIELLK 277

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  113 bits (284), Expect = 1e-27
 Identities = 61/231 (26%), Positives = 85/231 (36%), Gaps = 44/231 (19%)

Query: 16  SVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
           S LGKG  G+V          N G  VAVK        +  D   RE ++LK +  + IV
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF-QREIQILKALHSDFIV 87

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           K   +      +   +VME    G L + L    +   L     LL    +  GM++L  
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 132 NRLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
            R VHRDL   NI+   +          K+ DFG A+ L  D+              D Y
Sbjct: 146 RRCVHRDLAARNILVESEAHV-------KIADFGLAKLLPLDK--------------DYY 184

Query: 189 ERAVLRK-PV----------GKTFGATVDLWSIGVTLYHVAT-GNLPFRPY 227
                 + P+             F    D+WS GV LY + T  +    P 
Sbjct: 185 VVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPS 234

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  112 bits (282), Expect = 1e-27
 Identities = 58/235 (24%), Positives = 98/235 (41%), Gaps = 39/235 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL +
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGV 77

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +      I+ E  T G+L + L +      +     L +   +++ M++L     +H
Sbjct: 78  CTREPPF--YIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKNFIH 134

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK- 195
           RDL   N +  + ++   + K+ DFG +R +  D                 Y      K 
Sbjct: 135 RDLAARNCL--VGENH--LVKVADFGLSRLMTGDT----------------YTAHAGAKF 174

Query: 196 PV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           P+           K F    D+W+ GV L+ +AT      PY G    +    + 
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT--YGMSPYPGIDLSQVYELLE 226

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  112 bits (283), Expect = 1e-27
 Identities = 61/226 (26%), Positives = 94/226 (41%), Gaps = 37/226 (16%)

Query: 15  TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH---DVQM-----REFEVLKKVK 66
             +LG G    V    +  +   VAVK       +R     D        RE +    + 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKV------LRADLARDPSFYLRFRREAQNAAALN 70

Query: 67  HENIVKLLAIEEEQEGRGKV--IVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLT 123
           H  IV +    E +   G +  IVME   G +L +I+       G +  +  + V+    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 126

Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM----SLYGT 179
             +     N ++HRD+KP NIM  I    +   K+ DFG AR + +    +    ++ GT
Sbjct: 127 QALNFSHQNGIIHRDVKPANIM--ISATNAV--KVMDFGIARAIADSGNSVTQTAAVIGT 182

Query: 180 EEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
            +YL P   E+A      G +  A  D++S+G  LY V TG  PF 
Sbjct: 183 AQYLSP---EQA-----RGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  111 bits (281), Expect = 1e-27
 Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 41/235 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG G  G V  G  +     VA+K   + S M   +  + E +V+  + HE +V+L  +
Sbjct: 31  ELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEF-IEEAKVMMNLSHEKLVQLYGV 87

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             +Q      I+ E    G L N L +  +    Q ++ L + + +   M++L   + +H
Sbjct: 88  CTKQRPI--FIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESKQFLH 143

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK- 195
           RDL   N +  + D G  + K++DFG +R + +D+                Y  +V  K 
Sbjct: 144 RDLAARNCL--VNDQG--VVKVSDFGLSRYVLDDE----------------YTSSVGSKF 183

Query: 196 PV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           PV           K F +  D+W+ GV ++ + +  L   PY    N ET  +I 
Sbjct: 184 PVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS--LGKMPYERFTNSETAEHIA 235

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  112 bits (283), Expect = 1e-27
 Identities = 60/253 (23%), Positives = 91/253 (35%), Gaps = 54/253 (21%)

Query: 16  SVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHEN 69
             LG+G  G V        N   GE VAVK     +   P       +E ++L+ + HE+
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK--ADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           I+K     E+       +VME    GSL + L      + +   + LL  + +  GM +L
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYL 150

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
                +HRDL   N++  + +D   + K+ DFG A+ + E                + Y 
Sbjct: 151 HAQHYIHRDLAARNVL--LDND--RLVKIGDFGLAKAVPEGH--------------EYYR 192

Query: 190 RAVLRK-PV----------GKTFGATVDLWSIGVTLYHVAT------------GNLPFRP 226
                  PV           K F    D+WS GVTLY + T              L    
Sbjct: 193 VREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251

Query: 227 YGGRRNKETMYYI 239
            G          +
Sbjct: 252 QGQMTVLRLTELL 264

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  112 bits (283), Expect = 2e-27
 Identities = 62/244 (25%), Positives = 99/244 (40%), Gaps = 41/244 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
            LG GA G V++G             VAVKT  ++   +     + E  ++ K  H+NIV
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLEHLTAGMK 127
           + + +  +   R   I+MEL  GG L + L      P     L   + L V   +  G +
Sbjct: 97  RCIGVSLQSLPR--FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           +L +N  +HRD+   N +      G    K+ DFG AR++                    
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVA-KIGDFGMARDIYRA---------------SY 198

Query: 188 YERAVLRK-PV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
           Y +      PV          G  F +  D WS GV L+ + +  L + PY  + N+E +
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVL 255

Query: 237 YYIT 240
            ++T
Sbjct: 256 EFVT 259

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  112 bits (283), Expect = 2e-27
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 23/211 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL- 74
           +GKG    V    +   G  VA+K  ++ + + P  +Q   RE  ++K + H NIVKL  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            IE E+      ++ME  +GG +F+ L        ++E+E       + + +++    R+
Sbjct: 82  VIETEKTL---YLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQIVSAVQYCHQKRI 135

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           VHRDLK  N++    D    I K+ DFG + E     +  +  G   Y  P++++     
Sbjct: 136 VHRDLKAENLL---LDADMNI-KIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ----- 186

Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
              GK + G  VD+WS+GV LY + +G+LPF
Sbjct: 187 ---GKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  112 bits (283), Expect = 2e-27
 Identities = 52/220 (23%), Positives = 102/220 (46%), Gaps = 16/220 (7%)

Query: 11  VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN 69
           ++    ++G G  G V++G +   G+  A+K  + ++     +++ +E  +LKK   H N
Sbjct: 25  IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIK-QEINMLKKYSHHRN 82

Query: 70  IVKLLAI---EEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           I         +       ++ +VME C  GS+ +++        L+EE    +   +  G
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRG 141

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMSLYGTEEYLH 184
           + HL  ++++HRD+K  N++  + ++     KL DFG + +L     +  +  GT  ++ 
Sbjct: 142 LSHLHQHKVIHRDIKGQNVL--LTENAEV--KLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           P   E     +    T+    DLWS+G+T   +A G  P 
Sbjct: 198 P---EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  111 bits (280), Expect = 2e-27
 Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 37/233 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG G  G V+ G    +   VAVK+  Q   M P    + E  ++K+++H+ +V+L A+
Sbjct: 20  RLGAGQFGEVWMGYYNGHT-KVAVKSLKQ-GSMSPDAF-LAEANLMKQLQHQRLVRLYAV 76

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +H
Sbjct: 77  VTQE---PIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIH 132

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           RDL+  NI+  + D      K+ DFG AR +E++          EY       R   + P
Sbjct: 133 RDLRAANIL--VSDTL--SCKIADFGLARLIEDN----------EY-----TAREGAKFP 173

Query: 197 VGKT---------FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           +  T         F    D+WS G+ L  + T      PY G  N E +  + 
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLE 224

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  111 bits (281), Expect = 2e-27
 Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 35/238 (14%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G+G  G V+ G   +N       AVK+ N+++ +      + E  ++K   H N++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           L I    EG   ++V+     G L N + +  +      ++ +     +  GMK+L   +
Sbjct: 92  LGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYLASKK 148

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
            VHRDL   N M  + +      K+ DFG AR++ +          E Y    ++ +   
Sbjct: 149 FVHRDLAARNCM--LDEKF--TVKVADFGLARDMYDK---------EYYS---VHNKTGA 192

Query: 194 RKPV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           + PV           K F    D+WS GV L+ + T      PY      +   Y+  
Sbjct: 193 KLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLLQ 247

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  113 bits (284), Expect = 3e-27
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 37/235 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            +G+G  G VF G  + +   VAVK+  +          ++E  +LK+  H NIV+L+ +
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             +++     IVMEL  GG     L        L+ +  L ++    AGM++L     +H
Sbjct: 181 CTQKQPI--YIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLESKCCIH 236

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK- 195
           RDL   N +  + +    + K++DFG +RE  +                  Y  +   + 
Sbjct: 237 RDLAARNCL--VTEKN--VLKISDFGMSREEADGV----------------YAASGGLRQ 276

Query: 196 -PV---------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
            PV            + +  D+WS G+ L+   +  L   PY    N++T  ++ 
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFS--LGASPYPNLSNQQTREFVE 329

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  112 bits (283), Expect = 3e-27
 Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 41/244 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
            LG GA G V++G             VAVKT  ++   +     + E  ++ K  H+NIV
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLEHLTAGMK 127
           + + +  +   R   I++EL  GG L + L      P     L   + L V   +  G +
Sbjct: 138 RCIGVSLQSLPR--FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           +L +N  +HRD+   N +      G    K+ DFG AR++                    
Sbjct: 196 YLEENHFIHRDIAARNCLLTCPGPGRVA-KIGDFGMARDIYRA---------------GY 239

Query: 188 YERAVLRK-PV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
           Y +      PV          G  F +  D WS GV L+ + +  L + PY  + N+E +
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVL 296

Query: 237 YYIT 240
            ++T
Sbjct: 297 EFVT 300

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  112 bits (283), Expect = 4e-27
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 41/241 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G+G  G V+ G   +N       AVK+ N+++ +      + E  ++K   H N++ L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           L I    EG   ++V+     G L N + +  +      ++ +     +  GMK L   +
Sbjct: 156 LGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLASKK 212

Query: 134 LVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
            VHRDL   N M   KF         K+ DFG AR++ +           E+    ++ +
Sbjct: 213 FVHRDLAARNCMLDEKFTV-------KVADFGLARDMYDK----------EF--DSVHNK 253

Query: 191 AVLRKPV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
              + PV           K F    D+WS GV L+ + T      PY      +   Y+ 
Sbjct: 254 TGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL 310

Query: 241 T 241
            
Sbjct: 311 Q 311

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  112 bits (281), Expect = 4e-27
 Identities = 63/242 (26%), Positives = 104/242 (42%), Gaps = 46/242 (19%)

Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           V+G G  G V++G+ K +      PVA+KT       +     + E  ++ +  H NI++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L  +  + +    +I+ E    G+L   L + +        + + +L  + AGMK+L + 
Sbjct: 111 LEGVISKYKPM--MIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLANM 166

Query: 133 RLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
             VHRDL   NI+     +C       K++DFG +R LE+D         E       Y 
Sbjct: 167 NYVHRDLAARNILVNSNLVC-------KVSDFGLSRVLEDDP--------EAT-----YT 206

Query: 190 RAVLRKPV----------GKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYY 238
            +  + P+           K F +  D+WS G+ ++ V T G    RPY    N E M  
Sbjct: 207 TSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGE---RPYWELSNHEVMKA 262

Query: 239 IT 240
           I 
Sbjct: 263 IN 264

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  110 bits (276), Expect = 7e-27
 Identities = 58/242 (23%), Positives = 93/242 (38%), Gaps = 48/242 (19%)

Query: 17  VLGKGATGAVFQGV-NKNNGE--PVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIV 71
            LG G+ G V +G  +  +G+   VAVK        +P  +   +RE   +  + H N++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           +L  +          +V EL   GSL + L   +  + L           +  GM +L  
Sbjct: 85  RLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLES 139

Query: 132 NRLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
            R +HRDL   N++   + +        K+ DFG  R L ++               D Y
Sbjct: 140 KRFIHRDLAARNLLLATRDLV-------KIGDFGLMRALPQN--------------DDHY 178

Query: 189 ERAVLRK-PVG---------KTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMY 237
                RK P           +TF    D W  GVTL+ + T G     P+ G    + ++
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ---EPWIGLNGSQILH 235

Query: 238 YI 239
            I
Sbjct: 236 KI 237

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  110 bits (278), Expect = 7e-27
 Identities = 54/242 (22%), Positives = 84/242 (34%), Gaps = 50/242 (20%)

Query: 17  VLGKGATGAVFQGV----NKNNGEPVAVKTFNQ-LSHMRPHDVQMREFEVLKKVKHENIV 71
           VLG G  G V +GV     ++   PV +K             V       +  + H +IV
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV-TDHMLAIGSLDHAHIV 78

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           +LL +          +V +    GSL + +       G Q    L     +  GM +L +
Sbjct: 79  RLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQL--LLNWGVQIAKGMYYLEE 133

Query: 132 NRLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
           + +VHR+L   N++              ++ DFG A  L  D               D  
Sbjct: 134 HGMVHRNLAARNVLLKSPSQV-------QVADFGVADLLPPD---------------DKQ 171

Query: 189 ERAVLRK-PVG---------KTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMY 237
                 K P+            +    D+WS GVT++ + T G     PY G R  E   
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA---EPYAGLRLAEVPD 228

Query: 238 YI 239
            +
Sbjct: 229 LL 230

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  110 bits (278), Expect = 8e-27
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 23/212 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71

Query: 78  EEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             +       + +E C+GG LF+ +   E   G+ E +       L AG+ +L    + H
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY---GTEEYLHPDMYERAVL 193
           RD+KP N++     D     K++DFG A     + +   L    GT  Y+ P++ +    
Sbjct: 129 RDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK---- 180

Query: 194 RKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
                + F    VD+WS G+ L  +  G LP+
Sbjct: 181 ----RREFHAEPVDVWSCGIVLTAMLAGELPW 208

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  113 bits (285), Expect = 9e-27
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 35/233 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG G  G V++GV K     VAVKT  +   M   +  ++E  V+K++KH N+V+LL +
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEF-LKEAAVMKEIKHPNLVQLLGV 284

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +      I+ E  T G+L + L +      +     L +   +++ M++L     +H
Sbjct: 285 CTREP--PFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKNFIH 341

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           R+L   N +  + ++   + K+ DFG +R +  D           Y        A  + P
Sbjct: 342 RNLAARNCL--VGENH--LVKVADFGLSRLMTGD----------TY-----TAHAGAKFP 382

Query: 197 VGKT---------FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           +  T         F    D+W+ GV L+ +AT      PY G    +    + 
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT--YGMSPYPGIDLSQVYELLE 433

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  110 bits (276), Expect = 1e-26
 Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 26/219 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-----REFEVLKKV----KH 67
           +LGKG  G VF G    +   VA+K   +   +    +        E  +L KV     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 68  ENIVKLLAIEEEQEGRGKVIVMEL-CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM 126
             +++LL   E Q   G ++V+E       LF+ + +      L E         + A +
Sbjct: 98  PGVIRLLDWFETQ--EGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAI 152

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
           +H     +VHRD+K  NI   + D      KL DFG+   L  D+ +    GT  Y  P+
Sbjct: 153 QHCHSRGVVHRDIKDENI---LIDLRRGCAKLIDFGSGA-LLHDEPYTDFDGTRVYSPPE 208

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
              R        +       +WS+G+ LY +  G++PF 
Sbjct: 209 WISR-------HQYHALPATVWSLGILLYDMVCGDIPFE 240

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  110 bits (278), Expect = 1e-26
 Identities = 52/301 (17%), Positives = 107/301 (35%), Gaps = 49/301 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQM--------------REFE 60
            L +G    +     + + +  A+K +    L   R                     E +
Sbjct: 38  TLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILD-----DPENTYGLQEEE 114
           ++  +K+E  +    I    +   +V I+ E     S+    +     D   T  +  + 
Sbjct: 96  IITDIKNEYCLTCEGIITNYD---EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 115 FLLVLEHLTAGMKHL-RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF 173
              +++ +     ++  +  + HRD+KP NI+    D    + KL+DFG + E   D++ 
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL---MDKNGRV-KLSDFGES-EYMVDKKI 207

Query: 174 MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK 233
               GT E++ P+        +      GA VD+WS+G+ LY +    +PF     + + 
Sbjct: 208 KGSRGTYEFMPPEF----FSNE--SSYNGAKVDIWSLGICLYVMFYNVVPFS---LKISL 258

Query: 234 ETMY-YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSK 292
             ++  I  +  +      +      +       +N  LS          L   L  +  
Sbjct: 259 VELFNNI--RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF----LKLFLRKNPA 312

Query: 293 K 293
           +
Sbjct: 313 E 313

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  114 bits (287), Expect = 1e-26
 Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 44/238 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
            +G+G  G V QG+  +       VA+KT    +     +  ++E   +++  H +IVKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           + +  E       I+MELCT G L + L   + +  L     +L    L+  + +L   R
Sbjct: 457 IGVITENP---VWIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLESKR 511

Query: 134 LVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
            VHRD+   N++              KL DFG +R +E+            Y     Y+ 
Sbjct: 512 FVHRDIAARNVLVSSNDCV-------KLGDFGLSRYMEDS----------TY-----YKA 549

Query: 191 AVLRKPVG---------KTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
           +  + P+          + F +  D+W  GV ++ +       +P+ G +N + +  I
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM--HGVKPFQGVKNNDVIGRI 605

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  108 bits (273), Expect = 1e-26
 Identities = 58/235 (24%), Positives = 95/235 (40%), Gaps = 41/235 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG G  G V  G  K     VAVK   +   M   +   +E + + K+ H  +VK   +
Sbjct: 15  ELGSGQFGVVKLGKWKGQ-YDVAVKMIKE-GSMSEDEF-FQEAQTMMKLSHPKLVKFYGV 71

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             ++      IV E  + G L N L    +  GL+  + L +   +  GM  L  ++ +H
Sbjct: 72  CSKEYPI--YIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK- 195
           RDL   N +  +  D     K++DFG  R + +DQ                Y  +V  K 
Sbjct: 128 RDLAARNCL--VDRDL--CVKVSDFGMTRYVLDDQ----------------YVSSVGTKF 167

Query: 196 PV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           PV           K + +  D+W+ G+ ++ V +  L   PY    N E +  ++
Sbjct: 168 PVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFS--LGKMPYDLYTNSEVVLKVS 219

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  109 bits (275), Expect = 1e-26
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 28/221 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           V+G GAT  V         E VA+K  N L   +   +   ++E + + +  H NIV   
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQT-SMDELLKEIQAMSQCHHPNIVS-- 77

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNIL-----DDPENTYGLQEEEFLLVLEHLTAGMKHL 129
                       +VM+L +GGS+ +I+          +  L E     +L  +  G+++L
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY------GTEEYL 183
             N  +HRD+K GNI+  + +DGS   ++ DFG +  L                GT  ++
Sbjct: 138 HKNGQIHRDVKAGNIL--LGEDGSV--QIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            P++ E+        + +    D+WS G+T   +ATG  P+
Sbjct: 194 APEVMEQ-------VRGYDFKADIWSFGITAIELATGAAPY 227

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  108 bits (273), Expect = 2e-26
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 24/212 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLLA 75
           LG G  G V  G ++  G  VAVK  N+        V    RE + LK  +H +I+KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY- 77

Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDNR 133
             +         +VME  +GG LF+ +      +G ++E E   + + + + + +   + 
Sbjct: 78  --QVISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +VHRDLKP N++    D      K+ DFG +  + + +   +  G+  Y  P++      
Sbjct: 132 VVHRDLKPENVL---LDAHMNA-KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS---- 183

Query: 194 RKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
               G+ + G  VD+WS GV LY +  G LPF
Sbjct: 184 ----GRLYAGPEVDIWSCGVILYALLCGTLPF 211

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  110 bits (277), Expect = 2e-26
 Identities = 68/280 (24%), Positives = 110/280 (39%), Gaps = 46/280 (16%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G G  G      +K   E VAVK   +       +VQ RE    + ++H NIV+     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQ-REIINHRSLRHPNIVRFK--- 82

Query: 78  EEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
           E       + I+ME  +GG L+  +    N     E+E     + L +G+ +    ++ H
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query: 137 RDLKPGNIMKFICDDGSTIY--KLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           RDLK  N +     DGS     K+ DFG ++      Q  S  GT  Y+ P++       
Sbjct: 140 RDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL----- 190

Query: 195 KPVGKTF-GATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQT 253
               + + G   D+WS GVTLY +  G  PF        +   Y    +K    I   + 
Sbjct: 191 ---RQEYDGKIADVWSCGVTLYVMLVGAYPFE----DPEEPRDY----RKTIQRILSVKY 239

Query: 254 SENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKK 293
           S          +P++ ++S     L    ++ +   D   
Sbjct: 240 S----------IPDDIRISPECCHL----ISRIFVADPAT 265

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  109 bits (275), Expect = 2e-26
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 24/217 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-----REFEVLKKVKHE--N 69
           +LG G  G+V+ G+  ++  PVA+K   +       ++        E  +LKKV      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTG-GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           +++LL   E       V+++E       LF+ + +      LQEE        +   ++H
Sbjct: 110 VIRLLDWFERP--DSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRH 164

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMY 188
             +  ++HRD+K  NI   + D      KL DFG+   L +D  +    GT  Y  P+  
Sbjct: 165 CHNCGVLHRDIKDENI---LIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 220

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                     +  G +  +WS+G+ LY +  G++PF 
Sbjct: 221 RY-------HRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  109 bits (274), Expect = 2e-26
 Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 18/217 (8%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK-VKHENIVKLL- 74
            +G G  G V++   +  G  +AVK   +  +   +   + + +V+ K      IV+   
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
                      V I MEL    +             + E     +   +   + +L++  
Sbjct: 92  TFITN----TDVFIAMELMGTCAE---KLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 134 -LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRD+KP NI+  + + G    KL DFG +  L +D+      G   Y+ P   ER  
Sbjct: 145 GVIHRDVKPSNIL--LDERGQI--KLCDFGISGRLVDDKAKDRSAGCAAYMAP---ERID 197

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
              P    +    D+WS+G++L  +ATG  P++    
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  109 bits (274), Expect = 3e-26
 Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 44/239 (18%)

Query: 17  VLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+     +    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL I          ++ +L   G L + + + ++  G Q    L     +  GM +L D 
Sbjct: 82  LLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYLEDR 136

Query: 133 RLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
           RLVHRDL   N++              K+TDFG A+ L  +         E+      Y 
Sbjct: 137 RLVHRDLAARNVLVKTPQHV-------KITDFGLAKLLGAE---------EKE-----YH 175

Query: 190 RAVLRKPVG---------KTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
               + P+          + +    D+WS GVT++ + T     +PY G    E    +
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT--FGSKPYDGIPASEISSIL 232

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  110 bits (278), Expect = 3e-26
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 36/232 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           V+G+GA G V    +K+  +  A+K  ++   ++  D      E +++       +V+L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEE-------EFLLVLEHLTAGMK 127
                Q+ R   +VME   GG L N++    + Y + E+       E +L L+ +     
Sbjct: 136 Y--AFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFYTAEVVLALDAI----- 184

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS--LYGTEEYLHP 185
           H      +HRD+KP N++  +   G    KL DFG   ++ ++         GT +Y+ P
Sbjct: 185 HSMG--FIHRDVKPDNML--LDKSGHL--KLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238

Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           ++    +  +     +G   D WS+GV LY +  G+ PF  Y    +    Y
Sbjct: 239 EV----LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YA--DSLVGTY 282

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  108 bits (271), Expect = 3e-26
 Identities = 56/242 (23%), Positives = 102/242 (42%), Gaps = 51/242 (21%)

Query: 17  VLGKGATGAVFQGV--NKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVK 72
            LG G  G V +G    K   + VAVK         P      + E  V++++ +  IV+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           ++ I E +     ++VME+   G L   L    +   ++++  + ++  ++ GMK+L ++
Sbjct: 83  MIGICEAE---SWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 136

Query: 133 RLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
             VHRDL   N++   +          K++DFG ++ L  D+              + Y+
Sbjct: 137 NFVHRDLAARNVLLVTQHYA-------KISDFGLSKALRADE--------------NYYK 175

Query: 190 RAVLRK-PV----------GKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMY 237
                K PV           K F +  D+WS GV ++   + G    +PY G +  E   
Sbjct: 176 AQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQ---KPYRGMKGSEVTA 231

Query: 238 YI 239
            +
Sbjct: 232 ML 233

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (271), Expect = 3e-26
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 20/208 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+GA+G V+  ++   G+ VA++  N     +   +   E  V+++ K+ NIV  L  +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYL--D 84

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    +VME   GGSL +++        + E +   V       ++ L  N+++HR
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  NI+  +  DGS   KLTDFG   ++  +Q +  ++ GT  ++ P++  R      
Sbjct: 141 DIKSDNIL--LGMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR------ 190

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
             K +G  VD+WS+G+    +  G  P+
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPY 216

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  108 bits (271), Expect = 4e-26
 Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 18/219 (8%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK-VKHENIVKLL 74
             LG+GA G V +  +  +G+ +AVK      + +     + + ++  + V     V   
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 75  -AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFL-LVLEHLTAGMKHLRD 131
            A+  E    G V I MEL    SL        +      E+ L  +   +   ++HL  
Sbjct: 73  GALFRE----GDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127

Query: 132 N-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              ++HRD+KP N++  I   G    K+ DFG +  L +D       G + Y+ P   ER
Sbjct: 128 KLSVIHRDVKPSNVL--INALGQV--KMCDFGISGYLVDDVAKDIDAGCKPYMAP---ER 180

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
            +  +   K +    D+WS+G+T+  +A    P+  +G 
Sbjct: 181 -INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  109 bits (275), Expect = 4e-26
 Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 43/240 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K   +    VA+KT       +     + E  ++ +  H NI++L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  + +    +IV E    GSL + L   +        + + +L  + +GMK+L D  
Sbjct: 112 EGVVTKSKPV--MIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYLSDMG 167

Query: 134 LVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
            VHRDL   NI+     +C       K++DFG  R LE+D         E       Y  
Sbjct: 168 YVHRDLAARNILINSNLVC-------KVSDFGLGRVLEDDP--------EAA-----YTT 207

Query: 191 AVLRKPV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
              + P+           K F +  D+WS G+ L+ V +     RPY    N++ +  + 
Sbjct: 208 RGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMS--YGERPYWEMSNQDVIKAVD 264

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  108 bits (272), Expect = 5e-26
 Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 20/208 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           +G+G+TG V     K++G  VAVK  +     R   +   E  +++  +H N+V++   +
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHFNVVEMY--K 109

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
               G    ++ME   GG+L +I+        L EE+   V E +   + +L    ++HR
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQGVIHR 165

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K  +I+  +  DG    KL+DFG   ++ +D  +  SL GT  ++ P+     V+ + 
Sbjct: 166 DIKSDSIL--LTLDGRV--KLSDFGFCAQISKDVPKRKSLVGTPYWMAPE-----VISR- 215

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +   VD+WS+G+ +  +  G  P+
Sbjct: 216 --SLYATEVDIWSLGIMVIEMVDGEPPY 241

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  108 bits (272), Expect = 5e-26
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           ++G G +G V  G  +  G+   PVA+K        R     + E  ++ +  H NI++L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +         +IV E    GSL   L   +        + + +L  + AGM++L D  
Sbjct: 116 EGVVTRGRLA--MIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYLSDLG 171

Query: 134 LVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
            VHRDL   N++     +C       K++DFG +R LE+D         +       Y  
Sbjct: 172 YVHRDLAARNVLVDSNLVC-------KVSDFGLSRVLEDDP--------DAA-----YTT 211

Query: 191 AVLRKPV----------GKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYI 239
              + P+             F +  D+WS GV ++ V   G    RPY    N++ +  +
Sbjct: 212 TGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGE---RPYWNMTNRDVISSV 267

Query: 240 T 240
            
Sbjct: 268 E 268

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  107 bits (269), Expect = 6e-26
 Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 41/231 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEV--LKKVKHENIVK 72
            +GKG  G V++G     GE VAVK F         D +   RE E+     ++HENI+ 
Sbjct: 15  CVGKGRYGEVWRG--SWQGENVAVKIF------SSRDEKSWFRETELYNTVMLRHENILG 66

Query: 73  LLAIEEEQEGRGKV--IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
            +A +           ++      GSL++ L        L     L ++  + +G+ HL 
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLH 122

Query: 131 DNRL--------VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY----- 177
                        HRDLK  NI+  +  +G     + D G A    +    + +      
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNIL--VKKNGQC--CIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 178 GTEEYLHPDMYERAVLRKPVGKTFGAT--VDLWSIGVTLYHVATGNLPFRP 226
           GT+ Y+ P++ +           F +   VD+W+ G+ L+ VA   +    
Sbjct: 179 GTKRYMAPEVLD----ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  107 bits (270), Expect = 7e-26
 Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 35/222 (15%)

Query: 15  TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH---DVQ-----MREFEVLKKVK 66
             ++G+G  G V++  +      VA+K       M      D        RE     +++
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKL------MSETLSSDPVFRTRMQREARTAGRLQ 92

Query: 67  HENIVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
             ++V +    E     G++ + M L  G  L  +L        L     + ++  + + 
Sbjct: 93  EPHVVPIHDFGEID---GQLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSA 146

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ--QFMSLYGTEEYL 183
           +         HRD+KP NI+  +  D      L DFG A    +++  Q  +  GT  Y+
Sbjct: 147 LDAAHAAGATHRDVKPENIL--VSADDFA--YLVDFGIASATTDEKLTQLGNTVGTLYYM 202

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
            P   ER               D++++   LY   TG+ P++
Sbjct: 203 AP---ERF-----SESHATYRADIYALTCVLYECLTGSPPYQ 236

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  108 bits (273), Expect = 1e-25
 Identities = 58/242 (23%), Positives = 106/242 (43%), Gaps = 42/242 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL- 73
            +GKG+ G V      +  +  A+K  N+   +  ++V+   +E ++++ ++H  +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 74  --------LAIEEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEH 121
                   +            +V++L  GG L   L       E T  L   E ++ L++
Sbjct: 82  YSFQDEEDM-----------FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDY 130

Query: 122 LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEE 181
           L        + R++HRD+KP NI+  + + G     +TDF  A  L  + Q  ++ GT+ 
Sbjct: 131 L-----Q--NQRIIHRDMKPDNIL--LDEHGHV--HITDFNIAAMLPRETQITTMAGTKP 179

Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           Y+ P+     +     G  +   VD WS+GVT Y +  G  P+       +KE ++   T
Sbjct: 180 YMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET 234

Query: 242 KK 243
             
Sbjct: 235 TV 236

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  106 bits (268), Expect = 1e-25
 Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 35/222 (15%)

Query: 15  TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH---DVQM-----REFEVLKKVK 66
              LG G    V+   +      VA+K       +        +      RE     ++ 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKA------IFIPPREKEETLKRFEREVHNSSQLS 69

Query: 67  HENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAG 125
           H+NIV ++ ++EE +     +VME   G +L   ++     +G L  +  +     +  G
Sbjct: 70  HQNIVSMIDVDEEDDCY--YLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDG 123

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ--QFMSLYGTEEYL 183
           +KH  D R+VHRD+KP NI+  I  + +   K+ DFG A+ L E    Q   + GT +Y 
Sbjct: 124 IKHAHDMRIVHRDIKPQNIL--IDSNKTL--KIFDFGIAKALSETSLTQTNHVLGTVQYF 179

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
            P   E+A      G+      D++SIG+ LY +  G  PF 
Sbjct: 180 SP---EQA-----KGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  109 bits (274), Expect = 2e-25
 Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 37/233 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG+G  G V+ G        VA+KT      M P    ++E +V+KK++HE +V+L A+
Sbjct: 191 KLGQGCFGEVWMGTWNGTT-RVAIKTLKP-GTMSPEAF-LQEAQVMKKLRHEKLVQLYAV 247

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VH
Sbjct: 248 VSEE---PIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 303

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           RDL+  NI+  + ++   + K+ DFG AR +E++          EY       R   + P
Sbjct: 304 RDLRAANIL--VGENL--VCKVADFGLARLIEDN----------EY-----TARQGAKFP 344

Query: 197 VGKT---------FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           +  T         F    D+WS G+ L  + T      PY G  N+E +  + 
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVE 395

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  110 bits (276), Expect = 2e-25
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 37/233 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG+G  G V+ G        VA+KT      M P    ++E +V+KK++HE +V+L A+
Sbjct: 274 KLGQGCFGEVWMGTWNGTT-RVAIKTLKP-GTMSPEAF-LQEAQVMKKLRHEKLVQLYAV 330

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             E+      IV E  + GSL + L      Y L+  + + +   + +GM ++     VH
Sbjct: 331 VSEE---PIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 386

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           RDL+  NI+  + ++   + K+ DFG AR +E++               +   R   + P
Sbjct: 387 RDLRAANIL--VGENL--VCKVADFGLARLIEDN---------------EYTARQGAKFP 427

Query: 197 VGKT---------FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT 240
           +  T         F    D+WS G+ L  + T      PY G  N+E +  + 
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVE 478

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (265), Expect = 2e-25
 Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 45/238 (18%)

Query: 18  LGKGATGAVFQGVNKNNGE--PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LG G  G+V QGV +   +   VA+K   Q +     +  MRE +++ ++ +  IV+L+ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           + + +     ++VME+  GG L   L        +       +L  ++ GMK+L +   V
Sbjct: 78  VCQAEA---LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKNFV 132

Query: 136 HRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           HRDL   N++   +          K++DFG ++ L  D                 Y    
Sbjct: 133 HRDLAARNVLLVNRHYA-------KISDFGLSKALGADD--------------SYYTARS 171

Query: 193 LRK-PV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
             K P+           K F +  D+WS GVT++   +     +PY   +  E M +I
Sbjct: 172 AGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALS--YGQKPYKKMKGPEVMAFI 226

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  107 bits (269), Expect = 2e-25
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +G G+ GAV+   +  N E VA+K  +          Q  ++E   L+K++H N ++  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY- 119

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
                       +VME C  GS  ++L+  +    LQE E   V      G+ +L  + +
Sbjct: 120 -RGCYLREHTAWLVMEYC-LGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNM 175

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           +HRD+K GNI+  + + G    KL DFG+A  +     F+   GT  ++ P+     V+ 
Sbjct: 176 IHRDVKAGNIL--LSEPGLV--KLGDFGSASIMAPANSFV---GTPYWMAPE-----VIL 223

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                 +   VD+WS+G+T   +A    P 
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  105 bits (265), Expect = 3e-25
 Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 27/219 (12%)

Query: 11  VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFN-QLSHMRPHDVQMREFEVLKKVKHEN 69
           ++     +GKG+ G VF+G++    + VA+K  + + +     D+Q +E  VL +     
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPY 81

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           + K        +     I+ME   GGS  ++L+       L E +   +L  +  G+ +L
Sbjct: 82  VTKYYG--SYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYL 135

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ----FMSLYGTEEYLHP 185
              + +HRD+K  N++  + + G    KL DFG A +L + Q     F+   GT  ++ P
Sbjct: 136 HSEKKIHRDIKAANVL--LSEHGEV--KLADFGVAGQLTDTQIKRNTFV---GTPFWMAP 188

Query: 186 DMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +     V+++     + +  D+WS+G+T   +A G  P 
Sbjct: 189 E-----VIKQ---SAYDSKADIWSLGITAIELARGEPPH 219

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  105 bits (264), Expect = 4e-25
 Identities = 56/208 (26%), Positives = 107/208 (51%), Gaps = 20/208 (9%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIE 77
           LG+G+ G+V++ ++K  G+ VA+K    +      ++  +E  ++++    ++VK     
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVP-VES-DLQEII-KEISIMQQCDSPHVVKY--YG 91

Query: 78  EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHR 137
              +     IVME C  GS+ +I+     T  L E+E   +L+    G+++L   R +HR
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYLHFMRKIHR 149

Query: 138 DLKPGNIMKFICDDGSTIYKLTDFGAAREL-EEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           D+K GNI+  +  +G    KL DFG A +L +   +  ++ GT  ++ P+     V+++ 
Sbjct: 150 DIKAGNIL--LNTEGHA--KLADFGVAGQLTDTMAKRNTVIGTPFWMAPE-----VIQE- 199

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPF 224
               +    D+WS+G+T   +A G  P+
Sbjct: 200 --IGYNCVADIWSLGITAIEMAEGKPPY 225

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  109 bits (273), Expect = 5e-25
 Identities = 56/238 (23%), Positives = 99/238 (41%), Gaps = 43/238 (18%)

Query: 17  VLGKGATGAVFQGV--NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
            LG G  G+V QGV   +     VA+K   Q +     +  MRE +++ ++ +  IV+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            + + +     ++VME+  GG L   L        +       +L  ++ GMK+L +   
Sbjct: 403 GVCQAEA---LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKNF 457

Query: 135 VHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
           VHR+L   N++   +          K++DFG ++ L  D                 Y   
Sbjct: 458 VHRNLAARNVLLVNRHYA-------KISDFGLSKALGADD--------------SYYTAR 496

Query: 192 VLRK-PVG---------KTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
              K P+          + F +  D+WS GVT++   +     +PY   +  E M +I
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS--YGQKPYKKMKGPEVMAFI 552

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  105 bits (264), Expect = 5e-25
 Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 47/248 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
            LG+G+ G V++GV K   +      VA+KT N+ + MR     + E  V+K+    ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT-------A 124
           +LL +  + +    +++MEL T G L + L                 L  +         
Sbjct: 92  RLLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
           GM +L  N+ VHRDL   N M  + +D     K+ DFG  R++ E               
Sbjct: 150 GMAYLNANKFVHRDLAARNCM--VAEDF--TVKIGDFGMTRDIYET-------------- 191

Query: 185 PDMYERAVLRK-PV----------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK 233
            D Y +      PV          G  F    D+WS GV L+ +AT  L  +PY G  N+
Sbjct: 192 -DYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT--LAEQPYQGLSNE 247

Query: 234 ETMYYITT 241
           + + ++  
Sbjct: 248 QVLRFVME 255

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  104 bits (262), Expect = 1e-24
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 19/220 (8%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK-VKHENIVKLL 74
             +G+GA G+V + V+K +G+ +AVK        +     + + +V+ +      IV+  
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 75  -AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLL--VLEHLTAGMKHLR 130
            A+  E    G   I MEL    S         +       E +L  +       + HL+
Sbjct: 88  GALFRE----GDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 131 DNR-LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
           +N  ++HRD+KP NI+  +   G+   KL DFG + +L +        G   Y+ P   E
Sbjct: 143 ENLKIIHRDIKPSNIL--LDRSGNI--KLCDFGISGQLVDSIAKTRDAGCRPYMAP---E 195

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
           R +      + +    D+WS+G+TLY +ATG  P+  +  
Sbjct: 196 R-IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  106 bits (267), Expect = 1e-24
 Identities = 60/237 (25%), Positives = 93/237 (39%), Gaps = 45/237 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG G  G V+      +   VAVKT      M      + E  V+K ++H+ +VKL A+
Sbjct: 195 KLGAGQFGEVWMATYNKHT-KVAVKTMKP-GSMSVEAF-LAEANVMKTLQHDKLVKLHAV 251

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             ++      I+ E    GSL + L   E +      + +     +  GM  +     +H
Sbjct: 252 VTKE---PIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRNYIH 307

Query: 137 RDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           RDL+  NI+     +C       K+ DFG AR +E++          EY       R   
Sbjct: 308 RDLRAANILVSASLVC-------KIADFGLARVIEDN----------EY-----TAREGA 345

Query: 194 RKPVGKT---------FGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYIT 240
           + P+  T         F    D+WS G+ L  + T G     PY G  N E +  + 
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR---IPYPGMSNPEVIRALE 399

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  103 bits (259), Expect = 1e-24
 Identities = 59/240 (24%), Positives = 94/240 (39%), Gaps = 55/240 (22%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREF----EVLKKVKHENIVK 72
            +GKG  G V  G  + N   VAVK           D   + F     V+ +++H N+V+
Sbjct: 28  TIGKGEFGDVMLGDYRGN--KVAVKCIKN-------DATAQAFLAEASVMTQLRHSNLVQ 78

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL +  E++G G  IV E    GSL + L     +  L  +  L     +   M++L  N
Sbjct: 79  LLGVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN 136

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
             VHRDL   N++  + +D   + K++DFG  +                    +      
Sbjct: 137 NFVHRDLAARNVL--VSEDN--VAKVSDFGLTK--------------------EASSTQD 172

Query: 193 LRK-PV----------GKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYIT 240
             K PV           K F    D+WS G+ L+ + + G     PY     K+ +  + 
Sbjct: 173 TGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGR---VPYPRIPLKDVVPRVE 228

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  104 bits (261), Expect = 2e-24
 Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 39/230 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDD----PENT---YGLQEEEFLLVLEHLTAGMK 127
                ++     +VME   GG +F+ L       E     Y     + +L  E+L     
Sbjct: 108 F--SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA---AQIVLTFEYL----- 157

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           H  D  L++RDLKP N++  I   G    ++TDFG A+ ++   +  +L GT E L P++
Sbjct: 158 HSLD--LIYRDLKPENLL--IDQQGYI--QVTDFGFAKRVKG--RTWTLCGTPEALAPEI 209

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
               +L K   K     VD W++GV +Y +A G  PF  +        +Y
Sbjct: 210 ----ILSKGYNKA----VDWWALGVLIYEMAAGYPPF--FA--DQPIQIY 247

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  102 bits (257), Expect = 2e-24
 Identities = 56/259 (21%), Positives = 99/259 (38%), Gaps = 63/259 (24%)

Query: 17  VLGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
            LG+   G V++G             VA+KT    +     +    E  +  +++H N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 72  KLLAI--EEEQEGRGKVIVMELCTGGSLFNIL-------------DDPENTYGLQEEEFL 116
            LL +  +++       ++   C+ G L   L             DD      L+  +F+
Sbjct: 76  CLLGVVTKDQP----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 117 LVLEHLTAGMKHLRDNRLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQF 173
            ++  + AGM++L  + +VH+DL   N++   K          K++D G  RE+      
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV-------KISDLGLFREVYAA--- 181

Query: 174 MSLYGTEEYLHPDMYERAVLRK-PV----------GKTFGATVDLWSIGVTLYHVATGNL 222
                       D Y+       P+          GK F    D+WS GV L+ V +   
Sbjct: 182 ------------DYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFS--Y 226

Query: 223 PFRPYGGRRNKETMYYITT 241
             +PY G  N++ +  I  
Sbjct: 227 GLQPYCGYSNQDVVEMIRN 245

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  107 bits (268), Expect = 2e-24
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 19/224 (8%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           VLGKG  G V     +  G+  A K   +    +       + E ++L+KV    +V L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
              E ++    + +V+ L  GG L   +       G  E   +     +  G++ L   R
Sbjct: 251 YAYETKD---ALCLVLTLMNGGDLKFHIYH-MGQAGFPEARAVFYAAEICCGLEDLHRER 306

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           +V+RDLKP NI+  + D G    +++D G A  + E Q      GT  Y+ P+     V+
Sbjct: 307 IVYRDLKPENIL--LDDHGHI--RISDLGLAVHVPEGQTIKGRVGTVGYMAPE-----VV 357

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           +    + +  + D W++G  LY +  G  PF+    +  +E + 
Sbjct: 358 K---NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  103 bits (259), Expect = 3e-24
 Identities = 63/258 (24%), Positives = 88/258 (34%), Gaps = 63/258 (24%)

Query: 17  VLGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
            LG+GA G VF     N         VAVK   + S         RE E+L  ++H++IV
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIV 106

Query: 72  KLLAI--EEEQEGRGKVIVMELCTGGSLFNIL-----DDPENTYGLQEEEFLLVLEHLT- 123
           +   +  E        ++V E    G L   L     D      G       L L  L  
Sbjct: 107 RFFGVCTEGRP----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162

Query: 124 ------AGMKHLRDNRLVHRDLKPGNIM---KFICDDGSTIYKLTDFGAARELEEDQQFM 174
                 AGM +L     VHRDL   N +     +        K+ DFG +R++       
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV-------KIGDFGMSRDIYST---- 211

Query: 175 SLYGTEEYLHPDMYERAVLRK-PV----------GKTFGATVDLWSIGVTLYHVATGNLP 223
                      D Y        P+           K F    D+WS GV L+ + T    
Sbjct: 212 -----------DYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFT--YG 257

Query: 224 FRPYGGRRNKETMYYITT 241
            +P+    N E +  IT 
Sbjct: 258 KQPWYQLSNTEAIDCITQ 275

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  105 bits (264), Expect = 3e-24
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 26/213 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM---REFEVLKKVKHENIVKLL 74
           LG G  G V  G ++  G  VAVK  N+   +R  DV     RE + LK  +H +I+KL 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDN 132
              +       + +VME  +GG LF+ +       G L E+E   + + + +G+ +   +
Sbjct: 83  ---QVISTPSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH 135

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            +VHRDLKP N++    D      K+ DFG +  + + +   +  G+  Y  P++     
Sbjct: 136 MVVHRDLKPENVL---LDAHMNA-KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS--- 188

Query: 193 LRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
                G+ + G  VD+WS GV LY +  G LPF
Sbjct: 189 -----GRLYAGPEVDIWSSGVILYALLCGTLPF 216

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  104 bits (261), Expect = 4e-24
 Identities = 61/233 (26%), Positives = 95/233 (40%), Gaps = 33/233 (14%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           V+G+GA   V     K  G+  A+K  N+   ++  +V     E +VL       I +L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 75  -AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEE-------EFLLVLEHLTAGM 126
            A    Q+     +VME   GG L  +L        +  E       E ++ ++ +    
Sbjct: 128 FAF---QDENYLYLVMEYYVGGDLLTLLSKFGER--IPAEMARFYLAEIVMAIDSV---- 178

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS--LYGTEEYLH 184
            H      VHRD+KP NI+  +   G    +L DFG+  +L  D    S    GT +YL 
Sbjct: 179 -HRLG--YVHRDIKPDNIL--LDRCGHI--RLADFGSCLKLRADGTVRSLVAVGTPDYLS 231

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           P++ +        G  +G   D W++GV  Y +  G  PF  Y    +    Y
Sbjct: 232 PEILQAVGGGPGTGS-YGPECDWWALGVFAYEMFYGQTPF--YA--DSTAETY 279

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  106 bits (265), Expect = 4e-24
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 20/226 (8%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           VLG+G  G VF    K  G+  A K  N+    +    Q  M E ++L KV    IV L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLF-NILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              E +     + +VM +  GG +  +I +  E+  G QE   +     + +G++HL   
Sbjct: 252 YAFETKT---DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERA 191
            +++RDLKP N++  + DDG+   +++D G A EL+  Q     Y GT  ++ P+     
Sbjct: 309 NIIYRDLKPENVL--LDDDGNV--RISDLGLAVELKAGQTKTKGYAGTPGFMAPE----- 359

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           +L    G+ +  +VD +++GVTLY +     PFR  G +   + + 
Sbjct: 360 LLL---GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  101 bits (254), Expect = 4e-24
 Identities = 30/223 (13%), Positives = 55/223 (24%), Gaps = 59/223 (26%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--------MREFEVLKKVKH 67
              G       +Q ++      VA+        + P  V         +     L ++  
Sbjct: 37  IFHGGVPPLQFWQALDTALDRQVALTF------VDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
             + ++L +       G ++V E   GGSL  + D             +  ++ L A   
Sbjct: 91  PGVARVLDVVHT-RAGG-LVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAAD 143

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
                 +      P  +   +  DG     L                        +    
Sbjct: 144 AAHRAGVALSIDHPSRVR--VSIDGDV--VLAYPA-------------------TMPDA- 179

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR 230
                             D+  IG +LY +     P    G R
Sbjct: 180 --------------NPQDDIRGIGASLYALLVNRWPLPEAGVR 208

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (259), Expect = 4e-24
 Identities = 49/222 (22%), Positives = 85/222 (38%), Gaps = 30/222 (13%)

Query: 17  VLGKGAT--GAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVK 72
           V+GKG      V     K  GE V V+  N L       V     E  V K   H NIV 
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 73  LLA--IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
             A  I + +      +V      GS  +++       G+ E     +L+ +   + ++ 
Sbjct: 91  YRATFIADNE----LWVVTSFMAYGSAKDLIC-THFMDGMNELAIAYILQGVLKALDYIH 145

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ--------FMSLYGTEEY 182
               VHR +K  +I+  I  DG     L+   +   +    Q                 +
Sbjct: 146 HMGYVHRSVKASHIL--ISVDGKV--YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 183 LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           L P++ ++ +      + + A  D++S+G+T   +A G++PF
Sbjct: 202 LSPEVLQQNL------QGYDAKSDIYSVGITACELANGHVPF 237

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  102 bits (257), Expect = 5e-24
 Identities = 58/246 (23%), Positives = 102/246 (41%), Gaps = 40/246 (16%)

Query: 6   GSTNYVWCTTS-------VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMRE 58
           G    V  T +        +GKG  G V++G  K  GE VAVK F+     R      RE
Sbjct: 31  GLPLLVQRTIARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS----REERSWFRE 84

Query: 59  FEV--LKKVKHENIVKLLAIEEEQEGRGKV--IVMELCTGGSLFNILDDPENTYGLQEEE 114
            E+     ++HENI+  +A + +  G      +V +    GSLF+ L    N Y +  E 
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEG 140

Query: 115 FLLVLEHLTAGMKHLRDNRL--------VHRDLKPGNIMKFICDDGSTIYKLTDFGAARE 166
            + +     +G+ HL    +         HRDLK  NI+  +  +G+    + D G A  
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL--VKKNGTC--CIADLGLAVR 196

Query: 167 LEEDQQFMSLY-----GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGN 221
            +     + +      GT+ Y+ P++ + ++  K          D++++G+  + +A   
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH--FESFKRADIYAMGLVFWEIARRC 254

Query: 222 LPFRPY 227
                +
Sbjct: 255 SIGGIH 260

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  101 bits (254), Expect = 6e-24
 Identities = 59/254 (23%), Positives = 92/254 (36%), Gaps = 58/254 (22%)

Query: 18  LGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           LG+GA G VF     N         VAVK     + +       RE E+L  ++HE+IVK
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVK 81

Query: 73  LLAI--EEEQEGRGKVIVMELCTGGSLFNIL------DDPENTYGLQEEEFLLVLEHLT- 123
              +  + +      ++V E    G L   L               ++ +  L L  +  
Sbjct: 82  FYGVCGDGDP----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 124 ------AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY 177
                 +GM +L     VHRDL   N +  +  +   + K+ DFG +R++          
Sbjct: 138 IASQIASGMVYLASQHFVHRDLATRNCL--VGANL--LVKIGDFGMSRDVYST------- 186

Query: 178 GTEEYLHPDMYERAVLRK-PV----------GKTFGATVDLWSIGVTLYHVATGNLPFRP 226
                   D Y        P+           K F    D+WS GV L+ + T     +P
Sbjct: 187 --------DYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFT--YGKQP 235

Query: 227 YGGRRNKETMYYIT 240
           +    N E +  IT
Sbjct: 236 WFQLSNTEVIECIT 249

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  102 bits (256), Expect = 8e-24
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 27/213 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM---REFEVLKKVKHENIVKLL 74
           LG+G+ G V    +    + VA+K  ++   ++  D+ M   RE   LK ++H +I+KL 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHLRDN 132
              +       + +V+E   GG LF+ +         + E+E     + +   +++   +
Sbjct: 76  ---DVITTPTDIVMVIEYA-GGELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCHRH 127

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
           ++VHRDLKP N++    DD   + K+ DFG +  + +     +  G+  Y  P++     
Sbjct: 128 KIVHRDLKPENLL---LDDNLNV-KIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN--- 180

Query: 193 LRKPVGKTF-GATVDLWSIGVTLYHVATGNLPF 224
                GK + G  VD+WS G+ LY +  G LPF
Sbjct: 181 -----GKLYAGPEVDVWSCGIVLYVMLVGRLPF 208

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  101 bits (254), Expect = 1e-23
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 42/238 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEV--LKKVKHENIVK 72
           ++G+G  GAV++G    +  PVAVK F         + Q  + E  +  +  ++H+NI +
Sbjct: 20  LIGRGRYGAVYKG--SLDERPVAVKVF------SFANRQNFINEKNIYRVPLMEHDNIAR 71

Query: 73  LLAIEEEQEGRGKV---IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
            +  +E     G++   +VME    GSL   L                +   +T G+ +L
Sbjct: 72  FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYL 127

Query: 130 RDNRL---------VHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL---------EEDQ 171
                          HRDL   N+   + +DG+    ++DFG +  L         EED 
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNV--LVKNDGTC--VISDFGLSMRLTGNRLVRPGEEDN 183

Query: 172 QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
             +S  GT  Y+ P++ E AV  +         VD++++G+  + +        P   
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESAL-KQVDMYALGLIYWEIFMRCTDLFPGES 240

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  101 bits (253), Expect = 1e-23
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 39/230 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            LG G+ G V    +++NG   A+K   +   +R   V+    E  +L  V H  I+++ 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDD----PENT---YGLQEEEFLLVLEHLTAGMK 127
                Q+ +   ++M+   GG LF++L      P      Y     E  L LE+L     
Sbjct: 73  G--TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA---AEVCLALEYL----- 122

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
           H +D  +++RDLKP NI+  +  +G    K+TDFG A+ + +     +L GT +Y+ P++
Sbjct: 123 HSKD--IIYRDLKPENIL--LDKNGHI--KITDFGFAKYVPD--VTYTLCGTPDYIAPEV 174

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
               V  KP  K+    +D WS G+ +Y +  G  PF  Y    N    Y
Sbjct: 175 ----VSTKPYNKS----IDWWSFGILIYEMLAGYTPF--YD--SNTMKTY 212

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  101 bits (253), Expect = 2e-23
 Identities = 54/256 (21%), Positives = 97/256 (37%), Gaps = 54/256 (21%)

Query: 17  VLGKGATGAVFQGV-------NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHE 68
            LG+GA G V                  VAVK     +  +     + E E++K + KH+
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNIL------DDPENTYGLQEEEFLLVLEHL 122
           NI+ LL    +       +++E  + G+L   L          +    +  E  +  + L
Sbjct: 102 NIINLLGACTQDGPL--YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 123 T-------AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS 175
                    GM++L   + +HRDL   N++  + ++   + K+ DFG AR++        
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVL--VTENN--VMKIADFGLARDINNI----- 210

Query: 176 LYGTEEYLHPDMYERAVLRK-PV---------GKTFGATVDLWSIGVTLYHVATGNLPFR 225
                     D Y++    + PV          + +    D+WS GV ++ + T  L   
Sbjct: 211 ----------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGS 258

Query: 226 PYGGRRNKETMYYITT 241
           PY G   +E    +  
Sbjct: 259 PYPGIPVEELFKLLKE 274

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  102 bits (256), Expect = 2e-23
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 37/234 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           V+G+GA G V     KN  +  A+K  N+   ++  +      E +VL     + I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140

Query: 75  -AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEE-------EFLLVLEHLTAGM 126
            A    Q+     +VM+   GG L  +L   E+   L EE       E ++ ++ +    
Sbjct: 141 YAF---QDDNNLYLVMDYYVGGDLLTLLSKFEDR--LPEEMARFYLAEMVIAIDSV---- 191

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS--LYGTEEYLH 184
            H      VHRD+KP NI+  +  +G    +L DFG+  +L ED    S    GT +Y+ 
Sbjct: 192 -HQLH--YVHRDIKPDNIL--MDMNGHI--RLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244

Query: 185 PDMYERAVLRKPVGKT-FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           P++    +     GK  +G   D WS+GV +Y +  G  PF  Y    +    Y
Sbjct: 245 PEI----LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF--YA--ESLVETY 290

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  102 bits (256), Expect = 3e-23
 Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 49/236 (20%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ---MREFEVLKKVKHENIVKL 73
            +GKG  G V  G  + N   VAVK       ++        + E  V+ +++H N+V+L
Sbjct: 200 TIGKGEFGDVMLGDYRGN--KVAVKC------IKNDATAQAFLAEASVMTQLRHSNLVQL 251

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           L +  E++G    IV E    GSL + L     +  L  +  L     +   M++L  N 
Sbjct: 252 LGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNN 309

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT---------EEYLH 184
            VHRDL   N++  + +D   + K++DFG  +E    Q                 E    
Sbjct: 310 FVHRDLAARNVL--VSEDN--VAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALRE 360

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYI 239
                         K F    D+WS G+ L+ + + G     PY     K+ +  +
Sbjct: 361 --------------KKFSTKSDVWSFGILLWEIYSFGR---VPYPRIPLKDVVPRV 399

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 99.7 bits (249), Expect = 4e-23
 Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 52/253 (20%)

Query: 17  VLGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENI 70
            LG+GA G V +       +      VAVK   + +    H   M E ++L  +  H N+
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNIL------DDPENTYGLQEEEFLLVLEHLT- 123
           V LL     + G   ++++E C  G+L   L        P         +  L LEHL  
Sbjct: 94  VNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 124 ------AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY 177
                  GM+ L   + +HRDL   NI+  + +    + K+ DFG AR++ +D       
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNIL--LSEKN--VVKICDFGLARDIYKD------- 201

Query: 178 GTEEYLHPDMYERAVLRK-PV---------GKTFGATVDLWSIGVTLYHVAT-GNLPFRP 226
                     Y R    + P+          + +    D+WS GV L+ + + G  P+  
Sbjct: 202 --------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-- 251

Query: 227 YGGRRNKETMYYI 239
            G + ++E    +
Sbjct: 252 PGVKIDEEFCRRL 264

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  100 bits (250), Expect = 4e-23
 Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 37/229 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV----LKKVKHENIVK 72
            +GKG  G V+ G  K  GE VAVK F         +      E        ++HENI+ 
Sbjct: 44  QIGKGRYGEVWMG--KWRGEKVAVKVF------FTTEEASWFRETEIYQTVLMRHENILG 95

Query: 73  LLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL- 129
            +A + +  G      ++ +    GSL++ L        L  +  L +     +G+ HL 
Sbjct: 96  FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLH 151

Query: 130 -------RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY----- 177
                      + HRDLK  NI+  +  +G+    + D G A +   D   + +      
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNIL--VKKNGTC--CIADLGLAVKFISDTNEVDIPPNTRV 207

Query: 178 GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
           GT+ Y+ P++ + ++ R           D++S G+ L+ VA   +    
Sbjct: 208 GTKRYMPPEVLDESLNRN--HFQSYIMADMYSFGLILWEVARRCVSGGI 254

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  102 bits (256), Expect = 8e-23
 Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 24/233 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHEN---IV 71
           ++G+G  G V+     + G+  A+K  ++            + E  +L  V   +   IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255

Query: 72  KLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
            +       +   K+  +++L  GG L   L          E +       +  G++H+ 
Sbjct: 256 CMSYAFHTPD---KLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGLEHMH 309

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
           +  +V+RDLKP NI+  + + G    +++D G A +  + +   +  GT  Y+ P+    
Sbjct: 310 NRFVVYRDLKPANIL--LDEHGHV--RISDLGLACDFSKKKPH-ASVGTHGYMAPE---- 360

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
            VL+K V      + D +S+G  L+ +  G+ PFR +  +   E      T  
Sbjct: 361 -VLQKGVAYDS--SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 98.8 bits (247), Expect = 8e-23
 Identities = 59/260 (22%), Positives = 99/260 (38%), Gaps = 59/260 (22%)

Query: 17  VLGKGATGAVFQG----VNKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
            LG+G  G V +     +    G   VAVK   + +        + EF VLK+V H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNIL--------------DDPENTYGLQEEEFLL 117
           KL     +      ++++E    GSL   L                  ++     +E  L
Sbjct: 90  KLYGACSQDGPL--LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 118 VLEHLT-------AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED 170
            +  L         GM++L + +LVHRDL   NI+  + +      K++DFG +R++ E+
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL--VAEGR--KMKISDFGLSRDVYEE 203

Query: 171 QQFMSLYGTEEYLHPDMYERAVLRK-PV---------GKTFGATVDLWSIGVTLYHVATG 220
                          D Y +    + PV            +    D+WS GV L+ + T 
Sbjct: 204 ---------------DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT- 247

Query: 221 NLPFRPYGGRRNKETMYYIT 240
            L   PY G   +     + 
Sbjct: 248 -LGGNPYPGIPPERLFNLLK 266

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 99.0 bits (247), Expect = 9e-23
 Identities = 50/227 (22%), Positives = 92/227 (40%), Gaps = 38/227 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV--LKKVKHENIVKLL 74
           V  +G  G V++       E VAVK F     ++       E+EV  L  +KHENI++ +
Sbjct: 31  VKARGRFGCVWKAQL--LNEYVAVKIFP----IQDKQSWQNEYEVYSLPGMKHENILQFI 84

Query: 75  AIEEEQEGRGKV--IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
             E+          ++      GSL + L        +   E   + E +  G+ +L ++
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHED 140

Query: 133 RL----------VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF---MSLYGT 179
                        HRD+K  N++  + ++ +    + DFG A + E  +         GT
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVL--LKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGT 196

Query: 180 EEYLHPDMYERAVLRKPVGKTFGAT--VDLWSIGVTLYHVATGNLPF 224
             Y+ P   E  VL   +     A   +D++++G+ L+ +A+     
Sbjct: 197 RRYMAP---E--VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 58/256 (22%), Positives = 97/256 (37%), Gaps = 54/256 (21%)

Query: 17  VLGKGATGAVFQGV-------NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHE 68
            LG+GA G V             N    VAVK     +  +     + E E++K + KH+
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNIL------DDPENTYGLQEEEFLLVLEHL 122
           NI+ LL    +       +++E  + G+L   L          +       E  L  + L
Sbjct: 136 NIINLLGACTQDGPL--YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 123 T-------AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS 175
                    GM++L   + +HRDL   N++  + +D   + K+ DFG AR++        
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVL--VTEDN--VMKIADFGLARDIHHI----- 244

Query: 176 LYGTEEYLHPDMYERAVLRK-PV---------GKTFGATVDLWSIGVTLYHVATGNLPFR 225
                     D Y++    + PV          + +    D+WS GV L+ + T  L   
Sbjct: 245 ----------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--LGGS 292

Query: 226 PYGGRRNKETMYYITT 241
           PY G   +E    +  
Sbjct: 293 PYPGVPVEELFKLLKE 308

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 98.7 bits (246), Expect = 4e-22
 Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 33/230 (14%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL 73
            +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKH 128
               +  +   ++  VME   GG LF  L       E+       E +  L++L     H
Sbjct: 214 KYSFQTHD---RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL-----H 265

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLHPDM 187
              N +V+RDLK  N+M  +  DG    K+TDFG  +E +++     +  GT EYL P++
Sbjct: 266 SEKN-VVYRDLKLENLM--LDKDGHI--KITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
            E           +G  VD W +GV +Y +  G LPF  Y   ++ E ++
Sbjct: 321 LE--------DNDYGRAVDWWGLGVVMYEMMCGRLPF--YN--QDHEKLF 358

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.0 bits (242), Expect = 5e-22
 Identities = 54/260 (20%), Positives = 92/260 (35%), Gaps = 59/260 (22%)

Query: 17  VLGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
            +G+GA G VFQ              VAVK   + +         RE  ++ +  + NIV
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNIL--------------DDPENTYGLQEEEFLL 117
           KLL +    +     ++ E    G L   L              D              L
Sbjct: 114 KLLGVCAVGKPM--CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 118 VLEHLT-------AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED 170
                        AGM +L + + VHRDL   N +  + ++   + K+ DFG +R +   
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL--VGENM--VVKIADFGLSRNI--- 224

Query: 171 QQFMSLYGTEEYLHPDMYERAVLRKPV----------GKTFGATVDLWSIGVTLYHVATG 220
                 Y  + Y          +  P+           + +    D+W+ GV L+ + + 
Sbjct: 225 ------YSADYYK---ADGNDAI--PIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS- 271

Query: 221 NLPFRPYGGRRNKETMYYIT 240
               +PY G  ++E +YY+ 
Sbjct: 272 -YGLQPYYGMAHEEVIYYVR 290

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 97.0 bits (242), Expect = 5e-22
 Identities = 56/252 (22%), Positives = 87/252 (34%), Gaps = 51/252 (20%)

Query: 17  VLGKGATGAVFQG----VNKNNGE-PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENI 70
            LG GA G V +     + K +    VAVK     +H    +  M E +++  + +HENI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNIL----DDPENTYGLQEEEFLLVLEHLT--- 123
           V LL           +++ E C  G L N L       E                L    
Sbjct: 113 VNLLGACTHGGPV--LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 124 ----AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGT 179
                GM  L     +HRD+   N++     +G    K+ DFG AR++  D         
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVL---LTNGHVA-KIGDFGLARDIMND--------- 217

Query: 180 EEYLHPDMYERAVLRK-PV---------GKTFGATVDLWSIGVTLYHVAT-GNLPFRPYG 228
                   Y      + PV            +    D+WS G+ L+ + + G  P+   G
Sbjct: 218 ------SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY--PG 269

Query: 229 GRRNKETMYYIT 240
              N +    + 
Sbjct: 270 ILVNSKFYKLVK 281

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 55/249 (22%), Positives = 92/249 (36%), Gaps = 52/249 (20%)

Query: 17  VLGKGATGAVFQGVNKNNGE--PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKL 73
           V+G+G  G V +   K +G     A+K   + +    H     E EVL K+  H NI+ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNIL------DDPENTYGLQEEEFLLVLEHLT---- 123
           L   E +      + +E    G+L + L      +              L  + L     
Sbjct: 92  LGACEHRGYL--YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 124 ---AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
               GM +L   + +HRDL   NI+  + ++   + K+ DFG +R               
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNIL--VGEN--YVAKIADFGLSRG-------------- 191

Query: 181 EYLHPDMYERAVLRK-PV---------GKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR 230
                ++Y +  + + PV            +    D+WS GV L+ + +  L   PY G 
Sbjct: 192 ----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGTPYCGM 245

Query: 231 RNKETMYYI 239
              E    +
Sbjct: 246 TCAELYEKL 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 96.7 bits (241), Expect = 1e-21
 Identities = 53/256 (20%), Positives = 96/256 (37%), Gaps = 54/256 (21%)

Query: 17  VLGKGATGAVFQGV-------NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHE 68
            LG+G  G V                  VAVK     +  +     + E E++K + KH+
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNIL------DDPENTYGLQEEEFLLVLEHL 122
           NI+ LL    +       +++E  + G+L   L          +    +  E  +  + L
Sbjct: 148 NIINLLGACTQDGPL--YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 123 T-------AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS 175
                    GM++L   + +HRDL   N++  + ++   + K+ DFG AR++        
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVL--VTENN--VMKIADFGLARDINNI----- 256

Query: 176 LYGTEEYLHPDMYERAVLRK-PV---------GKTFGATVDLWSIGVTLYHVATGNLPFR 225
                     D Y++    + PV          + +    D+WS GV ++ + T  L   
Sbjct: 257 ----------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--LGGS 304

Query: 226 PYGGRRNKETMYYITT 241
           PY G   +E    +  
Sbjct: 305 PYPGIPVEELFKLLKE 320

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 62/257 (24%), Positives = 94/257 (36%), Gaps = 55/257 (21%)

Query: 17  VLGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENI 70
            LG GA G V +      +  +    VAVK     +H+   +  M E +VL  +  H NI
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNIL--------DDPENTYGLQEEEFLLVLEHL 122
           V LL           +++ E C  G L N L            +   ++++E  L LE L
Sbjct: 90  VNLLGACTIGGPT--LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 123 T-------AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS 175
                    GM  L     +HRDL   NI+  +      I K+ DFG AR+++ D     
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNIL--LTHGR--ITKICDFGLARDIKND----- 198

Query: 176 LYGTEEYLHPDMYERAVLRK-PV---------GKTFGATVDLWSIGVTLYHVATGNLPFR 225
                       Y      + PV            +    D+WS G+ L+ + +  L   
Sbjct: 199 ----------SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS--LGSS 246

Query: 226 PYGGR-RNKETMYYITT 241
           PY G   + +    I  
Sbjct: 247 PYPGMPVDSKFYKMIKE 263

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 93.8 bits (234), Expect = 6e-21
 Identities = 65/238 (27%), Positives = 100/238 (42%), Gaps = 52/238 (21%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 75  AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEE-------------EFLLVLE 120
              +  +   ++  VME   GG LF         + L  E             E +  LE
Sbjct: 72  YAFQTHD---RLCFVMEYANGGELF---------FHLSRERVFTEERARFYGAEIVSALE 119

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGT 179
           +L     H     +V+RD+K  N+M  +  DG    K+TDFG  +E + +     +  GT
Sbjct: 120 YL-----H--SRDVVYRDIKLENLM--LDKDGHI--KITDFGLCKEGISDGATMKTFCGT 168

Query: 180 EEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
            EYL P+     VL       +G  VD W +GV +Y +  G LPF  Y   ++ E ++
Sbjct: 169 PEYLAPE-----VLE---DNDYGRAVDWWGLGVVMYEMMCGRLPF--YN--QDHERLF 214

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 46/210 (21%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD--VQMREFEVLKKVKHENIVKLLA 75
           +G+G+ G VF+  N++ G+ VA+K F   S   P    + +RE  +LK++KH N+V LL 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69

Query: 76  IEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
           +      + ++ +V E C   ++ + LD  +   G+ E     +       +     +  
Sbjct: 70  VFRR---KRRLHLVFEYCDH-TVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNC 123

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-------------LYGTEE 181
           +HRD+KP NI+  I      + KL DFG AR L     +               L G  +
Sbjct: 124 IHRDVKPENIL--ITKHS--VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179

Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIG 211
           Y                   G  VD+W+IG
Sbjct: 180 Y-------------------GPPVDVWAIG 190

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 71/249 (28%), Positives = 105/249 (42%), Gaps = 70/249 (28%)

Query: 17  VLGKGATGAVFQ---GVNKNNGEPVAVKTF---------NQLSHMRPHDVQMREFEVLKK 64
           VLGKG  G VFQ       N G+  A+K              +H         E  +L++
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT------KAERNILEE 77

Query: 65  VKHENIVKLL-AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEE--------- 113
           VKH  IV L+ A +      GK+ +++E  +GG LF           L+ E         
Sbjct: 78  VKHPFIVDLIYAFQTG----GKLYLILEYLSGGELF---------MQLEREGIFMEDTAC 124

Query: 114 ----EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LE 168
               E  + L HL     H     +++RDLKP NIM  +   G    KLTDFG  +E + 
Sbjct: 125 FYLAEISMALGHL-----H--QKGIIYRDLKPENIM--LNHQGHV--KLTDFGLCKESIH 173

Query: 169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
           +     +  GT EY+ P++    ++R    +     VD WS+G  +Y + TG  PF   G
Sbjct: 174 DGTVTHTFCGTIEYMAPEI----LMRSGHNRA----VDWWSLGALMYDMLTGAPPF--TG 223

Query: 229 GRRNKETMY 237
              N++   
Sbjct: 224 --ENRKKTI 230

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 93.6 bits (233), Expect = 1e-20
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 35/209 (16%)

Query: 15  TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
           T V+G G+ G V+Q    ++GE VA+K   Q    R    + RE ++++K+ H NIV+L 
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKR---FKNRELQIMRKLDHCNIVRLR 113

Query: 75  -AIEEEQEGRGKV---IVMELCTGGSLFNILDD-PENTYGLQEEEFLLVLEHLTAGMKHL 129
                  E + +V   +V++     +++ +          L      L +  L   + ++
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
               + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +  Y       
Sbjct: 173 HSFGICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY------- 222

Query: 190 RA--VLRKPVGKTFGAT-----VDLWSIG 211
           RA  ++       FGAT     +D+WS G
Sbjct: 223 RAPELI-------FGATDYTSSIDVWSAG 244

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 92.2 bits (230), Expect = 2e-20
 Identities = 68/241 (28%), Positives = 115/241 (47%), Gaps = 56/241 (23%)

Query: 17  VLGKGATGAVFQ---GVNKNNGEPVAVKTFNQLSHMRPHDVQMR-EFEVLKKVKHENIVK 72
           VLG+G+ G VF        +  +  A+K   + +      V+ + E ++L +V H  IVK
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 73  LL-AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEE-------------EFLL 117
           L  A + E    GK+ ++++   GG LF           L +E             E  L
Sbjct: 91  LHYAFQTE----GKLYLILDFLRGGDLF---------TRLSKEVMFTEEDVKFYLAELAL 137

Query: 118 VLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSL 176
            L+HL     H     +++RDLKP NI+  + ++G    KLTDFG ++E ++ +++  S 
Sbjct: 138 ALDHL-----H--SLGIIYRDLKPENIL--LDEEGHI--KLTDFGLSKESIDHEKKAYSF 186

Query: 177 YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
            GT EY+ P++    V R+   ++     D WS GV ++ + TG LPF   G  ++++  
Sbjct: 187 CGTVEYMAPEV----VNRRGHTQS----ADWWSFGVLMFEMLTGTLPF--QG--KDRKET 234

Query: 237 Y 237
            
Sbjct: 235 M 235

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 90.8 bits (226), Expect = 7e-20
 Identities = 58/264 (21%), Positives = 91/264 (34%), Gaps = 66/264 (25%)

Query: 17  VLGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENI 70
           VLG GA G V                VAVK   + +     +  M E +++ ++  HENI
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 71  VKLLA---IEEEQEGRGKVIVMELCTGGSLFNIL-------------DDPENTYGLQEEE 114
           V LL    +          ++ E C  G L N L              + +     +E+ 
Sbjct: 112 VNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 115 FLLVLEHLT-------AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL 167
            +L  E L         GM+ L     VHRDL   N++  +      + K+ DFG AR++
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL--VTHGK--VVKICDFGLARDI 222

Query: 168 EEDQQFMSLYGTEEYLHPDMYERAVLRK-PV---------GKTFGATVDLWSIGVTLYHV 217
             D                 Y      + PV            +    D+WS G+ L+ +
Sbjct: 223 MSD---------------SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

Query: 218 AT-GNLPFRPYGGRRNKETMYYIT 240
            + G  P+   G   +      I 
Sbjct: 268 FSLGVNPY--PGIPVDANFYKLIQ 289

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 90.4 bits (225), Expect = 8e-20
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 52/213 (24%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHD-----VQMREFEVLKKVKHENIVK 72
           +G+G+ G V +  NK+ G  VA+K F         D     + MRE ++LK+++HEN+V 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKF----LESDDDKMVKKIAMREIKLLKQLRHENLVN 88

Query: 73  LLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           LL + ++   + +  +V E     ++ + L+   N  GL  +     L  +  G+     
Sbjct: 89  LLEVCKK---KKRWYLVFEFVD-HTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHS 142

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-------------LYG 178
           + ++HRD+KP NI+  +   G  + KL DFG AR L    +                L G
Sbjct: 143 HNIIHRDIKPENIL--VSQSG--VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG 198

Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIG 211
             +Y                   G  VD+W+IG
Sbjct: 199 DVKY-------------------GKAVDVWAIG 212

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 72/239 (30%), Positives = 104/239 (43%), Gaps = 53/239 (22%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVL-KKVKHENIVKL 73
           V+GKG+ G V    +K      AVK   + + ++  + +  M E  VL K VKH  +V L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEE-------------EFLLVL 119
               +  +   K+  V++   GG LF         Y LQ E             E    L
Sbjct: 105 HFSFQTAD---KLYFVLDYINGGELF---------YHLQRERCFLEPRARFYAAEIASAL 152

Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYG 178
            +L     H     +V+RDLKP NI+  +   G     LTDFG  +E +E +    +  G
Sbjct: 153 GYL-----H--SLNIVYRDLKPENIL--LDSQGHI--VLTDFGLCKENIEHNSTTSTFCG 201

Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           T EYL P++    + ++P  +    TVD W +G  LY +  G  PF  Y   RN   MY
Sbjct: 202 TPEYLAPEV----LHKQPYDR----TVDWWCLGAVLYEMLYGLPPF--YS--RNTAEMY 248

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 92.2 bits (228), Expect = 2e-19
 Identities = 95/675 (14%), Positives = 190/675 (28%), Gaps = 201/675 (29%)

Query: 99  NILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKL 158
           ++ D P++   L +EE     +H+    K    +  +        +   +      +   
Sbjct: 37  DVQDMPKSI--LSKEEI----DHII-MSKD-AVSGTLR-------LFWTLLSKQEEMV-- 79

Query: 159 TDFGAARELEEDQQFMSLYGTEEYLHPDMYE------RAVLRKPVGKT--FGATVD-LWS 209
                       Q+F+     EE L  + Y+      +   R+P   T  +    D L+ 
Sbjct: 80  ------------QKFV-----EEVLRIN-YKFLMSPIKTEQRQPSMMTRMYIEQRDRLY- 120

Query: 210 IGVTLYHVATGNLPFRPYGGRRNKETMYYITT-----KKASGVI------SG-------- 250
                      N  F  Y   R  +    +       + A  V+      SG        
Sbjct: 121 ---------NDNQVFAKYNVSR-LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170

Query: 251 -----TQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT 305
                 Q   + +I W         L+L        +L  L                   
Sbjct: 171 CLSYKVQCKMDFKIFW---------LNLKNCNSPETVLEML------------------- 202

Query: 306 KTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILL-----YKNTH 360
           + L  ++   +         I L       +L+ L++ +    P +  LL          
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK----PYENCLLVLLNVQNAKA 258

Query: 361 FSHIFPSSHQKNPSSYSVSVENDATLAKQACSTGHVCKRRIEKLSKSSCLTH-YSVGVFI 419
           ++  F      N S   +       +     S        ++  S +  LT      + +
Sbjct: 259 WNA-F------NLSCKILLTTRFKQVT-DFLSAATTTHISLDHHSMT--LTPDEVKSLLL 308

Query: 420 TVLN---QQLSEISAKIHHLKQVTGAVQSLVDHISRSYNSIFSLMEDKSNNANDFKDEID 476
             L+   Q L       +  + ++   +S+ D ++   N        K  N +     I+
Sbjct: 309 KYLDCRPQDLPREVLTTNPRR-LSIIAESIRDGLATWDNW-------KHVNCDKLTTIIE 360

Query: 477 -SLRTNQLNSLSLNVEQLYQRCVL--------DKTLSKEWTNATRPIICPGKVKVPARAK 527
            SL  N L        +++ R  +           LS  W +  +       V       
Sbjct: 361 SSL--NVLEPAEY--RKMFDRLSVFPPSAHIPTILLSLIWFDVIK--SDVMVVVNKLHKY 414

Query: 528 TLTERLRDSWQHLLRDRATRTLSYNDEQFHVLERIKIGETGKRIKCLLDDDTYPHVLQLS 587
           +L          + +     T+S       +  +++  E       ++D    P      
Sbjct: 415 SL----------VEKQPKESTISIPSIYLELKVKLE-NEYALHRS-IVDHYNIPKTFDSD 462

Query: 588 DCLADW---YKMAQTIYLQSNFLSKDMQTF--AHSLAEFQTKVIDEDVKFHENLMNLSKI 642
           D +  +   Y      Y   + +   ++       +  F+   +D   +F E      KI
Sbjct: 463 DLIPPYLDQY-----FY---SHIGHHLKNIEHPERMTLFRMVFLD--FRFLEQ-----KI 507

Query: 643 KFTNHLNSNVNKLNNCLRIKSQDLK----YIRTSIKDLSLIKNEFNQFLEN-NSHLVDD- 696
           +  +   +    + N L    Q LK    YI  +      + N    FL     +L+   
Sbjct: 508 RHDSTAWNASGSILNTL----QQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK 563

Query: 697 ------IKLLSEQSS 705
                 I L++E  +
Sbjct: 564 YTDLLRIALMAEDEA 578

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 67.2 bits (163), Expect = 1e-11
 Identities = 88/511 (17%), Positives = 158/511 (30%), Gaps = 150/511 (29%)

Query: 253 TSENGEIDWCTDLPNNCQLSLGL--------KKLVTPILAGLLEVDSKKIWS-------- 296
           + E  EID      +    +L L        +++V   +  +L ++ K + S        
Sbjct: 47  SKE--EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ 104

Query: 297 ----FERFFSEVTKTLNRKLVHLF---HINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTP 349
                  +  +  +  N     +F   +++RLQ           Y +L+  + E   + P
Sbjct: 105 PSMMTRMYIEQRDRLYND--NQVFAKYNVSRLQP----------YLKLRQALLE---LRP 149

Query: 350 NKQILLY------KNTHFSHIFPSSHQKNPSSYSVSVENDATLAKQACSTGHVCKRRIEK 403
            K +L+       K                     +      +A   C +  V       
Sbjct: 150 AKNVLIDGVLGSGK---------------------TW-----VALDVCLSYKV------- 176

Query: 404 LSKSSCLTHYSVGVF-ITVLNQQLSEISAKIHHLKQVTGAVQSLVDHISRSYNSIFSLME 462
                        +F + + N    E          V   +Q L+  I  ++ S      
Sbjct: 177 ------QCKMDFKIFWLNLKNCNSPE---------TVLEMLQKLLYQIDPNWTSRSDHSS 221

Query: 463 DKSNNANDFKDEIDSLRTNQLNSLSLNVEQLYQRC--VLDKTLSKEWTNATRPIICPGKV 520
           +     +  + E+  L             + Y+ C  VL    + +  NA   + C  K+
Sbjct: 222 NIKLRIHSIQAELRRLLK----------SKPYENCLLVLLNVQNAKAWNAFN-LSC--KI 268

Query: 521 KVPARAKTLTERLR-DSWQHLLRDRATRTLSYNDEQFHVLERIKIGETGKRIKCL--LDD 577
            +  R K +T+ L   +  H+  D  + TL+  DE   +L +        R + L     
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLT-PDEVKSLLLKY----LDCRPQDLPREVL 323

Query: 578 DTYPHVL-----QLSDCLADW--------YKMAQTIYLQSNFLS-KDMQTFAHSLAEFQT 623
            T P  L      + D LA W         K+   I    N L   + +     L+ F  
Sbjct: 324 TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP- 382

Query: 624 KVIDEDVKFHENLMNLSKIKFTNHLNSNVNKLNNCLRIKS---QDLKYIRTSIKDLSLIK 680
                       L+    + + + + S+V  + N L   S   +  K    SI  + L  
Sbjct: 383 ----PSAHIPTILL---SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL-- 433

Query: 681 NEFNQFLENNS--H--LVDDIKLLSEQSSSD 707
            E    LEN    H  +VD   +     S D
Sbjct: 434 -ELKVKLENEYALHRSIVDHYNIPKTFDSDD 463

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.2 bits (119), Expect = 2e-06
 Identities = 80/606 (13%), Positives = 175/606 (28%), Gaps = 178/606 (29%)

Query: 3   FLRGS--TNYVWCTTSVLGK-----GATGAVFQGVNK--NNGEPVAVKTFNQLSHMRPHD 53
           F+      NY +  + +  +       T    +  ++  N+ +      F + +  R   
Sbjct: 82  FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV-----FAKYNVSRLQP 136

Query: 54  V-QMREFEVLKKVKHENIVKLLAIEEEQEGRGK-VIVMELCTGGSLFNILDDPEN----- 106
             ++R+   L +++    V +    +   G GK  + +++C     + +    +      
Sbjct: 137 YLKLRQ--ALLELRPAKNVLI----DGVLGSGKTWVALDVC---LSYKVQCKMDFKIFWL 187

Query: 107 TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE 166
                     + LE L          +L+++             D S+  KL        
Sbjct: 188 NLKNCNSPETV-LEML---------QKLLYQIDPNWTSR----SDHSSNIKL-------R 226

Query: 167 LEEDQQFMSLYGTEEYLHPDMYERA--VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
           +   Q  +        L    YE    VL            ++ +              +
Sbjct: 227 IHSIQAELR-----RLLKSKPYENCLLVLL-----------NVQNAKA-----------W 259

Query: 225 RPYGGR-RNKETMYYITTKKAS--GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTP 281
             +    +    +  +TT+       +S   T+                        +  
Sbjct: 260 NAFNLSCK---IL--LTTRFKQVTDFLSAATTTH---------------------ISLDH 293

Query: 282 ILAGLLEVDSKKIWSFERFFSEVTKTLNR--KLVHLFHIN------RLQCIRI--YLHPD 331
               L   + K +    ++     + L R     +   ++      R        + H +
Sbjct: 294 HSMTLTPDEVKSL--LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351

Query: 332 DAYDQLQDLIQEQTDV-TPNKQILLYKNTHFSHIFPSSHQKNPSS------YSVSVENDA 384
              D+L  +I+   +V  P +   ++     S +FP S    P+       + V   +  
Sbjct: 352 --CDKLTTIIESSLNVLEPAEYRKMFDR--LS-VFPPS-AHIPTILLSLIWFDVIKSDVM 405

Query: 385 TLAKQACSTGHVCKRRIEKLSKSSCLTHYSVGVFITVLNQQLSEISAKIHHLKQVTGAVQ 444
            +  +           +EK  K S ++  S    I +  +   E    +H         +
Sbjct: 406 VVVNKLHK-----YSLVEKQPKESTISIPS----IYLELKVKLENEYALH---------R 447

Query: 445 SLVDH--ISRSYNSIFSLMEDKSNNAND----------FKDEIDSLRTNQLNSLSLNVEQ 492
           S+VDH  I ++++S     +D      D           K+     R      + L+   
Sbjct: 448 SIVDHYNIPKTFDS-----DDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF 502

Query: 493 LYQRCVLDKTLSKEWTNAT---------RPIICPGKVKVPARAKTLTERLRDSWQHLLRD 543
           L Q+   D T      +           +P IC    K       + + L    ++L+  
Sbjct: 503 LEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICS 562

Query: 544 RATRTL 549
           + T  L
Sbjct: 563 KYTDLL 568

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 65/251 (25%), Positives = 102/251 (40%), Gaps = 66/251 (26%)

Query: 17  VLGKGATGAVFQ---GVNKNNGEPVAVKTF---------NQLSHMRPHDVQMREFEVLKK 64
           VLG GA G VF        + G+  A+K               H         E +VL+ 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT------RTERQVLEH 114

Query: 65  VKHEN-IVKLL-AIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEE-------- 113
           ++    +V L  A + E     K+ ++++   GG LF           L +         
Sbjct: 115 IRQSPFLVTLHYAFQTE----TKLHLILDYINGGELF---------THLSQRERFTEHEV 161

Query: 114 -----EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-- 166
                E +L LEHL     H     +++RD+K  NI+  +  +G     LTDFG ++E  
Sbjct: 162 QIYVGEIVLALEHL-----H--KLGIIYRDIKLENIL--LDSNGHV--VLTDFGLSKEFV 210

Query: 167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
            +E ++     GT EY+ PD+    V     G      VD WS+GV +Y + TG  PF  
Sbjct: 211 ADETERAYDFCGTIEYMAPDI----VRGGDSG--HDKAVDWWSLGVLMYELLTGASPFTV 264

Query: 227 YGGRRNKETMY 237
            G + ++  + 
Sbjct: 265 DGEKNSQAEIS 275

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 44/211 (20%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL-A 75
           V+G G+ G VFQ     + E VA+K   Q         + RE ++++ VKH N+V L   
Sbjct: 47  VIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAF 100

Query: 76  IEEEQEGRGKV---IVMELCTGGSLFNILDD-PENTYGLQEEEFLLVLEHLTAGMKHLRD 131
                + + +V   +V+E     +++       +    +      L +  L   + ++  
Sbjct: 101 FYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM----SLYGTEEYLHPDM 187
             + HRD+KP N++    D  S + KL DFG+A+ L   +  +    S Y    Y     
Sbjct: 160 IGICHRDIKPQNLL---LDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY----Y----- 207

Query: 188 YERA--VLRKPVGKTFGAT-----VDLWSIG 211
             RA  ++       FGAT     +D+WS G
Sbjct: 208 --RAPELI-------FGATNYTTNIDIWSTG 229

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 87.7 bits (218), Expect = 7e-19
 Identities = 60/239 (25%), Positives = 101/239 (42%), Gaps = 53/239 (22%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVKL 73
           VLGKG+ G V     K  G+  AVK   +   ++  DV+  M E  +L     H  + +L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEE-------------EFLLVL 119
               +  +   ++  VME   GG L          + +Q+              E +  L
Sbjct: 90  FCCFQTPD---RLFFVMEFVNGGDLM---------FHIQKSRRFDEARARFYAAEIISAL 137

Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYG 178
             L     H  D  +++RDLK  N++  +  +G    KL DFG  +E +       +  G
Sbjct: 138 MFL-----H--DKGIIYRDLKLDNVL--LDHEGHC--KLADFGMCKEGICNGVTTATFCG 186

Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           T +Y+ P+     +L+      +G  VD W++GV LY +  G+ PF       N++ ++
Sbjct: 187 TPDYIAPE-----ILQ---EMLYGPAVDWWAMGVLLYEMLCGHAPF--EA--ENEDDLF 233

>4efo_A Serine/threonine-protein kinase TBK1; ubiquitin like domain, transferase; 1.77A {Homo sapiens} Length = 94

 Score = 80.4 bits (198), Expect = 1e-18
 Identities = 13/61 (21%), Positives = 31/61 (50%)

Query: 301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTH 360
               +  L+R ++H+F + ++   +IY+H  +      +L+ +QT +  + Q L+Y+   
Sbjct: 3   LGSTSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRR 62

Query: 361 F 361
            
Sbjct: 63  L 63

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 64/239 (26%), Positives = 103/239 (43%), Gaps = 53/239 (22%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVKL 73
           +LGKG+ G VF    K   +  A+K   +   +   DV+  M E  VL    +H  +  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEE-------------EFLLVL 119
               + +E    +  VME   GG L          Y +Q               E +L L
Sbjct: 84  FCTFQTKE---NLFFVMEYLNGGDLM---------YHIQSCHKFDLSRATFYAAEIILGL 131

Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYG 178
           + L     H     +V+RDLK  NI+  +  DG    K+ DFG  +E +  D +  +  G
Sbjct: 132 QFL-----H--SKGIVYRDLKLDNIL--LDKDGHI--KIADFGMCKENMLGDAKTNTFCG 180

Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           T +Y+ P++    +L +        +VD WS GV LY +  G  PF  +G  +++E ++
Sbjct: 181 TPDYIAPEI----LLGQKYNH----SVDWWSFGVLLYEMLIGQSPF--HG--QDEEELF 227

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 53/238 (22%), Positives = 101/238 (42%), Gaps = 42/238 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVKL 73
           V+G+G+   V     K      A+K   +       D+     E  V ++   H  +V L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEH-------LTAG 125
            +  + +    ++  V+E   GG L          + +Q +  L   EH       ++  
Sbjct: 76  HSCFQTES---RLFFVIEYVNGGDLM---------FHMQRQRKLP-EEHARFYSAEISLA 122

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLH 184
           + +L +  +++RDLK  N++  +  +G    KLTD+G  +E L       +  GT  Y+ 
Sbjct: 123 LNYLHERGIIYRDLKLDNVL--LDSEGHI--KLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-----RNKETMY 237
           P+     +LR   G+ +G +VD W++GV ++ +  G  PF   G         ++ ++
Sbjct: 179 PE-----ILR---GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 53/239 (22%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVKL 73
           VLGKG+ G V     K   E  AVK   +   ++  DV+  M E  VL    K   + +L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEE-------------EFLLVL 119
            +  +  +   ++  VME   GG L          Y +Q+              E  + L
Sbjct: 87  HSCFQTMD---RLYFVMEYVNGGDLM---------YHIQQVGRFKEPHAVFYAAEIAIGL 134

Query: 120 EHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYG 178
             L           +++RDLK  N+M  +  +G    K+ DFG  +E + +     +  G
Sbjct: 135 FFL-----Q--SKGIIYRDLKLDNVM--LDSEGHI--KIADFGMCKENIWDGVTTKTFCG 183

Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           T +Y+ P+     ++     + +G +VD W+ GV LY +  G  PF   G   +++ ++
Sbjct: 184 TPDYIAPE-----IIA---YQPYGKSVDWWAFGVLLYEMLAGQAPF--EG--EDEDELF 230

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 85.7 bits (212), Expect = 3e-18
 Identities = 40/185 (21%), Positives = 74/185 (40%), Gaps = 27/185 (14%)

Query: 44  NQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDD 103
             LS   P D    +   +     +N V  L     +      I M+LC   +L + ++ 
Sbjct: 97  WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPK--VYLYIQMQLCRKENLKDWMNR 154

Query: 104 PENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA 163
             +    +    L +   +   ++ L    L+HRDLKP NI  F   D   + K+ DFG 
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI--FFTMDD--VVKVGDFGL 210

Query: 164 ARELEEDQQFMSLY-------------GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSI 210
              +++D++  ++              GT+ Y+ P+           G  +   VD++S+
Sbjct: 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH--------GNNYSHKVDIFSL 262

Query: 211 GVTLY 215
           G+ L+
Sbjct: 263 GLILF 267

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 85.1 bits (211), Expect = 8e-18
 Identities = 52/238 (21%), Positives = 101/238 (42%), Gaps = 42/238 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVKL 73
           V+G+G+   V     K      A++   +       D+     E  V ++   H  +V L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118

Query: 74  LAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEH-------LTAG 125
            +  + +    ++  V+E   GG L          + +Q +   L  EH       ++  
Sbjct: 119 HSCFQTES---RLFFVIEYVNGGDLM---------FHMQRQR-KLPEEHARFYSAEISLA 165

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLH 184
           + +L +  +++RDLK  N++  +  +G    KLTD+G  +E L       +  GT  Y+ 
Sbjct: 166 LNYLHERGIIYRDLKLDNVL--LDSEGHI--KLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-----RNKETMY 237
           P+     +LR   G+ +G +VD W++GV ++ +  G  PF   G         ++ ++
Sbjct: 222 PE-----ILR---GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 86.6 bits (214), Expect = 1e-17
 Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 39/233 (16%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVK 72
            VLGKG+ G V     K   E  AVK   +   ++  DV+  M E  VL    K   + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 73  LLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLV------LEHLTAG 125
           L +  +  +   ++  VME   GG L          Y +Q+               +  G
Sbjct: 407 LHSCFQTMD---RLYFVMEYVNGGDLM---------YHIQQVGRFKEPHAVFYAAEIAIG 454

Query: 126 MKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMSLYGTEEYLH 184
           +  L+   +++RDLK  N+M  +  +G    K+ DFG  +E + +     +  GT +Y+ 
Sbjct: 455 LFFLQSKGIIYRDLKLDNVM--LDSEGHI--KIADFGMCKENIWDGVTTKTFCGTPDYIA 510

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
           P+     ++     + +G +VD W+ GV LY +  G  PF   G   +++ ++
Sbjct: 511 PE-----IIA---YQPYGKSVDWWAFGVLLYEMLAGQAPF--EG--EDEDELF 551

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 26/205 (12%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-----MREFEVLKKVK---HEN 69
           +G GA G V++  + ++G  VA+K+   + +            +RE  +L++++   H N
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVR-VPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 70  IVKLLAI--EEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGM 126
           +V+L+ +      +   KV +V E      L   LD      GL  E    ++     G+
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAETIKDLMRQFLRGL 133

Query: 127 KHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
             L  N +VHRDLKP NI+  +   G    KL DFG AR          +  T  Y  P+
Sbjct: 134 DFLHANCIVHRDLKPENIL--VTSGG--TVKLADFGLARIYSYQMALTPVVVTLWYRAPE 189

Query: 187 MYERAVLRKPVGKTFGATVDLWSIG 211
                VL   +  T+   VD+WS+G
Sbjct: 190 -----VL---LQSTYATPVDMWSVG 206

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 55/214 (25%), Positives = 82/214 (38%), Gaps = 54/214 (25%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-------MREFEVLKKVKHENI 70
           +G+G  G VF+  N+   E VA+K       +R  D         +RE  +LK++KH+NI
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALK------RVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           V+L  +      +   +V E C    L    D       L  E     L  L  G+    
Sbjct: 64  VRLHDVL--HSDKKLTLVFEFCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCH 118

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-------------LY 177
              ++HRDLKP N+   I  +G    KL +FG AR      +  S             L+
Sbjct: 119 SRNVLHRDLKPQNL--LINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 178 GTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIG 211
           G + Y                     ++D+WS G
Sbjct: 175 GAKLY-------------------STSIDMWSAG 189

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 54/213 (25%), Positives = 81/213 (38%), Gaps = 53/213 (24%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ------MREFEVLKKVKHENIV 71
           LG+G    V++G +K     VA+K       +R    +      +RE  +LK +KH NIV
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALK------EIRLEHEEGAPCTAIREVSLLKDLKHANIV 63

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
            L  I      +   +V E      L   LDD  N   +      L L  L  G+ +   
Sbjct: 64  TLHDII--HTEKSLTLVFEYLDK-DLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHR 118

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-------------LYG 178
            +++HRDLKP N++  I + G    KL DFG AR      +                L G
Sbjct: 119 QKVLHRDLKPQNLL--INERG--ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG 174

Query: 179 TEEYLHPDMYERAVLRKPVGKTFGATVDLWSIG 211
           + +Y                      +D+W +G
Sbjct: 175 STDY-------------------STQIDMWGVG 188

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 52/222 (23%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL 73
             LG G  G VF  V+ +  + VA+K   ++    P  V+  +RE ++++++ H+NIVK+
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHDNIVKV 73

Query: 74  LAIEEEQEGRGKV------------IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEH 121
             I      +               IV E      L N+L        L EE   L +  
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVL----EQGPLLEEHARLFMYQ 128

Query: 122 LTAGMKHLRDNRLVHRDLKPGNIM--KFICDDGSTIYKLTDFGAARELEEDQ---QFMSL 176
           L  G+K++    ++HRDLKP N+              K+ DFG AR ++        +S 
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLV-----LKIGDFGLARIMDPHYSHKGHLSE 183

Query: 177 Y-GTEEY------LHPDMYERAVLRKPVGKTFGATVDLWSIG 211
              T+ Y      L P+ Y +A             +D+W+ G
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKA-------------IDMWAAG 212

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 82.9 bits (205), Expect = 4e-17
 Identities = 45/209 (21%), Positives = 86/209 (41%), Gaps = 29/209 (13%)

Query: 18  LGKGATGAVFQGVNKN--NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           +G+G  G V++   K+  + +  A+K               RE  +L+++KH N++ L  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSA-CREIALLRELKHPNVISLQK 85

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL------VLEHLTAGMKHL 129
           +      R   ++ +      L++I+     +   ++   L       +L  +  G+ +L
Sbjct: 86  VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
             N ++HRDLKP NI+           K+ D G AR          L+ +      D+  
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR----------LFNSPLKPLADLDP 194

Query: 190 RAVL---RKP---VG-KTFGATVDLWSIG 211
             V    R P   +G + +   +D+W+IG
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIG 223

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 82.3 bits (204), Expect = 5e-17
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 44/215 (20%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-------MREFEVLKKVKHENI 70
           +G+G  G VF+  ++  G+ VA+K       +   + +       +RE ++L+ +KHEN+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALK------KVLMENEKEGFPITALREIKILQLLKHENV 78

Query: 71  VKLLAI-----EEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
           V L+ I           +G + +V + C    L  +L +          E   V++ L  
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK--FTLSEIKRVMQMLLN 135

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
           G+ ++  N+++HRD+K  N++  I  DG  + KL DFG AR           +   +   
Sbjct: 136 GLYYIHRNKILHRDMKAANVL--ITRDG--VLKLADFGLAR----------AFSLAKNSQ 181

Query: 185 PDMYERAVL----RKP---VG-KTFGATVDLWSIG 211
           P+ Y   V+    R P   +G + +G  +DLW  G
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 82.4 bits (204), Expect = 5e-17
 Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 31/205 (15%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDVQ--MREFEVLKKVKHENIVK 72
             +G GA G V    +      VA+K       +      +   RE  ++K V H+NI+ 
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIIG 88

Query: 73  LLAIEEEQEGRGKV----IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           LL +   Q+   +     IVMEL    +L  ++        L  E    +L  +  G+KH
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME-----LDHERMSYLLYQMLCGIKH 142

Query: 129 LRDNRLVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPD 186
           L    ++HRDLKP NI+ K  C       K+ DFG AR        M+ Y  T  Y  P+
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCT-----LKILDFGLARTAGTS-FMMTPYVVTRYYRAPE 196

Query: 187 MYERAVLRKPVGKTFGATVDLWSIG 211
           +         +G  +   VD+WS+G
Sbjct: 197 VI--------LGMGYKENVDIWSVG 213

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 81.9 bits (203), Expect = 5e-17
 Identities = 46/217 (21%), Positives = 82/217 (37%), Gaps = 35/217 (16%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAI 76
           LG+G    VF+ +N  N E V VK    +   +      RE ++L+ ++   NI+ L  I
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKK----IKREIKILENLRGGPNIITLADI 99

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
            ++   R   +V E         +         L + +    +  +   + +     ++H
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMGIMH 153

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-------GTEEYLHPDMYE 189
           RD+KP N+M    D      +L D+G A       Q  ++        G E  +   MY+
Sbjct: 154 RDVKPHNVM---IDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYD 209

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
            +             +D+WS+G  L  +     PF  
Sbjct: 210 YS-------------LDMWSLGCMLASMIFRKEPFFH 233

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 46/216 (21%), Positives = 84/216 (38%), Gaps = 55/216 (25%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--------MREFEVLKKVKHEN 69
           LG+G    V++  +KN  + VA+K       +              +RE ++L+++ H N
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKI----KLGHRSEAKDGINRTALREIKLLQELSHPN 73

Query: 70  IVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           I+ LL        +  + +V +      L  I+ D      L        +     G+++
Sbjct: 74  IIGLLDAFG---HKSNISLVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEY 127

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS------------- 175
           L  + ++HRDLKP N+   + ++G  + KL DFG A+      +  +             
Sbjct: 128 LHQHWILHRDLKPNNL--LLDENG--VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 176 LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIG 211
           L+G   Y                   G  VD+W++G
Sbjct: 184 LFGARMY-------------------GVGVDMWAVG 200

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 57/215 (26%), Positives = 79/215 (36%), Gaps = 40/215 (18%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK----TFNQLSHMRPHDVQM------REFEVLKKV 65
             +  G+ GAV  GV+   G PVA+K    T +    +             RE  +L   
Sbjct: 28  RFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86

Query: 66  KHENIVKLLAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHL 122
            H NI+ L  I    EE       +V EL     L  ++ D      +  +     + H+
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIV--ISPQHIQYFMYHI 143

Query: 123 TAGMKHLRDNRLVHRDLKPGNI-MKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTE 180
             G+  L +  +VHRDL PGNI +    D       + DF  ARE   D    + Y    
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADNND-----ITICDFNLAREDTAD-ANKTHYVTHR 197

Query: 181 EYLHPDMYERAVLRKP----VGKTFGATVDLWSIG 211
            Y           R P      K F   VD+WS G
Sbjct: 198 WY-----------RAPELVMQFKGFTKLVDMWSAG 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.8 bits (202), Expect = 2e-16
 Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 31/205 (15%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDVQ--MREFEVLKKVKHENIVK 72
             +G GA G V    +      VA+K       +      +   RE  ++K V H+NI+ 
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIIS 125

Query: 73  LLAIEEEQEGRGKV----IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           LL +   Q+   +     +VMEL    +L  ++        L  E    +L  +  G+KH
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME-----LDHERMSYLLYQMLCGIKH 179

Query: 129 LRDNRLVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPD 186
           L    ++HRDLKP NI+ K  C       K+ DFG AR        M+ Y  T  Y  P+
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCT-----LKILDFGLARTAGTS-FMMTPYVVTRYYRAPE 233

Query: 187 MYERAVLRKPVGKTFGATVDLWSIG 211
                V+   +G  +   VD+WS+G
Sbjct: 234 -----VI---LGMGYKENVDIWSVG 250

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 54/216 (25%), Positives = 82/216 (37%), Gaps = 54/216 (25%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ------MREFEVLKKVKHENIV 71
           LG G    V++G+NK  G  VA+K       ++    +      +RE  ++K++KHENIV
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALK------EVKLDSEEGTPSTAIREISLMKELKHENIV 66

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTY---GLQEEEFLLVLEHLTAGMKH 128
           +L  +          +V E      L   +D         GL+          L  G+  
Sbjct: 67  RLYDVI--HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 129 LRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS------------- 175
             +N+++HRDLKP N++  I   G    KL DFG AR         S             
Sbjct: 124 CHENKILHRDLKPQNLL--INKRG--QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179

Query: 176 LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIG 211
           L G+  Y                     ++D+WS G
Sbjct: 180 LMGSRTY-------------------STSIDIWSCG 196

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.2 bits (198), Expect = 3e-16
 Identities = 48/240 (20%), Positives = 88/240 (36%), Gaps = 65/240 (27%)

Query: 15  TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLL 74
              LG G+ G V +  +  +G+  A+K   Q         + RE +++K + H NI+KL+
Sbjct: 12  GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLV 66

Query: 75  AI-----EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFL-LVLEH------- 121
                  +EE +            G +               + ++L +++E+       
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 122 -----------------------LTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKL 158
                                  L   +  +    + HRD+KP N++    +      KL
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL---VNSKDNTLKL 183

Query: 159 TDFGAARELEEDQQFMSLYGTEEYLHPDMYERA--VLRKPVGKTFGAT-----VDLWSIG 211
            DFG+A++L   +  ++   +  Y       RA  ++        GAT     +DLWSIG
Sbjct: 184 CDFGSAKKLIPSEPSVAYICSRFY-------RAPELM-------LGATEYTPSIDLWSIG 229

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 29/205 (14%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +G+GA G V    +  N   VA+K  +   H      Q  +RE ++L + +HENI+ + 
Sbjct: 34  YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGIN 91

Query: 75  AI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
            I      ++ +   IV +L     L+ +L     T  L  +     L  +  G+K++  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDL-METDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHS 146

Query: 132 NRLVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQ---FMSLY-GTEEYLHPD 186
             ++HRDLKP N++    CD      K+ DFG AR  + D     F++ Y  T  Y  P+
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201

Query: 187 MYERAVLRKPVGKTFGATVDLWSIG 211
           +    +L     K +  ++D+WS+G
Sbjct: 202 I----MLN---SKGYTKSIDIWSVG 219

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 46/218 (21%), Positives = 81/218 (37%), Gaps = 58/218 (26%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-------MREFEVLKKVKHENI 70
           LG+G  G V++ ++    E VA+K       +R    +       +RE  +LK+++H NI
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIK------RIRLEHEEEGVPGTAIREVSLLKELQHRNI 95

Query: 71  VKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           ++L ++        ++ ++ E      L   +D       +        L  L  G+   
Sbjct: 96  IELKSVIH---HNHRLHLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFC 148

Query: 130 RDNRLVHRDLKPGNI---MKFICDDGSTIYKLTDFGAARELEEDQQFMS----------- 175
              R +HRDLKP N+   +    +    + K+ DFG AR      +  +           
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETP--VLKIGDFGLARAFGIPIRQFTHEIITLWYRPP 206

Query: 176 --LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIG 211
             L G+  Y                     +VD+WSI 
Sbjct: 207 EILLGSRHY-------------------STSVDIWSIA 225

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.5 bits (194), Expect = 9e-16
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 36/207 (17%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDVQ--MREFEVLKKVKHENIVK 72
           + +G GA G+V   ++K +GE VA+K              +   RE  +LK ++HEN++ 
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHENVIG 87

Query: 73  LLAI----EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           LL +       +      +VM       L  I+          EE+   ++  +  G+K+
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPF-MQTDLQKIMGLK-----FSEEKIQYLVYQMLKGLKY 141

Query: 129 LRDNRLVHRDLKPGNI-MKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPD 186
           +    +VHRDLKPGN+ +   C+      K+ DFG AR  + +   M+ Y  T  Y    
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCE-----LKILDFGLARHADAE---MTGYVVTRWY---- 189

Query: 187 MYERA--VLRKPVGKTFGATVDLWSIG 211
              RA  V+       +  TVD+WS+G
Sbjct: 190 ---RAPEVILSW--MHYNQTVDIWSVG 211

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 57/215 (26%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-------MREFEVLKKVKHENI 70
           +G+G  G V++  N   GE  A+K       +R            +RE  +LK++KH NI
Sbjct: 10  IGEGTYGVVYKAQNNY-GETFALK------KIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 71  VKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           VKL  +      + ++ +V E      L  +LD  E   GL+       L  L  G+ + 
Sbjct: 63  VKLYDVIH---TKKRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYC 116

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-------------L 176
            D R++HRDLKP N++  I  +G    K+ DFG AR      +  +             L
Sbjct: 117 HDRRVLHRDLKPQNLL--INREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 177 YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIG 211
            G+++Y                     T+D+WS+G
Sbjct: 173 MGSKKY-------------------STTIDIWSVG 188

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 34/208 (16%)

Query: 18  LGKGATGAVFQGVN-KNNGEPVAVKTFNQLSHMRPHDVQ-------MREFEVLKKVK--- 66
           +G+GA G VF+  + KN G  VA+K       +R    +       +RE  VL+ ++   
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALK------RVRVQTGEEGMPLSTIREVAVLRHLETFE 72

Query: 67  HENIVKLLAIEEEQEGRGK---VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLT 123
           H N+V+L  +        +    +V E      L   LD      G+  E    ++  L 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP-GVPTETIKDMMFQLL 130

Query: 124 AGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYL 183
            G+  L  +R+VHRDLKP NI+  +   G    KL DFG AR         S+  T  Y 
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNIL--VTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYR 186

Query: 184 HPDMYERAVLRKPVGKTFGATVDLWSIG 211
            P+     VL   +  ++   VDLWS+G
Sbjct: 187 APE-----VL---LQSSYATPVDLWSVG 206

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 36/213 (16%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL 73
           S+LG+GA G V    +K  GE VA+K         P      +RE ++LK  KHENI+ +
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHENIITI 74

Query: 74  LAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
             I   +  +      I+ EL     L  ++    +T  L ++     +      +K L 
Sbjct: 75  FNIQRPDSFENFNEVYIIQEL-MQTDLHRVI----STQMLSDDHIQYFIYQTLRAVKVLH 129

Query: 131 DNRLVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
            + ++HRDLKP N++    CD      K+ DFG AR ++E     S    ++     M E
Sbjct: 130 GSNVIHRDLKPSNLLINSNCD-----LKVCDFGLARIIDESAADNSEPTGQQ---SGMVE 181

Query: 190 -------RAVLRKP----VGKTFGATVDLWSIG 211
                  RA    P        +   +D+WS G
Sbjct: 182 FVATRWYRA----PEVMLTSAKYSRAMDVWSCG 210

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 78.3 bits (193), Expect = 2e-15
 Identities = 48/222 (21%), Positives = 88/222 (39%), Gaps = 37/222 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL 73
           ++G G+ G V +  +K     VA+K            D +  +RE  +L ++ H+++VK+
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED--LIDCKRILREIAILNRLNHDHVVKV 117

Query: 74  LAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           L I   ++ ++     +V+E+        +   P     L E     +L +L  G+K++ 
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVY---LTELHIKTLLYNLLVGVKYVH 173

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              ++HRDLKP N +  +  D S   K+ DFG AR ++  +   S               
Sbjct: 174 SAGILHRDLKPANCL--VNQDCSV--KVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229

Query: 191 AVLRKPVGKTF---------------------GATVDLWSIG 211
               K + +                          +D+WSIG
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 57/215 (26%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-------MREFEVLKKVKHENI 70
           +G+G  G V++  +   G  VA+K       +R            +RE  +LK++ H NI
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALK------RIRLDAEDEGIPSTAIREISLLKELHHPNI 81

Query: 71  VKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           V L+ +         + +V E      L  +LD+ +   GLQ+ +  + L  L  G+ H 
Sbjct: 82  VSLIDVIH---SERCLTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHC 135

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS-------------L 176
             +R++HRDLKP N+   I  DG    KL DFG AR      +  +             L
Sbjct: 136 HQHRILHRDLKPQNL--LINSDG--ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191

Query: 177 YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIG 211
            G+++Y                     +VD+WSIG
Sbjct: 192 MGSKKY-------------------STSVDIWSIG 207

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 49/212 (23%), Positives = 83/212 (39%), Gaps = 39/212 (18%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVK-TFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLL 74
           + G+G  G V  G  K+ G  VA+K          R    +++  + L  + H NIV+L 
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR----ELQIMQDLAVLHHPNIVQLQ 85

Query: 75  AIEEEQEGRGK-----VIVMELCTGGSLFNILDD-PENTYGLQEEEFLLVLEHLTAGMK- 127
           +       R +      +VME     +L     +              + L  L   +  
Sbjct: 86  SYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144

Query: 128 -HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD 186
            HL    + HRD+KP N++    ++     KL DFG+A++L   +  ++   +  Y    
Sbjct: 145 LHLPSVNVCHRDIKPHNVL---VNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY---- 197

Query: 187 MYERA--VLRKPVGKTFGAT-----VDLWSIG 211
              RA  ++       FG       VD+WS+G
Sbjct: 198 ---RAPELI-------FGNQHYTTAVDIWSVG 219

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 77.9 bits (192), Expect = 3e-15
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 34/218 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKL 73
           ++G+G+ G V+   +KN  + VA+K            D +  +RE  +L ++K + I++L
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED--LIDCKRILREITILNRLKSDYIIRL 90

Query: 74  LAI---EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
             +   ++  +     IV+E+     L  +   P     L EE    +L +L  G   + 
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIF---LTEEHIKTILYNLLLGENFIH 146

Query: 131 DNRLVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
           ++ ++HRDLKP N +    C       K+ DFG AR +  ++    +   EE   P  + 
Sbjct: 147 ESGIIHRDLKPANCLLNQDCS-----VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201

Query: 190 RAVL------------RKP----VGKTFGATVDLWSIG 211
           + +             R P    + + +  ++D+WS G
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.4 bits (186), Expect = 9e-15
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 39/209 (18%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDVQ--MREFEVLKKVKHENIVK 72
             +G GA GAV   V+   G  VA+K  +           +   RE  +LK ++HEN++ 
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHENVIG 88

Query: 73  LLAIEEEQEGRGKV----IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKH 128
           LL +    E         +VM    G  L  ++        L E+    ++  +  G+++
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPF-MGTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRY 143

Query: 129 LRDNRLVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPD 186
           +    ++HRDLKPGN+     C+      K+ DFG AR+ + +   M+ Y  T  Y    
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCE-----LKILDFGLARQADSE---MTGYVVTRWY---- 191

Query: 187 MYERAVLRKP----VGKTFGATVDLWSIG 211
                  R P        +  TVD+WS+G
Sbjct: 192 -------RAPEVILNWMRYTQTVDIWSVG 213

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 72.8 bits (179), Expect = 8e-14
 Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 41/210 (19%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM------REFEVLKKVKHEN 69
           S +G GA G+V    +   G  VAVK        RP    +      RE  +LK +KHEN
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVK-----KLSRPFQSIIHAKRTYRELRLLKHMKHEN 89

Query: 70  IVKLLAIEEEQEGRGKV----IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
           ++ LL +        +     +V  L  G  L NI+        L ++    ++  +  G
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIV----KCQKLTDDHVQFLIYQILRG 144

Query: 126 MKHLRDNRLVHRDLKPGNIM-KFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYL 183
           +K++    ++HRDLKP N+     C+      K+ DFG AR   +    M+ Y  T  Y 
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCE-----LKILDFGLARHTAD---EMTGYVATRWY- 195

Query: 184 HPDMYERA--VLRKPVGKTFGATVDLWSIG 211
                 RA  ++       +  TVD+WS+G
Sbjct: 196 ------RAPEIMLNW--MHYNQTVDIWSVG 217

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 52/235 (22%), Positives = 97/235 (41%), Gaps = 37/235 (15%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE------N 69
            V+GKG+ G V +  +    + VA+K     +  R H     E  +L+ ++ +      N
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTMN 160

Query: 70  IVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTY-GLQEEEFLLVLEHLTAGMK 127
           ++ +L   E    R  + +  EL    +L+ ++   +N + G            +   + 
Sbjct: 161 VIHML---ENFTFRNHICMTFELL-SMNLYELIK--KNKFQGFSLPLVRKFAHSILQCLD 214

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
            L  NR++H DLKP NI+  +   G +  K+ DFG++    E Q+  +   +  Y     
Sbjct: 215 ALHKNRIIHCDLKPENIL--LKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRFY----- 265

Query: 188 YERAVLRKP---VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                 R P   +G  +G  +D+WS+G  L  + TG        G    + +  +
Sbjct: 266 ------RAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP---GEDEGDQLACM 311

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 56/237 (23%), Positives = 103/237 (43%), Gaps = 26/237 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH-ENIVKLLAI 76
           +G G+ G ++ G +   GE VA+K          H     E ++ K ++    I  +   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIK---LECVKTKHPQLHIESKIYKMMQGGVGIPTI--R 71

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
               EG   V+VMEL  G SL ++ +     + L+    LL+ + + + ++++     +H
Sbjct: 72  WCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLK--TVLLLADQMISRIEYIHSKNFIH 128

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM--------SLYGTEEYLHPDMY 188
           RD+KP N +  +   G+ +Y + DFG A++  + +           +L GT  Y      
Sbjct: 129 RDVKPDNFLMGLGKKGNLVY-IIDFGLAKKYRDARTHQHIPYRENKNLTGTARY------ 181

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS 245
             A +   +G       DL S+G  L +   G+LP++       ++    I+ KK S
Sbjct: 182 --ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 32/216 (14%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK-TFNQLSHMRPHDVQ--MREFEVLKKVK-HENIV 71
             LGKGA G V++ +++  GE VAVK  F+   +    D Q   RE  +L ++  HENIV
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMILTELSGHENIV 72

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
            LL +      R   +V +      L  ++        L+      V+  L   +K+L  
Sbjct: 73  NLLNVLRADNDRDVYLVFDYM-ETDLHAVI----RANILEPVHKQYVVYQLIKVIKYLHS 127

Query: 132 NRLVHRDLKPGNI-MKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
             L+HRD+KP NI +   C       K+ DFG +R     ++  +        + + ++ 
Sbjct: 128 GGLLHRDMKPSNILLNAECH-----VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182

Query: 191 AVL-----------RKP----VGKTFGATVDLWSIG 211
                         R P        +   +D+WS+G
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 49/231 (21%), Positives = 87/231 (37%), Gaps = 38/231 (16%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK--------- 66
             LG G    V+   +  N   VA+K                E ++L++V          
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA--EDEIKLLQRVNDADNTKEDS 82

Query: 67  --HENIVKLLAIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTY-GLQEEEFLLVLEH 121
               +I+KLL     +   G   V+V E+  G +L  ++   +  + G+       + + 
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIK--KYEHRGIPLIYVKQISKQ 139

Query: 122 LTAGMKHL-RDNRLVHRDLKPGNIMKFICDD--GSTIYKLTDFGAARELEEDQQFMSLYG 178
           L  G+ ++ R   ++H D+KP N++  I D        K+ D G A   +E         
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT------ 193

Query: 179 TEEYLHPDMYERAVLRKP---VGKTFGATVDLWSIGVTLYHVATGNLPFRP 226
               +    Y     R P   +G  +G   D+WS    ++ + TG+  F P
Sbjct: 194 --NSIQTREY-----RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 52/237 (21%), Positives = 99/237 (41%), Gaps = 26/237 (10%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAI 76
           +G G+ G ++ G N    E VA+K     +    H   + E ++ + ++    I  +   
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKIYRILQGGTGIPNV--R 69

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
               EG   V+VM+L  G SL ++ +       L  +  L++ + +   ++ +     +H
Sbjct: 70  WFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLH 126

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM--------SLYGTEEYLHPDMY 188
           RD+KP N +  +    + +Y + DFG A++  +             +L GT  Y      
Sbjct: 127 RDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY------ 179

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS 245
             A +   +G       DL S+G  L +   G+LP++       K+    I+ KK +
Sbjct: 180 --ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 54/239 (22%), Positives = 99/239 (41%), Gaps = 28/239 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH-ENIVKLLAI 76
           +G+G+ G +F+G N  N + VA+K                E+   K +     I  +   
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAPQLRDEYRTYKLLAGCTGIPNV--Y 72

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              QEG   V+V++L  G SL ++LD     + +  +   +  + + A ++ + +  LV+
Sbjct: 73  YFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIHEKSLVY 129

Query: 137 RDLKPGNIM--KFICDDGSTIYKLTDFGAARELEEDQQFM--------SLYGTEEYLHPD 186
           RD+KP N +  +    + + IY + DFG  +   +             +L GT  Y    
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY---- 184

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS 245
                 +   +G+      DL ++G    +   G+LP++      NK+    I  KK S
Sbjct: 185 ----MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 66.7 bits (163), Expect = 7e-12
 Identities = 53/238 (22%), Positives = 96/238 (40%), Gaps = 39/238 (16%)

Query: 15  TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE------ 68
            S++GKG+ G V +  ++   E VA+K           +    E  +L+ +         
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDTEMKY 116

Query: 69  NIVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTY-GLQEEEFLLVLEHLTAGM 126
            IV L         R  + +V E+    +L+++L      + G+         + +   +
Sbjct: 117 YIVHLK---RHFMFRNHLCLVFEML-SYNLYDLLR--NTNFRGVSLNLTRKFAQQMCTAL 170

Query: 127 KHLRDNRL--VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
             L    L  +H DLKP NI+  +C+   +  K+ DFG++ +L +      +Y   +Y+ 
Sbjct: 171 LFLATPELSIIHCDLKPENIL--LCNPKRSAIKIVDFGSSCQLGQR-----IY---QYIQ 220

Query: 185 PDMYERAVLRKP---VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
              Y     R P   +G  +   +D+WS+G  L  + TG   F    G    + M  I
Sbjct: 221 SRFY-----RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS---GANEVDQMNKI 270

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 53/239 (22%), Positives = 95/239 (39%), Gaps = 28/239 (11%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH-ENIVKLLAI 76
           +G G  G +  G N    E VA+K                E+   K++   + I ++   
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYRFYKQLGSGDGIPQV--Y 71

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
                G+   +V+EL  G SL ++ D  + T+ L  +  L++   L + M+++    L++
Sbjct: 72  YFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHSKNLIY 128

Query: 137 RDLKPGNIM--KFICDDGSTIYKLTDFGAARELEEDQQFM--------SLYGTEEYLHPD 186
           RD+KP N +  +        I+ + DF  A+E  + +           SL GT  Y    
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIH-IIDFALAKEYIDPETKKHIPYREHKSLTGTARY---- 183

Query: 187 MYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS 245
                 +   +GK      DL ++G    +   G+LP++       KE    I   K +
Sbjct: 184 ----MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 64.5 bits (158), Expect = 2e-11
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 49/233 (21%)

Query: 7   STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREF--EV- 61
               +    + +G+G  G V++G    N   VAVK   +L+ M     +   ++F  E+ 
Sbjct: 28  DERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVK---KLAAMVDITTEELKQQFDQEIK 82

Query: 62  -LKKVKHENIVKLLA--IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLV 118
            + K +HEN+V+LL    + +       +V      GSL + L   + T  L       +
Sbjct: 83  VMAKCQHENLVELLGFSSDGDD----LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI 138

Query: 119 LEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ------ 172
            +    G+  L +N  +HRD+K  NI+     D +   K++DFG AR  E+  Q      
Sbjct: 139 AQGAANGINFLHENHHIHRDIKSANILL----DEAFTAKISDFGLARASEKFAQTVMTSR 194

Query: 173 FMSLYGTE-----EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG 220
            +   GT      E L  ++  ++              D++S GV L  + TG
Sbjct: 195 IV---GTTAYMAPEALRGEITPKS--------------DIYSFGVVLLEIITG 230

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 54/270 (20%), Positives = 90/270 (33%), Gaps = 74/270 (27%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK--------HEN 69
           LG G    V+   +    + VA+K      H       + E  +LK V+         E 
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA--LDEIRLLKSVRNSDPNDPNREM 102

Query: 70  IVKLLAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
           +V+LL   +     G    +V E+  G  L   +    N  GL       +++ +  G+ 
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLD 160

Query: 128 HL-RDNRLVHRDLKPGNIM---------------------KFICDDGSTIY--------- 156
           +L    R++H D+KP NI+                           GS +          
Sbjct: 161 YLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220

Query: 157 ---------------KLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA--VLRKPVGK 199
                          K+ D G A  + +           E +    Y R+  VL   +G 
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHFT--------EDIQTRQY-RSLEVL---IGS 268

Query: 200 TFGATVDLWSIGVTLYHVATGNLPFRPYGG 229
            +    D+WS     + +ATG+  F P+ G
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSG 298

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 56.9 bits (138), Expect = 8e-09
 Identities = 62/255 (24%), Positives = 96/255 (37%), Gaps = 55/255 (21%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE-----NI 70
             +G G  G V    + +N +  AVK    +           E ++LKK++++     NI
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY--TRSAKIEADILKKIQNDDINNNNI 98

Query: 71  VKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTY-GLQEEEFLLVLEHLTAGMKH 128
           VK      +      + ++ E   G SL+ I+    N Y G   E+  L    +   + +
Sbjct: 99  VKYH---GKFMYYDHMCLIFEPL-GPSLYEIIT--RNNYNGFHIEDIKLYCIEILKALNY 152

Query: 129 LRDNRLVHRDLKPGNIM---------------------KFICDDGSTIYKLTDFGAAREL 167
           LR   L H DLKP NI+                       I    ST  KL DFG A   
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--T 210

Query: 168 EEDQQFMSLYGTEEYLHPDMYERA---VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
            +     S+  T +Y       RA   +L       +  + D+WS G  L  + TG+L F
Sbjct: 211 FKSDYHGSIINTRQY-------RAPEVIL----NLGWDVSSDMWSFGCVLAELYTGSLLF 259

Query: 225 RPYGGRRNKETMYYI 239
           R      + E +  +
Sbjct: 260 R---THEHMEHLAMM 271

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 54/251 (21%), Positives = 90/251 (35%), Gaps = 51/251 (20%)

Query: 16  SVLGKGATGAVFQGV-NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE------ 68
             LG+G  G V + + +      VA+K    +      +    E  VLKK+K +      
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY--REAARLEINVLKKIKEKDKENKF 82

Query: 69  NIVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTY-GLQEEEFLLVLEHLTAGM 126
             V +    +     G + I  EL  G + F  L   EN +          +   L   +
Sbjct: 83  LCVLMS---DWFNFHGHMCIAFELL-GKNTFEFLK--ENNFQPYPLPHVRHMAYQLCHAL 136

Query: 127 KHLRDNRLVHRDLKPGNIM---------------KFICDDGSTIYKLTDFGAARELEEDQ 171
           + L +N+L H DLKP NI+                      +T  ++ DFG+A    + +
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHE 194

Query: 172 QFMSLYGTEEYLHPDMYERA---VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
              ++  T  Y       R    +L       +    D+WSIG  L+    G   F+   
Sbjct: 195 HHTTIVATRHY-------RPPEVIL----ELGWAQPCDVWSIGCILFEYYRGFTLFQ--- 240

Query: 229 GRRNKETMYYI 239
              N+E +  +
Sbjct: 241 THENREHLVMM 251

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 60/252 (23%), Positives = 94/252 (37%), Gaps = 53/252 (21%)

Query: 16  SVLGKGATGAVFQGVN-KNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE------ 68
             LG+GA G V + ++ K  G  VAVK    +      +    E +VL+ +         
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY--CEAARSEIQVLEHLNTTDPNSTF 77

Query: 69  NIVKLLAIEEEQEGRGKV-IVMELCTGGSLFNILDDPENTY-GLQEEEFLLVLEHLTAGM 126
             V++L   E  E  G + IV EL  G S ++ +   EN +   + +    +   +   +
Sbjct: 78  RCVQML---EWFEHHGHICIVFELL-GLSTYDFIK--ENGFLPFRLDHIRKMAYQICKSV 131

Query: 127 KHLRDNRLVHRDLKPGNIM---------------KFICDDGSTIYKLTDFGAARELEEDQ 171
             L  N+L H DLKP NI+               +      +   K+ DFG+A     D 
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA---TYDD 188

Query: 172 QFMSLY-GTEEYLHPDMYERA---VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
           +  S    T  Y       RA   +L       +    D+WSIG  L     G   F   
Sbjct: 189 EHHSTLVSTRHY-------RAPEVIL----ALGWSQPCDVWSIGCILIEYYLGFTVFP-- 235

Query: 228 GGRRNKETMYYI 239
               +KE +  +
Sbjct: 236 -THDSKEHLAMM 246

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 54.5 bits (132), Expect = 5e-08
 Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 54/226 (23%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREF----EVLKKVKHENI 70
            ++G G  G V++GV   +G  VA+K     S       Q + EF    E L   +H ++
Sbjct: 45  FLIGHGVFGKVYKGV-LRDGAKVALKRRTPESS------QGIEEFETEIETLSFCRHPHL 97

Query: 71  VKLLA--IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLL--------VLE 120
           V L+    E  +     +++ +    G+L   L      YG       +         + 
Sbjct: 98  VSLIGFCDERNE----MILIYKYMENGNLKRHL------YGSDLPTMSMSWEQRLEICIG 147

Query: 121 HLTA-GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE-LEEDQQFMS--L 176
              A G+ +L    ++HRD+K  NI+     D + + K+TDFG +++  E DQ  +S  +
Sbjct: 148 --AARGLHYLHTRAIIHRDVKSINILL----DENFVPKITDFGISKKGTELDQTHLSTVV 201

Query: 177 YGTEEYLHPDMYERAVLRKPVGKTFGATV--DLWSIGVTLYHVATG 220
            GT  Y+ P+ + +  L          T   D++S GV L+ V   
Sbjct: 202 KGTLGYIDPEYFIKGRL----------TEKSDVYSFGVVLFEVLCA 237

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 58/299 (19%), Positives = 94/299 (31%), Gaps = 94/299 (31%)

Query: 17  VLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENI 70
            LG+GA G V +              VAVK   + +    H   M E ++L  +  H N+
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNIL------DDPENTYGLQEEEFLLVLEHLTA 124
           V LL    +  G   VI +E C  G+L   L        P  T G +  +    +  +  
Sbjct: 89  VNLLGACTKPGGPLMVI-VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147

Query: 125 GMK---------------------------------HLRDNRLVHRDL-----KPGNIMK 146
            +K                                  L  + L    L     +    M+
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207

Query: 147 F---------------ICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
           F               I      + K+ DFG AR++ +D                 Y R 
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD---------------PDYVRK 252

Query: 192 VLRK-PV---------GKTFGATVDLWSIGVTLYHVATGNLPFRPY-GGRRNKETMYYI 239
              + P+          + +    D+WS GV L+ + +  L   PY G + ++E    +
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--LGASPYPGVKIDEEFCRRL 309

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 45/266 (16%), Positives = 76/266 (28%), Gaps = 64/266 (24%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV-----------LKKVK 66
           +G G  G ++     N  E  A      +  +   +      E+           +KK  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARH----VVKVEYQENGPLFSELKFYQRVAKKDCIKKWI 100

Query: 67  HENIVKLLAI--------EEEQEGRGKVIVMELCTGGSLFNILDD----PENTYGLQEEE 114
               +  L I         E +    + +VME   G  L  I        ++T       
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIR 159

Query: 115 FLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM 174
            L VLE++     H  +N  VH D+K  N++     +   +Y L D+G +     +    
Sbjct: 160 MLDVLEYI-----H--ENEYVHGDIKAANLL-LGYKNPDQVY-LADYGLSYRYCPNGNHK 210

Query: 175 --------SLYGTEEY----LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNL 222
                      GT E+     H             G       D+  +G  +     G L
Sbjct: 211 QYQENPRKGHNGTIEFTSLDAH------------KGVALSRRSDVEILGYCMLRWLCGKL 258

Query: 223 PFRPYGGRRN---KETMYYITTKKAS 245
           P+                 +     S
Sbjct: 259 PWEQNLKDPVAVQTAKTNLLDELPQS 284

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 41/257 (15%), Positives = 75/257 (29%), Gaps = 46/257 (17%)

Query: 18  LGKGATGAVFQGVNKNNG--------EPVAVK--------TFNQLSHMRPHDV-QMREFE 60
             +   G +++    +          +  ++K           Q    R     Q+ +++
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 61  VLKKVKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLE 120
            L       I   +      + + + +V+    G SL + LD     + L E   L V  
Sbjct: 110 KLYSTPLLAIPTCMGFGV-HQDKYRFLVLPSL-GRSLQSALDV-SPKHVLSERSVLQVAC 166

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM------ 174
            L   ++ L +N  VH ++   NI     +D S +  L  +G A       + +      
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIF-VDPEDQSQVT-LAGYGFAFRYCPSGKHVAYVEGS 224

Query: 175 --SLYGTEEY----LHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG 228
                G  E+    LH             G       DL S+G  +     G LP+    
Sbjct: 225 RSPHEGDLEFISMDLH------------KGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272

Query: 229 GRRNKETMYYITTKKAS 245
                            
Sbjct: 273 PNTEDIMKQKQKFVDKP 289

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 50.7 bits (122), Expect = 8e-07
 Identities = 53/242 (21%), Positives = 98/242 (40%), Gaps = 60/242 (24%)

Query: 4   LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM--REF-- 59
           L+ +++  +   ++LG+G  G V++G   + G  VAVK   +L   R    Q    +F  
Sbjct: 25  LQVASDN-FSNKNILGRGGFGKVYKGRLAD-GTLVAVK---RLKEER---TQGGELQFQT 76

Query: 60  --EVLKKVKHENIVKLLA--IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEF 115
             E++    H N+++L    +   +    +++V      GS+ + L          E + 
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTE----RLLVYPYMANGSVASCL------RERPESQP 126

Query: 116 LL--------------VLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTD 160
            L               L +L     H   + +++HRD+K  NI+     D      + D
Sbjct: 127 PLDWPKRQRIALGSARGLAYL-----HDHCDPKIIHRDVKAANILL----DEEFEAVVGD 177

Query: 161 FGAARELEEDQQFMS--LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVA 218
           FG A+ ++     ++  + GT  ++ P   E     K   KT     D++  GV L  + 
Sbjct: 178 FGLAKLMDYKDTHVTTAVRGTIGHIAP---EYLSTGKSSEKT-----DVFGYGVMLLELI 229

Query: 219 TG 220
           TG
Sbjct: 230 TG 231

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.5 bits (113), Expect = 9e-06
 Identities = 41/258 (15%), Positives = 85/258 (32%), Gaps = 48/258 (18%)

Query: 18  LGKGATGAVFQGVNKNN-----GEPVAVKTFN----QLSH------MRPHDVQMREFEVL 62
           +G+G  G ++     ++       P  VK        L              Q++++   
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 63  KKVKHENIVKLLA--IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQ-----EEEF 115
           +K+K+  + K     + ++     + ++M+   G  L  I +     +  +         
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 116 LLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM- 174
           L +LE++     H  ++  VH D+K  N++     +   +Y L D+G A     +     
Sbjct: 162 LDILEYI-----H--EHEYVHGDIKASNLL-LNYKNPDQVY-LVDYGLAYRYCPEGVHKA 212

Query: 175 -------SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
                     GT E+          +    G       DL  +G  +    TG+LP+   
Sbjct: 213 YAADPKRCHDGTIEF--------TSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264

Query: 228 GGRRNKETMYYITTKKAS 245
                      I  ++  
Sbjct: 265 LKDPKYVRDSKIRYRENI 282

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 44.9 bits (105), Expect = 5e-05
 Identities = 35/186 (18%), Positives = 59/186 (31%), Gaps = 51/186 (27%)

Query: 18  LGKGATGAVFQGVNKNNGEPVAVK-------TFNQLSHMRPHDVQMREFEVLKKV----- 65
           +G+G  G VFQ +      PVA+K            SH +  +  + E  + K++     
Sbjct: 28  IGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 66  ----KHENIVKLLAIEEEQEGRGKV----------------------------IVMELCT 93
               + E  + L ++   Q     +                            IV+E   
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 94  GGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDG 152
           GG     +    ++          +L  LTA +     + R  HRDL  GN++       
Sbjct: 146 GGIDLEQMRTKLSS----LATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK 201

Query: 153 STIYKL 158
              Y L
Sbjct: 202 KLHYTL 207

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	708
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.61
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.15
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.01
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.95
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.92
4efo_A	94	Serine/threonine-protein kinase TBK1; ubiquitin li	98.75
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.62
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.27
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.24
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.99
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.89
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.84
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.7
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.61
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.1
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.71
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.48
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.42
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.42
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.39
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.22
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.97
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.68
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.52
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.34
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.09
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	94.64
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.52
3mes_A	424	Choline kinase; malaria, structural genomics, stru	92.45
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	81.27

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-55  Score=483.58  Aligned_cols=369  Identities=55%  Similarity=0.991  Sum_probs=333.4

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      +..+.+|.+.+.||+|+||.||+|.+..+|+.||||+++........+.+.+|++++++++||||+++++++...+....
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            45688999999999999999999999999999999999865555556677899999999999999999999988776679


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|||||+||+|.+++.......++++..++.++.||+.||.|||++||+||||||+|||+...+++.+.+||+|||+|.
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999999998765555699999999999999999999999999999999999987777888899999999999


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC-CChhhHHHHHHhccc
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g-~~~~e~~~~i~~~~~  244 (708)
                      ............||+.|+|||++.........+..++.++|||||||++|+|+||..||.+..+ ....+.+..+....+
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            8877777777889999999999975433322235678899999999999999999999987655 667888999999999


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccccc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCI  324 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~~  324 (708)
                      ...+.+......+.+.|...+|..+.++..++..+.++|++||+.||++||++++++..+.+++.+++.|++........
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~~~~~~~~~~~~~  324 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAH  324 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEEEEEEETTTTEEE
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceEEEEEEeccceEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcccHHHHHHHHHhhcCCCccceEEEeeCCcccc-------cCCCCCCCCCC
Q psy15481        325 RIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFSH-------IFPSSHQKNPS  374 (708)
Q Consensus       325 ~~~i~~~e~~~~l~~~i~~~t~i~~~~q~~~~~~~~~~~-------~~~~~~~~~p~  374 (708)
                      .+++++.++...+++.+..++++.++.|.++++++.+.+       .|+.+++.+|+
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~t~i~~~~q~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (396)
T 4eut_A          325 KIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPI  381 (396)
T ss_dssp             EEEECTTCBHHHHHHHHHHHHCCCSTTEEEESSSSEECCCSSCBTTSSCCCCSSSCE
T ss_pred             EEEcCchhHHHHHHHHHHHhcCCChhhhHHHhcCCCCCCCCCCccccCCCCCCCCCe
Confidence            999999999999999999999999999999999866632       88888888884

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.7e-53  Score=456.99  Aligned_cols=263  Identities=24%  Similarity=0.382  Sum_probs=221.4

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ++....|.+.+.||+|+||.||+|.++.+|+.||||+++.... ...+.+.+|+.++++++|||||++++++.+.+  .+
T Consensus        70 ~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~  146 (346)
T 4fih_A           70 GDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--EL  146 (346)
T ss_dssp             SCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred             CChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EE
Confidence            3444679999999999999999999999999999999975443 23455679999999999999999999998755  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |||||||+||+|.+++...    .+++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|+
T Consensus       147 ~ivmEy~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----~~~g~vKl~DFGla~  218 (346)
T 4fih_A          147 WVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL----THDGRVKLSDFGFCA  218 (346)
T ss_dssp             EEEECCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE----CCCCCEEEecCcCce
Confidence            9999999999999999753    39999999999999999999999999999999999998    667789999999998


Q ss_pred             ccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .+... ....+.+||+.|||||++.        +..|+.++|||||||++|||+||.+||.   +.+..+.+..+....+
T Consensus       219 ~~~~~~~~~~~~~GTp~YmAPEvl~--------~~~y~~~~DiWSlGvilyeml~G~~PF~---~~~~~~~~~~i~~~~~  287 (346)
T 4fih_A          219 QVSKEVPRRKSLVGTPYWMAPELIS--------RLPYGPEVDIWSLGIMVIEMVDGEPPYF---NEPPLKAMKMIRDNLP  287 (346)
T ss_dssp             ECCSSSCCBCCCCSCGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCTTT---TSCHHHHHHHHHHSSC
T ss_pred             ecCCCCCcccccccCcCcCCHHHHC--------CCCCCcHHHHHHHHHHHHHHHHCCCCCC---CcCHHHHHHHHHcCCC
Confidence            76544 3456789999999999987        6789999999999999999999999997   4566666666654311


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcccc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQC  323 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~  323 (708)
                      +                  .++.+..+|++    +.+||.+||..||++|||++++           +.|||+......
T Consensus       288 ~------------------~~~~~~~~s~~----~~dli~~~L~~dP~~R~ta~e~-----------l~Hp~~~~~~~p  333 (346)
T 4fih_A          288 P------------------RLKNLHKVSPS----LKGFLDRLLVRDPAQRATAAEL-----------LKHPFLAKAGPP  333 (346)
T ss_dssp             C------------------CCSCGGGSCHH----HHHHHHHHSCSSTTTSCCHHHH-----------TTCGGGGGCCCG
T ss_pred             C------------------CCCccccCCHH----HHHHHHHHcCCChhHCcCHHHH-----------hcCHhhcCCCCC
Confidence            1                  22333345554    4559999999999999999997           779999765443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-52  Score=452.05  Aligned_cols=263  Identities=24%  Similarity=0.272  Sum_probs=218.4

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|+++.+|+.||||+++....      ..+|+.++++++|||||++++++.+.+  .+||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~--~~~ivm  129 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGP--WVNIFM  129 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEE
Confidence            468899999999999999999999999999999975432      137999999999999999999998754  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCc-eEEEeccCcccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST-IYKLTDFGAARELE  168 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~-~vKL~DFGlA~~~~  168 (708)
                      |||+||+|.+++....   .+++..++.++.||+.||.|||++|||||||||+|||+    +..+ .+||+|||+|+...
T Consensus       130 Ey~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL----SSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             CCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE----CTTSCCEEECCCTTCEEC-
T ss_pred             eccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE----eCCCCEEEEeeCCCCeEcc
Confidence            9999999999997643   39999999999999999999999999999999999998    5544 59999999998765


Q ss_pred             cccc------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        169 EDQQ------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       169 ~~~~------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .+..      ....+||+.|||||++.        +..|+.++|||||||++|+|+||++||..   .+..+.+.++...
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~--------~~~y~~~~DiwSlGvilyemltG~~Pf~~---~~~~~~~~~i~~~  271 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVM--------GKPCDAKVDIWSSCCMMLHMLNGCHPWTQ---YFRGPLCLKIASE  271 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSSCSSTT---TCCSCCHHHHHHS
T ss_pred             CCCcccceecCCccccCccccCHHHHC--------CCCCCcHHHHHHHHHHHHHHHHCcCCCCC---CCHHHHHHHHHcC
Confidence            4421      22357999999999997        78899999999999999999999999973   4455566666653


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh--hhcCcccCCc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR--KLVHLFHINR  320 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~--~l~h~~~~~~  320 (708)
                      .+                      ....+++.++..+.++|.+||+.||.+|||+.+++.++...+..  .+.|||....
T Consensus       272 ~~----------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          272 PP----------------------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             CC----------------------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             CC----------------------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            21                      11123334455666799999999999999999999999888875  4789998553

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.5e-53  Score=450.82  Aligned_cols=259  Identities=22%  Similarity=0.353  Sum_probs=217.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|+++.+|+.||||++++..  .......+.+|++++++++|||||++++++.+.+  .+|||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~yiv  110 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE--KLYFG  110 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEE
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEEEE
Confidence            4999999999999999999999999999999997532  1233456679999999999999999999998754  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||+||+|.+++.....   +++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|+.+.
T Consensus       111 mEy~~gG~L~~~i~~~~~---l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl----~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL----NEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE----cCCCCEEEEEcCCceecC
Confidence            999999999999976433   9999999999999999999999999999999999998    677789999999998765


Q ss_pred             cc---ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 ED---QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~---~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ..   ....+.+||+.|||||++.        +..|+.++|||||||++|+|+||++||.   +.+..+++.++..... 
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPEvl~--------~~~y~~~~DiWSlGvilyeml~G~~PF~---~~~~~~~~~~i~~~~~-  251 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPELLT--------EKSACKSSDLWALGCIIYQLVAGLPPFR---AGNEGLIFAKIIKLEY-  251 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHHHHH--------HSCBCHHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHTCC-
T ss_pred             CCCCcccccCcccCcccCCHHHHc--------CCCCCcHHHHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHcCCC-
Confidence            33   2345679999999999998        6789999999999999999999999997   4666777777765321 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                        .+|  ..+|++    +.+||.+||++||++|||++|+...     .+-..||||..
T Consensus       252 ------------------~~p--~~~s~~----~~dli~~lL~~dp~~R~t~~e~~~~-----~~i~~Hp~F~~  296 (311)
T 4aw0_A          252 ------------------DFP--EKFFPK----ARDLVEKLLVLDATKRLGCEEMEGY-----GPLKAHPFFES  296 (311)
T ss_dssp             ------------------CCC--TTCCHH----HHHHHHHHSCSSGGGSTTSGGGTCH-----HHHHTSGGGTT
T ss_pred             ------------------CCC--cccCHH----HHHHHHHHccCCHhHCcChHHHcCC-----HHHHCCCCcCC
Confidence                              122  234554    4569999999999999999985432     12357999854

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.5e-53  Score=456.06  Aligned_cols=258  Identities=26%  Similarity=0.428  Sum_probs=211.6

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|.+.+.||+|+||.||+|+++.+|+.||||+++..... ...+.+.+|+.++++|+|||||++++++.+.+  .+||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~--~~yiVm  102 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG--SLYIVM  102 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC--EEEEEE
Confidence            799999999999999999999999999999999765332 22345679999999999999999999998754  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||+||+|.+++..... ..+++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|+....
T Consensus       103 Ey~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL----TKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE----CTTCCEEECSTTEESCCCH
T ss_pred             eCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE----CCCCCEEEcccccceeecC
Confidence            99999999999965332 237999999999999999999999999999999999998    6667899999999998765


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .. ...+.+||+.|||||++.        +..|+.++|||||||++|+|+||++||.   +.+..+.+.++.....+   
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~--------~~~y~~~~DiwSlGvilyemltG~~PF~---~~~~~~~~~~i~~~~~~---  243 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICE--------NKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLVLKIISGSFP---  243 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHHHHTCCC---
T ss_pred             CcccccccCCCccccCHHHHC--------CCCCCcHHHHHHHHHHHHHHHHCCCCCC---CcCHHHHHHHHHcCCCC---
Confidence            43 345678999999999997        6789999999999999999999999997   46777777777754211   


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                       |.+..+|+    .+.+||.+||+.||++|||++++           +.|||+..+.
T Consensus       244 -----------------~~~~~~s~----~~~~li~~~L~~dP~~R~s~~e~-----------l~hp~~~~~~  284 (350)
T 4b9d_A          244 -----------------PVSLHYSY----DLRSLVSQLFKRNPRDRPSVNSI-----------LEKGFIAKRI  284 (350)
T ss_dssp             -----------------CCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHH-----------HTSHHHHTTG
T ss_pred             -----------------CCCccCCH----HHHHHHHHHccCChhHCcCHHHH-----------hcCHHhhcCC
Confidence                             11223444    45669999999999999999997           6689886543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4e-52  Score=436.84  Aligned_cols=258  Identities=25%  Similarity=0.419  Sum_probs=196.9

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      |..-.+|.+.+.||+|+||.||+|.++.+|+.||||++++....  .....+.+|+.++++++|||||++++++.+.+  
T Consensus         9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--   86 (275)
T 3hyh_A            9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD--   86 (275)
T ss_dssp             -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--
Confidence            33345799999999999999999999999999999999764322  23455679999999999999999999998754  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|+||||| +|+|.+++....   .+++..++.++.||+.||+|||++||+||||||+|||+    +..+.+||+|||+
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl----~~~~~vkl~DFGl  158 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL----DEHLNVKIADFGL  158 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE----CTTCCEEECCSSC
T ss_pred             EEEEEEeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE----CCCCCEEEeecCC
Confidence            599999999 789999987644   39999999999999999999999999999999999998    6777899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcC-CccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~-s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      |+.........+.+||+.|+|||++.        +..| +.++||||+||++|+|+||++||.   +.+..+.+..+...
T Consensus       159 a~~~~~~~~~~~~~GT~~Y~APE~~~--------~~~y~~~~~DiwSlGvily~lltg~~PF~---~~~~~~~~~~i~~~  227 (275)
T 3hyh_A          159 SNIMTDGNFLKTSCGSPNYAAPEVIS--------GKLYAGPEVDVWSCGVILYVMLCRRLPFD---DESIPVLFKNISNG  227 (275)
T ss_dssp             C---------------CTTSCHHHHS--------SSSCCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHT
T ss_pred             CeecCCCCccCCeeECcccCChhhhc--------CCCCCCChhhhHHHHHHHHHHHHCCCCCC---CCCHHHHHHHHHcC
Confidence            99877666667789999999999997        5554 689999999999999999999997   45555555555542


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ..                   .+|  ..+|++    +.+||.+||+.||++|||++++           +.|||+...
T Consensus       228 ~~-------------------~~p--~~~s~~----~~~li~~~L~~dP~~R~s~~ei-----------l~hpw~k~~  269 (275)
T 3hyh_A          228 VY-------------------TLP--KFLSPG----AAGLIKRMLIVNPLNRISIHEI-----------MQDDWFKVD  269 (275)
T ss_dssp             CC-------------------CCC--TTSCHH----HHHHHHHHSCSSGGGSCCHHHH-----------HHCHHHHTT
T ss_pred             CC-------------------CCC--CCCCHH----HHHHHHHHccCChhHCcCHHHH-----------HcCcccccC
Confidence            11                   122  234444    4569999999999999999997           569998543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.1e-52  Score=458.98  Aligned_cols=261  Identities=23%  Similarity=0.380  Sum_probs=221.3

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      +....|.+.+.||+|+||.||+|.++.+|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+  .+|
T Consensus       148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~  224 (423)
T 4fie_A          148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELW  224 (423)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred             ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECC--EEE
Confidence            444679999999999999999999999999999999976543 33556779999999999999999999998754  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ||||||+||+|.+++...    .+++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|+.
T Consensus       225 iVmEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl----~~~g~vKl~DFGla~~  296 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL----THDGRVKLSDFGFCAQ  296 (423)
T ss_dssp             EEEECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE----CTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE----cCCCCEEEecCccceE
Confidence            999999999999999753    29999999999999999999999999999999999998    6677899999999987


Q ss_pred             cccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      +... ....+.+||+.|||||++.        +..|+.++|||||||++|+|++|.+||.   +.+..+.+..+......
T Consensus       297 ~~~~~~~~~~~~GTp~YmAPEvl~--------~~~y~~~~DiWSlGvilyeml~G~~PF~---~~~~~~~~~~i~~~~~~  365 (423)
T 4fie_A          297 VSKEVPRRKSLVGTPYWMAPELIS--------RLPYGPEVDIWSLGIMVIEMVDGEPPYF---NEPPLKAMKMIRDNLPP  365 (423)
T ss_dssp             CCSSCCCBCCCEECTTTCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCTTT---TSCHHHHHHHHHHSCCC
T ss_pred             CCCCCccccccccCcCcCCHHHHC--------CCCCCcHHHHHHHHHHHHHHHHCCCCCC---CcCHHHHHHHHHcCCCC
Confidence            6544 3456789999999999997        6789999999999999999999999997   46666777666643211


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                        .++.+..+|++    +.+||.+||..||++|||+.++           +.|||+.....
T Consensus       366 ------------------~~~~~~~~s~~----~~dli~~~L~~dP~~R~ta~el-----------l~Hp~~~~~~~  409 (423)
T 4fie_A          366 ------------------RLKNLHKVSPS----LKGFLDRLLVRDPAQRATAAEL-----------LKHPFLAKAGP  409 (423)
T ss_dssp             ------------------CCSCTTSSCHH----HHHHHHHHSCSSTTTSCCHHHH-----------TTCGGGGGCCC
T ss_pred             ------------------CCcccccCCHH----HHHHHHHHcCCChhHCcCHHHH-----------hcCHHhcCCCC
Confidence                              22333345555    4559999999999999999997           77999976544

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-51  Score=436.65  Aligned_cols=255  Identities=24%  Similarity=0.358  Sum_probs=205.1

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEec--CCceEEEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQ--EGRGKVIV   88 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~--~~~~~~LV   88 (708)
                      |.+.+.||+|+||.||+|.++.+|..||+|.+...... ...+.+.+|+.++++|+|||||++++++.+.  +...+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            47888999999999999999999999999999754322 2234568999999999999999999998753  33468999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEEEecCC-CceEEEeccCccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR--LVHRDLKPGNIMKFICDDG-STIYKLTDFGAAR  165 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g--IVHrDIKP~NILl~~~~d~-~~~vKL~DFGlA~  165 (708)
                      ||||+||+|.+++....   .+++..++.++.||+.||.|||++|  ||||||||+|||+    ++ .+.+||+|||+|+
T Consensus       108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl----~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI----TGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEE----SSTTSCEEECCTTGGG
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeE----ECCCCCEEEEeCcCCE
Confidence            99999999999997643   3999999999999999999999998  9999999999998    43 5689999999998


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ... .....+.+||+.|||||++.        + .|+.++|||||||++|+|+||++||..   ..+...+.........
T Consensus       181 ~~~-~~~~~~~~GTp~YmAPE~~~--------~-~y~~~~DiwSlGvilyelltg~~Pf~~---~~~~~~~~~~i~~~~~  247 (290)
T 3fpq_A          181 LKR-ASFAKAVIGTPEFMAPEMYE--------E-KYDESVDVYAFGMCMLEMATSEYPYSE---CQNAAQIYRRVTSGVK  247 (290)
T ss_dssp             GCC-TTSBEESCSSCCCCCGGGGG--------T-CCCTHHHHHHHHHHHHHHHHSSCTTTT---CSSHHHHHHHHTTTCC
T ss_pred             eCC-CCccCCcccCccccCHHHcC--------C-CCCcHHHHHHHHHHHHHHHHCCCCCCC---CCcHHHHHHHHHcCCC
Confidence            543 33455678999999999885        3 489999999999999999999999973   3444444443321100


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  +.    .  .+...++    .+.+||.+||..||++|||++++           +.|||+..
T Consensus       248 ------------~~----~--~~~~~~~----~~~~li~~~L~~dP~~R~s~~e~-----------l~Hp~~~~  288 (290)
T 3fpq_A          248 ------------PA----S--FDKVAIP----EVKEIIEGCIRQNKDERYSIKDL-----------LNHAFFQE  288 (290)
T ss_dssp             ------------CG----G--GGGCCCH----HHHHHHHHHSCSSGGGSCCHHHH-----------HTSGGGC-
T ss_pred             ------------CC----C--CCccCCH----HHHHHHHHHccCChhHCcCHHHH-----------hcCccccC
Confidence                        00    0  0112333    45669999999999999999997           67999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2e-51  Score=437.30  Aligned_cols=254  Identities=30%  Similarity=0.445  Sum_probs=205.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEc---CCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .+|++.+.||+|+||.||+|++.   .+++.||||++++.... .....+.+|+.++++++|||||++++++.+.+  .+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG--KL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT--EE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EE
Confidence            46999999999999999999884   46889999999754221 12234568999999999999999999998754  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|||||+||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----~~~g~vKl~DFGla~  174 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL----DEEGHIKLTDFGLSK  174 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE----CTTSCEEEESSEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE----cCCCCEEecccccce
Confidence            999999999999999976443   9999999999999999999999999999999999998    677789999999998


Q ss_pred             ccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ..... ....+.+||+.|||||++.        +..|+.++|||||||++|+|+||++||.   +.+..+.+..+.....
T Consensus       175 ~~~~~~~~~~~~~GT~~YmAPE~~~--------~~~y~~~~DiwSlGvilyemltG~~PF~---~~~~~~~~~~i~~~~~  243 (304)
T 3ubd_A          175 ESIDHEKKAYSFCGTVEYMAPEVVN--------RRGHTQSADWWSFGVLMFEMLTGTLPFQ---GKDRKETMTMILKAKL  243 (304)
T ss_dssp             C-----CCCCSCCCCGGGCCHHHHH--------TSCCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCC
T ss_pred             eccCCCccccccccCcccCCHHHhc--------cCCCCCCCcccchHHHHHHHHhCCCCCC---CcCHHHHHHHHHcCCC
Confidence            65443 3455688999999999998        6889999999999999999999999997   5667777777765321


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH-----HHHHHHHHHHHhhhhcCcccCC
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF-----ERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa-----~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                         .+|  ..+|++    +.+||.+||+.||++|||+     +++           +.|||+..
T Consensus       244 -------------------~~p--~~~s~~----~~~li~~~L~~dP~~R~ta~~~~~~ei-----------l~Hp~f~~  287 (304)
T 3ubd_A          244 -------------------GMP--QFLSPE----AQSLLRMLFKRNPANRLGAGPDGVEEI-----------KRHSFFST  287 (304)
T ss_dssp             -------------------CCC--TTSCHH----HHHHHHHHTCSSGGGSTTCSTTTHHHH-----------HTSGGGTT
T ss_pred             -------------------CCC--CcCCHH----HHHHHHHHcccCHHHCCCCCcCCHHHH-----------HcCccccC
Confidence                               122  234554    4569999999999999995     454           67999854

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-49  Score=423.47  Aligned_cols=257  Identities=22%  Similarity=0.343  Sum_probs=195.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC--------
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG--------   82 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~--------   82 (708)
                      .|++.+.||+|+||.||+|+++.+|+.||||+++........+.+.+|+.++++|+|||||++++++.+.+.        
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            589999999999999999999999999999999765443344567899999999999999999999875542        


Q ss_pred             --ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         83 --RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        83 --~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                        ..+|+|||||+||+|.+++.........++..++.++.||+.||+|||++|||||||||+|||+    +..+.+||+|
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl----~~~~~vKl~D  161 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF----TMDDVVKVGD  161 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEEECC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE----CCCCcEEEcc
Confidence              2479999999999999999875443335667789999999999999999999999999999998    6677899999


Q ss_pred             cCcccccccccc-------------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCC
Q psy15481        161 FGAARELEEDQQ-------------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY  227 (708)
Q Consensus       161 FGlA~~~~~~~~-------------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~  227 (708)
                      ||+|+....+..             ..+.+||+.|||||++.        +..|+.++|||||||++|||++   ||.. 
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~--------~~~y~~~~DiwSlGvilyell~---Pf~~-  229 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH--------GNSYSHKVDIFSLGLILFELLY---PFST-  229 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHT--------TCCCCTHHHHHHHHHHHHHHHS---CCSS-
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHc--------CCCCCCHHHHHHHHHHHHHHcc---CCCC-
Confidence            999987654322             23457999999999997        6789999999999999999996   7752 


Q ss_pred             CCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        228 GGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       228 ~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                       .......+..+...                     .+|.   ..+.....+.+||.+||+.||++|||+.++       
T Consensus       230 -~~~~~~~~~~~~~~---------------------~~p~---~~~~~~~~~~~li~~~L~~dP~~Rps~~ei-------  277 (299)
T 4g31_A          230 -QMERVRTLTDVRNL---------------------KFPP---LFTQKYPCEYVMVQDMLSPSPMERPEAINI-------  277 (299)
T ss_dssp             -HHHHHHHHHHHHTT---------------------CCCH---HHHHHCHHHHHHHHHHTCSSGGGSCCHHHH-------
T ss_pred             -ccHHHHHHHHHhcC---------------------CCCC---CCcccCHHHHHHHHHHcCCChhHCcCHHHH-------
Confidence             11111222222211                     1111   112222335569999999999999999997       


Q ss_pred             HhhhhcCcccCC
Q psy15481        308 LNRKLVHLFHIN  319 (708)
Q Consensus       308 l~~~l~h~~~~~  319 (708)
                          +.|||+.+
T Consensus       278 ----l~h~~~~~  285 (299)
T 4g31_A          278 ----IENAVFED  285 (299)
T ss_dssp             ----HTSGGGCC
T ss_pred             ----hcCHhhCC
Confidence                66999864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.8e-49  Score=421.85  Aligned_cols=264  Identities=24%  Similarity=0.347  Sum_probs=211.9

Q ss_pred             ccCCCCceEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEE
Q psy15481          4 LRGSTNYVWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEE   78 (708)
Q Consensus         4 l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~   78 (708)
                      ++.-....|.+.+.||+|+||.||+|.+.     .+|..||||+++..+ ....+.+.+|++++++++|||||++++++.
T Consensus         7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            33334457999999999999999999875     368899999997542 223455789999999999999999999998


Q ss_pred             ecCCceEEEEEeccCCCCHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEE
Q psy15481         79 EQEGRGKVIVMELCTGGSLFNILDDPE----------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFI  148 (708)
Q Consensus        79 ~~~~~~~~LVmEy~~ggsL~~~L~~~~----------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~  148 (708)
                      +.+.  +|||||||+||||.+++....          ....+++..++.++.||+.||.|||+++||||||||+|||+  
T Consensus        86 ~~~~--~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl--  161 (299)
T 4asz_A           86 EGDP--LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV--  161 (299)
T ss_dssp             SSSS--EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             eCCE--EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE--
Confidence            7554  999999999999999996421          22349999999999999999999999999999999999998  


Q ss_pred             ecCCCceEEEeccCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCC
Q psy15481        149 CDDGSTIYKLTDFGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF  224 (708)
Q Consensus       149 ~~d~~~~vKL~DFGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF  224 (708)
                        +.++.+||+|||+|+........   ....||+.|||||++.        +..|+.++|||||||++|||+| |+.||
T Consensus       162 --~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~--------~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf  231 (299)
T 4asz_A          162 --GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM--------YRKFTTESDVWSLGVVLWEIFTYGKQPW  231 (299)
T ss_dssp             --CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             --CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHc--------CCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence              77788999999999876544322   2356999999999998        5779999999999999999999 99999


Q ss_pred             CCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        225 RPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       225 ~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      .   +.++.+.+..+.....                    ++.+..++    ..+.+|+.+||+.||++|||+.++...+
T Consensus       232 ~---~~~~~~~~~~i~~~~~--------------------~~~p~~~~----~~~~~li~~cl~~dP~~RPs~~~i~~~L  284 (299)
T 4asz_A          232 Y---QLSNNEVIECITQGRV--------------------LQRPRTCP----QEVYELMLGCWQREPHMRKNIKGIHTLL  284 (299)
T ss_dssp             T---TSCHHHHHHHHHHTCC--------------------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             C---CCCHHHHHHHHHcCCC--------------------CCCCccch----HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            7   4666777776665321                    11122233    4456699999999999999999998877


Q ss_pred             HHHHh
Q psy15481        305 TKTLN  309 (708)
Q Consensus       305 ~~il~  309 (708)
                      +++..
T Consensus       285 ~~~~~  289 (299)
T 4asz_A          285 QNLAK  289 (299)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            76654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.9e-49  Score=420.98  Aligned_cols=255  Identities=21%  Similarity=0.328  Sum_probs=209.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ..+.+.+.||+|+||.||+|...     .+++.||||+++........+.+.+|+.++++++|||||++++++...+.  
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~--  103 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP--  103 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE--
Confidence            46788999999999999999863     46789999999866555556778899999999999999999999976554  


Q ss_pred             EEEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecC
Q psy15481         85 KVIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDD  151 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d  151 (708)
                      ++||||||++|||.++|.....             ...+++..+..++.||+.||.|||+++||||||||+|||+    +
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl----~  179 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV----Y  179 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----C
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE----C
Confidence            8999999999999999965321             1348999999999999999999999999999999999998    7


Q ss_pred             CCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCC
Q psy15481        152 GSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPY  227 (708)
Q Consensus       152 ~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~  227 (708)
                      ..+.+||+|||+|+.......   ....+||+.|||||++.        +..|+.++|||||||++|||+| |..||.  
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~--------~~~~s~ksDVwSfGvvl~El~t~g~~Pf~--  249 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM--------YGKFSIDSDIWSYGVVLWEVFSYGLQPYC--  249 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTTCCTTT--
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh--------CCCCCccchhhhHHHHHHHHHhCCCCCCC--
Confidence            778899999999987654432   33467999999999998        5779999999999999999999 899997  


Q ss_pred             CCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        228 GGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       228 ~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                       +.++.+.+..+....                    .+|.+    +.++..+.+|+.+||+.||++||||.++.+.|+
T Consensus       250 -~~~~~~~~~~i~~~~--------------------~~~~p----~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~  302 (308)
T 4gt4_A          250 -GYSNQDVVEMIRNRQ--------------------VLPCP----DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR  302 (308)
T ss_dssp             -TCCHHHHHHHHHTTC--------------------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCCHHHHHHHHHcCC--------------------CCCCc----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence             456667666665421                    11222    223345667999999999999999999988764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=414.13  Aligned_cols=304  Identities=61%  Similarity=1.079  Sum_probs=272.6

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ...+.+|.+.+.||+|+||.||+|.+..+|+.||||+++........+.+.+|+.++++++||||+++++++...+....
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            45688999999999999999999999999999999999865545556677899999999999999999999988776679


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++|++|.+++........+++..++.++.||+.||.|||++||+||||||+|||+...+++.+.+||+|||+|.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999999998865555599999999999999999999999999999999999987777888899999999999


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC-CChhhHHHHHHhccc
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-RRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g-~~~~e~~~~i~~~~~  244 (708)
                      ............||+.|+|||++.........+..++.++|||||||++|+|+||..||.+..+ ....+.+..+....+
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            8777766677889999999999986655555567899999999999999999999999987654 567788888998888


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      ...+........+.+.|...+|..+.++..++..+.++|++||+.||++|||+++++.+..+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            88888888888999999999999999999999999999999999999999999999998776643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-49  Score=421.68  Aligned_cols=257  Identities=23%  Similarity=0.383  Sum_probs=200.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .+.+.+.||+|+||.||+|.+..   .||||+++..... ...+.+.+|+.++++++|||||++++++...   .+||||
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~---~~~iVm  110 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD---NLAIVT  110 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEEEE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC---eEEEEE
Confidence            45688999999999999998643   5999998754322 2234568999999999999999999987542   389999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||+||||.+++.....  .+++..+..++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|+....
T Consensus       111 Ey~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl----~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL----HEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             ECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE----ETTEEEEECCCSSCBC---
T ss_pred             EcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE----CCCCcEEEeeccCceeccc
Confidence            99999999999976443  39999999999999999999999999999999999998    6778999999999986543


Q ss_pred             c---ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 D---QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~---~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      .   ......+||+.|||||++...     ....|+.++|||||||++|||+||+.||.   +.++...+..+.....  
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~-----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~---~~~~~~~~~~~~~~~~--  254 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQ-----DNNPFSFQSDVYSYGIVLYELMTGELPYS---HINNRDQIIFMVGRGY--  254 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTTT---TCCCHHHHHHHHHTTC--
T ss_pred             CCcceeecccccCCCccCHHHhhcc-----CCCCCCcHHHhHhHHHHHHHHHHCCCCCC---CCChHHHHHHHHhcCC--
Confidence            2   234457899999999998621     13458999999999999999999999997   3444444444443211  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                                       ..|....+++.++..+.+|+.+||+.||++|||+.++++.++.
T Consensus       255 -----------------~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          255 -----------------ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             -----------------CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             -----------------CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                             1122223334455567779999999999999999999888754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=431.64  Aligned_cols=283  Identities=23%  Similarity=0.339  Sum_probs=216.6

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEec----CCc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQ----EGR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~----~~~   83 (708)
                      +.+|.+.+.||+|+||.||+|+++.+|+.||||+++..... .......+|+.+|+.++|||||++++++...    ..+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            45799999999999999999999999999999999754322 1233457999999999999999999998643    235


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|||||||. |+|.+++....   .+++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~----~~~~~~Ki~DFGl  204 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV----NENCELKIGDFGM  204 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTCCEEECCCTT
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc----CCCCCEEEeecce
Confidence            6999999995 78999997644   39999999999999999999999999999999999998    7778899999999


Q ss_pred             ccccccc-----ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHH
Q psy15481        164 ARELEED-----QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       164 A~~~~~~-----~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~  238 (708)
                      |+.+...     ....+.+||+.|+|||++..       ...|+.++||||+||++|+|++|++||.   +.+..+.+..
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~-------~~~~~~~~DiWSlG~il~ell~G~~pF~---g~~~~~~l~~  274 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLS-------LHEYTQAIDLWSVGCIFGEMLARRQLFP---GKNYVHQLQL  274 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHHHTSCSSC---CSSHHHHHHH
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcC-------CCCCCChhheehhHHHHHHHHHCCCCCC---CCCHHHHHHH
Confidence            9865432     23446789999999999872       3567999999999999999999999997   5777777777


Q ss_pred             HHhcccCCcccccccCCCC-cccccCCCCCcc-----cCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhh
Q psy15481        239 ITTKKASGVISGTQTSENG-EIDWCTDLPNNC-----QLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKL  312 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g-~~~~~~~lp~~~-----~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l  312 (708)
                      |.................. ...+...+|...     .+.+.++..+.+||.+||.+||.+|||+.++           +
T Consensus       275 I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~-----------L  343 (398)
T 4b99_A          275 IMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA-----------L  343 (398)
T ss_dssp             HHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH-----------T
T ss_pred             HHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH-----------h
Confidence            7653221111000000000 000011112111     1122344566779999999999999999996           7


Q ss_pred             cCcccCCc
Q psy15481        313 VHLFHINR  320 (708)
Q Consensus       313 ~h~~~~~~  320 (708)
                      .|||+..-
T Consensus       344 ~Hp~f~~~  351 (398)
T 4b99_A          344 RHPFLAKY  351 (398)
T ss_dssp             TSGGGTTT
T ss_pred             cCHhhCcC
Confidence            89999754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=420.92  Aligned_cols=259  Identities=24%  Similarity=0.327  Sum_probs=205.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ..|.+.+.||+|+||.||+|.++     .+++.||||+++..+ ....+.+.+|++++++++|||||++++++.+.+  .
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--~  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGR--P  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--S
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--E
Confidence            46888999999999999999865     368899999997532 223455789999999999999999999998655  4


Q ss_pred             EEEEEeccCCCCHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC
Q psy15481         85 KVIVMELCTGGSLFNILDDPEN------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG  152 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~  152 (708)
                      +|||||||+||+|.+++.....            ...+++.++..++.||+.||.|||+++||||||||+|||+    +.
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl----~~  193 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV----GQ  193 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----ET
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE----CC
Confidence            9999999999999999976321            2348999999999999999999999999999999999998    67


Q ss_pred             CceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCC
Q psy15481        153 STIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYG  228 (708)
Q Consensus       153 ~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~  228 (708)
                      .+.+||+|||+|+.......   ....+||+.|||||++.        +..|+.++|||||||++|||+| |+.||.   
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~--------~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~---  262 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL--------YRKFTTESDVWSFGVVLWEIFTYGKQPWY---  262 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHTTSCCTTC---
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhc--------CCCCCccccccchHHHHHHHHcCCCCCCC---
Confidence            78999999999987644322   23467999999999997        6789999999999999999999 999997   


Q ss_pred             CCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        229 GRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       229 g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                      +.++.+.+..+....                    .++.+..++    ..+.+|+.+||+.||++|||+.+++..|+.+.
T Consensus       263 ~~~~~~~~~~i~~g~--------------------~~~~p~~~~----~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          263 QLSNTEAIDCITQGR--------------------ELERPRACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             SSCHHHHHHHHHHTC--------------------CCCCCTTCC----HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHcCC--------------------CCCCccccc----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            456677776665431                    112222233    44566999999999999999999999988876


Q ss_pred             hh
Q psy15481        309 NR  310 (708)
Q Consensus       309 ~~  310 (708)
                      +.
T Consensus       319 ~~  320 (329)
T 4aoj_A          319 QA  320 (329)
T ss_dssp             HS
T ss_pred             hC
Confidence            54

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.3e-48  Score=421.70  Aligned_cols=272  Identities=22%  Similarity=0.347  Sum_probs=205.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc---CCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~   84 (708)
                      +.+|.+.+.||+|+||.||+|.++   .+++.||+|.+....   ......+|+.+++.+ +||||+++++++.+.+  .
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~--~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND--H   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT--E
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC--E
Confidence            457999999999999999999875   468899999986543   234567899999998 7999999999998754  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC-ceEEEeccCc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS-TIYKLTDFGA  163 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~-~~vKL~DFGl  163 (708)
                      +|+|||||+||+|.+++..      +++.+++.++.||+.||+|||++|||||||||+|||+    +.. +.+||+|||+
T Consensus        95 ~~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl----~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLY----NRRLKKYALVDFGL  164 (361)
T ss_dssp             EEEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----ETTTTEEEECCCTT
T ss_pred             EEEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEE----eCCCCeEEECcCCC
Confidence            9999999999999999953      8999999999999999999999999999999999997    333 6899999999


Q ss_pred             ccccccc-----------------------------ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHH
Q psy15481        164 ARELEED-----------------------------QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTL  214 (708)
Q Consensus       164 A~~~~~~-----------------------------~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviL  214 (708)
                      |+...+.                             ....+.+||+.|+|||++.+       ...|+.++||||+||++
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~y~~~~DiWSlG~il  237 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-------CPNQTTAIDMWSAGVIF  237 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHH
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCCccchhhhHHHH
Confidence            9754322                             12234679999999999873       35689999999999999


Q ss_pred             HHHhcCCCCCCCCCCCChhhHHHHHHhcccC------------CcccccccCCC--------------Cccc-------c
Q psy15481        215 YHVATGNLPFRPYGGRRNKETMYYITTKKAS------------GVISGTQTSEN--------------GEID-------W  261 (708)
Q Consensus       215 yeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~------------~~i~~~~~~~~--------------g~~~-------~  261 (708)
                      |+|+||++||.+  +.++.+.+..|..-...            ...........              ....       .
T Consensus       238 ~ell~G~~Pf~~--~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~  315 (361)
T 4f9c_A          238 LSLLSGRYPFYK--ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGH  315 (361)
T ss_dssp             HHHHHTCSSSSC--CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------
T ss_pred             HHHHHCCCCCCC--CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccc
Confidence            999999999964  56677777666531100            00000000000              0000       0


Q ss_pred             cCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        262 CTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       262 ~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ....+.+..+|    +.+.+||.+||++||++|||++++           +.||||.+
T Consensus       316 ~~~~~~~~~is----~~a~DLl~~lL~~dP~~R~ta~ea-----------L~Hp~f~~  358 (361)
T 4f9c_A          316 ATNLEGWNEVP----DEAYDLLDKLLDLNPASRITAEEA-----------LLHPFFKD  358 (361)
T ss_dssp             ------CTTCC----HHHHHHHHHHTCSCTTTSCCHHHH-----------HTSGGGTT
T ss_pred             cccccccccCC----HHHHHHHHHHCcCChhHCcCHHHH-----------hcCcccCC
Confidence            00111222334    445669999999999999999996           77999964

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.3e-48  Score=418.44  Aligned_cols=262  Identities=21%  Similarity=0.315  Sum_probs=209.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCC-----CceEEEEEeccCCCCCchHHHHHHHHHHHhCCC-CCccceeEEEEecCCc
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNN-----GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH-ENIVKLLAIEEEQEGR   83 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~H-pNIVkl~~v~~~~~~~   83 (708)
                      .+|.+.+.||+|+||.||+|.+..+     ++.||||.++..........+.+|+.++.+++| ||||++++++..++ .
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-~  142 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-G  142 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-S
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC-C
Confidence            3689999999999999999998654     468999999765443334557899999999965 89999999986543 3


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec
Q psy15481         84 GKVIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD  150 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~  150 (708)
                      .+|||||||+||+|.++|....+             ...+++..+..++.||+.||.|||+++||||||||+|||+    
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl----  218 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL----  218 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee----
Confidence            48999999999999999964221             2338999999999999999999999999999999999998    


Q ss_pred             CCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCC
Q psy15481        151 DGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRP  226 (708)
Q Consensus       151 d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~  226 (708)
                      +.++.+||+|||+|+....+..   ....+||+.|||||++.        +..|+.++|||||||++|||+| |..||.+
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~--------~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--------DRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh--------cCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            7778899999999987654432   23467999999999998        5789999999999999999998 9999974


Q ss_pred             CCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        227 YGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       227 ~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                         .+..+.+........                 ....|.  ..++    .+.+++.+||+.||++||||.+++.+|..
T Consensus       291 ---~~~~~~~~~~i~~g~-----------------~~~~p~--~~~~----~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          291 ---VKIDEEFCRRLKEGT-----------------RMRAPD--YTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             ---CCCSHHHHHHHHHTC-----------------CCCCCT--TCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCHHHHHHHHHHcCC-----------------CCCCCc--cCCH----HHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence               333333333332211                 002222  2344    45668999999999999999999999988


Q ss_pred             HHhh
Q psy15481        307 TLNR  310 (708)
Q Consensus       307 il~~  310 (708)
                      +++.
T Consensus       345 llq~  348 (353)
T 4ase_A          345 LLQA  348 (353)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8764

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-46  Score=436.53  Aligned_cols=345  Identities=26%  Similarity=0.381  Sum_probs=278.7

Q ss_pred             ccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEe----
Q psy15481          4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEE----   79 (708)
Q Consensus         4 l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~----   79 (708)
                      +.|....+|.+.+.||+|+||.||+|.+..+|+.||||+++........+.+.+|+.++++++||||+++++++..    
T Consensus         8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A            8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred             CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence            3456678999999999999999999999999999999998765433334556799999999999999999998754    


Q ss_pred             cCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         80 QEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        80 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      ..++..|+|||||+||+|.+++....+..++++..++.++.|++.||.|||++||+||||||+||++ ..+++...+||+
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl-~~~g~~~~vKL~  166 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVL-QPGPQRLIHKII  166 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEE-ECCSSSCEEEEC
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEe-ecCCCceeEEEc
Confidence            2244589999999999999999886655569999999999999999999999999999999999997 222334569999


Q ss_pred             ccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        160 DFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       160 DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      |||.+.............||+.|+|||++.        +..++.++|||||||++|+|++|..||.+.   .....+...
T Consensus       167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~--------~~~~s~ksDIwSLGviLyeLltG~~Pf~~~---~~~~~~~~~  235 (676)
T 3qa8_A          167 DLGYAKELDQGELCTEFVGTLQYLAPELLE--------QKKYTVTVDYWSFGTLAFECITGFRPFLPN---WQPVQWHGK  235 (676)
T ss_dssp             SCCCCCBTTSCCCCCCCCSCCTTCSSCSSC--------CSCCSTTHHHHHHHHHHHHHHSSCSSCCSS---CHHHHSSTT
T ss_pred             ccccccccccccccccccCCcccCChHHhc--------cCCCCchhHHHHHHHHHHHHHHCCCCCCcc---cchhhhhhh
Confidence            999999877666666778999999999986        678899999999999999999999999742   111111111


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHH-----HHHHHHHHHhhhhcC
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFER-----FFSEVTKTLNRKLVH  314 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q-----~~~~l~~il~~~l~h  314 (708)
                      ........ ........+...|...+|.+..+++.++..+.++|.+||.+||.+|||+.+     +|..+.+++..++.+
T Consensus       236 i~~~~~~~-~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~kil~  314 (676)
T 3qa8_A          236 VREKSNEH-IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLS  314 (676)
T ss_dssp             CC-------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCEEE
T ss_pred             hhcccchh-hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccccc
Confidence            11111111 112233456677888888888899999999999999999999999999986     999999999999999


Q ss_pred             cccCCcccccccccCCcccHHHHHHHHHhhcCCCccceEEEeeCCcc
Q psy15481        315 LFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHF  361 (708)
Q Consensus       315 ~~~~~~~~~~~~~i~~~e~~~~l~~~i~~~t~i~~~~q~~~~~~~~~  361 (708)
                      +|..+.....+++++++++...++..|..+|+|++++|.+++++++.
T Consensus       315 ~f~~~~~~~~~~~i~~~~tl~~l~~~i~~~T~i~~~~q~~~~~~~~~  361 (676)
T 3qa8_A          315 VMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLA  361 (676)
T ss_dssp             CCCSSSSCCCEEECCTTCCHHHHHHHHHTTSCCCSTTCEEESSSSCC
T ss_pred             cccccccccceeecCCCccHHHHHHHHHHHhCCCHHHHHHHhccCCC
Confidence            99999999999999999999999999999999999999999997655

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.2e-47  Score=439.84  Aligned_cols=263  Identities=27%  Similarity=0.412  Sum_probs=220.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .+|.+.+.||+|+||.||+|.++.+|+.||+|++.... ....+...+|+.+|+.++|||||++++++.+.+  .+||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~iv~  233 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--EMVMIY  233 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS--EEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEEE
Confidence            47999999999999999999999999999999987543 222345679999999999999999999998754  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||.||+|.+++.....  .+++.+++.++.||+.||.|||++||+||||||+|||+  +.+..+.+||+|||+|+.+..
T Consensus       234 E~~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill--~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          234 EFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF--TTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             ECCCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--SSSSCCCEEECCCSSCEECCT
T ss_pred             eecCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccc--cCCCCCCEEEeeccceeEccC
Confidence            99999999999965432  39999999999999999999999999999999999997  444457899999999998887


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      .......+||+.|+|||++.        +..|+.++|||||||++|+|++|.+||.   +.+..+++..+......    
T Consensus       310 ~~~~~~~~GT~~y~APEv~~--------~~~y~~~~DiWSlGvilyeml~G~~Pf~---~~~~~~~~~~i~~~~~~----  374 (573)
T 3uto_A          310 KQSVKVTTGTAEFAAPEVAE--------GKPVGYYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVKSCDWN----  374 (573)
T ss_dssp             TSEEEEECSSGGGCCHHHHT--------TCCBCHHHHHHHHHHHHHHHHHSCCSSC---CSSHHHHHHHHHTTCCC----
T ss_pred             CCceeeeEECccccCHHHhC--------CCCCCcHHHHHHHHHHHHHHHHCCCCCC---CcCHHHHHHHHHhCCCC----
Confidence            77777889999999999997        7889999999999999999999999997   56677777777653211    


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                   ...+.+..+|+.    +.+||.+||..||.+|||+.++           +.|||+.....
T Consensus       375 -------------~~~~~~~~~s~~----~~dli~~~L~~dp~~R~t~~e~-----------l~Hpw~~~~~~  419 (573)
T 3uto_A          375 -------------MDDSAFSGISED----GKDFIRKLLLADPNTRMTIHQA-----------LEHPWLTPGNA  419 (573)
T ss_dssp             -------------CCSGGGTTSCHH----HHHHHHTTSCSSGGGSCCHHHH-----------HHSTTTSCCCC
T ss_pred             -------------CCcccccCCCHH----HHHHHHHHccCChhHCcCHHHH-----------hcCcCcCCCCC
Confidence                         011122334544    5569999999999999999997           56999876543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.2e-46  Score=435.40  Aligned_cols=256  Identities=20%  Similarity=0.356  Sum_probs=206.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHH---HHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQM---REFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~---~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .|.+.+.||+|+||.||+|+++.+|+.||||++++...  ........   +++.+++.++|||||++++++.+.+  .+
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~--~l  267 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KL  267 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--EE
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC--EE
Confidence            69999999999999999999999999999999964321  11122233   3466777889999999999998755  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|||||+||+|..++.....   +++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|+
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl----d~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL----DEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE----CTTSCEEECCCTTCE
T ss_pred             EEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE----eCCCCEEecccceee
Confidence            999999999999999976433   9999999999999999999999999999999999998    777889999999998


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ..... ...+.+||+.|||||++..       +..|+.++|||||||++|+|++|.+||.+.......+....+...   
T Consensus       341 ~~~~~-~~~t~~GTp~YmAPEvl~~-------~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---  409 (689)
T 3v5w_A          341 DFSKK-KPHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---  409 (689)
T ss_dssp             ECSSC-CCCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---
T ss_pred             ecCCC-CCCCccCCcCccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---
Confidence            76544 3456799999999999963       467999999999999999999999999753333333333333332   


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                        .++.+..+|++    +.+||.+||..||.+|++     ++++           ..||||..
T Consensus       410 ------------------~~~~p~~~S~~----a~dLI~~lL~~dP~~Rl~~~~~ga~ei-----------~~HpfF~~  455 (689)
T 3v5w_A          410 ------------------AVELPDSFSPE----LRSLLEGLLQRDVNRRLGCLGRGAQEV-----------KESPFFRS  455 (689)
T ss_dssp             ------------------CCCCCTTSCHH----HHHHHHHHTCSCGGGCTTCSSSTHHHH-----------TTSGGGTT
T ss_pred             ------------------CCCCCccCCHH----HHHHHHHHccCCHhHCCCCCCCCHHHH-----------hcCccccC
Confidence                              11222235554    455999999999999998     5775           67999865

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-45  Score=393.56  Aligned_cols=270  Identities=20%  Similarity=0.279  Sum_probs=199.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC--ceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG--RGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~--~~~~L   87 (708)
                      .+|.+.+.||+|+||.||+|.+  +|+.||||+++....  .......|+..+.+++|||||++++++...+.  ..+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            4689999999999999999987  589999999864321  11122345666678899999999999976543  35899


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN--------RLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~--------gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      |||||+||||.+++....    +++..+..++.|++.||.|||++        |||||||||+|||+    +.++.+||+
T Consensus        79 V~Ey~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl----~~~~~~Ki~  150 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----KKNGTCCIA  150 (303)
T ss_dssp             EEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE----CTTSCEEEC
T ss_pred             EecCCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE----CCCCCEEEE
Confidence            999999999999997643    89999999999999999999987        99999999999998    777889999


Q ss_pred             ccCcccccccccc-----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC-----
Q psy15481        160 DFGAARELEEDQQ-----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG-----  229 (708)
Q Consensus       160 DFGlA~~~~~~~~-----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g-----  229 (708)
                      |||+|+.......     ....+||+.|||||++.....  .....|+.++|||||||++|||+||.+||.....     
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~--~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~  228 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSC--TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhccccc--ccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence            9999987654322     223579999999999863110  0012478899999999999999999887753211     


Q ss_pred             ------CChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        230 ------RRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       230 ------~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                            ....+.+.......                .....+|... .+......+.+|+.+||..||++||||.++.+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~----------------~~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          229 YDLVPSDPSVEEMRKVVCEQ----------------KLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTS----------------CCCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhcc----------------cCCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                  11112222221100                0111223221 233456678889999999999999999999998


Q ss_pred             HHHHHhh
Q psy15481        304 VTKTLNR  310 (708)
Q Consensus       304 l~~il~~  310 (708)
                      |+.+.+.
T Consensus       292 L~~l~~~  298 (303)
T 3hmm_A          292 LSQLSQQ  298 (303)
T ss_dssp             HHHHHHC
T ss_pred             HHHHHHH
Confidence            8877553

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.9e-44  Score=390.31  Aligned_cols=269  Identities=30%  Similarity=0.469  Sum_probs=220.7

Q ss_pred             CcccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-----chHHHHHHHHHHHhCCCCCccceeEE
Q psy15481          2 SFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-----PHDVQMREFEVLKKVKHENIVKLLAI   76 (708)
Q Consensus         2 s~l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-----~~~~~~~Ei~iL~kL~HpNIVkl~~v   76 (708)
                      ++..+.....|.+.+.||+|+||.||+|.++.+|+.||+|+++......     ..+.+.+|+.+++.++||||++++++
T Consensus         4 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   83 (361)
T 2yab_A            4 TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV   83 (361)
T ss_dssp             CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence            3455677788999999999999999999999999999999997654322     23556799999999999999999999


Q ss_pred             EEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC--Cc
Q psy15481         77 EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG--ST  154 (708)
Q Consensus        77 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~--~~  154 (708)
                      +.+..  .+|+||||++||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+  .+++  ..
T Consensus        84 ~~~~~--~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll--~~~~~~~~  156 (361)
T 2yab_A           84 YENRT--DVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIP  156 (361)
T ss_dssp             EECSS--EEEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--SCTTSSSC
T ss_pred             EEeCC--EEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--eCCCCCcc
Confidence            97644  5999999999999999997644   39999999999999999999999999999999999997  2222  23


Q ss_pred             eEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhh
Q psy15481        155 IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE  234 (708)
Q Consensus       155 ~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e  234 (708)
                      .+||+|||++.....+......+||+.|+|||++.        +..++.++|||||||++|+|++|.+||.   +.+..+
T Consensus       157 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslGvil~~ll~g~~Pf~---~~~~~~  225 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN--------YEPLGLEADMWSIGVITYILLSGASPFL---GDTKQE  225 (361)
T ss_dssp             CEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSCCSSC---CSSHHH
T ss_pred             CEEEEecCCceEcCCCCccccCCCCccEECchHHc--------CCCCCccccHHHHHHHHHHHHhCCCCCC---CCCHHH
Confidence            79999999999877766667788999999999987        6778999999999999999999999997   455666


Q ss_pred             HHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcC
Q psy15481        235 TMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVH  314 (708)
Q Consensus       235 ~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h  314 (708)
                      .+..+.....               .+..  +.+..++    ..+.++|.+||..||.+|||+.++           +.|
T Consensus       226 ~~~~i~~~~~---------------~~~~--~~~~~~s----~~~~~li~~~L~~dP~~R~t~~e~-----------l~h  273 (361)
T 2yab_A          226 TLANITAVSY---------------DFDE--EFFSQTS----ELAKDFIRKLLVKETRKRLTIQEA-----------LRH  273 (361)
T ss_dssp             HHHHHHTTCC---------------CCCH--HHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHH-----------HTS
T ss_pred             HHHHHHhcCC---------------CCCc--hhccCCC----HHHHHHHHHHCCCChhHCcCHHHH-----------hcC
Confidence            6666554211               0000  0112233    445669999999999999999997           679


Q ss_pred             cccCCc
Q psy15481        315 LFHINR  320 (708)
Q Consensus       315 ~~~~~~  320 (708)
                      ||+...
T Consensus       274 p~~~~~  279 (361)
T 2yab_A          274 PWITPV  279 (361)
T ss_dssp             TTTSCS
T ss_pred             cCcCCC
Confidence            999643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-43  Score=380.96  Aligned_cols=255  Identities=27%  Similarity=0.456  Sum_probs=213.4

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..|.+.+.||+|+||.||+|.+..+|+.||||++...... .......+|+.+++.++||||+++++++...+  ..|+|
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv   92 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK--TLYLI   92 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEE
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--EEEEE
Confidence            3699999999999999999999999999999999754322 22344679999999999999999999987644  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++||+|.+++.....   +++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll----~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL----DADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             ECCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECSTTCCGGGS
T ss_pred             EECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE----cCCCCEEEeeccCceecC
Confidence            999999999999876433   9999999999999999999999999999999999998    777789999999998777


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcC-CccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~-s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      .+......+||+.|+|||++.        +..+ +.++|||||||++|+|++|.+||.   +.+..+....+.....   
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~il~ell~g~~pf~---~~~~~~~~~~i~~~~~---  231 (328)
T 3fe3_A          166 VGGKLDAFCGAPPYAAPELFQ--------GKKYDGPEVDVWSLGVILYTLVSGSLPFD---GQNLKELRERVLRGKY---  231 (328)
T ss_dssp             SSCGGGTTSSSGGGCCHHHHH--------TCCCCSHHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCC---
T ss_pred             CCCccccccCCcceeCccccc--------CCCcCCchhhhhhhHHHHHHHHhCCCCCC---CCCHHHHHHHHHhCCC---
Confidence            666667788999999999997        4444 589999999999999999999997   4555555555554311   


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                      .+|.  .+++    .+.+++.+||..||.+|||++++           +.|||+...
T Consensus       232 ----------------~~p~--~~s~----~~~~li~~~L~~dP~~R~t~~ei-----------l~h~~~~~~  271 (328)
T 3fe3_A          232 ----------------RIPF--YMST----DCENLLKRFLVLNPIKRGTLEQI-----------MKDRWINAG  271 (328)
T ss_dssp             ----------------CCCT--TSCH----HHHHHHHHHCCSSTTTSCCHHHH-----------TTCTTTTTT
T ss_pred             ----------------CCCC--CCCH----HHHHHHHHHCCCChhHCcCHHHH-----------hcCHhhcCC
Confidence                            1222  2344    45569999999999999999997           779998643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-43  Score=374.18  Aligned_cols=263  Identities=26%  Similarity=0.443  Sum_probs=217.4

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      .|....+|.+.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+  .
T Consensus        15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~   91 (297)
T 3fxz_A           15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGD--E   91 (297)
T ss_dssp             SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--E
T ss_pred             cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC--E
Confidence            45667789999999999999999999999999999999875443 23556779999999999999999999998754  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||++||+|.+++....    +++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~----~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           92 LWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL----GMDGSVKLTDFGFC  163 (297)
T ss_dssp             EEEEEECCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTTC
T ss_pred             EEEEEECCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE----CCCCCEEEeeCCCc
Confidence            999999999999999997642    8999999999999999999999999999999999998    66678999999999


Q ss_pred             ccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        165 RELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       165 ~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ....... ......||+.|+|||++.        +..++.++|||||||++|+|+||..||.   +.........+....
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~---~~~~~~~~~~~~~~~  232 (297)
T 3fxz_A          164 AQITPEQSKRSTMVGTPYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALYLIATNG  232 (297)
T ss_dssp             EECCSTTCCBCCCCSCGGGCCHHHHH--------CSCBCTHHHHHHHHHHHHHHHHSSCTTT---TSCHHHHHHHHHHHC
T ss_pred             eecCCcccccCCccCCcCccChhhhc--------CCCCCcHHHHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHhCC
Confidence            8765443 334568999999999997        6789999999999999999999999997   344455555444321


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      .+                  .++.+    ..++..+.++|.+||..||.+|||+.++           +.|||+.....
T Consensus       233 ~~------------------~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~el-----------l~h~~~~~~~~  278 (297)
T 3fxz_A          233 TP------------------ELQNP----EKLSAIFRDFLNRCLEMDVEKRGSAKEL-----------LQHQFLKIAKP  278 (297)
T ss_dssp             SC------------------CCSCG----GGSCHHHHHHHHHHSCSSTTTSCCHHHH-----------TTCGGGGGCCC
T ss_pred             CC------------------CCCCc----cccCHHHHHHHHHHccCChhHCcCHHHH-----------hhChhhcccCc
Confidence            11                  11122    2334456679999999999999999997           77999965443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=377.48  Aligned_cols=264  Identities=22%  Similarity=0.366  Sum_probs=217.6

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||+|.+....  .......+|+.+++.++||||+++++++.+.+  .+|+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~l   78 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESME--ELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--EEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC--EEEE
Confidence            4568999999999999999999999999999999986432  22344679999999999999999999998754  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||||+||+|.+++....  ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+.+||+|||++...
T Consensus        79 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~--~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           79 IFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY--QTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--SSSSCCCEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE--ccCCCCCEEEEECCCCeEC
Confidence            999999999999997643  239999999999999999999999999999999999997  3333678999999999987


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..+.......||+.|+|||++.        +..++.++|||||||++|+|++|.+||.   +..+.+.+..+....... 
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~---~~~~~~~~~~i~~~~~~~-  222 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQ--------HDVVSTATDMWSLGTLVYVLLSGINPFL---AETNQQIIENIMNAEYTF-  222 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHT--------TCEECHHHHHHHHHHHHHHHHHSSCTTC---CSSHHHHHHHHHHTCCCC-
T ss_pred             CCCCccccccCChhhcCcHHhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCc---CCCHHHHHHHHHcCCCCC-
Confidence            7766666788999999999987        5678999999999999999999999997   455666666666432110 


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                      ..+.+..++    ..+.+++.+||..||.+|||+.++           +.|||+.....
T Consensus       223 ----------------~~~~~~~~s----~~~~~li~~~L~~dp~~Rpt~~e~-----------l~hp~~~~~~~  266 (321)
T 1tki_A          223 ----------------DEEAFKEIS----IEAMDFVDRLLVKERKSRMTASEA-----------LQHPWLKQKIE  266 (321)
T ss_dssp             ----------------CHHHHTTSC----HHHHHHHHTTSCSSGGGSCCHHHH-----------HHSHHHHSCGG
T ss_pred             ----------------ChhhhccCC----HHHHHHHHHHcCCChhHCcCHHHH-----------hcChhhccCcc
Confidence                            000111233    445669999999999999999997           55899876544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=376.61  Aligned_cols=268  Identities=27%  Similarity=0.442  Sum_probs=216.6

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-----chHHHHHHHHHHHhCCCCCccceeEEEEec
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-----PHDVQMREFEVLKKVKHENIVKLLAIEEEQ   80 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-----~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~   80 (708)
                      ......|.+.+.||+|+||.||+|.++.+|+.||+|++.......     ..+.+.+|+.++++++||||+++++++...
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            445568999999999999999999999999999999997643321     245577999999999999999999999764


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                      .  ..|+||||++|++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+.-.......+||+|
T Consensus        87 ~--~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           87 T--DVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             S--EEEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             C--EEEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            4  5999999999999999997643   3999999999999999999999999999999999999711111123799999


Q ss_pred             cCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        161 FGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       161 FGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ||++.............||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +....+.+..+.
T Consensus       162 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~---~~~~~~~~~~~~  230 (326)
T 2y0a_A          162 FGLAHKIDFGNEFKNIFGTPEFVAPEIVN--------YEPLGLEADMWSIGVITYILLSGASPFL---GDTKQETLANVS  230 (326)
T ss_dssp             CTTCEECCTTSCCCCCCSCTTTCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSCCSSC---CSSHHHHHHHHH
T ss_pred             CCCCeECCCCCccccccCCcCcCCceeec--------CCCCCcHHHHHHHHHHHHHHHHCcCCCC---CCCHHHHHHHHH
Confidence            99999876666666778999999999986        6778999999999999999999999997   355555555554


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ....                   .++.  ...+..+..+.++|.+||..||.+|||+.++           +.|||+...
T Consensus       231 ~~~~-------------------~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~-----------l~hp~~~~~  278 (326)
T 2y0a_A          231 AVNY-------------------EFED--EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS-----------LQHPWIKPK  278 (326)
T ss_dssp             HTCC-------------------CCCH--HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHH-----------HHSTTTSCC
T ss_pred             hcCC-------------------CcCc--cccccCCHHHHHHHHHHccCChhhCCCHHHH-----------hcCCCccCC
Confidence            3211                   0110  0111223456679999999999999999997           569999765


Q ss_pred             c
Q psy15481        321 L  321 (708)
Q Consensus       321 ~  321 (708)
                      .
T Consensus       279 ~  279 (326)
T 2y0a_A          279 D  279 (326)
T ss_dssp             S
T ss_pred             c
Confidence            3

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.4e-43  Score=380.88  Aligned_cols=264  Identities=27%  Similarity=0.399  Sum_probs=215.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...|.+.+.||+|+||.||+|.++.+|+.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+  ..|+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~l  105 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FHYL  105 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEEE
Confidence            34799999999999999999999999999999999754332 22345679999999999999999999997654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||+.||+|.+.+.....   +++..+..++.||+.||.|||++||+||||||+|||+ ...+..+.+||+|||++...
T Consensus       106 v~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll-~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLL-ASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE-SCSSTTCCEEECCCTTCBCC
T ss_pred             EEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEE-ecCCCCCCEEEeecCcceEe
Confidence            9999999999999876443   8999999999999999999999999999999999997 11222357999999999887


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..........||+.|+|||++.        +..|+.++|||||||++|+|++|.+||.   +.+..+....+......  
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~ll~g~~Pf~---~~~~~~~~~~i~~~~~~--  248 (362)
T 2bdw_A          182 NDSEAWHGFAGTPGYLSPEVLK--------KDPYSKPVDIWACGVILYILLVGYPPFW---DEDQHRLYAQIKAGAYD--  248 (362)
T ss_dssp             TTCCSCCCSCSCTTTCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHTCCC--
T ss_pred             cCCcccccCCCCccccCHHHHc--------cCCCCchhhHHHHHHHHHHHHHCCCCCC---CCCHHHHHHHHHhCCCC--
Confidence            7666566678999999999987        5678999999999999999999999997   35555555555543211  


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                   +  ..+.+..+++    .+.++|.+||..||.+||++.++           +.|||+....
T Consensus       249 -------------~--~~~~~~~~~~----~~~~li~~~L~~dP~~R~t~~e~-----------l~hp~~~~~~  292 (362)
T 2bdw_A          249 -------------Y--PSPEWDTVTP----EAKSLIDSMLTVNPKKRITADQA-----------LKVPWICNRE  292 (362)
T ss_dssp             -------------C--CTTGGGGSCH----HHHHHHHHHSCSSGGGSCCHHHH-----------TTSHHHHTHH
T ss_pred             -------------C--CcccccCCCH----HHHHHHHHHcCCChhhCcCHHHH-----------hcCcccCCCc
Confidence                         0  1122233444    45569999999999999999997           7789886543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-42  Score=375.32  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=209.8

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|.+.+.||+|+||.||+|.++.+|+.||+|++++..  .........+|+.+++.++||||+++++++...+  .+|+
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~~~l   82 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCF   82 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--EEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC--EEEE
Confidence            47999999999999999999999999999999997532  1223445678999999999999999999997654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|...
T Consensus        83 v~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML----DKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEECCCTTCBCS
T ss_pred             EEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE----CCCCCEEEeeccchhhc
Confidence            9999999999999876432   8999999999999999999999999999999999998    67778999999999864


Q ss_pred             c-ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 E-EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~-~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      . ........+||+.|+|||++.        +..++.++|+|||||++|+|++|..||.   +.+.......+.....  
T Consensus       156 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~---~~~~~~~~~~i~~~~~--  222 (337)
T 1o6l_A          156 ISDGATMKTFCGTPEYLAPEVLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPFY---NQDHERLFELILMEEI--  222 (337)
T ss_dssp             CCTTCCBCCCEECGGGCCGGGGS--------SSCBCTTHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCC--
T ss_pred             ccCCCcccccccChhhCChhhhc--------CCCCCchhhcccchhHHHHHhcCCCCCC---CCCHHHHHHHHHcCCC--
Confidence            3 333455678999999999987        6778999999999999999999999997   3445555555553211  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                       .+|.  .+++    .+.++|.+||..||.+||     +++++           +.|||+..
T Consensus       223 -----------------~~p~--~~s~----~~~~li~~lL~~dP~~R~g~~~~~~~ei-----------~~h~~f~~  266 (337)
T 1o6l_A          223 -----------------RFPR--TLSP----EAKSLLAGLLKKDPKQRLGGGPSDAKEV-----------MEHRFFLS  266 (337)
T ss_dssp             -----------------CCCT--TSCH----HHHHHHHHHTCSSTTTSTTCSTTTHHHH-----------HTSGGGTT
T ss_pred             -----------------CCCC--CCCH----HHHHHHHHHhhcCHHHhcCCCCCCHHHH-----------HcCCCcCC
Confidence                             1221  2344    456699999999999999     78886           66888854

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.9e-43  Score=364.52  Aligned_cols=268  Identities=26%  Similarity=0.410  Sum_probs=210.7

Q ss_pred             ccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         4 l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      ..|+.+..|.+.+.||+|+||.||+|.+..+|..||+|.+.........+.+.+|+.++++++||||+++++++.+..  
T Consensus        16 ~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--   93 (285)
T 3is5_A           16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH--   93 (285)
T ss_dssp             ESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred             CCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC--
Confidence            568888999999999999999999999999999999999987665555677789999999999999999999997644  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         84 GKVIVMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                      ..|+||||++||+|.+.+.... ....+++..++.++.||+.||.|||++||+||||||+||++ ...+..+.+||+|||
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~-~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILF-QDTSPHSPIKIIDFG  172 (285)
T ss_dssp             EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE-SSSSTTCCEEECCCC
T ss_pred             eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEE-ecCCCCCCEEEEeee
Confidence            5999999999999999885421 11238999999999999999999999999999999999997 222445689999999


Q ss_pred             ccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        163 AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       163 lA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      ++.............||+.|+|||++.         ..++.++|||||||++|+|++|..||..   ....+....+...
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~il~~ll~g~~pf~~---~~~~~~~~~~~~~  240 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFK---------RDVTFKCDIWSAGVVMYFLLTGCLPFTG---TSLEEVQQKATYK  240 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHT---------TCCCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHC
T ss_pred             cceecCCcccCcCcccccCcCChHHhc---------cCCCcccCeehHHHHHHHHHhCCCCCCC---CCHHHHHhhhccC
Confidence            998776666566778999999999874         4578999999999999999999999973   4444444433332


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ....                  ......+++    .+.+++.+||..||.+|||+.++           +.|||+.+
T Consensus       241 ~~~~------------------~~~~~~~~~----~~~~li~~~L~~dP~~Rps~~e~-----------l~hp~f~~  284 (285)
T 3is5_A          241 EPNY------------------AVECRPLTP----QAVDLLKQMLTKDPERRPSAAQV-----------LHHEWFKQ  284 (285)
T ss_dssp             CCCC------------------CC--CCCCH----HHHHHHHHHTCSCTTTSCCHHHH-----------HTSGGGGC
T ss_pred             Cccc------------------ccccCcCCH----HHHHHHHHHccCChhhCcCHHHH-----------hcCHHhhc
Confidence            1110                  011112333    45569999999999999999997           67999853

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.3e-43  Score=379.01  Aligned_cols=254  Identities=24%  Similarity=0.390  Sum_probs=205.6

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|.+.+.||+|+||.||+|+++.+|+.||+|++++..  .........+|..+++.+ +||||+++++++.+.+  .+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~--~~~  100 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD--RLF  100 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC--EEE
Confidence            46999999999999999999999999999999997532  112234457899999988 7999999999997654  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|||||+||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|..
T Consensus       101 lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl----~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL----DHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE----CCCCCEEEccccceee
Confidence            99999999999999976443   9999999999999999999999999999999999998    7777899999999986


Q ss_pred             cc-ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LE-EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~-~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .. ........+||+.|+|||++.        +..|+.++|||||||++|+|++|.+||.   +.+..+....+..... 
T Consensus       174 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~G~~Pf~---~~~~~~~~~~i~~~~~-  241 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAPEILQ--------EMLYGPAVDWWAMGVLLYEMLCGHAPFE---AENEDDLFEAILNDEV-  241 (353)
T ss_dssp             SCC---------CCGGGCCHHHHH--------HHHCTTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCC-
T ss_pred             cccCCccccccCCCcCeEChhhcC--------CCCcCCccCCCcchHHHHHHHhCCCCCC---CCCHHHHHHHHHcCCC-
Confidence            43 333445678999999999997        4678999999999999999999999997   4566666666665311 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH------HHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF------ERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa------~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                        .+|.  .+++    .+.++|.+||..||.+||++      +++           +.|||+..
T Consensus       242 ------------------~~p~--~~~~----~~~~li~~lL~~dP~~R~~~~~~~~~~~i-----------l~hp~f~~  286 (353)
T 3txo_A          242 ------------------VYPT--WLHE----DATGILKSFMTKNPTMRLGSLTQGGEHAI-----------LRHPFFKE  286 (353)
T ss_dssp             ------------------CCCT--TSCH----HHHHHHHHHTCSSGGGSTTSGGGTCTHHH-----------HTSGGGTT
T ss_pred             ------------------CCCC--CCCH----HHHHHHHHHhhhCHHHccCCcccCCHHHH-----------hhCCcccC
Confidence                              1121  2344    45669999999999999998      665           67888854

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2e-42  Score=373.67  Aligned_cols=263  Identities=25%  Similarity=0.369  Sum_probs=210.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...|.+.+.||+|+||.||+|.++.+|+.||+|++......     ..+|++++.++ +||||+++++++.+..  ..|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~l   93 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGK--YVYV   93 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSS--EEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCC--EEEE
Confidence            45799999999999999999999999999999999754321     23688888888 8999999999987644  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec-CCCceEEEeccCcccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD-DGSTIYKLTDFGAARE  166 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~-d~~~~vKL~DFGlA~~  166 (708)
                      |||||+||+|.+++.....   +++..+..++.||+.||.|||++||+||||||+|||+ ... +..+.+||+|||++..
T Consensus        94 v~E~~~gg~L~~~i~~~~~---~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~-~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY-VDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTT---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-SSSSCSGGGEEECCCTTCEE
T ss_pred             EEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEE-ecCCCCcCeEEEEECCCccc
Confidence            9999999999999976543   9999999999999999999999999999999999997 222 2235699999999987


Q ss_pred             cccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .... ......+||+.|+|||++.        +..|+.++|||||||++|+|++|..||.........+.+..+......
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  241 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLE--------RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS  241 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHH--------HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred             CcCCCCceeccCCCccccCHHHhc--------CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence            6543 3345678999999999997        456889999999999999999999999854444555555555543211


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                     +  ..+.+..++    ..+.++|.+||..||.+|||+.++           +.|||+.....
T Consensus       242 ---------------~--~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~i-----------l~hp~~~~~~~  286 (342)
T 2qr7_A          242 ---------------L--SGGYWNSVS----DTAKDLVSKMLHVDPHQRLTAALV-----------LRHPWIVHWDQ  286 (342)
T ss_dssp             ---------------C--CSTTTTTSC----HHHHHHHHHHTCSSTTTSCCHHHH-----------TTSHHHHTGGG
T ss_pred             ---------------c--CccccccCC----HHHHHHHHHHCCCChhHCcCHHHH-----------hcCCeecCccc
Confidence                           0  011112334    445669999999999999999987           67898865433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4e-42  Score=373.72  Aligned_cols=262  Identities=23%  Similarity=0.354  Sum_probs=198.6

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...+|.+.+.||+|+||.||++.+..+|+.||+|++.....  ..+...+|+.++++++||||+++++++...+  .+|+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~l   93 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAI   93 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC--EEEE
Confidence            45689999999999999999999999999999999975432  2345679999999999999999999998654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+  +.++.+.+||+|||+|+..
T Consensus        94 v~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill--~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           94 IMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEE--CSSSSCCEEECCCCCC---
T ss_pred             EEEeCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE--cCCCCceEEEeecCccccc
Confidence            9999999999999876433   9999999999999999999999999999999999997  4444456999999999865


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCC-ccccchhhhhHHHHHhcCCCCCCCCCCCC-hhhHHHHHHhcccC
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFG-ATVDLWSIGVTLYHVATGNLPFRPYGGRR-NKETMYYITTKKAS  245 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s-~ksDIWSLGviLyeLlTG~~PF~~~~g~~-~~e~~~~i~~~~~~  245 (708)
                      ..........||+.|+|||++.        +..++ .++|||||||++|+|++|+.||....... ....+..+....  
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~--  238 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLL--------RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK--  238 (361)
T ss_dssp             ------------CTTSCHHHHH--------CSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC--
T ss_pred             cccCCCCCCcCCCCcCChhhhc--------CCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC--
Confidence            5555556678999999999997        45554 44899999999999999999997533322 222333333211  


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                       ..+|....+++.    +.+||.+||..||.+|||+.++           +.|||+...
T Consensus       239 -----------------~~~~~~~~~s~~----~~~li~~~L~~dP~~Rps~~el-----------l~hp~f~~~  281 (361)
T 3uc3_A          239 -----------------YSIPDDIRISPE----CCHLISRIFVADPATRISIPEI-----------KTHSWFLKN  281 (361)
T ss_dssp             -----------------CCCCTTSCCCHH----HHHHHHHHSCSCTTTSCCHHHH-----------HTSHHHHTT
T ss_pred             -----------------CCCCCcCCCCHH----HHHHHHHHccCChhHCcCHHHH-----------HhCcchhcC
Confidence                             123333344554    4569999999999999999997           668887443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=364.20  Aligned_cols=259  Identities=23%  Similarity=0.423  Sum_probs=203.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-------------------------chHHHHHHHHHHHh
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-------------------------PHDVQMREFEVLKK   64 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-------------------------~~~~~~~Ei~iL~k   64 (708)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++.......                         ..+.+.+|+.++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            47999999999999999999999999999999997543211                         12446789999999


Q ss_pred             CCCCCccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q psy15481         65 VKHENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNI  144 (708)
Q Consensus        65 L~HpNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NI  144 (708)
                      ++||||+++++++.+......|+||||+++++|.+++...    .+++..++.++.||+.||.|||++||+||||||+||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            9999999999999876667899999999999998866432    399999999999999999999999999999999999


Q ss_pred             EEEEecCCCceEEEeccCccccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCC
Q psy15481        145 MKFICDDGSTIYKLTDFGAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP  223 (708)
Q Consensus       145 Ll~~~~d~~~~vKL~DFGlA~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~P  223 (708)
                      |+    +..+.+||+|||++....... ......||+.|+|||++....     ...++.++|||||||++|+|++|..|
T Consensus       169 l~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          169 LV----GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR-----KIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             EE----CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC-----CCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             EE----CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCC-----CCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            98    666789999999998765432 334568999999999986210     11247889999999999999999999


Q ss_pred             CCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        224 FRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       224 F~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                      |..   .........+.....                   .+|....+++    .+.++|.+||..||.+|||+.++   
T Consensus       240 f~~---~~~~~~~~~~~~~~~-------------------~~~~~~~~~~----~l~~li~~~l~~dp~~R~s~~e~---  290 (298)
T 2zv2_A          240 FMD---ERIMCLHSKIKSQAL-------------------EFPDQPDIAE----DLKDLITRMLDKNPESRIVVPEI---  290 (298)
T ss_dssp             SCC---SSHHHHHHHHHHCCC-------------------CCCSSSCCCH----HHHHHHHHHTCSCTTTSCCHHHH---
T ss_pred             CCC---ccHHHHHHHHhcccC-------------------CCCCccccCH----HHHHHHHHHhhcChhhCCCHHHH---
Confidence            973   333343333332111                   1222233444    45569999999999999999997   


Q ss_pred             HHHHHhhhhcCcccC
Q psy15481        304 VTKTLNRKLVHLFHI  318 (708)
Q Consensus       304 l~~il~~~l~h~~~~  318 (708)
                              +.|||+.
T Consensus       291 --------l~hp~~~  297 (298)
T 2zv2_A          291 --------KLHPWVT  297 (298)
T ss_dssp             --------TTCHHHH
T ss_pred             --------hcCcccc
Confidence                    6788873

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4e-42  Score=360.51  Aligned_cols=281  Identities=23%  Similarity=0.323  Sum_probs=210.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|++....... ......+|+.++++++||||+++++++.+.+  ..++||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~   80 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLVF   80 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC--EEEEEE
Confidence            6999999999999999999999999999999997654332 2355679999999999999999999998654  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+.| +|...+....  ..+++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++.....
T Consensus        81 e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~----~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI----NRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             ECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTTCEECCS
T ss_pred             ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEeecccceecCC
Confidence            99975 5555554422  239999999999999999999999999999999999998    6677899999999987653


Q ss_pred             c-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC---
Q psy15481        170 D-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS---  245 (708)
Q Consensus       170 ~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~---  245 (708)
                      . .......||+.|+|||++..       ...++.++|||||||++|+|++|..||.+  +.+..+.+..+......   
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~~~~p~~~--~~~~~~~~~~i~~~~~~~~~  224 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCT
T ss_pred             ccccccCCccccCCcChHHHcC-------CCCcCchHHHHHHHHHHHHHHHcCCCCcC--CCCHHHHHHHHHHHhCCCCh
Confidence            3 23345679999999999863       34589999999999999999998888643  45555555555432111   


Q ss_pred             CcccccccCCC-CcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        246 GVISGTQTSEN-GEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       246 ~~i~~~~~~~~-g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ........... .+..............+.++..+.++|.+||..||++|||++++           +.|||+..-
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~-----------l~hp~f~~~  289 (292)
T 3o0g_A          225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA-----------LQHPYFSDF  289 (292)
T ss_dssp             TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH-----------HTSGGGTTC
T ss_pred             hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHH-----------hcCcccccC
Confidence            11110000000 00000000111112333455667779999999999999999997           679999764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-42  Score=376.84  Aligned_cols=268  Identities=25%  Similarity=0.399  Sum_probs=219.2

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      .|+....|.+.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+..  .
T Consensus        46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~  122 (387)
T 1kob_A           46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--E  122 (387)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS--E
T ss_pred             CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC--E
Confidence            45556689999999999999999999999999999999875421 12345679999999999999999999997644  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||+.||+|.+++....  ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+.+||+|||+|
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll--~~~~~~~vkL~DFG~a  198 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC--ETKKASSVKIIDFGLA  198 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--SSTTCCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEE--ecCCCCceEEEecccc
Confidence            999999999999999997643  238999999999999999999999999999999999997  3345567999999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .............||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +.+..+.+..+.....
T Consensus       199 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltg~~Pf~---~~~~~~~~~~i~~~~~  267 (387)
T 1kob_A          199 TKLNPDEIVKVTTATAEFAAPEIVD--------REPVGFYTDMWAIGVLGYVLLSGLSPFA---GEDDLETLQNVKRCDW  267 (387)
T ss_dssp             EECCTTSCEEEECSSGGGCCHHHHT--------TCCBCHHHHHHHHHHHHHHHHHSCCSSC---CSSHHHHHHHHHHCCC
T ss_pred             eecCCCcceeeeccCCCccCchhcc--------CCCCCCcccEeeHhHHHHHHHhCCCCCC---CCCHHHHHHHHHhCCC
Confidence            9876665556678999999999987        5778999999999999999999999997   3555566655554211


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                       ....+....+++    .+.++|.+||..||.+|||+.++           +.|||+.....
T Consensus       268 -----------------~~~~~~~~~~s~----~~~~li~~~L~~dP~~Rpt~~el-----------l~hp~~~~~~~  313 (387)
T 1kob_A          268 -----------------EFDEDAFSSVSP----EAKDFIKNLLQKEPRKRLTVHDA-----------LEHPWLKGDHS  313 (387)
T ss_dssp             -----------------CCCSSTTTTSCH----HHHHHHHTTSCSSGGGSCCHHHH-----------HTSTTTSSCCT
T ss_pred             -----------------CCCccccccCCH----HHHHHHHHHcCCChhHCcCHHHH-----------hhCccccCCcc
Confidence                             001111223344    45669999999999999999997           67999977544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=379.88  Aligned_cols=260  Identities=24%  Similarity=0.406  Sum_probs=213.4

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|.+.+.||+|+||.||+|.+..+|+.||+|++....  .........+|+.+++.++||||+++++++.+.+  ..|+
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~l   92 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE--DMFM   92 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EEEE
Confidence            47999999999999999999999999999999986432  1223445679999999999999999999998654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||+.||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|...
T Consensus        93 v~e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll----~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQNVH---FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL----DEHGHVHITDFNIAAML  165 (384)
T ss_dssp             EECCCTTEEHHHHHHTTCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE----CCCCCEEEeccceeeec
Confidence            9999999999999987543   9999999999999999999999999999999999998    77778999999999987


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      .........+||+.|+|||++...     .+..|+.++|||||||++|+|++|..||.........+....+....    
T Consensus       166 ~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~----  236 (384)
T 4fr4_A          166 PRETQITTMAGTKPYMAPEMFSSR-----KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV----  236 (384)
T ss_dssp             CTTCCBCCCCSCGGGCCGGGTCCC-----SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC----
T ss_pred             cCCCceeccCCCccccCCeeeccC-----CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc----
Confidence            776667778999999999998621     13568999999999999999999999998544444444444433311    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                       .+.+..+    +..+.++|.+||..||.+||+ ++++           ..|||+..
T Consensus       237 -----------------~~~p~~~----s~~~~~li~~lL~~dP~~R~s~~~~l-----------~~hp~f~~  277 (384)
T 4fr4_A          237 -----------------VTYPSAW----SQEMVSLLKKLLEPNPDQRFSQLSDV-----------QNFPYMND  277 (384)
T ss_dssp             -----------------CCCCTTS----CHHHHHHHHHHSCSSGGGSCCSHHHH-----------HTSGGGTT
T ss_pred             -----------------cCCCCcC----CHHHHHHHHHHhcCCHhHhcccHHHH-----------HcChhhhc
Confidence                             1111223    345666999999999999999 5664           56888854

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.1e-42  Score=368.62  Aligned_cols=262  Identities=25%  Similarity=0.374  Sum_probs=207.5

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .....|.+.+.||+|+||.||+|.+..+|+.||+|++.........+.+.+|+.+++.++||||+++++++.+.+  ..|
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~   81 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQY   81 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS--EEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--eEE
Confidence            355689999999999999999999999999999999976544444455679999999999999999999987644  589


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|||||+||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll----~~~~~~kl~Dfg~a~~  154 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL----DERDNLKISDFGLATV  154 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE----eCCCCEEEEEeeccce
Confidence            99999999999999976433   9999999999999999999999999999999999998    6777899999999986


Q ss_pred             ccccc---cccccCCCCCcCChhhhhhhhhcCCCCCc-CCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        167 LEEDQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKT-FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       167 ~~~~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~-~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .....   ......||+.|+|||++.        +.. ++.++|||||||++|+|++|..||.......  .........
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~  224 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELLK--------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEK  224 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHHH--------CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--HHHHHHHTT
T ss_pred             eccCCcccccCCCccCcCccCcHHhc--------cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHhcc
Confidence            54332   234568999999999997        444 4789999999999999999999997432211  112212211


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                      .                   ..++....+++    .+.++|.+||..||.+|||+.++           +.|||+....
T Consensus       225 ~-------------------~~~~~~~~~~~----~~~~li~~~L~~dP~~R~t~~ei-----------l~h~~~~~~~  269 (323)
T 3tki_A          225 K-------------------TYLNPWKKIDS----APLALLHKILVENPSARITIPDI-----------KKDRWYNKPL  269 (323)
T ss_dssp             C-------------------TTSTTGGGSCH----HHHHHHHHHSCSSTTTSCCHHHH-----------TTCTTTTCCC
T ss_pred             c-------------------ccCCccccCCH----HHHHHHHHHccCChhhCcCHHHH-----------hhChhhcccc
Confidence            0                   01222233444    45569999999999999999997           7799997643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.1e-42  Score=368.11  Aligned_cols=280  Identities=25%  Similarity=0.385  Sum_probs=201.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..+|.+.+.||+|+||.||+|.++.+|+.||+|.++............+|+.++++++||||+++++++...+  ..|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN--KLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT--EEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC--eEEEE
Confidence            4579999999999999999999999999999999986654444566779999999999999999999987644  59999


Q ss_pred             EeccCCCCHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         89 MELCTGGSLFNILDDPE---NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~---~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |||+. |+|.+++....   ....+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~----~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI----NKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCSSCE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE----cCCCCEEECcCccce
Confidence            99997 69998876421   12348999999999999999999999999999999999998    667789999999998


Q ss_pred             ccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc--
Q psy15481        166 ELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK--  242 (708)
Q Consensus       166 ~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~--  242 (708)
                      ..... .......||+.|+|||++..       ...++.++|||||||++|+|++|..||.   +.+..+.+..+...  
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~---~~~~~~~~~~i~~~~~  226 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMG-------SRTYSTSIDIWSCGCILAEMITGKPLFP---GTNDEEQLKLIFDIMG  226 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHHHHHHC
T ss_pred             ecCCCcccCCCCcccccccCchHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCC---CCChHHHHHHHHHHhC
Confidence            76533 33445689999999999862       3568999999999999999999999997   35555555555432  


Q ss_pred             -ccCCcccccccCCCCcccccCCCCCc----------ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        243 -KASGVISGTQTSENGEIDWCTDLPNN----------CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       243 -~~~~~i~~~~~~~~g~~~~~~~lp~~----------~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                       .............    .|...++..          ......++..+.++|.+||..||.+|||+.++           
T Consensus       227 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~-----------  291 (317)
T 2pmi_A          227 TPNESLWPSVTKLP----KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA-----------  291 (317)
T ss_dssp             SCCTTTCGGGGGCT----TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHH-----------
T ss_pred             CCChhHhhhhhhhh----hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHH-----------
Confidence             1111111110000    011011100          00111234456779999999999999999997           


Q ss_pred             hcCcccCCc
Q psy15481        312 LVHLFHINR  320 (708)
Q Consensus       312 l~h~~~~~~  320 (708)
                      +.|||+..-
T Consensus       292 l~hp~f~~~  300 (317)
T 2pmi_A          292 LHHPWFAEY  300 (317)
T ss_dssp             TTSGGGGGG
T ss_pred             hCChhhhcc
Confidence            779998654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.2e-42  Score=363.84  Aligned_cols=282  Identities=24%  Similarity=0.367  Sum_probs=209.3

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ....+|.+.+.||+|+||.||+|.+. +|+.||+|++....... ......+|+.++++++||||+++++++.+..  ..
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~   94 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER--CL   94 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS--CE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC--EE
Confidence            34578999999999999999999985 59999999997543322 2345679999999999999999999987654  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ++||||++ ++|.+.+.....  ++++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.
T Consensus        95 ~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~----~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           95 TLVFEFME-KDLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI----NSDGALKLADFGLAR  167 (311)
T ss_dssp             EEEEECCS-EEHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCTTCE
T ss_pred             EEEEcCCC-CCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE----CCCCCEEEccCcCce
Confidence            99999996 588888876432  39999999999999999999999999999999999998    666789999999998


Q ss_pred             ccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ..... .......||+.|+|||++..       ...++.++|||||||++|+|++|..||.+.........+..+.....
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  240 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMG-------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN  240 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcC-------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC
Confidence            76433 33445679999999999862       35689999999999999999999999985443333333333333222


Q ss_pred             CCcccccccCCCCcccccC------CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        245 SGVISGTQTSENGEIDWCT------DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~------~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      +.........    ..|..      .......+.+.+...+.+||.+||..||.+|||+.++           +.|||+.
T Consensus       241 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el-----------l~hp~f~  305 (311)
T 3niz_A          241 PREWPQVQEL----PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA-----------MNHPYFK  305 (311)
T ss_dssp             TTTSGGGTTS----HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH-----------HTSGGGT
T ss_pred             hHHhhhhhcc----chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH-----------hcCcccc
Confidence            2111111000    00000      0001111223344566779999999999999999997           6799997


Q ss_pred             Cc
Q psy15481        319 NR  320 (708)
Q Consensus       319 ~~  320 (708)
                      .-
T Consensus       306 ~~  307 (311)
T 3niz_A          306 DL  307 (311)
T ss_dssp             TS
T ss_pred             cC
Confidence            53

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.4e-42  Score=366.38  Aligned_cols=259  Identities=20%  Similarity=0.299  Sum_probs=206.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC------
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG------   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~------   82 (708)
                      ...|.+.+.||+|+||.||+|.++.+|+.||||+++........+.+.+|+.++++++||||+++++++.+.+.      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            35799999999999999999999999999999999865555555677899999999999999999998865432      


Q ss_pred             -------------------------------------------------ceEEEEEeccCCCCHHHHhcCCCCCCCCCHH
Q psy15481         83 -------------------------------------------------RGKVIVMELCTGGSLFNILDDPENTYGLQEE  113 (708)
Q Consensus        83 -------------------------------------------------~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~  113 (708)
                                                                       ...++|||||+|++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                             2389999999999999999886554446777


Q ss_pred             HHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc-------------cccccCCCC
Q psy15481        114 EFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-------------QFMSLYGTE  180 (708)
Q Consensus       114 ~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~-------------~~~~~~GT~  180 (708)
                      .++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.......             ......||+
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF----TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE----eCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            899999999999999999999999999999998    666789999999998765442             223457999


Q ss_pred             CcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCccc
Q psy15481        181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEID  260 (708)
Q Consensus       181 ~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~  260 (708)
                      .|+|||++.        +..++.++|||||||++|+|++|..|+.     .....+..+...                  
T Consensus       241 ~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~------------------  289 (332)
T 3qd2_B          241 LYMSPEQIH--------GNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNL------------------  289 (332)
T ss_dssp             GGSCHHHHH--------CCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTT------------------
T ss_pred             CccChHHhc--------CCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhcc------------------
Confidence            999999997        6778999999999999999999877653     112222222211                  


Q ss_pred             ccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        261 WCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       261 ~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                         .+|.   ........+.+++.+||..||.+|||+.++           +.|||+.+
T Consensus       290 ---~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~-----------l~~~~f~~  331 (332)
T 3qd2_B          290 ---KFPL---LFTQKYPQEHMMVQDMLSPSPTERPEATDI-----------IENAIFEN  331 (332)
T ss_dssp             ---CCCH---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHH-----------HHSTTCCC
T ss_pred             ---CCCc---ccccCChhHHHHHHHHccCCCCcCCCHHHH-----------hhchhhhc
Confidence               1111   112233445779999999999999999997           56898854

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.8e-42  Score=367.21  Aligned_cols=264  Identities=28%  Similarity=0.470  Sum_probs=216.4

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-----chHHHHHHHHHHHhCCCCCccceeEEEEe
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-----PHDVQMREFEVLKKVKHENIVKLLAIEEE   79 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-----~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~   79 (708)
                      .......|.+.+.||+|+||.||+|.+..+|+.||+|++.......     ..+.+.+|+.++++++||||+++++++.+
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            3445568999999999999999999999999999999997643322     24557799999999999999999999876


Q ss_pred             cCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCc----e
Q psy15481         80 QEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST----I  155 (708)
Q Consensus        80 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~----~  155 (708)
                      .+  ..|+||||++|++|.+++....   .+++..++.++.|++.||.|||++||+||||||+||++    +..+    .
T Consensus        87 ~~--~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~----~~~~~~~~~  157 (321)
T 2a2a_A           87 RT--DVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML----LDKNIPIPH  157 (321)
T ss_dssp             SS--EEEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----SCTTSSSCC
T ss_pred             CC--EEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEE----ecCCCCcCC
Confidence            44  5999999999999999997644   38999999999999999999999999999999999997    3333    7


Q ss_pred             EEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhH
Q psy15481        156 YKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKET  235 (708)
Q Consensus       156 vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~  235 (708)
                      +||+|||++.............||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +....+.
T Consensus       158 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~---~~~~~~~  226 (321)
T 2a2a_A          158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN--------YEPLGLEADMWSIGVITYILLSGASPFL---GDTKQET  226 (321)
T ss_dssp             EEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSCCSSC---CSSHHHH
T ss_pred             EEEccCccceecCccccccccCCCCCccCccccc--------CCCCCCccccHHHHHHHHHHHHCCCCCC---CCCHHHH
Confidence            9999999998877666666778999999999987        6778999999999999999999999997   3555555


Q ss_pred             HHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCc
Q psy15481        236 MYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHL  315 (708)
Q Consensus       236 ~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~  315 (708)
                      +..+.....                   .++.  ......+..+.++|.+||..||.+|||+.++           +.||
T Consensus       227 ~~~i~~~~~-------------------~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~-----------l~hp  274 (321)
T 2a2a_A          227 LANITSVSY-------------------DFDE--EFFSHTSELAKDFIRKLLVKETRKRLTIQEA-----------LRHP  274 (321)
T ss_dssp             HHHHHTTCC-------------------CCCH--HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHH-----------HHST
T ss_pred             HHHHHhccc-------------------ccCh--hhhcccCHHHHHHHHHHcCCChhhCcCHHHH-----------hcCc
Confidence            555543211                   0110  1111233456679999999999999999997           5699


Q ss_pred             ccCCc
Q psy15481        316 FHINR  320 (708)
Q Consensus       316 ~~~~~  320 (708)
                      |+.+.
T Consensus       275 ~~~~~  279 (321)
T 2a2a_A          275 WITPV  279 (321)
T ss_dssp             TTSCS
T ss_pred             cccCC
Confidence            98654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=371.86  Aligned_cols=263  Identities=26%  Similarity=0.411  Sum_probs=196.0

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|++....   ..+.+.+|+.++++++||||+++++++...+  ..++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT--EISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSS--EEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCC--eEEEE
Confidence            456999999999999999999999999999999997543   2344568999999999999999999997654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+ ...+..+.+||+|||++....
T Consensus       127 ~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll-~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLY-ATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-SSSSTTCCEEECCCC------
T ss_pred             EEeCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEE-ecCCCCCCEEEccCccccccC
Confidence            999999999999976443   8999999999999999999999999999999999997 122346789999999998776


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .........||+.|+|||++.        +..++.++|||||||++|+|++|..||..  .......+..+......   
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~~--~~~~~~~~~~i~~~~~~---  269 (349)
T 2w4o_A          203 HQVLMKTVCGTPGYCAPEILR--------GCAYGPEVDMWSVGIITYILLCGFEPFYD--ERGDQFMFRRILNCEYY---  269 (349)
T ss_dssp             ----------CGGGSCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSSCTTCC--TTCHHHHHHHHHTTCCC---
T ss_pred             cccccccccCCCCccCHHHhc--------CCCCCcccchHHHHHHHHHHHhCCCCCCC--CcccHHHHHHHHhCCCc---
Confidence            655556678999999999987        66789999999999999999999999974  22233334444432110   


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                  +  ..+.+..+    +..+.++|.+||..||++|||+.++           +.|||+.....
T Consensus       270 ------------~--~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~-----------l~hp~~~~~~~  314 (349)
T 2w4o_A          270 ------------F--ISPWWDEV----SLNAKDLVRKLIVLDPKKRLTTFQA-----------LQHPWVTGKAA  314 (349)
T ss_dssp             ------------C--CTTTTTTS----CHHHHHHHHTTSCSSGGGSCCHHHH-----------HHSTTTTSTTC
T ss_pred             ------------c--CCchhhhC----CHHHHHHHHHHccCChhhCcCHHHH-----------hcCcccCCCcc
Confidence                        0  01111223    3455669999999999999999997           56999987654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.8e-42  Score=358.07  Aligned_cols=271  Identities=26%  Similarity=0.378  Sum_probs=219.2

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ...+..|.+.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+|+.++++++||||+++++++...+  .
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~   79 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES--F   79 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC--E
Confidence            45678899999999999999999999999999999999754322 22344578999999999999999999987644  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .++||||++|++|.+.+.....   +++..+..++.|++.||.|||++||+||||||+||++ ..++..+.+||+|||.+
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~-~~~~~~~~~kl~Dfg~~  155 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLL-ASKAKGAAVKLADFGLA  155 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-SSSSTTCCEEECCCTTC
T ss_pred             EEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEE-ecCCCCCcEEEeeceee
Confidence            8999999999999888876443   8999999999999999999999999999999999997 11222356999999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .............||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +.........+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~pf~---~~~~~~~~~~~~~~~~  224 (284)
T 3kk8_A          156 IEVNDSEAWHGFAGTPGYLSPEVLK--------KDPYSKPVDIWACGVILYILLVGYPPFW---DEDQHRLYAQIKAGAY  224 (284)
T ss_dssp             EECCSSCBCCCSCSCGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHTCC
T ss_pred             EEcccCccccCCCCCcCCcCchhhc--------CCCCCcccchHHHHHHHHHHHHCCCCCC---CCchhHHHHHHHhccc
Confidence            8877666666778999999999987        6778999999999999999999999997   3445555544443211


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccccc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCI  324 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~~  324 (708)
                      .                 ...+....+++    .+.+++.+||..||.+|||+.++           +.|||+.......
T Consensus       225 ~-----------------~~~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~~-----------l~h~~~~~~~~~~  272 (284)
T 3kk8_A          225 D-----------------YPSPEWDTVTP----EAKSLIDSMLTVNPKKRITADQA-----------LKVPWICNRERVA  272 (284)
T ss_dssp             C-----------------CCTTTTTTSCH----HHHHHHHHHSCSSTTTSCCHHHH-----------TTSHHHHSCCCGG
T ss_pred             c-----------------CCchhhcccCH----HHHHHHHHHcccChhhCCCHHHH-----------hcCccccCChhHH
Confidence            1                 01122223444    45669999999999999999997           7799997765554


Q ss_pred             c
Q psy15481        325 R  325 (708)
Q Consensus       325 ~  325 (708)
                      .
T Consensus       273 ~  273 (284)
T 3kk8_A          273 S  273 (284)
T ss_dssp             G
T ss_pred             h
Confidence            4

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=385.20  Aligned_cols=264  Identities=27%  Similarity=0.387  Sum_probs=213.3

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ....|.+.+.||+|+||.||+|.++.+|+.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+  ..|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~   86 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG--HHY   86 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS--EEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC--EEE
Confidence            446899999999999999999999999999999999754322 12344579999999999999999999997654  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|||||.||+|.+.+.....   +++..+..++.||+.||.|||++||+||||||+|||+ ......+.+||+|||+|..
T Consensus        87 lv~E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll-~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLL-ASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEE-SBSSTTCCEEECCCSSCBC
T ss_pred             EEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE-eccCCCCcEEEccCceeEE
Confidence            99999999999998876543   9999999999999999999999999999999999997 1122456899999999987


Q ss_pred             ccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ..... ......||+.|+|||++.        +..|+.++|||||||++|+|++|.+||.   +.+..+....+......
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~--------~~~~~~~~DIwSlGvilyell~G~~Pf~---~~~~~~~~~~i~~~~~~  231 (444)
T 3soa_A          163 VEGEQQAWFGFAGTPGYLSPEVLR--------KDPYGKPVDLWACGVILYILLVGYPPFW---DEDQHRLYQQIKAGAYD  231 (444)
T ss_dssp             CCTTCCBCCCSCSCGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHHHHTCCC
T ss_pred             ecCCCceeecccCCcccCCHHHhc--------CCCCCCccccHHHHHHHHHHHhCCCCCC---CccHHHHHHHHHhCCCC
Confidence            65443 335578999999999987        6778999999999999999999999997   45566666665543211


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                       ...|.+..+++.    +.++|.+||..||.+|||+.++           +.|||+...
T Consensus       232 -----------------~~~~~~~~~s~~----~~~li~~~L~~dP~~Rpta~e~-----------L~hp~~~~~  274 (444)
T 3soa_A          232 -----------------FPSPEWDTVTPE----AKDLINKMLTINPSKRITAAEA-----------LKHPWISHR  274 (444)
T ss_dssp             -----------------CCTTTTTTSCHH----HHHHHHHHSCSSTTTSCCHHHH-----------HHSCTTHHH
T ss_pred             -----------------CCccccccCCHH----HHHHHHHHcCCChhHCCCHHHH-----------hcCccccCC
Confidence                             011222334444    5569999999999999999997           669998654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-42  Score=362.80  Aligned_cols=286  Identities=22%  Similarity=0.282  Sum_probs=212.9

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC----CCchHHHHHHHHHHHhC---CCCCccceeEEEEe
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH----MRPHDVQMREFEVLKKV---KHENIVKLLAIEEE   79 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~----~~~~~~~~~Ei~iL~kL---~HpNIVkl~~v~~~   79 (708)
                      ....+|.+.+.||+|+||.||+|.+..+|+.||+|++.....    ........+|+.+++++   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            345689999999999999999999999999999999864332    11223455788877776   49999999999876


Q ss_pred             cCCc---eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceE
Q psy15481         80 QEGR---GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY  156 (708)
Q Consensus        80 ~~~~---~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~v  156 (708)
                      ....   ..++||||+. ++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~----~~~~~~  159 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV----TSGGTV  159 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE----CTTSCE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----cCCCCE
Confidence            5432   5799999995 699999987543 238999999999999999999999999999999999998    666789


Q ss_pred             EEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHH
Q psy15481        157 KLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM  236 (708)
Q Consensus       157 KL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~  236 (708)
                      ||+|||+|.............||+.|+|||++.        +..++.++|||||||++|+|++|.+||.   +.+..+.+
T Consensus       160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~l~~g~~pf~---~~~~~~~~  228 (308)
T 3g33_A          160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLL--------QSTYATPVDMWSVGCIFAEMFRRKPLFC---GNSEADQL  228 (308)
T ss_dssp             EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHH--------TSCCCSTHHHHHHHHHHHHTTTSSCSCC---CSSHHHHH
T ss_pred             EEeeCccccccCCCcccCCccccccccCchHHc--------CCCCCchHHHHHHHHHHHHHHhCCCCCC---CCCHHHHH
Confidence            999999998776666666778999999999997        6778999999999999999999999997   45556666


Q ss_pred             HHHHhcccCCcccccccCC-CCcccccCCCC-CcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcC
Q psy15481        237 YYITTKKASGVISGTQTSE-NGEIDWCTDLP-NNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVH  314 (708)
Q Consensus       237 ~~i~~~~~~~~i~~~~~~~-~g~~~~~~~lp-~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h  314 (708)
                      ..+................ .....+....+ ....+.+.++..+.++|.+||..||.+|||+.++           +.|
T Consensus       229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~-----------l~h  297 (308)
T 3g33_A          229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA-----------LQH  297 (308)
T ss_dssp             HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHH-----------HTS
T ss_pred             HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHH-----------hcC
Confidence            6555421111000000000 00000110000 0111223445567779999999999999999997           679


Q ss_pred             cccCCc
Q psy15481        315 LFHINR  320 (708)
Q Consensus       315 ~~~~~~  320 (708)
                      ||+...
T Consensus       298 ~~~~~~  303 (308)
T 3g33_A          298 SYLHKD  303 (308)
T ss_dssp             TTC---
T ss_pred             ccccCC
Confidence            999764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.8e-42  Score=359.54  Aligned_cols=274  Identities=25%  Similarity=0.371  Sum_probs=205.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|.+.+.||+|+||.||+|.+ .+|+.||+|.+...... .......+|+.++++++||||+++++++...+  ..|+||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~   79 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVLVF   79 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEEEE
T ss_pred             cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC--eEEEEE
Confidence            689999999999999999998 68999999999654322 22355679999999999999999999998654  499999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+. ++|.+++.....  ++++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.....
T Consensus        80 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           80 EHLD-QDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI----NREGELKIADFGLARAFGI  152 (288)
T ss_dssp             ECCS-EEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECCTTHHHHHCC
T ss_pred             EecC-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCCEEEeECccccccCc
Confidence            9996 599998876432  39999999999999999999999999999999999998    6677899999999986543


Q ss_pred             c-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc---ccC
Q psy15481        170 D-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK---KAS  245 (708)
Q Consensus       170 ~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~---~~~  245 (708)
                      . .......||+.|+|||++..       ...++.++|||||||++|+|++|..||..   .+..+.+..+...   ...
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~---~~~~~~~~~~~~~~~~~~~  222 (288)
T 1ob3_A          153 PVRKYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFPG---VSEADQLMRIFRILGTPNS  222 (288)
T ss_dssp             ---------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCchheeC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHHCCCCh
Confidence            3 23345679999999999862       35689999999999999999999999973   4555555554431   111


Q ss_pred             CcccccccCCCCcccccCCCC-----CcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLP-----NNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp-----~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      .........    ..+...++     .+......++..+.++|.+||..||++|||+.++           +.|||+..
T Consensus       223 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~-----------l~hp~f~~  286 (288)
T 1ob3_A          223 KNWPNVTEL----PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA-----------LEHAYFKE  286 (288)
T ss_dssp             TTSTTGGGS----TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH-----------HTSGGGGC
T ss_pred             hhchhhhcc----cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHH-----------hcCcchhh
Confidence            111000000    00111111     1111223345566779999999999999999997           67999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-42  Score=366.25  Aligned_cols=252  Identities=23%  Similarity=0.388  Sum_probs=210.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|.+.+.||+|+||.||+|.++.+|+.||+|++++..  .....+...+|..+++.++||||+++++++.+..  .+|+
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~l   83 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ--QIFM   83 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS--EEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC--EEEE
Confidence            47999999999999999999999999999999997532  1223445678999999999999999999997644  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++...
T Consensus        84 v~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL----DKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             EECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE----CTTSCEEECCCSSCEEC
T ss_pred             EEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE----cCCCCEEEeecCcceec
Confidence            9999999999999976443   8999999999999999999999999999999999998    67778999999999865


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ...  ....+||+.|+|||++.        +..++.++|+|||||++|+|++|..||.   +.+.......+.....   
T Consensus       157 ~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~---~~~~~~~~~~i~~~~~---  220 (318)
T 1fot_A          157 PDV--TYTLCGTPDYIAPEVVS--------TKPYNKSIDWWSFGILIYEMLAGYTPFY---DSNTMKTYEKILNAEL---  220 (318)
T ss_dssp             SSC--BCCCCSCTTTCCHHHHT--------TCCBCTTHHHHHHHHHHHHHHHSSCTTC---CSSHHHHHHHHHHCCC---
T ss_pred             CCc--cccccCCccccCHhHhc--------CCCCCcccchhhhHHHHHHHHhCCCCCC---CCCHHHHHHHHHhCCC---
Confidence            432  34578999999999987        6778999999999999999999999997   3555566666654311   


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                      .+|  ..++    ..+.++|.+||..||.+||     +++++           +.|||+..
T Consensus       221 ----------------~~p--~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i-----------~~hp~f~~  264 (318)
T 1fot_A          221 ----------------RFP--PFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDV-----------KNHPWFKE  264 (318)
T ss_dssp             ----------------CCC--TTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHH-----------HTSGGGSS
T ss_pred             ----------------CCC--CCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHH-----------hcCccccC
Confidence                            112  1233    4456699999999999999     78886           67899864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7e-42  Score=377.18  Aligned_cols=257  Identities=23%  Similarity=0.394  Sum_probs=205.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|.+.+.||+|+||.||+|+++.+|+.||+|++++....  .......+|..++.++ +||||+++++++.+.+  .+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~--~~~  129 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLF  129 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC--EEE
Confidence            4799999999999999999999999999999999764322  2233456899999887 8999999999997654  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+.
T Consensus       130 lV~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl----~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL----DSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEECCCTTCBC
T ss_pred             EEEEcCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE----CCCCCEEEeecceeee
Confidence            99999999999999876433   9999999999999999999999999999999999998    7777899999999986


Q ss_pred             c-cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC-----ChhhHHHH-H
Q psy15481        167 L-EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-----RNKETMYY-I  239 (708)
Q Consensus       167 ~-~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~-----~~~e~~~~-i  239 (708)
                      . .........+||+.|+|||++.        +..|+.++|+|||||++|+|++|.+||...+..     ...+.+.. +
T Consensus       203 ~~~~~~~~~~~~gt~~Y~aPE~l~--------~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i  274 (396)
T 4dc2_A          203 GLRPGDTTSTFCGTPNYIAPEILR--------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI  274 (396)
T ss_dssp             CCCTTCCBCCCCBCGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH
T ss_pred             cccCCCccccccCCcccCCchhhc--------CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH
Confidence            3 3444556688999999999997        678999999999999999999999999643221     11222222 3


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH------HHHHHHHHHHHhhhhc
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF------ERFFSEVTKTLNRKLV  313 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa------~q~~~~l~~il~~~l~  313 (708)
                      .....                   .+|.  .+++    .+.++|.+||..||.+||++      .++           +.
T Consensus       275 ~~~~~-------------------~~p~--~~s~----~~~~li~~lL~~dP~~R~~~~~~~~~~ei-----------~~  318 (396)
T 4dc2_A          275 LEKQI-------------------RIPR--SLSV----KAASVLKSFLNKDPKERLGCHPQTGFADI-----------QG  318 (396)
T ss_dssp             HHCCC-------------------CCCT--TSCH----HHHHHHHHHTCSCTTTSTTCSTTTHHHHH-----------HH
T ss_pred             hcccc-------------------CCCC--cCCH----HHHHHHHHHhcCCHhHcCCCCCCCCHHHH-----------hc
Confidence            22110                   1222  2344    45669999999999999996      343           56


Q ss_pred             CcccCC
Q psy15481        314 HLFHIN  319 (708)
Q Consensus       314 h~~~~~  319 (708)
                      ||||..
T Consensus       319 Hpff~~  324 (396)
T 4dc2_A          319 HPFFRN  324 (396)
T ss_dssp             STTTTT
T ss_pred             CccccC
Confidence            888854

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-42  Score=373.84  Aligned_cols=280  Identities=23%  Similarity=0.312  Sum_probs=201.7

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++...... .......+|+.+++.+. ||||+++++++...+...+|+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            5799999999999999999999999999999998643222 22344578999999996 999999999998776667999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||||. ++|..++...    .+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+..
T Consensus        89 v~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll----~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCTTCEES
T ss_pred             EecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE----cCCCCEEecCCcccccc
Confidence            999996 6999998763    28999999999999999999999999999999999998    77778999999999864


Q ss_pred             cc----------------------cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCC
Q psy15481        168 EE----------------------DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR  225 (708)
Q Consensus       168 ~~----------------------~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~  225 (708)
                      ..                      .......+||+.|+|||++..       ...|+.++|||||||++|+|++|.+||.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~  232 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-------STKYTKGIDMWSLGCILGEILCGKPIFP  232 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcC-------CCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence            32                      122344689999999999872       3678999999999999999999999997


Q ss_pred             CCCCCChhhHHHHHHhcccCC---cccccccCC-------------CCcccccCCCCCcc------cCChhHHHHHHHHH
Q psy15481        226 PYGGRRNKETMYYITTKKASG---VISGTQTSE-------------NGEIDWCTDLPNNC------QLSLGLKKLVTPIL  283 (708)
Q Consensus       226 ~~~g~~~~e~~~~i~~~~~~~---~i~~~~~~~-------------~g~~~~~~~lp~~~------~ls~~l~~~l~~LL  283 (708)
                         +.+..+.+..+.......   .+.......             .....+...++.+.      .....++..+.+||
T Consensus       233 ---~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll  309 (388)
T 3oz6_A          233 ---GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL  309 (388)
T ss_dssp             ---CSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred             ---CCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence               466666666665321110   000000000             00000000000000      00012334567799


Q ss_pred             HhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        284 AGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       284 ~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      .+||..||.+|||++++           +.|||+..
T Consensus       310 ~~~L~~dP~~R~t~~e~-----------l~Hp~~~~  334 (388)
T 3oz6_A          310 DKLLQFNPNKRISANDA-----------LKHPFVSI  334 (388)
T ss_dssp             HHHCCSSGGGSCCHHHH-----------TTSTTTTT
T ss_pred             HHhhccCcccCCCHHHH-----------hCCHHHHH
Confidence            99999999999999997           77999743

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.5e-42  Score=372.59  Aligned_cols=255  Identities=25%  Similarity=0.387  Sum_probs=210.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ...|.+.+.||+|+||.||+|.++.+|+.||+|++++..  .........+|..++..+ +||||+++++++.+.+  .+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~--~~   93 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE--NL   93 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC--EE
Confidence            457999999999999999999999999999999997532  122344566899999877 9999999999997654  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL----DKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE----CCCCCEEEeEChhhh
Confidence            999999999999999976433   8999999999999999999999999999999999998    677789999999998


Q ss_pred             cccc-cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEE-DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~-~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .... .......+||+.|+|||++.        +..++.++|+|||||++|+|++|..||.   +.+..+....+....+
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~---~~~~~~~~~~i~~~~~  235 (345)
T 1xjd_A          167 ENMLGDAKTNTFCGTPDYIAPEILL--------GQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRMDNP  235 (345)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCC
T ss_pred             hcccCCCcccCCCCCcccCChhhhc--------CCCCCChhhhHHHHHHHHHHhcCCCCCC---CCCHHHHHHHHHhCCC
Confidence            6432 23445678999999999997        6778999999999999999999999997   4555666665654211


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHH-HHHHHHHHHHhhhhcCcccCC
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-RFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~-q~~~~l~~il~~~l~h~~~~~  319 (708)
                                         .+|.  .++    ..+.++|.+||..||.+||++. ++           ..|||+..
T Consensus       236 -------------------~~p~--~~s----~~~~~li~~lL~~dp~~R~~~~~~i-----------~~hp~f~~  275 (345)
T 1xjd_A          236 -------------------FYPR--WLE----KEAKDLLVKLFVREPEKRLGVRGDI-----------RQHPLFRE  275 (345)
T ss_dssp             -------------------CCCT--TSC----HHHHHHHHHHSCSSGGGSBTTBSCG-----------GGSGGGTT
T ss_pred             -------------------CCCc--ccC----HHHHHHHHHHhcCCHhHcCCChHHH-----------HcCccccC
Confidence                               1121  233    4456699999999999999987 54           67888854

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.2e-42  Score=384.97  Aligned_cols=278  Identities=23%  Similarity=0.354  Sum_probs=207.7

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecC----Cce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE----GRG   84 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~----~~~   84 (708)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++..... ........+|+.+++.++||||+++++++....    ...
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            468999999999999999999999999999999975421 122344579999999999999999999986543    246


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      +|+||||+. ++|...+..     .+++..++.++.||+.||+|||++||+||||||+|||+    +..+.+||+|||+|
T Consensus       142 ~~lv~E~~~-~~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll----~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          142 VYLVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEECCS-EEHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEECCCCCC
T ss_pred             EEEEEeCCC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE----eCCCCEEEEEEEee
Confidence            899999996 557777743     28999999999999999999999999999999999998    67778999999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      +...........+||+.|+|||++.        +..|+.++|||||||++|+|++|++||.   +.+..+.+..+.....
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~ell~g~~pF~---g~~~~~~~~~i~~~lg  280 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVIL--------GMGYKENVDIWSVGCIMGEMVRHKILFP---GRDYIDQWNKVIEQLG  280 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHT--------TCCCCTTHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHHHC
T ss_pred             eecCCCcccCCCcccccccCHHHHc--------CCCCCHHHHHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHHhcC
Confidence            9877665566788999999999997        6789999999999999999999999997   4666666666654211


Q ss_pred             CC---ccccccc---------CCCCcccccCCC-----CCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        245 SG---VISGTQT---------SENGEIDWCTDL-----PNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       245 ~~---~i~~~~~---------~~~g~~~~~~~l-----p~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ..   .+.....         .......|...+     |............+.+||.+||.+||.+|||++++       
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~-------  353 (464)
T 3ttj_A          281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA-------  353 (464)
T ss_dssp             SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH-------
T ss_pred             CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH-------
Confidence            11   0000000         000011111111     11111112235668889999999999999999997       


Q ss_pred             HhhhhcCcccCC
Q psy15481        308 LNRKLVHLFHIN  319 (708)
Q Consensus       308 l~~~l~h~~~~~  319 (708)
                          +.|||+..
T Consensus       354 ----L~Hp~~~~  361 (464)
T 3ttj_A          354 ----LQHPYINV  361 (464)
T ss_dssp             ----HTSTTTGG
T ss_pred             ----hcChhhhh
Confidence                67999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.3e-42  Score=356.74  Aligned_cols=265  Identities=26%  Similarity=0.419  Sum_probs=216.6

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      .|..+.+|.+.+.||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+..  .
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~   80 (277)
T 3f3z_A            4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT--D   80 (277)
T ss_dssp             --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--E
T ss_pred             hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--e
Confidence            45667899999999999999999999999999999999876433 33566779999999999999999999997644  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||++|++|.+++.....   +++..++.++.|++.||.|||++||+||||||+||++ ..++..+.++|+|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~-~~~~~~~~~~l~Dfg~~  156 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLF-LTDSPDSPLKLIDFGLA  156 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE-SSSSTTCCEEECCCTTC
T ss_pred             EEEEEeccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEE-ecCCCCCcEEEEecccc
Confidence            9999999999999998876433   8999999999999999999999999999999999997 33455678999999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .............||+.|+|||++.         ..++.++|||||||++|+|++|..||.   +....+....+.....
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~p~~---~~~~~~~~~~~~~~~~  224 (277)
T 3f3z_A          157 ARFKPGKMMRTKVGTPYYVSPQVLE---------GLYGPECDEWSAGVMMYVLLCGYPPFS---APTDSEVMLKIREGTF  224 (277)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTTHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCC
T ss_pred             eeccCccchhccCCCCCccChHHhc---------ccCCchhhehhHHHHHHHHHHCCCCCC---CCCHHHHHHHHHhCCC
Confidence            8877666666788999999999985         348999999999999999999999997   3555565555554311


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                         .+|..  ....++..+.+++.+||..||.+|||+.++           +.|||+...
T Consensus       225 -------------------~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~s~~~~-----------l~h~~~~~~  268 (277)
T 3f3z_A          225 -------------------TFPEK--DWLNVSPQAESLIRRLLTKSPKQRITSLQA-----------LEHEWFEKQ  268 (277)
T ss_dssp             -------------------CCCHH--HHTTSCHHHHHHHHHHTCSSTTTSCCHHHH-----------TTSHHHHHH
T ss_pred             -------------------CCCch--hhhcCCHHHHHHHHHHccCChhhCcCHHHH-----------hcCHHHhcc
Confidence                               11110  001223456669999999999999999997           678888554

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.4e-41  Score=361.20  Aligned_cols=257  Identities=24%  Similarity=0.398  Sum_probs=212.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+  ..|+||
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  121 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE--ELWVLM  121 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEEEE
Confidence            35888899999999999999999999999999997544 333556779999999999999999999998754  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++|++|.+++...    .+++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++.....
T Consensus       122 e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~~~~~~~  193 (321)
T 2c30_A          122 EFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL----TLDGRVKLSDFGFCAQISK  193 (321)
T ss_dssp             CCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCcEEEeeeeeeeeccc
Confidence            999999999999753    29999999999999999999999999999999999998    6667899999999987654


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .. ......||+.|+|||++.        +..++.++|||||||++|+|++|..||..   ......+..+.....+   
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~il~el~~g~~pf~~---~~~~~~~~~~~~~~~~---  259 (321)
T 2c30_A          194 DVPKRKSLVGTPYWMAPEVIS--------RSLYATEVDIWSLGIMVIEMVDGEPPYFS---DSPVQAMKRLRDSPPP---  259 (321)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHHHHHSSCC---
T ss_pred             CccccccccCCccccCHhhhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcCCCC---
Confidence            32 334568999999999987        57789999999999999999999999973   4455555555432111   


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                     .++....++    ..+.+++.+||..||++|||+.++           +.|||+....
T Consensus       260 ---------------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~el-----------l~hp~~~~~~  302 (321)
T 2c30_A          260 ---------------KLKNSHKVS----PVLRDFLERMLVRDPQERATAQEL-----------LDHPFLLQTG  302 (321)
T ss_dssp             ---------------CCTTGGGSC----HHHHHHHHHHSCSSTTTSCCHHHH-----------HTSGGGGGCC
T ss_pred             ---------------CcCccccCC----HHHHHHHHHHccCChhhCcCHHHH-----------hcChhhccCC
Confidence                           111222233    445669999999999999999997           6799997543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.4e-42  Score=359.71  Aligned_cols=261  Identities=23%  Similarity=0.387  Sum_probs=204.8

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .+.+|.+.+.||+|+||.||+|.+..+|+.||+|.+........  ...+.+|+.++++++||||+++++++...+  .+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~   86 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD--CY   86 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS--EE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC--eE
Confidence            45689999999999999999999999999999999865443322  244678999999999999999999987644  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++|++|.+++.....   +++..++.++.|++.||.|||++||+||||||+||++    +..+.+||+|||++.
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~----~~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI----DSNKTLKIFDFGIAK  159 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEECCCSSST
T ss_pred             EEEEeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEEeCCCcc
Confidence            999999999999999976443   8999999999999999999999999999999999998    667789999999998


Q ss_pred             cccccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        166 ELEEDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       166 ~~~~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ......  ......||+.|+|||++.        +..++.++|||||||++|+|+||+.||.+   ..............
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~ll~g~~pf~~---~~~~~~~~~~~~~~  228 (294)
T 4eqm_A          160 ALSETSLTQTNHVLGTVQYFSPEQAK--------GEATDECTDIYSIGIVLYEMLVGEPPFNG---ETAVSIAIKHIQDS  228 (294)
T ss_dssp             TC-------------CCSSCCHHHHH--------TCCCCTTHHHHHHHHHHHHHHHSSCSSCS---SCHHHHHHHHHSSC
T ss_pred             ccccccccccCccccCccccCHhHhc--------CCCCCchHhHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHhhcc
Confidence            765442  233467999999999987        67789999999999999999999999973   44444444444321


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-CHHHHHHHHHHHH
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-SFERFFSEVTKTL  308 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-sa~q~~~~l~~il  308 (708)
                      .+                    +......+.++..+.+++.+||..||.+|| +++++...+..++
T Consensus       229 ~~--------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          229 VP--------------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             CC--------------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             CC--------------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            11                    001122333445667799999999999999 7777766655443

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-42  Score=375.07  Aligned_cols=258  Identities=23%  Similarity=0.387  Sum_probs=207.7

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      +.....|.+.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++.++||||+++++++...+  
T Consensus         5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--   82 (336)
T 3h4j_B            5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT--   82 (336)
T ss_dssp             CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--
Confidence            344567999999999999999999999999999999986431  1222345679999999999999999999998754  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||+ +|+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll----~~~~~~kl~DFG~  154 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL----DDNLNVKIADFGL  154 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE----CTTCCEEECCSSC
T ss_pred             EEEEEEECC-CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE----cCCCCEEEEEecc
Confidence            599999999 7899888865433   9999999999999999999999999999999999998    7777899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcC-CccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~-s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      +.....+......+||+.|+|||++.        +..+ +.++|||||||++|+|++|..||...   ......      
T Consensus       155 s~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~---~~~~~~------  217 (336)
T 3h4j_B          155 SNIMTDGNFLKTSCGSPNYAAPEVIN--------GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE---FIPNLF------  217 (336)
T ss_dssp             TBTTTTSBTTCCCTTSTTTSCGGGSC--------CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS---SSTTCB------
T ss_pred             ceeccCCcccccccCCcCcCCHHHHc--------CCCCCCCccchhHHHHHHHHHHhCCCCCCCc---cHHHHH------
Confidence            98877766667788999999999987        4554 78999999999999999999999731   111100      


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                            ..+   ..+..    .+|  ..++    ..+.++|.+||..||.+|||+.++           +.|||+...
T Consensus       218 ------~~i---~~~~~----~~p--~~~s----~~~~~li~~~L~~dP~~Rpt~~ei-----------l~hp~~~~~  265 (336)
T 3h4j_B          218 ------KKV---NSCVY----VMP--DFLS----PGAQSLIRRMIVADPMQRITIQEI-----------RRDPWFNVN  265 (336)
T ss_dssp             ------CCC---CSSCC----CCC--TTSC----HHHHHHHHTTSCSSGGGSCCHHHH-----------TTCHHHHTT
T ss_pred             ------HHH---HcCCC----CCc--ccCC----HHHHHHHHHHcCCChhHCcCHHHH-----------HhChhhccC
Confidence                  000   00000    112  1233    445669999999999999999997           679998654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.3e-42  Score=371.63  Aligned_cols=265  Identities=23%  Similarity=0.338  Sum_probs=209.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccC----CCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQL----SHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~----s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ...|.+.+.||+|+||.||+|.++.+|+.||||++...    ......+.+.+|+.+++.++||||+++++++.+.+  .
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~  100 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG--M  100 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--E
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--E
Confidence            45799999999999999999999999999999998632    11223556789999999999999999999998754  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         85 KVIVMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      +|+|||||+|++|.+.+.... ....+++..++.++.||+.||.|||++||+||||||+|||+ ..++....+||+|||+
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~-~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLL-ASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-CSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEE-ecCCCCCcEEEecCcc
Confidence            999999999999987775421 12238999999999999999999999999999999999997 2222345699999999


Q ss_pred             ccccccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        164 ARELEEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       164 A~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      +........ ....+||+.|+|||++.        +..++.++|||||||++|+|++|..||..    .+......+...
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~~----~~~~~~~~i~~~  247 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVK--------REPYGKPVDVWGCGVILFILLSGCLPFYG----TKERLFEGIIKG  247 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCSSCS----SHHHHHHHHHHT
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHc--------CCCCCchHhhHHHHHHHHHHHHCCCCCCC----cHHHHHHHHHcC
Confidence            987655433 34568999999999987        56789999999999999999999999973    334444444432


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ....                 ..+.+..++    ..+.++|.+||..||.+|||+.++           +.|||+...
T Consensus       248 ~~~~-----------------~~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~e~-----------l~hp~~~~~  293 (351)
T 3c0i_A          248 KYKM-----------------NPRQWSHIS----ESAKDLVRRMLMLDPAERITVYEA-----------LNHPWLKER  293 (351)
T ss_dssp             CCCC-----------------CHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHH-----------HTSHHHHTH
T ss_pred             CCCC-----------------CccccccCC----HHHHHHHHHHCCCChhHCcCHHHH-----------hcChhhcCC
Confidence            1100                 000112233    345669999999999999999997           668888654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.9e-41  Score=366.44  Aligned_cols=258  Identities=24%  Similarity=0.380  Sum_probs=206.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhC-CCCCccceeEEEEecCCceE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~   85 (708)
                      -..|.+.+.||+|+||.||+|+++.+|+.||+|++++......  .....+|..+++++ +||||+++++++.+.+  .+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--~~   85 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RL   85 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC--EE
Confidence            3579999999999999999999999999999999976543222  23456899999988 8999999999997654  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|.
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~~kL~DFG~a~  158 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL----DSEGHIKLTDYGMCK  158 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEECCGGGCB
T ss_pred             EEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE----CCCCCEEEEeccccc
Confidence            999999999999999976432   9999999999999999999999999999999999998    677789999999998


Q ss_pred             ccc-ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC-----ChhhHHH-H
Q psy15481        166 ELE-EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-----RNKETMY-Y  238 (708)
Q Consensus       166 ~~~-~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~-----~~~e~~~-~  238 (708)
                      ... ........+||+.|+|||++.        +..++.++|+|||||++|+|++|..||...+..     .....+. .
T Consensus       159 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (345)
T 3a8x_A          159 EGLRPGDTTSTFCGTPNYIAPEILR--------GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  230 (345)
T ss_dssp             CSCCTTCCBCCCCSCGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred             cccCCCCcccccCCCccccCccccC--------CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence            643 333455678999999999997        677899999999999999999999999743221     1122222 2


Q ss_pred             HHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH------HHHHHHHHHHHhhhh
Q psy15481        239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF------ERFFSEVTKTLNRKL  312 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa------~q~~~~l~~il~~~l  312 (708)
                      +.....                   .+|.  .++    ..+.++|.+||..||.+||++      .++           +
T Consensus       231 i~~~~~-------------------~~p~--~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~~i-----------~  274 (345)
T 3a8x_A          231 ILEKQI-------------------RIPR--SLS----VKAASVLKSFLNKDPKERLGCHPQTGFADI-----------Q  274 (345)
T ss_dssp             HHHCCC-------------------CCCT--TSC----HHHHHHHHHHTCSSTTTSTTCCTTTHHHHH-----------H
T ss_pred             HHcCCC-------------------CCCC--CCC----HHHHHHHHHHhcCCHhHCCCCCCcCCHHHH-----------h
Confidence            222110                   1221  233    445669999999999999996      343           6


Q ss_pred             cCcccCC
Q psy15481        313 VHLFHIN  319 (708)
Q Consensus       313 ~h~~~~~  319 (708)
                      .|||+..
T Consensus       275 ~hp~f~~  281 (345)
T 3a8x_A          275 GHPFFRN  281 (345)
T ss_dssp             TSGGGTT
T ss_pred             cCCccCC
Confidence            7999854

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=362.87  Aligned_cols=261  Identities=23%  Similarity=0.368  Sum_probs=209.8

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCc---eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      -...+|.+.+.||+|+||.||+|.+..+|.   .||||++...........+.+|+.++++++||||+++++++.+.+  
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  123 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR--  123 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG--
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--
Confidence            345689999999999999999999986655   499999976543333455679999999999999999999987644  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||++||+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~  197 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV----DSNLVCKVSDFGL  197 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECCCSS
T ss_pred             ccEEEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE----CCCCCEEECCCCc
Confidence            48999999999999999976432  39999999999999999999999999999999999998    7777899999999


Q ss_pred             ccccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHH
Q psy15481        164 ARELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       164 A~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~  238 (708)
                      +........    .....+|+.|+|||++.        +..++.++|||||||++|+|++ |..||.   +....+....
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~Di~slG~il~ell~~g~~p~~---~~~~~~~~~~  266 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIA--------FRTFSSASDVWSFGVVMWEVLAYGERPYW---NMTNRDVISS  266 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHH--------HCEECHHHHHHHHHHHHHHHHTTSCCTTT---TSCHHHHHHH
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhc--------CCCCCcHHHHHHHHHHHHHHHcCCCCCcc---cCCHHHHHHH
Confidence            987654322    22345678899999997        5678999999999999999999 999997   3455555554


Q ss_pred             HHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      +....                    ..+....++    ..+.+++..||..||.+|||+.++++.++.++..
T Consensus       267 ~~~~~--------------------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          267 VEEGY--------------------RLPAPMGCP----HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             HHTTC--------------------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHcCC--------------------CCCCCCCcC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            44321                    122222233    4566699999999999999999999998887653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.8e-42  Score=384.01  Aligned_cols=261  Identities=26%  Similarity=0.434  Sum_probs=217.5

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ...+|.+.+.||+|+||.||+|.++.+|+.||||++.....  ....+...+|+.++++++||||+++++++.+.+  ..
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~  101 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG--YF  101 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EE
Confidence            34579999999999999999999999999999999975433  234556789999999999999999999998644  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|||||.||+|.+.+.....   +++..++.++.||+.||.|||++||+||||||+|||+ ...+..+.+||+|||+|.
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~-~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL-ESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSC---CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-SSSSTTCCEEECCTTHHH
T ss_pred             EEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE-ecCCCCCcEEEEeeeeeE
Confidence            999999999999999876543   9999999999999999999999999999999999997 222345689999999998


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ...........+||+.|+|||++.        + .|+.++|||||||++|+|++|.+||.   +.+..+.+..+......
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~--------~-~~~~~~DiwslG~il~~ll~g~~pf~---~~~~~~~~~~i~~~~~~  245 (484)
T 3nyv_A          178 HFEASKKMKDKIGTAYYIAPEVLH--------G-TYDEKCDVWSTGVILYILLSGCPPFN---GANEYDILKKVEKGKYT  245 (484)
T ss_dssp             HBCCCCSHHHHTTGGGTCCHHHHH--------T-CCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCCC
T ss_pred             EcccccccccCCCCccccCceeec--------C-CCCCcceeHHHHHHHHHHHHCCCCCC---CCCHHHHHHHHHcCCCC
Confidence            877666666778999999999986        3 58999999999999999999999997   45666666666653211


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                                       ...|.+..+++.    +.++|.+||..||.+|||+.++           +.|||+.
T Consensus       246 -----------------~~~~~~~~~s~~----~~~li~~~L~~dp~~R~s~~e~-----------l~h~~~~  286 (484)
T 3nyv_A          246 -----------------FELPQWKKVSES----AKDLIRKMLTYVPSMRISARDA-----------LDHEWIQ  286 (484)
T ss_dssp             -----------------CCSGGGGGSCHH----HHHHHHHHTCSSGGGSCCHHHH-----------HTSHHHH
T ss_pred             -----------------CCCcccccCCHH----HHHHHHHHCCCChhHCcCHHHH-----------hhChhhc
Confidence                             123333445554    5569999999999999999997           6789884

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.6e-42  Score=379.66  Aligned_cols=263  Identities=23%  Similarity=0.370  Sum_probs=212.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ...|.+.+.||+|+||.||+|.++.+|+.||+|++++..  .......+.+|+.+++.++||||+++++++.+..  .+|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~  145 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR--YLY  145 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS--EEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEE
Confidence            347999999999999999999999999999999986421  1122334568999999999999999999998644  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|||||+||+|.+++...    .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|..
T Consensus       146 lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl----~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL----DKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTTCEE
T ss_pred             EEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE----CCCCCEEEeccceeEe
Confidence            999999999999999753    28999999999999999999999999999999999998    7777899999999987


Q ss_pred             ccccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        167 LEEDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       167 ~~~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .....  ...+.+||+.|+|||++...    +....|+.++|||||||++|+|++|.+||.   +.+..+....+.....
T Consensus       218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~---~~~~~~~~~~i~~~~~  290 (410)
T 3v8s_A          218 MNKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFY---ADSLVGTYSKIMNHKN  290 (410)
T ss_dssp             CCTTSEEECCSCCSCGGGCCHHHHHTT----TTTCEEETHHHHHHHHHHHHHHHHSSCTTC---CSSHHHHHHHHHTHHH
T ss_pred             eccCCcccccCCcCCccccCHHHhhcc----CCCcCCCCcceEecchHHHHHHHhCCCCCC---CCChhhHHHHHHhccc
Confidence            65443  23467899999999999731    111238899999999999999999999997   4556666666654211


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCccc--CCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKK--IWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~k--Rpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      .                 ..+|....+++.+    .+||.+||..+|.+  ||+++++           +.||||..-
T Consensus       291 ~-----------------~~~p~~~~~s~~~----~~li~~lL~~~~~rlgR~~~~ei-----------~~Hp~f~~~  336 (410)
T 3v8s_A          291 S-----------------LTFPDDNDISKEA----KNLICAFLTDREVRLGRNGVEEI-----------KRHLFFKND  336 (410)
T ss_dssp             H-----------------CCCCTTCCCCHHH----HHHHHHHSSCGGGCTTSSCHHHH-----------HTSGGGCCS
T ss_pred             c-----------------ccCCCcccccHHH----HHHHHHHccChhhhCCCCCHHHH-----------hcCccccCC
Confidence            0                 1234444455554    45889999999988  9999997           679998653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=375.34  Aligned_cols=261  Identities=26%  Similarity=0.440  Sum_probs=209.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      |.+...+.||+|+||.||+|.+..+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+  ..|+||
T Consensus        89 ~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~  165 (373)
T 2x4f_A           89 YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKN--DIVLVM  165 (373)
T ss_dssp             EEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEE
T ss_pred             eeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEEE
Confidence            455557899999999999999999999999999975432 23445679999999999999999999998654  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++|++|.+++....  ..+++..++.++.||+.||.|||++||+||||||+|||+  ..++.+.+||+|||++.....
T Consensus       166 E~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~~~~~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          166 EYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC--VNRDAKQIKIIDFGLARRYKP  241 (373)
T ss_dssp             ECCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--EETTTTEEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE--ecCCCCcEEEEeCCCceecCC
Confidence            9999999998886532  238999999999999999999999999999999999996  445556899999999998776


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      ........||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +.+..+.+..+......    
T Consensus       242 ~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~elltg~~pf~---~~~~~~~~~~i~~~~~~----  306 (373)
T 2x4f_A          242 REKLKVNFGTPEFLAPEVVN--------YDFVSFPTDMWSVGVIAYMLLSGLSPFL---GDNDAETLNNILACRWD----  306 (373)
T ss_dssp             TCBCCCCCSSCTTCCHHHHT--------TCBCCHHHHHHHHHHHHHHHHHSSCTTC---CSSHHHHHHHHHHTCCC----
T ss_pred             ccccccccCCCcEeChhhcc--------CCCCCcHHhHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHhccCC----
Confidence            66666678999999999986        6778999999999999999999999997   45666666666653211    


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                   ...+....++    ..+.+||.+||..||.+|||+.++           +.|||+...
T Consensus       307 -------------~~~~~~~~~~----~~~~~li~~~L~~dp~~Rps~~e~-----------l~hp~~~~~  349 (373)
T 2x4f_A          307 -------------LEDEEFQDIS----EEAKEFISKLLIKEKSWRISASEA-----------LKHPWLSDH  349 (373)
T ss_dssp             -------------SCSGGGTTSC----HHHHHHHHTTSCSSGGGSCCHHHH-----------HHSHHHHCH
T ss_pred             -------------CChhhhccCC----HHHHHHHHHHcCCChhhCCCHHHH-----------hcCcCcCCC
Confidence                         0111112233    455669999999999999999997           568888654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-41  Score=369.50  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=210.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      -..|.+.+.||+|+||.||+|.++.+|+.||+|+++...  .....+...+|+.+++.++||||+++++++.+.+  .+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~  117 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLY  117 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC--EEE
Confidence            357999999999999999999999999999999986532  1223455678999999999999999999987644  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++..
T Consensus       118 lv~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~~kL~DFg~a~~  190 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTTCEE
T ss_pred             EEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE----CCCCCEEEccccccee
Confidence            99999999999999976433   8999999999999999999999999999999999998    6777899999999987


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ....  ....+||+.|+|||++.        +..++.++|||||||++|+|++|.+||.   +.+..+....+.....  
T Consensus       191 ~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~---~~~~~~~~~~i~~~~~--  255 (350)
T 1rdq_E          191 VKGR--TWTLCGTPEALAPEIIL--------SKGYNKAVDWWALGVLIYEMAAGYPPFF---ADQPIQIYEKIVSGKV--  255 (350)
T ss_dssp             CSSC--BCCCEECGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCC--
T ss_pred             ccCC--cccccCCccccCHHHhc--------CCCCCCcCCEecccHhHhHHhhCCCCCC---CCCHHHHHHHHHcCCC--
Confidence            6443  34568999999999987        6778999999999999999999999997   3555566666654311  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                       .+|  ..++    ..+.++|.+||..||.+||+     ++++           +.|||+..
T Consensus       256 -----------------~~p--~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei-----------~~h~~f~~  299 (350)
T 1rdq_E          256 -----------------RFP--SHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDI-----------KNHKWFAT  299 (350)
T ss_dssp             -----------------CCC--TTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHH-----------HTSGGGTT
T ss_pred             -----------------CCC--CCCC----HHHHHHHHHHhhcCHHhccCCccCCHHHH-----------HhCcCcCC
Confidence                             112  1233    44566999999999999998     7776           67898854

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.4e-42  Score=387.46  Aligned_cols=265  Identities=28%  Similarity=0.474  Sum_probs=215.8

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      .|+...+|.+.+.||+|+||.||+|.++.+|+.||+|++..... ........+|+.++++++||||+++++++.+..  
T Consensus        17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--   94 (486)
T 3mwu_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS--   94 (486)
T ss_dssp             CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred             cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC--
Confidence            45667789999999999999999999999999999999864321 223456679999999999999999999997644  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|+|||||.||+|.+.+.....   +++..++.++.||+.||.|||++||+||||||+|||+ ...+..+.+||+|||+
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~-~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL-ESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-SSSSTTCCEEECSCSC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEE-ecCCCCCCEEEEECCc
Confidence            59999999999999998865433   9999999999999999999999999999999999997 2223456799999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      |............+||+.|+|||++.        + .|+.++|||||||++|+|++|.+||.   +.+..+.+..+....
T Consensus       171 a~~~~~~~~~~~~~gt~~y~aPE~~~--------~-~~~~~~DiwslG~il~~ll~g~~pf~---~~~~~~~~~~i~~~~  238 (486)
T 3mwu_A          171 STCFQQNTKMKDRIGTAYYIAPEVLR--------G-TYDEKCDVWSAGVILYILLSGTPPFY---GKNEYDILKRVETGK  238 (486)
T ss_dssp             TTTBCCC----CCTTGGGGCCGGGGG--------S-CCCHHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHTC
T ss_pred             CeECCCCCccCCCcCCCCCCCHHHhC--------C-CCCchhhHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHhCC
Confidence            98877666667788999999999986        3 48999999999999999999999997   456666666665432


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ..                 ...|.+..+|+.    +.++|.+||..||.+|||+.++           +.|||+..
T Consensus       239 ~~-----------------~~~~~~~~~s~~----~~~li~~~L~~dp~~R~t~~~~-----------l~hp~~~~  282 (486)
T 3mwu_A          239 YA-----------------FDLPQWRTISDD----AKDLIRKMLTFHPSLRITATQC-----------LEHPWIQK  282 (486)
T ss_dssp             CC-----------------SCSGGGGGSCHH----HHHHHHHHTCSSTTTSCCHHHH-----------HHCHHHHH
T ss_pred             CC-----------------CCCcccCCCCHH----HHHHHHHHcCCChhhCcCHHHH-----------hcCHhhcc
Confidence            21                 123333445554    4569999999999999999997           55888743

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-41  Score=356.10  Aligned_cols=274  Identities=21%  Similarity=0.267  Sum_probs=215.1

Q ss_pred             CCcccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEe
Q psy15481          1 MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEE   79 (708)
Q Consensus         1 ms~l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~   79 (708)
                      ||-.....+.+|.+.+.||+|+||.||+|.+..+|+.||+|++.....   .....+|+.+++++ +||||+.+++++..
T Consensus         1 Ms~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~   77 (298)
T 1csn_A            1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQE   77 (298)
T ss_dssp             -----CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             CCCcCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence            455555567889999999999999999999999999999999865432   23456899999999 89999999999876


Q ss_pred             cCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec-CCCceEEE
Q psy15481         80 QEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD-DGSTIYKL  158 (708)
Q Consensus        80 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~-d~~~~vKL  158 (708)
                      ..  ..++||||+ |++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+||++.... +....+||
T Consensus        78 ~~--~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           78 GL--HNVLVIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             TT--EEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             Cc--eeEEEEEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence            44  599999999 9999999986432  389999999999999999999999999999999999971111 12335999


Q ss_pred             eccCcccccccccc--------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC
Q psy15481        159 TDFGAARELEEDQQ--------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR  230 (708)
Q Consensus       159 ~DFGlA~~~~~~~~--------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~  230 (708)
                      +|||++........        .....||+.|+|||++.        +..++.++|||||||++|+|++|..||......
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  224 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL--------GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA  224 (298)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred             EECccccccccccccccccccCccCCCCCcccCCchhhc--------CCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence            99999987654422        23467999999999987        677899999999999999999999999865545


Q ss_pred             ChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        231 RNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       231 ~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      .....+..+.......                    ....+.+.++..+.+++..||..||.+||+++++.+.+..++..
T Consensus       225 ~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          225 TNKQKYERIGEKKQST--------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             CHHHHHHHHHHHHHHS--------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHhhccCc--------------------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            5555555544321110                    01111223345567799999999999999999999999888764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.9e-42  Score=370.22  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=208.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|.+.+.||+|+||.||+|.++.+|+.||+|++++..  .....+...+|..++..+ +||||+++++++.+.+  ..|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--~~~   97 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLY   97 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS--EEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC--EEE
Confidence            47999999999999999999999999999999997532  122345567899999988 8999999999997654  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|..
T Consensus        98 lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll----~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML----DSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE----cCCCcEEEEeCCcccc
Confidence            99999999999999976433   9999999999999999999999999999999999998    7777899999999986


Q ss_pred             cc-ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LE-EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~-~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .. ........+||+.|+|||++.        +..++.++|+|||||++|+|++|.+||.   +.+..+....+..... 
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~G~~Pf~---~~~~~~~~~~i~~~~~-  238 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAPEIIA--------YQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDELFQSIMEHNV-  238 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHT--------TCCBSTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCC-
T ss_pred             cccCCcccccccCCccccChhhhc--------CCCcCCcccccchHHHHHHHHcCCCCCC---CCCHHHHHHHHHhCCC-
Confidence            43 233455678999999999987        6778999999999999999999999997   4556666666664311 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH-----HHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF-----ERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa-----~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                        .+|  ..++    ..+.++|.+||..||.+||++     +++           +.|||+..
T Consensus       239 ------------------~~p--~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~i-----------~~h~~f~~  282 (353)
T 2i0e_A          239 ------------------AYP--KSMS----KEAVAICKGLMTKHPGKRLGCGPEGERDI-----------KEHAFFRY  282 (353)
T ss_dssp             ------------------CCC--TTSC----HHHHHHHHHHTCSCTTSCTTCSTTHHHHH-----------HTSGGGTT
T ss_pred             ------------------CCC--CCCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHH-----------hcCccccC
Confidence                              112  1233    445669999999999999964     554           56777753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=358.26  Aligned_cols=284  Identities=23%  Similarity=0.344  Sum_probs=206.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++....... ......+|+.++++++||||+++++++...+  ..++|
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv   80 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR--RLHLV   80 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC--eEEEE
Confidence            46999999999999999999999999999999986543221 1344568999999999999999999998654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++|++|..++.....   +++..+..++.|++.||.|||++||+||||||+||++    +..+.+||+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI----TKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             EECCSEEHHHHHHHTSSC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTTCEECC
T ss_pred             EEeCCCchHHHHHhhhcC---CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE----cCCCCEEEeeCCCchhcc
Confidence            999999999998876443   9999999999999999999999999999999999998    667789999999998765


Q ss_pred             cc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 ED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      .. .......||+.|+|||++..       ...++.++|||||||++|+|++|.+||.+   ....+....+........
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~~~~~~  223 (311)
T 4agu_A          154 GPSDYYDDEVATRWYRSPELLVG-------DTQYGPPVDVWAIGCVFAELLSGVPLWPG---KSDVDQLYLIRKTLGDLI  223 (311)
T ss_dssp             ------------GGGCCHHHHHT-------CSCCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHHHCSCC
T ss_pred             CcccccCCCcCCccccChHHHhc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHhcccc
Confidence            33 33345679999999999873       36789999999999999999999999973   444554444432111000


Q ss_pred             ------ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        248 ------ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       248 ------i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                            .........................+.++..+.+++.+||..||.+|||++++           +.|||+.+-.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el-----------l~hp~f~~~~  292 (311)
T 4agu_A          224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL-----------LHHPYFENIR  292 (311)
T ss_dssp             HHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHH-----------HTSGGGTTCC
T ss_pred             cccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHH-----------hcChHHHhcc
Confidence                  00000000000000000000000112334456779999999999999999997           6799997654


Q ss_pred             cc
Q psy15481        322 QC  323 (708)
Q Consensus       322 ~~  323 (708)
                      ..
T Consensus       293 ~~  294 (311)
T 4agu_A          293 EI  294 (311)
T ss_dssp             --
T ss_pred             CH
Confidence            43

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.5e-41  Score=360.77  Aligned_cols=255  Identities=29%  Similarity=0.432  Sum_probs=200.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc---CCCceEEEEEeccCCCC---CchHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSHM---RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~~~~~s~~---~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      ...|.+.+.||+|+||.||++++.   .+|+.||+|+++.....   .......+|+.+++.++||||+++++++...+ 
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG-   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC-
Confidence            357999999999999999999985   68999999999764321   22334568999999999999999999997654 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                       .+|+||||++|++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||
T Consensus        95 -~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg  166 (327)
T 3a62_A           95 -KLYLILEYLSGGELFMQLEREGI---FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML----NHQGHVKLTDFG  166 (327)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE----CTTSCEEECCCS
T ss_pred             -EEEEEEeCCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE----CCCCcEEEEeCC
Confidence             49999999999999999976433   8999999999999999999999999999999999998    667789999999


Q ss_pred             cccccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        163 AARELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       163 lA~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      ++...... ......+||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +.+..+.+..+..
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~g~~pf~---~~~~~~~~~~i~~  235 (327)
T 3a62_A          167 LCKESIHDGTVTHTFCGTIEYMAPEILM--------RSGHNRAVDWWSLGALMYDMLTGAPPFT---GENRKKTIDKILK  235 (327)
T ss_dssp             CC----------CTTSSCCTTSCHHHHT--------TSCCCTHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHHHH
T ss_pred             cccccccCCccccccCCCcCccCHhhCc--------CCCCCCcccchhHHHHHHHHHHCCCCCC---CCCHHHHHHHHHh
Confidence            99864433 3344568999999999987        5678999999999999999999999997   3555566666554


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcc
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLF  316 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~  316 (708)
                      ...                   .+|      +.++..+.++|.+||..||.+||     ++.++           +.|||
T Consensus       236 ~~~-------------------~~p------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~-----------l~hp~  279 (327)
T 3a62_A          236 CKL-------------------NLP------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEV-----------QAHPF  279 (327)
T ss_dssp             TCC-------------------CCC------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHH-----------HHSGG
T ss_pred             CCC-------------------CCC------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHH-----------HcCCc
Confidence            211                   112      22334556699999999999999     66676           66999


Q ss_pred             cCC
Q psy15481        317 HIN  319 (708)
Q Consensus       317 ~~~  319 (708)
                      +..
T Consensus       280 f~~  282 (327)
T 3a62_A          280 FRH  282 (327)
T ss_dssp             GSS
T ss_pred             ccC
Confidence            864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.5e-42  Score=385.72  Aligned_cols=264  Identities=27%  Similarity=0.461  Sum_probs=212.0

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      |....+|.+.+.||+|+||.||+|.++.+|..||+|++..... ......+.+|+.+++.++||||+++++++.+..  .
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~  110 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR--N  110 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS--E
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--E
Confidence            3445589999999999999999999999999999999976542 233456679999999999999999999997644  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      +|+|||||+||+|.+.+.....   +++..++.++.||+.||.|||++||+||||||+|||+ ...+..+.+||+|||+|
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~-~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLL-ESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-SCSSTTCCEEECCCTTC
T ss_pred             EEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEE-eCCCCCCcEEEEECCCC
Confidence            9999999999999998865433   8999999999999999999999999999999999997 12223457999999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ............+||+.|+|||++.         ..|+.++|||||||++|+|++|.+||.   +....+.+..+.....
T Consensus       187 ~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwslG~il~~ll~g~~pf~---~~~~~~~~~~i~~~~~  254 (494)
T 3lij_A          187 AVFENQKKMKERLGTAYYIAPEVLR---------KKYDEKCDVWSIGVILFILLAGYPPFG---GQTDQEILRKVEKGKY  254 (494)
T ss_dssp             EECBTTBCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHTCC
T ss_pred             eECCCCccccccCCCcCeeCHHHHc---------ccCCCchhHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHhCCC
Confidence            8877766667788999999999874         458999999999999999999999997   4566666666654321


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ..                 ..|.+..+++.    +.++|.+||..||.+|||+.++           +.|||+..
T Consensus       255 ~~-----------------~~~~~~~~s~~----~~~li~~~L~~dp~~R~s~~e~-----------l~hp~~~~  297 (494)
T 3lij_A          255 TF-----------------DSPEWKNVSEG----AKDLIKQMLQFDSQRRISAQQA-----------LEHPWIKE  297 (494)
T ss_dssp             CC-----------------CSGGGTTSCHH----HHHHHHHHTCSSTTTSCCHHHH-----------HTCHHHHH
T ss_pred             CC-----------------CchhcccCCHH----HHHHHHHHCCCChhhCccHHHH-----------hcCccccc
Confidence            10                 11222334444    5569999999999999999997           67898843

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.3e-41  Score=364.04  Aligned_cols=284  Identities=23%  Similarity=0.359  Sum_probs=208.7

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      +..-.+|.+.+.||+|+||.||+|.+..+|+.||||+++...... ....+.+|+.++++++||||+++++++....  .
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~  107 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH--R  107 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT--E
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC--E
Confidence            344568999999999999999999999999999999997543322 2334468999999999999999999998754  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec-CCCceEEEeccCc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD-DGSTIYKLTDFGA  163 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~-d~~~~vKL~DFGl  163 (708)
                      .|+||||+. |+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+.... +..+.+||+|||+
T Consensus       108 ~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          108 LHLIFEYAE-NDLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEEEEECCS-EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEEEEecCC-CCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999999996 699999976543   99999999999999999999999999999999999984332 3456799999999


Q ss_pred             ccccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        164 ARELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       164 A~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      |...... .......||+.|+|||++..       ...++.++|||||||++|+|++|..||.   +....+.+..+...
T Consensus       184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~---~~~~~~~~~~~~~~  253 (329)
T 3gbz_A          184 ARAFGIPIRQFTHEIITLWYRPPEILLG-------SRHYSTSVDIWSIACIWAEMLMKTPLFP---GDSEIDQLFKIFEV  253 (329)
T ss_dssp             HHHHC-----------CCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHH
T ss_pred             ccccCCcccccCCCcCCccccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHHCCCCcC---CCCHHHHHHHHHHH
Confidence            9876533 33445678999999999873       3558999999999999999999999997   45566666665542


Q ss_pred             ccC---CcccccccCCCCcccccCCCCCccc------CChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhc
Q psy15481        243 KAS---GVISGTQTSENGEIDWCTDLPNNCQ------LSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLV  313 (708)
Q Consensus       243 ~~~---~~i~~~~~~~~g~~~~~~~lp~~~~------ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~  313 (708)
                      ...   ....+.    .....|...+|....      +...++..+.+||.+||..||.+|||+.++           +.
T Consensus       254 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~-----------l~  318 (329)
T 3gbz_A          254 LGLPDDTTWPGV----TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA-----------LE  318 (329)
T ss_dssp             HCCCCTTTSTTG----GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH-----------HT
T ss_pred             hCCCchhhhhhh----hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH-----------hC
Confidence            111   111111    011223333333211      111234566789999999999999999997           67


Q ss_pred             CcccCCc
Q psy15481        314 HLFHINR  320 (708)
Q Consensus       314 h~~~~~~  320 (708)
                      |||+...
T Consensus       319 hp~f~~~  325 (329)
T 3gbz_A          319 HPYFSHN  325 (329)
T ss_dssp             SGGGSSS
T ss_pred             CcccCCC
Confidence            9999754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.9e-42  Score=363.58  Aligned_cols=274  Identities=27%  Similarity=0.399  Sum_probs=212.0

Q ss_pred             CCcccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-------CchHHHHHHHHHHHhCCCCCccce
Q psy15481          1 MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-------RPHDVQMREFEVLKKVKHENIVKL   73 (708)
Q Consensus         1 ms~l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-------~~~~~~~~Ei~iL~kL~HpNIVkl   73 (708)
                      |+.........|.+.+.||+|+||.||+|.+..+|+.||||++......       .....+.+|+.++++++||||+++
T Consensus         1 M~~~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   80 (322)
T 2ycf_A            1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI   80 (322)
T ss_dssp             -CCCCHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred             CccchhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence            7777777788999999999999999999999999999999998754221       112335689999999999999999


Q ss_pred             eEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC
Q psy15481         74 LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS  153 (708)
Q Consensus        74 ~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~  153 (708)
                      ++++....   .|+||||++|++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+ ...+..
T Consensus        81 ~~~~~~~~---~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~-~~~~~~  153 (322)
T 2ycf_A           81 KNFFDAED---YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL-SSQEED  153 (322)
T ss_dssp             EEEEESSS---EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE-SSSSSS
T ss_pred             eeEEcCCc---eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE-ecCCCC
Confidence            99986533   899999999999999987643   39999999999999999999999999999999999997 112223


Q ss_pred             ceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChh
Q psy15481        154 TIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK  233 (708)
Q Consensus       154 ~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~  233 (708)
                      ..+||+|||++.............||+.|+|||++....     +..++.++|||||||++|+|++|..||.....  ..
T Consensus       154 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~  226 (322)
T 2ycf_A          154 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVG-----TAGYNRAVDCWSLGVILFICLSGYPPFSEHRT--QV  226 (322)
T ss_dssp             CCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTT-----TTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC--SS
T ss_pred             CeEEEccCccceecccccccccccCCcCccCchhhccCC-----CCCCCchhhHHHHHHHHHHHHhCCCCCcccch--HH
Confidence            469999999998776655555677999999999985211     45688999999999999999999999974322  22


Q ss_pred             hHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhc
Q psy15481        234 ETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLV  313 (708)
Q Consensus       234 e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~  313 (708)
                      .....+.....                     +........++..+.+++.+||..||.+||++.++           +.
T Consensus       227 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~-----------l~  274 (322)
T 2ycf_A          227 SLKDQITSGKY---------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA-----------LR  274 (322)
T ss_dssp             CHHHHHHHTCC---------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH-----------HT
T ss_pred             HHHHHHHhCcc---------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHH-----------hh
Confidence            22222332111                     00001111233456679999999999999999997           67


Q ss_pred             CcccCCc
Q psy15481        314 HLFHINR  320 (708)
Q Consensus       314 h~~~~~~  320 (708)
                      |||+...
T Consensus       275 h~~~~~~  281 (322)
T 2ycf_A          275 HPWLQDE  281 (322)
T ss_dssp             SGGGCCH
T ss_pred             CcCcCCH
Confidence            9998654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.3e-41  Score=359.87  Aligned_cols=275  Identities=25%  Similarity=0.383  Sum_probs=205.2

Q ss_pred             cccCCCCceEEEe-eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEec
Q psy15481          3 FLRGSTNYVWCTT-SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQ   80 (708)
Q Consensus         3 ~l~~~~n~~y~i~-~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~   80 (708)
                      .+.|.....|.+. +.||+|+||.||+|.+..+|+.||||++.... ........+|+.++.++ +||||+++++++.+.
T Consensus         5 ~~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A            5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             SSCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            3578888899995 78999999999999999999999999997543 23355667999999985 799999999999875


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC-CceEEEe
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG-STIYKLT  159 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~-~~~vKL~  159 (708)
                      +  .+|+||||++|++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+  +.++ ...+||+
T Consensus        84 ~--~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~--~~~~~~~~~kl~  156 (316)
T 2ac3_A           84 D--RFYLVFEKMRGGSILSHIHKRRH---FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC--EHPNQVSPVKIC  156 (316)
T ss_dssp             T--EEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--SCSSSSCSEEEC
T ss_pred             C--EEEEEEEcCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE--ccCCCcCceEEE
Confidence            4  59999999999999999976432   8999999999999999999999999999999999997  2222 2359999


Q ss_pred             ccCccccccccc--------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCC
Q psy15481        160 DFGAARELEEDQ--------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR  231 (708)
Q Consensus       160 DFGlA~~~~~~~--------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~  231 (708)
                      |||++.......        .....+||+.|+|||++.....   ....++.++|||||||++|+|++|..||.......
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  233 (316)
T 2ac3_A          157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE---EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD  233 (316)
T ss_dssp             CTTCCC-------------------CCSGGGCCHHHHHHTSH---HHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC
T ss_pred             EccCccccccCCccccccccccccccCCcCccChHHhhcccc---cccCCCcccccHhHHHHHHHHHHCCCCCccccccc
Confidence            999997654221        2234569999999999863100   01457899999999999999999999997532211


Q ss_pred             ------------hhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHH
Q psy15481        232 ------------NKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFER  299 (708)
Q Consensus       232 ------------~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q  299 (708)
                                  .......+.....                   .+|..  ....++..+.++|.+||..||.+|||+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~i~~~~~-------------------~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e  292 (316)
T 2ac3_A          234 CGWDRGEACPACQNMLFESIQEGKY-------------------EFPDK--DWAHISCAAKDLISKLLVRDAKQRLSAAQ  292 (316)
T ss_dssp             SCC----CCHHHHHHHHHHHHHCCC-------------------CCCHH--HHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ccccccccchhHHHHHHHHHhccCc-------------------ccCch--hcccCCHHHHHHHHHHhhCChhhCCCHHH
Confidence                        1112222222110                   11110  00112345667999999999999999999


Q ss_pred             HHHHHHHHHhhhhcCcccCCc
Q psy15481        300 FFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       300 ~~~~l~~il~~~l~h~~~~~~  320 (708)
                      +           +.|||+...
T Consensus       293 ~-----------l~hp~~~~~  302 (316)
T 2ac3_A          293 V-----------LQHPWVQGC  302 (316)
T ss_dssp             H-----------HHSTTCC--
T ss_pred             H-----------hcChhhcCC
Confidence            7           569999754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.9e-42  Score=364.06  Aligned_cols=282  Identities=24%  Similarity=0.341  Sum_probs=203.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|+++............+|+.++++++||||+++++++...+  ..++|||
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e   80 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK--SLTLVFE   80 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS--CEEEEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC--EEEEEec
Confidence            69999999999999999999999999999999975443322223347999999999999999999997654  4999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+. |+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++......
T Consensus        81 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~----~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI----NERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             CCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE----CTTCCEEECSSSEEECC---
T ss_pred             ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE----CCCCCEEEccCcccccccCC
Confidence            996 689888876433  38999999999999999999999999999999999998    66678999999999865433


Q ss_pred             -ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc---ccCC
Q psy15481        171 -QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK---KASG  246 (708)
Q Consensus       171 -~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~---~~~~  246 (708)
                       .......||+.|+|||++..       ...++.++|||||||++|+|++|..||.+   .+..+.+..+...   ....
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~---~~~~~~~~~i~~~~~~~~~~  223 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMATGRPLFPG---STVEEQLHFIFRILGTPTEE  223 (324)
T ss_dssp             ---------CGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccCcccccChhhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHhCCCChH
Confidence             33445678999999999862       36689999999999999999999999974   4555555554432   1111


Q ss_pred             cccccccCCC-CcccccCC-CCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        247 VISGTQTSEN-GEIDWCTD-LPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       247 ~i~~~~~~~~-g~~~~~~~-lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      ...+...... ....+... ........+.++..+.+||.+||..||.+|||+.++           +.|||+.....
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~-----------l~hp~f~~~~~  290 (324)
T 3mtl_A          224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA-----------MKHPFFLSLGE  290 (324)
T ss_dssp             TSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH-----------TTSGGGGGGCS
T ss_pred             hchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH-----------hcChhhhhccc
Confidence            1111000000 00000000 000001122334556779999999999999999997           77999976544

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.2e-41  Score=359.76  Aligned_cols=261  Identities=24%  Similarity=0.337  Sum_probs=200.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...|.+.+.||+|+||.||+|.+  +|+.||+|++....... ....+.+|+.++++++||||+++++++...+  ..++
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~l  111 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP--NLSI  111 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--CCEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--ceEE
Confidence            45799999999999999999976  58899999987543321 2234678999999999999999999987655  4899


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR--LVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g--IVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ||||++||+|.+++........+++..++.++.||+.||.|||++|  |+||||||+|||+    +..+.+||+|||++.
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll----~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV----DKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE----CTTCCEEECCCC---
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE----eCCCcEEECCCCCCc
Confidence            9999999999999987442223899999999999999999999999  9999999999998    677789999999998


Q ss_pred             cccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ...... ......||+.|+|||++.        +..++.++|||||||++|+|+||..||..   .+..+....+.....
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~elltg~~Pf~~---~~~~~~~~~~~~~~~  256 (309)
T 3p86_A          188 LKASTFLSSKSAAGTPEWMAPEVLR--------DEPSNEKSDVYSFGVILWELATLQQPWGN---LNPAQVVAAVGFKCK  256 (309)
T ss_dssp             --------------CCTTSCHHHHT--------TCCCCTTHHHHHHHHHHHHHHHCCCTTTT---SCHHHHHHHHHHSCC
T ss_pred             cccccccccccCCCCccccChhhhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcCC
Confidence            644332 234567999999999987        67789999999999999999999999973   444444444432111


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                                         ..+    ++..++..+.++|.+||..||.+|||+.++++.+..++...
T Consensus       257 -------------------~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          257 -------------------RLE----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             -------------------CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             -------------------CCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                               111    12223345667999999999999999999999888877654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.1e-41  Score=352.99  Aligned_cols=263  Identities=22%  Similarity=0.397  Sum_probs=216.2

Q ss_pred             ccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         4 l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      +....+..|.+.+.||+|+||.||+|.+..+|+.||+|++.........+.+.+|+.++++++||||+++++++....  
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   93 (303)
T 3a7i_A           16 LKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--   93 (303)
T ss_dssp             CEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred             CCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence            445667789999999999999999999999999999999986655555667789999999999999999999988654  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||++|++|.+++...    .+++..+..++.|++.||.|||++||+||||||+||++    +..+.+||+|||.
T Consensus        94 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl~Dfg~  165 (303)
T 3a7i_A           94 KLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL----SEHGEVKLADFGV  165 (303)
T ss_dssp             EEEEEEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTT
T ss_pred             eEEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE----CCCCCEEEeeccc
Confidence            599999999999999999753    38999999999999999999999999999999999998    6667899999999


Q ss_pred             cccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        164 ARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       164 A~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      +....... ......||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .........+...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~  234 (303)
T 3a7i_A          166 AGQLTDTQIKRNTFVGTPFWMAPEVIK--------QSAYDSKADIWSLGITAIELARGEPPHSE---LHPMKVLFLIPKN  234 (303)
T ss_dssp             CEECBTTBCCBCCCCSCGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHHHHHS
T ss_pred             ceecCccccccCccCCCcCccCHHHHh--------cCCCCchhhhHHHHHHHHHHccCCCCCCC---cCHHHHHHHhhcC
Confidence            98765443 234567999999999987        57789999999999999999999999973   3444444333322


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      ..+                  .      +...++..+.+++.+||..||.+|||+.++           +.|||+.....
T Consensus       235 ~~~------------------~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l-----------l~~~~~~~~~~  279 (303)
T 3a7i_A          235 NPP------------------T------LEGNYSKPLKEFVEACLNKEPSFRPTAKEL-----------LKHKFILRNAK  279 (303)
T ss_dssp             CCC------------------C------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHH-----------TTCHHHHHHCC
T ss_pred             CCC------------------C------CccccCHHHHHHHHHHcCCChhhCcCHHHH-----------hhChhhhcCCC
Confidence            110                  1      112223446679999999999999999997           67888866544

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.5e-41  Score=385.09  Aligned_cols=264  Identities=25%  Similarity=0.404  Sum_probs=213.6

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC------------CchHHHHHHHHHHHhCCCCCccc
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM------------RPHDVQMREFEVLKKVKHENIVK   72 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~------------~~~~~~~~Ei~iL~kL~HpNIVk   72 (708)
                      .|.....|.+.+.||+|+||.||+|.++.+|+.||+|++......            ...+...+|+.++++++||||++
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            455678899999999999999999999999999999999754322            22455679999999999999999


Q ss_pred             eeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC
Q psy15481         73 LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG  152 (708)
Q Consensus        73 l~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~  152 (708)
                      +++++.+..  .+|+|||||+||+|.+.+.....   +++..++.++.||+.||.|||++||+||||||+|||+  ..++
T Consensus       111 ~~~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~--~~~~  183 (504)
T 3q5i_A          111 LFDVFEDKK--YFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILL--ENKN  183 (504)
T ss_dssp             EEEEEECSS--EEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--SSTT
T ss_pred             EEEEEEcCC--EEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEE--ecCC
Confidence            999997644  59999999999999998866433   9999999999999999999999999999999999997  2222


Q ss_pred             -CceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCC
Q psy15481        153 -STIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR  231 (708)
Q Consensus       153 -~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~  231 (708)
                       ...+||+|||+|............+||+.|+|||++.         ..|+.++|||||||++|+|++|.+||.   +.+
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~---~~~  251 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK---------KKYNEKCDVWSCGVIMYILLCGYPPFG---GQN  251 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSC---CSS
T ss_pred             CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc---------cCCCchHHHHHHHHHHHHHHhCCCCCC---CCC
Confidence             2369999999999877766667788999999999975         458999999999999999999999997   456


Q ss_pred             hhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        232 NKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       232 ~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      ..+.+..+.......                 ..+.+..+++    .+.++|.+||.+||.+|||+.++           
T Consensus       252 ~~~~~~~i~~~~~~~-----------------~~~~~~~~s~----~~~~li~~~L~~dp~~R~t~~e~-----------  299 (504)
T 3q5i_A          252 DQDIIKKVEKGKYYF-----------------DFNDWKNISD----EAKELIKLMLTYDYNKRCTAEEA-----------  299 (504)
T ss_dssp             HHHHHHHHHHCCCCC-----------------CHHHHTTSCH----HHHHHHHHHTCSSTTTSCCHHHH-----------
T ss_pred             HHHHHHHHHcCCCCC-----------------CccccCCCCH----HHHHHHHHHcCCChhHCCCHHHH-----------
Confidence            666666666532110                 1111223444    45569999999999999999997           


Q ss_pred             hcCcccCC
Q psy15481        312 LVHLFHIN  319 (708)
Q Consensus       312 l~h~~~~~  319 (708)
                      +.|||+..
T Consensus       300 l~h~~~~~  307 (504)
T 3q5i_A          300 LNSRWIKK  307 (504)
T ss_dssp             HTSHHHHH
T ss_pred             hcCHhhhh
Confidence            67898854

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.4e-41  Score=379.25  Aligned_cols=254  Identities=27%  Similarity=0.425  Sum_probs=201.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|.+.+.||+|+||.||+|.+..+|+.||+|++....  .........+|+.+++.++||||+++++++...+  .+|+
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~~l  225 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCF  225 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT--EEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC--EEEE
Confidence            46999999999999999999999999999999997531  2222334568999999999999999999998754  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ||||++||+|..++.....   +++..++.++.||+.||.|||+ +||+||||||+|||+    +..+.+||+|||+|..
T Consensus       226 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll----~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML----DKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EECCCSSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE----CSSSCEEECCCCCCCT
T ss_pred             EEeeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE----CCCCCEEEccCCCcee
Confidence            9999999999999876443   8999999999999999999998 999999999999998    6677899999999986


Q ss_pred             cc-ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LE-EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~-~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .. ........+||+.|+|||++.        +..|+.++|||||||++|+|++|.+||.   +.+.......+..... 
T Consensus       299 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~---~~~~~~~~~~i~~~~~-  366 (446)
T 4ejn_A          299 GIKDGATMKTFCGTPEYLAPEVLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPFY---NQDHEKLFELILMEEI-  366 (446)
T ss_dssp             TCC-----CCSSSCGGGCCHHHHH--------TSCCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCC-
T ss_pred             ccCCCcccccccCCccccCHhhcC--------CCCCCCccchhhhHHHHHHHhhCCCCCC---CCCHHHHHHHHHhCCC-
Confidence            43 334455678999999999997        6789999999999999999999999997   3445555555543211 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                        .+|  ..++    ..+.++|.+||..||.+||     +++++           +.|||+..
T Consensus       367 ------------------~~p--~~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~el-----------l~hp~f~~  410 (446)
T 4ejn_A          367 ------------------RFP--RTLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEI-----------MQHRFFAG  410 (446)
T ss_dssp             ------------------CCC--TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHH-----------HTSGGGTT
T ss_pred             ------------------CCC--ccCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHH-----------HhCccccC
Confidence                              112  1233    4456699999999999999     99987           67888865

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-41  Score=381.52  Aligned_cols=255  Identities=28%  Similarity=0.429  Sum_probs=211.8

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|.+.+.||+|+||.||+|.+..+|+.||||+++...  .........+|+.+++.++||||+++++++...+  .+|+
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~~~l   93 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS--DIFM   93 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEE
Confidence            47999999999999999999999999999999996432  1222445679999999999999999999997654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++...
T Consensus        94 v~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll----~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           94 VMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL----DAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EEECCSSEEHHHHTTSSSS---CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE----CTTCCEEECCCSSCEEC
T ss_pred             EEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE----ecCCCeEEEeccchhhc
Confidence            9999999999999976433   9999999999999999999999999999999999998    67778999999999987


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCc-CCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKT-FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~-~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ..+......+||+.|+|||++.        +.. ++.++|||||||++|+|++|..||..   .........+.....  
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~--  233 (476)
T 2y94_A          167 SDGEFLRTSCGSPNYAAPEVIS--------GRLYAGPEVDIWSSGVILYALLCGTLPFDD---DHVPTLFKKICDGIF--  233 (476)
T ss_dssp             CTTCCBCCCCSCSTTCCHHHHT--------TCCBCSHHHHHHHHHHHHHHHHHSSCSSCC---SSSHHHHHHHHTTCC--
T ss_pred             cccccccccCCCcCeEChhhcc--------CCCCCCCcceehhhHHHHHHHhhCCCCCCC---CCHHHHHHHHhcCCc--
Confidence            7666666788999999999987        444 47899999999999999999999973   444455555543210  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                       ..|  ..+++    .+.++|.+||..||.+|||+.++           +.|||+...
T Consensus       234 -----------------~~p--~~~s~----~~~~Li~~~L~~dP~~Rpt~~ei-----------l~hp~~~~~  273 (476)
T 2y94_A          234 -----------------YTP--QYLNP----SVISLLKHMLQVDPMKRATIKDI-----------REHEWFKQD  273 (476)
T ss_dssp             -----------------CCC--TTCCH----HHHHHHHHHTCSSTTTSCCHHHH-----------HTCHHHHTT
T ss_pred             -----------------CCC--ccCCH----HHHHHHHHHcCCCchhCcCHHHH-----------HhCHHhhhc
Confidence                             111  22344    45669999999999999999997           568888654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4e-41  Score=371.13  Aligned_cols=264  Identities=25%  Similarity=0.391  Sum_probs=197.7

Q ss_pred             ceEEEe-eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHh-CCCCCccceeEEEEe--cCCceE
Q psy15481         10 YVWCTT-SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK-VKHENIVKLLAIEEE--QEGRGK   85 (708)
Q Consensus        10 ~~y~i~-~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~k-L~HpNIVkl~~v~~~--~~~~~~   85 (708)
                      ..|.+. +.||+|+||.||+|.++.+|+.||||++..      .....+|+.++.+ .+||||+++++++..  .+...+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            456665 799999999999999999999999999863      2345688888754 589999999999864  234568


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|||||.||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ ...+..+.+||+|||++.
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill-~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY-TSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE-SSSSTTCCEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEE-ecCCCCccEEEEeccccc
Confidence            999999999999999987432 249999999999999999999999999999999999997 111126789999999999


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCCh-hhHHHHHHhccc
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN-KETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~-~e~~~~i~~~~~  244 (708)
                      ...........+||+.|+|||++.        +..|+.++|||||||++|+|++|..||....+... ......+.....
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~  284 (400)
T 1nxk_A          213 ETTSHNSLTTPCYTPYYVAPEVLG--------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY  284 (400)
T ss_dssp             ECC-----------CTTCCGGGSC--------CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred             ccCCCCccccCCCCCCccCHhhcC--------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence            776655566788999999999986        67899999999999999999999999975433221 112222322110


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                       ....+.+..+++    .+.+||.+||..||.+|||+.++           +.|||+....
T Consensus       285 -----------------~~~~~~~~~~s~----~~~~li~~~L~~dP~~Rpt~~ei-----------l~hp~~~~~~  329 (400)
T 1nxk_A          285 -----------------EFPNPEWSEVSE----EVKMLIRNLLKTEPTQRMTITEF-----------MNHPWIMQST  329 (400)
T ss_dssp             -----------------CCCTTTTTTSCH----HHHHHHHTTSCSSGGGSCCHHHH-----------HHSHHHHTTT
T ss_pred             -----------------cCCCcccccCCH----HHHHHHHHHCCCChhHCcCHHHH-----------hcCccccCCC
Confidence                             001122233444    45569999999999999999997           5688887643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-40  Score=354.84  Aligned_cols=276  Identities=19%  Similarity=0.307  Sum_probs=215.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      +..|.+.+.||+|+||.||+|.+..+|+.||+|++...    ....+.+|+.++++++ ||||+++++++.++.....++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            46799999999999999999999999999999998642    2456779999999996 999999999998876677999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC-ceEEEeccCcccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS-TIYKLTDFGAARE  166 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~-~~vKL~DFGlA~~  166 (708)
                      ||||+.+++|..++..      +++..++.++.||+.||.|||++||+||||||+|||+    +.. ..+||+|||+|..
T Consensus       111 v~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~----~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI----DHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----ETTTTEEEECCCTTCEE
T ss_pred             EEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----cCCCCEEEEEeCCCceE
Confidence            9999999999999864      8999999999999999999999999999999999997    433 3899999999987


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ...........||+.|+|||++..       ...++.++|||||||++|+|++|..||..  +..+.+.+..+.......
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~p~~~--~~~~~~~l~~~~~~~~~~  251 (330)
T 3nsz_A          181 YHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTE  251 (330)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSSSC--CSSHHHHHHHHHHHHCHH
T ss_pred             cCCCCccccccccccccChhhhcC-------CCcCCchhhHHHHHHHHHHHHhCCCCccc--CCchHHHHHHHHHhcCCc
Confidence            776666667789999999999862       36789999999999999999999999964  444444444433211100


Q ss_pred             cc----cccc----------cCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhh
Q psy15481        247 VI----SGTQ----------TSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKL  312 (708)
Q Consensus       247 ~i----~~~~----------~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l  312 (708)
                      ..    ....          ........|....+..  ....++..+.+||.+||..||.+|||+.++           +
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpta~e~-----------l  318 (330)
T 3nsz_A          252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSE--NQHLVSPEALDFLDKLLRYDHQSRLTAREA-----------M  318 (330)
T ss_dssp             HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTT--TGGGCCHHHHHHHHTTSCSSGGGSCCHHHH-----------H
T ss_pred             hhhhHHHHhccccccchhhhhhhccccchhhhcccc--ccccCCHHHHHHHHHHhcCCcccCCCHHHH-----------h
Confidence            00    0000          0000111222111111  112234556779999999999999999997           7


Q ss_pred             cCcccCCc
Q psy15481        313 VHLFHINR  320 (708)
Q Consensus       313 ~h~~~~~~  320 (708)
                      .|||+..-
T Consensus       319 ~hp~f~~~  326 (330)
T 3nsz_A          319 EHPYFYTV  326 (330)
T ss_dssp             TSGGGTTC
T ss_pred             cCccHhhh
Confidence            79999754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.2e-41  Score=350.91  Aligned_cols=256  Identities=29%  Similarity=0.469  Sum_probs=201.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-----chHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-----PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-----~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ..|.+.+.||+|+||.||+|.+..+|+.||+|++.......     ..+.+.+|+.++++++||||+++++++...+  .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~   82 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT--D   82 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC--e
Confidence            46999999999999999999999999999999987543221     2456779999999999999999999987644  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .++||||++|++|.+++....   .+++..++.++.||+.||.|||++|++||||||+||++.-.......+||+|||.+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999999997543   28999999999999999999999999999999999997211112337999999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .............|++.|+|||++.        +..++.++||||||+++|+|++|..||..   ....+.+..+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~~~  228 (283)
T 3bhy_A          160 HKIEAGNEFKNIFGTPEFVAPEIVN--------YEPLGLEADMWSIGVITYILLSGASPFLG---ETKQETLTNISAVNY  228 (283)
T ss_dssp             EECC--------CCCGGGCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHTTCC
T ss_pred             eeccCCCcccccCCCcCccCcceec--------CCCCCcchhhhhHHHHHHHHHHCCCCCCC---cchHHHHHHhHhccc
Confidence            8876666666678999999999987        56789999999999999999999999973   444555544443211


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                                         ..+  ....+..+..+.+++.+||..||.+|||+.+++.
T Consensus       229 -------------------~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 -------------------DFD--EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -------------------CCC--HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------------------CCc--chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                               000  0111123345667999999999999999999733

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-40  Score=344.65  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=209.6

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.+. +++.||+|++....  ...+.+.+|+.++++++||||+++++++.+.+  ..|+||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~   84 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLVF   84 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SEEEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--ceEEEE
Confidence            57999999999999999999986 57889999997543  23455779999999999999999999987654  499999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++|++|.+++.....  .+++..++.++.|++.||.|||++||+||||||+||++    +..+.+||+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV----GENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             ECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CGGGCEEECCTTGGGGBCC
T ss_pred             EeCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE----cCCCCEEeccccccccccc
Confidence            99999999999976443  38999999999999999999999999999999999998    6667899999999986654


Q ss_pred             cc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ..  ......+|+.|+|||.+.        +..++.++|||||||++|+|++ |.+||.   +....+....+....   
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~ll~~g~~p~~---~~~~~~~~~~~~~~~---  224 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFS--------FSRYSSKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGF---  224 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCTTT---TCCHHHHHHHHHTTC---
T ss_pred             cccccccCcccccccCCHHHhc--------CCCCCchhhhHHHHHHHHHHhcCCCCCCC---CCCHHHHHHHHhcCc---
Confidence            43  223456788999999997        5678999999999999999999 999997   355555555554321   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                                       ..+.+...    +..+.+++.+||..||.+|||+.++++++..+...
T Consensus       225 -----------------~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          225 -----------------RLYKPRLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -----------------CCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----------------cCCCCCcC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                             11111122    34466799999999999999999999999888754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.9e-41  Score=369.25  Aligned_cols=286  Identities=17%  Similarity=0.173  Sum_probs=208.1

Q ss_pred             CCceEEEeeEeecC--CceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          8 TNYVWCTTSVLGKG--ATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         8 ~n~~y~i~~~LG~G--~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      .+.+|.+.+.||+|  +||.||+|.++.+|+.||||+++...... ....+.+|+.+++.++||||+++++++...+  .
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~  100 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--E  100 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--E
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC--E
Confidence            35579999999999  99999999999999999999997643322 2344568999999999999999999998754  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||.+
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll----~~~~~~kl~dfg~~  175 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI----SVDGKVYLSGLRSN  175 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCGGGC
T ss_pred             EEEEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEcccccc
Confidence            9999999999999999876422 239999999999999999999999999999999999998    66778999999998


Q ss_pred             ccccccc--------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHH
Q psy15481        165 RELEEDQ--------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM  236 (708)
Q Consensus       165 ~~~~~~~--------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~  236 (708)
                      .......        ......||+.|+|||++...      ...++.++|||||||++|+|++|+.||.+   .+....+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~---~~~~~~~  246 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN------LQGYDAKSDIYSVGITACELANGHVPFKD---MPATQML  246 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT------SSCBCTHHHHHHHHHHHHHHHHSSCTTTT---CCSTTHH
T ss_pred             eeeccccccccccccccccccccccccCHHHHhcc------CCCCCcHhHHHHHHHHHHHHHHCCCCCCC---CCHHHHH
Confidence            7543221        11234789999999998721      15789999999999999999999999974   3333334


Q ss_pred             HHHHhcccCCcccccccCCC-------------C--------cccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC
Q psy15481        237 YYITTKKASGVISGTQTSEN-------------G--------EIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW  295 (708)
Q Consensus       237 ~~i~~~~~~~~i~~~~~~~~-------------g--------~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp  295 (708)
                      ..+.....+...........             +        .................++..+.+||.+||..||.+||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp  326 (389)
T 3gni_B          247 LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP  326 (389)
T ss_dssp             HHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC
Confidence            33332222111100000000             0        00000000001112334455677799999999999999


Q ss_pred             CHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        296 SFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       296 sa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      |+.++           +.|||+..-
T Consensus       327 ta~el-----------l~hp~f~~~  340 (389)
T 3gni_B          327 SASTL-----------LNHSFFKQI  340 (389)
T ss_dssp             CHHHH-----------TTSGGGGGC
T ss_pred             CHHHH-----------hcCHHHHHH
Confidence            99997           779999653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-41  Score=364.55  Aligned_cols=290  Identities=20%  Similarity=0.300  Sum_probs=209.1

Q ss_pred             CCcccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC----chHHHHHHHHHHHhCCCCCccceeEE
Q psy15481          1 MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR----PHDVQMREFEVLKKVKHENIVKLLAI   76 (708)
Q Consensus         1 ms~l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~----~~~~~~~Ei~iL~kL~HpNIVkl~~v   76 (708)
                      |+.-.++...+|.+.+.||+|+||.||+|.+..+|+.||+|++.......    ......+|+.++++++||||++++++
T Consensus         1 m~l~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (346)
T 1ua2_A            1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA   80 (346)
T ss_dssp             ------------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CchhhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence            55566777889999999999999999999999999999999987533221    12345689999999999999999999


Q ss_pred             EEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceE
Q psy15481         77 EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY  156 (708)
Q Consensus        77 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~v  156 (708)
                      +...+  ..++||||+. ++|..++....  ..+++..++.++.|++.||.|||++||+||||||+|||+    +..+.+
T Consensus        81 ~~~~~--~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~----~~~~~~  151 (346)
T 1ua2_A           81 FGHKS--NISLVFDFME-TDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL----DENGVL  151 (346)
T ss_dssp             ECCTT--CCEEEEECCS-EEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCE
T ss_pred             EeeCC--ceEEEEEcCC-CCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE----cCCCCE
Confidence            87654  4999999996 48988887643  238999999999999999999999999999999999998    667789


Q ss_pred             EEeccCcccccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhH
Q psy15481        157 KLTDFGAARELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKET  235 (708)
Q Consensus       157 KL~DFGlA~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~  235 (708)
                      ||+|||++...... .......||+.|+|||++..       ...++.++|||||||++|+|++|.+||.   +.+..+.
T Consensus       152 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~~~~---~~~~~~~  221 (346)
T 1ua2_A          152 KLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLP---GDSDLDQ  221 (346)
T ss_dssp             EECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSC---CSSHHHH
T ss_pred             EEEecccceeccCCcccCCcccccccccCchHhhC-------CCCCCchhhhHhHHHHHHHHHHCCCCCC---CCCHHHH
Confidence            99999999876433 33445789999999999862       3558999999999999999999999997   4566666


Q ss_pred             HHHHHhcccCCc---ccccccCCCCcccccCCCCCc--ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        236 MYYITTKKASGV---ISGTQTSENGEIDWCTDLPNN--CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       236 ~~~i~~~~~~~~---i~~~~~~~~g~~~~~~~lp~~--~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      +..+........   ........ ..+.+. ..|..  ..+...++..+.++|.+||..||.+|||+.++          
T Consensus       222 ~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el----------  289 (346)
T 1ua2_A          222 LTRIFETLGTPTEEQWPDMCSLP-DYVTFK-SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA----------  289 (346)
T ss_dssp             HHHHHHHHCCCCTTTSSSTTSST-TCCCCC-CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH----------
T ss_pred             HHHHHHHcCCCChhhhhhhccCc-cccccc-ccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHH----------
Confidence            666654311110   00000000 000000 01110  11123445667789999999999999999997          


Q ss_pred             hhcCcccCCccc
Q psy15481        311 KLVHLFHINRLQ  322 (708)
Q Consensus       311 ~l~h~~~~~~~~  322 (708)
                       +.|||+.+...
T Consensus       290 -l~h~~f~~~~~  300 (346)
T 1ua2_A          290 -LKMKYFSNRPG  300 (346)
T ss_dssp             -HTSGGGTSSSC
T ss_pred             -hcChhhhcCCC
Confidence             67999976543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-41  Score=364.50  Aligned_cols=265  Identities=27%  Similarity=0.398  Sum_probs=189.8

Q ss_pred             ceEEEe---eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceE
Q psy15481         10 YVWCTT---SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        10 ~~y~i~---~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~   85 (708)
                      .+|.+.   +.||+|+||.||+|.++.+|+.||||++...    ......+|+.+++.+. ||||+++++++.+..  ..
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~--~~   81 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQL--HT   81 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC--EE
Confidence            356664   7899999999999999999999999998643    2445668999999996 999999999997654  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+ ..+++...+||+|||++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll-~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLF-TDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE-EC----CEEEECCCTTCE
T ss_pred             EEEEEccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEE-ecCCCcccEEEeccccce
Confidence            999999999999999976543   9999999999999999999999999999999999997 222334489999999998


Q ss_pred             ccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC----CChhhHHHHHH
Q psy15481        166 ELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG----RRNKETMYYIT  240 (708)
Q Consensus       166 ~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g----~~~~e~~~~i~  240 (708)
                      ..... ......+||+.|+|||++.        +..++.++|||||||++|+|++|..||...+.    ....+.+..+.
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~  229 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLN--------QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK  229 (325)
T ss_dssp             ECCC------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT
T ss_pred             ecCCCCCcccccCCCcCccCHHHhc--------CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH
Confidence            65443 3345567899999999987        67789999999999999999999999975332    12233333333


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ....                     +........++..+.++|.+||..||.+|||+.++           +.|||+...
T Consensus       230 ~~~~---------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el-----------l~h~w~~~~  277 (325)
T 3kn6_A          230 KGDF---------------------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL-----------RYNEWLQDG  277 (325)
T ss_dssp             TTCC---------------------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTS-----------TTCGGGCTT
T ss_pred             cCCC---------------------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHH-----------hcChhhccC
Confidence            2110                     11101111233456669999999999999999986           789999876


Q ss_pred             cccc
Q psy15481        321 LQCI  324 (708)
Q Consensus       321 ~~~~  324 (708)
                      ....
T Consensus       278 ~~~~  281 (325)
T 3kn6_A          278 SQLS  281 (325)
T ss_dssp             CCCC
T ss_pred             ccCC
Confidence            5443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5e-41  Score=366.29  Aligned_cols=260  Identities=20%  Similarity=0.326  Sum_probs=208.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc-------CCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEec
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK-------NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQ   80 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~-------~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~   80 (708)
                      ...|.+.+.||+|+||.||+|.+.       .++..||+|+++..........+.+|+.+++++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            357999999999999999999875       356689999997553333334567999999999 899999999998765


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEE
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKF  147 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~  147 (708)
                      +  .+|+||||++||+|.+++.....             ...+++..++.++.||+.||.|||++||+||||||+|||+ 
T Consensus       160 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll-  236 (370)
T 2psq_A          160 G--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-  236 (370)
T ss_dssp             S--SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-
T ss_pred             C--CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE-
Confidence            4  49999999999999999875321             1238999999999999999999999999999999999998 


Q ss_pred             EecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCC
Q psy15481        148 ICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLP  223 (708)
Q Consensus       148 ~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~P  223 (708)
                         +..+.+||+|||+|........   .....+|+.|+|||++.        +..++.++|||||||++|+|+| |..|
T Consensus       237 ---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DvwslG~il~ellt~g~~p  305 (370)
T 2psq_A          237 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF--------DRVYTHQSDVWSFGVLMWEIFTLGGSP  305 (370)
T ss_dssp             ---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH--------TCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc--------CCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence               6677899999999986554322   23356788999999997        6779999999999999999999 9999


Q ss_pred             CCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        224 FRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       224 F~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                      |..   ....+....+.....                  ...|      ..++..+.+++.+||..||.+||++.+++..
T Consensus       306 ~~~---~~~~~~~~~~~~~~~------------------~~~~------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          306 YPG---IPVEELFKLLKEGHR------------------MDKP------ANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             STT---CCGGGHHHHHHTTCC------------------CCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC---CCHHHHHHHHhcCCC------------------CCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            973   444444443332110                  0111      2233456679999999999999999999999


Q ss_pred             HHHHHh
Q psy15481        304 VTKTLN  309 (708)
Q Consensus       304 l~~il~  309 (708)
                      ++.++.
T Consensus       359 L~~il~  364 (370)
T 2psq_A          359 LDRILT  364 (370)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            988875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.7e-41  Score=369.54  Aligned_cols=259  Identities=29%  Similarity=0.394  Sum_probs=203.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHH-HHhCCCCCccceeEEEEecCCceE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEV-LKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~i-L~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ...|.+.+.||+|+||.||+|+++.+|+.||+|++++.....  ......+|..+ ++.++||||+++++++.+.+  .+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~--~~  114 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KL  114 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS--EE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC--EE
Confidence            357999999999999999999999999999999997643221  22234566665 56789999999999997654  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+++
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll----~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL----DSQGHIVLTDFGLCK  187 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEECCCCBCG
T ss_pred             EEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE----CCCCCEEEeeCcccc
Confidence            999999999999999976432   8999999999999999999999999999999999998    677789999999998


Q ss_pred             ccc-ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELE-EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~-~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ... ........+||+.|+|||++.        +..++.++|+|||||++|+|++|..||.   +.+..+....+.....
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~G~~Pf~---~~~~~~~~~~i~~~~~  256 (373)
T 2r5t_A          188 ENIEHNSTTSTFCGTPEYLAPEVLH--------KQPYDRTVDWWCLGAVLYEMLYGLPPFY---SRNTAEMYDNILNKPL  256 (373)
T ss_dssp             GGBCCCCCCCSBSCCCCCCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSSCTTC---CSBHHHHHHHHHHSCC
T ss_pred             ccccCCCccccccCCccccCHHHhC--------CCCCCchhhhHHHHHHHHHHHcCCCCCC---CCCHHHHHHHHHhccc
Confidence            643 333455678999999999987        6779999999999999999999999997   4555666666654311


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                         .+|  ..++    ..+.++|.+||..||.+||++.+.+.+       ...|||+..
T Consensus       257 -------------------~~~--~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~-------i~~h~~f~~  299 (373)
T 2r5t_A          257 -------------------QLK--PNIT----NSARHLLEGLLQKDRTKRLGAKDDFME-------IKSHVFFSL  299 (373)
T ss_dssp             -------------------CCC--SSSC----HHHHHHHHHHTCSSGGGSTTTTTTHHH-------HHTSGGGTT
T ss_pred             -------------------CCC--CCCC----HHHHHHHHHHcccCHHhCCCCCCCHHH-------HhCCccccC
Confidence                               112  1234    345669999999999999998643222       256888753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.5e-41  Score=351.43  Aligned_cols=259  Identities=23%  Similarity=0.385  Sum_probs=198.3

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCC---CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNN---GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ...+|.+.+.||+|+||.||+|.+..+   +..||+|.+.........+.+.+|+.++++++||||+++++++.+   +.
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~   89 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP   89 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---Cc
Confidence            346899999999999999999998654   557999998754433334556799999999999999999999743   24


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||+++++|.+++....  ..+++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV----SSNDCVKLGDFGLS  163 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECC----
T ss_pred             cEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE----CCCCCEEECccccc
Confidence            899999999999999997543  238999999999999999999999999999999999998    45568999999999


Q ss_pred             ccccccccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHh
Q psy15481        165 RELEEDQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       165 ~~~~~~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      .........  ....+++.|+|||++.        +..++.++|||||||++|+|++ |..||..   ....+....+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~ell~~g~~pf~~---~~~~~~~~~i~~  232 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESIN--------FRRFTSASDVWMFGVCMWEILMHGVKPFQG---VKNNDVIGRIEN  232 (281)
T ss_dssp             ---------------CCGGGCCHHHHH--------HCCCSHHHHHHHHHHHHHHHHTTSCCTTTT---CCGGGHHHHHHT
T ss_pred             cccCcccccccccCCCcccccChhhcc--------cCCCCCccCchHHHHHHHHHHhcCCCCCCc---CCHHHHHHHHHc
Confidence            876544322  2345778999999997        4678999999999999999997 9999973   444555555543


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ..                    ..+.    ++.++..+.+++.+||..||.+|||+.++++.+..++..
T Consensus       233 ~~--------------------~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          233 GE--------------------RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             TC--------------------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC--------------------CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            21                    1111    122334566799999999999999999999999888764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-41  Score=376.74  Aligned_cols=266  Identities=27%  Similarity=0.403  Sum_probs=198.0

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-------CCchHHHHHHHHHHHhCCCCCccceeEEEEecC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-------MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE   81 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-------~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~   81 (708)
                      ...|.+.+.||+|+||.||+|.+..+|+.||+|++.....       ......+.+|+.++++++||||+++++++... 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            3569999999999999999999999999999999875321       11122356899999999999999999997532 


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                        ..|+||||++||+|.+++....   .+++..++.++.|++.||.|||++||+||||||+|||+ ...+....+||+||
T Consensus       213 --~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll-~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          213 --DYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL-SSQEEDCLIKITDF  286 (419)
T ss_dssp             --EEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-SSSSSSCCEEECCS
T ss_pred             --ceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE-ecCCCcceEEEeec
Confidence              4899999999999999887644   39999999999999999999999999999999999997 22223456999999


Q ss_pred             CccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        162 GAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       162 GlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      |+|............+||+.|+|||++....     ...|+.++|||||||++|+|+||.+||....  ........+..
T Consensus       287 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~~i~~  359 (419)
T 3i6u_A          287 GHSKILGETSLMRTLCGTPTYLAPEVLVSVG-----TAGYNRAVDCWSLGVILFICLSGYPPFSEHR--TQVSLKDQITS  359 (419)
T ss_dssp             STTTSCC-----------CTTCCTTTTC---------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS--SSCCHHHHHHT
T ss_pred             ccceecCCCccccccCCCCCccCceeeecCC-----CCCCCchhhhHhHHHHHHHHHHCCCCCCCCc--chHHHHHHHhc
Confidence            9999877666666788999999999985210     3567889999999999999999999997422  22222222222


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ...                     +........++..+.++|.+||..||.+|||+.++           +.|||+...
T Consensus       360 ~~~---------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~-----------l~hp~~~~~  406 (419)
T 3i6u_A          360 GKY---------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA-----------LRHPWLQDE  406 (419)
T ss_dssp             TCC---------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH-----------HHSGGGCCH
T ss_pred             CCC---------------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHH-----------hCCcccCCh
Confidence            110                     00001111233456679999999999999999997           669999653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-41  Score=362.71  Aligned_cols=267  Identities=25%  Similarity=0.413  Sum_probs=207.7

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC----CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS----HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s----~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      +.+|.+.+.||+|+||.||+|.+..+++.||+|++....    .....+.+.+|+.++++++||||+++++++.+.+  .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~  102 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ--Y  102 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC--e
Confidence            457999999999999999999999999999999986431    2333456779999999999999999999997644  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHHHH
Q psy15481         85 KVIVMELCTGGSLFNILDDPE-------------------------------------NTYGLQEEEFLLVLEHLTAGMK  127 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~-------------------------------------~~~~L~e~~v~~il~qIl~aL~  127 (708)
                      .|+|||||+||+|.+++....                                     ....+++..++.++.||+.||.
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            999999999999999985200                                     0111468889999999999999


Q ss_pred             HHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc-----cccccCCCCCcCChhhhhhhhhcCCCCCcCC
Q psy15481        128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFG  202 (708)
Q Consensus       128 yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s  202 (708)
                      |||++||+||||||+|||+  +.++...+||+|||++.......     ......||+.|+|||++...      +..++
T Consensus       183 ~LH~~~ivH~Dlkp~NIll--~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~  254 (345)
T 3hko_A          183 YLHNQGICHRDIKPENFLF--STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT------NESYG  254 (345)
T ss_dssp             HHHHTTEECCCCCGGGEEE--SCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS------SSCCC
T ss_pred             HHHHCCccccCCChhhEEE--ecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC------CCCCC
Confidence            9999999999999999997  44444589999999998654321     23456799999999998621      36789


Q ss_pred             ccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHH
Q psy15481        203 ATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPI  282 (708)
Q Consensus       203 ~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~L  282 (708)
                      .++|||||||++|+|++|..||.   +....+....+.......                 ..|....++    ..+.++
T Consensus       255 ~~~DiwslG~il~el~~g~~pf~---~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~----~~~~~l  310 (345)
T 3hko_A          255 PKCDAWSAGVLLHLLLMGAVPFP---GVNDADTISQVLNKKLCF-----------------ENPNYNVLS----PLARDL  310 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCCCT-----------------TSGGGGGSC----HHHHHH
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCC---CCChHHHHHHHHhccccc-----------------CCcccccCC----HHHHHH
Confidence            99999999999999999999997   455666666666532110                 111112233    456669


Q ss_pred             HHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        283 LAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       283 L~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      |.+||..||.+||++.++           +.|||+..-
T Consensus       311 i~~~l~~~p~~Rps~~~~-----------l~hp~~~~~  337 (345)
T 3hko_A          311 LSNLLNRNVDERFDAMRA-----------LQHPWISQF  337 (345)
T ss_dssp             HHHHSCSCTTTSCCHHHH-----------HHSHHHHTT
T ss_pred             HHHHcCCChhHCCCHHHH-----------hcChhhccC
Confidence            999999999999999997           558888654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.7e-41  Score=354.18  Aligned_cols=258  Identities=19%  Similarity=0.313  Sum_probs=205.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+|+.++++++||||+++++++.+.+  ..++|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv   85 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK--RLNFI   85 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC--eeEEE
Confidence            458999999999999999999999999999999885422 223445679999999999999999999998654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++||+|.+++.....  .+++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++....
T Consensus        86 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV----RENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE----CTTSCEEECCCTTCEECC
T ss_pred             EEecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE----CCCCCEEEeecccceecc
Confidence            999999999999976432  39999999999999999999999999999999999998    677789999999998654


Q ss_pred             ccccc---------------cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChh
Q psy15481        169 EDQQF---------------MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK  233 (708)
Q Consensus       169 ~~~~~---------------~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~  233 (708)
                      .....               ....||+.|+|||++.        +..++.++|||||||++|+|++|..||..+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~  231 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN--------GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD  231 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhc--------CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence            33221               1467999999999997        678899999999999999999999999753221110


Q ss_pred             --hHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        234 --ETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       234 --e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                        .........                     ..|.  .+++    .+.+++.+||..||++|||+.++.+.+..+...
T Consensus       232 ~~~~~~~~~~~---------------------~~~~--~~~~----~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          232 FGLNVRGFLDR---------------------YCPP--NCPP----SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             SSBCHHHHHHH---------------------TCCT--TCCT----THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Hhhhhhccccc---------------------cCCC--CCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence              001111100                     1111  1233    456699999999999999999998887766543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.7e-41  Score=359.97  Aligned_cols=262  Identities=22%  Similarity=0.249  Sum_probs=211.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      +..|.+.+.||+|+||.||+|.+..+|+.||||++.....   .+.+.+|+.+++++ +||||+++++++....  ..|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK--YNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT--EEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC--ccEE
Confidence            4679999999999999999999999999999999875432   23466899999999 9999999999987744  5899


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCce-----EEEeccC
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTI-----YKLTDFG  162 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~-----vKL~DFG  162 (708)
                      ||||+ |++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.     +||+|||
T Consensus        83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill----~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI----GRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CCGGGTCTTSEEECCCT
T ss_pred             EEEeC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee----ccCCCCCCceEEEEEcc
Confidence            99999 9999999976422  39999999999999999999999999999999999998    44444     9999999


Q ss_pred             cccccccccc--------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhh
Q psy15481        163 AARELEEDQQ--------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE  234 (708)
Q Consensus       163 lA~~~~~~~~--------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e  234 (708)
                      +|........        .....||+.|+|||++.        +..++.++|||||||++|+|++|..||.........+
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~  227 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHL--------GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE  227 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHc--------CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH
Confidence            9987644332        24568999999999987        6778999999999999999999999998654444445


Q ss_pred             HHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        235 TMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       235 ~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      .+..+...+...                   |. ..+....+ .+.+++..||..||.+||+++++.+.+.+++.+.
T Consensus       228 ~~~~i~~~~~~~-------------------~~-~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          228 RYQKIGDTKRAT-------------------PI-EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHHHHHHHHS-------------------CH-HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHhhhccC-------------------CH-HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            555444321110                   10 00111223 5777999999999999999999999888776654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.8e-41  Score=351.73  Aligned_cols=263  Identities=25%  Similarity=0.308  Sum_probs=204.6

Q ss_pred             CceEEEeeEeecCCceEEEEEE----EcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~----~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ...|.+.+.||+|+||.||+|.    +..+|+.||+|++...........+.+|+.++++++||||+++++++...+...
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            4569999999999999999998    567899999999986655555567789999999999999999999998776667


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      +++||||++|++|.+++.....  .+++..++.++.|++.||.|||++||+||||||+||++    +..+.+||+|||++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV----ESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETTEEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE----cCCCCEEECccccc
Confidence            9999999999999999955332  38999999999999999999999999999999999998    55568999999999


Q ss_pred             cccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCC-----------CC
Q psy15481        165 RELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY-----------GG  229 (708)
Q Consensus       165 ~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~-----------~g  229 (708)
                      ........    .....||..|+|||++.        +..++.++|||||||++|+|+||..||...           .+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  245 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLM--------QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG  245 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHH--------HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeec--------CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc
Confidence            87654432    23456888999999997        567889999999999999999999987421           11


Q ss_pred             CChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        230 RRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       230 ~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                      ......+......                   ....+.+    +.++..+.+++.+||..||.+|||+.++++.++.++
T Consensus       246 ~~~~~~~~~~~~~-------------------~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          246 QMTVTRLVNTLKE-------------------GKRLPCP----PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             GGHHHHHHHHHHT-------------------TCCCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHhc-------------------cCCCCCC----CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1111111111110                   0012222    233445667999999999999999999999988765

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.2e-40  Score=356.72  Aligned_cols=284  Identities=21%  Similarity=0.329  Sum_probs=212.5

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecC----
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQE----   81 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~----   81 (708)
                      ..-.+|.+.+.||+|+||.||+|.+..+|+.||+|++...... .......+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            3446899999999999999999999999999999998655432 22345679999999999999999999987643    


Q ss_pred             --CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         82 --GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        82 --~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                        .+.+|+||||+. ++|...+.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+
T Consensus        94 ~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~----~~~~~~kl~  166 (351)
T 3mi9_A           94 RCKGSIYLVFDFCE-HDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI----TRDGVLKLA  166 (351)
T ss_dssp             ---CEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEEC
T ss_pred             cCCceEEEEEeccC-CCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE----cCCCCEEEc
Confidence              346899999996 578777766433  39999999999999999999999999999999999998    667789999


Q ss_pred             ccCcccccccc-----ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhh
Q psy15481        160 DFGAARELEED-----QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE  234 (708)
Q Consensus       160 DFGlA~~~~~~-----~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e  234 (708)
                      |||+|......     .......||+.|+|||++..       ...++.++|||||||++|+|+||.+||.+   .....
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~---~~~~~  236 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQH  236 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHH
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcC-------CCCCCcHhHHHHHHHHHHHHHhCCCCCCC---CChHH
Confidence            99999865422     23345678999999999862       35689999999999999999999999984   44444


Q ss_pred             HHHHHHh---cccCCcccccccCCCCcccccCCCCCc----ccCChhH-----HHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        235 TMYYITT---KKASGVISGTQTSENGEIDWCTDLPNN----CQLSLGL-----KKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       235 ~~~~i~~---~~~~~~i~~~~~~~~g~~~~~~~lp~~----~~ls~~l-----~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      ....+..   ...+........     ..+...+...    ..+...+     +..+.+||.+||..||.+|||++++  
T Consensus       237 ~~~~i~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~--  309 (351)
T 3mi9_A          237 QLALISQLCGSITPEVWPNVDN-----YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA--  309 (351)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGG-----CGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH--
T ss_pred             HHHHHHHHhCCCChhhcccccc-----chhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH--
Confidence            4444432   111111111100     0000000000    0111111     2346789999999999999999997  


Q ss_pred             HHHHHHhhhhcCcccCCcccc
Q psy15481        303 EVTKTLNRKLVHLFHINRLQC  323 (708)
Q Consensus       303 ~l~~il~~~l~h~~~~~~~~~  323 (708)
                               +.|||+...+..
T Consensus       310 ---------l~hp~f~~~~~~  321 (351)
T 3mi9_A          310 ---------LNHDFFWSDPMP  321 (351)
T ss_dssp             ---------HTSGGGGSSSCC
T ss_pred             ---------hCCCCcCCCCCc
Confidence                     679999765443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.2e-41  Score=363.26  Aligned_cols=263  Identities=21%  Similarity=0.317  Sum_probs=208.5

Q ss_pred             CceEEEeeEeecCCceEEEEEE-----EcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGV-----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEG   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~-----~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~   82 (708)
                      ..+|.+.+.||+|+||.||+|.     +..+++.||||+++..........+.+|+.+++++ +||||+++++++...+ 
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-   99 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-   99 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC-
Confidence            4579999999999999999998     55678999999997654333345578999999999 8999999999987643 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCC--------------------------------------------------------
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPEN--------------------------------------------------------  106 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~--------------------------------------------------------  106 (708)
                      ...++|||||+||+|.+++.....                                                        
T Consensus       100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3vhe_A          100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  179 (359)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred             CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence            358999999999999999976432                                                        


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc---ccccc
Q psy15481        107 -------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ---QFMSL  176 (708)
Q Consensus       107 -------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~---~~~~~  176 (708)
                             ...+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.......   .....
T Consensus       180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE----cCCCcEEEEeccceeeecccccchhcccc
Confidence                   1128999999999999999999999999999999999998    667789999999998654332   22345


Q ss_pred             CCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCcccccccCC
Q psy15481        177 YGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSE  255 (708)
Q Consensus       177 ~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~  255 (708)
                      .||+.|+|||++.        +..++.++|||||||++|+|+| |..||.+   ....+.+........           
T Consensus       256 ~~t~~y~aPE~~~--------~~~~~~~~Di~slG~il~ellt~g~~p~~~---~~~~~~~~~~~~~~~-----------  313 (359)
T 3vhe_A          256 RLPLKWMAPETIF--------DRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VKIDEEFCRRLKEGT-----------  313 (359)
T ss_dssp             EECGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHTTTSCCSSTT---CCCSHHHHHHHHHTC-----------
T ss_pred             CCCceeEChhhhc--------CCCCCchhhhhhHHHHHHHHHhcCCCCCCc---cchhHHHHHHHHcCC-----------
Confidence            6889999999997        5678999999999999999998 9999974   222223333222110           


Q ss_pred             CCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        256 NGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       256 ~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                              ..+.+...+    ..+.+++.+||..||.+|||+.+++.++..++..
T Consensus       314 --------~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          314 --------RMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             --------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                    111112233    3456699999999999999999999999888754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-40  Score=348.01  Aligned_cols=262  Identities=23%  Similarity=0.360  Sum_probs=206.9

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEec--CC
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQ--EG   82 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~--~~   82 (708)
                      ...+..|.+.+.||+|+||.||+|.+..++..||+|.+...... .....+.+|+.++++++||||+++++++...  +.
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            34566799999999999999999999999999999998754322 2234567899999999999999999998653  34


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEEEecC-CCceEEEe
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR--LVHRDLKPGNIMKFICDD-GSTIYKLT  159 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g--IVHrDIKP~NILl~~~~d-~~~~vKL~  159 (708)
                      ..+|+||||++|++|.+++.....   +++..++.++.||+.||.|||++|  |+||||||+||++    + ..+.+||+
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~----~~~~~~~kl~  174 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI----TGPTGSVKIG  174 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE----SSTTSCEEEC
T ss_pred             ceEEEEEEecCCCCHHHHHHHccC---CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEE----ECCCCCEEEe
Confidence            568999999999999999976432   899999999999999999999999  9999999999998    4 45689999


Q ss_pred             ccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        160 DFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       160 DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      |||++...... ......||+.|+|||++.         ..++.++|||||||++|+|++|..||..   ..+.......
T Consensus       175 Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~pf~~---~~~~~~~~~~  241 (290)
T 1t4h_A          175 DLGLATLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSE---CQNAAQIYRR  241 (290)
T ss_dssp             CTTGGGGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTT---CSSHHHHHHH
T ss_pred             eCCCccccccc-ccccccCCcCcCCHHHHh---------ccCCCcchHHHHHHHHHHHHhCCCCCCC---cCcHHHHHHH
Confidence            99999754333 334567999999999875         3488999999999999999999999973   2333333332


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ......                    +  ...+......+.++|.+||..||.+|||+.++           +.|||+..
T Consensus       242 ~~~~~~--------------------~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el-----------l~h~~f~~  288 (290)
T 1t4h_A          242 VTSGVK--------------------P--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL-----------LNHAFFQE  288 (290)
T ss_dssp             HTTTCC--------------------C--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHH-----------HTSGGGC-
T ss_pred             HhccCC--------------------c--cccCCCCCHHHHHHHHHHccCChhhCCCHHHH-----------hhCccccc
Confidence            221100                    0  01111222346679999999999999999997           67999865


Q ss_pred             c
Q psy15481        320 R  320 (708)
Q Consensus       320 ~  320 (708)
                      .
T Consensus       289 ~  289 (290)
T 1t4h_A          289 E  289 (290)
T ss_dssp             -
T ss_pred             C
Confidence            3

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=364.91  Aligned_cols=256  Identities=29%  Similarity=0.456  Sum_probs=209.8

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-------chHHHHHHHHHHHhCCCCCccceeEEEE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-------PHDVQMREFEVLKKVKHENIVKLLAIEE   78 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-------~~~~~~~Ei~iL~kL~HpNIVkl~~v~~   78 (708)
                      |....+|.+.+.||+|+||.||+|.++.+|+.||||+++......       ....+.+|+.++++++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            445668999999999999999999999999999999997653221       1223458999999999999999999997


Q ss_pred             ecCCceEEEEEeccCCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEE
Q psy15481         79 EQEGRGKVIVMELCTGG-SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYK  157 (708)
Q Consensus        79 ~~~~~~~~LVmEy~~gg-sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vK  157 (708)
                      ..+  ..++||||+.+| +|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+|
T Consensus       100 ~~~--~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~k  170 (335)
T 3dls_A          100 NQG--FFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI----AEDFTIK  170 (335)
T ss_dssp             CSS--EEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEE
T ss_pred             eCC--EEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE----cCCCcEE
Confidence            644  599999998766 99999987543   9999999999999999999999999999999999998    6677899


Q ss_pred             EeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcC-CccccchhhhhHHHHHhcCCCCCCCCCCCChhhHH
Q psy15481        158 LTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTF-GATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM  236 (708)
Q Consensus       158 L~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~-s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~  236 (708)
                      |+|||++.............||+.|+|||++.        +..+ +.++|||||||++|+|++|..||....     .  
T Consensus       171 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~--  235 (335)
T 3dls_A          171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM--------GNPYRGPELEMWSLGVTLYTLVFEENPFCELE-----E--  235 (335)
T ss_dssp             ECCCTTCEECCTTCCBCEECSCGGGCCHHHHT--------TCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG-----G--
T ss_pred             EeecccceECCCCCceeccCCCccccChhhhc--------CCCCCCCcccchhHHHHHHHHHhCCCchhhHH-----H--
Confidence            99999999877766666788999999999987        4444 889999999999999999999996310     0  


Q ss_pred             HHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcc
Q psy15481        237 YYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLF  316 (708)
Q Consensus       237 ~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~  316 (708)
                        ...                     ...+.+..+++    .+.++|.+||..||.+|||+.++           +.|||
T Consensus       236 --~~~---------------------~~~~~~~~~~~----~l~~li~~~L~~dP~~Rps~~el-----------l~hp~  277 (335)
T 3dls_A          236 --TVE---------------------AAIHPPYLVSK----ELMSLVSGLLQPVPERRTTLEKL-----------VTDPW  277 (335)
T ss_dssp             --GTT---------------------TCCCCSSCCCH----HHHHHHHHHTCSSGGGSCCHHHH-----------HHCTT
T ss_pred             --HHh---------------------hccCCCcccCH----HHHHHHHHHccCChhhCcCHHHH-----------hcCcc
Confidence              000                     01111122344    45669999999999999999997           66999


Q ss_pred             cCCcccc
Q psy15481        317 HINRLQC  323 (708)
Q Consensus       317 ~~~~~~~  323 (708)
                      +......
T Consensus       278 ~~~~~~~  284 (335)
T 3dls_A          278 VTQPVNL  284 (335)
T ss_dssp             TTCCCCG
T ss_pred             ccCCccc
Confidence            9775443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2e-41  Score=378.83  Aligned_cols=285  Identities=21%  Similarity=0.311  Sum_probs=194.8

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecC---Cc
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQE---GR   83 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~---~~   83 (708)
                      ...+|.+.+.||+|+||.||+|.++.+|+.||||++...... .....+.+|+.++++++||||+++++++....   ..
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            346799999999999999999999999999999998654222 12344679999999999999999999985432   24


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|+||||+ +++|..++.....   +++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl----~~~~~~kl~DFGl  202 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTPVY---LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV----NQDCSVKVCDFGL  202 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSSCC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTCCEEECCCTT
T ss_pred             eEEEEEecc-ccchhhhcccCCC---CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE----CCCCCEeeccccc
Confidence            699999998 6899999987543   9999999999999999999999999999999999998    7777899999999


Q ss_pred             cccccccc----------------------------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHH
Q psy15481        164 ARELEEDQ----------------------------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLY  215 (708)
Q Consensus       164 A~~~~~~~----------------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLy  215 (708)
                      |+......                            .....+||+.|+|||++..       +..|+.++|||||||++|
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~~DiwSlG~il~  275 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-------QENYTEAIDVWSIGCIFA  275 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHH
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC-------CCCCCcHhHHHHHHHHHH
Confidence            98654221                            2344678999999998752       567999999999999999


Q ss_pred             HHhc-----------CCCCCCCCCC-----------------CChhhHHHHHHh---cccCCcccccccCCCCcccccCC
Q psy15481        216 HVAT-----------GNLPFRPYGG-----------------RRNKETMYYITT---KKASGVISGTQTSENGEIDWCTD  264 (708)
Q Consensus       216 eLlT-----------G~~PF~~~~g-----------------~~~~e~~~~i~~---~~~~~~i~~~~~~~~g~~~~~~~  264 (708)
                      ||+|           |.+||.+.+.                 ..+.+.+..+..   ......+......  ....|...
T Consensus       276 elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~--~~~~~~~~  353 (458)
T 3rp9_A          276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE--DAKRYIRI  353 (458)
T ss_dssp             HHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCH--HHHHHHTT
T ss_pred             HHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCH--HHHHHHHh
Confidence            9999           6666653210                 001222222221   1111100000000  00000001


Q ss_pred             CCC-----cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        265 LPN-----NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       265 lp~-----~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      +|.     .....+..+..+.+||.+||.+||.+|||++++           +.|||+..-
T Consensus       354 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~-----------L~Hp~f~~~  403 (458)
T 3rp9_A          354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINEC-----------LAHPFFKEV  403 (458)
T ss_dssp             SCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHH-----------HHSGGGTTT
T ss_pred             cCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHH-----------hcCHhhhhc
Confidence            111     011122334556779999999999999999997           568988654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.4e-41  Score=374.66  Aligned_cols=265  Identities=26%  Similarity=0.365  Sum_probs=212.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ...|.+.+.||+|+||.||+|.++.+|+.||+|++++...  ......+.+|..++..++||||+++++++.+.+  .+|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~--~~~  150 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN--NLY  150 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS--EEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--EEE
Confidence            3579999999999999999999999999999999964211  112233568999999999999999999998654  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|||||+||+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+.
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl----~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM----DMNGHIRLADFGSCLK  224 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE----cCCCCEEEcchhhhhh
Confidence            99999999999999987432  39999999999999999999999999999999999998    7777899999999987


Q ss_pred             cccccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        167 LEEDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       167 ~~~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ...+..  ....+||+.|+|||++.....   .+..|+.++|||||||++|||++|.+||.   +.+..+....+.....
T Consensus       225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~---~~~~~~~~~DvwSlGvil~elltG~~Pf~---~~~~~~~~~~i~~~~~  298 (437)
T 4aw2_A          225 LMEDGTVQSSVAVGTPDYISPEILQAMEG---GKGRYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHKE  298 (437)
T ss_dssp             CCTTSCEECCSCCSCGGGCCHHHHHHHHT---SCCEECTHHHHHHHHHHHHHHHHSSCTTC---CSSHHHHHHHHHTHHH
T ss_pred             cccCCCcccccccCCcCeeChHHHhhccc---CCCCCCCcCeeHHHHHHHHHHHhCCCCCC---CCChhHHHHhhhhccc
Confidence            654433  234689999999999863211   13568999999999999999999999997   4566666666654211


Q ss_pred             CCcccccccCCCCcccccCCCCCc-ccCChhHHHHHHHHHHhhcccCccc--CCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNN-CQLSLGLKKLVTPILAGLLEVDSKK--IWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~-~~ls~~l~~~l~~LL~~mL~~DP~k--Rpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      .                 ..+|.. ..+++.    +.+||.+||..+|++  |++++++           +.|||+..
T Consensus       299 ~-----------------~~~p~~~~~~s~~----~~dLi~~lL~~~~~r~~r~~~~ei-----------l~Hpff~~  344 (437)
T 4aw2_A          299 R-----------------FQFPTQVTDVSEN----AKDLIRRLICSREHRLGQNGIEDF-----------KKHPFFSG  344 (437)
T ss_dssp             H-----------------CCCCSSCCCSCHH----HHHHHHTTSSCGGGCTTTTTTHHH-----------HTSGGGTT
T ss_pred             c-----------------ccCCcccccCCHH----HHHHHHHHhcccccccCCCCHHHH-----------hCCCccCC
Confidence            0                 022222 234444    555899999999988  9999997           66888854

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.7e-41  Score=358.09  Aligned_cols=259  Identities=24%  Similarity=0.335  Sum_probs=200.3

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      .+....+|.+.+.||+|+||.||+|.+..+|+.||+|++........  ...+.+|+.++++++||||+++++++.....
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            44567789999999999999999999999999999999976433222  2345789999999999999999999865543


Q ss_pred             --ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         83 --RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        83 --~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                        ...|+||||++|++|.+++.....   +++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~D  159 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI----SATNAVKVMD  159 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETTSCEEECC
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE----cCCCCEEEee
Confidence              246999999999999999976432   8999999999999999999999999999999999998    5566799999


Q ss_pred             cCccccccccc----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHH
Q psy15481        161 FGAARELEEDQ----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM  236 (708)
Q Consensus       161 FGlA~~~~~~~----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~  236 (708)
                      ||++.......    ......||+.|+|||++.        +..++.++|||||||++|+|+||..||.   +....+..
T Consensus       160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~ll~g~~pf~---~~~~~~~~  228 (311)
T 3ork_A          160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR--------GDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSVA  228 (311)
T ss_dssp             CSCC------------------CCTTCCHHHHH--------TCCCCHHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHH
T ss_pred             ccCcccccccccccccccccCcCcccCCHHHhc--------CCCCCchHhHHHHHHHHHHHHhCCCCCC---CCChHHHH
Confidence            99998654432    223456999999999997        6778999999999999999999999997   35555555


Q ss_pred             HHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        237 YYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       237 ~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      ........                     .........++..+.++|.+||..||.+||++.+.+.
T Consensus       229 ~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          229 YQHVREDP---------------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             HHHHHCCC---------------------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             HHHhcCCC---------------------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            54443211                     0111111223445667999999999999998777544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-41  Score=364.75  Aligned_cols=278  Identities=24%  Similarity=0.393  Sum_probs=207.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCC----c
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG----R   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~----~   83 (708)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||.+...... .......+|+.+++.++||||+++++++.....    .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            45799999999999999999999999999999998654322 123445799999999999999999999875432    3


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|+||||+ |++|.+++...    .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE----cCCCCEEEEeeec
Confidence            479999999 89999999763    28999999999999999999999999999999999998    6677899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      |+....  .....+||+.|+|||++..       ...++.++||||+||++|+|++|++||.   +.+..+.+..+....
T Consensus       175 a~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~---~~~~~~~l~~i~~~~  242 (367)
T 1cm8_A          175 ARQADS--EMTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGKTLFK---GSDHLDQLKEIMKVT  242 (367)
T ss_dssp             CEECCS--SCCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHHH
T ss_pred             cccccc--ccCcCcCCCCcCCHHHHhC-------CCCCChhhhHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHHhc
Confidence            987543  2445689999999999873       3678999999999999999999999997   455566665554321


Q ss_pred             c---CCcccccccCCCCcccccCCC-----CCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCc
Q psy15481        244 A---SGVISGTQTSENGEIDWCTDL-----PNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHL  315 (708)
Q Consensus       244 ~---~~~i~~~~~~~~g~~~~~~~l-----p~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~  315 (708)
                      .   ...+.......  ...+...+     .....+.+.++..+.+||.+||..||.+|||+.++           +.||
T Consensus       243 g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~-----------l~hp  309 (367)
T 1cm8_A          243 GTPPAEFVQRLQSDE--AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA-----------LAHP  309 (367)
T ss_dssp             CCCCHHHHHTCSCHH--HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH-----------HHSG
T ss_pred             CCCCHHHHHHhhhHH--HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH-----------hcCh
Confidence            1   11111100000  00000001     11112223445567779999999999999999997           5689


Q ss_pred             ccCCc
Q psy15481        316 FHINR  320 (708)
Q Consensus       316 ~~~~~  320 (708)
                      |+..-
T Consensus       310 ~f~~~  314 (367)
T 1cm8_A          310 YFESL  314 (367)
T ss_dssp             GGTTT
T ss_pred             HHHhh
Confidence            88653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.7e-41  Score=345.59  Aligned_cols=260  Identities=25%  Similarity=0.388  Sum_probs=209.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.+..+|+.||+|++.........+.+.+|+.+++.++||||+++++++.+.+  ..|+||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~   84 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQYLFL   84 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC--EEEEEE
Confidence            579999999999999999999999999999999976554444566789999999999999999999987644  589999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++|++|.+++....   .+++..++.++.|++.||.|||++|++||||||+||++    +..+.+||+|||.+.....
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL----DERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECCCTTCEECEE
T ss_pred             EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE----ccCCCEEEeeCCCccccCC
Confidence            9999999999997643   38999999999999999999999999999999999998    6667899999999986543


Q ss_pred             cc---cccccCCCCCcCChhhhhhhhhcCCCCCc-CCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        170 DQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKT-FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       170 ~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~-~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ..   ......||+.|+|||.+.        +.. ++.++|||||||++|+|++|..||......  ......+..... 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-  226 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLK--------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWKEKKT-  226 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGT--------CSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT--SHHHHHHHTTCT-
T ss_pred             CcchhcccCCccccCccChHHHh--------cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHhhhccc-
Confidence            32   234567999999999987        333 478899999999999999999999753221  122222221100 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                        ..+....+++    .+.++|.+||..||.+|||+.++           +.|||+.....
T Consensus       227 ------------------~~~~~~~~~~----~~~~li~~~l~~~p~~Rps~~~i-----------l~~~~~~~~~~  270 (276)
T 2yex_A          227 ------------------YLNPWKKIDS----APLALLHKILVENPSARITIPDI-----------KKDRWYNKPLK  270 (276)
T ss_dssp             ------------------TSTTGGGSCH----HHHHHHHHHSCSSTTTSCCHHHH-----------TTCTTTTCCCC
T ss_pred             ------------------ccCchhhcCH----HHHHHHHHHCCCCchhCCCHHHH-----------hcCccccChhh
Confidence                              1122223343    45669999999999999999997           67999976543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.3e-41  Score=355.55  Aligned_cols=266  Identities=28%  Similarity=0.430  Sum_probs=211.7

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ......|.+.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.++++++||||+++++++.+.+  ..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~   81 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTT--HY   81 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSS--EE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCC--EE
Confidence            44567899999999999999999999999999999999754322 2345679999999999999999999987644  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++|++|.+++.....   +++..+..++.|++.||.|||++||+||||||+||++ ...++.+.+||+|||++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~-~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLY-LTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEE-SSSSTTCCEEBCSCSTTC
T ss_pred             EEEEEcCCCccHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE-ecCCCCCCEEEccCCcce
Confidence            999999999999998865432   8999999999999999999999999999999999996 334556789999999997


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ..... ......||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .........+..... 
T Consensus       158 ~~~~~-~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~~---~~~~~~~~~i~~~~~-  224 (304)
T 2jam_A          158 MEQNG-IMSTACGTPGYVAPEVLA--------QKPYSKAVDCWSIGVITYILLCGYPPFYE---ETESKLFEKIKEGYY-  224 (304)
T ss_dssp             CCCCB-TTHHHHSCCCBCCTTTBS--------SCSCCHHHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHHHHHCCC-
T ss_pred             ecCCC-ccccccCCCCccChHHhc--------cCCCCchhhHHHHHHHHHHHHHCCCCCCC---CCHHHHHHHHHcCCC-
Confidence            54432 234457999999999986        67789999999999999999999999973   445555555544211 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                    .+  ..+.    .+.++..+.++|.+||..||.+|||+.++           +.|||+.....
T Consensus       225 --------------~~--~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~-----------l~h~~~~~~~~  270 (304)
T 2jam_A          225 --------------EF--ESPF----WDDISESAKDFICHLLEKDPNERYTCEKA-----------LSHPWIDGNTA  270 (304)
T ss_dssp             --------------CC--CTTT----TTTSCHHHHHHHHHHHCSSTTTSCCHHHH-----------HTSHHHHSSCS
T ss_pred             --------------CC--Cccc----cccCCHHHHHHHHHHcCCChhHCcCHHHH-----------hcCccccCCCc
Confidence                          01  1111    12233456669999999999999999997           66999876543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.1e-41  Score=357.05  Aligned_cols=265  Identities=24%  Similarity=0.381  Sum_probs=206.6

Q ss_pred             CceEEEe-eEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceE
Q psy15481          9 NYVWCTT-SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         9 n~~y~i~-~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~   85 (708)
                      +.+|.+. +.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.+ +||||+++++++...+  ..
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~--~~  104 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS--EI  104 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC--eE
Confidence            4567776 8999999999999999999999999999754332 2245567999999999 5699999999997644  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||+.||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ ......+.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~-~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILL-SSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-SCBTTBCCEEECCGGGCE
T ss_pred             EEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEE-ecCCCCCcEEEeeCcccc
Confidence            99999999999999986532 2349999999999999999999999999999999999998 111125689999999999


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ............||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +....+....+......
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~---~~~~~~~~~~i~~~~~~  251 (327)
T 3lm5_A          183 KIGHACELREIMGTPEYLAPEILN--------YDPITTATDMWNIGIIAYMLLTHTSPFV---GEDNQETYLNISQVNVD  251 (327)
T ss_dssp             EC---------CCCGGGCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHTCCC
T ss_pred             ccCCccccccccCCcCccCCeeec--------CCCCCchhhHHHHHHHHHHHHhCCCCCC---CCCchHHHHHHHhcccc
Confidence            877666666778999999999987        6778999999999999999999999997   34555555554432110


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                     +  ..+    ....++..+.++|.+||..||.+|||++++           +.|||+...
T Consensus       252 ---------------~--~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~~l-----------l~h~~~~~~  294 (327)
T 3lm5_A          252 ---------------Y--SEE----TFSSVSQLATDFIQSLLVKNPEKRPTAEIC-----------LSHSWLQQW  294 (327)
T ss_dssp             ---------------C--CTT----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHH-----------TTCGGGCCC
T ss_pred             ---------------c--Cch----hhcccCHHHHHHHHHHcCCChhhCcCHHHH-----------hCCHhhccc
Confidence                           0  111    112234456679999999999999999997           779998653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-40  Score=362.32  Aligned_cols=273  Identities=23%  Similarity=0.354  Sum_probs=197.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecC----Cc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQE----GR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~----~~   83 (708)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++...... .......+|+.+++.++||||+++++++....    ..
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            35799999999999999999999999999999999754322 22344578999999999999999999987543    23


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||+. ++|.+.+..     .+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~----~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECCCCC
T ss_pred             ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE----cCCCCEEEEEeec
Confidence            6899999996 678888863     28999999999999999999999999999999999998    6677899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      |.............||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +.+..+.+..+....
T Consensus       174 a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~g~~pf~---~~~~~~~~~~i~~~~  242 (371)
T 2xrw_A          174 ARTAGTSFMMTPYVVTRYYRAPEVIL--------GMGYKENVDIWSVGCIMGEMIKGGVLFP---GTDHIDQWNKVIEQL  242 (371)
T ss_dssp             ----------------CTTCCHHHHT--------TCCCCTTHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHC-C
T ss_pred             ccccccccccCCceecCCccCHHHhc--------CCCCCchHhHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHHHh
Confidence            98776655556678999999999997        5678999999999999999999999997   455666666655421


Q ss_pred             cCCc---ccccc---------cCCCCcccccC-----CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        244 ASGV---ISGTQ---------TSENGEIDWCT-----DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       244 ~~~~---i~~~~---------~~~~g~~~~~~-----~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      ....   .....         ........|..     ..|.....+...+..+.+||.+||..||.+|||+++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            1110   00000         00000000000     011111122334667889999999999999999999733

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.9e-41  Score=363.26  Aligned_cols=280  Identities=23%  Similarity=0.360  Sum_probs=213.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecC---CceE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE---GRGK   85 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~---~~~~   85 (708)
                      +.+|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.++++++||||+++++++....   ....
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            4589999999999999999999999999999999975443333355679999999999999999999986543   2458


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||+. |+|.+++....    +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~----~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCTTCE
T ss_pred             EEEEcccC-cCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE----CCCCCEEEEeCcceE
Confidence            99999996 69999987642    8999999999999999999999999999999999998    677789999999998


Q ss_pred             ccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        166 ELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       166 ~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      .......    ....+||+.|+|||++..       +..++.++|||||||++|+|++|.+||.+   ....+.+..+..
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~---~~~~~~~~~i~~  246 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILG  246 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHT-------BCSCSTHHHHHHHHHHHHHHHHSSCSSCC---SSGGGHHHHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcC-------CCCCCcchhHHHHHHHHHHHHHCCCCCCC---CChHHHHHHHHH
Confidence            7654432    234589999999998763       45689999999999999999999999974   445555555443


Q ss_pred             cccCC---cccccccCCCCcccccCCCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhc
Q psy15481        242 KKASG---VISGTQTSENGEIDWCTDLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLV  313 (708)
Q Consensus       242 ~~~~~---~i~~~~~~~~g~~~~~~~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~  313 (708)
                      .....   .+......  ....+...+|..     ..+.+.++..+.+||.+||..||.+|||+.++           +.
T Consensus       247 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~-----------l~  313 (364)
T 3qyz_A          247 ILGSPSQEDLNCIINL--KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA-----------LA  313 (364)
T ss_dssp             HHCSCCHHHHHTCCCH--HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH-----------HT
T ss_pred             HhCCCCHHHHHHhhhh--hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH-----------hc
Confidence            11110   00000000  000000011111     11223344556779999999999999999997           67


Q ss_pred             CcccCCc
Q psy15481        314 HLFHINR  320 (708)
Q Consensus       314 h~~~~~~  320 (708)
                      |||+...
T Consensus       314 hp~~~~~  320 (364)
T 3qyz_A          314 HPYLEQY  320 (364)
T ss_dssp             SGGGTTT
T ss_pred             Ccchhhc
Confidence            8988764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.3e-41  Score=353.50  Aligned_cols=261  Identities=21%  Similarity=0.313  Sum_probs=208.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      ...|.+.+.||+|+||.||+|.+.     .+++.||+|++...........+.+|+.++++++||||+++++++...+  
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--   99 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG--   99 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC--
Confidence            468999999999999999999883     4568999999975443333345679999999999999999999987654  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q psy15481         84 GKVIVMELCTGGSLFNILDDPEN---------------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPG  142 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~---------------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~  142 (708)
                      ..|+||||++|++|.+++.....                     ...+++..++.++.||+.||.|||++||+||||||+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~  179 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR  179 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence            48999999999999999976432                     123899999999999999999999999999999999


Q ss_pred             cEEEEEecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc
Q psy15481        143 NIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT  219 (708)
Q Consensus       143 NILl~~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT  219 (708)
                      ||++    +..+.+||+|||++........   .....+|+.|+|||.+.        +..++.++|||||||++|+|+|
T Consensus       180 NIli----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~t  247 (314)
T 2ivs_A          180 NILV----AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF--------DHIYTTQSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             GEEE----ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH--------HCEECHHHHHHHHHHHHHHHHT
T ss_pred             eEEE----cCCCCEEEccccccccccccccceeccCCCCcccccChhhhc--------CCCcCchhhHHHHHHHHHHHHh
Confidence            9998    5566899999999986644332   22346788999999997        5678999999999999999999


Q ss_pred             -CCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHH
Q psy15481        220 -GNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE  298 (708)
Q Consensus       220 -G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~  298 (708)
                       |..||..   .........+....                    ..+.+    ..++..+.+++.+||..||.+|||+.
T Consensus       248 ~g~~p~~~---~~~~~~~~~~~~~~--------------------~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~  300 (314)
T 2ivs_A          248 LGGNPYPG---IPPERLFNLLKTGH--------------------RMERP----DNCSEEMYRLMLQCWKQEPDKRPVFA  300 (314)
T ss_dssp             TSCCSSTT---CCGGGHHHHHHTTC--------------------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCC---CCHHHHHHHhhcCC--------------------cCCCC----ccCCHHHHHHHHHHccCChhhCcCHH
Confidence             9999973   33444443333211                    01111    22334566799999999999999999


Q ss_pred             HHHHHHHHHHhh
Q psy15481        299 RFFSEVTKTLNR  310 (708)
Q Consensus       299 q~~~~l~~il~~  310 (708)
                      +++..+..++.+
T Consensus       301 ~l~~~l~~~~~~  312 (314)
T 2ivs_A          301 DISKDLEKMMVK  312 (314)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhh
Confidence            999999888764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.8e-41  Score=364.80  Aligned_cols=275  Identities=20%  Similarity=0.330  Sum_probs=209.0

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEec-------
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ-------   80 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~-------   80 (708)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||||++.......     .+|+.+++.++||||+++++++...       
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~-----~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-----NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC-----CHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH-----HHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4568999999999999999999999999999999986543221     2799999999999999999998543       


Q ss_pred             -----------------------------CCceEEEEEeccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy15481         81 -----------------------------EGRGKVIVMELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLR  130 (708)
Q Consensus        81 -----------------------------~~~~~~LVmEy~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH  130 (708)
                                                   .....++||||++ |+|.+.+... .....+++..++.++.||+.||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                         2335889999997 5777666431 11123999999999999999999999


Q ss_pred             HCCCcccCCCCCcEEEEEecC-CCceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchh
Q psy15481        131 DNRLVHRDLKPGNIMKFICDD-GSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWS  209 (708)
Q Consensus       131 ~~gIVHrDIKP~NILl~~~~d-~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWS  209 (708)
                      ++||+||||||+|||+    + ..+.+||+|||+|.............||+.|+|||++..       ...++.++||||
T Consensus       159 ~~gi~H~Dikp~Nil~----~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Diws  227 (383)
T 3eb0_A          159 SLGICHRDIKPQNLLV----NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG-------ATEYTPSIDLWS  227 (383)
T ss_dssp             TTTEECSCCCGGGEEE----ETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT-------CSSCCTHHHHHH
T ss_pred             HCcCccCccCHHHEEE----cCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC-------CCCCCcchhhhh
Confidence            9999999999999997    4 356899999999998776666677889999999999862       345899999999


Q ss_pred             hhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc----------cccccCCCCcccccCCCCCcccCChhHHHHH
Q psy15481        210 IGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI----------SGTQTSENGEIDWCTDLPNNCQLSLGLKKLV  279 (708)
Q Consensus       210 LGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i----------~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l  279 (708)
                      +||++|+|++|++||.   +.+..+.+..+.........          ............|...+      +...+..+
T Consensus       228 lG~il~ell~g~~pf~---~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~  298 (383)
T 3eb0_A          228 IGCVFGELILGKPLFS---GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL------PEGTPSLA  298 (383)
T ss_dssp             HHHHHHHHHHSSCSSC---CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHS------CTTCCHHH
T ss_pred             HHHHHHHHHhCCCCCC---CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhC------CCCCCHHH
Confidence            9999999999999997   45566666665532111000          00000000111222222      23344567


Q ss_pred             HHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        280 TPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       280 ~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      .+||.+||..||.+|||+.++           +.|||+..
T Consensus       299 ~~li~~~L~~dP~~R~t~~e~-----------l~hp~f~~  327 (383)
T 3eb0_A          299 IDLLEQILRYEPDLRINPYEA-----------MAHPFFDH  327 (383)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHH-----------HTSGGGHH
T ss_pred             HHHHHHHccCChhhCCCHHHH-----------hcCHHHHH
Confidence            779999999999999999997           67999853

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.9e-41  Score=385.87  Aligned_cols=261  Identities=23%  Similarity=0.369  Sum_probs=213.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ...|.+.+.||+|+||.||+|.++.+|+.||+|++....  .........+|+.++++++||||+++++++.+.+  .+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~l~  260 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--ALC  260 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC--EEE
Confidence            356999999999999999999999999999999986532  1223445678999999999999999999987654  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++||+|..++..... ..+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|..
T Consensus       261 lVmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl----d~~g~vKL~DFGla~~  335 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL----DDHGHIRISDLGLAVH  335 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTSCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE----eCCCCeEEEeccccee
Confidence            99999999999999976432 349999999999999999999999999999999999998    7777899999999998


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ...+......+||+.|+|||++.        +..|+.++|||||||++|+|++|.+||...........+...+....  
T Consensus       336 ~~~~~~~~~~~GT~~Y~APEvl~--------~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~--  405 (576)
T 2acx_A          336 VPEGQTIKGRVGTVGYMAPEVVK--------NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--  405 (576)
T ss_dssp             CCTTCCEECCCSCGGGCCHHHHT--------TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC--
T ss_pred             cccCccccccCCCccccCHHHHc--------CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc--
Confidence            77666666779999999999997        67799999999999999999999999985433323333333332111  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                  .    .+|  ..++    ..+.++|.+||..||.+||     +++++           +.|||+..
T Consensus       406 ------------~----~~p--~~~s----~~~~dLI~~lL~~dP~~R~g~~~~sa~ei-----------l~HpfF~~  450 (576)
T 2acx_A          406 ------------E----EYS--ERFS----PQARSLCSQLLCKDPAERLGCRGGSAREV-----------KEHPLFKK  450 (576)
T ss_dssp             ------------C----CCC--TTSC----HHHHHHHHHHTCSSGGGSTTCSSSHHHHH-----------HTSGGGTT
T ss_pred             ------------c----cCC--ccCC----HHHHHHHHHhccCCHHHcCCCCCCCHHHH-----------HhChhhcc
Confidence                        0    111  1233    4556699999999999999     67776           67999964

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.8e-41  Score=356.35  Aligned_cols=269  Identities=22%  Similarity=0.336  Sum_probs=193.7

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCc---eEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc-
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR-   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~-   83 (708)
                      +.+|.+.+.||+|+||.||+|.+..++.   .||+|++..... ....+.+.+|+.++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4579999999999999999999887765   899999875432 22345567999999999999999999998765432 


Q ss_pred             ---eEEEEEeccCCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEE
Q psy15481         84 ---GKVIVMELCTGGSLFNILDDP---ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYK  157 (708)
Q Consensus        84 ---~~~LVmEy~~ggsL~~~L~~~---~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vK  157 (708)
                         ..++||||+.||+|.+++...   .....+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+|
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli----~~~~~~k  177 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML----AEDMTVC  177 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTSCEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE----cCCCCEE
Confidence               249999999999999988542   122248999999999999999999999999999999999998    6667899


Q ss_pred             EeccCccccccccccc---cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChh
Q psy15481        158 LTDFGAARELEEDQQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNK  233 (708)
Q Consensus       158 L~DFGlA~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~  233 (708)
                      |+|||+|.........   ....+++.|+|||.+.        +..++.++|||||||++|+|++ |.+||.+   ....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~ell~~g~~p~~~---~~~~  246 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA--------DNLYTVHSDVWAFGVTMWEIMTRGQTPYAG---IENA  246 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTT---CCGG
T ss_pred             EeeccccccccccccccccccccCcccccCchhhc--------CCCCCCccchhhHHHHHHHHHhCCCCCccc---cChH
Confidence            9999999876544322   2345788999999997        5678999999999999999999 9999973   4555


Q ss_pred             hHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhc
Q psy15481        234 ETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLV  313 (708)
Q Consensus       234 e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~  313 (708)
                      +....+.....                    .+....+    +..+.+++.+||..||.+|||+.+++..+..+    +.
T Consensus       247 ~~~~~~~~~~~--------------------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~----l~  298 (323)
T 3qup_A          247 EIYNYLIGGNR--------------------LKQPPEC----MEEVYDLMYQCWSADPKQRPSFTCLRMELENI----LG  298 (323)
T ss_dssp             GHHHHHHTTCC--------------------CCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH----HH
T ss_pred             HHHHHHhcCCC--------------------CCCCCcc----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH----HH
Confidence            55555543211                    1111223    34566799999999999999999998887776    45


Q ss_pred             CcccCCc
Q psy15481        314 HLFHINR  320 (708)
Q Consensus       314 h~~~~~~  320 (708)
                      |+|+...
T Consensus       299 ~~~~~~~  305 (323)
T 3qup_A          299 HLSVLST  305 (323)
T ss_dssp             C------
T ss_pred             HhhhcCC
Confidence            7777554

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.8e-40  Score=346.37  Aligned_cols=269  Identities=27%  Similarity=0.422  Sum_probs=215.2

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--------chHHHHHHHHHHHhCC-CCCccceeEE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--------PHDVQMREFEVLKKVK-HENIVKLLAI   76 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--------~~~~~~~Ei~iL~kL~-HpNIVkl~~v   76 (708)
                      ......|.+.+.||+|+||.||+|.++.+|+.||+|++.......        ..+...+|+.+++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            445678999999999999999999999999999999997543211        1233568999999995 9999999999


Q ss_pred             EEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceE
Q psy15481         77 EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY  156 (708)
Q Consensus        77 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~v  156 (708)
                      +...  ...++||||++|++|.+++....   .+++..++.++.||+.||.|||++|++||||||+||++    +..+.+
T Consensus        93 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~  163 (298)
T 1phk_A           93 YETN--TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL----DDDMNI  163 (298)
T ss_dssp             EECS--SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCE
T ss_pred             eccC--CeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE----cCCCcE
Confidence            8764  45999999999999999997643   28999999999999999999999999999999999998    666789


Q ss_pred             EEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHH
Q psy15481        157 KLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM  236 (708)
Q Consensus       157 KL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~  236 (708)
                      ||+|||.+.............|++.|+|||++.....  .....++.++|||||||++|+|++|..||..   .......
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~---~~~~~~~  238 (298)
T 1phk_A          164 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN--DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLML  238 (298)
T ss_dssp             EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC--TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHH
T ss_pred             EEecccchhhcCCCcccccccCCccccCHHHhccccc--cccccCCcccccHhHHHHHHHHHHCCCCCcC---ccHHHHH
Confidence            9999999988776666667789999999999864321  1145688999999999999999999999973   4444544


Q ss_pred             HHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcc
Q psy15481        237 YYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLF  316 (708)
Q Consensus       237 ~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~  316 (708)
                      ..+......                 ...+....+    +..+.+++.+||..||.+|||+.++           +.|||
T Consensus       239 ~~~~~~~~~-----------------~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l-----------l~h~~  286 (298)
T 1phk_A          239 RMIMSGNYQ-----------------FGSPEWDDY----SDTVKDLVSRFLVVQPQKRYTAEEA-----------LAHPF  286 (298)
T ss_dssp             HHHHHTCCC-----------------CCTTTGGGS----CHHHHHHHHHHCCSSGGGSCCHHHH-----------TTSGG
T ss_pred             HHHhcCCcc-----------------cCccccccc----CHHHHHHHHHHccCCcccCCCHHHH-----------HhChH
Confidence            444432111                 011222223    3456669999999999999999997           67999


Q ss_pred             cCCc
Q psy15481        317 HINR  320 (708)
Q Consensus       317 ~~~~  320 (708)
                      +.+.
T Consensus       287 ~~~~  290 (298)
T 1phk_A          287 FQQY  290 (298)
T ss_dssp             GCTT
T ss_pred             hhhc
Confidence            8654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-40  Score=359.85  Aligned_cols=278  Identities=24%  Similarity=0.330  Sum_probs=207.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-----CCCccceeEEEEecCCc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-----HENIVKLLAIEEEQEGR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-----HpNIVkl~~v~~~~~~~   83 (708)
                      +.+|.+.+.||+|+||.||+|.+..+|+.||||++...  .........|+.+++.+.     ||||+++++++...+  
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~--  109 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD--  109 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT--
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC--
Confidence            56899999999999999999999999999999998632  122344568999999996     999999999998754  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec-------------
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD-------------  150 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~-------------  150 (708)
                      ..|+||||+ |++|.+++..... .++++..++.++.||+.||.|||++||+||||||+|||+  +.             
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL--DDPYFEKSLITVRRV  185 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--SCTTCCEEEEEEECT
T ss_pred             eeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEE--ccccccccccchhcc
Confidence            599999999 9999999976442 249999999999999999999999999999999999997  21             


Q ss_pred             ----------CCCceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC
Q psy15481        151 ----------DGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG  220 (708)
Q Consensus       151 ----------d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG  220 (708)
                                ...+.+||+|||+|......  .....||+.|+|||++.        +..++.++|||||||++|+|+||
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g  255 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVIL--------NLGWDVSSDMWSFGCVLAELYTG  255 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHT--------TCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHc--------CCCCCCccchHHHHHHHHHHHHC
Confidence                      12567999999999864432  34568999999999997        67799999999999999999999


Q ss_pred             CCCCCCCCCCChhhHHHHHHhcccC---Cccc--------ccccCCCCcccccCCCCCcc----------cCChhHHHHH
Q psy15481        221 NLPFRPYGGRRNKETMYYITTKKAS---GVIS--------GTQTSENGEIDWCTDLPNNC----------QLSLGLKKLV  279 (708)
Q Consensus       221 ~~PF~~~~g~~~~e~~~~i~~~~~~---~~i~--------~~~~~~~g~~~~~~~lp~~~----------~ls~~l~~~l  279 (708)
                      +.||..   .+..+.+..+.....+   ....        ...........|........          ..+......+
T Consensus       256 ~~pf~~---~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          256 SLLFRT---HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             SCSCCC---SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             CCCCCC---CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            999974   4444444443321110   0000        00000011111211111000          0000112556


Q ss_pred             HHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        280 TPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       280 ~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      .+||.+||+.||.+|||+.++           +.|||+.
T Consensus       333 ~~li~~~L~~dP~~Rpta~el-----------L~hp~f~  360 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAEL-----------LKHKFLE  360 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHH-----------TTSGGGC
T ss_pred             HHHHHHHhcCChhhCCCHHHH-----------hcCcccC
Confidence            789999999999999999997           7799973

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.5e-40  Score=369.89  Aligned_cols=203  Identities=24%  Similarity=0.410  Sum_probs=169.5

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCC---
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG---   82 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~---   82 (708)
                      ....+|.+.+.||+|+||.||+|.++.+|+.||||++...... .....+.+|+.++++++||||+++++++...+.   
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            3567899999999999999999999999999999999754322 223456799999999999999999999875532   


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                      ...|+||||+. ++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||
T Consensus       103 ~~~~lv~e~~~-~~L~~~~~~~~~---l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl----~~~~~~kL~DFG  174 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLFKTPIF---LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL----NQDCSVKVCDFG  174 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHHHSSCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCT
T ss_pred             CeEEEEEecCC-cCHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE----CCCCCEEEccCC
Confidence            46999999995 799999987543   9999999999999999999999999999999999998    677789999999


Q ss_pred             ccccccccc-----------------------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc
Q psy15481        163 AARELEEDQ-----------------------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT  219 (708)
Q Consensus       163 lA~~~~~~~-----------------------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT  219 (708)
                      +|+......                       .....+||+.|+|||++..       +..|+.++|||||||++|+|++
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~~~~~~DiwSlG~il~ell~  247 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-------QENYTKSIDIWSTGCIFAELLN  247 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHHT
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc-------CCCCCcccccchHHHHHHHHHh
Confidence            998764432                       2356789999999998753       5679999999999999999998


Q ss_pred             CCCCC
Q psy15481        220 GNLPF  224 (708)
Q Consensus       220 G~~PF  224 (708)
                      |..||
T Consensus       248 g~~p~  252 (432)
T 3n9x_A          248 MLQSH  252 (432)
T ss_dssp             TCTTT
T ss_pred             ccccc
Confidence            65544

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.5e-41  Score=346.84  Aligned_cols=261  Identities=23%  Similarity=0.388  Sum_probs=187.1

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      |..-..|.+.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.++++++||||+++++++.+.+  
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   84 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN--   84 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS--
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC--
Confidence            445567999999999999999999999999999999986432  1122355679999999999999999999987644  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||+++++|.+++.....  .+++..++.++.|++.||.|||++|++||||||+||++    +..+.+||+|||.
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili----~~~~~~kl~dfg~  158 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL----TRNMNIKIADFGL  158 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE----CTTCCEEECCCTT
T ss_pred             eEEEEEecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCCEEEEeecc
Confidence            59999999999999999986432  38999999999999999999999999999999999998    6667899999999


Q ss_pred             ccccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        164 ARELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       164 A~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      +...... .......||+.|+|||++.        +..++.++|||||||++|+|++|..||...   .....+..+.. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~-  226 (278)
T 3cok_A          159 ATQLKMPHEKHYTLCGTPNYISPEIAT--------RSAHGLESDVWSLGCMFYTLLIGRPPFDTD---TVKNTLNKVVL-  226 (278)
T ss_dssp             CEECC------------------------------------CTHHHHHHHHHHHHHHSSCSSCCC---SCC-----CCS-
T ss_pred             eeeccCCCCcceeccCCCCcCCcchhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCh---hHHHHHHHHhh-
Confidence            9876533 2334567999999999987        567889999999999999999999999742   21121111110 


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                    .      ..+    .+..++..+.+++.+||..||.+|||+.++           +.|||+....
T Consensus       227 --------------~------~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~-----------l~h~~~~~~~  270 (278)
T 3cok_A          227 --------------A------DYE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSV-----------LDHPFMSRNS  270 (278)
T ss_dssp             --------------S------CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHH-----------TTSTTTC---
T ss_pred             --------------c------ccC----CccccCHHHHHHHHHHcccCHhhCCCHHHH-----------hcCccccCCC
Confidence                          0      011    112233455679999999999999999997           7799997654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-41  Score=357.99  Aligned_cols=260  Identities=22%  Similarity=0.274  Sum_probs=209.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      ...|.+.+.||+|+||.||+|.+.     .+++.||+|+++..........+.+|+.++++++||||+++++++...+  
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--  123 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK--  123 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC--
Confidence            457899999999999999999987     4568999999976543333455679999999999999999999987644  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q psy15481         84 GKVIVMELCTGGSLFNILDDPEN---------------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPG  142 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~---------------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~  142 (708)
                      ..|+||||++||+|.+++.....                     ...+++..++.++.||+.||.|||++||+||||||+
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  203 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  203 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence            48999999999999999876321                     134899999999999999999999999999999999


Q ss_pred             cEEEEEecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc
Q psy15481        143 NIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT  219 (708)
Q Consensus       143 NILl~~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT  219 (708)
                      |||+    +..+.+||+|||++........   .....||+.|+|||++.        +..++.++|||||||++|+|+|
T Consensus       204 NIl~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~t  271 (343)
T 1luf_A          204 NCLV----GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--------YNRYTTESDVWAYGVVLWEIFS  271 (343)
T ss_dssp             GEEE----CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eEEE----CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc--------cCCcCcccccHHHHHHHHHHHh
Confidence            9998    6677899999999986544322   23456889999999987        4668999999999999999999


Q ss_pred             -CCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHH
Q psy15481        220 -GNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE  298 (708)
Q Consensus       220 -G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~  298 (708)
                       |..||.   +....+....+......                  .+|      ..++..+.+++.+||..||.+|||+.
T Consensus       272 ~g~~p~~---~~~~~~~~~~~~~~~~~------------------~~~------~~~~~~l~~li~~~l~~~p~~Rps~~  324 (343)
T 1luf_A          272 YGLQPYY---GMAHEEVIYYVRDGNIL------------------ACP------ENCPLELYNLMRLCWSKLPADRPSFC  324 (343)
T ss_dssp             TTCCTTT---TSCHHHHHHHHHTTCCC------------------CCC------TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cCCCcCC---CCChHHHHHHHhCCCcC------------------CCC------CCCCHHHHHHHHHHcccCcccCCCHH
Confidence             999997   34555555555432110                  111      22334566799999999999999999


Q ss_pred             HHHHHHHHHHh
Q psy15481        299 RFFSEVTKTLN  309 (708)
Q Consensus       299 q~~~~l~~il~  309 (708)
                      ++++.+.++..
T Consensus       325 ~~~~~L~~~~~  335 (343)
T 1luf_A          325 SIHRILQRMCE  335 (343)
T ss_dssp             HHHHHHHHTTC
T ss_pred             HHHHHHHHHHh
Confidence            99998877654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.7e-41  Score=350.11  Aligned_cols=276  Identities=24%  Similarity=0.292  Sum_probs=203.7

Q ss_pred             CCceEEEeeEeecCCceEEEEEE----EcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~----~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      .+.+|.+.+.||+|+||.||+|.    +..+|+.||+|++.... ......+.+|+.++++++||||+++++++...+..
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            45789999999999999999998    56789999999987432 22234567999999999999999999998765555


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+++||||++||+|.+++.....  .+++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~----~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV----ENENRVKIGDFGL  160 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECCCCS
T ss_pred             ceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE----cCCCeEEEccCcc
Confidence            68999999999999999976432  38999999999999999999999999999999999998    5556899999999


Q ss_pred             ccccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        164 ARELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       164 A~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      +........    .....++..|+|||.+.        +..++.++|||||||++|+|+||..||..    ...+.. ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~~~~~----~~~~~~-~~  227 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKS----PPAEFM-RM  227 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHHTTCTTCS----HHHHHH-HH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhc--------CCCCChHHHHHHHHHHHHHHHhcccccCC----ChHHHH-hh
Confidence            987654432    22345777899999997        56789999999999999999999999863    111111 11


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      ..............  .....-....+.+    ..++..+.+++..||..||.+|||+.++++.+..+..
T Consensus       228 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          228 IGNDKQGQMIVFHL--IELLKNNGRLPRP----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HCTTCCTHHHHHHH--HHHHHTTCCCCCC----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCccccchhHHHH--HHHHhccCcCCCC----cCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            11000000000000  0000000012222    2334456679999999999999999999999887764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-40  Score=355.79  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=201.4

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceE----EEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPV----AVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~V----AIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      .+..|.+.+.||+|+||.||+|.+..+|+.+    |+|.+...........+.+|+.++++++||||+++++++....  
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   90 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--   90 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--
Confidence            4568999999999999999999998887754    7777765544455566789999999999999999999998643  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                       .++|++|+.+|+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~  163 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDFGL  163 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----EETTEEEECCTTH
T ss_pred             -eEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE----CCCCCEEEccCcc
Confidence             7899999999999999876432  38999999999999999999999999999999999998    5556799999999


Q ss_pred             ccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHH
Q psy15481        164 ARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       164 A~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i  239 (708)
                      |+.......   .....||+.|+|||.+.        +..++.++|||||||++|+|+| |..||..   ....+....+
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~Di~slG~il~ellt~g~~p~~~---~~~~~~~~~~  232 (327)
T 3poz_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESIL--------HRIYTHQSDVWSYGVTVWELMTFGSKPYDG---IPASEISSIL  232 (327)
T ss_dssp             HHHHTTTCC-------CCCGGGSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTT---CCGGGHHHHH
T ss_pred             eeEccCCcccccccCCCccccccChHHhc--------cCCCCchhhhhhhHHHHHHHHhcCCCCccC---CCHHHHHHHH
Confidence            987654432   22345788999999998        5778999999999999999999 9999974   3333333333


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      ....                    ..+.....    +..+.+++.+||..||.+||++.+++.++..+....
T Consensus       233 ~~~~--------------------~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          233 EKGE--------------------RLPQPPIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             HTTC--------------------CCCCCTTB----CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             HcCC--------------------CCCCCccC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence            3210                    11222223    344666999999999999999999999988876543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.2e-40  Score=346.06  Aligned_cols=269  Identities=23%  Similarity=0.313  Sum_probs=204.1

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHh--CCCCCccceeEEEEec--C
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK--VKHENIVKLLAIEEEQ--E   81 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~k--L~HpNIVkl~~v~~~~--~   81 (708)
                      ......|.+.+.||+|+||.||+|.+  +|+.||||++...    ......+|.+++..  ++||||+++++++...  .
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            45677899999999999999999987  6899999998643    23444567777776  7999999999987543  2


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCcccCCCCCcEEEEEecCCC
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR--------DNRLVHRDLKPGNIMKFICDDGS  153 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH--------~~gIVHrDIKP~NILl~~~~d~~  153 (708)
                      ....|+||||+++|+|.+++...    .+++..++.++.|++.||.|||        ++||+||||||+|||+    +..
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill----~~~  149 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV----KKN  149 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE----CTT
T ss_pred             CceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE----cCC
Confidence            34689999999999999999653    3999999999999999999999        9999999999999998    667


Q ss_pred             ceEEEeccCcccccccccc-----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC--------
Q psy15481        154 TIYKLTDFGAARELEEDQQ-----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG--------  220 (708)
Q Consensus       154 ~~vKL~DFGlA~~~~~~~~-----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG--------  220 (708)
                      +.+||+|||+|........     .....||+.|+|||++.....  .....++.++|||||||++|+|+||        
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~  227 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ--VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE  227 (301)
T ss_dssp             SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCC--TTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCC--CCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence            7899999999976544332     223479999999999873100  0000456799999999999999999        


Q ss_pred             --CCCCCCCCC-CChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH
Q psy15481        221 --NLPFRPYGG-RRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF  297 (708)
Q Consensus       221 --~~PF~~~~g-~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa  297 (708)
                        ..||..... ......+.........                ...+|. ...+......+.+++.+||..||.+|||+
T Consensus       228 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~  290 (301)
T 3q4u_A          228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQ----------------RPNIPN-RWFSDPTLTSLAKLMKECWYQNPSARLTA  290 (301)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCC----------------CCCCCG-GGGGSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred             cccccccccCCCCcchhhhhHHHhccCC----------------CCCCCh-hhccCccHHHHHHHHHHHhhcChhhCCCH
Confidence              888864322 2222333322211000                001111 12344567788899999999999999999


Q ss_pred             HHHHHHHHHH
Q psy15481        298 ERFFSEVTKT  307 (708)
Q Consensus       298 ~q~~~~l~~i  307 (708)
                      .++++.+..+
T Consensus       291 ~~i~~~L~~i  300 (301)
T 3q4u_A          291 LRIKKTLTKI  300 (301)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHhcc
Confidence            9999887754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.3e-41  Score=348.73  Aligned_cols=258  Identities=23%  Similarity=0.374  Sum_probs=206.2

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .-..|.+.+.||+|+||.||+|.+..++..||+|++.....  ......+.+|+.++++++||||+++++++.+.+  ..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~   84 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT--RV   84 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC--EE
Confidence            34579999999999999999999999999999999854321  122345678999999999999999999997654  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ++||||+++++|.+++.....   +++..++.++.||+.||.|||++||+||||||+||++    +..+.++|+|||++.
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili----~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL----GSAGELKIADFGWSV  157 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE----CTTSCEEECSCCEES
T ss_pred             EEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE----cCCCCEEEEeccccc
Confidence            999999999999999876433   8999999999999999999999999999999999998    667789999999987


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ..... ......||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +....+....+..... 
T Consensus       158 ~~~~~-~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~---~~~~~~~~~~~~~~~~-  224 (279)
T 3fdn_A          158 HAPSS-RRTDLCGTLDYLPPEMIE--------GRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEF-  224 (279)
T ss_dssp             CC---------CCCCTTCCHHHHT--------TCCCCTTHHHHHHHHHHHHHHHSSCTTC---CSSHHHHHHHHHHTCC-
T ss_pred             cCCcc-cccccCCCCCccCHhHhc--------cCCCCccchhHhHHHHHHHHHHCCCCCC---CCcHHHHHHHHHhCCC-
Confidence            54433 234567999999999987        6778999999999999999999999997   3444444444443110 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                        .+|  ..++    ..+.++|.+||..||.+|||+.++           +.|||+.....
T Consensus       225 ------------------~~~--~~~~----~~~~~li~~~l~~~p~~Rps~~e~-----------l~h~~~~~~~~  266 (279)
T 3fdn_A          225 ------------------TFP--DFVT----EGARDLISRLLKHNPSQRPMLREV-----------LEHPWITANSS  266 (279)
T ss_dssp             ------------------CCC--TTSC----HHHHHHHHHHCCSSGGGSCCHHHH-----------HHCHHHHHHCS
T ss_pred             ------------------CCC--CcCC----HHHHHHHHHHhccChhhCCCHHHH-----------hhCccccCCcc
Confidence                              111  1233    445669999999999999999997           55888865443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-41  Score=365.14  Aligned_cols=264  Identities=22%  Similarity=0.359  Sum_probs=208.6

Q ss_pred             CceEEEeeEeecCCceEEEEEE-----EcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGV-----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~-----~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      ...|.+.+.||+|+||.||+|.     +..+++.||||++...........+.+|+.++++++||||+++++++..... 
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP-  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC-
Confidence            4579999999999999999999     4567889999999754433334456789999999999999999999876544 


Q ss_pred             eEEEEEeccCCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecC-CCceEEE
Q psy15481         84 GKVIVMELCTGGSLFNILDDPE----NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDD-GSTIYKL  158 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~----~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d-~~~~vKL  158 (708)
                       .|+|||||+||+|.+++....    ....+++..++.++.||+.||.|||++||+||||||+|||+  +.+ ....+||
T Consensus       149 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~~~~~~~kL  225 (367)
T 3l9p_A          149 -RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL--TCPGPGRVAKI  225 (367)
T ss_dssp             -CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--SCSSTTCCEEE
T ss_pred             -CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE--ecCCCCceEEE
Confidence             799999999999999987532    12348999999999999999999999999999999999997  222 3456999


Q ss_pred             eccCccccccccc---cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhh
Q psy15481        159 TDFGAARELEEDQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKE  234 (708)
Q Consensus       159 ~DFGlA~~~~~~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e  234 (708)
                      +|||+|+......   ......||+.|+|||++.        +..++.++|||||||++|+|+| |..||.   +....+
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DvwslG~il~ellt~g~~pf~---~~~~~~  294 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYP---SKSNQE  294 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCSST---TCCHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhc--------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCCHHH
Confidence            9999998654332   223356899999999997        5678999999999999999998 999997   355555


Q ss_pred             HHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        235 TMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       235 ~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      ....+.....                    .+..    ..++..+.+++.+||..||.+|||+.++++.++.+....
T Consensus       295 ~~~~i~~~~~--------------------~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          295 VLEFVTSGGR--------------------MDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHHHHHTTCC--------------------CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHHHHcCCC--------------------CCCC----ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            5555543211                    1111    122344667999999999999999999999988776543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.3e-41  Score=368.25  Aligned_cols=257  Identities=23%  Similarity=0.363  Sum_probs=206.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.+..+|+.||||+++..........+.+|+.++++++||||+++++++...+  ..|+||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~  191 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVM  191 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS--SCEEEE
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC--CcEEEE
Confidence            478999999999999999999999999999999875432222234568999999999999999999987654  489999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++||+|.+++.....  .+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+++....
T Consensus       192 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~----~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV----TEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             ECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECCGGGCEECTT
T ss_pred             EcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE----cCCCcEEECcCCCceecCC
Confidence            99999999999975332  28999999999999999999999999999999999998    6667899999999986543


Q ss_pred             ccccc---ccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        170 DQQFM---SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       170 ~~~~~---~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      +....   ...+++.|+|||.+.        +..++.++|||||||++|||+| |..||..   ..+.+....+....  
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~t~g~~p~~~---~~~~~~~~~~~~~~--  332 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALN--------YGRYSSESDVWSFGILLWETFSLGASPYPN---LSNQQTREFVEKGG--  332 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHH--------HCEEEHHHHHHHHHHHHHHHHTTSCCSSTT---SCHHHHHHHHHTTC--
T ss_pred             CceeecCCCCCCCcCcCCHhHhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHcCC--
Confidence            32111   123467899999997        4678999999999999999998 9999973   44444444333211  


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                                        .+|.+..    ++..+.+++..||..||.+|||+.+++..+..+..
T Consensus       333 ------------------~~~~~~~----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          333 ------------------RLPCPEL----CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             ------------------CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------------CCCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                              1122222    23456679999999999999999999998887754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.6e-40  Score=361.46  Aligned_cols=263  Identities=29%  Similarity=0.471  Sum_probs=211.8

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-------hHHHHHHHHHHHhC-CCCCccceeEEEEecC
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-------HDVQMREFEVLKKV-KHENIVKLLAIEEEQE   81 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-------~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~   81 (708)
                      ..|.+.+.||+|+||.||+|.++.+|+.||||+++.......       .+.+.+|+.+++++ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            469999999999999999999999999999999976543211       23356899999999 8999999999987644


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                        ..|+||||++|++|.+++....   .+++..++.++.||+.||.|||+.||+||||||+|||+    +..+.+||+||
T Consensus       174 --~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~----~~~~~ikl~Df  244 (365)
T 2y7j_A          174 --FMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL----DDNMQIRLSDF  244 (365)
T ss_dssp             --EEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECCC
T ss_pred             --EEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCEEEEec
Confidence              5999999999999999997543   39999999999999999999999999999999999998    66678999999


Q ss_pred             CccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        162 GAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       162 GlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      |++.............||+.|+|||++.....  .....++.++|||||||++|+|++|..||.   +......+..+..
T Consensus       245 G~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~il~ell~g~~pf~---~~~~~~~~~~i~~  319 (365)
T 2y7j_A          245 GFSCHLEPGEKLRELCGTPGYLAPEILKCSMD--ETHPGYGKEVDLWACGVILFTLLAGSPPFW---HRRQILMLRMIME  319 (365)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHTTC--TTSCCBCTTHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHH
T ss_pred             CcccccCCCcccccCCCCCCccChhhcccccc--ccCcCCCchhhHHhHHHHHHHHHHCCCCCC---CCCHHHHHHHHHh
Confidence            99988776666677889999999999864211  113468899999999999999999999997   3445555554443


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      ....               +  ..|.+...+    ..+.++|.+||..||.+|||+.++           +.|||+.
T Consensus       320 ~~~~---------------~--~~~~~~~~~----~~~~~li~~~L~~dP~~Rps~~el-----------l~hp~f~  364 (365)
T 2y7j_A          320 GQYQ---------------F--SSPEWDDRS----STVKDLISRLLQVDPEARLTAEQA-----------LQHPFFE  364 (365)
T ss_dssp             TCCC---------------C--CHHHHSSSC----HHHHHHHHHHSCSSTTTSCCHHHH-----------HHSGGGC
T ss_pred             CCCC---------------C--CCcccccCC----HHHHHHHHHHcCCChhHCcCHHHH-----------hcCcccC
Confidence            2110               0  111112233    345669999999999999999997           5699985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.7e-40  Score=350.03  Aligned_cols=264  Identities=23%  Similarity=0.365  Sum_probs=210.6

Q ss_pred             CceEEEeeEeecCCceEEEEEEE-----cCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVN-----KNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEG   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~   82 (708)
                      ..+|.+.+.||+|+||.||+|.+     ..+++.||+|++.........+.+.+|+.+++++ +||||+++++++...+ 
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-  100 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG-  100 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC-
Confidence            35799999999999999999985     4578899999997654333345678999999999 9999999999987654 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEE
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPEN---------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKF  147 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~---------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~  147 (708)
                       ..++||||++||+|.+++.....               ...+++..++.++.||+.||.|||++||+||||||+||++ 
T Consensus       101 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~-  178 (313)
T 1t46_A          101 -PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-  178 (313)
T ss_dssp             -SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             -CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE-
Confidence             48999999999999999876432               1238999999999999999999999999999999999998 


Q ss_pred             EecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCC
Q psy15481        148 ICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLP  223 (708)
Q Consensus       148 ~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~P  223 (708)
                         +..+.+||+|||++........   .....||+.|+|||++.        +..++.++|||||||++|+|+| |..|
T Consensus       179 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~ellt~g~~p  247 (313)
T 1t46_A          179 ---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--------NCVYTFESDVWSYGIFLWELFSLGSSP  247 (313)
T ss_dssp             ---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc--------CCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence               5667899999999987654432   22345788999999987        4678999999999999999999 9999


Q ss_pred             CCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        224 FRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       224 F~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                      |..   ...............                   ..+.....    +..+.+++.+||..||.+|||+.+++..
T Consensus       248 ~~~---~~~~~~~~~~~~~~~-------------------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          248 YPG---MPVDSKFYKMIKEGF-------------------RMLSPEHA----PAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             STT---CCSSHHHHHHHHHTC-------------------CCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCc---ccchhHHHHHhccCC-------------------CCCCcccC----CHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            974   333333333333211                   11111223    3456669999999999999999999999


Q ss_pred             HHHHHhhhh
Q psy15481        304 VTKTLNRKL  312 (708)
Q Consensus       304 l~~il~~~l  312 (708)
                      +.+++....
T Consensus       302 L~~~~~~~~  310 (313)
T 1t46_A          302 IEKQISEST  310 (313)
T ss_dssp             HHHHHHHTC
T ss_pred             HHHHHHHhh
Confidence            988876543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.8e-40  Score=344.92  Aligned_cols=263  Identities=21%  Similarity=0.309  Sum_probs=204.3

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch------HHHHHHHHHHHhCCCCCccceeEEEEe
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH------DVQMREFEVLKKVKHENIVKLLAIEEE   79 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~------~~~~~Ei~iL~kL~HpNIVkl~~v~~~   79 (708)
                      .-.+.+|.+.+.||+|+||.||+|.+..+++.||+|++.........      ..+.+|+.++++++||||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            34567899999999999999999999999999999998765433322      456799999999999999999999854


Q ss_pred             cCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEEEec-CCCceE
Q psy15481         80 QEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR--LVHRDLKPGNIMKFICD-DGSTIY  156 (708)
Q Consensus        80 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g--IVHrDIKP~NILl~~~~-d~~~~v  156 (708)
                      .    .++||||++||+|.+.+.....  .+++..++.++.|++.||.|||++|  |+||||||+|||+.... ++...+
T Consensus        95 ~----~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           95 P----PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             T----TEEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             C----CeEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence            3    2799999999999998866443  3999999999999999999999999  99999999999972111 122349


Q ss_pred             EEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHH
Q psy15481        157 KLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM  236 (708)
Q Consensus       157 KL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~  236 (708)
                      ||+|||++.....  ......||+.|+|||++..      .+..++.++|||||||++|+|++|..||..... ......
T Consensus       169 kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~  239 (287)
T 4f0f_A          169 KVADFGLSQQSVH--SVSGLLGNFQWMAPETIGA------EEESYTEKADTYSFAMILYTILTGEGPFDEYSY-GKIKFI  239 (287)
T ss_dssp             EECCCTTCBCCSS--CEECCCCCCTTSCGGGSSC------SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC-CHHHHH
T ss_pred             EeCCCCccccccc--cccccCCCccccCchhhcc------CCCCcCchhhHHHHHHHHHHHHcCCCCCccccc-cHHHHH
Confidence            9999999985443  3445679999999999841      145678999999999999999999999975322 222222


Q ss_pred             HHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        237 YYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       237 ~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                      ..+.....                 ...      ++..++..+.+++.+||..||.+|||+.++++.+.+
T Consensus       240 ~~~~~~~~-----------------~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          240 NMIREEGL-----------------RPT------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHHSCC-----------------CCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHhccCC-----------------CCC------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            22222110                 001      222334556779999999999999999999887653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-40  Score=354.50  Aligned_cols=261  Identities=24%  Similarity=0.336  Sum_probs=204.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEE-----cCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCc
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVN-----KNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGR   83 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~   83 (708)
                      ..|.+.+.||+|+||.||+|.+     ..++..||+|++.........+.+.+|+.+++++ +||||+++++++...+  
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--  122 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG--  122 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC--
Confidence            4789999999999999999997     3467789999998654444456678999999999 9999999999987654  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENT--------------------YGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGN  143 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~--------------------~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~N  143 (708)
                      ..|+||||++||+|.+++......                    ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  202 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  202 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence            489999999999999999764321                    237999999999999999999999999999999999


Q ss_pred             EEEEEecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-
Q psy15481        144 IMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-  219 (708)
Q Consensus       144 ILl~~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-  219 (708)
                      ||+    +..+.+||+|||++........   .....||+.|+|||++.        +..++.++|||||||++|+|+| 
T Consensus       203 Ill----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~t~  270 (344)
T 1rjb_A          203 VLV----THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--------EGIYTIKSDVWSYGILLWEIFSL  270 (344)
T ss_dssp             EEE----ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             EEE----cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc--------cCCCChhHhHHHHHHHHHHHHcC
Confidence            998    5667899999999987654432   22345788999999987        4678999999999999999998 


Q ss_pred             CCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHH
Q psy15481        220 GNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFER  299 (708)
Q Consensus       220 G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q  299 (708)
                      |..||..   ......+..+.....                   ..+.+...    +..+.+++.+||..||.+|||+.+
T Consensus       271 g~~p~~~---~~~~~~~~~~~~~~~-------------------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~  324 (344)
T 1rjb_A          271 GVNPYPG---IPVDANFYKLIQNGF-------------------KMDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPN  324 (344)
T ss_dssp             SCCSSTT---CCCSHHHHHHHHTTC-------------------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCccc---CCcHHHHHHHHhcCC-------------------CCCCCCCC----CHHHHHHHHHHcCCCchhCcCHHH
Confidence            9999974   333333434333211                   11111122    345666999999999999999999


Q ss_pred             HHHHHHHHHhh
Q psy15481        300 FFSEVTKTLNR  310 (708)
Q Consensus       300 ~~~~l~~il~~  310 (708)
                      ++..+..++..
T Consensus       325 l~~~l~~~~~~  335 (344)
T 1rjb_A          325 LTSFLGCQLAD  335 (344)
T ss_dssp             HHHHHHHHC--
T ss_pred             HHHHHHHHHHH
Confidence            99988877653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=353.02  Aligned_cols=252  Identities=27%  Similarity=0.317  Sum_probs=196.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|.+.+.||+|+||.||+|.+..+|+.||||++....... .......|+..+.++ +||||+++++++.+.+  ..|+
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~--~~~l  134 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG--ILYL  134 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC--EEEE
Confidence            56999999999999999999999999999999986543221 122334566555555 9999999999997644  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||+ +++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++...
T Consensus       135 v~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll----~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL----GPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CGGGCEEECCCTTCEEC
T ss_pred             EEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE----CCCCCEEEccceeeeec
Confidence            99999 7899888876432  39999999999999999999999999999999999998    67778999999999887


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..........||+.|+|||++.        + .++.++|||||||++|+|++|..||..      ......+....    
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~--------~-~~~~~~DiwslG~il~el~~g~~~~~~------~~~~~~~~~~~----  268 (311)
T 3p1a_A          208 GTAGAGEVQEGDPRYMAPELLQ--------G-SYGTAADVFSLGLTILEVACNMELPHG------GEGWQQLRQGY----  268 (311)
T ss_dssp             C------CCCCCGGGCCGGGGG--------T-CCSTHHHHHHHHHHHHHHHHTCCCCSS------HHHHHHHTTTC----
T ss_pred             ccCCCCcccCCCccccCHhHhc--------C-CCCchhhHHHHHHHHHHHHhCCCCCCC------ccHHHHHhccC----
Confidence            6665556678999999999886        3 588999999999999999999766642      12222222110    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                       .+.  .++..++..+.+++.+||..||++|||+.++           +.|||+.+
T Consensus       269 -----------------~~~--~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el-----------l~hp~~~~  310 (311)
T 3p1a_A          269 -----------------LPP--EFTAGLSSELRSVLVMMLEPDPKLRATAEAL-----------LALPVLRQ  310 (311)
T ss_dssp             -----------------CCH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH-----------HTSGGGSC
T ss_pred             -----------------CCc--ccccCCCHHHHHHHHHHcCCChhhCcCHHHH-----------HhCccccC
Confidence                             000  1112234456679999999999999999997           67999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.8e-41  Score=357.84  Aligned_cols=281  Identities=18%  Similarity=0.207  Sum_probs=204.4

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecC--CceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE--GRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~--~~~~~   86 (708)
                      ...|.+.+.||+|+||.||+|.+.  |+.||||++....  .......+|+.++++++||||+++++++....  ...+|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            358999999999999999999875  8999999986432  11223456888899999999999999997654  34589


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCcccCCCCCcEEEEEecCCCceE
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN----------RLVHRDLKPGNIMKFICDDGSTIY  156 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~----------gIVHrDIKP~NILl~~~~d~~~~v  156 (708)
                      +|||||++|+|.+++....    +++..++.++.|++.||.|||+.          ||+||||||+|||+    +..+.+
T Consensus        99 lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill----~~~~~~  170 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL----KNNLTA  170 (322)
T ss_dssp             EEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE----CTTCCE
T ss_pred             EEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE----CCCCeE
Confidence            9999999999999997643    89999999999999999999999          99999999999998    677789


Q ss_pred             EEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChh
Q psy15481        157 KLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK  233 (708)
Q Consensus       157 KL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~  233 (708)
                      ||+|||+|........   .....||+.|+|||++....   .....++.++|||||||++|+|+||..||.+.......
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAI---NFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCC---CCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhccccc---ccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            9999999986654332   23467999999999987310   00135677899999999999999999999753221111


Q ss_pred             hHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        234 ETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       234 e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      ..............+........    ....++.. .-.......+.+++.+||..||++|||+.++++.+..+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKK----KRPVLRDY-WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSC----CCCCCCGG-GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhccc----CCCCcccc-ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11100000000000000000000    00011111 0122345568889999999999999999999999887754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.5e-40  Score=346.03  Aligned_cols=265  Identities=22%  Similarity=0.339  Sum_probs=208.2

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCC---CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecC
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNN---GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE   81 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~   81 (708)
                      .+....+|.+.+.||+|+||.||+|.+..+   +..||+|.++........+.+.+|+.++++++||||+++++++...+
T Consensus        20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            456678999999999999999999997543   34689999876443333455679999999999999999999875443


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                       +..++||||++||+|.+++.....  .+++..++.++.|++.||.|||++||+||||||+||++    +..+.+||+||
T Consensus       100 -~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~kl~Df  172 (298)
T 3f66_A          100 -GSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML----DEKFTVKVADF  172 (298)
T ss_dssp             -SCCEEEEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTCCEEECSC
T ss_pred             -CceEEEEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE----CCCCCEEECcc
Confidence             358999999999999999976432  38999999999999999999999999999999999998    67778999999


Q ss_pred             Ccccccccccc-----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhH
Q psy15481        162 GAARELEEDQQ-----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKET  235 (708)
Q Consensus       162 GlA~~~~~~~~-----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~  235 (708)
                      |.+........     .....||+.|+|||.+.        +..++.++|||||||++|+|++ |.+||..   ....+.
T Consensus       173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~  241 (298)
T 3f66_A          173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--------TQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDI  241 (298)
T ss_dssp             GGGCCCSCGGGCBC-----CCBCGGGSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTT---SCTTTH
T ss_pred             cccccccccchhccccccCCCCCccccChHHhc--------CCCCChHHHHHHHHHHHHHHHhCCCCCCcc---CCHHHH
Confidence            99986654332     22356788999999997        5678999999999999999999 6666653   334444


Q ss_pred             HHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        236 MYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       236 ~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      ...+.....                    .+.+    ..++..+.+++.+||..||.+|||+.++++.+..++..-
T Consensus       242 ~~~~~~~~~--------------------~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          242 TVYLLQGRR--------------------LLQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             HHHHHTTCC--------------------CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             HHHHhcCCC--------------------CCCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            444443211                    1111    122345667999999999999999999999998887643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.1e-40  Score=345.16  Aligned_cols=261  Identities=25%  Similarity=0.414  Sum_probs=212.6

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      ......+|.+.+.||+|+||.||+|.+..+|+.||+|++.......  ..+.+.+|+.+++.++||||+++++++.+.+ 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-   88 (294)
T 2rku_A           10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-   88 (294)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred             CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC-
Confidence            3466789999999999999999999999999999999987543322  2345678999999999999999999987644 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                       ..++||||+.|++|.+++.....   +++..++.++.|++.||.|||++|++||||||+||++    +..+.+||+|||
T Consensus        89 -~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl~dfg  160 (294)
T 2rku_A           89 -FVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL----NEDLEVKIGDFG  160 (294)
T ss_dssp             -EEEEEEECCTTCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCT
T ss_pred             -EEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE----cCCCCEEEEecc
Confidence             59999999999999998876432   8999999999999999999999999999999999998    667789999999


Q ss_pred             cccccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        163 AARELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       163 lA~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      .+...... .......||+.|+|||.+.        +..++.++|||||||++|+|++|..||..   ....+....+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~p~~~---~~~~~~~~~~~~  229 (294)
T 2rku_A          161 LATKVEYDGERKKVLCGTPNYIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFET---SCLKETYLRIKK  229 (294)
T ss_dssp             TCEECCSTTCCBCCCCSCCSSCCHHHHT--------TSCBCTHHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHT
T ss_pred             CceecccCccccccccCCCCcCCcchhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhh
Confidence            99876433 2334567999999999987        56789999999999999999999999973   444444444432


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                      ...                   .+|      ..++..+.+++.+||..||.+|||+.++           +.|||+....
T Consensus       230 ~~~-------------------~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~l-----------l~~~~~~~~~  273 (294)
T 2rku_A          230 NEY-------------------SIP------KHINPVAASLIQKMLQTDPTARPTINEL-----------LNDEFFTSGY  273 (294)
T ss_dssp             TCC-------------------CCC------TTSCHHHHHHHHHHTCSSGGGSCCGGGG-----------GGSHHHHTSC
T ss_pred             ccC-------------------CCc------cccCHHHHHHHHHHcccChhhCcCHHHH-----------hhChheecCC
Confidence            110                   111      2233456679999999999999999997           6688886543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.7e-40  Score=344.17  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=198.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++.++||||+++++++...+  ..|+
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l   88 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT--DFFM   88 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--eEEE
Confidence            47999999999999999999999999999999986432  1223445679999999999999999999987644  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++|++|.+++.....   +++..++.++.||+.||.|||++|++||||||+||++    +..+.++|+|||++...
T Consensus        89 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL----DAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE----CTTSCEEECCCCGGGCC
T ss_pred             EEeccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE----CCCCCEEEeeccccccc
Confidence            9999999999999976433   8999999999999999999999999999999999998    66778999999999877


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCc-CCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKT-FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~-~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ..........||+.|+|||.+.        +.. .+.++||||||+++|+|++|..||..   .........+.....  
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~---~~~~~~~~~~~~~~~--  228 (276)
T 2h6d_A          162 SDGEFLRTSCGSPNYAAPEVIS--------GRLYAGPEVDIWSCGVILYALLCGTLPFDD---EHVPTLFKKIRGGVF--  228 (276)
T ss_dssp             CC-------------CCTGGGT--------TSCCCHHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHCCC--
T ss_pred             CCCcceecccCCccccCHHHHc--------CCCCCCccchHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHhhcCcc--
Confidence            6655555678999999999987        343 36899999999999999999999973   444444444433210  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                       .+|      ..++..+.+++.+||..||.+|||+.++           +.|||+...
T Consensus       229 -----------------~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~~-----------l~h~~~~~~  268 (276)
T 2h6d_A          229 -----------------YIP------EYLNRSVATLLMHMLQVDPLKRATIKDI-----------REHEWFKQD  268 (276)
T ss_dssp             -----------------CCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHH-----------HHSHHHHTT
T ss_pred             -----------------cCc------hhcCHHHHHHHHHHccCChhhCCCHHHH-----------HhChhhccC
Confidence                             111      1223456679999999999999999997           458888654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.5e-40  Score=341.98  Aligned_cols=256  Identities=22%  Similarity=0.343  Sum_probs=206.0

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..+|.+.+.||+|+||.||+|.+. ++..||+|++.....  ..+.+.+|+.++++++||||+++++++...+  ..|+|
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv   97 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR--PIFII   97 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC--CeEEE
Confidence            357999999999999999999876 678899999975432  2455779999999999999999999987654  49999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++|++|.+++.....  .+++..++.++.|++.||.|||++||+||||||+||++    +..+.+||+|||++....
T Consensus        98 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili----~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV----NDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE----CTTSCEEECSTTGGGGBC
T ss_pred             EeccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE----cCCCCEEEcccccccccc
Confidence            999999999999976332  39999999999999999999999999999999999998    677789999999998665


Q ss_pred             cccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ....  .....+|+.|+|||++.        +..++.++|||||||++|+|+| |..||..   ....+....+..... 
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~---~~~~~~~~~~~~~~~-  239 (283)
T 3gen_A          172 DDEYTSSVGSKFPVRWSPPEVLM--------YSKFSSKSDIWAFGVLMWEIYSLGKMPYER---FTNSETAEHIAQGLR-  239 (283)
T ss_dssp             CHHHHSTTSTTSCGGGCCHHHHH--------HCCCSHHHHHHHHHHHHHHHHTTTCCTTTT---SCHHHHHHHHHTTCC-
T ss_pred             ccccccccCCccCcccCCHHHhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCccc---cChhHHHHHHhcccC-
Confidence            4422  23345778899999997        4668999999999999999998 9999973   445555554443211 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                                         .+.+...+    ..+.+++.+||..||.+|||+.++++++.+++..
T Consensus       240 -------------------~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          240 -------------------LYRPHLAS----EKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -------------------CCCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------------CCCCCcCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                               11111223    4566799999999999999999999999888754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.9e-40  Score=367.91  Aligned_cols=279  Identities=21%  Similarity=0.288  Sum_probs=206.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecC----CceE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE----GRGK   85 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~----~~~~   85 (708)
                      ..|.+.+.||+|+||.||+|.+..+|+.||||.+......     ..+|++++++++||||+++++++....    ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            4799999999999999999999999999999998654221     237999999999999999999885432    2346


Q ss_pred             EEEEeccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         86 VIVMELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      ++||||++ ++|...+... .....+++..++.++.||+.||.|||++||+||||||+|||+  +. ..+.+||+|||+|
T Consensus       129 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl--~~-~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DP-DTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE--ET-TTTEEEECCCTTC
T ss_pred             Eeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEE--eC-CCCeEEeccchhh
Confidence            79999996 4666655421 111239999999999999999999999999999999999998  21 3457899999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      +....+.......||+.|+|||++..       ...|+.++|||||||++|+|++|++||.   +.+..+.+..+.....
T Consensus       205 ~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~G~~pf~---~~~~~~~l~~i~~~lg  274 (420)
T 1j1b_A          205 KQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLGQPIFP---GDSGVDQLVEIIKVLG  274 (420)
T ss_dssp             EECCTTCCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHHHC
T ss_pred             hhcccCCCceeeeeCCCcCCHHHHcC-------CCCCCchhhhHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHHHhC
Confidence            97766665667789999999999862       3478999999999999999999999997   4555666666554211


Q ss_pred             CC---cccccccCCCCcccccCC--CCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        245 SG---VISGTQTSENGEIDWCTD--LPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       245 ~~---~i~~~~~~~~g~~~~~~~--lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ..   .+.... .....+.+...  .+-...+.+.++..+.+||.+||..||.+|||+.++           +.|||+..
T Consensus       275 ~p~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~-----------l~hp~f~~  342 (420)
T 1j1b_A          275 TPTREQIREMN-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA-----------CAHSFFDE  342 (420)
T ss_dssp             SCCHHHHHHHC-SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH-----------HTSGGGGG
T ss_pred             CCCHHHHHhhC-hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHH-----------hCCHhhcc
Confidence            10   000000 00000001000  000001223344567779999999999999999996           67999854

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-40  Score=343.93  Aligned_cols=263  Identities=20%  Similarity=0.301  Sum_probs=203.8

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhC-CCCCccceeEEEEecCC
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKV-KHENIVKLLAIEEEQEG   82 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~   82 (708)
                      .+.....|.+.+.||+|+||.||+|.+..+|+.||+|++....... ......+|+..+.++ +||||+++++++.+.+ 
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~-   84 (289)
T 1x8b_A            6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD-   84 (289)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT-
T ss_pred             cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence            4445678999999999999999999999999999999997653332 234457899999999 9999999999997654 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec-----------
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPEN-TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD-----------  150 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~-~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~-----------  150 (708)
                       ..++||||++|++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||+....           
T Consensus        85 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           85 -HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             -EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred             -eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence             59999999999999999875311 12389999999999999999999999999999999999972111           


Q ss_pred             ----CCCceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCC
Q psy15481        151 ----DGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP  226 (708)
Q Consensus       151 ----d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~  226 (708)
                          +....+||+|||.+.......   ...||+.|+|||++..       ...++.++|||||||++|+|++|.+|+..
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQE-------NYTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTT-------CCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             ccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcC-------CCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence                144579999999998765432   3469999999999873       34667899999999999999999987752


Q ss_pred             CCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        227 YGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       227 ~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                         .   .....+....                     .+.   ++..++..+.+++.+||..||.+|||+.++      
T Consensus       234 ---~---~~~~~~~~~~---------------------~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l------  277 (289)
T 1x8b_A          234 ---G---DQWHEIRQGR---------------------LPR---IPQVLSQEFTELLKVMIHPDPERRPSAMAL------  277 (289)
T ss_dssp             ---S---HHHHHHHTTC---------------------CCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHH------
T ss_pred             ---h---hHHHHHHcCC---------------------CCC---CCcccCHHHHHHHHHHhCCCcccCCCHHHH------
Confidence               1   2233333211                     111   112233456679999999999999999997      


Q ss_pred             HHhhhhcCcccCCc
Q psy15481        307 TLNRKLVHLFHINR  320 (708)
Q Consensus       307 il~~~l~h~~~~~~  320 (708)
                           +.|||+...
T Consensus       278 -----l~h~~~~~~  286 (289)
T 1x8b_A          278 -----VKHSVLLSA  286 (289)
T ss_dssp             -----HTCTTC---
T ss_pred             -----hhChHhhhh
Confidence                 779998754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.1e-40  Score=353.70  Aligned_cols=259  Identities=21%  Similarity=0.316  Sum_probs=204.7

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCce----EEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEP----VAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~----VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      .+..|.+.+.||+|+||.||+|.+..+|+.    ||+|.+...........+.+|+.++++++||||+++++++.+   .
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~   87 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---S   87 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---S
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---C
Confidence            456899999999999999999999888876    777777554433334455689999999999999999998863   2


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..++||||+.||+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~----~~~~~~kl~Dfg~  161 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL----KSPSQVQVADFGV  161 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE----SSSSCEEECSCSG
T ss_pred             ccEEEEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE----CCCCeEEECCCCc
Confidence            48999999999999999976422  38999999999999999999999999999999999998    6677899999999


Q ss_pred             ccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHH
Q psy15481        164 ARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       164 A~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i  239 (708)
                      |+.......   .....|+..|+|||++.        +..++.++|||||||++|+|+| |..||..   ....+....+
T Consensus       162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~~~g~~p~~~---~~~~~~~~~~  230 (325)
T 3kex_A          162 ADLLPPDDKQLLYSEAKTPIKWMALESIH--------FGKYTHQSDVWSYGVTVWELMTFGAEPYAG---LRLAEVPDLL  230 (325)
T ss_dssp             GGGSCCCTTCCC-----CCTTTSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTT---SCTTHHHHHH
T ss_pred             ccccCcccccccccCCCCcccccChHHhc--------cCCCChhhHhHHhHHHHHHHHhCCCCCccc---cCHHHHHHHH
Confidence            987654432   23456888999999997        5678999999999999999999 9999974   3333443333


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ....                    ..+.....++.    +.+++.+||..||.+|||+.++++++..+...
T Consensus       231 ~~~~--------------------~~~~~~~~~~~----~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          231 EKGE--------------------RLAQPQICTID----VYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             HTTC--------------------BCCCCTTBCTT----TTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             HcCC--------------------CCCCCCcCcHH----HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            3211                    11111122333    45599999999999999999999998877654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.7e-40  Score=347.19  Aligned_cols=268  Identities=25%  Similarity=0.379  Sum_probs=208.3

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..+..|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.++++++||||+++++++...+  ..+
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~   92 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG--KLW   92 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC--eEE
Confidence            45678999999999999999999999999999999987543 233456679999999999999999999998654  499


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++|++|..++.....  .+++..++.++.||+.||.|||++|++||||||+||++    +..+.+||+|||++..
T Consensus        93 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM----TLEGDIRLADFGVSAK  166 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----CTTSCEEECCCHHHHH
T ss_pred             EEEEeCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE----CCCCCEEEEECCCCcc
Confidence            99999999999998865322  38999999999999999999999999999999999998    6667899999999865


Q ss_pred             cccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .... .......||+.|+|||++.....   .+..++.++|||||||++|+|++|..||..   .+.......+.....+
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Di~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~~~~  240 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETM---KDTPYDYKADIWSLGITLIEMAQIEPPHHE---LNPMRVLLKIAKSDPP  240 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHT---TSTTTTTHHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHHHHHSCCC
T ss_pred             ccccccccccccCChhhcCCeeeccccC---CCCCCchhhhHHHHHHHHHHHhcCCCCCcc---CCHHHHHHHHhccCCc
Confidence            4322 22345679999999999853211   145688999999999999999999999974   3444444444432111


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                        ..+..    ..++..+.++|.+||..||.+|||+.++           +.|||+.....
T Consensus       241 ------------------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l-----------l~h~~~~~~~~  284 (302)
T 2j7t_A          241 ------------------TLLTP----SKWSVEFRDFLKIALDKNPETRPSAAQL-----------LEHPFVSSITS  284 (302)
T ss_dssp             ------------------CCSSG----GGSCHHHHHHHHHHSCSCTTTSCCHHHH-----------TTSTTTTTCCC
T ss_pred             ------------------ccCCc----cccCHHHHHHHHHHcccChhhCCCHHHH-----------hcChHHhhhcc
Confidence                              11111    2233456679999999999999999997           77999976543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-40  Score=342.33  Aligned_cols=266  Identities=17%  Similarity=0.245  Sum_probs=207.2

Q ss_pred             CCcccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEe
Q psy15481          1 MSFLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEE   79 (708)
Q Consensus         1 ms~l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~   79 (708)
                      |..-.+-.-..|.+.+.||+|+||.||+|.+.  |+.||+|++...... .....+.+|+.++++++||||+++++++.+
T Consensus         1 m~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (271)
T 3kmu_A            1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS   78 (271)
T ss_dssp             ---CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred             CCCcCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence            33344455568999999999999999999985  889999999764322 223456799999999999999999999987


Q ss_pred             cCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEEEecCCCceEE
Q psy15481         80 QEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR--LVHRDLKPGNIMKFICDDGSTIYK  157 (708)
Q Consensus        80 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g--IVHrDIKP~NILl~~~~d~~~~vK  157 (708)
                      ......++||||++||+|.+++..... ..+++..++.++.||+.||.|||++|  ++||||||+||++    +..+.++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~----~~~~~~~  153 (271)
T 3kmu_A           79 PPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI----DEDMTAR  153 (271)
T ss_dssp             TTSSSCEEEEECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE----CTTSCEE
T ss_pred             CCCCCeEeeecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE----cCCccee
Confidence            755679999999999999999987543 24899999999999999999999999  9999999999998    6666788


Q ss_pred             EeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH
Q psy15481        158 LTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       158 L~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~  237 (708)
                      |+|||++.....    ....||+.|+|||++....     ...++.++|||||||++|+|++|..||..   .+..+...
T Consensus       154 l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~---~~~~~~~~  221 (271)
T 3kmu_A          154 ISMADVKFSFQS----PGRMYAPAWVAPEALQKKP-----EDTNRRSADMWSFAVLLWELVTREVPFAD---LSNMEIGM  221 (271)
T ss_dssp             EEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCG-----GGSCHHHHHHHHHHHHHHHHHHCSCTTTT---SCHHHHHH
T ss_pred             EEeccceeeecc----cCccCCccccChhhhccCC-----CCCCCchhhHHHHHHHHHHHHhCCCCccc---cChHHHHH
Confidence            888887764322    2457899999999987211     12234489999999999999999999973   44555544


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                      .+......                   .+    ++..++..+.+++.+||..||.+|||+.++++.+..+.
T Consensus       222 ~~~~~~~~-------------------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          222 KVALEGLR-------------------PT----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHHHSCCC-------------------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHhcCCC-------------------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            44432110                   11    12233445667999999999999999999999887764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.1e-40  Score=352.37  Aligned_cols=275  Identities=20%  Similarity=0.267  Sum_probs=212.6

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ....|.+.+.||+|+||.||+|.+ .+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+  ..|+
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN--EMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT--CCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--eEEE
Confidence            345788899999999999999996 478999999986543 233456679999999999999999999987654  4899


Q ss_pred             EEeccCCCCHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         88 VMELCTGGSLFNILDDPEN-TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~-~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ||||++||+|.+++..... ...+++..++.++.|++.||.|||++||+||||||+||++    +..+.+||+|||++..
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL----DENFVPKITDFGISKK  188 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE----CTTCCEEECCCTTCEE
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE----CCCCCEEEeecccccc
Confidence            9999999999999876432 2248999999999999999999999999999999999998    6777899999999986


Q ss_pred             ccccc---cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        167 LEEDQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       167 ~~~~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      .....   ......||+.|+|||++.        +..++.++|||||||++|+|+||+.||...................
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  260 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFI--------KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH  260 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHH--------HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred             cccccccccccccCCCccccCHHHhc--------CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence            43321   123346899999999987        4678999999999999999999999997532222111111111111


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      ..+.+..           .........+++.....+.+++.+||..||++|||+.+++..++.++.
T Consensus       261 ~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          261 NNGQLEQ-----------IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TTTCCCS-----------SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccHHH-----------hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            1110000           001111223567788889999999999999999999999999887764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-41  Score=370.67  Aligned_cols=266  Identities=24%  Similarity=0.339  Sum_probs=209.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ...|.+.+.||+|+||.||+|+++.+|+.||+|++++...  ......+.+|..++..++||||+++++++.+.+  .+|
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~--~~~  137 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN--YLY  137 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS--EEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC--EEE
Confidence            3579999999999999999999999999999999964211  111233568999999999999999999997654  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++||+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|..
T Consensus       138 lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl----d~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL----DRCGHIRLADFGSCLK  211 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTTCEE
T ss_pred             EEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee----cCCCCEEEeechhhee
Confidence            99999999999999976322  39999999999999999999999999999999999998    7777899999999987


Q ss_pred             cccccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        167 LEEDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       167 ~~~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ...+..  ....+||+.|+|||++.... ....+..|+.++|+|||||++|+|++|+.||.   +.+..+....+...+.
T Consensus       212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~---~~~~~~~~~~i~~~~~  287 (412)
T 2vd5_A          212 LRADGTVRSLVAVGTPDYLSPEILQAVG-GGPGTGSYGPECDWWALGVFAYEMFYGQTPFY---ADSTAETYGKIVHYKE  287 (412)
T ss_dssp             CCTTSCEECSSCCSCGGGCCHHHHHHHH-TCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC---CSSHHHHHHHHHTHHH
T ss_pred             ccCCCccccceeccccCcCCHHHHhhcc-cCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC---CCCHHHHHHHHHhccc
Confidence            655433  23468999999999997421 11113568999999999999999999999997   4556666666654211


Q ss_pred             CCcccccccCCCCcccccCCCCC-cccCChhHHHHHHHHHHhhcccCcccCC---CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPN-NCQLSLGLKKLVTPILAGLLEVDSKKIW---SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~-~~~ls~~l~~~l~~LL~~mL~~DP~kRp---sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      .                 ..+|. ...+++    .+.++|.+||. ||.+|+   +++++           +.||||..
T Consensus       288 ~-----------------~~~p~~~~~~s~----~~~dli~~lL~-~p~~Rlgr~~~~ei-----------~~Hpff~~  333 (412)
T 2vd5_A          288 H-----------------LSLPLVDEGVPE----EARDFIQRLLC-PPETRLGRGGAGDF-----------RTHPFFFG  333 (412)
T ss_dssp             H-----------------CCCC----CCCH----HHHHHHHTTSS-CGGGCTTTTTHHHH-----------HTSGGGTT
T ss_pred             C-----------------cCCCccccCCCH----HHHHHHHHHcC-ChhhcCCCCCHHHH-----------hcCCCcCC
Confidence            0                 01221 122344    45669999999 999984   78886           67898854

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.5e-40  Score=345.12  Aligned_cols=264  Identities=26%  Similarity=0.393  Sum_probs=210.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...|.+.+.||+|+||.||+|.+..+|+.||+|.+...... ...+.+.+|+.++++++||||+++++++.+......|+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            45899999999999999999999999999999999764432 22345679999999999999999999987666667999


Q ss_pred             EEeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         88 VMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNR-----LVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~g-----IVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                      ||||++|++|.+++.... ....+++..++.++.|++.||.|||++|     |+||||||+||++    +..+.+||+||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~----~~~~~~kl~df  160 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL----DGKQNVKLGDF  160 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE----CSSSCEEECCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE----cCCCCEEEecC
Confidence            999999999999987522 1223899999999999999999999999     9999999999998    66778999999


Q ss_pred             Ccccccccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        162 GAARELEEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       162 GlA~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      |.+........ .....||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .+..+....+.
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~~---~~~~~~~~~i~  229 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMN--------RMSYNEKSDIWSLGCLLYELCALMPPFTA---FSQKELAGKIR  229 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHH--------CC-CCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHH
T ss_pred             chheeeccccccccccCCCccccChHHhc--------cCCCCchhhHHHHHHHHHHHHHCCCCCcc---cCHHHHHHHHh
Confidence            99987654322 23457999999999987        56789999999999999999999999973   44445554444


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      .....                  .      ++..++..+.+++.+||..||.+|||+.++           +.|+|+...
T Consensus       230 ~~~~~------------------~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l-----------l~~~~~~~~  274 (279)
T 2w5a_A          230 EGKFR------------------R------IPYRYSDELNEIITRMLNLKDYHRPSVEEI-----------LENPLILEH  274 (279)
T ss_dssp             HTCCC------------------C------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH-----------HTSTTCCGG
T ss_pred             hcccc------------------c------CCcccCHHHHHHHHHHcCCCcccCCCHHHH-----------HhChhhhhh
Confidence            32110                  1      112233456679999999999999999997           568887665


Q ss_pred             cc
Q psy15481        321 LQ  322 (708)
Q Consensus       321 ~~  322 (708)
                      ..
T Consensus       275 ~~  276 (279)
T 2w5a_A          275 HH  276 (279)
T ss_dssp             GS
T ss_pred             cc
Confidence            43

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.9e-40  Score=345.52  Aligned_cols=269  Identities=20%  Similarity=0.268  Sum_probs=212.4

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..+.+|.+.+.||+|+||.||+|.+..+|+.||+|++.....   ...+.+|+.+++.++|++++..+..+... ....+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~   81 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNV   81 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCC-CCceE
Confidence            456789999999999999999999999999999999875432   33467899999999999888877766543 34689


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||+ +++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+ ...+..+.+||+|||++..
T Consensus        82 lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~-~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM-GLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-CCGGGTTCEEECCCTTCEE
T ss_pred             EEEEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEE-ecCCCCCeEEEeeCCCccc
Confidence            999999 9999999974332  39999999999999999999999999999999999997 1123456799999999987


Q ss_pred             cccccc--------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHH
Q psy15481        167 LEEDQQ--------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       167 ~~~~~~--------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~  238 (708)
                      ......        .....||+.|+|||++.        +..++.++|||||||++|+|++|+.||...........+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHL--------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhc--------CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh
Confidence            654432        23467999999999987        67789999999999999999999999986544444444444


Q ss_pred             HHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      +......                   .| ...+...++..+.+++..||..||.+|||+.++...+..++...
T Consensus       230 ~~~~~~~-------------------~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          230 ISEKKMS-------------------TP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHHH-------------------SC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hcccccC-------------------Cc-hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            4432111                   01 00111223345667999999999999999999999988887654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-40  Score=358.70  Aligned_cols=262  Identities=24%  Similarity=0.357  Sum_probs=208.8

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      .....|.+.+.||+|+||.||+|.+..+|+.||||++........  ...+.+|+.++++++||||+++++++...+  .
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~  128 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--T  128 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--E
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--e
Confidence            344679999999999999999999999999999999975433221  234579999999999999999999998654  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||+. |+|.+++....  ..+++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kL~DfG~a  201 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL----SEPGLVKLGDFGSA  201 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE----ETTTEEEECCCTTC
T ss_pred             EEEEEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----CCCCCEEEeeccCc
Confidence            999999996 68888775422  238999999999999999999999999999999999998    56678999999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ......   ....||+.|+|||++....     +..++.++|||||||++|+|++|..||..   .+....+..+.....
T Consensus       202 ~~~~~~---~~~~gt~~y~aPE~~~~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~---~~~~~~~~~~~~~~~  270 (348)
T 1u5q_A          202 SIMAPA---NSFVGTPYWMAPEVILAMD-----EGQYDGKVDVWSLGITCIELAERKPPLFN---MNAMSALYHIAQNES  270 (348)
T ss_dssp             BSSSSB---CCCCSCGGGCCHHHHHTTS-----SCCBCTHHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHHHHHSCC
T ss_pred             eecCCC---CcccCCcceeCHhhhcccc-----CCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHhcCC
Confidence            865433   3467999999999985211     45689999999999999999999999973   444555555544211


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      +.                   .    .+...+..+.++|.+||..||.+|||+.++           +.|||+.....
T Consensus       271 ~~-------------------~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l-----------l~h~~~~~~~~  314 (348)
T 1u5q_A          271 PA-------------------L----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL-----------LKHRFVLRERP  314 (348)
T ss_dssp             CC-------------------C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH-----------TTCHHHHSCCC
T ss_pred             CC-------------------C----CCCCCCHHHHHHHHHHcccChhhCcCHHHH-----------hhChhhhccCC
Confidence            10                   0    011223456679999999999999999997           67898866543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.1e-40  Score=352.05  Aligned_cols=261  Identities=21%  Similarity=0.319  Sum_probs=207.8

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceE--EEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPV--AVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~V--AIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|.+.+.||+|+||.||+|.+..+|..+  |+|.+...........+.+|+.+++++ +||||+++++++...+  ..|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--EEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC--ceE
Confidence            57899999999999999999999898865  999987654444455677999999999 9999999999997654  599


Q ss_pred             EEEeccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC
Q psy15481         87 IVMELCTGGSLFNILDDPE-------------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS  153 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~-------------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~  153 (708)
                      +||||++|++|.+++....             ....+++..++.++.||+.||.|||++||+||||||+||++    +..
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~----~~~  178 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV----GEN  178 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE----cCC
Confidence            9999999999999997643             12348999999999999999999999999999999999998    667


Q ss_pred             ceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCCh
Q psy15481        154 TIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRN  232 (708)
Q Consensus       154 ~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~  232 (708)
                      +.+||+|||++.............+++.|+|||++.        +..++.++|||||||++|+|+| |..||..   ...
T Consensus       179 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~ellt~g~~pf~~---~~~  247 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN--------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---MTC  247 (327)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHH--------HCEECHHHHHHHHHHHHHHHHTTSCCTTTT---CCH
T ss_pred             CeEEEcccCcCccccccccccCCCCCccccChhhhc--------cccCCchhcchHHHHHHHHHHcCCCCCCCC---CcH
Confidence            789999999998654444444556789999999987        5678999999999999999998 9999973   444


Q ss_pred             hhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        233 KETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       233 ~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      .+....+....                    ..+....++    ..+.+++.+||..||.+|||+.+++..+..++...
T Consensus       248 ~~~~~~~~~~~--------------------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          248 AELYEKLPQGY--------------------RLEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HHHHHHGGGTC--------------------CCCCCTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHHHhhcCC--------------------CCCCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            44444333210                    111112233    45667999999999999999999999999888753

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9e-40  Score=342.09  Aligned_cols=266  Identities=22%  Similarity=0.355  Sum_probs=210.7

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCc---eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      ......|.+.+.||+|+||.||+|.+..++.   .||+|.+.........+.+.+|+.++++++||||+++++++.+.+.
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   96 (298)
T 3pls_A           17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG   96 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence            4456689999999999999999999765554   7999998754433334556799999999999999999999876543


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                       ..++||||+.+|+|.+++.....  .+++..++.++.|++.||.|||++||+||||||+||++    +..+.+||+|||
T Consensus        97 -~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili----~~~~~~kl~Dfg  169 (298)
T 3pls_A           97 -LPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML----DESFTVKVADFG  169 (298)
T ss_dssp             -CCEEEECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTCCEEECCTT
T ss_pred             -CcEEEEecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE----cCCCcEEeCcCC
Confidence             35899999999999999987433  38999999999999999999999999999999999998    677789999999


Q ss_pred             ccccccccc-----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH
Q psy15481        163 AARELEEDQ-----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       163 lA~~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~  237 (708)
                      ++.......     ......+++.|+|||.+.        +..++.++|||||||++|+|++|..||..  +....+...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~~~~~--~~~~~~~~~  239 (298)
T 3pls_A          170 LARDILDREYYSVQQHRHARLPVKWTALESLQ--------TYRFTTKSDVWSFGVLLWELLTRGAPPYR--HIDPFDLTH  239 (298)
T ss_dssp             SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHT--------TCCCCHHHHHHHHHHHHHHHHHTSCCTTT--TSCGGGHHH
T ss_pred             CcccccCCcccccccCcCCCCCccccChhhhc--------cCCCChhhchhhHHHHHHHHhhCCCCCCc--cCCHHHHHH
Confidence            998654432     223456889999999997        67789999999999999999995555432  344444444


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhh
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKL  312 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l  312 (708)
                      .+....                    ..+....++    ..+.+++.+||..||.+|||+.+++..+..++..-.
T Consensus       240 ~~~~~~--------------------~~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          240 FLAQGR--------------------RLPQPEYCP----DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             HHHTTC--------------------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             HhhcCC--------------------CCCCCccch----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            443321                    112222233    456679999999999999999999999998877543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.3e-40  Score=351.70  Aligned_cols=260  Identities=25%  Similarity=0.417  Sum_probs=212.7

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      .....+|.+.+.||+|+||.||++.+..+++.||+|++.......  ..+.+.+|+.+++.++||||+++++++.+.+  
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  114 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND--  114 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence            456779999999999999999999999999999999987543322  2345678999999999999999999997644  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||+.|++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~----~~~~~~kl~Dfg~  187 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL----NEDLEVKIGDFGL  187 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTCCEEECCCTT
T ss_pred             eEEEEEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE----cCCCCEEEeeccC
Confidence            5999999999999999987643   28999999999999999999999999999999999998    6667899999999


Q ss_pred             ccccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        164 ARELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       164 A~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      +...... .......||+.|+|||++.        +..++.++|||||||++|+|++|..||..   ....+....+...
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~~---~~~~~~~~~~~~~  256 (335)
T 2owb_A          188 ATKVEYDGERKKVLCGTPNYIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFET---SCLKETYLRIKKN  256 (335)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHH--------TSCBCTHHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHHT
T ss_pred             ceecccCcccccccCCCccccCHHHhc--------cCCCCchhhHHHHHHHHHHHHHCcCCCCC---CCHHHHHHHHhcC
Confidence            9876433 2334567999999999997        67789999999999999999999999973   4444444444332


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                      ..                   .+|      ..+...+.++|.+||..||.+|||+.++           +.|+|+....
T Consensus       257 ~~-------------------~~~------~~~~~~~~~li~~~l~~dp~~Rps~~el-----------l~~~~~~~~~  299 (335)
T 2owb_A          257 EY-------------------SIP------KHINPVAASLIQKMLQTDPTARPTINEL-----------LNDEFFTSGY  299 (335)
T ss_dssp             CC-------------------CCC------TTSCHHHHHHHHHHTCSSGGGSCCGGGG-----------GGSHHHHTSC
T ss_pred             CC-------------------CCC------ccCCHHHHHHHHHHccCChhHCcCHHHH-----------hcCccccCCC
Confidence            10                   111      1223446669999999999999999996           6688886543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.8e-40  Score=341.49  Aligned_cols=254  Identities=23%  Similarity=0.349  Sum_probs=205.9

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...+|.+.+.||+|+||.||+|.+. ++..||+|++.....  ..+.+.+|+.++++++||||+++++++...+  ..++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~l   80 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY--PIYI   80 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--ceEE
Confidence            3568999999999999999999875 677899999975432  2455679999999999999999999987654  4999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++|++|.+++.....  .+++..++.++.|++.||.|||++||+||||||+||++    +..+.+||+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV----DRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             EEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE----CTTCCEEECCTTCEEEC
T ss_pred             EEEccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE----CCCCCEEEccCccceec
Confidence            9999999999999976432  38999999999999999999999999999999999998    67778999999999866


Q ss_pred             ccccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        168 EEDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       168 ~~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .....  .....+|+.|+|||.+.        +..++.++|||||||++|+|+| |..||..   ....+....+.... 
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~~g~~p~~~---~~~~~~~~~~~~~~-  222 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFH--------YFKYSSKSDVWAFGILMWEVFSLGKMPYDL---YTNSEVVLKVSQGH-  222 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHH--------HSEEETTHHHHHHHHHHHHHHTTTCCTTTT---SCHHHHHHHHHTTC-
T ss_pred             chhhhhcccCCCcCcccCCHHHHh--------ccCCchhhhhHHHHHHHHHHHcCCCCCccc---cChHHHHHHHHcCC-
Confidence            54432  23345677899999997        5678899999999999999999 9999973   44555554444321 


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                         ..+.+...+    +.+.+++..||..||.+|||+.++++.++.+
T Consensus       223 -------------------~~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          223 -------------------RLYRPHLAS----DTIYQIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             -------------------CCCCCTTSC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             -------------------CCCCCCcCh----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                               111111223    3466799999999999999999999887654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.9e-40  Score=350.31  Aligned_cols=259  Identities=23%  Similarity=0.349  Sum_probs=203.1

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceE----EEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPV----AVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~V----AIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      .+.+|.+.+.||+|+||.||+|.+..+|+.|    |+|.+...........+.+|+.++++++||||+++++++....  
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--   90 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--   90 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--
Confidence            4568999999999999999999998888765    6666655544555667789999999999999999999998643  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                       .++|++|+.+|+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~----~~~~~~kL~DfG~  163 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDFGL  163 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----EETTEEEECCTTC
T ss_pred             -ceEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE----cCCCCEEEccCcc
Confidence             8899999999999999876432  38999999999999999999999999999999999998    5556799999999


Q ss_pred             ccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHH
Q psy15481        164 ARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       164 A~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i  239 (708)
                      +........   .....+|+.|+|||++.        +..++.++|||||||++|+|++ |..||..   ....+....+
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~Di~slG~il~ell~~g~~p~~~---~~~~~~~~~~  232 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESIL--------HRIYTHQSDVWSYGVTVWELMTFGSKPYDG---IPASEISSIL  232 (327)
T ss_dssp             ----------------CCCGGGSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTT---CCGGGHHHHH
T ss_pred             eeEccCccccccccCCCccccccCHHHHc--------CCCCChHHHHHHHHHHHHHHHHCCCCCCCC---CCHHHHHHHH
Confidence            987644332   22345788999999998        5778999999999999999999 9999974   3334433333


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ....                    ..+.....+    ..+.+++.+||..||.+|||+.+++..+..+...
T Consensus       233 ~~~~--------------------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          233 EKGE--------------------RLPQPPICT----IDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HTTC--------------------CCCCCTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HcCC--------------------CCCCCccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            3211                    122222233    3466699999999999999999999998888754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.7e-40  Score=339.33  Aligned_cols=256  Identities=26%  Similarity=0.417  Sum_probs=193.2

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC---CchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM---RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~---~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ....|.+.+.||+|+||.||+|.+.  |+.||+|++......   ...+.+.+|+.+++.++||||+++++++...+  .
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~   80 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP--N   80 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC--c
Confidence            3467999999999999999999874  889999998754322   22355678999999999999999999987654  4


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCCCcEEEEEecC----CCceEE
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR---LVHRDLKPGNIMKFICDD----GSTIYK  157 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g---IVHrDIKP~NILl~~~~d----~~~~vK  157 (708)
                      .|+||||++|++|.+++...    .+++..++.++.|++.||.|||++|   |+||||||+||++....+    ..+.+|
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             eEEEEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence            89999999999999999643    3899999999999999999999999   899999999999711100    256799


Q ss_pred             EeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH
Q psy15481        158 LTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       158 L~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~  237 (708)
                      |+|||.+........ ....||+.|+|||.+.        +..++.++|||||||++|+|++|..||..   ........
T Consensus       157 l~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~p~~~---~~~~~~~~  224 (271)
T 3dtc_A          157 ITDFGLAREWHRTTK-MSAAGAYAWMAPEVIR--------ASMFSKGSDVWSYGVLLWELLTGEVPFRG---IDGLAVAY  224 (271)
T ss_dssp             ECCCCC--------------CCGGGSCHHHHH--------HCCCSHHHHHHHHHHHHHHHHHCCCTTTT---SCHHHHHH
T ss_pred             EccCCcccccccccc-cCCCCccceeCHHHhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHH
Confidence            999999986654432 3567999999999987        56789999999999999999999999973   44444444


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                      .+.....                   ..+.    +..++..+.+++.+||..||.+|||+.++++.+..
T Consensus       225 ~~~~~~~-------------------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          225 GVAMNKL-------------------ALPI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HHHTSCC-------------------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             hhhcCCC-------------------CCCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            4443211                   1111    12233456679999999999999999999887753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=347.29  Aligned_cols=262  Identities=24%  Similarity=0.382  Sum_probs=205.3

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ......|.+.+.||+|+||.||+|.+..+|+.||+|.+....   ....+.+|+.++++++||||+++++++...+  ..
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~   99 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT--DL   99 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--EE
Confidence            345678999999999999999999999999999999997543   2455679999999999999999999987644  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++|++|.+++....  ..+++..++.++.||+.||.|||++|++|+||||+||++    +..+.+||+|||.+.
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl~dfg~~~  173 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL----NTEGHAKLADFGVAG  173 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTTCE
T ss_pred             EEEeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE----CCCCCEEEeecccch
Confidence            99999999999999986322  238999999999999999999999999999999999998    666789999999998


Q ss_pred             cccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ...... ......||+.|+|||++.        +..++.++|||||||++|+|++|..||..   .........+.....
T Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~~~~  242 (314)
T 3com_A          174 QLTDTMAKRNTVIGTPFWMAPEVIQ--------EIGYNCVADIWSLGITAIEMAEGKPPYAD---IHPMRAIFMIPTNPP  242 (314)
T ss_dssp             ECBTTBSCBCCCCSCGGGCCHHHHS--------SSCBCTTHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHHHHHSCC
T ss_pred             hhhhhccccCccCCCCCccChhhcC--------CCCCCccccHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHhcCCC
Confidence            665432 234567999999999987        56789999999999999999999999973   333343333332211


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      .                  .+..    +..++..+.++|.+||..||.+|||+.++           +.|||+.....
T Consensus       243 ~------------------~~~~----~~~~~~~l~~li~~~l~~dp~~Rpt~~~l-----------l~~~~~~~~~~  287 (314)
T 3com_A          243 P------------------TFRK----PELWSDNFTDFVKQCLVKSPEQRATATQL-----------LQHPFVRSAKG  287 (314)
T ss_dssp             C------------------CCSS----GGGSCHHHHHHHHHHTCSCTTTSCCHHHH-----------TTSHHHHTCCC
T ss_pred             c------------------ccCC----cccCCHHHHHHHHHHccCChhhCcCHHHH-----------HhCHHHhcCCc
Confidence            0                  1111    12233456679999999999999999997           77999876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.8e-40  Score=376.78  Aligned_cols=262  Identities=27%  Similarity=0.424  Sum_probs=211.1

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ....|.+.+.||+|+||.||+|.++.+|+.||+|++++...  ........+|+.++++++||||+++++++....  .+
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~l  260 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT--DL  260 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC--EE
Confidence            44679999999999999999999999999999999965321  222455678999999999999999999987654  59


Q ss_pred             EEEEeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         86 VIVMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      |+||||++||+|..++.... ....+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl----~~~g~vkL~DFGla  336 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL----DDDGNVRISDLGLA  336 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTSCEEECCCTTC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE----eCCCCEEEeeccee
Confidence            99999999999999987643 12349999999999999999999999999999999999998    77778999999999


Q ss_pred             cccccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC-ChhhHHHHHHhc
Q psy15481        165 RELEEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-RNKETMYYITTK  242 (708)
Q Consensus       165 ~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~-~~~e~~~~i~~~  242 (708)
                      ........ ....+||+.|+|||++.        +..|+.++|||||||++|+|+||.+||...... ...+....+...
T Consensus       337 ~~~~~~~~~~~~~~GT~~Y~APE~l~--------~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~  408 (543)
T 3c4z_A          337 VELKAGQTKTKGYAGTPGFMAPELLL--------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ  408 (543)
T ss_dssp             EECCTTCCCBCCCCSCTTTSCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred             eeccCCCcccccccCCccccChhhhc--------CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc
Confidence            87655443 33468999999999997        678999999999999999999999999854332 233333334332


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH-----HHHHHHHHHHHhhhhcCccc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF-----ERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa-----~q~~~~l~~il~~~l~h~~~  317 (708)
                      ..                   .+|  ..++    ..+.++|.+||..||.+||++     +++           ..|||+
T Consensus       409 ~~-------------------~~p--~~~s----~~~~~li~~lL~~dP~~R~~~~~~~a~ei-----------~~Hpff  452 (543)
T 3c4z_A          409 AV-------------------TYP--DKFS----PASKDFCEALLQKDPEKRLGFRDGSCDGL-----------RTHPLF  452 (543)
T ss_dssp             CC-------------------CCC--TTSC----HHHHHHHHHHSCSSGGGSCCCBTTBSHHH-----------HTSGGG
T ss_pred             cc-------------------CCC--cccC----HHHHHHHHHhccCCHhHCCCCcccCHHHH-----------HcCccc
Confidence            10                   112  2234    445669999999999999975     554           679998


Q ss_pred             CC
Q psy15481        318 IN  319 (708)
Q Consensus       318 ~~  319 (708)
                      ..
T Consensus       453 ~~  454 (543)
T 3c4z_A          453 RD  454 (543)
T ss_dssp             TT
T ss_pred             cC
Confidence            65

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-40  Score=358.90  Aligned_cols=261  Identities=20%  Similarity=0.329  Sum_probs=210.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcC-------CCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEec
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKN-------NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQ   80 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~-------tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~   80 (708)
                      ..+|.+.+.||+|+||.||+|.+..       ++..||+|++...........+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4589999999999999999999754       34579999997654333345567999999999 999999999998765


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEE
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKF  147 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~  147 (708)
                      +  ..|+||||++||+|.+++.....             ...+++..++.++.||+.||.|||++||+||||||+|||+ 
T Consensus       148 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-  224 (382)
T 3tt0_A          148 G--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-  224 (382)
T ss_dssp             S--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-
T ss_pred             C--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE-
Confidence            4  48999999999999999975431             1248999999999999999999999999999999999998 


Q ss_pred             EecCCCceEEEeccCccccccccc---cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCC
Q psy15481        148 ICDDGSTIYKLTDFGAARELEEDQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLP  223 (708)
Q Consensus       148 ~~~d~~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~P  223 (708)
                         +..+.+||+|||+|.......   ......+|+.|+|||++.        +..++.++|||||||++|+|++ |..|
T Consensus       225 ---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DiwslG~il~ellt~g~~p  293 (382)
T 3tt0_A          225 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--------DRIYTHQSDVWSFGVLLWEIFTLGGSP  293 (382)
T ss_dssp             ---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH--------SCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc--------CCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence               666789999999998765432   223456788999999997        6789999999999999999999 9999


Q ss_pred             CCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        224 FRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       224 F~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                      |.   +....+....+....                    ..+....++    ..+.+++.+||..||.+|||+.++++.
T Consensus       294 ~~---~~~~~~~~~~~~~~~--------------------~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          294 YP---GVPVEELFKLLKEGH--------------------RMDKPSNCT----NELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             ST---TCCHHHHHHHHHTTC--------------------CCCCCSSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC---CCCHHHHHHHHHcCC--------------------CCCCCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            97   344444444443321                    111112233    456669999999999999999999999


Q ss_pred             HHHHHhh
Q psy15481        304 VTKTLNR  310 (708)
Q Consensus       304 l~~il~~  310 (708)
                      ++.++..
T Consensus       347 L~~~~~~  353 (382)
T 3tt0_A          347 LDRIVAL  353 (382)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9888754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-39  Score=352.11  Aligned_cols=287  Identities=22%  Similarity=0.307  Sum_probs=203.7

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc----------hHHHHHHHHHHHhCCCCCccceeEEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP----------HDVQMREFEVLKKVKHENIVKLLAIE   77 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~----------~~~~~~Ei~iL~kL~HpNIVkl~~v~   77 (708)
                      ....|.+.+.||+|+||.||+|.+.. |+.||||.+........          ...+.+|+.++++++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            45679999999999999999999864 99999999865433221          14567999999999999999999998


Q ss_pred             Eec---CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCc
Q psy15481         78 EEQ---EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST  154 (708)
Q Consensus        78 ~~~---~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~  154 (708)
                      ...   .....|+||||+. |+|.+.+....  ..+++..++.++.||+.||.|||++||+||||||+|||+    +..+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~----~~~~  171 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNN  171 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTC
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE----cCCC
Confidence            653   3346899999996 68888887543  238999999999999999999999999999999999998    6667


Q ss_pred             eEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhh
Q psy15481        155 IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE  234 (708)
Q Consensus       155 ~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e  234 (708)
                      .+||+|||++.............||+.|+|||++..       ...++.++|||||||++|+|++|..||.   +....+
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~---~~~~~~  241 (362)
T 3pg1_A          172 DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ-------FKGFTKLVDMWSAGCVMAEMFNRKALFR---GSTFYN  241 (362)
T ss_dssp             CEEECCTTC---------------CGGGCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCC---CSSHHH
T ss_pred             CEEEEecCcccccccccccceecccceecCcHHhcC-------CCCCCcHhHHHhHHHHHHHHHhCCCCCC---CCCHHH
Confidence            899999999987666655666789999999999872       3668999999999999999999999997   355555


Q ss_pred             HHHHHHhcccCCcccccccCCC-Ccccc----cCCC--CCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        235 TMYYITTKKASGVISGTQTSEN-GEIDW----CTDL--PNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       235 ~~~~i~~~~~~~~i~~~~~~~~-g~~~~----~~~l--p~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      .+..+................. ....+    ....  .......+..+..+.++|.+||..||.+|||+.++       
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el-------  314 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA-------  314 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH-------
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH-------
Confidence            5555543211110000000000 00000    0000  11112223344567789999999999999999997       


Q ss_pred             HhhhhcCcccCCcccc
Q psy15481        308 LNRKLVHLFHINRLQC  323 (708)
Q Consensus       308 l~~~l~h~~~~~~~~~  323 (708)
                          +.|||+..-...
T Consensus       315 ----l~hp~f~~~~~~  326 (362)
T 3pg1_A          315 ----LRHPYFESLFDP  326 (362)
T ss_dssp             ----HTSGGGTTTCCG
T ss_pred             ----HcCchhhhccCc
Confidence                679998765433

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.4e-40  Score=345.67  Aligned_cols=270  Identities=20%  Similarity=0.253  Sum_probs=207.9

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      -..+.+|.+.+.||+|+||.||+|.+..+|+.||+|++......   ....+|+.+++.++|++++..+..+... ....
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~   80 (296)
T 4hgt_A            5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYN   80 (296)
T ss_dssp             ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEE
T ss_pred             cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCce
Confidence            34567899999999999999999999999999999987654332   2356899999999999888888776543 3468


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ++||||+ |++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+ ...+..+.+||+|||++.
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~-~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM-GLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-CCGGGTTCEEECCCTTCE
T ss_pred             EEEEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeee-eccCCCCeEEEecCccce
Confidence            9999999 9999999974332  39999999999999999999999999999999999997 222345679999999998


Q ss_pred             ccccccc--------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH
Q psy15481        166 ELEEDQQ--------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       166 ~~~~~~~--------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~  237 (708)
                      .......        .....||+.|+|||++.        +..++.++|||||||++|+|++|..||...........+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  228 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHL--------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE  228 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhc--------CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh
Confidence            7654422        23467999999999987        6778999999999999999999999998654444444444


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      .+.......                   |. ..+...++..+.+++..||..||++|||+.++++.+.+++...
T Consensus       229 ~~~~~~~~~-------------------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          229 RISEKKMST-------------------PI-EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHHHHS-------------------CH-HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hhhcccccc-------------------hh-hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            443321110                   00 0111223345677999999999999999999999998887754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-40  Score=361.15  Aligned_cols=278  Identities=24%  Similarity=0.390  Sum_probs=194.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecC----Cc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQE----GR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~----~~   83 (708)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++...... .......+|+.+++.++||||+++++++....    ..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            35799999999999999999999999999999998654221 22344579999999999999999999986532    24


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||+|+ |++|.+++...    .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll----~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE----CCCCCEEEeeccc
Confidence            589999999 79999988653    39999999999999999999999999999999999998    6677899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ++.....  .....||+.|+|||++..       ...++.++|||||||++|+|++|++||.   +.+..+.+..+....
T Consensus       179 a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~---~~~~~~~l~~i~~~~  246 (367)
T 2fst_X          179 ARHTADE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQLKLILRLV  246 (367)
T ss_dssp             --------------CCCTTCCHHHHTT-------CCSCCTTHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHHHHHH
T ss_pred             ccccccc--CCCcCcCcCccChHHHcC-------CcCCCchhhHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHHHh
Confidence            9865432  345689999999999872       3678999999999999999999999997   455556665554321


Q ss_pred             cC---CcccccccCCCCcccccCCCCCcc-----cCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCc
Q psy15481        244 AS---GVISGTQTSENGEIDWCTDLPNNC-----QLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHL  315 (708)
Q Consensus       244 ~~---~~i~~~~~~~~g~~~~~~~lp~~~-----~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~  315 (708)
                      ..   ..+..+...  ....+...++...     .+.+..+..+.+||.+||..||.+|||+.++           +.||
T Consensus       247 g~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~-----------L~hp  313 (367)
T 2fst_X          247 GTPGAELLKKISSE--SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA-----------LAHA  313 (367)
T ss_dssp             CSCCHHHHTTCCCH--HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH-----------HTSG
T ss_pred             CCCCHHHHHHhhhH--HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH-----------hcCh
Confidence            11   111100000  0000111111111     1122334567789999999999999999997           6789


Q ss_pred             ccCCc
Q psy15481        316 FHINR  320 (708)
Q Consensus       316 ~~~~~  320 (708)
                      |+..-
T Consensus       314 ~~~~~  318 (367)
T 2fst_X          314 YFAQY  318 (367)
T ss_dssp             GGTTT
T ss_pred             hhhhc
Confidence            88754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.8e-41  Score=366.97  Aligned_cols=274  Identities=21%  Similarity=0.277  Sum_probs=204.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC----ce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG----RG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~----~~   84 (708)
                      +.+|.+.+.||+|+||.||+|.+..+++ ||+|.+......     ..+|+.+++.++||||+++++++...+.    ..
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            4579999999999999999999987766 888877543221     1279999999999999999999865432    34


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecC-CCceEEEeccCc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDD-GSTIYKLTDFGA  163 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d-~~~~vKL~DFGl  163 (708)
                      .++||||++++.+............+++..++.++.||+.||.|||++||+||||||+|||+    + ..+.+||+|||+
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill----~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL----DPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----ETTTTEEEECCCTT
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEE----cCCCCcEEEeeCCC
Confidence            78999999765443332211111239999999999999999999999999999999999998    4 567899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      |+....+.......||+.|+|||++..       ...|+.++|||||||++|+|++|++||.   +.+..+.+..+....
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~---~~~~~~~l~~i~~~~  258 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFG-------ATNYTTNIDIWSTGCVMAELMQGQPLFP---GESGIDQLVEIIKVL  258 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHHH
T ss_pred             cccccCCCCCcccccCcCccCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHHHh
Confidence            998766666667889999999999862       3468999999999999999999999998   455555555554321


Q ss_pred             cCCc---ccc-------cccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhc
Q psy15481        244 ASGV---ISG-------TQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLV  313 (708)
Q Consensus       244 ~~~~---i~~-------~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~  313 (708)
                      ....   +..       .......+..|.      ..+++.++..+.+||.+||..||.+|||+.++           +.
T Consensus       259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~-----------l~  321 (394)
T 4e7w_A          259 GTPSREQIKTMNPNYMEHKFPQIRPHPFS------KVFRPRTPPDAIDLISRLLEYTPSARLTAIEA-----------LC  321 (394)
T ss_dssp             CCCCHHHHHHHCGGGSSSCCCCCCCCCHH------HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH-----------HT
T ss_pred             CCCCHHHHHhhChhhhhhccccccCCcHH------HhccccCCHHHHHHHHHHhCCChhhCCCHHHH-----------hc
Confidence            1000   000       000000001111      11222344567779999999999999999997           67


Q ss_pred             CcccCC
Q psy15481        314 HLFHIN  319 (708)
Q Consensus       314 h~~~~~  319 (708)
                      |||+..
T Consensus       322 hp~f~~  327 (394)
T 4e7w_A          322 HPFFDE  327 (394)
T ss_dssp             SGGGST
T ss_pred             Chhhhh
Confidence            999865

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.4e-40  Score=354.52  Aligned_cols=282  Identities=21%  Similarity=0.282  Sum_probs=201.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC-----ce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG-----RG   84 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~-----~~   84 (708)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++......  .....+++..++.++||||+++++++...+.     ..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            3699999999999999999999999999999998654322  3345578888899999999999999865332     23


Q ss_pred             EEEEEeccCCCCHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCCCcEEEEEecCC-CceEEEec
Q psy15481         85 KVIVMELCTGGSLFNILDD-PENTYGLQEEEFLLVLEHLTAGMKHLR--DNRLVHRDLKPGNIMKFICDDG-STIYKLTD  160 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~-~~~~~~L~e~~v~~il~qIl~aL~yLH--~~gIVHrDIKP~NILl~~~~d~-~~~vKL~D  160 (708)
                      .++||||+.| +|...+.. ......+++..++.++.|++.||.|||  ++||+||||||+|||+    +. .+.+||+|
T Consensus       101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll----~~~~~~~kl~D  175 (360)
T 3e3p_A          101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV----NEADGTLKLCD  175 (360)
T ss_dssp             EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEE----ETTTTEEEECC
T ss_pred             EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEE----eCCCCcEEEee
Confidence            7899999975 55443321 111233899999999999999999999  9999999999999998    43 56899999


Q ss_pred             cCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        161 FGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       161 FGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ||++.............||+.|+|||++..       ...++.++|||||||++|+|+||..||.+   .+....+..+.
T Consensus       176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~ell~g~~pf~~---~~~~~~~~~~~  245 (360)
T 3e3p_A          176 FGSAKKLSPSEPNVAYICSRYYRAPELIFG-------NQHYTTAVDIWSVGCIFAEMMLGEPIFRG---DNSAGQLHEIV  245 (360)
T ss_dssp             CTTCBCCCTTSCCCSTTSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHH
T ss_pred             CCCceecCCCCCcccccCCcceeCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCcCC---CChHHHHHHHH
Confidence            999998776666667789999999999862       35589999999999999999999999974   55555555554


Q ss_pred             hcccCC---cc-------cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        241 TKKASG---VI-------SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       241 ~~~~~~---~i-------~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ......   .+       ............|...++.   .+...+..+.+||.+||..||.+|||+.++          
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~----------  312 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD---HSLKDAKEAYDLLSALLQYLPEERMKPYEA----------  312 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTT---CCCTTHHHHHHHHHHHTCSSGGGSCCHHHH----------
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccch---hhccccHHHHHHHHHHhccCccccCCHHHH----------
Confidence            321100   00       0000011112223222222   223356678889999999999999999997          


Q ss_pred             hhcCcccCCccc
Q psy15481        311 KLVHLFHINRLQ  322 (708)
Q Consensus       311 ~l~h~~~~~~~~  322 (708)
                       +.|||+.....
T Consensus       313 -l~hp~f~~~~~  323 (360)
T 3e3p_A          313 -LCHPYFDELHD  323 (360)
T ss_dssp             -TTSGGGGGGGC
T ss_pred             -hcCccccccCC
Confidence             77999976543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=366.33  Aligned_cols=292  Identities=19%  Similarity=0.282  Sum_probs=195.8

Q ss_pred             CceEEE-eeEeecCCceEEEEEEEc--CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          9 NYVWCT-TSVLGKGATGAVFQGVNK--NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         9 n~~y~i-~~~LG~G~fG~Vy~a~~~--~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ...|.+ +++||+|+||.||+|.++  .+++.||+|++.....   .....+|+.++++++||||+++++++........
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            345666 558999999999999976  5789999999864322   3456799999999999999999999987767789


Q ss_pred             EEEEeccCCCCHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         86 VIVMELCTGGSLFNILDDP------ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~------~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      |+||||+. ++|.+++...      .....+++..++.++.||+.||.|||++||+||||||+|||+....+..+.+||+
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99999995 6888777521      1112389999999999999999999999999999999999973333556789999


Q ss_pred             ccCcccccccc----ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC-----
Q psy15481        160 DFGAARELEED----QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-----  230 (708)
Q Consensus       160 DFGlA~~~~~~----~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~-----  230 (708)
                      |||+|+.....    ......+||+.|+|||++..       ...++.++|||||||++|+|++|.+||.+....     
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTT-------CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcC-------CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            99999876543    22345689999999999872       356899999999999999999999999743211     


Q ss_pred             -ChhhHHHHHHhcc---cCCcccccccCCCCc---ccccCCCCCcccC-------ChhHHHHHHHHHHhhcccCcccCCC
Q psy15481        231 -RNKETMYYITTKK---ASGVISGTQTSENGE---IDWCTDLPNNCQL-------SLGLKKLVTPILAGLLEVDSKKIWS  296 (708)
Q Consensus       231 -~~~e~~~~i~~~~---~~~~i~~~~~~~~g~---~~~~~~lp~~~~l-------s~~l~~~l~~LL~~mL~~DP~kRps  296 (708)
                       ...+.+..+....   ...............   ..+.......+.+       .......+.+||.+||..||.+|||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence             1124444443311   111000000000000   0000000000000       0011335667999999999999999


Q ss_pred             HHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        297 FERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       297 a~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      +.++           +.|||+...+.
T Consensus       328 a~e~-----------L~hp~f~~~~~  342 (405)
T 3rgf_A          328 SEQA-----------MQDPYFLEDPL  342 (405)
T ss_dssp             HHHH-----------HTSGGGTSSSC
T ss_pred             HHHH-----------hcChhhccCCC
Confidence            9997           77999976543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.5e-40  Score=343.19  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=208.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      -..|.+.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.++++++||||+++++++.+.+  ..|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~   90 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK--RIY   90 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC--EEE
Confidence            357999999999999999999999999999999986432  1222455679999999999999999999987643  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||+++++|.+++.....   +++..++.++.|++.||.|||++|++||||||+||++    +..+.+||+|||.+..
T Consensus        91 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM----GYKGELKIADFGWSVH  163 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE----CTTCCEEECCCTTCEE
T ss_pred             EEEEeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE----cCCCCEEEeccccccc
Confidence            99999999999999876432   8999999999999999999999999999999999998    6667899999999976


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      .... ......|++.|+|||++.        +..++.++|||||||++|+|++|..||..   ....+....+.....  
T Consensus       164 ~~~~-~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~~---~~~~~~~~~~~~~~~--  229 (284)
T 2vgo_A          164 APSL-RRRTMCGTLDYLPPEMIE--------GKTHDEKVDLWCAGVLCYEFLVGMPPFDS---PSHTETHRRIVNVDL--  229 (284)
T ss_dssp             CSSS-CBCCCCSCGGGCCHHHHT--------TCCBCTTHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHTTCC--
T ss_pred             Cccc-ccccccCCCCcCCHHHhc--------cCCCCcccchhhHHHHHHHHHHCCCCCCC---CCHhHHHHHHhcccc--
Confidence            5432 234567999999999987        56789999999999999999999999973   444444444443110  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                       .+|      +.++..+.++|.+||..||.+|||+.++           +.|||+...
T Consensus       230 -----------------~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~l-----------l~h~~~~~~  269 (284)
T 2vgo_A          230 -----------------KFP------PFLSDGSKDLISKLLRYHPPQRLPLKGV-----------MEHPWVKAN  269 (284)
T ss_dssp             -----------------CCC------TTSCHHHHHHHHHHSCSSGGGSCCHHHH-----------HTCHHHHHH
T ss_pred             -----------------CCC------CcCCHHHHHHHHHHhhcCHhhCCCHHHH-----------hhCHHHHhh
Confidence                             111      2233455669999999999999999997           668888543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-40  Score=354.97  Aligned_cols=282  Identities=23%  Similarity=0.333  Sum_probs=207.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      -.+|.+.+.||+|+||.||+|.+..+|+.||+|++....... ......+|+.++++++||||+++++++...+  ..|+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l  101 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK--RWYL  101 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC--EEEE
Confidence            457999999999999999999999999999999986543322 1234568999999999999999999998654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||+.|++|..++.....   +++..+..++.||+.||.|||++||+||||||+||++    +..+.+||+|||.+...
T Consensus       102 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV----SQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEECCCTTC---
T ss_pred             EEecCCcchHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE----cCCCcEEEEeCCCceee
Confidence            9999999999888765443   9999999999999999999999999999999999998    66778999999999865


Q ss_pred             ccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 EED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ... .......||+.|+|||++..       ...++.++|||||||++|+|++|.+||..   ....+.+..+.......
T Consensus       175 ~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~---~~~~~~~~~~~~~~~~~  244 (331)
T 4aaa_A          175 AAPGEVYDDEVATRWYRAPELLVG-------DVKYGKAVDVWAIGCLVTEMFMGEPLFPG---DSDIDQLYHIMMCLGNL  244 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHHHCSC
T ss_pred             cCCccccCCCcCCccccCcccccC-------CCCcchHHHHHHHHHHHHHHHhCCCCCCC---CCcHHHHHHHHHHhCCC
Confidence            443 33445679999999999862       34689999999999999999999999973   45555555444211100


Q ss_pred             cc------cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        247 VI------SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       247 ~i------~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      .-      ........................+.++..+.++|.+||..||.+|||+.++           +.|||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el-----------l~hp~f~~~  313 (331)
T 4aaa_A          245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL-----------LHHDFFQMD  313 (331)
T ss_dssp             CHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG-----------GGSHHHHGG
T ss_pred             ChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH-----------hcCchhccC
Confidence            00      0000000000000000001111122345567789999999999999999996           779998554

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-40  Score=347.43  Aligned_cols=258  Identities=28%  Similarity=0.456  Sum_probs=208.3

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      .|....+|.+.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.++++++||||+++++++...+  
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   94 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS--   94 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC--
Confidence            45566789999999999999999999999999999999975432 233556779999999999999999999987644  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||++|++|.+.+.....   +++..++.++.||+.||.|||++|++||||||+||++ ...+....+||+|||+
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv-~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL-ESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-SCSSTTCCEEECSTTG
T ss_pred             eEEEEEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEE-ecCCCcccEEEeccCc
Confidence            59999999999999988865432   8999999999999999999999999999999999997 1122345799999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      +.............||+.|+|||.+.         ..++.++|||||||++|+|++|..||..   ....+.+..+....
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~p~~~---~~~~~~~~~~~~~~  238 (287)
T 2wei_A          171 STCFQQNTKMKDRIGTAYYIAPEVLR---------GTYDEKCDVWSAGVILYILLSGTPPFYG---KNEYDILKRVETGK  238 (287)
T ss_dssp             GGTBCCCSSCSCHHHHHTTCCHHHHT---------TCCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHCC
T ss_pred             ceeecCCCccccccCcccccChHHhc---------CCCCCchhhHhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHcCC
Confidence            98776655555567899999999885         3488999999999999999999999973   44555555554422


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHH
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFF  301 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~  301 (708)
                      ..                 ...|....+++    .+.++|.+||..||.+|||+.+++
T Consensus       239 ~~-----------------~~~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~ell  275 (287)
T 2wei_A          239 YA-----------------FDLPQWRTISD----DAKDLIRKMLTFHPSLRITATQCL  275 (287)
T ss_dssp             CC-----------------CCSGGGTTSCH----HHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CC-----------------CCchhhhhcCH----HHHHHHHHHcccChhhCcCHHHHh
Confidence            11                 01222223444    456699999999999999999973

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.2e-40  Score=342.18  Aligned_cols=260  Identities=24%  Similarity=0.355  Sum_probs=204.7

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcC---CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKN---NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~---tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      -....|.+.+.||+|+||.||+|.+..   ++..||+|.+.........+.+.+|+.++++++||||+++++++.+.   
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   85 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---   85 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS---
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---
Confidence            345689999999999999999998653   34569999987654333445667999999999999999999997643   


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||++|++|.+++.....  .+++..+..++.|++.||.|||++||+||||||+||++    +..+.+||+|||.
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV----ASPECVKLGDFGL  159 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----EETTEEEECCCCG
T ss_pred             CCEEEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE----CCCCcEEeCccCC
Confidence            36899999999999999976432  38999999999999999999999999999999999998    4556899999999


Q ss_pred             ccccccccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHH
Q psy15481        164 ARELEEDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       164 A~~~~~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~  240 (708)
                      +........  .....+++.|+|||++.        +..++.++|||||||++|+|+| |..||..   ....+....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~llt~g~~p~~~---~~~~~~~~~~~  228 (281)
T 3cc6_A          160 SRYIEDEDYYKASVTRLPIKWMSPESIN--------FRRFTTASDVWMFAVCMWEILSFGKQPFFW---LENKDVIGVLE  228 (281)
T ss_dssp             GGCC---------CCCCCGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTTCCTTTT---SCGGGHHHHHH
T ss_pred             CcccccccccccccCCCCcceeCchhhc--------cCCCCchhccHHHHHHHHHHHhCCCCCccc---CChHHHHHHHh
Confidence            987654432  23356788999999987        5678999999999999999998 9999973   33344444333


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ...                    ..+.+..++    ..+.+++.+||..||.+|||+.+++..+..++..
T Consensus       229 ~~~--------------------~~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          229 KGD--------------------RLPKPDLCP----PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             HTC--------------------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCC--------------------CCCCCCCCC----HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            211                    112222233    4466699999999999999999999998887653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.6e-40  Score=358.99  Aligned_cols=201  Identities=29%  Similarity=0.461  Sum_probs=174.5

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .+..|.+.+.||+|+||.||+|.+..+|+.||+|++...........+.+|+.++++++||||+++++++...+  ..|+
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l  108 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISI  108 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT--EEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC--EEEE
Confidence            45689999999999999999999999999999999986543333455679999999999999999999998654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ||||++|++|.+++.....   +++..+..++.+++.||.|||+. ||+||||||+|||+    +..+.+||+|||++..
T Consensus       109 v~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             EECCCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE----CTTCCEEECCCCCCHH
T ss_pred             EEECCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE----CCCCCEEEEECCCCcc
Confidence            9999999999999976433   89999999999999999999996 99999999999998    6667899999999976


Q ss_pred             ccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCC
Q psy15481        167 LEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP  226 (708)
Q Consensus       167 ~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~  226 (708)
                      .... ......||+.|+|||++.        +..++.++|||||||++|+|++|..||.+
T Consensus       182 ~~~~-~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          182 LIDS-MANSFVGTRSYMSPERLQ--------GTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             HHHH-C----CCCCTTCCHHHHT--------TCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             cccc-cccCCCCCCCeECHHHHc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            5433 334568999999999987        67789999999999999999999999974

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-39  Score=336.03  Aligned_cols=256  Identities=23%  Similarity=0.343  Sum_probs=209.0

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||+|.+. +++.||+|.+.....  ..+.+.+|+.++++++||||+++++++...+  ..++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv   81 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLV   81 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SCEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--CeEEE
Confidence            357899999999999999999986 678999999975432  2456779999999999999999999987654  48999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++|++|.+++.....  .+++..+..++.|++.||.|||++|++||||||+||++    +..+.+||+|||.+....
T Consensus        82 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili----~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV----GENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE----CGGGCEEECCTTGGGGBC
T ss_pred             EeCCCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE----CCCCCEEEcccccccccc
Confidence            999999999999976432  38999999999999999999999999999999999998    667789999999998664


Q ss_pred             ccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ...  ......+++.|+|||++.        +..++.++||||||+++|+|++ |..||.   +....+....+..... 
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~~g~~p~~---~~~~~~~~~~i~~~~~-  223 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFS--------FSRYSSKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFR-  223 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCTTT---TCCHHHHHHHHHTTCC-
T ss_pred             cccccccccccccccccChhhhc--------CCCccchhchhhhHHHHHHHhccCCCCCC---CCCHHHHHHHHhcCCc-
Confidence            432  223456788999999997        4668999999999999999999 999997   3455555555443210 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                                       ...|  ...    +..+.+++.+||..||.+|||+.++++.+..+...
T Consensus       224 -----------------~~~~--~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          224 -----------------LYKP--RLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             -----------------CCCC--TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----------------CCCC--ccC----cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                             0111  122    34466799999999999999999999999887654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3e-40  Score=344.36  Aligned_cols=265  Identities=20%  Similarity=0.274  Sum_probs=191.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHH-HHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDV-QMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~-~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...|.+.+.||+|+||.||+|.+..+|+.||+|++........... ...+...++.++||||+++++++...+  ..|+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~--~~~l   83 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG--DVWI   83 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--SEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC--CEEE
Confidence            4579999999999999999999999999999999975433222222 234445577889999999999998655  4999


Q ss_pred             EEeccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         88 VMELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ||||++ |+|.+++... .....+++..++.++.|++.||.|||++ ||+||||||+||++    +..+.+||+|||++.
T Consensus        84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI----NALGQVKMCDFGISG  158 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE----CTTCCEEBCCC----
T ss_pred             EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE----CCCCCEEEeecCCcc
Confidence            999996 5887766431 1112399999999999999999999998 99999999999998    667789999999998


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ............||+.|+|||++...    ..+..++.++|||||||++|+|+||..||...  ......+........+
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~  232 (290)
T 3fme_A          159 YLVDDVAKDIDAGCKPYMAPERINPE----LNQKGYSVKSDIWSLGITMIELAILRFPYDSW--GTPFQQLKQVVEEPSP  232 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCC----TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC--SCHHHHHHHHHHSCCC
T ss_pred             cccccccccccCCCccccChhhcChh----hcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc--CchHHHHHHHhccCCC
Confidence            77666555566899999999997311    01567899999999999999999999999742  3344444444432111


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                        ..+     ...++..+.+++.+||..||.+|||+.++           +.|||+...
T Consensus       233 ------------------~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~-----------l~hp~f~~~  273 (290)
T 3fme_A          233 ------------------QLP-----ADKFSAEFVDFTSQCLKKNSKERPTYPEL-----------MQHPFFTLH  273 (290)
T ss_dssp             ------------------CCC-----TTTSCHHHHHHHHHHTCSSGGGSCCHHHH-----------TTSHHHHHH
T ss_pred             ------------------Ccc-----cccCCHHHHHHHHHHhhcChhhCcCHHHH-----------HhCcccccC
Confidence                              111     11233456679999999999999999997           779999654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-39  Score=353.75  Aligned_cols=284  Identities=23%  Similarity=0.322  Sum_probs=208.6

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC--------CCCccceeEEEEe
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK--------HENIVKLLAIEEE   79 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~--------HpNIVkl~~v~~~   79 (708)
                      .+.+|.+.+.||+|+||.||+|.+..+|+.||||+++..  ....+...+|+.+++.++        ||||+++++++..
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            356899999999999999999999999999999998643  122345678999999985        7889999999864


Q ss_pred             c--CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCC----
Q psy15481         80 Q--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDG----  152 (708)
Q Consensus        80 ~--~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~----  152 (708)
                      .  .+..+|+||||+ +++|.+.+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||+  +.++    
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll--~~~~~~~~  188 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL--SVNEQYIR  188 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE--CCCHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE--eccchhhh
Confidence            3  445699999999 566666554432 13499999999999999999999998 99999999999998  2221    


Q ss_pred             -------------------------------------------CceEEEeccCccccccccccccccCCCCCcCChhhhh
Q psy15481        153 -------------------------------------------STIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE  189 (708)
Q Consensus       153 -------------------------------------------~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~  189 (708)
                                                                 ...+||+|||.|......  .....||+.|+|||++.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhc
Confidence                                                       137999999999875433  44568999999999998


Q ss_pred             hhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCC---hhhHHHHHHh---cccCCcc-----cccccCCCCc
Q psy15481        190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR---NKETMYYITT---KKASGVI-----SGTQTSENGE  258 (708)
Q Consensus       190 ~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~---~~e~~~~i~~---~~~~~~i-----~~~~~~~~g~  258 (708)
                              +..++.++|||||||++|+|+||..||.+..+..   ....+..+..   ..+...+     ........+.
T Consensus       267 --------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  338 (397)
T 1wak_A          267 --------GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD  338 (397)
T ss_dssp             --------TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred             --------CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence                    6779999999999999999999999998654432   2223322221   1111000     0000000010


Q ss_pred             ccccCCCC---------CcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        259 IDWCTDLP---------NNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       259 ~~~~~~lp---------~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      ........         .....+......+.+||.+||..||.+|||+.++           +.|||+.
T Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~-----------l~hp~~~  396 (397)
T 1wak_A          339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC-----------LRHPWLN  396 (397)
T ss_dssp             BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHH-----------HTSGGGG
T ss_pred             cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHH-----------hhCcccc
Confidence            00000000         0112456677788899999999999999999997           6799985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.3e-40  Score=346.95  Aligned_cols=270  Identities=23%  Similarity=0.361  Sum_probs=187.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||+|.+..+|+.||+|.+.........+.+.+|+.++++++||||+++++++...+  ..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv   91 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD--ELWLV   91 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS--CEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--CcEEE
Confidence            4579999999999999999999998999999999876544444455678999999999999999999998755  49999


Q ss_pred             EeccCCCCHHHHhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         89 MELCTGGSLFNILDD-----PENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        89 mEy~~ggsL~~~L~~-----~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      |||++|++|.+++..     ......+++..++.++.||+.||.|||++|++||||||+||++    +..+.+||+|||.
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl~dfg~  167 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL----GEDGSVQIADFGV  167 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----CTTCCEEECCCHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE----cCCCCEEEEeccc
Confidence            999999999998863     1112338999999999999999999999999999999999998    6667899999999


Q ss_pred             cccccccc------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH
Q psy15481        164 ARELEEDQ------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       164 A~~~~~~~------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~  237 (708)
                      +.......      ......||+.|+|||++..       ...++.++|||||||++|+|++|..||..   ........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~---~~~~~~~~  237 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ-------VRGYDFKADIWSFGITAIELATGAAPYHK---YPPMKVLM  237 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHH-------HHCCCTHHHHHHHHHHHHHHHHSSCTTTT---SCGGGHHH
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhcc-------ccCCCchhhHHHHHHHHHHHHhCCCCCcc---CchhhHHH
Confidence            97654332      1234579999999999873       24578999999999999999999999974   33333333


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ............+.           ....    .....+..+.+++.+||..||.+|||+.++           +.|||+
T Consensus       238 ~~~~~~~~~~~~~~-----------~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l-----------l~h~~~  291 (303)
T 2vwi_A          238 LTLQNDPPSLETGV-----------QDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAEL-----------LRHKFF  291 (303)
T ss_dssp             HHHTSSCCCTTC----------------C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHH-----------HTSTTC
T ss_pred             HHhccCCCcccccc-----------ccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHH-----------hhChhh
Confidence            33322111110000           0001    112223456679999999999999999997           679998


Q ss_pred             CCc
Q psy15481        318 INR  320 (708)
Q Consensus       318 ~~~  320 (708)
                      ...
T Consensus       292 ~~~  294 (303)
T 2vwi_A          292 QKA  294 (303)
T ss_dssp             ---
T ss_pred             hcC
Confidence            653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=353.96  Aligned_cols=267  Identities=23%  Similarity=0.342  Sum_probs=199.9

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCC--CCccceeEEEEecCCc
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKH--ENIVKLLAIEEEQEGR   83 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~H--pNIVkl~~v~~~~~~~   83 (708)
                      -.+.+|.+.+.||+|+||.||++.+ .+++.||||++...... ...+.+.+|+.++++++|  |||+++++++....  
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~--   82 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--   82 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC--
Confidence            3567899999999999999999988 46899999999754322 122456789999999976  99999999987644  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+|||+ .+++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    + .+.+||+|||+
T Consensus        83 ~~~lv~e~-~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll----~-~~~~kl~DFG~  153 (343)
T 3dbq_A           83 YIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----V-DGMLKLIDFGI  153 (343)
T ss_dssp             EEEEEECC-CSEEHHHHHHHSCC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----E-TTEEEECCCSS
T ss_pred             EEEEEEeC-CCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE----E-CCcEEEeeccc
Confidence            59999995 58999999987543   8999999999999999999999999999999999997    2 34699999999


Q ss_pred             ccccccccc---ccccCCCCCcCChhhhhhhhhcCC---CCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH
Q psy15481        164 ARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKP---VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       164 A~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~---~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~  237 (708)
                      +........   .....||+.|+|||++........   ....++.++|||||||++|+|++|+.||...  ......+.
T Consensus       154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~  231 (343)
T 3dbq_A          154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--INQISKLH  231 (343)
T ss_dssp             SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC--CSHHHHHH
T ss_pred             ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh--hhHHHHHH
Confidence            987654432   235679999999999863211100   1256899999999999999999999999742  23333344


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .+......             .    .+|.      ..+..+.+++.+||..||.+|||+.++           +.|||+
T Consensus       232 ~~~~~~~~-------------~----~~~~------~~~~~l~~li~~~L~~dp~~Rpt~~e~-----------l~hp~~  277 (343)
T 3dbq_A          232 AIIDPNHE-------------I----EFPD------IPEKDLQDVLKCCLKRDPKQRISIPEL-----------LAHPYV  277 (343)
T ss_dssp             HHHCTTSC-------------C----CCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHH-----------HTSHHH
T ss_pred             HHhcCCcc-------------c----CCcc------cCCHHHHHHHHHHcCCChhHCCCHHHH-----------HhCccc
Confidence            33321110             0    1121      112346679999999999999999997           668988


Q ss_pred             CCcc
Q psy15481        318 INRL  321 (708)
Q Consensus       318 ~~~~  321 (708)
                      ....
T Consensus       278 ~~~~  281 (343)
T 3dbq_A          278 QIQT  281 (343)
T ss_dssp             HSCC
T ss_pred             cccC
Confidence            6543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.2e-40  Score=342.05  Aligned_cols=258  Identities=22%  Similarity=0.331  Sum_probs=209.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||+|.+..++..||+|.+...  ....+.+.+|+.++++++||||+++++++.+.+  ..|+|
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~v   87 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYII   87 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SEEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--CEEEE
Confidence            45799999999999999999999999999999998743  223456679999999999999999999987654  49999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||+.|++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||++    +..+.++|+|||.+....
T Consensus        88 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE----CGGGCEEECCCCGGGTSC
T ss_pred             EEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE----cCCCCEEEccCccceecc
Confidence            999999999999976332 338999999999999999999999999999999999998    667789999999998765


Q ss_pred             ccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ...  ......+|+.|+|||.+.        +..++.++|||||||++|+|++ |.+||..   .+.......+... . 
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~ll~~g~~p~~~---~~~~~~~~~~~~~-~-  229 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLA--------YNKFSIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYELLEKD-Y-  229 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTT---CCGGGHHHHHHTT-C-
T ss_pred             CCccccccCCccccCcCChhhhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHhcc-C-
Confidence            432  223345788999999997        4678999999999999999999 9999974   3333333333321 0 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                                        ..+.+..+    +..+.+++..||..||.+|||+.++++.+..++..
T Consensus       230 ------------------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          230 ------------------RMERPEGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             ------------------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------------CCCCCCCC----CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence                              11111223    34566799999999999999999999988877654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.7e-39  Score=343.18  Aligned_cols=287  Identities=24%  Similarity=0.295  Sum_probs=214.8

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEc-CCCceEEEEEeccCCCC-CchHHHHHHHHHHHhC---CCCCccceeEEEEec--
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNK-NNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKV---KHENIVKLLAIEEEQ--   80 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~-~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL---~HpNIVkl~~v~~~~--   80 (708)
                      .+.+|.+.+.||+|+||.||+|.+. .+|+.||+|++...... .......+|+.+++.+   +||||+++++++...  
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999995 67899999998654322 2223445777777766   899999999998632  


Q ss_pred             -CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         81 -EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        81 -~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                       .....++||||+. |+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili----~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV----TSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE----cCCCCEEEe
Confidence             3456899999996 699999876432 238999999999999999999999999999999999998    666789999


Q ss_pred             ccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        160 DFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       160 DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      |||.+.............||+.|+|||++.        +..++.++|||||||++|+|++|..||.   +....+.+..+
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~---~~~~~~~~~~i  231 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLL--------QSSYATPVDLWSVGCIFAEMFRRKPLFR---GSSDVDQLGKI  231 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHH
T ss_pred             cCcccccccCCCCccccccccceeCHHHHh--------cCCCCcchhHHHHHHHHHHHHcCCCCCC---CCCHHHHHHHH
Confidence            999998776666666778999999999987        5678999999999999999999999997   35555555555


Q ss_pred             HhcccCCcccccccCC-CCccccc-CCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        240 TTKKASGVISGTQTSE-NGEIDWC-TDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~-~g~~~~~-~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ................ .....+. ...+....+.+.++..+.++|.+||..||.+|||+.++           +.|||+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~-----------l~hp~~  300 (326)
T 1blx_A          232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA-----------LSHPYF  300 (326)
T ss_dssp             HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH-----------HTSGGG
T ss_pred             HHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHH-----------hcCccc
Confidence            5321100000000000 0000000 00111112233445567779999999999999999997           679999


Q ss_pred             CCccc
Q psy15481        318 INRLQ  322 (708)
Q Consensus       318 ~~~~~  322 (708)
                      .....
T Consensus       301 ~~~~~  305 (326)
T 1blx_A          301 QDLER  305 (326)
T ss_dssp             TTCCC
T ss_pred             cccch
Confidence            76543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.6e-40  Score=347.89  Aligned_cols=262  Identities=18%  Similarity=0.307  Sum_probs=198.1

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      |..-..|.+.+.||+|+||.||+|.+..+|+.||+|++........  .+.+.+|+.++++++||||+++++++...+  
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--  107 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG--  107 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC--
Confidence            4455689999999999999999999999999999999875432221  245678999999999999999999997744  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..|+||||++|++|.+++.....   +++..++.++.|++.||.|||++||+||||||+||++    +..+.+||+|||+
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~----~~~~~~kl~Dfg~  180 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV----SADDFAYLVDFGI  180 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECSCCC
T ss_pred             eEEEEEEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE----cCCCCEEEecCcc
Confidence            59999999999999999976432   8999999999999999999999999999999999998    6667899999999


Q ss_pred             cccccccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        164 ARELEEDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       164 A~~~~~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      +.......  ......|++.|+|||++.        +..++.++|||||||++|+|++|..||..   . +...+.....
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~~---~-~~~~~~~~~~  248 (309)
T 2h34_A          181 ASATTDEKLTQLGNTVGTLYYMAPERFS--------ESHATYRADIYALTCVLYECLTGSPPYQG---D-QLSVMGAHIN  248 (309)
T ss_dssp             ----------------CCGGGCCGGGTC--------C----CCCHHHHHHHHHHHHHHSSCSSCS---C-HHHHHHHHHH
T ss_pred             CccccccccccccccCCCcCccCHHHHc--------CCCCCchHhHHHHHHHHHHHHHCCCCCCC---c-hHHHHHHHhc
Confidence            98665432  233567999999999987        56789999999999999999999999973   2 2333333332


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-CHHHHHHHHHHHHh
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-SFERFFSEVTKTLN  309 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-sa~q~~~~l~~il~  309 (708)
                      ..                     .+......+.++..+.++|.+||..||.+|| +++++...+...+.
T Consensus       249 ~~---------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          249 QA---------------------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             SC---------------------CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             cC---------------------CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            21                     1111122233344566799999999999999 89998887765543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.2e-40  Score=359.53  Aligned_cols=260  Identities=24%  Similarity=0.358  Sum_probs=198.3

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEc---CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ....|.+.+.||+|+||.||+|.+.   .++..||||.++..........+.+|+.++++++||||+++++++...+  .
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~  120 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK--P  120 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--S
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--c
Confidence            3457889999999999999999886   5678899999975443333445679999999999999999999987654  4


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||++||+|.+++.....  .+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLG  194 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECCC---
T ss_pred             eEEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE----cCCCCEEECcCccc
Confidence            8999999999999999976432  38999999999999999999999999999999999998    77778999999999


Q ss_pred             cccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHH
Q psy15481        165 RELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       165 ~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i  239 (708)
                      +.......    .....++..|+|||++.        +..++.++|||||||++|+|++ |..||..   .+..+....+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~SlG~il~ellt~g~~P~~~---~~~~~~~~~i  263 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIA--------YRKFTSASDVWSYGIVLWEVMSYGERPYWE---MSNQDVIKAV  263 (373)
T ss_dssp             -------------------CTTSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTC-CTTTT---CCHHHHHHHH
T ss_pred             cccccCCccceeccCCCcCCCccChhhhc--------cCCcCchhcHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHH
Confidence            87654322    12234577899999997        5678999999999999999998 9999973   4455544444


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ....                    ..|....    ++..+.+++..||..||.+||++.+++..++.++..
T Consensus       264 ~~~~--------------------~~~~~~~----~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          264 DEGY--------------------RLPPPMD----CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HTTE--------------------ECCCCTT----CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HcCC--------------------CCCCCcc----ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            3211                    1122222    234566799999999999999999999998887653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.5e-40  Score=349.63  Aligned_cols=263  Identities=19%  Similarity=0.312  Sum_probs=209.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc-------CCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEec
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK-------NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQ   80 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~-------~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~   80 (708)
                      ...|.+.+.||+|+||.||+|.+.       .++..||+|+++..........+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            458999999999999999999975       467889999997554333344567999999999 999999999998765


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEE
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKF  147 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~  147 (708)
                      +  ..|+||||++||+|.+++.....             ...+++..++.++.||+.||.|||++||+||||||+||++ 
T Consensus       114 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-  190 (334)
T 2pvf_A          114 G--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-  190 (334)
T ss_dssp             S--CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-
T ss_pred             C--ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE-
Confidence            4  48999999999999999986432             1238999999999999999999999999999999999998 


Q ss_pred             EecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCC
Q psy15481        148 ICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLP  223 (708)
Q Consensus       148 ~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~P  223 (708)
                         +..+.+||+|||++........   .....+|+.|+|||++.        +..++.++|||||||++|+|+| |..|
T Consensus       191 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~ellt~g~~p  259 (334)
T 2pvf_A          191 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF--------DRVYTHQSDVWSFGVLMWEIFTLGGSP  259 (334)
T ss_dssp             ---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH--------HCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhc--------CCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence               6677899999999987654322   23356788999999987        4678999999999999999999 9999


Q ss_pred             CCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        224 FRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       224 F~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                      |..   ....+....+.....                    .+.    +..++..+.+++.+||..||.+|||+.+++..
T Consensus       260 ~~~---~~~~~~~~~~~~~~~--------------------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          260 YPG---IPVEELFKLLKEGHR--------------------MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             STT---CCHHHHHHHHHHTCC--------------------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCc---CCHHHHHHHHhcCCC--------------------CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            973   444444444433210                    111    12233456679999999999999999999999


Q ss_pred             HHHHHhhhh
Q psy15481        304 VTKTLNRKL  312 (708)
Q Consensus       304 l~~il~~~l  312 (708)
                      +..++....
T Consensus       313 L~~l~~~~~  321 (334)
T 2pvf_A          313 LDRILTLTT  321 (334)
T ss_dssp             HHHHHHHHC
T ss_pred             HHHHHhccc
Confidence            998876543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.2e-40  Score=352.39  Aligned_cols=287  Identities=22%  Similarity=0.323  Sum_probs=211.4

Q ss_pred             ccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecC--
Q psy15481          4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE--   81 (708)
Q Consensus         4 l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~--   81 (708)
                      +....+..|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.++++++||||+++++++....  
T Consensus         5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A            5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE   84 (353)
T ss_dssp             CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred             cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence            345667899999999999999999999999999999999965433223345579999999999999999999876432  


Q ss_pred             -CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         82 -GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        82 -~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                       ....|+||||+. ++|.+++...    .+++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|
T Consensus        85 ~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~----~~~~~~kl~D  155 (353)
T 2b9h_A           85 NFNEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCD  155 (353)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTCCEEECC
T ss_pred             ccceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----cCCCcEEEEe
Confidence             246899999996 7999998763    28999999999999999999999999999999999998    6677899999


Q ss_pred             cCccccccccc-----------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC
Q psy15481        161 FGAARELEEDQ-----------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG  229 (708)
Q Consensus       161 FGlA~~~~~~~-----------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g  229 (708)
                      ||++.......           ......||+.|+|||++..       +..++.++|||||||++|+|++|.+||.+   
T Consensus       156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~---  225 (353)
T 2b9h_A          156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-------SAKYSRAMDVWSCGCILAELFLRRPIFPG---  225 (353)
T ss_dssp             CTTCEECC----------------CCCCCCGGGCCHHHHHS-------CCCCCHHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred             cccccccccccccccCccccccchhhccccccccCCeeecc-------CCCccchhhHHHHHHHHHHHHhCCCCCCC---
Confidence            99998654321           1223578999999999863       46789999999999999999999999974   


Q ss_pred             CChhhHHHHHHhcccCCc-ccccccCCCC-cccccCCCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        230 RRNKETMYYITTKKASGV-ISGTQTSENG-EIDWCTDLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       230 ~~~~e~~~~i~~~~~~~~-i~~~~~~~~g-~~~~~~~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      .+....+..+........ .......... ...+...++..     ....+.++..+.++|.+||..||.+|||+.++  
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el--  303 (353)
T 2b9h_A          226 RDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA--  303 (353)
T ss_dssp             SSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHH--
T ss_pred             CCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHH--
Confidence            444444443332110000 0000000000 00011111111     11122344556779999999999999999997  


Q ss_pred             HHHHHHhhhhcCcccCCc
Q psy15481        303 EVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       303 ~l~~il~~~l~h~~~~~~  320 (708)
                               +.|||+...
T Consensus       304 ---------l~hp~~~~~  312 (353)
T 2b9h_A          304 ---------LEHPYLQTY  312 (353)
T ss_dssp             ---------HTSGGGTTT
T ss_pred             ---------hcCcccccc
Confidence                     668988653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.7e-40  Score=345.96  Aligned_cols=264  Identities=21%  Similarity=0.319  Sum_probs=208.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEE-----cCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVN-----KNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEG   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~   82 (708)
                      ..+|.+.+.||+|+||.||+|.+     ..+++.||+|++...........+.+|+.+++++ +||||+++++++...+ 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-  104 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-  104 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC-
Confidence            45899999999999999999985     4578899999997654333344567999999999 7999999999987543 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEe
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFIC  149 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~  149 (708)
                      ..+++||||++||+|.+++.....             ...+++..++.++.||+.||.|||++||+||||||+||++   
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---  181 (316)
T 2xir_A          105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---  181 (316)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred             CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---
Confidence            358999999999999999987543             1127899999999999999999999999999999999998   


Q ss_pred             cCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCC
Q psy15481        150 DDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFR  225 (708)
Q Consensus       150 ~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~  225 (708)
                       +..+.+||+|||++........   .....||+.|+|||++.        +..++.++|||||||++|+|+| |..||.
T Consensus       182 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          182 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--------DRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             -CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             -CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc--------cccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence             6677899999999986644322   23356788999999997        5678999999999999999998 999997


Q ss_pred             CCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        226 PYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       226 ~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                      ..  .........+....                    ..+.....+    ..+.+++.+||..||.+|||+.+++.++.
T Consensus       253 ~~--~~~~~~~~~~~~~~--------------------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~  306 (316)
T 2xir_A          253 GV--KIDEEFCRRLKEGT--------------------RMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLG  306 (316)
T ss_dssp             TC--CCSHHHHHHHHHTC--------------------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cc--chhHHHHHHhccCc--------------------cCCCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            42  22223333333211                    111111233    34566999999999999999999999998


Q ss_pred             HHHhhh
Q psy15481        306 KTLNRK  311 (708)
Q Consensus       306 ~il~~~  311 (708)
                      .++...
T Consensus       307 ~~~~~~  312 (316)
T 2xir_A          307 NLLQAN  312 (316)
T ss_dssp             HHHHHH
T ss_pred             HHHhhh
Confidence            887643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-39  Score=339.32  Aligned_cols=261  Identities=22%  Similarity=0.341  Sum_probs=207.2

Q ss_pred             ceEEEee-EeecCCceEEEEEEEc--CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTS-VLGKGATGAVFQGVNK--NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~-~LG~G~fG~Vy~a~~~--~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|.+.+ .||+|+||.||+|.+.  .++..||+|++.........+.+.+|+.++++++||||+++++++.. +  ..+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~--~~~   85 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E--ALM   85 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S--SEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-C--CcE
Confidence            3455554 9999999999999864  46889999999865433334556799999999999999999999843 2  389


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++|++|.+++....  ..+++..++.++.|++.||.|||++||+||||||+||++    +..+.+||+|||++..
T Consensus        86 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL----VNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----EETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE----cCCCCEEECcccceee
Confidence            9999999999999996543  239999999999999999999999999999999999998    4556899999999987


Q ss_pred             cccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHh
Q psy15481        167 LEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       167 ~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      ......    .....||+.|+|||++.        +..++.++|||||||++|+|+| |..||..   ....+.+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~ellt~g~~p~~~---~~~~~~~~~i~~  228 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECIN--------FRKFSSRSDVWSYGVTMWEALSYGQKPYKK---MKGPEVMAFIEQ  228 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHH--------HCEECHHHHHHHHHHHHHHHHTTSCCTTTT---CCTHHHHHHHHT
T ss_pred             eccCcceeeccccccccccccCHHHhc--------cCCCCchhhHHHHHHHHHHHHcCCCCCccc---CCHHHHHHHHhc
Confidence            654322    22345689999999987        4678999999999999999998 9999974   444455544443


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcC
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVH  314 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h  314 (708)
                      ...                    .+    +++.++..+.+++..||..||.+||++.+++..++.++...-..
T Consensus       229 ~~~--------------------~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          229 GKR--------------------ME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             TCC--------------------CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCc--------------------CC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence            211                    11    11223345667999999999999999999999998887765443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.4e-40  Score=343.55  Aligned_cols=262  Identities=24%  Similarity=0.413  Sum_probs=194.4

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .+.+|.+.+.||+|+||.||+|.+.   ..||+|+++..... ...+.+.+|+.++++++||||++++++...   ...+
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~   95 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLA   95 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---CccE
Confidence            4568999999999999999999764   35999999754332 223456799999999999999999997543   2489


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||+.|++|.+++.....  .+++..++.++.|++.||.|||++||+||||||+||++    +..+.+||+|||++..
T Consensus        96 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~----~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL----HEDNTVKIGDFGLATE  169 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----ETTTEEEECCCC----
T ss_pred             EEEEecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE----CCCCCEEEccceeccc
Confidence            99999999999999965433  38999999999999999999999999999999999998    5567899999999986


Q ss_pred             ccc---cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        167 LEE---DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       167 ~~~---~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ...   ........||+.|+|||++...     .+..++.++|||||||++|+|++|..||..   ..+.+.+.......
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~---~~~~~~~~~~~~~~  241 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQ-----DSNPYSFQSDVYAFGIVLYELMTGQLPYSN---INNRDQIIEMVGRG  241 (289)
T ss_dssp             --------------CCCTTCCHHHHC---------CCSCHHHHHHHHHHHHHHHHHSSCTTSS---CCCHHHHHHHHHHT
T ss_pred             cccccccccccccCCCccccCchhhccc-----CCCCCCcccchHHHHHHHHHHHHCCCCccc---cchHHHHHHHhccc
Confidence            543   2233456799999999998521     145688899999999999999999999974   33333333333221


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                      .                   ..+....+...++..+.+++..||..||.+|||+.++++.+++++
T Consensus       242 ~-------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          242 S-------------------LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             S-------------------CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             c-------------------cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            1                   011112223344456777999999999999999999999887764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.4e-40  Score=385.31  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=210.7

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|.+.+.||+|+||.||+|.++.+|+.||||++++..  .....+....|..++..+ +||||+.+++++.+.+  .+|
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~--~~~  418 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLY  418 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS--EEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC--EEE
Confidence            46999999999999999999999999999999987531  122345567899999988 7999999999987644  599


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++||+|..++.....   +++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|..
T Consensus       419 lV~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl----~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML----DSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE----CSSSCEEECCCTTCEE
T ss_pred             EEEeCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE----cCCCcEEEeecceeec
Confidence            99999999999999986443   9999999999999999999999999999999999998    7777899999999986


Q ss_pred             cc-ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        167 LE-EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       167 ~~-~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      .. ........+||+.|+|||++.        +..|+.++|||||||++|||++|.+||.   +.+..+.+..+..... 
T Consensus       492 ~~~~~~~~~~~~GT~~Y~APE~l~--------~~~~~~~~DvwSlGvilyelltG~~Pf~---~~~~~~~~~~i~~~~~-  559 (674)
T 3pfq_A          492 NIWDGVTTKTFCGTPDYIAPEIIA--------YQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDELFQSIMEHNV-  559 (674)
T ss_dssp             CCCTTCCBCCCCSCSSSCCHHHHT--------CCCBSTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHSSCC-
T ss_pred             cccCCcccccccCCCcccCHhhhc--------CCCCCccceEechHHHHHHHHcCCCCCC---CCCHHHHHHHHHhCCC-
Confidence            43 334455678999999999997        6789999999999999999999999997   4566666666664311 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCH-----HHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSF-----ERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa-----~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                        .+|  ..++    ..+.+||.+||..||.+||++     +++           ..||||..
T Consensus       560 ------------------~~p--~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~ei-----------~~h~ff~~  603 (674)
T 3pfq_A          560 ------------------AYP--KSMS----KEAVAICKGLMTKHPGKRLGCGPEGERDI-----------KEHAFFRY  603 (674)
T ss_dssp             ------------------CCC--TTSC----HHHHHHHHHHSCSSSTTCTTCSTTHHHHH-----------HSSGGGSS
T ss_pred             ------------------CCC--ccCC----HHHHHHHHHHccCCHHHCCCCCCCcHHHH-----------hcCccccC
Confidence                              122  1234    445669999999999999997     554           66888854

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2e-39  Score=343.02  Aligned_cols=263  Identities=21%  Similarity=0.311  Sum_probs=198.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcC---CCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCc-
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKN---NGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR-   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~---tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~-   83 (708)
                      ...|.+.+.||+|+||.||+|.+..   ++..||+|.++..... ...+.+.+|+.++++++||||+++++++...+.. 
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            4579999999999999999998765   5668999998754322 2234567999999999999999999998765432 


Q ss_pred             --eEEEEEeccCCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEE
Q psy15481         84 --GKVIVMELCTGGSLFNILDDP---ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKL  158 (708)
Q Consensus        84 --~~~LVmEy~~ggsL~~~L~~~---~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL  158 (708)
                        ..++||||+++|+|.+++...   .....+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli----~~~~~~kl  188 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML----RDDMTVCV  188 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE----CTTSCEEE
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE----cCCCcEEE
Confidence              369999999999999988421   112349999999999999999999999999999999999998    66678999


Q ss_pred             eccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhh
Q psy15481        159 TDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKE  234 (708)
Q Consensus       159 ~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e  234 (708)
                      +|||++........   .....+++.|+|||.+.        +..++.++|||||||++|+|++ |.+||..   ....+
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~~g~~p~~~---~~~~~  257 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA--------DRVYTSKSDVWAFGVTMWEIATRGMTPYPG---VQNHE  257 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHH--------SSCCCHHHHHHHHHHHHHHHHTTSCCSSTT---CCGGG
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhc--------CCCccchhhhHHHHHHHHHHHhcCCCCCcc---CCHHH
Confidence            99999987654322   22346788999999997        6778999999999999999999 9999973   44444


Q ss_pred             HHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        235 TMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       235 ~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ....+.....                    .+.+    ..++..+.+++.+||..||.+|||+.+++..+.+++..
T Consensus       258 ~~~~~~~~~~--------------------~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          258 MYDYLLHGHR--------------------LKQP----EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             HHHHHHTTCC--------------------CCCB----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCC--------------------CCCC----ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            4444443211                    1111    22334566799999999999999999999999888653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=345.30  Aligned_cols=268  Identities=22%  Similarity=0.388  Sum_probs=204.5

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecC----C
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQE----G   82 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~----~   82 (708)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||+|++....  ...+.+.+|+.+++++ +||||+++++++....    .
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            4568999999999999999999999999999999987543  2345567999999999 8999999999997643    4


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                      ...|+||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~----~~~~~~kl~Dfg  174 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL----TENAEVKLVDFG  174 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----CTTCCEEECCCT
T ss_pred             ceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE----cCCCCEEEeeCc
Confidence            56899999999999999997642 1238999999999999999999999999999999999998    666789999999


Q ss_pred             ccccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        163 AARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       163 lA~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      ++....... ......||+.|+|||++....   ..+..++.++|||||||++|+|++|..||..   ......+..+..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~---~~~~~~~~~~~~  248 (326)
T 2x7f_A          175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEGAPPLCD---MHPMRALFLIPR  248 (326)
T ss_dssp             TTC-------------CCGGGCCHHHHC-----------CCTTHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHHHHH
T ss_pred             CceecCcCccccccccCCccccChhhhcccc---ccCcCCCccchHHHHHHHHHHHHhCCCCCCC---CcHHHHHHHhhc
Confidence            998764432 234467999999999985211   1135688999999999999999999999973   444444444433


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                      ...+                     .  ..+..++..+.++|.+||..||.+||++.++           +.|||+....
T Consensus       249 ~~~~---------------------~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l-----------l~hp~~~~~~  294 (326)
T 2x7f_A          249 NPAP---------------------R--LKSKKWSKKFQSFIESCLVKNHSQRPATEQL-----------MKHPFIRDQP  294 (326)
T ss_dssp             SCCC---------------------C--CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHH-----------HTSHHHHCCT
T ss_pred             Cccc---------------------c--CCccccCHHHHHHHHHHhccChhhCCCHHHH-----------hhChHHhhCc
Confidence            2111                     0  0112223456679999999999999999997           6799987654


Q ss_pred             c
Q psy15481        322 Q  322 (708)
Q Consensus       322 ~  322 (708)
                      .
T Consensus       295 ~  295 (326)
T 2x7f_A          295 N  295 (326)
T ss_dssp             T
T ss_pred             c
Confidence            4

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-40  Score=355.39  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=203.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEEc---CCCceEEEEEeccCCC---CCchHHHHHHHHHHHhC-CCCCccceeEEEEecCC
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSH---MRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEG   82 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~~~~~s~---~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~   82 (708)
                      ..|.+.+.||+|+||.||+|.+.   .+|+.||||+++....   ....+...+|+.+++++ +||||+++++++...+ 
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-  132 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET-  132 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc-
Confidence            58999999999999999999984   5899999999864321   12233445799999999 7999999999987654 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                       ..|+||||++|++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||
T Consensus       133 -~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~DfG  204 (355)
T 1vzo_A          133 -KLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL----DSNGHVVLTDFG  204 (355)
T ss_dssp             -EEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEESCSS
T ss_pred             -eEEEEeecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCcEEEeeCC
Confidence             59999999999999999976433   8999999999999999999999999999999999998    677789999999


Q ss_pred             ccccccccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCCh-hhHHHHH
Q psy15481        163 AARELEEDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN-KETMYYI  239 (708)
Q Consensus       163 lA~~~~~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~-~e~~~~i  239 (708)
                      +++......  .....+||+.|+|||++...      ...++.++|||||||++|+|++|..||...+.... ......+
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  278 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGG------DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI  278 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTC------C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCC------CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence            998654332  23346799999999998621      24578999999999999999999999975433222 2222222


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcC
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVH  314 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h  314 (708)
                      ...                     ..+    .+..++..+.++|.+||..||.+||     +++++           +.|
T Consensus       279 ~~~---------------------~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~el-----------l~h  322 (355)
T 1vzo_A          279 LKS---------------------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI-----------KEH  322 (355)
T ss_dssp             HHC---------------------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH-----------HTS
T ss_pred             hcc---------------------CCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHH-----------HcC
Confidence            221                     111    1223344566799999999999999     88887           668


Q ss_pred             cccCC
Q psy15481        315 LFHIN  319 (708)
Q Consensus       315 ~~~~~  319 (708)
                      ||+..
T Consensus       323 ~~f~~  327 (355)
T 1vzo_A          323 LFFQK  327 (355)
T ss_dssp             GGGTT
T ss_pred             cchhc
Confidence            88864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-40  Score=359.60  Aligned_cols=275  Identities=16%  Similarity=0.191  Sum_probs=202.6

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCC-----CceEEEEEeccCCCCCc----------hHHHHHHHHHHHhCCCCCcc
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNN-----GEPVAVKTFNQLSHMRP----------HDVQMREFEVLKKVKHENIV   71 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAIK~~~~~s~~~~----------~~~~~~Ei~iL~kL~HpNIV   71 (708)
                      .....|.+.+.||+|+||.||+|.+..+     ++.||||++........          ......|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            4556899999999999999999998765     58899999875431100          01123455566777899999


Q ss_pred             ceeEEEEecCC--ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEe
Q psy15481         72 KLLAIEEEQEG--RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFIC  149 (708)
Q Consensus        72 kl~~v~~~~~~--~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~  149 (708)
                      ++++++.....  ...|+||||+ |++|.+++....  ..+++..++.++.||+.||.|||++||+||||||+|||+  +
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill--~  186 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL--N  186 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--E
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEE--e
Confidence            99999865432  4589999999 999999997643  239999999999999999999999999999999999997  3


Q ss_pred             cCCCceEEEeccCccccccccccc--------cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCC
Q psy15481        150 DDGSTIYKLTDFGAARELEEDQQF--------MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGN  221 (708)
Q Consensus       150 ~d~~~~vKL~DFGlA~~~~~~~~~--------~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~  221 (708)
                      .+..+.+||+|||+|+........        ....||+.|+|||++.        +..++.++|||||||++|+|+||.
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~~g~  258 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN--------GVAPSRRGDLEILGYCMIQWLTGH  258 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC--------CCCCCchhhHHHHHHHHHHHHhCC
Confidence            236678999999999876544322        2345999999999987        677999999999999999999999


Q ss_pred             CCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHH
Q psy15481        222 LPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFF  301 (708)
Q Consensus       222 ~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~  301 (708)
                      .||....  .+.............. +.              .+...|.....++..+.+++..||..||.+||++.++.
T Consensus       259 ~Pf~~~~--~~~~~~~~~~~~~~~~-~~--------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~  321 (364)
T 3op5_A          259 LPWEDNL--KDPKYVRDSKIRYREN-IA--------------SLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLR  321 (364)
T ss_dssp             CTTGGGT--TCHHHHHHHHHHHHHC-HH--------------HHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred             CCccccc--cCHHHHHHHHHHhhhh-HH--------------HHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHH
Confidence            9997421  1222221111100000 00              00000000112234566799999999999999999999


Q ss_pred             HHHHHHHhhh
Q psy15481        302 SEVTKTLNRK  311 (708)
Q Consensus       302 ~~l~~il~~~  311 (708)
                      ..+.+++...
T Consensus       322 ~~l~~~~~~~  331 (364)
T 3op5_A          322 DILLQGLKAI  331 (364)
T ss_dssp             HHHHHHHHHT
T ss_pred             HHHHHHHHHc
Confidence            9888887643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-39  Score=346.44  Aligned_cols=262  Identities=24%  Similarity=0.375  Sum_probs=203.4

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCC----ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecC
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNG----EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQE   81 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg----~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~   81 (708)
                      .-....|.+.+.||+|+||.||+|.+..++    ..||+|.+...........+.+|+.++++++||||+++++++...+
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            344568999999999999999999987553    4599999975443333345679999999999999999999987644


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                        ..++||||++||+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+||
T Consensus       120 --~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~----~~~~~~kl~Df  191 (333)
T 1mqb_A          120 --PMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV----NSNLVCKVSDF  191 (333)
T ss_dssp             --SEEEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECCC
T ss_pred             --CcEEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE----CCCCcEEECCC
Confidence              49999999999999999976432  38999999999999999999999999999999999998    66778999999


Q ss_pred             Ccccccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHH
Q psy15481        162 GAARELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM  236 (708)
Q Consensus       162 GlA~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~  236 (708)
                      |++........    .....+|+.|+|||++.        +..++.++|||||||++|+|++ |..||..   ....+.+
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~ellt~g~~pf~~---~~~~~~~  260 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS--------YRKFTSASDVWSFGIVMWEVMTYGERPYWE---LSNHEVM  260 (333)
T ss_dssp             CC-----------------CCCGGGSCHHHHH--------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHH
T ss_pred             CcchhhccccccccccCCCCccccccCchhcc--------cCCCCchhhhHHHHHHHHHHHcCCCCCccc---CCHHHHH
Confidence            99987654321    12245678999999987        6778999999999999999999 9999973   4455555


Q ss_pred             HHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        237 YYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       237 ~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ..+....                    .+|....    ++..+.+++.+||..||.+||++.++++.+..++..
T Consensus       261 ~~~~~~~--------------------~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          261 KAINDGF--------------------RLPTPMD----CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             HHHHTTC--------------------CCCCCTT----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHCCC--------------------cCCCccc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            5444321                    1122222    334566799999999999999999999998887653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-39  Score=358.15  Aligned_cols=265  Identities=23%  Similarity=0.354  Sum_probs=199.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCC--CCCccceeEEEEecCCceE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVK--HENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~--HpNIVkl~~v~~~~~~~~~   85 (708)
                      +..|.+.+.||+|+||.||+|.+.. |+.||||+++..... ...+.+.+|+.++++++  ||||+++++++...+  .+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~--~~  131 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YI  131 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC--EE
Confidence            4569999999999999999999865 999999999764332 22345679999999996  599999999987654  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||| +.+++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    + .+.+||+|||++.
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----V-DGMLKLIDFGIAN  202 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE----S-SSCEEECCCSSSC
T ss_pred             EEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----E-CCeEEEEecCccc
Confidence            99999 56899999998654   38999999999999999999999999999999999997    3 2579999999998


Q ss_pred             ccccccc---ccccCCCCCcCChhhhhhhhhcC---CCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        166 ELEEDQQ---FMSLYGTEEYLHPDMYERAVLRK---PVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       166 ~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~---~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      .......   ....+||+.|+|||++.......   .....++.++|||||||++|+|++|..||...  ......+..+
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~--~~~~~~~~~~  280 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--INQISKLHAI  280 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC--CCHHHHHHHH
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh--hHHHHHHHHH
Confidence            7654432   34567999999999986311000   01246899999999999999999999999742  2333444444


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ......                 ..+|..  .    +..+.++|.+||..||.+|||+.++           +.|||+..
T Consensus       281 ~~~~~~-----------------~~~~~~--~----~~~~~~li~~~L~~dP~~Rps~~el-----------l~hp~~~~  326 (390)
T 2zmd_A          281 IDPNHE-----------------IEFPDI--P----EKDLQDVLKCCLKRDPKQRISIPEL-----------LAHPYVQI  326 (390)
T ss_dssp             HCTTSC-----------------CCCCCC--S----CHHHHHHHHHHTCSSTTTSCCHHHH-----------HTSHHHHS
T ss_pred             hCcccc-----------------CCCCcc--c----hHHHHHHHHHHcccChhhCCCHHHH-----------hhCcCccc
Confidence            421110                 011221  1    2346679999999999999999997           66888865


Q ss_pred             cc
Q psy15481        320 RL  321 (708)
Q Consensus       320 ~~  321 (708)
                      ..
T Consensus       327 ~~  328 (390)
T 2zmd_A          327 QT  328 (390)
T ss_dssp             CC
T ss_pred             cC
Confidence            43

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.6e-40  Score=347.69  Aligned_cols=260  Identities=24%  Similarity=0.369  Sum_probs=207.4

Q ss_pred             CceEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      ..+|.+.+.||+|+||.||+|.+.     .+++.||+|.++..........+.+|+.++++++||||+++++++...+  
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--  101 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ--  101 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC--
Confidence            457999999999999999999886     4678999999975443333445679999999999999999999987654  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceE
Q psy15481         84 GKVIVMELCTGGSLFNILDDPE-------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY  156 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~-------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~v  156 (708)
                      ..++||||++||+|.+++....       ....+++..++.++.||+.||.|||++||+||||||+||++    +..+.+
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli----~~~~~~  177 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFTV  177 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE----CTTCCE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE----cCCCeE
Confidence            4899999999999999886421       11237999999999999999999999999999999999998    666789


Q ss_pred             EEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCCh
Q psy15481        157 KLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRN  232 (708)
Q Consensus       157 KL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~  232 (708)
                      ||+|||++........   .....||+.|+|||++.        +..++.++|||||||++|+|+| |..||..   ...
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~~g~~p~~~---~~~  246 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK--------DGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSN  246 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHHTSCCTTTT---SCH
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhc--------cCCCCchhhHHHHHHHHHHHHhcCCCcccc---CCH
Confidence            9999999986654432   22345788999999987        4668999999999999999999 8999973   444


Q ss_pred             hhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        233 KETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       233 ~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      .+....+.....                    .+.    +..++..+.+++.+||..||.+|||+.+++..+.+.+.
T Consensus       247 ~~~~~~~~~~~~--------------------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          247 EQVLRFVMEGGL--------------------LDK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHHHTTCC--------------------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHHHcCCc--------------------CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            555444443211                    111    12233456679999999999999999999988765543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.7e-40  Score=349.22  Aligned_cols=262  Identities=21%  Similarity=0.354  Sum_probs=207.0

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCc-----eEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEG   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~-----~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~   82 (708)
                      ...|.+.+.||+|+||.||+|.+..+|.     .||+|.+.........+.+.+|+.+++++ +||||+++++++...+ 
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-  123 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG-  123 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC-
Confidence            3468999999999999999999987665     79999997654333345567999999999 8999999999987654 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPE-----------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDD  151 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~-----------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d  151 (708)
                       ..|+||||++||+|.+++....           ....+++..++.++.||+.||.|||++||+||||||+|||+    +
T Consensus       124 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~----~  198 (333)
T 2i1m_A          124 -PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL----T  198 (333)
T ss_dssp             -SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE----E
T ss_pred             -ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE----C
Confidence             4899999999999999886421           01238999999999999999999999999999999999998    5


Q ss_pred             CCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCC
Q psy15481        152 GSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPY  227 (708)
Q Consensus       152 ~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~  227 (708)
                      ..+.+||+|||++........   .....||+.|+|||++.        +..++.++|||||||++|+|+| |..||.. 
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~t~g~~p~~~-  269 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF--------DCVYTVQSDVWSYGILLWEIFSLGLNPYPG-  269 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH--------HCCCCHHHHHHHHHHHHHHHTTTSCCSSTT-
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhc--------cCCCChHHHHHHHHHHHHHHHcCCCCCCcc-
Confidence            667899999999986654432   22345788999999987        4678999999999999999999 9999974 


Q ss_pred             CCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        228 GGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       228 ~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                        ......+..+.....                   ..+.+...    +..+.+++.+||..||.+|||+.++++.+..+
T Consensus       270 --~~~~~~~~~~~~~~~-------------------~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          270 --ILVNSKFYKLVKDGY-------------------QMAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             --CCSSHHHHHHHHHTC-------------------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --cchhHHHHHHHhcCC-------------------CCCCCCCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence              333333333333211                   11111112    34566799999999999999999999988877


Q ss_pred             Hhh
Q psy15481        308 LNR  310 (708)
Q Consensus       308 l~~  310 (708)
                      ...
T Consensus       325 ~~~  327 (333)
T 2i1m_A          325 AQE  327 (333)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.5e-40  Score=341.59  Aligned_cols=259  Identities=20%  Similarity=0.322  Sum_probs=200.6

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCC-------ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNG-------EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEE   78 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg-------~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~   78 (708)
                      .-.+.+|.+.+.||+|+||.||+|.+..+|       ..||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            345678999999999999999999998877       479999986532 233456779999999999999999999997


Q ss_pred             ecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC-----
Q psy15481         79 EQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS-----  153 (708)
Q Consensus        79 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~-----  153 (708)
                      ..+  ..++||||+.||+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+  +.++.     
T Consensus        83 ~~~--~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll--~~~~~~~~~~  156 (289)
T 4fvq_A           83 CGD--ENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL--IREEDRKTGN  156 (289)
T ss_dssp             CTT--CCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--EECCBGGGTB
T ss_pred             eCC--CCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEE--ecCCcccccc
Confidence            654  48999999999999999976432  28999999999999999999999999999999999997  32322     


Q ss_pred             -ceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC-CCCCCCCCCCC
Q psy15481        154 -TIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG-NLPFRPYGGRR  231 (708)
Q Consensus       154 -~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG-~~PF~~~~g~~  231 (708)
                       +.+||+|||.+.......   ...||+.|+|||++..       ...++.++|||||||++|+|++| .+||.   +..
T Consensus       157 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~~~~~---~~~  223 (289)
T 4fvq_A          157 PPFIKLSDPGISITVLPKD---ILQERIPWVPPECIEN-------PKNLNLATDKWSFGTTLWEICSGGDKPLS---ALD  223 (289)
T ss_dssp             CCEEEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHC-------GGGCCHHHHHHHHHHHHHHHHTTTCCTTT---TSC
T ss_pred             cceeeeccCcccccccCcc---ccCCcCcccCHHHhCC-------CCCCCchhHHHHHHHHHHHHHcCCCCCcc---ccc
Confidence             239999999997654432   3457889999999972       26689999999999999999995 45554   222


Q ss_pred             hhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        232 NKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       232 ~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ..... .......                   .+|.  ..++.    +.+++.+||..||.+|||+.++++.+..++..
T Consensus       224 ~~~~~-~~~~~~~-------------------~~~~--~~~~~----l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          224 SQRKL-QFYEDRH-------------------QLPA--PKAAE----LANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHHH-HHHHTTC-------------------CCCC--CSSCT----THHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             hHHHH-HHhhccC-------------------CCCC--CCCHH----HHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            22222 2222100                   1111  12333    45699999999999999999999988766543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.9e-39  Score=336.80  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=204.4

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEec-------
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ-------   80 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~-------   80 (708)
                      .+..|.+.+.||+|+||.||+|.+..+|+.||+|.+....     +...+|+.++++++||||+++++++...       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            4567999999999999999999999999999999987532     3456899999999999999999988641       


Q ss_pred             -------CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC
Q psy15481         81 -------EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS  153 (708)
Q Consensus        81 -------~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~  153 (708)
                             ....+|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||++    +..
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~~~  158 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL----VDT  158 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EET
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE----cCC
Confidence                   23458999999999999999965321 238999999999999999999999999999999999998    555


Q ss_pred             ceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChh
Q psy15481        154 TIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNK  233 (708)
Q Consensus       154 ~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~  233 (708)
                      +.+||+|||++.............||+.|+|||++.        +..++.++|||||||++|+|++|..||..     ..
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~  225 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS--------SQDYGKEVDLYALGLILAELLHVCDTAFE-----TS  225 (284)
T ss_dssp             TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHH--------CSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HH
T ss_pred             CCEEECcchhheeccccccccccCCcccccChhhhc--------cCCCcchhhhHHHHHHHHHHHhcCCcchh-----HH
Confidence            689999999998776665556678999999999997        67789999999999999999999988841     11


Q ss_pred             hHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        234 ETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       234 e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                      .....+...                     .++  ..++    ..+.+++.+||..||.+|||+.+++..++.+.
T Consensus       226 ~~~~~~~~~---------------------~~~--~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          226 KFFTDLRDG---------------------IIS--DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHHHHHTT---------------------CCC--TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             HHHHHhhcc---------------------ccc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            112111110                     111  1123    34566999999999999999999988876553

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.7e-39  Score=340.38  Aligned_cols=257  Identities=21%  Similarity=0.348  Sum_probs=203.1

Q ss_pred             CceEEEee-EeecCCceEEEEEE--EcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          9 NYVWCTTS-VLGKGATGAVFQGV--NKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         9 n~~y~i~~-~LG~G~fG~Vy~a~--~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ..+|.+.+ .||+|+||.||+|.  +..+++.||+|+++...... ..+.+.+|+.+++.++||||+++++++..   ..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~   91 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ES   91 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---CC
Confidence            35788888 99999999999994  46678999999997653322 24556799999999999999999999843   24


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||++|++|.+++.....   +++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||++
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~----~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL----VTQHYAKISDFGLS  164 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETTEEEECCCTTC
T ss_pred             cEEEEEeCCCCCHHHHHHhCcC---CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE----eCCCcEEEccCCcc
Confidence            8999999999999999976443   8999999999999999999999999999999999998    45568999999999


Q ss_pred             ccccccccc----cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHH
Q psy15481        165 RELEEDQQF----MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       165 ~~~~~~~~~----~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i  239 (708)
                      .........    ....+++.|+|||.+.        +..++.++|||||||++|+|+| |..||..   ....+....+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~~g~~p~~~---~~~~~~~~~~  233 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECIN--------YYKFSSKSDVWSFGVLMWEAFSYGQKPYRG---MKGSEVTAML  233 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHH--------HCEEEHHHHHHHHHHHHHHHHTTTCCSSTT---CCHHHHHHHH
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhc--------cCCCChhhhHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHHH
Confidence            876544322    2245678999999997        4668899999999999999999 9999973   4444444444


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      .....                    .+    .+..++..+.+++.+||..||.+|||+.+++..+..++..
T Consensus       234 ~~~~~--------------------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          234 EKGER--------------------MG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             HTTCC--------------------CC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HcCCC--------------------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            33210                    11    1123344566799999999999999999999998887654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.6e-40  Score=342.19  Aligned_cols=260  Identities=22%  Similarity=0.393  Sum_probs=198.4

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEec--------
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ--------   80 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~--------   80 (708)
                      ...|.+.+.||+|+||.||+|.+..+|+.||+|.+....  ...+.+.+|+.++++++||||+++++++.+.        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            457999999999999999999999999999999986421  2234567899999999999999999988653        


Q ss_pred             ---CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEE
Q psy15481         81 ---EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYK  157 (708)
Q Consensus        81 ---~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vK  157 (708)
                         .....|+||||++||+|.+++....  ..+++..++.++.|++.||.|||++||+||||||+||++    +..+.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~----~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI----DESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE----cCCCCEE
Confidence               2356899999999999999997533  237899999999999999999999999999999999998    6677899


Q ss_pred             EeccCcccccccc---------------ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCC
Q psy15481        158 LTDFGAARELEED---------------QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNL  222 (708)
Q Consensus       158 L~DFGlA~~~~~~---------------~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~  222 (708)
                      |+|||.+......               .......||+.|+|||++..       ...++.++|||||||++|+|++   
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~---  226 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-------TGHYNEKIDMYSLGIIFFEMIY---  226 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTS-------CSCCCTHHHHHHHHHHHHHHHS---
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC-------CCCCcchhhHHHHHHHHHHHHh---
Confidence            9999999865422               22334679999999999862       3468999999999999999998   


Q ss_pred             CCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        223 PFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       223 PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      ||..  +.........+....               .    .+|  ..++...+..+.+++.+||..||.+|||+.++  
T Consensus       227 p~~~--~~~~~~~~~~~~~~~---------------~----~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l--  281 (303)
T 1zy4_A          227 PFST--GMERVNILKKLRSVS---------------I----EFP--PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL--  281 (303)
T ss_dssp             CCSS--HHHHHHHHHHHHSTT---------------C----CCC--TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHH--
T ss_pred             ccCC--chhHHHHHHhccccc---------------c----ccC--ccccccchHHHHHHHHHHHhcCcccCcCHHHH--
Confidence            6642  122223333222110               0    111  11333444556779999999999999999997  


Q ss_pred             HHHHHHhhhhcCcccCCc
Q psy15481        303 EVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       303 ~l~~il~~~l~h~~~~~~  320 (708)
                               +.|||+...
T Consensus       282 ---------l~h~~~~~~  290 (303)
T 1zy4_A          282 ---------LNSGWLPVK  290 (303)
T ss_dssp             ---------HHSSCSCCC
T ss_pred             ---------hCCCCcCCC
Confidence                     569999654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=341.17  Aligned_cols=265  Identities=27%  Similarity=0.417  Sum_probs=203.5

Q ss_pred             CCceEEEee-----EeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481          8 TNYVWCTTS-----VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus         8 ~n~~y~i~~-----~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      ..+.|...+     .||+|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+ 
T Consensus        15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-   92 (295)
T 2clq_A           15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-   92 (295)
T ss_dssp             CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred             ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-
Confidence            345555555     8999999999999999999999999997543 233455679999999999999999999997654 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC-CceEEEecc
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG-STIYKLTDF  161 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~-~~~vKL~DF  161 (708)
                       ..++||||++|++|.+++........+++..+..++.|++.||.|||++|++||||||+||++    +. .+.+||+||
T Consensus        93 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~~kl~Df  167 (295)
T 2clq_A           93 -FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI----NTYSGVLKISDF  167 (295)
T ss_dssp             -EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----ETTTCCEEECCT
T ss_pred             -cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEE----ECCCCCEEEeec
Confidence             599999999999999999765443447899999999999999999999999999999999997    33 567999999


Q ss_pred             Cccccccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        162 GAARELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       162 GlA~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      |.+....... ......||+.|+|||++...      ...++.++|||||||++|+|++|..||...  ......+....
T Consensus       168 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~  239 (295)
T 2clq_A          168 GTSKRLAGINPCTETFTGTLQYMAPEIIDKG------PRGYGKAADIWSLGCTIIEMATGKPPFYEL--GEPQAAMFKVG  239 (295)
T ss_dssp             TTCEESCC-----CCCCCCGGGCCHHHHHHG------GGGCSHHHHHHHHHHHHHHHHHTSCTTGGG--SSHHHHHHHHH
T ss_pred             ccccccCCCCCcccccCCCccccChhhhcCC------CCCCCcHHHHHHHHHHHHHHHHCCCCccCC--CchhHHHHhhc
Confidence            9998664432 23456799999999998742      134789999999999999999999999632  12222222221


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ...                 +...      ++..++..+.+++.+||..||++||++.++           +.|||+...
T Consensus       240 ~~~-----------------~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l-----------l~~~~~~~~  285 (295)
T 2clq_A          240 MFK-----------------VHPE------IPESMSAEAKAFILKCFEPDPDKRACANDL-----------LVDEFLKVS  285 (295)
T ss_dssp             HHC-----------------CCCC------CCTTSCHHHHHHHHHTTCSSTTTSCCHHHH-----------HTSGGGCC-
T ss_pred             ccc-----------------cccc------ccccCCHHHHHHHHHHccCChhhCCCHHHH-----------hcChhhhhc
Confidence            100                 0001      122334456679999999999999999997           679998654


Q ss_pred             c
Q psy15481        321 L  321 (708)
Q Consensus       321 ~  321 (708)
                      .
T Consensus       286 ~  286 (295)
T 2clq_A          286 S  286 (295)
T ss_dssp             -
T ss_pred             c
Confidence            3

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.6e-40  Score=344.54  Aligned_cols=285  Identities=24%  Similarity=0.321  Sum_probs=205.0

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEec-----
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ-----   80 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~-----   80 (708)
                      ...+.+|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+|+.++++++||||+++++++...     
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            345678999999999999999999999999999999987432 22234567999999999999999999987432     


Q ss_pred             -------CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC
Q psy15481         81 -------EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS  153 (708)
Q Consensus        81 -------~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~  153 (708)
                             .....|+||||+. |+|.+++...    .+++..++.++.|++.||.|||++||+||||||+||++  + ...
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~--~-~~~  157 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI--N-TED  157 (320)
T ss_dssp             C----CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE--E-TTT
T ss_pred             cccccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE--c-CCC
Confidence                   2356899999996 6999999653    28999999999999999999999999999999999997  1 234


Q ss_pred             ceEEEeccCcccccccc----ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC
Q psy15481        154 TIYKLTDFGAARELEED----QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG  229 (708)
Q Consensus       154 ~~vKL~DFGlA~~~~~~----~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g  229 (708)
                      +.+||+|||++......    .......+|+.|+|||.+..       ...++.++|||||||++|+|++|..||.   +
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~---~  227 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAEMLTGKTLFA---G  227 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC-------TTCCCHHHHHHHHHHHHHHHHHSSCSSC---C
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcC-------cccCCchhhhHhHHHHHHHHHhCCCCCC---C
Confidence            68999999999875432    12334568999999999863       3678999999999999999999999997   3


Q ss_pred             CChhhHHHHHHhcccCCcccccccCCC-Cc----ccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        230 RRNKETMYYITTKKASGVISGTQTSEN-GE----IDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       230 ~~~~e~~~~i~~~~~~~~i~~~~~~~~-g~----~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      ....+.+..+....+............ .+    ..+.........+.+.++..+.++|.+||..||.+|||+.++    
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el----  303 (320)
T 2i6l_A          228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA----  303 (320)
T ss_dssp             SSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH----
T ss_pred             CCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH----
Confidence            555555555554321100000000000 00    000000011111223345567779999999999999999997    


Q ss_pred             HHHHhhhhcCcccCCc
Q psy15481        305 TKTLNRKLVHLFHINR  320 (708)
Q Consensus       305 ~~il~~~l~h~~~~~~  320 (708)
                             +.|||+...
T Consensus       304 -------l~hp~~~~~  312 (320)
T 2i6l_A          304 -------LSHPYMSIY  312 (320)
T ss_dssp             -------HTSHHHHTT
T ss_pred             -------hCCcccccc
Confidence                   668888643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.8e-39  Score=360.57  Aligned_cols=254  Identities=23%  Similarity=0.351  Sum_probs=205.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.+.  |+.||||+++...   ..+.+.+|+.++++++||||+++++++.... ...|+||
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~iv~  266 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVT  266 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SCEEEEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-CceEEEE
Confidence            47899999999999999999875  7899999997543   3456789999999999999999999987543 2589999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+++....
T Consensus       267 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV----SEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             ECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTSCEEECCCTTCEECC-
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE----CCCCCEEEeeCCCcccccc
Confidence            99999999999976432 237999999999999999999999999999999999998    6677899999999986443


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .  .....++..|+|||++.        +..++.++|||||||++|+|+| |..||..   ....+....+....     
T Consensus       342 ~--~~~~~~~~~y~aPE~~~--------~~~~~~~sDvwslG~~l~el~t~g~~P~~~---~~~~~~~~~i~~~~-----  403 (450)
T 1k9a_A          342 T--QDTGKLPVKWTAPEALR--------EKKFSTKSDVWSFGILLWEIYSFGRVPYPR---IPLKDVVPRVEKGY-----  403 (450)
T ss_dssp             -------CCCTTTSCHHHHH--------SSCCCHHHHHHHHHHHHHHHHTTTCCSSTT---SCTTTHHHHHHTTC-----
T ss_pred             c--ccCCCCCcceeCHHHhc--------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHcCC-----
Confidence            2  22346789999999997        6779999999999999999998 9999974   33444444443211     


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                                     .++.+    ..++..+.+++.+||..||.+|||+.+++..++.+....
T Consensus       404 ---------------~~~~p----~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          404 ---------------KMDAP----DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             ---------------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ---------------CCCCC----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence                           11111    223345666999999999999999999999988876543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.4e-40  Score=347.87  Aligned_cols=272  Identities=17%  Similarity=0.211  Sum_probs=207.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||+|.+ .+|+.||+|++...........+.+|+.++++++||||+++++++...+.  .++|
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv  105 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE--RLLV  105 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC--CEEE
T ss_pred             hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCc--eEEE
Confidence            45688899999999999999985 47999999999765544444457799999999999999999999976554  8999


Q ss_pred             EeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         89 MELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDN---RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~---gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      |||+.||+|.+++.... ....+++..+..++.|++.||.|||++   ||+||||||+|||+    +..+.+||+|||++
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~----~~~~~~kl~Dfg~~  181 (326)
T 3uim_A          106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL----DEEFEAVVGDFGLA  181 (326)
T ss_dssp             EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE----CTTCCEEECCCSSC
T ss_pred             EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE----CCCCCEEeccCccc
Confidence            99999999999998643 223489999999999999999999999   99999999999998    66778999999999


Q ss_pred             ccccccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCC--CCChhhHHHHHH
Q psy15481        165 RELEEDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG--GRRNKETMYYIT  240 (708)
Q Consensus       165 ~~~~~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~--g~~~~e~~~~i~  240 (708)
                      .......  ......||+.|+|||++.        +..++.++|||||||++|+|+||..||....  ...... .....
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~  252 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLS--------TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM-LLDWV  252 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHH--------HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB-HHHHH
T ss_pred             cccCcccccccccccCCcCccCHHHhc--------cCCCCccccchhHHHHHHHHHhCCCcccccccccccchh-HHHHH
Confidence            8664332  233456999999999997        4668999999999999999999999995210  011111 11111


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                      ......          ...............++.....+.+++..||..||.+|||+.+++++++.
T Consensus       253 ~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          253 KGLLKE----------KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTTSS----------CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHhhc----------hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            110000          00000001111223456777889999999999999999999999888764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.2e-39  Score=350.63  Aligned_cols=278  Identities=25%  Similarity=0.383  Sum_probs=205.4

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCc----
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR----   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~----   83 (708)
                      +.+|.+.+.||+|+||.||+|.+..+|+.||||++....... ......+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            457899999999999999999999999999999997543221 234457999999999999999999999765431    


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|+||||+. ++|.+++..     .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll----~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE----CCCCCEEEEecCc
Confidence            2499999996 789888843     28999999999999999999999999999999999998    6677899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      +......  .....||+.|+|||++..       ...++.++|||||||++|+|++|..||.   +.+..+.+..+....
T Consensus       191 a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~---~~~~~~~~~~i~~~~  258 (371)
T 4exu_A          191 ARHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGKTLFK---GKDYLDQLTQILKVT  258 (371)
T ss_dssp             C----------CTTCCCTTSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHHHHHH
T ss_pred             ccccccC--cCCcccCccccCHHHhcC-------CCCCCcHHhHHHHHHHHHHHHhCCCCCC---CCChHHHHHHHHHHh
Confidence            9865433  345679999999999862       3678999999999999999999999997   455555555554321


Q ss_pred             cCCcccccccCCC-CcccccCCCCC-----cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        244 ASGVISGTQTSEN-GEIDWCTDLPN-----NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       244 ~~~~i~~~~~~~~-g~~~~~~~lp~-----~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ............. ....|...++.     ...+.+..+..+.+||.+||..||.+|||+.++           +.|||+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el-----------l~hp~f  327 (371)
T 4exu_A          259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA-----------LTHPFF  327 (371)
T ss_dssp             CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH-----------HTSGGG
T ss_pred             CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH-----------hcCccc
Confidence            1100000000000 00000000111     111223345567779999999999999999997           679998


Q ss_pred             CC
Q psy15481        318 IN  319 (708)
Q Consensus       318 ~~  319 (708)
                      ..
T Consensus       328 ~~  329 (371)
T 4exu_A          328 EP  329 (371)
T ss_dssp             TT
T ss_pred             cc
Confidence            65

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-39  Score=354.63  Aligned_cols=267  Identities=21%  Similarity=0.343  Sum_probs=201.8

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCC---ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNG---EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg---~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      +.....|.+.+.||+|+||.||+|.+..++   ..||+|.++..........+.+|+.++++++||||+++++++...+ 
T Consensus        85 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-  163 (373)
T 3c1x_A           85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-  163 (373)
T ss_dssp             CSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS-
T ss_pred             ChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence            345568999999999999999999876432   4689999875444444456789999999999999999999875433 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                      +..|+||||++||+|.+++.....  .+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~kL~DFG  237 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML----DEKFTVKVADFG  237 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECCC-
T ss_pred             CCeEEEEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE----CCCCCEEEeecc
Confidence            348999999999999999976443  38999999999999999999999999999999999998    677789999999


Q ss_pred             cccccccccc-----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHH
Q psy15481        163 AARELEEDQQ-----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETM  236 (708)
Q Consensus       163 lA~~~~~~~~-----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~  236 (708)
                      +++.......     .....+|+.|+|||.+.        +..++.++|||||||++|+|+| |.+||..   .+..+..
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwSlG~il~ellt~~~~p~~~---~~~~~~~  306 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQ--------TQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDIT  306 (373)
T ss_dssp             --------------------CCGGGSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCSCTT---SCSSCHH
T ss_pred             ccccccccccccccccCCCCCcccccChHHhc--------CCCCCcHHHHHHHHHHHHHHHhCcCCCCCC---CCHHHHH
Confidence            9986543321     22345788999999997        5678999999999999999999 7888863   3333444


Q ss_pred             HHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcC
Q psy15481        237 YYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVH  314 (708)
Q Consensus       237 ~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h  314 (708)
                      ..+....                    ..+.+    ..++..+.+++.+||..||.+|||+.++++.+..++..-...
T Consensus       307 ~~~~~~~--------------------~~~~p----~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          307 VYLLQGR--------------------RLLQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             HHHHTTC--------------------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             HHHHcCC--------------------CCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence            4443321                    11111    122345667999999999999999999999999887654433

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-39  Score=361.82  Aligned_cols=283  Identities=21%  Similarity=0.328  Sum_probs=207.2

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC------CCCCccceeEEEEecC
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV------KHENIVKLLAIEEEQE   81 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL------~HpNIVkl~~v~~~~~   81 (708)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||+++...  .......+|+.+++.+      +||||+.+++++...+
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            4568999999999999999999999999999999986431  2233456788888877      5779999999998754


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                        .+|+||||+. ++|.+++..... .++++..++.++.||+.||.|||++||+||||||+|||+  +.++...+||+||
T Consensus       173 --~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl--~~~~~~~vkL~DF  246 (429)
T 3kvw_A          173 --HICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL--KQQGRSGIKVIDF  246 (429)
T ss_dssp             --EEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE--SSTTSCCEEECCC
T ss_pred             --eEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE--ccCCCcceEEeec
Confidence              5999999995 799998876432 248999999999999999999999999999999999997  4444445999999


Q ss_pred             CccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        162 GAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       162 GlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      |+|.....  .....+||+.|+|||++.        +..++.++|||||||++|+|+||.+||.   +.+..+.+..+..
T Consensus       247 G~a~~~~~--~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltG~~pf~---~~~~~~~l~~i~~  313 (429)
T 3kvw_A          247 GSSCYEHQ--RVYTYIQSRFYRAPEVIL--------GARYGMPIDMWSLGCILAELLTGYPLLP---GEDEGDQLACMIE  313 (429)
T ss_dssp             TTCEETTC--CCCSSCSCGGGCCHHHHH--------TBCCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHH
T ss_pred             ccceecCC--cccccCCCCCccChHHHh--------CCCCCchHHHHhHHHHHHHHHhCCCCCC---CCCHHHHHHHHHH
Confidence            99976433  344578999999999998        6779999999999999999999999997   4555555555443


Q ss_pred             c---ccCCccccc------------------ccCCCCccccc---------CCCCCccc----CChhHHHHHHHHHHhhc
Q psy15481        242 K---KASGVISGT------------------QTSENGEIDWC---------TDLPNNCQ----LSLGLKKLVTPILAGLL  287 (708)
Q Consensus       242 ~---~~~~~i~~~------------------~~~~~g~~~~~---------~~lp~~~~----ls~~l~~~l~~LL~~mL  287 (708)
                      .   .+...+...                  .....+...+.         ...|....    +.......+.+||.+||
T Consensus       314 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L  393 (429)
T 3kvw_A          314 LLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCL  393 (429)
T ss_dssp             HHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHT
T ss_pred             HcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHC
Confidence            1   100000000                  00000000000         00000000    11112345778999999


Q ss_pred             ccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        288 EVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       288 ~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      ++||.+|||+.++           +.|||+.....
T Consensus       394 ~~dP~~Rpta~e~-----------L~Hpw~~~~~~  417 (429)
T 3kvw_A          394 EWDPAVRMTPGQA-----------LRHPWLRRRLP  417 (429)
T ss_dssp             CSSTTTSCCHHHH-----------HTSTTTC----
T ss_pred             CCChhhCCCHHHH-----------hCChhhccCCC
Confidence            9999999999997           77999987543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-39  Score=347.73  Aligned_cols=268  Identities=22%  Similarity=0.367  Sum_probs=206.0

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEE-----EcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEec
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGV-----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ   80 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~-----~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~   80 (708)
                      .-....|.+.+.||+|+||.||+|.     +..+++.||+|.+...........+.+|+.++++++||||+++++++...
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            3456789999999999999999998     55688899999997544333344567899999999999999999998765


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceE
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPEN----TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIY  156 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~----~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~v  156 (708)
                      ..  .|+||||++|++|.+++.....    ...+++..++.++.||+.||.|||++||+||||||+|||+ ..++....+
T Consensus       106 ~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli-~~~~~~~~~  182 (327)
T 2yfx_A          106 LP--RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL-TCPGPGRVA  182 (327)
T ss_dssp             SS--CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-SCSSTTCCE
T ss_pred             CC--cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEE-ecCCCcceE
Confidence            44  8999999999999999976431    1338999999999999999999999999999999999997 111234579


Q ss_pred             EEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCCh
Q psy15481        157 KLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRN  232 (708)
Q Consensus       157 KL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~  232 (708)
                      ||+|||++........   .....||+.|+|||++.        +..++.++|||||||++|+|+| |..||..   ...
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~ellt~g~~p~~~---~~~  251 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM--------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---KSN  251 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTT---CCH
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhc--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCC---cCH
Confidence            9999999986543321   22356899999999987        4668999999999999999998 9999973   444


Q ss_pred             hhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        233 KETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       233 ~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      .+.+..+.....                    .+..    ..++..+.+++.+||..||.+||++.+++..++.+....
T Consensus       252 ~~~~~~~~~~~~--------------------~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          252 QEVLEFVTSGGR--------------------MDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHHHHHHHTTCC--------------------CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHHHHHhcCCC--------------------CCCC----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            555544443211                    1111    122345667999999999999999999999988776543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.1e-39  Score=344.92  Aligned_cols=263  Identities=23%  Similarity=0.296  Sum_probs=205.4

Q ss_pred             Cce-EEEeeEeecCCceEEEEEE----EcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc
Q psy15481          9 NYV-WCTTSVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         9 n~~-y~i~~~LG~G~fG~Vy~a~----~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~   83 (708)
                      +.+ |.+.+.||+|+||.||++.    +..+|+.||+|+++..........+.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA  108 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence            444 4999999999999998775    34589999999998654333345568999999999999999999999887667


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+++||||+++|+|.+++....    +++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~----~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL----DNDRLVKIGDFGL  180 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECCGGG
T ss_pred             eEEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE----cCCCCEEECCccc
Confidence            8999999999999999997643    8999999999999999999999999999999999998    6677899999999


Q ss_pred             ccccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCC--------CC
Q psy15481        164 ARELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGG--------RR  231 (708)
Q Consensus       164 A~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g--------~~  231 (708)
                      +........    .....||+.|+|||++.        +..++.++|||||||++|+|+||..||.....        ..
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~  252 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLK--------EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ  252 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHH--------HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred             cccccccccccccccCCCCCceeeChHHhc--------CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc
Confidence            987654432    23456888999999997        56788999999999999999999999963100        00


Q ss_pred             hhh---HHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        232 NKE---TMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       232 ~~e---~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                      ...   .+......                   ....+..    ..++..+.+++.+||..||.+|||+.++++.+..+.
T Consensus       253 ~~~~~~~~~~~~~~-------------------~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          253 GQMTVLRLTELLER-------------------GERLPRP----DKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHHHHHHHHHHHHT-------------------TCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhHHHHHHHHhc-------------------ccCCCCC----ccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            000   01111110                   0011222    233345667999999999999999999999888776


Q ss_pred             hh
Q psy15481        309 NR  310 (708)
Q Consensus       309 ~~  310 (708)
                      ..
T Consensus       310 ~~  311 (318)
T 3lxp_A          310 EK  311 (318)
T ss_dssp             HH
T ss_pred             Hh
Confidence            54

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.9e-39  Score=349.44  Aligned_cols=292  Identities=22%  Similarity=0.357  Sum_probs=214.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-----------CCCccceeEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-----------HENIVKLLAIE   77 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-----------HpNIVkl~~v~   77 (708)
                      +.+|.+.+.||+|+||.||+|.+..+|+.||||++....  ...+...+|+.++++++           ||||+++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            458999999999999999999999999999999986421  22345578999999886           89999999998


Q ss_pred             EecC--CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEec--CC
Q psy15481         78 EEQE--GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICD--DG  152 (708)
Q Consensus        78 ~~~~--~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~--d~  152 (708)
                      ...+  +..+++||||+ |++|.+++..... .++++..++.++.||+.||.|||++ ||+||||||+|||+...+  +.
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence            7543  33689999999 8999999876432 2399999999999999999999998 999999999999984433  44


Q ss_pred             CceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC--
Q psy15481        153 STIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR--  230 (708)
Q Consensus       153 ~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~--  230 (708)
                      .+.+||+|||++......  .....||+.|+|||++.        +..++.++|||||||++|+|+||..||.+..+.  
T Consensus       174 ~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLL--------GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             EEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHH--------TCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             cceEEEcccccccccCCC--CCCCCCCccccCcHHHh--------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence            568999999999865433  34568999999999997        677899999999999999999999999854322  


Q ss_pred             -ChhhHHHHHHhc---ccCCcccccc-----cCCCCcc-------ccc--CCCCCcccCChhHHHHHHHHHHhhcccCcc
Q psy15481        231 -RNKETMYYITTK---KASGVISGTQ-----TSENGEI-------DWC--TDLPNNCQLSLGLKKLVTPILAGLLEVDSK  292 (708)
Q Consensus       231 -~~~e~~~~i~~~---~~~~~i~~~~-----~~~~g~~-------~~~--~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~  292 (708)
                       .....+..+...   .+........     ....+..       .|.  ..+.....++...+..+.+||.+||..||.
T Consensus       244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence             123333333321   0000000000     0000000       000  000111234567788899999999999999


Q ss_pred             cCCCHHHHHHHHHHHHhhhhcCcccCCcccccc
Q psy15481        293 KIWSFERFFSEVTKTLNRKLVHLFHINRLQCIR  325 (708)
Q Consensus       293 kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~~~  325 (708)
                      +|||+.++           +.|||+........
T Consensus       324 ~Rpt~~el-----------l~hp~f~~~~~~~~  345 (373)
T 1q8y_A          324 KRADAGGL-----------VNHPWLKDTLGMEE  345 (373)
T ss_dssp             TCBCHHHH-----------HTCGGGTTCTTCTT
T ss_pred             ccCCHHHH-----------hhChhhhcccCccc
Confidence            99999997           77999987654443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.7e-40  Score=361.04  Aligned_cols=266  Identities=14%  Similarity=0.101  Sum_probs=186.1

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhC--CCCCcccee-------E
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKV--KHENIVKLL-------A   75 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL--~HpNIVkl~-------~   75 (708)
                      .....|.+.+.||+|+||.||+|.+..+|+.||+|++.......  ..+.+.+|+.+++.|  +||||++++       +
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred             CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence            34456999999999999999999999999999999998654322  223345675444444  699987755       5


Q ss_pred             EEEecCC---------------ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHHCCC
Q psy15481         76 IEEEQEG---------------RGKVIVMELCTGGSLFNILDDPENTYGLQEEEF------LLVLEHLTAGMKHLRDNRL  134 (708)
Q Consensus        76 v~~~~~~---------------~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v------~~il~qIl~aL~yLH~~gI  134 (708)
                      ++...+.               ..+|+|||||+ |+|.+++......  +++...      ..++.||+.||.|||++||
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i  215 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--YVFRGDEGILALHILTAQLIRLAANLQSKGL  215 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--cchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence            5544332               45899999997 8999999763221  444444      5677999999999999999


Q ss_pred             cccCCCCCcEEEEEecCCCceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCC--CcCCccccchhhhh
Q psy15481        135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVG--KTFGATVDLWSIGV  212 (708)
Q Consensus       135 VHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~--~~~s~ksDIWSLGv  212 (708)
                      +||||||+|||+    +..+.+||+|||+|+......  ....+|+.|+|||++.        +  ..++.++|||||||
T Consensus       216 vHrDikp~NIll----~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~--------~~~~~~~~~~DiwSlG~  281 (371)
T 3q60_A          216 VHGHFTPDNLFI----MPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLN--------ASTATFTHALNAWQLGL  281 (371)
T ss_dssp             EETTCSGGGEEE----CTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHT--------CSEEECCHHHHHHHHHH
T ss_pred             ccCcCCHHHEEE----CCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhcc--------CCCCCcCccccHHHHHH
Confidence            999999999998    667789999999998764332  2456779999999996        4  67899999999999


Q ss_pred             HHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcc
Q psy15481        213 TLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSK  292 (708)
Q Consensus       213 iLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~  292 (708)
                      ++|+|+||+.||.........             ..........+..  ...+|....+++    .+.++|.+||..||+
T Consensus       282 il~elltg~~Pf~~~~~~~~~-------------~~~~~~~~~~~~~--~~~~~~~~~~~~----~~~~li~~~L~~dP~  342 (371)
T 3q60_A          282 SIYRVWCLFLPFGLVTPGIKG-------------SWKRPSLRVPGTD--SLAFGSCTPLPD----FVKTLIGRFLNFDRR  342 (371)
T ss_dssp             HHHHHHHSSCSTTBCCTTCTT-------------CCCBCCTTSCCCC--SCCCTTSSCCCH----HHHHHHHHHTCSSTT
T ss_pred             HHHHHHhCCCCCCCcCccccc-------------chhhhhhhhcccc--ccchhhccCCCH----HHHHHHHHHcCCChh
Confidence            999999999999743211000             0000000000111  112222233444    456699999999999


Q ss_pred             cCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        293 KIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       293 kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      +|||+.++           +.|||+..
T Consensus       343 ~Rpt~~e~-----------l~hp~f~~  358 (371)
T 3q60_A          343 RRLLPLEA-----------METPEFLQ  358 (371)
T ss_dssp             TCCCHHHH-----------TTSHHHHH
T ss_pred             hCCCHHHH-----------hcCHHHHH
Confidence            99999997           67888754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-39  Score=345.98  Aligned_cols=280  Identities=24%  Similarity=0.336  Sum_probs=209.2

Q ss_pred             CCceEEEeeEeecCCceEEEEEEE-cCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCC------CccceeEEEEec
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVN-KNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE------NIVKLLAIEEEQ   80 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~-~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~Hp------NIVkl~~v~~~~   80 (708)
                      .+.+|.+.+.||+|+||.||+|.+ ..+|+.||+|+++...  ...+...+|+.+++.++|+      +|+++++++...
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            346899999999999999999998 5689999999986431  2234567899999988665      499999998765


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCC--------
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDG--------  152 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~--------  152 (708)
                      +  ..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+  ..++        
T Consensus        90 ~--~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~--~~~~~~~~~~~~  163 (339)
T 1z57_A           90 G--HICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF--VQSDYTEAYNPK  163 (339)
T ss_dssp             T--EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--SCCCEEEEEC--
T ss_pred             C--cEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEE--eccccccccCCc
Confidence            4  599999999 8999999876432 238999999999999999999999999999999999997  2221        


Q ss_pred             ---------CceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCC
Q psy15481        153 ---------STIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP  223 (708)
Q Consensus       153 ---------~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~P  223 (708)
                               .+.+||+|||.+.....  ......||+.|+|||++.        +..++.++|||||||++|+|++|..|
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVIL--------ALGWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHT--------TSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhh--------CCCCCcchhhHHHHHHHHHHHhCCCC
Confidence                     45799999999986433  234568999999999987        67789999999999999999999999


Q ss_pred             CCCCCCCChhhHHHHH---HhcccCCcccccc---cCCCCcccccC-------------CCCCcccCChhHHHHHHHHHH
Q psy15481        224 FRPYGGRRNKETMYYI---TTKKASGVISGTQ---TSENGEIDWCT-------------DLPNNCQLSLGLKKLVTPILA  284 (708)
Q Consensus       224 F~~~~g~~~~e~~~~i---~~~~~~~~i~~~~---~~~~g~~~~~~-------------~lp~~~~ls~~l~~~l~~LL~  284 (708)
                      |..   .+..+.+..+   ....+...+....   ....+...|..             .++.........+..+.++|.
T Consensus       234 f~~---~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  310 (339)
T 1z57_A          234 FPT---HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ  310 (339)
T ss_dssp             CCC---SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCC---CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence            974   3333333222   2211111100000   00011122221             111112233455677889999


Q ss_pred             hhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        285 GLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       285 ~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      +||..||.+|||+.++           +.|||+..
T Consensus       311 ~~L~~dP~~Rpt~~el-----------l~hp~f~~  334 (339)
T 1z57_A          311 KMLEYDPAKRITLREA-----------LKHPFFDL  334 (339)
T ss_dssp             HHTCSSTTTSCCHHHH-----------TTSGGGGG
T ss_pred             HHhCcCcccccCHHHH-----------hcCHHHHH
Confidence            9999999999999997           77999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.4e-40  Score=362.70  Aligned_cols=261  Identities=15%  Similarity=0.164  Sum_probs=192.3

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHH---HHHhCCCCCcccee-------
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFE---VLKKVKHENIVKLL-------   74 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~---iL~kL~HpNIVkl~-------   74 (708)
                      .....|.+.+.||+|+||.||+|.+..+|+.||||++......  ...+.+.+|+.   ++++++||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            3467899999999999999999999999999999999754322  23455678994   55556899999998       


Q ss_pred             EEEEecCC----------c-----eEEEEEeccCCCCHHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q psy15481         75 AIEEEQEG----------R-----GKVIVMELCTGGSLFNILDDPEN----TYGLQEEEFLLVLEHLTAGMKHLRDNRLV  135 (708)
Q Consensus        75 ~v~~~~~~----------~-----~~~LVmEy~~ggsL~~~L~~~~~----~~~L~e~~v~~il~qIl~aL~yLH~~gIV  135 (708)
                      +++.+.+.          +     ..|+||||+ +|+|.+++.....    ...+++..++.++.||+.||.|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            66654421          1     278999999 6899999975321    01133588888999999999999999999


Q ss_pred             ccCCCCCcEEEEEecCCCceEEEeccCccccccccccccccCCCCCcCChhhhhhh---hhcCCCCCcCCccccchhhhh
Q psy15481        136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA---VLRKPVGKTFGATVDLWSIGV  212 (708)
Q Consensus       136 HrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~---~~~~~~~~~~s~ksDIWSLGv  212 (708)
                      ||||||+|||+    +..+.+||+|||+|+....  ......| +.|+|||++...   .........++.++|||||||
T Consensus       229 HrDikp~NIll----~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          229 HTYLRPVDIVL----DQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             CSCCCGGGEEE----CTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             cCCCCHHHEEE----cCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            99999999998    6667899999999986433  3445678 999999999842   000001127899999999999


Q ss_pred             HHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcc
Q psy15481        213 TLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSK  292 (708)
Q Consensus       213 iLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~  292 (708)
                      ++|+|+||..||...   ........+.                         +....+++    .+.++|.+||..||.
T Consensus       302 il~elltg~~Pf~~~---~~~~~~~~~~-------------------------~~~~~~~~----~~~~li~~~L~~dp~  349 (377)
T 3byv_A          302 VIYWIWCADLPITKD---AALGGSEWIF-------------------------RSCKNIPQ----PVRALLEGFLRYPKE  349 (377)
T ss_dssp             HHHHHHHSSCCC---------CCSGGGG-------------------------SSCCCCCH----HHHHHHHHHTCSSGG
T ss_pred             HHHHHHHCCCCCccc---ccccchhhhh-------------------------hhccCCCH----HHHHHHHHHcCCCch
Confidence            999999999999732   1111111110                         11122333    456699999999999


Q ss_pred             cCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        293 KIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       293 kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      +|||+.++           +.|||+.
T Consensus       350 ~Rpt~~e~-----------l~hp~f~  364 (377)
T 3byv_A          350 DRLLPLQA-----------METPEYE  364 (377)
T ss_dssp             GCCCHHHH-----------HTSHHHH
T ss_pred             hCCCHHHH-----------hhChHHH
Confidence            99999997           5577764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=340.47  Aligned_cols=263  Identities=24%  Similarity=0.402  Sum_probs=205.0

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC---CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS---HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s---~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|+++...   .......+.+|+.++++++||||+++++++........
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            457899999999999999999999999999999986532   12334556799999999999999999999866555679


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||+.++ |.+++..... ..+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||.+.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~----~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL----TTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE----cCCCcEEeecccccc
Confidence            9999999766 7676654322 349999999999999999999999999999999999998    666789999999998


Q ss_pred             cccc---cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        166 ELEE---DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       166 ~~~~---~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      ....   ........||+.|+|||++...      ...++.++|||||||++|+|++|..||.   +....+....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~---~~~~~~~~~~i~~~  228 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGL------DTFSGFKVDIWSAGVTLYNITTGLYPFE---GDNIYKLFENIGKG  228 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCC------SCEESHHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHHHHC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCc------ccCCcchhhHHHHHHHHHHHHhCCCCCC---CchHHHHHHHHhcC
Confidence            6543   2233456799999999998621      2335789999999999999999999997   34444544444432


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      ..                   .+|.  ..+    ..+.++|.+||..||.+|||+.++           +.|||+.....
T Consensus       229 ~~-------------------~~~~--~~~----~~l~~li~~~l~~dp~~Rps~~~l-----------l~~~~~~~~~~  272 (305)
T 2wtk_C          229 SY-------------------AIPG--DCG----PPLSDLLKGMLEYEPAKRFSIRQI-----------RQHSWFRKKHP  272 (305)
T ss_dssp             CC-------------------CCCS--SSC----HHHHHHHHHHTCSSTTTSCCHHHH-----------HHSHHHHSCCC
T ss_pred             CC-------------------CCCC--ccC----HHHHHHHHHHccCChhhCCCHHHH-----------hcCcccccCCC
Confidence            11                   1111  233    445669999999999999999997           55888865433

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=350.86  Aligned_cols=270  Identities=16%  Similarity=0.183  Sum_probs=204.4

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCC--------CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccc-----
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNN--------GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK-----   72 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~t--------g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVk-----   72 (708)
                      +..+..|.+.+.||+|+||.||+|.+..+        ++.||+|++...      ..+.+|+.++++++||||++     
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhh
Confidence            34567999999999999999999999874        899999998753      34568999999999999988     


Q ss_pred             ----------eeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q psy15481         73 ----------LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPG  142 (708)
Q Consensus        73 ----------l~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~  142 (708)
                                +++++... ....|+||||+ |++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus       112 ~~~~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~  188 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE  188 (352)
T ss_dssp             TTCTTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred             ccCCccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence                      55666542 34699999999 999999998642 123999999999999999999999999999999999


Q ss_pred             cEEEEEecCCCceEEEeccCccccccccccc--------cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHH
Q psy15481        143 NIMKFICDDGSTIYKLTDFGAARELEEDQQF--------MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTL  214 (708)
Q Consensus       143 NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~--------~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviL  214 (708)
                      |||+  +.++...+||+|||++.........        ....||+.|+|||++.        +..++.++|||||||++
T Consensus       189 NIl~--~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il  258 (352)
T 2jii_A          189 NIFV--DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK--------GCGPSRRSDLQSLGYCM  258 (352)
T ss_dssp             GEEE--ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT--------TCCCCHHHHHHHHHHHH
T ss_pred             HEEE--cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc--------cCCCCchhhHHHHHHHH
Confidence            9997  3333238999999999876544321        2347999999999987        66789999999999999


Q ss_pred             HHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccC
Q psy15481        215 YHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKI  294 (708)
Q Consensus       215 yeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kR  294 (708)
                      |+|++|..||....  .+...+.........           .+..+.........++    ..+.+++.+||..||.+|
T Consensus       259 ~el~~g~~pf~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~R  321 (352)
T 2jii_A          259 LKWLYGFLPWTNCL--PNTEDIMKQKQKFVD-----------KPGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEK  321 (352)
T ss_dssp             HHHHHSCCTTGGGT--TCHHHHHHHHHHHHH-----------SCCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCC
T ss_pred             HHHHhCCCCcccCC--cCHHHHHHHHHhccC-----------ChhhhhhhccccCCCc----HHHHHHHHHHHhCChhhC
Confidence            99999999997422  122222222211000           0000111111112233    456669999999999999


Q ss_pred             CCHHHHHHHHHHHHhhh
Q psy15481        295 WSFERFFSEVTKTLNRK  311 (708)
Q Consensus       295 psa~q~~~~l~~il~~~  311 (708)
                      ||+.++++.+..++...
T Consensus       322 ps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          322 PPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             CCHHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHHHHhc
Confidence            99999999998887654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.8e-39  Score=332.59  Aligned_cols=256  Identities=23%  Similarity=0.368  Sum_probs=206.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||+|.+. ++..||+|.+....  ...+.+.+|+.++++++||||+++++++...   ..++|
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~v   85 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYII   85 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC---CcEEE
Confidence            467999999999999999999975 67789999987543  2355677999999999999999999997632   38999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++|++|.+++..... ..+++..+..++.|++.||.|||++||+||||||+||++    +..+.+||+|||.+....
T Consensus        86 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV----SDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             EECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEEECCCTTCEECS
T ss_pred             EecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE----cCCCCEEECCCccccccc
Confidence            999999999999975321 138999999999999999999999999999999999998    667789999999998765


Q ss_pred             cccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ....  .....++..|+|||++.        +..++.++|||||||++|+|++ |..||.   +....+....+....  
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~~g~~p~~---~~~~~~~~~~~~~~~--  227 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAIN--------YGTFTIKSDVWSFGILLTEIVTHGRIPYP---GMTNPEVIQNLERGY--  227 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHH--------HCEECHHHHHHHHHHHHHHHHTTTCCSST---TCCHHHHHHHHHTTC--
T ss_pred             CcccccccCCCCccCccChhhhc--------cCCCCchhhhHHHHHHHHHHHhCCCCCCc---ccCHHHHHHHHhccc--
Confidence            4322  23345788999999997        4678999999999999999999 999997   344555554443211  


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                                        ..+....+    +..+.+++.+||..||.+|||++++...++.++..
T Consensus       228 ------------------~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          228 ------------------RMVRPDNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             ------------------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------------CCCCcccc----cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence                              01111123    34566799999999999999999999988877643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=343.50  Aligned_cols=262  Identities=20%  Similarity=0.352  Sum_probs=188.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEe------cC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEE------QE   81 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~------~~   81 (708)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++++. ||||+++++++..      ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            458999999999999999999999999999999985432 222344578999999995 9999999999853      23


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR--LVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g--IVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      ...+++||||+. |+|.+++........+++..++.++.||+.||.|||++|  |+||||||+|||+    +..+.+||+
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~----~~~~~~kl~  180 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL----SNQGTIKLC  180 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE----CTTSCEEBC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE----CCCCCEEEe
Confidence            446899999995 799888865222234999999999999999999999999  9999999999998    666789999


Q ss_pred             ccCccccccccccc-------------cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCC
Q psy15481        160 DFGAARELEEDQQF-------------MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP  226 (708)
Q Consensus       160 DFGlA~~~~~~~~~-------------~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~  226 (708)
                      |||++.........             ....||+.|+|||++...     .+..++.++|||||||++|+|+||..||..
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-----SNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CC-----TTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-----ccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            99999876543221             145699999999998411     156789999999999999999999999963


Q ss_pred             CCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        227 YGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       227 ~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                         ......    ....                   ...+.....++.    +.+++.+||..||.+|||+.+++..+..
T Consensus       256 ---~~~~~~----~~~~-------------------~~~~~~~~~~~~----~~~li~~~l~~~p~~Rps~~e~l~~l~~  305 (337)
T 3ll6_A          256 ---GAKLRI----VNGK-------------------YSIPPHDTQYTV----FHSLIRAMLQVNPEERLSIAEVVHQLQE  305 (337)
T ss_dssp             ------------------------------------CCCCTTCCSSGG----GHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ---hhHHHh----hcCc-------------------ccCCcccccchH----HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               111111    1100                   011222223333    4559999999999999999999999888


Q ss_pred             HHhhh
Q psy15481        307 TLNRK  311 (708)
Q Consensus       307 il~~~  311 (708)
                      +....
T Consensus       306 ~~~~~  310 (337)
T 3ll6_A          306 IAAAR  310 (337)
T ss_dssp             HHHHT
T ss_pred             HHhcc
Confidence            87543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.2e-39  Score=348.09  Aligned_cols=268  Identities=22%  Similarity=0.385  Sum_probs=180.6

Q ss_pred             CCCceEEEe-eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEec--CCc
Q psy15481          7 STNYVWCTT-SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ--EGR   83 (708)
Q Consensus         7 ~~n~~y~i~-~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~--~~~   83 (708)
                      ....+|.+. +.||+|+||.||+|.++.+|+.||+|++...     ..........++.++||||+++++++...  +..
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            445678885 4699999999999999999999999998642     22222333446677999999999998653  234


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      ..++|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ ..++..+.+||+|||+
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll-~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLY-TSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-SCSSTTCCEEECCCTT
T ss_pred             eEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-EecCCCceEEEecccc
Confidence            58999999999999999987543 349999999999999999999999999999999999997 2223356799999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      +...... ......||+.|+|||++.        +..++.++|||||||++|+|++|..||....+......+.....  
T Consensus       178 ~~~~~~~-~~~~~~~t~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--  246 (336)
T 3fhr_A          178 AKETTQN-ALQTPCYTPYYVAPEVLG--------PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR--  246 (336)
T ss_dssp             CEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             ceecccc-ccccCCCCcCccChhhhC--------CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh--
Confidence            9865433 334567899999999986        57789999999999999999999999974322111000000000  


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                  .+  .+....+.+..+++    .+.++|.+||..||.+|||+.++           +.|||+....
T Consensus       247 ------------~~--~~~~~~~~~~~~~~----~~~~li~~~L~~dP~~Rpt~~el-----------l~hp~~~~~~  295 (336)
T 3fhr_A          247 ------------LG--QYGFPNPEWSEVSE----DAKQLIRLLLKTDPTERLTITQF-----------MNHPWINQSM  295 (336)
T ss_dssp             ------------------CCCTTTSTTCCH----HHHHHHHHHSCSSGGGSCCHHHH-----------HHSHHHHTGG
T ss_pred             ------------cc--ccccCchhhccCCH----HHHHHHHHHCCCChhHCcCHHHH-----------hcCccccccc
Confidence                        00  00111122233444    45669999999999999999997           5588886543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=343.01  Aligned_cols=277  Identities=24%  Similarity=0.364  Sum_probs=204.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCC----c
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEG----R   83 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~----~   83 (708)
                      ...|.+.+.||+|+||.||+|.++.+|+.||||++....... ....+.+|+.+++.++||||+++++++...+.    .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            357999999999999999999999999999999997543221 13445789999999999999999999876543    2


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|+||||+. ++|.+++..     .+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~----~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE----CTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE----CCCCcEEEeeccc
Confidence            3699999996 688887743     28999999999999999999999999999999999998    6677899999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      +......  .....||+.|+|||++..       ...++.++|||||||++|+|++|..||.+   .+..+.+..+....
T Consensus       173 ~~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~---~~~~~~~~~i~~~~  240 (353)
T 3coi_A          173 ARHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKG---KDYLDQLTQILKVT  240 (353)
T ss_dssp             TTC----------CCSBCCSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSSCSSBS---SCHHHHHHHHHHHH
T ss_pred             ccCCCCC--ccccccCcCcCCHHHHhC-------cCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHh
Confidence            9865433  345679999999999862       36789999999999999999999999973   44455555444311


Q ss_pred             cC---CcccccccCCCCcccccCC-----CCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCc
Q psy15481        244 AS---GVISGTQTSENGEIDWCTD-----LPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHL  315 (708)
Q Consensus       244 ~~---~~i~~~~~~~~g~~~~~~~-----lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~  315 (708)
                      ..   .........  ....+...     .+....+.+..+..+.++|.+||..||.+|||+.++           +.||
T Consensus       241 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~-----------l~hp  307 (353)
T 3coi_A          241 GVPGTEFVQKLNDK--AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA-----------LTHP  307 (353)
T ss_dssp             CBCCHHHHTTCSCH--HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH-----------HTSG
T ss_pred             CCCCHHHHHHHhhH--HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH-----------hcCc
Confidence            10   000000000  00000000     011112233445567779999999999999999997           6688


Q ss_pred             ccCCc
Q psy15481        316 FHINR  320 (708)
Q Consensus       316 ~~~~~  320 (708)
                      |+..-
T Consensus       308 ~f~~~  312 (353)
T 3coi_A          308 FFEPF  312 (353)
T ss_dssp             GGTTT
T ss_pred             chhhc
Confidence            88653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=338.47  Aligned_cols=265  Identities=24%  Similarity=0.347  Sum_probs=200.8

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC--CCCCccceeEEEEecCC--c
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV--KHENIVKLLAIEEEQEG--R   83 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL--~HpNIVkl~~v~~~~~~--~   83 (708)
                      ...+|.+.+.||+|+||.||+|.+.  |+.||||++....    .....+|.+++..+  +||||+++++++.....  .
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            3468999999999999999999875  8999999986432    33344666666654  99999999999876533  5


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccCCCCCcEEEEEecCCCce
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN--------RLVHRDLKPGNIMKFICDDGSTI  155 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~--------gIVHrDIKP~NILl~~~~d~~~~  155 (708)
                      ..|+||||++||+|.+++....    +++..++.++.|++.||.|||++        ||+||||||+|||+    +..+.
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill----~~~~~  180 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV----KKNGT  180 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE----CTTSC
T ss_pred             ceEEEEeccCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE----CCCCC
Confidence            6999999999999999997642    89999999999999999999999        99999999999998    66778


Q ss_pred             EEEeccCccccccccccc-----cccCCCCCcCChhhhhhhhhcCCCCCcCCc------cccchhhhhHHHHHhcC----
Q psy15481        156 YKLTDFGAARELEEDQQF-----MSLYGTEEYLHPDMYERAVLRKPVGKTFGA------TVDLWSIGVTLYHVATG----  220 (708)
Q Consensus       156 vKL~DFGlA~~~~~~~~~-----~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~------ksDIWSLGviLyeLlTG----  220 (708)
                      +||+|||+|.........     ....||+.|+|||++.        +..++.      ++|||||||++|+|+||    
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD--------ESLNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHT--------TCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcc--------cccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            999999999765443322     2457999999999987        333333      49999999999999999    


Q ss_pred             ------CCCCCCCCC-CChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCccc
Q psy15481        221 ------NLPFRPYGG-RRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKK  293 (708)
Q Consensus       221 ------~~PF~~~~g-~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~k  293 (708)
                            ..||..... ......+........                ....+|. ...+..+...+.+++.+||..||.+
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~  315 (337)
T 3mdy_A          253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKK----------------LRPSFPN-RWSSDECLRQMGKLMTECWAHNPAS  315 (337)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----------------CCCCCCG-GGGGSHHHHHHHHHHHHHSCSSGGG
T ss_pred             cccccccccHhhhcCCCCchhhhHHHHhhhc----------------cCccccc-cchhhHHHHHHHHHHHHhhhhChhh
Confidence                  666654322 112222222221100                0001111 1112366777889999999999999


Q ss_pred             CCCHHHHHHHHHHHHhhh
Q psy15481        294 IWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       294 Rpsa~q~~~~l~~il~~~  311 (708)
                      |||+.++++++..+....
T Consensus       316 Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          316 RLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             SCCHHHHHHHHHHHHHTT
T ss_pred             CCCHHHHHHHHHHHHhhc
Confidence            999999999998887643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.3e-39  Score=337.86  Aligned_cols=267  Identities=21%  Similarity=0.278  Sum_probs=205.6

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC---CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH---MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~---~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      |...+.||+|+||.||+|.+  +|+.||+|.+.....   ....+.+.+|+.++++++||||+++++++...+  ..++|
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv  108 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD--DLCLV  108 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC--ceEEE
Confidence            44568999999999999976  588999999875432   223455679999999999999999999987654  48999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++|++|.+++........+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||++....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~kl~Dfg~~~~~~  184 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL----DEAFTAKISDFGLARASE  184 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTCCEEECCCTTCEECC
T ss_pred             EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE----cCCCcEEEeecccccccc
Confidence            9999999999999754333458999999999999999999999999999999999998    667789999999998654


Q ss_pred             ccc---cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ...   ......||+.|+|||.+.         ..++.++|||||||++|+|++|.+||...........+.........
T Consensus       185 ~~~~~~~~~~~~g~~~y~aPE~~~---------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  255 (307)
T 2nru_A          185 KFAQTVMTSRIVGTTAYMAPEALR---------GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK  255 (307)
T ss_dssp             SCSSCEECSSCCSCGGGCCHHHHT---------TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC
T ss_pred             cccccccccccCCCcCcCChHHhc---------CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh
Confidence            332   123457999999999875         34789999999999999999999999753322211111111111000


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                      .           ...|..  +.....+......+.+++.+||..||.+|||+.+++..+..+.
T Consensus       256 ~-----------~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          256 T-----------IEDYID--KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             C-----------HHHHSC--SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             h-----------hhhhcc--ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            0           001111  1112245667778889999999999999999999999887663

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2e-38  Score=334.93  Aligned_cols=264  Identities=22%  Similarity=0.331  Sum_probs=195.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC--chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR--PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~--~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ...|.+.+.||+|+||.||+|.+..+|+.||+|++.......  ....+.+|+.++++++||||+++++++...+  ..+
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~  108 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELN  108 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--cEE
Confidence            357999999999999999999999999999999997543322  2344679999999999999999999998654  599


Q ss_pred             EEEeccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         87 IVMELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      +||||+.+++|.+++.... ....+++..++.++.|++.||.|||++|++||||||+||++    +..+.+||+|||++.
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~----~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI----TATGVVKLGDLGLGR  184 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEECCC----
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE----cCCCCEEEEecccee
Confidence            9999999999999886411 11238999999999999999999999999999999999998    667789999999998


Q ss_pred             cccccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ...... ......|++.|+|||++.        +..++.++|||||||++|+|++|..||.+.. .........+.... 
T Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~-  254 (310)
T 2wqm_A          185 FFSSKTTAAHSLVGTPYYMSPERIH--------ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKIEQCD-  254 (310)
T ss_dssp             --------------CCSSCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHHSSCTTC----CCHHHHHHHHHTTC-
T ss_pred             eecCCCccccccCCCeeEeChHHhC--------CCCCCchhhHHHHHHHHHHHHhCCCCCcccc-hhHHHHHHHhhccc-
Confidence            654432 233467999999999987        5678999999999999999999999997421 12222222222211 


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                                          .+..  .+..++..+.+++.+||..||.+|||+.++++.+.++...
T Consensus       255 --------------------~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          255 --------------------YPPL--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             --------------------SCCC--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------------CCCC--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence                                0110  0122334566799999999999999999999988777543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.6e-39  Score=344.94  Aligned_cols=273  Identities=23%  Similarity=0.268  Sum_probs=204.9

Q ss_pred             ceEEEeeEeecCCceEEEEEE----EcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~----~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .+|.+.+.||+|+||.||+|.    +..+|+.||+|++.... ......+.+|+.++++++||||+++++++...+....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            589999999999999999998    56789999999987542 2223446799999999999999999999987777789


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++|++|.+++.....  .+++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|||.+.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~----~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV----ESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETTEEEECCGGGCE
T ss_pred             EEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE----CCCCCEEEcccccce
Confidence            999999999999999976322  28999999999999999999999999999999999998    556679999999998


Q ss_pred             ccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        166 ELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       166 ~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      .......    .....||+.|+|||++.        +..++.++|||||||++|+|++|..||..    ...+.......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~ll~g~~p~~~----~~~~~~~~~~~  243 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLS--------DNIFSRQSDVWSFGVVLYELFTYCDKSCS----PSAEFLRMMGC  243 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHH--------HCEEEHHHHHHHHHHHHHHHHTTTCGGGS----HHHHHHHHCC-
T ss_pred             ecccCCccceeeccCCccccccCHHHhc--------cCCCChHHhHHHHHHHHHHHHhCCCCCcc----ccchhhhhccc
Confidence            7644322    23356888899999987        56789999999999999999999999963    11111100000


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      ...........    ..+.-....+.    ++.++..+.+++.+||..||.+|||+.++++.++.+..
T Consensus       244 ~~~~~~~~~~~----~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          244 ERDVPALSRLL----ELLEEGQRLPA----PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             ---CCHHHHHH----HHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             ccccccHHHHH----HHhhcccCCCC----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            00000000000    00000001122    22334456679999999999999999999988776644

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.1e-39  Score=365.76  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=206.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.++.++..||||.++...  ...+.+.+|+.++++++||||+++++++...+  ..|+||
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~  295 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYIIT  295 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEE
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC--cEEEEE
Confidence            46899999999999999999999999999999987543  23566789999999999999999999987654  489999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+++....
T Consensus       296 E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll----~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV----GENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             ECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CGGGCEEECCTTCEECCTT
T ss_pred             EccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE----CCCCcEEEeecccceeccC
Confidence            99999999999975322 238999999999999999999999999999999999998    6677899999999987644


Q ss_pred             ccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      +..  .....++..|+|||++.        +..++.++|||||||++|+|+| |..||..   .+..+....+... .  
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDvwSlG~~l~el~t~g~~p~~~---~~~~~~~~~~~~~-~--  436 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLA--------YNKFSIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYELLEKD-Y--  436 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHH--------HCEECHHHHHHHHHHHHHHHHTTSCCSSTT---CCGGGHHHHHHTT-C--
T ss_pred             CceeecCCCcCCcceeCHhHHh--------cCCCCcHHhHHhHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHcC-C--
Confidence            321  22345678999999997        4678999999999999999999 9999974   3444444333321 0  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                       .++.+..+    +..+.+++.+||..||.+|||+.+++..++.+
T Consensus       437 -----------------~~~~~~~~----~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          437 -----------------RMERPEGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             -----------------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -----------------CCCCCCCC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence                             11111223    34566699999999999999999998876544

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.7e-39  Score=341.52  Aligned_cols=291  Identities=18%  Similarity=0.252  Sum_probs=201.7

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHH--HHhCCCCCccceeEEEEe---cCC
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEV--LKKVKHENIVKLLAIEEE---QEG   82 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~i--L~kL~HpNIVkl~~v~~~---~~~   82 (708)
                      .-..|.+.+.||+|+||.||+|.+  +|+.||||++....    ......|.++  +..++||||+++++.+..   .+.
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            345799999999999999999976  68999999986432    2333344444  445899999999986543   233


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCcccCCCCCcEEEEEecCCC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN---------RLVHRDLKPGNIMKFICDDGS  153 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~---------gIVHrDIKP~NILl~~~~d~~  153 (708)
                      ..+|+|||||+||+|.+++....    .++..+..++.||+.||.|||+.         ||+||||||+|||+    +..
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill----~~~  156 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV----KND  156 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE----CTT
T ss_pred             ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE----cCC
Confidence            45799999999999999997643    68999999999999999999999         99999999999998    666


Q ss_pred             ceEEEeccCcccccccc---------ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCC
Q psy15481        154 TIYKLTDFGAARELEED---------QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF  224 (708)
Q Consensus       154 ~~vKL~DFGlA~~~~~~---------~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF  224 (708)
                      +.+||+|||+|......         .......||+.|+|||++...... .....++.++|||||||++|+|+||..||
T Consensus       157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL-RDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCG-GGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccc-ccccccccccchHHHHHHHHHHHhcCCcC
Confidence            78999999999865432         122345799999999998731100 00145678999999999999999998777


Q ss_pred             CCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        225 RPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       225 ~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      .+..................+.. ..... ..........+|....-....+..+.++|.+||..||++|||+.++++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L  313 (336)
T 3g2f_A          236 FPGESVPEYQMAFQTEVGNHPTF-EDMQV-LVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM  313 (336)
T ss_dssp             STTSCCCCCCCTTHHHHCSSCCH-HHHHH-HHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             CCccchhHHHHhhhcccCCCchH-HHHHh-hhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence            54322111111100000000000 00000 00000111233333333445667788899999999999999999999988


Q ss_pred             HHHHhhhhcCcccCCc
Q psy15481        305 TKTLNRKLVHLFHINR  320 (708)
Q Consensus       305 ~~il~~~l~h~~~~~~  320 (708)
                      ..++     ++|..+.
T Consensus       314 ~~ll-----~~~~~~~  324 (336)
T 3g2f_A          314 AELM-----MIWERNK  324 (336)
T ss_dssp             HHHH-----HCCCC--
T ss_pred             HHHH-----HHHHhcc
Confidence            7765     5555444

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.2e-39  Score=340.75  Aligned_cols=265  Identities=19%  Similarity=0.293  Sum_probs=200.4

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEec--CCceE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ--EGRGK   85 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~--~~~~~   85 (708)
                      .+.+|.+.+.||+|+||.||++.+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++...  .....
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            3568999999999999999999999999999999986532 22344567999999999999999999998643  33468


Q ss_pred             EEEEeccCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         86 VIVMELCTGGSLFNILDDP-ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~-~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      |+||||+.+|+|.+++... .....+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||.+
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~----~~~~~~kl~dfg~~  181 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL----GDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTSCEEECCCSSC
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----cCCCCEEEEecCcc
Confidence            9999999999999988752 112238999999999999999999999999999999999998    66678999999998


Q ss_pred             ccccccc----------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhh
Q psy15481        165 RELEEDQ----------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKE  234 (708)
Q Consensus       165 ~~~~~~~----------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e  234 (708)
                      .......          ......||+.|+|||++...     ....++.++|||||||++|+|++|..||...... ...
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~  255 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ-----SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-GDS  255 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC-----SEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-TSC
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccC-----CCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-cch
Confidence            7543211          12235689999999998621     0123788999999999999999999999521000 011


Q ss_pred             HHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        235 TMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       235 ~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ....+.. .                   ..+|....++    ..+.++|.+||..||.+|||+.+++..+..+
T Consensus       256 ~~~~~~~-~-------------------~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          256 VALAVQN-Q-------------------LSIPQSPRHS----SALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             HHHHHHC-C---------------------CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             hhHHhhc-c-------------------CCCCccccCC----HHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence            1111111 0                   0223223334    4466699999999999999999998887654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.3e-39  Score=358.98  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=205.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.+. ++..||||.++...  ...+.+.+|+.++++++||||+++++++..   ...|+||
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~~~lv~  261 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIIT  261 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEE
T ss_pred             HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC---CccEEEE
Confidence            46899999999999999999985 57889999997543  235667899999999999999999999863   2489999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+++|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+++....
T Consensus       262 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV----SASLVCKIADFGLARVIED  336 (454)
T ss_dssp             CCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE----CTTCCEEECSTTGGGGBCC
T ss_pred             eecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE----CCCCcEEEeeCCCceEcCC
Confidence            99999999999975321 128999999999999999999999999999999999998    6677899999999987654


Q ss_pred             ccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ...  .....++..|+|||++.        +..++.++|||||||++|+|+| |+.||.   +.++.+....+....   
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~~l~el~t~g~~P~~---~~~~~~~~~~i~~~~---  402 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAIN--------FGSFTIKSDVWSFGILLMEIVTYGRIPYP---GMSNPEVIRALERGY---  402 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCSST---TCCHHHHHHHHHHTC---
T ss_pred             CceeccCCCcccccccCHHHhc--------cCCCCcHHHHHhHHHHHHHHHhCCCCCCC---CCCHHHHHHHHHcCC---
Confidence            322  23345678999999997        4668999999999999999999 999997   455566655554321   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                       .+|.+..++    ..+.+++.+||..||.+|||++++...++++
T Consensus       403 -----------------~~~~~~~~~----~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~  442 (454)
T 1qcf_A          403 -----------------RMPRPENCP----EELYNIMMRCWKNRPEERPTFEYIQSVLDDF  442 (454)
T ss_dssp             -----------------CCCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -----------------CCCCCCCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                             122222233    4566699999999999999999998876654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=336.59  Aligned_cols=255  Identities=26%  Similarity=0.414  Sum_probs=195.5

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ....|.+.+.||+|+||.||+|.+.  ++.||+|.+...   .....+.+|+.++++++||||+++++++.+    ..++
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~l   76 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCL   76 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEE
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEE
Confidence            3458999999999999999999874  789999998642   234566799999999999999999998753    2799


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD---NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~---~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      ||||++||+|.+++........+++..+..++.|++.||.|||+   +||+||||||+|||+  +.+ ...+||+|||++
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll--~~~-~~~~kl~Dfg~~  153 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL--VAG-GTVLKICDFGTA  153 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEE--ETT-TTEEEECCCCC-
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEE--eCC-CCEEEEcccccc
Confidence            99999999999999875543347899999999999999999999   899999999999997  222 235899999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ......  .....||+.|+|||++.        +..++.++|||||||++|+|+||+.||..... .....+..+.... 
T Consensus       154 ~~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~-  221 (307)
T 2eva_A          154 CDIQTH--MTNNKGSAAWMAPEVFE--------GSNYSEKCDVFSWGIILWEVITRRKPFDEIGG-PAFRIMWAVHNGT-  221 (307)
T ss_dssp             -------------CCTTSSCHHHHT--------CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS-SHHHHHHHHHTTC-
T ss_pred             cccccc--cccCCCCCceEChhhhC--------CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc-cHHHHHHHHhcCC-
Confidence            865432  23456999999999987        67789999999999999999999999974322 2222332222211 


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                                         ..+....++    ..+.+++.+||..||.+|||+.++++.+..+..
T Consensus       222 -------------------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          222 -------------------RPPLIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             -------------------CCCCBTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             -------------------CCCcccccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                               111112233    446679999999999999999999998877653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.4e-39  Score=345.05  Aligned_cols=272  Identities=19%  Similarity=0.300  Sum_probs=207.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch----------------HHHHHHHHHHHhCCCCCccce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH----------------DVQMREFEVLKKVKHENIVKL   73 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~----------------~~~~~Ei~iL~kL~HpNIVkl   73 (708)
                      .+|.+.+.||+|+||.||+|.+  +|+.||+|++.........                +.+.+|+.++++++||||+++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            5799999999999999999998  8999999998643221111                667899999999999999999


Q ss_pred             eEEEEecCCceEEEEEeccCCCCHHHH------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEE
Q psy15481         74 LAIEEEQEGRGKVIVMELCTGGSLFNI------LDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMK  146 (708)
Q Consensus        74 ~~v~~~~~~~~~~LVmEy~~ggsL~~~------L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl  146 (708)
                      ++++.+.+  ..|+||||++|++|.++      +.... ...+++..++.++.||+.||.|||+ +||+||||||+||++
T Consensus       109 ~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSS--EEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCC--eEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            99997654  59999999999999998      55421 2349999999999999999999999 999999999999998


Q ss_pred             EEecCCCceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCc-cccchhhhhHHHHHhcCCCCCC
Q psy15481        147 FICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGA-TVDLWSIGVTLYHVATGNLPFR  225 (708)
Q Consensus       147 ~~~~d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~-ksDIWSLGviLyeLlTG~~PF~  225 (708)
                          +..+.+||+|||.+...... ......||+.|+|||++..       +..++. ++|||||||++|+|++|..||.
T Consensus       186 ----~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~  253 (348)
T 2pml_X          186 ----DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSN-------ESSYNGAKVDIWSLGICLYVMFYNVVPFS  253 (348)
T ss_dssp             ----CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSS-------CCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ----cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcC-------CCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence                66678999999999876443 4456789999999999872       225555 9999999999999999999997


Q ss_pred             CCCCCCh-hhHHHHHHhcccCCcccccccCCCCcccccCCCCC--cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHH
Q psy15481        226 PYGGRRN-KETMYYITTKKASGVISGTQTSENGEIDWCTDLPN--NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFS  302 (708)
Q Consensus       226 ~~~g~~~-~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~--~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~  302 (708)
                      .   ... .+....+.........        ....|......  .......++..+.++|.+||..||.+|||+.++  
T Consensus       254 ~---~~~~~~~~~~i~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~--  320 (348)
T 2pml_X          254 L---KISLVELFNNIRTKNIEYPL--------DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA--  320 (348)
T ss_dssp             C---SSCSHHHHHHHTSCCCCCCC--------SSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHH--
T ss_pred             C---CCcHHHHHHHHhccCcCCcc--------chhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHH--
Confidence            4   233 4444444432111000        00000000000  011113344556779999999999999999997  


Q ss_pred             HHHHHHhhhhcCcccCCc
Q psy15481        303 EVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       303 ~l~~il~~~l~h~~~~~~  320 (708)
                               +.|||+...
T Consensus       321 ---------l~hp~f~~~  329 (348)
T 2pml_X          321 ---------LKHEWLADT  329 (348)
T ss_dssp             ---------HTSGGGTTC
T ss_pred             ---------hcCccccCC
Confidence                     679999654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4e-39  Score=334.93  Aligned_cols=255  Identities=23%  Similarity=0.348  Sum_probs=196.7

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|.+.+.||+|+||.||++.+.  |+.||+|+++...   ..+.+.+|+.++++++||||+++++++.... +..|+|
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv   93 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIV   93 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-CceEEE
Confidence            357999999999999999999874  8899999987432   3456779999999999999999999875433 358999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||++|++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||++    +..+.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV----SEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTSCEEECCCCC-----
T ss_pred             EecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE----eCCCcEEEeecccccccc
Confidence            999999999999875321 127899999999999999999999999999999999998    666789999999998654


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..  .....+++.|+|||.+.        +..++.++|||||||++|+|+| |..||..   ....+....+....    
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~t~g~~p~~~---~~~~~~~~~~~~~~----  231 (278)
T 1byg_A          169 ST--QDTGKLPVKWTAPEALR--------EKKFSTKSDVWSFGILLWEIYSFGRVPYPR---IPLKDVVPRVEKGY----  231 (278)
T ss_dssp             ---------CCTTTSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCSCTT---SCGGGHHHHHTTTC----
T ss_pred             cc--ccCCCccccccCHHHhC--------CCCCCchhcHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHhcCC----
Confidence            33  23446889999999987        4678999999999999999998 9999973   33334333333210    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                                      ..+.    +..++..+.+++.+||..||.+|||+.++++.++.+....
T Consensus       232 ----------------~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          232 ----------------KMDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             ----------------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----------------CCCC----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence                            0111    1223345667999999999999999999999988876543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.7e-39  Score=345.70  Aligned_cols=266  Identities=15%  Similarity=0.167  Sum_probs=197.1

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcC---CCceEEEEEeccCCCCCc----------hHHHHHHHHHHHhCCCCCccce
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKN---NGEPVAVKTFNQLSHMRP----------HDVQMREFEVLKKVKHENIVKL   73 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~---tg~~VAIK~~~~~s~~~~----------~~~~~~Ei~iL~kL~HpNIVkl   73 (708)
                      ..+.+|.+.+.||+|+||.||+|.+..   ++..||+|++........          .....+|+..++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            456789999999999999999999987   888999999875432110          1123578888999999999999


Q ss_pred             eEEEEec--CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecC
Q psy15481         74 LAIEEEQ--EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDD  151 (708)
Q Consensus        74 ~~v~~~~--~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d  151 (708)
                      ++++...  +....|+||||+ |++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+  +.+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--~~~  187 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL--GYK  187 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--ESS
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEE--ccC
Confidence            9998763  245699999999 999999997654   39999999999999999999999999999999999997  444


Q ss_pred             CCceEEEeccCcccccccccc--------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCC
Q psy15481        152 GSTIYKLTDFGAARELEEDQQ--------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLP  223 (708)
Q Consensus       152 ~~~~vKL~DFGlA~~~~~~~~--------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~P  223 (708)
                      +.+.+||+|||+|+....+..        .....||+.|+|||++.        +..++.++|||||||++|+|+||..|
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~ell~g~~p  259 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK--------GVALSRRSDVEILGYCMLRWLCGKLP  259 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH--------TCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhc--------CCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            444899999999987644321        13457999999999987        67789999999999999999999999


Q ss_pred             CCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcc---cCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        224 FRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNC---QLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       224 F~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~---~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      |...  ..+.............                  .+|...   .-+..++..+.+++..||..||.+|||+.++
T Consensus       260 f~~~--~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  319 (345)
T 2v62_A          260 WEQN--LKDPVAVQTAKTNLLD------------------ELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQAL  319 (345)
T ss_dssp             TGGG--TTCHHHHHHHHHHHHH------------------TTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             cccc--ccccHHHHHHHHhhcc------------------cccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHH
Confidence            9631  1222222222211000                  111100   0001233456669999999999999999998


Q ss_pred             HHHHHH
Q psy15481        301 FSEVTK  306 (708)
Q Consensus       301 ~~~l~~  306 (708)
                      ++.+..
T Consensus       320 ~~~L~~  325 (345)
T 2v62_A          320 KKILNP  325 (345)
T ss_dssp             HHHHCT
T ss_pred             HHHHhc
Confidence            876543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.9e-39  Score=342.42  Aligned_cols=294  Identities=21%  Similarity=0.311  Sum_probs=187.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHH-HHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFE-VLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~-iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...|.+.+.||+|+||.||+|.+..+|+.||||++..............|+. +++.++||||+++++++...+  ..++
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~--~~~l   98 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG--DCWI   98 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS--EEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC--ceEE
Confidence            3578899999999999999999999999999999976533222233445655 677789999999999998654  5999


Q ss_pred             EEeccCCCCHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         88 VMELCTGGSLFNILDDP--ENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~--~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      ||||+. ++|.+++...  .....+++..+..++.|++.||.|||++ ||+||||||+||++    +..+.+||+|||++
T Consensus        99 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           99 CMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL----DRSGNIKLCDFGIS  173 (327)
T ss_dssp             EECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE----ETTTEEEECCCSSS
T ss_pred             EEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE----cCCCCEEEccCCCc
Confidence            999996 5887776520  0112389999999999999999999999 99999999999998    56678999999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .............||+.|+|||++....    .+..++.++|||||||++|+|++|..||.....  ..+.+..+..   
T Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~---  244 (327)
T 3aln_A          174 GQLVDSIAKTRDAGCRPYMAPERIDPSA----SRQGYDVRSDVWSLGITLYELATGRFPYPKWNS--VFDQLTQVVK---  244 (327)
T ss_dssp             CC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCC---
T ss_pred             eecccccccccCCCCccccCceeecccc----CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch--HHHHHHHHhc---
Confidence            8776555555567999999999984211    145689999999999999999999999974221  1111111110   


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccccc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQCI  324 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~~  324 (708)
                           +      ...    .++.  .....++..+.+++.+||..||.+|||+.++           +.|||+.....  
T Consensus       245 -----~------~~~----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el-----------l~hp~~~~~~~--  294 (327)
T 3aln_A          245 -----G------DPP----QLSN--SEEREFSPSFINFVNLCLTKDESKRPKYKEL-----------LKHPFILMYEE--  294 (327)
T ss_dssp             -----S------CCC----CCCC--CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHH-----------TTSHHHHHHHH--
T ss_pred             -----C------CCC----CCCC--cccccCCHHHHHHHHHHhhCChhhCcCHHHH-----------HhChHHHHhHh--
Confidence                 0      000    0111  0112233456679999999999999999997           67888854322  


Q ss_pred             ccccCCcccHHHHHHHHHhhcCCCccce
Q psy15481        325 RIYLHPDDAYDQLQDLIQEQTDVTPNKQ  352 (708)
Q Consensus       325 ~~~i~~~e~~~~l~~~i~~~t~i~~~~q  352 (708)
                          ...+....+...+......+...+
T Consensus       295 ----~~~~~~~~~~~~~~~~~~~~~~~~  318 (327)
T 3aln_A          295 ----RAVEVACYVCKILDQMPATPSSPM  318 (327)
T ss_dssp             ----SCCCHHHHHHHHHHHC--------
T ss_pred             ----hHHHHHHHHHHHHhcCCCCCCCCc
Confidence                222345556666666555444444

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=342.27  Aligned_cols=256  Identities=16%  Similarity=0.210  Sum_probs=196.5

Q ss_pred             CceEEEeeEeecCCceEEEEE-----EEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC---CCCccceeEEEEec
Q psy15481          9 NYVWCTTSVLGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK---HENIVKLLAIEEEQ   80 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a-----~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~---HpNIVkl~~v~~~~   80 (708)
                      +..|.+.+.||+|+||.||+|     .+..+++.||+|++...    ....+.+|+.+++.++   |+||+.+++++...
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            567999999999999999999     46778999999998643    2445668888888886   99999999999876


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEe-------cC
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDP--ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFIC-------DD  151 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~--~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~-------~d  151 (708)
                      +.  .|+|||||+||+|.+++...  .....+++..++.++.||+.||.|||++|||||||||+|||+...       ++
T Consensus       140 ~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          140 NG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             SC--EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             CC--cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence            54  89999999999999999641  112339999999999999999999999999999999999998110       11


Q ss_pred             CCceEEEeccCcccccc---ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCC
Q psy15481        152 GSTIYKLTDFGAARELE---EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYG  228 (708)
Q Consensus       152 ~~~~vKL~DFGlA~~~~---~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~  228 (708)
                      ..+.+||+|||+|+...   ........+||+.|+|||++.        +..|+.++|||||||++|+|+||+.||.+..
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~elltg~~pf~~~~  289 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS--------NKPWNYQIDYFGVAATVYCMLFGTYMKVKNE  289 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT--------TCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc--------CCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence            26789999999997543   334456678999999999997        6779999999999999999999999996321


Q ss_pred             CCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-CHHHHHHHHHHH
Q psy15481        229 GRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-SFERFFSEVTKT  307 (708)
Q Consensus       229 g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-sa~q~~~~l~~i  307 (708)
                      ...  .                         .....++..     ...+.+.+++..||..+|.+|+ ++.++...+.++
T Consensus       290 ~~~--~-------------------------~~~~~~~~~-----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          290 GGE--C-------------------------KPEGLFRRL-----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             TTE--E-------------------------EECSCCTTC-----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             CCc--e-------------------------eechhcccc-----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            100  0                         000011111     1144566799999999999985 566666666666


Q ss_pred             Hhh
Q psy15481        308 LNR  310 (708)
Q Consensus       308 l~~  310 (708)
                      +..
T Consensus       338 l~~  340 (365)
T 3e7e_A          338 FQQ  340 (365)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            554

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=366.93  Aligned_cols=253  Identities=22%  Similarity=0.369  Sum_probs=201.5

Q ss_pred             EeeEeecCCceEEEEEEEc--CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEec
Q psy15481         14 TTSVLGKGATGAVFQGVNK--NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        14 i~~~LG~G~fG~Vy~a~~~--~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      ....||+|+||.||+|.++  .++..||||+++........+.+.+|+.++++++||||+++++++...   ..|+||||
T Consensus       340 ~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv~E~  416 (613)
T 2ozo_A          340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEM  416 (613)
T ss_dssp             EEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---SEEEEEEC
T ss_pred             cCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---CeEEEEEe
Confidence            3348999999999999875  456789999998765555566778999999999999999999998752   38999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ  171 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~  171 (708)
                      |.||+|.+++....  ..+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+....+.
T Consensus       417 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl----~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          417 AGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL----VNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             CTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECCCSTTTTCC---
T ss_pred             CCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE----cCCCcEEEeeccCcccccCCC
Confidence            99999999997543  239999999999999999999999999999999999998    556689999999998765433


Q ss_pred             cc----cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        172 QF----MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       172 ~~----~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ..    ....+++.|+|||++.        +..++.++|||||||++|||+| |..||..   ....+.+..+....   
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~--------~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~---~~~~~~~~~i~~~~---  556 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECIN--------FRKFSSRSDVWSYGVTMWEALSYGQKPYKK---MKGPEVMAFIEQGK---  556 (613)
T ss_dssp             -----------CCTTSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCTTTT---CCSHHHHHHHHTTC---
T ss_pred             ceeeeccCCCCccceeCHhhhc--------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---CCHHHHHHHHHcCC---
Confidence            21    2234568999999997        5678999999999999999998 9999974   45555555555321   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                                       .++.    ++.++..+.+++..||..||.+||++.+++..+..++..
T Consensus       557 -----------------~~~~----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          557 -----------------RMEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             -----------------CCCC----CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -----------------CCCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                             1111    122334566699999999999999999999888776543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=338.92  Aligned_cols=275  Identities=24%  Similarity=0.291  Sum_probs=203.4

Q ss_pred             CceEEEeeEeecCCceEEEEEE----EcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGV----NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~----~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ...|.+.+.||+|+||.||+|.    +..+|+.||+|.+.... ......+.+|+.++++++||||+++++++...+...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            4569999999999999999998    46789999999987532 223345679999999999999999999987665556


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .++||||++|++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||++
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli----~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV----ENENRVKIGDFGLT  192 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----EETTEEEECCCTTC
T ss_pred             eEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE----cCCCcEEEecCcch
Confidence            8999999999999999976432  38999999999999999999999999999999999998    55568999999999


Q ss_pred             cccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        165 RELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       165 ~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ........    .....++..|+|||.+.        +..++.++|||||||++|+|+||..||...    ..+.. ...
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~tg~~~~~~~----~~~~~-~~~  259 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLT--------ESKFSVASDVWSFGVVLYELFTYIEKSKSP----PAEFM-RMI  259 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHH--------HCEEEHHHHHHHHHHHHHHHHHTTCGGGSH----HHHHH-HHH
T ss_pred             hhccccccccccccCCCCceeEECchhhc--------CCCCCchhhHHHHHHHHHHHHhcCCCCCCC----HHHHH-Hhh
Confidence            87654432    22345778899999987        466889999999999999999999998631    11111 111


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      .....+.......  ...+.-...++.+    ..++..+.+++.+||..||.+|||+.+++..++.+..
T Consensus       260 ~~~~~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          260 GNDKQGQMIVFHL--IELLKNNGRLPRP----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             CTTCCTHHHHHHH--HHHHHTTCCCCCC----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccchhhhHHHH--HHHhhcCCCCCCC----CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0000000000000  0000000011222    2334456679999999999999999999998887754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=335.42  Aligned_cols=263  Identities=22%  Similarity=0.337  Sum_probs=186.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCch-HHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPH-DVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~-~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..|.+.+.||+|+||.||+|.++.+|+.||||++......... .....+..+++.++||||+++++++...+  ..|+|
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--~~~lv  102 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT--DVFIA  102 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEEE
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--cEEEE
Confidence            3688899999999999999999999999999999765432222 22334455678889999999999997654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN-RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~-gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||+ ++.+..+.....  ..+++..++.++.|++.||.|||++ ||+||||||+||++    +..+.+||+|||++...
T Consensus       103 ~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~----~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL----DERGQIKLCDFGISGRL  175 (318)
T ss_dssp             ECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE----CTTSCEEECCCTTC---
T ss_pred             Eecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE----CCCCCEEEEECCCchhc
Confidence            9999 677766665322  2389999999999999999999995 99999999999998    66778999999999877


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..........||+.|+|||++....   ..+..++.++|||||||++|+|++|..||..  .....+.+..+.....+  
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~pf~~--~~~~~~~~~~~~~~~~~--  248 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPD---PTKPDYDIRADVWSLGISLVELATGQFPYKN--CKTDFEVLTKVLQEEPP--  248 (318)
T ss_dssp             -----------CCTTCCHHHHC-----------CCTHHHHHHHHHHHHHHHHSSCTTTT--CCSHHHHHHHHHHSCCC--
T ss_pred             cCCccccccCCCccccChhhccccc---ccccCCccccchhhHHHHHHHHHhCCCCCCC--CCccHHHHHHHhccCCC--
Confidence            6655555678999999999985211   0145688999999999999999999999974  23455555555543211  


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                      .+|....+++    .+.+++.+||..||.+||++.++           +.|||+..
T Consensus       249 ----------------~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l-----------l~h~~~~~  289 (318)
T 2dyl_A          249 ----------------LLPGHMGFSG----DFQSFVKDCLTKDHRKRPKYNKL-----------LEHSFIKR  289 (318)
T ss_dssp             ----------------CCCSSSCCCH----HHHHHHHHHTCSCTTTSCCHHHH-----------TTSHHHHH
T ss_pred             ----------------CCCccCCCCH----HHHHHHHHHccCChhHCcCHHHH-----------hhCHHHHh
Confidence                            2233233444    45569999999999999999997           66888753

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.3e-38  Score=336.21  Aligned_cols=270  Identities=21%  Similarity=0.341  Sum_probs=207.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHh--CCCCCccceeEEEEecCC--ce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKK--VKHENIVKLLAIEEEQEG--RG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~k--L~HpNIVkl~~v~~~~~~--~~   84 (708)
                      +..|.+.+.||+|+||.||+|.+  +|+.||||+++..    ....+.+|.+++..  ++||||+++++++.....  ..
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            35799999999999999999987  4899999998643    24455688888887  799999999999876553  25


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCcccCCCCCcEEEEEecCCCceE
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR--------DNRLVHRDLKPGNIMKFICDDGSTIY  156 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH--------~~gIVHrDIKP~NILl~~~~d~~~~v  156 (708)
                      .|+||||+++|+|.+++...    .+++..++.++.|++.||.|||        ++||+||||||+|||+    +..+.+
T Consensus       115 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll----~~~~~~  186 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----KKNGTC  186 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE----CTTSCE
T ss_pred             eEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE----CCCCCE
Confidence            89999999999999999753    2899999999999999999999        8999999999999998    666789


Q ss_pred             EEeccCccccccccc-----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC----------C
Q psy15481        157 KLTDFGAARELEEDQ-----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG----------N  221 (708)
Q Consensus       157 KL~DFGlA~~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG----------~  221 (708)
                      ||+|||++.......     ......||+.|+|||++......  ....++.++|||||||++|+|+||          .
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM--KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT--TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccc--cccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            999999998765443     22445799999999998631100  001344789999999999999999          7


Q ss_pred             CCCCCCCC-CChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        222 LPFRPYGG-RRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       222 ~PF~~~~g-~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      .||..... ....+.+.......                .+...+|.. ..+......+.+++.+||..||.+|||+.++
T Consensus       265 ~p~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i  327 (342)
T 1b6c_B          265 LPYYDLVPSDPSVEEMRKVVCEQ----------------KLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRI  327 (342)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTS----------------CCCCCCCGG-GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cCccccCcCcccHHHHHHHHHHH----------------HhCCCCccc-ccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence            88864322 12222332222110                001112211 1234667788899999999999999999999


Q ss_pred             HHHHHHHHhhh
Q psy15481        301 FSEVTKTLNRK  311 (708)
Q Consensus       301 ~~~l~~il~~~  311 (708)
                      ++++..+....
T Consensus       328 ~~~L~~i~~~~  338 (342)
T 1b6c_B          328 KKTLSQLSQQE  338 (342)
T ss_dssp             HHHHHHHHHTT
T ss_pred             HHHHHHHHHHh
Confidence            99998886643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.4e-39  Score=334.48  Aligned_cols=259  Identities=21%  Similarity=0.298  Sum_probs=195.0

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcC-CCc--eEEEEEeccCCCC--CchHHHHHHHHHHHhCCCCCccceeEEEEecCC
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKN-NGE--PVAVKTFNQLSHM--RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG   82 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~-tg~--~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~   82 (708)
                      .+..|.+.+.||+|+||.||+|.+.. +++  .||+|+++.....  ...+.+.+|+.++++++||||+++++++.... 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            35689999999999999999998643 333  6999998754322  22345679999999999999999999987643 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                        .++||||+++++|.+++.....  .+++..+..++.|++.||.|||++|++||||||+||++    +..+.+||+|||
T Consensus        95 --~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili----~~~~~~kl~Dfg  166 (291)
T 1u46_A           95 --MKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL----ATRDLVKIGDFG  166 (291)
T ss_dssp             --CEEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----EETTEEEECCCT
T ss_pred             --ceeeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE----cCCCCEEEcccc
Confidence              7999999999999999875322  28999999999999999999999999999999999998    555689999999


Q ss_pred             cccccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHH
Q psy15481        163 AARELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       163 lA~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~  237 (708)
                      ++........    .....+|..|+|||++.        +..++.++|||||||++|+|++ |..||..   .+..+.+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~il~~l~~~g~~p~~~---~~~~~~~~  235 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLK--------TRTFSHASDTWMFGVTLWEMFTYGQEPWIG---LNGSQILH  235 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHH--------HCEEEHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHH
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhc--------CCCCCchhhHHHHHHHHHHHHhCCCCCccc---CCHHHHHH
Confidence            9987654322    22356788999999997        4668899999999999999999 9999973   44555555


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      .+.....                   .++....+    +..+.+++.+||..||.+|||+.++++.+..+..
T Consensus       236 ~~~~~~~-------------------~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          236 KIDKEGE-------------------RLPRPEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHHTSCC-------------------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHHccCC-------------------CCCCCcCc----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            5443211                   11222223    3456669999999999999999999888776543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.2e-38  Score=346.05  Aligned_cols=280  Identities=20%  Similarity=0.321  Sum_probs=208.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CC-----CccceeEEEEecCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HE-----NIVKLLAIEEEQEG   82 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-Hp-----NIVkl~~v~~~~~~   82 (708)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||+++...  .......+|+.+++.++ |+     +|+.+++++...+ 
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~-  129 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN-  129 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT-
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC-
Confidence            357999999999999999999999999999999996421  11234467888888884 55     4899999887654 


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR--DNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH--~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                       ..|+||||+. ++|.+++..... .++++..++.++.|++.||.|||  +.||+||||||+|||+  ..++.+.+||+|
T Consensus       130 -~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll--~~~~~~~~kL~D  204 (382)
T 2vx3_A          130 -HLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL--CNPKRSAIKIVD  204 (382)
T ss_dssp             -EEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEE--SSTTSCCEEECC
T ss_pred             -ceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEE--ecCCCCcEEEEe
Confidence             5999999995 699999876432 24899999999999999999999  5799999999999996  445567899999


Q ss_pred             cCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        161 FGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       161 FGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ||+|.....  ......||+.|+|||++.        +..++.++|||||||++|+|+||.+||.   +.+..+.+..+.
T Consensus       205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltg~~pf~---~~~~~~~~~~i~  271 (382)
T 2vx3_A          205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLL--------GMPYDLAIDMWSLGCILVEMHTGEPLFS---GANEVDQMNKIV  271 (382)
T ss_dssp             CTTCEETTC--CCCSSCSCGGGCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHH
T ss_pred             ccCceeccc--ccccccCCccccChHHHc--------CCCCCcHHHHHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHH
Confidence            999987643  244678999999999997        5679999999999999999999999998   455666666655


Q ss_pred             hcccC--C-ccccccc-----CCCCcccccC----------CCC---------------------CcccCChhHHHHHHH
Q psy15481        241 TKKAS--G-VISGTQT-----SENGEIDWCT----------DLP---------------------NNCQLSLGLKKLVTP  281 (708)
Q Consensus       241 ~~~~~--~-~i~~~~~-----~~~g~~~~~~----------~lp---------------------~~~~ls~~l~~~l~~  281 (708)
                      .....  . .......     ..-....|..          ..|                     ............+.+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  351 (382)
T 2vx3_A          272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD  351 (382)
T ss_dssp             HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred             HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence            42110  0 0000000     0000000100          000                     001112223356788


Q ss_pred             HHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        282 ILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       282 LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ||.+||++||++|||+.++           +.|||+...
T Consensus       352 li~~mL~~dP~~Rpta~e~-----------L~hp~f~~~  379 (382)
T 2vx3_A          352 LILRMLDYDPKTRIQPYYA-----------LQHSFFKKT  379 (382)
T ss_dssp             HHHHHTCSCTTTSCCHHHH-----------TTSGGGCC-
T ss_pred             HHHHhcCCChhhCCCHHHH-----------hcCcccccC
Confidence            9999999999999999997           789999654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.9e-38  Score=355.11  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=199.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.+.. +..||||+++...  ...+.+.+|+.++++++||||+++++++..   ...|+||
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv~  257 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVT  257 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEE
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEEe
Confidence            468999999999999999999864 5679999997543  234567899999999999999999999865   2489999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||++||+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+++....
T Consensus       258 e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADFGLARLIED  332 (452)
T ss_dssp             CCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCCCTTC----
T ss_pred             hhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE----CCCCCEEECCCccceecCC
Confidence            99999999999974211 228999999999999999999999999999999999998    6677899999999987654


Q ss_pred             ccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ...  .....++..|+|||.+.        +..++.++|||||||++|+|+| |..||.   +..+.+.+..+....   
T Consensus       333 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDvwslG~~l~el~t~g~~P~~---~~~~~~~~~~i~~~~---  398 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPEAAL--------YGRFTIKSDVWSFGILLTELTTKGRVPYP---GMVNREVLDQVERGY---  398 (452)
T ss_dssp             ----------CCGGGSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTTCCSST---TCCHHHHHHHHHTTC---
T ss_pred             CceecccCCcccccccCHhHHh--------cCCCCccccHHhHHHHHHHHHhCCCCCCC---CCCHHHHHHHHHcCC---
Confidence            321  22345778999999987        4678999999999999999999 999997   455556555554321   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                                       .+|.+.    .++..+.+++.+||..||++|||+++++..+.+++
T Consensus       399 -----------------~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          399 -----------------RMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             -----------------CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             -----------------CCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                             112222    23345666999999999999999999988766543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2e-38  Score=339.29  Aligned_cols=283  Identities=23%  Similarity=0.324  Sum_probs=206.3

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCC-ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCC------ccceeEEEEec
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNG-EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHEN------IVKLLAIEEEQ   80 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg-~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpN------IVkl~~v~~~~   80 (708)
                      ...+|.+.+.||+|+||.||+|.+..++ +.||+|+++..  ....+...+|+.++++++|++      ++.+++++...
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            4568999999999999999999998777 79999998642  122345678999999997665      88888888765


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec----------
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD----------  150 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~----------  150 (708)
                      +  ..|+||||+ +++|.+.+..... ..+++..++.++.||+.||.|||++||+||||||+|||+...+          
T Consensus        95 ~--~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           95 G--HMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             T--EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             C--eEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence            4  599999999 6677776654321 2389999999999999999999999999999999999972111          


Q ss_pred             -----CCCceEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCC
Q psy15481        151 -----DGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR  225 (708)
Q Consensus       151 -----d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~  225 (708)
                           +..+.+||+|||++.....  ......||+.|+|||++.        +..++.++|||||||++|+|++|..||.
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVIL--------ELGWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeee--------cCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence                 3456899999999986433  234568999999999997        6778999999999999999999999998


Q ss_pred             CCCCCChhhHHHHH---HhcccCCccccccc---CCCCcccccCC-------------CCCcccCChhHHHHHHHHHHhh
Q psy15481        226 PYGGRRNKETMYYI---TTKKASGVISGTQT---SENGEIDWCTD-------------LPNNCQLSLGLKKLVTPILAGL  286 (708)
Q Consensus       226 ~~~g~~~~e~~~~i---~~~~~~~~i~~~~~---~~~g~~~~~~~-------------lp~~~~ls~~l~~~l~~LL~~m  286 (708)
                      .   ....+.+..+   ....+.........   ...+...|...             ++............+.+||.+|
T Consensus       241 ~---~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  317 (355)
T 2eu9_A          241 T---HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM  317 (355)
T ss_dssp             C---SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred             C---CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence            4   3333333322   22111111000000   00011112111             0111112234456788899999


Q ss_pred             cccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        287 LEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       287 L~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      |..||.+|||+.++           +.|||+..-
T Consensus       318 L~~dP~~Rpt~~e~-----------l~hp~f~~~  340 (355)
T 2eu9_A          318 LEFDPAQRITLAEA-----------LLHPFFAGL  340 (355)
T ss_dssp             TCSSTTTSCCHHHH-----------TTSGGGGGC
T ss_pred             hcCChhhCcCHHHH-----------hcChhhcCC
Confidence            99999999999997           779999754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3e-38  Score=336.51  Aligned_cols=253  Identities=24%  Similarity=0.387  Sum_probs=203.1

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-----chHHHHHHHHHHHhCC--CCCccceeEEEEe
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-----PHDVQMREFEVLKKVK--HENIVKLLAIEEE   79 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-----~~~~~~~Ei~iL~kL~--HpNIVkl~~v~~~   79 (708)
                      ..+.+|.+.+.||+|+||.||+|.+..+|+.||||++.......     ....+.+|+.++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            45678999999999999999999999999999999997653322     1233458999999996  5999999999986


Q ss_pred             cCCceEEEEEeccCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecC-CCceEE
Q psy15481         80 QEGRGKVIVMELCTG-GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDD-GSTIYK  157 (708)
Q Consensus        80 ~~~~~~~LVmEy~~g-gsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d-~~~~vK  157 (708)
                      .+  ..++|||++.+ ++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    + ..+.+|
T Consensus       120 ~~--~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~~k  190 (320)
T 3a99_A          120 PD--SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI----DLNRGELK  190 (320)
T ss_dssp             SS--EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----ETTTTEEE
T ss_pred             CC--cEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEE----eCCCCCEE
Confidence            54  59999999976 89999987643   28999999999999999999999999999999999998    4 456899


Q ss_pred             EeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH
Q psy15481        158 LTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       158 L~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~  237 (708)
                      |+|||++...... ......||+.|+|||++..       ...++.++|||||||++|+|++|..||..     ..    
T Consensus       191 L~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~-----~~----  253 (320)
T 3a99_A          191 LIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEH-----DE----  253 (320)
T ss_dssp             ECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCS-----HH----
T ss_pred             EeeCccccccccc-cccCCCCCccCCChHHhcc-------CCCCCccchHHhHHHHHHHHHHCCCCCCC-----hh----
Confidence            9999999876543 3445679999999999873       34447889999999999999999999963     11    


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .+...                     .......++    ..+.++|.+||..||.+|||+.++           +.|||+
T Consensus       254 ~~~~~---------------------~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~l-----------l~hp~~  297 (320)
T 3a99_A          254 EIIRG---------------------QVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEI-----------QNHPWM  297 (320)
T ss_dssp             HHHHC---------------------CCCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHH-----------HTSGGG
T ss_pred             hhhcc---------------------cccccccCC----HHHHHHHHHHccCChhhCcCHHHH-----------hcCHhh
Confidence            11111                     001111233    345669999999999999999997           679998


Q ss_pred             CCcc
Q psy15481        318 INRL  321 (708)
Q Consensus       318 ~~~~  321 (708)
                      ....
T Consensus       298 ~~~~  301 (320)
T 3a99_A          298 QDVL  301 (320)
T ss_dssp             SSCC
T ss_pred             cCcc
Confidence            7654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.9e-38  Score=332.06  Aligned_cols=267  Identities=23%  Similarity=0.356  Sum_probs=197.0

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCC--CCCccceeEEEEecCCce
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVK--HENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~--HpNIVkl~~v~~~~~~~~   84 (708)
                      .+..|.+.+.||+|+||.||++.+. +|+.||+|++...... ...+.+.+|+.++++++  ||||+++++++...+  .
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~--~  102 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--Y  102 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS--E
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC--E
Confidence            3568999999999999999999985 5899999999754322 22345679999999997  599999999987644  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||| +.+++|.+++....   .+++..++.++.|++.||.|||++||+||||||+|||+    ++ +.+||+|||++
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~----~~-~~~kL~Dfg~~  173 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VD-GMLKLIDFGIA  173 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ET-TEEEECCCSSS
T ss_pred             EEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE----EC-CeEEEeecccc
Confidence            999999 55899999997644   38999999999999999999999999999999999997    22 57999999999


Q ss_pred             cccccccc---ccccCCCCCcCChhhhhhhhhcC---CCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHH
Q psy15481        165 RELEEDQQ---FMSLYGTEEYLHPDMYERAVLRK---PVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       165 ~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~---~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~  238 (708)
                      ........   .....||+.|+|||++.......   .....++.++|||||||++|+|++|..||...  ......+..
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~--~~~~~~~~~  251 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--INQISKLHA  251 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC--CSHHHHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH--HHHHHHHHH
Confidence            87654432   23457999999999986311000   00246889999999999999999999999742  233333333


Q ss_pred             HHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      +......                 ..+|.  ..    +..+.+++.+||..||.+|||+.++           +.|||+.
T Consensus       252 ~~~~~~~-----------------~~~~~--~~----~~~l~~li~~~l~~dp~~Rps~~el-----------l~h~~~~  297 (313)
T 3cek_A          252 IIDPNHE-----------------IEFPD--IP----EKDLQDVLKCCLKRDPKQRISIPEL-----------LAHPYVQ  297 (313)
T ss_dssp             HHCTTSC-----------------CCCCC--CS----CHHHHHHHHHHTCSSTTTSCCHHHH-----------HTSHHHH
T ss_pred             HHhcccc-----------------cCCcc--cc----hHHHHHHHHHHccCCcccCcCHHHH-----------hcCcccc
Confidence            3321100                 01121  12    2356679999999999999999997           6688886


Q ss_pred             Cccc
Q psy15481        319 NRLQ  322 (708)
Q Consensus       319 ~~~~  322 (708)
                      ....
T Consensus       298 ~~~~  301 (313)
T 3cek_A          298 IQTH  301 (313)
T ss_dssp             CC--
T ss_pred             CCCC
Confidence            5533

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-38  Score=349.64  Aligned_cols=262  Identities=24%  Similarity=0.396  Sum_probs=194.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...|.+.+.||+|+||.||. ....+|+.||||++....    .....+|+.+++.+ +||||+++++++.+..  ..|+
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--~~~l   95 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNVIRYFCTEKDRQ--FQYI   95 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT----EEECHHHHHHHHHSCCCTTBCCEEEEEEETT--EEEE
T ss_pred             cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCC--EEEE
Confidence            46799999999999999764 345689999999986532    22245899999999 8999999999987644  5899


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEe-cCCCceEEEeccCcccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFIC-DDGSTIYKLTDFGAARE  166 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~-~d~~~~vKL~DFGlA~~  166 (708)
                      |||||. |+|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+... .++...+||+|||+|..
T Consensus        96 v~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            999995 699999987543  25566778999999999999999999999999999997221 24455789999999987


Q ss_pred             ccccc----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHh
Q psy15481        167 LEEDQ----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       167 ~~~~~----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      ...+.    .....+||+.|+|||++...     .+..++.++|||||||++|+|+| |..||..    ........+..
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~t~~~DiwSlG~il~ellt~g~~pf~~----~~~~~~~~~~~  243 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSED-----CKENPTYTVDIFSAGCVFYYVISEGSHPFGK----SLQRQANILLG  243 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC--------CCCTHHHHHHHHHHHHHHHTTSCBTTBS----TTTHHHHHHTT
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcc-----cccCCCcHHHHHHHHHHHHHHHcCCCCCcch----hhHHHHHHHhc
Confidence            65442    23446799999999998621     13456789999999999999999 9999952    22222222221


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                      ...                    .+. ..........+.++|.+||..||.+|||+.++           +.|||++...
T Consensus       244 ~~~--------------------~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ev-----------l~hp~f~~~~  291 (432)
T 3p23_A          244 ACS--------------------LDC-LHPEKHEDVIARELIEKMIAMDPQKRPSAKHV-----------LKHPFFWSLE  291 (432)
T ss_dssp             CCC--------------------CTT-SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHH-----------HTSTTTCCHH
T ss_pred             cCC--------------------ccc-cCccccccHHHHHHHHHHHhCCHhhCCCHHHH-----------HhCccccChH
Confidence            100                    000 00112345557789999999999999999997           6799997643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.9e-38  Score=355.83  Aligned_cols=268  Identities=20%  Similarity=0.260  Sum_probs=210.2

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .+..|.+.+.||+|+||.||+|.+..+|+.||||++.....   ...+.+|+.+++.++|++++..+..+... ....|+
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~-~~~~~l   80 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVE-GDYNVL   80 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEE-TTEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEee-CCEEEE
Confidence            45689999999999999999999999999999999875433   23356899999999886555555444332 346899


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||+ |++|.+++.....  .+++..++.++.||+.||.|||++|||||||||+|||+. ..+..+.+||+|||++...
T Consensus        81 vme~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~-~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG-LGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-CGGGTTCEEECCCTTCEEC
T ss_pred             EEECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEe-cCCCCCeEEEEeCCcceec
Confidence            99999 9999999975332  399999999999999999999999999999999999972 2234568999999999876


Q ss_pred             cccccc--------cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        168 EEDQQF--------MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       168 ~~~~~~--------~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      ......        ....||+.|+|||++.        +..++.++|||||||++|+|++|..||...........+..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i  228 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHL--------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred             cCCccccccccccccccCCCccccCHHHhc--------CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence            554321        2567999999999987        677899999999999999999999999865555555555555


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhh
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK  311 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~  311 (708)
                      ........+                    ..+...++..+.+++..||..||.+||++.++...+.+++...
T Consensus       229 ~~~~~~~~~--------------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          229 SEKKVATSI--------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHHSCH--------------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hhccccccH--------------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            443221110                    0011122345677999999999999999999999988887643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.7e-38  Score=365.24  Aligned_cols=251  Identities=22%  Similarity=0.363  Sum_probs=199.4

Q ss_pred             eeEeecCCceEEEEEEE--cCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEec
Q psy15481         15 TSVLGKGATGAVFQGVN--KNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~--~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      .+.||+|+||.||+|.+  +.+++.||||+++..... ...+.+.+|+.++++++||||+++++++...   ..++||||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~E~  450 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEM  450 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEEC
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEEEc
Confidence            45899999999999954  567889999999764322 2245678999999999999999999998643   38999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccc
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ  171 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~  171 (708)
                      |+||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+....+.
T Consensus       451 ~~~g~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl----~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          451 AELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL----VTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             CTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECCTTHHHHTTC--
T ss_pred             cCCCCHHHHHhhCCC---CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE----eCCCCEEEEEcCCccccccCc
Confidence            999999999976433   8999999999999999999999999999999999998    556689999999998765443


Q ss_pred             c----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        172 Q----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       172 ~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      .    .....+|+.|+|||++.        +..++.++|||||||++|+|++ |+.||.   +....+....+....   
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~--------~~~~~~~sDvwSlGv~l~ellt~G~~Pf~---~~~~~~~~~~i~~~~---  589 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECIN--------YYKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEKGE---  589 (635)
T ss_dssp             -----------CGGGSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTTCCSST---TCCHHHHHHHHHTTC---
T ss_pred             cccccccCCCCceeeeChhhhc--------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCCHHHHHHHHHcCC---
Confidence            2    22345678999999997        5678999999999999999998 999997   355555555554321   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                                       ..+.    +..++..+.++|..||..||++||++.+++..+.+++..
T Consensus       590 -----------------~~~~----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          590 -----------------RMGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             -----------------CCCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -----------------CCCC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                             1111    122335566799999999999999999999988877643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-38  Score=332.91  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=195.3

Q ss_pred             CCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-----chHHHHHHHHHHHhC----CCCCccceeEEE
Q psy15481          7 STNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-----PHDVQMREFEVLKKV----KHENIVKLLAIE   77 (708)
Q Consensus         7 ~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-----~~~~~~~Ei~iL~kL----~HpNIVkl~~v~   77 (708)
                      ....+|.+.+.||+|+||.||+|.+..+|+.||+|++.......     ......+|+.+++++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            44568999999999999999999999999999999997543221     112234799999998    899999999998


Q ss_pred             EecCCceEEEEEec-cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecC-CCce
Q psy15481         78 EEQEGRGKVIVMEL-CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDD-GSTI  155 (708)
Q Consensus        78 ~~~~~~~~~LVmEy-~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d-~~~~  155 (708)
                      ...+  ..++|||| +.+++|.+++.....   +++..++.++.||+.||.|||++||+||||||+||++    + ..+.
T Consensus       108 ~~~~--~~~~v~e~~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~  178 (312)
T 2iwi_A          108 ETQE--GFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI----DLRRGC  178 (312)
T ss_dssp             -------CEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEE----ETTTTE
T ss_pred             ecCC--eEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEE----eCCCCe
Confidence            7654  48999999 789999999976433   8999999999999999999999999999999999998    4 5568


Q ss_pred             EEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhH
Q psy15481        156 YKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKET  235 (708)
Q Consensus       156 vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~  235 (708)
                      +||+|||++...... ......||..|+|||++..       ...++.++|||||||++|+|++|..||..     ... 
T Consensus       179 ~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~-----~~~-  244 (312)
T 2iwi_A          179 AKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISR-------HQYHALPATVWSLGILLYDMVCGDIPFER-----DQE-  244 (312)
T ss_dssp             EEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCS-----HHH-
T ss_pred             EEEEEcchhhhcccC-cccccCCcccccCceeeec-------CCCCCccchHHHHHHHHHHHHHCCCCCCC-----hHH-
Confidence            999999999876543 3455679999999999873       33345689999999999999999999962     111 


Q ss_pred             HHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCc
Q psy15481        236 MYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHL  315 (708)
Q Consensus       236 ~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~  315 (708)
                         +....               .    .++      ..++..+.++|.+||..||.+|||+.++           +.||
T Consensus       245 ---~~~~~---------------~----~~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~-----------l~~~  285 (312)
T 2iwi_A          245 ---ILEAE---------------L----HFP------AHVSPDCCALIRRCLAPKPSSRPSLEEI-----------LLDP  285 (312)
T ss_dssp             ---HHHTC---------------C----CCC------TTSCHHHHHHHHHHTCSSTTTSCCHHHH-----------HHST
T ss_pred             ---Hhhhc---------------c----CCc------ccCCHHHHHHHHHHccCChhhCcCHHHH-----------hcCh
Confidence               11110               0    111      1223455669999999999999999997           5699


Q ss_pred             ccCCccccc
Q psy15481        316 FHINRLQCI  324 (708)
Q Consensus       316 ~~~~~~~~~  324 (708)
                      |+.......
T Consensus       286 ~~~~~~~~~  294 (312)
T 2iwi_A          286 WMQTPAEDV  294 (312)
T ss_dssp             TTCC-----
T ss_pred             hhcCchhcc
Confidence            997765533

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.7e-37  Score=345.59  Aligned_cols=273  Identities=23%  Similarity=0.388  Sum_probs=197.2

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCc
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGR   83 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~   83 (708)
                      ....+..|.+.+.||+|+||.||.+ ...+|+.||||++....    .+...+|+.+++++ +||||+++++++.+.  +
T Consensus        10 ~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~   82 (434)
T 2rio_A           10 EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTD--R   82 (434)
T ss_dssp             SCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECS--S
T ss_pred             hhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecC--C
Confidence            3455677889999999999999875 45689999999986432    34567899999886 899999999998754  4


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCC----CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec---------
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYG----LQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD---------  150 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~----L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~---------  150 (708)
                      ..|+|||||. |+|.+++........    .++..++.++.||+.||.|||++||+||||||+|||+....         
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            5999999995 699999987542110    13335678999999999999999999999999999973211         


Q ss_pred             CCCceEEEeccCcccccccccc-----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCC
Q psy15481        151 DGSTIYKLTDFGAARELEEDQQ-----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF  224 (708)
Q Consensus       151 d~~~~vKL~DFGlA~~~~~~~~-----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF  224 (708)
                      ++...+||+|||+|.....+..     .....||+.|+|||++..... ......++.++|||||||++|+|+| |..||
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNN-LQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCT-TSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccc-cccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence            3456899999999987654432     234579999999999863110 0113668999999999999999999 99999


Q ss_pred             CCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCC-cccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHH
Q psy15481        225 RPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPN-NCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSE  303 (708)
Q Consensus       225 ~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~-~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~  303 (708)
                      ..   ....+  ..+.....                   .++. .+.....++..+.+++.+||..||.+|||+.++   
T Consensus       241 ~~---~~~~~--~~i~~~~~-------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei---  293 (434)
T 2rio_A          241 GD---KYSRE--SNIIRGIF-------------------SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV---  293 (434)
T ss_dssp             CS---TTTHH--HHHHHTCC-------------------CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH---
T ss_pred             CC---chhhH--HHHhcCCC-------------------CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHH---
Confidence            63   21111  22222110                   0111 111234567778889999999999999999997   


Q ss_pred             HHHHHhhhhcCcccCCcc
Q psy15481        304 VTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       304 l~~il~~~l~h~~~~~~~  321 (708)
                              +.|||+++..
T Consensus       294 --------l~hp~f~~~~  303 (434)
T 2rio_A          294 --------LRHPLFWPKS  303 (434)
T ss_dssp             --------HTSGGGSCHH
T ss_pred             --------HhCCccCCcH
Confidence                    6799998653

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1e-37  Score=365.06  Aligned_cols=257  Identities=23%  Similarity=0.395  Sum_probs=205.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCC---CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNN---GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .+|.+.+.||+|+||.||+|.+..+   +..||+|.+.........+.+.+|+.++++++||||+++++++.+   +..|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~  466 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVW  466 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---CceE
Confidence            4699999999999999999998653   567999998754433334566799999999999999999999843   2389


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +||||++||+|.+++....  ..+++..++.++.|++.||.|||++||+||||||+|||+    +..+.+||+|||++..
T Consensus       467 lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl----~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV----SSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECCCCCCCS
T ss_pred             EEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE----eCCCCEEEEecCCCee
Confidence            9999999999999997543  238999999999999999999999999999999999998    5556899999999987


Q ss_pred             ccccccc--cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        167 LEEDQQF--MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       167 ~~~~~~~--~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      .......  ....+|+.|+|||++.        +..++.++|||||||++|+|++ |..||.   +....+.+..+....
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DiwSlG~il~ellt~g~~Pf~---~~~~~~~~~~i~~~~  609 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESIN--------FRRFTSASDVWMFGVCMWEILMHGVKPFQ---GVKNNDVIGRIENGE  609 (656)
T ss_dssp             CCC----------CCGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCTTT---TCCHHHHHHHHHHTC
T ss_pred             cCCCcceeccCCCCCcceeCHHHhc--------CCCCCchhhHHHHHHHHHHHHHcCCCCCC---CCCHHHHHHHHHcCC
Confidence            6544322  2345778999999997        4678999999999999999997 999997   455566665555421


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                                          .++.    ++.++..+.+++.+||..||.+|||+.+++..+..++..
T Consensus       610 --------------------~~~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          610 --------------------RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             --------------------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------------CCCC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                                1111    122334566799999999999999999999999888754

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=356.28  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=203.8

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.+.. +..||||+++...  ...+.+.+|+.++++++||||+++++++..   ...|+||
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv~  340 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVT  340 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEE
T ss_pred             hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEee
Confidence            468999999999999999999864 5679999997543  234567899999999999999999999865   2489999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      ||+.+|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+++....
T Consensus       341 e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll----~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADFGLARLIED  415 (535)
T ss_dssp             CCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCTTSTTTCCC
T ss_pred             ehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE----cCCCcEEEcccccceecCC
Confidence            99999999999964211 128999999999999999999999999999999999998    6677899999999987654


Q ss_pred             ccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ...  .....++..|+|||++.        +..++.++|||||||++|+|+| |..||.   +..+.+.+..+....   
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDvwSlGv~l~el~t~g~~P~~---~~~~~~~~~~i~~~~---  481 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAAL--------YGRFTIKSDVWSFGILLTELTTKGRVPYP---GMVNREVLDQVERGY---  481 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHH--------HCCCCHHHHHHHHHHHHHHHTTTTCCSST---TCCHHHHHHHHHTTC---
T ss_pred             CceecccCCcCcccccCHHHhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCCHHHHHHHHHcCC---
Confidence            321  22345778999999987        4678999999999999999999 999997   455566655554321   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                       .++...    .++..+.+||.+||..||++|||+++++..|+++
T Consensus       482 -----------------~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          482 -----------------RMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             -----------------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -----------------CCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                             112222    2334566799999999999999999988766543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=329.09  Aligned_cols=264  Identities=19%  Similarity=0.303  Sum_probs=197.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ...|.+.+.||+|+||.||+|.+..   .||+|+++.... ......+.+|+.++++++||||+++++++...+  ..++
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~i  106 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP--HLAI  106 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS--CEEE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--ceEE
Confidence            4579999999999999999998853   499999875432 222334568999999999999999999998755  4999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++|++|.+++....  ..+++..++.++.||+.||.|||++|++||||||+||++    + .+.+||+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~----~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY----D-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE----C---CCEECCCSCCC--
T ss_pred             EeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE----e-CCCEEEeecCCcccc
Confidence            999999999999997643  238999999999999999999999999999999999998    3 357999999998754


Q ss_pred             ccc------ccccccCCCCCcCChhhhhhhhhcC-CCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        168 EED------QQFMSLYGTEEYLHPDMYERAVLRK-PVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       168 ~~~------~~~~~~~GT~~YlAPE~l~~~~~~~-~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ...      .......||+.|+|||++....... .....++.++|||||||++|+|++|..||..   .........+.
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~---~~~~~~~~~~~  256 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT---QPAEAIIWQMG  256 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS---CCHHHHHHHHH
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHhc
Confidence            321      2223456899999999986311000 0124578999999999999999999999973   44444444444


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      ....+                  .+ ....++..    +.+++.+||..||.+|||+.++++.+..+..+
T Consensus       257 ~~~~~------------------~~-~~~~~~~~----l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          257 TGMKP------------------NL-SQIGMGKE----ISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             TTCCC------------------CC-CCSSCCTT----HHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             cCCCC------------------CC-CcCCCCHH----HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            32111                  00 01123333    55699999999999999999999887665543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.7e-37  Score=323.68  Aligned_cols=250  Identities=26%  Similarity=0.435  Sum_probs=185.8

Q ss_pred             cCCCCceEEEe-eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHH-HhCCCCCccceeEEEEe--c
Q psy15481          5 RGSTNYVWCTT-SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVL-KKVKHENIVKLLAIEEE--Q   80 (708)
Q Consensus         5 ~~~~n~~y~i~-~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL-~kL~HpNIVkl~~v~~~--~   80 (708)
                      .|.....|.+. +.||+|+||.||+|.+..+|+.||+|++..      .....+|+.++ +.++||||+++++++..  .
T Consensus        12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            34555667776 889999999999999999999999999863      23456888888 55699999999999865  2


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                      +....|+||||++||+|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||++ ...+..+.+||+|
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~-~~~~~~~~~kl~D  163 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY-TSKRPNAILKLTD  163 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE-SSSSTTCCEEECC
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE-ecCCCCCcEEEec
Confidence            34468999999999999999976432 249999999999999999999999999999999999997 1111267899999


Q ss_pred             cCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        161 FGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       161 FGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ||++....                             +..++.++|||||||++|+|+||..||....+   ......+.
T Consensus       164 fg~a~~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~---~~~~~~~~  211 (299)
T 3m2w_A          164 FGFAKETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMK  211 (299)
T ss_dssp             CTTCEECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------CCSC
T ss_pred             cccccccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc---hhhhHHHH
Confidence            99986422                             24467899999999999999999999974221   11000000


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      .           ....+..    .+|.  .....++..+.+++.+||..||.+|||+.++           +.|||+...
T Consensus       212 ~-----------~~~~~~~----~~~~--~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~-----------l~hp~~~~~  263 (299)
T 3m2w_A          212 T-----------RIRMGQY----EFPN--PEWSEVSEEVKMLIRNLLKTEPTQRMTITEF-----------MNHPWIMQS  263 (299)
T ss_dssp             C-----------SSCTTCC----SSCH--HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH-----------HTSHHHHTG
T ss_pred             H-----------HHhhccc----cCCc--hhcccCCHHHHHHHHHHcccChhhCCCHHHH-----------hcChhhccc
Confidence            0           0000000    1111  0011234456669999999999999999997           668888665


Q ss_pred             cc
Q psy15481        321 LQ  322 (708)
Q Consensus       321 ~~  322 (708)
                      ..
T Consensus       264 ~~  265 (299)
T 3m2w_A          264 TK  265 (299)
T ss_dssp             GG
T ss_pred             cc
Confidence            44

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.4e-36  Score=317.86  Aligned_cols=236  Identities=13%  Similarity=0.125  Sum_probs=182.8

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .+.+|.+.+.||+|+||.||+|.+..+|+.||||++........  ...+.+|+.++++++||||+++++++...+  ..
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~  106 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA--GG  106 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC--cE
Confidence            45789999999999999999999999999999999976543322  245679999999999999999999998754  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++|++|.+++...     ....++..++.||+.||.|||++||+||||||+|||+    +..+.+||+++|   
T Consensus       107 ~lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll----~~~g~~kl~~~~---  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV----SIDGDVVLAYPA---  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----ETTSCEEECSCC---
T ss_pred             EEEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE----cCCCCEEEEecc---
Confidence            9999999999999999542     4566789999999999999999999999999999998    555678887543   


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                                      |++|               ++.++|||||||++|+|+||+.||................     
T Consensus       175 ----------------~~~~---------------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-----  218 (286)
T 3uqc_A          175 ----------------TMPD---------------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-----  218 (286)
T ss_dssp             ----------------CCTT---------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-----
T ss_pred             ----------------ccCC---------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-----
Confidence                            2222               5789999999999999999999997422111000000000     


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                                      ....+....+.+.++..+.++|.+||+.||.+| |+.+++..+..+...
T Consensus       219 ----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          219 ----------------AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             ----------------TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             ----------------ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence                            001111122233445567779999999999999 999999998877654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-36  Score=333.18  Aligned_cols=253  Identities=15%  Similarity=0.154  Sum_probs=183.4

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC--CchHHHHHHHHHHHhCCC-CCc---------cceeE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM--RPHDVQMREFEVLKKVKH-ENI---------VKLLA   75 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~--~~~~~~~~Ei~iL~kL~H-pNI---------Vkl~~   75 (708)
                      ....|...+.||+|+||.||+|.+..+|+.||||+++.....  ...+.+.+|+.+++.++| +|+         +...+
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            344689999999999999999999999999999998743322  224556799999999977 322         11111


Q ss_pred             EE------------EecC---CceEEEEEeccCCCCHHHHhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q psy15481         76 IE------------EEQE---GRGKVIVMELCTGGSLFNILDD----PENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH  136 (708)
Q Consensus        76 v~------------~~~~---~~~~~LVmEy~~ggsL~~~L~~----~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVH  136 (708)
                      ..            ....   ...++++|+++ +++|.+++..    ......+++..+..++.||+.||.|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            11            1111   22367888877 7999998841    111223788899999999999999999999999


Q ss_pred             cCCCCCcEEEEEecCCCceEEEeccCccccccccccccccCCCCCcCChhhhhhhh--hcCCCCCcCCccccchhhhhHH
Q psy15481        137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV--LRKPVGKTFGATVDLWSIGVTL  214 (708)
Q Consensus       137 rDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~--~~~~~~~~~s~ksDIWSLGviL  214 (708)
                      |||||+|||+    +..+.+||+|||+++.....  ....+| +.|+|||++....  .+...+..++.++|||||||++
T Consensus       235 rDiKp~NILl----~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          235 TYLRPVDIVL----DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             SCCCGGGEEE----CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             CCcccceEEE----ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999998    66677999999999865544  455678 9999999995321  0000256688999999999999


Q ss_pred             HHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccC
Q psy15481        215 YHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKI  294 (708)
Q Consensus       215 yeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kR  294 (708)
                      |+|+||+.||..   .........                         .++....++    ..+.++|.+||..||.+|
T Consensus       308 ~elltg~~Pf~~---~~~~~~~~~-------------------------~~~~~~~~~----~~~~~li~~~l~~dP~~R  355 (413)
T 3dzo_A          308 YWIWCADLPNTD---DAALGGSEW-------------------------IFRSCKNIP----QPVRALLEGFLRYPKEDR  355 (413)
T ss_dssp             HHHHHSSCCCCT---TGGGSCSGG-------------------------GGSSCCCCC----HHHHHHHHHHTCSSGGGS
T ss_pred             HHHHHCCCCCCC---cchhhhHHH-------------------------HHhhcccCC----HHHHHHHHHHccCChhhC
Confidence            999999999973   221111110                         111111233    346669999999999999


Q ss_pred             CCHHHH
Q psy15481        295 WSFERF  300 (708)
Q Consensus       295 psa~q~  300 (708)
                      |++.++
T Consensus       356 pt~~~~  361 (413)
T 3dzo_A          356 LLPLQA  361 (413)
T ss_dssp             CCHHHH
T ss_pred             cCHHHH
Confidence            999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.1e-36  Score=351.33  Aligned_cols=246  Identities=24%  Similarity=0.319  Sum_probs=192.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcC-CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCc---e
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKN-NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGR---G   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~-tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~---~   84 (708)
                      ..+|.+.+.||+|+||.||+|.+.. +|+.||||++...........+.+|+.++++++||||+++++++...+..   .
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3689999999999999999999976 79999999987543333344567999999999999999999999765431   2


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .|+||||++|++|.+++..     .+++..++.++.||+.||.|||++||+||||||+|||+    +.. .+||+|||++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll----~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML----TEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CSS-CEEECCCTTC
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE----eCC-cEEEEecccc
Confidence            6999999999999988754     28999999999999999999999999999999999997    332 7899999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ......   ....||+.|+|||++..         .++.++|||||||++|+|++|.+||.+...               
T Consensus       229 ~~~~~~---~~~~gt~~y~aPE~~~~---------~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------------  281 (681)
T 2pzi_A          229 SRINSF---GYLYGTPGFQAPEIVRT---------GPTVATDIYTVGRTLAALTLDLPTRNGRYV---------------  281 (681)
T ss_dssp             EETTCC---SCCCCCTTTSCTTHHHH---------CSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------------
T ss_pred             hhcccC---CccCCCccccCHHHHcC---------CCCCceehhhhHHHHHHHHhCCCCCccccc---------------
Confidence            876543   45679999999999863         238899999999999999999988863100               


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-HHHHHHHHHHHHhh
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-FERFFSEVTKTLNR  310 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-a~q~~~~l~~il~~  310 (708)
                                        ..++.... .......+.++|.+||..||.+||+ ++++...+..++..
T Consensus       282 ------------------~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          282 ------------------DGLPEDDP-VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             ------------------SSCCTTCH-HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             ------------------cccccccc-ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence                              01111100 0122345677999999999999996 55555555555543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1e-35  Score=318.61  Aligned_cols=251  Identities=17%  Similarity=0.197  Sum_probs=186.8

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-------CCchHHHHHHHHHHHhCC---------CCCccce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-------MRPHDVQMREFEVLKKVK---------HENIVKL   73 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-------~~~~~~~~~Ei~iL~kL~---------HpNIVkl   73 (708)
                      .+|.+.+.||+|+||.||+|++  +|+.||||++.....       ........+|+.+++.++         ||||+++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            4688899999999999999987  689999999976532       122355679999999886         7777777


Q ss_pred             eEEEEec----------------------------CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q psy15481         74 LAIEEEQ----------------------------EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG  125 (708)
Q Consensus        74 ~~v~~~~----------------------------~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~a  125 (708)
                      .+++...                            +....|+|||||++|++.+.+...    .+++..++.++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----CCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----CCCHHHHHHHHHHHHHH
Confidence            6654311                            145699999999999776666442    28999999999999999


Q ss_pred             HHHHH-HCCCcccCCCCCcEEEEEecCC------------------CceEEEeccCccccccccccccccCCCCCcCChh
Q psy15481        126 MKHLR-DNRLVHRDLKPGNIMKFICDDG------------------STIYKLTDFGAARELEEDQQFMSLYGTEEYLHPD  186 (708)
Q Consensus       126 L~yLH-~~gIVHrDIKP~NILl~~~~d~------------------~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE  186 (708)
                      |.||| ++||+||||||+|||+  +.++                  ...+||+|||+|+.....    ..+||+.|+|||
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl--~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE  247 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLL--KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEE--EECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred             HHHHHHhCCEeECCCCHHHEEE--eccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence            99999 9999999999999997  2222                  238999999999876543    347999999999


Q ss_pred             hhhhhhhcCCCCCcCCccccchhhhhH-HHHHhcCCCCCCCCCCCCh-hhHHHHHHhcccCCcccccccCCCCcccccCC
Q psy15481        187 MYERAVLRKPVGKTFGATVDLWSIGVT-LYHVATGNLPFRPYGGRRN-KETMYYITTKKASGVISGTQTSENGEIDWCTD  264 (708)
Q Consensus       187 ~l~~~~~~~~~~~~~s~ksDIWSLGvi-LyeLlTG~~PF~~~~g~~~-~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~  264 (708)
                      ++.        +.. +.++||||+|++ .+++++|..||..   ... ......+.....                +  .
T Consensus       248 ~~~--------g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---~~~~~~~~~~~~~~~~----------------~--~  297 (336)
T 2vuw_A          248 LFT--------GDG-DYQFDIYRLMKKENNNRWGEYHPYSN---VLWLHYLTDKMLKQMT----------------F--K  297 (336)
T ss_dssp             GGC--------CCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---HHHHHHHHHHHHHTCC----------------C--S
T ss_pred             hhc--------CCC-ccceehhhhhCCCCcccccccCCCcc---hhhhhHHHHhhhhhhc----------------c--C
Confidence            986        343 889999998777 8889999999951   000 111222221100                0  0


Q ss_pred             CCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhh-cCcccC
Q psy15481        265 LPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKL-VHLFHI  318 (708)
Q Consensus       265 lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l-~h~~~~  318 (708)
                      .+......+.++..+.+||.+||+.|     |+.++           + .|||+.
T Consensus       298 ~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~-----------l~~Hp~f~  336 (336)
T 2vuw_A          298 TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDL-----------LCQHSLFK  336 (336)
T ss_dssp             SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHH-----------HHHCGGGC
T ss_pred             cccchhhhhhcCHHHHHHHHHHhccC-----CHHHH-----------HhcCCCcC
Confidence            01112234567788899999999987     88886           5 699873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=8.2e-30  Score=293.37  Aligned_cols=186  Identities=20%  Similarity=0.163  Sum_probs=130.8

Q ss_pred             eecCCceEEEEEEEcCCCceEEEEEeccCCCC---------CchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEE
Q psy15481         18 LGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM---------RPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        18 LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~---------~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .+.|+.|.+..++....|+.||+|++......         ...+.+.+|+++|+++ .|+||+++++++++.+  .+||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~--~~yL  319 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ--SGWL  319 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS--EEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC--EEEE
Confidence            55677888887777778999999999754211         1123357899999999 7999999999998754  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||++|++|.+++.....   +++.   .|+.||+.||.|+|++|||||||||+|||+    +..+.+||+|||+|+..
T Consensus       320 VMEyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL----~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV----DARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE----CTTSCEEECCCTTEESC
T ss_pred             EEecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE----CCCCCEEEeecccCeeC
Confidence            9999999999999987543   6654   488999999999999999999999999998    66678999999999876


Q ss_pred             ccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCC
Q psy15481        168 EED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF  224 (708)
Q Consensus       168 ~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF  224 (708)
                      ..+ ....+.+||+.|+|||++.         ..+..++|+||+|+++|.+.+|..||
T Consensus       390 ~~~~~~~~t~vGTp~YmAPE~l~---------g~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          390 PQDCSWPTNLVQSFFVFVNELFA---------ENKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             C---CCSHHHHHHHHHHHHHHC--------------------------CCCCTTHHHH
T ss_pred             CCCCccccCceechhhccHHHhC---------CCCCCcccccccccchhhhccccchh
Confidence            544 3345678999999999986         23567899999999998887765444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=2.9e-25  Score=254.01  Aligned_cols=186  Identities=19%  Similarity=0.247  Sum_probs=142.7

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-------hHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-------HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-------~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ...+.||+|+||.||+|.  ..++.+++|..........       .+.+.+|++++++++||||+++..++...+.  .
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--~  414 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--K  414 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT--T
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc--c
Confidence            456799999999999993  4688999998754332221       1225799999999999999955544444433  6


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+||||++|++|.+++..           +..++.|++.||.|||++||+||||||+|||+    +.  .+||+|||+|+
T Consensus       415 ~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl----~~--~~kL~DFGla~  477 (540)
T 3en9_A          415 RIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF----DK--DLYIIDFGLGK  477 (540)
T ss_dssp             EEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE----SS--SEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE----CC--eEEEEECccCE
Confidence            999999999999999975           45799999999999999999999999999998    44  89999999999


Q ss_pred             ccccccc--------ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCC
Q psy15481        166 ELEEDQQ--------FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR  225 (708)
Q Consensus       166 ~~~~~~~--------~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~  225 (708)
                      .......        .....||+.|+|||++....      ..|+..+|+||.+.-..+-+.++-+|.
T Consensus       478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~------~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL------EGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH------HHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHH------HHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            8765432        23568999999999998432      567888999999998888888777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=2.9e-22  Score=210.50  Aligned_cols=146  Identities=21%  Similarity=0.247  Sum_probs=115.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-----------------chHHHHHHHHHHHhCCCCCccce
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-----------------PHDVQMREFEVLKKVKHENIVKL   73 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-----------------~~~~~~~Ei~iL~kL~HpNIVkl   73 (708)
                      .|.+.+.||+|+||.||+|.+ .+|+.||+|+++......                 ....+.+|+.++++++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            445569999999999999999 889999999986432110                 1234579999999999  4 666


Q ss_pred             eEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC
Q psy15481         74 LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS  153 (708)
Q Consensus        74 ~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~  153 (708)
                      .+++...   ..|+||||++|++|.+ +..         .....++.|++.||.|||++||+||||||+|||+    + .
T Consensus       167 ~~~~~~~---~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl----~-~  228 (282)
T 1zar_A          167 PKVYAWE---GNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV----S-E  228 (282)
T ss_dssp             CCEEEEE---TTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE----E-T
T ss_pred             CeEEecc---ceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE----E-C
Confidence            6655432   3699999999999998 522         1245799999999999999999999999999998    4 5


Q ss_pred             ceEEEeccCccccccccccccccCCCCCcCChhhhhh
Q psy15481        154 TIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER  190 (708)
Q Consensus       154 ~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~  190 (708)
                      +.+||+|||+|+.            +..|.|||.+.+
T Consensus       229 ~~vkl~DFG~a~~------------~~~~~a~e~l~r  253 (282)
T 1zar_A          229 EGIWIIDFPQSVE------------VGEEGWREILER  253 (282)
T ss_dssp             TEEEECCCTTCEE------------TTSTTHHHHHHH
T ss_pred             CcEEEEECCCCeE------------CCCCCHHHHHHH
Confidence            6899999999973            456789999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=3.8e-19  Score=184.06  Aligned_cols=142  Identities=24%  Similarity=0.327  Sum_probs=109.8

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCce--EEEEEeccCCCCCc-----------------------hHHHHHHHHHH
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEP--VAVKTFNQLSHMRP-----------------------HDVQMREFEVL   62 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~--VAIK~~~~~s~~~~-----------------------~~~~~~Ei~iL   62 (708)
                      .+..|.+.+.||+|+||.||+|.+..+|+.  ||||+++.......                       .....+|+.++
T Consensus        45 ~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  124 (258)
T 1zth_A           45 KGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL  124 (258)
T ss_dssp             TTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred             CCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence            346789999999999999999998778999  99999764321100                       12456899999


Q ss_pred             HhCCCCCc--cceeEEEEecCCceEEEEEeccCC-C----CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCC
Q psy15481         63 KKVKHENI--VKLLAIEEEQEGRGKVIVMELCTG-G----SLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR-DNRL  134 (708)
Q Consensus        63 ~kL~HpNI--Vkl~~v~~~~~~~~~~LVmEy~~g-g----sL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH-~~gI  134 (708)
                      +++.|+++  +.+++.   .   ..++||||+.+ |    +|.+....      .++..+..++.|++.||.||| +.||
T Consensus       125 ~~l~~~~i~~p~~~~~---~---~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~gi  192 (258)
T 1zth_A          125 ERAKEAGVSVPQPYTY---M---KNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAEL  192 (258)
T ss_dssp             HHHHHTTCCCCCEEEE---E---TTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSCE
T ss_pred             HHHHhCCCCCCeEEEc---C---CCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCCE
Confidence            99988865  333332   1   26899999932 3    77776532      345577899999999999999 9999


Q ss_pred             cccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481        135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus       135 VHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      +||||||+|||+    +.  .++|+|||+|...
T Consensus       193 vHrDlkp~NILl----~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMY----ID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEE----SS--SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEE----cC--cEEEEECcccccC
Confidence            999999999998    44  7999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.61  E-value=5e-16  Score=169.60  Aligned_cols=145  Identities=18%  Similarity=0.201  Sum_probs=100.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-----C--------CchHHH--------HHHHHHHHhCCC
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-----M--------RPHDVQ--------MREFEVLKKVKH   67 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-----~--------~~~~~~--------~~Ei~iL~kL~H   67 (708)
                      +..|.+...||+|++|.||+|.+. +|+.||||+++....     .        ......        .+|+..+.++.+
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~  172 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE  172 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence            446899999999999999999985 699999999753210     0        001111        246666666644


Q ss_pred             CCccceeEEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEE
Q psy15481         68 ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKF  147 (708)
Q Consensus        68 pNIVkl~~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~  147 (708)
                      +++....-+ ....   .+|||||+.|++|..+...         +....++.||+.+|.+||+.|||||||||.|||+.
T Consensus       173 ~gv~vp~p~-~~~~---~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          173 EGFPVPEPI-AQSR---HTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIR  239 (397)
T ss_dssp             TTCSCCCEE-EEET---TEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred             cCCCCCeee-eccC---ceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence            443222111 1111   3799999999888765432         12456889999999999999999999999999983


Q ss_pred             EecCC------CceEEEeccCccccc
Q psy15481        148 ICDDG------STIYKLTDFGAAREL  167 (708)
Q Consensus       148 ~~~d~------~~~vKL~DFGlA~~~  167 (708)
                      -+.++      ...+.|+||+-+...
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCCcccccccccceEEEEeCCcccC
Confidence            33221      124899999988753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.15  E-value=1.2e-10  Score=119.30  Aligned_cols=138  Identities=15%  Similarity=0.147  Sum_probs=105.9

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEEEEe
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      |.+...+|.|+.+.||++..  .|..+++|+...... .......+|+.+++.+ .+..+++++++....  +..|+|||
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e   90 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLMS   90 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEE
T ss_pred             ceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEEEEE
Confidence            56677888888999999964  368899999864211 1233466899999998 467788899887654  35899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD---------------------------------------  131 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~---------------------------------------  131 (708)
                      |++|.+|...+..        ......++.++..+|..||+                                       
T Consensus        91 ~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           91 EADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             ecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            9999999876421        11234688899999999998                                       


Q ss_pred             --------------------CCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481        132 --------------------NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       132 --------------------~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                                          .+++|+|++|+|||+    ++...+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~----~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV----KDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE----ETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE----ECCcEEEEEEchhccc
Confidence                                458999999999997    4445678999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.01  E-value=1.4e-09  Score=110.13  Aligned_cols=132  Identities=17%  Similarity=0.097  Sum_probs=94.1

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCC--ccceeEEEEecCCceEEEEEe
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHEN--IVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpN--IVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .+....+.|..+.||++.. .+|..|++|+....    ......+|+.+++.+.+.+  +++++++....+  ..|+|||
T Consensus        23 ~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~--~~~~v~e   95 (264)
T 1nd4_A           23 DWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG--RDWLLLG   95 (264)
T ss_dssp             EEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS--CEEEEEE
T ss_pred             ceEecccCCCCceEEEEec-CCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC--CCEEEEE
Confidence            3333334566699999954 56788999997643    1234568999999885444  566887766543  4899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR-------------------------------------  133 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g-------------------------------------  133 (708)
                      |++|.+|.  ...      .+.   ..++.+++..|..||+..                                     
T Consensus        96 ~i~G~~l~--~~~------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           96 EVPGQDLL--SSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             CCSSEETT--TSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             ecCCcccC--cCc------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99998884  211      222   256777778888888643                                     


Q ss_pred             ---------------------CcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481        134 ---------------------LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       134 ---------------------IVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                                           ++|+|++|+||++    ++...+.|+|||.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~----~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMV----ENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE----ETTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE----ECCcEEEEEcchhccc
Confidence                                 9999999999997    4456778999999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.95  E-value=2.2e-09  Score=115.46  Aligned_cols=145  Identities=15%  Similarity=0.260  Sum_probs=104.9

Q ss_pred             EeeEeecCCceEEEEEEEcCCCceEEEEEec--cCCCCCchHHHHHHHHHHHhCC--CCCccceeEEEEecCC-ceEEEE
Q psy15481         14 TTSVLGKGATGAVFQGVNKNNGEPVAVKTFN--QLSHMRPHDVQMREFEVLKKVK--HENIVKLLAIEEEQEG-RGKVIV   88 (708)
Q Consensus        14 i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~--~~s~~~~~~~~~~Ei~iL~kL~--HpNIVkl~~v~~~~~~-~~~~LV   88 (708)
                      ....|+.|.++.||+....  +..+++|+..  ............+|+.+++.+.  +..+++++.++.+.+. +..|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            3567899999999998754  4678888875  3322222345568999999996  4567888888765421 347899


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-------------------------------------  131 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-------------------------------------  131 (708)
                      |||++|..+.+...     ..+++.....++.+++.+|..||+                                     
T Consensus       120 me~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          120 MEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            99999887744211     127888899999999999999997                                     


Q ss_pred             ---------------------CCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481        132 ---------------------NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus       132 ---------------------~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                                           .+++|+|++|+|||+  .+++..++.|+||+.+...
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~--~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMF--HPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEE--CSSSSCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEE--eCCCCcEEEEECccccccC
Confidence                                 368999999999997  3333356799999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.92  E-value=1.8e-09  Score=113.55  Aligned_cols=196  Identities=18%  Similarity=0.241  Sum_probs=123.9

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCC--ccceeEEEEecCC-ceEEEEEe
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHEN--IVKLLAIEEEQEG-RGKVIVME   90 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpN--IVkl~~v~~~~~~-~~~~LVmE   90 (708)
                      .+.++.|.+..||+..     ..+++|+....   .......+|+.+++.+ .+..  ++.++......+. ...|+||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            3568999999999862     46889986422   2234567899999888 4433  3444443322221 13589999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD---------------------------------------  131 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~---------------------------------------  131 (708)
                      +++|.+|......     .++..+...++.+++..|..||+                                       
T Consensus        97 ~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           97 KIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             ccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            9999888653321     17888888899999999988886                                       


Q ss_pred             -------------------CCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccccccCCCCCcCChhhhhhhh
Q psy15481        132 -------------------NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV  192 (708)
Q Consensus       132 -------------------~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~  192 (708)
                                         ..++|+|++|+||++  +++....+.|+||+.+....+............-..|+......
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~--~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILF--DTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEE--ETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEE--eCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence                               136999999999997  33225678999999987543322111111110113444433221


Q ss_pred             hcCCCCC--c----CCccccchhhhhHHHHHhcCCCCCC
Q psy15481        193 LRKPVGK--T----FGATVDLWSIGVTLYHVATGNLPFR  225 (708)
Q Consensus       193 ~~~~~~~--~----~s~ksDIWSLGviLyeLlTG~~PF~  225 (708)
                      ..-+...  .    .....++|++|.++|.+.+|..||.
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            0000000  0    1122589999999999999998874

>4efo_A Serine/threonine-protein kinase TBK1; ubiquitin like domain, transferase; 1.77A {Homo sapiens}

Probab=98.75  E-value=7.4e-10  Score=95.89  Aligned_cols=75  Identities=23%  Similarity=0.528  Sum_probs=69.7

Q ss_pred             HHHHHHHHHhhhhcCcccCCcccccccccCCcccHHHHHHHHHhhcCCCccceEEEeeCCcccc-------cCCCCCCCC
Q psy15481        300 FFSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFSH-------IFPSSHQKN  372 (708)
Q Consensus       300 ~~~~l~~il~~~l~h~~~~~~~~~~~~~i~~~e~~~~l~~~i~~~t~i~~~~q~~~~~~~~~~~-------~~~~~~~~~  372 (708)
                      +|.++.+||+++++|+|..+++..+++++++++++..|++.|+++|||++++|+++++|..+++       +||.|++++
T Consensus         2 ~F~e~~dIL~rkvvHVf~~~~a~~h~v~I~~~etv~~~ke~V~eqTgIp~~~Q~LL~eg~~l~l~p~~~a~~~p~Tt~~~   81 (94)
T 4efo_A            2 PLGSTSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEEN   81 (94)
T ss_dssp             CCCGGGCGGGEEEEEEEETTTTEEEEEEEETTCBHHHHHHHHHHHHCCCGGGEEEEETTEEECCCTTCBGGGSCCCBTTB
T ss_pred             chHHHHHHHhceeEEEEEcccceEEEEEeccchHHHHHHHHHHHHhCCCHHHHHHHhCCCccccCCCCccccCCCCCCCC
Confidence            4667889999999999999999999999999999999999999999999999999999977643       999999999


Q ss_pred             CC
Q psy15481        373 PS  374 (708)
Q Consensus       373 p~  374 (708)
                      ||
T Consensus        82 Pl   83 (94)
T 4efo_A           82 PI   83 (94)
T ss_dssp             CE
T ss_pred             CE
Confidence            95

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.27  E-value=6.7e-06  Score=86.52  Aligned_cols=138  Identities=18%  Similarity=0.154  Sum_probs=94.0

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCC---CccceeEEEEecCCceEEEEEec
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE---NIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~Hp---NIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      ...++.|....||+.     |..+++|+...   ........+|+.+++.+.+.   .++..+.+.... .+..|+||+|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~-~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS-DGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-TSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-CCceEEEEec
Confidence            345788999999988     56788998431   12234567999999999642   356666665432 3457899999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN---------------------------------------  132 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~---------------------------------------  132 (708)
                      ++|.++......     .++......+..++...|..||+.                                       
T Consensus        95 i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           95 VQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             CCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             cCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            999888763221     145556666666666666666642                                       


Q ss_pred             ---------------------CCcccCCCCCcEEEEEec--CCCceEEEeccCcccccc
Q psy15481        133 ---------------------RLVHRDLKPGNIMKFICD--DGSTIYKLTDFGAARELE  168 (708)
Q Consensus       133 ---------------------gIVHrDIKP~NILl~~~~--d~~~~vKL~DFGlA~~~~  168 (708)
                                           .++|+|++|+||++  .+  ++...+.|+||+.+....
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~--~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLT--NLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEE--CTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEE--ecCCCCCceEEEEehhhcCCCC
Confidence                                 34899999999997  22  113456899999987543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.24  E-value=6.9e-06  Score=83.95  Aligned_cols=139  Identities=14%  Similarity=0.208  Sum_probs=96.9

Q ss_pred             CceEEEeeEeecCCce-EEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEE
Q psy15481          9 NYVWCTTSVLGKGATG-AVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG-~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~   86 (708)
                      +++|.   .+..|..| .||+......+..+++|+-...    ......+|..+|+.+. +--+.++++++.+.+  ..|
T Consensus        26 g~~~~---~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~--~~~   96 (272)
T 4gkh_A           26 GYRWA---RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD--DAW   96 (272)
T ss_dssp             TCEEE---EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT--EEE
T ss_pred             CCeEE---EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC--eEE
Confidence            45564   34456555 6999887777888999986532    2344568999998883 334677888776654  589


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN----------------------------------  132 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~----------------------------------  132 (708)
                      +||++++|.++.+.....       ......+..++...|.-||+.                                  
T Consensus        97 lvme~l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (272)
T 4gkh_A           97 LLTTAIPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD  169 (272)
T ss_dssp             EEEECCCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred             EEEEeeCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence            999999998887755321       122334556666666666642                                  


Q ss_pred             ------------------------CCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481        133 ------------------------RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus       133 ------------------------gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                                              .++|+|+.|.|||+    ++.+.+-|+||+.+...
T Consensus       170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~----~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIF----DEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEE----ETTEEEEECCCTTCEEE
T ss_pred             cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEE----ECCeEEEEEECcccccC
Confidence                                    15899999999997    55567789999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.89  E-value=5e-05  Score=82.46  Aligned_cols=77  Identities=17%  Similarity=0.150  Sum_probs=49.5

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCC------CCchHHHHHHHHHHHhCCC--CC-ccceeEEEEecCCceE
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH------MRPHDVQMREFEVLKKVKH--EN-IVKLLAIEEEQEGRGK   85 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~------~~~~~~~~~Ei~iL~kL~H--pN-IVkl~~v~~~~~~~~~   85 (708)
                      .+.||.|.++.||++....+++.|++|.......      ....+...+|.++++.+..  |. +++++.+  +.+.  .
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~--~  110 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM--A  110 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--T
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc--c
Confidence            5689999999999997666678999998653211      1223455689999988732  33 4455543  2222  5


Q ss_pred             EEEEeccCCC
Q psy15481         86 VIVMELCTGG   95 (708)
Q Consensus        86 ~LVmEy~~gg   95 (708)
                      ++||||++|.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            8999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.70  E-value=0.00012  Score=78.13  Aligned_cols=87  Identities=13%  Similarity=0.091  Sum_probs=56.2

Q ss_pred             EEEeeEe-ecCCceEEEEEEEc--C----CCceEEEEEeccCCC--CCchHHHHHHHHHHHhCC-C--CCccceeEEEEe
Q psy15481         12 WCTTSVL-GKGATGAVFQGVNK--N----NGEPVAVKTFNQLSH--MRPHDVQMREFEVLKKVK-H--ENIVKLLAIEEE   79 (708)
Q Consensus        12 y~i~~~L-G~G~fG~Vy~a~~~--~----tg~~VAIK~~~~~s~--~~~~~~~~~Ei~iL~kL~-H--pNIVkl~~v~~~   79 (708)
                      ......| +.|....+|+....  .    +|..+++|+......  ........+|+.+++.+. +  ..+++++.+..+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            4445678 88889999988643  0    266799998653220  111234568888888883 3  356777777654


Q ss_pred             cC-CceEEEEEeccCCCCHH
Q psy15481         80 QE-GRGKVIVMELCTGGSLF   98 (708)
Q Consensus        80 ~~-~~~~~LVmEy~~ggsL~   98 (708)
                      .+ .+..|+||||++|..+.
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCC
T ss_pred             CCccCCceEEEEecCCCChh
Confidence            32 12468999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.61  E-value=0.00026  Score=74.23  Aligned_cols=74  Identities=12%  Similarity=0.148  Sum_probs=40.8

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC--CCCccceeEE------EEecCCceEE
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK--HENIVKLLAI------EEEQEGRGKV   86 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~--HpNIVkl~~v------~~~~~~~~~~   86 (708)
                      ...|+.|.++.||++...  +..+++|+....     ......|+.+++.|.  .-.+++++..      ...  .+..+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~--~~~~~  107 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH--GSFLF  107 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE--TTEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE--CCEEE
Confidence            345666778999998753  345899998641     233335666666552  1123333321      112  23589


Q ss_pred             EEEeccCCCCH
Q psy15481         87 IVMELCTGGSL   97 (708)
Q Consensus        87 LVmEy~~ggsL   97 (708)
                      ++|+|++|..+
T Consensus       108 ~l~~~i~G~~~  118 (346)
T 2q83_A          108 VVYDWIEGRPF  118 (346)
T ss_dssp             EEEECCCCBCC
T ss_pred             EEEEeecCccC
Confidence            99999998653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.10  E-value=0.0019  Score=70.61  Aligned_cols=74  Identities=15%  Similarity=0.171  Sum_probs=44.8

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCC---CC---chHHHHHHHHHHHhC---CCCCccceeEEEEecCCceE
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH---MR---PHDVQMREFEVLKKV---KHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~---~~---~~~~~~~Ei~iL~kL---~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ...||.|..+.||++..  ++..+++|.......   ..   ..+....|.+++..+   ....+++++.+.  .+  ..
T Consensus        39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~--~~  112 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RT--MA  112 (420)
T ss_dssp             EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TT--TT
T ss_pred             EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CC--cc
Confidence            46789999999999953  567899995432111   11   112223344444333   334566777664  22  36


Q ss_pred             EEEEecc-CC
Q psy15481         86 VIVMELC-TG   94 (708)
Q Consensus        86 ~LVmEy~-~g   94 (708)
                      ++||||+ +|
T Consensus       113 ~lv~e~l~~g  122 (420)
T 2pyw_A          113 LIGMRYLEPP  122 (420)
T ss_dssp             EEEECCCCTT
T ss_pred             EEEEeecCCc
Confidence            8999999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.71  E-value=0.012  Score=62.13  Aligned_cols=76  Identities=14%  Similarity=0.097  Sum_probs=57.0

Q ss_pred             EeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC---CCCccceeEEEEecCCceEEEEEe
Q psy15481         14 TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK---HENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        14 i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~---HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      -...|+.|....+|+...  ++..+++|+....    ....+.+|+..|+.|.   ...+++.+.+....  +..|+|||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEE
Confidence            346789999999999864  4678889987532    2455678999988883   35678888776553  35899999


Q ss_pred             ccCCCCH
Q psy15481         91 LCTGGSL   97 (708)
Q Consensus        91 y~~ggsL   97 (708)
                      |++|..+
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.48  E-value=0.0087  Score=62.08  Aligned_cols=71  Identities=11%  Similarity=0.137  Sum_probs=43.9

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCc-cceeEEEEecCCceEEEEEecc-
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI-VKLLAIEEEQEGRGKVIVMELC-   92 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNI-Vkl~~v~~~~~~~~~~LVmEy~-   92 (708)
                      ...|+.|.+..+|++      ..+++|+....... ..+ ..+|+.+++.+...++ ++++...  .+.  -+++++|+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~-r~~E~~~l~~l~~~g~~P~~~~~~--~~~--~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YIN-RANEAVAAREAAKAGVSPEVLHVD--PAT--GVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-----CCC-HHHHHHHHHHHHHTTSSCCEEEEC--TTT--CCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc-eeC-HHHHHHHHHHHHHcCCCCceEEEE--CCC--CEEEEeecC
Confidence            678889999999998      45889987643211 111 2368877777632222 5565543  222  36899999 


Q ss_pred             CCCCH
Q psy15481         93 TGGSL   97 (708)
Q Consensus        93 ~ggsL   97 (708)
                      +|.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.42  E-value=0.021  Score=59.56  Aligned_cols=75  Identities=13%  Similarity=0.103  Sum_probs=46.4

Q ss_pred             eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCC--CCccceeEE-----EEecCCceEEEE
Q psy15481         16 SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH--ENIVKLLAI-----EEEQEGRGKVIV   88 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~H--pNIVkl~~v-----~~~~~~~~~~LV   88 (708)
                      ..++ |....||+... .+|+.+++|+.+...  ...+....|..+++.|..  -.+++++..     ...  .+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~--~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH--QGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE--TTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEE--CCEEEEE
Confidence            3466 88889998754 356689999986432  123445578888887732  123444432     111  2356889


Q ss_pred             EeccCCCC
Q psy15481         89 MELCTGGS   96 (708)
Q Consensus        89 mEy~~ggs   96 (708)
                      |+|++|..
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.42  E-value=0.012  Score=61.76  Aligned_cols=77  Identities=8%  Similarity=0.083  Sum_probs=38.6

Q ss_pred             eEeecCCceE-EEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCC--CCccceeEEEEecCCceEEEEEecc
Q psy15481         16 SVLGKGATGA-VFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH--ENIVKLLAIEEEQEGRGKVIVMELC   92 (708)
Q Consensus        16 ~~LG~G~fG~-Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~H--pNIVkl~~v~~~~~~~~~~LVmEy~   92 (708)
                      ..|+.|+... +|+... .+|..+++|.......    +....|+.+++.+..  -.+++++.+.  ...+  +++||++
T Consensus        24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l   94 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDL   94 (333)
T ss_dssp             CC--------CCEEEEC-TTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCC
T ss_pred             eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeC
Confidence            3455555544 667643 2366788876543211    122367777776632  2355666652  2222  6899999


Q ss_pred             CCCCHHHHh
Q psy15481         93 TGGSLFNIL  101 (708)
Q Consensus        93 ~ggsL~~~L  101 (708)
                      .|..+.+.+
T Consensus        95 ~~~~l~~~l  103 (333)
T 3csv_A           95 GDALFTEVI  103 (333)
T ss_dssp             CSCBHHHHH
T ss_pred             CCcchHHHh
Confidence            776665443

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.39  E-value=0.032  Score=58.04  Aligned_cols=143  Identities=14%  Similarity=0.145  Sum_probs=75.9

Q ss_pred             EeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCC--ccceeEEE-----EecCCceEE
Q psy15481         14 TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHEN--IVKLLAIE-----EEQEGRGKV   86 (708)
Q Consensus        14 i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpN--IVkl~~v~-----~~~~~~~~~   86 (708)
                      -...|+.|....+|+.... +| .+++|+.....   ..+....|+.+++.|...+  +++++...     ... .+..+
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~-~g~~~   99 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL-SGRPA   99 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE-TTEEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE-CCEEE
Confidence            4466788888999998653 33 68899987521   1233446777777663211  33333210     011 23478


Q ss_pred             EEEeccCCCCHH------------------HHhcCCCCC--CCCCHHHHHHH---------------HHHHHHHHHHHHH
Q psy15481         87 IVMELCTGGSLF------------------NILDDPENT--YGLQEEEFLLV---------------LEHLTAGMKHLRD  131 (708)
Q Consensus        87 LVmEy~~ggsL~------------------~~L~~~~~~--~~L~e~~v~~i---------------l~qIl~aL~yLH~  131 (708)
                      ++|+|++|..+.                  .........  ...........               -..+...+..+..
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            999999886531                  111110000  00111110100               0113344555542


Q ss_pred             -------CCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481        132 -------NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       132 -------~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                             .+++|+|+.|+|||+    ++...+.|+||+.+..
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~----~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFF----LGDELSGLIDFYFACN  217 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEE----ETTEEEEECCCTTCEE
T ss_pred             hCcccCCcccCCCCCCccCEEE----eCCceEEEecchhccC
Confidence                   379999999999997    4445668999998864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.22  E-value=0.068  Score=54.87  Aligned_cols=79  Identities=11%  Similarity=0.101  Sum_probs=55.2

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCC---CccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHE---NIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~Hp---NIVkl~~v~~~~~~~~~~   86 (708)
                      ....-...+|.|..+.||+... .+|+.|++|+..... ......+.+|+..|+.|.-.   -+++++.+  + .   .+
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~-~---~~   86 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D-D---RT   86 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E-T---TE
T ss_pred             CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec--c-C---ce
Confidence            3456678899999999999975 578999999865332 33345567899999988421   24455443  2 1   37


Q ss_pred             EEEeccCCCC
Q psy15481         87 IVMELCTGGS   96 (708)
Q Consensus        87 LVmEy~~ggs   96 (708)
                      +||||+.++.
T Consensus        87 lv~e~l~~~~   96 (288)
T 3f7w_A           87 LAMEWVDERP   96 (288)
T ss_dssp             EEEECCCCCC
T ss_pred             EEEEeecccC
Confidence            8999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.97  E-value=0.014  Score=64.27  Aligned_cols=74  Identities=14%  Similarity=0.131  Sum_probs=49.5

Q ss_pred             eeEeecCCceEEEEEEEcC-------CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCc-cceeEEEEecCCceEE
Q psy15481         15 TSVLGKGATGAVFQGVNKN-------NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI-VKLLAIEEEQEGRGKV   86 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~-------tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNI-Vkl~~v~~~~~~~~~~   86 (708)
                      ...|+.|....+|++....       ++..|++|+....   ...+...+|..+++.|...++ +++++.+.  +    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFS--G----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C----C
Confidence            4678889999999997653       2578999987431   122445589999988843333 56665542  2    2


Q ss_pred             EEEeccCCCCH
Q psy15481         87 IVMELCTGGSL   97 (708)
Q Consensus        87 LVmEy~~ggsL   97 (708)
                      +|++|++|.+|
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            89999987443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.68  E-value=0.02  Score=61.99  Aligned_cols=143  Identities=15%  Similarity=0.153  Sum_probs=78.8

Q ss_pred             eEeecCCceEEEEEEEcC-------CCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEE
Q psy15481         16 SVLGKGATGAVFQGVNKN-------NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        16 ~~LG~G~fG~Vy~a~~~~-------tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..|..|-+..+|++....       +++.|++|+...  .........+|..+++.|. +.-.+++++.+.  +    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C----cc
Confidence            467778888999987642       357899998632  1223444568999998883 322356665543  2    28


Q ss_pred             EEeccCCCCHHH--------------H---hcCCCCCC--CC--CHHHHHHHHHHHHH-------------------HHH
Q psy15481         88 VMELCTGGSLFN--------------I---LDDPENTY--GL--QEEEFLLVLEHLTA-------------------GMK  127 (708)
Q Consensus        88 VmEy~~ggsL~~--------------~---L~~~~~~~--~L--~e~~v~~il~qIl~-------------------aL~  127 (708)
                      ||||++|..|..              .   +.......  ..  -...+..++.++-.                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            999998865421              0   11111100  01  23455555544422                   233


Q ss_pred             HHH----H----CCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481        128 HLR----D----NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       128 yLH----~----~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      .|.    .    ..++|+|+.++||++.-+.+..+.+.++||..|..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            333    2    25899999999999721111235789999999864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.52  E-value=0.077  Score=58.91  Aligned_cols=75  Identities=15%  Similarity=0.216  Sum_probs=48.5

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCc-cceeEEEEecCCceEEEEEeccC
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI-VKLLAIEEEQEGRGKVIVMELCT   93 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNI-Vkl~~v~~~~~~~~~~LVmEy~~   93 (708)
                      ...|+.|-...+|++....++..|++|+...... ...+ ..+|..+++.|...++ +++++.+  .++    +||+|++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~id-R~~E~~vl~~L~~~gl~P~ll~~~--~~G----~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIIN-REREKKISCILYNKNIAKKIYVFF--TNG----RIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSC-HHHHHHHHHHHTTSSSBCCEEEEE--TTE----EEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcC-HHHHHHHHHHHHhcCCCCCEEEEe--CCe----EEEEeeC
Confidence            4578889999999998754457899998754321 1112 2489999999865444 5666665  222    4999998


Q ss_pred             CCCH
Q psy15481         94 GGSL   97 (708)
Q Consensus        94 ggsL   97 (708)
                      |.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.34  E-value=0.025  Score=60.45  Aligned_cols=74  Identities=20%  Similarity=0.186  Sum_probs=43.1

Q ss_pred             eeEeecCCceEEEEEEEcC--------CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCC-ccceeEEEEecCCceE
Q psy15481         15 TSVLGKGATGAVFQGVNKN--------NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHEN-IVKLLAIEEEQEGRGK   85 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~--------tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpN-IVkl~~v~~~~~~~~~   85 (708)
                      ...|+.|....+|+.....        .+..|++|+........ . ....|..+++.+...+ .+++++..   .+   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~-~~~~E~~~l~~L~~~g~~P~~~~~~---~~---  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-Y-NTISEFEVYKTMSKYKIAPQLLNTF---NG---  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-S-CHHHHHHHHHHHHHTTSSCCEEEEE---TT---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-e-cHHHHHHHHHHHHhcCCCCceEEec---CC---
Confidence            4567888889999987643        13688999865421110 1 1247888888774333 44666543   22   


Q ss_pred             EEEEeccCCCC
Q psy15481         86 VIVMELCTGGS   96 (708)
Q Consensus        86 ~LVmEy~~ggs   96 (708)
                      ++||+|++|..
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.09  E-value=0.038  Score=58.56  Aligned_cols=32  Identities=19%  Similarity=0.320  Sum_probs=26.3

Q ss_pred             CCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481        132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus       132 ~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      .+++|+|+.|.||++    +..+.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~----~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLV----GNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEE----CGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEE----eCCCeEEEEECCCCeeC
Confidence            368999999999997    44456899999988753

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=94.64  E-value=0.074  Score=53.11  Aligned_cols=101  Identities=20%  Similarity=0.129  Sum_probs=59.6

Q ss_pred             CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCCCceEEEeccCccccccccccc
Q psy15481         95 GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF  173 (708)
Q Consensus        95 gsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~~~~  173 (708)
                      -||.++|.....  +++|++++.++.|.+.+|.-+-. ..-..+=+.|..|++  ..||  .|.+.+ +.+         
T Consensus        33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l--~~dG--~V~f~~-~~s---------   96 (229)
T 2yle_A           33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV--WRDG--AVTLAP-AAD---------   96 (229)
T ss_dssp             EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE--ETTS--CEEECC-C-----------
T ss_pred             ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE--ecCC--ceeccc-ccc---------
Confidence            478898877543  39999999999999999877632 221122334677775  3343  344443 111         


Q ss_pred             cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCC
Q psy15481        174 MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNL  222 (708)
Q Consensus       174 ~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~  222 (708)
                        ......+.|||...         ...+.+.=|||||+++|..+--.+
T Consensus        97 --~~~~~~~~~pe~~~---------~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           97 --DAGEPPPVAGKLGY---------SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ------------CCSS---------SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             --cccccCCCChhhcc---------ccchHHHHHHHHHHHHHHHhhcCC
Confidence              01233466787652         334567789999999999988443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=92.45  E-value=0.25  Score=54.14  Aligned_cols=75  Identities=15%  Similarity=0.124  Sum_probs=47.5

Q ss_pred             eeEeecCCceEEEEEEEcCC-------CceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEE
Q psy15481         15 TSVLGKGATGAVFQGVNKNN-------GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~t-------g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ...+..|-+..+|+......       +..|++++..... ....+ ..+|..+++.+. +.-.+++++.+  . +   +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~id-R~~E~~~l~~L~~~gi~P~l~~~~--~-~---~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYD-SKVELDVFRYLSNINIAPNIIADF--P-E---G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCC-HHHHHHHHHHHHHTTSSCCEEEEE--T-T---E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcC-HHHHHHHHHHHHhcCCCCCEEEEc--C-C---C
Confidence            35667788899999876521       5789999865432 11122 247888888884 33245555432  2 2   6


Q ss_pred             EEEeccCCCCH
Q psy15481         87 IVMELCTGGSL   97 (708)
Q Consensus        87 LVmEy~~ggsL   97 (708)
                      .||+|++|..|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=81.27  E-value=0.36  Score=52.28  Aligned_cols=33  Identities=24%  Similarity=0.342  Sum_probs=25.2

Q ss_pred             CcccCCCCCcEEEEEe--cCCCceEEEeccCcccc
Q psy15481        134 LVHRDLKPGNIMKFIC--DDGSTIYKLTDFGAARE  166 (708)
Q Consensus       134 IVHrDIKP~NILl~~~--~d~~~~vKL~DFGlA~~  166 (708)
                      ++|+|+.++|||+.-.  ++....+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999996221  13456799999999864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	708
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-43
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-42
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-41
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-40
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-39
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-38
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-38
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-37
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-34
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-34
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-33
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-32
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-32
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-32
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-32
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-31
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-31
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-31
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-31
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-31
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-31
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-30
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-30
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-30
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-29
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-29
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-29
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-29
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-29
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-29
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-29
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-29
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-28
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-28
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-25
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-25
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-18

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  158 bits (400), Expect = 2e-43
 Identities = 86/367 (23%), Positives = 136/367 (37%), Gaps = 64/367 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG GA G V +   +  G   A K            V+ +E + +  ++H  +V L   
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR-KEIQTMSVLRHPTLVNLHDA 91

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
            E+      V++ E  +GG LF  + D  N   + E+E +  +  +  G+ H+ +N  VH
Sbjct: 92  FEDDNEM--VMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENNYVH 147

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
            DLKP NIM       S   KL DFG    L+  Q      GT E+  P++ E       
Sbjct: 148 LDLKPENIM--FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE------- 198

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSEN 256
            GK  G   D+WS+GV  Y + +G  PF   GG  + ET+  +                 
Sbjct: 199 -GKPVGYYTDMWSVGVLSYILLSGLSPF---GGENDDETLRNVK---------------- 238

Query: 257 GEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-----RFFSEVTKTLNRK 311
              DW  D      +S   K      +  LL  D     +        + +         
Sbjct: 239 -SCDWNMDDSAFSGISEDGKDF----IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 312 LVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFSHIFPSSHQK 371
            +                P   Y +++D I+ + D  P     L + +++S    S  + 
Sbjct: 294 QI----------------PSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYS----SLRKH 333

Query: 372 NPSSYSV 378
            P  YS+
Sbjct: 334 RPQEYSI 340

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 1e-42
 Identities = 68/316 (21%), Positives = 124/316 (39%), Gaps = 29/316 (9%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S LG G  G VF+  +K +G  +A K  +        +  +RE +VL +     IV    
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRL 134
                      I ME   GGSL  +L        + E+    V   +  G+ +LR+ +++
Sbjct: 72  AFYSDGEI--SICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKI 126

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           +HRD+KP NI+  +   G    KL DFG + +L +     S  GT  Y+ P+  +     
Sbjct: 127 MHRDVKPSNIL--VNSRGE--IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQ----- 176

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTS 254
              G  +    D+WS+G++L  +A G  P  P     + + +  +   +  G  + T   
Sbjct: 177 ---GTHYSVQSDIWSMGLSLVEMAVGRYPIPP----PDAKELELMFGCQVEGDAAETPPR 229

Query: 255 ENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVH 314
                   +    + +  + + +L+  I+          ++S E       +    K + 
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE------FQDFVNKCLI 283

Query: 315 LFHINRLQCIRIYLHP 330
                R    ++ +H 
Sbjct: 284 KNPAERADLKQLMVHA 299

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 3e-42
 Identities = 74/303 (24%), Positives = 116/303 (38%), Gaps = 43/303 (14%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG GA G V++  NK      A K  +  S     D  M E ++L    H NIVKLL  
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY-MVEIDILASCDHPNIVKLLDA 77

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +      I++E C GG++  ++ + E    L E +  +V +     + +L DN+++H
Sbjct: 78  FYYENNL--WILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDNKIIH 133

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDMYERAVLRK 195
           RDLK GNI+     DG    KL DFG + +     Q   S  GT  ++ P   E  +   
Sbjct: 134 RDLKAGNIL--FTLDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYWMAP---EVVMCET 186

Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSE 255
              + +    D+WS+G+TL  +A    P            +  I   +            
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHH---ELNPMRVLLKIAKSEPP---------- 233

Query: 256 NGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-----RFFSEVTKTLNR 310
                    L    + S   K      L   LE +    W+        F +  +    R
Sbjct: 234 --------TLAQPSRWSSNFKDF----LKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 281

Query: 311 KLV 313
           +L+
Sbjct: 282 ELI 284

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  153 bits (388), Expect = 7e-42
 Identities = 79/369 (21%), Positives = 144/369 (39%), Gaps = 64/369 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG GA G V + V K  G     K  N    +  + V+  E  ++ ++ H  ++ L   
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK-NEISIMNQLHHPKLINLHDA 94

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
            E++     V+++E  +GG LF+ +      Y + E E +  +     G+KH+ ++ +VH
Sbjct: 95  FEDKYEM--VLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 150

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
            D+KP NIM       ++  K+ DFG A +L  D+       T E+  P++ +       
Sbjct: 151 LDIKPENIM--CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD------- 201

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSEN 256
             +  G   D+W+IGV  Y + +G  PF    G  + ET+  +                 
Sbjct: 202 -REPVGFYTDMWAIGVLGYVLLSGLSPFA---GEDDLETLQNVK---------------- 241

Query: 257 GEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-----RFFSEVTKTLNRK 311
              DW  D      +S   K      +  LL+ + +K  +        +       L  +
Sbjct: 242 -RCDWEFDEDAFSSVSPEAKDF----IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296

Query: 312 LVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQILLYKNTHFSHIF---PSS 368
           +                 P   Y++++  I+E+    P  Q  + +  +FS +    P  
Sbjct: 297 I-----------------PSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQE 339

Query: 369 HQKNPSSYS 377
           +Q   S + 
Sbjct: 340 YQIYDSYFD 348

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 8e-42
 Identities = 58/302 (19%), Positives = 118/302 (39%), Gaps = 45/302 (14%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG+G  G V + V  ++ +    K            +  +E  +L   +H NI+ L   
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
            E  E    V++ E  +G  +F  ++   + + L E E +  +  +   ++ L  + + H
Sbjct: 70  FESMEE--LVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSHNIGH 125

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
            D++P NI+       S+  K+ +FG AR+L+    F  L+   EY  P++++       
Sbjct: 126 FDIRPENII--YQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ------- 176

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSEN 256
                    D+WS+G  +Y + +G  PF       N++ +  I                N
Sbjct: 177 -HDVVSTATDMWSLGTLVYVLLSGINPFL---AETNQQIIENIM---------------N 217

Query: 257 GEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-----RFFSEVTKTLNRK 311
            E  +  D     ++S+         +  LL  + K   +        +  +  + ++ K
Sbjct: 218 AEYTF--DEEAFKEISIEAMDF----VDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271

Query: 312 LV 313
           ++
Sbjct: 272 VI 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 1e-41
 Identities = 66/236 (27%), Positives = 100/236 (42%), Gaps = 25/236 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +G G+ G   +   K++G+ +  K  +    M   + Q  + E  +L+++KH NIV+  
Sbjct: 11  TIGTGSYGRCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-LQEEEFLLVLEHLTAGMKHL---- 129
               ++      IVME C GG L +++         L EE  L V+  LT  +K      
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 130 -RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM-SLYGTEEYLHPDM 187
              + ++HRDLKP N+      DG    KL DFG AR L  D  F  +  GT  Y+ P+ 
Sbjct: 130 DGGHTVLHRDLKPANVFL----DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
                       ++    D+WS+G  LY +     PF        KE    I   K
Sbjct: 186 MN--------RMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKELAGKIREGK 230

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-40
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 26/232 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +G G+ G V++G    +   VAVK  N ++   P  +Q    E  VL+K +H NI+  +
Sbjct: 15  RIGSGSFGTVYKGKWHGD---VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
                 +     IV + C G SL++ L   E     +  + + +      GM +L    +
Sbjct: 71  GYSTAPQ---LAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSI 125

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED---QQFMSLYGTEEYLHPDMYERA 191
           +HRDLK  NI            K+ DFG A          QF  L G+  ++ P+     
Sbjct: 126 IHRDLKSNNIFL----HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE----- 176

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
           V+R      +    D+++ G+ LY + TG LP+       N++ + ++  + 
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRG 225

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 6e-40
 Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 23/229 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            LGKG  G V+    K +   +A+K   +    +        RE E+   ++H NI++L 
Sbjct: 13  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
               +       +++E    G+++  L          E+     +  L   + +    R+
Sbjct: 73  GYFHDATRV--YLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRV 127

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           +HRD+KP N++  +   G    K+ DFG +       +  +L GT +YL P+M E     
Sbjct: 128 IHRDIKPENLL--LGSAGE--LKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIE----- 177

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
              G+     VDLWS+GV  Y    G  PF        +ET   I+  +
Sbjct: 178 ---GRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVE 220

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-39
 Identities = 68/283 (24%), Positives = 121/283 (42%), Gaps = 45/283 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            +G+GA+G V+  ++   G+ VA++  N L      ++ + E  V+++ K+ NIV  L  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
               +     +VME   GGSL +++ +        E +   V       ++ L  N+++H
Sbjct: 86  YLVGDEL--WVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHSNQVIH 139

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVLRK 195
           RD+K  NI+  +  DGS   KLTDFG   ++  +Q   S   GT  ++ P++        
Sbjct: 140 RDIKSDNIL--LGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT------ 189

Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSE 255
              K +G  VD+WS+G+    +  G  P+           +Y I T              
Sbjct: 190 --RKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALYLIATNGTP---------- 234

Query: 256 NGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE 298
                   +L N  +LS   +  +       L++D +K  S +
Sbjct: 235 --------ELQNPEKLSAIFRDFLN----RCLDMDVEKRGSAK 265

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 72/282 (25%), Positives = 116/282 (41%), Gaps = 38/282 (13%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           VLG GA   V    +K   + VA+K   + +          E  VL K+KH NIV L  I
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
            E        ++M+L +GG LF+ +          E +   ++  +   +K+L D  +VH
Sbjct: 76  YESGGHL--YLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 130

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           RDLKP N++ +  D+ S I  ++DFG ++  +      +  GT  Y+ P++         
Sbjct: 131 RDLKPENLLYYSLDEDSKI-MISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA------- 182

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSEN 256
             K +   VD WSIGV  Y +  G  PF       + +    I                 
Sbjct: 183 -QKPYSKAVDCWSIGVIAYILLCGYPPFY---DENDAKLFEQILKA-------------- 224

Query: 257 GEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE 298
              ++  D P    +S   K      +  L+E D +K ++ E
Sbjct: 225 ---EYEFDSPYWDDISDSAKDF----IRHLMEKDPEKRFTCE 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (363), Expect = 8e-39
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 22/229 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +G G+ GAV+   +  N E VA+K  +          Q  ++E   L+K++H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
                +      +VME C G +   +     +   LQE E   V      G+ +L  + +
Sbjct: 82  GCYLREHTA--WLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           +HRD+K GNI+  + + G  + KL DFG+A  +     F+   GT  ++ P+     V+ 
Sbjct: 137 IHRDVKAGNIL--LSEPG--LVKLGDFGSASIMAPANSFV---GTPYWMAPE-----VIL 184

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
                 +   VD+WS+G+T   +A    P            +Y+I   +
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNE 230

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  142 bits (359), Expect = 1e-38
 Identities = 54/231 (23%), Positives = 83/231 (35%), Gaps = 18/231 (7%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LG G    V    +      VAVK         P       RE +    + H  IV + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 75  AIEEEQEGRGKV--IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
              E +   G +  IVME   G +L +I+        +  +  + V+      +     N
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN 130

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            ++HRD+KP NIM    +    +        A       Q  ++ GT +YL P+      
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR--- 187

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
                G +  A  D++S+G  LY V TG  PF    G       Y    + 
Sbjct: 188 -----GDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSVAYQHVRED 230

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 4e-38
 Identities = 58/301 (19%), Positives = 113/301 (37%), Gaps = 31/301 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
           V+G G+ G V+Q    ++GE VA+K   Q    +      RE ++++K+ H NIV+L   
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYF 81

Query: 77  ----EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
                E+++     +V++                   L      L +  L   + ++   
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAV 192
            + HRD+KP N++    D  + + KL DFG+A++L   +  +S   +  Y  P++     
Sbjct: 142 GICHRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-- 196

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQ 252
                   + +++D+WS G  L  +  G   F    G    + +  I     +      +
Sbjct: 197 -----ATDYTSSIDVWSAGCVLAELLLGQPIFP---GDSGVDQLVEIIKVLGTPTREQIR 248

Query: 253 TSENGEIDWCTDLPNNCQLSLGLKKLVTP----ILAGLLEVDSKKIWSFE-----RFFSE 303
                  ++          +   +    P    + + LLE       +        FF E
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

Query: 304 V 304
           +
Sbjct: 309 L 309

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 7e-38
 Identities = 50/232 (21%), Positives = 93/232 (40%), Gaps = 25/232 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LG+G+   V            A+K   +   ++ + V    RE +V+ ++ H   VKL 
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              ++ E       +     G L   +    +     E         + + +++L    +
Sbjct: 75  FTFQDDEKL--YFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKGI 129

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEEYLHPDMYERA 191
           +HRDLKP NI+  + +D     ++TDFG A+ L  + +     S  GT +Y+ P++    
Sbjct: 130 IHRDLKPENIL--LNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT-- 183

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
                  K+   + DLW++G  +Y +  G  PFR             I   +
Sbjct: 184 ------EKSACKSSDLWALGCIIYQLVAGLPPFR---AGNEYLIFQKIIKLE 226

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-37
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 23/214 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +G+G+   V++G++      VA         +   + Q    E E+LK ++H NIV+  
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQD-RKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 75  AIEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK--HLR 130
              E      K  V+V EL T G+L   L        ++ +        +  G++  H R
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              ++HRDLK  NI  FI     ++ K+ D G A  L+      ++ GT E++ P+MYE 
Sbjct: 132 TPPIIHRDLKCDNI--FITGPTGSV-KIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE 187

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                     +  +VD+++ G+ +  +AT   P+
Sbjct: 188 ---------KYDESVDVYAFGMCMLEMATSEYPY 212

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 70/304 (23%), Positives = 121/304 (39%), Gaps = 44/304 (14%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLA 75
           VLG G  G V Q  NK   E  A+K        R      RE E+  +  +  +IV+++ 
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVRIVD 72

Query: 76  IEEEQEGRGK--VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           + E      K  +IVME   GG LF+ + D  +     E E   +++ +   +++L    
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSIN 131

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           + HRD+KP N++ +     + I KLTDFG A+E        +   T  Y+ P++      
Sbjct: 132 IAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG---- 186

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQT 253
                + +  + D+WS+GV +Y +  G  PF              + T+   G       
Sbjct: 187 ----PEKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMG------- 232

Query: 254 SENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-----RFFSEVTKTL 308
                  +    P   ++S  +K L+      LL+ +  +  +        +  + TK  
Sbjct: 233 ------QYEFPNPEWSEVSEEVKMLIR----NLLKTEPTQRMTITEFMNHPWIMQSTKVP 282

Query: 309 NRKL 312
              L
Sbjct: 283 QTPL 286

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 3e-37
 Identities = 72/310 (23%), Positives = 124/310 (40%), Gaps = 49/310 (15%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-----MREFEVLKKVKHENIV 71
            LG G    V +   K+ G   A K   +                RE  +LK+++H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
            L  + E +     ++++EL  GG LF   D       L EEE    L+ +  G+ +L  
Sbjct: 77  TLHEVYENKTDV--ILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
            ++ H DLKP NIM    +      K+ DFG A +++   +F +++GT E++ P++    
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-- 189

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT 251
                  +  G   D+WSIGV  Y + +G  PF    G   +ET+  ++           
Sbjct: 190 ------YEPLGLEADMWSIGVITYILLSGASPFL---GDTKQETLANVS----------- 229

Query: 252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-----RFFSEV-- 304
                   ++  +  +N   S   K      +  LL  D KK  + +      +      
Sbjct: 230 ----AVNYEFEDEYFSNT--SALAKDF----IRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279

Query: 305 TKTLNRKLVH 314
            + L+    H
Sbjct: 280 QQALSSAWSH 289

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  138 bits (348), Expect = 3e-37
 Identities = 74/301 (24%), Positives = 126/301 (41%), Gaps = 49/301 (16%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--------MREFEVLKKVK-H 67
           +LG+G +  V + ++K   +  AVK  +          +        ++E ++L+KV  H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 68  ENIVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
            NI++L    E        +V +L   G LF+ L +      L E+E   ++  L   + 
Sbjct: 70  PNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVIC 124

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
            L    +VHRDLKP NI+     D     KLTDFG + +L+  ++   + GT  YL P++
Sbjct: 125 ALHKLNIVHRDLKPENILL----DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV 247
            E ++        +G  VD+WS GV +Y +  G+ PF     R+    +  I +      
Sbjct: 181 IECSMNDNH--PGYGKEVDMWSTGVIMYTLLAGSPPFW---HRKQMLMLRMIMSGN---- 231

Query: 248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-----RFFS 302
                        +    P     S  +K L    ++  L V  +K ++ E      FF 
Sbjct: 232 -------------YQFGSPEWDDYSDTVKDL----VSRFLVVQPQKRYTAEEALAHPFFQ 274

Query: 303 E 303
           +
Sbjct: 275 Q 275

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-36
 Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 24/231 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKV-KHENIVKL 73
           +LGKG+ G VF    K   +  A+K   +   +   DV+  M E  VL    +H  +  +
Sbjct: 9   MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
               + +E      VME   GG L   +   ++ +             +  G++ L    
Sbjct: 69  FCTFQTKENL--FFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE-EDQQFMSLYGTEEYLHPDMYERAV 192
           +V+RDLK  NI+     D     K+ DFG  +E    D +  +  GT +Y+ P++     
Sbjct: 124 IVYRDLKLDNIL----LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL--- 176

Query: 193 LRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
                G+ +  +VD WS GV LY +  G  PF    G+  +E  + I    
Sbjct: 177 -----GQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRMDN 219

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 2e-36
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 19/211 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG+GA G V   VN+   E VAVK  +    +   +   +E  + K + HEN+VK    
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
               EG  + + +E C+GG LF+ +   E   G+ E +       L AG+ +L    + H
Sbjct: 72  RR--EGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 126

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVL 193
           RD+KP N++     D     K++DFG A     + +      + GT  Y+ P++ +R   
Sbjct: 127 RDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR--- 179

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPF 224
                +     VD+WS G+ L  +  G LP+
Sbjct: 180 ----REFHAEPVDVWSCGIVLTAMLAGELPW 206

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-34
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 23/223 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            +GKG  G V  G  +  G  VAVK     +  +     + E  V+ +++H N+V+LL +
Sbjct: 14  TIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF---LAEASVMTQLRHSNLVQLLGV 68

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             E++G    IV E    GSL + L     +  L  +  L     +   M++L  N  VH
Sbjct: 69  IVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNFVH 126

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKP 196
           RDL   N++  + +D   + K++DFG  +E    Q   +     ++  P+          
Sbjct: 127 RDLAARNVL--VSEDN--VAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALR------- 173

Query: 197 VGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
             K F    D+WS G+ L+ + +      PY     K+ +  +
Sbjct: 174 -EKKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPRV 213

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 4e-34
 Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 25/232 (10%)

Query: 18  LGKGATGAVFQGVNK--NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           LG G  G+V QGV +       VA+K   Q +     +  MRE +++ ++ +  IV+L+ 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           +    +    ++VME+  GG L   L        +       +L  ++ GMK+L +   V
Sbjct: 77  VC---QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY----GTEEYLHPDMYERA 191
           HRDL   N    +        K++DFG ++ L  D  + +         ++  P+     
Sbjct: 132 HRDLAARN----VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-- 185

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
                  + F +  D+WS GVT++   +      PY   +  E M +I   K
Sbjct: 186 ------FRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQGK 229

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 5e-34
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 23/225 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG G  G V+ G        VAVK+  Q   M P    + E  ++K+++H+ +V+L A+
Sbjct: 20  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQ-GSMSPDAF-LAEANLMKQLQHQRLVRLYAV 76

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             ++      I+ E    GSL + L  P     L   + L +   +  GM  + +   +H
Sbjct: 77  VTQEP---IYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERNYIH 132

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM--SLYGTEEYLHPDMYERAVLR 194
           RDL+  NI+  + D      K+ DFG AR +E+++           ++  P+        
Sbjct: 133 RDLRAANIL--VSDTL--SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN----- 183

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                TF    D+WS G+ L  + T      PY G  N E +  +
Sbjct: 184 ---YGTFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNL 223

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 7e-34
 Identities = 56/302 (18%), Positives = 112/302 (37%), Gaps = 36/302 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ----MREFEVLKKVKHENIVK 72
            LG+G    V++  +KN  + VA+K           D      +RE ++L+++ H NI+ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL     +      +V +         I    +N+  L        +     G+++L  +
Sbjct: 65  LLDAFGHKSNI--SLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERA 191
            ++HRDLKP N++     D + + KL DFG A+      +  +    T  Y  P++    
Sbjct: 120 WILHRDLKPNNLLL----DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG- 174

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT 251
                  + +G  VD+W++G  L  +           G  + + +  I   +  G  +  
Sbjct: 175 ------ARMYGVGVDMWAVGCILAELLLRVPFLP---GDSDLDQLTRI--FETLGTPTEE 223

Query: 252 QTSENGEIDWCTDLPNNCQLSL-----GLKKLVTPILAGLLEVDSKKIWSFE-----RFF 301
           Q  +   +       +   + L          +  ++ GL   +     +       ++F
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

Query: 302 SE 303
           S 
Sbjct: 284 SN 285

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  129 bits (326), Expect = 1e-33
 Identities = 57/308 (18%), Positives = 111/308 (36%), Gaps = 40/308 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLA 75
            LG+G    VF+ +N  N E V VK    +   +      RE ++L+ ++   NI+ L  
Sbjct: 42  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK----IKREIKILENLRGGPNIITLAD 97

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           I ++   R   +V E         +         L + +    +  +   + +     ++
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIM 151

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRK 195
           HRD+KP N+M  I  +   + +L D+G A      Q++     +  +  P++        
Sbjct: 152 HRDVKPHNVM--IDHEHRKL-RLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD----- 203

Query: 196 PVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTSE 255
              + +  ++D+WS+G  L  +     PF  + G  N + +  I     +  +       
Sbjct: 204 --YQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259

Query: 256 NGEIDWCTDLPNNCQLSLGLKKLVTP------------ILAGLLEVDSKKIWSFE----- 298
           N E+D   +           ++ V               L  LL  D +   +       
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319

Query: 299 RFFSEVTK 306
            +F  V K
Sbjct: 320 PYFYTVVK 327

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 8e-33
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 23/227 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            +G G  G V  G   N  + VA+KT  +   M   D  + E EV+ K+ H  +V+L  +
Sbjct: 12  EIGSGQFGLVHLGYWLN-KDKVAIKTIRE-GAMSEEDF-IEEAEVMMKLSHPKLVQLYGV 68

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             EQ      +V E    G L + L      +    E  L +   +  GM +L +  ++H
Sbjct: 69  CLEQAPI--CLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEEACVIH 124

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ--QFMSLYGTEEYLHPDMYERAVLR 194
           RDL   N +  + ++   + K++DFG  R + +DQ           ++  P+++      
Sbjct: 125 RDLAARNCL--VGENQ--VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS----- 175

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
                 + +  D+WS GV ++ V +      PY  R N E +  I+T
Sbjct: 176 ---FSRYSSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDIST 217

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  126 bits (318), Expect = 2e-32
 Identities = 44/225 (19%), Positives = 91/225 (40%), Gaps = 22/225 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQM-----REFEVLKKVKHENIV 71
           ++G+G  G V+     + G+  A+K  ++          +         ++       IV
Sbjct: 11  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
            +       +      +++L  GG L   L          E +       +  G++H+ +
Sbjct: 71  CMSYAFHTPDKL--SFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGLEHMHN 125

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
             +V+RDLKP NI+     D     +++D G A +  + +   S  GT  Y+ P++ ++ 
Sbjct: 126 RFVVYRDLKPANILL----DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK- 179

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM 236
                 G  + ++ D +S+G  L+ +  G+ PFR +  +   E  
Sbjct: 180 ------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 4e-32
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 22/216 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-----MREFEVLKKVK--HEN 69
           +LG G  G+V+ G+  ++  PVA+K   +       ++        E  +LKKV      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 70  IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           +++LL   E  +    V+++E                   LQEE        +   ++H 
Sbjct: 71  VIRLLDWFERPDSF--VLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC 126

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYE 189
            +  ++HRD+K  NI+    D      KL DFG+   L +D  +    GT  Y  P+   
Sbjct: 127 HNCGVLHRDIKDENIL---IDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIR 182

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFR 225
                    +  G +  +WS+G+ LY +  G++PF 
Sbjct: 183 Y-------HRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  124 bits (311), Expect = 7e-32
 Identities = 52/229 (22%), Positives = 97/229 (42%), Gaps = 24/229 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            LG G+ G V    +++NG   A+K   +   +R   V+    E  +L  V H  I+++ 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              ++ +     ++M+   GG LF        +              +   +++L    +
Sbjct: 71  GTFQDAQQI--FMIMDYIEGGELF---SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           ++RDLKP NI+  +  +G    K+TDFG A+ +       +L GT +Y+ P++       
Sbjct: 126 IYRDLKPENIL--LDKNGH--IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVS----- 174

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
               K +  ++D WS G+ +Y +  G  PF         +T   I   +
Sbjct: 175 ---TKPYNKSIDWWSFGILIYEMLAGYTPFY---DSNTMKTYEKILNAE 217

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 7e-32
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 16/226 (7%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLA 75
           S +G+GA G V    +  N   VA+K  +   H       +RE ++L + +HENI+ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 76  I--EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           I      E    V ++    G  L+ +L     T  L  +     L  +  G+K++    
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN 129

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVL 193
           ++HRDLKP N++  +        K+ DFG AR  + D                 + RA  
Sbjct: 130 VLHRDLKPSNLL--LNTTCD--LKICDFGLARVADPDHDHTGFLTE---YVATRWYRAPE 182

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                K +  ++D+WS+G  L  + +    F    G+   + + +I
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP---GKHYLDQLNHI 225

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  123 bits (310), Expect = 7e-32
 Identities = 55/232 (23%), Positives = 99/232 (42%), Gaps = 27/232 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G G  G V  G  K  G+    VA+KT       +     + E  ++ +  H N++ L
Sbjct: 33  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 92

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
             +  +      +I+ E    GSL + L   +  +     + + +L  + AGMK+L D  
Sbjct: 93  EGVVTKSTPV--MIITEFMENGSLDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLADMN 148

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSL------YGTEEYLHPDM 187
            VHRDL   NI+  +  +   + K++DFG +R LE+D    +            +  P+ 
Sbjct: 149 YVHRDLAARNIL--VNSNL--VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
            +         + F +  D+WS G+ ++ V +      PY    N++ +  I
Sbjct: 205 IQ--------YRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTNQDVINAI 246

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-31
 Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 23/225 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG G  G V  G  +     VA+K   + S        + E +V+  + HE +V+L  +
Sbjct: 11  ELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKLVQLYGV 67

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             +Q      I+ E    G L N L +  +    Q ++ L + + +   M++L   + +H
Sbjct: 68  CTKQRPI--FIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESKQFLH 123

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ--QFMSLYGTEEYLHPDMYERAVLR 194
           RDL   N +     +   + K++DFG +R + +D+    +       +  P++       
Sbjct: 124 RDLAARNCL----VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM----- 174

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                 F +  D+W+ GV ++ + +      PY    N ET  +I
Sbjct: 175 ---YSKFSSKSDIWAFGVLMWEIYSLGKM--PYERFTNSETAEHI 214

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 2e-31
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 23/225 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG+G  G V+ G        VA+KT      M P    ++E +V+KK++HE +V+L A+
Sbjct: 24  KLGQGCFGEVWMGTWNGTTR-VAIKTLKP-GTMSPEAF-LQEAQVMKKLRHEKLVQLYAV 80

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
             E+      IV E  + GSL + L      Y  +  + + +   + +GM ++     VH
Sbjct: 81  VSEEP---IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMNYVH 136

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ--QFMSLYGTEEYLHPDMYERAVLR 194
           RDL+  NI+  + ++   + K+ DFG AR +E+++           ++  P+        
Sbjct: 137 RDLRAANIL--VGENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL----- 187

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                 F    D+WS G+ L  + T      PY G  N+E +  +
Sbjct: 188 ---YGRFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQV 227

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 2e-31
 Identities = 61/311 (19%), Positives = 121/311 (38%), Gaps = 41/311 (13%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVKHENIVKLLA 75
            +G+G  G VF+  ++  G+ VA+K     +      +  +RE ++L+ +KHEN+V L+ 
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 76  IEEEQEGRGKV------IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL 129
           I   +            +V + C       + +           E   V++ L  G+ ++
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 133

Query: 130 RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-----QFMSLYGTEEYLH 184
             N+++HRD+K  N++  I  DG  + KL DFG AR     +     ++ +   T  Y  
Sbjct: 134 HRNKILHRDMKAANVL--ITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA 244
           P++           + +G  +DLW  G  +  + T +   +   G   +  +  I+    
Sbjct: 190 PELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQ---GNTEQHQLALISQLCG 239

Query: 245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTP-------ILAGLLEVDSKKIWSF 297
           S         +N E+    +L    +  +  +            ++  LL +D  +    
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

Query: 298 E-----RFFSE 303
           +      FF  
Sbjct: 300 DDALNHDFFWS 310

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 5e-31
 Identities = 68/308 (22%), Positives = 113/308 (36%), Gaps = 36/308 (11%)

Query: 16  SVLGKGATGAVFQGVN-KNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKK---VKHENI 70
           + +G+GA G VF+  + KN G  VA+K     +      +  +RE  VL+     +H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 71  VKLLAIEEEQEGRGKV---IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMK 127
           V+L  +        +    +V E         +   PE   G+  E    ++  L  G+ 
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLD 130

Query: 128 HLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM 187
            L  +R+VHRDLKP NI+       S   KL DFG AR         S+  T  Y  P++
Sbjct: 131 FLHSHRVVHRDLKPQNIL----VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV 247
                       ++   VDLWS+G     +      FR   G  + + +  I      G+
Sbjct: 187 LL--------QSSYATPVDLWSVGCIFAEMFRRKPLFR---GSSDVDQLGKI--LDVIGL 233

Query: 248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTP----ILAGLLEVDSKKIWSFE----- 298
                   +  +        + Q        +      +L   L  +  K  S       
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293

Query: 299 RFFSEVTK 306
            +F ++ +
Sbjct: 294 PYFQDLER 301

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 6e-31
 Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 24/228 (10%)

Query: 17  VLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
            +G+G  G V QG+     N    VA+KT    +     +  ++E   +++  H +IVKL
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           + +  E       I+MELCT G L +        Y L     +L    L+  + +L   R
Sbjct: 74  IGVITENP---VWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAYLESKR 128

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS--LYGTEEYLHPDMYERA 191
            VHRD+   N++       +   KL DFG +R +E+   + +       +++ P+     
Sbjct: 129 FVHRDIAARNVLV----SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN-- 182

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                  + F +  D+W  GV ++ +    +   P+ G +N + +  I
Sbjct: 183 ------FRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRI 222

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 7e-31
 Identities = 51/236 (21%), Positives = 88/236 (37%), Gaps = 28/236 (11%)

Query: 17  VLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIV 71
            LG G+ G V +G           VAVK        +P  +   +RE   +  + H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           +L  +      +   +V EL   GSL + L   +                +  GM +L  
Sbjct: 75  RLYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYLES 129

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY----GTEEYLHPDM 187
            R +HRDL   N++  +      + K+ DFG  R L ++     +         +  P+ 
Sbjct: 130 KRFIHRDLAARNLL--LATRD--LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
            +         +TF    D W  GVTL+ + T      P+ G    + ++ I  + 
Sbjct: 186 LK--------TRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQILHKIDKEG 231

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 7e-31
 Identities = 65/309 (21%), Positives = 122/309 (39%), Gaps = 39/309 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            +GKG  G V++G  K  GE VAVK F+  S       +  E      ++HENI+  +A 
Sbjct: 10  SIGKGRFGEVWRG--KWRGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 77  EEEQEGRGKV--IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHL----- 129
           + +  G      +V +    GSLF+ L    N Y +  E  + +     +G+ HL     
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 130 ---RDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-----GTEE 181
                  + HRDLK  NI+  +  +G+    + D G A   +     + +      GT+ 
Sbjct: 122 GTQGKPAIAHRDLKSKNIL--VKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           Y+ P++ + ++  K          D++++G+  + +A         G   + +  YY   
Sbjct: 178 YMAPEVLDDSINMK--HFESFKRADIYAMGLVFWEIARRCSIG---GIHEDYQLPYYDLV 232

Query: 242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFF 301
                V    +     ++    ++PN  Q    L+ +   I+      +     +     
Sbjct: 233 PSDPSVEEMRKVVCEQKLR--PNIPNRWQSCEALRVMAK-IMRECWYANGAARLT----A 285

Query: 302 SEVTKTLNR 310
             + KTL++
Sbjct: 286 LRIKKTLSQ 294

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 1e-30
 Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 25/235 (10%)

Query: 17  VLGKGATGAVFQGV---NKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKL 73
           V+G+G  G V+ G    N       AVK+ N+++ +      + E  ++K   H N++ L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR 133
           L I    EG   ++V+     G L N       T+    ++ +     +  GMK L   +
Sbjct: 94  LGICLRSEGS-PLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150

Query: 134 LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQ-----QFMSLYGTEEYLHPDMY 188
            VHRDL   N M     D     K+ DFG AR++ + +              +++  +  
Sbjct: 151 FVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
           +         + F    D+WS GV L+ + T   P  PY      +   Y+   +
Sbjct: 207 Q--------TQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGR 251

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-30
 Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 23/230 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
           +LGKG  G V     K  G   A+K   +   +   +V   + E  VL+  +H  +  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
              +  +      VME   GG LF  L          EE        + + +++L    +
Sbjct: 72  YAFQTHDRL--CFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRDV 126

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLY-GTEEYLHPDMYERAVL 193
           V+RD+K  N+M  +  DG    K+TDFG  +E   D   M  + GT EYL P++ E    
Sbjct: 127 VYRDIKLENLM--LDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---- 178

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
                  +G  VD W +GV +Y +  G LPF     + ++     I  ++
Sbjct: 179 ----DNDYGRAVDWWGLGVVMYEMMCGRLPFY---NQDHERLFELILMEE 221

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 3e-30
 Identities = 51/231 (22%), Positives = 98/231 (42%), Gaps = 29/231 (12%)

Query: 17  VLGKGATGAVFQGV--NKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVK 72
            LG G  G V +G    K   + VAVK         P      + E  V++++ +  IV+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           ++ I E +     ++VME+   G L   L    +   ++++  + ++  ++ GMK+L ++
Sbjct: 73  MIGICEAES---WMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS----LYGTEEYLHPDMY 188
             VHRDL   N++  +        K++DFG ++ L  D+ +           ++  P+  
Sbjct: 127 NFVHRDLAARNVL--LVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                       F +  D+WS GV ++   +      PY G +  E    +
Sbjct: 183 N--------YYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAML 223

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  117 bits (295), Expect = 6e-30
 Identities = 47/238 (19%), Positives = 93/238 (39%), Gaps = 24/238 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            +G+G+ G +F+G N  N + VA+K   + S          E+   K +     +  +  
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNV-Y 67

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              QEG   V+V++L        +            +   +  + + A ++ + +  LV+
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 137 RDLKPGNIM-KFICDDGSTIYKLTDFGAARELEED--------QQFMSLYGTEEYLHPDM 187
           RD+KP N +        + +  + DFG  +   +         ++  +L GT  Y+  + 
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 188 YERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS 245
           +         G+      DL ++G    +   G+LP++      NK+    I  KK S
Sbjct: 185 HL--------GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 8e-30
 Identities = 67/299 (22%), Positives = 109/299 (36%), Gaps = 31/299 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +G+G  G VF+  N+   E VA+K    L           +RE  +LK++KH+NIV+  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKNIVR-- 65

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
             +     +   +V E C             +      E     L  L  G+       +
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCHSRNV 122

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYG-TEEYLHPDMYERAVL 193
           +HRDLKP N++  I  +G    KL +FG AR      +  S    T  Y  PD+      
Sbjct: 123 LHRDLKPQNLL--INRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG--- 175

Query: 194 RKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT----TKKASGVIS 249
                K +  ++D+WS G     +A    P   + G    + +  I     T       S
Sbjct: 176 ----AKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEEQWPS 229

Query: 250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-----RFFSE 303
            T+  +           +   +   L      +L  LL+ +  +  S E      +FS+
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  117 bits (293), Expect = 1e-29
 Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 21/225 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            LG G  G V++GV K     VAVKT  + +        ++E  V+K++KH N+V+LL +
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGV 81

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
              +      I+ E  T G+L + L +  N   +     L +   +++ M++L     +H
Sbjct: 82  CTREPPF--YIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 138

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ--FMSLYGTEEYLHPDMYERAVLR 194
           RDL   N +     +   + K+ DFG +R +  D            ++  P+        
Sbjct: 139 RDLAARNCL---VGENHLV-KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----- 189

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                 F    D+W+ GV L+ +AT  +   PY G    +    +
Sbjct: 190 ---YNKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVYELL 229

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 1e-29
 Identities = 71/302 (23%), Positives = 113/302 (37%), Gaps = 31/302 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVKHENIVKLLA 75
            +G+G  G V++  NK  GE VA+K     +         +RE  +LK++ H NIVKLL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68

Query: 76  IEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLV 135
           +   +      +V E            D     G+        L  L  G+     +R++
Sbjct: 69  VIHTENKL--YLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124

Query: 136 HRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE-EYLHPDMYERAVLR 194
           HRDLKP N++  I  +G+   KL DFG AR      +  +       Y  P++       
Sbjct: 125 HRDLKPQNLL--INTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG---- 176

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTS 254
               K +   VD+WS+G     + T    F    G    + ++ I     +         
Sbjct: 177 ---CKYYSTAVDIWSLGCIFAEMVTRRALFP---GDSEIDQLFRIFRTLGTP-DEVVWPG 229

Query: 255 ENGEIDWCTDLPNNCQLSL-----GLKKLVTPILAGLLEVDSKKIWSFE-----RFFSEV 304
                D+    P   +         L +    +L+ +L  D  K  S +      FF +V
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

Query: 305 TK 306
           TK
Sbjct: 290 TK 291

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 2e-29
 Identities = 52/239 (21%), Positives = 87/239 (36%), Gaps = 32/239 (13%)

Query: 17  VLGKGATGAVFQGVNKNNGE--PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKL 73
           V+G+G  G V +   K +G     A+K   + +    H     E EVL K+  H NI+ L
Sbjct: 17  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76

Query: 74  LAIEEEQEGRGKVIVMELCTGGSLFNIL-------------DDPENTYGLQEEEFLLVLE 120
           L   E +      + +E    G+L + L                     L  ++ L    
Sbjct: 77  LGACEHRGYL--YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134

Query: 121 HLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTE 180
            +  GM +L   + +HRDL   NI+       + + K+ DFG +R  E   +        
Sbjct: 135 DVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLSRGQEVYVKKTMGRLPV 190

Query: 181 EYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
            ++  +              +    D+WS GV L+ + +      PY G    E    +
Sbjct: 191 RWMAIESLN--------YSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKL 239

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 4e-29
 Identities = 55/234 (23%), Positives = 101/234 (43%), Gaps = 26/234 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           VLG GA G V++G+    GE    PVA+K   + +  + +   + E  V+  V + ++ +
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           LL I      +   ++ +L   G L + + + ++  G   +  L     +  GM +L D 
Sbjct: 76  LLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMNYLEDR 130

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYE 189
           RLVHRDL   N++         + K+TDFG A+ L  +++           +++  +   
Sbjct: 131 RLVHRDLAARNVL---VKTPQHV-KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 190 RAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
                    + +    D+WS GVT++ + T      PY G    E    +   +
Sbjct: 187 --------HRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSILEKGE 230

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (289), Expect = 4e-29
 Identities = 49/235 (20%), Positives = 92/235 (39%), Gaps = 24/235 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAI 76
            +G G+ G ++ G +   GE VA+K          H     E ++ K ++    +  +  
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIK---LECVKTKHPQLHIESKIYKMMQGGVGIPTI-R 69

Query: 77  EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVH 136
               EG   V+VMEL                     +  LL+ + + + ++++     +H
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 137 RDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM--------SLYGTEEYLHPDMY 188
           RD+KP N +  +   G+ +Y   DFG A++  + +           +L GT  Y   + +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYI-IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK 243
                    G       DL S+G  L +   G+LP++       ++    I+ KK
Sbjct: 186 L--------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (288), Expect = 5e-29
 Identities = 54/256 (21%), Positives = 94/256 (36%), Gaps = 45/256 (17%)

Query: 17  VLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
            +G+GA G VFQ              VAVK   + +         RE  ++ +  + NIV
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDD---------------------PENTYGL 110
           KLL +    +     ++ E    G L   L                             L
Sbjct: 80  KLLGVCAVGKPM--CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137

Query: 111 QEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED 170
              E L +   + AGM +L + + VHRDL   N +  + ++   + K+ DFG +R +   
Sbjct: 138 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL--VGENM--VVKIADFGLSRNIYSA 193

Query: 171 QQFM---SLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
             +    +      ++ P+              +    D+W+ GV L+ + +  L   PY
Sbjct: 194 DYYKADGNDAIPIRWMPPESIF--------YNRYTTESDVWAYGVVLWEIFSYGLQ--PY 243

Query: 228 GGRRNKETMYYITTKK 243
            G  ++E +YY+    
Sbjct: 244 YGMAHEEVIYYVRDGN 259

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 7e-29
 Identities = 56/256 (21%), Positives = 93/256 (36%), Gaps = 45/256 (17%)

Query: 17  VLGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENI 70
           VLG GA G V         +      VAVK   + +     +  M E +++ ++  HENI
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNIL--------------------DDPENTYGL 110
           V LL            ++ E C  G L N L                    ++ E+   L
Sbjct: 104 VNLLGACTLSGPI--YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161

Query: 111 QEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED 170
             E+ L     +  GM+ L     VHRDL   N++      G  +  + DFG AR++  D
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL---VTHGKVVK-ICDFGLARDIMSD 217

Query: 171 QQF---MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
             +    +     +++ P+              +    D+WS G+ L+ + +  +   PY
Sbjct: 218 SNYVVRGNARLPVKWMAPESLF--------EGIYTIKSDVWSYGILLWEIFSLGVN--PY 267

Query: 228 GGRRNKETMYYITTKK 243
            G       Y +    
Sbjct: 268 PGIPVDANFYKLIQNG 283

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 9e-29
 Identities = 54/235 (22%), Positives = 88/235 (37%), Gaps = 38/235 (16%)

Query: 17  VLGKGATGAVFQG-----VNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENI 70
            LG GA G V +      +  +    VAVK     +H+   +  M E +VL  +  H NI
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNIL---------------DDPENTYGLQEEEF 115
           V LL           +++ E C  G L N L                  ++   L  E+ 
Sbjct: 90  VNLLGACTIGGPT--LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 116 LLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMS 175
           L     +  GM  L     +HRDL   NI+  +      I K+ DFG AR+++ D  ++ 
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNIL--LTHGR--ITKICDFGLARDIKNDSNYVV 203

Query: 176 ---LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPY 227
                   +++ P+              +    D+WS G+ L+ + +      P 
Sbjct: 204 KGNARLPVKWMAPESIF--------NCVYTFESDVWSYGIFLWELFSLGSSPYPG 250

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  113 bits (282), Expect = 2e-28
 Identities = 67/298 (22%), Positives = 114/298 (38%), Gaps = 31/298 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            +G+G  G V++  N   GE  A+K    L           +RE  +LK++KH NIVKL 
Sbjct: 9   KIGEGTYGVVYKAQNNY-GETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
            +   +  +  V+V E         +        GL+       L  L  G+ +  D R+
Sbjct: 67  DVIHTK--KRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           +HRDLKP N++  I  +G    K+ DFG AR      +  +                VL 
Sbjct: 122 LHRDLKPQNLL--INREG--ELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLM 173

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT----TKKASGVISG 250
               K +  T+D+WS+G     +  G   F    G    + +  I     T  +    + 
Sbjct: 174 G--SKKYSTTIDIWSVGCIFAEMVNGTPLFP---GVSEADQLMRIFRILGTPNSKNWPNV 228

Query: 251 TQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-----RFFSE 303
           T+  +        +         GL +    +L+ +L++D  +  + +      +F E
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 3e-28
 Identities = 60/242 (24%), Positives = 105/242 (43%), Gaps = 31/242 (12%)

Query: 17  VLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
            LG+G+ G V++GV K          VA+KT N+ + MR     + E  V+K+    ++V
Sbjct: 27  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNIL-------DDPENTYGLQEEEFLLVLEHLTA 124
           +LL +  + +    +++MEL T G L + L        +          + + +   +  
Sbjct: 87  RLLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---SLYGTEE 181
           GM +L  N+ VHRDL   N M  + +D     K+ DFG  R++ E   +           
Sbjct: 145 GMAYLNANKFVHRDLAARNCM--VAEDF--TVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 182 YLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT 241
           ++ P+  +           F    D+WS GV L+ +AT      PY G  N++ + ++  
Sbjct: 201 WMSPESLK--------DGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFVME 250

Query: 242 KK 243
             
Sbjct: 251 GG 252

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  114 bits (285), Expect = 4e-28
 Identities = 74/350 (21%), Positives = 135/350 (38%), Gaps = 69/350 (19%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ--MREFEVLKKVKHENIVKLL 74
            LG G+ G V    +K +G   A+K  ++   ++   ++  + E  +L+ V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 75  AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRL 134
                ++     +VME   GG +F+ L          E         +    ++L    L
Sbjct: 108 --FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDL 162

Query: 135 VHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLR 194
           ++RDLKP N++  I   G    ++TDFG A+      +  +L GT E L P++       
Sbjct: 163 IYRDLKPENLL--IDQQG--YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIIL----- 211

Query: 195 KPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGTQTS 254
               K +   VD W++GV +Y +A G  PF      +  +    I               
Sbjct: 212 ---SKGYNKAVDWWALGVLIYEMAAGYPPFF---ADQPIQIYEKIV-------------- 251

Query: 255 ENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFER----------FFSEV 304
            +G++ + +   ++ +           +L  LL+VD  K +   +          +F+  
Sbjct: 252 -SGKVRFPSHFSSDLK----------DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

Query: 305 --TKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQ 352
                  RK+   F       I  +  P D      D  +E+  V+ N++
Sbjct: 301 DWIAIYQRKVEAPF-------IPKFKGPGDT-SNFDDYEEEEIRVSINEK 342

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 3e-27
 Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 26/231 (11%)

Query: 17  VLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVK 72
           V+G G  G V++G+ K +      PVA+KT       +     + E  ++ +  H NI++
Sbjct: 14  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73

Query: 73  LLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN 132
           L  +  + +    +I+ E    G+L   L + +        + + +L  + AGMK+L + 
Sbjct: 74  LEGVISKYKPM--MIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLANM 129

Query: 133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQ----FMSLYGTEEYLHPDMY 188
             VHRDL   NI+  +  +   + K++DFG +R LE+D +             +  P+  
Sbjct: 130 NYVHRDLAARNIL--VNSNL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 189 ERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI 239
                     + F +  D+WS G+ ++ V T      PY    N E M  I
Sbjct: 186 S--------YRKFTSASDVWSFGIVMWEVMTYGER--PYWELSNHEVMKAI 226

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 2e-26
 Identities = 69/303 (22%), Positives = 120/303 (39%), Gaps = 35/303 (11%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVKHENIVKLL 74
           S +G GA G+V    +   G  VAVK  ++      H  +  RE  +LK +KHEN++ LL
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 75  AIEEEQEG---RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
            +            V ++    G  L NI         L ++    ++  +  G+K++  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNI----VKCQKLTDDHVQFLIYQILRGLKYIHS 139

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
             ++HRDLKP N+      +     K+ DFG AR    D +      T  Y  P++    
Sbjct: 140 ADIIHRDLKPSNLA----VNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLN- 192

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS-GVISG 250
                    +  TVD+WS+G  +  + TG   F    G  + + +  I     + G    
Sbjct: 193 ------WMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQLKLILRLVGTPGAELL 243

Query: 251 TQTSENGEIDWCTDLPNNCQLSL-----GLKKLVTPILAGLLEVDSKKIWSFE-----RF 300
            + S     ++   L    +++      G   L   +L  +L +DS K  +        +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303

Query: 301 FSE 303
           F++
Sbjct: 304 FAQ 306

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 1e-25
 Identities = 70/344 (20%), Positives = 134/344 (38%), Gaps = 44/344 (12%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVKHENIVKLLA 75
            +G GA GAV   V+   G  VA+K   +         +  RE  +LK ++HEN++ LL 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 76  IEEEQEGRGKV----IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           +    E         +VM    G  L  ++        L E+    ++  +  G++++  
Sbjct: 85  VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA 139

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
             ++HRDLKPGN+      +     K+ DFG AR+   D +      T  Y  P++    
Sbjct: 140 AGIIHRDLKPGNLAV----NEDCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVILN- 192

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT 251
                    +  TVD+WS+G  +  + TG   F+   G  + + +  I     +      
Sbjct: 193 ------WMRYTQTVDIWSVGCIMAEMITGKTLFK---GSDHLDQLKEIMKVTGTPPAEFV 243

Query: 252 QTSENGEI-DWCTDLPNNCQLSL-----GLKKLVTPILAGLLEVDSKKIWSFE-----RF 300
           Q  ++ E  ++   LP   +            L   +L  +L +D+++  +        +
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303

Query: 301 FSEVTKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQ 344
           F  +  T +   V  +  +       +   D   D+ + +  ++
Sbjct: 304 FESLHDTEDEPQVQKYDDS-------FDDVDRTLDEWKRVTYKE 340

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 1e-25
 Identities = 51/227 (22%), Positives = 94/227 (41%), Gaps = 18/227 (7%)

Query: 17  VLGKGATGAVFQG---VNKNNGEPVAVKTFNQ---LSHMRPHDVQMREFEVLKKVKHENI 70
           VLG GA G VF        + G+  A+K   +   +   +  +    E +VL+ ++    
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 71  VKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLR 130
           +  L    + E +   ++++   GG LF  L          E E  + +  +   ++HL 
Sbjct: 91  LVTLHYAFQTETK-LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLH 146

Query: 131 DNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYER 190
              +++RD+K  NI+     D +    LTDFG ++E   D+   +          +    
Sbjct: 147 KLGIIYRDIKLENILL----DSNGHVVLTDFGLSKEFVADETERAYD---FCGTIEYMAP 199

Query: 191 AVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY 237
            ++R          VD WS+GV +Y + TG  PF   G + ++  + 
Sbjct: 200 DIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 4e-25
 Identities = 49/251 (19%), Positives = 92/251 (36%), Gaps = 40/251 (15%)

Query: 17  VLGKGATGAVFQGVNK-------NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHE 68
            LG+GA G V             N    VAVK     +  +     + E E++K + KH+
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 69  NIVKLLAIEEEQEGRGKVIVMELCTGGSLFNIL-------------DDPENTYGLQEEEF 115
           NI+    +    +     +++E  + G+L   L                     L  ++ 
Sbjct: 80  NIIN--LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137

Query: 116 LLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQF-- 173
           +     +  GM++L   + +HRDL   N++         + K+ DFG AR++     +  
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVL----VTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 174 -MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRN 232
             +     +++ P+            + +    D+WS GV L+ + T      PY G   
Sbjct: 194 TTNGRLPVKWMAPEALF--------DRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPV 243

Query: 233 KETMYYITTKK 243
           +E    +    
Sbjct: 244 EELFKLLKEGH 254

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 7e-25
 Identities = 63/319 (19%), Positives = 114/319 (35%), Gaps = 35/319 (10%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQ-MREFEVLKKVKHENIVKLLA 75
            +G GA G V    +      VA+K  ++    + H  +  RE  ++K V H+NI+ LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 76  I----EEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD 131
           +    +  +E +   +VMEL        I  + +       E    +L  +  G+KHL  
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137

Query: 132 NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERA 191
             ++HRDLKP NI+           K+ DFG AR             T  Y  P++    
Sbjct: 138 AGIIHRDLKPSNIVV----KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-- 191

Query: 192 VLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVISGT 251
                 G  +   VD+WS+G  +  +    + F    GR   +    +  +  +      
Sbjct: 192 ------GMGYKENVDIWSVGCIMGEMVRHKILFP---GRDYIDQWNKVIEQLGTPCPEFM 242

Query: 252 QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRK 311
           +  +    ++  + P    L+               +          +  +   + L  K
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKL---------FPDSLFPADSEHNKLKASQARDLLSK 293

Query: 312 LVHLFHINRLQCIRIYLHP 330
           ++ +    R+       HP
Sbjct: 294 MLVIDPAKRISVDDALQHP 312

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (259), Expect = 9e-25
 Identities = 60/350 (17%), Positives = 119/350 (34%), Gaps = 33/350 (9%)

Query: 17  VLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHEN------- 69
            LG G    V+   +  N   VA+K           +    E ++L++V   +       
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDADNTKEDSM 77

Query: 70  ----IVKLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAG 125
               I+KLL     +   G  +VM     G     L       G+       + + L  G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 126 MKHLRDNR-LVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
           + ++     ++H D+KP N++  I D    + ++           D+ + +   T EY  
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA 244
           P++          G  +G   D+WS    ++ + TG+  F P  G    +   +I     
Sbjct: 198 PEVLL--------GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI----- 244

Query: 245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV 304
              I          +            S GL + ++ +    LE    + + F +  ++ 
Sbjct: 245 -AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303

Query: 305 TKTLNRKLVHLFHINRLQCIRIYLHPDDAYDQLQDLIQEQTDVTPNKQIL 354
                  ++ L    R     +  HP      L+D +  +    P++++ 
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGLVNHP-----WLKDTLGMEEIRVPDRELY 348

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 4e-24
 Identities = 53/244 (21%), Positives = 93/244 (38%), Gaps = 35/244 (14%)

Query: 17  VLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIV 71
            LG+GA G V +              VAVK   + +    H   M E ++L  + H   V
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 72  KLLAIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYG-------------LQEEEFLLV 118
             L     + G   ++++E C  G+L   L    N +              L  E  +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 119 LEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFM---S 175
              +  GM+ L   + +HRDL   NI+     + + + K+ DFG AR++ +D  ++    
Sbjct: 140 SFQVAKGMEFLASRKCIHRDLAARNIL---LSEKNVV-KICDFGLARDIYKDPDYVRKGD 195

Query: 176 LYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKET 235
                +++ P+            + +    D+WS GV L+ + +      PY G +  E 
Sbjct: 196 ARLPLKWMAPETIF--------DRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDEE 245

Query: 236 MYYI 239
               
Sbjct: 246 FCRR 249

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.8 bits (201), Expect = 2e-18
 Identities = 37/207 (17%), Positives = 74/207 (35%), Gaps = 37/207 (17%)

Query: 16  SVLGKGATGAVFQGVNKNNGEPVAVK-------TFNQLSHMRPHDV--QMREFEVLKKVK 66
            ++G+G   AVF   ++       VK       +F ++   R +             + +
Sbjct: 6   KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 67  HENIVKLL--AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTA 124
              + KL   A+ +     G  ++MEL           D +  Y ++ E    VL+ +  
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELI----------DAKELYRVRVENPDEVLDMILE 114

Query: 125 GMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEEDQQFMSLYGTEEYLH 184
            +       +VH DL   N++  + ++G     + DF  + E+ E+          E L 
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVL--VSEEG---IWIIDFPQSVEVGEEG-------WREILE 162

Query: 185 PDMYERAVLRKPVGKTFGATVDLWSIG 211
            D+     +     +T+    D+ S  
Sbjct: 163 RDVR---NIITYFSRTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	708
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.07
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.42
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.37
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.13
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.06
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	91.73

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-51  Score=437.57  Aligned_cols=264  Identities=27%  Similarity=0.385  Sum_probs=201.5

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ....|.+.+.||+|+||.||+|.++.+|+.||||++...........+.+|+.++++++|||||++++++.+.+  .+|+
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~l   84 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG--HLYL   84 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS--EEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEE
Confidence            34569999999999999999999999999999999986554444455678999999999999999999998654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||||+||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+ ...+..+.+||+|||+|...
T Consensus        85 vmE~~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~-~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLY-YSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             EECCCCSCBHHHHHHTCSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-SSSSTTCCEEECCC------
T ss_pred             EEeccCCCcHHHhhhcccC---CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceee-cccCCCceEEEeccceeEEc
Confidence            9999999999999976443   9999999999999999999999999999999999997 33345678999999999987


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..+....+.+||+.|+|||++.        +..|+.++|||||||++|+|+||.+||.   +....+....+......  
T Consensus       161 ~~~~~~~~~~GT~~y~APE~~~--------~~~~~~~~DiwSlGvilyell~g~~Pf~---~~~~~~~~~~i~~~~~~--  227 (307)
T d1a06a_         161 DPGSVLSTACGTPGYVAPEVLA--------QKPYSKAVDCWSIGVIAYILLCGYPPFY---DENDAKLFEQILKAEYE--  227 (307)
T ss_dssp             ------------CTTSCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHHHTTCCC--
T ss_pred             cCCCeeeeeeeCccccCcHHHc--------CCCCCcHHHhhhhhHHHHHHHhCCCCCC---CCCHHHHHHHHhccCCC--
Confidence            7776667788999999999997        6789999999999999999999999997   45666666666643211  


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                     ...|....+|+    .+.+||.+||..||++|||+.++           +.|||+...
T Consensus       228 ---------------~~~~~~~~~s~----~~~~li~~~L~~dP~~R~s~~ei-----------l~hp~~~~~  270 (307)
T d1a06a_         228 ---------------FDSPYWDDISD----SAKDFIRHLMEKDPEKRFTCEQA-----------LQHPWIAGD  270 (307)
T ss_dssp             ---------------CCTTTTTTSCH----HHHHHHHHHSCSSGGGSCCHHHH-----------HHSTTTTSS
T ss_pred             ---------------CCCccccCCCH----HHHHHHHHHccCCHhHCcCHHHH-----------hcCHhhCCC
Confidence                           01222233444    45569999999999999999997           669999764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-52  Score=431.25  Aligned_cols=259  Identities=25%  Similarity=0.395  Sum_probs=208.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.++.+|+.||||+++........+.+.+|+.++++++|||||++++++.+.+  .+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~--~~~ivm   82 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQYLFL   82 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--eeEEEE
Confidence            469999999999999999999999999999999976544444455779999999999999999999998754  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||+||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+....
T Consensus        83 Ey~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl----~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          83 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL----DERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTCCEEECCCTTCEECEE
T ss_pred             eccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE----CCCCCEEEccchhheeecc
Confidence            9999999999997644   39999999999999999999999999999999999998    6667899999999987654


Q ss_pred             cc---cccccCCCCCcCChhhhhhhhhcCCCCCc-CCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        170 DQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKT-FGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       170 ~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~-~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      +.   .....+||+.|+|||++.        +.. ++.++|||||||++|+|+||++||..   ..+.............
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~--------~~~~~~~~~DiwSlGvilyeml~G~~pf~~---~~~~~~~~~~~~~~~~  224 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLK--------RREFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKT  224 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHH--------CSSBCHHHHHHHHHHHHHHHHHHSSCSCSS---SSTTSHHHHHHHTTCT
T ss_pred             CCccccccceeeCcCccCHhHhc--------CCCCCCCceeeeHhHHHHHHHHhCCCCCCC---CChHHHHHHHHhcCCC
Confidence            32   234578999999999997        454 46889999999999999999999974   2222223332221110


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                        ..+.+..+|++    +.+||.+||..||++|||++++           +.|||+....
T Consensus       225 ------------------~~~~~~~~s~~----~~~li~~~L~~dP~~R~t~~ei-----------l~hpwf~~~l  267 (271)
T d1nvra_         225 ------------------YLNPWKKIDSA----PLALLHKILVENPSARITIPDI-----------KKDRWYNKPL  267 (271)
T ss_dssp             ------------------TSTTGGGSCHH----HHHHHHHHSCSSTTTSCCHHHH-----------TTCTTTTCCC
T ss_pred             ------------------CCCccccCCHH----HHHHHHHHcCCChhHCcCHHHH-----------hcCHhhCcCC
Confidence                              11222334444    4569999999999999999997           7799997543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-51  Score=430.56  Aligned_cols=259  Identities=26%  Similarity=0.456  Sum_probs=217.6

Q ss_pred             CCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          6 GSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         6 ~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      |+...+|.+.+.||+|+||.||+|.++.+|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+.+  .+
T Consensus        16 ~dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~   92 (293)
T d1yhwa1          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGD--EL   92 (293)
T ss_dssp             SCTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred             CCcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECC--EE
Confidence            44556899999999999999999999999999999999755432 3566789999999999999999999998755  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|||||+||+|.+++...    .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+
T Consensus        93 ~ivmEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl----~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          93 WVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL----GMDGSVKLTDFGFCA  164 (293)
T ss_dssp             EEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE----CCCCcEeeccchhhe
Confidence            9999999999999988653    29999999999999999999999999999999999998    666789999999998


Q ss_pred             ccccc-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        166 ELEED-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       166 ~~~~~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      ....+ ......+||+.|+|||++.        +..|+.++|||||||++|+|+||.+||.   +.+..+.+..+.....
T Consensus       165 ~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~~~~~DiwSlGvilyemltG~~Pf~---~~~~~~~~~~~~~~~~  233 (293)
T d1yhwa1         165 QITPEQSKRSTMVGTPYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALYLIATNGT  233 (293)
T ss_dssp             ECCSTTCCBCCCCSCGGGCCHHHHS--------SSCBCTHHHHHHHHHHHHHHHHSSCTTT---TSCHHHHHHHHHHHCS
T ss_pred             eeccccccccccccCCCccChhhhc--------CCCCCchhceehHhHHHHHHhhCCCCCC---CCCHHHHHHHHHhCCC
Confidence            76544 3345678999999999997        6789999999999999999999999997   4555666666654321


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      +                  .++.+..+|+    .+.+||.+||..||.+|||++++           +.|||+..
T Consensus       234 ~------------------~~~~~~~~s~----~~~~li~~~L~~dP~~R~s~~ei-----------l~Hp~~~~  275 (293)
T d1yhwa1         234 P------------------ELQNPEKLSA----IFRDFLNRCLDMDVEKRGSAKEL-----------LQHQFLKI  275 (293)
T ss_dssp             C------------------CCSSGGGSCH----HHHHHHHHHTCSSTTTSCCHHHH-----------TTCGGGGG
T ss_pred             C------------------CCCCcccCCH----HHHHHHHHHccCChhHCcCHHHH-----------hcCHhhCC
Confidence            1                  1222233444    45569999999999999999997           77999954

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-51  Score=424.21  Aligned_cols=253  Identities=24%  Similarity=0.397  Sum_probs=211.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|.++.+|+.||+|++.+..  .......+.+|+.++++++|||||++++++.+.+  .+|+|
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~iv   84 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT--RVYLI   84 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC--EEEEE
Confidence            5899999999999999999999999999999986432  1233455679999999999999999999998654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||+||+|.+++.....   +++..++.++.||+.||+|||++|||||||||+|||+    +..+.+||+|||+|....
T Consensus        85 mEy~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill----~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL----GSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEECCCCSCSCCC
T ss_pred             EeecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee----cCCCCEeecccceeeecC
Confidence            999999999999976443   9999999999999999999999999999999999998    666789999999998665


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      .. .....+||+.|+|||++.        +..|+.++|||||||++|+|+||++||.   +.+..+.+..+.....    
T Consensus       158 ~~-~~~~~~Gt~~Y~APE~~~--------~~~~~~~~DiwSlGvilyell~G~~Pf~---~~~~~~~~~~i~~~~~----  221 (263)
T d2j4za1         158 SS-RRTTLCGTLDYLPPEMIE--------GRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEF----  221 (263)
T ss_dssp             CC-CCEETTEEGGGCCHHHHT--------TCCCCTTHHHHHHHHHHHHHHHSSCTTC---CSSHHHHHHHHHTTCC----
T ss_pred             CC-cccccCCCCcccCHHHHc--------CCCCCchhhhhhHhHHHHHHhcCCCCCC---CCCHHHHHHHHHcCCC----
Confidence            43 344678999999999997        6779999999999999999999999997   4555666655553211    


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                     .+|.  .+|+    .+.+||.+||+.||++|||++++           +.|||+...
T Consensus       222 ---------------~~p~--~~s~----~~~~li~~~L~~dp~~R~t~~ei-----------l~hp~~~~~  261 (263)
T d2j4za1         222 ---------------TFPD--FVTE----GARDLISRLLKHNPSQRPMLREV-----------LEHPWITAN  261 (263)
T ss_dssp             ---------------CCCT--TSCH----HHHHHHHHHTCSSGGGSCCHHHH-----------HTCHHHHHH
T ss_pred             ---------------CCCc--cCCH----HHHHHHHHHccCCHhHCcCHHHH-----------HcCcCcCCc
Confidence                           1222  2344    45569999999999999999997           679998543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=426.89  Aligned_cols=270  Identities=27%  Similarity=0.439  Sum_probs=221.6

Q ss_pred             cccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-----CchHHHHHHHHHHHhCCCCCccceeEEE
Q psy15481          3 FLRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-----RPHDVQMREFEVLKKVKHENIVKLLAIE   77 (708)
Q Consensus         3 ~l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-----~~~~~~~~Ei~iL~kL~HpNIVkl~~v~   77 (708)
                      |-+.+.+.+|.+.+.||+|+||.||+|+++.+|+.||||++++....     ...+.+.+|+.++++++|||||++++++
T Consensus         3 ~~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (293)
T d1jksa_           3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   82 (293)
T ss_dssp             CBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            44566777899999999999999999999999999999999754322     1245677999999999999999999999


Q ss_pred             EecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEE
Q psy15481         78 EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYK  157 (708)
Q Consensus        78 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vK  157 (708)
                      .+.+  .+|+|||||+||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+.........+|
T Consensus        83 ~~~~--~~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          83 ENKT--DVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             ECSS--EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EECC--EEEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceE
Confidence            8754  5999999999999999997644   3999999999999999999999999999999999999722222234699


Q ss_pred             EeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHH
Q psy15481        158 LTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMY  237 (708)
Q Consensus       158 L~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~  237 (708)
                      |+|||+|.....+.......||+.|+|||++.        +..++.++||||+||++|+|+||..||.   +.+..+.+.
T Consensus       158 l~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~--------~~~~~~~~DiwSlGvilyell~g~~Pf~---~~~~~~~~~  226 (293)
T d1jksa_         158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN--------YEPLGLEADMWSIGVITYILLSGASPFL---GDTKQETLA  226 (293)
T ss_dssp             ECCCTTCEECTTSCBCSCCCCCGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHH
T ss_pred             ecchhhhhhcCCCccccccCCCCcccCHHHHc--------CCCCCCcccchhhhHHHHHHHcCCCCCC---CCCHHHHHH
Confidence            99999999887776677788999999999997        6789999999999999999999999997   466666666


Q ss_pred             HHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        238 YITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       238 ~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .+......                   ++  ....+.++..+.+||.+||..||.+|||++++           +.|||+
T Consensus       227 ~i~~~~~~-------------------~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei-----------l~hp~~  274 (293)
T d1jksa_         227 NVSAVNYE-------------------FE--DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS-----------LQHPWI  274 (293)
T ss_dssp             HHHTTCCC-------------------CC--HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH-----------HHSTTT
T ss_pred             HHHhcCCC-------------------CC--chhcCCCCHHHHHHHHHHccCChhHCcCHHHH-----------hcCccc
Confidence            66543211                   11  11112233445669999999999999999997           569999


Q ss_pred             CCc
Q psy15481        318 INR  320 (708)
Q Consensus       318 ~~~  320 (708)
                      ...
T Consensus       275 ~~~  277 (293)
T d1jksa_         275 KPK  277 (293)
T ss_dssp             CC-
T ss_pred             CCC
Confidence            653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=424.64  Aligned_cols=262  Identities=27%  Similarity=0.407  Sum_probs=215.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|++.+.||+|+||.||+|+++.+|+.||+|+++... ....+.+.+|++++++++|||||++++++.+.+  .+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--eEEEEE
Confidence            36999999999999999999999999999999997643 233455679999999999999999999998755  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||+||+|.+++.+...  .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+|.....
T Consensus        89 Ey~~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll----~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          89 EFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF----TLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             ECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTTCEECHH
T ss_pred             ecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE----CCCCCEEEEechhhhccCC
Confidence            99999999998765332  39999999999999999999999999999999999998    6667899999999986654


Q ss_pred             c-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        170 D-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       170 ~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      . ....+.+||+.|+|||++...   ...+..|+.++|||||||++|+|+||++||.   +.+..+.+..+....++   
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~---~~~~~~y~~k~DiwSlGvilyemltg~~Pf~---~~~~~~~~~~i~~~~~~---  233 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCE---TSKDRPYDYKADVWSLGITLIEMAEIEPPHH---ELNPMRVLLKIAKSEPP---  233 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTC---STTTSSTTTHHHHHHHHHHHHHHHHSSCTTT---TSCGGGHHHHHHHSCCC---
T ss_pred             CcccccccccccccCCHHHHhhc---ccCCCCCChhhhHHHHHHHHHHHhhCCCCCC---CCCHHHHHHHHHcCCCC---
Confidence            3 334567899999999998521   1115678999999999999999999999997   45666777777653221   


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                     .++.+..+|+    .+.+||.+||+.||.+|||+.++           +.|||+..
T Consensus       234 ---------------~~~~~~~~s~----~~~~li~~~L~~dp~~R~t~~el-----------l~hp~~~~  274 (288)
T d2jfla1         234 ---------------TLAQPSRWSS----NFKDFLKKCLEKNVDARWTTSQL-----------LQHPFVTV  274 (288)
T ss_dssp             ---------------CCSSGGGSCH----HHHHHHHHHSCSSTTTSCCHHHH-----------TTSGGGCC
T ss_pred             ---------------CCCccccCCH----HHHHHHHHHccCChhHCcCHHHH-----------hcCcccCC
Confidence                           1222233444    45569999999999999999997           77999854

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.5e-50  Score=432.34  Aligned_cols=262  Identities=27%  Similarity=0.408  Sum_probs=219.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .+|.+.+.||+|+||.||+|.++.+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+  .+|+||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~ivm  102 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--EMVMIY  102 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT--EEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEE
Confidence            46999999999999999999999999999999997543 222445679999999999999999999998754  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||+||+|.+++.....  .+++..++.++.||+.||.|||++|||||||||+|||+  ..++.+.+||+|||+|+....
T Consensus       103 E~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll--~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         103 EFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF--TTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--SSTTSCCEEECCCTTCEECCT
T ss_pred             EcCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeee--ccCCCCeEEEeecchheeccc
Confidence            99999999999865432  39999999999999999999999999999999999996  444567899999999998877


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      ........||+.|+|||++.        +..|+.++|||||||++|+|+||+.||.   +.+..+.+..+......    
T Consensus       179 ~~~~~~~~gT~~Y~aPEv~~--------~~~~~~~~DiwSlGvilyell~G~~Pf~---~~~~~~~~~~i~~~~~~----  243 (350)
T d1koaa2         179 KQSVKVTTGTAEFAAPEVAE--------GKPVGYYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVKSCDWN----  243 (350)
T ss_dssp             TSCEEEECSCTTTCCHHHHH--------TCCBCHHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHTCCC----
T ss_pred             ccccceecCcccccCHHHHc--------CCCCChhHhhhhhhHHHHHHHhCCCCCC---CCCHHHHHHHHHhCCCC----
Confidence            77677789999999999998        6789999999999999999999999997   46667777777653211    


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcc
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRL  321 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~  321 (708)
                                   ...+....+|+    .+.+||.+||..||++|||++++           +.|||+....
T Consensus       244 -------------~~~~~~~~~s~----~~~~li~~~L~~dP~~R~t~~ei-----------l~hp~~~~~~  287 (350)
T d1koaa2         244 -------------MDDSAFSGISE----DGKDFIRKLLLADPNTRMTIHQA-----------LEHPWLTPGN  287 (350)
T ss_dssp             -------------SCCGGGGGCCH----HHHHHHHHHCCSSGGGSCCHHHH-----------HHSTTTSCTT
T ss_pred             -------------CCcccccCCCH----HHHHHHHHHccCChhHCcCHHHH-----------hcCcccCCCC
Confidence                         01111223444    45569999999999999999997           5699997643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.1e-50  Score=431.80  Aligned_cols=268  Identities=25%  Similarity=0.398  Sum_probs=222.0

Q ss_pred             cCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          5 RGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         5 ~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      .|+....|.+.+.||+|+||.||+|.++.+|+.||||+++.... .....+.+|+.++++++|||||++++++.+.+  .
T Consensus        24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~  100 (352)
T d1koba_          24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--E  100 (352)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS--E
T ss_pred             CCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--E
Confidence            34555679999999999999999999999999999999875431 22345578999999999999999999998654  5


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      +|+|||||+||+|.+.+.....  .+++.+++.++.||+.||.|||++|||||||||+|||+  +.++.+.+||+|||+|
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl--~~~~~~~vkL~DFGla  176 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC--ETKKASSVKIIDFGLA  176 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--SSTTCCCEEECCCTTC
T ss_pred             EEEEEEcCCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccc--cccCCCeEEEeecccc
Confidence            9999999999999998765432  39999999999999999999999999999999999997  3335678999999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      .....+.......||+.|+|||++.        +..|+.++|||||||++|+|+||++||.   +.+..+.+..+.....
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlGvilyelltG~~Pf~---~~~~~~~~~~i~~~~~  245 (352)
T d1koba_         177 TKLNPDEIVKVTTATAEFAAPEIVD--------REPVGFYTDMWAIGVLGYVLLSGLSPFA---GEDDLETLQNVKRCDW  245 (352)
T ss_dssp             EECCTTSCEEEECSSGGGCCHHHHT--------TCCBCHHHHHHHHHHHHHHHHHSCCSSC---CSSHHHHHHHHHHCCC
T ss_pred             eecCCCCceeeccCcccccCHHHHc--------CCCCCCccchHHHHHHHHHHHhCCCCCC---CCCHHHHHHHHHhCCC
Confidence            9887777677789999999999997        6789999999999999999999999997   4666777777765321


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                      .               +  ..+.+..+|+    .+.+||.+||+.||.+|||++++           +.|||+.....
T Consensus       246 ~---------------~--~~~~~~~~s~----~~~~li~~~L~~dp~~R~s~~ei-----------l~Hp~~~~~~~  291 (352)
T d1koba_         246 E---------------F--DEDAFSSVSP----EAKDFIKNLLQKEPRKRLTVHDA-----------LEHPWLKGDHS  291 (352)
T ss_dssp             C---------------C--CSSTTTTSCH----HHHHHHHTTSCSSGGGSCCHHHH-----------HTSTTTSSCCT
T ss_pred             C---------------C--CcccccCCCH----HHHHHHHHHccCChhHCcCHHHH-----------hcCHhhCCCcc
Confidence            1               0  0111123444    45569999999999999999997           67999976543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=421.30  Aligned_cols=257  Identities=28%  Similarity=0.412  Sum_probs=199.6

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|++.+.||+|+||.||+|+++.+|+.||+|.++...... ..+.+.+|+.++++++|||||++++++.+...+.+|+||
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm   84 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   84 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence            5899999999999999999999999999999997654322 234467999999999999999999999776666799999


Q ss_pred             eccCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         90 ELCTGGSLFNILDDPE-NTYGLQEEEFLLVLEHLTAGMKHLRDNR-----LVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~-~~~~L~e~~v~~il~qIl~aL~yLH~~g-----IVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      |||+||+|.+++.... ....+++..++.++.||+.||.|||++|     |+||||||+|||+    +..+.+||+|||+
T Consensus        85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll----~~~~~vkl~DFG~  160 (269)
T d2java1          85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL----DGKQNVKLGDFGL  160 (269)
T ss_dssp             ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE----CTTSCEEECCHHH
T ss_pred             ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc----CCCCcEEEeeccc
Confidence            9999999999886421 1123999999999999999999999976     9999999999998    6677899999999


Q ss_pred             ccccccccc-ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        164 ARELEEDQQ-FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       164 A~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      |+....+.. ....+||+.|+|||++.        +..|+.++|||||||++|+|+||++||.   +.+..+....+...
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~--------~~~~~~~~DIwSlGvilyel~tg~~Pf~---~~~~~~~~~~i~~~  229 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMN--------RMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKELAGKIREG  229 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHHHHT
T ss_pred             eeecccCCCccccCCCCcccCCHHHHc--------CCCCChHHHHHhhCHHHHHHhhCCCCCC---CCCHHHHHHHHHcC
Confidence            998765433 34578999999999997        6779999999999999999999999997   45556666666543


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      ..+                  .+|  ..+|+    .+.+||.+||+.||.+|||++++           +.|||.
T Consensus       230 ~~~------------------~~~--~~~s~----~l~~li~~~L~~dp~~Rps~~el-----------l~hp~i  269 (269)
T d2java1         230 KFR------------------RIP--YRYSD----ELNEIITRMLNLKDYHRPSVEEI-----------LENPLI  269 (269)
T ss_dssp             CCC------------------CCC--TTSCH----HHHHHHHHHTCSSGGGSCCHHHH-----------HTSTTC
T ss_pred             CCC------------------CCC--cccCH----HHHHHHHHHcCCChhHCcCHHHH-----------HhCCcC
Confidence            211                  111  22344    45669999999999999999997           668884

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-50  Score=415.46  Aligned_cols=255  Identities=23%  Similarity=0.355  Sum_probs=203.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEec--CCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQ--EGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~--~~~~~~L   87 (708)
                      .|.+...||+|+||.||+|.++.+|+.||+|.+...... ...+.+.+|++++++++|||||++++++.+.  +...+|+
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            347888999999999999999999999999998754322 2234567999999999999999999998653  3456899


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNR--LVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~g--IVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |||||+||+|.+++.....   +++..++.++.||+.||+|||++|  |+||||||+|||+  + +..+.+||+|||+|+
T Consensus        90 vmE~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl--~-~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--T-GPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE--S-STTSCEEECCTTGGG
T ss_pred             EEeCCCCCcHHHHHhcccc---ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhcee--e-CCCCCEEEeecCcce
Confidence            9999999999999976433   999999999999999999999998  9999999999997  1 235679999999998


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHH-HHhccc
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY-ITTKKA  244 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~-i~~~~~  244 (708)
                      .... ....+.+||+.|+|||++.        + .|+.++|||||||++|+|+||++||..   ..+...+.. +.....
T Consensus       164 ~~~~-~~~~~~~GT~~Y~aPE~~~--------~-~~~~~~DIwSlGvilyel~~g~~Pf~~---~~~~~~~~~~i~~~~~  230 (270)
T d1t4ha_         164 LKRA-SFAKAVIGTPEFMAPEMYE--------E-KYDESVDVYAFGMCMLEMATSEYPYSE---CQNAAQIYRRVTSGVK  230 (270)
T ss_dssp             GCCT-TSBEESCSSCCCCCGGGGG--------T-CCCTHHHHHHHHHHHHHHHHSSCTTTT---CSSHHHHHHHHTTTCC
T ss_pred             eccC-CccCCcccCccccCHHHhC--------C-CCCCcCchhhHHHHHHHHHHCCCCCCC---cccHHHHHHHHHcCCC
Confidence            5433 3345678999999999985        3 489999999999999999999999973   333333333 332111


Q ss_pred             CCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        245 SGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       245 ~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                      +             ..      .....++    .+.++|.+||..||++|||++++           +.|||+.
T Consensus       231 ~-------------~~------~~~~~~~----~~~~li~~~l~~dp~~R~s~~el-----------l~Hp~fk  270 (270)
T d1t4ha_         231 P-------------AS------FDKVAIP----EVKEIIEGCIRQNKDERYSIKDL-----------LNHAFFQ  270 (270)
T ss_dssp             C-------------GG------GGGCCCH----HHHHHHHHHSCSSGGGSCCHHHH-----------HTSGGGC
T ss_pred             C-------------cc------cCccCCH----HHHHHHHHHccCCHhHCcCHHHH-----------hCCcccC
Confidence            0             00      0112333    45669999999999999999997           6799973

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=423.11  Aligned_cols=259  Identities=22%  Similarity=0.353  Sum_probs=211.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|.++.+|+.||||+++...  .....+.+.+|+.++++++||||+++++++.+.+  .+|+|
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~iv   86 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE--KLYFG   86 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS--EEEEE
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC--EEEEE
Confidence            5999999999999999999999999999999986432  1233456779999999999999999999998654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||+||+|.+++.....   +++..++.++.|++.||.|||++|||||||||+|||+    +..+.+||+|||+|+...
T Consensus        87 mEy~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll----~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL----NEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEEECCCTTCEECC
T ss_pred             EEccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc----CCCceEEecccccceecc
Confidence            999999999998876443   9999999999999999999999999999999999998    667789999999998765


Q ss_pred             ccc---cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 EDQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ...   ...+.+||+.|+|||++.        +..|+.++|||||||++|+|+||..||.   +.+..+.+.++..... 
T Consensus       160 ~~~~~~~~~~~~GT~~Y~APE~~~--------~~~~~~~~DiwSlGvilyell~g~~Pf~---~~~~~~~~~~i~~~~~-  227 (288)
T d1uu3a_         160 PESKQARANSFVGTAQYVSPELLT--------EKSACKSSDLWALGCIIYQLVAGLPPFR---AGNEYLIFQKIIKLEY-  227 (288)
T ss_dssp             ----------CCCCGGGCCHHHHH--------TCCCCHHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHTTCC-
T ss_pred             cCCcccccccccCCccccCceeec--------cCCCCcccceehhhHHHHHHhhCCCCCC---CcCHHHHHHHHHcCCC-
Confidence            332   334578999999999998        6789999999999999999999999997   4566666666664211 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                        .+|  ..++++    +.+||.+||+.||.+|||++|++..     .+-..||||..
T Consensus       228 ------------------~~p--~~~s~~----~~~li~~~L~~dP~~R~t~~e~~~~-----~~i~~Hpff~~  272 (288)
T d1uu3a_         228 ------------------DFP--EKFFPK----ARDLVEKLLVLDATKRLGCEEMEGY-----GPLKAHPFFES  272 (288)
T ss_dssp             ------------------CCC--TTCCHH----HHHHHHTTSCSSGGGSTTSGGGTCH-----HHHHTSGGGTT
T ss_pred             ------------------CCC--ccCCHH----HHHHHHHHccCCHhHCcCHHHHcCC-----HHHHcCCccCC
Confidence                              122  234444    5569999999999999999986443     12246898854

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=431.14  Aligned_cols=200  Identities=29%  Similarity=0.464  Sum_probs=177.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      +..|.+.+.||+|+||.||+|.++.+|+.||+|+++........+.+.+|+.++++++|||||++++++.+.+  .+|+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--EEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEE
Confidence            4579999999999999999999999999999999987655555566789999999999999999999998755  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||+||+|.+++.+...   +++..++.++.|++.||.|||+ +||+||||||+|||+    +..+.+||+|||+|...
T Consensus        83 mEy~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl----~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE----CTTCCEEECCCCCCHHH
T ss_pred             EEcCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE----CCCCCEEEeeCCCcccc
Confidence            999999999999976433   9999999999999999999997 599999999999998    66778999999999876


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCC
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRP  226 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~  226 (708)
                      .+. ...+.+||+.|+|||++.        +..|+.++||||+||++|||+||+.||.+
T Consensus       156 ~~~-~~~~~~GT~~Y~APEvl~--------~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         156 IDS-MANSFVGTRSYMSPERLQ--------GTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             HHH-TC---CCSSCCCCHHHHH--------CSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             CCC-ccccccCCccccCchHHc--------CCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            543 344678999999999998        77899999999999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-49  Score=420.98  Aligned_cols=263  Identities=23%  Similarity=0.353  Sum_probs=214.8

Q ss_pred             ccCCCCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecC
Q psy15481          4 LRGSTNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQE   81 (708)
Q Consensus         4 l~~~~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~   81 (708)
                      .....+..|...+.||+|+||.||+|+++.+|+.||||+++.......  ...+.+|+.++++++|||||++++++.+.+
T Consensus         9 ~~~dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   88 (309)
T d1u5ra_           9 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (309)
T ss_dssp             CCSCHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             cccCcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence            344556679999999999999999999999999999999976543322  234579999999999999999999998754


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                        .+|+|||||.||+|..++....   .+++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+||
T Consensus        89 --~~~iv~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl----~~~~~~Kl~DF  159 (309)
T d1u5ra_          89 --TAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL----SEPGLVKLGDF  159 (309)
T ss_dssp             --EEEEEEECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE----ETTTEEEECCC
T ss_pred             --EEEEEEEecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE----CCCCCEEEeec
Confidence              5999999999999987765543   39999999999999999999999999999999999998    66678999999


Q ss_pred             CccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        162 GAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       162 GlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      |+|......   ....||+.|+|||++....     ...|+.++|||||||++|+|++|..||.   +.+..+.+..+..
T Consensus       160 G~a~~~~~~---~~~~GT~~Y~APE~~~~~~-----~~~y~~~~DiwSlGvilyel~~g~~Pf~---~~~~~~~~~~i~~  228 (309)
T d1u5ra_         160 GSASIMAPA---NSFVGTPYWMAPEVILAMD-----EGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQ  228 (309)
T ss_dssp             TTCBSSSSB---CCCCSCGGGCCHHHHTTTT-----SCCBCTHHHHHHHHHHHHHHHHSSCTTT---TSCHHHHHHHHHH
T ss_pred             ccccccCCC---CccccCccccCHHHHhccC-----CCCcCchhhhhhHHHHHHHHHHCCCCCC---CCCHHHHHHHHHh
Confidence            999865443   3567999999999986211     3468999999999999999999999997   4556666766665


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ...+.                   +....+|+    .+.+||.+||+.||.+|||++++           +.|||+...
T Consensus       229 ~~~~~-------------------~~~~~~s~----~~~~li~~~L~~dP~~Rpt~~el-----------l~Hp~~~~~  273 (309)
T d1u5ra_         229 NESPA-------------------LQSGHWSE----YFRNFVDSCLQKIPQDRPTSEVL-----------LKHRFVLRE  273 (309)
T ss_dssp             SCCCC-------------------CSCTTSCH----HHHHHHHHHTCSSGGGSCCHHHH-----------TTCHHHHSC
T ss_pred             CCCCC-------------------CCCCCCCH----HHHHHHHHHCcCChhHCcCHHHH-----------HhCHHhcCC
Confidence            32211                   11122344    45669999999999999999997           679998654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=419.97  Aligned_cols=253  Identities=27%  Similarity=0.416  Sum_probs=212.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|+++.+|+.||||++++..  .........+|+.++++++||||+++++++.+.+  .+|+|
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~iv   83 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFV   83 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--EEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc--ccccc
Confidence            5899999999999999999999999999999997532  1223455679999999999999999999998754  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||+||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+...
T Consensus        84 ~ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl----~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML----DKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEECCCTTCBCSC
T ss_pred             eeccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe----cCCCCEEEeecccccccc
Confidence            999999999999987543   9999999999999999999999999999999999998    677789999999998764


Q ss_pred             c-cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        169 E-DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       169 ~-~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      . .......+||+.|+|||++.        +..|+.++|||||||++|+|++|.+||.   +.+..+....+....    
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~--------~~~y~~~~DiwSlGvilyeml~G~~pf~---~~~~~~~~~~i~~~~----  221 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLE--------DNDYGRAVDWWGLGVVMYEMMCGRLPFY---NQDHERLFELILMEE----  221 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGS--------SSCBCTTHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCC----
T ss_pred             cCCcccccceeCHHHhhhhhcc--------CCCCChhhcccchhhHHHHHHHCCCCCC---CcCHHHHHHHHhcCC----
Confidence            4 34455678999999999997        6889999999999999999999999997   455555555555431    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                       ++.+..+|++    +.+||.+||++||.+|++     ++++           +.|||+..
T Consensus       222 -----------------~~~p~~~s~~----~~dli~~~L~~dP~~R~~~~~~~~~ei-----------l~Hp~f~~  266 (337)
T d1o6la_         222 -----------------IRFPRTLSPE----AKSLLAGLLKKDPKQRLGGGPSDAKEV-----------MEHRFFLS  266 (337)
T ss_dssp             -----------------CCCCTTSCHH----HHHHHHHHTCSSTTTSTTCSTTTHHHH-----------HTSGGGTT
T ss_pred             -----------------CCCCccCCHH----HHHHHHhhccCCchhhcccccccHHHH-----------HcCccccc
Confidence                             1112235554    455999999999999995     6665           56888854

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.1e-48  Score=406.69  Aligned_cols=265  Identities=28%  Similarity=0.430  Sum_probs=219.0

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--------hHHHHHHHHHHHhCC-CCCccceeEEEEe
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--------HDVQMREFEVLKKVK-HENIVKLLAIEEE   79 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--------~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~   79 (708)
                      ..+|.+.+.||+|+||.||+|+++.+|+.||||++........        .+...+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            4579999999999999999999999999999999976543221        123568999999996 9999999999986


Q ss_pred             cCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         80 QEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        80 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      .+  .+|+|||||+||||.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        82 ~~--~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill----~~~~~~kl~  152 (277)
T d1phka_          82 NT--FFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL----DDDMNIKLT  152 (277)
T ss_dssp             SS--EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEEC
T ss_pred             Cc--ceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE----cCCCCeEEc
Confidence            54  5999999999999999997644   39999999999999999999999999999999999998    777789999


Q ss_pred             ccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        160 DFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       160 DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      |||+|.....+.......||+.|+|||.+......  ....++.++||||+||++|+|+||+.||.   +.+..+.+..+
T Consensus       153 DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~--~~~~~~~~~DiwslGvilyeml~g~~Pf~---~~~~~~~~~~i  227 (277)
T d1phka_         153 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND--NHPGYGKEVDMWSTGVIMYTLLAGSPPFW---HRKQMLMLRMI  227 (277)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCT--TSCCBCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHH
T ss_pred             cchheeEccCCCceeeeeccCCCCCHHHhhccccc--cCCCCCchheEcccchhhhhhccCCCCCC---CCCHHHHHHHH
Confidence            99999988776666678899999999999754321  24568999999999999999999999997   45666666666


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ......                 ...+....+|+    .+.+++.+||+.||.+|||++++           +.|||+..
T Consensus       228 ~~~~~~-----------------~~~~~~~~~s~----~~~~li~~~L~~~p~~R~s~~ei-----------l~h~~~~~  275 (277)
T d1phka_         228 MSGNYQ-----------------FGSPEWDDYSD----TVKDLVSRFLVVQPQKRYTAEEA-----------LAHPFFQQ  275 (277)
T ss_dssp             HHTCCC-----------------CCTTTGGGSCH----HHHHHHHHHCCSSGGGSCCHHHH-----------TTSGGGCT
T ss_pred             HhCCCC-----------------CCCcccccCCH----HHHHHHHHHccCChhHCcCHHHH-----------HcCHHHHH
Confidence            653211                 11222334454    45569999999999999999997           77999853

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=417.41  Aligned_cols=262  Identities=21%  Similarity=0.379  Sum_probs=218.4

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .+|.+.+.||+|+||.||+|.++.+|+.||||+++...  .....+.+|+.+++.++|||||++++++.+.+  .+|+||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~lvm   80 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESME--ELVMIF   80 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--EEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEEE
Confidence            36999999999999999999999999999999997542  22334579999999999999999999998754  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||+||+|.+++....  ..+++.+++.++.||+.||.|||++||+||||||+|||+  +.++...+||+|||++.....
T Consensus        81 E~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll--~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY--QTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--SSSSCCCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceee--cCCCceEEEEcccchhhcccc
Confidence            9999999999997643  239999999999999999999999999999999999996  445667899999999998777


Q ss_pred             cccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        170 DQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       170 ~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                      .......+||+.|+|||.+.        +..|+.++|||||||++|+|++|..||.   +.+..+.+..+......    
T Consensus       157 ~~~~~~~~~t~~y~ape~~~--------~~~~~~~~DiWSlGvily~ll~G~~Pf~---~~~~~~~~~~i~~~~~~----  221 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQ--------HDVVSTATDMWSLGTLVYVLLSGINPFL---AETNQQIIENIMNAEYT----  221 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHT--------TCEECHHHHHHHHHHHHHHHHHSSCTTC---CSSHHHHHHHHHHTCCC----
T ss_pred             CCcccccccccccccchhcc--------CCCCCchhhcccHHHHHHHHHhCCCCCC---CCCHHHHHHHHHhCCCC----
Confidence            66667788999999999987        6789999999999999999999999997   46667777777653211    


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCccc
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQ  322 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~  322 (708)
                                 +.  .+.+..+|+    .+.+||.+||..||.+|||++++           +.|||+.....
T Consensus       222 -----------~~--~~~~~~~s~----~~~~li~~~L~~dp~~R~s~~ei-----------l~hp~~~~~~~  266 (321)
T d1tkia_         222 -----------FD--EEAFKEISI----EAMDFVDRLLVKERKSRMTASEA-----------LQHPWLKQKIE  266 (321)
T ss_dssp             -----------CC--HHHHTTSCH----HHHHHHHTTSCSSGGGSCCHHHH-----------HHSHHHHSCGG
T ss_pred             -----------CC--hhhccCCCH----HHHHHHHHHccCChhHCcCHHHH-----------hcCHhhccCcc
Confidence                       00  011112344    45669999999999999999997           55899866544

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-48  Score=409.66  Aligned_cols=258  Identities=23%  Similarity=0.366  Sum_probs=201.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCc---eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGE---PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~---~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ...|.+.+.||+|+||.||+|.++.+|+   .||||.+...........+.+|+.++++++|||||++++++...+  .+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~~  102 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST--PV  102 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SC
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--EE
Confidence            4578999999999999999999987765   588998875544434456789999999999999999999997654  49


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|||||+||+|.+++.....  .+++.+++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+|+
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl----~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV----NSNLVCKVSDFGLSR  176 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECCC----
T ss_pred             EEEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE----CCCCcEEECCcccce
Confidence            999999999999998876443  38999999999999999999999999999999999998    777889999999998


Q ss_pred             cccccccc------cccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHH
Q psy15481        166 ELEEDQQF------MSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       166 ~~~~~~~~------~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~  238 (708)
                      ........      ....||+.|+|||++.        +..|+.++|||||||++|||+| |.+||.   +.+..+.+..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~---~~~~~~~~~~  245 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ--------YRKFTSASDVWSYGIVMWEVMSYGERPYW---DMTNQDVINA  245 (299)
T ss_dssp             -------------------CGGGSCHHHHH--------SCCCCHHHHHHHHHHHHHHHHTTSCCTTT---TCCHHHHHHH
T ss_pred             EccCCCCcceeeecccccCCccccCHHHHh--------cCCCCcccccccchHHHHHHHhCCCCCCC---CCCHHHHHHH
Confidence            76544322      2245789999999997        6789999999999999999998 899997   4556666665


Q ss_pred             HHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      +....                    .+|.+..+++    .+.+++..||..||.+|||+.+++..|+.+++
T Consensus       246 i~~~~--------------------~~~~~~~~~~----~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         246 IEQDY--------------------RLPPPMDCPS----ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HHTTC--------------------CCCCCTTCCH----HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHcCC--------------------CCCCCccchH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            55321                    2232233344    45669999999999999999999999887765

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-48  Score=412.90  Aligned_cols=251  Identities=23%  Similarity=0.374  Sum_probs=212.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      .|.+.+.||+|+||.||+|+++.+|+.||||++++..  .....+.+.+|+.++++++|||||++++++.+.+  .+|+|
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~iv   82 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ--QIFMI   82 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS--EEEEE
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC--eeeeE
Confidence            5899999999999999999999999999999996432  2233456779999999999999999999998654  59999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||.||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+|+...
T Consensus        83 mE~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl----~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL----DKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE----CTTSCEEECCCSSCEECS
T ss_pred             eeecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE----cCCCCEEEecCccceEec
Confidence            999999999999877554   8999999999999999999999999999999999998    777789999999998765


Q ss_pred             ccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCcc
Q psy15481        169 EDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGVI  248 (708)
Q Consensus       169 ~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~i  248 (708)
                      ..  ..+.+||+.|+|||++.        +..|+.++|||||||++|+|+||+.||.   +.+..+.+.++.....    
T Consensus       156 ~~--~~~~~Gt~~Y~APE~l~--------~~~y~~~~DiwSlGvilyemltG~~Pf~---~~~~~~~~~~i~~~~~----  218 (316)
T d1fota_         156 DV--TYTLCGTPDYIAPEVVS--------TKPYNKSIDWWSFGILIYEMLAGYTPFY---DSNTMKTYEKILNAEL----  218 (316)
T ss_dssp             SC--BCCCCSCTTTCCHHHHT--------TCCBCTTHHHHHHHHHHHHHHHSSCTTC---CSSHHHHHHHHHHCCC----
T ss_pred             cc--cccccCcccccCHHHHc--------CCCCCchhhccccchhHHHHHhCCCCCC---CcCHHHHHHHHHcCCC----
Confidence            43  34678999999999997        6789999999999999999999999997   4666677777665311    


Q ss_pred             cccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        249 SGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       249 ~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                       +.+..++++    +.+++.+||..||.+|+     |++++           +.|||+..
T Consensus       219 -----------------~~p~~~s~~----~~~li~~~L~~dp~~R~~~~r~t~~~i-----------l~Hp~f~~  262 (316)
T d1fota_         219 -----------------RFPPFFNED----VKDLLSRLITRDLSQRLGNLQNGTEDV-----------KNHPWFKE  262 (316)
T ss_dssp             -----------------CCCTTSCHH----HHHHHHHHTCSCTTTCTTSSTTTTHHH-----------HTSGGGSS
T ss_pred             -----------------CCCCCCCHH----HHHHHHHHhhhCHHhccccchhhHHHH-----------HcCccccc
Confidence                             111234444    55699999999999996     78886           67999855

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-49  Score=420.92  Aligned_cols=270  Identities=25%  Similarity=0.404  Sum_probs=208.4

Q ss_pred             cCCCCceEEEe-eEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEec--
Q psy15481          5 RGSTNYVWCTT-SVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQ--   80 (708)
Q Consensus         5 ~~~~n~~y~i~-~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~--   80 (708)
                      ++..-..|.+. +.||+|+||.||+|.++.+|+.||||+++.      .....+|+.++.++ +|||||++++++.+.  
T Consensus         6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1           6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            34444567766 569999999999999999999999999863      24456899987655 899999999998753  


Q ss_pred             CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEec
Q psy15481         81 EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTD  160 (708)
Q Consensus        81 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~D  160 (708)
                      ....+|+|||||+||+|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+|||+ ...++.+.+||+|
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll-~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY-TSKRPNAILKLTD  157 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE-SCSSTTCCEEECC
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccc-ccccccccccccc
Confidence            34568999999999999999976432 249999999999999999999999999999999999997 2233467899999


Q ss_pred             cCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        161 FGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       161 FGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ||+|+...........+||+.|+|||++.        +..|+.++|||||||++|+|+||++||.+.   +.......+.
T Consensus       158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~y~~~~DiwSlGvily~lltg~~Pf~~~---~~~~~~~~~~  226 (335)
T d2ozaa1         158 FGFAKETTSHNSLTTPCYTPYYVAPEVLG--------PEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HGLAISPGMK  226 (335)
T ss_dssp             CTTCEECCCCCCCCCCSCCCSSCCCCCCC--------GGGGSHHHHHHHHHHHHHHHTTSSCSCEET---TCC-------
T ss_pred             cceeeeccCCCccccccCCcccCCcHHHc--------CCCCCHHHHHHhhchhHHHHhhCCCCCCCC---CHHHHHHHHH
Confidence            99999877776677789999999999987        577999999999999999999999999742   2222222222


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                      ....           .+..    .+|..  ....++..+.+||.+||+.||++|||+.++           +.|||+...
T Consensus       227 ~~i~-----------~~~~----~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~s~~ei-----------l~hp~~~~~  278 (335)
T d2ozaa1         227 TRIR-----------MGQY----EFPNP--EWSEVSEEVKMLIRNLLKTEPTQRMTITEF-----------MNHPWIMQS  278 (335)
T ss_dssp             -CCC-----------SCSS----SCCTT--HHHHSCHHHHHHHHHHSCSSTTTSCCHHHH-----------HHSHHHHTT
T ss_pred             HHHh-----------cCCC----CCCCc--ccccCCHHHHHHHHHHccCChhHCcCHHHH-----------HcCHHhhCC
Confidence            1110           0111    12211  112233445669999999999999999997           558888554


Q ss_pred             c
Q psy15481        321 L  321 (708)
Q Consensus       321 ~  321 (708)
                      .
T Consensus       279 ~  279 (335)
T d2ozaa1         279 T  279 (335)
T ss_dssp             T
T ss_pred             C
Confidence            3

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=410.98  Aligned_cols=279  Identities=19%  Similarity=0.297  Sum_probs=210.8

Q ss_pred             EeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc----hHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         14 TTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP----HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        14 i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~----~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..++||+|+||.||+|+++.+|+.||||+++.......    ...+.+|+.++++++|||||++++++...+  .+|+||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ivm   79 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLVF   79 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ceeehh
Confidence            35789999999999999999999999999875432221    234679999999999999999999998765  499999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||.|+++..+.....   .+++..++.++.||+.||+|||++||+||||||+|||+    +..+.+||+|||.|.....
T Consensus        80 E~~~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli----~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          80 DFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL----DENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             ECCSEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEEECCCGGGSTTTS
T ss_pred             hhhcchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe----cCCCccccccCccccccCC
Confidence            9998887777665433   38999999999999999999999999999999999998    7777899999999987654


Q ss_pred             c-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC---
Q psy15481        170 D-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS---  245 (708)
Q Consensus       170 ~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~---  245 (708)
                      . ......+||+.|+|||++..       +..|+.++|||||||++|+|+||.+||.   +.++.+.+..+......   
T Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~---~~~~~~~l~~i~~~~~~~~~  222 (299)
T d1ua2a_         153 PNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLP---GDSDLDQLTRIFETLGTPTE  222 (299)
T ss_dssp             CCCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHHHCCCCT
T ss_pred             CcccccceecChhhccHHHHcc-------CCCCChhhhhhhcchHHHHHHhCcCCCC---CCCHHHHHHHHHHhcCCCCh
Confidence            4 33445789999999999863       5678999999999999999999999997   56777777776643111   


Q ss_pred             CcccccccCCCCcccccCCCCCc--ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCcccc
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNN--CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINRLQC  323 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~--~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~~~~  323 (708)
                      ..+..... ......+. ..|..  ..+.+.++..+.+||.+||+.||++||||+++           +.|||+.+.+.+
T Consensus       223 ~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~-----------L~Hp~f~~~p~p  289 (299)
T d1ua2a_         223 EQWPDMCS-LPDYVTFK-SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA-----------LKMKYFSNRPGP  289 (299)
T ss_dssp             TTSSSTTS-STTCCCCC-CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH-----------HTSGGGTSSSCC
T ss_pred             hhccchhc-cchhhhhc-cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHH-----------hCCHhhCCCCCC
Confidence            11100000 00000111 11110  11122334557779999999999999999997           679999876543


Q ss_pred             c
Q psy15481        324 I  324 (708)
Q Consensus       324 ~  324 (708)
                      .
T Consensus       290 ~  290 (299)
T d1ua2a_         290 T  290 (299)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-48  Score=403.95  Aligned_cols=261  Identities=23%  Similarity=0.369  Sum_probs=203.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ..|.+.+.||+|+||.||+|...   ..||||+++.... ....+.+.+|+.++++++|||||++++++..+   .+++|
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~---~~~lv   81 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---QLAIV   81 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc---EEEEE
Confidence            46788999999999999999754   3599999975432 33345677999999999999999999987543   38999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||+||+|.+++.....  .+++..+..++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|+...
T Consensus        82 ~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl----~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL----HEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----ETTSSEEECCCCCSCC--
T ss_pred             EecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE----cCCCCEEEccccceeecc
Confidence            999999999999976433  39999999999999999999999999999999999998    666789999999998654


Q ss_pred             cc---ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        169 ED---QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       169 ~~---~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ..   ....+..||+.|+|||++...     ....|+.++|||||||++|||+||+.||..   .++...+........ 
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~---~~~~~~~~~~~~~~~-  226 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQ-----DKNPYSFQSDVYAFGIVLYELMTGQLPYSN---INNRDQIIFMVGRGY-  226 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTT---CCCHHHHHHHHHHTS-
T ss_pred             ccCCcccccccccCcccCCHHHHhcc-----cCCCCCchhhhhhhHHHHHHHHHCCCCCCC---CChHHHHHHHHhcCC-
Confidence            33   234457899999999998621     124589999999999999999999999973   344444444443211 


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                                        ..|....++..+++.+.+++.+||..||.+|||+.+++..++.+.+
T Consensus       227 ------------------~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         227 ------------------LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             ------------------CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------------CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                              1122223334445567779999999999999999999998876653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-47  Score=400.07  Aligned_cols=261  Identities=23%  Similarity=0.342  Sum_probs=206.2

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCC--c
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEG--R   83 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~--~   83 (708)
                      .+.+|.+.+.||+|+||.||+|.+..+|+.||||+++.......  ...+.+|+.++++++||||+++++++...+.  .
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            45679999999999999999999999999999999976543322  2346799999999999999999999876543  4


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .+|+|||||+|++|..++.....   +++.+++.++.||+.||.|||++||+||||||+|||+    +..+..+|+|||.
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll----~~~~~~~l~d~~~  157 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI----SATNAVKVMDFGI  157 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----ETTSCEEECCCTT
T ss_pred             eEEEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc----Cccccceeehhhh
Confidence            58999999999999998876543   9999999999999999999999999999999999998    6666799999999


Q ss_pred             cccccccc----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        164 ARELEEDQ----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       164 A~~~~~~~----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      +.......    .....+||+.|+|||++.        +..|+.++|||||||++|+|+||++||.   +.+..+.+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--------~~~~~~~~DiwSlGvilyelltG~~Pf~---~~~~~~~~~~~  226 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQAR--------GDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSVAYQH  226 (277)
T ss_dssp             CEECC----------------TTCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHH
T ss_pred             hhhhccccccccccccccCcccccCHHHHc--------CCCCCcceecccchHHHHHHHhCCCCCC---CcCHHHHHHHH
Confidence            87553332    334568999999999987        6789999999999999999999999997   46666666666


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-CHHHHHHHHHHH
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-SFERFFSEVTKT  307 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-sa~q~~~~l~~i  307 (708)
                      ....+.                     ......+.++..+.++|.+||+.||.+|| |++++...+.++
T Consensus       227 ~~~~~~---------------------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         227 VREDPI---------------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             HHCCCC---------------------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HhcCCC---------------------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            653211                     01111122334456699999999999999 789987776655

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=395.52  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=199.7

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.++ +++.||||+++...  ...+.+.+|+.++++++||||+++++++...+.  .|+||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~--~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--CEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCc--eEEEE
Confidence            46889999999999999999986 67889999997533  335567899999999999999999999976554  89999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||++|+|.+++.....  .+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+|+....
T Consensus        80 E~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill----~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV----GENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             ECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE----CGGGCEEECSCC-------
T ss_pred             EecCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee----cCCCCeEecccchheeccC
Confidence            99999999999876543  38999999999999999999999999999999999998    7778899999999987654


Q ss_pred             ccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        170 DQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       170 ~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      ...  .....||+.|+|||++.        +..|+.++|||||||++|||+| |.+||.   +.+..+.+..+.....  
T Consensus       154 ~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~k~DVwS~Gvil~el~t~~~~~~~---~~~~~~~~~~i~~~~~--  220 (263)
T d1sm2a_         154 DQYTSSTGTKFPVKWASPEVFS--------FSRYSSKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFR--  220 (263)
T ss_dssp             -----------CTTSCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHTTSCCTTC---SCCHHHHHHHHHHTCC--
T ss_pred             CCceeecceecCcccCChHHhc--------CCCCCchhhhcchHHHHHHHHHCCCCCCC---CCCHHHHHHHHHhcCC--
Confidence            432  22357899999999997        6779999999999999999999 566554   4555566655554211  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                                      ...|.  ..+    ..+.+++.+||+.||++|||+++++++|+++++
T Consensus       221 ----------------~~~p~--~~~----~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         221 ----------------LYKPR--LAS----THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ----------------CCCCT--TSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------------CCCcc--ccC----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                            01122  223    345679999999999999999999999988764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.2e-48  Score=414.87  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=212.4

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .+|.+.+.||+|+||.||+|+++.+|+.||||++.+..  .....+...+|+.+++.++|||||++++++.+..  ..++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~~  118 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLYM  118 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc--cccc
Confidence            36999999999999999999999999999999986432  2233455679999999999999999999998654  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      ||||+.||+|..++.....   +++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|+..
T Consensus       119 v~e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl----~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTTCEEC
T ss_pred             ccccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc----CCCCCEEeeeceeeeec
Confidence            9999999999999876443   9999999999999999999999999999999999998    66778999999999876


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ...  ....+||+.|+|||++.        +..|+.++|||||||++|+|+||++||.   +.+....+..+....+   
T Consensus       192 ~~~--~~~~~Gt~~Y~APE~~~--------~~~~~~~~DiwSlGvilyemltG~~Pf~---~~~~~~~~~~i~~~~~---  255 (350)
T d1rdqe_         192 KGR--TWTLCGTPEALAPEIIL--------SKGYNKAVDWWALGVLIYEMAAGYPPFF---ADQPIQIYEKIVSGKV---  255 (350)
T ss_dssp             SSC--BCCCEECGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCC---
T ss_pred             ccc--cccccCccccCCHHHHc--------CCCCCccccccchhHHHHHHHhCCCCCC---CcCHHHHHHHHhcCCC---
Confidence            543  34578999999999997        6789999999999999999999999997   4566666666665321   


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCC-----CHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIW-----SFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRp-----sa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                                        +.+..++++    +.++|++||..||.+|+     |++++           +.||||...
T Consensus       256 ------------------~~p~~~s~~----~~~li~~~L~~dP~kR~~~~r~t~~el-----------l~Hp~f~~~  300 (350)
T d1rdqe_         256 ------------------RFPSHFSSD----LKDLLRNLLQVDLTKRFGNLKNGVNDI-----------KNHKWFATT  300 (350)
T ss_dssp             ------------------CCCTTCCHH----HHHHHHHHSCSCTTTCTTSSTTTTHHH-----------HTSGGGTTC
T ss_pred             ------------------CCCccCCHH----HHHHHHHHhhhCHHhccccccccHHHH-----------HcCccccCC
Confidence                              112234554    45699999999999995     78886           669998543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-47  Score=399.59  Aligned_cols=284  Identities=24%  Similarity=0.291  Sum_probs=215.7

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCC-CceEEEEEeccCCCC-CchHHHHHHHHHHHhC---CCCCccceeEEEEec--
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNN-GEPVAVKTFNQLSHM-RPHDVQMREFEVLKKV---KHENIVKLLAIEEEQ--   80 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~t-g~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL---~HpNIVkl~~v~~~~--   80 (708)
                      .+.+|.+.+.||+|+||.||+|++..+ ++.||||+++..... .......+|+.+++.|   +||||+++++++...  
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            467899999999999999999999765 678999998754322 2233455788877766   799999999998543  


Q ss_pred             -CCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         81 -EGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        81 -~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                       .....|++||||.|+++........  ..+++..++.++.|++.||+|||++|||||||||+|||+    +..+.+||+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi----~~~~~~kl~  158 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV----TSSGQIKLA  158 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEEEC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE----cCCCCeeec
Confidence             2346899999998877765544433  239999999999999999999999999999999999998    777789999


Q ss_pred             ccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        160 DFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       160 DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      |||.+.............||+.|+|||++.        +..|+.++||||+||++|+|+||++||.   +.++.+.+..+
T Consensus       159 dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~--------~~~y~~~~DiwSlG~il~ell~g~~pf~---~~~~~~~~~~i  227 (305)
T d1blxa_         159 DFGLARIYSFQMALTSVVVTLWYRAPEVLL--------QSSYATPVDLWSVGCIFAEMFRRKPLFR---GSSDVDQLGKI  227 (305)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHT--------TCCCCTHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHH
T ss_pred             chhhhhhhcccccCCCcccChhhcCcchhc--------CCCCChhehhhchHHHHHHHHHCCCCCC---CCCHHHHHHHH
Confidence            999999877777777889999999999997        6789999999999999999999999997   46677777776


Q ss_pred             HhcccCCcccccccCCCC-ccccc-CCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCccc
Q psy15481        240 TTKKASGVISGTQTSENG-EIDWC-TDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFH  317 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g-~~~~~-~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~  317 (708)
                      .................. ...+. ........+...++..+.+||.+||++||++|||++++           +.|||+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~-----------L~Hpff  296 (305)
T d1blxa_         228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA-----------LSHPYF  296 (305)
T ss_dssp             HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH-----------HTSGGG
T ss_pred             HHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH-----------hcChhh
Confidence            543211110000000000 00000 01111122233445566779999999999999999997           779999


Q ss_pred             CC
Q psy15481        318 IN  319 (708)
Q Consensus       318 ~~  319 (708)
                      ..
T Consensus       297 ~~  298 (305)
T d1blxa_         297 QD  298 (305)
T ss_dssp             TT
T ss_pred             cC
Confidence            65

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=400.36  Aligned_cols=255  Identities=22%  Similarity=0.362  Sum_probs=204.9

Q ss_pred             ceEEEeeE-eecCCceEEEEEEEcC--CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSV-LGKGATGAVFQGVNKN--NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~-LG~G~fG~Vy~a~~~~--tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      ..|.+.+. ||+|+||.||+|.++.  ++..||||+++........+.+.+|++++++++|||||++++++.+.   .+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eEE
Confidence            35667775 9999999999998764  45589999998655444455678999999999999999999998643   389


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|||||+||+|.+++.....  .+++..+..++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+.
T Consensus        85 lvmE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill----~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL----VNRHYAKISDFGLSKA  158 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----EETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee----ccCCceeeccchhhhc
Confidence            99999999999999865432  39999999999999999999999999999999999998    5566899999999987


Q ss_pred             cccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHh
Q psy15481        167 LEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       167 ~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      ......    .....||+.|+|||++.        +..++.++|||||||++|||+| |..||..   .+..+.+..+..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~---~~~~~~~~~i~~  227 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECIN--------FRKFSSRSDVWSYGVTMWEALSYGQKPYKK---MKGPEVMAFIEQ  227 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHH--------HCEECHHHHHHHHHHHHHHHHTTSCCTTTT---CCTHHHHHHHHT
T ss_pred             ccccccccccccccccCccccChHHHh--------CCCCCccchhhcchHHHHHHHhCCCCCCCC---CCHHHHHHHHHc
Confidence            654322    22356899999999997        5678999999999999999998 9999973   445566655553


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                      ..                    .++.+..++    ..+.+|+..||..||++|||+.++...+....
T Consensus       228 ~~--------------------~~~~p~~~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         228 GK--------------------RMECPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             TC--------------------CCCCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC--------------------CCCCCCcCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            21                    111112233    45566999999999999999999887765544

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-47  Score=401.69  Aligned_cols=255  Identities=23%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.++.+|+.||||+++...  ...+.+.+|+.++++++|||||++++++.+.+  .+|+||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~iv~   92 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYIIT   92 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCC--eeEEEe
Confidence            36899999999999999999999999999999987543  23456789999999999999999999997654  489999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||++|+|..++..... ..+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+....
T Consensus        93 E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl----~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          93 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             ECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCCCCTTTCCS
T ss_pred             ecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE----CCCCcEEEccccceeecCC
Confidence            99999999999865332 348999999999999999999999999999999999998    7778899999999987654


Q ss_pred             ccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        170 DQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       170 ~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      +..  .....|++.|+|||++.        +..|+.++|||||||++|||++|..||.+  +.+... +..+.....   
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~k~DiwS~Gv~l~ell~~~~p~~~--~~~~~~-~~~~i~~~~---  233 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLA--------YNKFSIKSDVWAFGVLLWEIATYGMSPYP--GIDLSQ-VYELLEKDY---  233 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHH--------HCCCSHHHHHHHHHHHHHHHHTTSCCSST--TCCHHH-HHHHHHTTC---
T ss_pred             CCceeeccccccccccChHHHc--------CCCCCchhhhhhHHHHHHHHHhCCCCCCC--cchHHH-HHHHHhcCC---
Confidence            422  23356899999999998        56789999999999999999997766642  333333 333333211   


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                                      .++.+..++    ..+.+|+.+||..||++|||+++++..++.+
T Consensus       234 ----------------~~~~~~~~~----~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         234 ----------------RMERPEGCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             ----------------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ----------------CCCCCccch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                            112222233    4566699999999999999999997766544

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-47  Score=415.56  Aligned_cols=256  Identities=20%  Similarity=0.356  Sum_probs=202.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC--CCchHHHH---HHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH--MRPHDVQM---REFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~--~~~~~~~~---~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .|.+.+.||+|+||.||+|+++.+|+.||||++.+...  ........   +++.+++.++|||||++++++.+.+  .+
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~--~~   82 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KL   82 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--EE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC--EE
Confidence            58999999999999999999999999999999864221  11122223   4467777889999999999998754  59


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      |+|||||+||+|.+++.....   +++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|+
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl----~~~g~iKl~DFGla~  155 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL----DEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CSSSCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE----cCCCcEEEeeeceee
Confidence            999999999999999976443   8999999999999999999999999999999999998    777789999999998


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ..... .....+||+.|+|||++..       +..|+.++|||||||++|+|+||+.||..............+...   
T Consensus       156 ~~~~~-~~~~~~GT~~y~APE~~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~---  224 (364)
T d1omwa3         156 DFSKK-KPHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---  224 (364)
T ss_dssp             ECSSS-CCCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC---
T ss_pred             ecCCC-cccccccccccchhHHhhc-------CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---
Confidence            76544 3445689999999999863       467899999999999999999999999853322222211111110   


Q ss_pred             CcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HHHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~q~~~~l~~il~~~l~h~~~~~  319 (708)
                                        ..+.+..+|+.    +.+||.+||..||.+|||     |+++           +.|||+.+
T Consensus       225 ------------------~~~~~~~~s~~----~~~li~~~L~~dP~~R~t~~~~~a~ei-----------l~Hp~f~~  270 (364)
T d1omwa3         225 ------------------AVELPDSFSPE----LRSLLEGLLQRDVNRRLGCLGRGAQEV-----------KESPFFRS  270 (364)
T ss_dssp             ------------------CCCCCSSSCHH----HHHHHHHHTCSSTTTSTTTSSSTHHHH-----------HTSGGGTT
T ss_pred             ------------------CCCCCCCCCHH----HHHHHHHHcccCHHHhCCCcccCHHHH-----------HcCccccC
Confidence                              11222234444    556999999999999999     6776           67999865

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-47  Score=405.47  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=204.3

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCc-----eEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCce
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGE-----PVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~-----~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~   84 (708)
                      .|.+.+.||+|+||.||+|.+..+++     .||+|.+...........+.+|+.++.++ +|||||++++++.+.+.  
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~--  115 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP--  115 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe--
Confidence            68999999999999999999876554     69999987655555556678999999998 89999999999987654  


Q ss_pred             EEEEEeccCCCCHHHHhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q psy15481         85 KVIVMELCTGGSLFNILDDPEN--------------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNI  144 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~--------------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NI  144 (708)
                      .|+|||||+||+|.+++.....                    ...+++..++.++.||+.||.|||++|||||||||+||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni  195 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV  195 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence            9999999999999999976431                    12489999999999999999999999999999999999


Q ss_pred             EEEEecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-C
Q psy15481        145 MKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-G  220 (708)
Q Consensus       145 Ll~~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G  220 (708)
                      |+    +..+.+||+|||+|+.......   ..+..||+.|+|||++.        +..|+.++|||||||++|||+| |
T Consensus       196 ll----~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         196 LV----THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF--------EGIYTIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             EE----ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             cc----ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc--------CCCCCcceeccchhHHHHHHHhCC
Confidence            98    6677899999999987654432   23456899999999987        5778999999999999999998 8


Q ss_pred             CCCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        221 NLPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       221 ~~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                      .+||.+   .+....+..+.....                   .++.+..++    +.+.+||.+||+.||++|||++++
T Consensus       264 ~~Pf~~---~~~~~~~~~~~~~~~-------------------~~~~p~~~~----~~l~~li~~cl~~dP~~RPt~~ei  317 (325)
T d1rjba_         264 VNPYPG---IPVDANFYKLIQNGF-------------------KMDQPFYAT----EEIYIIMQSCWAFDSRKRPSFPNL  317 (325)
T ss_dssp             CCSSTT---CCCSHHHHHHHHTTC-------------------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCC---CCHHHHHHHHHhcCC-------------------CCCCCCcCC----HHHHHHHHHHcCCChhHCcCHHHH
Confidence            999973   444455555554321                   112222233    456669999999999999999999


Q ss_pred             HHHHH
Q psy15481        301 FSEVT  305 (708)
Q Consensus       301 ~~~l~  305 (708)
                      +++|.
T Consensus       318 ~~~L~  322 (325)
T d1rjba_         318 TSFLG  322 (325)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            88764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=406.55  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=209.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCC--CCCchHHHHHHHHHHH-hCCCCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLS--HMRPHDVQMREFEVLK-KVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s--~~~~~~~~~~Ei~iL~-kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .|.+.+.||+|+||.||+|.++.+|+.||||++++..  .....+...+|..++. .++|||||++++++.+.+  .+|+
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~--~~yi   80 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE--NLFF   80 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC--ceeE
Confidence            4889999999999999999999999999999996532  1223444567777665 689999999999998754  5999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||||+||+|..++.....   +++.+++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|...
T Consensus        81 vmEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~----~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL----DKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEECCCTTCBCC
T ss_pred             EEeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee----cCCCceeccccchhhhc
Confidence            9999999999999976443   8999999999999999999999999999999999998    67778999999999866


Q ss_pred             cccc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        168 EEDQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       168 ~~~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      .... ......||+.|+|||++.        +..|+.++|||||||++|+|+||+.||.   +.+..+.+..+....+  
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlGvilyemltG~~PF~---~~~~~~~~~~i~~~~~--  220 (320)
T d1xjda_         154 MLGDAKTNTFCGTPDYIAPEILL--------GQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRMDNP--  220 (320)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHT--------TCCBCTHHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHCCC--
T ss_pred             ccccccccccCCCCCcCCHHHHc--------CCCCCchhhhhhhhHHHHHHHhCCCCCC---CCCHHHHHHHHHcCCC--
Confidence            5433 334478999999999998        6789999999999999999999999997   4666666666654321  


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHH-HHHHHHHHHHhhhhcCcccCC
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFE-RFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~-q~~~~l~~il~~~l~h~~~~~  319 (708)
                                       .+|  ..+|+    .+.+||.+||..||.+|||+. ++           +.|||+..
T Consensus       221 -----------------~~p--~~~s~----~~~dli~~~L~~dP~~R~s~~~~l-----------~~hpff~~  260 (320)
T d1xjda_         221 -----------------FYP--RWLEK----EAKDLLVKLFVREPEKRLGVRGDI-----------RQHPLFRE  260 (320)
T ss_dssp             -----------------CCC--TTSCH----HHHHHHHHHSCSSGGGSBTTBSCG-----------GGSGGGTT
T ss_pred             -----------------CCC--ccCCH----HHHHHHHHhcccCCCCCcCHHHHH-----------HhCchhcc
Confidence                             112  12344    456699999999999999985 54           56999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-47  Score=398.40  Aligned_cols=278  Identities=26%  Similarity=0.380  Sum_probs=210.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      .|.+.+.||+|+||.||+|.++.+|+.||||+++..... ...+.+.+|+.++++++|||||++++++.+.+  .+|+||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~--~~~iv~   80 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYLVF   80 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc--ceeEEE
Confidence            588999999999999999999999999999999754332 23456679999999999999999999998754  599999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||.|+ +...+.... ..++++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||.|.....
T Consensus        81 e~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~----~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          81 EFLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI----NTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             ECCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECSTTHHHHHCC
T ss_pred             eecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee----cccCcceeccCCcceeccC
Confidence            999654 444443222 2349999999999999999999999999999999999998    6777899999999987654


Q ss_pred             c-ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC--
Q psy15481        170 D-QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG--  246 (708)
Q Consensus       170 ~-~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~--  246 (708)
                      + .......||+.|+|||++..       ...++.++||||+||++|+|++|+.||.   +.++.+.+..+.......  
T Consensus       155 ~~~~~~~~~gt~~y~apE~~~~-------~~~~~~~~DiwSlGvily~m~~G~~Pf~---~~~~~~~~~~i~~~~~~~~~  224 (298)
T d1gz8a_         155 PVRTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFP---GDSEIDQLFRIFRTLGTPDE  224 (298)
T ss_dssp             CSBCTTCCBCCCTTCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHHHHHHCCCCT
T ss_pred             Ccccceeecccceeeehhhhcc-------ccCCCccccccccchhhhHHhhCCCCCC---CCCHHHHHHHHHHhcCCCch
Confidence            3 34445689999999999873       4456899999999999999999999997   466677777765432111  


Q ss_pred             -cccccccCCCCcccccCCCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCCc
Q psy15481        247 -VISGTQTSENGEIDWCTDLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHINR  320 (708)
Q Consensus       247 -~i~~~~~~~~g~~~~~~~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~~  320 (708)
                       ........    ..+....+..     ....+.++..+.+||.+||..||++|||++++           +.|||+.+-
T Consensus       225 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el-----------l~H~ff~~~  289 (298)
T d1gz8a_         225 VVWPGVTSM----PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA-----------LAHPFFQDV  289 (298)
T ss_dssp             TTSTTGGGS----TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH-----------HTSGGGTTC
T ss_pred             hhccccccc----cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHH-----------hCCHhhccC
Confidence             11111100    0111111111     11122334556779999999999999999997           679999654


Q ss_pred             c
Q psy15481        321 L  321 (708)
Q Consensus       321 ~  321 (708)
                      .
T Consensus       290 ~  290 (298)
T d1gz8a_         290 T  290 (298)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=392.28  Aligned_cols=257  Identities=23%  Similarity=0.375  Sum_probs=199.6

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCC---CceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNN---GEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKV   86 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~   86 (708)
                      .+|.+.+.||+|+||.||+|.+..+   +..||||.++........+.+.+|+.++++++||||+++++++.+   +.+|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~   83 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVW   83 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSCE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeEE
Confidence            4799999999999999999998754   456899988655444444567899999999999999999999853   2489


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      +|||||++|+|..++.....  .+++..++.++.||+.||.|||++||+||||||+||++    +..+.+||+|||+|+.
T Consensus        84 iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll----~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV----SSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECC------
T ss_pred             EEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee----cCCCcEEEccchhhee
Confidence            99999999999998765432  38999999999999999999999999999999999998    5566899999999987


Q ss_pred             cccccc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        167 LEEDQQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       167 ~~~~~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      ......  .....||+.|+|||++.        +..|+.++|||||||++|||+| |.+||.   +.+..+.+..+....
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~--------~~~~~~~~DiwSlGvil~e~lt~g~~P~~---~~~~~~~~~~i~~~~  226 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESIN--------FRRFTSASDVWMFGVCMWEILMHGVKPFQ---GVKNNDVIGRIENGE  226 (273)
T ss_dssp             -------------CCGGGCCHHHHH--------HCCCSHHHHHHHHHHHHHHHHTTSCCTTT---TCCGGGHHHHHHTTC
T ss_pred             ccCCcceeccceecCcccchhhHhc--------cCCCCCccccccchHHHHHHHhcCCCCCC---CCCHHHHHHHHHcCC
Confidence            654432  23456899999999998        5778999999999999999998 899997   355566666555421


Q ss_pred             cCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        244 ASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       244 ~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                                          .+|.+..+|    ..+.+||.+||..||.+|||+.++++.+..+++.
T Consensus       227 --------------------~~~~~~~~~----~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         227 --------------------RLPMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             --------------------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------------CCCCCCCCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                                112222334    4556699999999999999999999999888764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-47  Score=394.30  Aligned_cols=251  Identities=21%  Similarity=0.351  Sum_probs=197.3

Q ss_pred             EEEe-eEeecCCceEEEEEEEc--CCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         12 WCTT-SVLGKGATGAVFQGVNK--NNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        12 y~i~-~~LG~G~fG~Vy~a~~~--~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      +.+. +.||+|+||.||+|.+.  .+++.||||+++..... ...+.+.+|+.++++++|||||++++++...   ..|+
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~l   84 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWML   84 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEE
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEEE
Confidence            3444 47999999999999864  45678999999754332 2235578999999999999999999998643   3799


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||||+||+|.+++.....   +++..+..++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|+..
T Consensus        85 vmE~~~~g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill----~~~~~~kl~DFGla~~~  157 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL----VTQHYAKISDFGLSKAL  157 (277)
T ss_dssp             EEECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETTEEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc----cccCcccccchhhhhhc
Confidence            9999999999999976543   9999999999999999999999999999999999998    66678999999999876


Q ss_pred             ccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhc
Q psy15481        168 EEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       168 ~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .....    .....||+.|+|||++.        +..++.++|||||||++|||+| |++||.   +.+..+....+...
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~---~~~~~~~~~~i~~~  226 (277)
T d1xbba_         158 RADENYYKAQTHGKWPVKWYAPECIN--------YYKFSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEKG  226 (277)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHH--------HCEEEHHHHHHHHHHHHHHHHTTTCCSST---TCCHHHHHHHHHTT
T ss_pred             cccccccccccccCCCceecCchhhc--------CCCCCchhhhccchhhhhHHhhCCCCCCC---CCCHHHHHHHHHcC
Confidence            44322    22357999999999998        5678999999999999999998 999997   35555555555432


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      .                    .++.+..++    ..+.+|+.+||..||++|||+.++...+...
T Consensus       227 ~--------------------~~~~p~~~~----~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         227 E--------------------RMGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             C--------------------CCCCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             C--------------------CCCCCcccC----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            1                    112222233    4556699999999999999999987765443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=391.10  Aligned_cols=254  Identities=23%  Similarity=0.336  Sum_probs=204.7

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      ..|.+.+.||+|+||.||+|.++ +++.||||+++...  ...+.+.+|+.++++++|||||++++++.+.   ..|+||
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~iv~   86 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYIIT   86 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC---CeEEEE
Confidence            47899999999999999999975 67899999997543  3356678999999999999999999987542   379999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      |||++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+|+....
T Consensus        87 Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll----~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV----SDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             ECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee----ecccceeeccccceEEccC
Confidence            99999999998765332 238999999999999999999999999999999999998    7778899999999987654


Q ss_pred             cc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        170 DQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       170 ~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..  ......||+.|+|||++.        +..|+.++|||||||++|||+||..||..  +.+..+.+..+....    
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~--------~~~~~~~sDvwS~Gvvl~ellt~~~~~~~--~~~~~~~~~~i~~~~----  227 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAIN--------YGTFTIKSDVWSFGILLTEIVTHGRIPYP--GMTNPEVIQNLERGY----  227 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHH--------HCEECHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHHHTTC----
T ss_pred             CccccccccCCcccccChHHHh--------CCCCCchhhhhhhHHHHHHHHhCCCCCCC--CCCHHHHHHHHHhcC----
Confidence            43  233467999999999997        46789999999999999999995544432  355555555554321    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTL  308 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il  308 (708)
                                      .++.+..+++    .+.+|+.+||+.||++|||++++++.|+++.
T Consensus       228 ----------------~~~~p~~~~~----~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         228 ----------------RMVRPDNCPE----ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             ----------------CCCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------------CCCCcccChH----HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence                            1122223344    4566999999999999999999988766554

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-47  Score=393.69  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=201.7

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCc-----hHHHHHHHHHHHhCC--CCCccceeEEEEec
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRP-----HDVQMREFEVLKKVK--HENIVKLLAIEEEQ   80 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~-----~~~~~~Ei~iL~kL~--HpNIVkl~~v~~~~   80 (708)
                      .+.+|.+.+.||+|+||.||+|+++.+|+.||||+++.......     ...+.+|+.++++++  |||||++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            35689999999999999999999999999999999975432211     122358999999996  89999999999875


Q ss_pred             CCceEEEEEeccCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEe
Q psy15481         81 EGRGKVIVMELCTG-GSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLT  159 (708)
Q Consensus        81 ~~~~~~LVmEy~~g-gsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~  159 (708)
                      +  ..|+||||+.+ +++..++.....   +++.+++.++.||+.||.|||++||+||||||+|||+  + .+.+.+||+
T Consensus        82 ~--~~~lv~e~~~~~~~l~~~~~~~~~---l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll--~-~~~~~vkl~  153 (273)
T d1xwsa_          82 D--SFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--D-LNRGELKLI  153 (273)
T ss_dssp             S--EEEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--E-TTTTEEEEC
T ss_pred             C--eEEEEEEeccCcchHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEE--e-cCCCeEEEC
Confidence            5  59999999976 688888865433   9999999999999999999999999999999999997  2 134689999


Q ss_pred             ccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHH
Q psy15481        160 DFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       160 DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i  239 (708)
                      |||+|..... ....+..||+.|+|||++..       ...++.++|||||||++|+|+||+.||..     ..    .+
T Consensus       154 DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~-----~~----~i  216 (273)
T d1xwsa_         154 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEH-----DE----EI  216 (273)
T ss_dssp             CCTTCEECCS-SCBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCS-----HH----HH
T ss_pred             ccccceeccc-ccccccccCCCcCCHHHHcC-------CCCCCcccccccceeeehhHhhCCCCCCC-----ch----HH
Confidence            9999986543 33456789999999999973       34457889999999999999999999963     11    12


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ....                     ......+|++    +.+||.+||..||++|||++++           +.|||+.+
T Consensus       217 ~~~~---------------------~~~~~~~s~~----~~~li~~~L~~dp~~R~s~~ei-----------l~hp~~~~  260 (273)
T d1xwsa_         217 IRGQ---------------------VFFRQRVSSE----CQHLIRWCLALRPSDRPTFEEI-----------QNHPWMQD  260 (273)
T ss_dssp             HHCC---------------------CCCSSCCCHH----HHHHHHHHTCSSGGGSCCHHHH-----------HTSGGGSS
T ss_pred             hhcc---------------------cCCCCCCCHH----HHHHHHHHccCCHhHCcCHHHH-----------hcCHhhCC
Confidence            2210                     1111234444    5569999999999999999997           67999965


Q ss_pred             c
Q psy15481        320 R  320 (708)
Q Consensus       320 ~  320 (708)
                      .
T Consensus       261 ~  261 (273)
T d1xwsa_         261 V  261 (273)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=391.18  Aligned_cols=258  Identities=23%  Similarity=0.341  Sum_probs=200.7

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCC----ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNG----EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg----~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      ..|.+.++||+|+||.||+|.++.++    ..||||.++..........+.+|+.++++++|||||++++++.+.+.  .
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~--~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP--M   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--E
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc--e
Confidence            36899999999999999999987655    47999999765443334456799999999999999999999976554  8


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      ++|||||.++++.+++.....  .+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+|+
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl----~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV----NSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECCCCC--
T ss_pred             EEEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccccccCccccceEEE----CCCCeEEEcccchhh
Confidence            999999999999998765433  29999999999999999999999999999999999998    777899999999998


Q ss_pred             ccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        166 ELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       166 ~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      ....+..    .....||+.|+|||++.        +..++.++|||||||++|||+||..||..  +.+..+.+..+..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~--------~~~~~~~sDI~S~Gvil~el~t~~~~~~~--~~~~~~~~~~i~~  228 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAIS--------YRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAIND  228 (283)
T ss_dssp             ---------------CCCGGGSCHHHHH--------SCCCCHHHHHHHHHHHHHHHHTTSCCTTT--TCCHHHHHHHHHT
T ss_pred             cccCCCccceEeccCCCCccccCHHHHc--------cCCCCCcccccccHHHHHHHHhCCCCccc--cCCHHHHHHHHhc
Confidence            7654422    22356899999999997        67899999999999999999996555542  3455555554443


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      ..                    .+|.+.    .++..+.+++..||..||++|||+.++++.++.++.
T Consensus       229 ~~--------------------~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         229 GF--------------------RLPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             TC--------------------CCCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             cC--------------------CCCCch----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            21                    112222    233456679999999999999999999998877765

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.6e-46  Score=389.32  Aligned_cols=277  Identities=23%  Similarity=0.324  Sum_probs=208.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCC-CCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSH-MRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~-~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|.+.+.||+|+||.||+|.++ +|+.||||+++.... ......+.+|+.++++++||||+++++++...+.  .|++|
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~i~~   79 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR--LVLVF   79 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC--EEEEE
T ss_pred             CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc--eeEEE
Confidence            6899999999999999999985 889999999976432 2234567799999999999999999999987654  99999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      +|+.++++..+.....   .+++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||.|.....
T Consensus        80 e~~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll----~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI----NREGELKIADFGLARAFGI  152 (286)
T ss_dssp             ECCSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECCTTHHHHHCC
T ss_pred             EeehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE----cCCCCEEecccccceeccc
Confidence            9998777776665433   39999999999999999999999999999999999998    6677899999999987654


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC--
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG--  246 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~--  246 (708)
                      .. ......|++.|+|||.+..       ...++.++|||||||++|+|++|++||.   +.++.+.+.++.......  
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~~DiwslGv~l~el~~G~~pf~---~~~~~~~~~~i~~~~~~~~~  222 (286)
T d1ob3a_         153 PVRKYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFP---GVSEADQLMRIFRILGTPNS  222 (286)
T ss_dssp             ---------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHHHHHHCCCCT
T ss_pred             CccccceecccchhhhHHHHhC-------CCCCCcceeehhcCcHHHHHHHCCCCCC---CCCHHHHHHHHHHhhCCCCh
Confidence            32 2345679999999999873       4567999999999999999999999997   455666666655321111  


Q ss_pred             -cccccccCCCCccccc-CCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccC
Q psy15481        247 -VISGTQTSENGEIDWC-TDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHI  318 (708)
Q Consensus       247 -~i~~~~~~~~g~~~~~-~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~  318 (708)
                       ..............+. ..........+.++..+.+||.+||++||++|||+.|+           +.|||+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~el-----------l~Hp~f~  285 (286)
T d1ob3a_         223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA-----------LEHAYFK  285 (286)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH-----------HTSGGGG
T ss_pred             hhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHH-----------hcCcccC
Confidence             1111100000000000 00111112223344566779999999999999999997           6799985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2e-45  Score=391.84  Aligned_cols=276  Identities=18%  Similarity=0.295  Sum_probs=211.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      ..+|.+.+.||+|+||.||+|+++.+|+.||||+++...    .....+|+.++++++ ||||+++++++........|+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            346999999999999999999999999999999987432    455679999999995 999999999998776677999


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||||.+++|..+...      +++..++.++.||+.||.|||++|||||||||+|||+  +. ....+||+|||+|...
T Consensus       110 v~e~~~~~~L~~~~~~------l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi--~~-~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         110 VFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI--DH-EHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EEECCCSCBGGGTTTS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--ET-TTTEEEECCGGGCEEC
T ss_pred             EEeecCCCcHHHHhcC------CCHHHHHHHHHHHHHHHHHHhhcccccccccccceEE--cC-CCCeeeecccccceec
Confidence            9999999999876532      9999999999999999999999999999999999997  22 2347999999999988


Q ss_pred             cccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc---
Q psy15481        168 EEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA---  244 (708)
Q Consensus       168 ~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~---  244 (708)
                      ..+......+||+.|+|||.+..       ...++.++||||+||++|+|++|..||..  +.++......+.....   
T Consensus       181 ~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~e~~~g~~pf~~--~~~~~~~~~~i~~~~g~~~  251 (328)
T d3bqca1         181 HPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTED  251 (328)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSSSC--CSSHHHHHHHHHHHHCHHH
T ss_pred             cCCCcccccccCccccCcccccC-------CCCCCcccchhhhhhhhHHhccCCCCCCC--CchhHHHHHHHHHHHCCch
Confidence            77777777889999999999873       45689999999999999999999999975  3333333333221000   


Q ss_pred             ---------CCcccccc--cCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhc
Q psy15481        245 ---------SGVISGTQ--TSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLV  313 (708)
Q Consensus       245 ---------~~~i~~~~--~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~  313 (708)
                               ........  ........|....+.  .....++..+.+||.+||.+||++|||++++           +.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~-----------L~  318 (328)
T d3bqca1         252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS--ENQHLVSPEALDFLDKLLRYDHQSRLTAREA-----------ME  318 (328)
T ss_dssp             HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCT--TTGGGCCHHHHHHHHHHSCSSGGGSCCHHHH-----------HT
T ss_pred             hhhhhhhcccccCcccchhcccccccchhhcccc--cccccCCHHHHHHHHHHccCChhHCcCHHHH-----------hc
Confidence                     00000000  000001111111111  1112234456679999999999999999997           67


Q ss_pred             CcccCC
Q psy15481        314 HLFHIN  319 (708)
Q Consensus       314 h~~~~~  319 (708)
                      ||||+.
T Consensus       319 Hp~F~~  324 (328)
T d3bqca1         319 HPYFYT  324 (328)
T ss_dssp             SGGGTT
T ss_pred             CcccCC
Confidence            999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=392.45  Aligned_cols=257  Identities=24%  Similarity=0.380  Sum_probs=203.3

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCc----eEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGE----PVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~----~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ...|++.+.||+|+||.||+|.+..+|+    +||+|.++..........+.+|+.++++++|||||++++++.+.+   
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~---   84 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---   84 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS---
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            3469999999999999999999988876    588888876555555667789999999999999999999997643   


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .+++|+|+.+|+|.+.+.....  .+++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll----~~~~~~kl~DFGla  158 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDFGLA  158 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----EETTEEEECCCSHH
T ss_pred             eeEEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee----CCCCCeEeeccccc
Confidence            7889999999999988776433  39999999999999999999999999999999999998    66678999999999


Q ss_pred             cccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHH
Q psy15481        165 RELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       165 ~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~  240 (708)
                      +.......   .....||+.|+|||++.        +..|+.++|||||||++|||+| |.+||.   +.+..+....+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~~sDvwS~Gvil~el~t~g~~p~~---~~~~~~~~~~i~  227 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESIL--------HRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILE  227 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCTTT---TSCGGGHHHHHH
T ss_pred             eecccccccccccccccCccccChHHHh--------cCCCChhhhhhhHHHHHHHHHHCCCCCCC---CCCHHHHHHHHH
Confidence            87654432   23356899999999998        5679999999999999999999 899997   344444444443


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      ...                    .+|.+..+++    .+.+++.+||..||.+|||+.+++.++..+..
T Consensus       228 ~~~--------------------~~~~p~~~~~----~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         228 KGE--------------------RLPQPPICTI----DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HTC--------------------CCCCCTTBCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCC--------------------CCCCCcccCH----HHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            321                    1222223344    45669999999999999999999998877654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-46  Score=385.40  Aligned_cols=249  Identities=23%  Similarity=0.350  Sum_probs=206.8

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|.+.+.||+|+||.||+|+++ +++.||||+++....  ..+.+.+|+.++++++||||+++++++.+.+.  +++|||
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~--~~iv~E   79 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP--IFIITE   79 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS--EEEEEE
T ss_pred             HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc--eEEEEE
Confidence            5678899999999999999984 788999999986433  34567899999999999999999999976554  999999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+++|+|..++......  +++..+..++.|++.||.|||++||+||||||+|||+    +..+.+||+|||+|+.....
T Consensus        80 y~~~g~l~~~~~~~~~~--~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill----~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV----NDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             CCTTEEHHHHHHSGGGC--CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE----CTTCCEEECCCSSCCBCSSS
T ss_pred             ccCCCcHHHhhhccccC--CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE----cCCCcEEECcchhheeccCC
Confidence            99999999997665433  8999999999999999999999999999999999998    77778999999999866544


Q ss_pred             cc--ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCc
Q psy15481        171 QQ--FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGV  247 (708)
Q Consensus       171 ~~--~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~  247 (708)
                      ..  .....||+.|+|||.+.        +..|+.++|||||||++|||+| |+.||.   +.+..++...+....    
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~--------~~~~~~ksDiwS~G~~l~el~t~g~~Pf~---~~~~~~~~~~i~~~~----  218 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLM--------YSKFSSKSDIWAFGVLMWEIYSLGKMPYE---RFTNSETAEHIAQGL----  218 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCTTT---TSCHHHHHHHHHTTC----
T ss_pred             CceeecccCCCCCcCCcHHhc--------CCCCCcceeecccchhhHhHHhcCCCCCC---CCCHHHHHHHHHhCC----
Confidence            32  23466899999999998        5778999999999999999998 899997   456666666665421    


Q ss_pred             ccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHH
Q psy15481        248 ISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVT  305 (708)
Q Consensus       248 i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~  305 (708)
                                      .++.+...+    ..+.+|+.+||+.||++|||+++++++|.
T Consensus       219 ----------------~~~~p~~~~----~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         219 ----------------RLYRPHLAS----EKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             ----------------CCCCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ----------------CCCCccccc----HHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence                            112222233    45667999999999999999999988764

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-46  Score=400.93  Aligned_cols=281  Identities=21%  Similarity=0.273  Sum_probs=208.5

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEec----CCce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQ----EGRG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~----~~~~   84 (708)
                      ...|...++||+|+||+||+|+++.+|+.||||++......     ..+|+.++++++||||+++++++...    +..+
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            34799999999999999999999999999999999764322     23799999999999999999998543    3345


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCC-ceEEEeccCc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGS-TIYKLTDFGA  163 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~-~~vKL~DFGl  163 (708)
                      +|+|||||+++.+..+.........+++..++.++.||+.||+|||++||+||||||+|||+    +.. ..+||+|||+
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl----~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL----DPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE----CTTTCCEEECCCTT
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEE----ecCCCceeEecccc
Confidence            89999999765433332211112349999999999999999999999999999999999998    543 4799999999


Q ss_pred             cccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcc
Q psy15481        164 ARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKK  243 (708)
Q Consensus       164 A~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~  243 (708)
                      |..........+.+||+.|+|||.+..       ...|+.++||||+||++|||++|.+||.   +.+..+.+..+....
T Consensus       170 a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DIwSlG~il~el~~g~~pf~---~~~~~~~l~~i~~~~  239 (350)
T d1q5ka_         170 AKQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLGQPIFP---GDSGVDQLVEIIKVL  239 (350)
T ss_dssp             CEECCTTSCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHTSCSSC---CSSHHHHHHHHHHHH
T ss_pred             hhhccCCcccccccccccccChHHhhc-------ccCCCcceeecccceEEEehhhCCCCCC---CCCHHHHHHHHHHHh
Confidence            998777776777899999999998863       4678999999999999999999999997   355666666655321


Q ss_pred             cCCcccccccCCC--CcccccC--CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        244 ASGVISGTQTSEN--GEIDWCT--DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       244 ~~~~i~~~~~~~~--g~~~~~~--~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      .............  ....+..  ..+......+.++..+.+||.+||.+||++|||+.++           +.|||+..
T Consensus       240 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~-----------L~Hp~f~~  308 (350)
T d1q5ka_         240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA-----------CAHSFFDE  308 (350)
T ss_dssp             CCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH-----------HTSGGGGG
T ss_pred             CCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH-----------hcCHhhcc
Confidence            1100000000000  0000000  0000011122334456779999999999999999997           67999854

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=397.35  Aligned_cols=279  Identities=22%  Similarity=0.359  Sum_probs=207.8

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCC--ceEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG--RGKV   86 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~--~~~~   86 (708)
                      +.+|.+.+.||+|+||.||+|.++.+|+.||||+++..........+.+|+.++++++||||+++++++.....  ...+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45799999999999999999999999999999999765443334566799999999999999999999865432  1234


Q ss_pred             EEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481         87 IVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus        87 LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      ++++|+.||+|.+++...    .+++..++.++.||+.||.|||++|||||||||+|||+    +..+.+||+|||+|..
T Consensus        87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl----~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCTTCEE
T ss_pred             EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE----CCCCCEEEcccCceee
Confidence            444556699999999753    39999999999999999999999999999999999998    6777899999999987


Q ss_pred             cccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        167 LEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       167 ~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      ......    ....+||+.|+|||++..       +..++.++||||+||++|+|++|+.||..   .+..+........
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlG~il~eml~g~~pf~~---~~~~~~~~~~~~~  228 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGI  228 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTT-------BCSCSTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhc-------CCCCCchhhhhccCceehHHhhCCCCCCC---CCHHHHHHHHhhh
Confidence            654432    344679999999999863       56688999999999999999999999973   4444444443321


Q ss_pred             ccCCccccc-------------ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        243 KASGVISGT-------------QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       243 ~~~~~i~~~-------------~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      .........             .........|       ..+.+.++..+.+||.+||+.||.+|||++++         
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~---------  292 (345)
T d1pmea_         229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPW-------NRLFPNADSKALDLLDKMLTFNPHKRIEVEQA---------  292 (345)
T ss_dssp             HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCH-------HHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHH---------
T ss_pred             ccCCChhhhhhhhhhhhhcccccCCccCCCCH-------HHhCCCCCHHHHHHHHHHccCChhHCcCHHHH---------
Confidence            111000000             0000011111       11223344456779999999999999999997         


Q ss_pred             hhhcCcccCCcccc
Q psy15481        310 RKLVHLFHINRLQC  323 (708)
Q Consensus       310 ~~l~h~~~~~~~~~  323 (708)
                        +.|||+......
T Consensus       293 --L~hpf~~~~~~~  304 (345)
T d1pmea_         293 --LAHPYLEQYYDP  304 (345)
T ss_dssp             --HTSGGGTTTCCG
T ss_pred             --hcCHhhccCCCC
Confidence              679988754443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-46  Score=398.29  Aligned_cols=278  Identities=23%  Similarity=0.385  Sum_probs=206.6

Q ss_pred             CCceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecCC----
Q psy15481          8 TNYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQEG----   82 (708)
Q Consensus         8 ~n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~----   82 (708)
                      ...+|.+.+.||+|+||.||+|.++.+|+.||||+++..... ...+...+|+.+|+.++|||||++++++...+.    
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            457899999999999999999999999999999999754322 223456799999999999999999999975432    


Q ss_pred             ceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccC
Q psy15481         83 RGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFG  162 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFG  162 (708)
                      ..+|+||||| |++|..+++...    +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~~----l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~----~~~~~~kl~Dfg  166 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFG  166 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCT
T ss_pred             ceEEEEEecc-cccHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc----cccccccccccc
Confidence            3579999999 788988886532    9999999999999999999999999999999999998    777889999999


Q ss_pred             ccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        163 AARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       163 lA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .|+....  ......||+.|+|||++..       ...++.++||||+||++|+|++|++||.+   .+....+..+...
T Consensus       167 ~a~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~ell~g~~pf~~---~~~~~~~~~~~~~  234 (346)
T d1cm8a_         167 LARQADS--EMTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGKTLFKG---SDHLDQLKEIMKV  234 (346)
T ss_dssp             TCEECCS--SCCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHH
T ss_pred             ceeccCC--ccccccccccccCHHHHcC-------CCCCCccchhhcchHHHHHHHHCcCCCCC---CChHHHHHHHHhc
Confidence            9987543  3456789999999999873       35679999999999999999999999974   4555555444332


Q ss_pred             ccC---CcccccccCCCCcccccC-----CCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcC
Q psy15481        243 KAS---GVISGTQTSENGEIDWCT-----DLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVH  314 (708)
Q Consensus       243 ~~~---~~i~~~~~~~~g~~~~~~-----~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h  314 (708)
                      ...   ..+.......  ...+..     .......+.+.++..+.+||.+||..||.+|||++++           +.|
T Consensus       235 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei-----------L~H  301 (346)
T d1cm8a_         235 TGTPPAEFVQRLQSDE--AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA-----------LAH  301 (346)
T ss_dssp             HCCCCHHHHHTCSCHH--HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH-----------HHS
T ss_pred             cCCCcHHHHhhhcchh--hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHH-----------hcC
Confidence            111   0000000000  000000     0011112223344566779999999999999999997           569


Q ss_pred             cccCC
Q psy15481        315 LFHIN  319 (708)
Q Consensus       315 ~~~~~  319 (708)
                      ||+..
T Consensus       302 p~f~~  306 (346)
T d1cm8a_         302 PYFES  306 (346)
T ss_dssp             GGGTT
T ss_pred             hhhCc
Confidence            99865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=386.53  Aligned_cols=262  Identities=21%  Similarity=0.297  Sum_probs=197.3

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcC-----CCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCc
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGR   83 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~   83 (708)
                      .+|.+.+.||+|+||.||+|.+..     +++.||||+++..........+.+|..++.++ +||||+.+++++...+ .
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-~   91 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-G   91 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-S
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC-C
Confidence            469999999999999999999754     45789999987554433344566788888777 7899999999876543 3


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec
Q psy15481         84 GKVIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD  150 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~  150 (708)
                      .+++|||||+||+|.+++.....             ...+++..++.++.||+.||.|||++|||||||||+|||+    
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl----  167 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL----  167 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE----
Confidence            58999999999999999864321             1238999999999999999999999999999999999998    


Q ss_pred             CCCceEEEeccCccccccccc---cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC-CCCCCC
Q psy15481        151 DGSTIYKLTDFGAARELEEDQ---QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG-NLPFRP  226 (708)
Q Consensus       151 d~~~~vKL~DFGlA~~~~~~~---~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG-~~PF~~  226 (708)
                      +..+.+||+|||+|+......   ......||+.|+|||++.        +..++.++|||||||++|||+|| .+||..
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF--------DRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhh--------cCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            777889999999998654432   233467999999999998        57789999999999999999996 567763


Q ss_pred             CCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        227 YGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       227 ~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                         ....+.+........                   .++.+..+++    .+.+++.+||+.||++|||+++++++|++
T Consensus       240 ---~~~~~~~~~~~~~~~-------------------~~~~~~~~~~----~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         240 ---VKIDEEFCRRLKEGT-------------------RMRAPDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             ---CCCSHHHHHHHHHTC-------------------CCCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCHHHHHHHHHhcCC-------------------CCCCCccCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               333333333332211                   1111122344    45669999999999999999999999998


Q ss_pred             HHhh
Q psy15481        307 TLNR  310 (708)
Q Consensus       307 il~~  310 (708)
                      +++.
T Consensus       294 ilq~  297 (299)
T d1ywna1         294 LLQA  297 (299)
T ss_dssp             HHHH
T ss_pred             HHhC
Confidence            8764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-45  Score=384.68  Aligned_cols=283  Identities=20%  Similarity=0.303  Sum_probs=205.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecC------
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQE------   81 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~------   81 (708)
                      -.+|.+.+.||+|+||.||+|+++.+|+.||||++...... .......+|+.++++++||||+++++++....      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36899999999999999999999999999999998655433 33455679999999999999999999885432      


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEecc
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDF  161 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DF  161 (708)
                      .+..|+|||||.++++........   .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl----~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI----TRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee----cCCCcEEeeec
Confidence            245899999997766655544333   38999999999999999999999999999999999998    67778999999


Q ss_pred             Cccccccccc-----cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHH
Q psy15481        162 GAARELEEDQ-----QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETM  236 (708)
Q Consensus       162 GlA~~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~  236 (708)
                      |+|.......     ...+.+||+.|+|||++..       ...|+.++||||+||++|+|++|++||.+   ..+.+..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-------~~~~~~k~DiwSlGvil~el~~g~~pf~~---~~~~~~~  231 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQL  231 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHH
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcC-------CCCCCcHHHcccCCceeeeHhhCCCCCCC---CCHHHHH
Confidence            9997654322     2334679999999999873       45789999999999999999999999973   5555555


Q ss_pred             HHHHhc---ccCCcccccccCCC-CcccccCCCCCcccCChh-----HHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        237 YYITTK---KASGVISGTQTSEN-GEIDWCTDLPNNCQLSLG-----LKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       237 ~~i~~~---~~~~~i~~~~~~~~-g~~~~~~~lp~~~~ls~~-----l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ..+...   .............. ..+......+  ....+.     ....+.+||.+||++||++|||++++       
T Consensus       232 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el-------  302 (318)
T d3blha1         232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQK--RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA-------  302 (318)
T ss_dssp             HHHHHHHCCCCTTTSTTCCCC-------CCSSCC--BCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH-------
T ss_pred             HHHHHhcCCCChhhccccchhhhhhhhccccccc--ccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH-------
Confidence            444332   11111111110000 0000000000  111111     12345679999999999999999997       


Q ss_pred             HhhhhcCcccCCcc
Q psy15481        308 LNRKLVHLFHINRL  321 (708)
Q Consensus       308 l~~~l~h~~~~~~~  321 (708)
                          +.||||+..+
T Consensus       303 ----L~Hpff~~~p  312 (318)
T d3blha1         303 ----LNHDFFWSDP  312 (318)
T ss_dssp             ----HHSGGGSSSS
T ss_pred             ----HcChhhccCC
Confidence                6699998653

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=377.97  Aligned_cols=280  Identities=23%  Similarity=0.308  Sum_probs=217.4

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVM   89 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVm   89 (708)
                      +|.+.+.||+|+||.||+|+++.+|+.||||+++...... ....+.+|+.+++.++||||+++++++.+..  ..++||
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~iv~   80 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLVF   80 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--ceeEEe
Confidence            6999999999999999999999999999999997654332 3455679999999999999999999998765  489999


Q ss_pred             eccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccccc
Q psy15481         90 ELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEE  169 (708)
Q Consensus        90 Ey~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~  169 (708)
                      +++.|++|..++.....   +++..++.++.|++.||+|||++||+||||||+|||+    +..+.+||+|||.|.....
T Consensus        81 ~~~~~~~l~~~~~~~~~---~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli----~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI----NRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             ECCSEEHHHHHHHTTTC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTTCEECCS
T ss_pred             eeccccccccccccccc---cchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc----ccCCceeeeecchhhcccC
Confidence            99999999888876543   8999999999999999999999999999999999998    6667899999999987655


Q ss_pred             cc-cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCCc-
Q psy15481        170 DQ-QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASGV-  247 (708)
Q Consensus       170 ~~-~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~~-  247 (708)
                      .. ......+++.|+|||.+..       ...++.++||||+||++|+|++|..||..  +.+..+.+..+........ 
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~  224 (292)
T d1unla_         154 PVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCT
T ss_pred             CCccceeeccccchhhhhHhcc-------CCCCCchhhccccchHHHHHhhCCCCCCC--CCCHHHHHHHHHhhcCCCCh
Confidence            43 3344568899999999873       34579999999999999999999999753  5666666666553221111 


Q ss_pred             --cccc-ccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        248 --ISGT-QTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       248 --i~~~-~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                        .... .....................+.++..+.+||.+||+.||.+||||+|+           +.|||+..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~-----------L~Hp~f~~  288 (292)
T d1unla_         225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA-----------LQHPYFSD  288 (292)
T ss_dssp             TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH-----------TTSGGGSS
T ss_pred             hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH-----------hcChhhcC
Confidence              0000 0000111111111112222334455667789999999999999999997           78999964

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-45  Score=386.92  Aligned_cols=259  Identities=22%  Similarity=0.314  Sum_probs=207.2

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCce--EEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEP--VAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~--VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .|.+.+.||+|+||.||+|.++.+|..  ||||.++........+.+.+|+.++.++ +|||||++++++.+.+  ..|+
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--~~~i   88 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYL   88 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--EEEE
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--eeEE
Confidence            678899999999999999999988874  6778876554444455678999999999 7999999999998654  5999


Q ss_pred             EEeccCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCc
Q psy15481         88 VMELCTGGSLFNILDDPE-------------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST  154 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~-------------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~  154 (708)
                      |||||+||+|.+++....             ....+++..+..++.||+.||.|||++||+||||||+|||+    +..+
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~----~~~~  164 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV----GENY  164 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CGGG
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE----cCCC
Confidence            999999999999997531             22349999999999999999999999999999999999998    7778


Q ss_pred             eEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCC-CCCCCCCCCChh
Q psy15481        155 IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGN-LPFRPYGGRRNK  233 (708)
Q Consensus       155 ~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~-~PF~~~~g~~~~  233 (708)
                      .+||+|||+|+............||..|+|||.+.        +..|+.++|||||||++|||++|. +||.   +.+..
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~sDvwSfGvil~ell~~~~~p~~---~~~~~  233 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN--------YSVYTTNSDVWSYGVLLWEIVSLGGTPYC---GMTCA  233 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHH--------HCEECHHHHHHHHHHHHHHHHTTSCCTTT---TCCHH
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhc--------cCCCCccceeehhHHHHHHHHhcCCCCCC---CCCHH
Confidence            89999999998766555555667999999999997        577899999999999999999965 5675   45556


Q ss_pred             hHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        234 ETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       234 e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      +.+..+....                    .++.+..++    +.+.+||.+||+.||++|||+.++++.|.++++.
T Consensus       234 ~~~~~i~~~~--------------------~~~~~~~~~----~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         234 ELYEKLPQGY--------------------RLEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HHHHHGGGTC--------------------CCCCCTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHhcC--------------------CCCCCccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            6555554321                    112222234    4556699999999999999999999999888753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-45  Score=385.50  Aligned_cols=257  Identities=21%  Similarity=0.269  Sum_probs=207.9

Q ss_pred             eEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~   85 (708)
                      .|.+.+.||+|+||.||+|+++     .+++.||||+++..........+.+|+.++++++||||+++++++...+  ..
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~   91 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK--PM   91 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SC
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC--ce
Confidence            5899999999999999999975     3568999999976544333455789999999999999999999997654  49


Q ss_pred             EEEEeccCCCCHHHHhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q psy15481         86 VIVMELCTGGSLFNILDDPE---------------------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNI  144 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~---------------------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NI  144 (708)
                      ++||||+++|+|.+++....                     ....+++..++.++.||+.||.|||++|||||||||+||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI  171 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC  171 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence            99999999999999886421                     122389999999999999999999999999999999999


Q ss_pred             EEEEecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCC
Q psy15481        145 MKFICDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGN  221 (708)
Q Consensus       145 Ll~~~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~  221 (708)
                      |+    ++.+.+||+|||+|+.......   ..+..||+.|+|||.+.        +..|+.++|||||||++|||++|.
T Consensus       172 Ll----d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         172 LV----GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF--------YNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             EE----CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             EE----CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc--------cCCCChhhhhccchhhHHHHHccC
Confidence            98    7778899999999986654432   23467899999999998        577999999999999999999985


Q ss_pred             -CCCCCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        222 -LPFRPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       222 -~PF~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                       +||.   +.+..+.+..+.....                    ++.+..++    ..+.+|+.+||+.||++||||.++
T Consensus       240 ~~p~~---~~~~~e~~~~v~~~~~--------------------~~~p~~~~----~~~~~li~~cl~~~P~~RPt~~ev  292 (301)
T d1lufa_         240 LQPYY---GMAHEEVIYYVRDGNI--------------------LACPENCP----LELYNLMRLCWSKLPADRPSFCSI  292 (301)
T ss_dssp             CCTTT---TSCHHHHHHHHHTTCC--------------------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCC---CCCHHHHHHHHHcCCC--------------------CCCCccch----HHHHHHHHHHcCCChhHCcCHHHH
Confidence             5675   4666777666654321                    11112233    346679999999999999999999


Q ss_pred             HHHHHHHH
Q psy15481        301 FSEVTKTL  308 (708)
Q Consensus       301 ~~~l~~il  308 (708)
                      .+.|++++
T Consensus       293 ~~~L~~i~  300 (301)
T d1lufa_         293 HRILQRMC  300 (301)
T ss_dssp             HHHHHHTT
T ss_pred             HHHHHHhc
Confidence            88777653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=374.75  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=196.5

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEEEe
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIVME   90 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LVmE   90 (708)
                      .|.+.+.||+|+||.||+|.++  |+.||||+++...   ..+.+.+|++++++++||||+++++++.+.. +.+|+|||
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~e   81 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTE   81 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEEC
T ss_pred             HeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEEEEe
Confidence            5888999999999999999874  7899999996432   3456779999999999999999999885433 24899999


Q ss_pred             ccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccccc
Q psy15481         91 LCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELEED  170 (708)
Q Consensus        91 y~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~~~  170 (708)
                      |+++|+|.+++..... ..+++..++.++.||+.||.|||+++|+||||||+|||+    +..+.+||+|||+++.....
T Consensus        82 y~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~----~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          82 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV----SEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTSCEEECCCCC-------
T ss_pred             ccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee----cCCCCEeecccccceecCCC
Confidence            9999999999865321 128999999999999999999999999999999999998    77778999999999875443


Q ss_pred             ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHHHhcccCCccc
Q psy15481        171 QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYITTKKASGVIS  249 (708)
Q Consensus       171 ~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i~~~~~~~~i~  249 (708)
                        .....+|..|+|||.+.        +..++.++|||||||++|||+| |.+||.   +.+..+....+....      
T Consensus       157 --~~~~~~~~~y~aPE~l~--------~~~~t~~sDIwSfG~il~el~t~~~~p~~---~~~~~~~~~~i~~~~------  217 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALR--------EKKFSTKSDVWSFGILLWEIYSFGRVPYP---RIPLKDVVPRVEKGY------  217 (262)
T ss_dssp             -------CCTTTSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCSCT---TSCGGGHHHHHTTTC------
T ss_pred             --CccccccccCCChHHHh--------CCCCChHHHHHhHHHHHHHHHHCCCCCCC---CCCHHHHHHHHHcCC------
Confidence              33457899999999997        5678999999999999999998 788886   344455555444311      


Q ss_pred             ccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        250 GTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       250 ~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                                    .++.+...+    ..+.+++.+||..||.+|||+.++++.|+.+...
T Consensus       218 --------------~~~~~~~~~----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         218 --------------KMDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             --------------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------CCCCCccCC----HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence                          112222233    4456699999999999999999999988877543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=378.11  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=196.2

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      ...|++.+.||+|+||.||+|.++.+ +.||||+++...  ...+.+.+|+.++++++|||||++++++.+.   ..|+|
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~~~lv   89 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYIV   89 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEecC---CeEEE
Confidence            35799999999999999999998654 679999997443  3356678999999999999999999998542   37999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      ||||++|+|..++..... ..+++.+++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+|+...
T Consensus        90 ~Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll----~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADFGLARLIE  164 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCCCTTC---
T ss_pred             EEecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE----CCCCcEEEcccchhhhcc
Confidence            999999999988865321 238999999999999999999999999999999999998    777889999999998764


Q ss_pred             ccc--cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccCC
Q psy15481        169 EDQ--QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKASG  246 (708)
Q Consensus       169 ~~~--~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~~  246 (708)
                      .+.  ......||+.|+|||.+.        +..++.++|||||||++|||+||..||..  +....+.+..+....   
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDI~S~Giil~el~t~~~p~~~--~~~~~~~~~~i~~~~---  231 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAAL--------YGRFTIKSDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVERGY---  231 (285)
T ss_dssp             -----------CCGGGSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHHHTTC---
T ss_pred             CCCceeeccccccccccChHHHh--------CCCCCcHHhhhcchHHHHHHHhCCCCCCC--CCCHHHHHHHHHhcC---
Confidence            443  233467999999999998        57789999999999999999996555542  455556665554321   


Q ss_pred             cccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        247 VISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       247 ~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                                       ..|.+..+++    .+.+++.+||+.||++|||++++.+.+
T Consensus       232 -----------------~~~~~~~~~~----~l~~li~~cl~~dP~~Rps~~~i~~~L  268 (285)
T d1fmka3         232 -----------------RMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFL  268 (285)
T ss_dssp             -----------------CCCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -----------------CCCCCcccCH----HHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence                             1222223344    456699999999999999999986643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=388.83  Aligned_cols=279  Identities=24%  Similarity=0.355  Sum_probs=201.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCC-chHHHHHHHHHHHhCCCCCccceeEEEEec----CCce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMR-PHDVQMREFEVLKKVKHENIVKLLAIEEEQ----EGRG   84 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~-~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~----~~~~   84 (708)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||+++...... ......+|+.++++++||||+++++++...    ....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            46999999999999999999999999999999997654322 223467999999999999999999999654    2357


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      +|+|||||.|+ +...+..     .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+|++|||.+
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~----~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECCCCC-
T ss_pred             eEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc----ccccceeeechhhh
Confidence            99999999655 5455532     28999999999999999999999999999999999998    66778999999999


Q ss_pred             ccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhccc
Q psy15481        165 RELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKA  244 (708)
Q Consensus       165 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~  244 (708)
                      +...........+||+.|+|||++.        +..++.++||||+||++|+|++|++||.   +.+....+..+.....
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~l~--------~~~~~~~~DiwSlG~~l~ell~g~~pF~---~~~~~~~~~~i~~~~~  235 (355)
T d2b1pa1         167 RTAGTSFMMTPYVVTRYYRAPEVIL--------GMGYKENVDIWSVGCIMGEMVRHKILFP---GRDYIDQWNKVIEQLG  235 (355)
T ss_dssp             --------------CCTTCCHHHHT--------TCCCCTTHHHHHHHHHHHHHHHSSCSSC---CSSHHHHHHHHHHHHC
T ss_pred             hccccccccccccccccccChhhhc--------CCCCCCCcccccccchHHHHhhCCCCCC---CCCHHHHHHHHHHhcc
Confidence            9877777777788999999999987        6789999999999999999999999997   4555555555543221


Q ss_pred             CCc---cccccc---------CCCCccccc-----CCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        245 SGV---ISGTQT---------SENGEIDWC-----TDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       245 ~~~---i~~~~~---------~~~g~~~~~-----~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      ...   +.....         .......|.     ...+.........+..+.+||.+||..||++||||+++       
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el-------  308 (355)
T d2b1pa1         236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA-------  308 (355)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH-------
T ss_pred             CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH-------
Confidence            110   000000         000000111     01111112223456678889999999999999999997       


Q ss_pred             HhhhhcCcccCCc
Q psy15481        308 LNRKLVHLFHINR  320 (708)
Q Consensus       308 l~~~l~h~~~~~~  320 (708)
                          +.|||+...
T Consensus       309 ----L~Hpw~~~~  317 (355)
T d2b1pa1         309 ----LQHPYINVW  317 (355)
T ss_dssp             ----HTSTTTGGG
T ss_pred             ----hcCcccCCC
Confidence                779999753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=377.38  Aligned_cols=254  Identities=22%  Similarity=0.320  Sum_probs=193.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcC-CC--ceEEEEEeccCCCCCc--hHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKN-NG--EPVAVKTFNQLSHMRP--HDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~-tg--~~VAIK~~~~~s~~~~--~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ..|++.+.||+|+||.||+|+... ++  ..||||+++.......  .+.+.+|+.++++++||||+++++++.++   .
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~   84 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---P   84 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---S
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---c
Confidence            469999999999999999998643 33  4789999876533222  34568999999999999999999999653   3


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcc
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAA  164 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA  164 (708)
                      .++|||||++|++.+.+.....  .+++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||++
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll----~~~~~vkl~DfGl~  158 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL----ATRDLVKIGDFGLM  158 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----EETTEEEECCCTTC
T ss_pred             hheeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc----ccccceeeccchhh
Confidence            7899999999999987765332  39999999999999999999999999999999999998    55568999999999


Q ss_pred             cccccccc----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCCCCCCCCChhhHHHHH
Q psy15481        165 RELEEDQQ----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPFRPYGGRRNKETMYYI  239 (708)
Q Consensus       165 ~~~~~~~~----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF~~~~g~~~~e~~~~i  239 (708)
                      +.......    .....|+..|+|||.+.        +..++.++|||||||++|||+| |.+||.   +.+..+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Di~S~Gvil~emlt~G~~Pf~---~~~~~~~~~~i  227 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAPESLK--------TRTFSHASDTWMFGVTLWEMFTYGQEPWI---GLNGSQILHKI  227 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHH--------HCEEEHHHHHHHHHHHHHHHHTTSCCTTT---TCCHHHHHHHH
T ss_pred             hhcccCCCcceecCccccCcccCCHHHHh--------CCCCCcchhhhhhHHHHHHHHhCCCCCCC---CcCHHHHHHHH
Confidence            97644422    22346788999999998        5778999999999999999998 899997   46666666666


Q ss_pred             HhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHH
Q psy15481        240 TTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTK  306 (708)
Q Consensus       240 ~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~  306 (708)
                      .....                   .+|.+..+++    .+.+++..||..||++||||.++++.|.+
T Consensus       228 ~~~~~-------------------~~~~~~~~~~----~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         228 DKEGE-------------------RLPRPEDCPQ----DIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             HTSCC-------------------CCCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HhCCC-------------------CCCCcccccH----HHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            54211                   2233333444    45669999999999999999998775543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-44  Score=377.74  Aligned_cols=259  Identities=20%  Similarity=0.324  Sum_probs=203.5

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCC-------ceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecC
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNG-------EPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQE   81 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg-------~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~   81 (708)
                      .+|.+++.||+|+||.||+|++..++       ..||||+++..........+.+|+..+.++ +|||||++++++.+.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            58999999999999999999876554       479999997655444445567898999888 8999999999998654


Q ss_pred             CceEEEEEeccCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEE
Q psy15481         82 GRGKVIVMELCTGGSLFNILDDPEN-------------TYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFI  148 (708)
Q Consensus        82 ~~~~~LVmEy~~ggsL~~~L~~~~~-------------~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~  148 (708)
                        ..|+|||||.+|+|.+++.....             ...+++..++.++.||+.||+|||++|||||||||+|||+  
T Consensus        93 --~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl--  168 (299)
T d1fgka_          93 --PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--  168 (299)
T ss_dssp             --SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             --eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee--
Confidence              49999999999999999975431             1238999999999999999999999999999999999998  


Q ss_pred             ecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCC
Q psy15481        149 CDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF  224 (708)
Q Consensus       149 ~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF  224 (708)
                        +..+.+||+|||.++.......   .....||+.|+|||.+.        +..|+.++|||||||++|+|+| |.+||
T Consensus       169 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~--------~~~y~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         169 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF--------DRIYTHQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             --CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             --cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc--------CCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence              7777899999999987655432   33467899999999998        5789999999999999999998 79998


Q ss_pred             CCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        225 RPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       225 ~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      .   +.+.......+... .                   .++.+..+++    .+.+|+.+||+.||.+|||+.++++.|
T Consensus       239 ~---~~~~~~~~~~i~~~-~-------------------~~~~p~~~~~----~l~~li~~cl~~dP~~Rps~~eil~~L  291 (299)
T d1fgka_         239 P---GVPVEELFKLLKEG-H-------------------RMDKPSNCTN----ELYMMMRDCWHAVPSQRPTFKQLVEDL  291 (299)
T ss_dssp             T---TCCHHHHHHHHHTT-C-------------------CCCCCSSCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             C---CCCHHHHHHHHHcC-C-------------------CCCCCccchH----HHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence            6   34444333333221 1                   1222223444    456699999999999999999999998


Q ss_pred             HHHHh
Q psy15481        305 TKTLN  309 (708)
Q Consensus       305 ~~il~  309 (708)
                      +.++.
T Consensus       292 ~~i~a  296 (299)
T d1fgka_         292 DRIVA  296 (299)
T ss_dssp             HHHHH
T ss_pred             HHHhh
Confidence            88764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-44  Score=377.62  Aligned_cols=259  Identities=22%  Similarity=0.340  Sum_probs=204.1

Q ss_pred             eEEEeeEeecCCceEEEEEEEcCCC---ceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEE
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKNNG---EPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~tg---~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~L   87 (708)
                      .+.+.++||+|+||.||+|.+..++   ..||||.++..........+.+|++++++++||||+++++++...+ +..++
T Consensus        28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~l  106 (311)
T d1r0pa_          28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLV  106 (311)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEEEE
T ss_pred             eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-CceEE
Confidence            4456789999999999999986543   3699999975444444456789999999999999999999986544 35899


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAREL  167 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~  167 (708)
                      |||||++|+|.+++......  +++..+..++.|++.||.|||++||+||||||+|||+    ++.+.+||+|||+++..
T Consensus       107 v~E~~~~g~l~~~~~~~~~~--~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl----~~~~~~kL~DFG~~~~~  180 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML----DEKFTVKVADFGLARDM  180 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCC--CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTCCEEECSSGGGCCT
T ss_pred             EEEEeecCchhhhhcccccc--chHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE----CCCCCEEEecccchhhc
Confidence            99999999999998875432  7889999999999999999999999999999999998    77788999999999876


Q ss_pred             ccccc-----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhc
Q psy15481        168 EEDQQ-----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTK  242 (708)
Q Consensus       168 ~~~~~-----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~  242 (708)
                      .....     .....||+.|+|||.+.        +..++.++|||||||++|||+||..||..  +.+..+....+...
T Consensus       181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDI~SfGivl~El~t~~~p~~~--~~~~~~~~~~i~~g  250 (311)
T d1r0pa_         181 YDKEFDSVHNKTGAKLPVKWMALESLQ--------TQKFTTKSDVWSFGVLLWELMTRGAPPYP--DVNTFDITVYLLQG  250 (311)
T ss_dssp             TTTTCCCTTCTTCSSCCGGGSCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTT
T ss_pred             cccccccceecccccccccccChHHHh--------cCCCCChhHhhhhHHHHHHHHHCCCCCCC--CCCHHHHHHHHHcC
Confidence            54422     22356899999999988        46789999999999999999998888764  23344444444432


Q ss_pred             ccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        243 KASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       243 ~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      +.                    ++.+..++    +.+.+++.+||..||++|||+.+++++|+.++..
T Consensus       251 ~~--------------------~~~p~~~~----~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         251 RR--------------------LLQPEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CC--------------------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CC--------------------CCCcccCc----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            11                    11111233    4466799999999999999999999999888653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=384.93  Aligned_cols=303  Identities=23%  Similarity=0.353  Sum_probs=215.8

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-CchHHHHHHHHHHHhCCCCCccceeEEEEecC---CceE
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-RPHDVQMREFEVLKKVKHENIVKLLAIEEEQE---GRGK   85 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~---~~~~   85 (708)
                      .+|.+.+.||+|+||+||+|+++.+|+.||||+++..... .......+|+.++++++|||||++++++....   ....
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            3699999999999999999999999999999999754332 12334679999999999999999999986432   2235


Q ss_pred             EEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCccc
Q psy15481         86 VIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAAR  165 (708)
Q Consensus        86 ~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~  165 (708)
                      +++|+|+.||+|.+++...    .+++..++.++.||+.||+|||++||+||||||+|||+    +..+.+|++|||.|.
T Consensus        98 ~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi----~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGLAR  169 (348)
T ss_dssp             CEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEEECCC----
T ss_pred             EEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc----cccccccccccchhc
Confidence            6667777899999999653    29999999999999999999999999999999999998    777789999999998


Q ss_pred             cccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHhcccC
Q psy15481        166 ELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITTKKAS  245 (708)
Q Consensus       166 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~~~~~  245 (708)
                      ....  ...+..||+.|+|||.+..       ...++.++|||||||++|+|++|++||.   +.+.......+......
T Consensus       170 ~~~~--~~~~~~g~~~y~apE~~~~-------~~~~~~~~DiwSlGv~l~~ll~g~~pF~---~~~~~~~~~~i~~~~~~  237 (348)
T d2gfsa1         170 HTDD--EMTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQLKLILRLVGT  237 (348)
T ss_dssp             CCTG--GGSSSCHHHHTSCHHHHTT-------CSCCCTTHHHHHHHHHHHHHHHSSCSCC---CSSHHHHHHHHHHHHCC
T ss_pred             ccCc--ccccccccccccCchhhcC-------CccCCcccchhhhhHHHHHHHhCCCCCC---CCCHHHHHHHHHHhcCC
Confidence            6543  3456789999999998763       4567899999999999999999999997   45556655555542211


Q ss_pred             Cccccccc-CCCCcccccCCCCCc-----ccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhhhhcCcccCC
Q psy15481        246 GVISGTQT-SENGEIDWCTDLPNN-----CQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNRKLVHLFHIN  319 (708)
Q Consensus       246 ~~i~~~~~-~~~g~~~~~~~lp~~-----~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~~l~h~~~~~  319 (708)
                      ........ .......+...++..     ......++..+.+||.+||..||.+|||+.++           +.|||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el-----------L~Hp~f~~  306 (348)
T d2gfsa1         238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA-----------LAHAYFAQ  306 (348)
T ss_dssp             CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH-----------HTSGGGTT
T ss_pred             CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH-----------hcCHhhCC
Confidence            10000000 000000000011110     01112334456679999999999999999997           67999874


Q ss_pred             cccccc---------cccCCcccHHHHHHHHHh
Q psy15481        320 RLQCIR---------IYLHPDDAYDQLQDLIQE  343 (708)
Q Consensus       320 ~~~~~~---------~~i~~~e~~~~l~~~i~~  343 (708)
                      -.....         .......+.++++.++.+
T Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~  339 (348)
T d2gfsa1         307 YHDPDDEPVADPYDQSFESRDLLIDEWKSLTYD  339 (348)
T ss_dssp             TCCTTSCCCCCCCCCGGGGCCCCHHHHHHHHHH
T ss_pred             CCCCccCCCCCCCCCcccchhcCHHHHHHHHHH
Confidence            322111         112334456667766543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-44  Score=377.95  Aligned_cols=261  Identities=24%  Similarity=0.379  Sum_probs=208.9

Q ss_pred             ceEEEeeEeecCCceEEEEEEEc-----CCCceEEEEEeccCCCCCchHHHHHHHHHHHhC-CCCCccceeEEEEecCCc
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNK-----NNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKV-KHENIVKLLAIEEEQEGR   83 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL-~HpNIVkl~~v~~~~~~~   83 (708)
                      .+|.+.+.||+|+||.||+|.+.     .+++.||||+++..........+.+|+.+++++ +|||||++++++.+... 
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~-  101 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP-  101 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE-
Confidence            47889999999999999999863     467899999998655444445568999999999 79999999999976554 


Q ss_pred             eEEEEEeccCCCCHHHHhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEE
Q psy15481         84 GKVIVMELCTGGSLFNILDDPE---------------NTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFI  148 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~---------------~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~  148 (708)
                       .|+|||||+||+|.+++....               ....+++..++.++.||+.||.|||++|+|||||||+||++  
T Consensus       102 -~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~--  178 (311)
T d1t46a_         102 -TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--  178 (311)
T ss_dssp             -CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             -EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc--
Confidence             899999999999999986532               12248999999999999999999999999999999999998  


Q ss_pred             ecCCCceEEEeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhc-CCCCC
Q psy15481        149 CDDGSTIYKLTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVAT-GNLPF  224 (708)
Q Consensus       149 ~~d~~~~vKL~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlT-G~~PF  224 (708)
                        +..+.+||+|||.++.......   ....+||+.|+|||.+.        +..++.++|||||||++|||+| |.+||
T Consensus       179 --~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DIwS~G~~l~ellt~g~p~~  248 (311)
T d1t46a_         179 --THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF--------NCVYTFESDVWSYGIFLWELFSLGSSPY  248 (311)
T ss_dssp             --ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             --cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc--------CCCCCCcccccchHHHHHHHHhCCCCCC
Confidence              6677899999999987654432   23467899999999998        5778999999999999999999 66666


Q ss_pred             CCCCCCChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHH
Q psy15481        225 RPYGGRRNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEV  304 (708)
Q Consensus       225 ~~~~g~~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l  304 (708)
                      .   +.+..+.+..+.....                   .++.+...+    ..+.+||.+||+.||.+|||+++++..|
T Consensus       249 ~---~~~~~~~~~~~i~~~~-------------------~~~~~~~~~----~~l~~Li~~cl~~dP~~RPs~~~il~~L  302 (311)
T d1t46a_         249 P---GMPVDSKFYKMIKEGF-------------------RMLSPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLI  302 (311)
T ss_dssp             T---TCCSSHHHHHHHHHTC-------------------CCCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             C---CCCHHHHHHHHHhcCC-------------------CCCCccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            5   3444444555543211                   112222233    4466699999999999999999999988


Q ss_pred             HHHHhh
Q psy15481        305 TKTLNR  310 (708)
Q Consensus       305 ~~il~~  310 (708)
                      ++++..
T Consensus       303 ~~~i~~  308 (311)
T d1t46a_         303 EKQISE  308 (311)
T ss_dssp             HHHHHH
T ss_pred             HHhhcc
Confidence            777643

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-43  Score=373.31  Aligned_cols=265  Identities=20%  Similarity=0.266  Sum_probs=198.6

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCceEEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRGKVIV   88 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~~~LV   88 (708)
                      +.+|++.+.||+|+||.||+|.+..+|+.||||++.....   ...+.+|+++++.++|+|++..+..+... +...++|
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~iv   81 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV   81 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEE
Confidence            3469999999999999999999999999999999875432   23356899999999888766665554433 3368999


Q ss_pred             EeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCcccccc
Q psy15481         89 MELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARELE  168 (708)
Q Consensus        89 mEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~~~  168 (708)
                      |||+ +++|...+.....  .+++..+..++.|++.||.|||++||+||||||+|||+. ..+....+||+|||+|+...
T Consensus        82 me~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~-~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          82 MELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG-LGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-CGGGTTCEEECCCSSCEECB
T ss_pred             EEEc-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccc-ccCCCceeeeeccCcceecc
Confidence            9999 5677666654332  399999999999999999999999999999999999972 23345679999999998765


Q ss_pred             ccc--------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHH
Q psy15481        169 EDQ--------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYIT  240 (708)
Q Consensus       169 ~~~--------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~  240 (708)
                      ...        ......||+.|+|||++.        +..++.++|||||||++|||+||.+||................
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~  229 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHL--------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  229 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHT--------TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHh--------CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh
Confidence            432        223467999999999987        6779999999999999999999999998654433333332222


Q ss_pred             hcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHh
Q psy15481        241 TKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLN  309 (708)
Q Consensus       241 ~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~  309 (708)
                      ..+..                   .| ...+.+.++..+.+++..||..||.+||++.++...++.++.
T Consensus       230 ~~~~~-------------------~~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         230 EKKMS-------------------TP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHHH-------------------SC-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccCC-------------------CC-hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            21100                   01 111222334556679999999999999999987666655543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=378.78  Aligned_cols=259  Identities=27%  Similarity=0.435  Sum_probs=202.7

Q ss_pred             eEEEeeEeecCCceEEEEEEEc---CCCceEEEEEeccCCC---CCchHHHHHHHHHHHhCCC-CCccceeEEEEecCCc
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNK---NNGEPVAVKTFNQLSH---MRPHDVQMREFEVLKKVKH-ENIVKLLAIEEEQEGR   83 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~---~tg~~VAIK~~~~~s~---~~~~~~~~~Ei~iL~kL~H-pNIVkl~~v~~~~~~~   83 (708)
                      .|.+.+.||+|+||.||+|++.   .+|+.||||+++....   ....+.+.+|+.++++++| |||+++++++.+..  
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~--  102 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET--  102 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT--
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC--
Confidence            4999999999999999999874   4799999999864321   1223455689999999966 89999999998765  


Q ss_pred             eEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEEEeccCc
Q psy15481         84 GKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYKLTDFGA  163 (708)
Q Consensus        84 ~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vKL~DFGl  163 (708)
                      .++++|||+.||+|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +..+.+||+|||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill----~~~~~vkL~DFG~  175 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL----DSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEESCSSE
T ss_pred             ceeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee----cCCCCEEEeeccc
Confidence            59999999999999999976543   8899999999999999999999999999999999998    7777899999999


Q ss_pred             ccccccc--ccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHHHHh
Q psy15481        164 ARELEED--QQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYYITT  241 (708)
Q Consensus       164 A~~~~~~--~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~i~~  241 (708)
                      |......  .......|++.|+|||.+...      ...++.++|||||||+||+|+||..||...........+.....
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~------~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~  249 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGG------DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  249 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTC------C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             hhhhcccccccccccccccccchhHHhhcC------CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence            9865433  334557899999999999631      24578899999999999999999999975433332222222221


Q ss_pred             cccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCC-----HHHHHHHHHHHHhhhhcCcc
Q psy15481        242 KKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWS-----FERFFSEVTKTLNRKLVHLF  316 (708)
Q Consensus       242 ~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRps-----a~q~~~~l~~il~~~l~h~~  316 (708)
                      .                    ..++.+..+|    ..+.++|.+||.+||.+|||     ++|+           +.|||
T Consensus       250 ~--------------------~~~~~~~~~s----~~~~~li~~~l~~dP~~R~s~~~~t~~ei-----------l~Hpf  294 (322)
T d1vzoa_         250 K--------------------SEPPYPQEMS----ALAKDLIQRLLMKDPKKRLGCGPRDADEI-----------KEHLF  294 (322)
T ss_dssp             H--------------------CCCCCCTTSC----HHHHHHHHHHTCSSGGGSTTSSTTTHHHH-----------HTSGG
T ss_pred             c--------------------CCCCCcccCC----HHHHHHHHHHcccCHHHcCCCCcccHHHH-----------HcCHh
Confidence            1                    0112222334    45566999999999999995     6776           67999


Q ss_pred             cCC
Q psy15481        317 HIN  319 (708)
Q Consensus       317 ~~~  319 (708)
                      +..
T Consensus       295 f~~  297 (322)
T d1vzoa_         295 FQK  297 (322)
T ss_dssp             GTT
T ss_pred             hcC
Confidence            853

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=374.33  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=207.1

Q ss_pred             ceEEEeeEeecCCceEEEEEEEcC-----CCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCccceeEEEEecCCce
Q psy15481         10 YVWCTTSVLGKGATGAVFQGVNKN-----NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENIVKLLAIEEEQEGRG   84 (708)
Q Consensus        10 ~~y~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNIVkl~~v~~~~~~~~   84 (708)
                      ..|.+.+.||+|+||.||+|.+..     +++.||||+++..........+.+|+.++++++||||+++++++...+.  
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--   97 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP--   97 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS--
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc--
Confidence            468999999999999999998853     4678999999765444444456899999999999999999999976554  


Q ss_pred             EEEEEeccCCCCHHHHhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCceEE
Q psy15481         85 KVIVMELCTGGSLFNILDDP-------ENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGSTIYK  157 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~-------~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~~vK  157 (708)
                      .++|||||++|+|.+++...       .....+++..+..++.+++.||.|||+++|+||||||+|||+    ++++.+|
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl----d~~~~~K  173 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFTVK  173 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE----CTTCCEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee----cCCceEE
Confidence            89999999999999987531       122237899999999999999999999999999999999998    7788999


Q ss_pred             EeccCcccccccccc---ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcC-CCCCCCCCCCChh
Q psy15481        158 LTDFGAARELEEDQQ---FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATG-NLPFRPYGGRRNK  233 (708)
Q Consensus       158 L~DFGlA~~~~~~~~---~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG-~~PF~~~~g~~~~  233 (708)
                      |+|||+|+.......   ....+||+.|+|||.+.        +..++.++|||||||++|||+|| .+||.   +.+..
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~--------~~~~~~~~Dv~S~G~il~El~t~~~~p~~---~~~~~  242 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK--------DGVFTTYSDVWSFGVVLWEIATLAEQPYQ---GLSNE  242 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH--------HCCCCHHHHHHHHHHHHHHHHHTSCCTTT---TSCHH
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHc--------cCCCCcccccccHHHHHHHHHhCCCCCCC---CCCHH
Confidence            999999987654432   23356899999999998        57789999999999999999998 57775   46666


Q ss_pred             hHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHH
Q psy15481        234 ETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKT  307 (708)
Q Consensus       234 e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~i  307 (708)
                      +.+..+....                    .++.+..++    ..+.+++.+||+.||.+|||+.++++.|.+.
T Consensus       243 ~~~~~i~~~~--------------------~~~~p~~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         243 QVLRFVMEGG--------------------LLDKPDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHHHHHTTC--------------------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHHHHhCC--------------------CCCCcccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            6666665421                    111222233    4566799999999999999999998865433

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.6e-43  Score=366.44  Aligned_cols=266  Identities=21%  Similarity=0.278  Sum_probs=208.9

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCC-CCccceeEEEEecCCceEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKH-ENIVKLLAIEEEQEGRGKVI   87 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~H-pNIVkl~~v~~~~~~~~~~L   87 (708)
                      +.+|.+.+.||+|+||.||+|++..+|+.||||+++....   .....+|++.++.|+| +||+.+++++....  ..|+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL--HNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--EEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC--ccEE
Confidence            4579999999999999999999999999999999865432   2335689999999965 89999999887644  5899


Q ss_pred             EEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEec-CCCceEEEeccCcccc
Q psy15481         88 VMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICD-DGSTIYKLTDFGAARE  166 (708)
Q Consensus        88 VmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~-d~~~~vKL~DFGlA~~  166 (708)
                      ||||+ |++|.+++.....  .+++..+..++.|++.||.|||++||+||||||+|||+.... ...+.+||+|||+|+.
T Consensus        79 vme~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99999 7999998876543  389999999999999999999999999999999999972211 1346799999999987


Q ss_pred             ccccc--------cccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCChhhHHHH
Q psy15481        167 LEEDQ--------QFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRRNKETMYY  238 (708)
Q Consensus       167 ~~~~~--------~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~~~e~~~~  238 (708)
                      .....        ...+.+||+.|+|||++.        +..++.++|||||||++|+|+||.+||.+...........+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~--------~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~  227 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHL--------GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  227 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT--------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhc--------CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence            54321        233467999999999997        67899999999999999999999999986555555555544


Q ss_pred             HHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHHHHHHHHHHhh
Q psy15481        239 ITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERFFSEVTKTLNR  310 (708)
Q Consensus       239 i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~~~~l~~il~~  310 (708)
                      +...+...                    ....+.+.++..+.+++..|+..+|++||+++.+.+.+.+++.+
T Consensus       228 i~~~~~~~--------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         228 IGEKKQST--------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             HHHHHHHS--------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHhccCCC--------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence            44322110                    01111222334566799999999999999998877767666543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-42  Score=365.10  Aligned_cols=269  Identities=20%  Similarity=0.287  Sum_probs=199.1

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHH--HHHHHHhCCCCCccceeEEEEecCC--ce
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMR--EFEVLKKVKHENIVKLLAIEEEQEG--RG   84 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~--Ei~iL~kL~HpNIVkl~~v~~~~~~--~~   84 (708)
                      +..|.+.+.||+|+||.||+|+.  +|+.||||+++...    .....+  |+..+..++||||+++++++...+.  ..
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            45789999999999999999986  58999999986432    223334  4445567899999999999976543  35


Q ss_pred             EEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCcccCCCCCcEEEEEecCCCceE
Q psy15481         85 KVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD--------NRLVHRDLKPGNIMKFICDDGSTIY  156 (708)
Q Consensus        85 ~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~--------~gIVHrDIKP~NILl~~~~d~~~~v  156 (708)
                      +|+|||||++|+|..++.+..    +++.....++.+++.||.|||+        +|||||||||+|||+    +.++.+
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl----~~~~~~  147 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----KKNGTC  147 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE----CTTSCE
T ss_pred             EEEEEecccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE----cCCCCe
Confidence            899999999999999998643    8999999999999999999996        699999999999998    777889


Q ss_pred             EEeccCcccccccccc-----ccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCC-
Q psy15481        157 KLTDFGAARELEEDQQ-----FMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGR-  230 (708)
Q Consensus       157 KL~DFGlA~~~~~~~~-----~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~-  230 (708)
                      ||+|||++........     .....||+.|+|||++.....  .....++.++|||||||++|||+||..||...... 
T Consensus       148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~  225 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  225 (303)
T ss_dssp             EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSC--TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred             EEEecCccccccCCCcceeccccceecccCcCChhhcccccc--ccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence            9999999987654321     234679999999999863110  00124678999999999999999999887532111 


Q ss_pred             ----------ChhhHHHHHHhcccCCcccccccCCCCcccccCCCCCcccCChhHHHHHHHHHHhhcccCcccCCCHHHH
Q psy15481        231 ----------RNKETMYYITTKKASGVISGTQTSENGEIDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKIWSFERF  300 (708)
Q Consensus       231 ----------~~~e~~~~i~~~~~~~~i~~~~~~~~g~~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kRpsa~q~  300 (708)
                                .....+.......                .....+|... .+......+.+++.+||..||++|||+.++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~----------------~~~p~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ei  288 (303)
T d1vjya_         226 LPYYDLVPSDPSVEEMRKVVCEQ----------------KLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRI  288 (303)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTS----------------CCCCCCCGGG-GGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred             cchhhcccccchHHHHHHHHhcc----------------ccCCCCCccc-CChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence                      0111111111000                0011222211 133455668889999999999999999999


Q ss_pred             HHHHHHHHhh
Q psy15481        301 FSEVTKTLNR  310 (708)
Q Consensus       301 ~~~l~~il~~  310 (708)
                      +..|..+...
T Consensus       289 ~~~L~~i~~~  298 (303)
T d1vjya_         289 KKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHh
Confidence            9988776553

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.7e-40  Score=355.54  Aligned_cols=295  Identities=21%  Similarity=0.298  Sum_probs=206.7

Q ss_pred             CceEEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-----------CCCccceeEEE
Q psy15481          9 NYVWCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-----------HENIVKLLAIE   77 (708)
Q Consensus         9 n~~y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-----------HpNIVkl~~v~   77 (708)
                      |.+|.+.+.||+|+||.||+|+++.+|+.||||+++...  ...+...+|+.+++.++           ||||+++++++
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            567999999999999999999999999999999997532  12345578999888875           57899999998


Q ss_pred             EecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEEEecCC--Cc
Q psy15481         78 EEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRD-NRLVHRDLKPGNIMKFICDDG--ST  154 (708)
Q Consensus        78 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~-~gIVHrDIKP~NILl~~~~d~--~~  154 (708)
                      ........+++|.++.++..............+++..++.++.||+.||.|||+ .||+||||||+|||+....+.  ..
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence            766666677777776555433222222223348999999999999999999998 899999999999998433322  23


Q ss_pred             eEEEeccCccccccccccccccCCCCCcCChhhhhhhhhcCCCCCcCCccccchhhhhHHHHHhcCCCCCCCCCCCC---
Q psy15481        155 IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDMYERAVLRKPVGKTFGATVDLWSIGVTLYHVATGNLPFRPYGGRR---  231 (708)
Q Consensus       155 ~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~l~~~~~~~~~~~~~s~ksDIWSLGviLyeLlTG~~PF~~~~g~~---  231 (708)
                      .++++|||.|.....  .....+||+.|+|||++.        +..|+.++||||+||++++|++|+.||.+..+..   
T Consensus       170 ~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~  239 (362)
T d1q8ya_         170 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLL--------GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  239 (362)
T ss_dssp             EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHH--------TCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             eeeEeeccccccccc--ccccccccccccChhhcc--------ccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence            689999999986543  335678999999999988        6778999999999999999999999998654321   


Q ss_pred             hhhHHHHHHh---cccCCcccccc-----cCCCCc---------ccccCCCCCcccCChhHHHHHHHHHHhhcccCcccC
Q psy15481        232 NKETMYYITT---KKASGVISGTQ-----TSENGE---------IDWCTDLPNNCQLSLGLKKLVTPILAGLLEVDSKKI  294 (708)
Q Consensus       232 ~~e~~~~i~~---~~~~~~i~~~~-----~~~~g~---------~~~~~~lp~~~~ls~~l~~~l~~LL~~mL~~DP~kR  294 (708)
                      ..+.+.....   ..+........     ....+.         ..+...++.....+......+.+||.+||.+||.+|
T Consensus       240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R  319 (362)
T d1q8ya_         240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  319 (362)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence            2222222211   10000000000     000000         000001111223456777889999999999999999


Q ss_pred             CCHHHHHHHHHHHHhhhhcCcccCCccccccc
Q psy15481        295 WSFERFFSEVTKTLNRKLVHLFHINRLQCIRI  326 (708)
Q Consensus       295 psa~q~~~~l~~il~~~l~h~~~~~~~~~~~~  326 (708)
                      ||++++           +.|||+.+.....++
T Consensus       320 pta~e~-----------L~Hp~f~~~~~~~~~  340 (362)
T d1q8ya_         320 ADAGGL-----------VNHPWLKDTLGMEEI  340 (362)
T ss_dssp             BCHHHH-----------HTCGGGTTCTTCTTC
T ss_pred             cCHHHH-----------hcCcccCCCCCcccC
Confidence            999997           779999865544443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=6.8e-23  Score=200.22  Aligned_cols=167  Identities=22%  Similarity=0.239  Sum_probs=118.8

Q ss_pred             EEEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCC-----Cc------------hHHHHHHHHHHHhCCCCCcccee
Q psy15481         12 WCTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHM-----RP------------HDVQMREFEVLKKVKHENIVKLL   74 (708)
Q Consensus        12 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~-----~~------------~~~~~~Ei~iL~kL~HpNIVkl~   74 (708)
                      +.+++.||+|+||.||+|.+. +|+.||||+++.....     ..            .....+|+..+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            468899999999999999985 7999999987532110     00            01124688899999999999987


Q ss_pred             EEEEecCCceEEEEEeccCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEEEecCCCc
Q psy15481         75 AIEEEQEGRGKVIVMELCTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDNRLVHRDLKPGNIMKFICDDGST  154 (708)
Q Consensus        75 ~v~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~gIVHrDIKP~NILl~~~~d~~~  154 (708)
                      ++.   .   .+++|||++++.+..          ++...+..++.|++.|+.|||++||+||||||+|||+    +.. 
T Consensus        81 ~~~---~---~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv----~~~-  139 (191)
T d1zara2          81 AWE---G---NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV----SEE-  139 (191)
T ss_dssp             EEE---T---TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE----ETT-
T ss_pred             Eec---C---CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheee----eCC-
Confidence            653   1   379999998765432          4445567899999999999999999999999999997    332 


Q ss_pred             eEEEeccCccccccccccccccCCCCCcCChhh--hhhhhhcCCCCCcCCccccchhhhh
Q psy15481        155 IYKLTDFGAARELEEDQQFMSLYGTEEYLHPDM--YERAVLRKPVGKTFGATVDLWSIGV  212 (708)
Q Consensus       155 ~vKL~DFGlA~~~~~~~~~~~~~GT~~YlAPE~--l~~~~~~~~~~~~~s~ksDIWSLGv  212 (708)
                      .++|+|||.|.....+..       ..|+..++  +....     .+.|+.++|+||+.-
T Consensus       140 ~~~liDFG~a~~~~~~~~-------~~~l~rd~~~~~~~f-----~r~y~~~~d~~s~~~  187 (191)
T d1zara2         140 GIWIIDFPQSVEVGEEGW-------REILERDVRNIITYF-----SRTYRTEKDINSAID  187 (191)
T ss_dssp             EEEECCCTTCEETTSTTH-------HHHHHHHHHHHHHHH-----HHHHCCCCCHHHHHH
T ss_pred             CEEEEECCCcccCCCCCc-------HHHHHHHHHHHHHHH-----cCCCCCcccHHHHHH
Confidence            388999999976542211       11221110  11100     356889999999754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.07  E-value=9.9e-06  Score=79.86  Aligned_cols=137  Identities=15%  Similarity=0.128  Sum_probs=87.8

Q ss_pred             EEeeEeecCCceEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCCceEEEEEec
Q psy15481         13 CTTSVLGKGATGAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEGRGKVIVMEL   91 (708)
Q Consensus        13 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~~~~~LVmEy   91 (708)
                      ...+..+.|+.+.||+..  .++..+++|+........ .....+|..+++.+. +--+++++++....  +..|+||++
T Consensus        17 ~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv~~~   91 (263)
T d1j7la_          17 RCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLMSE   91 (263)
T ss_dssp             EEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEEC
T ss_pred             EEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEEEEe
Confidence            444444444557899875  456678888875443222 223457888888773 33366777776554  358999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q psy15481         92 CTGGSLFNILDDPENTYGLQEEEFLLVLEHLTAGMKHLRDN---------------------------------------  132 (708)
Q Consensus        92 ~~ggsL~~~L~~~~~~~~L~e~~v~~il~qIl~aL~yLH~~---------------------------------------  132 (708)
                      ++|.++........     .   ...++.++...+..||+.                                       
T Consensus        92 l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          92 ADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             CSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             cccccccccccccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            99988866543211     1   122344444555555531                                       


Q ss_pred             --------------------CCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481        133 --------------------RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       133 --------------------gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                                          .++|+|+.|.|||+    ++.....|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~----~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV----KDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEE----ETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceee----cCCceEEEeechhccc
Confidence                                15899999999998    5556677999999874

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.42  E-value=0.00027  Score=74.39  Aligned_cols=78  Identities=19%  Similarity=0.155  Sum_probs=49.9

Q ss_pred             eeEeecCCceEEEEEEEcCCCceEEEEEecc------CCCCCchHHHHHHHHHHHhC-CC--CCccceeEEEEecCCceE
Q psy15481         15 TSVLGKGATGAVFQGVNKNNGEPVAVKTFNQ------LSHMRPHDVQMREFEVLKKV-KH--ENIVKLLAIEEEQEGRGK   85 (708)
Q Consensus        15 ~~~LG~G~fG~Vy~a~~~~tg~~VAIK~~~~------~s~~~~~~~~~~Ei~iL~kL-~H--pNIVkl~~v~~~~~~~~~   85 (708)
                      .+.||.|....||+..+..+|+.|++|.-..      .+.....++..+|.+.++.+ .+  ..+++++.+.  ++.  .
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~--~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEM--A  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTT--T
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCC--C
Confidence            4568999999999998888888999997532      11223344556788888877 23  3455565442  222  5


Q ss_pred             EEEEeccCCCC
Q psy15481         86 VIVMELCTGGS   96 (708)
Q Consensus        86 ~LVmEy~~ggs   96 (708)
                      ++|||++.+..
T Consensus       107 ~lvmE~L~~~~  117 (392)
T d2pula1         107 VTVMEDLSHLK  117 (392)
T ss_dssp             EEEECCCTTSE
T ss_pred             EEEEeccCCcc
Confidence            78999997654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.37  E-value=0.00026  Score=68.86  Aligned_cols=74  Identities=18%  Similarity=0.086  Sum_probs=48.9

Q ss_pred             EeecCCc-eEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCC--CCCccceeEEEEecCCceEEEEEeccC
Q psy15481         17 VLGKGAT-GAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK--HENIVKLLAIEEEQEGRGKVIVMELCT   93 (708)
Q Consensus        17 ~LG~G~f-G~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~--HpNIVkl~~v~~~~~~~~~~LVmEy~~   93 (708)
                      .+..|.. +.||+... .+|..+++|......    ......|...++.+.  .-.+++++.+..+.+  ..++||++++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~--~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAG--RDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS--CEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeeccccc--ceEEEEEeee
Confidence            4455554 68898865 457778899865432    223457888887773  233667777765543  5899999998


Q ss_pred             CCCH
Q psy15481         94 GGSL   97 (708)
Q Consensus        94 ggsL   97 (708)
                      |.++
T Consensus        90 G~~~   93 (255)
T d1nd4a_          90 GQDL   93 (255)
T ss_dssp             SEET
T ss_pred             cccc
Confidence            8665

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.13  E-value=0.025  Score=58.60  Aligned_cols=77  Identities=13%  Similarity=0.056  Sum_probs=50.3

Q ss_pred             eEEEeeEeecCCceEEEEEEEcC-------CCceEEEEEeccCCCCCchHHHHHHHHHHHhCC-CCCccceeEEEEecCC
Q psy15481         11 VWCTTSVLGKGATGAVFQGVNKN-------NGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVK-HENIVKLLAIEEEQEG   82 (708)
Q Consensus        11 ~y~i~~~LG~G~fG~Vy~a~~~~-------tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~-HpNIVkl~~v~~~~~~   82 (708)
                      .+.+ +.|+.|-+=.+|++....       .++.|.+++... . .. .....+|..+++.+. +.-.+++++++.  + 
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~--~-  116 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ET-ESHLVAESVIFTLLSERHLGPKLYGIFS--G-  116 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CC-HHHHHHHHHHHHHHHHTTSSSCEEEEET--T-
T ss_pred             ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC--C-
Confidence            3444 578888999999987653       345687877652 1 22 233458999999884 433457777653  2 


Q ss_pred             ceEEEEEeccCCCCH
Q psy15481         83 RGKVIVMELCTGGSL   97 (708)
Q Consensus        83 ~~~~LVmEy~~ggsL   97 (708)
                         .+||+|++|..|
T Consensus       117 ---g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ---GRLEEYIPSRPL  128 (395)
T ss_dssp             ---EEEECCCCEEEC
T ss_pred             ---ceEEEEeccccC
Confidence               578999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.06  E-value=0.049  Score=54.76  Aligned_cols=67  Identities=13%  Similarity=0.143  Sum_probs=40.6

Q ss_pred             eEEEEEEEcCCCceEEEEEeccCCCCCchHHHHHHHHHHHhCCCCCc--cceeE-----EEEecCCceEEEEEeccCCC
Q psy15481         24 GAVFQGVNKNNGEPVAVKTFNQLSHMRPHDVQMREFEVLKKVKHENI--VKLLA-----IEEEQEGRGKVIVMELCTGG   95 (708)
Q Consensus        24 G~Vy~a~~~~tg~~VAIK~~~~~s~~~~~~~~~~Ei~iL~kL~HpNI--Vkl~~-----v~~~~~~~~~~LVmEy~~gg   95 (708)
                      -.||++.. .+|..|++|+.+...  ...+....|...+..|...+|  +..+.     .+.  .....+.++++++|.
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~--~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN--HQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE--ETTEEEEEEECCCCE
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeee--eeeEEEEEEeecCCc
Confidence            47999865 578899999986432  234445578888877732222  11111     111  123578899998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=91.73  E-value=0.2  Score=49.42  Aligned_cols=30  Identities=30%  Similarity=0.362  Sum_probs=26.3

Q ss_pred             CCcccCCCCCcEEEEEecCCCceEEEeccCcccc
Q psy15481        133 RLVHRDLKPGNIMKFICDDGSTIYKLTDFGAARE  166 (708)
Q Consensus       133 gIVHrDIKP~NILl~~~~d~~~~vKL~DFGlA~~  166 (708)
                      |+||+|+.|+||++    ++..+.-++||+.|..
T Consensus       184 giIHgDl~~dNvl~----~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFF----LGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEE----ETTEEEEECCCTTCEE
T ss_pred             ccccCCcchhhhhc----ccccceeEeccccccc
Confidence            79999999999997    6666778999999863